Citrus Sinensis ID: 004402
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 755 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LW83 | 850 | G-type lectin S-receptor- | yes | no | 0.398 | 0.354 | 0.575 | 1e-101 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.525 | 0.467 | 0.484 | 1e-100 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.441 | 0.395 | 0.519 | 5e-99 | |
| O64793 | 818 | G-type lectin S-receptor- | no | no | 0.4 | 0.369 | 0.570 | 3e-98 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.429 | 0.384 | 0.536 | 2e-96 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.535 | 0.476 | 0.456 | 1e-95 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.531 | 0.474 | 0.438 | 5e-95 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.520 | 0.462 | 0.441 | 1e-94 | |
| Q9LDQ3 | 669 | Putative cysteine-rich re | no | no | 0.447 | 0.505 | 0.489 | 1e-94 | |
| Q8L7G3 | 659 | Cysteine-rich receptor-li | no | no | 0.474 | 0.543 | 0.464 | 2e-94 |
| >sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 368 bits (945), Expect = e-101, Method: Compositional matrix adjust.
Identities = 176/306 (57%), Positives = 235/306 (76%), Gaps = 5/306 (1%)
Query: 422 LQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNE 481
LQ+FSF + AT+ FS ANKLGEGGFGPVYKG L G+E A+KRLS S QGL EFKNE
Sbjct: 512 LQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFKNE 571
Query: 482 VSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
L A+LQH NL+++LG C E+DE MLIYEY+PNKSLD +LFDP+R+ VLDW+ R I+E
Sbjct: 572 AMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRIME 631
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
G+ QGLLYL +YS +VIHRD+KA NILLD ++NPKISDFGMA++F +ANT R+ G
Sbjct: 632 GIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRVAG 691
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN-LNFLEYAFEQWKD 660
T+GY+ PEY ++G++S K DV+SFGVL+L+II ++N ++ SE LN + + + +K+
Sbjct: 692 TFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHVWNLFKE 751
Query: 661 SKGKEFIDPSLDDSS--SPCKLLNCMQVALLCVQENPEDRPSMLEVSSML-KDDSMAIAA 717
++ +E IDPSL DS+ +P ++L C+QVALLCVQ+N +DRPSML+V SM+ D + A++
Sbjct: 752 NRVREVIDPSLGDSAVENP-QVLRCVQVALLCVQQNADDRPSMLDVVSMIYGDGNNALSL 810
Query: 718 PKRPAF 723
PK PAF
Sbjct: 811 PKEPAF 816
|
Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 367 bits (941), Expect = e-100, Method: Compositional matrix adjust.
Identities = 201/415 (48%), Positives = 264/415 (63%), Gaps = 18/415 (4%)
Query: 359 KQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMII--------LGRRNLRTPGTSTP 410
+ R +I IG+ ++L+ S I +F + + ++I L R+L
Sbjct: 436 RNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVIS 495
Query: 411 AAEYF----DSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKR 466
+ + ++D L + F ++ ATNNFS+ANKLG+GGFG VYKG L GQE AVKR
Sbjct: 496 SRRHISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKR 555
Query: 467 LSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI 526
LS TS QG +EFKNEV L ARLQH+NL+R+L C + E MLIYEYL N SLD +LFD
Sbjct: 556 LSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKS 615
Query: 527 RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586
R L+WQ R +II G+ +GLLYL + S FR+IHRDLKASNILLD + PKISDFGMA++
Sbjct: 616 RNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARI 675
Query: 587 FRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
F +D EANT ++VGTYGY+ PEY GI+SMK DV+SFGVLLL+IISSKRN +Y +
Sbjct: 676 FGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDR 735
Query: 647 NLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCK---LLNCMQVALLCVQENPEDRPSMLE 703
+LN L + WK+ KG E IDP + DSSS + +L C+Q+ LLCVQE EDRP+M
Sbjct: 736 DLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSL 795
Query: 704 VSSMLKDDSMAIAAPKRPAFSAKGDENAETSSTSRQ---EIYSFNDPELSQLEPR 755
V ML +S I PK P + + SS+S+Q E ++ N +S L+ R
Sbjct: 796 VILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 362 bits (930), Expect = 5e-99, Method: Compositional matrix adjust.
Identities = 174/335 (51%), Positives = 235/335 (70%), Gaps = 2/335 (0%)
Query: 422 LQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNE 481
L +F F + +T++FS NKLG+GGFGPVYKG LP GQE AVKRLS S QGLEE NE
Sbjct: 509 LPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQGLEELMNE 568
Query: 482 VSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
V + ++LQH NL+++LG C E +E ML+YEY+P KSLD YLFDP+++ +LDW+ R NI+E
Sbjct: 569 VVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDWKTRFNIME 628
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
G+ +GLLYL S ++IHRDLKASNILLD LNPKISDFG+A++FR + DEANT R+VG
Sbjct: 629 GICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDEANTRRVVG 688
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDS 661
TYGY+ PEY +G +S K DV+S GV+ L+IIS +RN+ + NLN L YA++ W D
Sbjct: 689 TYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEENNLNLLAYAWKLWNDG 748
Query: 662 KGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAPKRP 721
+ DP++ D ++ C+ + LLCVQE DRP++ V ML ++M++A PK+P
Sbjct: 749 EAASLADPAVFDKCFEKEIEKCVHIGLLCVQEVANDRPNVSNVIWMLTTENMSLADPKQP 808
Query: 722 AFSA-KGDENAETSSTSRQEIYSFNDPELSQLEPR 755
AF +G AE+S S Q++ S ND L+ + R
Sbjct: 809 AFIVRRGASEAESSDQSSQKV-SINDVSLTAVTGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 360 bits (923), Expect = 3e-98, Method: Compositional matrix adjust.
Identities = 174/305 (57%), Positives = 231/305 (75%), Gaps = 3/305 (0%)
Query: 422 LQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNE 481
LQ+FSF + +AT++FS NKLGEGGFGPVYKG L G+E A+KRLS S QGL EFKNE
Sbjct: 481 LQIFSFESVVSATDDFSDENKLGEGGFGPVYKGKLLNGEEVAIKRLSLASGQGLVEFKNE 540
Query: 482 VSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
L A+LQH NL++VLG C E+DE MLIYEY+ NKSLD +LFDP+R+ VLDW R I+E
Sbjct: 541 AILIAKLQHTNLVQVLGCCIEKDEKMLIYEYMQNKSLDYFLFDPLRKNVLDWTLRFRIME 600
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
G+ QGLLYL +YS +VIHRD+KASNILLD ++NPKISDFG+A++F + ANT R+ G
Sbjct: 601 GIIQGLLYLHKYSRLKVIHRDIKASNILLDEDMNPKISDFGLARIFGAEETRANTKRVAG 660
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN-LNFLEYAFEQWKD 660
T+GY+ PEY ++G++S K DV+SFGVL+L+II ++N ++ E LN + + + +K+
Sbjct: 661 TFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDLEGPLNLIVHVWNLFKE 720
Query: 661 SKGKEFIDPSLDDSSSPC-KLLNCMQVALLCVQENPEDRPSMLEVSSML-KDDSMAIAAP 718
+K +E ID SL DS+ ++L C+QVALLCVQEN EDRPSML+V SM+ + + A++ P
Sbjct: 721 NKIREVIDLSLRDSALDYPQVLRCVQVALLCVQENAEDRPSMLDVVSMIYGEGNNALSLP 780
Query: 719 KRPAF 723
K PAF
Sbjct: 781 KEPAF 785
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 353 bits (907), Expect = 2e-96, Method: Compositional matrix adjust.
Identities = 177/330 (53%), Positives = 225/330 (68%), Gaps = 6/330 (1%)
Query: 432 AATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHV 491
ATNNFS+ NKLG+GGFG VYKG L G+E AVKRLS S+QG +EF NEV L A+LQH+
Sbjct: 514 TATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHI 573
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
NL+R+LG C ++ E MLIYEYL N SLD +LFD R L+WQKR +II G+ +GLLYL
Sbjct: 574 NLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLH 633
Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV 611
+ S R+IHRDLKASN+LLD + PKISDFGMA++F ++ EANT R+VGTYGY+ PEY
Sbjct: 634 QDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYA 693
Query: 612 KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP-- 669
GI+SMK DV+SFGVLLL+IIS KRN +Y ++ +LN L + + WK+ E +DP
Sbjct: 694 MDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPIN 753
Query: 670 --SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAPKRPAFSAKG 727
SL ++L C+Q+ LLCVQE EDRP M V ML ++ AI PKRP F
Sbjct: 754 IDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGR 813
Query: 728 D--ENAETSSTSRQEIYSFNDPELSQLEPR 755
E +SST R + + N LS ++ R
Sbjct: 814 SPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 351 bits (901), Expect = 1e-95, Method: Compositional matrix adjust.
Identities = 194/425 (45%), Positives = 268/425 (63%), Gaps = 21/425 (4%)
Query: 348 AAQIEENNDKDKQRLLLLILLPIGLVLILIASLICYF-------RRTAIKSKVMIILGRR 400
A +E+ K K+ +I IG+ ++L+ S I + R I++ ++ ++ +
Sbjct: 427 AGDLEDKRIKSKK----IIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQ 482
Query: 401 ----NLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNL 456
N + + ++ +D L + + + ATNNFS+ NKLG+GGFG VYKG L
Sbjct: 483 DSLMNELVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGML 542
Query: 457 PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK 516
G+E AVKRLS S+QG +EF NEV L A+LQH+NL+R+LG C ++ E MLIYEYL N
Sbjct: 543 LDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENL 602
Query: 517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP 576
SLD +LFD R L+WQKR +II G+ +GLLYL + S R+IHRDLKASN+LLD + P
Sbjct: 603 SLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTP 662
Query: 577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
KISDFGMA++F ++ EANT R+VGTYGY+ PEY GI+SMK DV+SFGVLLL+IIS K
Sbjct: 663 KISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGK 722
Query: 637 RNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP-SLDDSSS---PCKLLNCMQVALLCVQ 692
RN +Y ++ +LN L + + WK+ K E +DP ++D SS ++L C+Q+ LLCVQ
Sbjct: 723 RNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQ 782
Query: 693 ENPEDRPSMLEVSSMLKDDSMAIAAPKRPAFSA--KGDENAETSSTSRQEIYSFNDPELS 750
E EDRP M V ML ++ AI PKRP F E +SST R + + N LS
Sbjct: 783 ERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLS 842
Query: 751 QLEPR 755
++ R
Sbjct: 843 VIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 349 bits (895), Expect = 5e-95, Method: Compositional matrix adjust.
Identities = 188/429 (43%), Positives = 275/429 (64%), Gaps = 28/429 (6%)
Query: 346 SRAAQIEENNDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILGRRNLRTP 405
S A+ N K+RL+L+++ I +V++L+ S CY R+ +++ R + P
Sbjct: 426 SELARWNGNGASGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQ-----SNRLRKAP 480
Query: 406 GTSTPAAEYFD-------------SDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVY 452
+ P++ FD S + L +F S I ATNNF+ NKLG GGFGPVY
Sbjct: 481 SSFAPSS--FDLEDSFILEELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVY 538
Query: 453 KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512
KG L G E AVKRLS +S QG+EEFKNEV L ++LQH NL+R+LG C E +E ML+YEY
Sbjct: 539 KGVLQNGMEIAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEY 598
Query: 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN 572
LPNKSLD ++F +R LDW KR+ II G+ +G+LYL + S R+IHRDLKASN+LLDN
Sbjct: 599 LPNKSLDYFIFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDN 658
Query: 573 ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
E+ PKI+DFG+A++F + E +T R+VGTYGY+ PEY G +S+K DVYSFGVL+L+I
Sbjct: 659 EMIPKIADFGLARIFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEI 718
Query: 633 ISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL-DDSSSPCKLLNCMQVALLCV 691
I+ KRN+ +Y E+LN +++ +++W++ + E ID + +++ +++ C+ + LLCV
Sbjct: 719 ITGKRNSAFY--EESLNLVKHIWDRWENGEAIEIIDKLMGEETYDEGEVMKCLHIGLLCV 776
Query: 692 QENPEDRPSMLEVSSMLKDDSMAIAAPKRPAFSAKGDENAETSSTSR-----QEIYSFND 746
QEN DRP M V ML +++ + +PK PAF+A N +T +S + + ND
Sbjct: 777 QENSSDRPDMSSVVFMLGHNAIDLPSPKHPAFTAGRRRNTKTGGSSDNWPSGETSSTIND 836
Query: 747 PELSQLEPR 755
L+ ++ R
Sbjct: 837 VTLTDVQGR 845
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 348 bits (893), Expect = 1e-94, Method: Compositional matrix adjust.
Identities = 182/412 (44%), Positives = 267/412 (64%), Gaps = 19/412 (4%)
Query: 353 ENNDKDKQRLLLLILLPIGLVLILIASLI------------CYFRRTAIKSKVMIILGRR 400
E + K ++ +++ + +G++LI I +L+ Y + S V+ L +
Sbjct: 430 EVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKS 489
Query: 401 NLRTP---GTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLP 457
T G+ E +T L VFS + I ATN+F N+LG GGFGPVYKG L
Sbjct: 490 KETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLE 549
Query: 458 RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKS 517
G+E AVKRLS S QG++EFKNE+ L A+LQH NL+R+LG C E +E ML+YEY+PNKS
Sbjct: 550 DGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKS 609
Query: 518 LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPK 577
LD +LFD ++ ++DW+ R +IIEG+ +GLLYL S R+IHRDLK SN+LLD E+NPK
Sbjct: 610 LDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPK 669
Query: 578 ISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
ISDFGMA++F + +EANT R+VGTYGY+ PEY +G++S+K DVYSFGVLLL+I+S KR
Sbjct: 670 ISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKR 729
Query: 638 NARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPED 697
N +SE+ + + YA+ + + +E +DP + + S + L C+ VA+LCVQ++ +
Sbjct: 730 NTSLR-SSEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAE 788
Query: 698 RPSMLEVSSMLKDDSMAIAAPKRPAFSAKGDENAETS---STSRQEIYSFND 746
RP+M V ML+ D+ +AAP++P F++ + + + +S+Q I S N+
Sbjct: 789 RPNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNE 840
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LDQ3|CRK35_ARATH Putative cysteine-rich receptor-like protein kinase 35 OS=Arabidopsis thaliana GN=CRK35 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 347 bits (891), Expect = 1e-94, Method: Compositional matrix adjust.
Identities = 169/345 (48%), Positives = 233/345 (67%), Gaps = 7/345 (2%)
Query: 417 SDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLE 476
+ T +LQ FSF I+AAT+ FS +N +G GGFG VY+G L G E AVKRLS TS QG E
Sbjct: 326 TTTHSLQ-FSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKTSGQGAE 384
Query: 477 EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKR 536
EFKNE L ++LQH NL+R+LG+C E +E +L+YE++PNKSLD +LFDP ++ LDW +R
Sbjct: 385 EFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGELDWTRR 444
Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
NII G+ +G+LYL + S +IHRDLKASNILLD ++NPKI+DFGMA++F D +ANT
Sbjct: 445 YNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQANT 504
Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN-LNFLEYAF 655
RI GT+GY+ PEY +G +SMK DVYSFGVL+L+IIS K+N+ +Y ++ N + +A+
Sbjct: 505 RRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDDSGSNLVTHAW 564
Query: 656 EQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAI 715
W++ E +DP++ +S + C+ +ALLCVQE+P DRP + + ML + +
Sbjct: 565 RLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCVQEDPADRPLLPAIIMMLTSSTTTL 624
Query: 716 AAPKRPAFSAKG-----DENAETSSTSRQEIYSFNDPELSQLEPR 755
P+ P F G D T STSR S ND +++ PR
Sbjct: 625 HVPRAPGFCLSGRDLEQDGVEYTESTSRSIPGSINDASITEFYPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8L7G3|CRK7_ARATH Cysteine-rich receptor-like protein kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 347 bits (889), Expect = 2e-94, Method: Compositional matrix adjust.
Identities = 169/364 (46%), Positives = 241/364 (66%), Gaps = 6/364 (1%)
Query: 397 LGRRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNL 456
+R +T GT TPA + D T + I+AATN+FS NK+G GGFG VYKG
Sbjct: 297 FAKRAKKTYGT-TPALDEDDKTTIESLQLDYRAIQAATNDFSENNKIGRGGFGDVYKGTF 355
Query: 457 PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK 516
G E AVKRLS TS QG EFKNEV + A L+H NL+R+LG+ ER+E +L+YEY+ NK
Sbjct: 356 SNGTEVAVKRLSKTSEQGDTEFKNEVVVVANLRHKNLVRILGFSIEREERILVYEYVENK 415
Query: 517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP 576
SLD +LFDP ++ L W +R +II G+ +G+LYL + S +IHRDLKASNILLD ++NP
Sbjct: 416 SLDNFLFDPAKKGQLYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNP 475
Query: 577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
KI+DFGMA++F D + NT RIVGTYGY+ PEY +G +SMK DVYSFGVL+L+IIS +
Sbjct: 476 KIADFGMARIFGMDQTQQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGR 535
Query: 637 RNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPE 696
+N + T + + + +A+ W++ + +DP + DS +++ C + LLCVQE+P
Sbjct: 536 KNNSFIETDDAQDLVTHAWRLWRNGTALDLVDPFIADSCRKSEVVRCTHIGLLCVQEDPV 595
Query: 697 DRPSMLEVSSMLKDDSMAIAAPKRPAFSAKGDE-----NAETSSTSRQEIYSFNDPELSQ 751
RP+M +S ML ++MA+ AP++P F + +++ S+T++ S +D +S
Sbjct: 596 KRPAMSTISVMLTSNTMALPAPQQPGFFVRSRPGTNRLDSDQSTTNKSVTVSIDDKSMSD 655
Query: 752 LEPR 755
L+PR
Sbjct: 656 LDPR 659
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 755 | ||||||
| 359484771 | 781 | PREDICTED: G-type lectin S-receptor-like | 0.964 | 0.932 | 0.602 | 0.0 | |
| 359497026 | 738 | PREDICTED: G-type lectin S-receptor-like | 0.927 | 0.948 | 0.592 | 0.0 | |
| 296088199 | 1130 | unnamed protein product [Vitis vinifera] | 0.947 | 0.632 | 0.561 | 0.0 | |
| 356558668 | 909 | PREDICTED: uncharacterized protein LOC10 | 0.952 | 0.790 | 0.545 | 0.0 | |
| 224142425 | 763 | predicted protein [Populus trichocarpa] | 0.968 | 0.958 | 0.535 | 0.0 | |
| 255565055 | 721 | conserved hypothetical protein [Ricinus | 0.913 | 0.957 | 0.515 | 0.0 | |
| 147787796 | 658 | hypothetical protein VITISV_036051 [Viti | 0.851 | 0.977 | 0.512 | 0.0 | |
| 296084604 | 580 | unnamed protein product [Vitis vinifera] | 0.737 | 0.960 | 0.614 | 0.0 | |
| 5814093 | 739 | receptor-like kinase CHRK1 [Nicotiana ta | 0.916 | 0.936 | 0.496 | 0.0 | |
| 224082290 | 335 | predicted protein [Populus trichocarpa] | 0.442 | 0.997 | 0.776 | 1e-153 |
| >gi|359484771|ref|XP_003633158.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RKS1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 931 bits (2407), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/770 (60%), Positives = 588/770 (76%), Gaps = 42/770 (5%)
Query: 21 FSDAQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFA 80
+S +TWIKAGYW AG E P+ DI S LFTHL+CAFA+++ +TYQLSISS+ + YFS F
Sbjct: 19 YSHGETWIKAGYWYAGSESPIPDIKSGLFTHLLCAFADINPTTYQLSISSSEEHYFSTFT 78
Query: 81 NSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTAR 140
+ V+R+NPS+ TLLSIW GQ T SILG + +N S++S MV S+RKSFIES+++TAR
Sbjct: 79 DIVKRRNPSVVTLLSIWGGQGPTGLSILGER-VNSSMVSLMVRQPSYRKSFIESAMKTAR 137
Query: 141 LYGFQGIDLFWLWPNS-TDLNSLGILLDEWKASA------SDQPELTLSMAVRYSPTHET 193
LYGF G+DLFWLWPN+ +D+ ++G LLDE +A+ S + L L+MAV Y PT +
Sbjct: 138 LYGFHGLDLFWLWPNTESDMKNMGALLDELRAAVKLESRNSGKAPLILTMAVHYVPTLYS 197
Query: 194 VSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPA 253
VSY I+++++NL+WAH+ AYDY++PS+ N T HAALY+P SN+STDFGIREW+ +GFPA
Sbjct: 198 VSYHIEAIQRNLDWAHIPAYDYYLPSRVNFTHAHAALYDPLSNVSTDFGIREWISKGFPA 257
Query: 254 NKLVLG-------------------ARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYN 294
+KLVLG A SG +T DGSM YK+I+ F+++YG A +YN
Sbjct: 258 SKLVLGLPYHGYAWTLVNPNHNGIGAPTSGIAMTADGSMSYKYIKWFLRSYG--ATSMYN 315
Query: 295 ASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAAQIEEN 354
A+YVVN T G TWI FD V+ I+AKISYAKEK LLGY FQ+SNDDNWALS+AAQ ++
Sbjct: 316 ATYVVNYVTIGTTWIGFDDVQAIRAKISYAKEKKLLGYNVFQVSNDDNWALSQAAQDDDK 375
Query: 355 NDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILGRRNL-----RTPGTST 409
KQ LL+ IL+PI +++++ S++C + R S+V+ +G RNL G+ +
Sbjct: 376 VHHKKQELLIKILVPIAVLILVAGSIMCCYSR----SRVLKAIGTRNLGKISLHEVGSKS 431
Query: 410 PAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSA 469
E F+S+ PNL+VFSF++IK ATNNFS NKLGEGGFGPVYKG +G+E AVKRLS
Sbjct: 432 SGVENFNSNAPNLRVFSFAEIKEATNNFSFENKLGEGGFGPVYKGKSQKGEEMAVKRLSK 491
Query: 470 TSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRY 529
TS QG EEFKNEV+LTA+LQHVNL+R+ G+CTE +E MLIYEY+PNKSLD YLFDP RRY
Sbjct: 492 TSNQGAEEFKNEVTLTAKLQHVNLVRLQGFCTEGEEKMLIYEYMPNKSLDFYLFDPTRRY 551
Query: 530 VLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589
LDW KR+ IIEG+TQGLLYLQEYSNF +IHRDLKASNILLD+E+ PKISDFG+A+ F+K
Sbjct: 552 FLDWTKRIAIIEGITQGLLYLQEYSNFTIIHRDLKASNILLDSEMKPKISDFGIARAFQK 611
Query: 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLN 649
D EA+TGRIVGTYGYVPPEYV++GIYSMKYDVYSFGVLLLQIISS+RN+ YG S+NLN
Sbjct: 612 DEHEASTGRIVGTYGYVPPEYVRRGIYSMKYDVYSFGVLLLQIISSRRNSCTYGLSQNLN 671
Query: 650 FLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709
LEYA+E WK+ +G F+DPSLDDSSS CKL+ CMQVALLC+QENP+ RP+MLEVSSMLK
Sbjct: 672 LLEYAYELWKEGEGMRFMDPSLDDSSSSCKLMACMQVALLCIQENPDHRPTMLEVSSMLK 731
Query: 710 DDSMAIAAPKRPAFSAKGDENA----ETSSTSRQEIYSFNDPELSQLEPR 755
++ A+ AP RPAFS K +E+ + +++S+Q I S ND +S L PR
Sbjct: 732 SETAAMPAPLRPAFSIKSNEDKLSVNDATTSSQQNILSVNDATISDLVPR 781
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359497026|ref|XP_003635401.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 880 bits (2275), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 448/756 (59%), Positives = 569/756 (75%), Gaps = 56/756 (7%)
Query: 1 MAIKSIRVLFFIFLSSFQLEFSDAQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVD 60
MA K+I +L FI +F S++QTW+KAGYW +G E P+ DINSALFTHL+CAFA +D
Sbjct: 1 MASKNIALLLFI---AFHFRLSNSQTWVKAGYWYSGNESPVPDINSALFTHLLCAFAWLD 57
Query: 61 SSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSS 120
S YQ+ IS +++QYF+ F N V+++NPSI TLLSIW G+N + + SS
Sbjct: 58 PSAYQIYISPSDEQYFATFTNIVKKRNPSIITLLSIWAGKNDSTK------------FSS 105
Query: 121 MVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-TDLNSLGILLDEWKASASD---- 175
M+ S+RKSFIESSI+TARLYGFQG+DL WP + ++ ++GIL DEW+A+ +
Sbjct: 106 MISQPSYRKSFIESSIKTARLYGFQGLDLSGYWPRTVSNTINMGILFDEWRAAVNSESRD 165
Query: 176 --QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNP 233
Q L L++ V Y PT +VSY +DS+++N++W H+ AYDY++PS N T HAALY+P
Sbjct: 166 PSQSPLILTLEVHYLPTLGSVSYEVDSIRRNMDWVHVAAYDYYLPSSVNFTHAHAALYDP 225
Query: 234 SSNISTDFGIREWLRRGFPANKLVLG-------------------ARASGPGITIDGSMG 274
S ++TDFGI EW+ RG PA KLVLG A ASG +T DGS+
Sbjct: 226 VSRVNTDFGIGEWIGRGLPAGKLVLGLAYHGYAWTLLNPKENGIGAPASGLAMTPDGSVS 285
Query: 275 YKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKA 334
YK+I+ FI++Y A VYNA+YVVN + GATWI +D VE I+ K+SYAKEK LLGY
Sbjct: 286 YKYIKWFIRSYE--CASVYNATYVVNYCSFGATWIGYDDVEAIRTKVSYAKEKGLLGYNV 343
Query: 335 FQLSNDDNWALSRAAQIEENNDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVM 394
+++S+D+NW LS AAQ E+ ++ +KQRLL++ILLPI +V++L++S I + +T KS +
Sbjct: 344 WEVSHDENWVLSLAAQGEDQDEGNKQRLLVIILLPIAIVVLLVSS-IMFMMQTRPKSLPI 402
Query: 395 IILGRRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG 454
+ G++ +A +SD PNLQVFSFS IK ATNNFSS N+LGEGGFGPVYKG
Sbjct: 403 KL---------GSNISSA---NSDDPNLQVFSFSTIKVATNNFSSENRLGEGGFGPVYKG 450
Query: 455 NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514
LP+GQE AVKRLS TS QGLEEFKNEV+LTA LQHVNL+++LG+CT+R+E MLIYE +P
Sbjct: 451 KLPKGQEIAVKRLSKTSHQGLEEFKNEVTLTATLQHVNLVKLLGFCTQREEKMLIYECMP 510
Query: 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL 574
NKSLD YLFDP RRY LDW KR+ IIEG+TQGLLYLQEYSNF +IHRDLKASNILLD+E+
Sbjct: 511 NKSLDFYLFDPTRRYFLDWTKRIAIIEGITQGLLYLQEYSNFTIIHRDLKASNILLDSEM 570
Query: 575 NPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
PKISDFG+A+ F+KD EA+TGRIVGTYGYVPPEYV++GIYSMKYDVYSFGVLLLQIIS
Sbjct: 571 KPKISDFGIARAFQKDEHEASTGRIVGTYGYVPPEYVRRGIYSMKYDVYSFGVLLLQIIS 630
Query: 635 SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQEN 694
S+RN+ YG S+NLN LEYA+E WK+ +G F+DPSLDDSSS CKL+ CMQVALLC+QEN
Sbjct: 631 SRRNSCTYGLSQNLNLLEYAYELWKEGEGMRFMDPSLDDSSSSCKLMACMQVALLCIQEN 690
Query: 695 PEDRPSMLEVSSMLKDDSMAIAAPKRPAFSAKGDEN 730
P+ RP+MLEVSSMLK ++ A+ AP RPAFS K +E+
Sbjct: 691 PDHRPTMLEVSSMLKSETAAMPAPLRPAFSIKSNED 726
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296088199|emb|CBI35714.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 855 bits (2210), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/775 (56%), Positives = 565/775 (72%), Gaps = 60/775 (7%)
Query: 1 MAIKSIRVLFFIFLSSFQLEFSDAQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVD 60
MA K+I +L FI +F S++QTW+KAGYW +G E P+ DINSALFTHL+CAFA +D
Sbjct: 396 MASKNIALLLFI---AFHFRLSNSQTWVKAGYWYSGNESPVPDINSALFTHLLCAFAWLD 452
Query: 61 SSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSS 120
S YQ+ IS +++QYF+ F N V+++NPSI TLLSIW G+N + + SS
Sbjct: 453 PSAYQIYISPSDEQYFATFTNIVKKRNPSIITLLSIWAGKNDSTK------------FSS 500
Query: 121 MVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-TDLNSLGILLDEWKASASD---- 175
M+ S+RKSFIESSI+TARLYGFQG+DL WP + ++ ++GIL DEW+A+ +
Sbjct: 501 MISQPSYRKSFIESSIKTARLYGFQGLDLSGYWPRTVSNTINMGILFDEWRAAVNSESRD 560
Query: 176 --QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSK----ENVTGI--H 227
Q L L++ V Y PT +VSY +DS+++N++W H+ AYDY++PS+ + V G+ H
Sbjct: 561 PSQSPLILTLEVHYLPTLGSVSYEVDSIRRNMDWVHVAAYDYYLPSRLPAGKLVLGLAYH 620
Query: 228 A---ALYNPSSNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQN 284
L NP N GI GA ASG +T DGS+ YK+I+ FI++
Sbjct: 621 GYAWTLLNPKEN-----GI---------------GAPASGLAMTPDGSVSYKYIKWFIRS 660
Query: 285 YGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWA 344
Y A VYNA+YVVN + GATWI +D VE I+ K+SYAKEK LLGY +++S+D+NW
Sbjct: 661 YE--CASVYNATYVVNYCSFGATWIGYDDVEAIRTKVSYAKEKGLLGYNVWEVSHDENWV 718
Query: 345 LSRAAQIEENNDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILGRRNLRT 404
LS AAQ E+ ++ +KQRLL++ILLPI +V++L++S++C+ + + + +++ R
Sbjct: 719 LSLAAQGEDQDEGNKQRLLVIILLPIAIVVLLVSSIMCHRWKGRLIFNIKVMMQTRPKSL 778
Query: 405 P---GTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQE 461
P G++ +A +SD PNLQVFSFS IK ATNNFSS N+LGEGGFGPVYKG LP+GQE
Sbjct: 779 PIKLGSNISSA---NSDDPNLQVFSFSTIKVATNNFSSENRLGEGGFGPVYKGKLPKGQE 835
Query: 462 FAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLY 521
AVKRLS TS QGLEEFKNEV+LTA LQHVNL+++LG+CT+R+E MLIYE +PNKSLD Y
Sbjct: 836 IAVKRLSKTSHQGLEEFKNEVTLTATLQHVNLVKLLGFCTQREEKMLIYECMPNKSLDFY 895
Query: 522 LFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDF 581
LFDP + +LDW KR++IIEG+TQGLLYLQEYS R+IHRDLKASNILLD E+ PKI+DF
Sbjct: 896 LFDPEGQVLLDWGKRIHIIEGITQGLLYLQEYSRLRIIHRDLKASNILLDGEMKPKIADF 955
Query: 582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY 641
G+A++F+KD +EANTGRIVGTYGYV PEYV+KG YS+K DVYSFGVLLLQIIS K+N +
Sbjct: 956 GIARIFQKDENEANTGRIVGTYGYVSPEYVQKGTYSVKSDVYSFGVLLLQIISGKKNTCF 1015
Query: 642 YGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSM 701
YG +NL+ LEYA+E WKD K EF+DPSLDD+ S CKL CMQVALLCVQENP DRPS+
Sbjct: 1016 YGLDQNLHLLEYAYELWKDGKSMEFMDPSLDDACSSCKLTRCMQVALLCVQENPADRPSV 1075
Query: 702 LEVSSMLKDDSMAIAAPKRPAFSAKGDE-NAETSSTSRQEIYSFNDPELSQLEPR 755
LEV SM+K+++ AIA P+RPAF+AK DE A+ S S EI S N +SQ+ PR
Sbjct: 1076 LEVDSMIKNETAAIATPRRPAFAAKRDEVEADGKSASGHEIGSVNVTTISQVLPR 1130
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558668|ref|XP_003547625.1| PREDICTED: uncharacterized protein LOC100787480 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 835 bits (2156), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/777 (54%), Positives = 540/777 (69%), Gaps = 58/777 (7%)
Query: 5 SIRVLFFIFLSSFQLEFSDAQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTY 64
+I ++ F FL + E AQTW++AGYW +G FP+SDINSAL+THLICAFAE++SSTY
Sbjct: 6 TIALVLFEFLLCQEFEPLKAQTWLQAGYWYSGSGFPVSDINSALYTHLICAFAELNSSTY 65
Query: 65 QLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGD 124
+L +S ++Q FS F +V++KNPSI TLLSI G N N +VLS MV
Sbjct: 66 ELYVSPEDEQSFSSFTTTVKQKNPSITTLLSIAGG------------NGNDTVLSLMVSK 113
Query: 125 SSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPE------ 178
S RK FI+SSIR ARLYGFQG+DL W+ +D+N++G L +EW+A+A +
Sbjct: 114 DSSRKYFIQSSIRIARLYGFQGLDLSWVPETISDMNNMGRLFEEWRAAAKSEAANDSTQV 173
Query: 179 LTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNIS 238
L L+ AV + P ++ SYP++S++ NLNW H++ YDYHMP N T HAALY+PSS+++
Sbjct: 174 LILTAAVHFRPGLDSASYPVESIQNNLNWVHILTYDYHMPQLANFTAAHAALYDPSSSVN 233
Query: 239 TDFGIREWLRRGFPANKLVLG-------------------ARASGPGITIDGSMGYKFIR 279
TD GI+EW+ G A+KLVLG A A+GP I G+M YK I+
Sbjct: 234 TDNGIKEWIGSGVTASKLVLGLPFYGYAWNLRNPEDNAIGASATGPAIGKSGAMNYKDIK 293
Query: 280 AFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSN 339
A+IQ YG YNA+YVVN F++G+TWI +D VE +K K+SYA+E LLGY +Q+
Sbjct: 294 AYIQRYG--GHVKYNATYVVNYFSNGSTWIGYDDVEVVKMKVSYARENKLLGYAVWQVPY 351
Query: 340 DDNWALSRAA-QIEENNDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILG 398
DDNW LS AA + + N ++ RLL++IL+ + +IL+ LI Y RR
Sbjct: 352 DDNWVLSSAAAEHVDQNGRNSWRLLVIILIITAMSVILLGILIYYLRR------------ 399
Query: 399 RRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPR 458
R P ST A+ F S+ P+LQVFSFSDI+ ATN FS NK+G+GG+GPVYKG L
Sbjct: 400 ----RFP-KSTDASRLFHSNAPDLQVFSFSDIEQATNRFSIENKVGQGGYGPVYKGILSN 454
Query: 459 GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL 518
QE AVK+LS STQG EEFKNEV LTARLQHVNL+R+LG+ + ++ ML+YEY+PNKSL
Sbjct: 455 RQEVAVKKLSKASTQGFEEFKNEVMLTARLQHVNLVRLLGFYIDGEQQMLVYEYMPNKSL 514
Query: 519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI 578
D YLFDPIRRY+LDW+KR+ IIEG+TQGLLYLQEYS +IHRD+KASNILLDNE+ PKI
Sbjct: 515 DSYLFDPIRRYLLDWRKRIYIIEGITQGLLYLQEYSRLTIIHRDIKASNILLDNEMKPKI 574
Query: 579 SDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRN 638
SDFGMA++FRKD EANT +IVGTYGYV PEY KG+YS K DVYSFGVLLLQI+S +R
Sbjct: 575 SDFGMARIFRKDELEANTSKIVGTYGYVSPEYAMKGLYSTKSDVYSFGVLLLQIVSGRRT 634
Query: 639 ARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDR 698
A +YG ENLN +EYA+E WK+ KG EF DPSLDDS S CKLL CMQ+ALLCVQE+ DR
Sbjct: 635 ACFYGEHENLNLMEYAYELWKEGKGMEFADPSLDDSHSTCKLLRCMQIALLCVQEDANDR 694
Query: 699 PSMLEVSSMLKDDSMAIAAPKRPAFSAKGDENAETSSTSRQEIYSFNDPELSQLEPR 755
P++ E+SSMLK D++ I P++PAFS DE +E S ND +SQ+ R
Sbjct: 695 PTVKEISSMLKSDTILI-IPQKPAFSINRDEKKPNKFIMHEEKCSINDATISQVVAR 750
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224142425|ref|XP_002324558.1| predicted protein [Populus trichocarpa] gi|222865992|gb|EEF03123.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 825 bits (2131), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/778 (53%), Positives = 551/778 (70%), Gaps = 47/778 (6%)
Query: 5 SIRVLFFIFLSSFQLEFSDAQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTY 64
+I +LF +FLS +L + AQ WIKAGYW +G + P+SDINS L+THLICAFA ++SS+Y
Sbjct: 6 TIIILFHVFLS-LKLHTAKAQAWIKAGYWFSGSDLPISDINSTLYTHLICAFAGLNSSSY 64
Query: 65 QLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGD 124
LSISS++ Q+FS F N+V++KNPSI TLLSI G + N S LS+MVG+
Sbjct: 65 HLSISSSDDQFFSAFTNTVKQKNPSITTLLSI------------GGGSANYSTLSAMVGN 112
Query: 125 SSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTD-LNSLGILLDEWKAS------ASDQP 177
S++RKSFI+ SI+ AR YGFQG+D W+ N++D ++S+G L +EW+A+ S
Sbjct: 113 STYRKSFIDDSIKIARHYGFQGLDFSWVSANTSDNMDSMGTLFEEWRAAIALERRKSSLS 172
Query: 178 ELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNI 237
EL L+ AV+YSP ++ S+PIDS++KNLNW H++A+DY+MP+ T AALY+P S++
Sbjct: 173 ELILTAAVQYSPRLDSGSFPIDSIRKNLNWTHVLAFDYYMPTWAKFTAAFAALYDPDSDV 232
Query: 238 STDFGIREWLRRGFPANKLVLG-------------------ARASGPGITIDGSMGYKFI 278
+TDFGI W+ G PA+KLVLG A A+GP +T DG + YK I
Sbjct: 233 NTDFGIAAWINGGLPASKLVLGLPFYGYAWKLANLNESAIGAPATGPAVTEDGDLSYKDI 292
Query: 279 RAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLS 338
+ + G P+YN++YVVN G WI+FDGV+ ++ K+SYAKEK LLGY +++S
Sbjct: 293 NNYFKTNGR-VNPIYNSTYVVNYGIVGPAWISFDGVDVVRTKVSYAKEKALLGYVVWEVS 351
Query: 339 NDDNWALSRAAQIEENNDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILG 398
DDNW LS+A ++ + K R+L++IL V+IL+ + R +KSK
Sbjct: 352 YDDNWVLSQAGVDLKHEGRPKSRILIIILTTTAAVIILLGLAFYFIRNRILKSK------ 405
Query: 399 RRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPR 458
+ + + AA FDS+ P+L V+S +DI+ AT+ F+ NKLGEGGFGPVYKG LP
Sbjct: 406 SKETKLKVNNAAAAGDFDSNNPDLIVYSLADIEKATDQFAFENKLGEGGFGPVYKGVLPG 465
Query: 459 GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL 518
GQE AVK+LS +STQG +EFKNEV LTA+LQHVNL++VLG+C ER+E +LIYEY+P KSL
Sbjct: 466 GQEIAVKKLSKSSTQGFDEFKNEVMLTAKLQHVNLVKVLGFCVEREEKVLIYEYMPKKSL 525
Query: 519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI 578
D YLFDPIRRY+LDW++R IIEG+TQGLLYLQEYS +IHRDLKASNILLD ++ PKI
Sbjct: 526 DSYLFDPIRRYLLDWKRREEIIEGITQGLLYLQEYSRLTIIHRDLKASNILLDGDMKPKI 585
Query: 579 SDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRN 638
SDFGMA++F KD EANT R+VGTYGYVPPEYV+ G+YS+K DVYSFG++LL IIS K+N
Sbjct: 586 SDFGMARIFTKDEQEANTSRLVGTYGYVPPEYVRNGVYSIKSDVYSFGIVLLHIISGKKN 645
Query: 639 ARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDR 698
YG+ E L+ LEYA+E WKD KG E +DPSLDD+ S CKL+ C+Q+ALLCVQENP DR
Sbjct: 646 GSLYGSDETLSLLEYAYELWKDGKGMEIMDPSLDDTLSSCKLIKCLQIALLCVQENPIDR 705
Query: 699 PSMLEVSSMLKDDSMAIAAPKRPAFSAKGDENAETSSTSRQ-EIYSFNDPELSQLEPR 755
PSMLEVSSMLK+++ + PKRPAFS K DE+ + +I S +D +SQ+ R
Sbjct: 706 PSMLEVSSMLKNETAIVTIPKRPAFSVKTDEDDKNRPDQLHIKICSVDDATISQVVGR 763
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255565055|ref|XP_002523520.1| conserved hypothetical protein [Ricinus communis] gi|223537227|gb|EEF38859.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 754 bits (1948), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/762 (51%), Positives = 513/762 (67%), Gaps = 72/762 (9%)
Query: 24 AQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSV 83
A+ WIKA Y+ + P S +NSALFTH+ FA +D+STYQLS +N+Q S F ++
Sbjct: 2 AKPWIKAAYYDSSGNLPASSVNSALFTHIYYGFAGIDNSTYQLSYPFSNEQDVSTFTATL 61
Query: 84 RRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG 143
+RKNPSI TLLSI G N S S+MV S+RK+FI SSI+ AR YG
Sbjct: 62 KRKNPSIITLLSI------------GLAYRNYSTFSTMVSQPSYRKAFIRSSIKIARRYG 109
Query: 144 FQGIDLFWLWPNST-DLNSLGILLDEWKASA------SDQPELTLSMAVRYSPTHETVSY 196
F G+DL WLWPN++ D+ ++G+LL+EW+A+ S +P++ L+M P +++
Sbjct: 110 FHGLDLAWLWPNTSFDMKNVGVLLEEWRAAVNSESRNSSEPQIILTMMTYRLPVIGNLTF 169
Query: 197 PIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKL 256
P++S+++NLNW +++ +DYH+P KE TG HAALY+PS +++TDF +R WL RG P +KL
Sbjct: 170 PVESIERNLNWVNILTFDYHLPLKERATGNHAALYDPSGHVNTDFCVRAWLERGLPPSKL 229
Query: 257 VLG-------------------ARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASY 297
VLG A +SGP +T+DGS+GYK I++ I YGYG A YNA+Y
Sbjct: 230 VLGLPYHGYAWTLVNPNDNSVGAPSSGPDLTMDGSIGYKMIQSVISGYGYGVASTYNATY 289
Query: 298 VVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAAQIEENNDK 357
VN FT TWINFD VE I+ KISYA K LLGY FQL+NDD+W LSRAA N++K
Sbjct: 290 AVNYFTIRTTWINFDDVEAIRTKISYAVTKGLLGYFVFQLANDDDWKLSRAAYGVGNDEK 349
Query: 358 DKQ-RLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILGRRNLRTPGTS-TPAAEYF 415
K+ +++++++ + ++L+L A Y R +KS+ G G T EY
Sbjct: 350 KKKSQIIIVLVPIVVVILLLFAPASYYIRCRTLKSRGNTEFGEVPSFELGQPITVVNEYP 409
Query: 416 DSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGL 475
D + PNLQ G LPRGQE AVKRLS TS QGL
Sbjct: 410 DQNAPNLQ------------------------------GKLPRGQEIAVKRLSKTSNQGL 439
Query: 476 EEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQK 535
+EFKNE+ LTA+LQHVNL+R+LGYCTER E MLIYEY+PNKSLD YLFD RR L+W+K
Sbjct: 440 KEFKNELKLTAKLQHVNLVRLLGYCTERKEKMLIYEYMPNKSLDFYLFDQKRRLELNWEK 499
Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
RV+IIEG+ QGLLYLQEYSN +IH+D+K+SNILLD+ + PKISDFGMA++F+K+ EAN
Sbjct: 500 RVHIIEGIAQGLLYLQEYSNLTIIHKDIKSSNILLDSNMKPKISDFGMARIFQKENHEAN 559
Query: 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAF 655
T +IVGTYGYVPPEYVK+G+YS KYDVYSFGVLLLQIIS K+N YYG+ NLN LEYA+
Sbjct: 560 TCQIVGTYGYVPPEYVKRGVYSTKYDVYSFGVLLLQIISGKKNTCYYGSHVNLNLLEYAY 619
Query: 656 EQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAI 715
E W+ GKEF+DP LDDS S CKLL C+QV LLCVQE+P DRPS+L++ SMLK+++ I
Sbjct: 620 EFWETGNGKEFLDPVLDDSHSTCKLLRCLQVGLLCVQESPIDRPSILQICSMLKNENDII 679
Query: 716 AAPKRPAFSAKGDENAE--TSSTSRQEIYSFNDPELSQLEPR 755
+PKRPAFS ++ E S ++ Q++ S N LS+L PR
Sbjct: 680 VSPKRPAFSVTSNDEIEKNVSKSTSQDVGSVNSASLSELLPR 721
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147787796|emb|CAN60684.1| hypothetical protein VITISV_036051 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 743 bits (1918), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/770 (51%), Positives = 505/770 (65%), Gaps = 127/770 (16%)
Query: 1 MAIKSIRVLFFIFLSSFQLEFSDAQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVD 60
MA K+I +L FI +F S++QTW+KAGYW +G E P+ DINSALFTHL+CAFA +D
Sbjct: 1 MASKNIALLLFI---AFHFRLSNSQTWVKAGYWYSGNESPVPDINSALFTHLLCAFAWLD 57
Query: 61 SSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSS 120
SSTYQ+ IS +++QYF+ F N V+++NPSI TLLSIW G+N + + SS
Sbjct: 58 SSTYQIYISPSDEQYFATFTNIVKKRNPSITTLLSIWAGKNDS------------TNFSS 105
Query: 121 MVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-TDLNSLGILLDEWKASASD---- 175
M+ SHRKSFIESSI+TARLYGFQG+DL WP + ++ ++GIL DEW+A+ +
Sbjct: 106 MISQPSHRKSFIESSIKTARLYGFQGLDLSGYWPRTVSNTINMGILFDEWRAAVNSESRD 165
Query: 176 --QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNP 233
Q L L++ V PT E+VSY +DS+++NL+W H+ AYDY++PS N T HAALY+P
Sbjct: 166 PSQSPLILTLKVHCLPTLESVSYEVDSIRRNLDWVHVAAYDYYLPSSVNFTHAHAALYDP 225
Query: 234 SSNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVY 293
R +G + +G+G V
Sbjct: 226 ---------------------------RVTG----------------WEAGFGFGVPWVC 242
Query: 294 NAS-------YVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALS 346
+ Y + GATWI +D VE I+ K+SYAKEK LLGY +++S+D+NW LS
Sbjct: 243 MDTLEPQGKWYWSTCISFGATWIGYDDVEAIRTKVSYAKEKGLLGYFVWEVSHDENWVLS 302
Query: 347 RAAQIEENNDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILGRRNLRTPG 406
AAQ E+ ++ +KQRLL +ILLPI +V++L T +KS + + G
Sbjct: 303 LAAQDEDQDEGNKQRLLAIILLPIAIVVLL----------TTLKSLPIKL---------G 343
Query: 407 TSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKR 466
++ +A +SD PNLQVFSF+ IK ATNNFSS NKLGEGGFGPVYKG LP+GQE AVKR
Sbjct: 344 SNISSA---NSDDPNLQVFSFTTIKVATNNFSSENKLGEGGFGPVYKGKLPKGQEIAVKR 400
Query: 467 LSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI 526
LS TS QGLEEFKNEV+LTA LQHVNL+++LG+CT+R+E MLIYE +P SLD YLFDP
Sbjct: 401 LSKTSHQGLEEFKNEVTLTATLQHVNLVKLLGFCTQREEKMLIYECMPXXSLDFYLFDPE 460
Query: 527 RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586
+ +LDW KR++IIEG+TQGLLYLQEYS R+IHRDLKASNILLD E+ PKI+DFG+A++
Sbjct: 461 GQVLLDWGKRIHIIEGITQGLLYLQEYSRLRIIHRDLKASNILLDGEMKPKIADFGIARI 520
Query: 587 FRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
F+KD +EANTGRIVGTYGYV PEYV+KG YS+K D
Sbjct: 521 FQKDENEANTGRIVGTYGYVSPEYVQKGTYSVKSD------------------------- 555
Query: 647 NLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706
A+E WKD K EF+DPSLDD+ S CKL CMQVALLCVQENP DRPSMLEV S
Sbjct: 556 -------AYELWKDGKSMEFMDPSLDDACSSCKLTRCMQVALLCVQENPADRPSMLEVDS 608
Query: 707 MLKDDSMAIAAPKRPAFSAKGDE-NAETSSTSRQEIYSFNDPELSQLEPR 755
M+K+++ AIA P+RPAF+ K DE A+ S S EI S N +SQ+ PR
Sbjct: 609 MIKNETAAIAIPRRPAFAXKRDEVEADGKSASGHEIGSVNVTTISQVLPR 658
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296084604|emb|CBI25625.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 730 bits (1884), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/596 (61%), Positives = 458/596 (76%), Gaps = 39/596 (6%)
Query: 183 MAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFG 242
MAV Y PT +VSY I+++++NL+WAH+ AYDY++PS+ N T HAALY+P SN+STDFG
Sbjct: 1 MAVHYVPTLYSVSYHIEAIQRNLDWAHIPAYDYYLPSRVNFTHAHAALYDPLSNVSTDFG 60
Query: 243 IREWLRRGFPANKLVLG-------------------ARASGPGITIDGSMGYKFIRAFIQ 283
IREW+ +GFPA+KLVLG A SG +T DGSM YK+I+ F++
Sbjct: 61 IREWISKGFPASKLVLGLPYHGYAWTLVNPNHNGIGAPTSGIAMTADGSMSYKYIKWFLR 120
Query: 284 NYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNW 343
+YG A +YNA+YVVN T G TWI FD V+ I+AKISYAKEK LLGY FQ+SNDDNW
Sbjct: 121 SYG--ATSMYNATYVVNYVTIGTTWIGFDDVQAIRAKISYAKEKKLLGYNVFQVSNDDNW 178
Query: 344 ALSRAAQIEENNDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILGRRNLR 403
ALS+AAQ ++ KQ LL+ IL+PI +++++ S++C + R S+V+ +G ++
Sbjct: 179 ALSQAAQDDDKVHHKKQELLIKILVPIAVLILVAGSIMCCYSR----SRVLKAIGNFSV- 233
Query: 404 TPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFA 463
E F+S+ PNL+VFSF++IK ATNNFS NKLGEGGFGPVYKG +G+E A
Sbjct: 234 ---------ENFNSNAPNLRVFSFAEIKEATNNFSFENKLGEGGFGPVYKGKSQKGEEMA 284
Query: 464 VKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF 523
VKRLS TS QG EEFKNEV+LTA+LQHVNL+R+ G+CTE +E MLIYEY+PNKSLD YLF
Sbjct: 285 VKRLSKTSNQGAEEFKNEVTLTAKLQHVNLVRLQGFCTEGEEKMLIYEYMPNKSLDFYLF 344
Query: 524 DPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM 583
DP RRY LDW KR+ IIEG+TQGLLYLQEYSNF +IHRDLKASNILLD+E+ PKISDFG+
Sbjct: 345 DPTRRYFLDWTKRIAIIEGITQGLLYLQEYSNFTIIHRDLKASNILLDSEMKPKISDFGI 404
Query: 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG 643
A+ F+KD EA+TGRIVGTYGYVPPEYV++GIYSMKYDVYSFGVLLLQIISS+RN+ YG
Sbjct: 405 ARAFQKDEHEASTGRIVGTYGYVPPEYVRRGIYSMKYDVYSFGVLLLQIISSRRNSCTYG 464
Query: 644 TSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLE 703
S+NLN LEYA+E WK+ +G F+DPSLDDSSS CKL+ CMQVALLC+QENP+ RP+MLE
Sbjct: 465 LSQNLNLLEYAYELWKEGEGMRFMDPSLDDSSSSCKLMACMQVALLCIQENPDHRPTMLE 524
Query: 704 VSSMLKDDSMAIAAPKRPAFSAKGDENA----ETSSTSRQEIYSFNDPELSQLEPR 755
VSSMLK ++ A+ AP RPAFS K +E+ + +++S+Q I S ND +S L PR
Sbjct: 525 VSSMLKSETAAMPAPLRPAFSIKSNEDKLSVNDATTSSQQNILSVNDATISDLVPR 580
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|5814093|gb|AAD52097.1|AF088885_1 receptor-like kinase CHRK1 [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 714 bits (1844), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/761 (49%), Positives = 505/761 (66%), Gaps = 69/761 (9%)
Query: 22 SDAQTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFAN 81
SDA WIK+G+W AG EFP+ +I S +FTH+ AFA +++S+++L +S +++ Y S F+N
Sbjct: 21 SDATAWIKSGFWYAGSEFPVPEIPSTMFTHIHFAFAYINASSFELYVSHSDEPYISTFSN 80
Query: 82 SVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARL 141
+V++KNPS+ TLLSIW G++ + P+ + M S RKSFI +SI+TAR
Sbjct: 81 TVKQKNPSVITLLSIWGGRDES-----------PNFFA-MTSQFSRRKSFITTSIKTARQ 128
Query: 142 YGFQGIDLFWLWPNS-TDLNSLGILLDEWKASASDQPE------LTLSMAVRYSPTHETV 194
YGFQG+DL + PN+ ++ ++ ++EW+ + + + + L L+M YSP +++
Sbjct: 129 YGFQGLDLIGVNPNTDANMTNMRSFIEEWRTAINSESKSSGTRTLILTMGAYYSPMLDSM 188
Query: 195 SYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPAN 254
SYPID++ +N +W HL AY AALY+P+S ++TD+GI+EW++RG PAN
Sbjct: 189 SYPIDTIIRNFDWVHLKAY--------------AALYDPTSKLNTDYGIKEWIKRGLPAN 234
Query: 255 KLVLG-------------------ARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNA 295
K+VLG A G IT DGS+ Y++I+ ++++YG PVYN+
Sbjct: 235 KIVLGLAYHGYAWTLVNPKHNTVRTPARGLAITQDGSISYRYIKQYMKSYG--VTPVYNS 292
Query: 296 SYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD-NWALSRAAQIEEN 354
++VVN T G+ WI +D VE I+ K+SYAK+K LLG+ AFQ+ +DD NW LS+ AQ EE
Sbjct: 293 TFVVNYVTIGSFWIGYDDVEAIRTKVSYAKDKGLLGFAAFQIPSDDVNWELSKTAQDEEE 352
Query: 355 NDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILGRRNLRTPGTSTPAAEY 414
D+ LL +L L L ++ F IL ++ LR+ G
Sbjct: 353 EDQSGSNRRLLAILLPTLTLTILLLSTIVF-----------ILKKKTLRSEGIRELNERA 401
Query: 415 FDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQG 474
NL+VF F IKAAT+NFS NKLGEGGFGPVYKG L GQE A+KRLSA S QG
Sbjct: 402 IGH---NLKVFKFDKIKAATDNFSIKNKLGEGGFGPVYKGRLSDGQEIAIKRLSAYSKQG 458
Query: 475 LEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQ 534
+EEF+NEV+L ++LQHVN+L++ G CTER+E +LIYEY+PNKSLD YL+DP++ LDW+
Sbjct: 459 VEEFQNEVTLASKLQHVNVLQLQGCCTEREEKILIYEYMPNKSLDFYLYDPVQSLQLDWE 518
Query: 535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594
RV IIEGVTQGLLYLQEYS F VIHRDLKASNILLD+E+ PKISDFG+AKLF+KD EA
Sbjct: 519 TRVRIIEGVTQGLLYLQEYSAFTVIHRDLKASNILLDDEMKPKISDFGIAKLFQKDEKEA 578
Query: 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYA 654
NTGRIVGTYG VPPEYVK+G+YS KYDVYSFGVLLLQI+ K+N+ YG +LN LEYA
Sbjct: 579 NTGRIVGTYGCVPPEYVKRGLYSRKYDVYSFGVLLLQILGEKKNSSEYGIKNDLNLLEYA 638
Query: 655 FEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMA 714
+E W+ G +F+D SL D S K L MQ ALLCVQE EDRPSMLEV SMLK+++
Sbjct: 639 YELWEKGNGVDFLDLSLQDDSRIGKQLRYMQAALLCVQEKWEDRPSMLEVYSMLKNETEV 698
Query: 715 IAAPKRPAFSAKGDENAETSSTSRQEIYSFNDPELSQLEPR 755
+ PK PAFS D + + + + S N +SQL R
Sbjct: 699 LPNPKVPAFSKNKDNDTQETLVTPDLTCSDNSLTISQLIAR 739
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224082290|ref|XP_002335492.1| predicted protein [Populus trichocarpa] gi|222834258|gb|EEE72735.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 548 bits (1411), Expect = e-153, Method: Compositional matrix adjust.
Identities = 260/335 (77%), Positives = 294/335 (87%), Gaps = 1/335 (0%)
Query: 422 LQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNE 481
LQVFSF IKAATNNFS N+LGEGGFGPVYKG LPRG E AVKRLSA+STQGLEEFKNE
Sbjct: 1 LQVFSFESIKAATNNFSRENQLGEGGFGPVYKGKLPRGLEIAVKRLSASSTQGLEEFKNE 60
Query: 482 VSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
VSLTARLQHVNL+R+LG+C+ER E MLIYEY+PNKSLDLYLFDPIRRY LDW KRV IIE
Sbjct: 61 VSLTARLQHVNLVRLLGFCSERGEKMLIYEYMPNKSLDLYLFDPIRRYSLDWSKRVRIIE 120
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
GVTQGLLYLQEYSNF +IHRDLK+SNILLD+E+NPKISDFGMAKLFRKDV EANT RIVG
Sbjct: 121 GVTQGLLYLQEYSNFTIIHRDLKSSNILLDDEMNPKISDFGMAKLFRKDVYEANTSRIVG 180
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDS 661
TYGY+PPEY +KGIYS+KYDVYSFGV+LLQ+IS K N R+Y +E+LN LEYA++ WK+
Sbjct: 181 TYGYIPPEYARKGIYSIKYDVYSFGVVLLQMISGKTNTRFYSENEDLNLLEYAYDLWKNG 240
Query: 662 KGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK-DDSMAIAAPKR 720
+G EFIDP LDDSSSPCKLL CMQVALLCVQENP+ RP+MLE SMLK DDS+AIA P+R
Sbjct: 241 RGMEFIDPFLDDSSSPCKLLTCMQVALLCVQENPDARPTMLEAFSMLKNDDSLAIATPER 300
Query: 721 PAFSAKGDENAETSSTSRQEIYSFNDPELSQLEPR 755
P FS K + ET+S+S+Q + SFND ++SQLEPR
Sbjct: 301 PGFSEKKKGDMETASSSQQVMCSFNDSQVSQLEPR 335
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 755 | ||||||
| TAIR|locus:2093397 | 850 | CES101 "CALLUS EXPRESSION OF R | 0.398 | 0.354 | 0.575 | 3.8e-95 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.447 | 0.399 | 0.528 | 8.9e-95 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.450 | 0.4 | 0.546 | 2.1e-93 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.434 | 0.389 | 0.501 | 5.4e-93 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.449 | 0.402 | 0.524 | 7e-92 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.450 | 0.400 | 0.505 | 2.1e-91 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.434 | 0.386 | 0.506 | 1.5e-89 | |
| TAIR|locus:2197714 | 792 | AT1G61440 [Arabidopsis thalian | 0.410 | 0.391 | 0.523 | 2e-89 | |
| TAIR|locus:2121636 | 659 | CRK7 "cysteine-rich RLK (RECEP | 0.470 | 0.538 | 0.476 | 3e-89 | |
| TAIR|locus:2137010 | 849 | AT4G11900 [Arabidopsis thalian | 0.441 | 0.392 | 0.501 | 3e-89 |
| TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 927 (331.4 bits), Expect = 3.8e-95, Sum P(2) = 3.8e-95
Identities = 176/306 (57%), Positives = 235/306 (76%)
Query: 422 LQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNE 481
LQ+FSF + AT+ FS ANKLGEGGFGPVYKG L G+E A+KRLS S QGL EFKNE
Sbjct: 512 LQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFKNE 571
Query: 482 VSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
L A+LQH NL+++LG C E+DE MLIYEY+PNKSLD +LFDP+R+ VLDW+ R I+E
Sbjct: 572 AMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRIME 631
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
G+ QGLLYL +YS +VIHRD+KA NILLD ++NPKISDFGMA++F +ANT R+ G
Sbjct: 632 GIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRVAG 691
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN-LNFLEYAFEQWKD 660
T+GY+ PEY ++G++S K DV+SFGVL+L+II ++N ++ SE LN + + + +K+
Sbjct: 692 TFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHVWNLFKE 751
Query: 661 SKGKEFIDPSLDDSS--SPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD-SMAIAA 717
++ +E IDPSL DS+ +P ++L C+QVALLCVQ+N +DRPSML+V SM+ D + A++
Sbjct: 752 NRVREVIDPSLGDSAVENP-QVLRCVQVALLCVQQNADDRPSMLDVVSMIYGDGNNALSL 810
Query: 718 PKRPAF 723
PK PAF
Sbjct: 811 PKEPAF 816
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 894 (319.8 bits), Expect = 8.9e-95, Sum P(3) = 8.9e-95
Identities = 183/346 (52%), Positives = 238/346 (68%)
Query: 417 SDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLE 476
+D L + + + ATNNFS+ NKLG+GGFG VYKG L G+E AVKRLS S+QG +
Sbjct: 503 TDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTD 562
Query: 477 EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKR 536
EF NEV L A+LQH+NL+R+LG C ++ E MLIYEYL N SLD +LFD R L+WQKR
Sbjct: 563 EFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKR 622
Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
+II G+ +GLLYL + S R+IHRDLKASN+LLD + PKISDFGMA++F ++ EANT
Sbjct: 623 FDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANT 682
Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFE 656
R+VGTYGY+ PEY GI+SMK DV+SFGVLLL+IIS KRN +Y ++ +LN L + +
Sbjct: 683 RRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWR 742
Query: 657 QWKDSKGKEFIDP-SLDDSSS--PC-KLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712
WK+ K E +DP ++D SS P ++L C+Q+ LLCVQE EDRP M V ML ++
Sbjct: 743 HWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSET 802
Query: 713 MAIAAPKRPAFSAKGDENAE---TSSTSRQEIYSFNDPELSQLEPR 755
AI PKRP F G + E +SST R + + N LS ++ R
Sbjct: 803 TAIPQPKRPGFCV-GRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 930 (332.4 bits), Expect = 2.1e-93, P = 2.1e-93
Identities = 189/346 (54%), Positives = 238/346 (68%)
Query: 416 DSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGL 475
++D L + F ++ ATNNFS+ANKLG+GGFG VYKG L GQE AVKRLS TS QG
Sbjct: 505 NTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGT 564
Query: 476 EEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQK 535
+EFKNEV L ARLQH+NL+R+L C + E MLIYEYL N SLD +LFD R L+WQ
Sbjct: 565 DEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQM 624
Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
R +II G+ +GLLYL + S FR+IHRDLKASNILLD + PKISDFGMA++F +D EAN
Sbjct: 625 RFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEAN 684
Query: 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAF 655
T ++VGTYGY+ PEY GI+SMK DV+SFGVLLL+IISSKRN +Y + +LN L +
Sbjct: 685 TRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVW 744
Query: 656 EQWKDSKGKEFIDPSLDDSSSPCK---LLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712
WK+ KG E IDP + DSSS + +L C+Q+ LLCVQE EDRP+M V ML +S
Sbjct: 745 RNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSES 804
Query: 713 MAIAAPKRPAFSAKGDENAETSSTSRQ---EIYSFNDPELSQLEPR 755
I PK P + + SS+S+Q E ++ N +S L+ R
Sbjct: 805 TTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 867 (310.3 bits), Expect = 5.4e-93, Sum P(3) = 5.4e-93
Identities = 165/329 (50%), Positives = 224/329 (68%)
Query: 418 DTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEE 477
DTP+L +FSF + +AT +F+ NKLG+GGFG VYKGN G+E AVKRLS S QGLEE
Sbjct: 506 DTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEE 565
Query: 478 FKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV 537
FKNE+ L A+LQH NL+R+LG C E +E ML+YEY+PNKSLD +LFD ++ LDW+KR
Sbjct: 566 FKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRW 625
Query: 538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
+I G+ +GLLYL S ++IHRDLKASNILLD E+NPKISDFGMA++F D ANT
Sbjct: 626 EVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTI 685
Query: 598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQ 657
R+VGTYGY+ PEY +GI+S K DVYSFGVL+L+I+S ++N + GT + + YA+
Sbjct: 686 RVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHG-SLIGYAWHL 744
Query: 658 WKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAA 717
W K KE IDP + D+ + + C+ V +LC Q++ RP+M V ML+ + +
Sbjct: 745 WSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPP 804
Query: 718 PKRPAFSAKGDENAETSSTSRQEIYSFND 746
P++P F + + + ++ S ND
Sbjct: 805 PRQPTFHSFLNSGDIELNFDGHDVASVND 833
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 890 (318.4 bits), Expect = 7.0e-92, Sum P(2) = 7.0e-92
Identities = 181/345 (52%), Positives = 236/345 (68%)
Query: 417 SDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLE 476
S+ L + + ATNNFS+ NKLG+GGFG VYKG L G+E AVKRLS S+QG +
Sbjct: 499 SEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTD 558
Query: 477 EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKR 536
EF NEV L A+LQH+NL+R+LG C ++ E MLIYEYL N SLD +LFD R L+WQKR
Sbjct: 559 EFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKR 618
Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
+II G+ +GLLYL + S R+IHRDLKASN+LLD + PKISDFGMA++F ++ EANT
Sbjct: 619 FDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANT 678
Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFE 656
R+VGTYGY+ PEY GI+SMK DV+SFGVLLL+IIS KRN +Y ++ +LN L + +
Sbjct: 679 RRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWR 738
Query: 657 QWKDSKGKEFIDP-SLDDSSS--PC-KLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712
WK+ E +DP ++D SS P ++L C+Q+ LLCVQE EDRP M V ML ++
Sbjct: 739 HWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSET 798
Query: 713 MAIAAPKRPAFS-AKGDENAETSS-TSRQEIYSFNDPELSQLEPR 755
AI PKRP F + A++SS T R + + N LS ++ R
Sbjct: 799 TAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 911 (325.7 bits), Expect = 2.1e-91, P = 2.1e-91
Identities = 172/340 (50%), Positives = 238/340 (70%)
Query: 416 DSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGL 475
D + L+V+S I+ AT+NFS +NKLGEGGFGPVY G LP G+E AVKRL S QGL
Sbjct: 509 DGKSHELKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGL 568
Query: 476 EEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQK 535
EEFKNEV L A+LQH NL+R+LG C R+E +L+YEY+PNKSLD +LF+P ++ +LDW+K
Sbjct: 569 EEFKNEVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKK 628
Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
R +IIEG+ +GLLYL S RV+HRDLKASNILLD ++ PKISDFGMA++F D ++ N
Sbjct: 629 RFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFN 688
Query: 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAF 655
T R+VGT+GY+ PEY +GI+S+K DVY FGVL+L+II+ KR ++ ++LN YA+
Sbjct: 689 TNRVVGTFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYAW 748
Query: 656 EQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAI 715
QW + E IDP + S S ++L C+ +ALLCVQ++ ++RP + V ML +DS ++
Sbjct: 749 RQWNEDNAAELIDPVIRASCSVRQVLRCIHIALLCVQDHADERPDIPTVILMLSNDSSSL 808
Query: 716 AAPKRPAFSAKGDENAETSSTSRQEIYSFNDPELSQLEPR 755
P+ P +G E + S+ + +S ++QL R
Sbjct: 809 PNPRPPTLMLRGREIESSKSSEKDRSHSIGTVTMTQLHGR 848
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 868 (310.6 bits), Expect = 1.5e-89, Sum P(2) = 1.5e-89
Identities = 168/332 (50%), Positives = 237/332 (71%)
Query: 418 DTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEE 477
+T L VFS + I ATN+F N+LG GGFGPVYKG L G+E AVKRLS S QG++E
Sbjct: 510 NTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDE 569
Query: 478 FKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV 537
FKNE+ L A+LQH NL+R+LG C E +E ML+YEY+PNKSLD +LFD ++ ++DW+ R
Sbjct: 570 FKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRF 629
Query: 538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
+IIEG+ +GLLYL S R+IHRDLK SN+LLD E+NPKISDFGMA++F + +EANT
Sbjct: 630 SIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTV 689
Query: 598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQ 657
R+VGTYGY+ PEY +G++S+K DVYSFGVLLL+I+S KRN +SE+ + + YA+
Sbjct: 690 RVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLR-SSEHGSLIGYAWYL 748
Query: 658 WKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAA 717
+ + +E +DP + + S + L C+ VA+LCVQ++ +RP+M V ML+ D+ +AA
Sbjct: 749 YTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAA 808
Query: 718 PKRPAFSAKGDENAETS---STSRQEIYSFND 746
P++P F++ + + + +S+Q I S N+
Sbjct: 809 PRQPTFTSTRRNSIDVNFALDSSQQYIVSSNE 840
|
|
| TAIR|locus:2197714 AT1G61440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 835 (299.0 bits), Expect = 2.0e-89, Sum P(3) = 2.0e-89
Identities = 165/315 (52%), Positives = 220/315 (69%)
Query: 418 DTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEE 477
D P L+ F + I+ AT+NFS +NKLG GGFG VYKG L G+E AVKRLS++S QG +E
Sbjct: 459 DVPGLEFFEMNTIQTATSNFSLSNKLGHGGFGSVYKGKLQDGREIAVKRLSSSSEQGKQE 518
Query: 478 FKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV 537
F NE+ L ++LQH NL+RVLG C E E +LIYE++ NKSLD ++F +R LDW KR
Sbjct: 519 FMNEIVLISKLQHRNLVRVLGCCVEGKEKLLIYEFMKNKSLDTFVFGSRKRLELDWPKRF 578
Query: 538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
+II+G+ +GLLYL S RVIHRDLK SNILLD ++NPKISDFG+A+LF+ + T
Sbjct: 579 DIIQGIVRGLLYLHRDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARLFQGSQYQDKTR 638
Query: 598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY-YGTSENLNFLEYAFE 656
R+VGT GY+ PEY G++S K D+YSFGVLLL+IIS ++ +R+ YG E L Y +E
Sbjct: 639 RVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIISGEKISRFSYG-EEGKALLAYVWE 697
Query: 657 QWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIA 716
W +++G +D +LDDSS P ++ C+Q+ LLCVQ P DRP+ LE+ SML S +
Sbjct: 698 CWCETRGVNLLDQALDDSSHPAEVGRCVQIGLLCVQHQPADRPNTLELLSMLTTTS-DLP 756
Query: 717 APKRPAFSA--KGDE 729
PK+P F+ + DE
Sbjct: 757 LPKQPTFAVHTRNDE 771
|
|
| TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 867 (310.3 bits), Expect = 3.0e-89, Sum P(2) = 3.0e-89
Identities = 173/363 (47%), Positives = 246/363 (67%)
Query: 399 RRNLRTPGTSTPAAEYFDSDT-PNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLP 457
+R +T GT TPA + D T +LQ+ + I+AATN+FS NK+G GGFG VYKG
Sbjct: 299 KRAKKTYGT-TPALDEDDKTTIESLQL-DYRAIQAATNDFSENNKIGRGGFGDVYKGTFS 356
Query: 458 RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKS 517
G E AVKRLS TS QG EFKNEV + A L+H NL+R+LG+ ER+E +L+YEY+ NKS
Sbjct: 357 NGTEVAVKRLSKTSEQGDTEFKNEVVVVANLRHKNLVRILGFSIEREERILVYEYVENKS 416
Query: 518 LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPK 577
LD +LFDP ++ L W +R +II G+ +G+LYL + S +IHRDLKASNILLD ++NPK
Sbjct: 417 LDNFLFDPAKKGQLYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPK 476
Query: 578 ISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
I+DFGMA++F D + NT RIVGTYGY+ PEY +G +SMK DVYSFGVL+L+IIS ++
Sbjct: 477 IADFGMARIFGMDQTQQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRK 536
Query: 638 NARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPED 697
N + T + + + +A+ W++ + +DP + DS +++ C + LLCVQE+P
Sbjct: 537 NNSFIETDDAQDLVTHAWRLWRNGTALDLVDPFIADSCRKSEVVRCTHIGLLCVQEDPVK 596
Query: 698 RPSMLEVSSMLKDDSMAIAAPKRPAF---SAKGDE--NAETSSTSRQEIYSFNDPELSQL 752
RP+M +S ML ++MA+ AP++P F S G +++ S+T++ S +D +S L
Sbjct: 597 RPAMSTISVMLTSNTMALPAPQQPGFFVRSRPGTNRLDSDQSTTNKSVTVSIDDKSMSDL 656
Query: 753 EPR 755
+PR
Sbjct: 657 DPR 659
|
|
| TAIR|locus:2137010 AT4G11900 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 860 (307.8 bits), Expect = 3.0e-89, Sum P(2) = 3.0e-89
Identities = 171/341 (50%), Positives = 228/341 (66%)
Query: 416 DSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGL 475
D N+ + DI ATN+FS KLGEGGFGPVYKG LP G E A+KRLS S+QGL
Sbjct: 516 DDAGENMCYLNLHDIMVATNSFSRKKKLGEGGFGPVYKGKLPNGMEVAIKRLSKKSSQGL 575
Query: 476 EEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQK 535
EFKNEV L +LQH NL+R+LGYC E DE +LIYEY+ NKSLD LFD ++ LDW+
Sbjct: 576 TEFKNEVVLIIKLQHKNLVRLLGYCVEGDEKLLIYEYMSNKSLDGLLFDSLKSRELDWET 635
Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR-KDVDEA 594
R+ I+ G T+GL YL EYS R+IHRDLKASNILLD+E+NPKISDFG A++F K +D++
Sbjct: 636 RMKIVNGTTRGLQYLHEYSRLRIIHRDLKASNILLDDEMNPKISDFGTARIFGCKQIDDS 695
Query: 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYA 654
T RIVGT+GY+ PEY G+ S K D+YSFGVLLL+IIS K+ R+ + + + Y
Sbjct: 696 -TQRIVGTFGYMSPEYALGGVISEKSDIYSFGVLLLEIISGKKATRFVHNDQKHSLIAYE 754
Query: 655 FEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMA 714
+E W ++KG ID + S S + + C+ +ALLCVQ++P+DRP + ++ ML +D+
Sbjct: 755 WESWCETKGVSIIDEPMCCSYSLEEAMRCIHIALLCVQDHPKDRPMISQIVYMLSNDN-T 813
Query: 715 IAAPKRPAFSAKGDENAETSSTSRQEIYSFNDPELSQLEPR 755
+ PK+P FS N ++S N+ ++LE R
Sbjct: 814 LPIPKQPTFS-----NVLNGDQQLDYVFSINEATQTELEAR 849
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 3.2.1.14 | LOW CONFIDENCE prediction! |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 755 | |||
| cd02879 | 299 | cd02879, GH18_plant_chitinase_class_V, The class V | 1e-115 | |
| smart00636 | 334 | smart00636, Glyco_18, Glyco_18 domain | 3e-57 | |
| pfam00704 | 325 | pfam00704, Glyco_hydro_18, Glycosyl hydrolases fam | 4e-52 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-44 | |
| cd02872 | 362 | cd02872, GH18_chitolectin_chitotriosidase, This co | 6e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-41 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-34 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-32 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-29 | |
| cd06548 | 322 | cd06548, GH18_chitinase, The GH18 (glycosyl hydrol | 7e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-27 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-26 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-24 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-23 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-22 | |
| cd02873 | 413 | cd02873, GH18_IDGF, The IDGF's (imaginal disc grow | 1e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-21 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-21 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-20 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-19 | |
| cd00598 | 210 | cd00598, GH18_chitinase-like, The GH18 (glycosyl h | 5e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-13 | |
| COG3325 | 441 | COG3325, ChiA, Chitinase [Carbohydrate transport a | 2e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-06 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.001 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.003 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.003 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.004 |
| >gnl|CDD|119358 cd02879, GH18_plant_chitinase_class_V, The class V plant chitinases have a glycosyl hydrolase family 18 (GH18) domain, but lack the chitin-binding domain present in other GH18 enzymes | Back alignment and domain information |
|---|
Score = 348 bits (896), Expect = e-115
Identities = 141/334 (42%), Positives = 204/334 (61%), Gaps = 47/334 (14%)
Query: 25 QTWIKAGYWLAG-REFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSV 83
T +K GYW A EFP S+I+S+LFTHL AFA++D STY++ IS +++ FS F +V
Sbjct: 1 STIVKGGYWPAWSEEFPPSNIDSSLFTHLFYAFADLDPSTYEVVISPSDESEFSTFTETV 60
Query: 84 RRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG 143
+RKNPS+KTLLSI G + S ++M D + RK+FI SSI+ AR YG
Sbjct: 61 KRKNPSVKTLLSIGGG------------GSDSSAFAAMASDPTARKAFINSSIKVARKYG 108
Query: 144 FQGIDLFWLWPNS-TDLNSLGILLDEWKASASD------QPELTLSMAVRYSPT----HE 192
F G+DL W +P+S ++ + G LL+EW+A+ D +P L L+ AV +SP +
Sbjct: 109 FDGLDLDWEFPSSQVEMENFGKLLEEWRAAVKDEARSSGRPPLLLTAAVYFSPILFLSDD 168
Query: 193 TVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFP 252
+VSYPI+++ KNL+W +++AYDY+ + N TG AALY+P+SN+STD+GI+ W++ G P
Sbjct: 169 SVSYPIEAINKNLDWVNVMAYDYYGSWESNTTGPAAALYDPNSNVSTDYGIKSWIKAGVP 228
Query: 253 ANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFD 312
A KLVLG + YG A +Y+ + V + +G TWI +D
Sbjct: 229 AKKLVLG----------------------LPLYGR-AWTLYDTTTVSSYVYAGTTWIGYD 265
Query: 313 GVETIKAKISYAKEKNLLGYKAFQLSNDDNWALS 346
V++I K+ YAK+K LLGY A+ + DDN LS
Sbjct: 266 DVQSIAVKVKYAKQKGLLGYFAWAVGYDDNNWLS 299
|
The GH18 domain of the class V chitinases has endochitinase activity in some cases and no catalytic activity in others. Included in this family is a lectin found in black locust (Robinia pseudoacacia) bark, which binds chitin but lacks chitinase activity. Also included is a chitinase-related receptor-like kinase (CHRK1) from tobacco (Nicotiana tabacum), with an N-terminal GH18 domain and a C-terminal kinase domain, which is thought to be part of a plant signaling pathway. The GH18 domain of CHRK1 is expressed extracellularly where it binds chitin but lacks chitinase activity. Length = 299 |
| >gnl|CDD|214753 smart00636, Glyco_18, Glyco_18 domain | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 3e-57
Identities = 100/355 (28%), Positives = 155/355 (43%), Gaps = 65/355 (18%)
Query: 29 KAGYWLA----GREFPLSDINSALFTHLICAFAEVDSS-TYQLSISSANQQYFSIFANSV 83
GY+ GR FP+ DI ++ TH+I AFA +D T + A+ F ++
Sbjct: 2 VVGYFTNWGVYGRNFPVDDIPASKLTHIIYAFANIDPDGTVTIGDEWADIGNFGQL-KAL 60
Query: 84 RRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG 143
++KNP +K LLSI S SSM+ D + RK FI+S + + YG
Sbjct: 61 KKKNPGLKVLLSIGGWTESDN-------------FSSMLSDPASRKKFIDSIVSFLKKYG 107
Query: 144 FQGIDLFWLWPNS--TDLNSLGILLDEWKA----SASDQPELTLSMAVRYSPTHETVSYP 197
F GID+ W +P D + LL E + ++ L++AV P Y
Sbjct: 108 FDGIDIDWEYPGGRGDDRENYTALLKELREALDKEGAEGKGYLLTIAVPAGPDKIDKGYG 167
Query: 198 -IDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN---ISTDFGIREWLRRGFPA 253
+ ++ K L++ +L+ YD+H N TG +A LY + + D+ ++ +L +G P
Sbjct: 168 DLPAIAKYLDFINLMTYDFHGAW-SNPTGHNAPLYAGPGDPEKYNVDYAVKYYLCKGVPP 226
Query: 254 NKLVLG-------------------ARASGPGITI-----DGSMGYKFIRAFIQNYGYGA 289
+KLVLG A +GP G + Y+ I + GA
Sbjct: 227 SKLVLGIPFYGRGWTLVDGSNNGPGAPFTGPATGGPGTWEGGVVDYREICKLL-----GA 281
Query: 290 APVYN----ASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSND 340
VY+ A Y N W+++D +IKAK Y K+K L G ++L D
Sbjct: 282 TVVYDDTAKAPYAYNP--GTGQWVSYDDPRSIKAKADYVKDKGLGGVMIWELDAD 334
|
Length = 334 |
| >gnl|CDD|216071 pfam00704, Glyco_hydro_18, Glycosyl hydrolases family 18 | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 4e-52
Identities = 99/345 (28%), Positives = 150/345 (43%), Gaps = 48/345 (13%)
Query: 24 AQTWIKAGYWLAGRE-FPLSDINSALFTHLICAFAEVDSSTYQLSI----SSANQQYFSI 78
+ W E FPL DI + TH+I AFA +D + + + F
Sbjct: 1 GRIVGYYTQWGNYGEGFPLDDIPTDKLTHIIYAFANIDGNGTFGNNADTEDDGLKGCFEQ 60
Query: 79 FANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRT 138
+ + +NP +K LLSI S S + D + RK+F +S I
Sbjct: 61 LKDLKKCQNPGVKVLLSIGGWTFSGG-------------FSLLASDDAKRKTFADSIIDF 107
Query: 139 ARLYGFQGIDLFWLWPNST--DLNSLGILLDEWKA--SASDQPELTLSMAVRYSPTHETV 194
+ YGF GID+ W +P D ++ LL E +A + LS AV P
Sbjct: 108 LKKYGFDGIDIDWEYPGGKGDDKDNYTALLKELRAALKKEAKAGYLLSAAVPAGPDKIDG 167
Query: 195 SYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPAN 254
I + K L++ +L+ YD+H N+TG +A LY+ S + D+ ++ +L+ G PA+
Sbjct: 168 -SDIAKIGKYLDFINLMTYDFH--GWSNITGPNAPLYDG-SWQNVDYAVQYYLKAGVPAS 223
Query: 255 KLVLG-------------------ARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNA 295
KLVLG A A GPG G + YK I A +++ GA P Y+
Sbjct: 224 KLVLGIPFYGRGWTLVNGSGNGGGAPAPGPGTWEGGILSYKEICALLKS---GAGPGYDD 280
Query: 296 SYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSND 340
+ G ++++D +IKAK Y K+K L G + L D
Sbjct: 281 TAKAPYIYKGKQFVSYDDPRSIKAKAKYVKDKGLGGVMIWSLDQD 325
|
Length = 325 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 1e-47
Identities = 91/274 (33%), Positives = 134/274 (48%), Gaps = 29/274 (10%)
Query: 442 KLGEGGFGPVYKG-----NLPRGQEFAVKRLSA-TSTQGLEEFKNEVSLTARLQHVNLLR 495
KLGEG FG VYKG + E AVK L S Q +EEF E + +L H N+++
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
+LG CTE + ++ EY+ L YL R L ++ + +G+ YL +
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYL---ES 120
Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
IHRDL A N L+ L KISDFG+++ L+ D G++ ++ PE +K+G
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKEG 178
Query: 615 IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS 674
++ K DV+SFGVLL +I + + Y N LEY K +
Sbjct: 179 KFTSKSDVWSFGVLLWEIFT--LGEQPYPGMSNEEVLEYL-------KNGYRLPQP---P 226
Query: 675 SSPCKLLNCMQVALLCVQENPEDRPSMLEVSSML 708
+ P +L + M L C E+PEDRP+ E+ +L
Sbjct: 227 NCPPELYDLM---LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 2e-47
Identities = 94/274 (34%), Positives = 136/274 (49%), Gaps = 28/274 (10%)
Query: 442 KLGEGGFGPVYKGNL-----PRGQEFAVKRLSA-TSTQGLEEFKNEVSLTARLQHVNLLR 495
KLGEG FG VYKG L + E AVK L S Q +EEF E + +L H N+++
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
+LG CTE + M++ EY+P L YL R L ++ + +G+ YL +
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYL---ES 121
Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
IHRDL A N L+ L KISDFG+++ L+ D + G++ ++ PE +K+G
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEG 179
Query: 615 IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS 674
++ K DV+SFGVLL +I + Y N LEY K +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFT--LGEEPYPGMSNAEVLEYL-------KKGYRLPKP---P 227
Query: 675 SSPCKLLNCMQVALLCVQENPEDRPSMLEVSSML 708
+ P +L M L C E+PEDRP+ E+ +L
Sbjct: 228 NCPPELYKLM---LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 1e-45
Identities = 89/286 (31%), Positives = 133/286 (46%), Gaps = 41/286 (14%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLR 495
KLGEG FG VYKG L AVK L S + ++F E + +L H N++R
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYL------FDPIRRYVLDWQKRVNIIEGVTQGLLY 549
+LG CTE + L+ EY+ L YL F + L + ++ + +G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANTGRIVGTYGYVPP 608
L ++ + +HRDL A N L+ +L KISDFG+++ ++ D TG + ++ P
Sbjct: 121 L---ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY-YGTSENLNFLEYAFEQWKDSKGKEFI 667
E +K GI++ K DV+SFGVLL +I + Y N LEY
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT---LGATPYPGLSNEEVLEY-------------- 219
Query: 668 DPSLDDSSSPCKLLNC----MQVALLCVQENPEDRPSMLEVSSMLK 709
L K C ++ L C Q +PEDRP+ E+ L+
Sbjct: 220 ---LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 2e-45
Identities = 69/194 (35%), Positives = 105/194 (54%), Gaps = 11/194 (5%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
LGEGGFG VY + G++ A+K + S+ LEE E+ + +L H N++++ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
+ + L+ EY SL L + + L + + I+ + +GL YL +IH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 561 RDLKASNILLDN-ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK-KGIYSM 618
RDLK NILLD+ K++DFG++KL D T IVGT Y+ PE + KG YS
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 619 KYDVYSFGVLLLQI 632
K D++S GV+L ++
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 4e-44
Identities = 86/269 (31%), Positives = 124/269 (46%), Gaps = 26/269 (9%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLG 498
KLG G FG VYK + G+ AVK L S + + + E+ + RL H N++R++
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRY-VLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
++D L+ EY L FD + R L + I + +GL YL +SN
Sbjct: 66 AFEDKDHLYLVMEYCEGGDL----FDYLSRGGPLSEDEAKKIALQILRGLEYL--HSN-G 118
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI-Y 616
+IHRDLK NILLD KI+DFG+AK K T VGT Y+ PE + G Y
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGY 176
Query: 617 SMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSS 676
K DV+S GV+L ++++ + G EN+ + EF +P S
Sbjct: 177 GPKVDVWSLGVILYELLT--GKPPFSG--ENILDQLQLIRRILGPP-LEFDEPKWSSGSE 231
Query: 677 PCK-LLNCMQVALLCVQENPEDRPSMLEV 704
K L+ L +P RP+ E+
Sbjct: 232 EAKDLIKKC----LNK--DPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|119351 cd02872, GH18_chitolectin_chitotriosidase, This conserved domain family includes a large number of catalytically inactive chitinase-like lectins (chitolectins) including YKL-39, YKL-40 (HCGP39), YM1, oviductin, and AMCase (acidic mammalian chitinase), as well as catalytically active chitotriosidases | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 6e-44
Identities = 101/344 (29%), Positives = 157/344 (45%), Gaps = 60/344 (17%)
Query: 39 FPLSDINSALFTHLICAFAEVDSSTYQLSISSAN---QQYFSIFANSVRRKNPSIKTLLS 95
F +I+ L TH+I AFA ++ + + N + F N+++ KNP++KTLL+
Sbjct: 18 FVPENIDPFLCTHIIYAFAGLNPDGNIIILDEWNDIDLGLYERF-NALKEKNPNLKTLLA 76
Query: 96 I--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLW 153
I WN ++ + S+M +RK+FI+S+I R YGF G+DL W +
Sbjct: 77 IGGWNFGSAKF--------------SAMAASPENRKTFIKSAIAFLRKYGFDGLDLDWEY 122
Query: 154 PNS-----TDLNSLGILLDEWK-ASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNW 207
P D + LL E + A + P L L+ AV +Y I + K L++
Sbjct: 123 PGQRGGPPEDKENFVTLLKELREAFEPEAPRLLLTAAVSAGKETIDAAYDIPEISKYLDF 182
Query: 208 AHLVAYDYHMPSKENVTGIHAALYNPSSNI------STDFGIREWLRRGFPANKLVLG-- 259
+++ YD+H E VTG ++ LY S++ + D+ I+ WL +G P KLVLG
Sbjct: 183 INVMTYDFHGSW-EGVTGHNSPLYAGSADTGDQKYLNVDYAIKYWLSKGAPPEKLVLGIP 241
Query: 260 -----------------ARASGPG----ITI-DGSMGYKFIRAFIQNYGYGAAPVYNASY 297
A ASGPG T G + Y I F+++ G V++
Sbjct: 242 TYGRSFTLASPSNTGVGAPASGPGTAGPYTREAGFLAYYEICEFLKS---GWTVVWDDEQ 298
Query: 298 VVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
V G W+ +D E+I K+ Y K K L G + + DD
Sbjct: 299 KVPYAYKGNQWVGYDDEESIALKVQYLKSKGLGGAMVWSIDLDD 342
|
The conserved domain is an eight-stranded alpha/beta barrel fold belonging to the family 18 glycosyl hydrolases. The fold has a pronounced active-site cleft at the C-terminal end of the beta-barrel. The chitolectins lack a key active site glutamate (the proton donor required for hydrolytic activity) but retain highly conserved residues involved in oligosaccharide binding. Chitotriosidase is a chitinolytic enzyme expressed in maturing macrophages, which suggests that it plays a part in antimicrobial defense. Chitotriosidase hydrolyzes chitotriose, as well as colloidal chitin to yield chitobiose and is therefore considered an exochitinase. Chitotriosidase occurs in two major forms, the large form being converted to the small form by either RNA or post-translational processing. Although the small form, containing the chitinase domain alone, is sufficient for the chitinolytic activity, the additional C-terminal chitin-binding domain of the large form plays a role in processing colloidal chitin. The chitotriosidase gene is nonessential in humans, as about 35% of the population are heterozygous and 6% homozygous for an inactivated form of the gene. HCGP39 is a 39-kDa human cartilage glycoprotein thought to play a role in connective tissue remodeling and defense against pathogens. Length = 362 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 85/282 (30%), Positives = 133/282 (47%), Gaps = 44/282 (15%)
Query: 442 KLGEGGFGPVYKGNL-----PRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLR 495
KLGEG FG VYKG L + AVK L ++ + EEF E S+ +L H N++R
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
+LG CT+ + ++ EY+P L +L L + + + + +G+ YL +
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL---ES 120
Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEY 610
+HRDL A N L+ L KISDFG++ +D+ E + R G +P PE
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLS----RDIYEDDYYR-KRGGGKLPIKWMAPES 175
Query: 611 VKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670
+K G ++ K DV+SFGVLL +I + + + +E ++
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFT------------------LGEQPYPGMSNEEVLE-L 216
Query: 671 LDDSSSPCKLLNC----MQVALLCVQENPEDRPSMLEVSSML 708
L+D + NC ++ L C +PEDRP+ E+ L
Sbjct: 217 LEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 73/274 (26%), Positives = 117/274 (42%), Gaps = 40/274 (14%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARLQHVNLLRVLG 498
KLGEG FG VY + G+ A+K + + E E+ + +L+H N++R+
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 499 YCTERDENMLIYEYLPNKSLDLYL-----FDP--IRRYVLDWQKRVNIIEGVTQGLLYLQ 551
+ D+ L+ EY L L R Y+ + L YL
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQ----------ILSALEYLH 114
Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV 611
++HRDLK NILLD + + K++DFG+A+ ++ T VGT Y+ PE +
Sbjct: 115 SK---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTT--FVGTPEYMAPEVL 168
Query: 612 KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671
Y D++S GV+L ++++ K + G + L F++ K K P
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGK--PPFPGDDQ----LLELFKKIG--KPKPPFPPPE 220
Query: 672 DDSSSPCK-LLNCMQVALLCVQENPEDRPSMLEV 704
D S K L+ + L +PE R + E
Sbjct: 221 WDISPEAKDLIRKL----LVK--DPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 75/272 (27%), Positives = 123/272 (45%), Gaps = 39/272 (14%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHVNLLRVL 497
LG G FG VY + G+ AVK LS S + LE + E+ + + LQH N++R
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 498 GYCTERDENML-IY-EYLPNKSLD--LYLFDP-----IRRYVLDWQKRVNIIEGVTQGLL 548
G + ++N L I+ EY+ SL L F IR+Y + +GL
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ----------ILEGLA 115
Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
YL SN ++HRD+K +NIL+D++ K++DFG AK TG + GT ++ P
Sbjct: 116 YLH--SN-GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668
E ++ Y D++S G ++++ + K + + L +K E
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKPP--WSELGNPMAAL------YKIGSSGE--P 222
Query: 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPS 700
P + + S C++ +P+ RP+
Sbjct: 223 PEIPEHLSE----EAKDFLRKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 65/198 (32%), Positives = 107/198 (54%), Gaps = 6/198 (3%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRV 496
F+ KLG G FG V++G A+K L + ++F+ EV RL+H +L+ +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
C+ + +I E + SL +L P + VL +++ V +G+ YL+E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
IHRDL A NIL+ +L K++DFG+A+L ++DV ++ +I Y + PE G +
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 617 SMKYDVYSFGVLLLQIIS 634
S K DV+SFG+LL ++ +
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 92/289 (31%), Positives = 130/289 (44%), Gaps = 52/289 (17%)
Query: 441 NKLGEGGFGPVYKG--NLPRGQEF--AVKRLSA-TSTQGLEEFKNEVSLTARLQHVNLLR 495
+LG G FG V KG + G+E AVK L G +EF E S+ A+L H ++R
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ---GLLYLQE 552
++G C + ML+ E P L YL RR + ++ E Q G+ YL+
Sbjct: 61 LIGVCKG-EPLMLVMELAPLGPLLKYLKK--RREI----PVSDLKELAHQVAMGMAYLES 113
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGRIVGTYGYVP--- 607
+F +HRDL A N+LL N KISDFGM++ D A T G P
Sbjct: 114 -KHF--VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA------GRWPLKW 164
Query: 608 --PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT---SENLNFLEYAFEQWKDSK 662
PE + G +S K DV+S+GV L + S A+ YG +E + LE
Sbjct: 165 YAPECINYGKFSSKSDVWSYGVTLWEAFS--YGAKPYGEMKGAEVIAMLE---------S 213
Query: 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711
G+ P P ++ + M C + PEDRP+ E+ S + D
Sbjct: 214 GERLPRPEE----CPQEIYSIML---SCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 81/278 (29%), Positives = 127/278 (45%), Gaps = 33/278 (11%)
Query: 441 NKLGEGGFGPVYKGNL--PRGQEF---AVKRLSATS-TQGLEEFKNEVSLTARLQHVNLL 494
+LGEG FG V AVK L+ + Q +F+ E+ + L H N++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 495 RVLGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
+ G C + LI EYLP+ SL YL R ++ ++ + + +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG- 126
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD--EANTGRIVGTYGYVPPEY 610
+ R IHRDL A NIL+++E KISDFG+AK+ +D D + Y PE
Sbjct: 127 --SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA-PEC 183
Query: 611 VKKGIYSMKYDVYSFGVLLLQIISSKRN--------ARYYGTSENLNFLEYAFEQWKDSK 662
++ +S DV+SFGV L ++ + R G ++ + E K+
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE-- 241
Query: 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPS 700
G+ P S P ++ + M+ LC + P+DRPS
Sbjct: 242 GERLPRP----PSCPDEVYDLMK---LCWEAEPQDRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 71/199 (35%), Positives = 111/199 (55%), Gaps = 17/199 (8%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE 502
+G+G FG V G+ RGQ+ AVK L ST + F E S+ L+H NL+++LG +
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 503 RDENMLIYEYLPNKSLDLYLFDPIR---RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
+ ++ EY+ SL YL R R V+ +++ V +G+ YL+E NF +
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL----RSRGRAVITLAQQLGFALDVCEGMEYLEE-KNF--V 124
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
HRDL A N+L+ +L K+SDFG+AK + D +G++ + PE +++ +S K
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---SGKL--PVKWTAPEALREKKFSTK 179
Query: 620 YDVYSFGVLLLQIISSKRN 638
DV+SFG+LL +I S R
Sbjct: 180 SDVWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|119365 cd06548, GH18_chitinase, The GH18 (glycosyl hydrolases, family 18) type II chitinases hydrolyze chitin, an abundant polymer of N-acetylglucosamine and have been identified in bacteria, fungi, insects, plants, viruses, and protozoan parasites | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 7e-29
Identities = 86/332 (25%), Positives = 127/332 (38%), Gaps = 73/332 (21%)
Query: 39 FPLSDINSALFTHLICAFAEVDSST--YQLSISSANQQYFSIFAN--------------- 81
F DI + TH+ AFA++D +A++ S+
Sbjct: 16 FVTDDIPADKLTHINYAFADIDGDGGVVTSDDEAADEAAQSVDGGADTDDQPLKGNFGQL 75
Query: 82 -SVRRKNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRT 138
+++KNP +K LLSI W S S + R F +S++
Sbjct: 76 RKLKQKNPHLKILLSIGGWT--WSGG-------------FSDAAATEASRAKFADSAVDF 120
Query: 139 ARLYGFQGIDLFWLWPNST----------DLNSLGILLDEW-----KASASDQPELTLSM 183
R YGF GID+ W +P S D + +LL E A + L++
Sbjct: 121 IRKYGFDGIDIDWEYPGSGGAPGNVARPEDKENFTLLLKELREALDALGAETGRKYLLTI 180
Query: 184 AVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALY----NPSSNIST 239
A P + + K L++ +L+ YD+H N TG H+ LY +P S
Sbjct: 181 AAPAGPDKLDKLE-VAEIAKYLDFINLMTYDFHGAW-SNTTGHHSNLYASPADPPGGYSV 238
Query: 240 DFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVV 299
D + +L G P KLVLG G R + Y V A Y+
Sbjct: 239 DAAVNYYLSAGVPPEKLVLGVPFYG--------------RGW-TGYTRYWDEVAKAPYLY 283
Query: 300 NLFTSGATWINFDGVETIKAKISYAKEKNLLG 331
N S T+I++D +IKAK Y K+K L G
Sbjct: 284 N--PSTKTFISYDDPRSIKAKADYVKDKGLGG 313
|
The structure of this domain is an eight-stranded alpha/beta barrel with a pronounced active-site cleft at the C-terminal end of the beta-barrel. Length = 322 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 14/199 (7%)
Query: 443 LGEGGFGPVYKG--NLPRGQEF--AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVL 497
+G G FG V +G LP +E A+K L A S+ +F E S+ + H N++R+
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
G T+ M+I EY+ N SLD +L + + V ++ G+ G+ YL S
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYL---SEMN 126
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT--GRIVGTYGYVPPEYVKKGI 615
+HRDL A NIL+++ L K+SDFG+++ T G+I + PE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEAIAYRK 184
Query: 616 YSMKYDVYSFGVLLLQIIS 634
++ DV+SFG+++ +++S
Sbjct: 185 FTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 85/274 (31%), Positives = 131/274 (47%), Gaps = 31/274 (11%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
KLG G FG V+ G + AVK L T E F E + +L+H L+++ C+
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
E + ++ EY+ SL +L + L + V++ + +G+ YL+ IHR
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKK-LRLPQLVDMAAQIAEGMAYLESR---NYIHR 127
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR---IVGTYGYVPPEYVKKGIYSM 618
DL A NIL+ L KI+DFG+A+L D A G I T PE G +++
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANYGRFTI 183
Query: 619 KYDVYSFGVLLLQIISSKRNARYYGTS--ENLNFLEYAFEQWKDSKGKEFIDPSLDDSSS 676
K DV+SFG+LL +I++ R Y G + E L +E +G P +
Sbjct: 184 KSDVWSFGILLTEIVTYGR-VPYPGMTNREVLEQVE---------RGYRMPRP----PNC 229
Query: 677 PCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P +L + M L C ++PE+RP+ + S L+D
Sbjct: 230 PEELYDLM---LQCWDKDPEERPTFEYLQSFLED 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 76/274 (27%), Positives = 124/274 (45%), Gaps = 31/274 (11%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGL-EEFKNEVSLTARLQHVNLLRVLGYC 500
K+G+G FG VYKG L E AVK +T L +F E + + H N+++++G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
++ ++ E +P SL +L R L +K + + G+ YL E N IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYL-ESKN--CIH 116
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKY 620
RDL A N L+ KISDFGM++ + + G + PE + G Y+ +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 621 DVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID-----PSLDDSS 675
DV+S+G+LL + S G + + + + +E I+ P+
Sbjct: 177 DVWSYGILLWETFS-------LGDT--------PYPGMSNQQTRERIESGYRMPAPQ--L 219
Query: 676 SPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709
P ++ M C +PE+RPS E+ + L+
Sbjct: 220 CPEEIYRLML---QCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
F K+G+GGFG VYK + G+E A+K + S + E+ NE+ + + +H N+++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 496 VLGYCTERDENMLIYEYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
G ++DE ++ E+ SL DL L + + + + +GL YL
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLHSN- 117
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
+IHRD+KA+NILL ++ K+ DFG++ D +VGT ++ PE +
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQLS---DTKARNTMVGTPYWMAPEVINGK 172
Query: 615 IYSMKYDVYSFGVLLL 630
Y K D++S G+ +
Sbjct: 173 PYDYKADIWSLGITAI 188
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 86/271 (31%), Positives = 136/271 (50%), Gaps = 26/271 (9%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
KLG G FG V+ G + A+K L + E F E +L +LQH L+R+ T
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
++ +I EY+ N SL +L P L K +++ + +G+ ++ E N+ IHR
Sbjct: 72 -QEPIYIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFI-ERKNY--IHR 126
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
DL+A+NIL+ L KI+DFG+A+L + A G + PE + G +++K D
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSD 185
Query: 622 VYSFGVLLLQIISSKRNARYYGTS--ENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCK 679
V+SFG+LL +I++ R Y G + E + LE + P D + P +
Sbjct: 186 VWSFGILLTEIVTYGR-IPYPGMTNPEVIQNLERGYRM-----------PRPD--NCPEE 231
Query: 680 LLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
L M LC +E PE+RP+ + S+L+D
Sbjct: 232 LYELM---RLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 76/289 (26%), Positives = 135/289 (46%), Gaps = 44/289 (15%)
Query: 443 LGEGGFGPVYKG---NLPRGQEF---AVKRLSATSTQGLEE-FKNEVSLTARLQHVNLLR 495
LGEG FG V+ G +L + AVK L T++ + F+ E L QH N+++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYL--FDPIRRYV---------LDWQKRVNIIEGVT 544
G CTE D ++++EY+ + L+ +L P ++ L + + I +
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT-- 602
G++YL ++ +HRDL N L+ +L KI DFGM+ +DV + R+ G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMS----RDVYTTDYYRVGGHTM 185
Query: 603 --YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKD 660
++PPE + ++ + DV+SFGV+L +I + + +YG S N +E
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP-WYGLS-NEEVIECI------ 237
Query: 661 SKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709
++G+ P S + L C + +P+ R ++ ++ L+
Sbjct: 238 TQGRLLQRPRTCPS-------EVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 73/229 (31%), Positives = 112/229 (48%), Gaps = 32/229 (13%)
Query: 443 LGEGGFGPVYKGNL--PRGQE----FAVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLR 495
LGEG FG VYKG L P + A+K L + +EF+ E L + LQH N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLF-------------DPIRRYVLDWQKRVNIIEG 542
+LG CT+ +++EYL + L +L D + LD ++I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
+ G+ YL S+ +HRDL A N L+ L KISDFG++ +D+ A+ R+
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLS----RDIYSADYYRVQSK 185
Query: 603 ----YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN 647
++PPE + G ++ + D++SFGV+L +I S YYG S
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP-YYGFSNQ 233
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 67/277 (24%), Positives = 114/277 (41%), Gaps = 21/277 (7%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATST---QGLEEFKNEVSLTARLQH-VNLLRVL 497
KLGEG FG VY + A+K L+ + +E F E+ + A L H N++++
Sbjct: 7 KLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
+ + L+ EY+ SL+ L R+ L + + I+ + L YL
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KG 121
Query: 558 VIHRDLKASNILLDNELN-PKISDFGMAKLFRKDVDEAN----TGRIVGTYGYVPPEYVK 612
+IHRD+K NILLD + K+ DFG+AKL ++ VGT GY+ PE +
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 613 ---KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669
S D++S G+ L ++++ E + + +
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLP----PFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706
L S+ + + ++P++R S S
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 78/259 (30%), Positives = 125/259 (48%), Gaps = 21/259 (8%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
KLG G FG V++G AVK L T ++F E + +L+H L+++ CT
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
+ ++ E + SL YL R L + +++ V G+ YL E N+ IHR
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYL-EAQNY--IHR 127
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
DL A N+L+ K++DFG+A++ ++D+ EA G + PE +S+K D
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREG-AKFPIKWTAPEAALYNRFSIKSD 186
Query: 622 VYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLL 681
V+SFG+LL +I++ R Y N L+ + +G P P +L
Sbjct: 187 VWSFGILLTEIVTYGRMP--YPGMTNAEVLQ------QVDQGYRMPCP----PGCPKELY 234
Query: 682 NCMQVALLCVQENPEDRPS 700
+ M L C +E+P+DRP+
Sbjct: 235 DIM---LDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 81/272 (29%), Positives = 134/272 (49%), Gaps = 39/272 (14%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLS-----ATSTQGLEEFKNEVSLTARLQHVNLLRV 496
LG G FG VY+G NL G FAVK +S T + +++ + E++L ++LQH N+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 497 LGYCTERDE-NMLIY-EYLPNKSLDLYL--FDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
LG TER+E N+ I+ E +P SL L + V+ + GL YL
Sbjct: 68 LG--TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVI-----RLYTRQILLGLEYLH- 119
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV- 611
+ +HRD+K +NIL+D K++DFGMAK + V+ + G+ ++ PE +
Sbjct: 120 --DRNTVHRDIKGANILVDTNGVVKLADFGMAK---QVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 612 KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671
++G Y + D++S G +L++ + K + E + + +K + KE P +
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPP---WSQLEGVAAV------FKIGRSKEL--PPI 223
Query: 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLE 703
D S L C+Q +P RP+ E
Sbjct: 224 PDHLSD----EAKDFILKCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 65/204 (31%), Positives = 107/204 (52%), Gaps = 24/204 (11%)
Query: 443 LGEGGFGPVYKGN-LPRGQ----EFAVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLRV 496
LG G FG VYKG +P G+ A+K L TS + +E +E + A + H +++R+
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 497 LGYC-TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
LG C + + LI + +P L Y+ + + + Q +N + +G+ YL+E
Sbjct: 75 LGICLSSQ--VQLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEK-- 128
Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEY 610
R++HRDL A N+L+ + KI+DFG+AKL D E + G VP E
Sbjct: 129 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHA-----EGGKVPIKWMALES 182
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
+ IY+ K DV+S+GV + ++++
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 80/305 (26%), Positives = 138/305 (45%), Gaps = 60/305 (19%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN 492
+ + K+GEG G VYK + G+E A+K++ Q E NE+ + +H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG--------VT 544
++ DE ++ EY+ SL ++ Q V + E V
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSL---------TDIIT-QNFVRMNEPQIAYVCREVL 126
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
QGL YL + VIHRD+K+ NILL + + K++DFG A K+ + N+ +VGT
Sbjct: 127 QGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPY 181
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK---------RNARYYGTSENLNFLEYAF 655
++ PE +K+ Y K D++S G++ +++ + R A + T++ + L+
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALFLITTKGIPPLKNP- 239
Query: 656 EQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAI 715
E+W + K+F++ C+ ++PE RPS E +L+ +
Sbjct: 240 EKW-SPEFKDFLN--------------------KCLVKDPEKRPSAEE---LLQHPFLKK 275
Query: 716 AAPKR 720
A PK
Sbjct: 276 ACPKE 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 79/261 (30%), Positives = 120/261 (45%), Gaps = 26/261 (9%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
++G G FG V+ G ++ A+K R A S E+F E + +L H L+++ G
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
CTER L++E++ + L YL +R + + + V +G+ YL+ + VI
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
HRDL A N L+ K+SDFGM + D ++TG + PE YS K
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK-WSSPEVFSFSKYSSK 181
Query: 620 YDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCK 679
DV+SFGVL+ ++ S + Y N +E + G P L +
Sbjct: 182 SDVWSFGVLMWEVFSEGKTP--YENRSNSEVVE------TINAGFRLYKPRL----ASQS 229
Query: 680 LLNCMQVALLCVQENPEDRPS 700
+ MQ C +E PEDRPS
Sbjct: 230 VYELMQ---HCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 85/294 (28%), Positives = 134/294 (45%), Gaps = 56/294 (19%)
Query: 443 LGEGGFGPVYKG---NLPRGQEF---AVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLR 495
LG+G FG VY+G + +G+ A+K ++ ++ EF NE S+ +++R
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYL------------FDPIRRYVLDWQKRVNIIEGV 543
+LG + +++ E + L YL P QK + + +
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL-----QKFIQMAAEI 128
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
G+ YL + +HRDL A N ++ +L KI DFGM +D+ E + R G
Sbjct: 129 ADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMT----RDIYETDYYRKGGK- 180
Query: 604 GYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS--ENLNFLEYAFE 656
G +P PE +K G+++ K DV+SFGV+L ++ + Y G S E L F+
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP-YQGLSNEEVLKFV----- 234
Query: 657 QWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
G P + P KLL M+ +C Q NP+ RP+ LE+ S LKD
Sbjct: 235 ----IDGGHLDLP----ENCPDKLLELMR---MCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-25
Identities = 81/275 (29%), Positives = 130/275 (47%), Gaps = 30/275 (10%)
Query: 438 SSANKLGEGGFGPVYKGNLPRGQ-EFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRV 496
+ +LG G FG V+ G RG+ + A+K + + ++F E + +L H NL+++
Sbjct: 7 TFLKELGSGQFGVVHLGKW-RGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQL 64
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
G CT++ ++ EY+ N L YL + R+ L + +++ V + + YL+
Sbjct: 65 YGVCTKQRPIFIVTEYMANGCLLNYLRE--RKGKLGTEWLLDMCSDVCEAMEYLESNG-- 120
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT---YGYVPPEYVKK 613
IHRDL A N L+ + K+SDFG+A R +D+ T GT + PPE
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLA---RYVLDDQYTSS-QGTKFPVKWAPPEVFDY 175
Query: 614 GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673
+S K DV+SFGVL+ ++ S + Y N +E S G P L
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGKMP--YERFSNSEVVESV------SAGYRLYRPKL-- 225
Query: 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSML 708
+P ++ M C E PEDRP+ ++ S L
Sbjct: 226 --APTEVYTIMY---SCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 79/275 (28%), Positives = 126/275 (45%), Gaps = 41/275 (14%)
Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVN 492
N+ + +G G FG VYKG NL G A+K++S + L+ E+ L L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL--FDP-----IRRYVLDWQKRVNIIEGVTQ 545
+++ +G D +I EY N SL + F P + Y + V Q
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVY----------VYQVLQ 110
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
GL YL E VIHRD+KA+NIL + K++DFG+A + + +VGT +
Sbjct: 111 GLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYW 165
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665
+ PE ++ S D++S G ++++++ N YY +LN + F +D
Sbjct: 166 MAPEVIEMSGASTASDIWSLGCTVIELLTG--NPPYY----DLNPMAALFRIVQDD---- 215
Query: 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPS 700
P L + SP + C Q++P RP+
Sbjct: 216 --HPPLPEGISP----ELKDFLMQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 67/215 (31%), Positives = 103/215 (47%), Gaps = 21/215 (9%)
Query: 436 NFSSANKLGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARL 488
+ + LG G FG VY+G + AVK L + ++ E F E + ++
Sbjct: 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFD----PIRRYVLDWQKRVNIIEGVT 544
H N++R++G ER ++ E + L +L + P R L + + V
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAK-LFRKDVDEANTGRI 599
+G YL+E IHRD+ A N LL + P KI+DFGMA+ ++R GR
Sbjct: 127 KGCKYLEE---NHFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKG-GRA 181
Query: 600 VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
+ ++PPE GI++ K DV+SFGVLL +I S
Sbjct: 182 MLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 80/272 (29%), Positives = 136/272 (50%), Gaps = 27/272 (9%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
KLG G FG V+ G + AVK L T ++ F E +L LQH L+R+ T
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 502 ERDENMLIYEYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
+ + +I EY+ SL D D + +L K ++ + +G+ Y+ E N+ IH
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYI-ERKNY--IH 126
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKY 620
RDL+A+N+L+ L KI+DFG+A++ + A G + PE + G +++K
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKS 185
Query: 621 DVYSFGVLLLQIISSKRNARYYG--TSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPC 678
DV+SFG+LL +I++ + Y G S+ ++ L+ + P +++ P
Sbjct: 186 DVWSFGILLYEIVTYGK-IPYPGMSNSDVMSALQRGYRM-----------PRMENC--PD 231
Query: 679 KLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
+L + M+ C +E E+RP+ + S+L D
Sbjct: 232 ELYDIMK---TCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 68/207 (32%), Positives = 104/207 (50%), Gaps = 27/207 (13%)
Query: 443 LGEGGFGPVYKGNLPR--------GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
LG+G FG V L R G+ AVK+L ++ + L +F+ E+ + LQH N++
Sbjct: 12 LGKGNFGSV---ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 495 RVLGYCTE--RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
+ G C R L+ EYLP SL YL R LD +K + + +G+ YL
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGS 126
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD-----VDEANTGRIVGTYGYVP 607
R +HRDL NIL+++E KI DFG+ K+ +D V E I +
Sbjct: 127 K---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF----WYA 179
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
PE + + +S+ DV+SFGV+L ++ +
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 5e-23
Identities = 75/273 (27%), Positives = 132/273 (48%), Gaps = 30/273 (10%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
KLG G FG V+ + + AVK + + +E F E ++ LQH L+++ T
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 502 ERDENMLIYEYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
++ +I E++ SL D D + L K ++ + +G+ ++ E N+ IH
Sbjct: 72 -KEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFI-EQRNY--IH 125
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKY 620
RDL+A+NIL+ L KI+DFG+A++ + A G + PE + G +++K
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKS 184
Query: 621 DVYSFGVLLLQIISSKRNARYYGTS--ENLNFLEYAFE-QWKDSKGKEFIDPSLDDSSSP 677
DV+SFG+LL++I++ R Y G S E + LE + ++ +E +
Sbjct: 185 DVWSFGILLMEIVTYGRIP-YPGMSNPEVIRALERGYRMPRPENCPEELYN--------- 234
Query: 678 CKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
+ + C + PE+RP+ + S+L D
Sbjct: 235 --------IMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 6e-23
Identities = 76/275 (27%), Positives = 135/275 (49%), Gaps = 34/275 (12%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLS----ATSTQG--LEEFKNEVSLTARLQHVNLLR 495
LG G F Y+ ++ G AVK+++ +S Q +E + E+ L ARL H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 496 VLGYCTERDENMLIY-EYLPNKSLDLYL--FDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
+LG T D + ++ E++ S+ L + + V+ +N E + +GL YL E
Sbjct: 68 MLG-ATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHE 121
Query: 553 YSNFRVIHRDLKASNILLDNE-LNPKISDFGMAKLFRKDVDEAN--TGRIVGTYGYVPPE 609
++IHRD+K +N+L+D+ +I+DFG A A G+++GT ++ PE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669
++ Y DV+S G +++++ ++K + ++ N L F K + P
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPP---WNAEKHSNHLALIF---KIASATT--AP 230
Query: 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
S+ + SP V L C++ PEDRP E+
Sbjct: 231 SIPEHLSP----GLRDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 7e-23
Identities = 83/266 (31%), Positives = 125/266 (46%), Gaps = 24/266 (9%)
Query: 441 NKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
+KLG G +G VY+G + AVK L T +EEF E ++ ++H NL+++LG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
CT +I E++ +L YL + R ++ + + ++ + YL E NF I
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL-EKKNF--I 126
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
HRDL A N L+ K++DFG+++L D A+ G + PE + +S+K
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 185
Query: 620 YDVYSFGVLLLQIISSKRNARYYGTSENLNF-LEYAFEQWKDSKGKEFIDPSLDDSSSPC 678
DV++FGVLL +I + YG S L +E KG P P
Sbjct: 186 SDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYE--LLEKGYRMERP----EGCPP 232
Query: 679 KLLNCMQVALLCVQENPEDRPSMLEV 704
K+ M C Q NP DRPS E+
Sbjct: 233 KVYELM---RACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-22
Identities = 83/271 (30%), Positives = 128/271 (47%), Gaps = 26/271 (9%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
KLG G FG V+ G + AVK L T E F E + +L+H L+++ +
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
E ++ EY+ SL +L D R L V++ V G+ Y+ E N+ IHR
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYI-ERMNY--IHR 126
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY--GYVPPEYVKKGIYSMK 619
DL+++NIL+ + L KI+DFG+A+L D T R + + PE G +++K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 620 YDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCK 679
DV+SFG+LL ++++ R Y N LE +G P P
Sbjct: 184 SDVWSFGILLTELVTKGRVP--YPGMNNREVLEQV------ERGYRMPCP----QDCPIS 231
Query: 680 LLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
L M L C +++PE+RP+ + S L+D
Sbjct: 232 LHELM---LQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 67/216 (31%), Positives = 111/216 (51%), Gaps = 36/216 (16%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKR--LSATSTQG-------LEEFKNEVSLTARLQHVN 492
+G G FG VY G N G+ AVK+ L + S L+ E++L LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 493 LLRVLGYCTERDENMLIYEYLPNKS----LDLY--LFDPIRRYVLDWQKRVNIIEGVTQG 546
+++ LG + D + EY+P S L+ Y + + R N + + +G
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR---------NFVRQILKG 118
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR------IV 600
L YL N +IHRD+K +NIL+DN+ KISDFG++K + + + +T +
Sbjct: 119 LNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISK--KLEANSLSTKTNGARPSLQ 173
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
G+ ++ PE VK+ Y+ K D++S G L++++++ K
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 78/284 (27%), Positives = 131/284 (46%), Gaps = 37/284 (13%)
Query: 443 LGEGGFGPVYKGNLPRGQE------FAVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLR 495
LG G FG V+ +E VK L T + L+ EF+ E+ + +L H N++R
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYL------FDPIRRYVLDWQKRVNIIEGVTQGLLY 549
+LG C E + + +I EY L +L + ++ L +++V + + G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANTGRIVGTYGYVPP 608
L SN R +HRDL A N L+ ++ K+S ++K ++ + + I ++ P
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI--PLRWLAP 187
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS--ENLNFLEYAFEQWKDSKGKEF 666
E V++ +S K DV+SFGVL+ ++ + +YG S E LN L+ +
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELP-FYGLSDEEVLNRLQAGKLELPVP----- 241
Query: 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P +L M C NP+DRPS E+ S L +
Sbjct: 242 -------EGCPSRLYKLMTR---CWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 3e-22
Identities = 80/280 (28%), Positives = 140/280 (50%), Gaps = 42/280 (15%)
Query: 443 LGEGGFGPVYKGNL--PRGQEF--AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVL 497
+G G FG V G L P +E A+K L A T+ +F +E S+ + H N++ +
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQ----KRVNIIEGVTQGLLYLQEY 553
G T+ M++ EY+ N SLD +L R++ D Q + V ++ G+ G+ YL
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFL----RKH--DGQFTVIQLVGMLRGIASGMKYL--- 122
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----P 608
S+ +HRDL A NIL+++ L K+SDFG++++ D + A T R G +P P
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTAP 178
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668
E + ++ DV+S+G+++ +++S R Y N + ++ E ++ +
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVMSY--GERPYWEMSNQDVIKAIEEGYR-------LP 229
Query: 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSML 708
+D P L Q+ L C Q++ +RP ++ S+L
Sbjct: 230 APMD---CPAAL---HQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 8e-22
Identities = 63/200 (31%), Positives = 110/200 (55%), Gaps = 15/200 (7%)
Query: 443 LGEGGFGPVYKGNL--PRGQE--FAVKRLSATSTQGL-EEFKNEVSLTARLQHVNLLRVL 497
+G G FG V++G L P +E A+K L T+ ++F +E S+ + H N++R+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
G T+ M+I EY+ N +LD YL D + + V ++ G+ G+ YL S+
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSS--YQLVGMLRGIAAGMKYL---SDMN 127
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT---GRIVGTYGYVPPEYVKKG 614
+HRDL A NIL+++ L K+SDFG++++ D + T G+I + PE +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAPEAIAYR 185
Query: 615 IYSMKYDVYSFGVLLLQIIS 634
++ DV+SFG+++ +++S
Sbjct: 186 KFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 9e-22
Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 22/263 (8%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
+LG G FG V+ G + A+K ++ + E+F E + +L H L+++ G CT
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
++ ++ E++ N L YL R+ L +++ + V +G+ YL E ++F IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYL-ERNSF--IHR 124
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
DL A N L+ + K+SDFGM + D +++G + PPE YS K D
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKWSPPEVFNFSKYSSKSD 183
Query: 622 VYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLL 681
V+SFGVL+ ++ + + + N +E S+G P L +
Sbjct: 184 VWSFGVLMWEVFTEGKMP--FEKKSNYEVVEMI------SRGFRLYRPKLASMT------ 229
Query: 682 NCMQVALLCVQENPEDRPSMLEV 704
+V C E PE RP+ E+
Sbjct: 230 -VYEVMYSCWHEKPEGRPTFAEL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|119352 cd02873, GH18_IDGF, The IDGF's (imaginal disc growth factors) are a family of growth factors identified in insects that include at least five members, some of which are encoded by genes in a tight cluster | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 1e-21
Identities = 93/392 (23%), Positives = 150/392 (38%), Gaps = 104/392 (26%)
Query: 38 EFPLSDINSAL-F-THLICAFAEVDSSTYQLSISSAN-------QQYFSIFANSVRRKNP 88
+ L D+ AL F THL+ +A +D+ TY+ I S N Y +I S++RK P
Sbjct: 18 KMSLEDLEPALQFCTHLVYGYAGIDADTYK--IKSLNEDLDLDKSHYRAI--TSLKRKYP 73
Query: 89 SIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGID 148
+K LLS+ G + N+ ++ S R +FI S+ + YGF G+D
Sbjct: 74 HLKVLLSV--GGDRDTDEEGENEKYL-----LLLESSESRNAFINSAHSLLKTYGFDGLD 126
Query: 149 LFWLWP-------------------------NSTDLNS------LGILLDEWKAS-ASDQ 176
L W +P + D + L+ E K + D
Sbjct: 127 LAWQFPKNKPKKVRGTFGSAWHSFKKLFTGDSVVDEKAAEHKEQFTALVRELKNALRPDG 186
Query: 177 PELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAA-LY---- 231
LTL++ + T + + ++ N+++ +L +D+ P + + A +Y
Sbjct: 187 LLLTLTV---LPHVNSTWYFDVPAIANNVDFVNLATFDFLTPERNPEEADYTAPIYELYE 243
Query: 232 -NPSSNISTDFGIREWLRRGFPANKLVLG----AR------------------ASGPG-- 266
NP N+ D+ ++ WL +G PA+KL LG R GPG
Sbjct: 244 RNPHHNV--DYQVKYWLNQGTPASKLNLGIATYGRAWKLTKDSGITGVPPVLETDGPGPA 301
Query: 267 ---ITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNL---FTSGA-----------TWI 309
G + + I + + N V + F S A W+
Sbjct: 302 GPQTKTPGLLSWPEICSKLPNPANLKGADAPLRKVGDPTKRFGSYAYRPADENGEHGIWV 361
Query: 310 NFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
+++ +T K YAK K L G F LS DD
Sbjct: 362 SYEDPDTAANKAGYAKAKGLGGVALFDLSLDD 393
|
The IDGF's have an eight-stranded alpha/beta barrel fold and are related to the glycosyl hydrolase family 18 (GH18) chitinases, but they have an amino acid substitution known to abolish chitinase catalytic activity. IDGFs may have evolved from chitinases to gain new functions as growth factors, interacting with cell surface glycoproteins involved in growth-promoting processes. Length = 413 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 85/289 (29%), Positives = 135/289 (46%), Gaps = 40/289 (13%)
Query: 442 KLGEGGFGPVYKGNL-----PRGQEFAVKRLS-ATSTQGLEEFKNEVSLTARLQHVNLLR 495
+LGE FG +YKG+L Q A+K L + Q EF+ E SL A L H N++
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLF--------------DPIRRYVLDWQKRVNIIE 541
+LG T+ +++EYL L +L D + LD ++I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANTGRIV 600
+ G+ YL S+F +H+DL A NIL+ +L+ KISD G+++ ++ D ++
Sbjct: 132 QIAAGMEYLS--SHF-FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKD 660
++PPE + G +S D++SFGV+L +I S YYG S N +E
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP-YYGFS-NQEVIEMV------ 239
Query: 661 SKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709
K + P +D P ++ + M C QE P RP ++ + L+
Sbjct: 240 --RKRQLLPCSED--CPPRMYSLMTE---CWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-21
Identities = 68/217 (31%), Positives = 114/217 (52%), Gaps = 31/217 (14%)
Query: 442 KLGEGGFGPVYKGNL------PRGQEFAVKRLSATSTQGL-EEFKNEVSLTARLQHVNLL 494
+LGE FG VYKG+L + Q A+K L + L EEFK+E + +RLQH N++
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLF-------------DPIRRYVLDWQKRVNIIE 541
+LG T+ +I+ Y + L +L D + L+ V+I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
+ G+ +L S+ V+H+DL N+L+ ++LN KISD G LFR +V A+ +++G
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLG---LFR-EVYAADYYKLMG 184
Query: 602 T----YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
++ PE + G +S+ D++S+GV+L ++ S
Sbjct: 185 NSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 76/288 (26%), Positives = 135/288 (46%), Gaps = 40/288 (13%)
Query: 442 KLGEGGFGPVYKG---NLPRGQE---FAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
+LGEG FG V+ NL Q+ AVK L S ++F+ E L LQH +++R
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYL--FDPIRRYV----------LDWQKRVNIIEGV 543
G CTE ++++EY+ + L+ +L P + + L + + I +
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANTGRIVGT 602
G++YL ++ +HRDL N L+ L KI DFGM++ ++ D GR +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG-GRTMLP 187
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY-YGTSENLNFLEYAFEQWKDS 661
++PPE + ++ + D++SFGV+L +I + + Y +E + + +
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI---------T 238
Query: 662 KGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709
+G+E P + P ++ MQ C Q P+ R + ++ S L+
Sbjct: 239 QGRELERP----RTCPPEVYAIMQG---CWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (232), Expect = 5e-21
Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 35/206 (16%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKR--LSATSTQGLEEFKNEVSLTARLQHVNLLR-- 495
++G+G FG VY G+ + +K LS S + E+ NEV + +L H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 496 -----------VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRY-VLDWQKRVNIIEGV 543
V+ Y D + I + P +LDW
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEG-------KPFPEEQILDW---------F 109
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
Q L L+ + +++HRD+K NI L + K+ DFG++K+ VD A T +VGT
Sbjct: 110 VQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTP 167
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLL 629
Y+ PE + Y+ K D++S G +L
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 6e-21
Identities = 82/289 (28%), Positives = 143/289 (49%), Gaps = 42/289 (14%)
Query: 442 KLGEGGFGPVYKGN---LPRGQ---EFAVKRLS-ATSTQGLEEFKNEVSLTARLQHVNLL 494
+LG+G FG VY+GN + +G+ AVK ++ + S + EF NE S+ +++
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLF-------DPIRRYVLDWQKRVNIIEGVTQGL 547
R+LG ++ +++ E + + L YL + R Q+ + + + G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
YL + +HRDL A N ++ ++ KI DFGM + D+ E + R G G +P
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYR-KGGKGLLP 184
Query: 608 -----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662
PE +K G+++ D++SFGV+L +I +S Y G S N L++ +
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEI-TSLAEQPYQGLS-NEQVLKFVMD------ 236
Query: 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711
G P + P ++ + M+ +C Q NP+ RP+ LE+ ++LKDD
Sbjct: 237 GGYLDQPD----NCPERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 7e-21
Identities = 78/302 (25%), Positives = 133/302 (44%), Gaps = 46/302 (15%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLP---RGQEF---AVKRL-SATSTQGLEEFKNEVSLTAR 487
NN +G+G FG V++ P + F AVK L S +F+ E +L A
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFD-------------------PIRR 528
H N++++LG C L++EY+ L+ +L +
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 529 YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA-KLF 587
L +++ I + V G+ YL E + +HRDL N L+ + KI+DFG++ ++
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN 647
D +A+ + ++PPE + Y+ + DV+++GV+L +I S YYG +
Sbjct: 182 SADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP-YYGMAH- 238
Query: 648 LNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707
E +D G P + P +L N M+ LC + P DRPS ++ +
Sbjct: 239 ----EEVIYYVRD--GNVLSCP----DNCPLELYNLMR---LCWSKLPSDRPSFASINRI 285
Query: 708 LK 709
L+
Sbjct: 286 LQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQE-FAVKRLSATSTQGLE-EFKNEVSLTARLQHVN 492
++LGEG G V K L FA+K ++ L+ + E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 493 LLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRYVLDWQKRVN------IIEGVT 544
+++ G + + + EY SLD I + V R+ I E V
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLD-----SIYKKVKKRGGRIGEKVLGKIAESVL 115
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
+GL YL ++IHRD+K SNILL + K+ DFG++ + G GT
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTSF 168
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
Y+ PE ++ YS+ DV+S G+ LL++
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 62/216 (28%), Positives = 109/216 (50%), Gaps = 41/216 (18%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEF----KNEVSLTARLQHVNLLR 495
++GEG +G VYK N G+ A+K++ E F E+ L +L+H N++R
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 496 VLGYCTERDEN--MLIYEYLPNKSLDL--------YLFDP--IRRYVLDWQKRVNIIEGV 543
+ T + + +++EY+ + DL F I+ Y+ Q ++EG+
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIKCYMK--Q----LLEGL 113
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
YL +SN ++HRD+K SNIL++N+ K++DFG+A+ + K T R++ T
Sbjct: 114 Q----YL--HSN-GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TL 165
Query: 604 GYVPPEYV---KKGIYSMKYDVYSFGVLLLQIISSK 636
Y PPE + + Y + D++S G +L ++ K
Sbjct: 166 WYRPPELLLGATR--YGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 58/197 (29%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
KLGEG +G VYK + GQ A+K + L+E E+S+ + +++ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 501 TERDENMLIYEYLPNKS-LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
+ + ++ EY S D+ I L ++ I+ +GL YL +SN + I
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIM---KITNKTLTEEEIAAILYQTLKGLEYL--HSN-KKI 121
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
HRD+KA NILL+ E K++DFG++ + + NT ++GT ++ PE +++ Y+ K
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNNK 179
Query: 620 YDVYSFGVLLLQIISSK 636
D++S G+ +++ K
Sbjct: 180 ADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 81/299 (27%), Positives = 128/299 (42%), Gaps = 46/299 (15%)
Query: 442 KLGEGGFGPVY---------------KGNLPRGQE--FAVKRLSATSTQ-GLEEFKNEVS 483
KLGEG FG V+ N AVK L ++ E+F EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL--------FDPIRRYVLDWQK 535
+ +RL N+ R+LG CT +I EY+ N L+ +L L +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKD---V 591
+ + + G+ YL+ NF +HRDL N L+ KI+DFGM++ L+ D V
Sbjct: 132 LLYMATQIASGMRYLESL-NF--VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFL 651
GR ++ E V G ++ K DV++FGV L +I++ R + Y + +
Sbjct: 189 Q----GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR-EQPYEHLTDQQVI 243
Query: 652 EYAFEQWKDSKGKEFID-PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709
E A ++D + ++ P P + M L C + + EDRP+ E+ L+
Sbjct: 244 ENAGHFFRDDGRQIYLPRPPN----CPKDIYELM---LECWRRDEEDRPTFREIHLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 4e-20
Identities = 60/207 (28%), Positives = 86/207 (41%), Gaps = 44/207 (21%)
Query: 443 LGEGGFGPVYKGNLPR----GQEFAVKRLSATS---TQGLEEFKNEVSLTARLQH---VN 492
LG+G FG V L R G+ +A+K L + +E E ++ +R+ H V
Sbjct: 1 LGKGSFGKVL---LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 493 LLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ----- 545
L + + E L + EY P L +L K E +
Sbjct: 58 L-----HYAFQTEEKLYLVLEYAPGGELFSHL-----------SKEGRFSEERARFYAAE 101
Query: 546 ---GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
L YL +I+RDLK NILLD + + K++DFG+AK + NT GT
Sbjct: 102 IVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLL 629
Y+ PE + Y D +S GVLL
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLL 183
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-20
Identities = 77/276 (27%), Positives = 128/276 (46%), Gaps = 37/276 (13%)
Query: 443 LGEGGFGPVYKGN----LPRG---QEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLL 494
LG G FG VY+G L G AVK L +T Q +EF E L + H N++
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDP-IRRY---VLDWQKRVNIIEGVTQGLLYL 550
++LG C + +I E + L YL D + R+ +L ++ ++I V +G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 551 QEYSNFRVIHRDLKASNILL-----DNELNPKISDFGMAK-LFRKDVDEANTGRIVGTYG 604
++ IHRDL A N L+ D + KI DFG+A+ +++ D ++
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664
++ PE + G ++ + DV+SFGVL+ +I++ + Y N L++ G
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP--YPALNNQEVLQHVTA------GG 230
Query: 665 EFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPS 700
P + P K+ M C ++P +RP+
Sbjct: 231 RLQKP----ENCPDKIYQLMT---NCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-20
Identities = 76/282 (26%), Positives = 134/282 (47%), Gaps = 44/282 (15%)
Query: 443 LGEGGFGPVYKGNLP----RGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVL 497
+G G FG V +G L R A+K L + T + +F +E S+ + H N++ +
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 498 GYCTERDENMLIYEYLPNKSLDLYL------FDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
G T+ M+I E++ N +LD +L F I + V ++ G+ G+ YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI--------QLVGMLRGIAAGMKYLS 123
Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP---- 607
E + +HRDL A NIL+++ L K+SDFG+++ D + +G G +P
Sbjct: 124 EMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG--GKIPIRWT 178
Query: 608 -PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666
PE + ++ DV+S+G+++ +++S R Y N + + A EQ D +
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSY--GERPYWDMSNQDVIN-AIEQ--DYR---- 229
Query: 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSML 708
+ P +D ++ Q+ L C Q++ RP ++ S L
Sbjct: 230 LPPPMDCPTA------LHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 6e-20
Identities = 68/196 (34%), Positives = 103/196 (52%), Gaps = 13/196 (6%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE 502
+G+G FG V G+ RG + AVK + +T + F E S+ +L+H NL+++LG E
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 503 RDENMLIY-EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
+ I EY+ SL YL R VL + V + + YL E +NF +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL-EANNF--VHR 126
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
DL A N+L+ + K+SDFG+ K D TG++ + PE +++ +S K D
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKL--PVKWTAPEALREKKFSTKSD 181
Query: 622 VYSFGVLLLQIISSKR 637
V+SFG+LL +I S R
Sbjct: 182 VWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 77/281 (27%), Positives = 112/281 (39%), Gaps = 41/281 (14%)
Query: 442 KLGEGGFGPVYKG--NLPRGQEF--AVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRV 496
KLG+G FG V +G + G+ AVK L + +++F E ++ L H NL+R+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLD---WQKRVNIIEGVTQGLLYLQEY 553
G M++ E P SL L + L V I G+ YL+
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLESK 116
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGM--AKLFRKDVDEANTGRIVGTYGYVPPEYV 611
R IHRDL A NILL ++ KI DFG+ A +D V + + PE +
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESL 172
Query: 612 KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEF---ID 668
+ +S DV+ FGV L ++ + Y E W G + ID
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFT------------------YGEEPWAGLSGSQILKKID 214
Query: 669 PSLDDSSSP-CKLLNCMQVALLCVQENPEDRPSMLEVSSML 708
+ P + V L C NP DRP+ + L
Sbjct: 215 KEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 29/204 (14%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY-- 499
+GEG FG V +G GQ+ AVK + T + F E ++ +L H NL+R+LG
Sbjct: 13 IIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 500 ------CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
E + +L + L + ++ LD V +G+ YL+
Sbjct: 70 HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLD----------VAEGMEYLESK 119
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
+++HRDL A NIL+ + K+SDFG+A++ VD + + PE +K
Sbjct: 120 ---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL-----PVKWTAPEALKH 171
Query: 614 GIYSMKYDVYSFGVLLLQIISSKR 637
+S K DV+S+GVLL ++ S R
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 78/267 (29%), Positives = 120/267 (44%), Gaps = 22/267 (8%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCT 501
LG+G FG V+KG L AVK Q L+ +F +E + + H N+++++G CT
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
+R ++ E +P D F ++ L ++ V G+ YL+ + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYD 621
DL A N L+ KISDFGM++ D +++G + PE + G YS + D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQ-EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 622 VYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLL 681
V+S+G+LL + S Y G + + A EQ + KG P P +
Sbjct: 177 VWSYGILLWETFSLGV-CPYPGMTN-----QQAREQVE--KGYRMSCPQ----KCPDDVY 224
Query: 682 NCMQVALLCVQENPEDRPSMLEVSSML 708
MQ C PE+RP E+ L
Sbjct: 225 KVMQ---RCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 67/282 (23%), Positives = 124/282 (43%), Gaps = 57/282 (20%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLG- 498
LG+G G VYK + P G+ +A+K++ + ++ E+ + +++ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNII-EGVT--------QGLLY 549
+ E + + ++ EY+ SL D K+V I E V +GL Y
Sbjct: 68 FYKEGEIS-IVLEYMDGGSLA------------DLLKKVGKIPEPVLAYIARQILKGLDY 114
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
L ++ +IHRD+K SN+L++++ KI+DFG++K+ +D+ NT VGT Y+ PE
Sbjct: 115 L--HTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMSPE 170
Query: 610 YVKKGIYSMKYDVYSFGVLLLQI------ISSKRNARYYGTSENLNFLEYAF--EQWKDS 661
++ YS D++S G+ LL+ ++ + + +
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSP 230
Query: 662 KGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLE 703
+ ++FI C+Q++P+ RPS E
Sbjct: 231 EFRDFIS--------------------ACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 78/270 (28%), Positives = 128/270 (47%), Gaps = 32/270 (11%)
Query: 442 KLGEGGFGPVYKGNLPRGQ-EFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
+LG G FG V G RGQ + A+K + S +EF E + +L H L+++ G C
Sbjct: 11 ELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
T++ ++ EY+ N L YL + +R + + + + V +G+ YL+ + IH
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIH 123
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT---YGYVPPEYVKKGIYS 617
RDL A N L+D++ K+SDFG++ R +D+ T VG+ + PPE + +S
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLS---RYVLDDEYTSS-VGSKFPVRWSPPEVLLYSKFS 179
Query: 618 MKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSS 676
K DV++FGVL+ ++ S K + SE + K S+G P L
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE---------KVSQGLRLYRPHLASEK- 229
Query: 677 PCKLLNCMQVALLCVQENPEDRPSMLEVSS 706
+ C E E+RP+ ++ S
Sbjct: 230 ------VYAIMYSCWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 84/304 (27%), Positives = 137/304 (45%), Gaps = 52/304 (17%)
Query: 431 KAATNNFSSANKLGEGGFGPVYKGNLPRG-------QEFAVKRLS-ATSTQGLEEFKNEV 482
+ A + + +LG+G FG VY+G + +G A+K ++ A S + EF NE
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60
Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQ-------- 534
S+ +++R+LG ++ ++I E + L YL R + +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVQAPP 116
Query: 535 ---KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
K + + + G+ YL + +HRDL A N ++ + KI DFGM +D+
Sbjct: 117 SLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT----RDI 169
Query: 592 DEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
E + R G G +P PE +K G+++ DV+SFGV+L +I + Y G S
Sbjct: 170 YETDYYR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGMS- 226
Query: 647 NLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706
N L + E G P + P L M+ +C Q NP+ RPS LE+ S
Sbjct: 227 NEQVLRFVME------GGLLDKP----DNCPDMLFELMR---MCWQYNPKMRPSFLEIIS 273
Query: 707 MLKD 710
+K+
Sbjct: 274 SIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 4e-19
Identities = 69/205 (33%), Positives = 101/205 (49%), Gaps = 24/205 (11%)
Query: 443 LGEGGFGPV--YK---GNLPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARLQHVNLLRV 496
LGEG FG V Y N G+ AVK L Q +K E+++ L H N+++
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 497 LGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
G C+E+ LI EY+P SL YL ++ L+ + + + + +G+ YL
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PE 609
IHRDL A N+LLDN+ KI DFG+A K V E + V G P E
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLA----KAVPEGHEYYRVREDGDSPVFWYAVE 180
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIIS 634
+K+ +S DV+SFGV L ++++
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|119349 cd00598, GH18_chitinase-like, The GH18 (glycosyl hydrolase, family 18) type II chitinases hydrolyze chitin, an abundant polymer of beta-1,4-linked N-acetylglucosamine (GlcNAc) which is a major component of the cell wall of fungi and the exoskeleton of arthropods | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 5e-19
Identities = 45/185 (24%), Positives = 83/185 (44%), Gaps = 18/185 (9%)
Query: 33 WLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKT 92
W +GR +DI +L TH+I AFAE+ S +++ + K P +K
Sbjct: 8 WSSGRGPDPTDIPLSLCTHIIYAFAEISSDGSLNLFGDKSEEPLKGALEELASKKPGLKV 67
Query: 93 LLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWL 152
L+SI +S+ ++ D + R +F S + + YGF G+D+ W
Sbjct: 68 LISIGGWTDSSP--------------FTLASDPASRAAFANSLVSFLKTYGFDGVDIDWE 113
Query: 153 WPNS---TDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAH 209
+P + +D + LL E + SA L++AV S +Y + ++ +++ +
Sbjct: 114 YPGAADNSDRENFITLLRELR-SALGAANYLLTIAVPASYFDLGYAYDVPAIGDYVDFVN 172
Query: 210 LVAYD 214
++ YD
Sbjct: 173 VMTYD 177
|
Chitinases have been identified in viruses, bacteria, fungi, protozoan parasites, insects, and plants. The structure of the GH18 domain is an eight-stranded beta/alpha barrel with a pronounced active-site cleft at the C-terminal end of the beta-barrel. The GH18 family includes chitotriosidase, chitobiase, hevamine, zymocin-alpha, narbonin, SI-CLP (stabilin-1 interacting chitinase-like protein), IDGF (imaginal disc growth factor), CFLE (cortical fragment-lytic enzyme) spore hydrolase, the type III and type V plant chitinases, the endo-beta-N-acetylglucosaminidases, and the chitolectins. The GH85 (glycosyl hydrolase, family 85) ENGases (endo-beta-N-acetylglucosaminidases) are closely related to the GH18 chitinases and are included in this alignment model. Length = 210 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-19
Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 21/209 (10%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKR--LSATSTQG--------LEEFKNEVSLTARLQHV 491
+G+G +G VY N+ G+ AVK+ L AT ++ ++E+ L H+
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQGLLYL 550
N+++ LG+ T + + EY+P S+ L R Y + Q E V +GL YL
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCL----RTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
+ ++HRDLKA N+L+D + KISDFG++K D + G+ ++ PE
Sbjct: 125 H---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 611 V--KKGIYSMKYDVYSFGVLLLQIISSKR 637
+ YS K D++S G ++L++ + +R
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-19
Identities = 79/271 (29%), Positives = 132/271 (48%), Gaps = 26/271 (9%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
KLG+G FG V+ G + A+K L T E F E + +L+H L+ + +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
E + ++ E++ SL +L + +Y L + V++ + G+ Y+ E N+ IHR
Sbjct: 72 E-EPIYIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYI-ERMNY--IHR 126
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY--GYVPPEYVKKGIYSMK 619
DL+A+NIL+ + L KI+DFG+A+L D T R + + PE G +++K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 620 YDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCK 679
DV+SFG+LL ++++ R Y N LE +G P P
Sbjct: 184 SDVWSFGILLTELVTKGRVP--YPGMVNREVLEQV------ERGYRMPCPQ----GCPES 231
Query: 680 LLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
L M+ LC +++P++RP+ + S L+D
Sbjct: 232 LHELMK---LCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 78/273 (28%), Positives = 132/273 (48%), Gaps = 30/273 (10%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
KLG+G FG V+ G A+K L T E F E + +L+H L+++ +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
E + ++ EY+ SL +L + +Y L + V++ + G+ Y+ E N+ +HR
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYV-ERMNY--VHR 126
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY--GYVPPEYVKKGIYSMK 619
DL+A+NIL+ L K++DFG+A+L D T R + + PE G +++K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 620 YDVYSFGVLLLQIISSKRNARYYG--TSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSP 677
DV+SFG+LL + +++K Y G E L+ +E +G P P
Sbjct: 184 SDVWSFGILLTE-LTTKGRVPYPGMVNREVLDQVE---------RGYRMPCP----PECP 229
Query: 678 CKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
L + M C ++ PE+RP+ + + L+D
Sbjct: 230 ESLHDLM---CQCWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 8e-19
Identities = 76/301 (25%), Positives = 141/301 (46%), Gaps = 49/301 (16%)
Query: 442 KLGEGGFGPVYKG---NLPRGQE---FAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
+LGEG FG V+ NL ++ AVK L + ++F+ E L LQH ++++
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYL--FDPIRRYVLDWQKR-----------VNIIEG 542
G C + D ++++EY+ + L+ +L P ++D Q R ++I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG- 601
+ G++YL ++ +HRDL N L+ L KI DFGM+ +DV + R+ G
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS----RDVYSTDYYRVGGH 184
Query: 602 ---TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY-YGTSENLNFLEYAFEQ 657
++PPE + ++ + DV+SFGV+L +I + + + +E + +
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI------ 238
Query: 658 WKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAA 717
++G+ P + P ++ + M L C Q P+ R ++ E+ +L ++ A
Sbjct: 239 ---TQGRVLERPRV----CPKEVYDIM---LGCWQREPQQRLNIKEIYKILH--ALGKAT 286
Query: 718 P 718
P
Sbjct: 287 P 287
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKR--LSATSTQGLEEFKNEVSLTARLQHVN 492
+F NK+G+G FG V+K + +A+K+ LS + + EE +E + A+L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGV----TQGLL 548
++R ++ + ++ EY N L + + + R + V Q LL
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDL--------HKLLKMQRGRPLPEDQVWRFFIQILL 112
Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
L + +++HRD+K+ N+ LD N KI D G+AKL + + ANT IVGT Y+ P
Sbjct: 113 GLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSP 170
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIISSK 636
E + Y+ K DV++ GV+L + + K
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 20/199 (10%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---EVSLTARLQHVNLLRV 496
+LG G G V K + P G+ AVK + K E+ + + ++
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGF 64
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYL---FDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
G + + EY+ SLD L I +L I V +GL YL +
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYL--H 117
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
++IHRD+K SNIL+++ K+ DFG++ + A T VGT Y+ PE ++
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--AKT--FVGTSSYMAPERIQG 173
Query: 614 GIYSMKYDVYSFGVLLLQI 632
YS+K D++S G+ L+++
Sbjct: 174 NDYSVKSDIWSLGLSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 76/286 (26%), Positives = 125/286 (43%), Gaps = 42/286 (14%)
Query: 443 LGEGGFGPVYKGNLPRGQ---EFAVK--RLSATSTQGLEEFKNEVSLTARLQHVNLLRVL 497
LGEG FG V +G L + + AVK +++ + +E+F +E H N++R++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 498 GYCTERDEN------MLIYEYLPNKSLDLYLF------DPIRRYVLDWQKRVNIIEGVTQ 545
G C + E+ ++I ++ + L +L P L Q V + +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ---YLPTQMLVKFMTDIAS 123
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT-YG 604
G+ YL S+ IHRDL A N +L+ +N ++DFG++K D GRI
Sbjct: 124 GMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG-DYYRQGRIAKMPVK 179
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664
++ E + +Y+ K DV+SFGV + +I + R Y EN +Y Q K
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEI--ATRGQTPYPGVENSEIYDY-LRQGNRLK-- 234
Query: 665 EFIDPSLDDSSSPCKLLNCM-QVALLCVQENPEDRPSMLEVSSMLK 709
P L+ + + C NP+DRPS + L+
Sbjct: 235 -----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 57/194 (29%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKR--LSATSTQGLEEFKNEVSLTARLQHVNL 493
F+ +G+G FG VYK + Q A+K L + +E+ + E+ ++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
+ G + + +I EY S D ++ LD I+ V GL YL E
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
IHRD+KA+NILL E + K++DFG++ + + NT VGT ++ PE +K+
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQ 172
Query: 614 GIYSMKYDVYSFGV 627
Y K D++S G+
Sbjct: 173 SGYDEKADIWSLGI 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 8/198 (4%)
Query: 441 NKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLG 498
+G G VY LP ++ A+KR+ Q ++E + EV ++ H N+++
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
DE L+ YL SL + R LD +++ V +GL YL
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQ 123
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTYGYVPPEYVKKGI- 615
IHRD+KA NILL + + KI+DFG++ D R VGT ++ PE +++
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 616 YSMKYDVYSFGVLLLQII 633
Y K D++SFG+ +++
Sbjct: 184 YDFKADIWSFGITAIELA 201
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 71/277 (25%), Positives = 121/277 (43%), Gaps = 41/277 (14%)
Query: 443 LGEGGFGPVYKGNLPRG----QEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRV 496
LGEG FG V +G L + + AVK + + +EEF +E + H N++++
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 497 LGYCTERDEN------MLIYEYLPNKSLDLYLF------DPIRRYVLDWQKRVNIIEGVT 544
+G C E M+I ++ + L +L P + L Q + + +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEK---LPLQTLLKFMVDIA 123
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT-Y 603
G+ YL SN IHRDL A N +L ++ ++DFG++K D GRI
Sbjct: 124 LGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG-DYYRQGRIAKMPV 179
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG 663
++ E + +Y+ K DV++FGV + +I + R Y EN +Y + +
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGQTPYPGVENHEIYDYLRHGNRLKQP 237
Query: 664 KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPS 700
++ +D D S C + +P+DRP+
Sbjct: 238 EDCLDELYDLMYS-------------CWRADPKDRPT 261
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-18
Identities = 83/298 (27%), Positives = 139/298 (46%), Gaps = 55/298 (18%)
Query: 437 FSSANKLGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARLQH 490
F LG G FG VYKG +P G++ A+K L ATS + +E +E + A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNIIEG 542
++ R+LG C LI + +P L D +R +Y+L+W ++
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQI----- 118
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGRIV 600
+G+ YL+E R++HRDL A N+L+ + KI+DFG+AKL D E A G++
Sbjct: 119 -AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV- 173
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG--TSENLNFLEYAFEQW 658
++ E + IY+ + DV+S+GV + ++++ Y G SE + LE
Sbjct: 174 -PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASEISSILE------ 225
Query: 659 KDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPS----MLEVSSMLKDDS 712
KG+ P P ++ + + C + + RP ++E S M +D
Sbjct: 226 ---KGERLPQP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 4e-18
Identities = 75/285 (26%), Positives = 129/285 (45%), Gaps = 37/285 (12%)
Query: 442 KLGEGGFGPVYKGNLPRGQEF---------------AVKRLSATSTQ-GLEEFKNEVSLT 485
KLGEG FG V+ EF AVK L A T+ +F E+ +
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT- 544
+RL++ N++R+LG C D +I EY+ N L+ +L +R + N I V+
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL---SQREIESTFTHANNIPSVSI 128
Query: 545 QGLLY--------LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEAN 595
LLY ++ ++ +HRDL N L+ N KI+DFGM++ L+ D
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAF 655
GR V ++ E + G ++ DV++FGV L ++ + + Y S+ +E
Sbjct: 189 -GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-QVIENTG 246
Query: 656 EQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPS 700
E +++ + ++ S +P ++ + C + +DRP+
Sbjct: 247 EFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPT 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 73/290 (25%), Positives = 120/290 (41%), Gaps = 65/290 (22%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHVNLLRVL 497
NK+G G FG VY NL G+ AVK R+ + ++E +E+ + L+H NL++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 498 GYCTERDENMLIYEYLPNKSLDLYL----FDP---IRRYVLDWQKRVNIIEGVTQGLLYL 550
G R++ + EY +L+ L IR Y L + +GL YL
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQ----------LLEGLAYL 115
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG--RIVGTYGYVPP 608
+ ++HRD+K +NI LD+ K+ DFG A + + + GT Y+ P
Sbjct: 116 HSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
Query: 609 EYVKKGIYSMKY---DVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAF---------- 655
E + G D++S G ++L++ + KR SE N + F
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRP-----WSELDNEFQIMFHVGAGHKPPI 227
Query: 656 --EQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLE 703
+GK+F+D C++ +P+ RP+ E
Sbjct: 228 PDSLQLSPEGKDFLD--------------------RCLESDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 81/306 (26%), Positives = 143/306 (46%), Gaps = 48/306 (15%)
Query: 435 NNFSSANKLGEGGFGPVYKG---NLPRGQE---FAVKRLSATSTQGLEEFKNEVSLTARL 488
+N +LGEG FG V+ NL Q+ AVK L S ++F E L L
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF------------DPIRRYVLDWQKR 536
QH ++++ G C E D ++++EY+ + L+ +L + L +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE--LTQSQM 122
Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
++I + + G++YL ++ +HRDL N L+ L KI DFGM+ +DV +
Sbjct: 123 LHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMS----RDVYSTDY 175
Query: 597 GRIVG----TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLE 652
R+ G ++PPE + ++ + DV+S GV+L +I + + +Y S N +E
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-WYQLSNN-EVIE 233
Query: 653 YAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712
++G+ P + P ++ + M L C Q P R ++ E+ S+L++
Sbjct: 234 CI------TQGRVLQRP----RTCPKEVYDLM---LGCWQREPHMRLNIKEIHSLLQN-- 278
Query: 713 MAIAAP 718
+A A+P
Sbjct: 279 LAKASP 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 5e-18
Identities = 61/212 (28%), Positives = 90/212 (42%), Gaps = 40/212 (18%)
Query: 441 NKLGEGGFGPVYK-GNLPRGQEFAVKRLS--ATSTQGLEEFKNEVSLTARLQHVNLLR-- 495
+G+G FG V K G+ K + + + ++ +EV++ L+H N++R
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 496 -------------VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
V+ YC D LI + K Y+ + I
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKC---KKERKYIEEEF------------IWRI 110
Query: 543 VTQGLLYLQE-----YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
+TQ LL L E V+HRDLK +NI LD N K+ DFG+AK+ D A T
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT- 169
Query: 598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
VGT Y+ PE + Y K D++S G L+
Sbjct: 170 -YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLI 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 59/197 (29%), Positives = 103/197 (52%), Gaps = 15/197 (7%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVL-GYC 500
LG+G FG VYK + G A K + S + LE+F E+ + + +H N++ + Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
E +LI E+ +LD + + R + + Q R + + + L +L + +VIH
Sbjct: 73 YENKLWILI-EFCDGGALD-SIMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIH 126
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV-----KKGI 615
RDLKA NILL + + K++DFG++ + + + +T +GT ++ PE V K
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNP 184
Query: 616 YSMKYDVYSFGVLLLQI 632
Y K D++S G+ L+++
Sbjct: 185 YDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 7e-18
Identities = 78/305 (25%), Positives = 134/305 (43%), Gaps = 52/305 (17%)
Query: 442 KLGEGGFGPV---------------YKGNLPRGQEF--AVKRLSATSTQGLE-EFKNEVS 483
KLGEG FG V + N+ +G+ AVK L + + +F EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLD----------- 532
+ +RL+ N++R+LG C + D +I EY+ N L+ +L ++ D
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAVPP 128
Query: 533 --------WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584
+ +++ + G+ YL S+ +HRDL N L+ L KI+DFGM+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 585 K-LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG 643
+ L+ D GR V ++ E + G ++ DV++FGV L +I+ + + YG
Sbjct: 186 RNLYAGDYYRIQ-GRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK-EQPYG 243
Query: 644 TSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLE 703
+ +E A E ++D + ++ P L M L C + +RPS +
Sbjct: 244 ELTDEQVIENAGEFFRDQGRQVYLFRP---PPCPQGLYELM---LQCWSRDCRERPSFSD 297
Query: 704 VSSML 708
+ + L
Sbjct: 298 IHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 54/197 (27%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN--EVSLTARLQHVNLLRVLG 498
K+GEG +G VYK + G+ A+K++ E+ L L H N++++L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
+ + L++E++ DLY R+ L + + + QGL + + +
Sbjct: 66 VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE-YVKKGIYS 617
+HRDLK N+L++ E K++DFG+A+ F V T +V T Y PE + YS
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PYTHYVV-TRWYRAPELLLGDKGYS 177
Query: 618 MKYDVYSFGVLLLQIIS 634
D++S G + +++S
Sbjct: 178 TPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 1e-17
Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 34/275 (12%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLEEFKN---EVSLTARLQHVN 492
F+ ++G G FG VY R E A+K++S + Q E++++ EV R++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
+ G L+ EY + DL + + L + I G QGL YL
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV- 611
++ +IHRD+KA NILL K++DFG A + AN+ VGT ++ PE +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI----ASPANS--FVGTPYWMAPEVIL 194
Query: 612 --KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669
+G Y K DV+S G+ +++ ++R + N+N + + ++ P
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLF----NMNAMSALYHIAQNES------P 242
Query: 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
+L + N + C+Q+ P+DRP+ E+
Sbjct: 243 TLQSNEWSDYFRNFVDS---CLQKIPQDRPTSEEL 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 33/219 (15%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKR-----LSATSTQGLEEFKNEVSLTARL 488
N+ LG+G FG VY ++ G+E AVK+ S + + + + E+ L L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 489 QHVNLLRVLGYCTERDENMLIY-EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT--- 544
QH +++ G C DE + I+ EY+P S+ D ++ Y + E VT
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVK----DQLKAYGA-------LTETVTRKY 109
Query: 545 -----QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR- 598
+G+ YL +SN ++HRD+K +NIL D+ N K+ DFG +K + + + TG
Sbjct: 110 TRQILEGVEYL--HSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT-ICSSGTGMK 165
Query: 599 -IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
+ GT ++ PE + Y K DV+S G ++++++ K
Sbjct: 166 SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 1e-17
Identities = 79/303 (26%), Positives = 139/303 (45%), Gaps = 45/303 (14%)
Query: 443 LGEGGFGPVYKGN-LPRGQEF----AVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRV 496
LG G FG VYKG +P G+ A+K L+ T+ + EF +E + A + H +L+R+
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
LG C L+ + +P+ L Y+ + + + Q +N + +G++YL+E
Sbjct: 75 LGVCLS-PTIQLVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER--- 128
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
R++HRDL A N+L+ + + KI+DFG+A+L D E N ++ E + +
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 617 SMKYDVYSFGVLLLQIISSKRNARYYG--TSENLNFLEYAFEQWKDSKGKEFIDPSLDDS 674
+ + DV+S+GV + ++++ Y G T E + LE KG+ P
Sbjct: 189 THQSDVWSYGVTIWELMTFG-GKPYDGIPTREIPDLLE---------KGERLPQP----- 233
Query: 675 SSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK--------------DDSMAIAAPKR 720
P ++ V + C + + RP E+++ DD M + +P
Sbjct: 234 --PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKLPSPND 291
Query: 721 PAF 723
F
Sbjct: 292 SKF 294
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 80/311 (25%), Positives = 133/311 (42%), Gaps = 78/311 (25%)
Query: 443 LGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLR 495
LGEG FG V K AVK L ++ L + +E +L ++ H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 496 VLGYCTERDENMLIYEYLPNKSL----------------------DLYLFDPIRRYV--- 530
+ G C++ +LI EY SL YL +P R +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 531 ----LDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586
WQ +++G+ YL E +++HRDL A N+L+ KISDFG++
Sbjct: 128 DLISFAWQ--------ISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLS-- 174
Query: 587 FRKDVDEANT------GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR 640
+DV E ++ GRI ++ E + IY+ + DV+SFGVLL +I++ N
Sbjct: 175 --RDVYEEDSYVKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP- 229
Query: 641 YYGTS-ENL-NFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDR 698
Y G + E L N L+ + + E + + L C ++ P+ R
Sbjct: 230 YPGIAPERLFNLLKTGYRMERPENCSEEM----------------YNLMLTCWKQEPDKR 273
Query: 699 PSMLEVSSMLK 709
P+ ++S L+
Sbjct: 274 PTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 84/306 (27%), Positives = 130/306 (42%), Gaps = 62/306 (20%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSA---TSTQGLEEFKNEVSLTARL-Q 489
++F +GEG F V +E+A+K L + ++ K E + RL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 490 HVNLLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRYV-LDWQKRVNIIEGVTQG 546
H ++++ Y T +DE L + EY PN L IR+Y LD + +
Sbjct: 61 HPGIIKL--YYTFQDEENLYFVLEYAPNGEL----LQYIRKYGSLDEKCTRFYAAEILLA 114
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF-RKDVDEANTGRI------ 599
L YL + +IHRDLK NILLD +++ KI+DFG AK+ E+N G
Sbjct: 115 LEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 600 -----------VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL 648
VGT YV PE + + D+++ G ++ Q+++ K + G++E L
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK--PPFRGSNEYL 229
Query: 649 NF-----LEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLE 703
F LEY+F K+ I+ KLL +P+DR + E
Sbjct: 230 TFQKILKLEYSFPPNFPPDAKDLIE----------KLL----------VLDPQDRLGVNE 269
Query: 704 VSSMLK 709
LK
Sbjct: 270 GYDELK 275
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 3e-17
Identities = 75/304 (24%), Positives = 144/304 (47%), Gaps = 28/304 (9%)
Query: 413 EYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATS 471
++FDS + + +DI ++ N + G G YKG ++ G +F VK ++ +
Sbjct: 673 QFFDSKV--SKSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEINDVN 727
Query: 472 TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVL 531
+ +E++ +LQH N+++++G C LI+EY+ K+L L + L
Sbjct: 728 SIPS----SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------L 777
Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
W++R I G+ + L +L + V+ +L I++D + P + + L D
Sbjct: 778 SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT 836
Query: 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY-YGTSENLNF 650
+ + YV PE + + K D+Y FG++L+++++ K A +G ++
Sbjct: 837 ------KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSI-- 888
Query: 651 LEYAFEQWKDSKGKEFIDPSL--DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSML 708
+E+A + D +IDPS+ D S + +++ M +AL C +P RP +V L
Sbjct: 889 VEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
Query: 709 KDDS 712
+ S
Sbjct: 949 ESAS 952
|
Length = 968 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 70/218 (32%), Positives = 115/218 (52%), Gaps = 18/218 (8%)
Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATST-QGLEEFK-NEVSLTARLQHVN 492
+++ K+GEG +G VYKG N GQ A+K++ S +G+ E+SL LQH N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDL--YLFDPIRR-YVLDWQKRVNIIEGVTQGLLY 549
++ + + LI+E+L S+DL YL D + + +D + + + + QG+L+
Sbjct: 61 IVCLQDVLMQESRLYLIFEFL---SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
RV+HRDLK N+L+DN+ K++DFG+A+ F V T +V T Y PE
Sbjct: 117 CHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYTHEVV-TLWYRAPE 171
Query: 610 YVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
+ YS D++S G + ++ + K ++G SE
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMATKK--PLFHGDSE 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 40/221 (18%)
Query: 443 LGEGGFGPVYKG------NLPRGQEFAVKRLSATST-QGLEEFKNEVSLTARL-QHVNLL 494
LGEG FG V K N AVK L +T + L + +E+ + + +H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE------------- 541
+LG CT+ ++ EY + +L +L RR ++ +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRA--RRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 542 --GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK------LFRKDVDE 593
V +G+ +L + IHRDL A N+L+ + KI+DFG+A+ +RK +
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN- 193
Query: 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
GR+ ++ PE + +Y+ + DV+SFGVLL +I +
Sbjct: 194 ---GRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 77/295 (26%), Positives = 132/295 (44%), Gaps = 40/295 (13%)
Query: 442 KLGEGGFGPVYKGNLPRGQEF-----------------AVKRLSATSTQGLE-EFKNEVS 483
KLGEG FG V+ ++F AVK L + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF------DPIRRYV--LDWQK 535
+ +RL+ N++R+L C D +I EY+ N L+ +L + V + +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEA 594
+ + + G+ YL S+ +HRDL N L+ KI+DFGM++ L+ D
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYA 654
GR V ++ E + G ++ DV++FGV L +I++ + Y S+ +E
Sbjct: 189 Q-GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE-QVIENT 246
Query: 655 FEQWKDSKGKEFI-DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSML 708
E ++D + ++ P+L P L M L C + N ++RPS E+ + L
Sbjct: 247 GEFFRDQGRQVYLPKPAL----CPDSLYKLM---LSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 75/284 (26%), Positives = 126/284 (44%), Gaps = 26/284 (9%)
Query: 435 NNFSSANKLGEGGFGPVYKGN---LPRGQ---EFAVKRLSATSTQGLEE-FKNEVSLTAR 487
NN S LG G FG V + L + + AVK L T+ E +E+ + +
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 488 L-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
L H N++ +LG CT ++I EY L +L R L + ++ V +G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKG 153
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
+ +L + IHRDL A N+LL + KI DFG+A+ D + G ++
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666
PE + +Y+ + DV+S+G+LL +I S N Y G + F ++ K+ G
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFSLGSNP-YPGMPVDSKF----YKLIKE--GYRM 263
Query: 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P +P ++ + M+ C +P RP+ ++ ++
Sbjct: 264 AQPEH----APAEIYDIMKT---CWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 80/274 (29%), Positives = 129/274 (47%), Gaps = 40/274 (14%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---EVSLTARLQHVN 492
F+ ++G G FG VY ++ + A+K++S + Q E++++ EV +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 493 LLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
+ G C R+ L+ EY + D+ + + L + I G QGL YL
Sbjct: 77 TIEYKG-CYLREHTAWLVMEYCLGSASDIL---EVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV 611
+ IHRD+KA NILL K++DFG A L V AN+ VGT ++ PE +
Sbjct: 133 SHER---IHRDIKAGNILLTEPGTVKLADFGSASL----VSPANS--FVGTPYWMAPEVI 183
Query: 612 ---KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLE--YAFEQWKDSKGKEF 666
+G Y K DV+S G+ +++ ++R + N+N + Y Q DS
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL--AERKPPLF----NMNAMSALYHIAQ-NDS----- 231
Query: 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPS 700
P+L + N + C+Q+ P+DRPS
Sbjct: 232 --PTLSSNDWSDYFRNFVD---SCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 56/193 (29%), Positives = 97/193 (50%), Gaps = 10/193 (5%)
Query: 442 KLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
K+GEG G V G++ AVK + Q E NEV + QH N++ +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
+E ++ E+L +L D + + L+ ++ + E V Q L YL VIH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKY 620
RD+K+ +ILL + K+SDFG KDV + + +VGT ++ PE + + Y +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEV 198
Query: 621 DVYSFGVLLLQII 633
D++S G+++++++
Sbjct: 199 DIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 59/199 (29%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQG-LEEFKNEVSLTARLQHVNLL 494
F+ ++G+G FG VYKG R +E A+K + + +E+ + E+++ ++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 495 RVLGYCTERDENMLIYEYLPNKS-LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
R G + + +I EYL S LDL P+ + I+ + +GL YL
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLHSE 120
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
R IHRD+KA+N+LL + + K++DFG+A + NT VGT ++ PE +K+
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 175
Query: 614 GIYSMKYDVYSFGVLLLQI 632
Y K D++S G+ +++
Sbjct: 176 SAYDFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 52/194 (26%), Positives = 94/194 (48%), Gaps = 17/194 (8%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
++G G +G VYK ++ G+ A+K + E + E+S+ +H N++ G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 500 CTERDENMLIYEYLPNKSL-DLY--LFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
RD+ ++ EY SL D+Y P+ + + + +GL YL E
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY-----VCRETLKGLAYLHE---T 120
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV---KK 613
IHRD+K +NILL + + K++DFG++ + + + +GT ++ PE +K
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPEVAAVERK 178
Query: 614 GIYSMKYDVYSFGV 627
G Y K D+++ G+
Sbjct: 179 GGYDGKCDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 7e-17
Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 50/279 (17%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLEEFKN---EVSLTARLQHVN 492
FS ++G G FG VY R E A+K++S + Q E++++ EV +L+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
++ G L+ EY + DL + + L + + G QGL YL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLH- 132
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV- 611
+ +IHRD+KA NILL K+ DFG A + + AN VGT ++ PE +
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANX--FVGTPYWMAPEVIL 184
Query: 612 --KKGIYSMKYDVYSFGVLLLQIISSK--------RNARYYGTSENLNFLEYAFEQWKDS 661
+G Y K DV+S G+ +++ K +A Y+ L+ W +
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS--GHWSEY 242
Query: 662 KGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPS 700
+ F+D C+Q+ P+DRP+
Sbjct: 243 F-RNFVDS--------------------CLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 79/284 (27%), Positives = 120/284 (42%), Gaps = 57/284 (20%)
Query: 442 KLGEGGFGPVY---------KGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN 492
+LG+G FG VY + L +E V L+ T + E L ++L H
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV---QANQEAQLLSKLDHPA 63
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQK--RVNIIEGVTQGLLYL 550
+++ ERD +I EY + LD + + + E Q LL +
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLD----CKLEELKHTGKTLSENQVCEWFIQLLLGV 119
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
R++HRDLKA NI L N L KI DFG+++L D A T GT Y+ PE
Sbjct: 120 HYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEA 176
Query: 611 VKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID-- 668
+K Y K D++S G +L ++ L +AFE G+ F+
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEMCC----------------LAHAFE------GQNFLSVV 214
Query: 669 --------PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
PSL ++ S + LN + ++L ++P RPS E+
Sbjct: 215 LRIVEGPTPSLPETYS--RQLNSIMQSML--NKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 69/286 (24%), Positives = 127/286 (44%), Gaps = 33/286 (11%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQ 489
NF K+G+G F VYK L G+ A+K++ + ++ E+ L +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
H N+++ L E +E ++ E L R + ++K+ +I T +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDL--------SRMIKHFKKQKRLIPERTIWKYF 112
Query: 550 LQEYSNF------RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
+Q S R++HRD+K +N+ + K+ D G+ + F A++ +VGT
Sbjct: 113 VQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTP 170
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG 663
Y+ PE + + Y+ K D++S G LL ++ + + + +YG NL Y+ + K K
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKMNL----YSLCK-KIEKC 223
Query: 664 KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709
++ D S + + C+ +PE RP + V + K
Sbjct: 224 -DYPPLPADHYSEELR-----DLVSRCINPDPEKRPDISYVLQVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 9e-17
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 17/209 (8%)
Query: 436 NFSSANKLGEGGFGPVYKGNLPRG----QEFAVKRLSATSTQGLEEF--KNEVSLTARLQ 489
+ +G G FG V+ L R + +K++ E +NE + L
Sbjct: 1 KYEKIRVVGRGAFGIVH---LCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS 57
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
H N++ E M++ EY P +L Y+ LD I+ Q LL
Sbjct: 58 HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDED---TILHFFVQILLA 113
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
L ++HRDLK NILLD KI DFG++K+ ++ +VGT Y+ P
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCYISP 170
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
E + Y+ K D+++ G +L ++ S KR
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 61/202 (30%), Positives = 90/202 (44%), Gaps = 27/202 (13%)
Query: 443 LGEGGFGPVYK-GNLPRGQEFAVKRLS--ATSTQGLEE-FKNEVSLTARLQHVNLLRVLG 498
LG GGFG V + + FA+K + G +E +E + H ++++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 499 YCTERDEN---MLIYEYLPNKSLDLYLFDPIRRYVL--DWQKRVNIIEGVTQGLLYLQEY 553
Y T +D+ ML+ EY L + +R L ++ R I V YL
Sbjct: 59 YRTFKDKKYIYMLM-EYCLGGEL----WTILRDRGLFDEYTARF-YIACVVLAFEYL--- 109
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANTGRIVGTYGYVPPEYVK 612
N +I+RDLK N+LLD+ K+ DFG AK L T GT YV PE +
Sbjct: 110 HNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG----QKTWTFCGTPEYVAPEIIL 165
Query: 613 -KGIYSMKYDVYSFGVLLLQII 633
KG Y D +S G+LL +++
Sbjct: 166 NKG-YDFSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 1e-16
Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 50/218 (22%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN--------EVSLTARLQHVN 492
KLGEG +G VYK + G+ A+K++ L+ + E+SL L+H N
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIR------LDNEEEGIPSTALREISLLKELKHPN 59
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL------FDP--IRRYVLDWQKRVNIIEGVT 544
++++L + L++EY + L YL P I+ + +Q ++
Sbjct: 60 IVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIM--YQ----LL---- 108
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
+GL Y +S+ R++HRDLK NIL++ + K++DFG+A+ F + T +V T
Sbjct: 109 RGLAYC--HSH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVV-TLW 163
Query: 605 YVPPEYVKKGI------YSMKYDVYSFGVLLLQIISSK 636
Y PE I YS D++S G + ++I+ K
Sbjct: 164 YRAPE-----ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 81/299 (27%), Positives = 132/299 (44%), Gaps = 53/299 (17%)
Query: 437 FSSANKLGEGGFGPVY-KGNLPRGQEFAVKRLSATSTQGLEEFKN---EVSLTARLQHVN 492
F +++G G FG VY N + AVK++S + Q E++++ EV +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
+ G + L+ EY + DL + + L + I G QGL YL
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV- 611
++ +IHRD+KA NILL K++DFG A AN+ VGT ++ PE +
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANS--FVGTPYWMAPEVIL 190
Query: 612 --KKGIYSMKYDVYSFGVLLLQIISSK--------RNARYYGTSENLNFLEYAFEQWKDS 661
+G Y K DV+S G+ +++ K +A Y+ + L+ +W DS
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQS--NEWTDS 248
Query: 662 KGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAPKR 720
+ F+D C+Q+ P++RP+ E +L+ D + P R
Sbjct: 249 F-RGFVD--------------------YCLQKIPQERPASAE---LLRHDFVRRDRPAR 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 54/201 (26%), Positives = 104/201 (51%), Gaps = 10/201 (4%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
++ K+G+G G V+ ++ GQE A+K+++ E NE+ + L++ N++
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
L DE ++ EYL SL D + +D + + Q L +L ++N
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFL--HAN 134
Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI 615
+VIHRD+K+ N+LL + + K++DFG + + +T +VGT ++ PE V +
Sbjct: 135 -QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 191
Query: 616 YSMKYDVYSFGVLLLQIISSK 636
Y K D++S G++ ++++ +
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 71/280 (25%), Positives = 127/280 (45%), Gaps = 34/280 (12%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGL------EEFKNEVSLTARLQH 490
++ LG+G +G VY G +GQ AVK++ ++ L E+ + EV L L+H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYL--FDPIRRYVLDWQKRVNIIEGVTQGLL 548
VN+++ LG C + + + E++P S+ L F P+ V + I++GV
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA---- 116
Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK---LFRKDVDEANTGRIV-GTYG 604
YL V+HRD+K +N++L K+ DFG A+ +N + + GT
Sbjct: 117 YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664
++ PE + + Y K D++S G + ++ + K + + L + Y +
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP---LASMDRLAAMFYI------GAHR 224
Query: 665 EFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
+ P L DS S + C+ + +RPS L++
Sbjct: 225 GLM-PRLPDSFSA----AAIDFVTSCLTRDQHERPSALQL 259
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 443 LGEGGFGPVYKGNLPR--------GQEFAVKRLS-ATSTQGLEEFKNEVSLTARLQHVNL 493
LGEG FG V L R G++ AVK L + + + K E+ + L H N+
Sbjct: 12 LGEGHFGKV---ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 494 LRVLGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
++ G CTE N LI E+LP+ SL YL P + ++ ++++ + +G+ YL
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL- 125
Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD--EANTGRIVGTYGYVPPE 609
+ + +HRDL A N+L+++E KI DFG+ K D + + Y P
Sbjct: 126 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIIS 634
++ Y + DV+SFGV L ++++
Sbjct: 184 LIQSKFY-IASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 11/205 (5%)
Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFK-NEVSLTARLQHVNL 493
NF KLGEG + VYKG N G+ A+K + + +G E+SL L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
+R+ ++ ML++EY+ +K L Y+ R LD + + +G+ + E
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
RV+HRDLK N+L++ K++DFG+A+ F V+ + V T Y P+ V
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE--VVTLWYRAPD-VLL 173
Query: 614 G--IYSMKYDVYSFGVLLLQIISSK 636
G YS D++S G ++ ++I+ +
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 10/198 (5%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
++ K+G+G G VY ++ GQE A+K+++ E NE+ + +H N++
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
L DE ++ EYL SL D + +D + + Q L +L +SN
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFL--HSN 134
Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI 615
+VIHRD+K+ NILL + + K++DFG + + +T +VGT ++ PE V +
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 191
Query: 616 YSMKYDVYSFGVLLLQII 633
Y K D++S G++ ++++
Sbjct: 192 YGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 67/216 (31%), Positives = 113/216 (52%), Gaps = 15/216 (6%)
Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFK-NEVSLTARLQHVN 492
NF K+GEG +G VYK N G+ A+K++ T T+G+ E+SL L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL-FDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
++++L ++ L++E+L ++ L ++ P+ L K + + + QGL +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIK--SYLFQLLQGLAFCH 117
Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE-Y 610
+ RV+HRDLK N+L++ E K++DFG+A+ F V T +V T Y PE
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWYRAPEIL 172
Query: 611 VKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
+ YS D++S G + ++++ R A + G SE
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSE 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 12/198 (6%)
Query: 443 LGEGGFGPVYKGN-LPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLRV 496
LG G FG V+KG +P G A+K + + Q +E + + L H ++R+
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
LG C L+ + P SL ++ R LD Q+ +N + +G+ YL+E+
Sbjct: 75 LGICPGASLQ-LVTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
R++HR+L A NILL ++ +I+DFG+A L D + ++ E + G Y
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 617 SMKYDVYSFGVLLLQIIS 634
+ + DV+S+GV + +++S
Sbjct: 189 THQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 7e-16
Identities = 70/278 (25%), Positives = 121/278 (43%), Gaps = 38/278 (13%)
Query: 443 LGEGGFGPVYKGNLPRGQ-EFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
LG+G +G VY Q A+K + ++ ++ E++L + L+H N+++ LG +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 502 ERDENMLIYEYLPNKSLDLYL---FDPIRRYVLDWQKRVNII---EGVTQGLLYLQEYSN 555
E + E +P SL L + P++ II + + +GL YL +
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLK------DNEQTIIFYTKQILEGLKYLHDN-- 127
Query: 556 FRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
+++HRD+K N+L++ KISDFG +K R T GT Y+ PE + KG
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSK--RLAGINPCTETFTGTLQYMAPEVIDKG 184
Query: 615 I--YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672
Y D++S G ++++ + K G + F F+ I P +
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK----------IHPEIP 234
Query: 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
+S S L C + +P+ R S +L+D
Sbjct: 235 ESLS----AEAKNFILRCFEPDPDKRAS---AHDLLQD 265
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 57/197 (28%), Positives = 105/197 (53%), Gaps = 13/197 (6%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
+LG+G FG VYK N G A K + S + LE++ E+ + A H ++++LG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
+ ++ E+ P ++D + + + R + + Q +V I + + L YL + ++IH
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-ICRQMLEALQYLH---SMKIIH 133
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV-----KKGI 615
RDLKA N+LL + + K++DFG++ K + ++ +GT ++ PE V K
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCETMKDTP 191
Query: 616 YSMKYDVYSFGVLLLQI 632
Y K D++S G+ L+++
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 27/211 (12%)
Query: 436 NFSSANKLGEGGFGPVYK-GNLPRGQEFAVKR--LSATSTQGLEEFKNEVSLTARLQHVN 492
+F KLG+G +G VYK L Q +A+K L + S + E+ NE+ + A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 493 LLRVLGYCTER-DENML--IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT----- 544
++ Y D N L + EY P F + + + +K+ +I
Sbjct: 61 ---IISYKEAFLDGNKLCIVMEYAP--------FGDLSKAISKRKKKRKLIPEQEIWRIF 109
Query: 545 -QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
Q L LQ +++HRDLK++NILL KI D G++K+ +K++ A T +GT
Sbjct: 110 IQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM--AKT--QIGTP 165
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
Y+ PE K YS K D++S G LL ++ +
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT 196
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-16
Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 7/195 (3%)
Query: 442 KLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGY 499
++G G FG V+ G L AVK T L+ +F E + + H N++R++G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
CT++ ++ E + +L R L ++ + ++E G+ YL+ I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPR--LKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
HRDL A N L+ + KISDFGM++ V + G + PE + G YS +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 620 YDVYSFGVLLLQIIS 634
DV+SFG+LL + S
Sbjct: 177 SDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 9e-16
Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 10/199 (5%)
Query: 436 NFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
+ K+GEG G V G++ AVK++ Q E NEV + QH N++
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
+ DE ++ E+L +L D + ++ ++ + V + L +L
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLH--- 132
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
VIHRD+K+ +ILL ++ K+SDFG K+V + +VGT ++ PE + +
Sbjct: 133 AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVISRL 190
Query: 615 IYSMKYDVYSFGVLLLQII 633
Y + D++S G+++++++
Sbjct: 191 PYGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 60/214 (28%), Positives = 106/214 (49%), Gaps = 13/214 (6%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEV 482
+ S D K F K+G+G G VY ++ GQE A+K+++ E NE+
Sbjct: 11 IVSVGDPKKKYTRFE---KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
+ ++ N++ L DE ++ EYL SL D + +D + +
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
Q L +L +SN +VIHRD+K+ NILL + + K++DFG + + +T +VGT
Sbjct: 124 CLQALDFL--HSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
++ PE V + Y K D++S G++ ++++ +
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 75/280 (26%), Positives = 130/280 (46%), Gaps = 38/280 (13%)
Query: 442 KLGEGGFGPVYKG--NLPRGQE-FAVKRLSATSTQGL--EEFKNEVSLTARLQHVNLLRV 496
+LG G FG V KG + + ++ AVK L + +E E ++ +L + ++R+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
+G C E + ML+ E L+ +L ++V + + ++ V+ G+ YL+E +NF
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQK--NKHVTE-KNITELVHQVSMGMKYLEE-TNF 116
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYV 611
+HRDL A N+LL + KISDFG++K D + T+G P PE +
Sbjct: 117 --VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA----KTHGKWPVKWYAPECM 170
Query: 612 KKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670
+S K DV+SFGVL+ + S ++ + +E +E G+ P
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE---------SGERMECP- 220
Query: 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P ++ + M+ LC ++RP V L++
Sbjct: 221 ---QRCPPEMYDLMK---LCWTYGVDERPGFAVVELRLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 59/199 (29%), Positives = 102/199 (51%), Gaps = 13/199 (6%)
Query: 442 KLGEGGFGPVYKG--NLPRGQ-EFAVKRLSATSTQGL-EEFKNEVSLTARLQHVNLLRVL 497
+LG G FG V KG + + Q + A+K L + + + +E E + +L + ++R++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
G C E + ML+ E L+ +L ++ + V ++ V+ G+ YL+ NF
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEG-KNF- 116
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY--GYVPPEYVKKGI 615
+HRDL A N+LL N+ KISDFG++K D D R G + + PE +
Sbjct: 117 -VHRDLAARNVLLVNQHYAKISDFGLSKALGAD-DSYYKARSAGKWPLKWYAPECINFRK 174
Query: 616 YSMKYDVYSFGVLLLQIIS 634
+S + DV+S+G+ + + S
Sbjct: 175 FSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 2e-15
Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 13/214 (6%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEV 482
+ S D K F K+G+G G VY ++ GQE A+++++ E NE+
Sbjct: 12 IVSVGDPKKKYTRFE---KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
+ ++ N++ L DE ++ EYL SL D + +D + +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
Q L +L +SN +VIHRD+K+ NILL + + K++DFG +++ +VGT
Sbjct: 125 CLQALEFL--HSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGT 179
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
++ PE V + Y K D++S G++ +++I +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 72/284 (25%), Positives = 123/284 (43%), Gaps = 52/284 (18%)
Query: 443 LGEGGFGPVYKG--NLPRGQEFAVK----RLSATSTQGLEEFKNEVSLTARLQHVNLLRV 496
LG G FG + +G LP +E V R + Q F E + H N++R+
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALTLGQFDHSNIVRL 71
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRY--VLDWQKRVNIIEGVTQGLLYLQEYS 554
G T + M++ EY+ N +LD +L R++ L + + ++ G+ G+ YL E
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFL----RKHEGQLVAGQLMGMLPGLASGMKYLSEMG 127
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG------YVPP 608
+H+ L A +L++++L KIS F + +D EA I T + P
Sbjct: 128 ---YVHKGLAAHKVLVNSDLVCKISGFRRLQ---EDKSEA----IYTTMSGKSPVLWAAP 177
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668
E ++ +S DV+SFG+++ +++S Y + D G++ I
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMS------------------YGERPYWDMSGQDVIK 219
Query: 669 PSLDDSSSPCKLLNC----MQVALLCVQENPEDRPSMLEVSSML 708
D P NC Q+ L C Q+ +RP ++ S+L
Sbjct: 220 AVEDGFRLPAP-RNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 70/283 (24%), Positives = 123/283 (43%), Gaps = 31/283 (10%)
Query: 436 NFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSA---TSTQGLEEFKNEVSLTARLQHV 491
NF K+G G F VY+ L G A+K++ + + E+ L +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYL--FDPIRRYVLD---WQKRVNIIEGVTQG 546
N+++ E +E ++ E L + F +R + + W+ V +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA---- 118
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
L+ + RV+HRD+K +N+ + K+ D G+ + F A++ +VGT Y+
Sbjct: 119 ---LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666
PE + + Y+ K D++S G LL ++ + + + +YG NL L EQ
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKMNLYSLCKKIEQCDYPP---- 227
Query: 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709
PS S +L+N +C+ +PE RP + V + K
Sbjct: 228 -LPSDHYSEELRQLVN------MCINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 79/282 (28%), Positives = 119/282 (42%), Gaps = 29/282 (10%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFA---VKRLSATST-QGLEEFKNEVSLTARLQHVNLLRV 496
+++G G FG V G RG A VK L A++T F EV L H N+L+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV--NIIEGVTQGLLYLQEYS 554
LG C E +L+ E+ P L YL QK V + V GLL+L + +
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-A 119
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMA-KLFRKDVDEANTGRIVGTYGYVPPEYVK- 612
+F IH DL N L +L+ KI D+G+A + + +D V ++ PE V+
Sbjct: 120 DF--IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEI 176
Query: 613 -----KGIYSMKY-DVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666
K +++S GV + ++ + Y + L+ + +D K
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL--FTAADQPYPDLSDEQVLKQVVRE-QDIK---L 230
Query: 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSML 708
P LD S + MQ L +PE RP+ EV +L
Sbjct: 231 PKPQLDLKYSD-RWYEVMQFCWL----DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 436 NFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHV 491
+F +G+G FG V + FA+K ++ + NE + L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH- 59
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN------IIEGVTQ 545
L L Y + +ENM YL +DL L +R Y L + + + I +
Sbjct: 60 PFLVNLWYSFQDEENM----YL---VVDLLLGGDLR-YHLSQKVKFSEEQVKFWICEIVL 111
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
L YL +IHRD+K NILLD + + I+DF +A D T GT GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGY 165
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
+ PE + + YS+ D +S GV + + KR
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 42/124 (33%), Positives = 69/124 (55%), Gaps = 13/124 (10%)
Query: 511 EYLPNKSLD--LYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNI 568
E++ SLD PI +L I V +GL YL Y+ R++HRD+K SNI
Sbjct: 83 EFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYL--YNVHRIMHRDIKPSNI 135
Query: 569 LLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVL 628
L+++ K+ DFG++ + A+T VGT Y+ PE ++ G Y++K DV+S G+
Sbjct: 136 LVNSRGQIKLCDFGVSGELINSI--ADT--FVGTSTYMSPERIQGGKYTVKSDVWSLGIS 191
Query: 629 LLQI 632
++++
Sbjct: 192 IIEL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQG-LEEFKNEVSLTARLQHVNLL 494
F+ K+G+G FG V+KG R Q+ A+K + + +E+ + E+++ ++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 495 RVLGYCTERDENMLIYEYLPNKS-LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
+ G + + +I EYL S LDL P LD + I+ + +GL YL
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE 120
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
+ IHRD+KA+N+LL K++DFG+A + N VGT ++ PE +K+
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIKQ 175
Query: 614 GIYSMKYDVYSFGVLLLQI 632
Y K D++S G+ +++
Sbjct: 176 SAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 57/197 (28%), Positives = 103/197 (52%), Gaps = 13/197 (6%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
+LG+G FG VYK N G A K + S + LE++ E+ + A H N++++L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
+ ++ E+ ++D + + + R + + Q RV + + + L YL E ++IH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRV-VCKQTLEALNYLHEN---KIIH 126
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV-----KKGI 615
RDLKA NIL + + K++DFG++ + + ++ +GT ++ PE V K
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRP 184
Query: 616 YSMKYDVYSFGVLLLQI 632
Y K DV+S G+ L+++
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 70/274 (25%), Positives = 127/274 (46%), Gaps = 32/274 (11%)
Query: 443 LGEGGFGPVYKGNL----PRGQEFAVKRLSA-TSTQGLEEFKNEVSLTARLQHVNLLRVL 497
+G+G FG VY G L + AVK L+ T + +E+F E + H N+L +L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 498 GYCTERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
G C + + +++ Y+ + L ++ + + + V +G+ YL ++
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV--KDLIGFGLQVAKGMEYL---ASK 117
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAK-LFRKD---VDEANTGRIVGTYGYVPPEYVK 612
+ +HRDL A N +LD K++DFG+A+ ++ K+ V ++ ++ E ++
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL--PVKWMALESLQ 175
Query: 613 KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672
++ K DV+SFGVLL ++++ R A Y ++ + Y +G+ + P
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVDSFDITVYLL------QGRRLLQPEY- 226
Query: 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706
P L M L C PE RP+ E+ S
Sbjct: 227 ---CPDPLYEVM---LSCWHPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 19/212 (8%)
Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRL-----SATSTQGLEEFKNEVSLTARLQ 489
N+ LG+G FG VY ++ G+E A K++ S +++ + + E+ L LQ
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 490 HVNLLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRY-VLDWQKRVNIIEGVTQG 546
H +++ G +R E L EY+P S+ D ++ Y L + +G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEG 118
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG--RIVGTYG 604
+ YL +SN ++HRD+K +NIL D+ N K+ DFG +K + + + TG + GT
Sbjct: 119 MSYL--HSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRLQT-ICMSGTGIRSVTGTPY 174
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
++ PE + Y K DV+S G ++++++ K
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 62/217 (28%), Positives = 119/217 (54%), Gaps = 21/217 (9%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLS-ATSTQGLEEFK-NEVSLTARLQ---HVNLL 494
++GEG +G VYK +L G+ A+K++ S +G+ E++L +L+ H N++
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 495 RVLGYC-TERDEN----MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
R+L C R + L++E++ ++ L YL + L + +++ + +G+ +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
L +S+ R++HRDLK NIL+ ++ KI+DFG+A+++ + A T +V T Y PE
Sbjct: 123 L--HSH-RIVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTS-VVVTLWYRAPE 176
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
+ + Y+ D++S G + ++ +R + GTSE
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL--FRRRPLFRGTSE 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 54/199 (27%), Positives = 104/199 (52%), Gaps = 13/199 (6%)
Query: 437 FSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQG-LEEFKNEVSLTARLQHVNLL 494
F+ ++G+G FG V+KG R Q+ A+K + + +E+ + E+++ ++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 495 RVLGYCTERDENMLIYEYLPNKS-LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
+ G + + +I EYL S LDL P + + +++ + +GL YL
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI-----ATMLKEILKGLDYLHSE 120
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
+ IHRD+KA+N+LL + + K++DFG+A + NT VGT ++ PE +++
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQ 175
Query: 614 GIYSMKYDVYSFGVLLLQI 632
Y K D++S G+ +++
Sbjct: 176 SAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 54/235 (22%), Positives = 110/235 (46%), Gaps = 26/235 (11%)
Query: 404 TPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEF 462
+S+ ++ S + S S+++ N++G G G VYK + P G+ +
Sbjct: 50 PSSSSSSSSSSSASGSAPSAAKSLSELE-------RVNRIGSGAGGTVYKVIHRPTGRLY 102
Query: 463 AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLY 521
A+K + + + E+ + + H N+++ E ++ E++ SL+
Sbjct: 103 ALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE-- 160
Query: 522 LFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDF 581
++ D Q ++ + G+ YL ++HRD+K SN+L+++ N KI+DF
Sbjct: 161 -----GTHIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADF 212
Query: 582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKY-----DVYSFGVLLLQ 631
G++++ + +D N+ VGT Y+ PE + + Y D++S GV +L+
Sbjct: 213 GVSRILAQTMDPCNSS--VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 59/200 (29%), Positives = 104/200 (52%), Gaps = 19/200 (9%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLEEFKNEVSLTARLQHVNLLRVLGY- 499
+G G +G VY+G ++P G+ A+K ++ T + + + EV+L ++L+ + Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 500 -CTERDENM-LIYEYLPNKSL-DLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
+ + +I EY S+ L PI +Y+ II V L Y+ +
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYI------SVIIREVLVALKYIHKVG- 121
Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI 615
VIHRD+KA+NIL+ N N K+ DFG+A L ++ + +T VGT ++ PE + +G
Sbjct: 122 --VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEGK 177
Query: 616 -YSMKYDVYSFGVLLLQIIS 634
Y K D++S G+ + ++ +
Sbjct: 178 YYDTKADIWSLGITIYEMAT 197
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 71/279 (25%), Positives = 130/279 (46%), Gaps = 34/279 (12%)
Query: 437 FSSANKLGEGGFG-PVYKGNLPRGQEFAVKRL--SATSTQGLEEFKNEVSLTARLQHVNL 493
+ K+GEG FG + + G+++ +K + S S + EE + EV++ + ++H N+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
++ E ++ +Y DLY +R VL + + I++ Q L L+
Sbjct: 62 VQYQESFEENGNLYIVMDYCEGG--DLYKKINAQRGVLFPEDQ--ILDWFVQICLALKHV 117
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
+ +++HRD+K+ NI L + K+ DFG+A++ V+ A T +GT Y+ PE +
Sbjct: 118 HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEICEN 175
Query: 614 GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673
Y+ K D+++ G +L ++ + L++AFE K + +
Sbjct: 176 RPYNNKSDIWALGCVLYEMCT----------------LKHAFEA---GNMKNLVLKIIRG 216
Query: 674 SSSPCKLLNCMQVALLCVQ---ENPEDRPSMLEVSSMLK 709
S P + L Q NP DRPS V+S+L+
Sbjct: 217 SYPPVSSHYSYDLRNLVSQLFKRNPRDRPS---VNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 24/218 (11%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRG---QEFAVKRLSATSTQG-LEEFKNEVSLTARL-Q 489
N+ + +GEG FG V K + + + A+KR+ +++ +F E+ + +L
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL-------FDPI------RRYVLDWQKR 536
H N++ +LG C R L EY P+ +L +L DP L Q+
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
++ V +G+ YL S + IHRDL A NIL+ KI+DFG+++ V +
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT-M 182
Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
GR+ ++ E + +Y+ DV+S+GVLL +I+S
Sbjct: 183 GRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 32/216 (14%)
Query: 436 NFSSANKLGEGGFGPVYKGNLPRGQEFAVKR---LSATSTQGLEEFKNEVSLTARLQHVN 492
+ K+GEG FG +Y E V + L+ + E K EV L A+++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGV--------- 543
++ E ++ EY D KR+N GV
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGG---------------DLMKRINRQRGVLFSEDQILS 105
Query: 544 --TQGLLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIV 600
Q L L+ + +++HRD+K+ NI L N + K+ DFG+A+ ++ A T V
Sbjct: 106 WFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CV 163
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
GT Y+ PE + Y+ K D++S G +L ++ + K
Sbjct: 164 GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 74/285 (25%), Positives = 126/285 (44%), Gaps = 40/285 (14%)
Query: 443 LGEGGFGPVYK-GNLPRGQEF-AVKRLSAT----------STQGLEEFKNEVSLT-ARLQ 489
LG G FG VYK GQ A+K ++ + + + +EV++ +L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQGLL 548
H N++R E D ++ + + L + + ++ ++ NI + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
YL + R++HRDL +NI+L + I+DFG+AK + E+ +VGT Y P
Sbjct: 128 YLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSCP 182
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668
E VK Y K DV++FG +L Q+ + +Y T N L A K + +
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCT--LQPPFYST----NMLSLAT---KIVEAV--YE 231
Query: 669 PSLDDSSSPCKLLNCMQVALL---CVQENPEDRPSMLEVSSMLKD 710
P + S V + C+ + E RP +++VS+M+ D
Sbjct: 232 PLPEGMYSE-------DVTDVITSCLTPDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 60/210 (28%), Positives = 108/210 (51%), Gaps = 36/210 (17%)
Query: 443 LGEGGFGPVYKGN-LPRGQEF----AVKRLSA-TSTQGLEEFKNEVSLTARLQHVNLLRV 496
LG G FG VYKG +P G+ A+K L TS + +E +E + A + + R+
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNIIEGVTQGLL 548
LG C L+ + +P L D +R + +L+W ++ +G+
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCL----LDYVRENKDRIGSQDLLNWCVQI------AKGMS 123
Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE----ANTGRIVGTYG 604
YL+E R++HRDL A N+L+ + + KI+DFG+A+L D+DE A+ G++
Sbjct: 124 YLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLL--DIDETEYHADGGKV--PIK 176
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
++ E + ++ + DV+S+GV + ++++
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 71/278 (25%), Positives = 129/278 (46%), Gaps = 27/278 (9%)
Query: 442 KLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
K+GEG G V G++ AVK++ Q E NEV + H N++ +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
DE ++ E+L +L D + ++ ++ + V + L YL N VIH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLH---NQGVIH 141
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKY 620
RD+K+ +ILL ++ K+SDFG K+V + + +VGT ++ PE + + Y +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGTEV 199
Query: 621 DVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKL 680
D++S G++++++I + Y L A + +D+ + P + DS +
Sbjct: 200 DIWSLGIMVIEMIDGEPP---YFNEPPLQ----AMRRIRDN-----LPPRVKDSHKVSSV 247
Query: 681 LNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAP 718
L + L+ V+E P R + E +L+ + +A P
Sbjct: 248 LRGF-LDLMLVRE-PSQRATAQE---LLQHPFLKLAGP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 68/286 (23%), Positives = 123/286 (43%), Gaps = 54/286 (18%)
Query: 443 LGEGGFGPVYK-GNLPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQH-VNLLRVLGY 499
LG G +G V K ++P G AVKR+ AT ++Q + ++ ++ R + G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG- 67
Query: 500 CTERDENMLIYEYLPNKSLD-LYLFDPIRRYVLDWQKRV------NIIEGVTQGLLYLQE 552
R+ ++ I + + SLD Y + V D + I + + L YL
Sbjct: 68 ALFREGDVWICMEVMDTSLDKFY------KKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV- 611
VIHRD+K SN+L++ K+ DFG++ VD G Y+ PE +
Sbjct: 122 --KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL---VDSVAKTIDAGCKPYMAPERIN 176
Query: 612 ----KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKD--SKGKE 665
+KG Y +K DV+S G+ ++++ + + + ++ WK + K+
Sbjct: 177 PELNQKG-YDVKSDVWSLGITMIELATGR----------------FPYDSWKTPFQQLKQ 219
Query: 666 FID---PSL-DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707
++ P L + SP C+++N ++RP+ E+
Sbjct: 220 VVEEPSPQLPAEKFSP----EFQDFVNKCLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 66/275 (24%), Positives = 120/275 (43%), Gaps = 31/275 (11%)
Query: 436 NFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQHV 491
NF K+G G F VY+ L + A+K++ + ++ E+ L +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLD--LYLFDPIRRYVLD---WQKRVNIIEGVTQG 546
N+++ L E +E ++ E L + F +R + + W+ V + V
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV--- 119
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
+ + RV+HRD+K +N+ + K+ D G+ + F A++ +VGT Y+
Sbjct: 120 ----EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666
PE + + Y+ K D++S G LL ++ + + +YG NL L EQ
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM--AALQSPFYGDKMNLFSLCQKIEQCD------- 224
Query: 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSM 701
P L KL ++ +C+ +P+ RP +
Sbjct: 225 -YPPLPTEHYSEKL---RELVSMCIYPDPDQRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-14
Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 32/218 (14%)
Query: 443 LGEGGFGPVY--------KGNLPRGQEFAVKRLSATST-QGLEEFKNEVSLTARL-QHVN 492
LGEG FG V K + AVK L +T + L + +E+ L + +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL-----------FDPIR--RYVLDWQKRVNI 539
++ +LG CT+ +I EY +L +L FD + L ++ V+
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD---EANT 596
V +G+ YL+ R IHRDL A N+L+ + KI+DFG+A+ D+D + +
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVH-DIDYYKKTSN 195
Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
GR+ ++ PE + +Y+ + DV+SFG+L+ +I +
Sbjct: 196 GRL--PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 437 FSSANKLGEGGFGPVYKGNL-----PRGQEFAVKRLS--ATSTQGLEEFKNEVSLTARLQ 489
+ ++ L EG FG ++ G L + +E VK + A+ Q + E L L
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ-VTLLLQESCLLYGLS 66
Query: 490 HVNLLRVLGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYV-------LDWQKRVNIIE 541
H N+L +L C E + ++Y Y+ +L L+L R L Q+ V++
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQC--RLGEANNPQALSTQQLVHMAI 124
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVD--EANTGR 598
+ G+ YL + VIH+D+ A N ++D EL KI+D +++ LF D N R
Sbjct: 125 QIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR 181
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
V ++ E + YS DV+SFGVLL ++++
Sbjct: 182 PV---KWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 52/196 (26%), Positives = 96/196 (48%), Gaps = 10/196 (5%)
Query: 442 KLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
K+GEG G V + G+ AVK++ Q E NEV + QH N++ +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
DE ++ E+L +L D + ++ ++ + V + L L VIH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKY 620
RD+K+ +ILL ++ K+SDFG K+V + +VGT ++ PE + + Y +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGPEV 197
Query: 621 DVYSFGVLLLQIISSK 636
D++S G+++++++ +
Sbjct: 198 DIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 446 GGFGPVY---KGNLPRGQEFAVKRLSATSTQG---LEEFKNEVSLTARLQHVNLLRVLGY 499
G +G V+ K + G +A+K + +++ E + ++ Q +++ L Y
Sbjct: 4 GAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK-LYY 60
Query: 500 CTERDENM-LIYEYLPNKSLDLY-LFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
+ +N+ L+ EYLP DL L + + LD I + L YL +
Sbjct: 61 SFQGKKNLYLVMEYLPGG--DLASLLENVG--SLDEDVARIYIAEIVLALEYLH---SNG 113
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKL------FRKDVDEANTGRIVGTYGYVPPEYV 611
+IHRDLK NIL+D+ + K++DFG++K+ + DE RIVGT Y+ PE +
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 612 KKGIYSMKYDVYSFGVLLLQIIS 634
+S D +S G +L + +
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 13/207 (6%)
Query: 443 LGEGGFGPVYKGNLP-RGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLG 498
LG+GGFG V + G+ +A K+L +G + NE + ++ + L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLA 59
Query: 499 YCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
Y E +D+ L+ + L ++++ + + + + GL +L R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYN-VGEPGFPEARAIFYAAQIICGLEHLH---QRR 115
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYS 617
+++RDLK N+LLD+ N +ISD G+A + GT GY+ PE ++ +Y
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELK---GGKKIKGRAGTPGYMAPEVLQGEVYD 172
Query: 618 MKYDVYSFGVLLLQIISSKRNARYYGT 644
D ++ G L ++I+ + R
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPFRQRKE 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 57/218 (26%), Positives = 111/218 (50%), Gaps = 29/218 (13%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFK----NEVSLTARLQHV 491
F ++GEG +G VYK + G+ A+K++ + + E F E+ + +L H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHR 66
Query: 492 NLLRVLGYCTERDENM----------LIYEYLPNKSLDLYLFDPIRRYVLDWQKR--VNI 539
N++ + T++ + + L++EY+ D L + ++ + + +
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKSF 121
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI 599
++ + +GL Y + NF +HRD+K SNILL+N+ K++DFG+A+L+ + T ++
Sbjct: 122 MKQLLEGLNYCHK-KNF--LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 600 VGTYGYVPPE-YVKKGIYSMKYDVYSFGVLLLQIISSK 636
+ T Y PPE + + Y DV+S G +L ++ + K
Sbjct: 179 I-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|225862 COG3325, ChiA, Chitinase [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-13
Identities = 78/396 (19%), Positives = 136/396 (34%), Gaps = 111/396 (28%)
Query: 36 GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQ-------------------QYF 76
+++ DI TH+ AF +++S + A++
Sbjct: 52 RQDYFPGDIPLDQLTHINYAFLDINSDGKSIESWVADEAALYGVPNIEGVELDPWSDPLK 111
Query: 77 SIFA--NSVRRKNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFI 132
F ++ P +KTL+SI W+ S M D + R++F
Sbjct: 112 GHFGALFDLKATYPDLKTLISIGGWSDSGG---------------FSDMAADDASRENFA 156
Query: 133 ESSIRTARLYGFQGIDLFWLWPNS-----------------TDLNSLGILLDEWKASASD 175
+S++ R YGF G+D+ W +P S L L LD+ A D
Sbjct: 157 KSAVEFMRTYGFDGVDIDWEYPGSGGDAGNCGRPKDKANYVLLLQELRKKLDK--AGVED 214
Query: 176 QPELTLSMAVRYSPTHETVSY-PIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPS 234
L++A + + + + + +++ +++ YD+H E G HAALY
Sbjct: 215 GRHYQLTIAA--PASKDKLEGLNHAEIAQYVDYINIMTYDFHGAWNET-LGHHAALYGTP 271
Query: 235 -------------SNISTDFGIREWLRRGFPANKLVLGARASGPGITI------------ 269
+ + + E P +KLVLG G G
Sbjct: 272 KDPPLANGGFYVDAEVDGIDWLEEGFAGDVPPSKLVLGMPFYGRGWNGVDGGSLGTCPGL 331
Query: 270 ----------DGSMG-----YKFIRAFI--QN------YGYGAAPVYNASYVVNLFTSGA 306
G+ + +A+ N Y V A Y+ N
Sbjct: 332 YQGLDNSGIPKGTWEAGNGDKDYGKAYDLDANNAGKNGYERYWDDVAKAPYLYN--PEKG 389
Query: 307 TWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDN 342
+I++D ++KAK Y + NL G +++S D+N
Sbjct: 390 VFISYDDPRSVKAKAEYVADNNLGGMMFWEISGDEN 425
|
Length = 441 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 28/212 (13%)
Query: 443 LGEGGFGPVYKGNLPRG---QEFAVKRLSATSTQG-LEEFKNEVSLTARL-QHVNLLRVL 497
+GEG FG V + + + A+K L +++ +F E+ + +L H N++ +L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 498 GYCTERDENMLIYEYLPNKSLDLYL-------FDPI------RRYVLDWQKRVNIIEGVT 544
G C R + EY P +L +L DP L Q+ + V
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
G+ YL E + IHRDL A N+L+ L KI+DFG+++ +E + +G
Sbjct: 130 TGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTMGRLP 181
Query: 605 --YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
++ E + +Y+ K DV+SFGVLL +I+S
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 66/202 (32%), Positives = 106/202 (52%), Gaps = 17/202 (8%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVK--RLSATSTQGLEEFK-NEVSLTARLQHVNLLRVL 497
K+GEG +G VYK + G+ A+K RL T +G+ E+SL L H N++R+L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLE-TEDEGVPSTAIREISLLKELNHPNIVRLL 64
Query: 498 GYCTERDENMLIYEYLPNKSLDL--YLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
++ L++E+L LDL Y+ D LD + + + QG+ Y +S+
Sbjct: 65 DVVHSENKLYLVFEFL---DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYC--HSH 118
Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG- 614
RV+HRDLK N+L+D E K++DFG+A+ F V T +V T Y PE +
Sbjct: 119 -RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RTYTHEVV-TLWYRAPEILLGSR 175
Query: 615 IYSMKYDVYSFGVLLLQIISSK 636
YS D++S G + ++++ +
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 58/212 (27%), Positives = 105/212 (49%), Gaps = 19/212 (8%)
Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRL-----SATSTQGLEEFKNEVSLTARLQ 489
N+ LG+G FG VY + G+E AVK++ S +++ + + E+ L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 490 HVNLLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRY-VLDWQKRVNIIEGVTQG 546
H +++ G + E L E++P S+ D ++ Y L + +G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTRKYTRQILEG 118
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG--RIVGTYG 604
+ YL +SN ++HRD+K +NIL D+ N K+ DFG +K + + + TG + GT
Sbjct: 119 VSYL--HSNM-IVHRDIKGANILRDSVGNVKLGDFGASKRLQT-ICLSGTGMKSVTGTPY 174
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
++ PE + Y K D++S G ++++++ K
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 59/217 (27%), Positives = 116/217 (53%), Gaps = 22/217 (10%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEF-AVKRLSA-TSTQGLE-EFKNEVSLTARLQ---HVNLL 494
++GEG +G V+K +L G F A+KR+ T +G+ EV++ L+ H N++
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 495 RVLGYCT----ERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
R+ CT +R+ + L++E++ ++ L YL D + + + +++ + +GL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
L + RV+HRDLK NIL+ + K++DFG+A+++ + +V T Y PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPE 179
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
+ + Y+ D++S G + ++ +R + G+S+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMF--RRKPLFRGSSD 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 66/217 (30%), Positives = 110/217 (50%), Gaps = 30/217 (13%)
Query: 443 LGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARL-QHVN 492
LGEG FG V K R + AVK L + +T+ L + +E+ + + +H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL-----------FDP--IRRYVLDWQKRVNI 539
++ +LG CT+ +I EY +L YL ++P + L ++ V+
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANT-G 597
V +G+ YL ++ + IHRDL A N+L+ + KI+DFG+A+ + D + T G
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
R+ ++ PE + IY+ + DV+SFGVLL +I +
Sbjct: 203 RL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 19/212 (8%)
Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRL-----SATSTQGLEEFKNEVSLTARLQ 489
N+ LG G FG VY + G+E AVK++ S +++ + + E+ L L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 490 HVNLLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRY-VLDWQKRVNIIEGVTQG 546
H +++ G + +E L EY+P S+ D ++ Y L + QG
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQG 118
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG--RIVGTYG 604
+ YL +SN ++HRD+K +NIL D+ N K+ DFG +K + + + TG + GT
Sbjct: 119 VSYL--HSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRIQT-ICMSGTGIKSVTGTPY 174
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
++ PE + Y K DV+S ++++++ K
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-13
Identities = 53/168 (31%), Positives = 79/168 (47%), Gaps = 17/168 (10%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
V +G+ +L ++ + IHRDL A NILL KI DFG+A+ KD D G
Sbjct: 182 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662
++ PE + +Y+ + DV+SFGVLL +I S + Y G + F +
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP-YPGVQIDEEFC---------RR 288
Query: 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
KE + ++P + L C NPEDRP+ E+ +L D
Sbjct: 289 LKEGTRMRAPEYATP----EIYSIMLDCWHNNPEDRPTFSELVEILGD 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 42/132 (31%), Positives = 65/132 (49%), Gaps = 15/132 (11%)
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
+L L+ N V++RDLK +NILLD + +ISD G+A F K A+ VGT+GY+
Sbjct: 107 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYM 162
Query: 607 PPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665
PE ++KG+ Y D +S G +L +++ R + T + +
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----------DRMTL 212
Query: 666 FIDPSLDDSSSP 677
+ L DS SP
Sbjct: 213 TMAVELPDSFSP 224
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 28/212 (13%)
Query: 443 LGEGGFGPVYKGNLPRG---QEFAVKRLSATSTQG-LEEFKNEVSLTARL-QHVNLLRVL 497
+GEG FG V K + + + A+KR+ +++ +F E+ + +L H N++ +L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 498 GYCTERDENMLIYEYLPNKSLDLYL-------FDPI--RRY----VLDWQKRVNIIEGVT 544
G C R L EY P+ +L +L DP L Q+ ++ V
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
+G+ YL + + IHRDL A NIL+ KI+DFG+++ E + +G
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLP 174
Query: 605 --YVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
++ E + +Y+ DV+S+GVLL +I+S
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 28/200 (14%)
Query: 433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFK----NEVSLTAR 487
++ KLGEG FG VYK + G+ A+K++ + + + F E+ + +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKK 63
Query: 488 LQHVNLLRVLGYCTERDENML-----IYEYLPNKSLDL--YLFDPIRRYVLDWQKRVNII 540
L+H N++ ++ ER + +Y P DL L +P L + +
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP--SVKLTESQIKCYM 121
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
+ +G+ YL E ++HRD+KA+NIL+DN+ KI+DFG+A+ + G
Sbjct: 122 LQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 601 GTYGYV---------PPEYV 611
GT Y PPE +
Sbjct: 179 GTRKYTNLVVTRWYRPPELL 198
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 9e-13
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 34/209 (16%)
Query: 443 LGEGGFG-PVYKGNLPRGQEFAVKRLS-ATSTQGLEEFKNEVSLTARLQHVNLLR----- 495
+GEG FG + ++ Q++A+K + S+ +E+ + E L A+++H N++
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 496 --------VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
V+ YC D + + + + L+ D I L W Q
Sbjct: 68 EADGHLYIVMEYCDGGD----LMQKIKLQRGKLFPEDTI----LQW---------FVQMC 110
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
L +Q RV+HRD+K+ NI L K+ DFG A+L A T VGT YVP
Sbjct: 111 LGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVP 168
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
PE + Y+ K D++S G +L ++ + K
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 67/279 (24%), Positives = 121/279 (43%), Gaps = 45/279 (16%)
Query: 443 LGEGGFGP--VYK----GNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRV 496
LG+G FG +Y+ +L +E + RLS + + NE+ + + LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHPNIIAY 64
Query: 497 LGYCTERDENMLIYEYLPNKSL-------DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
+ + + ++ EY +L LF+ VL + + + + Y
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE--EEMVLWY------LFQIVSAVSY 116
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
+ + ++HRD+K NI L K+ DFG++K+ + A T +VGT Y+ PE
Sbjct: 117 IHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPE 171
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669
+ Y+ K D+++ G +L ++++ KR T + N L K +G P
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYELLTLKR------TFDATNPLNLV---VKIVQGNY--TP 220
Query: 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSML 708
+ SS + +Q++PE RP+ EV
Sbjct: 221 VVSVYSSELI-----SLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 436 NFSSANKLGEGGFGPVY----KGNLPRGQEFAVKRLSATS----TQGLEEFKNEVSLTAR 487
NF LG G +G V+ G G+ +A+K L + + E + E +
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 488 LQHVNLLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
++ L L Y + D + LI +Y+ L +L+ R + + + RV I E V
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIV--- 115
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
L L +I+RD+K NILLD+E + ++DFG++K F + +E GT Y+
Sbjct: 116 -LALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-EEERAYSFCGTIEYM 173
Query: 607 PPEYVKKGI--YSMKYDVYSFGVLLLQIIS 634
PE ++ G + D +S GVL ++++
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 29/213 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN----EVSLTARLQ 489
N + +GEG +G V K N G+ A+K+ + E+ K EV + +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLR 58
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDL-----YLFDP--IRRYVLDWQKRVNIIEG 542
H N++ + + L++EY+ L+L P +R Y+ WQ
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYI--WQ-------- 108
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
+ Q + Y +S+ +IHRD+K NIL+ K+ DFG A+ R T V T
Sbjct: 109 LLQAIAYC--HSH-NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT-DYVAT 164
Query: 603 YGYVPPE-YVKKGIYSMKYDVYSFGVLLLQIIS 634
Y PE V Y DV++ G ++ +++
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 33/214 (15%)
Query: 436 NFSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGL---EEFKNEVSLTARLQHV 491
+ +G G FG V+ + + A+K ++ L + NE + + H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 492 NLLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
++R+ + TE D+ L + EY+P L YL + R+ + GL Y
Sbjct: 62 FIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNS-GRF------------SNSTGLFY 106
Query: 550 -------LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
L+ + +++RDLK NILLD E + K++DFG AK K D T + GT
Sbjct: 107 ASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK---KLRDRTWT--LCGT 161
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
Y+ PE ++ ++ D ++ G+L+ +++
Sbjct: 162 PEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 32/218 (14%)
Query: 443 LGEGGFGPVY--------KGNLPRGQEFAVKRLSATST-QGLEEFKNEVSLTARL-QHVN 492
LGEG FG V K + AVK L +T + L + +E+ + + +H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL-----------FDPIR--RYVLDWQKRVNI 539
++ +LG CT+ ++ EY +L YL FD + L ++ V+
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD---EANT 596
V +G+ YL ++ + IHRDL A N+L+ + KI+DFG+A+ ++D +
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH-NIDYYKKTTN 195
Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
GR+ ++ PE + +Y+ + DV+SFGVLL +I +
Sbjct: 196 GRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 52/199 (26%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 442 KLGEGGFGPVYKG--NLPRGQEF--AVKRLSATSTQGL-EEFKNEVSLTARLQHVNLLRV 496
+GEG FG VY+G P ++ AVK ++ + E+F E + + H +++++
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
+G TE + ++ E P L YL + +Y LD + ++ L YL E F
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYL-ESKRF 128
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKD-VDEANTGRIVGTYGYVPPEYVKKGI 615
+HRD+ A N+L+ + K+ DFG+++ + +A+ G++ ++ PE +
Sbjct: 129 --VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PIKWMAPESINFRR 184
Query: 616 YSMKYDVYSFGVLLLQIIS 634
++ DV+ FGV + +I+
Sbjct: 185 FTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 62/235 (26%), Positives = 105/235 (44%), Gaps = 26/235 (11%)
Query: 437 FSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSAT--STQGLEEFKNEVSLTARLQH 490
F+ LG+G FG V + L Q+ AVK L A S+ +EEF E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 491 VNLLRVLGYCTERDEN------MLIYEYLPNKSLDLYLFDPIRR-----YVLDWQKRVNI 539
N+++++G M+I ++ K DL+ F + R + L Q V
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFM--KHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA-KLFRKDVDEANTGR 598
+ + G+ YL S+ IHRDL A N +L+ + ++DFG++ K++ D
Sbjct: 119 MIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEY 653
+ ++ E + +Y+ DV++FGV + +I++ R Y EN Y
Sbjct: 176 KLPV-KWLALESLADNVYTTHSDVWAFGVTMWEIMT--RGQTPYAGVENSEIYNY 227
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 21/200 (10%)
Query: 443 LGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTAR------LQHVNLLR 495
LG+G FG V+ L Q FA+K L L + E ++ + +H L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 496 VLGYCT-ERDENML-IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
+ YCT + EN+ + EYL L ++ ++ D + + GL +L
Sbjct: 61 L--YCTFQTKENLFFVMEYLNGGDL-MFHIQSCHKF--DLPRATFYAAEIICGLQFLHSK 115
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
+++RDLK NILLD + + KI+DFGM K + +A T GT Y+ PE +
Sbjct: 116 G---IVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLG 170
Query: 614 GIYSMKYDVYSFGVLLLQII 633
Y+ D +SFGVLL +++
Sbjct: 171 QKYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 62/216 (28%), Positives = 115/216 (53%), Gaps = 21/216 (9%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSA-TSTQGLE-EFKNEVSLTARLQ---HVNLLR 495
++G G +G VYK + G A+K + T+ GL EV+L RL+ H N++R
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 496 VLGYC----TERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL 550
++ C T+R+ + L++E++ ++ L YL D + L + +++ +GL +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
++N ++HRDLK NIL+ + K++DFG+A+++ + A T +V T Y PE
Sbjct: 125 --HAN-CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM--ALTPVVV-TLWYRAPEV 178
Query: 611 VKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
+ + Y+ D++S G + ++ +R + G SE
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSE 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 7e-12
Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 19/159 (11%)
Query: 481 EVSLTARLQHVNLLRVLGYCTERDENMLIYE-----YLPNKSLDLYLFDPIRRYVLDWQK 535
E L + H +++R+ + L+ LP+ S DLY + R L +
Sbjct: 107 EAMLLQNVNHPSVIRMK--------DTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQ 158
Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
+ I + + +GL YL R+IHRD+K NI +++ I D G A+ V
Sbjct: 159 ALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPA 212
Query: 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
+ GT PE + + Y+ K D++S G++L ++++
Sbjct: 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 56/198 (28%), Positives = 89/198 (44%), Gaps = 49/198 (24%)
Query: 442 KLGEGGFGPVYKG---NLPRGQEFAVKRLSATSTQ--GLEEFK-NEVSLTARLQHVNLLR 495
+G G +G VYK N G+E+A+K+ Q G+ + E++L L+H N++
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 496 VLGYCTERDENM--LIYEYLPNKSLDL-----YLFDPIRRYV-------LDWQKRVNIIE 541
++ E + L+++Y + DL + R + L WQ
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEH---DLWQIIKFHRQAKRVSIPPSMVKSLLWQ------- 116
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRK------DV 591
+ G+ YL +SN+ V+HRDLK +NIL+ E KI D G+A+LF D+
Sbjct: 117 -ILNGVHYL--HSNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172
Query: 592 DEANTGRIVGTYGYVPPE 609
D +V T Y PE
Sbjct: 173 D-----PVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 63/205 (30%), Positives = 92/205 (44%), Gaps = 31/205 (15%)
Query: 443 LGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLG--- 498
LG+G FG V L EF A+K L LE+ E ++ R RVL
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVV--LEDDDVECTMVER-------RVLALAW 53
Query: 499 --------YCTERDENMLIY--EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLL 548
+CT + + L + EYL L ++ R+ + R E + GL
Sbjct: 54 EHPFLTHLFCTFQTKEHLFFVMEYLNGGDL-MFHIQSSGRFDEA-RARFYAAE-IICGLQ 110
Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
+L + +I+RDLK N+LLD + + KI+DFGM K E GT Y+ P
Sbjct: 111 FLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKE--NMNGEGKASTFCGTPDYIAP 165
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQII 633
E +K Y+ D +SFGVLL +++
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
+F ++G G +G VYK N+ G+ A+K + + + E+ + +H N++
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 495 RVLGYCTERDENMLIYEYLPNKSL-DLY-LFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
G RD+ + E+ SL D+Y + P+ + + R + QGL YL
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHS 124
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV- 611
+HRD+K +NILL + + K++DFG++ + A +GT ++ PE
Sbjct: 125 KGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAA 179
Query: 612 --KKGIYSMKYDVYSFGVLLLQI 632
+KG Y+ D+++ G+ +++
Sbjct: 180 VERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 62/284 (21%)
Query: 443 LGEGGFGPVYKGNLPR----GQEFAVKRLSATSTQGLEE--FKNEVSLTARLQHVNLLR- 495
+G+G +G V +L R G+++ +K+L+ + E + E L ++L+H N++
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 496 -------------VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
V+G+C D +Y L + L V++W ++ +
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGD----LYHKLKEQKGKLLP----ENQVVEWFVQIAM--- 113
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
L YL E ++HRDLK N+ L K+ D G+A++ D A+T ++GT
Sbjct: 114 ---ALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR--NARYYGTSENLNFLEYAFEQWKD 660
Y+ PE Y+ K DV++ G + ++ + K NA+ ++N L Y + K
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK------DMNSLVYRIIEGKL 219
Query: 661 SKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
+ P L + + +L + PE RPS+ +
Sbjct: 220 PPMPKDYSPELGE----------LIATMLSKR--PEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-12
Identities = 53/168 (31%), Positives = 84/168 (50%), Gaps = 17/168 (10%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
V +G+ +L ++ + IHRDL A NILL KI DFG+A+ KD D G
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662
++ PE + +Y+ + DV+SFGVLL +I S + Y G N F ++ KD
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP-YPGVQINEEFC----QRLKD-- 292
Query: 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
G P ++++P ++ L C Q +P++RP+ + +L D
Sbjct: 293 GTRMRAP---ENATP----EIYRIMLACWQGDPKERPTFSALVEILGD 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 32/218 (14%)
Query: 443 LGEGGFGPVY--------KGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARL-QHVN 492
LGEG FG V K AVK L +T+ L + +E+ + + +H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL-----------FDPIR--RYVLDWQKRVNI 539
++ +LG CT+ +I EY +L YL +D R + ++ V+
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD---EANT 596
V +G+ YL ++ + IHRDL A N+L+ KI+DFG+A+ ++D +
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDV-NNIDYYKKTTN 198
Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
GR+ ++ PE + +Y+ + DV+SFGVL+ +I +
Sbjct: 199 GRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 37/94 (39%), Positives = 58/94 (61%), Gaps = 2/94 (2%)
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR-IVGTY 603
Q LL + + +IHRD+K++NILL + K+ DFG +K++ V + + GR GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD-DVGRTFCGTP 209
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
YV PE ++ YS K D++S GVLL ++++ KR
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-11
Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 26/195 (13%)
Query: 459 GQEFAVKRLSATSTQGLEE---FKNEVSLTARLQHVNLLRVL--GYCTERDENMLIYEYL 513
G E A+K L + + + F+ E +L ARL H N++ +L G ++EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGV---TQGLLYLQEYSNFRVIHRDLKASNILL 570
P ++L R VL + E Q L L N ++HRDLK NI++
Sbjct: 62 PGRTL---------REVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMV 112
Query: 571 ---DNELNPKISDFGMAKLFR--KDVDEAN---TGRIVGTYGYVPPEYVKKGIYSMKYDV 622
+ K+ DFG+ L +D D A T ++GT Y PE ++ + D+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 623 YSFGVLLLQIISSKR 637
Y++G++ L+ ++ +R
Sbjct: 173 YAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 38/104 (36%), Positives = 59/104 (56%), Gaps = 5/104 (4%)
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
T+ +L L+ N V++RDLK +NILLD + +ISD G+A F K A+ VGT+
Sbjct: 104 TEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTH 159
Query: 604 GYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
GY+ PE ++KG Y D +S G +L +++ R + T +
Sbjct: 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 32/205 (15%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLG-- 498
+GEG +G VYK + GQ A+K + + EE K E ++ + H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 499 ----YCTERDENMLIYEYLPNKSL-DLYLFDPIRRYVLDWQKRVN------IIEGVTQGL 547
D+ L+ E S+ DL + + KR+ I+ +GL
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKRLKEEWIAYILRETLRGL 126
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
YL E +VIHRD+K NILL K+ DFG++ + NT +GT ++
Sbjct: 127 AYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF--IGTPYWMA 181
Query: 608 PEYV-----KKGIYSMKYDVYSFGV 627
PE + Y + DV+S G+
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 443 LGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLG 498
LG+GGFG V + G+ +A K+L+ +G E E + A++ H + L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYV---------LDWQKRVNIIEGVTQGLLY 549
Y + ++ + + N +R ++ + + GL +
Sbjct: 60 YAFQTKTDLCLVMTIMNGG-------DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEH 112
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
L + R+I+RDLK N+LLDN+ N +ISD G+A + KD G GT G++ PE
Sbjct: 113 LHQR---RIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKG-YAGTPGFMAPE 167
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG 643
++ Y D ++ GV L ++I+++ R G
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 72/265 (27%), Positives = 125/265 (47%), Gaps = 34/265 (12%)
Query: 443 LGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNE-VSLTAR--LQHVN--LLRV 496
LG+GGFG V + G+ +A K+L + +++ K E ++L + L+ VN +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGEAMALNEKRILEKVNSRFVVS 64
Query: 497 LGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
L Y E +D L+ + L ++++ + D Q+ + + GL LQ
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQRE-- 121
Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT--GRIVGTYGYVPPEYVKK 613
R+++RDLK NILLD+ + +ISD G+A + E T GR VGT GY+ PE +
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGR-VGTVGYMAPEVINN 175
Query: 614 GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673
Y+ D + G L+ ++I + R E + E +D +E+ + +D
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPFRKR--KERVKREEVDRRVKEDQ--EEYSEKFSED 231
Query: 674 SSSPCKLLNCMQVALLCVQENPEDR 698
+ S C++L +NP++R
Sbjct: 232 AKSICRMLLT---------KNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
+++ ++G G +G VYK NL G+ AVK + + E+ + +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL-DLY-LFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
+ G R++ + EY SL D+Y + P+ + + R + QGL YL
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH 123
Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV 611
+HRD+K +NILL + + K++DFG+A + A +GT ++ PE
Sbjct: 124 SKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATI--AKRKSFIGTPYWMAPEVA 178
Query: 612 ---KKGIYSMKYDVYSFGVLLLQI 632
K G Y+ D+++ G+ +++
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 3e-11
Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 26/156 (16%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN--EV-SLTARLQHVNLLRVL 497
+LG+G FG VY N G+ A+K++ EE N EV SL +H N++++
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 498 GYCTERDENMLIYEYLPNKSLDLY------LFDP--IRRYVLDWQKRVNIIEGVTQGLLY 549
E DE ++EY+ L F IR +II + QGL +
Sbjct: 65 EVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIR----------SIIYQILQGLAH 114
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585
+ ++ F HRDLK N+L+ KI+DFG+A+
Sbjct: 115 IHKHGFF---HRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLL 494
F +G G +G VYKG ++ GQ A+K + T + EE K E+++ + H N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66
Query: 495 RVLGYCTER------DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLL 548
G ++ D+ L+ E+ S+ L + L + I + +GL
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT-DLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
+L ++ +VIHRD+K N+LL K+ DFG++ + V NT +GT ++ P
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAP 180
Query: 609 EYVK-----KGIYSMKYDVYSFGVLLLQI 632
E + Y K D++S G+ +++
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 443 LGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNE-VSLTAR--LQHVNLLRV-- 496
LG+GGFG V + G+ +A K+L + +++ K E ++L + L+ VN V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 497 LGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
L Y E +D L+ + L ++++ + D ++ V +T GL L
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYN-MGNPGFDEERAVFYAAEITCGLEDLHRE-- 121
Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI 615
R+++RDLK NILLD+ + +ISD G+A + E GR VGT GY+ PE VK
Sbjct: 122 -RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE--GETIRGR-VGTVGYMAPEVVKNER 177
Query: 616 YSMKYDVYSFGVLLLQIISSK 636
Y+ D + G L+ ++I K
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 35/221 (15%)
Query: 437 FSSAN-----KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQ 489
F++ + ++G G FG V K + P G AVKR+ +T + + ++ + R
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 490 H-VNLLRVLGYCTERDENMLIYEYLPNKSLD-LYLFDPIRRYVLDWQKRV---NIIEGVT 544
+++ G R+ + I L + SLD Y +YV + K V I+ +
Sbjct: 61 DCPYIVKFYG-ALFREGDCWICMELMDISLDKFY------KYVYEVLKSVIPEEILGKIA 113
Query: 545 ----QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA-KLFRKDVDEANTGRI 599
+ L YL+E ++IHRD+K SNILLD N K+ DFG++ +L VD R
Sbjct: 114 VATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL----VDSIAKTRD 167
Query: 600 VGTYGYVPPEYV----KKGIYSMKYDVYSFGVLLLQIISSK 636
G Y+ PE + + G Y ++ DV+S G+ L ++ + K
Sbjct: 168 AGCRPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 16/196 (8%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYC 500
LG G G VYK +L + AVK + T L+ + +E+ + + ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
+ + E++ SLD+Y I +VL I V +GL YL + +++H
Sbjct: 69 FVENRISICTEFMDGGSLDVY--RKIPEHVLG-----RIAVAVVKGLTYLW---SLKILH 118
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKY 620
RD+K SN+L++ K+ DFG++ + A T VGT Y+ PE + Y +
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKT--YVGTNAYMAPERISGEQYGIHS 174
Query: 621 DVYSFGVLLLQIISSK 636
DV+S G+ +++ +
Sbjct: 175 DVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 51/168 (30%), Positives = 76/168 (45%), Gaps = 17/168 (10%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
V +G+ +L ++ + IHRDL A NILL KI DFG+A+ KD D G
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662
++ PE + +Y+++ DV+SFGVLL +I S + Y G + F +
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFC---------RR 294
Query: 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
KE D ++P Q L C P RP+ E+ L +
Sbjct: 295 LKEGTRMRAPDYTTP----EMYQTMLDCWHGEPSQRPTFSELVEHLGN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 9e-11
Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 21/200 (10%)
Query: 443 LGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHV------NLLR 495
LG+G FG V L +G+ FAVK L + + ++V T + V N
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALK----KDVVLIDDDVECTMVEKRVLALAWENPFL 58
Query: 496 VLGYCT--ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
YCT ++ + E+L L ++ D R D + + GL +L
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSK 115
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
+I+RDLK N++LD + + KI+DFGM K + GT Y+ PE ++
Sbjct: 116 G---IIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQG 170
Query: 614 GIYSMKYDVYSFGVLLLQII 633
Y+ D +SFGVLL +++
Sbjct: 171 LKYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 9e-11
Identities = 61/232 (26%), Positives = 106/232 (45%), Gaps = 55/232 (23%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN-----------EVSLTARL 488
KLGEG + VYK + G+ A+K++ L E K E+ L L
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIK------LGERKEAKDGINFTALREIKLLQEL 59
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLP--------NKSLDLYLFDPIRRYVLDWQKRVNII 540
+H N++ +L + L++E++ +KS+ L D I+ Y+L
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPAD-IKSYMLM-------- 110
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI- 599
+GL YL +SN+ ++HRDLK +N+L+ ++ K++DFG+A+ F + R
Sbjct: 111 --TLRGLEYL--HSNW-ILHRDLKPNNLLIASDGVLKLADFGLARSF------GSPNRKM 159
Query: 600 ---VGTYGYVPPE--YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
V T Y PE + + Y + D++S G + +++ R G S+
Sbjct: 160 THQVVTRWYRAPELLFGAR-HYGVGVDMWSVGCIFAELL--LRVPFLPGDSD 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 43/172 (25%), Positives = 83/172 (48%), Gaps = 12/172 (6%)
Query: 442 KLGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQG--LEEFKNEVSLTARLQHVNLLRVLG 498
++GEG G V+K + G+ A+K+++ +G + E+ QH ++++L
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY-LQEYSNFR 557
+L+ EY+P+ DL + +R + ++ + LL +
Sbjct: 67 VFPHGSGFVLVMEYMPS---DLS--EVLRDEERPLPEA--QVKSYMRMLLKGVAYMHANG 119
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
++HRDLK +N+L+ + KI+DFG+A+LF ++ + + V T Y PE
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 15/198 (7%)
Query: 443 LGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTAR----LQHVN-LLRV 496
LG+G FG V L G+ +AVK L L++ E ++T + L + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
L C + + + N ++ RR+ D + +T L++L +
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF--DEARARFYAAEITSALMFLHDKG-- 116
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
+I+RDLK N+LLD+E + K++DFGM K + T GT Y+ PE +++ +Y
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLY 173
Query: 617 SMKYDVYSFGVLLLQIIS 634
D ++ GVLL +++
Sbjct: 174 GPSVDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 33/87 (37%), Positives = 46/87 (52%), Gaps = 5/87 (5%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
+ GL +L E +I+RDLK N+LLD+E + KI+DFGM K +T GT
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST--FCGT 159
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLL 629
Y+ PE + Y D ++ GVLL
Sbjct: 160 PDYIAPEILSYQPYGPAVDWWALGVLL 186
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 31/217 (14%)
Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQ-----GLEEFKNEVSLTARLQ 489
+ + + +GEG +G V + P G + A+K++S Q L E K + R +
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRFK 61
Query: 490 HVNLLRVLGYCTERD-ENM----LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT 544
H N++ +L E+ ++ E + DLY I+ L + +
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELMET---DLYKL--IKTQHLSNDHIQYFLYQIL 116
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VG 601
+GL Y+ +N V+HRDLK SN+LL+ + KI DFG+A++ D + +TG + V
Sbjct: 117 RGLKYIHS-AN--VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYVA 171
Query: 602 TYGYVPPEYV--KKGIYSMKYDVYSFGVLLLQIISSK 636
T Y PE + KG Y+ D++S G +L +++S++
Sbjct: 172 TRWYRAPEIMLNSKG-YTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 34/211 (16%)
Query: 442 KLGEGGFGPVYKGNLPRGQE-FAVK--RLSATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
K+GEG +G VYK E A+K RL E+SL +QH N++R+
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 499 YCTERDENMLIYEYL-----------PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
L++EYL P+ + + L I+ Y+ +Q + +G+
Sbjct: 69 VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRL---IKTYL--YQ--------ILRGI 115
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
Y + RV+HRDLK N+L+D N K++DFG+A+ F V T +V T Y
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-RTFTHEVV-TLWYR 170
Query: 607 PPE-YVKKGIYSMKYDVYSFGVLLLQIISSK 636
PE + YS D++S G + ++++ K
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 21/209 (10%)
Query: 437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNE-VSLTAR--LQHVN 492
F LG+GGFG V + G+ +A K+L + +++ K E ++L + L+ VN
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGESMALNEKQILEKVN 58
Query: 493 --LLRVLGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
+ L Y E +D L+ + L +++ + + + V + GL
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH-MGEAGFEEGRAVFYAAEICCGLED 117
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT--GRIVGTYGYVP 607
L + R+++RDLK NILLD+ + +ISD G+A V E T GR VGT GY+
Sbjct: 118 LHQE---RIVYRDLKPENILLDDHGHIRISDLGLA----VHVPEGQTIKGR-VGTVGYMA 169
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
PE VK Y+ D ++ G LL ++I+ +
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 2e-10
Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 29/198 (14%)
Query: 443 LGEGGFGPV----YKGNLPRGQEFAVKRLS----ATSTQGLEEFKNEVSLTARLQHVNLL 494
LG G FG V +KG+ G+ +A+K LS Q +E NE + ++H L+
Sbjct: 9 LGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLV 64
Query: 495 RVLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
+ G + +D++ L + EY+P L R+ R + V L YL
Sbjct: 65 NLYG--SFQDDSNLYLVMEYVPGGEL-FSHLRKSGRFPEP-VARFYAAQ-VVLALEYLH- 118
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV- 611
+ +++RDLK N+LLD++ KI+DFG AK + T + GT Y+ PE +
Sbjct: 119 --SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYLAPEIIL 171
Query: 612 KKGIYSMKYDVYSFGVLL 629
KG Y D ++ G+L+
Sbjct: 172 SKG-YGKAVDWWALGILI 188
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 52/203 (25%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 443 LGEGGFGPVYKGNLPR-GQEFAVK-----RLSATSTQGLEEFKNEVSLTARLQHVNLLRV 496
LG+GGFG V + G+ +A K RL S + + + E+ L+ VN +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI-----LEKVNSPFI 55
Query: 497 --LGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
L Y E ++ L+ + L ++++ R L+ ++ ++ +T G+L+L
Sbjct: 56 VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQITCGILHLHS- 113
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
+++RD+K N+LLD++ N ++SD G+A + D + GT GY+ PE +K+
Sbjct: 114 --MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK---DGKTITQRAGTNGYMAPEILKE 168
Query: 614 GIYSMKYDVYSFGVLLLQIISSK 636
YS D ++ G + ++++ +
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 34/217 (15%)
Query: 436 NFSSANKLGEGGFGPVYKGNLPRGQEF-AVKR---------LSATSTQGLEEFKNEVSLT 485
F N++GEG +G VY+ E A+K+ + +S + E++L
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-------EITLL 60
Query: 486 ARLQHVNLLRVLGYCTER--DENMLIYEYLPNKSLDL-YLFDPIRRYVLDWQKRVNIIEG 542
L+H N++ + + D L+ EY DL L D + + Q + ++
Sbjct: 61 LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ---DLASLLDNMPTPFSESQVKC-LMLQ 116
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
+ +GL YL E NF +IHRDLK SN+LL ++ KI+DFG+A+ + + T ++V T
Sbjct: 117 LLRGLQYLHE--NF-IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-T 171
Query: 603 YGYVPPEYV---KKGIYSMKYDVYSFGVLLLQIISSK 636
Y PE + Y+ D+++ G +L ++++ K
Sbjct: 172 LWYRAPELLLGCTT--YTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 55/196 (28%), Positives = 98/196 (50%), Gaps = 14/196 (7%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATS-TQGLEEFK-NEVSLTARLQHVNLLRVLG 498
K+GEG +G V+K N + A+KR+ +G+ E+ L L+H N++R+
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
+ L++EY ++ L Y FD + D + + + + +GL + + V
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGDI-DPEIVKSFMFQLLKGLAFCHSH---NV 120
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG--IY 616
+HRDLK N+L++ K++DFG+A+ F V + +V T Y PP+ V G +Y
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCYSAEVV-TLWYRPPD-VLFGAKLY 177
Query: 617 SMKYDVYSFGVLLLQI 632
S D++S G + ++
Sbjct: 178 STSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 5/91 (5%)
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
GL +L +I+RDLK N++LD+E + KI+DFGM K D T GT Y
Sbjct: 113 GLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDY 167
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
+ PE + Y D ++FGVLL ++++ +
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 51/209 (24%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 436 NFSSANKLGEGGFGPVY----KGNLPRGQEFAVKRLSATS----TQGLEEFKNEVSLTAR 487
NF LG G +G V+ G+ +A+K L + + +E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 488 LQHVNLLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
++ L L Y + + + LI +Y+ + +L+ R + + R E +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEII--- 115
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
L L+ +++RD+K NILLD+E + ++DFG++K F + ++ T GT Y+
Sbjct: 116 -LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE-EKERTYSFCGTIEYM 173
Query: 607 PPEYVK-KGIYSMKYDVYSFGVLLLQIIS 634
PE ++ KG + D +S G+L+ ++++
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 50/156 (32%), Positives = 75/156 (48%), Gaps = 10/156 (6%)
Query: 442 KLGEGGFGPVYKGNLPRG---QEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVL 497
++G G FG V G + G + VK L + S Q +F E LQH NLL+ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV--NIIEGVTQGLLYLQEYSN 555
G CTE +L+ E+ P L YL + ++ + + GLL+L + +N
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NN 120
Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKL-FRKD 590
F IH DL N LL +L KI D+G++ +++D
Sbjct: 121 F--IHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 53/191 (27%), Positives = 94/191 (49%), Gaps = 37/191 (19%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTA--------RLQHV 491
K+G+G FG V+K + Q A+K++ +E K +TA L+H
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVL------MENEKEGFPITALREIKILQLLKHE 71
Query: 492 NLLRVLGYCTE--------RDENMLIYEYLPNKSLDL--YLFDPIRRYVLDWQKRVNIIE 541
N++ ++ C + L++E+ + DL L + ++ L K+V ++
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEH---DLAGLLSNKNVKFTLSEIKKV--MK 126
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF-RKDVDEAN--TGR 598
+ GL Y+ + N +++HRD+KA+NIL+ + K++DFG+A+ F + N T R
Sbjct: 127 MLLNGLYYI--HRN-KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
Query: 599 IVGTYGYVPPE 609
+V T Y PPE
Sbjct: 184 VV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 22/210 (10%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLL 494
F +G G +G VYKG ++ GQ A+K + T + EE K E+++ + H N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIA 76
Query: 495 RVLGYCTER------DENMLIYEYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
G ++ D+ L+ E+ S+ DL DW I + +GL
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AYICREILRGL 134
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
+L + +VIHRD+K N+LL K+ DFG++ + V NT +GT ++
Sbjct: 135 AHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMA 189
Query: 608 PEYVK-----KGIYSMKYDVYSFGVLLLQI 632
PE + Y + D++S G+ +++
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
+ GL +L +I+RDLK N++LD E + KI+DFGM K T GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGT 164
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
Y+ PE + Y D ++FGVLL ++++
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 34/229 (14%)
Query: 443 LGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQ---------GLEEFKNEVSLTARLQHVN 492
LG+G F +YKG L + V S F SL ++L H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
L+++ G C RDEN+++ EY+ LD++L L W ++++ + + L YL++
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 553 YSNFRVIHRDLKASNILL----DNELNP---KISDFGMAK-LFRKDVDEANTGRIVGTYG 604
+++H ++ NIL+ NE K+SD G+ + ++ RI
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE---RI----P 169
Query: 605 YVPPEYVKKGIYSMKY--DVYSFGVLLLQIIS-SKRNARYYGTSENLNF 650
++ PE ++ G S+ D +SFG LL+I S + +SE F
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 2/92 (2%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
+ L L+ F VI+RDLK NILLD + + + DFG+ KL KD D+ NT GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
Y+ PE + Y+ D ++ GVLL ++++
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 39/123 (31%), Positives = 71/123 (57%), Gaps = 11/123 (8%)
Query: 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL 570
E++ SLD L R + +++I V +GL YL+E +++HRD+K SNIL+
Sbjct: 79 EHMDGGSLDQVL-KKAGRIPENILGKISI--AVLRGLTYLRE--KHKIMHRDVKPSNILV 133
Query: 571 DNELNPKISDFGMAKLFRKDVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
++ K+ DFG++ +D AN+ VGT Y+ PE ++ Y+++ D++S G+ L
Sbjct: 134 NSRGEIKLCDFGVSGQL---IDSMANS--FVGTRSYMSPERLQGTHYTVQSDIWSLGLSL 188
Query: 630 LQI 632
+++
Sbjct: 189 VEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 9e-10
Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 24/203 (11%)
Query: 443 LGEGGFGPVYKGNLPR-------GQEFAVKRLSATSTQGLEEF--KNEVSLTARLQHVNL 493
LG+G FG V+ L R GQ +A+K L + + + K E + A + H +
Sbjct: 4 LGQGSFGKVF---LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 494 LRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
++ L Y + + + LI ++L L F + + V+ ++ V + + L L
Sbjct: 61 VK-LHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY--LAELALALDH 113
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD-EANTGRIVGTYGYVPPEYV 611
+ +I+RDLK NILLD E + K++DFG++K + +D E GT Y+ PE V
Sbjct: 114 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVV 170
Query: 612 KKGIYSMKYDVYSFGVLLLQIIS 634
+ ++ D +SFGVL+ ++++
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 11/199 (5%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLG 498
+KLGEG + VYKG A+K + +G EVSL L+H N++ +
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
L++EYL +K L YL D ++ + + +GL Y +V
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRR---KV 125
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI-YS 617
+HRDLK N+L++ K++DFG+A+ K + V T Y PP+ + YS
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 618 MKYDVYSFGVLLLQIISSK 636
+ D++ G + ++ + +
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
++ GL +L +I+RDLK N++LD+E + KI+DFGM K VD T GT
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGT 164
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
Y+ PE + Y D +++GVLL ++++ +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 11/199 (5%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLG 498
KLGEG + V+KG + A+K + +G EVSL L+H N++ +
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
L++EYL +K L Y+ D ++ + + +GL Y +V
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRR---KV 125
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE-YVKKGIYS 617
+HRDLK N+L++ K++DFG+A+ K V V T Y PP+ + YS
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183
Query: 618 MKYDVYSFGVLLLQIISSK 636
+ D++ G + ++ S +
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 37/116 (31%), Positives = 63/116 (54%), Gaps = 7/116 (6%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
++ L YL E +I+RDLK N+LLD+E + K++D+GM K + D T GT
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGT 159
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN--LNFLEYAFE 656
Y+ PE ++ Y D ++ GVL+ ++++ + G+S+N N +Y F+
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 436 NFSSANKLGEGGFGPVYKGNLPR-------GQEFAVKRLS-ATSTQGLEEFKNEVSLTAR 487
NF LG G +G V+ L R G+ +A+K L AT Q + ++ +
Sbjct: 1 NFELLKVLGTGAYGKVF---LVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQV 57
Query: 488 LQHVN---LLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGV 543
L+H+ L L Y + D + LI +Y+ L +L R ++ V I G
Sbjct: 58 LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQEVQIYSG- 112
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
+ +L L+ +I+RD+K NILLD+ + ++DFG++K F +D E GT
Sbjct: 113 -EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTI 170
Query: 604 GYVPPEYVKKGI--YSMKYDVYSFGVLLLQIIS 634
Y+ P+ V+ G + D +S GVL+ ++++
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 58/224 (25%), Positives = 104/224 (46%), Gaps = 22/224 (9%)
Query: 479 KNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN 538
++E+ A H +++ D+ +LI EY L+ + ++ ++ + V
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 539 IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598
++ Q +L L E + +++HRDLK++NI L K+ DFG +K + V
Sbjct: 173 LL--FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQW 658
GT Y+ PE ++ YS K D++S GV+L ++++ R + E + + Y
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY----- 285
Query: 659 KDSKGKEFIDPSLDDSSSPCKLLNCMQVALL--CVQENPEDRPS 700
GK DP PC + + M+ ALL + +NP RP+
Sbjct: 286 ----GK--YDP------FPCPVSSGMK-ALLDPLLSKNPALRPT 316
|
Length = 478 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 23/226 (10%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKR-LSATSTQGLEEFK-NEVSLTARLQH- 490
+ + K+GEG +G VYK + G+ A+K+ +G+ E+SL L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 491 ---VNLLRVLGYCTERDENML--IYEYLPN---KSLDLYLFDPIRRYVLDWQKRVNIIEG 542
V LL V + + L ++EYL + K +D P R L + + +
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP--LPAKTIKSFMYQ 118
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVG 601
+ +G+ + ++ V+HRDLK N+L+D + KI+D G+ + F V ++ T IV
Sbjct: 119 LLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV-KSYTHEIV- 173
Query: 602 TYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
T Y PE + YS D++S G + ++ S++ + G SE
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEM--SRKQPLFPGDSE 217
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 57/213 (26%), Positives = 106/213 (49%), Gaps = 25/213 (11%)
Query: 442 KLGEGGFGPVYKGNLPRGQE---FAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
K+G G +G VYK G++ +A+K++ T E++L L+H N++ +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQK 65
Query: 499 -YCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL------ 550
+ + D + L+++Y + DL+ R +K V + G+ + LLY
Sbjct: 66 VFLSHADRKVWLLFDYAEH---DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 551 QEYSNFRVIHRDLKASNILLDNELNP-----KISDFGMAKLFRKDVDE-ANTGRIVGTYG 604
++N+ V+HRDLK +NIL+ E P KI+D G A+LF + A+ +V T+
Sbjct: 123 YLHANW-VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 605 YVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
Y PE + Y+ D+++ G + ++++S+
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
VT L++L + VI+RDLK NILLD E + K++DFGM K ++ T GT
Sbjct: 105 VTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGT 159
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
Y+ PE +++ Y D ++ GVL+ ++++ +
Sbjct: 160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
+ + L YL+E VIHRD+K SNILLD N K+ DFG++ VD R G
Sbjct: 123 IVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL---VDSKAKTRSAGC 177
Query: 603 YGYVPPEYV----KKGIYSMKYDVYSFGVLLLQI 632
Y+ PE + Y ++ DV+S G+ L+++
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 61/249 (24%), Positives = 111/249 (44%), Gaps = 15/249 (6%)
Query: 437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
F LG+GGFG V + G+ +A KRL + + ++ L+ VN
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 496 V--LGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
V L Y E +D L+ + L ++++ + + ++ + + GL L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
+ ++RDLK NILLD+ + +ISD G+A + E+ GR VGT GY+ PE +
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGR-VGTVGYMAPEVLN 174
Query: 613 KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672
Y++ D + G L+ ++I + R ++ + ++ +F +
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFS----E 230
Query: 673 DSSSPCKLL 681
++ S CK+L
Sbjct: 231 EAKSICKML 239
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 33/211 (15%)
Query: 435 NNFSSANKLGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
++F ++LG G G V K + P G A K + E+ R Q +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL-----------EIKPAIRNQIIRE 53
Query: 494 LRVLGYCTE------------RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
L+VL C E + E++ SLD L + +R + +V+I
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSI-- 110
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
V +GL YL+E +++HRD+K SNIL+++ K+ DFG++ + ++ VG
Sbjct: 111 AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVG 164
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
T Y+ PE ++ YS++ D++S G+ L+++
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSATSTQGLEEFK---NEVSLTAR 487
+F ++G+GG+G V+ L + G+ A+KR+ + L E + E +
Sbjct: 1 KDFQILTQVGQGGYGQVF---LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT 57
Query: 488 LQHVNLLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
+ L+++L Y + DE + L EY+P L + + + R + E
Sbjct: 58 TKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMF--- 111
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
+ IHRDLK N L+D + K++DFG++K V AN+ +VG+ Y+
Sbjct: 112 -EAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANS--VVGSPDYM 165
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
PE ++ Y D +S G +L + +
Sbjct: 166 APEVLRGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 6e-09
Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 443 LGEGGFGPVYKG--------NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
LG+G F ++KG E +K L + E F S+ ++L H +L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
G C DE++++ EY+ SLD YL + +++ ++ + + + L +L++
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD------EANTGRIVGTYGYVPP 608
+ H ++ A N+LL E + K + KL + E RI +VPP
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI----PWVPP 173
Query: 609 EYVKKG-IYSMKYDVYSFGVLLLQIIS 634
E ++ S+ D +SFG L +I S
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQ 489
TN + +G G FG V + GQ A+K++ +T ++ E+ L L+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLR 67
Query: 490 HVNLLRVLG-YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLL 548
H N++ + + + ++ + E L DL+ R L+ Q + + +GL
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRP--LEKQFIQYFLYQILRGLK 122
Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
Y+ V+HRDLK SNIL++ + KI DFG+A++ D TG V T Y P
Sbjct: 123 YVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTG-YVSTRYYRAP 174
Query: 609 EYV---KKGIYSMKYDVYSFGVLLLQIISSK 636
E + +K Y ++ D++S G + +++ K
Sbjct: 175 EIMLTWQK--YDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 1e-08
Identities = 52/184 (28%), Positives = 88/184 (47%), Gaps = 16/184 (8%)
Query: 457 PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE---YL 513
P+ + KR+ A S ++ +NE+ RL H N+L++ E +L E Y+
Sbjct: 190 PKCERLIAKRVKAGSRAAIQ-LENEILALGRLNHENILKI--------EEILRSEANTYM 240
Query: 514 PNKSLDLYLFDPIRRYVLDWQKR--VNIIEGVTQGLLYLQEYSNFR-VIHRDLKASNILL 570
+ D L+ + DW+ R + + + LL EY + + +IHRD+K NI L
Sbjct: 241 ITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL 300
Query: 571 DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLL 630
+ + + DFG A F K+ + + G VGT PE + Y D++S G++LL
Sbjct: 301 NCDGKIVLGDFGTAMPFEKEREAFDYG-WVGTVATNSPEILAGDGYCEITDIWSCGLILL 359
Query: 631 QIIS 634
++S
Sbjct: 360 DMLS 363
|
Length = 501 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 434 TNNFSSANKLGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHV 491
T+ + +G+G +G VYK N G AVK L S EE + E ++ L H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHP 79
Query: 492 NLLRVLGYCTERDENM-----LIYEYLPNKSLDLYLFDPIRR-YVLDWQKRVNIIEGVTQ 545
N+++ G + D+ + L+ E S+ + + LD I+ G
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG--- 136
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
LL LQ N R+IHRD+K +NILL E K+ DFG++ NT VGT +
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFW 194
Query: 606 VPPEYVK-----KGIYSMKYDVYSFGVLLLQI 632
+ PE + Y + DV+S G+ +++
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 68/276 (24%), Positives = 113/276 (40%), Gaps = 43/276 (15%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVK--RLSATSTQGLEEFK-----NEVSLTARLQHVN 492
++LG+G +G VYK + P G A+K RL L+E K E+ + +
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLE------LDESKFNQIIMELDILHKAVSPY 60
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
++ G + EY+ SLD + + I V +GL +L+E
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
N +IHRD+K +N+L++ K+ DFG++ + + N +G Y+ PE +K
Sbjct: 121 EHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAPERIK 174
Query: 613 KG------IYSMKYDVYSFGVLLLQIISSKRNARYY--GTSENLNFLEYAFEQWKDSKGK 664
G Y+++ DV+S G L I+ Y T N+ F Q S
Sbjct: 175 SGGPNQNPTYTVQSDVWSLG---LSILEMALGRYPYPPETYANI------FAQL--SAIV 223
Query: 665 EFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPS 700
+ P+L S + C+ + P RP+
Sbjct: 224 DGDPPTLPSGYSD----DAQDFVAKCLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-08
Identities = 63/233 (27%), Positives = 97/233 (41%), Gaps = 55/233 (23%)
Query: 442 KLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFK-------NEVSLTARLQHVNL 493
+G+GG G VY P + A+K++ + L E E + A L H +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIR----EDLSENPLLKKRFLREAKIAADLIHPGI 64
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---------------N 538
+ V C++ D +Y +P ++ Y + + V WQK +
Sbjct: 65 VPVYSICSDGD---PVYYTMP--YIEGYTLKSLLKSV--WQKESLSKELAEKTSVGAFLS 117
Query: 539 IIEGVTQGLLYLQEYSNFR-VIHRDLKASNILLDNELNPKISDFGMAK--------LFRK 589
I + + EY + + V+HRDLK NILL I D+G A L
Sbjct: 118 IFHKICATI----EYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI 173
Query: 590 DVDEANT--------GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
DVDE N G+IVGT Y+ PE + S D+Y+ GV+L Q+++
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 33/101 (32%), Positives = 56/101 (55%), Gaps = 4/101 (3%)
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYS 617
+I+RDLK N+LLD E + K++D+GM K + D +T GT Y+ PE ++ Y
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST--FCGTPNYIAPEILRGEDYG 174
Query: 618 MKYDVYSFGVLLLQIISSKRNARYYGTSEN--LNFLEYAFE 656
D ++ GVL+ ++++ + G S+N N +Y F+
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 58/230 (25%), Positives = 105/230 (45%), Gaps = 27/230 (11%)
Query: 433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFK--NEVSLTARLQ 489
A ++ + KLGEG + VYKG + GQ A+K +S + +G+ F E SL L+
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLK 61
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL------FDPIRRYVLDWQKRVNIIEGV 543
H N++ + ++ ++EY+ + L Y+ P + +Q +
Sbjct: 62 HANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ--------L 112
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
+GL Y+ ++HRDLK N+L+ K++DFG+A+ K + V T
Sbjct: 113 LRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTL 167
Query: 604 GYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLE 652
Y PP+ + YS D++ G + ++++ + + G S+ LE
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ--PAFPGVSDVFEQLE 215
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 35/104 (33%), Positives = 57/104 (54%), Gaps = 3/104 (2%)
Query: 531 LDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590
LD + ++ V +G+ +L ++ IHRDL A NILL + KI DFG+A+ R D
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
+ G ++ PE + +Y+ + DV+S+G+LL +I S
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 28/204 (13%)
Query: 443 LGEGGFGPV----YKGNLPRGQEFAVKRLSA---TSTQGLEEFKNE--VSLTA-RLQHVN 492
LG G FG V YK G+ +A+K L + +E E + TA +H
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 493 LLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
L+ + C + ++++ + EY L ++ I V + V V GL YL
Sbjct: 64 LVNLFA-CFQTEDHVCFVMEYAAGGDLMMH----IHTDVFSEPRAVFYAACVVLGLQYLH 118
Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAK--LFRKDVDEANTGRIVGTYGYVPPE 609
E ++++RDLK N+LLD E KI+DFG+ K + D T GT ++ PE
Sbjct: 119 EN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD----RTSTFCGTPEFLAPE 171
Query: 610 YVKKGIYSMKYDVYSFGVLLLQII 633
+ + Y+ D + GVL+ +++
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 43/218 (19%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLE-EFKNEVSLTARLQHVN 492
+++ KLGEG + VYKG G+ A+K + +G E SL L+H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 493 LLRVLGYCTERDENMLIYEY---------------LPNKSLDLYLFDPIRRYVLDWQKRV 537
++ + ++ L++EY L +++ L+LF +R
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR---------- 114
Query: 538 NIIEGVTQGLLYL-QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
GL Y+ Q Y ++HRDLK N+L+ + K++DFG+A+ K V
Sbjct: 115 --------GLSYIHQRY----ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTY 160
Query: 597 GRIVGTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQII 633
V T Y PP+ + YS D++ G + +++I
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 30/91 (32%), Positives = 56/91 (61%), Gaps = 6/91 (6%)
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
V +GL YL+E +++HRD+K SNIL+++ K+ DFG++ + ++ VG
Sbjct: 111 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVG 164
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
T Y+ PE ++ YS++ D++S G+ L+++
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 29/99 (29%), Positives = 54/99 (54%), Gaps = 2/99 (2%)
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYS 617
+I+RDLK N+LLD + + K++D+GM K D +T GT Y+ PE ++ Y
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST--FCGTPNYIAPEILRGEEYG 174
Query: 618 MKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFE 656
D ++ GVL+ ++++ + + ++N +Y F+
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 4e-08
Identities = 56/213 (26%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 442 KLGEGGFGPVYKGNLPRGQ---EFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
K+G G +G VYK G+ E+A+K++ T E++L L+H N++ +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIALQK 65
Query: 499 -YCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL------ 550
+ + D + L+++Y + DL+ R +K + + + + LLY
Sbjct: 66 VFLSHSDRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 551 QEYSNFRVIHRDLKASNILLDNELNP-----KISDFGMAKLFRKDVDE-ANTGRIVGTYG 604
++N+ V+HRDLK +NIL+ E P KI+D G A+LF + A+ +V T+
Sbjct: 123 YLHANW-VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 605 YVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
Y PE + Y+ D+++ G + ++++S+
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 44/167 (26%), Positives = 84/167 (50%), Gaps = 17/167 (10%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
V QG+ +L ++ IHRD+ A N+LL + KI DFG+A+ D + G
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662
++ PE + +Y+++ DV+S+G+LL +I S ++ Y G N F + ++ S+
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP-YPGILVNSKFYKMVKRGYQMSR 336
Query: 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709
P +P ++ + M+ +C P +RP+ ++S +++
Sbjct: 337 ------PDF----APPEIYSIMK---MCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 4e-08
Identities = 72/232 (31%), Positives = 114/232 (49%), Gaps = 41/232 (17%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRL-----SATSTQGLEEFKNEVSLTARLQH---- 490
KLG+G +G V+K + + A+K++ +AT Q F+ E+ L
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQ--RTFR-EIMFLQELGDHPNI 69
Query: 491 VNLLRVLGYCTERDENM----LIYEYLPNKSLDLYLFDPIRRYVL-DWQKRVNIIEGVTQ 545
V LL V+ + EN L++EY+ DL+ IR +L D KR I+ + +
Sbjct: 70 VKLLNVI-----KAENDKDIYLVFEYMET---DLHAV--IRANILEDVHKRY-IMYQLLK 118
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI----VG 601
L Y+ +S VIHRDLK SNILL+++ K++DFG+A+ + +E + V
Sbjct: 119 ALKYI--HSG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL-EENPENPVLTDYVA 174
Query: 602 TYGYVPPE-YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLE 652
T Y PE + Y+ D++S G +L +++ K + GTS LN LE
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK--PLFPGTS-TLNQLE 223
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
++S ++G G +G V + G++ A+K+LS S + E++L +QH N+
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 494 LRVLGYCTER---DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL 550
+ +L T DE Y +P DL I + L K ++ + GL Y+
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQTDL---QKIMGHPLSEDKVQYLVYQMLCGLKYI 133
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
+IHRDLK N+ ++ + KI DFG+A + D TG +V T Y PE
Sbjct: 134 HSAG---IIHRDLKPGNLAVNEDCELKILDFGLA----RHADAEMTGYVV-TRWYRAPEV 185
Query: 611 VKKGI-YSMKYDVYSFGVLLLQIISSK 636
+ + Y+ D++S G ++ ++++ K
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 5e-08
Identities = 57/213 (26%), Positives = 109/213 (51%), Gaps = 26/213 (12%)
Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFK----NEVSLTARLQH 490
+ N++ EG +G VY+ + G+ A+K+L + E F E+++ +LQH
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQH 63
Query: 491 VNLLR----VLGYCTERDENMLIYEYLPN--KSLDLYLFDPIRRYVLDWQKRVNIIEGVT 544
N++ V+G + D+ ++ EY+ + KSL + + ++ K ++ +
Sbjct: 64 PNIVTVKEVVVG--SNLDKIYMVMEYVEHDLKSL---METMKQPFLQSEVK--CLMLQLL 116
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
G+ +L + N+ ++HRDLK SN+LL+N KI DFG+A+ + + T ++V T
Sbjct: 117 SGVAHLHD--NW-ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYT-QLVVTLW 171
Query: 605 YVPPE-YVKKGIYSMKYDVYSFGVLLLQIISSK 636
Y PE + YS D++S G + ++++ K
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 31/159 (19%)
Query: 442 KLGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFKN-------EVSLTARLQH--- 490
K+GEG +G V+K N GQ A+K+ + E+ E+ + +L+H
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPNL 62
Query: 491 VNLLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYV--LDWQKRVNIIEGVTQGL 547
VNL+ V R + L++EY D + + + + + II Q +
Sbjct: 63 VNLIEVF----RRKRKLHLVFEYC-----DHTVLNELEKNPRGVPEHLIKKIIWQTLQAV 113
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586
+ +++ IHRD+K NIL+ + K+ DFG A++
Sbjct: 114 NFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARI 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 8/113 (7%)
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYS 617
+I+RDLK N+LLDN+ + K++DFG AK T + GT Y+ PE ++ +
Sbjct: 139 IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPEYLAPEVIQSKGHG 193
Query: 618 MKYDVYSFGVLLLQIISSKR---NARYYGTSENLNFLEYAFEQWKDSKGKEFI 667
D ++ GVLL + I+ + + E + F W D + ++ +
Sbjct: 194 KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLV 246
|
Length = 329 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLE-EFKNEVSLTARLQHVNLLRVLG 498
+KLGEG + V+KG + A+K + +G EVSL L+H N++ +
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
L++EYL + L YL D + ++ + + + +GL Y + ++
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQ-LLRGLSYCHKR---KI 124
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI-YS 617
+HRDLK N+L++ + K++DFG+A+ K V V T Y PP+ + YS
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 618 MKYDVYSFGVLLLQIISSK 636
D++ G +L ++ + +
Sbjct: 183 TPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 28/207 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLEEFKN----EVSLTARLQ 489
N F +GEG +G V K +E A+K+ ++ EE K E+ + L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK--DSEENEEVKETTLRELKMLRTLK 58
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLY-------LFDPIRRYVLDWQKRVNIIEG 542
N++ + R + L++EY+ L+L + +R Y+ K ++
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWC-- 116
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
+ N ++HRD+K N+L+ + K+ DFG A+ + + AN V T
Sbjct: 117 ----------HKN-DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYTEYVAT 164
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLL 629
Y PE + Y D++S G +L
Sbjct: 165 RWYRSPELLLGAPYGKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 443 LGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKN---EVSLTARLQHVNLLRVLG 498
+G G +G V + G++ A+K+LS Q K E+ L + H N++ +L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 499 YCTERDENMLIYE-YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
T + YL + L + ++ L ++ + +GL Y+ +
Sbjct: 82 VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH---SAG 138
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV-KKGIY 616
+IHRDLK SNI ++ + KI DFG+A+ D+ TG V T Y PE + Y
Sbjct: 139 IIHRDLKPSNIAVNEDCELKILDFGLARH----TDDEMTG-YVATRWYRAPEIMLNWMHY 193
Query: 617 SMKYDVYSFGVLLLQIISSK 636
+ D++S G ++ ++++ K
Sbjct: 194 NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 24/204 (11%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN--EVSLTARLQ-HVNLLRV 496
K+GEG F V K + G+ +A+K + + LE+ N E+ RL H N+LR+
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKH-FKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 497 LGYCTERDEN--MLIYEYLPNKSLDLYLFDPI--RRYVLDWQKRVNIIEGVTQGLLYLQE 552
+ +R L++E + D+ L++ I R+ L ++ + + + + L ++
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANTGRIVGTYGYVPPE-Y 610
F HRD+K NIL+ +++ K++DFG + ++ K T I T Y PE
Sbjct: 119 NGIF---HRDIKPENILIKDDI-LKLADFGSCRGIYSK---PPYTEYI-STRWYRAPECL 170
Query: 611 VKKGIYSMKYDVYSFGVLLLQIIS 634
+ G Y K D+++ G + +I+S
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 37/212 (17%)
Query: 443 LGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFKNEVS-LTARLQHVNLLRVLGYC 500
+G+G +G V+K N G + AVK L EE + E + L A H N+++ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 501 TERDEN-----MLIYEYLPNKSL-DLY---------LFDPIRRYVLDWQKRVNIIEGVTQ 545
++D L+ E S+ DL + +PI Y+L +
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH------------E 132
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
L+ LQ + IHRD+K +NILL E K+ DFG++ NT VGT +
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFW 190
Query: 606 VPPEYVK-----KGIYSMKYDVYSFGVLLLQI 632
+ PE + Y + DV+S G+ +++
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 18/201 (8%)
Query: 443 LGEGGFGPVYKGNLPR----GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN--LLRV 496
LG+G FG V L R G+ +A+K L +E + V+ + LQ+ L
Sbjct: 3 LGKGTFGKVI---LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 497 LGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
L Y + D + EY L F R V ++ + L YL
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHSRD- 115
Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI 615
V++RD+K N++LD + + KI+DFG+ K D A GT Y+ PE ++
Sbjct: 116 --VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 616 YSMKYDVYSFGVLLLQIISSK 636
Y D + GV++ +++ +
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 49/217 (22%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 435 NNFSSANKLGEGGFGPVYK-GNLPRGQEFAVKRLSATSTQGLEEFKN----EVSLTARLQ 489
+ + +GEG +G V K + GQ A+K+ + + K E+ + +L+
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLR 58
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLD-LYLF------DPIRRYVLDWQKRVNIIEG 542
H NL+ ++ + L++E++ + LD L + +R+Y+ +Q
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL--FQ-------- 108
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI--- 599
+ +G+ + + +IHRD+K NIL+ K+ DFG A+ A G +
Sbjct: 109 ILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL------AAPGEVYTD 159
Query: 600 -VGTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIIS 634
V T Y PE + Y D+++ G L+ ++++
Sbjct: 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 27/76 (35%), Positives = 42/76 (55%)
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
+HRDL A N+LL KI DFG+A+ D + + G ++ PE + +Y+
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318
Query: 619 KYDVYSFGVLLLQIIS 634
DV+S+G+LL +I S
Sbjct: 319 LSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 6e-07
Identities = 64/246 (26%), Positives = 105/246 (42%), Gaps = 46/246 (18%)
Query: 427 FSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKN-----E 481
+ D ++ N + K+G G FG V+ R QEF + A S +GL+E + E
Sbjct: 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIE 62
Query: 482 VSLTARLQHVNLLRVLG-YCTERDENMLI-YEYLPNKSLD------LYLFDPIRRYVLDW 533
V++ L+H N++R + + + ++ + I E+ L +F I + +
Sbjct: 63 VNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI-- 120
Query: 534 QKRVNIIEGVTQGLLYLQEYSNF----RVIHRDLKASNILLD-------------NELN- 575
V+I + L Y + RV+HRDLK NI L N LN
Sbjct: 121 ---VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 576 ---PKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV--KKGIYSMKYDVYSFGVLLL 630
KI DFG++K E+ VGT Y PE + + Y K D+++ G ++
Sbjct: 178 RPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 631 QIISSK 636
++ S K
Sbjct: 235 ELCSGK 240
|
Length = 1021 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 8/152 (5%)
Query: 481 EVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNII 540
E + + H +++++ G T LI LP DLY + +R + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRN-IAICDILAIE 188
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
V + + YL E R+IHRD+KA NI +++ + + DFG A F D++
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
GT PE + + Y D++S G++L ++
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 9e-07
Identities = 31/88 (35%), Positives = 49/88 (55%), Gaps = 5/88 (5%)
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
+L L+ + +++RDLK NILLD + + DFG++K D NT GT Y+
Sbjct: 106 VLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTTEYL 163
Query: 607 PPEYV--KKGIYSMKYDVYSFGVLLLQI 632
PE + +KG Y+ D +S GVL+ ++
Sbjct: 164 APEVLLDEKG-YTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 43/216 (19%)
Query: 443 LGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
+G G FG V+ PR G+ A+K++ F+N VS + + +L C
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNV-------FQNLVSCKRVFRELKML-----CF 55
Query: 502 ERDENML-IYEYLPNKSLDLYLFDPIRRYVL------DWQK-------------RVNIIE 541
+ +N+L + L +D F+ I YV+ D K +V + +
Sbjct: 56 FKHDNVLSALDILQPPHIDP--FEEI--YVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQ 111
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
+ +GL YL + ++HRD+K N+L+++ KI DFG+A++ D + T +V
Sbjct: 112 -ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVT 167
Query: 602 TYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
Y Y PE + Y+ D++S G + +++ +
Sbjct: 168 QY-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 66/241 (27%), Positives = 97/241 (40%), Gaps = 67/241 (27%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
++F +G G FG V+ L R GQ +A+K L K+++ ++ H
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLR----------KSDMIKRNQIAH 47
Query: 491 VNLLR-----------VLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRYVLD--WQK 535
V R V Y + +DE L + EY+P L L IR+ V
Sbjct: 48 VRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEET-A 103
Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK---------- 585
R I E V L L IHRD+K NIL+D + + K++DFG+ K
Sbjct: 104 RFYIAELV----LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159
Query: 586 --------LFRKDVDEANTGR---------IVGTYGYVPPEYVKKGIYSMKYDVYSFGVL 628
LFR +V VGT Y+ PE ++ Y ++ D +S GV+
Sbjct: 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVI 219
Query: 629 L 629
L
Sbjct: 220 L 220
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 48/205 (23%), Positives = 78/205 (38%), Gaps = 69/205 (33%)
Query: 443 LGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRV----- 496
LG G G V+ + AVK++ T Q ++ E+ + RL H N+++V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 497 ---------LGYCTERDENMLIYEY-------------LPNKSLDLYLFDPIRRYVLDWQ 534
+G TE + ++ EY L + L+++ +R
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR------- 125
Query: 535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMAKLFRKDVDE 593
GL Y+ + V+HRDLK +N+ ++ E L KI DFG+A++
Sbjct: 126 -----------GLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI------- 164
Query: 594 ANTGRIVGTYGYVPPEYVKKGIYSM 618
V P Y KG S
Sbjct: 165 ------------VDPHYSHKGYLSE 177
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (120), Expect = 2e-06
Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 49/220 (22%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---EVSLTARLQHVNLLRVL- 497
+G G +G V + G++ A+K++S L + K E+ L L+H N++ +L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLIDAKRILREIKLLRHLRHENIIGLLD 66
Query: 498 -----GYCTERDENMLIYEYLPNKSLDLY--------LFDPIRRYVLDWQKRVNIIEGVT 544
D +Y DL+ L D +Y L +Q +
Sbjct: 67 ILRPPSPEDFND----VYIVTELMETDLHKVIKSPQPLTDDHIQYFL-YQ--------IL 113
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI----V 600
+GL YL +N VIHRDLK SNIL+++ + KI DFG+A R + + V
Sbjct: 114 RGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLA---RGVDPDEDEKGFLTEYV 167
Query: 601 GTYGYVPPEYVKKGIYSMKY----DVYSFGVLLLQIISSK 636
T Y PE + + S +Y D++S G + ++++ K
Sbjct: 168 VTRWYRAPELL---LSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 71/286 (24%), Positives = 121/286 (42%), Gaps = 40/286 (13%)
Query: 442 KLGEGGFGPVYKGNL---PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVL 497
++G G FG V + VK L A S++ EF + LQH N+L+ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKR-VNIIE------GVTQGLLYL 550
G C E +L++EY L YL W +R ++ + G+ ++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMA-KLFRKDVDEANTGRIVGTYGYVPPE 609
++ NF +H DL N L ++L K+ D+G+ +++D E + V ++ PE
Sbjct: 116 HKH-NF--LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPE 171
Query: 610 YV---KKGIYSM---KY-DVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662
V G+ + K +V++ GV L ++ + A+ Y + L + KD +
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENA--AQPYSHLSDREVLNHVI---KDQQ 226
Query: 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSML 708
K F P L+ S + +Q L +PE R + EV +L
Sbjct: 227 VKLF-KPQLELPYSE-RWYEVLQFCWL----SPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 26/76 (34%), Positives = 43/76 (56%)
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
+HRDL A N+L+ KI DFG+A+ +D + + G ++ PE + +Y+
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 619 KYDVYSFGVLLLQIIS 634
DV+SFG+LL +I +
Sbjct: 321 LSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 52/236 (22%), Positives = 102/236 (43%), Gaps = 41/236 (17%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKN------------EVSLT 485
LGEG +G V K + G+ A+K++ S ++ + E+ +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLY-LFDPIRRYVLDWQKRVNIIEGVT 544
++H N++ ++ E D L+ + + + DL + D R+ L + I+ +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMAS---DLKKVVD--RKIRLTESQVKCILLQIL 129
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV------------- 591
GL L ++ +HRDL +NI ++++ KI+DFG+A+ +
Sbjct: 130 NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 592 DEANTGRIVGTYGYVPPEYV-KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
E T ++V T Y PE + Y D++S G + ++++ K + G +E
Sbjct: 187 REEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK--PLFPGENE 239
|
Length = 335 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 11/198 (5%)
Query: 443 LGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN--LLRVLGY 499
LG+G FG V G+ +A+K L +E + ++ LQ+ L L Y
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 500 CTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
+ + + + EY L F R V + + L YL N V
Sbjct: 63 SFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--V 117
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
++RDLK N++LD + + KI+DFG+ K K D A GT Y+ PE ++ Y
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 619 KYDVYSFGVLLLQIISSK 636
D + GV++ +++ +
Sbjct: 176 AVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 49/198 (24%), Positives = 87/198 (43%), Gaps = 12/198 (6%)
Query: 443 LGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN--LLRVLGY 499
LG+G FG V G+ +A+K L +E + ++ + L++ L L Y
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 500 CTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
+ +D + EY+ L F R V + + L YL + ++
Sbjct: 63 SFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGKI 116
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
++RDLK N++LD + + KI+DFG+ K D A GT Y+ PE ++ Y
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 619 KYDVYSFGVLLLQIISSK 636
D + GV++ +++ +
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 15/197 (7%)
Query: 443 LGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLEEFKNEVS----LTARLQHVNLLRVL 497
+G+G FG V F AVK L + +E + ++ L L+H L+ L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG-L 61
Query: 498 GYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
Y + E + + +Y+ L +L R L+ + R E V + YL +
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAE-VASAIGYLH---SL 115
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
+I+RDLK NILLD++ + ++DFG+ K + E T GT Y+ PE ++K Y
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 617 SMKYDVYSFGVLLLQII 633
D + G +L +++
Sbjct: 174 DRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 443 LGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQGL--EEFKNEVSLTARLQHVNLLRVLGY 499
+G G +G V + G + A+K+L L + E+ L ++H N++ +L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDP--------IRRYVLDWQKRVN-IIEGVTQGLLYL 550
T D ++ ++ D YL P + ++ + R+ ++ + +GL Y+
Sbjct: 83 FTP-DLSL-------DRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYI 134
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
+IHRDLK N+ ++ + KI DFG+A + D TG +V T Y PE
Sbjct: 135 HAAG---IIHRDLKPGNLAVNEDCELKILDFGLA----RQTDSEMTGYVV-TRWYRAPEV 186
Query: 611 VKKGI-YSMKYDVYSFGVLLLQIISSK 636
+ + Y+ D++S G ++ ++++ K
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 66/258 (25%), Positives = 107/258 (41%), Gaps = 48/258 (18%)
Query: 458 RGQEFAV--KRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515
G+E V K L + F SL +++ H++L V G C EN+++ E++ +
Sbjct: 41 NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100
Query: 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL----- 570
LD+ L R + W ++ + + + L YL++ + ++H ++ A NILL
Sbjct: 101 GPLDVCLRKEKGRVPVAW--KITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155
Query: 571 -DNELNP--KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI-YSMKYDVYSFG 626
+ P K+SD G++ F E RI ++ PE V G S D +SFG
Sbjct: 156 AEGTS-PFIKLSDPGVS--FTALSREERVERI----PWIAPECVPGGNSLSTAADKWSFG 208
Query: 627 VLLLQI-ISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQ 685
LL+I + + SE F E K +PS C +
Sbjct: 209 TTLLEICFDGEVPLKERTPSEKERFYE---------KKHRLPEPS------------CKE 247
Query: 686 VALL---CVQENPEDRPS 700
+A L C+ P RPS
Sbjct: 248 LATLISQCLTYEPTQRPS 265
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNL 493
+ + + +G G +G V + G AVK+LS S + E+ L ++H N+
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78
Query: 494 LRVLGYCTERDENMLIYEYLPNKSL----DLYLFDPIR----RYVLDWQKRVN-----II 540
+ +L T P +SL D+YL + ++ QK + +I
Sbjct: 79 IGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 126
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
+ +GL Y+ +IHRDLK SN+ ++ + KI DFG+A + D+ TG V
Sbjct: 127 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTG-YV 178
Query: 601 GTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSK 636
T Y PE + + Y+ D++S G ++ ++++ +
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 8e-06
Identities = 60/250 (24%), Positives = 100/250 (40%), Gaps = 76/250 (30%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSATSTQGLEEFKNEVSLTARLQH 490
++F S +G G FG V L + G +A+K+L K+E+ ++ H
Sbjct: 1 DDFESIKVIGRGAFGEV---RLVQKKDTGHIYAMKKLR----------KSEMLEKEQVAH 47
Query: 491 VNLLR-----------VLGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVL-DWQKR 536
V R V Y + +DEN LI EYLP + L +++ + + R
Sbjct: 48 VRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLL---MKKDTFTEEETR 104
Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD---- 592
I E + L + IHRD+K N+LLD + + K+SDFG+ +K
Sbjct: 105 FYIAETI----LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160
Query: 593 ------------------EANTGRI--------------VGTYGYVPPE-YVKKGIYSMK 619
++ + VGT Y+ PE +++ G Y+ +
Sbjct: 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKE 219
Query: 620 YDVYSFGVLL 629
D +S GV++
Sbjct: 220 CDWWSLGVIM 229
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 8e-06
Identities = 73/302 (24%), Positives = 111/302 (36%), Gaps = 75/302 (24%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFK--NEVSLTARLQHVNLLRVLG 498
KLGEG + VYKG + GQ A+K + +G F E SL L+H N++ +
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP-FTAIREASLLKDLKHANIVTLHD 70
Query: 499 YCTERDENMLIYEYL-----------PN----KSLDLYLFDPIRRYVLDWQKRVNIIEGV 543
+ L++EYL ++ L+LF +R
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR---------------- 114
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
GL Y + RV+HRDLK N+L+ K++DFG+A+ K V V T
Sbjct: 115 --GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR--AKSVPSKTYSNEVVTL 167
Query: 604 GYVPPEYVKKGI--YSMKYDVYSFGVLLLQIIS-----------------------SKRN 638
Y PP+ V G YS D++ G + ++ + +
Sbjct: 168 WYRPPD-VLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTE 226
Query: 639 ARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDR 698
+ G S N F Y+F + P LD +L +Q P+ R
Sbjct: 227 ETWPGVSSNPEFKPYSFPFYPPRPLINHA-PRLDRIPHGEELALKF------LQYEPKKR 279
Query: 699 PS 700
S
Sbjct: 280 IS 281
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 42/213 (19%)
Query: 443 LGEGGFGPVYKGNLPRGQE----FAVKRLS----ATSTQGLEEFKNEVSLTARLQH---V 491
LG+GG+G V++ G + FA+K L + + K E ++ ++H V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 492 NLLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNI-IEGVTQGLLY 549
+L+ Y + + LI EYL L ++L +R I +E Y
Sbjct: 64 DLI----YAFQTGGKLYLILEYLSGGELFMHL------------EREGIFMEDTAC--FY 105
Query: 550 LQEYS-------NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN-TGRIVG 601
L E S +I+RDLK NILLD + + K++DFG+ K + + E T G
Sbjct: 106 LSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK---ESIHEGTVTHTFCG 162
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634
T Y+ PE + + + D +S G L+ +++
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 48/197 (24%), Positives = 80/197 (40%), Gaps = 25/197 (12%)
Query: 446 GGFGPVYKGNLPR----GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHV-----NLLRV 496
G FG VY L + G FA+K L + + N V + + + ++
Sbjct: 7 GAFGSVY---LAKKRSTGDYFAIKVLKKSDMIAKNQVTN-VKAERAIMMIQGESPYVAKL 62
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
+D L+ EYL L + DW K I V G+ L +
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCA-SLIKTLGGLPEDWAK--QYIAEVVLGVEDLHQRG-- 117
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
+IHRD+K N+L+D + K++DFG+++ N + VGT Y+ PE +
Sbjct: 118 -IIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENK-KFVGTPDYLAPETILGVGD 170
Query: 617 SMKYDVYSFGVLLLQII 633
D +S G ++ + +
Sbjct: 171 DKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 40/144 (27%), Positives = 68/144 (47%), Gaps = 20/144 (13%)
Query: 499 YCTERDENML--IYEYLPNKSLDLYL--FDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
+C +D+ L + EY+P L + +D ++ + V +L L
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEV---------VLALDAIH 159
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMA-KLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
+ +IHRD+K N+LLD + K++DFG K+ + +T VGT Y+ PE +K
Sbjct: 160 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGTPDYISPEVLKS 217
Query: 614 ----GIYSMKYDVYSFGVLLLQII 633
G Y + D +S GV L +++
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 52/181 (28%), Positives = 75/181 (41%), Gaps = 44/181 (24%)
Query: 435 NNFSSANKLGEGGFGPV-YKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
+F + +G+G FG V G+ +A+K L + E FK + +L HV
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS-----EMFKKD-----QLAHVKA 50
Query: 494 LR-----------VLGYCTERDENML--IYEYLPNKSL-------DLYLFDPIRRYVLDW 533
R V Y + +D L I E+LP L D + D R Y+ +
Sbjct: 51 ERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAEC 110
Query: 534 QKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593
V IE V + IHRD+K NIL+D + K+SDFG++ F K D
Sbjct: 111 ---VLAIEAVHK----------LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157
Query: 594 A 594
A
Sbjct: 158 A 158
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 34/125 (27%), Positives = 52/125 (41%), Gaps = 4/125 (3%)
Query: 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN 572
+P DL+ + R L ++ + I + + L YL +IHRD+K NI LD
Sbjct: 165 MPKYKCDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDE 220
Query: 573 ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
N + DFG A D GT PE + Y K D++S G++L ++
Sbjct: 221 PENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
Query: 633 ISSKR 637
Sbjct: 281 SVKNV 285
|
Length = 392 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 24/77 (31%), Positives = 45/77 (58%), Gaps = 4/77 (5%)
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR-IVGTYGYVPPEYVKKGIY 616
V++RDLK N++LD + + KI+DFG+ K + + + T + GT Y+ PE ++ Y
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 617 SMKYDVYSFGVLLLQII 633
D + GV++ +++
Sbjct: 173 GRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 27/87 (31%), Positives = 46/87 (52%), Gaps = 7/87 (8%)
Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD-EANTGRIVGTYGYVP 607
YL +I+RDLK NILLD++ + ++DFG+ K + ++ T GT Y+
Sbjct: 111 YLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLA 164
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS 634
PE ++K Y D + G +L +++
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLY 191
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 27/100 (27%), Positives = 52/100 (52%), Gaps = 13/100 (13%)
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL-------------FRKDVDE 593
+L L+ N+ ++HRDLK N+L+ + + K++DFG++K+ KD E
Sbjct: 111 VLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
++ GT Y+ PE + + Y D ++ G++L + +
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 26/79 (32%), Positives = 40/79 (50%), Gaps = 3/79 (3%)
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT--GRIVGTYGYVPPEYV-KKG 614
VIHRDLK SN+L++ + +I DFGMA+ E V T Y PE +
Sbjct: 128 VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLP 187
Query: 615 IYSMKYDVYSFGVLLLQII 633
Y+ D++S G + +++
Sbjct: 188 EYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN--EVSLTARLQHVNLLRVLGY 499
+G G +G V + Q+ AVK+LS + + E+ L ++H N++ +L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 500 CTERDENMLIYE-YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
T E YL + L + ++ L + +I + +GL Y+ +
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG---I 139
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI-YS 617
IHRDLK SN+ ++ + +I DFG+A + D+ TG V T Y PE + + Y+
Sbjct: 140 IHRDLKPSNVAVNEDCELRILDFGLA----RQADDEMTG-YVATRWYRAPEIMLNWMHYN 194
Query: 618 MKYDVYSFGVLLLQIISSK 636
D++S G ++ +++ K
Sbjct: 195 QTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 28/79 (35%), Positives = 41/79 (51%), Gaps = 5/79 (6%)
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK----G 614
IHRD+K N+LLD + K++DFG K+ VGT Y+ PE +K G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 615 IYSMKYDVYSFGVLLLQII 633
Y + D +S GV L +++
Sbjct: 223 YYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 26/76 (34%), Positives = 41/76 (53%), Gaps = 3/76 (3%)
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYS 617
+IHRDLK SNI++ ++ KI DFG+A+ T +V Y Y PE + Y
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-YRAPEVILGMGYK 195
Query: 618 MKYDVYSFGVLLLQII 633
D++S G ++ ++I
Sbjct: 196 ENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 51/197 (25%), Positives = 92/197 (46%), Gaps = 15/197 (7%)
Query: 443 LGEGGFGPVYKGNLPRGQEF-AVKRLSATSTQGLEEFKNEVS----LTARLQHVNLLRVL 497
+G+G FG V ++F AVK L + +E K+ +S L ++H L+ +
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
D+ + +Y+ L +L R L+ + R E + L YL +
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAE-IASALGYLH---SLN 116
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD-EANTGRIVGTYGYVPPEYVKKGIY 616
+++RDLK NILLD++ + ++DFG+ K ++++ T GT Y+ PE + K Y
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 617 SMKYDVYSFGVLLLQII 633
D + G +L +++
Sbjct: 174 DRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 25/79 (31%), Positives = 43/79 (54%), Gaps = 2/79 (2%)
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
+ +++RDLK NILLD++ + ++DFG+ K D T GT Y+ PE ++K
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT--FCGTPEYLAPEVIRKQ 171
Query: 615 IYSMKYDVYSFGVLLLQII 633
Y D + G +L +++
Sbjct: 172 PYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 30/83 (36%), Positives = 47/83 (56%), Gaps = 5/83 (6%)
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPE-YVKK 613
V+HRDLK N+L++ + KI DFG+A+ F ++ E N G + V T Y PE +
Sbjct: 126 VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE-NAGFMTEYVATRWYRAPEIMLSF 184
Query: 614 GIYSMKYDVYSFGVLLLQIISSK 636
Y+ DV+S G +L +++ K
Sbjct: 185 QSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 32/161 (19%), Positives = 60/161 (37%), Gaps = 15/161 (9%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL--RVLGY 499
L G VY +++ +K S + + + EV++ L L +VL
Sbjct: 5 LLKGGLTNRVYLLGTK-DEDYVLKIN--PSREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
+ L+ E++ ++LD + +++ +I E + + L L + +
Sbjct: 62 GESDGWSYLLMEWIEGETLD----------EVSEEEKEDIAEQLAELLAKLHQLPLLVLC 111
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
H DL NIL+D+ I D+ A D A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYGPPAFDLAAALLFN 152
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 25/89 (28%), Positives = 47/89 (52%), Gaps = 5/89 (5%)
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
Q +L + + +++RDLK N+LLD + K++DFG AK+ + T + GT
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPE 193
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
Y+ PE + + D ++ G+ + +I+
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 36/168 (21%), Positives = 77/168 (45%), Gaps = 16/168 (9%)
Query: 475 LEEFKNEVSLTARLQHVNLLRVLGYCTERDENM----LIYEYLPNKSLDLYLFDPIRRYV 530
++ +NE+ R+ N+L++ G+ + +++ LI EY L L +
Sbjct: 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD---KEKD 118
Query: 531 LDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590
L ++ ++++ +GL L +Y+N +++L + + L+ KI G+ K+
Sbjct: 119 LSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKIL--- 173
Query: 591 VDEANTGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSK 636
+ + V Y + + Y++K D+YS GV+L +I + K
Sbjct: 174 --SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 25/79 (31%), Positives = 42/79 (53%), Gaps = 1/79 (1%)
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYS 617
V+HRDLK SN+LL+ + KI DFG+A+ + + T +V + P + Y+
Sbjct: 129 VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTRWYRAPELLLNCSEYT 187
Query: 618 MKYDVYSFGVLLLQIISSK 636
DV+S G + +++ K
Sbjct: 188 TAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 34/190 (17%)
Query: 459 GQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515
G AVK+LS T ++ E+ L + H N++ +L T P
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFT------------PQ 92
Query: 516 KSL----DLYL--------FDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDL 563
KSL D+YL + LD ++ ++ + G+ +L +IHRDL
Sbjct: 93 KSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 149
Query: 564 KASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVY 623
K SNI++ ++ KI DFG+A+ + T +V Y Y PE + Y D++
Sbjct: 150 KPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRY-YRAPEVILGMGYKENVDIW 206
Query: 624 SFGVLLLQII 633
S G ++ +++
Sbjct: 207 SVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 29/80 (36%), Positives = 44/80 (55%), Gaps = 7/80 (8%)
Query: 559 IHRDLKASNILLDNELNPKISDFGMA-KLFRKDVDEANTGRIVGTYGYVPPEYVKK---- 613
IHRD+K N+LLD + K++DFG K+ + +T VGT Y+ PE +K
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA--VGTPDYISPEVLKSQGGD 221
Query: 614 GIYSMKYDVYSFGVLLLQII 633
G Y + D +S GV L +++
Sbjct: 222 GYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 25/96 (26%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
+ + +L + +HRD+K N+LLD + +++DFG +D + VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD-GTVQSSVAVGT 166
Query: 603 YGYVPPEYVKK-----GIYSMKYDVYSFGVLLLQII 633
Y+ PE ++ G Y + D +S GV + +++
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 59/299 (19%), Positives = 110/299 (36%), Gaps = 61/299 (20%)
Query: 443 LGEGGFGPVYKGNLPRGQEFAVKR--LSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
+ + K P AVK+ L + S + L+ + E+ + +LQH N+L +
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV---NIIEGVTQGLLYLQEYSNFR 557
E ++ + S + D ++ + + + I++ V L Y+ +
Sbjct: 69 IVDSELYVVSPLMAYGSCE----DLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKG 121
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG--------YVPPE 609
IHR +KAS+ILL + +S + + R+V + ++ PE
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSM---IKHGKRQRVVHDFPKSSVKNLPWLSPE 178
Query: 610 YVKKGI--YSMKYDVYSFGV-------------------LLLQIISSKRNARYYGTSENL 648
+++ + Y+ K D+YS G+ +LL+ + GT L
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--------GTVPCL 230
Query: 649 ----NFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLL---NCMQVALLCVQENPEDRPS 700
+ Y S+ + D P + Q LC+Q +PE RPS
Sbjct: 231 LDKSTYPLYEDSM-SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS 288
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 17/208 (8%)
Query: 436 NFSSANKLGEGGFGPVYKGNLPRGQE-FAVKRLSATSTQGLEE---FKNEVSLTARLQHV 491
+F +G G FG V L + FA+K L+ E F+ E + +
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN- 60
Query: 492 NLLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL 550
+ L Y + + N+ L+ +Y L L L + + R + E V + +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYLAEMV----IAI 115
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
+HRD+K NIL+D + +++DFG +D + VGT Y+ PE
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGTPDYISPEI 174
Query: 611 VK-----KGIYSMKYDVYSFGVLLLQII 633
++ KG Y + D +S GV + +++
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 28/82 (34%), Positives = 46/82 (56%), Gaps = 9/82 (10%)
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE-ANTGRIVGTYGYVPPEYVK----- 612
+HRD+K N+L+D + K++DFG A R ++ N+ VGT Y+ PE +
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAA--RLTANKMVNSKLPVGTPDYIAPEVLTTMNGD 181
Query: 613 -KGIYSMKYDVYSFGVLLLQII 633
KG Y ++ D +S GV+ ++I
Sbjct: 182 GKGTYGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 25/82 (30%), Positives = 42/82 (51%), Gaps = 6/82 (7%)
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK---- 612
+HRD+K N+LLD + +++DFG D + VGT Y+ PE ++
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD-GTVQSNVAVGTPDYISPEILQAMED 180
Query: 613 -KGIYSMKYDVYSFGVLLLQII 633
KG Y + D +S GV + +++
Sbjct: 181 GKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 437 FSSANKLGEGGFGPV---YKGNLPRGQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQH 490
+ + +G G G V Y L R A+K+LS T ++ E+ L + H
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDR--NVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75
Query: 491 VNLLRVLGYCTERDENMLIYE-YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
N++ +L T + + YL + +D L I+ LD ++ ++ + G+ +
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKH 134
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
L +IHRDLK SNI++ ++ KI DFG+A+ T +V Y Y PE
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-YRAPE 188
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSK 636
+ Y D++S G ++ +++ K
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 9e-04
Identities = 26/79 (32%), Positives = 41/79 (51%), Gaps = 3/79 (3%)
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYS 617
+IHRDLK SNI++ ++ KI DFG+A+ T +V Y Y PE + Y
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-YRAPEVILGMGYK 203
Query: 618 MKYDVYSFGVLLLQIISSK 636
D++S G ++ ++I
Sbjct: 204 ENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 55/231 (23%), Positives = 106/231 (45%), Gaps = 48/231 (20%)
Query: 428 SDIKAATN-NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN-EVSL 484
+DI + N ++ N +G G FG VY+ + ++ A+K++ ++KN E+ +
Sbjct: 58 NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLI 112
Query: 485 TARLQHVNLLRVLGY----CTERDENML----IYEYLP-------------NKSLDLYLF 523
L H+N++ + Y C +++E + + E++P N +L L+L
Sbjct: 113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFL- 171
Query: 524 DPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFG 582
++ Y +Q + + L Y+ +S F + HRDLK N+L+D N K+ DFG
Sbjct: 172 --VKLY--SYQ--------LCRALAYI--HSKF-ICHRDLKPQNLLIDPNTHTLKLCDFG 216
Query: 583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
AK + + I + P + Y+ D++S G ++ ++I
Sbjct: 217 SAKNLLA--GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 65/256 (25%), Positives = 99/256 (38%), Gaps = 75/256 (29%)
Query: 436 NFSSANKLGEGGFGPVYKGNL-----PRGQEFAVKRLSATSTQGLEEFKNE------VSL 484
+F KLGEG FG VYK +L + ++ +K+ AT +E + NE +
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK--ATEYGAVEIWMNERVRRACPNS 190
Query: 485 TARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL-DL-------YLFDP-IRRYVLDWQK 535
A + L V + DE L++ Y +L DL Y +P + V D K
Sbjct: 191 CADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPK 248
Query: 536 ---RVN-IIEGVTQGLLY-LQEYSNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRK 589
R N II+ + + +L+ L + ++HRD+K NI+ KI D G A R
Sbjct: 249 GLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLR- 307
Query: 590 DVDEANTGRIVGTYGYVP------PEYVKKGIYSM------------------------- 618
VG Y+P P Y Y M
Sbjct: 308 ----------VG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356
Query: 619 --KYDVYSFGVLLLQI 632
++D+YS G++ LQ+
Sbjct: 357 PDRFDIYSAGLIFLQM 372
|
Length = 566 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 30/82 (36%), Positives = 45/82 (54%), Gaps = 12/82 (14%)
Query: 508 LIYEYLPN---KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLK 564
L+ EYL KSL L+++ D + V I V L YL + +IHRDLK
Sbjct: 81 LVMEYLIGGDVKSL-LHIYG-----YFDEEMAVKYISEVALALDYLHRHG---IIHRDLK 131
Query: 565 ASNILLDNELNPKISDFGMAKL 586
N+L+ NE + K++DFG++K+
Sbjct: 132 PDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 58/252 (23%), Positives = 100/252 (39%), Gaps = 49/252 (19%)
Query: 429 DIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL 488
DI +T F + LGEG FG V + + +E+ ++ + + K E+ ++
Sbjct: 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKV 182
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRY---VLDW---------QKR 536
+ + +R M I Y N++ + + P +Y +LDW +
Sbjct: 183 RQADP-------ADRFPLMKIQRYFQNETGHMCIVMP--KYGPCLLDWIMKHGPFSHRHL 233
Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL---DNELNP-------------KISD 580
II L Y ++ ++H DLK NIL+ D ++P +I D
Sbjct: 234 AQIIFQTGVALDYF--HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICD 291
Query: 581 FGMAKLFRKDVDEANT-GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNA 639
G DE ++ IV T Y PE V + D++S G ++ ++ + K
Sbjct: 292 LGGC------CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK--- 342
Query: 640 RYYGTSENLNFL 651
Y T +NL L
Sbjct: 343 LLYDTHDNLEHL 354
|
Length = 467 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 42/165 (25%), Positives = 76/165 (46%), Gaps = 23/165 (13%)
Query: 478 FKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV 537
F S+ ++ H +++ + G C EN+++ E++ LDL++ W +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KF 108
Query: 538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL-----DNELNP--KISDFG--MAKLFR 588
+ + + L YL++ ++H ++ NILL D E P K+SD G + L R
Sbjct: 109 KVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR 165
Query: 589 KDVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQI 632
++ E RI ++ PE V+ S+ D +SFG L +I
Sbjct: 166 QECVE----RI----PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 29/84 (34%), Positives = 42/84 (50%), Gaps = 7/84 (8%)
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT-GRIVGTYGYVPPEYVKKGIY 616
V HRDLK NIL + + KI DFG+A++ D A V T Y PE G +
Sbjct: 124 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC--GSF 181
Query: 617 SMKY----DVYSFGVLLLQIISSK 636
KY D++S G + ++++ K
Sbjct: 182 FSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 29/116 (25%), Positives = 49/116 (42%), Gaps = 41/116 (35%)
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFR----------------------KDVDEANT 596
IHRD+K NIL+D + + K++DFG+ FR ++ E +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 597 GR-------------------IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633
R +VGT Y+ PE + + Y+ D +S GV+L +++
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 40/153 (26%), Positives = 65/153 (42%), Gaps = 8/153 (5%)
Query: 480 NEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNI 539
+E L RL H +L +L L+ LP DLY + R L +
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQ---- 261
Query: 540 IEGVTQGLLYLQEYSNFR-VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598
+ V + LL +Y + +IHRD+K N+L++ + + DFG A R
Sbjct: 262 VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQ 631
I GT PE + Y+ D++S G+++ +
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 755 | |||
| cd02879 | 299 | GH18_plant_chitinase_class_V The class V plant chi | 100.0 | |
| cd02873 | 413 | GH18_IDGF The IDGF's (imaginal disc growth factors | 100.0 | |
| cd02872 | 362 | GH18_chitolectin_chitotriosidase This conserved do | 100.0 | |
| cd06548 | 322 | GH18_chitinase The GH18 (glycosyl hydrolases, fami | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| COG3325 | 441 | ChiA Chitinase [Carbohydrate transport and metabol | 100.0 | |
| KOG2806 | 432 | consensus Chitinase [Carbohydrate transport and me | 100.0 | |
| smart00636 | 334 | Glyco_18 Glycosyl hydrolase family 18. | 100.0 | |
| cd02878 | 345 | GH18_zymocin_alpha Zymocin, alpha subunit. Zymocin | 100.0 | |
| cd02876 | 318 | GH18_SI-CLP Stabilin-1 interacting chitinase-like | 100.0 | |
| PF00704 | 343 | Glyco_hydro_18: Glycosyl hydrolases family 18; Int | 100.0 | |
| cd02875 | 358 | GH18_chitobiase Chitobiase (also known as di-N-ace | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd02874 | 313 | GH18_CFLE_spore_hydrolase Cortical fragment-lytic | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd06545 | 253 | GH18_3CO4_chitinase The Bacteroides thetaiotaomicr | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd06549 | 298 | GH18_trifunctional GH18 domain of an uncharacteriz | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd00598 | 210 | GH18_chitinase-like The GH18 (glycosyl hydrolase, | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| COG3858 | 423 | Predicted glycosyl hydrolase [General function pre | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd06544 | 253 | GH18_narbonin Narbonin is a plant 2S protein from | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd06546 | 256 | GH18_CTS3_chitinase GH18 domain of CTS3 (chitinase | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| cd02871 | 312 | GH18_chitinase_D-like GH18 domain of Chitinase D ( | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG2091 | 392 | consensus Predicted member of glycosyl hydrolase f | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| cd06542 | 255 | GH18_EndoS-like Endo-beta-N-acetylglucosaminidases | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| cd06543 | 294 | GH18_PF-ChiA-like PF-ChiA is an uncharacterized ch | 99.86 | |
| cd02877 | 280 | GH18_hevamine_XipI_class_III This conserved domain | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.71 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.7 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.7 | |
| COG3469 | 332 | Chitinase [Carbohydrate transport and metabolism] | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.63 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.55 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.54 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.51 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.43 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.33 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.22 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.21 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.14 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.11 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.03 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.02 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.96 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.85 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.84 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.8 | |
| KOG4701 | 568 | consensus Chitinase [Cell wall/membrane/envelope b | 98.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.69 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.67 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.66 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.54 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.48 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.45 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.24 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.24 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.19 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.17 | |
| cd06547 | 339 | GH85_ENGase Endo-beta-N-acetylglucosaminidase (ENG | 98.1 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.04 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.91 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.91 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.91 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.85 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.75 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.71 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.7 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.66 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.65 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.53 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.51 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.47 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.41 | |
| PF02638 | 311 | DUF187: Glycosyl hydrolase like GH101; InterPro: I | 97.33 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.32 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.18 |
| >cd02879 GH18_plant_chitinase_class_V The class V plant chitinases have a glycosyl hydrolase family 18 (GH18) domain, but lack the chitin-binding domain present in other GH18 enzymes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-60 Score=497.40 Aligned_cols=283 Identities=48% Similarity=0.882 Sum_probs=251.6
Q ss_pred ceEEEEEecCCC-CCCCCCCCCCCcceEEEEEEEecCCCcEEecCCchhhHHHHHHHHHHhhCCCceEEEEecCCCCCcc
Q 004402 26 TWIKAGYWLAGR-EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTY 104 (755)
Q Consensus 26 ~~~~~gY~~~~~-~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg~~~~~~ 104 (755)
..|++|||..|. .|++++||+++||||+|+|+.++++++.+...+.....+..+.+.+|++||++|++|||
T Consensus 2 ~~~~~~Y~~~w~~~~~~~~i~~~~~THi~yaf~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lkvlisi-------- 73 (299)
T cd02879 2 TIVKGGYWPAWSEEFPPSNIDSSLFTHLFYAFADLDPSTYEVVISPSDESEFSTFTETVKRKNPSVKTLLSI-------- 73 (299)
T ss_pred CeEEEEEECCCCCCCChhHCCcccCCEEEEEEEEecCCCCEEeeccccHHHHHHHHHHHHHhCCCCeEEEEE--------
Confidence 468999999988 69999999999999999999999888777776656666777778899999999999999
Q ss_pred ccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCC-CCCcccHHHHHHHHHHHccC------CC
Q 004402 105 QSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN-STDLNSLGILLDEWKASASD------QP 177 (755)
Q Consensus 105 ~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~-~~~~~~~~~~l~~lr~~l~~------~~ 177 (755)
|||+.++..|+.+++|++.|++||+++++++++|||||||||||||. ++|+++|+.|+++||++|+. ++
T Consensus 74 ----GG~~~~s~~fs~~~~~~~~R~~fi~siv~~l~~~~fDGidiDWE~P~~~~d~~n~~~ll~elr~~l~~~~~~~~~~ 149 (299)
T cd02879 74 ----GGGGSDSSAFAAMASDPTARKAFINSSIKVARKYGFDGLDLDWEFPSSQVEMENFGKLLEEWRAAVKDEARSSGRP 149 (299)
T ss_pred ----eCCCCCCchhhHHhCCHHHHHHHHHHHHHHHHHhCCCceeecccCCCChhHHHHHHHHHHHHHHHHHHHhhccCCC
Confidence 66666666799999999999999999999999999999999999995 57899999999999999973 24
Q ss_pred ccEEEeeeecCCcc----cccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHHHHHHCCCCC
Q 004402 178 ELTLSMAVRYSPTH----ETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPA 253 (755)
Q Consensus 178 ~~~ls~~~~~~~~~----~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~~~~~~g~p~ 253 (755)
+++||+++|+.+.. ...+||+++++++||||||||||+||+|....++|+|||+.+....+++.+|++|++.|+|+
T Consensus 150 ~~~ls~av~~~~~~~~~~~~~~yd~~~l~~~vD~i~vMtYD~~g~~~~~~~~~~a~l~~~~~~~~~~~~v~~~~~~g~p~ 229 (299)
T cd02879 150 PLLLTAAVYFSPILFLSDDSVSYPIEAINKNLDWVNVMAYDYYGSWESNTTGPAAALYDPNSNVSTDYGIKSWIKAGVPA 229 (299)
T ss_pred cEEEEeecccchhhccccccccCCHHHHHhhCCEEEEEeecccCCCCCCCCCCCCcCCCCCCCCCHHHHHHHHHHcCCCH
Confidence 79999999987654 34568999999999999999999997766667899999998888889999999999999999
Q ss_pred CceeecccccCCCcccCCCcchHHHHHHHhhcCCCcccccccceeeeeeecCcEEEeeCCcchhhhhhhcccccCccccc
Q 004402 254 NKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYK 333 (755)
Q Consensus 254 ~KlvlG~p~yG~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~yd~~~S~~~K~~~a~~~~l~Gi~ 333 (755)
+|||||+|+|||+|++ ||+....+|...+.+||+|||++|++.|++||+++||||+|
T Consensus 230 ~KlvlGvp~YGr~~~~-----------------------~D~~~~~~y~~~~~~wi~ydd~~Si~~K~~~a~~~~lgGv~ 286 (299)
T cd02879 230 KKLVLGLPLYGRAWTL-----------------------YDTTTVSSYVYAGTTWIGYDDVQSIAVKVKYAKQKGLLGYF 286 (299)
T ss_pred HHEEEEeccccccccc-----------------------cCCCcceEEEEECCEEEEeCCHHHHHHHHHHHHhCCCCeEE
Confidence 9999999999999976 44555566777788999999999999999999999999999
Q ss_pred cccccccchh
Q 004402 334 AFQLSNDDNW 343 (755)
Q Consensus 334 ~W~l~~dd~~ 343 (755)
+|++++||..
T Consensus 287 ~W~l~~Dd~~ 296 (299)
T cd02879 287 AWAVGYDDNN 296 (299)
T ss_pred EEEeecCCcc
Confidence 9999999854
|
The GH18 domain of the class V chitinases has endochitinase activity in some cases and no catalytic activity in others. Included in this family is a lectin found in black locust (Robinia pseudoacacia) bark, which binds chitin but lacks chitinase activity. Also included is a chitinase-related receptor-like kinase (CHRK1) from tobacco (Nicotiana tabacum), with an N-terminal GH18 domain and a C-terminal kinase domain, which is thought to be part of a plant signaling pathway. The GH18 domain of CHRK1 is expressed extracellularly where it binds chitin but lacks chitinase activity. |
| >cd02873 GH18_IDGF The IDGF's (imaginal disc growth factors) are a family of growth factors identified in insects that include at least five members, some of which are encoded by genes in a tight cluster | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-56 Score=481.04 Aligned_cols=308 Identities=24% Similarity=0.427 Sum_probs=247.3
Q ss_pred EEEEEecCCC-------CCCCCCCCCCC--cceEEEEEEEecCCCcEEecCCchh----hHHHHHHHHHHhhCCCceEEE
Q 004402 28 IKAGYWLAGR-------EFPLSDINSAL--FTHLICAFAEVDSSTYQLSISSANQ----QYFSIFANSVRRKNPSIKTLL 94 (755)
Q Consensus 28 ~~~gY~~~~~-------~~~~~~i~~~~--~thi~~~f~~~~~~~~~~~~~~~~~----~~~~~~~~~~k~~~~~lk~~i 94 (755)
+++|||..|. .|.+++||..+ ||||+|+|+.++++++.+...+... ..+..+ +++|++||++|+|+
T Consensus 1 ~vvcyy~~~a~~r~~~~~~~~~~i~~~~~~~THl~yaf~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~lk~~~p~lKvll 79 (413)
T cd02873 1 KLVCYYDSKSYLREGLAKMSLEDLEPALQFCTHLVYGYAGIDADTYKIKSLNEDLDLDKSHYRAI-TSLKRKYPHLKVLL 79 (413)
T ss_pred CEEEEecchhhcCCCCCeeCHHHcCCccccCCeEEEEEEEEeCCCCEEEecCcccchhhhHHHHH-HHHHhhCCCCeEEE
Confidence 3688976532 47899999876 9999999999999877665533322 344444 67999999999999
Q ss_pred EecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCC-------------------
Q 004402 95 SIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN------------------- 155 (755)
Q Consensus 95 sigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~------------------- 155 (755)
|||||..+.- ...+..|+.+++|++.|++||+++++|+++|+|||||||||||.
T Consensus 80 SiGGw~~~~~-------~~~s~~fs~~~~~~~~R~~Fi~siv~~l~~~~fDGidiDWEyP~~~~~~~~g~~~~~~~~~~~ 152 (413)
T cd02873 80 SVGGDRDTDE-------EGENEKYLLLLESSESRNAFINSAHSLLKTYGFDGLDLAWQFPKNKPKKVRGTFGSAWHSFKK 152 (413)
T ss_pred eecCCCCCCC-------cccchhhHHHhCCHHHHHHHHHHHHHHHHHcCCCCeEeeeeCCCCcccccccccchhhhhhhc
Confidence 9977664221 11245799999999999999999999999999999999999995
Q ss_pred ------------CCCcccHHHHHHHHHHHccCCCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCc-
Q 004402 156 ------------STDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKEN- 222 (755)
Q Consensus 156 ------------~~~~~~~~~~l~~lr~~l~~~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~- 222 (755)
++|+++|+.||++||++|++. +++|++++++.... ...||+++|+++|||||||||||||+++.+
T Consensus 153 ~~~g~~~~~~~~~~d~~nf~~Ll~elr~~l~~~-~~~ls~av~~~~~~-~~~~d~~~l~~~vD~inlMtYD~~g~~~~~~ 230 (413)
T cd02873 153 LFTGDSVVDEKAAEHKEQFTALVRELKNALRPD-GLLLTLTVLPHVNS-TWYFDVPAIANNVDFVNLATFDFLTPERNPE 230 (413)
T ss_pred ccccccccCCCChhHHHHHHHHHHHHHHHhccc-CcEEEEEecCCchh-ccccCHHHHhhcCCEEEEEEecccCCCCCCC
Confidence 246899999999999999875 78999988754332 234899999999999999999999877665
Q ss_pred ccccCCCCCCCC---CCCcHHHHHHHHHHCCCCCCceeecccccCCCcccC---------------------------CC
Q 004402 223 VTGIHAALYNPS---SNISTDFGIREWLRRGFPANKLVLGARASGPGITID---------------------------GS 272 (755)
Q Consensus 223 ~~~~~a~l~~~~---~~~~~~~~v~~~~~~g~p~~KlvlG~p~yG~~~~~~---------------------------~~ 272 (755)
.++++|||+... ...+++.+|++|++.|+|++|||||+|+|||+|++. |.
T Consensus 231 ~~~~~apL~~~~~~~~~~~v~~~v~~~~~~gvp~~KlvlGip~YGr~w~l~~~~~~~g~~~~~~~~g~~~~G~~~~~~g~ 310 (413)
T cd02873 231 EADYTAPIYELYERNPHHNVDYQVKYWLNQGTPASKLNLGIATYGRAWKLTKDSGITGVPPVLETDGPGPAGPQTKTPGL 310 (413)
T ss_pred ccCcCCccCCCccccccccHHHHHHHHHHcCCCHHHeEEEEecceeeeEccCCCCCcCCCCCccCCCCCCCCCCcCCCcc
Confidence 589999998643 346899999999999999999999999999999632 34
Q ss_pred cchHHHHHHHhhcC------CCccccccccee-eeeee-------cCcEEEeeCCcchhhhhhhcccccCcccccccccc
Q 004402 273 MGYKFIRAFIQNYG------YGAAPVYNASYV-VNLFT-------SGATWINFDGVETIKAKISYAKEKNLLGYKAFQLS 338 (755)
Q Consensus 273 ~~y~~~~~~~~~~~------~~~~~~~~~~~~-~~~~~-------~~~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~ 338 (755)
++|.++|..+...+ ..|+..||.... .+|.. .++.||+|||++|++.|++||+++||||+|+|+++
T Consensus 311 l~y~ei~~~~~~~~~~~g~~~~~~~~~d~~~~~~~y~y~~~d~~~~~~~wvsydd~~Si~~K~~y~~~~gLgGv~~W~l~ 390 (413)
T cd02873 311 LSWPEICSKLPNPANLKGADAPLRKVGDPTKRFGSYAYRPADENGEHGIWVSYEDPDTAANKAGYAKAKGLGGVALFDLS 390 (413)
T ss_pred ccHHHHHHhhccCccccccccceeEeecccccccceEEeccccCCCCCeEEEeCCHHHHHHHHHHHHhCCCceEEEEeee
Confidence 78999998776532 124455665443 23332 23579999999999999999999999999999999
Q ss_pred ccchhhh
Q 004402 339 NDDNWAL 345 (755)
Q Consensus 339 ~dd~~~~ 345 (755)
.||..+.
T Consensus 391 ~DD~~g~ 397 (413)
T cd02873 391 LDDFRGQ 397 (413)
T ss_pred cCcCCCC
Confidence 9986553
|
The IDGF's have an eight-stranded alpha/beta barrel fold and are related to the glycosyl hydrolase family 18 (GH18) chitinases, but they have an amino acid substitution known to abolish chitinase catalytic activity. IDGFs may have evolved from chitinases to gain new functions as growth factors, interacting with cell surface glycoproteins involved in growth-promoting processes. |
| >cd02872 GH18_chitolectin_chitotriosidase This conserved domain family includes a large number of catalytically inactive chitinase-like lectins (chitolectins) including YKL-39, YKL-40 (HCGP39), YM1, oviductin, and AMCase (acidic mammalian chitinase), as well as catalytically active chitotriosidases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-56 Score=478.76 Aligned_cols=300 Identities=32% Similarity=0.553 Sum_probs=258.6
Q ss_pred EEEEecCCC-------CCCCCCCCCCCcceEEEEEEEecCCCcEEecCCch---hhHHHHHHHHHHhhCCCceEEEEecC
Q 004402 29 KAGYWLAGR-------EFPLSDINSALFTHLICAFAEVDSSTYQLSISSAN---QQYFSIFANSVRRKNPSIKTLLSIWN 98 (755)
Q Consensus 29 ~~gY~~~~~-------~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~---~~~~~~~~~~~k~~~~~lk~~isigg 98 (755)
|+|||..|. .|.+++||.++||||+|+|+.+++++.....+... ...+..+ .++|++||++|+++||
T Consensus 1 v~~y~~~w~~~~~~~~~~~~~~i~~~~~Thv~y~f~~i~~~g~~~~~~~~~d~~~~~~~~~-~~lk~~~p~lkvlisi-- 77 (362)
T cd02872 1 VVCYFTNWAQYRPGNGKFVPENIDPFLCTHIIYAFAGLNPDGNIIILDEWNDIDLGLYERF-NALKEKNPNLKTLLAI-- 77 (362)
T ss_pred CEEEECcchhcCCCCCCcChhHCCcccCCEEEEeeEEECCCCCEEecCchhhhhhhHHHHH-HHHHhhCCCceEEEEE--
Confidence 578976533 47899999999999999999999976655544433 2334444 6799999999999999
Q ss_pred CCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCC-----CCcccHHHHHHHHHHHc
Q 004402 99 GQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-----TDLNSLGILLDEWKASA 173 (755)
Q Consensus 99 ~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~-----~~~~~~~~~l~~lr~~l 173 (755)
|||+.++..|+.+++|++.|++||+++++++++|||||||||||+|.. +++++|+.||++||++|
T Consensus 78 ----------GG~~~~~~~f~~~~~~~~~r~~fi~~iv~~l~~~~~DGidiDwE~p~~~~~~~~d~~~~~~ll~~lr~~l 147 (362)
T cd02872 78 ----------GGWNFGSAKFSAMAASPENRKTFIKSAIAFLRKYGFDGLDLDWEYPGQRGGPPEDKENFVTLLKELREAF 147 (362)
T ss_pred ----------cCCCCCcchhHHHhCCHHHHHHHHHHHHHHHHHcCCCCeeeeeeccccCCCCHHHHHHHHHHHHHHHHHH
Confidence 666656667999999999999999999999999999999999999964 78999999999999999
Q ss_pred cCC-CccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCC------CCcHHHHHHHH
Q 004402 174 SDQ-PELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSS------NISTDFGIREW 246 (755)
Q Consensus 174 ~~~-~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~------~~~~~~~v~~~ 246 (755)
++. ++++||+++|+.+.....+||+++|+++|||||||+||+|| .|+..+|++|||+.... ..+++.+|++|
T Consensus 148 ~~~~~~~~ls~av~~~~~~~~~~~d~~~l~~~vD~v~vmtYD~~~-~~~~~~g~~spl~~~~~~~~~~~~~~v~~~v~~~ 226 (362)
T cd02872 148 EPEAPRLLLTAAVSAGKETIDAAYDIPEISKYLDFINVMTYDFHG-SWEGVTGHNSPLYAGSADTGDQKYLNVDYAIKYW 226 (362)
T ss_pred HhhCcCeEEEEEecCChHHHhhcCCHHHHhhhcceEEEecccCCC-CCCCCCCCCCCCCCCCCCccccccccHHHHHHHH
Confidence 752 47999999998876666679999999999999999999995 46778999999996443 35899999999
Q ss_pred HHCCCCCCceeecccccCCCcccC------------------------CCcchHHHHHHHhhcCCCcccccccceeeeee
Q 004402 247 LRRGFPANKLVLGARASGPGITID------------------------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLF 302 (755)
Q Consensus 247 ~~~g~p~~KlvlG~p~yG~~~~~~------------------------~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (755)
++.|+|++||+||+|+||++|++. |.++|.++|+.+ . .+|+..||+....+|.
T Consensus 227 ~~~gvp~~KlvlGlp~YG~~~~~~~~~~~~~g~~~~g~~~~g~~~~~~g~~~y~ei~~~~-~--~~~~~~~D~~~~~~y~ 303 (362)
T cd02872 227 LSKGAPPEKLVLGIPTYGRSFTLASPSNTGVGAPASGPGTAGPYTREAGFLAYYEICEFL-K--SGWTVVWDDEQKVPYA 303 (362)
T ss_pred HHcCCCHHHeEeccccccceeeecCCccCCCCCccCCCCCCCCCcCCCccchHHHHHHhh-c--CCcEEEEeCCcceeEE
Confidence 999999999999999999999753 346899999877 3 3588899999888888
Q ss_pred ecCcEEEeeCCcchhhhhhhcccccCccccccccccccchhhh
Q 004402 303 TSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWAL 345 (755)
Q Consensus 303 ~~~~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~dd~~~~ 345 (755)
..+++||+|||++|++.|++||+++||||+++|+++.||..+.
T Consensus 304 ~~~~~~v~ydd~~Si~~K~~~~~~~~lgGv~iW~l~~DD~~g~ 346 (362)
T cd02872 304 YKGNQWVGYDDEESIALKVQYLKSKGLGGAMVWSIDLDDFRGT 346 (362)
T ss_pred EECCEEEEeCCHHHHHHHHHHHHhCCCceEEEEeeecCcCCCc
Confidence 8889999999999999999999999999999999999997654
|
The conserved domain is an eight-stranded alpha/beta barrel fold belonging to the family 18 glycosyl hydrolases. The fold has a pronounced active-site cleft at the C-terminal end of the beta-barrel. The chitolectins lack a key active site glutamate (the proton donor required for hydrolytic activity) but retain highly conserved residues involved in oligosaccharide binding. Chitotriosidase is a chitinolytic enzyme expressed in maturing macrophages, which suggests that it plays a part in antimicrobial defense. Chitotriosidase hydrolyzes chitotriose, as well as colloidal chitin to yield chitobiose and is therefore considered an exochitinase. Chitotriosidase occurs in two major forms, the la |
| >cd06548 GH18_chitinase The GH18 (glycosyl hydrolases, family 18) type II chitinases hydrolyze chitin, an abundant polymer of N-acetylglucosamine and have been identified in bacteria, fungi, insects, plants, viruses, and protozoan parasites | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-55 Score=467.29 Aligned_cols=277 Identities=29% Similarity=0.465 Sum_probs=237.0
Q ss_pred EEEEecCCCCC----CCC-CCCCCCcceEEEEEEEecCCCcEEecCCc-------------------hhhHHHHHHHHHH
Q 004402 29 KAGYWLAGREF----PLS-DINSALFTHLICAFAEVDSSTYQLSISSA-------------------NQQYFSIFANSVR 84 (755)
Q Consensus 29 ~~gY~~~~~~~----~~~-~i~~~~~thi~~~f~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~k 84 (755)
|+|||..|..+ .+. +||+++||||+|||+.+++++..+...+. ....+..+ ..+|
T Consensus 1 v~~Y~~~W~~~~~~~~~~~~i~~~~~THl~yaf~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~lk 79 (322)
T cd06548 1 VVGYFTNWGIYGRNYFVTDDIPADKLTHINYAFADIDGDGGVVTSDDEAADEAAQSVDGGADTDDQPLKGNFGQL-RKLK 79 (322)
T ss_pred CEEEeCCCcccCCCCCcccCCChhHCcEEEEEeeeEcCCCCeEccChhhhhhccccCCcccccCCccchhHHHHH-HHHH
Confidence 58998877664 344 59999999999999999998876654321 22344444 6799
Q ss_pred hhCCCceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCC--------
Q 004402 85 RKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-------- 156 (755)
Q Consensus 85 ~~~~~lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~-------- 156 (755)
++||++|+++|||||. .+ ..|+.+++|++.|++||+++++++++|||||||||||+|..
T Consensus 80 ~~~p~lkvl~siGG~~------------~s-~~f~~~~~~~~~r~~Fi~siv~~l~~~~fDGidiDwE~p~~~~~~~~~~ 146 (322)
T cd06548 80 QKNPHLKILLSIGGWT------------WS-GGFSDAAATEASRAKFADSAVDFIRKYGFDGIDIDWEYPGSGGAPGNVA 146 (322)
T ss_pred HhCCCCEEEEEEeCCC------------CC-CCchhHhCCHHHHHHHHHHHHHHHHhcCCCeEEECCcCCCCCCCCCCCC
Confidence 9999999999995544 32 34999999999999999999999999999999999999963
Q ss_pred --CCcccHHHHHHHHHHHccCC-----CccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCC
Q 004402 157 --TDLNSLGILLDEWKASASDQ-----PELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAA 229 (755)
Q Consensus 157 --~~~~~~~~~l~~lr~~l~~~-----~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~ 229 (755)
+++++|+.||++||++|++. ++++||+++|+.+..... +++++++++|||||||||||||+ |...+||+||
T Consensus 147 ~~~d~~~~~~ll~~Lr~~l~~~~~~~~~~~~Ls~av~~~~~~~~~-~~~~~l~~~vD~vnlMtYD~~g~-w~~~~g~~sp 224 (322)
T cd06548 147 RPEDKENFTLLLKELREALDALGAETGRKYLLTIAAPAGPDKLDK-LEVAEIAKYLDFINLMTYDFHGA-WSNTTGHHSN 224 (322)
T ss_pred ChhHHHHHHHHHHHHHHHHHHhhhccCCceEEEEEccCCHHHHhc-CCHHHHhhcCCEEEEEEeeccCC-CCCCCCCCCC
Confidence 68899999999999999762 469999999988765544 78999999999999999999955 5578999999
Q ss_pred CCCCC----CCCcHHHHHHHHHHCCCCCCceeecccccCCCcccCCCcchHHHHHHHhhcCCCcccccccceeeeeeecC
Q 004402 230 LYNPS----SNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSG 305 (755)
Q Consensus 230 l~~~~----~~~~~~~~v~~~~~~g~p~~KlvlG~p~yG~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (755)
|+... ...+++.+|++|++.|+|++|||||||+|||+|++ +...||+....+|...+
T Consensus 225 L~~~~~~~~~~~~v~~~v~~~~~~gvp~~KlvlGip~YGr~~~~-------------------~~~~~D~~~~~~y~~~~ 285 (322)
T cd06548 225 LYASPADPPGGYSVDAAVNYYLSAGVPPEKLVLGVPFYGRGWTG-------------------YTRYWDEVAKAPYLYNP 285 (322)
T ss_pred CCCCCCCCCCCccHHHHHHHHHHcCCCHHHeEEEecccccccCC-------------------cEEEEcCCcceeEEEeC
Confidence 99654 35789999999999999999999999999999986 56677777777777655
Q ss_pred --cEEEeeCCcchhhhhhhcccccCcccccccccccc
Q 004402 306 --ATWINFDGVETIKAKISYAKEKNLLGYKAFQLSND 340 (755)
Q Consensus 306 --~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~d 340 (755)
++||+|||++|++.|++||+++||||+|+|++++|
T Consensus 286 ~~~~~v~ydd~~Si~~K~~~a~~~~LgGv~~W~l~~D 322 (322)
T cd06548 286 STKTFISYDDPRSIKAKADYVKDKGLGGVMFWELSGD 322 (322)
T ss_pred CCCeEEEeCCHHHHHHHHHHHHhcCCccEEEEeccCC
Confidence 89999999999999999999999999999999987
|
The structure of this domain is an eight-stranded alpha/beta barrel with a pronounced active-site cleft at the C-terminal end of the beta-barrel. |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-54 Score=459.68 Aligned_cols=289 Identities=43% Similarity=0.737 Sum_probs=254.8
Q ss_pred CccccCHHHHHHHhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeee
Q 004402 421 NLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500 (755)
Q Consensus 421 ~~~~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 500 (755)
....|+++++..+|++|+..+.||+|+||.||+|.+++|+.||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999999999999988766543135699999999999999999999999
Q ss_pred ecCCc-cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEE
Q 004402 501 TERDE-NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKIS 579 (755)
Q Consensus 501 ~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~ 579 (755)
.+.+. .+||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99984 99999999999999999875544 79999999999999999999999998899999999999999999999999
Q ss_pred ecCCccccccCCcccccccc-cccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHh
Q 004402 580 DFGMAKLFRKDVDEANTGRI-VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQW 658 (755)
Q Consensus 580 Dfgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 658 (755)
|||+++..... ....... .||.+|+|||++..+..|.|+|||||||+|+||+||+++...........+..|....+
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999765431 1111112 78999999999999999999999999999999999998887654444555888988888
Q ss_pred ccCCCccccCCCCC-CCCCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 659 KDSKGKEFIDPSLD-DSSSP-CKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 659 ~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
.+....+++|+.+. ..... .+...+.+++.+|++.+|++||+|.||+++|+...
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 88899999999987 44443 67888999999999999999999999999996543
|
|
| >COG3325 ChiA Chitinase [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-54 Score=442.15 Aligned_cols=310 Identities=24% Similarity=0.370 Sum_probs=244.3
Q ss_pred CCcceEEEEEecCCCC-----CCCCCCCCCCcceEEEEEEEecCCCcEEe-------------------cCCc---hhhH
Q 004402 23 DAQTWIKAGYWLAGRE-----FPLSDINSALFTHLICAFAEVDSSTYQLS-------------------ISSA---NQQY 75 (755)
Q Consensus 23 ~~~~~~~~gY~~~~~~-----~~~~~i~~~~~thi~~~f~~~~~~~~~~~-------------------~~~~---~~~~ 75 (755)
.+..++++|||..|.. |.+.+||+.++|||+|||+.|..++.... .+.+ ....
T Consensus 34 ~d~~~rvvgYY~sWs~~d~~~y~~~DIp~~qlTHInYAF~~I~~~g~~~~~~~~~~~~~~~~~~~~~~e~dp~~~~~~G~ 113 (441)
T COG3325 34 SDDQFKVVGYYTSWSQYDRQDYFPGDIPLDQLTHINYAFLDINSDGKSIESWVADEAALYGVPNIEGVELDPWSDPLKGH 113 (441)
T ss_pred CCCCceEEEEecccccCCCcccccccCCHHHhceeeEEEEEecCCCCccccccccchhhccccCcCceeeccccccccch
Confidence 3458999999876654 67899999999999999999998774210 1111 2233
Q ss_pred HHHHHHHHHhhCCCceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCC
Q 004402 76 FSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN 155 (755)
Q Consensus 76 ~~~~~~~~k~~~~~lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~ 155 (755)
+..+ ..+|+++|++|+++|||||+.|+. |+.|++|.+.|++|++++++|+++|+|||||||||||+
T Consensus 114 ~~~L-~~lk~~~~d~k~l~SIGGWs~S~~-------------F~~~aad~a~re~Fa~saVe~~r~~~FDGVDIDWEYP~ 179 (441)
T COG3325 114 FGAL-FDLKATYPDLKTLISIGGWSDSGG-------------FSDMAADDASRENFAKSAVEFMRTYGFDGVDIDWEYPG 179 (441)
T ss_pred HHHH-HHHhhhCCCceEEEeecccccCCC-------------cchhhcCHHHHHHHHHHHHHHHHhcCCCceeeccccCC
Confidence 4444 789999999999999977775543 99999999999999999999999999999999999993
Q ss_pred ----------CCCcccHHHHHHHHHHHccC-----CCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCC
Q 004402 156 ----------STDLNSLGILLDEWKASASD-----QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSK 220 (755)
Q Consensus 156 ----------~~~~~~~~~~l~~lr~~l~~-----~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~ 220 (755)
+++.++|+.||++||++|.. ++.|.||+|.|+.+.... +.+..+++++|||+|+||||||| .|
T Consensus 180 ~~~~~~~~~~~~d~~ny~~Ll~eLR~~LD~a~~edgr~Y~LTiA~~as~~~l~-~~~~~~~~~~vDyiNiMTYDf~G-~W 257 (441)
T COG3325 180 SGGDAGNCGRPKDKANYVLLLQELRKKLDKAGVEDGRHYQLTIAAPASKDKLE-GLNHAEIAQYVDYINIMTYDFHG-AW 257 (441)
T ss_pred CCCCCCCCCCcccHHHHHHHHHHHHHHHhhcccccCceEEEEEecCCchhhhh-cccHHHHHHHHhhhheeeeeccc-cc
Confidence 35789999999999999953 457999999999988776 58999999999999999999995 78
Q ss_pred CcccccCCCCCCCCCC-------C------cHHHHHHHHHHCCCCCCceeecccccCCCcccC--CCc------------
Q 004402 221 ENVTGIHAALYNPSSN-------I------STDFGIREWLRRGFPANKLVLGARASGPGITID--GSM------------ 273 (755)
Q Consensus 221 ~~~~~~~a~l~~~~~~-------~------~~~~~v~~~~~~g~p~~KlvlG~p~yG~~~~~~--~~~------------ 273 (755)
.+.+||||+||+.... + ...+.++...+.++|++|||||+|+|||+|... +..
T Consensus 258 n~~~Gh~a~Ly~~~~d~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~klvlG~p~YgRgw~~v~~~~~~~~~~~~q~~~n 337 (441)
T COG3325 258 NETLGHHAALYGTPKDPPLANGGFYVDAEVDGIDWLEEGFAGDVPPSKLVLGMPFYGRGWNGVDGGSLGTCPGLYQGLDN 337 (441)
T ss_pred ccccccccccccCCCCCccccCCeeEEEEechhHHHHhhhccCCCCceEEeeccccccccccccCcccCCCCCcccccCC
Confidence 8899999999952211 1 111244555667899999999999999999765 111
Q ss_pred ---------------chHH--HHHHHhhcCCCcccccccceeeeeee--cCcEEEeeCCcchhhhhhhcccccCcccccc
Q 004402 274 ---------------GYKF--IRAFIQNYGYGAAPVYNASYVVNLFT--SGATWINFDGVETIKAKISYAKEKNLLGYKA 334 (755)
Q Consensus 274 ---------------~y~~--~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~ 334 (755)
.|.. .......+..++...||+++..+|.. .++.+|+|||++|++.|++||++++|||+|+
T Consensus 338 ~g~~~Gtw~a~n~~~~~~~~~~l~~n~~~~~g~~~~~d~~a~apyL~n~~~~vFiSyDd~rSvkaK~eYv~~n~LGG~m~ 417 (441)
T COG3325 338 SGIPKGTWEAGNGDKDYGKAYDLDANNAGKNGYERYWDDVAKAPYLYNPEKGVFISYDDPRSVKAKAEYVADNNLGGMMF 417 (441)
T ss_pred CCCCCCcccccccCccchhhccccccccCCCCeeEecccccccceeecCCCCeEEEccCCcchhhHHHHHhhcCccceEE
Confidence 0000 00001112334778889888888874 5688999999999999999999999999999
Q ss_pred ccccccchhhhhhh
Q 004402 335 FQLSNDDNWALSRA 348 (755)
Q Consensus 335 W~l~~dd~~~~~~~ 348 (755)
|.+++|.+.-+..+
T Consensus 418 We~sgD~n~~llna 431 (441)
T COG3325 418 WEISGDENGVLLNA 431 (441)
T ss_pred EEecCCcchhHHHH
Confidence 99999955444433
|
|
| >KOG2806 consensus Chitinase [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-53 Score=461.76 Aligned_cols=307 Identities=24% Similarity=0.426 Sum_probs=266.1
Q ss_pred ceEEEEEecCCC-CCCCCCCCCCCcceEEEEEEEecCCCcEEecCCchhhHHHHHHHHHHhhCCCceEEEEecCCCCCcc
Q 004402 26 TWIKAGYWLAGR-EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTY 104 (755)
Q Consensus 26 ~~~~~gY~~~~~-~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg~~~~~~ 104 (755)
.+.++||+..+. .+.+++++..+|||++|+|+.++.++......+.....|..+.+.+|.+||+||+|+|||||
T Consensus 57 ~~~~~~~~~~~~~~~~~~~~~~~~~TH~vfafa~~~~~~~~~~~~~~~~~~f~~~~~~~k~~n~~vK~llSIGG~----- 131 (432)
T KOG2806|consen 57 EKSIVGYYPSRIGPETLEDQDPLKCTHLVYAFAKMKRVGYVVFCGARTMNRFSSYNQTAKSSNPTVKVMISIGGS----- 131 (432)
T ss_pred cceeEEEeCCCCCCCCccccChhhcCcceEEEeeecccccEEeccchhhhhhHHHHHHHHhhCCCceEEEEecCC-----
Confidence 688899998888 78999999999999999999999988888877777778888889999999999999999544
Q ss_pred ccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCC--CCCCcccHHHHHHHHHHHccCCC-c---
Q 004402 105 QSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWP--NSTDLNSLGILLDEWKASASDQP-E--- 178 (755)
Q Consensus 105 ~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p--~~~~~~~~~~~l~~lr~~l~~~~-~--- 178 (755)
..++..|+.|++|++.|+.||+++++++++|+||||||||||| +..|+.+|..|+++||++|.+.. .
T Consensus 132 -------~~ns~~fs~~~s~~~~r~~FI~Sii~fl~~~~fDGvDL~We~P~~~~~d~~~~~~~i~elr~~~~~~~~~~~~ 204 (432)
T KOG2806|consen 132 -------HGNSGLFSLVLSDRMIRAKFIESVVSFIKDYGFDGVDLAWEWPLFTPSDQLEFSRFIQELRSAFARETLKSPD 204 (432)
T ss_pred -------CCCccchhhhhcChHHHHHHHHHHHHHHHHcCCCceeeeeECCCCchhhHHHHHHHHHHHHHHHHHHhhccCC
Confidence 3334459999999999999999999999999999999999999 78899999999999999996431 2
Q ss_pred --cEEEeeeecC-CcccccccCcchhcccCChhhhhhhhccCCCCCc-ccccCCCCCCCC----CCCcHHHHHHHHHHCC
Q 004402 179 --LTLSMAVRYS-PTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKEN-VTGIHAALYNPS----SNISTDFGIREWLRRG 250 (755)
Q Consensus 179 --~~ls~~~~~~-~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~-~~~~~a~l~~~~----~~~~~~~~v~~~~~~g 250 (755)
..++.++.+. ......+||+++|.+++||||||+|||||+|..+ .+||+||||.+. ..+|++..+++|++.|
T Consensus 205 ~~~~l~~~v~~~~~~~~~~~ydi~~i~~~~DfiNi~syDf~gpw~~~~~tGp~aPl~~~~~~~~~~~Nvd~~~ky~~~~~ 284 (432)
T KOG2806|consen 205 TAKVLEAVVADSKQSAYSDGYDYENLSKYVDFINIMSYDYYGPWSLPCFTGPPSPLYKGPSMTNPKMNVDSLLKYWTEKG 284 (432)
T ss_pred ccceeeeccccCccchhhccCCHHHHHhhCCeEEEecccccCCCcCCCcCCCCcccCCCCcccccCcchhhhHHHHhhcC
Confidence 1344444444 3367788999999999999999999999866654 799999999753 4579999999999999
Q ss_pred CCCCceeecccccCCCcccC------------------------CCcchHHHHHHHhhcCCCcccccccceeeeeeec--
Q 004402 251 FPANKLVLGARASGPGITID------------------------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTS-- 304 (755)
Q Consensus 251 ~p~~KlvlG~p~yG~~~~~~------------------------~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 304 (755)
.|++|++||+|+||+.|++. |.++|.++|+...+.+ ...||.....+|...
T Consensus 285 ~~~~Kl~~gip~yg~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~g~ls~~ei~~~~~~~~---~~~~d~~~~~~Y~~~~~ 361 (432)
T KOG2806|consen 285 LPPSKLVLALPFYGRSWQLLEDSRSSAAPPFGQAAPVSMRSKGGGYMSYPEICERKINTG---VTHWDEETQTPYLYNIP 361 (432)
T ss_pred CCchheEEEEecceehhhhcCCcCCCCCccCCCcccCccccccCceeeHHHHHHHhcccC---CceecCCceeeeEEecC
Confidence 99999999999999999765 4578999999554433 677888888888888
Q ss_pred CcEEEeeCCcchhhhhhhcccccCccccccccccccchhhhhh
Q 004402 305 GATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSR 347 (755)
Q Consensus 305 ~~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~dd~~~~~~ 347 (755)
+.+||+|||++|++.|++||++++|||+++|.++.||..+...
T Consensus 362 ~~~wvtyen~~Si~~K~~Yvk~~~lGGv~iW~vd~DD~~~~~~ 404 (432)
T KOG2806|consen 362 YDQWVTYENERSIHIKADYAKDEGLGGVAIWNIDQDDESGSLL 404 (432)
T ss_pred CCeEEecCCHHHHHHHHHHHHhcCCceEEEEeccCCCCCCccc
Confidence 9999999999999999999999999999999999999877643
|
|
| >smart00636 Glyco_18 Glycosyl hydrolase family 18 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-53 Score=453.34 Aligned_cols=292 Identities=32% Similarity=0.548 Sum_probs=248.5
Q ss_pred EEEEEecCCCC----CCCCCCCCCCcceEEEEEEEecCCCcEEecCCchh--hHHHHHHHHHHhhCCCceEEEEecCCCC
Q 004402 28 IKAGYWLAGRE----FPLSDINSALFTHLICAFAEVDSSTYQLSISSANQ--QYFSIFANSVRRKNPSIKTLLSIWNGQN 101 (755)
Q Consensus 28 ~~~gY~~~~~~----~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~--~~~~~~~~~~k~~~~~lk~~isigg~~~ 101 (755)
+++|||.+|.. |++++++.++||||+|+|+.+++++. +...+... ..+.. +..+|++||++|++++||
T Consensus 1 ~~~~Y~~~w~~~~~~~~~~~~~~~~~thv~~~~~~~~~~g~-~~~~~~~~~~~~~~~-~~~l~~~~~~~kvl~svg---- 74 (334)
T smart00636 1 RVVGYFTNWGVYGRNFPVDDIPASKLTHIIYAFANIDPDGT-VTIGDEWADIGNFGQ-LKALKKKNPGLKVLLSIG---- 74 (334)
T ss_pred CEEEEECchhccCCCCChhHCCcccCcEEEEeeeeeCCCCC-EeeCCcchhhhhHHH-HHHHHHhCCCCEEEEEEe----
Confidence 37899988763 78999999999999999999998554 44332222 24554 467999999999999994
Q ss_pred CccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCC--CCcccHHHHHHHHHHHccC----
Q 004402 102 STYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS--TDLNSLGILLDEWKASASD---- 175 (755)
Q Consensus 102 ~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~--~~~~~~~~~l~~lr~~l~~---- 175 (755)
|+.. +..|+.+++|++.|++||+++++++++|+|||||||||+|.. +++++|+.|+++||++|++
T Consensus 75 --------g~~~-s~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGidiDwE~~~~~~~d~~~~~~ll~~lr~~l~~~~~~ 145 (334)
T smart00636 75 --------GWTE-SDNFSSMLSDPASRKKFIDSIVSFLKKYGFDGIDIDWEYPGARGDDRENYTALLKELREALDKEGAE 145 (334)
T ss_pred --------CCCC-CcchhHHHCCHHHHHHHHHHHHHHHHHcCCCeEEECCcCCCCCccHHHHHHHHHHHHHHHHHHhccc
Confidence 4433 345999999999999999999999999999999999999977 6889999999999999976
Q ss_pred CCccEEEeeeecCCcccccccC-cchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCC---CCcHHHHHHHHHHCCC
Q 004402 176 QPELTLSMAVRYSPTHETVSYP-IDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSS---NISTDFGIREWLRRGF 251 (755)
Q Consensus 176 ~~~~~ls~~~~~~~~~~~~~~~-~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~---~~~~~~~v~~~~~~g~ 251 (755)
+++++||+++|+.+.....+|+ ++++++++||||||+||+|+ .|+..+||+|||+.... ..+++.+|++|++.|+
T Consensus 146 ~~~~~lsi~v~~~~~~~~~~~~~~~~l~~~vD~v~vm~YD~~~-~~~~~~g~~spl~~~~~~~~~~~v~~~v~~~~~~gv 224 (334)
T smart00636 146 GKGYLLTIAVPAGPDKIDKGYGDLPAIAKYLDFINLMTYDFHG-AWSNPTGHNAPLYAGPGDPEKYNVDYAVKYYLCKGV 224 (334)
T ss_pred CCceEEEEEecCChHHHHhhhhhHHHHHhhCcEEEEeeeccCC-CCCCCCCCCCcCCCCCCCCCCccHHHHHHHHHHcCC
Confidence 3589999999987666555688 59999999999999999995 56668999999986554 4689999999999999
Q ss_pred CCCceeecccccCCCcccC------------------------CCcchHHHHHHHhhcCCCcccccccceeeeeeec--C
Q 004402 252 PANKLVLGARASGPGITID------------------------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTS--G 305 (755)
Q Consensus 252 p~~KlvlG~p~yG~~~~~~------------------------~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 305 (755)
|++||+||+|+||++|++. |.++|.++|+.. ++...||+....+|... +
T Consensus 225 p~~KlvlGip~YG~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~y~ei~~~~-----~~~~~~d~~~~~~y~~~~~~ 299 (334)
T smart00636 225 PPSKLVLGIPFYGRGWTLVDGSNNGPGAPFTGPATGGPGTWEGGVVDYREICKLL-----GATVVWDDTAKAPYAYNPGT 299 (334)
T ss_pred CHHHeEEeeccccCccccCCCCcCCCCCcccCCCCCCCCCCcccchhHHHHHhhc-----CcEEEEcCCCceeEEEECCC
Confidence 9999999999999999753 347789988864 47778887777777654 3
Q ss_pred cEEEeeCCcchhhhhhhcccccCcccccccccccc
Q 004402 306 ATWINFDGVETIKAKISYAKEKNLLGYKAFQLSND 340 (755)
Q Consensus 306 ~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~d 340 (755)
++||||||++|++.|++||+++||||+|+|++++|
T Consensus 300 ~~~v~ydd~~Si~~K~~~~~~~~lgGv~iW~l~~D 334 (334)
T smart00636 300 GQWVSYDDPRSIKAKADYVKDKGLGGVMIWELDAD 334 (334)
T ss_pred CEEEEcCCHHHHHHHHHHHHhCCCCeEEEEeecCC
Confidence 69999999999999999999999999999999987
|
|
| >cd02878 GH18_zymocin_alpha Zymocin, alpha subunit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-53 Score=449.12 Aligned_cols=293 Identities=20% Similarity=0.299 Sum_probs=229.4
Q ss_pred EEEEEecCCC------CCCCCCCCCCCcceEEEEEEEecCCCcEEecCCchhhHHHHHHHHHHhhCCCceEEEEecCCCC
Q 004402 28 IKAGYWLAGR------EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQN 101 (755)
Q Consensus 28 ~~~gY~~~~~------~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg~~~ 101 (755)
+++|||..|. .|++++||.++||||+|+|+.+++++ .+...+ ....+..+ .++| ++|+++|||||..
T Consensus 1 ~~v~Y~~~w~~~r~~~~~~~~~i~~~~~THi~yaf~~~~~~g-~l~~~~-~~~~~~~~-~~~k----~lkvllsiGG~~~ 73 (345)
T cd02878 1 KNIAYFEAYNLDRPCLNMDVTQIDTSKYTHIHFAFANITSDF-SVDVSS-VQEQFSDF-KKLK----GVKKILSFGGWDF 73 (345)
T ss_pred CEEEEEChhhcCCCCCCCCHhHCCcccCCEEEEEeEeecCCC-eEeecc-cHHHHHHH-Hhhc----CcEEEEEEeCCCC
Confidence 4789987763 47899999999999999999999754 444432 23344443 2232 3999999976664
Q ss_pred CccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCC-----------CCcccHHHHHHHHH
Q 004402 102 STYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-----------TDLNSLGILLDEWK 170 (755)
Q Consensus 102 ~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~-----------~~~~~~~~~l~~lr 170 (755)
+.. . .....|+.++ +++.|++||+++++++++|||||||||||||.. +|+++|+.||++||
T Consensus 74 s~~----~---~~~~~f~~~~-~~~~R~~Fi~si~~~~~~~~fDGidiDwE~P~~~~~~~~~~~~~~d~~n~~~ll~elr 145 (345)
T cd02878 74 STS----P---STYQIFRDAV-KPANRDTFANNVVNFVNKYNLDGVDFDWEYPGAPDIPGIPAGDPDDGKNYLEFLKLLK 145 (345)
T ss_pred CCC----C---ccchhhHhhc-CHHHHHHHHHHHHHHHHHcCCCceeecccCCcccCCCCCCCCChHHHHHHHHHHHHHH
Confidence 321 0 0112488888 999999999999999999999999999999942 47899999999999
Q ss_pred HHccCCCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCC-------CCCCCCCcHHHHH
Q 004402 171 ASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAAL-------YNPSSNISTDFGI 243 (755)
Q Consensus 171 ~~l~~~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l-------~~~~~~~~~~~~v 243 (755)
++|++ +++||+++|+.+... .+||+++++++|||+||||||+||+ |...+++++|. ....+..++..+|
T Consensus 146 ~~l~~--~~~ls~a~~~~~~~~-~~yd~~~l~~~vD~i~vMtYD~~g~-w~~~~~~~~p~~p~~~~~~~~~~~~~~~~~v 221 (345)
T cd02878 146 SKLPS--GKSLSIAAPASYWYL-KGFPIKDMAKYVDYIVYMTYDLHGQ-WDYGNKWASPGCPAGNCLRSHVNKTETLDAL 221 (345)
T ss_pred HHhCc--CcEEEEEcCCChhhh-cCCcHHHHHhhCcEEEEEeecccCC-cCccCCcCCCCCCcccccccCCCchhHHHHH
Confidence 99975 579999998875543 4599999999999999999999965 44444544442 1222234588899
Q ss_pred HHHHHCCCCCCceeecccccCCCcccC------------------------CCcc---hHHHHHHHhhcCCCcccccccc
Q 004402 244 REWLRRGFPANKLVLGARASGPGITID------------------------GSMG---YKFIRAFIQNYGYGAAPVYNAS 296 (755)
Q Consensus 244 ~~~~~~g~p~~KlvlG~p~yG~~~~~~------------------------~~~~---y~~~~~~~~~~~~~~~~~~~~~ 296 (755)
++|++.|+|++||+||+|+|||+|++. +..+ |.++|...... .++...||+.
T Consensus 222 ~~~~~~Gvp~~KlvlGip~YGr~~~l~~~~~~~~~~p~~g~~~~~~~g~~~~~~g~~~~~e~~~~~~~~-~~~~~~~d~~ 300 (345)
T cd02878 222 SMITKAGVPSNKVVVGVASYGRSFKMADPGCTGPGCTFTGPGSGAEAGRCTCTAGYGAISEIEIIDISK-SKNKRWYDTD 300 (345)
T ss_pred HHHHHcCCCHHHeEEeeccccceeeccCCCCCCCCCcccCCCCCCCCCCCCCchhhhhHHHHHHHHhcc-CCCcEEEecC
Confidence 999999999999999999999999744 1123 37777654332 2588899998
Q ss_pred eeeeee-ecCcEEEeeCCcchhhhhhhcccccCcccccccccccc
Q 004402 297 YVVNLF-TSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSND 340 (755)
Q Consensus 297 ~~~~~~-~~~~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~d 340 (755)
...+|. ..+.+||+|||++|++.|++||+++||||+|+|+++.|
T Consensus 301 ~~~~y~~~~~~~wv~ydd~~Si~~K~~y~~~~~LgGv~~W~ld~~ 345 (345)
T cd02878 301 SDSDILVYDDDQWVAYMSPATKAARIEWYKGLNFGGTSDWAVDLQ 345 (345)
T ss_pred CCccEEEEcCCEEEEcCCHHHHHHHHHHHHhCCCceEEEeeccCC
Confidence 888876 45669999999999999999999999999999999976
|
Zymocin is a heterotrimeric enzyme that inhibits yeast cell cycle progression. The zymocin alpha subunit has a chitinase activity that is essential for holoenzyme action from the cell exterior while the gamma subunit contains the intracellular toxin responsible for G1 phase cell cycle arrest. The zymocin alpha and beta subunits are thought to act from the cell's exterior by docking to the cell wall-associated chitin, thus mediating gamma-toxin translocation. The alpha subunit has an eight-stranded TIM barrel fold similar to that of family 18 glycosyl hydrolases such as hevamine, chitolectin, and chitobiase. |
| >cd02876 GH18_SI-CLP Stabilin-1 interacting chitinase-like protein (SI-CLP) is a eukaryotic chitinase-like protein of unknown function that interacts with the endocytic/sorting transmembrane receptor stabilin-1 and is secreted from the lysosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-50 Score=426.08 Aligned_cols=287 Identities=18% Similarity=0.234 Sum_probs=234.1
Q ss_pred EEEEEecCCCC--CCCCCCCCCCcceEEEEEEEecCCCcEEecCCchhhHHHHHHHHHHhhCCCceEE--EEecCCCCCc
Q 004402 28 IKAGYWLAGRE--FPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTL--LSIWNGQNST 103 (755)
Q Consensus 28 ~~~gY~~~~~~--~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~--isigg~~~~~ 103 (755)
.++|||..|.. |.+.+++.++||||+|+|+.++++++.+...+..+.. ...++.+|++||++|++ +++
T Consensus 4 ~~~~y~~~W~~~~~~~~~~~~~~lthv~~~f~~i~~~g~~~~~~~~~~~~-~~~~~~lk~~~~~lkvlp~i~~------- 75 (318)
T cd02876 4 PVLGYVTPWNSHGYDVAKKFAAKFTHVSPVWLQIKRKGNKFVIEGTHDID-KGWIEEVRKANKNIKILPRVLF------- 75 (318)
T ss_pred ceEEEEcCcCccchHHHHHHhccCCEecceEEEEecCCCeeeeecCcchh-hHHHHHHHhhCCCcEEEeEEEE-------
Confidence 47899988764 6788999999999999999999877755444322211 23457899999999999 555
Q ss_pred cccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCccccc-ccCCCC----CCcccHHHHHHHHHHHccCCCc
Q 004402 104 YQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLF-WLWPNS----TDLNSLGILLDEWKASASDQPE 178 (755)
Q Consensus 104 ~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiD-we~p~~----~~~~~~~~~l~~lr~~l~~~~~ 178 (755)
|||+. +.|+.+++|++.|++||+++++++++||||||||| ||+|.. +++++|+.||++||++|++. +
T Consensus 76 -----gg~~~--~~f~~~~~~~~~R~~fi~s~~~~~~~~~~DGidiD~we~p~~~~~~~d~~~~~~~l~el~~~l~~~-~ 147 (318)
T cd02876 76 -----EGWSY--QDLQSLLNDEQEREKLIKLLVTTAKKNHFDGIVLEVWSQLAAYGVPDKRKELIQLVIHLGETLHSA-N 147 (318)
T ss_pred -----CCCCH--HHHHHHHcCHHHHHHHHHHHHHHHHHcCCCcEEEechhhhcccCCHHHHHHHHHHHHHHHHHHhhc-C
Confidence 55432 24999999999999999999999999999999999 999965 48899999999999999875 6
Q ss_pred cEEEeeeecCCcc-----cccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHHHHHHCC-CC
Q 004402 179 LTLSMAVRYSPTH-----ETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRG-FP 252 (755)
Q Consensus 179 ~~ls~~~~~~~~~-----~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~~~~~~g-~p 252 (755)
+.+++++|+.... ...+||+++|+++|||+||||||+||+ ..+||+|||+ +++.+++++++.| +|
T Consensus 148 ~~l~~~v~~~~~~~~~~~~~~~~d~~~l~~~vD~v~lMtYD~~~~---~~~g~~apl~------~v~~~v~~~~~~~~vp 218 (318)
T cd02876 148 LKLILVIPPPREKGNQNGLFTRKDFEKLAPHVDGFSLMTYDYSSP---QRPGPNAPLS------WVRSCLELLLPESGKK 218 (318)
T ss_pred CEEEEEEcCccccccccccccccCHHHHHhhccEEEEEeeccCCC---CCCCCCCCcH------HHHHHHHHHHhcCCCC
Confidence 7888888764322 223489999999999999999999954 6799999985 7999999999987 99
Q ss_pred CCceeecccccCCCcccCC---CcchHHHHHHHhhcCCCcccccccceeee-eeec---CcEEEeeCCcchhhhhhhccc
Q 004402 253 ANKLVLGARASGPGITIDG---SMGYKFIRAFIQNYGYGAAPVYNASYVVN-LFTS---GATWINFDGVETIKAKISYAK 325 (755)
Q Consensus 253 ~~KlvlG~p~yG~~~~~~~---~~~y~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~---~~~~i~yd~~~S~~~K~~~a~ 325 (755)
++|||||+|+|||+|+..+ .+++.+..+++...+ ++..||+....+ |... .++||||||++|++.|++||+
T Consensus 219 ~~KlvlGip~YG~~w~~~~~~~~~~~~~~~~~~~~~~--~~~~~d~~~~~~~~~y~~~~~~~~v~ydd~~Si~~K~~~a~ 296 (318)
T cd02876 219 RAKILLGLNFYGNDYTLPGGGGAITGSEYLKLLKSNK--PKLQWDEKSAEHFFEYKNKGGKHAVFYPTLKSIQLRLDLAK 296 (318)
T ss_pred HHHeEEeccccccccccCCCCceeehHHHHHHHHhcC--CCceeccCCCcceEEEecCCCcEEEEeCCHHHHHHHHHHHH
Confidence 9999999999999998763 445555556665543 677787764433 3332 379999999999999999999
Q ss_pred ccCccccccccccccch
Q 004402 326 EKNLLGYKAFQLSNDDN 342 (755)
Q Consensus 326 ~~~l~Gi~~W~l~~dd~ 342 (755)
++|| |+|+|++++++.
T Consensus 297 ~~~l-Gv~~W~lg~~~~ 312 (318)
T cd02876 297 ELGT-GISIWELGQGLD 312 (318)
T ss_pred HcCC-cEEEEcccCCch
Confidence 9999 999999999865
|
SI-CLP has a glycosyl hydrolase family 18 (GH18) domain but lacks a chitin-binding domain. The catalytic amino acids of the GH18 domain are not conserved in SI-CLP, similar to the chitolectins YKL-39, YKL-40, and YM1/2. Human SI-CLP is sorted to late endosomes and secretory lysosomes in alternatively activated macrophages. |
| >PF00704 Glyco_hydro_18: Glycosyl hydrolases family 18; InterPro: IPR001223 O-Glycosyl hydrolases 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=418.55 Aligned_cols=298 Identities=28% Similarity=0.464 Sum_probs=248.4
Q ss_pred eEEEEEecCCCC-----CCCCCCCCCCcceEEEEEEEecCCCcEEe-----cCCchhhHHHHHHHHHHhhCCCceEEEEe
Q 004402 27 WIKAGYWLAGRE-----FPLSDINSALFTHLICAFAEVDSSTYQLS-----ISSANQQYFSIFANSVRRKNPSIKTLLSI 96 (755)
Q Consensus 27 ~~~~gY~~~~~~-----~~~~~i~~~~~thi~~~f~~~~~~~~~~~-----~~~~~~~~~~~~~~~~k~~~~~lk~~isi 96 (755)
++++|||..|+. |.+++++.+.||||+|+|+.++.++.... ............++.+|+++|++|+++||
T Consensus 1 ~~vv~Y~~~~~~~~~~~~~~~~i~~~~~t~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kvllsi 80 (343)
T PF00704_consen 1 KRVVGYYSNWNSYRPGSYKIEDIPWSKCTHIVYAFAGIDPNGNLNYPWNFDDDNDGDSSGFKNLKELKAKNPGVKVLLSI 80 (343)
T ss_dssp BEEEEEEEGGGGSSTGCSHGGGSHTTTESEEEEEEEEEETTTTEEEGTTTECSSTTHHHHHHHHHHHHHHHTT-EEEEEE
T ss_pred CEEEEEECCcCCCCCCCCCHHHCCcccCCEEEEEeeeecCCCceecccccccccCccccchhHHHHHHhhccCceEEEEe
Confidence 579999987654 56889999999999999999999877642 23333344444457889999999999999
Q ss_pred cCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCC----CcccHHHHHHHHHHH
Q 004402 97 WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNST----DLNSLGILLDEWKAS 172 (755)
Q Consensus 97 gg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~----~~~~~~~~l~~lr~~ 172 (755)
||+. .+...|+.+++|++.|++||+++++++++|||||||||||+|... ++.+|..|+++||++
T Consensus 81 gg~~------------~~~~~~~~~~~~~~~r~~f~~~i~~~l~~y~~DGidiD~e~~~~~~~~~~~~~~~~~l~~L~~~ 148 (343)
T PF00704_consen 81 GGWG------------MSSDGFSQLLSNPAKRQNFINNIVSFLKKYGFDGIDIDWEYPSSSGDPQDKDNYTAFLKELRKA 148 (343)
T ss_dssp EETT------------SSHHHHHHHHHSHHHHHHHHHHHHHHHHHHT-SEEEEEESSTTSTSSTTHHHHHHHHHHHHHHH
T ss_pred cccc------------ccccccccccccHHHHHHHHHhhhhhhcccCcceeeeeeeeccccccchhhhhhhhhhhhhhhh
Confidence 5443 344459999999999999999999999999999999999999776 899999999999999
Q ss_pred ccCC----CccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCC---CCCcHHHHHHH
Q 004402 173 ASDQ----PELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPS---SNISTDFGIRE 245 (755)
Q Consensus 173 l~~~----~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~---~~~~~~~~v~~ 245 (755)
|++. ++++||+++|+.+..... ++++++.++||||++|+||+++ .|...+++++||+... ...+++.++++
T Consensus 149 l~~~~~~~~~~~ls~a~p~~~~~~~~-~~~~~l~~~vD~v~~m~yD~~~-~~~~~~~~~~~l~~~~~~~~~~~~~~~v~~ 226 (343)
T PF00704_consen 149 LKRANRSGKGYILSVAVPPSPDYYDK-YDYKELAQYVDYVNLMTYDYHG-PWSDVTGPNAPLYDSSWDSNYYSVDSAVQY 226 (343)
T ss_dssp HHHHHHHHSTSEEEEEEECSHHHHTT-HHHHHHHTTSSEEEEETTSSSS-TTSSBETTSSSSSHTTTSGTSSSHHHHHHH
T ss_pred hcccccccceeEEeeccccccccccc-cccccccccccccccccccCCC-CcccccccccccccCCccCCCceeeeehhh
Confidence 9762 379999999988765544 5899999999999999999996 4555899999998665 46899999999
Q ss_pred HHHCCCCCCceeecccccCCCcccC----------------------CCcchHHHHHHHhhcCCCcccccccceeeeeee
Q 004402 246 WLRRGFPANKLVLGARASGPGITID----------------------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFT 303 (755)
Q Consensus 246 ~~~~g~p~~KlvlG~p~yG~~~~~~----------------------~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (755)
|+..|+|++||+||+|+||+.|+.. +.++|.+++.....++ +...||.....+|..
T Consensus 227 ~~~~g~p~~Kl~lglp~yg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~d~~~~~~y~~ 304 (343)
T PF00704_consen 227 WIKAGVPPSKLVLGLPFYGRSWTLVNGSPNGPWGPAYWSPGKGTKNAGILSYYELCALLKSNG--YTVQWDDTAQAPYAY 304 (343)
T ss_dssp HHHTTSTGGGEEEEEESEEEEEESSSSTTSTTTBBEESEETTTTSBTTEEEHHHHHHHTHHTT--EEEEEETTTTEEEEE
T ss_pred hccccCChhheeecCCcccccceecCCcCCCCCCcccccccccccCCCccccccchhhcccCC--cceEEeecccceEEE
Confidence 9999999999999999999998765 2478999998876544 677777767777776
Q ss_pred cC--cEEEeeCCcchhhhhhhcccccCcccccccccccc
Q 004402 304 SG--ATWINFDGVETIKAKISYAKEKNLLGYKAFQLSND 340 (755)
Q Consensus 304 ~~--~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~d 340 (755)
.. ++|++|||++|++.|++|++++||||+++|++++|
T Consensus 305 ~~~~~~~i~~e~~~Si~~K~~~v~~~glgGv~~W~l~~D 343 (343)
T PF00704_consen 305 NDDKKHWISYEDPRSIKAKMDYVKEKGLGGVAIWSLDQD 343 (343)
T ss_dssp ETTTTEEEEE--HHHHHHHHHHHHHTT-SEEEEETGGGS
T ss_pred ecCCCeEEEeCCHHHHHHHHHHHHhCCCCEEEEEecCCC
Confidence 55 89999999999999999999999999999999987
|
2.1. from EC are a widespread group of enzymes that hydrolyse the glycosidic bond between two or more carbohydrates, or between a carbohydrate and a non-carbohydrate moiety. A classification system for glycosyl hydrolases, based on sequence similarity, has led to the definition of 85 different families [, ]. This classification is available on the CAZy (CArbohydrate-Active EnZymes) web site. Some members of this family, GH18 from CAZY, belong to the chitinase class II group which includes chitinase, chitodextrinase and the killer toxin of Kluyveromyces lactis. The chitinases hydrolyse chitin oligosaccharides. The family also includes various glycoproteins from mammals; cartilage glycoprotein and the oviduct-specific glycoproteins are two examples.; GO: 0004553 hydrolase activity, hydrolyzing O-glycosyl compounds, 0005975 carbohydrate metabolic process; PDB: 1ITX_A 3ALG_A 3ALF_A 1NAR_A 3QOK_A 3G6L_A 3G6M_A 2DT1_A 2B31_A 2O92_A .... |
| >cd02875 GH18_chitobiase Chitobiase (also known as di-N-acetylchitobiase) is a lysosomal glycosidase that hydrolyzes the reducing-end N-acetylglucosamine from the chitobiose core of oligosaccharides during the ordered degradation of asparagine-linked glycoproteins in eukaryotes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-47 Score=402.73 Aligned_cols=278 Identities=15% Similarity=0.193 Sum_probs=224.5
Q ss_pred cceEEEEEecCCCCCCCCCCCCCCcceEEEEEEEecCCCcEEecCCchhhHHHHHHHHHHhhCCCceEEEEecCCCCCcc
Q 004402 25 QTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTY 104 (755)
Q Consensus 25 ~~~~~~gY~~~~~~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg~~~~~~ 104 (755)
+.+.|+||.... ..-...+++++|||.+. + .. + ..++..+|++ ++||+++.
T Consensus 34 ~~~~~~~~~~~~--~~~~~~~~~~~tti~~~-------~------~~-~---~~~~~~A~~~--~v~v~~~~-------- 84 (358)
T cd02875 34 PRFEFLVFSVNS--TNYPNYDWSKVTTIAIF-------G------DI-D---DELLCYAHSK--GVRLVLKG-------- 84 (358)
T ss_pred CceEEEEEEeCC--CcCcccccccceEEEec-------C------CC-C---HHHHHHHHHc--CCEEEEEC--------
Confidence 589999997653 34467999999999965 0 11 1 2333445554 79999874
Q ss_pred ccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCC---CCCcccHHHHHHHHHHHccCC-CccE
Q 004402 105 QSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN---STDLNSLGILLDEWKASASDQ-PELT 180 (755)
Q Consensus 105 ~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~---~~~~~~~~~~l~~lr~~l~~~-~~~~ 180 (755)
+. ....++|++.|++||+++++++++|||||||||||+|. ++++++|+.||++||++|++. ++++
T Consensus 85 -----~~------~~~~l~~~~~R~~fi~siv~~~~~~gfDGIdIDwE~p~~~~~~d~~~~t~llkelr~~l~~~~~~~~ 153 (358)
T cd02875 85 -----DV------PLEQISNPTYRTQWIQQKVELAKSQFMDGINIDIEQPITKGSPEYYALTELVKETTKAFKKENPGYQ 153 (358)
T ss_pred -----cc------CHHHcCCHHHHHHHHHHHHHHHHHhCCCeEEEcccCCCCCCcchHHHHHHHHHHHHHHHhhcCCCcE
Confidence 11 13468899999999999999999999999999999995 467999999999999999873 4799
Q ss_pred EEeeeecCCccccc-ccCcchhcccCChhhhhhhhccCCCCC--cccccCCCCCCCCCCCcHHHHHHHHHHCCCCCCcee
Q 004402 181 LSMAVRYSPTHETV-SYPIDSMKKNLNWAHLVAYDYHMPSKE--NVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLV 257 (755)
Q Consensus 181 ls~~~~~~~~~~~~-~~~~~~l~~~vD~~~vm~Yd~~~~~~~--~~~~~~a~l~~~~~~~~~~~~v~~~~~~g~p~~Klv 257 (755)
||+++|..+..... .||+++|+++|||+||||||+|++.|+ ..+|++||+ .+++.+|++|+..|+|++|||
T Consensus 154 Lsvav~~~p~~~~~~~yd~~~l~~~vD~v~lMtYD~h~~~w~~~~~~g~~ap~------~~v~~~v~~~~~~gvp~~KLv 227 (358)
T cd02875 154 ISFDVAWSPSCIDKRCYDYTGIADASDFLVVMDYDEQSQIWGKECIAGANSPY------SQTLSGYNNFTKLGIDPKKLV 227 (358)
T ss_pred EEEEEecCcccccccccCHHHHHhhCCEeeEEeecccCCCCCCCCCCCCCCCc------hhHHHHHHHHHHcCCCHHHeE
Confidence 99999977655443 399999999999999999999976665 357888886 378899999999999999999
Q ss_pred ecccccCCCcccC--------------------------CCcchHHHHHHHhhcCCCcccccccceeeeeee-----cCc
Q 004402 258 LGARASGPGITID--------------------------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFT-----SGA 306 (755)
Q Consensus 258 lG~p~yG~~~~~~--------------------------~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~ 306 (755)
||+|+|||+|++. +.++|.++++.++..+ +...||+....+|.. +..
T Consensus 228 LGip~YGr~w~~~~~~~~~~~~~~~~~p~~g~~~~~~~g~~i~Y~ei~~~~~~~~--~~~~wD~~~~~py~~y~d~~g~~ 305 (358)
T cd02875 228 MGLPWYGYDYPCLNGNLEDVVCTIPKVPFRGANCSDAAGRQIPYSEIMKQINSSI--GGRLWDSEQKSPFYNYKDKQGNL 305 (358)
T ss_pred EEeCCCCCceeCCCCcccCcccCCCCCCcCCCCCcCCCCCccCHHHHHHHHhcCC--CceeeccccccceEEEecCCCcE
Confidence 9999999999631 2467899988776543 566777776666542 224
Q ss_pred EEEeeCCcchhhhhhhcccccCccccccccccccchhhhhhhhh
Q 004402 307 TWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAAQ 350 (755)
Q Consensus 307 ~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~dd~~~~~~~~~ 350 (755)
+||||||++|++.|++||+++||+|+|+|+++.||..+.+.+.+
T Consensus 306 ~~V~ydD~~Si~~K~~~a~~~gL~Gv~iW~ld~dD~~g~~~~~~ 349 (358)
T cd02875 306 HQVWYDNPQSLSIKVAYAKNLGLKGIGMWNGDLLDYSGLPIAEK 349 (358)
T ss_pred EEEEeCCHHHHHHHHHHHHhCCCCeEEEEeccccccCCCchhhh
Confidence 79999999999999999999999999999999999887766653
|
Chitobiase can only do so if the asparagine that joins the oligosaccharide to protein is previously removed by a glycosylasparaginase. Chitobiase is therefore the final step in the lysosomal degradation of the protein/carbohydrate linkage component of asparagine-linked glycoproteins. The catalytic domain of chitobiase is an eight-stranded alpha/beta barrel fold similar to that of other family 18 glycosyl hydrolases such as hevamine and chitotriosidase. |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=397.45 Aligned_cols=256 Identities=30% Similarity=0.493 Sum_probs=207.6
Q ss_pred ccCcccccCCeeEEEEEcCCCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCceeeeeeeeecCC-ccEEEEeecCC
Q 004402 439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERD-ENMLIYEYLPN 515 (755)
Q Consensus 439 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e~~~~ 515 (755)
..+.||+|+||+||+|.+.....||||++..... ...+.|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 3466999999999999995444599999976532 22568999999999999999999999999887 79999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC-CeEEEecCCccccccCCccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~~~ 594 (755)
|+|..+++.. .+..+++..++.++.+||+||.|||+... ||||||||+|||++.++ ++||+|||+++...... .
T Consensus 125 GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~ 199 (362)
T KOG0192|consen 125 GSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T 199 (362)
T ss_pred CcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence 9999999764 45679999999999999999999999863 99999999999999997 99999999998654322 2
Q ss_pred ccccccccCCcccccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVK--KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~--~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
..+...||+.|||||++. ...|+.|+||||||++||||+||+.||..... ......+. ... ..+.+
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~v~---~~~-----~Rp~~- 267 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASAVV---VGG-----LRPPI- 267 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHH---hcC-----CCCCC-
Confidence 223368999999999999 66999999999999999999999999865433 11111111 111 11111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMA 714 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 714 (755)
+.+....+..++.+||+.||+.||++.|++.+|+.....
T Consensus 268 ---p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 268 ---PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred ---CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 112344788899999999999999999999999865443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=391.46 Aligned_cols=252 Identities=31% Similarity=0.460 Sum_probs=208.6
Q ss_pred ccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCCCh
Q 004402 439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL 518 (755)
Q Consensus 439 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 518 (755)
..+.||+|.||.||.|.+.....||+|.++... ...+.|.+|+++|++|+|+|||+++|+|..++.++||||||+.|+|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 458899999999999999778899999997753 2347899999999999999999999999998899999999999999
Q ss_pred hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccccccc
Q 004402 519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598 (755)
Q Consensus 519 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 598 (755)
.++|.. ..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+....+.... ...
T Consensus 289 l~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~-~~~ 363 (468)
T KOG0197|consen 289 LDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA-SEG 363 (468)
T ss_pred HHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee-cCC
Confidence 999976 34456889999999999999999999987 9999999999999999999999999999654443322 223
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCH
Q 004402 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISS-KRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSP 677 (755)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 677 (755)
..-+..|.|||.+..+.||.|||||||||+||||+|- +.|++ .....+.+..+. ...+-..+.
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~---~msn~ev~~~le-------------~GyRlp~P~ 427 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP---GMSNEEVLELLE-------------RGYRLPRPE 427 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC---CCCHHHHHHHHh-------------ccCcCCCCC
Confidence 3457899999999999999999999999999999994 44433 222223333222 112222344
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 678 CKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 678 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
.++..+++||..||+.+|++|||++.+...|++..
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 45668999999999999999999999999998754
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=406.85 Aligned_cols=260 Identities=30% Similarity=0.438 Sum_probs=213.7
Q ss_pred cCCCccCcccccCCeeEEEEEcC------CCCEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCceeeeeeeeecCCccE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM 507 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 507 (755)
.+....+.||+|+||+||+|... ..+.||||.++..... .+.+|++|+++|..++|||||+|+|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34455689999999999999542 3468999999887655 7889999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCc-----------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCe
Q 004402 508 LIYEYLPNKSLDLYLFDPIR-----------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP 576 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~ 576 (755)
+|+|||..|+|.+||..... +..|+..+.+.||.|||.||.||-+++ +|||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 99999999999999953211 234889999999999999999999887 9999999999999999999
Q ss_pred EEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHH
Q 004402 577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAF 655 (755)
Q Consensus 577 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 655 (755)
||+||||++.+.............-+.+|||||.+..++||++||||||||+|||++| |+.|+......+. .
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV-------I 715 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV-------I 715 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH-------H
Confidence 9999999997665544333333445789999999999999999999999999999999 5555543333322 2
Q ss_pred HHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 656 EQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 656 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
+.++.+++ -..+..++.+++.||..||+.+|++||+++||-.+|+....
T Consensus 716 e~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 716 ECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 22233332 12344566789999999999999999999999999987543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=363.89 Aligned_cols=248 Identities=25% Similarity=0.366 Sum_probs=205.8
Q ss_pred CccCcccccCCeeEEEEEc-CCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc-cEEEEeecC
Q 004402 438 SSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE-NMLIYEYLP 514 (755)
Q Consensus 438 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lv~e~~~ 514 (755)
+..+.||+|..|+|||+.+ .+++.+|+|++... ++...+++.+|+++++..+||+||.++|.|..... ..++||||.
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 3458999999999999965 46889999999654 45567789999999999999999999999999884 999999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 594 (755)
+|||+.++... ..+++...-+|+.+|++||.|||+.. .||||||||+|||++..|++||||||.++.+...
T Consensus 162 gGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---- 232 (364)
T KOG0581|consen 162 GGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---- 232 (364)
T ss_pred CCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence 99999998533 45889999999999999999999743 4999999999999999999999999999876543
Q ss_pred ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--CcccchHHHHHHHhccCCCccccCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT--SENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
.....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+..... .....++.+... + ..|.+.
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~----~-----ppP~lP 303 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD----E-----PPPRLP 303 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc----C-----CCCCCC
Confidence 34467999999999999999999999999999999999999999876411 222333333221 1 112333
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.. ....+++.++..||++||.+|||+.|+++
T Consensus 304 ~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 304 EG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred cc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 32 23447889999999999999999999985
|
|
| >cd02874 GH18_CFLE_spore_hydrolase Cortical fragment-lytic enzyme (CFLE) is a peptidoglycan hydrolase involved in bacterial endospore germination | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=390.43 Aligned_cols=286 Identities=20% Similarity=0.277 Sum_probs=232.9
Q ss_pred EEEEEecCCCCC--CCCCCCCCCcceEEEEEEEecCCCcEEecCCchhhHHHHHHHHHHhhCCCceEEEEecCCCCCccc
Q 004402 28 IKAGYWLAGREF--PLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQ 105 (755)
Q Consensus 28 ~~~gY~~~~~~~--~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg~~~~~~~ 105 (755)
.++||+..|+.. ....-..+++|||++.++.+++++. +.. .. ...+++.+|++ ++|++++|||+.+
T Consensus 3 ~~~g~~~~~~~~~~~~~~~~~~~lt~v~p~w~~~~~~g~-~~~--~~---~~~~~~~a~~~--~~kv~~~i~~~~~---- 70 (313)
T cd02874 3 EVLGYYTPRNGSDYESLRANAPYLTYIAPFWYGVDADGT-LTG--LP---DERLIEAAKRR--GVKPLLVITNLTN---- 70 (313)
T ss_pred eEEEEEecCCCchHHHHHHhcCCCCEEEEEEEEEcCCCC-CCC--CC---CHHHHHHHHHC--CCeEEEEEecCCC----
Confidence 488999887763 4445567899999999999998664 221 11 23455556665 7999999966652
Q ss_pred cccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCCCcccHHHHHHHHHHHccCCCccEEEeee
Q 004402 106 SILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAV 185 (755)
Q Consensus 106 ~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~~~~~~~~~l~~lr~~l~~~~~~~ls~~~ 185 (755)
..+++..|+.+++|++.|++||+++++++++|||||||||||++.++++++|+.||++||++|++. +++|++++
T Consensus 71 -----~~~~~~~~~~~l~~~~~r~~fi~~iv~~l~~~~~DGidiDwE~~~~~d~~~~~~fl~~lr~~l~~~-~~~lsv~~ 144 (313)
T cd02874 71 -----GNFDSELAHAVLSNPEARQRLINNILALAKKYGYDGVNIDFENVPPEDREAYTQFLRELSDRLHPA-GYTLSTAV 144 (313)
T ss_pred -----CCCCHHHHHHHhcCHHHHHHHHHHHHHHHHHhCCCcEEEecccCCHHHHHHHHHHHHHHHHHhhhc-CcEEEEEe
Confidence 125666799999999999999999999999999999999999999999999999999999999864 68888887
Q ss_pred ecCCc-----ccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHHHHHHCCCCCCceeecc
Q 004402 186 RYSPT-----HETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGA 260 (755)
Q Consensus 186 ~~~~~-----~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~~~~~~g~p~~KlvlG~ 260 (755)
++... .+...||+++++++|||+|||+||+|++ + ..+||+||+. +++..++++. .|+|++||+||+
T Consensus 145 ~p~~~~~~~~~~~~~~~~~~l~~~vD~v~lm~YD~~~~-~-~~~gp~a~~~------~~~~~~~~~~-~gvp~~KlvlGi 215 (313)
T cd02874 145 VPKTSADQFGNWSGAYDYAAIGKIVDFVVLMTYDWHWR-G-GPPGPVAPIG------WVERVLQYAV-TQIPREKILLGI 215 (313)
T ss_pred cCccccccccccccccCHHHHHhhCCEEEEEEeccCCC-C-CCCCccCChH------HHHHHHHHHH-hcCCHHHEEEee
Confidence 65432 2235589999999999999999999964 3 4589999873 5667776555 899999999999
Q ss_pred cccCCCcccC-------CCcchHHHHHHHhhcCCCcccccccceeeeeee-----cCcEEEeeCCcchhhhhhhcccccC
Q 004402 261 RASGPGITID-------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFT-----SGATWINFDGVETIKAKISYAKEKN 328 (755)
Q Consensus 261 p~yG~~~~~~-------~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~i~yd~~~S~~~K~~~a~~~~ 328 (755)
|+|||+|+.. +.++|.++++.+.+.+ +...||+....+|.. +..+||||||++|++.|++|++++|
T Consensus 216 p~YG~~w~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~d~~~~~~~~~y~~~~g~~~~v~y~d~~Si~~K~~~~~~~~ 293 (313)
T cd02874 216 PLYGYDWTLPYKKGGKASTISPQQAINLAKRYG--AEIQYDEEAQSPFFRYVDEQGRRHEVWFEDARSLQAKFELAKEYG 293 (313)
T ss_pred cccccccccCCCCCcCccccCHHHHHHHHHHcC--CCeEECcccCCCcEEEEeCCCCEEEEEeCcHHHHHHHHHHHHHcC
Confidence 9999999764 4577888888887754 777788776665432 3468999999999999999999999
Q ss_pred ccccccccccccch
Q 004402 329 LLGYKAFQLSNDDN 342 (755)
Q Consensus 329 l~Gi~~W~l~~dd~ 342 (755)
|||+++|++++||+
T Consensus 294 lgGv~iW~lg~dD~ 307 (313)
T cd02874 294 LRGVSYWRLGLEDP 307 (313)
T ss_pred CCeEEEEECCCCCc
Confidence 99999999999985
|
CFLE is expressed as an inactive preprotein (called SleB) in the forespore compartment of sporulating cells. SleB translocates across the forespore inner membrane and is deposited as a mature enzyme in the cortex layer of the spore. As part of a sensory mechanism capable of initiating germination, CFLE degrades a spore-specific peptidoglycan constituent called muramic-acid delta-lactam that comprises the outer cortex. CFLE has a C-terminal glycosyl hydrolase family 18 (GH18) catalytic domain as well as two N-terminal LysM peptidoglycan-binding domains. In addition to SleB, this family includes YaaH, YdhD, and YvbX from Bacillus subtilis. |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=356.61 Aligned_cols=199 Identities=29% Similarity=0.482 Sum_probs=178.8
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
..+|...+.||+|+||+||+|++ .++..||||.+... ..+.++.+..|+.+|+.++|||||.+++++...+..++||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 35677888899999999999965 45899999999776 5666778899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC------CCeEEEecCCc
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE------LNPKISDFGMA 584 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~------~~~kl~Dfgla 584 (755)
|||.+|+|..|++. +..+++.....++.|+|.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999964 336899999999999999999999998 9999999999999765 45899999999
Q ss_pred cccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004402 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY 641 (755)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~ 641 (755)
+.+... ......+|++.|||||++...+|+.|+|+||.|+||||+++|+.||..
T Consensus 163 R~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 163 RFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 987643 334457999999999999999999999999999999999999999864
|
|
| >cd06545 GH18_3CO4_chitinase The Bacteroides thetaiotaomicron protein represented by pdb structure 3CO4 is an uncharacterized bacterial member of the family 18 glycosyl hydrolases with homologs found in Flavobacterium, Stigmatella, and Pseudomonas | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=362.29 Aligned_cols=240 Identities=23% Similarity=0.343 Sum_probs=201.7
Q ss_pred EEEEecCCCCCC--CCCCCCCCcceEEEEEEEecCCCcEEecCCchhhHHHHHHHHHHhhCCCceEEEEecCCCCCcccc
Q 004402 29 KAGYWLAGREFP--LSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQS 106 (755)
Q Consensus 29 ~~gY~~~~~~~~--~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg~~~~~~~~ 106 (755)
|+|||..|+.+. ++++|.++||||+|+|+.++++|... ..+ ....+..+++.+|++ ++|+++|||||.
T Consensus 1 vigyy~~w~~~~~~~~~~~~~~lThv~~~f~~i~~~G~l~-~~~-~~~~~~~~~~~~~~~--~~kvl~sigg~~------ 70 (253)
T cd06545 1 VVGYLPNYDDLNALSPTIDFSKLTHINLAFANPDANGTLN-ANP-VRSELNSVVNAAHAH--NVKILISLAGGS------ 70 (253)
T ss_pred CEEEeCCcccccCCcccCChhhCCeEEEEEEEECCCCeEE-ecC-cHHHHHHHHHHHHhC--CCEEEEEEcCCC------
Confidence 689999998765 89999999999999999999866533 332 223445555666654 799999995443
Q ss_pred ccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCCCcccHHHHHHHHHHHccCCCccEEEeeee
Q 004402 107 ILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVR 186 (755)
Q Consensus 107 ~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~~~~~~~~~l~~lr~~l~~~~~~~ls~~~~ 186 (755)
.+. |..+++|++.|++||+++++++++|+|||||||||+|... +++|..|+++||++|++. ++.||++++
T Consensus 71 ------~~~--~~~~~~~~~~r~~fi~~lv~~~~~~~~DGIdiDwE~~~~~-~~~~~~fv~~Lr~~l~~~-~~~lt~av~ 140 (253)
T cd06545 71 ------PPE--FTAALNDPAKRKALVDKIINYVVSYNLDGIDVDLEGPDVT-FGDYLVFIRALYAALKKE-GKLLTAAVS 140 (253)
T ss_pred ------CCc--chhhhcCHHHHHHHHHHHHHHHHHhCCCceeEEeeccCcc-HhHHHHHHHHHHHHHhhc-CcEEEEEcc
Confidence 222 6779999999999999999999999999999999999765 789999999999999865 689999988
Q ss_pred cCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHHHHHHCCC-CCCceeecccccCC
Q 004402 187 YSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGF-PANKLVLGARASGP 265 (755)
Q Consensus 187 ~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~~~~~~g~-p~~KlvlG~p~yG~ 265 (755)
+.... +...++.+++||+|||+||++|+|....+||+||+. +++.++++|+..|+ |++||+||+|+|||
T Consensus 141 ~~~~~----~~~~~~~~~vD~i~vMtYD~~g~~~~~~~g~~a~~~------~~~~~v~~~~~~g~ip~~KlvlGlp~YG~ 210 (253)
T cd06545 141 SWNGG----AVSDSTLAYFDFINIMSYDATGPWWGDNPGQHSSYD------DAVNDLNYWNERGLASKDKLVLGLPFYGY 210 (253)
T ss_pred Ccccc----cccHHHHhhCCEEEEEcCcCCCCCCCCCCCCCCchH------hHHHHHHHHHHcCCCCHHHEEEEeCCccc
Confidence 65322 223678899999999999999777666789999863 67889999999998 99999999999999
Q ss_pred CcccCCCcchHHHHHHHhhcCCCcccccccceeeeeeecCcEEEeeCCcchhhhhhhcccccCccccccccccccc
Q 004402 266 GITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341 (755)
Q Consensus 266 ~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~dd 341 (755)
+| +|++..+++.|+++|+++ +||+|+|++++|.
T Consensus 211 ~w------------------------------------------~~~~~~~~~~~~~~~~~~-~gG~~~w~~~~d~ 243 (253)
T cd06545 211 GF------------------------------------------YYNGIPTIRNKVAFAKQN-YGGVMIWELSQDA 243 (253)
T ss_pred cc------------------------------------------cCCCHHHHHHHHHHHHHh-cCeEEEEeccCCC
Confidence 87 688889999999999999 9999999999986
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=386.71 Aligned_cols=256 Identities=26% Similarity=0.417 Sum_probs=212.8
Q ss_pred CCCccCcccccCCeeEEEEEcCC----CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 436 NFSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
...+.++||.|.||.||+|+++- ...||||.++... ++.+.+|+.|..+|.+++||||++|.|+.......++|.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 34467899999999999997643 4589999998874 445678999999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
|||+||+|+.||..... .+++.++.-++.+||.||.||.+++ +|||||.++|||++.+..+|++|||+++.+..+
T Consensus 710 EyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence 99999999999976543 4889999999999999999999987 999999999999999999999999999987655
Q ss_pred Cccc-ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 591 VDEA-NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 591 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
.... .+..-.-+.+|.|||.+..+++|.+||||||||+|||.++ |.+|+......+ .+.. ++
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd---VIka-------------Ie 848 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VIKA-------------IE 848 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH---HHHH-------------HH
Confidence 4222 1212223679999999999999999999999999999988 777764433322 2222 22
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
...+-..+.+++..|.+||+.||++|-.+||.+.+|+..|.+..
T Consensus 849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 22333455677889999999999999999999999999998753
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=370.31 Aligned_cols=250 Identities=26% Similarity=0.433 Sum_probs=210.3
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
..|...+.||+|+|+.||.++. ..|+.||+|++.+. .....+...+|+++-+.|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688889999999999999976 88999999999764 3344677899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
|+|++++|..++. ++..+++.+++.++.||+.||.|||+.+ |||||||-.|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999998884 5567999999999999999999999987 999999999999999999999999999987654
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
. .+....+|||.|+|||++.....+..+||||+||+||-|+.|++||+...-.+.. ..++. .++.-|
T Consensus 172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety-------~~Ik~---~~Y~~P- 238 (592)
T KOG0575|consen 172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY-------NKIKL---NEYSMP- 238 (592)
T ss_pred c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH-------HHHHh---cCcccc-
Confidence 3 3344689999999999999999999999999999999999999999643222211 11111 111111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH--HHhh
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVS--SMLK 709 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl--~~L~ 709 (755)
. ....+..+|+.++|+.||.+|||+.+|+ +++.
T Consensus 239 --~----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 239 --S----HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred --c----ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence 1 1223567899999999999999999999 4563
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=341.31 Aligned_cols=258 Identities=21% Similarity=0.334 Sum_probs=205.1
Q ss_pred CCCccCcccccCCeeEEEE-EcCCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeee-eecCC-ccEEEE
Q 004402 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGY-CTERD-ENMLIY 510 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~-~~~~~-~~~lv~ 510 (755)
+|.+.++||+|+||+|||+ .+.+|..||.|.+.-. +.+..+....|+.+|++|+|||||+.+++ +.++. .+++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 4556789999999999999 5678999999998643 45567789999999999999999999984 44444 489999
Q ss_pred eecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 511 EYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNF-RVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~-~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
|+|..|+|...+.... .+..++++..++++.|++.||..+|+.-+. -|+||||||.||+|+++|.+||+|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 9999999998885432 355789999999999999999999984422 38999999999999999999999999999886
Q ss_pred cCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
.... .....+|||.||+||.+.+..|+.+|||||+||++|||.....||... ++. ...+++..++...+.
T Consensus 180 s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~-~L~~KI~qgd~~~~p- 249 (375)
T KOG0591|consen 180 SKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLL-SLCKKIEQGDYPPLP- 249 (375)
T ss_pred chhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHH-HHHHHHHcCCCCCCc-
Confidence 5433 233579999999999999999999999999999999999999998532 111 223333333211111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
..-....+.+++..|+..||+.||+...+++.+..
T Consensus 250 -------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 250 -------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 12234578889999999999999996555555543
|
|
| >cd06549 GH18_trifunctional GH18 domain of an uncharacterized family of bacterial proteins, which share a common three-domain architecture: an N-terminal glycosyl hydrolase family 18 (GH18) domain, a glycosyl transferase family 2 domain, and a C-terminal polysaccharide deacetylase domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=363.76 Aligned_cols=284 Identities=13% Similarity=0.135 Sum_probs=217.8
Q ss_pred EEEEecCCCCCC--CCCCCCCCcceEEEEEEEecCCCcEEecCCchhhHHHHHHHHHHhhCCCceEEEEecCCCCCcccc
Q 004402 29 KAGYWLAGREFP--LSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQS 106 (755)
Q Consensus 29 ~~gY~~~~~~~~--~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg~~~~~~~~ 106 (755)
++|||..|+... .-......+|||+..+..+...++.+... .+......++++|+++|.++++.++
T Consensus 2 ~l~~~~~w~~~s~~sl~~~~~~l~~vsP~W~~~~~~~g~l~~~--~d~~~~~~~~~~k~~~~~l~~~~~~---------- 69 (298)
T cd06549 2 ALAFYTPWDDASFASLKRHAPRLDWLVPEWLNLTGPEGRIDVF--VDPQGVAIIAAAKAHPKVLPLVQNI---------- 69 (298)
T ss_pred eeEEEecCChhhHHHHHHhhccCCEEeceeEEEecCCCceecc--CChHHHHHHHHHHcCCceeEEEEec----------
Confidence 689998876633 33455668999999999998544544332 2222233346678777888888888
Q ss_pred ccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCCCcccHHHHHHHHHHHccCCCccEEEeeee
Q 004402 107 ILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVR 186 (755)
Q Consensus 107 ~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~~~~~~~~~l~~lr~~l~~~~~~~ls~~~~ 186 (755)
+|+.+++..|+.+++|++.|++||+++++++++|||||||||||++.++++++|+.||++||++|++. ++.||+++|
T Consensus 70 --~~~~~~~~~~~~~l~~~~~R~~fi~~iv~~~~~~~~dGidiD~E~~~~~d~~~~~~fl~eL~~~l~~~-~~~lsv~v~ 146 (298)
T cd06549 70 --SGGAWDGKNIARLLADPSARAKFIANIAAYLERNQADGIVLDFEELPADDLPKYVAFLSELRRRLPAQ-GKQLTVTVP 146 (298)
T ss_pred --CCCCCCHHHHHHHhcCHHHHHHHHHHHHHHHHHhCCCCEEEecCCCChhHHHHHHHHHHHHHHHhhhc-CcEEEEEec
Confidence 44455656699999999999999999999999999999999999999999999999999999999875 789999998
Q ss_pred cCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHHHHHHCCCCCCceeecccccCCC
Q 004402 187 YSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGARASGPG 266 (755)
Q Consensus 187 ~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~~~~~~g~p~~KlvlG~p~yG~~ 266 (755)
+.+. .||++++++++|+++|||||+|+++ ..+||.+|. .+++..+.+. ..|+|++||+||||+|||+
T Consensus 147 ~~~~----~~d~~~l~~~~D~v~lMtYD~~~~~--~~~gp~a~~------~~~~~~~~~~-~~~vp~~KlvlGip~YG~~ 213 (298)
T cd06549 147 ADEA----DWNLKALARNADKLILMAYDEHYQG--GAPGPIASQ------DWFESNLAQA-VKKLPPEKLIVALGSYGYD 213 (298)
T ss_pred CCCC----CCCHHHHHHhCCEEEEEEeccCCCC--CCCCCCCCh------hhHHHHHHHH-HhCCCHHHEEEEecccCcc
Confidence 7642 3899999999999999999999533 245666653 2555566554 4789999999999999999
Q ss_pred cccCC---CcchHHHHHHHhhcCCCccccccc----ceeeeeee-cCcEEEeeCCcchhhhhhhcccccCcccccccccc
Q 004402 267 ITIDG---SMGYKFIRAFIQNYGYGAAPVYNA----SYVVNLFT-SGATWINFDGVETIKAKISYAKEKNLLGYKAFQLS 338 (755)
Q Consensus 267 ~~~~~---~~~y~~~~~~~~~~~~~~~~~~~~----~~~~~~~~-~~~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~ 338 (755)
|++.+ ..+..+....+...+ ....|+. ++...+.. +..|+|||+|++|++.|+++|+++||+|+++|+++
T Consensus 214 w~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~g~~h~Vw~~d~~Sl~~K~~~a~~~~l~Gva~W~lg 291 (298)
T cd06549 214 WTKGGNTKAISSEAAWLLAAHAS--AAVKFDDKASNATYFFYDDEGVSHEVWMLDAVTLFNQLKAVQRLGPAGVALWRLG 291 (298)
T ss_pred ccCCCCCcccCHHHHHHHHHHcC--CcceecccccCCceEEEcCCCcEEEEEeccHHHHHHHHHHHHHcCCCcEEEEecc
Confidence 98753 344444444344433 3333432 22222222 33589999999999999999999999999999999
Q ss_pred ccch
Q 004402 339 NDDN 342 (755)
Q Consensus 339 ~dd~ 342 (755)
.||+
T Consensus 292 ~ed~ 295 (298)
T cd06549 292 SEDP 295 (298)
T ss_pred CCCC
Confidence 9874
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.08 Aligned_cols=264 Identities=27% Similarity=0.429 Sum_probs=214.6
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
......++||+|.||.|.++....+..||||+++..... ...+|.+|+++|.+++||||+.++|+|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 445667899999999999999878899999999887554 4578999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++|+|..|+..+.... +......+|+.|||.||+||.+.. +|||||.++|||++.++++||+|||+++-+......
T Consensus 618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999997653332 455667789999999999999987 999999999999999999999999999977666666
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcC--CCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISS--KRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
...++.+-+.+|||||.+.-+++|.+||||+||+++||+++. .+|+....+ ...++.............++
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~~~~~~l---- 766 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQGRQVVL---- 766 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCCCcceec----
Confidence 666677788999999999999999999999999999998764 445532222 22222222222222211111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
..+..++..++++++.||..+-++||+++++...|.+.
T Consensus 767 --~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 --SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred --cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 12233456788999999999999999999999999764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=346.52 Aligned_cols=252 Identities=24% Similarity=0.345 Sum_probs=198.4
Q ss_pred hcCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccCChh-------hHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQ-------GLEEFKNEVSLTARLQHVNLLRVLGYCTERDE 505 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 505 (755)
.+.|.+.+.||+|+||.|-+|. ..+|+.||||++++.... ......+|+++|++|+|||||++.+++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3456778999999999999994 567999999999764211 12235799999999999999999999999999
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC---CCeEEEecC
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE---LNPKISDFG 582 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~---~~~kl~Dfg 582 (755)
.|+||||+++|+|-+.+.. ...+.+..-..++.|++.|+.|||+++ |+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999988853 344667777889999999999999998 9999999999999766 789999999
Q ss_pred CccccccCCcccccccccccCCccccccccCCCC---CchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhc
Q 004402 583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY---SMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWK 659 (755)
Q Consensus 583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 659 (755)
+|+.... .......+||+.|.|||++....+ ..++|+||+||+||-++||..||...-... .+.+ ++.
T Consensus 325 lAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~e----QI~ 395 (475)
T KOG0615|consen 325 LAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKE----QIL 395 (475)
T ss_pred hhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHH----HHh
Confidence 9997652 233446799999999999976543 348899999999999999999996432221 1111 111
Q ss_pred cCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 660 DSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 660 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.++. .+.| ........+..+++.++|..||++|||+.|+++
T Consensus 396 ~G~y--~f~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 KGRY--AFGP----LQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cCcc--cccC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1111 1111 112233456789999999999999999999874
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=329.81 Aligned_cols=263 Identities=19% Similarity=0.283 Sum_probs=202.5
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
+.|+.+.++|+|+||+|||++.+ +|+.||||++..+. +...+-.++|+++|++++|+|+|.++.+|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35777889999999999999764 59999999996653 3344567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
||+..-|+++=.. ..-++.+...+++.|+++|+.|+|+++ +|||||||+||||+.++.+||||||+|+.+...
T Consensus 82 ~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 9998777655322 234788899999999999999999987 999999999999999999999999999987532
Q ss_pred cccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHH--------hcc-C
Q 004402 592 DEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQ--------WKD-S 661 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~-~ 661 (755)
....+..+.|.+|.|||.+.+ .+|+..+||||.||++.||++|.+.++...+.+..-++...... +.. +
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 223334678999999998877 78999999999999999999999877654444433222222211 111 1
Q ss_pred CCccccCCCCCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004402 662 KGKEFIDPSLDD-----SSSPCKLLNCMQVALLCVQENPEDRPSMLEVS 705 (755)
Q Consensus 662 ~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 705 (755)
....+.-|.... ..-+....-+++++..|++.||.+|++-+|++
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 111111111111 01112233568999999999999999999987
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=354.17 Aligned_cols=269 Identities=25% Similarity=0.407 Sum_probs=212.5
Q ss_pred HHHHHHhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 004402 428 SDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE 505 (755)
Q Consensus 428 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 505 (755)
++++...+.+...+.||+|.||+||+|.+. -.||||++... ..+..+.|++|+..+++-+|.||+-+.|||.+...
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 445555555667799999999999999873 47999999765 44567899999999999999999999999988766
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
.+|+.+|++.+|..++|... ..++..+.+.||.|||+||.|||..+ |||||||+.||+|.+++.|||+||||+.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 99999999999999998654 45788899999999999999999987 9999999999999999999999999997
Q ss_pred ccccCCcccccccccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC
Q 004402 586 LFRKDVDEANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
.-..-..........|...|||||++. ...|+.++|||||||++|||+||..|+.....+..+- ..++
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif---------mVGr 607 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF---------MVGR 607 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE---------Eecc
Confidence 543322223333456778999999986 3579999999999999999999999986222222111 1122
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccccC
Q 004402 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIA 716 (755)
Q Consensus 663 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 716 (755)
..-..|.... ...+..++.+|+..||..++++||.+.+|+.+|+....+++
T Consensus 608 G~l~pd~s~~---~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p 658 (678)
T KOG0193|consen 608 GYLMPDLSKI---RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP 658 (678)
T ss_pred cccCccchhh---hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence 2111222111 12345578899999999999999999999999987655433
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=380.89 Aligned_cols=261 Identities=31% Similarity=0.491 Sum_probs=209.5
Q ss_pred cCCCccCcccccCCeeEEEEEcCC--CC----EEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPR--GQ----EFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM 507 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 507 (755)
.+.+..+.||+|.||.||.|...+ |. .||||.+... +.+...+|++|..+|+.++|||||+++|.|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 344567899999999999996432 33 4999998765 5566789999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCc----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCC
Q 004402 508 LIYEYLPNKSLDLYLFDPIR----RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM 583 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl 583 (755)
+++|||++|+|..||.+.+. ...++....+.++.+||+|+.||++++ +|||||.++|+||++...+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999976432 456889999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG 663 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (755)
|+.+.............-+..|||||.+..+.||.|+|||||||+|||++|...++ ++...+.+....+.+ .+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~P--Y~~~~n~~v~~~~~~---gg-- 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATP--YPSRSNFEVLLDVLE---GG-- 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCC--CCCcchHHHHHHHHh---CC--
Confidence 99554433332333333467999999999999999999999999999999955322 333333333332221 11
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 664 KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 664 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
++ ..+..++..+++||.+||+.+|++||++..|++.+..+..
T Consensus 922 ------RL--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 922 ------RL--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred ------cc--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 11 1233445678999999999999999999999998877543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=332.43 Aligned_cols=242 Identities=23% Similarity=0.332 Sum_probs=198.2
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
.++|+..++||+|+||+||.++. ++++.+|+|++++.. ....+....|..+|.+++||.||++.-.|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 45788999999999999999954 569999999997753 33456789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
+||+.||.|..+|. ++..+++....-.+..|+.||.|||+.+ ||||||||+|||||++|+++|+||||++....
T Consensus 104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999998884 3445888888899999999999999998 99999999999999999999999999985433
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
. ...+...+||+.|||||++.+..|+.++|.||+|+++|||++|.+||........ . +.+...... ..
T Consensus 178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~---~----~~I~~~k~~-~~-- 245 (357)
T KOG0598|consen 178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM---Y----DKILKGKLP-LP-- 245 (357)
T ss_pred C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH---H----HHHhcCcCC-CC--
Confidence 2 2234457999999999999999999999999999999999999999954332221 1 111111100 00
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRP 699 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 699 (755)
+.-...+..+++...++.||++|-
T Consensus 246 ------p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 246 ------PGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ------CccCCHHHHHHHHHHhccCHHHhc
Confidence 111223677899999999999995
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=355.07 Aligned_cols=262 Identities=29% Similarity=0.406 Sum_probs=205.1
Q ss_pred hcCCCccCcccccCCeeEEEEEcCC--C---CEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPR--G---QEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE 505 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 505 (755)
.++....++||+|+||.||+|++.. + ..||||..+.. ......+|++|.++|++++|||||+++|++....+
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3344456899999999999996533 2 23899998752 45667899999999999999999999999999999
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
+++|||+|.+|+|+++|..... .++..++..++.+.|+||+|||+.+ +|||||.++|+|++.++.+||+|||+++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999999965332 5899999999999999999999997 9999999999999999999999999998
Q ss_pred ccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCc
Q 004402 586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGK 664 (755)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (755)
.... .........-+..|+|||.+..+.||.++|||||||++||+++ |..|+.... ......++. ..+.
T Consensus 311 ~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~---~~~v~~kI~---~~~~-- 380 (474)
T KOG0194|consen 311 AGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK---NYEVKAKIV---KNGY-- 380 (474)
T ss_pred CCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC---HHHHHHHHH---hcCc--
Confidence 6431 1111111234689999999999999999999999999999999 565553221 111211211 1111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccccCC
Q 004402 665 EFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAA 717 (755)
Q Consensus 665 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~ 717 (755)
....+...+..+..++.+||..+|++||+|.++.+.|+........
T Consensus 381 -------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 381 -------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred -------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 1111223345677888999999999999999999999876554443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=330.92 Aligned_cols=262 Identities=21% Similarity=0.338 Sum_probs=207.9
Q ss_pred hcCCCccCcccccCCeeEEEE-EcCCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.+.|+..++||.|..++||+| ..+.++.||||++.-.. ....+.+++|+..|+.++||||++.+..|..+..+++||+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 457888999999999999999 46778999999996543 3346889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
||.+||+.+++...-.. -+++..+..|+.++++||.|||.++ .||||||+.||||+.+|.+||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999998654333 3888999999999999999999997 9999999999999999999999999887654433
Q ss_pred ccc--ccccccccCCccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 592 DEA--NTGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 592 ~~~--~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
.+. .....+||+.|||||++.. ..|+.|+||||||+...||.+|..||..+..... ....+...-. ...
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv------Ll~tLqn~pp-~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV------LLLTLQNDPP-TLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH------HHHHhcCCCC-Ccc
Confidence 222 1256789999999999643 4689999999999999999999999976554332 1222221110 000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
-..+...........+.+++..||+.||.+|||++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 001111111223347889999999999999999999984
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.44 Aligned_cols=255 Identities=26% Similarity=0.416 Sum_probs=200.1
Q ss_pred CCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC--ccEEEEee
Q 004402 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD--ENMLIYEY 512 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv~e~ 512 (755)
++...+.||+|+||.||++... +|+..|||.+...+....+.+.+|+.+|.+++|||||+.+|...... ..++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 4566789999999999999654 49999999987664333677899999999999999999999855544 58999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC-CCCeEEEecCCccccccC-
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-ELNPKISDFGMAKLFRKD- 590 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~-~~~~kl~Dfgla~~~~~~- 590 (755)
+++|+|.+++..... .+++..+.....||++||.|||+++ ||||||||+|||++. ++.+||+|||+++.....
T Consensus 98 ~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred cCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999999999865433 5899999999999999999999886 999999999999999 799999999999876531
Q ss_pred CcccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
..........||+.|||||++..+ ....++|||||||++.||+||++|+... .....+.......... |
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~-----P 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSL-----P 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCC-----C
Confidence 111223357899999999999864 3345999999999999999999988543 1112222222121111 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 709 (755)
.+... ......+++..|++.+|++|||+.++++.--
T Consensus 243 ~ip~~----ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 243 EIPDS----LSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CCCcc----cCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 22222 2235678999999999999999999997653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=345.45 Aligned_cols=249 Identities=25% Similarity=0.388 Sum_probs=207.3
Q ss_pred cCCCccCcccccCCeeEEEE-EcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
..|....+||+|+.|.||.+ +..+++.||||++........+-+.+|+.+|+..+|+|||+++.-+...+++++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 45777789999999999999 55678999999998776666677899999999999999999999999899999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++|+|.+.+ ....+++.++..|+.++++||+|||..+ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 353 EGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 999998887 4455899999999999999999999997 99999999999999999999999999998765433
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
.....+||+.|||||++....|++++||||||++++||+-|.+|+-.... . ...|.. .... .+.+.
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P---l-rAlyLI---a~ng-----~P~lk- 490 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP---L-RALYLI---ATNG-----TPKLK- 490 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh---H-HHHHHH---hhcC-----CCCcC-
Confidence 44567999999999999999999999999999999999999988733111 1 111111 1111 11111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
........+.+++.+||+.|+++||++.|||+
T Consensus 491 -~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 491 -NPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 11223347889999999999999999999985
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=350.91 Aligned_cols=261 Identities=27% Similarity=0.416 Sum_probs=202.7
Q ss_pred hcCCCccCcccccCCeeEEEEEc------CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCC-
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERD- 504 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~- 504 (755)
.++|...++||+|+||.||+|.. ..++.||||++.... ....+.+.+|+.++.++ +||||++++++|....
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 45788889999999999999953 235689999987543 33456789999999999 8999999999887654
Q ss_pred ccEEEEeecCCCChhhhhcCCCc---------------------------------------------------------
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPIR--------------------------------------------------------- 527 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 527 (755)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999998854211
Q ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccccccccccCCc
Q 004402 528 --RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605 (755)
Q Consensus 528 --~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y 605 (755)
...+++.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 124778889999999999999999986 999999999999999999999999999865433222223334567889
Q ss_pred cccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHH
Q 004402 606 VPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCM 684 (755)
Q Consensus 606 ~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 684 (755)
+|||.+.+..++.++|||||||++|||++ |..|+....... .. ......+.. .... ......+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~----~~~~~~~~~-----~~~~----~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EF----CQRLKDGTR-----MRAP----ENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HH----HHHHhcCCC-----CCCC----CCCCHHHH
Confidence 99999999999999999999999999997 888875432211 11 111111111 1111 12234688
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 685 QVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 685 ~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
+++.+||+.||++|||+.|+++.|++..
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=341.63 Aligned_cols=263 Identities=22% Similarity=0.315 Sum_probs=203.7
Q ss_pred hcCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccCChhhHHH--HHHHHHHHhcCC-CCceeeeeeeeecCC-ccEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQGLEE--FKNEVSLTARLQ-HVNLLRVLGYCTERD-ENML 508 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~l 508 (755)
.++|...++||.|.||.||+|+ ...|..||||+++..-.. +++ =++|++.|++|+ ||||+++..++.+.+ .+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4578888999999999999995 556999999998765322 232 368999999998 999999999998888 8999
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
|||||+. +|..++.++ +..+++..++.|+.||++||+|+|.++ +.|||+||+|||+..+..+||+|||+||.+.
T Consensus 88 VfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 9999955 888887654 667999999999999999999999987 9999999999999999999999999999876
Q ss_pred cCCcccccccccccCCccccccc-cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC-----
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYV-KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK----- 662 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 662 (755)
+.... +..+.|.+|.|||++ +.+.|+.+.|||++|||++|+.+.++.|+.....+.+..+..+...-....
T Consensus 162 SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 SKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred cCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 54332 345789999999976 567899999999999999999999988865443333222211111100000
Q ss_pred ---------CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 663 ---------GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 663 ---------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
...+....+..-.+ ....++.+++.+|++.||.+|||++|+++.
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00011111111111 245578899999999999999999999975
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=327.61 Aligned_cols=265 Identities=28% Similarity=0.383 Sum_probs=201.3
Q ss_pred CccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhc--CCCCceeeeeeeeecCC----ccEEEEe
Q 004402 438 SSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTAR--LQHVNLLRVLGYCTERD----ENMLIYE 511 (755)
Q Consensus 438 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lv~e 511 (755)
...++||+|.||.||||++ +++.||||++... ..+.|++|-++.+. ++|+||+++++.-.... +.+||++
T Consensus 213 ~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 3457899999999999998 5699999998654 44567777777665 58999999999876554 7899999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY------SNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~------~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
|.++|+|.+||. ...++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+|||+|.
T Consensus 289 fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 289 FHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999994 55799999999999999999999974 35679999999999999999999999999999
Q ss_pred ccccCCcccccccccccCCccccccccCCC-CC-----chhhHHHHHHHHHHHHcCCCCCCCCCCCcc-----------c
Q 004402 586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGI-YS-----MKYDVYSFGVLLLQIISSKRNARYYGTSEN-----------L 648 (755)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~~sDVwS~Gvil~elltg~~p~~~~~~~~~-----------~ 648 (755)
.+.........-..+||.+|||||++.+.. +. .+.||||+|.|||||+++-..... +.... .
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccCchhHHhcCC
Confidence 888766655555689999999999997642 22 478999999999999997654422 11110 0
Q ss_pred chHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 004402 649 NFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMA 714 (755)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 714 (755)
.-++..+......+.+-.+....... ..+..+++.+..||+.||+.|-|+.=+-+++.+....
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 11111111111111111111111111 2345688999999999999999999999999876544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.67 Aligned_cols=265 Identities=25% Similarity=0.376 Sum_probs=202.6
Q ss_pred hcCCCccCcccccCCeeEEEE-EcCCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--CccEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DENML 508 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 508 (755)
.+.|+.+++||+|.||.||++ +..+|+.||+|+++... +.......+|+.+|++|.||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 456778899999999999999 56789999999987654 44556678999999999999999999998876 57999
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
|+|||++ +|.-++... .-.++..++..++.|++.||.|+|+.+ |+|||||.+|||||++|.+||+|||||+++.
T Consensus 196 VFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999987 666665432 335889999999999999999999997 9999999999999999999999999999887
Q ss_pred cCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHH-----HhccCC
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFE-----QWKDSK 662 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~-----~~~~~~ 662 (755)
.......+ ..+-|.+|.|||++.+ ..|+.++|+||.||||.||++|++.+......+.+..+-.... .|...+
T Consensus 270 ~~~~~~~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 270 PSGSAPYT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCCcccc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 65544333 3466999999998876 5799999999999999999999987754443332222211111 011111
Q ss_pred Cc--cccCCC------CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 663 GK--EFIDPS------LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 663 ~~--~~~d~~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+. ..+.+. +.+. ........++|+..+|..||.+|.|+.++++
T Consensus 349 LP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11 111111 0000 1112335678999999999999999999884
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=309.73 Aligned_cols=261 Identities=22% Similarity=0.388 Sum_probs=204.3
Q ss_pred cCCCccCcccccCCeeEEEE-EcCCCCEEEEEEeccCChh--hHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQ--GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.+|...++||+|.||.||+| +..+|+.||||+++..... .....++|++.|+.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 36777899999999999999 4577999999999766322 23467899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
||+. +|+..+.+ +...++..++..++.++.+|++|+|.+. |+||||||.|+|++++|.+||+|||+++.+.+..
T Consensus 82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9975 88888855 3456888999999999999999999998 9999999999999999999999999999887643
Q ss_pred cccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCc------
Q 004402 592 DEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK------ 664 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 664 (755)
.... ..+-|.+|.|||.+.+ ..|+..+||||.|||+.||+-|.+-++. ..+++.+...++.+......
T Consensus 156 ~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG---~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 156 RIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG---DSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred cccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC---CchHHHHHHHHHHcCCCCcccCcccc
Confidence 3322 2367999999998876 5799999999999999999987654432 23333344444433222111
Q ss_pred c---------ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 665 E---------FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 665 ~---------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
. +..+.+..- -+......++++..++..||.+|+|++|++++
T Consensus 231 ~lpdY~~~~~~P~~~~~~l-f~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNL-FPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHHHHhcCCCCccccc-cccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1 111112211 11223355899999999999999999999865
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=344.15 Aligned_cols=243 Identities=26% Similarity=0.371 Sum_probs=200.0
Q ss_pred ccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCCCh
Q 004402 439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL 518 (755)
Q Consensus 439 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 518 (755)
.++-||.|+.|.||+|++ .++.||||+++.-. ..+++.|++|+||||+.+.|+|......|||||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 457899999999999998 78999999885432 3578899999999999999999999999999999999999
Q ss_pred hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccccccc
Q 004402 519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598 (755)
Q Consensus 519 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 598 (755)
...|.. +..+.......+..+||.||.|||.+. |||||||+-||||+.+..+||+|||-++..... ...-.
T Consensus 200 ~~VLka---~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMS 270 (904)
T KOG4721|consen 200 YEVLKA---GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMS 270 (904)
T ss_pred HHHHhc---cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhh
Confidence 999953 445778889999999999999999986 999999999999999999999999999865432 22234
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHH
Q 004402 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPC 678 (755)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 678 (755)
+.||..|||||++.....++|+||||||||||||+||..|+..-+....+- ..+ ... |.-..+..
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw---------GVG--sNs----L~LpvPst 335 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW---------GVG--SNS----LHLPVPST 335 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE---------ecc--CCc----ccccCccc
Confidence 789999999999999999999999999999999999999986543332211 101 111 11122233
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 679 KLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 679 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
++.-+.-|+++||+..|.+||++.+++..|+-..+
T Consensus 336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred CchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 44466778999999999999999999999975443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=335.75 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=207.0
Q ss_pred HHHhcCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCc
Q 004402 431 KAATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSAT---STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDE 505 (755)
Q Consensus 431 ~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 505 (755)
+...++|...+.||+|+|++|++++ ...++.+|||++.+. .+...+-...|-+.|.+| .||.|++|+..|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 3445788999999999999999995 456999999998664 223334567788899999 89999999999999999
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
+|+|+||+++|+|.+++... ..+++.-.+.++.+|..||+|||+++ ||||||||+|||||.|+++||+|||.|+
T Consensus 149 LYFvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 99999999999999999543 45888899999999999999999987 9999999999999999999999999999
Q ss_pred ccccCCcc---------ccc--ccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHH
Q 004402 586 LFRKDVDE---------ANT--GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYA 654 (755)
Q Consensus 586 ~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~ 654 (755)
.+...... ... ..++||..|.+||++..+..+..+|+|+|||+||+|+.|++||.....- ...+..
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney---liFqkI 299 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY---LIFQKI 299 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH---HHHHHH
Confidence 87543211 112 4589999999999999999999999999999999999999999643221 111111
Q ss_pred HHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 655 FEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 655 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
+. ++-.+....+ ....+|+.+.|..||++|+|.++|-+.
T Consensus 300 ~~----------l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 300 QA----------LDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HH----------hcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence 10 1222222333 467789999999999999999888754
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=335.66 Aligned_cols=266 Identities=26% Similarity=0.421 Sum_probs=201.8
Q ss_pred cCCCccCcccccCCeeEEEEEcCC-----------------CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPR-----------------GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRV 496 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 496 (755)
++|...++||+|+||.||++...+ +..||+|.+.... ......|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467788999999999999996432 3479999987653 3345679999999999999999999
Q ss_pred eeeeecCCccEEEEeecCCCChhhhhcCCC----------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcee
Q 004402 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPI----------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560 (755)
Q Consensus 497 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiH 560 (755)
++++.+.+..++||||+++|+|.+++.... ....+++.....++.||+.||.|||+.+ ++|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999874321 1134688899999999999999999986 999
Q ss_pred cccCCCCEEEcCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004402 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR 640 (755)
Q Consensus 561 rDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~ 640 (755)
|||||+|||++.++.+||+|||+++.+.............++..|+|||.+..+.++.++|||||||++|||+++..+.+
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986543322222334456789999999988899999999999999999997543332
Q ss_pred CCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 641 YYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
+.... ..................... ..++..+..+.+++.+||+.||++|||+.+|.+.|++
T Consensus 242 ~~~~~-~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELT-DEQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCC-HHHHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 22211 111222111111111100000 0111223468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=331.63 Aligned_cols=260 Identities=19% Similarity=0.296 Sum_probs=203.2
Q ss_pred CccccCHHHHHHHhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhh---HHHHHHHHHHHhcCCCCceeeee
Q 004402 421 NLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQG---LEEFKNEVSLTARLQHVNLLRVL 497 (755)
Q Consensus 421 ~~~~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~ 497 (755)
+.+.++.+++ +......||+|++|.||+|.. +|+.||||+++...... .+.|.+|+.+|.+++||||++++
T Consensus 11 ~~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDI-----DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHc-----CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 3445555665 223346799999999999988 78999999997653322 56788999999999999999999
Q ss_pred eeeec----CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC
Q 004402 498 GYCTE----RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE 573 (755)
Q Consensus 498 g~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~ 573 (755)
|++.+ ....++||||+++|+|.+++.. ...+++.....++.+++.||.|||+.. +++||||||+|||++++
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~ 159 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTEN 159 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCC
Confidence 99876 3467899999999999999854 345889999999999999999999853 37899999999999999
Q ss_pred CCeEEEecCCccccccCCcccccccccccCCccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchH
Q 004402 574 LNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFL 651 (755)
Q Consensus 574 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~ 651 (755)
+.+||+|||+++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.|+...... ...
T Consensus 160 ~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~ 231 (283)
T PHA02988 160 YKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIY 231 (283)
T ss_pred CcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHH
Confidence 999999999998653221 12357889999999976 68999999999999999999999998643211 111
Q ss_pred HHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 652 EYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 652 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
.... .... .+.+. ......+.+++.+||+.||++|||+.|+++.|+..
T Consensus 232 ~~i~----~~~~----~~~~~----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 232 DLII----NKNN----SLKLP----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred HHHH----hcCC----CCCCC----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1111 0100 11111 12234688999999999999999999999999864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=330.54 Aligned_cols=248 Identities=27% Similarity=0.390 Sum_probs=207.5
Q ss_pred cCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
..|...+.||+|+||.||+|. ...++.||+|++... .....+.+++|+.+|.+++++||.+.+|.+.....++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 356667899999999999994 456899999999765 445577899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
|.+|++.+.|.. ...+++..+.-++.++..||.|||... .+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 93 ~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 999999988842 334577788889999999999999987 99999999999999999999999999988765443
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
. ...++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+.....++ .+-..|.+.
T Consensus 167 r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI------------pk~~PP~L~ 232 (467)
T KOG0201|consen 167 R--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI------------PKSAPPRLD 232 (467)
T ss_pred c--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec------------cCCCCCccc
Confidence 3 35689999999999999889999999999999999999999998655443322211 111234444
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..++ ..+.+++..||++||+.||++.++++
T Consensus 233 ~~~S----~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 233 GDFS----PPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cccC----HHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 4333 36889999999999999999999884
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=344.87 Aligned_cols=260 Identities=27% Similarity=0.440 Sum_probs=202.3
Q ss_pred hcCCCccCcccccCCeeEEEEEc------CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDE 505 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 505 (755)
.++|+..+.||+|+||.||+|.. ..+..||||+++... ....+.+.+|+.++..+ +||||++++++|...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45688889999999999999853 346689999986543 33456789999999999 89999999999999999
Q ss_pred cEEEEeecCCCChhhhhcCCCc----------------------------------------------------------
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIR---------------------------------------------------------- 527 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 527 (755)
.++|||||++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999988854211
Q ss_pred --------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 528 --------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 528 --------------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124788899999999999999999986 999999999999999999999999999865433222
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
.......++..|+|||.+.+..++.++|||||||++|||++ |..|+...... ...... +..+.. ...+
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~----~~~~~~--~~~~--- 339 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKM----IKEGYR--MLSP--- 339 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHH----HHhCcc--CCCC---
Confidence 22223345678999999999999999999999999999998 77676432211 111111 111110 0001
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
......+.+++.+||+.||++|||+.||+++|++.
T Consensus 340 ----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ----ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11224688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=377.31 Aligned_cols=268 Identities=26% Similarity=0.460 Sum_probs=213.4
Q ss_pred cCHHHHHHHhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC
Q 004402 425 FSFSDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTER 503 (755)
Q Consensus 425 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 503 (755)
++++++. ..+...+.||+|+||.||+|.. .++..||||++...... ..+|++.+++++||||++++|+|.+.
T Consensus 683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 3444443 4577788999999999999975 57899999998654322 23468899999999999999999999
Q ss_pred CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCC
Q 004402 504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM 583 (755)
Q Consensus 504 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl 583 (755)
+..++||||+++|+|.++++ .++|.++.+++.|+++||+|||+.++.+++||||||+||+++.++.+++. |+.
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~ 828 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL 828 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence 99999999999999999984 27899999999999999999998777789999999999999999998876 666
Q ss_pred ccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG 663 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (755)
...... .....+|..|||||++.+..++.++|||||||++|||+||+.|+.... ........|..........
T Consensus 829 ~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~ 901 (968)
T PLN00113 829 PGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHL 901 (968)
T ss_pred cccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccch
Confidence 543211 112367899999999999999999999999999999999999984321 1223344454444444444
Q ss_pred ccccCCCCCC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 664 KEFIDPSLDD--SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 664 ~~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
...+|+.+.. .....+..++.+++.+||+.||++||||.|+++.|++...
T Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred hheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 5566666543 2344566778899999999999999999999999987543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=335.96 Aligned_cols=260 Identities=25% Similarity=0.394 Sum_probs=210.5
Q ss_pred HHHHHhcCCCccCcccccCCeeEEEEEcCC-CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccE
Q 004402 429 DIKAATNNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM 507 (755)
Q Consensus 429 ~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 507 (755)
.++-...+..+..+||-|.||.||.|.|+. .-.||||.++.... ..++|++|..+|+.++|||+|+|+|+|..+...|
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 344444566788999999999999998765 67899999976544 4689999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
||.|||.+|+|.+||.+. .+..++....+.++.||+.||.||...+ +|||||.++|+|+.++..+|++||||++++
T Consensus 340 IiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhh
Confidence 999999999999999653 3445777889999999999999999987 999999999999999999999999999988
Q ss_pred ccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCcccchHHHHHHHhccCCCccc
Q 004402 588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISS-KRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666 (755)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (755)
..+.... ......+..|.|||.+..+.++.|+|||+|||+||||.|- -.|++..+. ..+...
T Consensus 416 tgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-------SqVY~L--------- 478 (1157)
T KOG4278|consen 416 TGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYGL--------- 478 (1157)
T ss_pred cCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-------HHHHHH---------
Confidence 6553322 2233457899999999999999999999999999999983 334422111 111211
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 667 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
+....+...+..++..+++||++||+.+|.+||++.|+-+.++.
T Consensus 479 LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 479 LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 22222222334455689999999999999999999999888753
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=332.03 Aligned_cols=260 Identities=24% Similarity=0.413 Sum_probs=211.4
Q ss_pred HHHHHHhcCCCccCcccccCCeeEEEEEc--C-CCC--EEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeee
Q 004402 428 SDIKAATNNFSSANKLGEGGFGPVYKGNL--P-RGQ--EFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501 (755)
Q Consensus 428 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~--~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 501 (755)
.+.+...+.....+.||+|.||.||+|.. . .|+ .||||..+.. ..+..+.|+.|..+|+.++||||++++|.|.
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 34444455566678999999999999943 2 333 6899999874 4556788999999999999999999999997
Q ss_pred cCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEec
Q 004402 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDF 581 (755)
Q Consensus 502 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Df 581 (755)
+ ...++|||.++.|.|..||.. ++..++......++.||+.+|+|||+.. +|||||.++|||+....-+||+||
T Consensus 462 e-~P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDF 535 (974)
T KOG4257|consen 462 E-QPMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADF 535 (974)
T ss_pred c-cceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeeccc
Confidence 6 578999999999999999964 4456888999999999999999999986 999999999999999999999999
Q ss_pred CCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhcc
Q 004402 582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKD 660 (755)
Q Consensus 582 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 660 (755)
|+++.+..+... ..+...-+..|||||.+...++|.+||||-|||.+||+++ |.+||..-...+.+-
T Consensus 536 GLSR~~ed~~yY-kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~----------- 603 (974)
T KOG4257|consen 536 GLSRYLEDDAYY-KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG----------- 603 (974)
T ss_pred chhhhccccchh-hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-----------
Confidence 999987654332 2334455789999999999999999999999999999987 777875433333221
Q ss_pred CCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 661 SKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 661 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
.+...-+-..++.++..++.++.+||..+|.+||++.|+...|.+
T Consensus 604 -----~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 604 -----HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred -----EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 122222234455667789999999999999999999999888754
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=342.39 Aligned_cols=261 Identities=27% Similarity=0.425 Sum_probs=202.5
Q ss_pred HhcCCCccCcccccCCeeEEEEEc------CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCC
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERD 504 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 504 (755)
..++|+..+.||+|+||.||++.. .++..||||++.... ....+.+.+|+.+++.+ +|+||++++++|....
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 345788899999999999999853 234589999997543 33456788999999999 8999999999999999
Q ss_pred ccEEEEeecCCCChhhhhcCCC----------------------------------------------------------
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPI---------------------------------------------------------- 526 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 526 (755)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999998874321
Q ss_pred ---------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccccc
Q 004402 527 ---------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597 (755)
Q Consensus 527 ---------~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 597 (755)
....+++.+.++++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++............
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 0124788889999999999999999976 9999999999999999999999999998654332222222
Q ss_pred cccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCC
Q 004402 598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSS 676 (755)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 676 (755)
...++..|||||++.+..++.++|||||||++|||++ |+.|+....... ... ...... ..+....
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~----~~~~~~-----~~~~~~~--- 338 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFY----KMVKRG-----YQMSRPD--- 338 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHH----HHHHcc-----cCccCCC---
Confidence 2345678999999998999999999999999999997 888875432211 111 111111 0110111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 677 PCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 677 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
.....+.+++.+||+.||++|||+.+|+++|++.
T Consensus 339 -~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 -FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred -CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1124688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=328.15 Aligned_cols=246 Identities=23% Similarity=0.345 Sum_probs=203.8
Q ss_pred cCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
++|...+.||+|+||+||||+ ..+.+.||+|.+.+. .++..+.+.+|+++++.++|||||.++.+|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 467788899999999999995 456899999999765 34567789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+.+ +|..+|.+ ...+++.....++.++..||.|||++. |+|||+||+|||++.++.+|+||||+|+.+..
T Consensus 82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-- 152 (808)
T ss_pred hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc--
Confidence 9977 99999854 345899999999999999999999987 99999999999999999999999999997643
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
.......+.||+.|||||+..++.|+..+|.||+|||+||+++|++||-.. ....++ +.+. -|+..
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---si~~Lv----~~I~-------~d~v~ 218 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---SITQLV----KSIL-------KDPVK 218 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---HHHHHH----HHHh-------cCCCC
Confidence 333445678999999999999999999999999999999999999998311 111111 1111 11111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+......+..++...+.+||..|-|-.+++.
T Consensus 219 ---~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 219 ---PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ---CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 11133346778899999999999999999884
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=322.30 Aligned_cols=250 Identities=34% Similarity=0.546 Sum_probs=192.1
Q ss_pred ccCcccccCCeeEEEEEcC-----CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 439 SANKLGEGGFGPVYKGNLP-----RGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 439 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
..+.||.|.||.||+|.+. .+..|+||.+... ..+..+.|.+|++.+++++||||++++|+|...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3478999999999999765 3678999999654 334578899999999999999999999999988889999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++|+|.++|... ....+++..+..|+.||+.||.|||+.+ ++|+||+++|||+++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999654 2346899999999999999999999986 99999999999999999999999999987632222
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
............|+|||.+....++.++||||||+++|||++ |+.|+... ........ +.......
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~~~~~~~~----~~~~~~~~------ 225 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY---DNEEIIEK----LKQGQRLP------ 225 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS---CHHHHHHH----HHTTEETT------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccc----ccccccce------
Confidence 222233456789999999999999999999999999999999 56665332 11111111 11111111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSML 708 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 708 (755)
.+......+.+++..||+.+|++|||+.++++.|
T Consensus 226 ---~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ---IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1111234688999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=323.37 Aligned_cols=256 Identities=27% Similarity=0.464 Sum_probs=203.3
Q ss_pred CCCccCcccccCCeeEEEEEcCC------CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 436 NFSSANKLGEGGFGPVYKGNLPR------GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
+|+..+.||+|+||.||+|.... ...||+|.+.... ......|.+|+.++.+++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 56778999999999999996532 2579999987543 3345678999999999999999999999998889999
Q ss_pred EEeecCCCChhhhhcCCCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC
Q 004402 509 IYEYLPNKSLDLYLFDPIR-------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN 575 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~ 575 (755)
+|||+++++|.+++..... ...+++...+.++.|++.||.|||+.+ ++||||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCc
Confidence 9999999999999854211 145788999999999999999999986 999999999999999999
Q ss_pred eEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHH
Q 004402 576 PKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYA 654 (755)
Q Consensus 576 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~ 654 (755)
+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..|+...... ..
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~---- 235 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EV---- 235 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH----
Confidence 99999999986543322222333456788999999998899999999999999999998 88887432211 11
Q ss_pred HHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 655 FEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 655 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
...+....... .+...+..+.+|+.+||+.||.+||+++||++.|++
T Consensus 236 ~~~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 IEMIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111111111 112234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=329.90 Aligned_cols=256 Identities=25% Similarity=0.404 Sum_probs=200.0
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCC----EEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQ----EFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
.+|+..+.||+|+||.||+|.+. +++ .||+|.+.... ....+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999643 343 48999987543 34456789999999999999999999999764 5789
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
++||+++|+|.+++... ...+++...+.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999998643 235788999999999999999999986 9999999999999999999999999998765
Q ss_pred cCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
............++..|+|||.+.+..++.++|||||||++|||++ |+.|+...... ... ...... ....
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~----~~~~~~--~~~~ 231 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EIS----SILEKG--ERLP 231 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HHHhCC--CCCC
Confidence 4332222222334678999999999999999999999999999998 88887432111 111 111111 0111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
. +......+.+++..||+.+|++||++.+++..|....
T Consensus 232 ~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 232 Q-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred C-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 1112246789999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=319.87 Aligned_cols=255 Identities=24% Similarity=0.350 Sum_probs=201.1
Q ss_pred cCCCccCcccccCCeeEEEEEcC----CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP----RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
++|+..+.||+|+||.||+|... .+..||+|.++... ....+.|.+|+.++.+++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46778899999999999999642 36789999987653 33446789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 9999999999998542 235889999999999999999999886 99999999999999999999999998765322
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
... .......++..|+|||.+.+..++.++|||||||++||+++ |+.|+...... .... ...... .
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~----~~~~~~--~--- 226 (266)
T cd05064 160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIK----AVEDGF--R--- 226 (266)
T ss_pred cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH----HHHCCC--C---
Confidence 211 11112234678999999999999999999999999999875 88887532211 1111 111111 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
.. .+...+..+.+++..||+.+|++||++.++.+.|++.
T Consensus 227 ~~----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 LP----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CC----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00 1122334688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=335.92 Aligned_cols=262 Identities=26% Similarity=0.390 Sum_probs=203.8
Q ss_pred HHhcCCCccCcccccCCeeEEEEEcC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCC-CCceeeeeeeeecC
Q 004402 432 AATNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTER 503 (755)
Q Consensus 432 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 503 (755)
...++|...++||+|+||.||+|... .+..||||++.... ....+.+.+|++++.++. ||||++++++|.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 34567888899999999999999642 23479999997543 334567999999999995 99999999999999
Q ss_pred CccEEEEeecCCCChhhhhcCCCc--------------------------------------------------------
Q 004402 504 DENMLIYEYLPNKSLDLYLFDPIR-------------------------------------------------------- 527 (755)
Q Consensus 504 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 527 (755)
...++|||||++|+|.+++.....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999988753210
Q ss_pred -------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE
Q 004402 528 -------------------------------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL 570 (755)
Q Consensus 528 -------------------------------------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll 570 (755)
...+++..+..++.|+++||.|||+.+ ++||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 124778888999999999999999986 9999999999999
Q ss_pred cCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccc
Q 004402 571 DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLN 649 (755)
Q Consensus 571 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~ 649 (755)
+.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+....... .
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~ 348 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--T 348 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--H
Confidence 9999999999999986543322222333456788999999999999999999999999999997 877774321111 1
Q ss_pred hHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 650 FLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
. ........ .... .......+.+++.+||+.+|++|||+.+|+++|+..
T Consensus 349 ~----~~~~~~~~-----~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 349 F----YNKIKSGY-----RMAK----PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred H----HHHHhcCC-----CCCC----CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 1 11111110 0011 112234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=321.97 Aligned_cols=251 Identities=23% Similarity=0.327 Sum_probs=197.8
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.|+..+.||+|+||.||++.. .+|+.||+|.+.... ......+.+|+.++.+++|+|++++++++.+.+..++|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 366788999999999999965 579999999986542 2233467899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++|+|..++... ....+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998877532 2235889999999999999999999986 9999999999999999999999999998653221
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
......||..|+|||++.+..++.++|||||||++|||++|+.|+........... ......... ..
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~~~~~~------~~- 223 (285)
T cd05631 157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE---VDRRVKEDQ------EE- 223 (285)
T ss_pred ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH---HHHHhhccc------cc-
Confidence 12234689999999999999999999999999999999999999864332211111 111111100 00
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPS-----MLEVSS 706 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 706 (755)
........+.+|+.+||+.||++||+ ++++++
T Consensus 224 ---~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 224 ---YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ---CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 11112336788999999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=326.62 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=202.3
Q ss_pred HhcCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccC----Ch-hhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCc
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSAT----ST-QGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDE 505 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 505 (755)
...+|...+.||+|+||.|+.|. ..+++.||+|++... .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 35678889999999999999994 456899999977653 12 23456678999999998 9999999999999999
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC-CCeEEEecCCc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMA 584 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~-~~~kl~Dfgla 584 (755)
.++||||+.+|+|.+++.+ +..+.+.+...++.|++.|++|+|+.+ |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999964 345788999999999999999999987 9999999999999999 99999999999
Q ss_pred cccccCCcccccccccccCCccccccccCCC-CC-chhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC
Q 004402 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGI-YS-MKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
.... .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||.... ...+. ..+..+.
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~---~~~l~----~ki~~~~ 239 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN---VPNLY----RKIRKGE 239 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc---HHHHH----HHHhcCC
Confidence 9764 1223344579999999999999877 85 78999999999999999999996521 11111 1111111
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004402 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVS 705 (755)
Q Consensus 663 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 705 (755)
+. +..... ...+..++.+|+..||.+|+|+.+++
T Consensus 240 ---~~---~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 240 ---FK---IPSYLL---SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ---cc---CCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11 111110 34688999999999999999999998
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.85 Aligned_cols=199 Identities=24% Similarity=0.335 Sum_probs=173.9
Q ss_pred hcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.++|+..+.||+|+||.||++... ++..||+|.+... .....+.+.+|++++.+++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367889999999999999999654 5889999998765 33445679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++|+|.+++.. ...+++..+..++.+++.||.|||+.+ +++||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999999853 235788999999999999999999864 4999999999999999999999999999765322
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY 641 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~ 641 (755)
......|+..|+|||.+.+..++.++|||||||++|||++|+.|+..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 12234689999999999999999999999999999999999999854
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=322.20 Aligned_cols=254 Identities=22% Similarity=0.291 Sum_probs=201.1
Q ss_pred HHhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccE
Q 004402 432 AATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM 507 (755)
Q Consensus 432 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 507 (755)
...++|+.+.+||+|+||.||+++. .+|..+|+|+++++. ....+..+.|-.+|....+|+||+|+-.|.+.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 3567899999999999999999954 469999999998874 334567889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
|||||++||++..+|. +...|++......+.+.+.|+..||..+ +|||||||+|+|||..|++||+||||+..+
T Consensus 218 LiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999995 4557899999999999999999999997 999999999999999999999999999743
Q ss_pred ccC---------------------Cccc-----cc-------------------ccccccCCccccccccCCCCCchhhH
Q 004402 588 RKD---------------------VDEA-----NT-------------------GRIVGTYGYVPPEYVKKGIYSMKYDV 622 (755)
Q Consensus 588 ~~~---------------------~~~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~s~~sDV 622 (755)
... .... .. -..+|||.|||||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 210 0000 00 01479999999999999999999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC--
Q 004402 623 YSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPS-- 700 (755)
Q Consensus 623 wS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-- 700 (755)
||+|||+|||+.|-+||......+....+......+.-. .......+..+|+.+|+. ||++|-.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP-------------~~~~~s~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP-------------EEVDLSDEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC-------------CcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence 999999999999999996544433322221111111111 001111356789999998 9999965
Q ss_pred -HHHHH
Q 004402 701 -MLEVS 705 (755)
Q Consensus 701 -~~evl 705 (755)
++||-
T Consensus 438 G~~EIK 443 (550)
T KOG0605|consen 438 GAEEIK 443 (550)
T ss_pred cHHHHh
Confidence 55554
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=294.12 Aligned_cols=265 Identities=22% Similarity=0.266 Sum_probs=210.3
Q ss_pred HHhcCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC-----c
Q 004402 432 AATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD-----E 505 (755)
Q Consensus 432 ~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~ 505 (755)
...++|.+.+.||+|||+.||+++ ..+++.+|+|++.....+..+..++|++.-++++|||++++++++..+. .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345788999999999999999995 5678999999998888788889999999999999999999999886544 3
Q ss_pred cEEEEeecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla 584 (755)
.+++++|...|+|.+.+.... ++..+++.+.++|+.+|++||.+||+.. +++.||||||.|||+.+.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 899999999999999886533 3447999999999999999999999976 47999999999999999999999999999
Q ss_pred cccccCCccc-------ccccccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHH
Q 004402 585 KLFRKDVDEA-------NTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYA 654 (755)
Q Consensus 585 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~ 654 (755)
+...-..... .......|..|.|||.+. +...++++|||||||+||+|+-|..||+..-...
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-------- 248 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-------- 248 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC--------
Confidence 8653221110 011235689999999885 4567899999999999999999999986422111
Q ss_pred HHHhccCCC-ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 655 FEQWKDSKG-KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 655 ~~~~~~~~~-~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
+++ ..+....+.-.........+.+++.+|++.||.+||++.+++..+.+.
T Consensus 249 ------gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 249 ------GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ------CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 111 011111111111112445788999999999999999999999998764
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=339.21 Aligned_cols=258 Identities=23% Similarity=0.313 Sum_probs=209.4
Q ss_pred hcCCCccCcccccCCeeEEEEEcCCC-CEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCceeeeee-eeec------CC
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPRG-QEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLG-YCTE------RD 504 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g-~~~~------~~ 504 (755)
..+.++.+.|.+|||+.||.+....+ ..+|+|++-..++...+...+|+++|+.|+ |+|||.+++ .... .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 44667789999999999999977665 999999998888888999999999999996 999999999 3222 13
Q ss_pred ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCc
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla 584 (755)
+.+|.||||.+|+|-+++..+.... |++.++++|+.++++|+++||... +||||||||-+||||+.+++.||||||.+
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence 5689999999999999996554444 999999999999999999999964 78999999999999999999999999999
Q ss_pred cccccCCcccc-c------ccccccCCccccccc---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHH
Q 004402 585 KLFRKDVDEAN-T------GRIVGTYGYVPPEYV---KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYA 654 (755)
Q Consensus 585 ~~~~~~~~~~~-~------~~~~gt~~y~aPE~~---~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~ 654 (755)
.-......... . -....|+.|+|||++ .+..+++|+|||+|||+||-|+-...||+..+...
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-------- 265 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-------- 265 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee--------
Confidence 85332221110 0 012458999999987 56789999999999999999999999996544322
Q ss_pred HHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 655 FEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 655 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
+++....-...+.....+.+||..||+.||++||++-+|++.+.++.
T Consensus 266 -----------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 266 -----------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred -----------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 22222222233456678899999999999999999999999886643
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=319.77 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=204.1
Q ss_pred cCCCccCcccccCCeeEEEEEcC------CCCEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCceeeeeeeeecCCccE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM 507 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 507 (755)
++|...+.||+|+||.||+|... +++.||||.+...... ..+.+.+|++++.+++|||++++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45777899999999999999653 3578999998765443 4578999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCC-----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCe
Q 004402 508 LIYEYLPNKSLDLYLFDPI-----------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP 576 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~ 576 (755)
++|||+++++|.+++.... ....+++.....++.+++.|+.|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999985432 2345788999999999999999999986 9999999999999999999
Q ss_pred EEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHH
Q 004402 577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAF 655 (755)
Q Consensus 577 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 655 (755)
||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..|+....... ...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~--- 235 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIE--- 235 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH---
Confidence 9999999986533222222223345788999999999999999999999999999998 888874332211 111
Q ss_pred HHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 656 EQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 656 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
....+.... . +......+.+++.+||+.||++||++.|+++.|++
T Consensus 236 -~~~~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 236 -CITQGRLLQ-----R----PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -HHHcCCcCC-----C----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111111111 0 11223468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.48 Aligned_cols=257 Identities=28% Similarity=0.416 Sum_probs=208.7
Q ss_pred ccCcccccCCeeEEEEE-cCCCC----EEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 439 SANKLGEGGFGPVYKGN-LPRGQ----EFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 439 ~~~~lG~G~~g~Vy~~~-~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
..++||+|+||+||+|. .+.|+ +||||++... ..+...++++|.-.|.++.|||+++|+|+|.... +.||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 46899999999999994 44444 7899998655 4455678999999999999999999999998765 8899999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
|+.|+|.+|++. .+..+..+..+.+..|||+||.|||.+. ++||||.++|||+..-..+||+|||+++....+..
T Consensus 779 mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 779 MPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred cccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999975 3445788999999999999999999875 99999999999999999999999999999887766
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
+.......-.+.|||-|.+....|+.++|||||||.+||++| |..|.......+..++ +....
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl----------------le~ge 917 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL----------------LEKGE 917 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH----------------Hhccc
Confidence 665555555789999999999999999999999999999999 5555533222221111 11111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccccCC
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAA 717 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~ 717 (755)
+-..++.+...++.++.+||..|+..||+++++...+.+.......
T Consensus 918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqr 963 (1177)
T KOG1025|consen 918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQR 963 (1177)
T ss_pred cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcce
Confidence 1223445566889999999999999999999999888765444433
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=309.63 Aligned_cols=269 Identities=22% Similarity=0.285 Sum_probs=214.0
Q ss_pred HHHHHHHhcCCCccCcccccCCeeEEEEEc------CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeee
Q 004402 427 FSDIKAATNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGY 499 (755)
Q Consensus 427 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~ 499 (755)
..++.....++.....+-+|.||.||+|-+ .+.+.|-+|.++... .-....++.|.-.+..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 344555567788888999999999999933 345678888886653 3345678999999999999999999999
Q ss_pred eecC-CccEEEEeecCCCChhhhhc-----CCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC
Q 004402 500 CTER-DENMLIYEYLPNKSLDLYLF-----DPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE 573 (755)
Q Consensus 500 ~~~~-~~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~ 573 (755)
+.+. +.+++++.++.-|+|..+|. +....+.++..+...++.|++.|++|||..+ +||.||.++|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 8664 56899999999999999997 5555667888999999999999999999987 9999999999999999
Q ss_pred CCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHH
Q 004402 574 LNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLE 652 (755)
Q Consensus 574 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~ 652 (755)
.++||+|=.+++.+.+......-.....+..||+||.+.+..|++++|||||||+||||+| |+.|+.. .+..++..
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae---IDPfEm~~ 509 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE---IDPFEMEH 509 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc---cCHHHHHH
Confidence 9999999999997766555544444456789999999999999999999999999999998 4445432 22222222
Q ss_pred HHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 004402 653 YAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMA 714 (755)
Q Consensus 653 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 714 (755)
+.. ++ .++ ..+.+++.++..++..||..+|++||++++++..|.+....
T Consensus 510 ylk----dG--yRl-------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 510 YLK----DG--YRL-------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred HHh----cc--cee-------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 221 11 111 12334566899999999999999999999999999875433
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=320.24 Aligned_cols=259 Identities=25% Similarity=0.425 Sum_probs=201.8
Q ss_pred HhcCCCccCcccccCCeeEEEEEcC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE 505 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 505 (755)
.+++|+..+.||+|+||.||+|... .+..||||.+.... .....++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567899999999999999998542 35689999986542 2344578999999999999999999999998889
Q ss_pred cEEEEeecCCCChhhhhcCCCc-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEE
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIR-------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI 578 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl 578 (755)
.++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999854221 234678889999999999999999976 999999999999999999999
Q ss_pred EecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHH
Q 004402 579 SDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQ 657 (755)
Q Consensus 579 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 657 (755)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+...... .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~~---- 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLRF---- 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----
Confidence 99999986543322222222345778999999999899999999999999999999 56676432211 11111
Q ss_pred hccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 658 WKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 658 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
........ ... .....+.+++.+||+.+|++|||+.|+++.|++
T Consensus 234 ~~~~~~~~-----~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLD-----KPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCC-----CCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111111 111 123468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=317.74 Aligned_cols=256 Identities=29% Similarity=0.456 Sum_probs=208.4
Q ss_pred HhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
...+|+..++||+|+||.||+|...+++.+|+|.+..........+.+|+.+++.++|||++++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568888999999999999998877999999999877665667899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++++|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999986532 345899999999999999999999886 99999999999999999999999999986543221
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
. .....++..|+|||.+....++.++||||||++++||++ |+.|+..... ........ ... ..
T Consensus 160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~----~~~-----~~-- 223 (261)
T cd05148 160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQIT----AGY-----RM-- 223 (261)
T ss_pred c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHH----hCC-----cC--
Confidence 1 112345678999999998899999999999999999998 7877743221 11111111 110 00
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
..+......+.+++.+||+.||++|||+.++++.|++
T Consensus 224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 --PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1112223467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.61 Aligned_cols=256 Identities=27% Similarity=0.423 Sum_probs=203.5
Q ss_pred cCCCccCcccccCCeeEEEEEcCC----CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
++|+..+.||+|+||.||+|.+.. ...||||.+.... ......|.+|+.++.+++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568888999999999999997632 4589999987553 33456789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+|||+++++.++|+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999985432 35889999999999999999999976 99999999999999999999999999997652
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
...........++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ... ........ .
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~----~~~~~~~~----~ 227 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVI----KAVEDGYR----L 227 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHH----HHHHcCCC----C
Confidence 222222222345678999999999999999999999999999998 88776432211 111 11111110 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
+ .+......+.+++.+||+.+|++||++.|+++.|++.
T Consensus 228 ~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 P-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0112234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.47 Aligned_cols=260 Identities=25% Similarity=0.404 Sum_probs=207.3
Q ss_pred cCCCccCcccccCCeeEEEEEc------CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
.+|...+.||+|+||.||++.. .++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 3567778999999999999963 2355799999877766666789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhcCCC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC
Q 004402 509 IYEYLPNKSLDLYLFDPI-------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN 575 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~ 575 (755)
||||+++++|.+++.... ....+++..++.++.+|+.||+|||+.+ ++||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985422 1234889999999999999999999987 999999999999999999
Q ss_pred eEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHH
Q 004402 576 PKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYA 654 (755)
Q Consensus 576 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~ 654 (755)
++|+|||++................++..|+|||.+.+..++.++|||||||++|||+| |+.|+...... ..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~---- 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EV---- 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HH----
Confidence 99999999986543322222233456788999999999999999999999999999999 88876432211 11
Q ss_pred HHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 655 FEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 655 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
......+..... ....+..+.+++.+||+.+|++|||+.+++++|++...
T Consensus 235 ~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 235 IECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 111111111111 11123468899999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=314.27 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=203.8
Q ss_pred hcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
.++|+..+.||+|++|.||+|...+++.||+|.++.... ..+.+.+|+.++++++|||++++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 456888899999999999999877788999999876532 3467899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++++|.+++.... ...+++..+..++.+++.|+.|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999985432 345899999999999999999999986 999999999999999999999999999876532111
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
.......+..|+|||.+.+..++.++||||||+++|||+| |+.|+..... .... ....... . .
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~----~~~~~~~--~---~--- 223 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVL----QQVDQGY--R---M--- 223 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHH----HHHHcCC--C---C---
Confidence 1111223457999999999999999999999999999999 8877743221 1111 1111110 0 0
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
.........+.+++.+||+.+|++||++.++++.|++
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 -PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0111223478899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.85 Aligned_cols=256 Identities=28% Similarity=0.432 Sum_probs=200.4
Q ss_pred CCCccCcccccCCeeEEEEEc-----CCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-----PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
+|+..+.||+|+||.||+|.. ..++.||+|.+... ..+....+.+|+.++++++||||+++++++......+++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 566778999999999999963 34678999998754 334456789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCC--------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC
Q 004402 510 YEYLPNKSLDLYLFDPI--------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN 575 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~ 575 (755)
|||+++++|.+++.... ....+++.+...++.+++.||.|||+.+ ++||||||+|||+++++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCc
Confidence 99999999999885321 1235788999999999999999999986 999999999999999999
Q ss_pred eEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHH
Q 004402 576 PKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYA 654 (755)
Q Consensus 576 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~ 654 (755)
+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+..... ....
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~--- 236 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVI--- 236 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHH---
Confidence 99999999986543322222233345678999999988889999999999999999998 7777643211 1111
Q ss_pred HHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 655 FEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 655 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
......... .... .....+.+++.+||+.||++||++.++++.|+.
T Consensus 237 -~~~~~~~~~-----~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 -EMVRKRQLL-----PCSE----DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHcCCcC-----CCCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111100 0111 123467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.09 Aligned_cols=259 Identities=29% Similarity=0.439 Sum_probs=200.8
Q ss_pred cCCCccCcccccCCeeEEEEEc------CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecC-Cc
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER-DE 505 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~~ 505 (755)
++|+..+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|+.++.++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 4688889999999999999943 235789999987543 23345688899999999 899999999988654 46
Q ss_pred cEEEEeecCCCChhhhhcCCCc----------------------------------------------------------
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIR---------------------------------------------------------- 527 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 527 (755)
.++++||+++++|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 7899999999999988753211
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccccccccccCCccc
Q 004402 528 RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607 (755)
Q Consensus 528 ~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a 607 (755)
...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 125789999999999999999999886 99999999999999999999999999987643332222333456778999
Q ss_pred cccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHH
Q 004402 608 PEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQV 686 (755)
Q Consensus 608 PE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 686 (755)
||++.+..++.++|||||||++|||++ |..|+......+ .+ ......... +.. +......+.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~----~~~~~~~~~-----~~~----~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EF----CRRLKEGTR-----MRA----PEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HH----HHHHhccCC-----CCC----CccCCHHHHHH
Confidence 999999999999999999999999998 888875322111 11 111111110 001 11123468899
Q ss_pred HHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 687 ALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 687 ~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
+.+||+.+|++||++.|+++.|++.
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=313.23 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=200.3
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecC
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 514 (755)
++|+..+.||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 34677889999999999999887888999998864432 34678899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 594 (755)
+|+|.+++.... ..+++..+..++.+++.||.|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 999999886432 35889999999999999999999887 999999999999999999999999999865332211
Q ss_pred ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ....... .... ....+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i----~~~~--~~~~~~--- 224 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMI----SRGF--RLYRPK--- 224 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH----HCCC--CCCCCC---
Confidence 1112235668999999988889999999999999999999 7877743221 1111111 1111 111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 709 (755)
.....+.+++.+||+.+|++||++.++++.|.
T Consensus 225 ----~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 ----LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ----CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 12236789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=328.79 Aligned_cols=253 Identities=21% Similarity=0.336 Sum_probs=201.1
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999764 58999999987542 234467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|+|.+++.. ...+++.....++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999853 335788999999999999999999987 99999999999999999999999999986433
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
......||+.|+|||++.+..++.++|||||||++|||++|+.|+......+. .... ..+... +-.+.
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~~~i-~~~~~~----~~~~~ 221 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET---WENL-KYWKET----LQRPV 221 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH---HHHH-Hhcccc----ccCCC
Confidence 22345789999999999999999999999999999999999999854322111 1111 111100 00111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
... ........+.+++.+||+.+|++||++.++++.
T Consensus 222 ~~~-~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDD-PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCc-cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 100 001223467889999999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=311.79 Aligned_cols=254 Identities=27% Similarity=0.424 Sum_probs=203.8
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecC
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 514 (755)
++|+..++||+|+||.||+|...+++.||+|.+..... ..+.+.+|+.++++++|+||+++++++...+..++++||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 46788899999999999999887888999999865432 35688999999999999999999999999899999999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 594 (755)
+++|.+++... ....+++..++.++.+++.||+|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05072 85 KGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT- 159 (261)
T ss_pred CCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence 99999998543 2345788999999999999999999976 999999999999999999999999999875432211
Q ss_pred ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
......++..|+|||.+....++.++|||||||++|||+| |+.|+...... ...... .... ..+. ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~----~~~~----~~~~-~~ 227 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSAL----QRGY----RMPR-ME 227 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHH----HcCC----CCCC-CC
Confidence 1122345678999999998889999999999999999998 88887532211 111111 1110 0011 11
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
.....+.+++.+||+.+|++||+++++.+.|++
T Consensus 228 ----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 228 ----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 123467899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=299.74 Aligned_cols=286 Identities=20% Similarity=0.287 Sum_probs=206.2
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhh--HHHHHHHHHHHhcCCCCceeeeeeeeec--CCccEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQG--LEEFKNEVSLTARLQHVNLLRVLGYCTE--RDENMLI 509 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv 509 (755)
+.|+.++.|++|+||.||+|+. .+++.||+|+++...+.. --.-++|+.+|.+++|||||.+-.+... -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4577789999999999999954 568999999997654321 1235899999999999999999877654 3568999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
||||+. +|..++.... ..+...+...+..|+++|++|||++. |+|||||++|+|++..|.+||+|||+|+.+..
T Consensus 156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999977 7888875433 45788889999999999999999998 99999999999999999999999999998765
Q ss_pred CCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC---Ccc
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK---GKE 665 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 665 (755)
... ..+..+-|.+|.|||.+.+ ..|+++.|+||+|||+.||+++++.+...+..+... ..++.+.-.. ...
T Consensus 230 p~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~---~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 230 PLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD---KIFKLLGTPSEAIWPG 304 (419)
T ss_pred Ccc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH---HHHHHhCCCccccCCC
Confidence 422 2334567999999998876 569999999999999999999998776544433322 2222221111 111
Q ss_pred ccC------CCC--------CCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH--HhhcCccccCCCCCCccccCCC
Q 004402 666 FID------PSL--------DDSSSPC-KLLNCMQVALLCVQENPEDRPSMLEVSS--MLKDDSMAIAAPKRPAFSAKGD 728 (755)
Q Consensus 666 ~~d------~~l--------~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~~~~~p~~p~~~~~~~ 728 (755)
+.. -.+ ...+... ....-.+++...+..||.+|.|+.|.++ .+.+.-.+..+..-|++.....
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~~ 384 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKSE 384 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCccccc
Confidence 100 000 0000000 1134467889999999999999999885 3433222223333555555444
Q ss_pred CCC
Q 004402 729 ENA 731 (755)
Q Consensus 729 ~~~ 731 (755)
...
T Consensus 385 ~~~ 387 (419)
T KOG0663|consen 385 QQR 387 (419)
T ss_pred ccc
Confidence 433
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=340.49 Aligned_cols=252 Identities=19% Similarity=0.238 Sum_probs=201.7
Q ss_pred CCCccCcccccCCeeEEEEEc-CC-CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
.|...+.||+|+||.||++.. .+ ++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 377889999999999999953 33 6789999876665555567888999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 514 PNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 514 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
++|+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 9999998885432 2446889999999999999999999986 99999999999999999999999999987654332
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ....... ..+.. ++ ..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---~~~~~~~----~~~~~----~~-~~ 292 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---REIMQQV----LYGKY----DP-FP 292 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH----HhCCC----CC-CC
Confidence 2233445789999999999999999999999999999999999999853221 1111111 11111 00 11
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. .....+.+++..||+.||++||++.++++
T Consensus 293 ~----~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 293 C----PVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred c----cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1 12236789999999999999999999864
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.05 Aligned_cols=259 Identities=26% Similarity=0.414 Sum_probs=205.8
Q ss_pred cCCCccCcccccCCeeEEEEEc------CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
++|...+.||+|+||.||++.. .++..+|+|.+........+.+.+|++++.+++|||++++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4678889999999999999963 2345799999987666666789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhcCCC----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEE
Q 004402 509 IYEYLPNKSLDLYLFDPI----------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI 578 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl 578 (755)
++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999885321 1234899999999999999999999886 999999999999999999999
Q ss_pred EecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHH
Q 004402 579 SDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQ 657 (755)
Q Consensus 579 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 657 (755)
+|||+++...............++..|+|||.+.+..++.++|||||||+++||++ |..|+..... .... ..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~~----~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVI----EC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHH----HH
Confidence 99999986543322222233445778999999998899999999999999999998 7777643221 1111 11
Q ss_pred hccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 658 WKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 658 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
...+.... .... ....+.+++.+||+.||.+|||+.|+++.|++..
T Consensus 235 i~~~~~~~-----~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 235 ITQGRVLQ-----RPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHcCCcCC-----CCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 11111110 1111 2236889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=294.50 Aligned_cols=236 Identities=25% Similarity=0.355 Sum_probs=193.1
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST---QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||.|+||+|.+++.+ +|..+|+|++.+... ...+...+|..+|+.+.||+++++.+.|.+.+.+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 35677899999999999999654 588999999977633 33456788999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|.|..+|+. .+.++++..+.+|.+|+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred eccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 99999999999954 345889999999999999999999998 99999999999999999999999999997543
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
.+-..+||+.|+|||++....|..++|.|||||++|||+.|..||-.... ... .+++.+++. .
T Consensus 197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~i----Y~KI~~~~v------~ 259 (355)
T KOG0616|consen 197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQI----YEKILEGKV------K 259 (355)
T ss_pred ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHH----HHHHHhCcc------c
Confidence 24467999999999999999999999999999999999999999854332 111 112222211 1
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDR 698 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 698 (755)
.....+ ..+.+|+...++.|-.+|
T Consensus 260 fP~~fs----~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 FPSYFS----SDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CCcccC----HHHHHHHHHHHhhhhHhh
Confidence 111122 256677777788887777
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.90 Aligned_cols=265 Identities=19% Similarity=0.265 Sum_probs=199.4
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
++|+..+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999764 58899999986542 2335678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|++++++..+.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999988765542 2235888999999999999999999886 9999999999999999999999999998754322
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHH--------HHH-hccCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYA--------FEQ-WKDSK 662 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~--------~~~-~~~~~ 662 (755)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.|+......+........ ... .....
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 1 1222356899999999999888999999999999999999999988643221111000000 000 00000
Q ss_pred CccccCCCCCCCC------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 663 GKEFIDPSLDDSS------SPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 663 ~~~~~d~~l~~~~------~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
......+...... .......+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000001010000 0112346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=321.87 Aligned_cols=199 Identities=25% Similarity=0.345 Sum_probs=173.1
Q ss_pred hcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.++|+..+.||+|+||.||++... ++..+|+|.+... .....+.+.+|++++.+++||||++++++|...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468889999999999999999664 5889999988764 33345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++|+|.+++.. ...+++.....++.+++.||.|||+.+ +++||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999999853 335788999999999999999999753 4999999999999999999999999999765322
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY 641 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~ 641 (755)
......|+..|+|||.+.+..++.++|||||||++|||++|+.|+..
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12234688999999999988999999999999999999999999854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=308.02 Aligned_cols=268 Identities=25% Similarity=0.371 Sum_probs=200.6
Q ss_pred HHHhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHH--hcCCCCceeeeeeeeecCC----
Q 004402 431 KAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLT--ARLQHVNLLRVLGYCTERD---- 504 (755)
Q Consensus 431 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l--~~l~H~niv~l~g~~~~~~---- 504 (755)
....++....+.||+|.||+||+|.+ .|+.||||++...++.+ +.+|.++. ..|+|+||+.+++.-..+.
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~S---WfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDERS---WFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccchhh---hhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 34456788889999999999999999 89999999998776644 34555554 4469999999998765433
Q ss_pred ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCceecccCCCCEEEcCCCCeEEE
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE-----YSNFRVIHRDLKASNILLDNELNPKIS 579 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~-----~~~~~iiHrDlk~~NIll~~~~~~kl~ 579 (755)
.++||.+|.++|||.+||. +..++....++++..+|.||++||. ++++.|.|||||+.|||+..++.+.|+
T Consensus 283 QLwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 4799999999999999993 4678999999999999999999995 567789999999999999999999999
Q ss_pred ecCCccccccCCcc--cccccccccCCccccccccCCC----CC--chhhHHHHHHHHHHHHcCC----------CCCCC
Q 004402 580 DFGMAKLFRKDVDE--ANTGRIVGTYGYVPPEYVKKGI----YS--MKYDVYSFGVLLLQIISSK----------RNARY 641 (755)
Q Consensus 580 Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~s--~~sDVwS~Gvil~elltg~----------~p~~~ 641 (755)
|+|||......... ......+||.+|||||++.... |. ..+||||||+|+||+..+- .|+-.
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 99999876554322 2244568999999999986532 22 3689999999999997522 22211
Q ss_pred CCCCcccchHHHHHHHhccCCCccccCCCCCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 642 YGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD-SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
..+.+ .. .+..++---.+-+.|.+.. ..+.+.+..+.+++..||..+|.-|-|+-.+-+.|.+..
T Consensus 439 ~Vp~D--Ps----~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 439 VVPSD--PS----FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCCCC--CC----HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 11111 00 1111111111122233322 234466778899999999999999999999999887765
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.97 Aligned_cols=245 Identities=21% Similarity=0.274 Sum_probs=197.3
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999654 68999999986532 233456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999998853 335888999999999999999999986 999999999999999999999999999865322
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.|+..... ..... ...... ..
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---~~~~~----~i~~~~------~~ 216 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP---FGIYE----KILAGK------LE 216 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH----HHHhCC------cC
Confidence 1234689999999999998999999999999999999999999853221 11111 111111 01
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPS-----MLEVSSM 707 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 707 (755)
+... ....+.+++.+||+.||.+||+ ++++++.
T Consensus 217 ~~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 FPRH----LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCcc----CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1111 1236789999999999999995 7777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=326.24 Aligned_cols=247 Identities=22% Similarity=0.374 Sum_probs=191.1
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
+|+..+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 445668999999999999965 468999999986543 334567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++|+|.... ..++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+.....
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 999986432 3456778899999999999999986 99999999999999999999999999986543221
Q ss_pred cccccccccCCccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 594 ANTGRIVGTYGYVPPEYVKK-----GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
......||..|+|||.+.. ...+.++|||||||++|||++|+.||............. ...... .
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~----~~~~~~-----~ 293 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC----AICMSQ-----P 293 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH----HHhccC-----C
Confidence 1223578999999998743 234568999999999999999999986322221111111 000000 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
+.. .......+.+++.+||+.||++|||+.|+++.
T Consensus 294 ~~~----~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 PEA----PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCC----CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011 11223468899999999999999999999863
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=317.15 Aligned_cols=268 Identities=26% Similarity=0.335 Sum_probs=200.5
Q ss_pred CCccCcccccCCeeEEEEE-----cCCCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCceeeeeeeeecC--CccEE
Q 004402 437 FSSANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DENML 508 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 508 (755)
|...+.||+|+||+||++. ..+++.||+|.+..... .....+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 3778899999999998763 24578999999876532 3456788999999999999999999988654 35789
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
+|||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999998843 34899999999999999999999986 9999999999999999999999999998664
Q ss_pred cCCcccc-cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 589 KDVDEAN-TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 589 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
....... .....++..|+|||.+....++.++||||||++++||+||+.|+......- .................+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhh
Confidence 3322111 112234667999999998899999999999999999999998874332110 00000000000000111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
+.......+...+..+.+++.+||+.+|++|||+++++++|++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111111112233457889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=317.49 Aligned_cols=266 Identities=25% Similarity=0.407 Sum_probs=199.9
Q ss_pred cCCCccCcccccCCeeEEEEEcCC---------------CCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPR---------------GQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLG 498 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g 498 (755)
++|+..+.||+|+||.||++.... ...||+|.++.. .......|.+|++++.+++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 478888999999999999986432 235899998764 3344567999999999999999999999
Q ss_pred eeecCCccEEEEeecCCCChhhhhcCCCc---------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEE
Q 004402 499 YCTERDENMLIYEYLPNKSLDLYLFDPIR---------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNIL 569 (755)
Q Consensus 499 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIl 569 (755)
++......++||||+++++|.+++..... ...+++..++.++.+++.||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999998854211 124688999999999999999999986 999999999999
Q ss_pred EcCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccc
Q 004402 570 LDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLN 649 (755)
Q Consensus 570 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~ 649 (755)
+++++.+||+|||++................++..|+|||.+..+.++.++|||||||+++||+++..+.++.... ...
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~-~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS-DEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC-hHH
Confidence 9999999999999998654332222223344577899999998889999999999999999999854332222211 111
Q ss_pred hHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 650 FLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
........+......... ......+..+.+++.+||+.+|++|||+.+|++.|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 VIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111111111111000000 0111123478899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=324.78 Aligned_cols=241 Identities=21% Similarity=0.259 Sum_probs=193.4
Q ss_pred CcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCC
Q 004402 441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK 516 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 516 (755)
+.||+|+||.||++.. .+|+.||||++.... ......+.+|+.++.+++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999965 568999999987542 233456789999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccccc
Q 004402 517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596 (755)
Q Consensus 517 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 596 (755)
+|..++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 99888853 345889999999999999999999987 9999999999999999999999999997532211 122
Q ss_pred ccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCC
Q 004402 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSS 676 (755)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 676 (755)
....||+.|+|||.+.+..++.++|||||||++|||++|+.|+..... ...... ..... ..+..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~----~~~~~------~~~p~--- 216 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFEL----ILMEE------IRFPR--- 216 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHHHH----HHcCC------CCCCC---
Confidence 345789999999999999999999999999999999999999843211 111111 11111 11111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004402 677 PCKLLNCMQVALLCVQENPEDRP-----SMLEVSS 706 (755)
Q Consensus 677 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 706 (755)
.....+.+++.+||+.||++|| ++.++++
T Consensus 217 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 -TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1234678999999999999999 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=321.82 Aligned_cols=242 Identities=21% Similarity=0.272 Sum_probs=193.6
Q ss_pred CcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCC
Q 004402 441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK 516 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 516 (755)
+.||+|+||.||++.. .+++.||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999964 46899999999754 2334567889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccccc
Q 004402 517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596 (755)
Q Consensus 517 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 596 (755)
+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 99888743 335889999999999999999999986 9999999999999999999999999987532211 122
Q ss_pred ccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCC
Q 004402 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSS 676 (755)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 676 (755)
....||+.|+|||.+.+..++.++|||||||++|||++|+.|+...... ... ...... +..+...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~----~~~~~~------~~~~p~~-- 217 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLF----ELILME------DIKFPRT-- 217 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHH----HHhccC------CccCCCC--
Confidence 3457899999999999999999999999999999999999998532211 111 111100 0111111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 004402 677 PCKLLNCMQVALLCVQENPEDRP-----SMLEVSSM 707 (755)
Q Consensus 677 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 707 (755)
....+.+++.+||+.||++|| ++.|+++.
T Consensus 218 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 --LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred --CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 223678899999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=316.14 Aligned_cols=258 Identities=25% Similarity=0.389 Sum_probs=201.5
Q ss_pred CCCccCcccccCCeeEEEEEcC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 436 NFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
+|...+.||+|+||.||+|... ....+++|.+.... ....+.+.+|+.++..++||||+++++.|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4667889999999999999642 23578999887553 3345678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhcCCC---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCC
Q 004402 509 IYEYLPNKSLDLYLFDPI---------------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASN 567 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~N 567 (755)
++||+.+++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875321 1234788999999999999999999876 9999999999
Q ss_pred EEEcCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 004402 568 ILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSE 646 (755)
Q Consensus 568 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~ 646 (755)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999986543322222223345678999999988889999999999999999999 88777432211
Q ss_pred ccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 647 NLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
. .+....... .... +......+.+++.+||+.+|++||++.|+++.|++..
T Consensus 237 --~----~~~~~~~~~-----~~~~----~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 237 --R----LFNLLKTGY-----RMER----PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred --H----HHHHHhCCC-----CCCC----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 1 111111110 1111 1122346889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=320.55 Aligned_cols=241 Identities=21% Similarity=0.266 Sum_probs=192.5
Q ss_pred CcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCC
Q 004402 441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK 516 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 516 (755)
+.||+|+||.||++.. .+|+.||+|++... .......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999964 46899999998754 2234456788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccccc
Q 004402 517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596 (755)
Q Consensus 517 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 596 (755)
+|..++.. ...+++.....++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 99888743 335889999999999999999999986 9999999999999999999999999987532211 122
Q ss_pred ccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCC
Q 004402 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSS 676 (755)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 676 (755)
....||+.|+|||.+.+..++.++|||||||++|||++|+.|+....... .. ....... ..+...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~----~~~~~~~------~~~p~~-- 217 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LF----ELILMEE------IRFPRT-- 217 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---HH----HHHhcCC------CCCCCC--
Confidence 23568999999999999999999999999999999999999985322111 11 1111111 011111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004402 677 PCKLLNCMQVALLCVQENPEDRP-----SMLEVSS 706 (755)
Q Consensus 677 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 706 (755)
....+.+++.+||+.||++|| ++.++++
T Consensus 218 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 218 --LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred --CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 223678999999999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=330.28 Aligned_cols=263 Identities=25% Similarity=0.382 Sum_probs=202.9
Q ss_pred HHHhcCCCccCcccccCCeeEEEEEcC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCC-CCceeeeeeeeec
Q 004402 431 KAATNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTE 502 (755)
Q Consensus 431 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~ 502 (755)
....++|...+.||+|+||.||+|.+. .++.||||++.... ....+.+.+|+++|.++. ||||++++++|..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 334456778899999999999999742 34689999997653 233457899999999997 9999999999999
Q ss_pred CCccEEEEeecCCCChhhhhcCCCc-------------------------------------------------------
Q 004402 503 RDENMLIYEYLPNKSLDLYLFDPIR------------------------------------------------------- 527 (755)
Q Consensus 503 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 527 (755)
....++|+||+++|+|.++++....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 8899999999999999998854211
Q ss_pred ----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCC
Q 004402 528 ----------------------------------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASN 567 (755)
Q Consensus 528 ----------------------------------------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~N 567 (755)
...+++.....++.|++.||.|||+.+ ++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcce
Confidence 124677888999999999999999876 9999999999
Q ss_pred EEEcCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 004402 568 ILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSE 646 (755)
Q Consensus 568 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~ 646 (755)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999986533222122223356788999999998889999999999999999998 777764322111
Q ss_pred ccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 647 NLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
.. ......+. . +. .+......+.+++.+||+.+|++||++.||++.|++.
T Consensus 350 ---~~---~~~~~~~~--~---~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 350 ---QF---YNAIKRGY--R---MA----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred ---HH---HHHHHcCC--C---CC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 11111110 0 00 1111234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.36 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=199.2
Q ss_pred CCccCcccccCCeeEEEEEcC------CCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 437 FSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
|...+.||+|+||.||+|... .++.||+|+++.... ...+.+.+|+.++..++||||+++++++......+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 556688999999999999652 257899999975543 2346788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCe
Q 004402 510 YEYLPNKSLDLYLFDPI-------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP 576 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~ 576 (755)
+||+++++|..++.... .+..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCce
Confidence 99999999999874211 1235788899999999999999999886 9999999999999999999
Q ss_pred EEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHH
Q 004402 577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAF 655 (755)
Q Consensus 577 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 655 (755)
||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..|+..... ... .
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~----~ 236 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDV----I 236 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHH----H
Confidence 9999999886543322222233455789999999988889999999999999999998 6666543211 111 1
Q ss_pred HHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 656 EQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 656 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
.......... . .......+.+++..||+.+|++||++++|++.|+.
T Consensus 237 ~~i~~~~~~~-----~----~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIRNRQVLP-----C----PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHcCCcCC-----C----CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111111110 1 11233467899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=316.46 Aligned_cols=263 Identities=26% Similarity=0.400 Sum_probs=200.4
Q ss_pred cCCCccCcccccCCeeEEEEEc-----CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--CccE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-----PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DENM 507 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 507 (755)
++|...+.||+|+||.||++.. .+++.||+|.+........+.+.+|++++.+++|||++++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4677889999999999999863 35789999999877666677899999999999999999999987543 4578
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
+|+||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998542 235889999999999999999999986 999999999999999999999999999876
Q ss_pred ccCCcccc-cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc--------c-cchHHHHHHH
Q 004402 588 RKDVDEAN-TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE--------N-LNFLEYAFEQ 657 (755)
Q Consensus 588 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~--------~-~~~~~~~~~~ 657 (755)
........ .....++..|+|||.+.+..++.++|||||||+++||++|..+.......- . ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 43322111 111223456999999998899999999999999999999876543221100 0 0000000000
Q ss_pred hccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 658 WKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 658 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
+...............+.+++.+||+.+|++|||+.||++.|+..
T Consensus 239 ---------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 ---------LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ---------HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000000011112234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=314.57 Aligned_cols=256 Identities=25% Similarity=0.389 Sum_probs=198.0
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCC----EEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQ----EFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
++|+..+.||+|+||+||+|.. .+++ .+++|.+.... .....++..|+..+.+++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 3566789999999999999965 3444 47888875443 2334678888889999999999999998854 45789
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
++||+++|+|.+++... ...+++.....++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999998542 335899999999999999999999986 9999999999999999999999999998664
Q ss_pred cCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
............++..|+|||.+.++.++.++|||||||++|||++ |+.|+....... .... +.... ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~----~~~~~--~~~ 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDL----LEKGE--RLA 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHCCC--cCC
Confidence 4332222334456788999999998999999999999999999998 887774322111 1111 11111 111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
.+. .....+.+++.+||..+|++|||+.|+++.|+...
T Consensus 232 ~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 232 QPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 111 12235778999999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=317.26 Aligned_cols=264 Identities=21% Similarity=0.324 Sum_probs=195.9
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
++|...++||+|+||.||+|.. .+++.||+|+++.... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 4688889999999999999965 4689999999865432 2345678999999999999999999999988889999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++ +|..++... ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 975 888877432 235788999999999999999999986 99999999999999999999999999976432211
Q ss_pred ccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHH-----Hhcc----CC
Q 004402 593 EANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFE-----QWKD----SK 662 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~-----~~~~----~~ 662 (755)
......+++.|+|||.+.+ ..++.++||||+||++|||+||+.|+......+.......... .+.. ..
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 1223467899999998865 5689999999999999999999998854332221111100000 0000 00
Q ss_pred CccccCCCCCCCC----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 663 GKEFIDPSLDDSS----SPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 663 ~~~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
......+...... .+.....+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0011111100000 0111235779999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=308.95 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=194.0
Q ss_pred CcccccCCeeEEEEEc-CCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCCCh
Q 004402 441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL 518 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 518 (755)
+.||+|+||.||+|.. .+++.||+|.+... ..+....+.+|++++++++||||++++++|......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999965 46899999987654 334456799999999999999999999999999999999999999999
Q ss_pred hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccccccc
Q 004402 519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598 (755)
Q Consensus 519 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 598 (755)
.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998532 235789999999999999999999886 99999999999999999999999999875432211111111
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCH
Q 004402 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSP 677 (755)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 677 (755)
...+..|+|||.+.++.++.++|||||||++|||++ |..|+...... .. ........ .. ....
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~----~~~~~~~~-----~~----~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QT----REAIEQGV-----RL----PCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HH----HHHHHcCC-----CC----CCcc
Confidence 123457999999999999999999999999999998 77666432111 11 11111100 00 1111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 004402 678 CKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709 (755)
Q Consensus 678 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 709 (755)
.....+.+++.+||+.+|++|||+.++.++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 22346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=311.60 Aligned_cols=255 Identities=27% Similarity=0.407 Sum_probs=201.9
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
.+|+..+.||+|++|.||+|.. ..++.||+|++.... ...+.+.+|++++.+++|||++++++++......+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 3467778999999999999965 458899999987543 33567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++++|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999988543 2345899999999999999999999886 999999999999999999999999999865432211
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
......++..|+|||.+.+..++.++|||||||++|||++ |..|+...... .. ....... ..+..
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~----~~~~~~~-----~~~~~- 226 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QV----YELLEKG-----YRMER- 226 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHHHHCC-----CCCCC-
Confidence 1112234568999999999999999999999999999998 88776432111 11 1111111 01111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
+...+..+.+++.+||+.+|++|||+.++++.|+..
T Consensus 227 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 ---PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 112234688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=322.43 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=208.2
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc-cEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE-NMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lv~ 510 (755)
++|...+++|+|+||.++..+. .+++.+++|.+... .....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 4678889999999999999854 35789999998654 33445578899999999999999999999999888 99999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
+||++|+|.+.+.... ...+++.++..++.|++.|+.|||++. |+|||||+.|||++.+..+||+|||+|+.+.+.
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999986533 456889999999999999999999876 999999999999999999999999999988765
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
.. .....+||+.||.||.+.+.+|..|+|||||||++|||.+.+++|....... ++....+. ..
T Consensus 160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~ki~~~--------~~--- 223 (426)
T KOG0589|consen 160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LILKINRG--------LY--- 223 (426)
T ss_pred hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHHHHhhc--------cC---
Confidence 42 3445799999999999999999999999999999999999999886443322 22111111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
...+.....++..++..|++.+|+.||++.+++.+
T Consensus 224 --~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 --SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 12223344578899999999999999999999865
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=327.72 Aligned_cols=249 Identities=25% Similarity=0.381 Sum_probs=201.2
Q ss_pred ccCcccccCCeeEEEEEcC--CCC--EEEEEEeccCChh-hHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 439 SANKLGEGGFGPVYKGNLP--RGQ--EFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 439 ~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
..++||+|+||.|++|.|. +|+ .||||.++..... ....|++|+.+|.+|+|||+++|+|...+ ....+|+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3578999999999999653 354 6899999876543 67899999999999999999999999987 7789999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
+.|||.+.|++ ..+..+-......++.|||.||.||.+++ +|||||.++|+||-....+||+||||.+.+......
T Consensus 193 plGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 193 PLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred ccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 99999999987 44556778889999999999999999887 999999999999999999999999999987655444
Q ss_pred ccc-ccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 594 ANT-GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK-RNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 594 ~~~-~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
+.. ....-+..|+|||.+....|+.+||||+|||+||||+|+. .|+..... ... .+.+|..-
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g---~qI-------------L~~iD~~e 332 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG---IQI-------------LKNIDAGE 332 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH---HHH-------------HHhccccc
Confidence 322 2223467899999999999999999999999999999954 34422111 111 11222222
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSML 708 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 708 (755)
.-..++.+...++++++.||..+|.+|||+..|.+.+
T Consensus 333 rLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 2233455677899999999999999999999997433
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=288.86 Aligned_cols=247 Identities=28% Similarity=0.377 Sum_probs=203.5
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||+|.||.||.|+. +++-.||+|++.+.. .+..+++.+|+++-+.|+||||+++++++.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 4678899999999999999965 457799999986653 223467899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||.++|+|...|.+.. ...+++.....+..|+|.||.|+|..+ +|||||||+|+|++.++.+||+|||.+..-+
T Consensus 102 Eya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 9999999999996433 234778888999999999999999987 9999999999999999999999999997633
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
.......+||..|.+||...+..++..+|+|++|++.||++.|.+||......+. ... +.. .++..|
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et---Ykr----I~k---~~~~~p- 242 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET---YKR----IRK---VDLKFP- 242 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH---HHH----HHH---ccccCC-
Confidence 2334467999999999999999999999999999999999999999965432221 111 111 122222
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. .......+++..|+..+|.+|.+..|++.
T Consensus 243 --~----~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 243 --S----TISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred --c----ccChhHHHHHHHHhccCccccccHHHHhh
Confidence 1 12236779999999999999999999875
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=309.66 Aligned_cols=251 Identities=27% Similarity=0.415 Sum_probs=199.5
Q ss_pred CCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCC
Q 004402 436 NFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
+|...+.||+|+||.||+++..++..+|+|.+..... ..+.|.+|+.++.+++||||+++++++...+..+++|||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 4667789999999999999887777899999875432 346789999999999999999999999988889999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
|+|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++........ .
T Consensus 84 ~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~ 157 (256)
T cd05113 84 GCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-S 157 (256)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-e
Confidence 99999885432 25899999999999999999999886 999999999999999999999999999865432211 1
Q ss_pred cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS 674 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 674 (755)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.|+....... .... ....... ..+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~----~~~~~~~--~~~----- 223 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEK----VSQGLRL--YRP----- 223 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHH----HhcCCCC--CCC-----
Confidence 112235678999999988889999999999999999999 888774332211 1111 1111100 001
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 004402 675 SSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709 (755)
Q Consensus 675 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 709 (755)
......+.+++.+||+.+|++||++.++++.|+
T Consensus 224 --~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 --HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112347889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=314.29 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=202.6
Q ss_pred cCCCccCcccccCCeeEEEEEc------CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
++|...++||+|+||.||++.. .++..+|+|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4667789999999999999953 2356899999887766667789999999999999999999999999899999
Q ss_pred EEeecCCCChhhhhcCCCc------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCe
Q 004402 509 IYEYLPNKSLDLYLFDPIR------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP 576 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~ 576 (755)
++||+++++|.+++..... ...+++..++.++.|++.|++|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999854321 134789999999999999999999886 9999999999999999999
Q ss_pred EEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHH
Q 004402 577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAF 655 (755)
Q Consensus 577 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 655 (755)
||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.|+...... ......
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~- 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---EAIECI- 237 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---HHHHHH-
Confidence 9999999976543222122223345678999999999999999999999999999998 77776432211 111111
Q ss_pred HHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 656 EQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 656 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
.... .. .... ..+..+.+++.+||+.||++||++.||++.|+.
T Consensus 238 ---~~~~--~~---~~~~----~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 238 ---TQGR--EL---ERPR----TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ---HcCc--cC---CCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1110 00 0011 122467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=315.88 Aligned_cols=260 Identities=25% Similarity=0.345 Sum_probs=204.6
Q ss_pred hcCCCccCcccccCCeeEEEEEcCC-----CCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeec-CCcc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPR-----GQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE-RDEN 506 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 506 (755)
.++|...+.||+|+||.||+|.... +..|++|++... .....+.+.+|+.++++++|||++++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678888999999999999997654 688999998754 33445678999999999999999999998766 4678
Q ss_pred EEEEeecCCCChhhhhcCCCcc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEec
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRR-----YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDF 581 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Df 581 (755)
++++||+++++|.+++...... ..+++..+..++.+++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998543222 46899999999999999999999876 999999999999999999999999
Q ss_pred CCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhcc
Q 004402 582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKD 660 (755)
Q Consensus 582 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 660 (755)
|+++.+.............++..|+|||.+.+..++.++|||||||++||+++ |+.|+..... ...... ...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~----~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAY----LKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHH----HHc
Confidence 99986543322222222345678999999998889999999999999999999 8888743211 111111 111
Q ss_pred CCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 661 SKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 661 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
.. ..... ...+..+.+++.+||+.+|++|||+.++++.|++..
T Consensus 235 ~~-----~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 235 GY-----RLAQP----INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred CC-----CCCCC----CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 10 00011 112346889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=315.52 Aligned_cols=265 Identities=27% Similarity=0.422 Sum_probs=203.2
Q ss_pred hcCCCccCcccccCCeeEEEEEcCC-----------------CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPR-----------------GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLR 495 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~ 495 (755)
.++|+..+.||+|+||.||++.... +..||+|.+.... ....+.+.+|++++.+++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999986432 2468999987653 344567899999999999999999
Q ss_pred eeeeeecCCccEEEEeecCCCChhhhhcCCC--------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCC
Q 004402 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPI--------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASN 567 (755)
Q Consensus 496 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~N 567 (755)
+++++...+..++++||+++++|..++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999899999999999999999986432 1225899999999999999999999886 9999999999
Q ss_pred EEEcCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCC
Q 004402 568 ILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS--SKRNARYYGTS 645 (755)
Q Consensus 568 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt--g~~p~~~~~~~ 645 (755)
|+++.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ +..|+....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999986543322222334456788999999988889999999999999999998 444443211
Q ss_pred cccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 646 ENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
...........+.......... .....+.++.+++.+||+.||++|||+.||++.|++
T Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 -DQQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -hHHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1111222211111111111110 111123478899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=323.13 Aligned_cols=245 Identities=25% Similarity=0.349 Sum_probs=201.8
Q ss_pred CCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
|...+.||+|+-|.|-+|+. .+|+.+|||++.+.. ......+.+|+.+|+-+.|||++++++++++...+|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 55678899999999999954 679999999996552 22234578999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++|-|.+++. .+..+.+.+..+++.||..|+.|.|..+ |+||||||+|+|||...++||+|||+|.+-..
T Consensus 94 v~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--- 164 (786)
T KOG0588|consen 94 VPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP--- 164 (786)
T ss_pred cCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC---
Confidence 99999999984 4566899999999999999999999988 99999999999999999999999999986432
Q ss_pred ccccccccccCCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
.......||.++|.|||++.+..| +.++||||.|||||.|+||+.||+ ++....++. +.+.+.. ++
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLl----KV~~G~f-~M----- 231 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLL----KVQRGVF-EM----- 231 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHH----HHHcCcc-cC-----
Confidence 223345689999999999999998 589999999999999999999995 222222222 2222211 11
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
+.....++.+|+.+|+..||++|.|++||++.
T Consensus 232 ----Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 232 ----PSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ----CCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 12233467899999999999999999999863
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=309.14 Aligned_cols=251 Identities=27% Similarity=0.422 Sum_probs=198.9
Q ss_pred CCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCC
Q 004402 436 NFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
+|+..+.||+|+||.||++....+..+|+|.+..... ..+.+.+|++++++++||||+++++++...+..++|+||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4667889999999999999887778999999865432 235788999999999999999999999998999999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
++|.+++.... ..+++...+.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++........ .
T Consensus 84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~ 157 (256)
T cd05059 84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-S 157 (256)
T ss_pred CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-c
Confidence 99999985432 35889999999999999999999987 999999999999999999999999999865432111 1
Q ss_pred cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS 674 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 674 (755)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+ ... ..... .....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~----~~~~~-----~~~~~--- 222 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVE----SVSAG-----YRLYR--- 222 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHH----HHHcC-----CcCCC---
Confidence 111223457999999999999999999999999999999 677775332211 111 11111 01111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 004402 675 SSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709 (755)
Q Consensus 675 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 709 (755)
+...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 223 -~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 223 -PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred -CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 1123347889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.96 Aligned_cols=264 Identities=25% Similarity=0.419 Sum_probs=200.8
Q ss_pred cCCCccCcccccCCeeEEEEEcC-----------------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-----------------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRV 496 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 496 (755)
++|+..+.||+|+||.||++... ++..||+|++.... ....+.|.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888999999999999998432 23469999987653 3445689999999999999999999
Q ss_pred eeeeecCCccEEEEeecCCCChhhhhcCCCc--------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCE
Q 004402 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIR--------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNI 568 (755)
Q Consensus 497 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NI 568 (755)
++++...+..+++|||+++++|..++..... ...+++.+...++.|++.||+|||+.+ ++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999864321 134778899999999999999999986 99999999999
Q ss_pred EEcCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCCc
Q 004402 569 LLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS--SKRNARYYGTSE 646 (755)
Q Consensus 569 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt--g~~p~~~~~~~~ 646 (755)
|++.++.++|+|||+++.+.........+...++..|++||....+.++.++|||||||++|||++ |..|+.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986543322222223345678999999888889999999999999999998 445553222111
Q ss_pred ccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 647 NLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
.................. +. +......+.+++.+||+.||++||++.||++.|++
T Consensus 242 ---~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 ---VIENTGEFFRDQGRQVYL-PK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---HHHHHHHHHhhccccccC-CC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111111111100111 10 11123578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=318.05 Aligned_cols=261 Identities=25% Similarity=0.366 Sum_probs=203.7
Q ss_pred HHhcCCCccCcccccCCeeEEEEEcC------CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecC
Q 004402 432 AATNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSAT-STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER 503 (755)
Q Consensus 432 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 503 (755)
...++|+..+.||+|+||.||++... ....+|+|.+... ..+....+.+|++++.++ +|+||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34457888899999999999999653 2368999998754 333456788999999999 899999999999999
Q ss_pred CccEEEEeecCCCChhhhhcCC-------------CccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE
Q 004402 504 DENMLIYEYLPNKSLDLYLFDP-------------IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL 570 (755)
Q Consensus 504 ~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll 570 (755)
...+++|||+++|+|..++... .....+++..++.++.|++.||.|||+.+ ++||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999999998532 12346889999999999999999999876 9999999999999
Q ss_pred cCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccc
Q 004402 571 DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLN 649 (755)
Q Consensus 571 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~ 649 (755)
+.++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+.......
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 242 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--- 242 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---
Confidence 9999999999999987644322222222345678999999998899999999999999999998 777764322111
Q ss_pred hHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 650 FLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
.. ........ . ..+......+.+++.+||+.+|++|||+.|+++.|++.
T Consensus 243 ~~----~~~~~~~~---~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 LF----KLLKEGYR---M------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HH----HHHHcCCc---C------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11 11111110 0 01112234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=309.90 Aligned_cols=256 Identities=23% Similarity=0.393 Sum_probs=198.9
Q ss_pred HHhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCCh--------------hhHHHHHHHHHHHhcCCCCceeee
Q 004402 432 AATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST--------------QGLEEFKNEVSLTARLQHVNLLRV 496 (755)
Q Consensus 432 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l 496 (755)
..-++|+..+.||+|.||.|-+++. .+++.||||++.+... ...+...+|+.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3457899999999999999999954 5699999999965421 123578999999999999999999
Q ss_pred eeeeecC--CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC
Q 004402 497 LGYCTER--DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL 574 (755)
Q Consensus 497 ~g~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~ 574 (755)
+.+..+. +.+|||+|||..|.+... ......++..+.++++.++..||.|||.++ ||||||||+|+||+++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 9998764 578999999999988533 222333899999999999999999999997 99999999999999999
Q ss_pred CeEEEecCCccccccCC---cccccccccccCCccccccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 004402 575 NPKISDFGMAKLFRKDV---DEANTGRIVGTYGYVPPEYVKKGI----YSMKYDVYSFGVLLLQIISSKRNARYYGTSEN 647 (755)
Q Consensus 575 ~~kl~Dfgla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~ 647 (755)
++||+|||.+..+.... ........+||+.|||||...++. .+.+.||||+||+||.|+-|+.||-..
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~----- 322 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD----- 322 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc-----
Confidence 99999999998764331 112233478999999999987633 257899999999999999999998321
Q ss_pred cchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 004402 648 LNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSML 708 (755)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 708 (755)
.......+ ++...+.-...++.-..+.+|+.++|++||+.|.+..+|....
T Consensus 323 --~~~~l~~K--------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 323 --FELELFDK--------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred --hHHHHHHH--------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 11111122 2222222222223445678999999999999999999887654
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.36 Aligned_cols=240 Identities=24% Similarity=0.335 Sum_probs=187.6
Q ss_pred CcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEEEeecCC
Q 004402 441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
+.||+|+||.||+|.. .+++.||||+++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999965 458899999987542 23344556677777654 899999999999999999999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
|+|..++.. ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 999888753 235888999999999999999999986 9999999999999999999999999998543222 22
Q ss_pred cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSS 675 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 675 (755)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.|+...... ... ...... .+.+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~----~~i~~~------~~~~~~~- 218 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELF----DSILND------RPHFPRW- 218 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHcC------CCCCCCC-
Confidence 33457899999999999999999999999999999999999998543211 111 111111 0111111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 004402 676 SPCKLLNCMQVALLCVQENPEDRPSML-EVS 705 (755)
Q Consensus 676 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl 705 (755)
....+.+++.+||+.||++||++. +++
T Consensus 219 ---~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 219 ---ISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred ---CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 223577899999999999999875 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.48 Aligned_cols=256 Identities=23% Similarity=0.401 Sum_probs=198.8
Q ss_pred CCccCcccccCCeeEEEEEcCC----CCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc-----
Q 004402 437 FSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE----- 505 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 505 (755)
|...+.||+|+||.||+|.... +..||+|+++.. .....+.+.+|++.++.++|||++++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999996532 468999998754 23345678999999999999999999998866554
Q ss_pred -cEEEEeecCCCChhhhhcCCC---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEec
Q 004402 506 -NMLIYEYLPNKSLDLYLFDPI---RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDF 581 (755)
Q Consensus 506 -~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Df 581 (755)
.++++||+++|+|..++.... ....+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999998885432 2346889999999999999999999986 999999999999999999999999
Q ss_pred CCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhcc
Q 004402 582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKD 660 (755)
Q Consensus 582 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 660 (755)
|+++...............++..|+|||.+....++.++|||||||++|||++ |..|+..... ....... ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~----~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYL----RH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----Hc
Confidence 99986644322222222334678999999988899999999999999999999 7777643221 1111111 11
Q ss_pred CCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 661 SKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 661 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
.... .. +......+.+++.+||+.||++|||+.|+++.|++.
T Consensus 231 ~~~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRL-----KQ----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCC-----CC----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 11 112234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=321.60 Aligned_cols=241 Identities=20% Similarity=0.258 Sum_probs=190.9
Q ss_pred ccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCCCh
Q 004402 443 LGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL 518 (755)
Q Consensus 443 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 518 (755)
||+|+||.||++.. .+++.||+|++... .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999965 45889999998653 233456788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccccccc
Q 004402 519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598 (755)
Q Consensus 519 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 598 (755)
.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 988853 335889999999999999999999986 9999999999999999999999999998543221 12234
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHH
Q 004402 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPC 678 (755)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 678 (755)
..||+.|+|||.+.+..++.++|||||||++|||++|+.|+..... ... ........ ..+.. .
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~---~~~----~~~~~~~~------~~~~~----~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV---NEM----YRKILQEP------LRFPD----G 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH---HHH----HHHHHcCC------CCCCC----c
Confidence 5789999999999999999999999999999999999999853211 111 11111110 01111 1
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 004402 679 KLLNCMQVALLCVQENPEDRPSMLEVSSML 708 (755)
Q Consensus 679 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 708 (755)
....+.+++.+||+.||++||++..+.+.|
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 224678999999999999998654444444
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=323.74 Aligned_cols=243 Identities=21% Similarity=0.279 Sum_probs=196.5
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++.+++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46788899999999999999664 58999999986542 234567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|+|.+++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999998853 335788889999999999999999987 999999999999999999999999999865332
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.|+..... ... ......... .
T Consensus 172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~----~~~i~~~~~------~ 233 (329)
T PTZ00263 172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP---FRI----YEKILAGRL------K 233 (329)
T ss_pred -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH---HHH----HHHHhcCCc------C
Confidence 1234689999999999999999999999999999999999999843211 111 111111110 0
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPS-----MLEVS 705 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl 705 (755)
+... ....+.+++.+||+.||++||+ +++++
T Consensus 234 ~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 234 FPNW----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred CCCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 1111 1235779999999999999997 67766
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=325.47 Aligned_cols=264 Identities=19% Similarity=0.311 Sum_probs=192.8
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC-----ccE
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD-----ENM 507 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 507 (755)
+|+..+.||+|+||.||+|.. .+++.||||++... .......+.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 477789999999999999964 46899999998643 2233456889999999999999999999875432 479
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
+|||||. ++|..++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 688877743 335889999999999999999999987 999999999999999999999999999864
Q ss_pred ccCCc-ccccccccccCCccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHH--------HHH
Q 004402 588 RKDVD-EANTGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEY--------AFE 656 (755)
Q Consensus 588 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~--------~~~ 656 (755)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+.............. ...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 33221 112234578999999999875 6789999999999999999999998854322111100000 000
Q ss_pred HhccCCCccccC---CCCCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 657 QWKDSKGKEFID---PSLDDS---SSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 657 ~~~~~~~~~~~d---~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+......+.+. +..... ..+.....+.+++.+||+.||++|||++|+++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000000000 000000 00011235779999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.32 Aligned_cols=254 Identities=25% Similarity=0.403 Sum_probs=195.0
Q ss_pred CccCcccccCCeeEEEEEcCC-CC--EEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC------Ccc
Q 004402 438 SSANKLGEGGFGPVYKGNLPR-GQ--EFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER------DEN 506 (755)
Q Consensus 438 ~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 506 (755)
...+.||+|+||.||+|.... ++ .||+|.++.. .....+.+.+|+++++.++||||++++++|... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456889999999999997644 33 6899988654 344467889999999999999999999987432 246
Q ss_pred EEEEeecCCCChhhhhcCCC---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCC
Q 004402 507 MLIYEYLPNKSLDLYLFDPI---RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM 583 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl 583 (755)
++++||+++|+|..++.... ....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998874221 2345889999999999999999999976 99999999999999999999999999
Q ss_pred ccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCC
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
++.+.............+++.|+|||.+.+..++.++|||||||++|||++ |+.|+..... .... .....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~----~~~~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIY----DYLRQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHH----HHHHcCC
Confidence 987643322111122345678999999999999999999999999999999 6777643211 1111 1112111
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 663 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
... . .......+.+++.+||+.+|++|||+.++++.|++
T Consensus 232 ~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 232 RLK-----Q----PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCC-----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 100 0 11223467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=337.51 Aligned_cols=257 Identities=23% Similarity=0.333 Sum_probs=202.5
Q ss_pred HHhcCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC----
Q 004402 432 AATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD---- 504 (755)
Q Consensus 432 ~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 504 (755)
...++|...+.||+|+||+||++. ..+|+.||||++... .......+.+|+..+..++|+|++++...+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 345689999999999999999995 456999999998654 3444567889999999999999999987764432
Q ss_pred ----ccEEEEeecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEE
Q 004402 505 ----ENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKIS 579 (755)
Q Consensus 505 ----~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~ 579 (755)
..++||||+++|+|.+++.... ....+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 2579999999999999886432 2346889999999999999999999986 9999999999999999999999
Q ss_pred ecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhc
Q 004402 580 DFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWK 659 (755)
Q Consensus 580 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 659 (755)
|||+++.+.............||+.|+|||.+.+..++.++|||||||++|||++|+.|+..... .... ....
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~---~~~~----~~~~ 258 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM---EEVM----HKTL 258 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHH----HHHh
Confidence 99999876543322233346789999999999999999999999999999999999999853211 1111 1111
Q ss_pred cCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 660 DSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 660 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
... .++ + +......+.+++..||+.||++||++.++++.
T Consensus 259 ~~~----~~~-~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGR----YDP-L----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCC----CCC-C----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 111 1 11223468899999999999999999999763
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=315.76 Aligned_cols=261 Identities=23% Similarity=0.320 Sum_probs=191.6
Q ss_pred cCCCccCcccccCCeeEEEEEc--CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcC---CCCceeeeeeeeec-----
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL--PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARL---QHVNLLRVLGYCTE----- 502 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~----- 502 (755)
++|+..+.||+|+||.||++.. .+++.||+|+++... ......+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688889999999999999965 346889999986542 22234556677776665 69999999998852
Q ss_pred CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecC
Q 004402 503 RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG 582 (755)
Q Consensus 503 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg 582 (755)
....++||||+. ++|..++... ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345899999996 6888887543 2335889999999999999999999986 9999999999999999999999999
Q ss_pred CccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC
Q 004402 583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.|+......+ .+...........
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~ 229 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPG 229 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCC
Confidence 99865432 22234568999999999998899999999999999999999999886433221 1111111110000
Q ss_pred ---C-------ccccCCCCCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 663 ---G-------KEFIDPSLDD---SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 663 ---~-------~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. ...+.+.... ...+.....+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 0000000000 000112335679999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=311.71 Aligned_cols=257 Identities=28% Similarity=0.416 Sum_probs=199.7
Q ss_pred hcCCCccCcccccCCeeEEEEEcC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN 506 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 506 (755)
.++|...+.||+|++|.||+|... .+..||+|.+.... ......|.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 467888899999999999999664 35689999886543 33445789999999999999999999999998899
Q ss_pred EEEEeecCCCChhhhhcCCCc----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC---CeEEE
Q 004402 507 MLIYEYLPNKSLDLYLFDPIR----RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL---NPKIS 579 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~---~~kl~ 579 (755)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999854321 235899999999999999999999986 99999999999998764 59999
Q ss_pred ecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHh
Q 004402 580 DFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQW 658 (755)
Q Consensus 580 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 658 (755)
|||+++.+..............+..|+|||.+.+..++.++|||||||++|||++ |..|+...... ......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~~---- 234 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEFV---- 234 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH----
Confidence 9999986633221111112233568999999999999999999999999999997 88777532221 111111
Q ss_pred ccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 004402 659 KDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709 (755)
Q Consensus 659 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 709 (755)
...... ..+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 235 ~~~~~~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGGGRL---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111000 011122346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=305.68 Aligned_cols=265 Identities=21% Similarity=0.335 Sum_probs=199.8
Q ss_pred hcCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeec-----CCc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE-----RDE 505 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~ 505 (755)
...|...+.||+|++|.|+.+. ..+|+.||||++... .....++..+|+++|+.++|+||+.+.+.+.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 4456667899999999999994 457999999998733 44456778999999999999999999998765 245
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
.|+|+|+| ..+|...+.. +..++......++.|+++||.|+|+.+ ++||||||+|+|++.+..+||+|||+|+
T Consensus 101 vYiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 79999999 5588777742 334889999999999999999999987 9999999999999999999999999999
Q ss_pred ccccCCcccccccccccCCcccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHH--------H
Q 004402 586 LFRKDVDEANTGRIVGTYGYVPPEYVK-KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAF--------E 656 (755)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~--------~ 656 (755)
...........+..+.|.+|.|||++. ...||.+.||||.|||+.||++|+.-|+....-..+.++.... .
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 875442222334567899999999764 5789999999999999999999998887654433332222111 1
Q ss_pred HhccCCCccccCCC-------CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 657 QWKDSKGKEFIDPS-------LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 657 ~~~~~~~~~~~d~~-------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+.......++... +....+ ......++|+.+||..||.+|+|++|.++
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111111111110 000011 11224578999999999999999999885
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=323.20 Aligned_cols=259 Identities=17% Similarity=0.190 Sum_probs=193.0
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
.++|+..+.||+|+||.||++.. .+++.||+|.... ..+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 35799999999999999999954 5689999997532 3567899999999999999999999988899999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+. ++|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~ 236 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-N 236 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc-c
Confidence 85 678777743 235789999999999999999999986 999999999999999999999999999753221 1
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc----ccchHHHHHHHhccC-------
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE----NLNFLEYAFEQWKDS------- 661 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~------- 661 (755)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+-...... ....+..........
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 112224578999999999999999999999999999999999997753211100 000111111100000
Q ss_pred ---CCcc---------ccCCCCCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 662 ---KGKE---------FIDPSLDDS--SSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 662 ---~~~~---------~~d~~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
...+ ...+..... ........+.+++.+||+.||++|||+.|+++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 000000000 00112346789999999999999999999984
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.14 Aligned_cols=259 Identities=25% Similarity=0.392 Sum_probs=202.7
Q ss_pred hcCCCccCcccccCCeeEEEEEc------CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDE 505 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 505 (755)
.++|...+.||+|+||.||++.. ..+..||||+++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 35688889999999999999953 134579999987653 34456789999999999 79999999999999999
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
.+++|||+++|+|.+++.... ...+++.+...++.+++.||.|||+.+ ++|+||||+|||++.++.++|+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999985422 234899999999999999999999986 9999999999999999999999999998
Q ss_pred ccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCc
Q 004402 586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGK 664 (755)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (755)
...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+....... ... .....+.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~----~~~~~~~-- 261 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFY----KLIKEGY-- 261 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHH----HHHHcCC--
Confidence 6543322112223345778999999999999999999999999999998 887764322111 111 1111110
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 665 EFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 665 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
.... .......+.+++.+||+.+|++|||+.|+++.|++.
T Consensus 262 ---~~~~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 ---RMAQ----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---cCCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0000 111224688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=326.93 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=200.7
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|...+.||+|+||.||++... +++.||||++.... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999654 68999999987542 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++++|.+++... ..+++.....++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998543 46889999999999999999999976 999999999999999999999999999865433
Q ss_pred C---------------------------cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004402 591 V---------------------------DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG 643 (755)
Q Consensus 591 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~ 643 (755)
. .........||+.|+|||.+.+..++.++|||||||++|||++|+.|+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0012233568999999999999999999999999999999999999985433
Q ss_pred CCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 004402 644 TSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPS-MLEVSSM 707 (755)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~evl~~ 707 (755)
... .. ....... ..+.-+. .......+.+++..|++ ||++||+ +.|+++.
T Consensus 235 ~~~---~~----~~i~~~~-~~~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQE---TY----NKIINWK-ESLRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHH---HH----HHHhccC-CcccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 111 11 1111100 0000010 00123467789999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=309.55 Aligned_cols=258 Identities=26% Similarity=0.429 Sum_probs=203.2
Q ss_pred hcCCCccCcccccCCeeEEEEEcC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN 506 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 506 (755)
.++|...+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.++..++|||++++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 356788899999999999999653 24689999986553 33445788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCc-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEE
Q 004402 507 MLIYEYLPNKSLDLYLFDPIR-------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKIS 579 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~ 579 (755)
++||||+++|+|..++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999854321 234788999999999999999999876 9999999999999999999999
Q ss_pred ecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHh
Q 004402 580 DFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQW 658 (755)
Q Consensus 580 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 658 (755)
|||+++.+.............++..|+|||.+.++.++.++|||||||++|||+| |..|+...... .... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~----~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLK----FV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHH----HH
Confidence 9999986544322222233456788999999988889999999999999999998 77776432211 1111 11
Q ss_pred ccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 659 KDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 659 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
....... ... .....+.+++.+||+.+|++|||+.++++.|++
T Consensus 235 ~~~~~~~-----~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGHLD-----LPE----NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCCCC-----CCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111111 111 123478899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=313.58 Aligned_cols=263 Identities=22% Similarity=0.298 Sum_probs=195.1
Q ss_pred hcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.++|+..+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367888999999999999999754 689999999875432 223467889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+. ++|.+++... ...++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 5776666432 235788899999999999999999987 9999999999999999999999999997543221
Q ss_pred cccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC--------
Q 004402 592 DEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK-------- 662 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 662 (755)
.......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||..... ....+...........
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchh
Confidence 11223467899999998865 4589999999999999999999999864322 1111111111111000
Q ss_pred -CccccCCCCC--CCCCH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 663 -GKEFIDPSLD--DSSSP-------CKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 663 -~~~~~d~~l~--~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
...+...... ..... .....+.+++..|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000 00000 01235678999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.14 Aligned_cols=251 Identities=21% Similarity=0.304 Sum_probs=196.2
Q ss_pred CCCccCcccccCCeeEEEEEc----CCCCEEEEEEeccC----ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCcc
Q 004402 436 NFSSANKLGEGGFGPVYKGNL----PRGQEFAVKRLSAT----STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDEN 506 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 506 (755)
+|+..+.||+|+||.||+++. .+++.||+|++... .....+.+..|+.++..+ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999854 35889999998653 223345688899999999 599999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
++||||+++|+|.+++.. +..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999988853 345889999999999999999999986 99999999999999999999999999986
Q ss_pred cccCCcccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcc
Q 004402 587 FRKDVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665 (755)
Q Consensus 587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (755)
+..... .......||+.|+|||.+.+. .++.++|||||||++|||+||+.|+............ ......
T Consensus 155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~---~~~~~~----- 225 (332)
T cd05614 155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV---SRRILK----- 225 (332)
T ss_pred ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH---HHHHhc-----
Confidence 543222 122245789999999998765 4789999999999999999999998644332221111 111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004402 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRP-----SMLEVSS 706 (755)
Q Consensus 666 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 706 (755)
.++.+... ....+.+++.+||+.||++|| +++++++
T Consensus 226 -~~~~~~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 -CDPPFPSF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -CCCCCCCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11111111 223678899999999999999 6677764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=306.69 Aligned_cols=259 Identities=20% Similarity=0.345 Sum_probs=204.6
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||+|+||.||+|.. .+++.||||.+... .......+.+|+++++.++|||++++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4788889999999999999965 46899999987542 3344557899999999999999999999999888999999
Q ss_pred eecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 511 EYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
||+++|+|.+++.... ....++......++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998875322 2345788999999999999999999886 99999999999999999999999999986543
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...... ...... .+
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~----~~~~~~-----~~ 226 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQ----KIEQCD-----YP 226 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHH----HHhcCC-----CC
Confidence 221 112345788999999998888999999999999999999999987432211 111111 111100 01
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
.. ........+.+++.+||+.+|++||++.++++.|++.
T Consensus 227 ~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 PL---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CC---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11 1112334688999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=313.87 Aligned_cols=260 Identities=27% Similarity=0.447 Sum_probs=201.3
Q ss_pred HhcCCCccCcccccCCeeEEEEEcC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE 505 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 505 (755)
..++|+..+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.++++++||||+++++++.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4568889999999999999999542 24589999886543 2334568899999999999999999999999899
Q ss_pred cEEEEeecCCCChhhhhcCCCc-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEE
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIR-------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI 578 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl 578 (755)
.++||||+++|+|.+++..... ....++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999854211 234567788999999999999999886 999999999999999999999
Q ss_pred EecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHH
Q 004402 579 SDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQ 657 (755)
Q Consensus 579 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 657 (755)
+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..|+...... .....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~~---- 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLKF---- 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----
Confidence 99999986543322222222345678999999999999999999999999999998 56666422111 11111
Q ss_pred hccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 658 WKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 658 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
........ ... .....+.+++.+||+.+|++|||+.++++.|++.
T Consensus 234 ~~~~~~~~-----~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 234 VMDGGYLD-----QPD----NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHcCCCCC-----CCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11111000 111 1234788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=305.57 Aligned_cols=254 Identities=27% Similarity=0.385 Sum_probs=191.7
Q ss_pred CcccccCCeeEEEEEcCC---CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCC
Q 004402 441 NKLGEGGFGPVYKGNLPR---GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK 516 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 516 (755)
+.||+|+||.||+|...+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999996533 4579999987653 233457889999999999999999999999988999999999999
Q ss_pred ChhhhhcCCCc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc
Q 004402 517 SLDLYLFDPIR--RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 517 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 594 (755)
+|.+++..... ....++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999864321 234567788899999999999999986 9999999999999999999999999997543322222
Q ss_pred ccccccccCCccccccccCC-------CCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccc
Q 004402 595 NTGRIVGTYGYVPPEYVKKG-------IYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~-------~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (755)
......++..|+|||++... .++.++||||||+++|||++ |+.|+....... ..... .......+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYT----VREQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH----hhcccCCC
Confidence 22234567889999988642 35789999999999999996 888885432221 11111 11111222
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 004402 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709 (755)
Q Consensus 667 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 709 (755)
.++.+.... ...+.+++..|| .+|++|||+.||+..|+
T Consensus 231 ~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 223222222 225677889999 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=306.19 Aligned_cols=253 Identities=26% Similarity=0.442 Sum_probs=200.6
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecC
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 514 (755)
++|+..+.||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46778899999999999999888888999999876433 3467899999999999999999999875 456899999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 594 (755)
+++|.+++... ....+++..+..++.+++.||.|||+.+ ++||||||+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05070 84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence 99999998643 2335789999999999999999999986 999999999999999999999999999865432211
Q ss_pred ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
......++..|+|||.+....++.++||||||+++|||++ |..|+..... ...... +.... ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~----~~~~~-----~~---- 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQ----VERGY-----RM---- 222 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH----HHcCC-----CC----
Confidence 1112234668999999988889999999999999999999 7777743221 111111 11110 00
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
..+......+.+++.+||+.+|++|||+.++.++|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111223468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=301.59 Aligned_cols=248 Identities=24% Similarity=0.394 Sum_probs=207.7
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
..+|++.+.||+|.||.|-++.. ..|+.||||.+++.. ++..-.+.+|+++|+.|+||||+.++.+|++.+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45788899999999999999954 679999999998763 44455689999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||..+|.|.+|+. .+..+++.+..+++.||..|+.|.|.+. ++|||||.+|||||.|+++||+|||++.++..
T Consensus 132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999995 4556999999999999999999999986 99999999999999999999999999987654
Q ss_pred CCcccccccccccCCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
. .....++|++-|.+||++.+..| .+.+|-|||||+||-|+-|..||+..+. .. ..+++..+. +..
T Consensus 206 ~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~----lvrQIs~Ga---YrE 272 (668)
T KOG0611|consen 206 K---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KR----LVRQISRGA---YRE 272 (668)
T ss_pred c---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HH----HHHHhhccc---ccC
Confidence 3 23346799999999999999988 5899999999999999999999854332 11 222223222 222
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSML 708 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 708 (755)
| ..+....-|+.+||..||++|-|+.+|....
T Consensus 273 P--------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 P--------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred C--------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 2 2223456789999999999999999998754
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=306.06 Aligned_cols=254 Identities=26% Similarity=0.351 Sum_probs=189.0
Q ss_pred CcccccCCeeEEEEEcCC---CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCC
Q 004402 441 NKLGEGGFGPVYKGNLPR---GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK 516 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 516 (755)
+.||+|+||.||+|...+ ...+|+|.+.... ......|.+|+..++.++||||+++++.|......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999996433 4578999876543 334567889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc
Q 004402 517 SLDLYLFDPIR--RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 517 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 594 (755)
+|.+++..... ....++.....++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865332 233567888999999999999999986 9999999999999999999999999987543222111
Q ss_pred ccccccccCCccccccccC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccc
Q 004402 595 NTGRIVGTYGYVPPEYVKK-------GIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~-------~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (755)
......++..|+|||++.. ..++.++|||||||++|||++ |..|+..... ....... .......+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~----~~~~~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD---EQVLKQV----VREQDIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHH----hhccCccC
Confidence 1223345678999998743 456889999999999999999 5666643211 1111111 11111222
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 004402 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709 (755)
Q Consensus 667 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 709 (755)
.++.+... ....+.+++..|| .||++|||+++|+++|.
T Consensus 231 ~~~~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 23322222 2235667888898 59999999999999883
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=306.16 Aligned_cols=253 Identities=25% Similarity=0.413 Sum_probs=200.0
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecC
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 514 (755)
++|...++||+|+||.||+|...++..||+|+++.... ..+.+.+|++++.+++||||+++++++. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 46888899999999999999877777899999875432 3467899999999999999999999875 456899999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 594 (755)
+|+|.+++... ....+++..+..++.++++||+|||+.+ ++||||||+||++++++.+||+|||.++.+......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 99999998543 2235789999999999999999999986 999999999999999999999999999865433221
Q ss_pred ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
......++..|+|||.+.+..++.++|||||||++|||+| |..|+...... ... ....... ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~----~~~~~~~-----~~---- 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVL----DQVERGY-----RM---- 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHH----HHHhcCC-----CC----
Confidence 1223345678999999988899999999999999999999 66666432211 111 1111110 00
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
......+..+.+++.+|++.+|++||++.+++++|++
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1112234568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=320.08 Aligned_cols=244 Identities=23% Similarity=0.331 Sum_probs=199.9
Q ss_pred HHhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCcc
Q 004402 432 AATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDEN 506 (755)
Q Consensus 432 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 506 (755)
..-++|...++||+|+||+|+++.. .+++.+|||.+++.. .+..+..+.|-.++... +||.+++++.++...+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 3457899999999999999999965 458899999998763 34567788888888877 599999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
++||||+.+|++..+. ....+++..+.-++..|+.||+|||+++ ||+||||-+|||||.+|.+||+|||+++.
T Consensus 445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999953332 3456899999999999999999999997 99999999999999999999999999985
Q ss_pred cccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccc
Q 004402 587 FRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666 (755)
Q Consensus 587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (755)
... ....++.++||+.|||||++.+..|+.++|.|||||+||||+.|..||+..+.++..+.+ ..
T Consensus 518 ~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI-------~~------ 582 (694)
T KOG0694|consen 518 GMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI-------VN------ 582 (694)
T ss_pred cCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------hc------
Confidence 332 233567799999999999999999999999999999999999999999654433221111 00
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 004402 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSM 701 (755)
Q Consensus 667 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 701 (755)
-++. ++.-...+...++.+.+..+|++|-.+
T Consensus 583 d~~~----yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 DEVR----YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCC----CCCcccHHHHHHHHHHhccCcccccCC
Confidence 1111 222334467789999999999999766
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=323.07 Aligned_cols=245 Identities=19% Similarity=0.249 Sum_probs=197.0
Q ss_pred cCCCccCcccccCCeeEEEEEcCC--CCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPR--GQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
++|...+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468888999999999999996433 368999998653 223456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||+++|+|.+++.. ...+++.....++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999998853 235888999999999999999999987 99999999999999999999999999986532
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.|+..... .... ........
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~~~----~~i~~~~~------ 245 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP---LLIY----QKILEGII------ 245 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH---HHHH----HHHhcCCC------
Confidence 2 2235789999999999988899999999999999999999999853221 1111 11111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRP-----SMLEVSSM 707 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 707 (755)
.+... ....+.+++.+|++.||++|+ +++++++.
T Consensus 246 ~~p~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 YFPKF----LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCC----CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01111 123577899999999999995 88888764
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=326.25 Aligned_cols=252 Identities=22% Similarity=0.318 Sum_probs=196.2
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||+|+||.||++.. .+++.||||++.... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4688899999999999999965 468999999997542 233456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999853 335889999999999999999999987 999999999999999999999999998754321
Q ss_pred Cccc------------------------------------ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc
Q 004402 591 VDEA------------------------------------NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS 634 (755)
Q Consensus 591 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt 634 (755)
.... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112468999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 004402 635 SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPS---MLEVSS 706 (755)
Q Consensus 635 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~evl~ 706 (755)
|..|+..... ........ .+. ..+..+ . .......+.+++.+|+. +|.+|++ +.|+++
T Consensus 235 G~~Pf~~~~~---~~~~~~i~-~~~----~~~~~~---~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNP---QETYRKII-NWK----ETLQFP---D--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCH---HHHHHHHH-cCC----CccCCC---C--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999853321 11111111 000 000000 0 00112356788888986 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=306.75 Aligned_cols=251 Identities=21% Similarity=0.317 Sum_probs=196.9
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
++|+..+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|++++.+++|||++++++++...+..++|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3567788999999999999954 56899999998654 334456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++++|..+. .+++.....++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999996543 3678888999999999999999986 999999999999999999999999999865332
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
......++..|+|||.+.+..++.++|||||||++|||++|+.|+....................... .+.+.
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 221 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVLP 221 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCCC
Confidence 12234688999999999998999999999999999999999999854322211111111111111111 11111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
. ......+.+++.+||+.+|++||++.|+++.
T Consensus 222 ~---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 V---GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred C---CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1 1122367899999999999999999998864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=316.58 Aligned_cols=241 Identities=23% Similarity=0.311 Sum_probs=191.4
Q ss_pred CcccccCCeeEEEEEc----CCCCEEEEEEeccCC----hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 441 NKLGEGGFGPVYKGNL----PRGQEFAVKRLSATS----TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
+.||+|+||.||++.. ..++.||||++.... ......+.+|+.+|+.++||||+++++++...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999964 357899999986532 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++++|.+++.. ...+.+.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 999999988843 335778888899999999999999987 9999999999999999999999999987532221
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.|+...... .. ........ ..+.
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~---~~----~~~~~~~~------~~~~ 220 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---KT----IDKILKGK------LNLP 220 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH---HH----HHHHHcCC------CCCC
Confidence 1122356899999999999888999999999999999999999998542211 11 11111111 0111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRP-----SMLEVSS 706 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 706 (755)
. .....+.+++.+||+.+|++|| ++.++++
T Consensus 221 ~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 221 P----YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred C----CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1 1223678999999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=323.60 Aligned_cols=253 Identities=20% Similarity=0.274 Sum_probs=193.6
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.|+..+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 577889999999999999954 568899999996542 2345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++|+|.+++.. ...+++.....++.||+.||.|||..+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999998853 235788889999999999999999986 9999999999999999999999999986432100
Q ss_pred c---------------------------------------------ccccccccccCCccccccccCCCCCchhhHHHHH
Q 004402 592 D---------------------------------------------EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFG 626 (755)
Q Consensus 592 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~G 626 (755)
. .......+||+.|+|||.+.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001234799999999999988999999999999
Q ss_pred HHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHH--cccCCCCCCCCHHHH
Q 004402 627 VLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALL--CVQENPEDRPSMLEV 704 (755)
Q Consensus 627 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPt~~ev 704 (755)
|++|||++|+.||........ .... ........ ... .......+.+++.+ |+..+|..||++.|+
T Consensus 236 ~il~elltG~~Pf~~~~~~~~---~~~i---~~~~~~~~-----~~~--~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTET---QLKV---INWENTLH-----IPP--QVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHH---HHHH---HccccccC-----CCC--CCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 999999999999854322110 0000 00000000 000 00112355677766 666777779999999
Q ss_pred HHH
Q 004402 705 SSM 707 (755)
Q Consensus 705 l~~ 707 (755)
++.
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.67 Aligned_cols=260 Identities=28% Similarity=0.419 Sum_probs=199.3
Q ss_pred hcCCCccCcccccCCeeEEEEEc------CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecC-C
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER-D 504 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~ 504 (755)
.++|...+.||+|+||.||+|.. ..++.||||+++... ......+.+|+.++.++ +||||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788899999999999999952 357899999997643 33456788999999999 789999999988654 4
Q ss_pred ccEEEEeecCCCChhhhhcCCCc---------------------------------------------------------
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPIR--------------------------------------------------------- 527 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 527 (755)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999998853210
Q ss_pred -------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccccccccc
Q 004402 528 -------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600 (755)
Q Consensus 528 -------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 600 (755)
...+++.....++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 123678888999999999999999986 9999999999999999999999999998654332222222334
Q ss_pred ccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHH
Q 004402 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCK 679 (755)
Q Consensus 601 gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 679 (755)
++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ... .......... .... .
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~~~~~~~-----~~~~----~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----RRLKEGTRMR-----APDY----T 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHH----HHHhccCCCC-----CCCC----C
Confidence 5678999999988899999999999999999997 777764322111 111 1111111100 0111 1
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 680 LLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 680 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
...+.+++..||+.+|++|||+.||++.|+..
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 23578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=305.30 Aligned_cols=246 Identities=25% Similarity=0.374 Sum_probs=193.5
Q ss_pred cccccCCeeEEEEEc---CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCC
Q 004402 442 KLGEGGFGPVYKGNL---PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK 516 (755)
Q Consensus 442 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 516 (755)
.||+|+||.||+|.+ .+++.+|+|+++... ....+.+.+|+.++..++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999953 357899999986543 334567899999999999999999999885 45678999999999
Q ss_pred ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc-
Q 004402 517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN- 595 (755)
Q Consensus 517 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~- 595 (755)
+|.+++.. ...+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99998843 235889999999999999999999886 99999999999999999999999999987644322111
Q ss_pred cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS 674 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 674 (755)
.....++..|+|||.+....++.++|||||||++|||++ |+.|+...... ... .....+.. +....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~----~~i~~~~~-----~~~~~- 221 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVT----QMIESGER-----MECPQ- 221 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHCCCC-----CCCCC-
Confidence 112234578999999988889999999999999999998 88887543221 111 11111111 11111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 675 SSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 675 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
.....+.+++.+||+.||++||++.+|.+.|++
T Consensus 222 ---~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 222 ---RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ---CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 123467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=310.57 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=197.8
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
+|+..+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 477789999999999999965 468999999986542 2223457889999999999999999999999899999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++|+|..++... ....+++.....++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999887532 2345889999999999999999999986 9999999999999999999999999998653221
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
......|+..|+|||.+.+..++.++|||||||++|||++|+.|+.......... ..........
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~--------- 221 (285)
T cd05605 157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE---EVERRVKEDQ--------- 221 (285)
T ss_pred ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH---HHHHHhhhcc---------
Confidence 1123468899999999998899999999999999999999999986432211111 1111111000
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRP-----SMLEVSS 706 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 706 (755)
..........+.+++..||+.||++|| ++.++++
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 -EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred -cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 011112334678999999999999999 7888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.20 Aligned_cols=258 Identities=25% Similarity=0.420 Sum_probs=201.7
Q ss_pred hcCCCccCcccccCCeeEEEEEcC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN 506 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 506 (755)
.++|+..+.||+|+||.||++... ++..||+|++.... ......+.+|+.++++++|||++++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888999999999999999643 46789999987653 34456799999999999999999999999998999
Q ss_pred EEEEeecCCCChhhhhcCCC-------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCC
Q 004402 507 MLIYEYLPNKSLDLYLFDPI-------------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASN 567 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~N 567 (755)
++++||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999985321 1234788899999999999999999886 9999999999
Q ss_pred EEEcCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 004402 568 ILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSE 646 (755)
Q Consensus 568 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~ 646 (755)
|++++++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..|+.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999986543322111222234667999999998899999999999999999998 6666532111
Q ss_pred ccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 647 NLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
... ........... .+......+.+++.+||+.+|++|||+.|+++.|++
T Consensus 239 -~~~----~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 -EEV----IYYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -HHH----HHHHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111 11111111110 011223478899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=309.55 Aligned_cols=256 Identities=23% Similarity=0.388 Sum_probs=199.1
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCC----EEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQ----EFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
++|+..+.||+|+||+||+|.. .+++ .||+|++... .....+.+.+|+.++..++||||++++++|.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 4677889999999999999964 3454 4899998754 33345678899999999999999999999975 45789
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
++||+++|+|.+++... ...+++...+.++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 ~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 99999999999998543 235889999999999999999999986 9999999999999999999999999998764
Q ss_pred cCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
............++..|+|||.+.+..++.++|||||||++|||++ |..|+...... ..... +......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~~~--- 230 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDL----LEKGERL--- 230 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----HHCCCcC---
Confidence 3322211222234678999999998899999999999999999998 77776432211 11111 1111000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
.. .......+.+++.+||+.||++||++.++++.|+...
T Consensus 231 --~~----~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 231 --PQ----PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred --CC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 00 1122346789999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=314.25 Aligned_cols=244 Identities=23% Similarity=0.334 Sum_probs=190.3
Q ss_pred CCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHH---hcCCCCceeeeeeeeecCCccEEE
Q 004402 437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLT---ARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
|+..+.||+|+||.||++.. .+++.||||++.... ....+.+..|..++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 45678999999999999965 468999999997542 22344566665554 567899999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||+++|+|..++. ...+++.....++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988774 235899999999999999999999986 99999999999999999999999999875322
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
. ........|++.|+|||.+.+..++.++|||||||++|||++|+.|+...... ... ....... .
T Consensus 154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~~~----~~i~~~~------~ 218 (324)
T cd05589 154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---EVF----DSIVNDE------V 218 (324)
T ss_pred C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCC------C
Confidence 1 11223457899999999999999999999999999999999999998533211 111 1111111 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRP-----SMLEVSS 706 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 706 (755)
.... .....+.+++.+||+.||++|| ++.++++
T Consensus 219 ~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 RYPR----FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCC----CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1111 1234678999999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.89 Aligned_cols=259 Identities=26% Similarity=0.392 Sum_probs=199.8
Q ss_pred cCCCccCcccccCCeeEEEEEcCC-CC--EEEEEEeccC-ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPR-GQ--EFAVKRLSAT-STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 509 (755)
++|+..+.||+|+||.||+|...+ +. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467888999999999999997643 33 5788888753 334456789999999999 799999999999998899999
Q ss_pred EeecCCCChhhhhcCCC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCe
Q 004402 510 YEYLPNKSLDLYLFDPI-------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP 576 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~ 576 (755)
+||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985422 1135888999999999999999999876 9999999999999999999
Q ss_pred EEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHH
Q 004402 577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAF 655 (755)
Q Consensus 577 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 655 (755)
||+|||++....... .......+..|+|||.+....++.++|||||||++|||++ |..|+...... .. .
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~----~ 228 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---EL----Y 228 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH----H
Confidence 999999986432111 1111223557999999998899999999999999999998 88887432211 11 1
Q ss_pred HHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccc
Q 004402 656 EQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAI 715 (755)
Q Consensus 656 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 715 (755)
....... .... +......+.+++.+||+.+|.+|||+.++++.|++.....
T Consensus 229 ~~~~~~~-----~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 229 EKLPQGY-----RMEK----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHhcCC-----CCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111110 0011 1112346789999999999999999999999998765443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=302.44 Aligned_cols=259 Identities=21% Similarity=0.357 Sum_probs=206.2
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+|++++++++...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888899999999999999765 7999999988643 2334567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 511 EYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
||+++++|..++.... ....+++.++..++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999998885422 2345889999999999999999999986 99999999999999999999999999876543
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
... ......++..|+|||.+.+..++.++|||||||++|||++|+.|+..... .... ......... ..+
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~-~~~~~~~~~----~~~ 227 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYS-LCKKIEKCD----YPP 227 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHH-HHhhhhcCC----CCC
Confidence 221 11234578899999999988899999999999999999999988743221 1111 111111111 111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
. ........+.+++.+||+.+|++|||+.+|+++|++.
T Consensus 228 -~---~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 -L---PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -C---ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1 1112334678999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=322.30 Aligned_cols=201 Identities=23% Similarity=0.358 Sum_probs=172.6
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||+|+||+||++.. .+++.||||++.... ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4688899999999999999954 468999999997542 233456888999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|+|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999853 345889999999999999999999986 999999999999999999999999999754321
Q ss_pred Ccc---------------------------------cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCC
Q 004402 591 VDE---------------------------------ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637 (755)
Q Consensus 591 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~ 637 (755)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCCC
Q 004402 638 NARY 641 (755)
Q Consensus 638 p~~~ 641 (755)
||..
T Consensus 235 Pf~~ 238 (363)
T cd05628 235 PFCS 238 (363)
T ss_pred CCCC
Confidence 9853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=299.51 Aligned_cols=264 Identities=23% Similarity=0.335 Sum_probs=199.1
Q ss_pred cCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccCChh--hHHHHHHHHHHHhcCCCCc-eeeeeeeeecCC------
Q 004402 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQ--GLEEFKNEVSLTARLQHVN-LLRVLGYCTERD------ 504 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------ 504 (755)
..|+..++||+|+||+||+|. ..+|+.||+|+++....+ .-....+|+.+|+.++|+| |+.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 345667889999999999995 456899999999776442 2345689999999999999 999999998877
Q ss_pred ccEEEEeecCCCChhhhhcCCCcc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCC
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPIRR-YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM 583 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl 583 (755)
.+++|+||+.. +|..++...... ..++...+..++.||++||+|||+++ |+||||||+||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 78899999955 888888543321 34677889999999999999999987 99999999999999999999999999
Q ss_pred ccccccCCcccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
|+.+.-... ..+..++|..|.|||++.+. .|+...||||+|||+.||++++.-|+.... .+.+....+.+....
T Consensus 167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTPN 241 (323)
T ss_pred HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCCC
Confidence 996543222 23445789999999998776 799999999999999999998877754333 222333333322211
Q ss_pred Cc------cccCC--CCCCCC-----C---HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 663 GK------EFIDP--SLDDSS-----S---PCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 663 ~~------~~~d~--~l~~~~-----~---~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
.. .+.+- ...... . +.......+++.+|++.+|.+|.|++.+++.
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 10 01110 000000 0 0111256789999999999999999999875
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=307.57 Aligned_cols=246 Identities=22% Similarity=0.326 Sum_probs=193.0
Q ss_pred ccccCCeeEEEEEc-CCCCEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCCCh
Q 004402 443 LGEGGFGPVYKGNL-PRGQEFAVKRLSATST---QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL 518 (755)
Q Consensus 443 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 518 (755)
||+|+||+||++.. .+++.||+|.+..... ...+.+..|+.+++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999965 4689999999865422 2345678899999999999999999999998899999999999999
Q ss_pred hhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccccc
Q 004402 519 DLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597 (755)
Q Consensus 519 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 597 (755)
..++.... ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 88875422 2346899999999999999999999986 99999999999999999999999999976543222 222
Q ss_pred cccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCH
Q 004402 598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSP 677 (755)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 677 (755)
...||+.|+|||.+.+..++.++|||||||++|||++|+.|+.......... ...... ..... ..+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~---~~~~~~--------~~~~~--~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK---ELKQRI--------LNDSV--TYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH---HHHHhh--------cccCC--CCcc
Confidence 3568999999999999999999999999999999999999986433221110 011110 00000 0111
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004402 678 CKLLNCMQVALLCVQENPEDRP-----SMLEVSS 706 (755)
Q Consensus 678 ~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 706 (755)
.....+.+++.+||+.||++|| +++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 2334678999999999999999 6677774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.75 Aligned_cols=260 Identities=24% Similarity=0.346 Sum_probs=202.6
Q ss_pred hcCCCccCcccccCCeeEEEEEc--------CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecC
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL--------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER 503 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 503 (755)
.++|...+.||+|+||.||++.. .++..||+|.+.... ....+.+.+|+.++..+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 45677889999999999999953 124579999986542 34456789999999999 899999999999999
Q ss_pred CccEEEEeecCCCChhhhhcCCCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE
Q 004402 504 DENMLIYEYLPNKSLDLYLFDPIR-------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL 570 (755)
Q Consensus 504 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll 570 (755)
...+++|||+++|+|..++..... ...+++.++..++.||+.||.|||+.+ ++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999864321 235788899999999999999999986 9999999999999
Q ss_pred cCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccc
Q 004402 571 DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLN 649 (755)
Q Consensus 571 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~ 649 (755)
++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~ 247 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EE 247 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HH
Confidence 9999999999999987644322222223345678999999998889999999999999999998 6666532211 11
Q ss_pred hHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 650 FLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
............ ........+.+++.+||+.+|++|||+.|+++.|++..
T Consensus 248 ----~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 248 ----LFKLLKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred ----HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 111111111100 01122346888999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=320.18 Aligned_cols=252 Identities=19% Similarity=0.271 Sum_probs=197.5
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|...+.||+|+||.||++.. .+|+.||+|+++... .+..+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688889999999999999964 468999999997542 234456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998543 235889999999999999999999987 999999999999999999999999999865433
Q ss_pred CcccccccccccCCcccccccc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCc
Q 004402 591 VDEANTGRIVGTYGYVPPEYVK------KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (755)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.|+....... ..... .......
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~i---~~~~~~~ 228 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK---TYNNI---MNFQRFL 228 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH---HHHHH---HcCCCcc
Confidence 221 222346899999999986 4567899999999999999999999985322111 11111 0111000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 665 EFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 665 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+. ........+.+++..|++ +|++|||+.++++
T Consensus 229 ~~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 KFP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 110 011123467789999997 9999999999884
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=305.75 Aligned_cols=256 Identities=27% Similarity=0.470 Sum_probs=201.3
Q ss_pred cCCCccCcccccCCeeEEEEEcCC-C---CEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPR-G---QEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
++|+..+.||+|+||.||+|.... + ..+|+|.+... .....+.+.+|++++.+++|||++++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467788999999999999997642 3 37999998765 334456789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||+++++|.+++... ...+++.++..++.+++.|+.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999998542 245889999999999999999999986 99999999999999999999999999986543
Q ss_pred CCccccc-ccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 590 DVDEANT-GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 590 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
....... .....+..|+|||.+....++.++|||||||++|||++ |+.|+...... . ....+.... .
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~----~~~~i~~~~----~ 228 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---E----VMKAINDGF----R 228 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---H----HHHHHhcCC----C
Confidence 2221111 11223457999999998889999999999999999997 88887432211 1 111111110 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
.+ ........+.+++.+||+.+|++||++.+|++.|++.
T Consensus 229 ~~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 LP-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01 1112234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=304.12 Aligned_cols=248 Identities=24% Similarity=0.368 Sum_probs=193.0
Q ss_pred cccccCCeeEEEEEcC---CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCCC
Q 004402 442 KLGEGGFGPVYKGNLP---RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKS 517 (755)
Q Consensus 442 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 517 (755)
.||+|+||.||+|.+. .+..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999653 35579999987653 334567999999999999999999999885 457899999999999
Q ss_pred hhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc-c
Q 004402 518 LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN-T 596 (755)
Q Consensus 518 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~ 596 (755)
|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++........... .
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99988532 346899999999999999999999986 99999999999999999999999999986543322111 1
Q ss_pred ccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCC
Q 004402 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSS 675 (755)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 675 (755)
....++..|+|||.+....++.++|||||||++|||++ |..|+...... ... ........ + ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~~~~~-----~----~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVM----SFIEQGKR-----L----DC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHH----HHHHCCCC-----C----CC
Confidence 11233578999999988889999999999999999996 88887432211 111 11111110 0 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 676 SPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 676 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
+.....++.+++.+||+.+|++||++.+|.+.|+..
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 112334788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=316.56 Aligned_cols=248 Identities=21% Similarity=0.334 Sum_probs=194.0
Q ss_pred CcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEEEeecCC
Q 004402 441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
++||+|+||.||++.. .+++.||+|+++.. .....+.+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999965 46889999999754 233445688899999988 799999999999999999999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
|+|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~ 152 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence 999888743 345899999999999999999999986 999999999999999999999999998742211 112
Q ss_pred cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc--ccchHHHHHHHhccCCCccccCCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE--NLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+...+... ......+.......... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p~ 226 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIPR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCCC
Confidence 234578999999999999999999999999999999999999996543322 11111122221111110 1111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCC------HHHHHH
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPS------MLEVSS 706 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt------~~evl~ 706 (755)
. ....+.+++.+||+.||++||+ +.++++
T Consensus 227 ~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 227 S----LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred C----CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1 2236789999999999999997 567663
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=316.39 Aligned_cols=243 Identities=21% Similarity=0.340 Sum_probs=190.1
Q ss_pred CcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEEEeecCC
Q 004402 441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
+.||+|+||.||++.. .+++.||+|++... .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999965 45889999998754 233445678899888877 899999999999999999999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
|+|..++.. ...+++.....++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 999888743 345889999999999999999999986 9999999999999999999999999997532211 12
Q ss_pred cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcc--cchHHHHHHHhccCCCccccCCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN--LNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+...+.... .....+.......... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~p~ 226 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RIPR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CCCC
Confidence 2345789999999999999999999999999999999999999864332221 1111222222111111 1111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSM 701 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 701 (755)
.....+.+++.+||+.||++||+.
T Consensus 227 ----~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 227 ----SLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ----CCCHHHHHHHHHHhcCCHHHcCCC
Confidence 122367799999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.92 Aligned_cols=243 Identities=21% Similarity=0.262 Sum_probs=192.2
Q ss_pred CcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCC
Q 004402 441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK 516 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 516 (755)
+.||+|+||.||++.. .+|+.||+|++... .......+..|++++..++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999964 56899999998754 2233456788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccccc
Q 004402 517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596 (755)
Q Consensus 517 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 596 (755)
+|..++.. ...+++..+..++.||+.||.|||+.. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~--~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 153 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATM 153 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--ccc
Confidence 99888743 335889999999999999999999732 39999999999999999999999999987533221 112
Q ss_pred ccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCC
Q 004402 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSS 676 (755)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 676 (755)
....||+.|+|||.+.+..++.++|||||||++|||++|+.|+....... ... ...... ..+...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---~~~----~i~~~~------~~~p~~-- 218 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFE----LILMEE------IRFPRT-- 218 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---HHH----HHhcCC------CCCCCC--
Confidence 23568999999999999999999999999999999999999985322111 111 111000 011111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 004402 677 PCKLLNCMQVALLCVQENPEDRP-----SMLEVSSM 707 (755)
Q Consensus 677 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 707 (755)
....+.+++.+||+.||++|+ ++.++++.
T Consensus 219 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 --LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred --CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 223678999999999999996 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=305.28 Aligned_cols=259 Identities=21% Similarity=0.345 Sum_probs=204.7
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
.+|+..+.||+|+||.||++.. .+++.+|||.+... .......+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3577788999999999999964 57899999987653 2334467899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 511 EYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
||+++++|.+++.... ....+++...+.++.+|+.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999885322 2346899999999999999999999986 99999999999999999999999999886543
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
... ......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ...... ... ....+
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~----~~~-----~~~~~ 226 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK----KIE-----QCDYP 226 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhh----hhh-----cCCCC
Confidence 221 112346788999999999888999999999999999999999987432211 111111 111 00111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
.. ........+.+++.+||+.+|++|||+.+|++.+++.
T Consensus 227 ~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 PL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11 1112334688999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=313.70 Aligned_cols=259 Identities=26% Similarity=0.354 Sum_probs=200.9
Q ss_pred cCCCccCcccccCCeeEEEEEcC--------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCC
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP--------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERD 504 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 504 (755)
++|...+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++.++ +||||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56888899999999999998542 23579999987642 34456788999999999 7999999999999999
Q ss_pred ccEEEEeecCCCChhhhhcCCCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPIR-------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD 571 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~ 571 (755)
..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+.+ ++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 99999999999999999864321 235889999999999999999999876 99999999999999
Q ss_pred CCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccch
Q 004402 572 NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNF 650 (755)
Q Consensus 572 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~ 650 (755)
.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+..... ..
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---~~- 250 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EE- 250 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---HH-
Confidence 999999999999976543211111112234568999999998889999999999999999998 7777642211 11
Q ss_pred HHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 651 LEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 651 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
........... ..+......+.+++.+||+.+|++|||+.++++.|++..
T Consensus 251 ---~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 251 ---LFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred ---HHHHHHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 11111111100 011122346788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=305.94 Aligned_cols=248 Identities=20% Similarity=0.331 Sum_probs=191.6
Q ss_pred ccccCCeeEEEEEc-CCCCEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCCCh
Q 004402 443 LGEGGFGPVYKGNL-PRGQEFAVKRLSATST---QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL 518 (755)
Q Consensus 443 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 518 (755)
||+|+||.||++.. .+|+.||+|++..... .....+..|++++.+++||||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999965 4589999999864321 1234556799999999999999999999999999999999999999
Q ss_pred hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccccccc
Q 004402 519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598 (755)
Q Consensus 519 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 598 (755)
..++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 8887543 2334888999999999999999999986 9999999999999999999999999998654322 1123
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHH
Q 004402 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPC 678 (755)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 678 (755)
..|+..|+|||++.+..++.++|||||||++|||++|+.|+......... .... ....... +.. . ...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~-~~~~~~~----~~~--~---~~~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELK-RRTLEDE----VKF--E---HQN 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHH-HHhhccc----ccc--c---ccc
Confidence 46889999999999888999999999999999999999998543221111 1111 1101100 000 0 011
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 004402 679 KLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709 (755)
Q Consensus 679 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 709 (755)
....+.+++..||+.||++||+++|+++.+.
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 2336789999999999999999987764443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=303.49 Aligned_cols=260 Identities=22% Similarity=0.309 Sum_probs=190.5
Q ss_pred CCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC-----ccEEE
Q 004402 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD-----ENMLI 509 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lv 509 (755)
.|...+++|.|+||.||+|.+. +++.||||++-....- -.+|+++|+++.|||||+++-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4556789999999999999764 4799999998554321 146999999999999999998875432 24689
Q ss_pred EeecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC-CCeEEEecCCcccc
Q 004402 510 YEYLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMAKLF 587 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~-~~~kl~Dfgla~~~ 587 (755)
||||+. +|...+... ..+..++...+.-+..||.+||+|||+.+ |+||||||.|+|+|.+ +.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999988 777776532 12345777778889999999999999966 9999999999999987 89999999999987
Q ss_pred ccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC----
Q 004402 588 RKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK---- 662 (755)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 662 (755)
...... . ....|..|.|||.+.+ ..|+.+.||||.||++.||+-|+.-|......+....+-........++
T Consensus 177 ~~~epn--i-SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKGEPN--I-SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccCCCc--e-eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 654333 2 2355889999998876 5799999999999999999999988865333332222211111100000
Q ss_pred ---CccccCCCCCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 663 ---GKEFIDPSLDDS-----SSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 663 ---~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
-.+.-.+.+... .......+.++++.+|++.+|.+|.++.|++.
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 011111222111 12223446789999999999999999999883
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=300.26 Aligned_cols=247 Identities=27% Similarity=0.393 Sum_probs=196.0
Q ss_pred CcccccCCeeEEEEEcCCCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCCChh
Q 004402 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLD 519 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 519 (755)
++||+|+||.||+|...+++.+|+|.+..... .....+.+|++++.+++|||++++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46999999999999888899999999876543 33457889999999999999999999999999999999999999999
Q ss_pred hhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccccccc
Q 004402 520 LYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI 599 (755)
Q Consensus 520 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 599 (755)
+++... ...+++..+..++.+++.+|.|||+.+ ++||||||+||+++.++.+||+|||++......... .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 988542 235789999999999999999999886 999999999999999999999999999754332211 11112
Q ss_pred cccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHH
Q 004402 600 VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPC 678 (755)
Q Consensus 600 ~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 678 (755)
.++..|+|||++....++.++||||||+++||+++ |..|+...... ... ........ .. ....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~----~~~~~~~~-----~~----~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAR----EQVEKGYR-----MS----CPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHH----HHHHcCCC-----CC----CCCC
Confidence 34567999999998899999999999999999998 88777432111 111 11111110 00 1112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 004402 679 KLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709 (755)
Q Consensus 679 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 709 (755)
....+.+++.+||+.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2347889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=302.29 Aligned_cols=249 Identities=29% Similarity=0.430 Sum_probs=201.5
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecC
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 514 (755)
++|+..+.||.|+||.||++.. .|+.||+|.+..... ..+.+.+|+.++.+++|+|++++++++......++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 4677889999999999999986 589999999976654 45788999999999999999999999998889999999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 594 (755)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 999999985432 235899999999999999999999987 99999999999999999999999999986532211
Q ss_pred ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
....+..|+|||.+..+.++.++||||||+++|||++ |+.|+...... ... ....... .....
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~----~~~~~~~-----~~~~~- 221 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV----PHVEKGY-----RMEAP- 221 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHH----HHHhcCC-----CCCCc-
Confidence 2234568999999998899999999999999999997 88776432211 111 1111110 00111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
...+..+.+++.+||+.+|++|||+.|++++|++
T Consensus 222 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 222 ---EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ---cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1123467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=301.50 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=199.5
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecC
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 514 (755)
++|...+.||+|++|.||++....+..+|+|.+.... ...+.+.+|+.++++++|||++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4577788999999999999988777789999886543 23467889999999999999999999875 456899999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 594 (755)
+++|.+++... ....+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 99999998643 2335789999999999999999999886 999999999999999999999999999865432211
Q ss_pred ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
......++..|+|||.+.+..++.++|||||||++|||+| |+.|+...... ..... ..... ..
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~-----~~---- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQ----VERGY-----RM---- 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCC-----CC----
Confidence 1112345678999999998899999999999999999999 77777432211 11111 11110 00
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
..+...+..+.+++.+||+.+|++||++++++++|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111233568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=337.65 Aligned_cols=260 Identities=23% Similarity=0.301 Sum_probs=201.2
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..++||+|+||.||+|.. .+|+.||+|++.... ....++|.+|++++++++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4788899999999999999965 458999999987542 233567999999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCc--------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecC
Q 004402 511 EYLPNKSLDLYLFDPIR--------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG 582 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg 582 (755)
||+++|+|.+++..... ...+++...+.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998853211 223567788999999999999999986 9999999999999999999999999
Q ss_pred CccccccCCc----------------ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 004402 583 MAKLFRKDVD----------------EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646 (755)
Q Consensus 583 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~ 646 (755)
+++....... .......+||+.|||||.+.+..++.++|||||||++|||+||+.|+.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 011123578999999999999999999999999999999999999985422111
Q ss_pred ccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhcC
Q 004402 647 NLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRP-SMLEVSSMLKDD 711 (755)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~ 711 (755)
. . ... ...++.-. ......+..+.+++.+|++.||++|| +++++.+.|+..
T Consensus 239 i---~---~~~-------~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 I---S---YRD-------VILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred h---h---hhh-------hccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 0 000 00011000 00112234678899999999999995 677788877654
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=311.52 Aligned_cols=242 Identities=23% Similarity=0.315 Sum_probs=191.4
Q ss_pred CcccccCCeeEEEEEcC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEEEeecCC
Q 004402 441 NKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT---STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
++||+|+||.||+|... +++.||||++... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999654 5889999998754 233445677888888866 899999999999999999999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 999888743 335888999999999999999999987 9999999999999999999999999987543221 12
Q ss_pred cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSS 675 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 675 (755)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+...... .... ...... .. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~----~i~~~~---~~---~p~-- 217 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFE----SILHDD---VL---YPV-- 217 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHH----HHHcCC---CC---CCC--
Confidence 23456899999999999999999999999999999999999998543211 1111 111111 00 111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHHH
Q 004402 676 SPCKLLNCMQVALLCVQENPEDRP-------SMLEVSSM 707 (755)
Q Consensus 676 ~~~~~~~l~~l~~~Cl~~dP~~RP-------t~~evl~~ 707 (755)
.....+.+++..||+.||++|| ++.++++.
T Consensus 218 --~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 --WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred --CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1123678999999999999999 77777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=304.00 Aligned_cols=254 Identities=22% Similarity=0.354 Sum_probs=199.2
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
++|+..+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++.+++||||+++++++...+..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688889999999999999975 568899999997655445567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++..+.....
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 89 GGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 99999998853 235789999999999999999999886 99999999999999999999999999986543211
Q ss_pred cccccccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
......++..|+|||.+. ...++.++|||||||++|||++|+.|+.......... ..... .+..+.
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~---~~~~~~ 230 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKS---NFQPPK 230 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecC---CCCCCC
Confidence 122346788999999874 4457889999999999999999998874222111000 00000 011111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSML 708 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 708 (755)
... .......+.+++.+||+.+|++|||++++++.|
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred Ccc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 111 111234788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=315.15 Aligned_cols=259 Identities=25% Similarity=0.352 Sum_probs=201.0
Q ss_pred cCCCccCcccccCCeeEEEEEcC--------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCC
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP--------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERD 504 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 504 (755)
.+|...+.||+|+||.||++... .+..||+|.+.... ....+.+.+|++++.++ +||||++++++|....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46788899999999999999531 12378999887543 34457899999999999 8999999999999988
Q ss_pred ccEEEEeecCCCChhhhhcCCC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPI-------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD 571 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~ 571 (755)
..++++||+++|+|.+++.... ....+++.++..++.|++.||.|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999985421 2235788999999999999999999986 99999999999999
Q ss_pred CCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccch
Q 004402 572 NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNF 650 (755)
Q Consensus 572 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~ 650 (755)
.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+..... ..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~- 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---EE- 244 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH---HH-
Confidence 999999999999986543221111222234567999999999999999999999999999998 6766643211 11
Q ss_pred HHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 651 LEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 651 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
............ . .......+.+++.+||+.+|++|||+.|+++.|++..
T Consensus 245 ---~~~~~~~~~~~~-----~----~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 245 ---LFKLLKEGHRMD-----K----PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred ---HHHHHHcCCCCC-----C----CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 111111111111 0 1122346789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=312.73 Aligned_cols=260 Identities=23% Similarity=0.357 Sum_probs=201.2
Q ss_pred cCCCccCcccccCCeeEEEEEc--------CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCC
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL--------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERD 504 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 504 (755)
++|...+.||+|+||.||++.. .....+|+|.++... ......+.+|+.++.++ +||||++++++|....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 4677889999999999999953 124579999987543 34456788999999999 6999999999999888
Q ss_pred ccEEEEeecCCCChhhhhcCCC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPI-------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD 571 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~ 571 (755)
..++++||+++|+|.+++.... ....+++.+...++.|++.||.|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 8999999999999999985422 1235889999999999999999999876 99999999999999
Q ss_pred CCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccch
Q 004402 572 NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNF 650 (755)
Q Consensus 572 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~ 650 (755)
.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+..... ...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~~ 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---EEL 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---HHH
Confidence 999999999999986543222111112234567999999998899999999999999999999 7777632211 111
Q ss_pred HHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 651 LEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 651 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
.. ......... . .......+.+++.+||+.+|++|||+.|+++.|++...
T Consensus 246 ~~----~~~~~~~~~-----~----~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 246 FK----LLREGHRMD-----K----PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HH----HHHcCCCCC-----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11 111111101 1 11223467799999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=303.35 Aligned_cols=254 Identities=29% Similarity=0.461 Sum_probs=201.9
Q ss_pred hcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
.++|...++||+|+||.||++...+++.||+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 456788899999999999999988899999999875543 3467899999999999999999999874 45789999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++++|.+++.... ...+++.+...++.+++.||.|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999885432 345889999999999999999999876 999999999999999999999999999865422211
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
......++..|+|||.+....++.++||||||++++||++ |+.|+...... .... ....... ....
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~~-----~~~~ 225 (260)
T cd05067 159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQ----NLERGYR-----MPRP 225 (260)
T ss_pred -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHH----HHHcCCC-----CCCC
Confidence 1122345678999999998889999999999999999999 88887532211 1111 1111100 0111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
. .....+.+++.+||+.+|++||+++++++.|++
T Consensus 226 ~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 D----NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred C----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1 123468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=301.89 Aligned_cols=240 Identities=22% Similarity=0.317 Sum_probs=186.9
Q ss_pred CcccccCCeeEEEEEcCC-------------CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccE
Q 004402 441 NKLGEGGFGPVYKGNLPR-------------GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM 507 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 507 (755)
+.||+|+||.||+|.... ...|++|.+..........|.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999996432 2358999887665555668899999999999999999999999988999
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC-------eEEEe
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN-------PKISD 580 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~-------~kl~D 580 (755)
++|||+++|+|+.++... ...+++..+..++.||++||+|||+.+ ++||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999887532 335889999999999999999999986 999999999999987664 89999
Q ss_pred cCCccccccCCcccccccccccCCcccccccc-CCCCCchhhHHHHHHHHHHHH-cCCCCCCCCCCCcccchHHHHHHHh
Q 004402 581 FGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK-KGIYSMKYDVYSFGVLLLQII-SSKRNARYYGTSENLNFLEYAFEQW 658 (755)
Q Consensus 581 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDVwS~Gvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~ 658 (755)
||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+....... ... .
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~~~---~- 221 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE----KER---F- 221 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH----HHH---H-
Confidence 9998754321 1235678899999886 567899999999999999998 4666653221110 000 0
Q ss_pred ccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 004402 659 KDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709 (755)
Q Consensus 659 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 709 (755)
..... . ... .....+.+++.+||+.||++||++.+|++.|+
T Consensus 222 ~~~~~-~-----~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 222 YEGQC-M-----LVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HhcCc-c-----CCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00000 0 001 11246789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=302.42 Aligned_cols=255 Identities=28% Similarity=0.452 Sum_probs=203.9
Q ss_pred hcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
.++|...+.||+|+||.||++..++++.||||.+..... ..+.+.+|+.++++++|+|++++++++......+++|||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 467888899999999999999887888999999875433 3467899999999999999999999999888999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++++|.+++.... ...+++..+..++.+++.|+.|||+.+ ++|+||||+||++++++.+||+|||++..+......
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999986532 245899999999999999999999987 999999999999999999999999999866432111
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
......++..|+|||.+.+..++.++|||||||+++||++ |+.|+..... ....... .... ....
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~----~~~~-----~~~~- 225 (261)
T cd05034 160 -AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQV----ERGY-----RMPR- 225 (261)
T ss_pred -hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcCC-----CCCC-
Confidence 1112234568999999998889999999999999999998 8888743211 1111111 1110 0000
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
+...+..+.+++.+|++.+|++||+++++.+.|++
T Consensus 226 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 ---PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11123468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=313.59 Aligned_cols=241 Identities=22% Similarity=0.288 Sum_probs=190.4
Q ss_pred CCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEEE
Q 004402 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 510 (755)
+|...+.||+|+||.||++... +++.||||++.... ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4777899999999999999654 57899999987542 22344567788888777 6899999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999888743 235888999999999999999999986 999999999999999999999999999753321
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
. .......||+.|+|||++.+..++.++|||||||++|||+||+.|+..... ....... .... ..
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i----~~~~------~~ 219 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSI----MEHN------VA 219 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHHH----HhCC------CC
Confidence 1 122345789999999999999999999999999999999999999854321 1111111 1111 01
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSM 701 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 701 (755)
+.. .....+.+++.+|++.||++|++.
T Consensus 220 ~p~----~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 YPK----SMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCC----cCCHHHHHHHHHHcccCHHhcCCC
Confidence 111 123467899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=309.35 Aligned_cols=261 Identities=22% Similarity=0.306 Sum_probs=199.0
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
++|+..+.||+|+||.||++.. .++..+|+|.+... .....+.+.+|++++.+++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3688899999999999999965 45888999988654 333456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++++|.+++... ..+++.....++.|+++||.|||+.+ +++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 9999999998532 45788999999999999999999843 4999999999999999999999999998754322
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC---------
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG--------- 663 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 663 (755)
......++..|+|||.+.+..++.++|||||||++|||++|+.|+........................
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 122346789999999998888999999999999999999999987532211110000000000000000
Q ss_pred ------------cccc---CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 664 ------------KEFI---DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 664 ------------~~~~---d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
.... .+.+. .......+.+++.+||+.+|++|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLP---SGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCc---CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00000 00123457899999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=305.27 Aligned_cols=255 Identities=24% Similarity=0.415 Sum_probs=199.2
Q ss_pred CCCccCcccccCCeeEEEEEcCC-C---CEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 436 NFSSANKLGEGGFGPVYKGNLPR-G---QEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
+|...+.||+|+||.||+|.... + ..||||.+... .......|..|+.++++++||||+++++++.+....++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46678899999999999996543 3 36999998765 3445678999999999999999999999999989999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++++|.+++... ...+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999998543 335889999999999999999999986 999999999999999999999999999865432
Q ss_pred Ccccccc-ccc--ccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccc
Q 004402 591 VDEANTG-RIV--GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666 (755)
Q Consensus 591 ~~~~~~~-~~~--gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (755)
....... ... .+..|+|||.+.+..++.++|||||||++||+++ |..|+..... ....... .... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i----~~~~--~- 229 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAI----EQDY--R- 229 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHH----HcCC--c-
Confidence 2211111 111 2357999999999999999999999999999886 8887743221 1111111 1100 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 667 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
. ....+.+..+.+++.+||+.+|++||++.++++.|++.
T Consensus 230 --~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 --L----PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --C----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00112234678999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.66 Aligned_cols=254 Identities=21% Similarity=0.267 Sum_probs=197.6
Q ss_pred HhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
..++|+..+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 356788899999999999999965 46889999998643 22233457889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
||||+++|+|..++.. ..++......++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998843 24778888899999999999999986 9999999999999999999999999998654
Q ss_pred cCCcccccccccccCCccccccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCc
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKG----IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (755)
.... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||....... . ...+.....
T Consensus 194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~----~~~i~~~~~- 264 (370)
T cd05596 194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---T----YSKIMDHKN- 264 (370)
T ss_pred CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH---H----HHHHHcCCC-
Confidence 3211 122345789999999998653 47899999999999999999999985432211 1 111111100
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 004402 665 EFIDPSLDDSSSPCKLLNCMQVALLCVQENPED--RPSMLEVSSM 707 (755)
Q Consensus 665 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 707 (755)
.+ .... .......+.+++.+|++.+|++ ||++.|+++.
T Consensus 265 ~~---~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 SL---TFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred cC---CCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00 0111 1112346788999999999988 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=303.08 Aligned_cols=258 Identities=24% Similarity=0.384 Sum_probs=199.8
Q ss_pred HHHHhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 430 IKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 430 l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
++.+++++.....||+|+||.||+|.. .++..||+|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 344566777778999999999999964 4578899999887766667789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC-CCCeEEEecCCcccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-ELNPKISDFGMAKLF 587 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~-~~~~kl~Dfgla~~~ 587 (755)
++||+++++|.+++.........++..+..++.||+.||+|||+.+ ++||||||+||+++. ++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 9999999999999864322212377888899999999999999876 999999999999986 679999999999765
Q ss_pred ccCCcccccccccccCCccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcc
Q 004402 588 RKDVDEANTGRIVGTYGYVPPEYVKKGI--YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665 (755)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (755)
..... ......++..|+|||.+.... ++.++||||||+++|||++|+.|+......... .+......
T Consensus 160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~~------ 228 (268)
T cd06624 160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMFK------ 228 (268)
T ss_pred ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhhhc------
Confidence 32211 122235788999999986643 789999999999999999999887532221100 00000000
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 666 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..+.+. ......+.+++.+||+.+|++|||+.|+++
T Consensus 229 -~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 -IHPEIP----ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -cCCCCC----cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 011111 122346789999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=298.47 Aligned_cols=250 Identities=32% Similarity=0.478 Sum_probs=201.0
Q ss_pred CcccccCCeeEEEEEcCC----CCEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCC
Q 004402 441 NKLGEGGFGPVYKGNLPR----GQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
+.||+|+||.||++.... +..|++|.+...... ..+.+.+|++.+..++|+|++++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999996643 789999999766443 367899999999999999999999999998899999999999
Q ss_pred CChhhhhcCCCc------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 516 KSLDLYLFDPIR------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 516 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
++|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865421 256899999999999999999999976 99999999999999999999999999987654
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
...........++..|+|||.+....++.++|||||||+++||++ |..|+..... ... ..........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~----~~~~~~~~~~---- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEV----LEYLRKGYRL---- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHH----HHHHHcCCCC----
Confidence 332222334467889999999988899999999999999999999 5777754311 111 1111111100
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 709 (755)
.. +......+.+++.+||+.+|++|||+.|+++.|+
T Consensus 227 -~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -PK----PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -CC----CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01 1112347889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=301.51 Aligned_cols=249 Identities=26% Similarity=0.399 Sum_probs=197.6
Q ss_pred CcccccCCeeEEEEEcCC--C--CEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCC
Q 004402 441 NKLGEGGFGPVYKGNLPR--G--QEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
+.||+|++|.||+|.+.+ + ..||||.+..... ...+.+.+|+.++++++||||+++++.+.. ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999996533 3 3699999987655 566789999999999999999999999988 889999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc-
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA- 594 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 594 (755)
++|.+++.+... ..+++...+.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999865432 46899999999999999999999986 9999999999999999999999999998765432211
Q ss_pred ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
......++..|+|||.+....++.++|||||||++|||++ |+.|+..... ......... .. ....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~---~~--~~~~------ 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG---SQILKKIDK---EG--ERLE------ 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHh---cC--CcCC------
Confidence 1123456788999999998899999999999999999999 8888742211 111111110 00 0000
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 709 (755)
.+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01122346889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=327.98 Aligned_cols=258 Identities=19% Similarity=0.266 Sum_probs=187.9
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--------C
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--------D 504 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~ 504 (755)
.++|...+.||+|+||.||+|.. .+++.||||++.... ....+|+.+|+.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 46799999999999999999965 468999999885432 2345799999999999999998876432 1
Q ss_pred ccEEEEeecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC-CeEEEecC
Q 004402 505 ENMLIYEYLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDFG 582 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~-~~kl~Dfg 582 (755)
..++||||+++ +|..++... .....+++.....++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 35689999985 565555321 23456889999999999999999999987 99999999999999765 69999999
Q ss_pred CccccccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccC
Q 004402 583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDS 661 (755)
Q Consensus 583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 661 (755)
+++.+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||......+. +..........
T Consensus 217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~---~~~i~~~~~~p 290 (440)
T PTZ00036 217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ---LVRIIQVLGTP 290 (440)
T ss_pred cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCC
Confidence 998654322 1223467899999998865 4689999999999999999999988854322211 11111111100
Q ss_pred C----------CccccCCC-----CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004402 662 K----------GKEFIDPS-----LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVS 705 (755)
Q Consensus 662 ~----------~~~~~d~~-----l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 705 (755)
. ..++.-+. +....+......+.+++.+||+.||++|||+.|++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0 00000000 00001111234678999999999999999999998
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=299.66 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=198.5
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC-----hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-----TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
++|...+.||+|++|.||++.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5788899999999999999964 468999999986442 1234568899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
++||+++++|.+++.. ...+++.....++.+++.||.|||+.+ ++||||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999988743 235788899999999999999999987 9999999999999999999999999997653
Q ss_pred cCCcccc-cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 589 KDVDEAN-TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 589 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~---~~~~~~~~~----- 224 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA---MAA---IFKIATQPT----- 224 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch---HHH---HHHHhccCC-----
Confidence 3211111 1234577899999999998899999999999999999999988743211 111 111111110
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
.+.+.. .....+.+++.+||+.+|++|||+.++++.
T Consensus 225 ~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 NPQLPS----HVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCc----cCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 011111 223367889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=307.56 Aligned_cols=249 Identities=24% Similarity=0.353 Sum_probs=200.7
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
.+|+..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|||++++++++......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4778889999999999999964 568999999997765555678899999999999999999999999888999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 99999998842 34788999999999999999999986 99999999999999999999999999886433221
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
......+++.|+|||.+.+..++.++|||||||++|||++|+.||....... . ......... +.+.
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~----~~~~~~~~~------~~~~- 237 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--A----LYLIATNGT------PELQ- 237 (296)
T ss_pred -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--h----HHHHhcCCC------CCCC-
Confidence 1223467889999999998889999999999999999999999985322111 0 001111110 0000
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
........+.+++.+||+.+|++||++.|+++
T Consensus 238 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 238 -NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred -CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 11122346788999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=313.55 Aligned_cols=237 Identities=21% Similarity=0.282 Sum_probs=185.4
Q ss_pred CcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHH-HHhcCCCCceeeeeeeeecCCccEEEEeecCC
Q 004402 441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVS-LTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
+.||+|+||+||++.. .+|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999965 468999999986542 222334555554 56788999999999999999999999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
|+|..++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence 999888853 345788999999999999999999986 999999999999999999999999998753221 112
Q ss_pred cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSS 675 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 675 (755)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.|+..... ..... ...... ..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~----~i~~~~------~~~~~-- 217 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT---AEMYD----NILNKP------LRLKP-- 217 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH---HHHHH----HHHcCC------CCCCC--
Confidence 2345789999999999999999999999999999999999999853221 11111 111110 01111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHH
Q 004402 676 SPCKLLNCMQVALLCVQENPEDRPSML 702 (755)
Q Consensus 676 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 702 (755)
.....+.+++.+||+.||++||++.
T Consensus 218 --~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 --NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1234678999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=312.36 Aligned_cols=243 Identities=20% Similarity=0.309 Sum_probs=191.4
Q ss_pred CcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEEEeecCC
Q 004402 441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
+.||+|+||.||++.. .+++.||+|++... .....+.+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999965 45789999999754 233456688999999888 699999999999999999999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
|+|..++.. ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDT 152 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCc
Confidence 999888743 235899999999999999999999986 999999999999999999999999998753221 112
Q ss_pred cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSS 675 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 675 (755)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+........................ .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~p~-- 224 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RIPR-- 224 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CCCC--
Confidence 23457899999999999999999999999999999999999999654332222222222222211110 1111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCH
Q 004402 676 SPCKLLNCMQVALLCVQENPEDRPSM 701 (755)
Q Consensus 676 ~~~~~~~l~~l~~~Cl~~dP~~RPt~ 701 (755)
.....+.+++.+||+.||++||++
T Consensus 225 --~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 225 --FLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred --CCCHHHHHHHHHHhccCHHHcCCC
Confidence 122357789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=298.06 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=201.2
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
+|+..+.||+|++|.||++.. .+++.|++|.+... .....+.+.+|++++++++|||++++++++.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 466778999999999999965 46899999998643 344567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++++|.+++... ....+++..++.++.+++.||.|||+.+ ++|+||||+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998653 2346889999999999999999999876 99999999999999999999999999986543221
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
......+++.|+|||++.+..++.++|||||||++|||++|+.|+..... ...... ....... .+.
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~----~~~~~~~-----~~~ 222 (256)
T cd08529 157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALILK----IIRGVFP-----PVS 222 (256)
T ss_pred --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHH----HHcCCCC-----CCc
Confidence 12234678899999999999999999999999999999999999853321 111111 1111111 111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
. .....+.+++.+||+.+|++||++.++++.
T Consensus 223 ~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 223 Q----MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred c----ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1 223468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=319.35 Aligned_cols=260 Identities=20% Similarity=0.300 Sum_probs=194.2
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC-----ccE
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD-----ENM 507 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 507 (755)
+|+..+.||+|+||.||++.. .+++.||||++... .....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999965 56899999998653 2334567889999999999999999999998766 689
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
+|+||+. ++|..++.. ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 567666632 345889999999999999999999987 999999999999999999999999999865
Q ss_pred ccCCcccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC---
Q 004402 588 RKDVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG--- 663 (755)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 663 (755)
...... ......++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+ .........
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~~~g~~~~~~~ 229 (372)
T cd07853 154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI---TDLLGTPSLEAM 229 (372)
T ss_pred ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHH---HHHcCCCCHHHH
Confidence 432221 12234578899999998764 5799999999999999999999998643322111111 000000000
Q ss_pred ------------ccccC-CCCCC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 664 ------------KEFID-PSLDD--SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 664 ------------~~~~d-~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..... +.... .........+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00000 00000 001112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=314.99 Aligned_cols=241 Identities=23% Similarity=0.282 Sum_probs=190.3
Q ss_pred CCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCC-ceeeeeeeeecCCccEEEE
Q 004402 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHV-NLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~ 510 (755)
+|+..+.||+|+||.||+|... +++.||||++... .....+.+..|..++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999654 5789999998754 233456788899999999765 6888999998889999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999888843 235788999999999999999999986 999999999999999999999999998743221
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
. .......||+.|+|||++.+..++.++|||||||++|||+||+.|+..... ...... ..... ..
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~----i~~~~------~~ 219 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQS----IMEHN------VS 219 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHH----HHcCC------CC
Confidence 1 122345789999999999999999999999999999999999999853221 111111 11110 11
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSM 701 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 701 (755)
+... ....+.+++.+||+.||++||+.
T Consensus 220 ~~~~----~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 YPKS----LSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCC----CCHHHHHHHHHHhhcCHHHcCCC
Confidence 1111 22367789999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=323.38 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=194.0
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|...+.||+|+||.||++.. .+++.||||++... .....+.+.+|++++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688889999999999999954 56899999998653 2334567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|+|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999998853 235788889999999999999999987 999999999999999999999999999643211
Q ss_pred Ccc---------------------------------------------cccccccccCCccccccccCCCCCchhhHHHH
Q 004402 591 VDE---------------------------------------------ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSF 625 (755)
Q Consensus 591 ~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~ 625 (755)
... ......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 00012468999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCC---CCHH
Q 004402 626 GVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDR---PSML 702 (755)
Q Consensus 626 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Pt~~ 702 (755)
||++|||++|+.||...... ....... .+. ....+ + . .......+.+++.+|++ +|.+| |++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~---~~~~~i~-~~~--~~~~~--p---~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSH---ETYRKII-NWR--ETLYF--P---D--DIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHH---HHHHHHH-ccC--CccCC--C---C--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 99999999999998532211 1111110 000 00011 0 0 00112357789999997 66665 5999
Q ss_pred HHHHH
Q 004402 703 EVSSM 707 (755)
Q Consensus 703 evl~~ 707 (755)
|+++.
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 88864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=299.73 Aligned_cols=248 Identities=27% Similarity=0.431 Sum_probs=196.6
Q ss_pred CcccccCCeeEEEEEcCCCCEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCCChh
Q 004402 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLD 519 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 519 (755)
++||+|+||.||++...+++.||+|.+...... ....+.+|++++++++||||+++++++......++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999998766999999998765433 5568999999999999999999999999999999999999999999
Q ss_pred hhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccccccc
Q 004402 520 LYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI 599 (755)
Q Consensus 520 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 599 (755)
+++... ...+++.....++.+++.+|.|||+.+ ++||||+|+||+++.++.+||+|||++...............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 988542 235788999999999999999999987 999999999999999999999999999865422211111122
Q ss_pred cccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHH
Q 004402 600 VGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPC 678 (755)
Q Consensus 600 ~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 678 (755)
..+..|+|||.+.++.++.++|||||||+++||+| |..|+....... .. ....... .. . .+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~----~~~~~~~--~~---~----~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TR----ERIESGY--RM---P----APQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HH----HHHhcCC--CC---C----CCcc
Confidence 33567999999988899999999999999999999 676664332211 11 1111110 00 0 1112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 004402 679 KLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709 (755)
Q Consensus 679 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 709 (755)
.+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 2347889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=313.54 Aligned_cols=236 Identities=23% Similarity=0.347 Sum_probs=187.8
Q ss_pred CcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEEEeecCC
Q 004402 441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
+.||+|+||.||++.. .+++.||||++... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999965 45889999998653 223455677888888876 799999999999999999999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
|+|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 999988753 235889999999999999999999986 9999999999999999999999999987532211 12
Q ss_pred cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSS 675 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 675 (755)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.|+...... ... ..+.... .. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~----~~i~~~~---~~---~~~-- 217 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLF----EAILNDE---VV---YPT-- 217 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHH----HHHhcCC---CC---CCC--
Confidence 23457899999999999999999999999999999999999998543211 111 1111111 00 111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCH
Q 004402 676 SPCKLLNCMQVALLCVQENPEDRPSM 701 (755)
Q Consensus 676 ~~~~~~~l~~l~~~Cl~~dP~~RPt~ 701 (755)
.....+.+++.+||+.||++||++
T Consensus 218 --~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 218 --WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred --CCCHHHHHHHHHHcccCHHHCCCC
Confidence 122367899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=311.56 Aligned_cols=241 Identities=24% Similarity=0.345 Sum_probs=189.0
Q ss_pred CcccccCCeeEEEEEcC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEEEeecCC
Q 004402 441 NKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
+.||+|+||.||+|... +++.||||+++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999754 57899999987542 22345566777788764 899999999999999999999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
|+|..++.. ...+++.+...++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 999988843 235788999999999999999999986 9999999999999999999999999987532211 12
Q ss_pred cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSS 675 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 675 (755)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ..... ..... .+.....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~----~i~~~------~~~~~~~- 218 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQ----SIRMD------NPCYPRW- 218 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHH----HHHhC------CCCCCcc-
Confidence 2345689999999999999999999999999999999999999854321 11111 11111 1111111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 004402 676 SPCKLLNCMQVALLCVQENPEDRPSML-EVSS 706 (755)
Q Consensus 676 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl~ 706 (755)
....+.+++.+||+.||++||++. ++.+
T Consensus 219 ---~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 219 ---LTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ---CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 223577899999999999999997 5643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=316.75 Aligned_cols=244 Identities=28% Similarity=0.413 Sum_probs=196.7
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.|+.++.||.|+||.||-++. .+.+.||||...-+ ..+.+.++++|+.+|.+++|||++.+-|||......+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 466778899999999999954 56889999998655 34557789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|| -||-.+++. ..+.++.+.++..|..+.++||+|||+.+ .||||||+.||||++.|.|||+|||.+....+
T Consensus 107 YC-lGSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 107 YC-LGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HH-hccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 99 457666663 23456888899999999999999999987 99999999999999999999999999976533
Q ss_pred cccccccccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 592 DEANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
...++|||.|||||++. .+.|+-++||||||++..||.-.++|.- . ++...... .+... -.
T Consensus 179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF--n----MNAMSALY-HIAQN-----es 242 (948)
T KOG0577|consen 179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF--N----MNAMSALY-HIAQN-----ES 242 (948)
T ss_pred ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc--C----chHHHHHH-HHHhc-----CC
Confidence 23479999999999874 6889999999999999999998887641 1 11111100 00000 11
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
|.+. ..++...+++++..||++-|.+|||.+++++
T Consensus 243 PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 243 PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 2232 4466778899999999999999999988764
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=304.18 Aligned_cols=239 Identities=24% Similarity=0.350 Sum_probs=185.5
Q ss_pred cccccCCeeEEEEEcCC-------------------------CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeee
Q 004402 442 KLGEGGFGPVYKGNLPR-------------------------GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRV 496 (755)
Q Consensus 442 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 496 (755)
.||+|+||.||+|.+.. ...|++|++..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999996411 13589999876655555678899999999999999999
Q ss_pred eeeeecCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC--
Q 004402 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-- 574 (755)
Q Consensus 497 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~-- 574 (755)
+++|.+....++||||+++|+|..++... ...+++..+..++.||++||+|||+.+ ++||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999888542 335788999999999999999999876 99999999999997643
Q ss_pred -----CeEEEecCCccccccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHH-cCCCCCCCCCCCcc
Q 004402 575 -----NPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQII-SSKRNARYYGTSEN 647 (755)
Q Consensus 575 -----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~ell-tg~~p~~~~~~~~~ 647 (755)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.|+.......
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~- 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE- 229 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence 3799999998643221 12346788999998865 56899999999999999995 6887774332211
Q ss_pred cchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 004402 648 LNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709 (755)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 709 (755)
.... .. .. ..+.... ...+.+++.+||+.+|++|||+.++++.|+
T Consensus 230 --~~~~-~~---~~-------~~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 --KERF-YE---KK-------HRLPEPS----CKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HHHH-HH---hc-------cCCCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1111 10 00 0011111 125788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=308.03 Aligned_cols=263 Identities=25% Similarity=0.384 Sum_probs=200.3
Q ss_pred cCCCccCcccccCCeeEEEEEc-----CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--Ccc
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-----PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DEN 506 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 506 (755)
+.|...+.||+|+||.||++.. .++..||+|.++... ......+.+|+.++++++|||++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467789999999999999963 357899999987553 34456799999999999999999999998775 467
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
++||||+++++|.+++... ...+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998532 235899999999999999999999986 99999999999999999999999999986
Q ss_pred cccCCcc-cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------CcccchHHHHHHH
Q 004402 587 FRKDVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT--------SENLNFLEYAFEQ 657 (755)
Q Consensus 587 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~--------~~~~~~~~~~~~~ 657 (755)
+...... .......++..|+|||.+.+..++.++|||||||++|||+|++.|...... .............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433221 112234567789999999888899999999999999999998765321100 0000001111111
Q ss_pred hccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 658 WKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 658 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
....... .........+.+++.+||+.+|++|||+.++++.|++.
T Consensus 239 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111100 01112334788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=307.86 Aligned_cols=263 Identities=28% Similarity=0.406 Sum_probs=202.2
Q ss_pred cCCCccCcccccCCeeEEEEEcC-----CCCEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCceeeeeeeeec--CCcc
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-----RGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTE--RDEN 506 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 506 (755)
+.|...+.||+|+||.||++... .+..+|||.+...... ..+.|.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35666789999999999999643 3689999999766443 46789999999999999999999999877 5578
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
+++|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999998543 225899999999999999999999986 99999999999999999999999999987
Q ss_pred cccCCcccc-cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccc--------chHHHHHHH
Q 004402 587 FRKDVDEAN-TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL--------NFLEYAFEQ 657 (755)
Q Consensus 587 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~ 657 (755)
......... .....++..|+|||.+....++.++||||||++++||+||+.|+......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 653222111 11223456799999998889999999999999999999999886432211100 001111111
Q ss_pred hccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 658 WKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 658 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
.... ............+.+++.+||+.+|++|||+.||+++|+++
T Consensus 239 ~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEG---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcC---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1110 00011112235688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=302.77 Aligned_cols=256 Identities=26% Similarity=0.439 Sum_probs=200.8
Q ss_pred cCCCccCcccccCCeeEEEEEcC----CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP----RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
.+|...+.||+|+||.||+|... .+..+|+|.++... ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999653 23479999987543 33456889999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||+++++|.+++... ...+++.+...++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998543 235789999999999999999999986 99999999999999999999999999987643
Q ss_pred CCcccc-cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 590 DVDEAN-TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 590 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
...... .....++..|+|||.+.+..++.++|||||||++||+++ |..|+......+ ..... .... ..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~----~~~~--~~- 228 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAI----EEGY--RL- 228 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHH----hCCC--cC-
Confidence 322111 111223568999999998899999999999999999887 888874332211 11111 1110 00
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
+ . ....+..+.+++.+||+.+|++||++.++++.|++.
T Consensus 229 -~-~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 -P-A----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -C-C----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1 0 111234678999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.91 Aligned_cols=240 Identities=24% Similarity=0.362 Sum_probs=188.5
Q ss_pred CcccccCCeeEEEEEcC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEEEeecCC
Q 004402 441 NKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
+.||+|+||.||++... +|+.||+|+++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999654 58899999987542 22345567788787754 899999999999999999999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
|+|..++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCc
Confidence 999888743 335788999999999999999999986 999999999999999999999999998743211 112
Q ss_pred cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSS 675 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 675 (755)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+...... .. ....... .+.+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~----~~~~~~~------~~~~~~~- 218 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---EL----FESIRVD------TPHYPRW- 218 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HH----HHHHHhC------CCCCCCC-
Confidence 23457899999999999999999999999999999999999998532211 11 1111111 1111111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 004402 676 SPCKLLNCMQVALLCVQENPEDRPSML-EVS 705 (755)
Q Consensus 676 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl 705 (755)
....+.+++.+||+.||++||++. ++.
T Consensus 219 ---~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 ---ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ---CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 223677899999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=318.63 Aligned_cols=238 Identities=23% Similarity=0.277 Sum_probs=189.7
Q ss_pred CcccccCCeeEEEEEc----CCCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecC
Q 004402 441 NKLGEGGFGPVYKGNL----PRGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 514 (755)
+.||+|+||.||++.. .+|+.||+|++..... .....+..|++++.+++||||+++++++......++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999853 3588999999975422 233467789999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 594 (755)
+|+|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 9999988843 345899999999999999999999987 9999999999999999999999999998643321 1
Q ss_pred ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS 674 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 674 (755)
......||+.|+|||.+.+..++.++|||||||++|||++|+.|+..... ...... ...... .+..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~~~----i~~~~~------~~p~- 219 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---KETMTM----ILKAKL------GMPQ- 219 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---HHHHHH----HHcCCC------CCCC-
Confidence 22235789999999999988899999999999999999999999853221 111111 111110 0111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 004402 675 SSPCKLLNCMQVALLCVQENPEDRPSMLE 703 (755)
Q Consensus 675 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 703 (755)
.....+.+++.+||+.||++||++.+
T Consensus 220 ---~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 ---FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ---CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 12236778999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=323.46 Aligned_cols=200 Identities=24% Similarity=0.366 Sum_probs=170.3
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.|+..++||+|+||.||++.. .+++.||+|++.... ....+.+.+|++++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578889999999999999964 568899999986542 2335578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
||++|+|.+++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999998853 235788889999999999999999987 9999999999999999999999999976432100
Q ss_pred c---------------------------------------------ccccccccccCCccccccccCCCCCchhhHHHHH
Q 004402 592 D---------------------------------------------EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFG 626 (755)
Q Consensus 592 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~G 626 (755)
. .......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 0001134689999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCC
Q 004402 627 VLLLQIISSKRNARY 641 (755)
Q Consensus 627 vil~elltg~~p~~~ 641 (755)
|++|||++|+.||..
T Consensus 236 vil~elltG~~Pf~~ 250 (382)
T cd05625 236 VILYEMLVGQPPFLA 250 (382)
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999854
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=320.71 Aligned_cols=254 Identities=19% Similarity=0.266 Sum_probs=195.6
Q ss_pred HhcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
..++|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3568899999999999999999654 5889999998643 22234568899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
||||+++|+|.+++.. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 9999999999998843 24788889999999999999999986 9999999999999999999999999998654
Q ss_pred cCCcccccccccccCCccccccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCc
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKG----IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (755)
... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....... . ...+.....
T Consensus 194 ~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~---~----~~~i~~~~~- 264 (370)
T cd05621 194 ETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG---T----YSKIMDHKN- 264 (370)
T ss_pred cCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH---H----HHHHHhCCc-
Confidence 321 1122345789999999998654 37899999999999999999999985332111 1 111111100
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 004402 665 EFIDPSLDDSSSPCKLLNCMQVALLCVQENPED--RPSMLEVSSM 707 (755)
Q Consensus 665 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 707 (755)
.+ .+.. .......+.+++..|++.++.+ ||++.|+++.
T Consensus 265 ~~---~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 SL---NFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cc---CCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00 0001 1112335678888899865544 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=310.78 Aligned_cols=241 Identities=24% Similarity=0.325 Sum_probs=191.4
Q ss_pred CcccccCCeeEEEEEcC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEEEeecCC
Q 004402 441 NKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
+.||+|+||.||++... +++.||||+++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999654 58899999997542 23455677888998888 799999999999999999999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
|+|..++.. ...+++.....++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 999888743 235899999999999999999999986 9999999999999999999999999987532211 12
Q ss_pred cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSS 675 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 675 (755)
.....|++.|+|||++.+..++.++|||||||++|||++|+.|+..... ... ........ .....
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~----~~~i~~~~------~~~~~-- 217 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DEL----FQSILEDE------VRYPR-- 217 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHH----HHHHHcCC------CCCCC--
Confidence 2235689999999999999999999999999999999999999853221 111 11111111 01111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 004402 676 SPCKLLNCMQVALLCVQENPEDRPSM-----LEVSS 706 (755)
Q Consensus 676 ~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~ 706 (755)
.....+.+++.+||+.||++||++ .++++
T Consensus 218 --~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 218 --WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred --cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 122467899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=300.43 Aligned_cols=254 Identities=22% Similarity=0.340 Sum_probs=188.4
Q ss_pred CcccccCCeeEEEEEcCCC---CEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCC
Q 004402 441 NKLGEGGFGPVYKGNLPRG---QEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK 516 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 516 (755)
+.||+|+||.||+|...++ ..+++|.+.... ....+.|.+|+.+++.++||||+++++.|......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999964333 356777776543 344578999999999999999999999999988999999999999
Q ss_pred ChhhhhcCCCc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 517 SLDLYLFDPIR-RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 517 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
+|.+++..... ....++.....++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999865322 234566778899999999999999876 99999999999999999999999999864322111112
Q ss_pred cccccccCCccccccccC-------CCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 596 TGRIVGTYGYVPPEYVKK-------GIYSMKYDVYSFGVLLLQIISS-KRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~-------~~~s~~sDVwS~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
.....++..|+|||++.. ..++.++|||||||++|||+++ ..|+.... ......... .+....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~---~~~~~~~~~----~~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS---DREVLNHVI----KDQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH----hhcccccC
Confidence 223467889999998753 2457899999999999999975 44543211 111111111 11222333
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 709 (755)
++.+....+ ..+.+++..|| .+|++||++++|++.|.
T Consensus 231 ~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 444433322 35677888999 67999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.46 Aligned_cols=248 Identities=30% Similarity=0.450 Sum_probs=194.2
Q ss_pred CcccccCCeeEEEEEcC-C---CCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCC
Q 004402 441 NKLGEGGFGPVYKGNLP-R---GQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
++||+|+||.||+|... . +..+|+|.+..... ...+.+.+|+.+++.+.|||++++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999542 2 36899999876543 34567899999999999999999999876 4567999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
|+|.+++... ..+++..+..++.|++.+|.|||+.+ ++|+||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999998543 25889999999999999999999886 99999999999999999999999999987644322211
Q ss_pred -cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 596 -TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 596 -~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
.....++..|+|||.+.+..++.++|||||||++|||++ |..|+..... ....... ..... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~----~~~~~--~------- 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAML----ESGER--L------- 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHH----HcCCc--C-------
Confidence 111223567999999998999999999999999999998 8888753321 1111111 11110 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
.........+.+++.+||+.+|++||++.++++.|++.
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 01111234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=304.03 Aligned_cols=253 Identities=23% Similarity=0.363 Sum_probs=196.1
Q ss_pred HHhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecC------
Q 004402 432 AATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER------ 503 (755)
Q Consensus 432 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------ 503 (755)
.+++.|+..+.||+|+||.||+|.. .+++.||+|++.... .....+..|+.++.++ +|||++++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 4567788889999999999999965 458899999986543 3345788999999998 799999999998653
Q ss_pred CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCC
Q 004402 504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM 583 (755)
Q Consensus 504 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl 583 (755)
...+++|||+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 3578999999999999988542 2345889999999999999999999986 99999999999999999999999999
Q ss_pred ccccccCCcccccccccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHh
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQW 658 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 658 (755)
+....... .......|+..|+|||++. +..++.++|||||||++|||++|+.|+....... .. ....
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~-~~~~ 229 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----AL-FLIP 229 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HH-HHHh
Confidence 98653321 1223456889999999886 3457889999999999999999999885322111 00 0000
Q ss_pred ccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 659 KDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 659 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. ....... .......+.+++.+||+.+|++|||+.|+++
T Consensus 230 ~-~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 R-NPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred c-CCCCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1 1001111 1112236789999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=323.63 Aligned_cols=252 Identities=21% Similarity=0.305 Sum_probs=192.8
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
+|+..+.||+|+||.||+++. .+++.||||++.... ......+.+|++++.+++||||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 688899999999999999964 458999999986532 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++|+|.+++.. ...++......++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999853 335788888999999999999999987 9999999999999999999999999985331100
Q ss_pred -----------------------------------------cccccccccccCCccccccccCCCCCchhhHHHHHHHHH
Q 004402 592 -----------------------------------------DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLL 630 (755)
Q Consensus 592 -----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ 630 (755)
.........||+.|||||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000011347899999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC---CHHHHHHH
Q 004402 631 QIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRP---SMLEVSSM 707 (755)
Q Consensus 631 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---t~~evl~~ 707 (755)
||++|+.||........ .... ..+. .....+. .. .....+.+++.+|+ .+|++|+ ++.|+++.
T Consensus 236 ell~G~~Pf~~~~~~~~---~~~i-~~~~----~~~~~~~-~~----~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAET---QLKV-INWE----TTLHIPS-QA----KLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHH---HHHH-hccC----ccccCCC-CC----CCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999854322111 0000 0000 0000000 01 11234566777766 4999999 88888754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.88 Aligned_cols=250 Identities=22% Similarity=0.328 Sum_probs=196.3
Q ss_pred CCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
|+..+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+.++.+++|+|++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 66778999999999999955 468999999986542 22234678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 9999999888532 2235888999999999999999999876 9999999999999999999999999997643221
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
......|+..|+|||.+.+..++.++|||||||++|||++|+.|+.................... ....
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~---------~~~~ 225 (285)
T cd05630 157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ---------EEYS 225 (285)
T ss_pred --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh---------hhcC
Confidence 11234689999999999999999999999999999999999999864322111111111100000 0111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPS-----MLEVSS 706 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 706 (755)
. .....+.+++..||+.||++||| +.|+++
T Consensus 226 ~----~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 226 E----KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred c----cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1 12235789999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=293.89 Aligned_cols=272 Identities=21% Similarity=0.278 Sum_probs=213.8
Q ss_pred CCCccCcccccCCeeEEEEEcCC-CCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 436 NFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.|+.++.||.|.-|+||++.+.+ +..+|+|++.+.. .+...+.+.|-+||+.+.||.+..|+..++.+...|++||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 45567899999999999998755 5899999997763 3345567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
||++|+|..+++. +....+++..++..+..|..||+|||-++ ||.|||||+||||.++|++.|+||.|+..+....
T Consensus 158 yCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 158 YCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred cCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 9999999988754 34556899999999999999999999997 9999999999999999999999999876431100
Q ss_pred ---------------------------------c---------------------ccccccccccCCccccccccCCCCC
Q 004402 592 ---------------------------------D---------------------EANTGRIVGTYGYVPPEYVKKGIYS 617 (755)
Q Consensus 592 ---------------------------------~---------------------~~~~~~~~gt~~y~aPE~~~~~~~s 617 (755)
. ..++..++||..|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0112336899999999999999999
Q ss_pred chhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCC
Q 004402 618 MKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPED 697 (755)
Q Consensus 618 ~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~ 697 (755)
.++|.|+|||+||||+-|+.||...+..+... .++...+.-...+.....+.+|+...|.+||++
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~---------------NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR---------------NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHH---------------HHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 99999999999999999999997665543221 111111111112234567889999999999999
Q ss_pred CCC----HHHHHH--HhhcCcccc----CCCCCCccccC
Q 004402 698 RPS----MLEVSS--MLKDDSMAI----AAPKRPAFSAK 726 (755)
Q Consensus 698 RPt----~~evl~--~L~~~~~~~----~~p~~p~~~~~ 726 (755)
|-. +.||-+ +++++..++ .+|..|...-.
T Consensus 379 Rlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~ 417 (459)
T KOG0610|consen 379 RLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDG 417 (459)
T ss_pred hhccccchHHhhcCccccCCChhheeccCCCcCCCcccc
Confidence 987 777763 566665555 44444554333
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=300.91 Aligned_cols=249 Identities=27% Similarity=0.415 Sum_probs=192.5
Q ss_pred CcccccCCeeEEEEEcCC-CC--EEEEEEeccC-ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEEEeecCC
Q 004402 441 NKLGEGGFGPVYKGNLPR-GQ--EFAVKRLSAT-STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
+.||+|+||.||+|...+ +. .+++|.+... .....+.+.+|++++.++ +||||+++++++......+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999997643 43 5788888754 334456789999999999 899999999999999999999999999
Q ss_pred CChhhhhcCCC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecC
Q 004402 516 KSLDLYLFDPI-------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG 582 (755)
Q Consensus 516 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg 582 (755)
|+|.+++.... ....+++.++..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999985422 1234789999999999999999999876 9999999999999999999999999
Q ss_pred CccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccC
Q 004402 583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDS 661 (755)
Q Consensus 583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 661 (755)
++...... ........+..|+|||++....++.++|||||||++|||++ |..|+...... .. .......
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~----~~~~~~~ 227 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---EL----YEKLPQG 227 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HH----HHHHhCC
Confidence 98632211 11111233567999999988889999999999999999997 88887432111 11 1111111
Q ss_pred CCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 662 KGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 662 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
.. . .. .......+.+++.+||+.+|.+|||+.++++.|++.
T Consensus 228 ~~---~--~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 YR---L--EK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CC---C--CC----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 00 0 01 111223678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=319.39 Aligned_cols=194 Identities=22% Similarity=0.270 Sum_probs=165.3
Q ss_pred hcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
..+|...+.||+|+||.||++... .++.||||.... ..+.+|+++|++++|+||+++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457888899999999999999654 488999996432 3457899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+. ++|..++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 6887777432 235899999999999999999999986 99999999999999999999999999986543322
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNA 639 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~ 639 (755)
........||..|+|||++.+..++.++|||||||+||||++|..++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 22223457899999999999999999999999999999999987654
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.34 Aligned_cols=248 Identities=27% Similarity=0.381 Sum_probs=196.3
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeee-cCCccEEEEeec
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT-ERDENMLIYEYL 513 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lv~e~~ 513 (755)
++|...+.||+|+||.||++.. .|..||+|.++... ..+.+.+|+.++++++|+|++++++++. .....++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4677889999999999999976 58889999986543 2467899999999999999999999764 445689999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++++|.+++.... ...+++..++.++.+++.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999986432 335889999999999999999999886 9999999999999999999999999987543221
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
....++..|+|||.+....++.++|||||||++|||++ |+.|+..... ...... ..... .+...
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~----~~~~~-----~~~~~ 221 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPR----VEKGY-----KMDAP 221 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HhcCC-----CCCCC
Confidence 12234568999999998899999999999999999998 8877642211 111111 11111 01111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 222 ----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 222 ----DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred ----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1223467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=300.91 Aligned_cols=255 Identities=25% Similarity=0.414 Sum_probs=199.1
Q ss_pred CCCccCcccccCCeeEEEEEcCC--CCEEEEEEeccC----------ChhhHHHHHHHHHHHhc-CCCCceeeeeeeeec
Q 004402 436 NFSSANKLGEGGFGPVYKGNLPR--GQEFAVKRLSAT----------STQGLEEFKNEVSLTAR-LQHVNLLRVLGYCTE 502 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~ 502 (755)
+|+..+.||+|+||.||+|.... ++.+|+|.+... ......++..|+.++.+ ++|||++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 46778899999999999997654 788999987532 22334567788888875 799999999999999
Q ss_pred CCccEEEEeecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEec
Q 004402 503 RDENMLIYEYLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDF 581 (755)
Q Consensus 503 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Df 581 (755)
.+..+++|||+++++|.+++... .....+++..++.++.|++.+|.|||+.. +++|+||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999998887432 23346889999999999999999999633 4999999999999999999999999
Q ss_pred CCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccC
Q 004402 582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDS 661 (755)
Q Consensus 582 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 661 (755)
|++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ..... .....
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~---~~~~~----~~~~~ 228 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLAT----KIVEA 228 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH---HHHHH----HHhhc
Confidence 9998654332 22345678899999999988899999999999999999999988743211 11111 11111
Q ss_pred CCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 662 KGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 662 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
.. .+.... .....+.+++.+||+.||++||++.|+..++++
T Consensus 229 ~~----~~~~~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 229 VY----EPLPEG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred cC----CcCCcc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 11 110011 122467899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=298.97 Aligned_cols=251 Identities=24% Similarity=0.382 Sum_probs=190.4
Q ss_pred CcccccCCeeEEEEEcC----CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeec-CCccEEEEeecC
Q 004402 441 NKLGEGGFGPVYKGNLP----RGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE-RDENMLIYEYLP 514 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~~ 514 (755)
+.||+|+||.||+|... ....||+|++... .....+.+.+|+.+++.++|||++++++++.. ....++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999642 2457999998543 34456788999999999999999999998764 456899999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc-
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE- 593 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~- 593 (755)
+|+|.+++... ....++.....++.+++.||.|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998543 234677888899999999999999876 999999999999999999999999999855332111
Q ss_pred -cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 594 -ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 594 -~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
.......++..|+|||.+.+..++.++|||||||++|||++|+.|+-. ............ ... . +...
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~--~~~~~~~~~~~~----~~~--~---~~~~ 224 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP--DVDSFDITVYLL----QGR--R---LLQP 224 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHHh----cCC--C---CCCC
Confidence 111123456789999999888999999999999999999996554321 111111111111 110 0 0001
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
...+..+.+++.+||+.+|++||++.|+++.|++.
T Consensus 225 ----~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 225 ----EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred ----CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=313.30 Aligned_cols=240 Identities=20% Similarity=0.262 Sum_probs=186.8
Q ss_pred CcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHH-HHhcCCCCceeeeeeeeecCCccEEEEeecCC
Q 004402 441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVS-LTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
+.||+|+||+||++.. .+|+.||+|++... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999964 56899999998654 2223345555654 46778999999999999999999999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
|+|..++.. ...+++.....++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 152 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT 152 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence 999888743 345889999999999999999999986 9999999999999999999999999987532211 12
Q ss_pred cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSS 675 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 675 (755)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.|+...... .... ....... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~----~~~~~~~------~~~~-- 217 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---EMYD----NILHKPL------VLRP-- 217 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---HHHH----HHHcCCc------cCCC--
Confidence 23457899999999999999999999999999999999999998532211 1111 1111110 0111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004402 676 SPCKLLNCMQVALLCVQENPEDRPSMLEVS 705 (755)
Q Consensus 676 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 705 (755)
.....+.+++.+|++.+|++||++.+.+
T Consensus 218 --~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 218 --GASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred --CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 1223677899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=311.73 Aligned_cols=237 Identities=21% Similarity=0.284 Sum_probs=184.3
Q ss_pred CcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHH-HHhcCCCCceeeeeeeeecCCccEEEEeecCC
Q 004402 441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVS-LTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
++||+|+||.||++.. .+++.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999965 458899999986542 222344555554 67889999999999999999999999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
|+|..++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET 152 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence 999887743 345788888999999999999999886 999999999999999999999999998753221 112
Q ss_pred cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSS 675 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 675 (755)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.|+..... ..... ...... ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~----~i~~~~------~~~---- 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---SQMYD----NILHKP------LQL---- 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---HHHHH----HHhcCC------CCC----
Confidence 2345789999999999998999999999999999999999999853221 11111 111110 011
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHH
Q 004402 676 SPCKLLNCMQVALLCVQENPEDRPSML 702 (755)
Q Consensus 676 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 702 (755)
+......+.+++.+||+.||++||+..
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 112234678999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=308.45 Aligned_cols=257 Identities=26% Similarity=0.386 Sum_probs=198.0
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCC--EEEEEEeccC-ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQ--EFAVKRLSAT-STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 509 (755)
++|+..+.||+|+||.||+|... ++. .+|+|.+... .....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46777899999999999999753 454 4688877643 334456788999999999 899999999999999999999
Q ss_pred EeecCCCChhhhhcCCC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCe
Q 004402 510 YEYLPNKSLDLYLFDPI-------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP 576 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~ 576 (755)
+||+++++|.+++.... ....+++.+++.++.|++.|++|||+.+ ++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986432 1235789999999999999999999886 9999999999999999999
Q ss_pred EEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHH
Q 004402 577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAF 655 (755)
Q Consensus 577 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 655 (755)
||+|||++...... .......++..|+|||.+.+..++.++|||||||++|||+| |..|+...... ...
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~---- 233 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELY---- 233 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHH----
Confidence 99999998642211 11111234567999999988889999999999999999998 88887432211 111
Q ss_pred HHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 656 EQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 656 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
....... .... .......+.+++.+||+.+|++||++.++++.|++...
T Consensus 234 ~~~~~~~-----~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 234 EKLPQGY-----RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HHHhcCC-----cCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111110 0000 11122367899999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=301.03 Aligned_cols=257 Identities=25% Similarity=0.374 Sum_probs=201.1
Q ss_pred cCCCccCcccccCCeeEEEEEcC------CCCEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCceeeeeeeeecCCccE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM 507 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 507 (755)
++|+..+.||+|+||.||++... ..+.|++|.+.....+ ..+.+.+|++++++++|||++++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46788899999999999999753 3467999988765443 4578999999999999999999999999988999
Q ss_pred EEEeecCCCChhhhhcCCCcc------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEec
Q 004402 508 LIYEYLPNKSLDLYLFDPIRR------YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDF 581 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Df 581 (755)
+||||+++|+|.+++...... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998643321 25899999999999999999999887 999999999999999999999999
Q ss_pred CCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhcc
Q 004402 582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKD 660 (755)
Q Consensus 582 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 660 (755)
|++....... ........++..|+|||.+.+..++.++||||||++++||++ |..|+..... ..... ....
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~----~~~~ 233 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLN----RLQA 233 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHH----HHHc
Confidence 9987543221 112223356778999999988889999999999999999999 6666632211 11111 1111
Q ss_pred CCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 661 SKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 661 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
..... .. ....+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 234 ~~~~~----~~----~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 234 GKLEL----PV----PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCcCC----CC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 11110 00 11223478899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.36 Aligned_cols=251 Identities=27% Similarity=0.440 Sum_probs=195.8
Q ss_pred CcccccCCeeEEEEEcCC-------CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 441 NKLGEGGFGPVYKGNLPR-------GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999996532 2579999886543 23456789999999999999999999999998899999999
Q ss_pred cCCCChhhhhcCCC----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC-----CeEEEecCC
Q 004402 513 LPNKSLDLYLFDPI----RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-----NPKISDFGM 583 (755)
Q Consensus 513 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~-----~~kl~Dfgl 583 (755)
+++++|.+++.... ....+++.+++.++.+++.||.|||+.+ ++|+||||+||+++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986432 2234788999999999999999999876 99999999999999887 899999999
Q ss_pred ccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCC
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
++...............++..|+|||.+.++.++.++|||||||++|||+| |+.|+..... ...... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~----~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQH----VTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHH----HhcCC
Confidence 986543322222223345678999999999999999999999999999998 8887743221 111111 11111
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 663 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
.. ......+..+.+++.+||+.+|++||++.++++.|++
T Consensus 231 --~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 --RL-------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --cc-------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 0111223467899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=296.87 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=200.8
Q ss_pred cCCCccCcccccCCeeEEEEEcCC-CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
++|+..+.||+|+||.||++.... ++.+++|.+..... .+.+.+|++++++++|||++++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578888999999999999997654 88999999876533 678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++++|.+++... ...+++.....++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999988532 346899999999999999999999986 99999999999999999999999999986543321
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
......++..|+|||.+.+..++.++|||||||++|||++|+.|+......... ...... ..+.+.
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~~~~-----~~~~~~- 220 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMIPNK-----PPPTLS- 220 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhhccC-----CCCCCC-
Confidence 122345788999999999889999999999999999999999988543221110 000000 001111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+......+.+++.+||+.+|++|||+.|+++
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 -DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 11122346789999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=302.49 Aligned_cols=252 Identities=29% Similarity=0.467 Sum_probs=197.2
Q ss_pred CCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChhhHH--HHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 437 FSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLE--EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
|+..+.||+|+||+||++... +++.||+|++......... ...+|+.++.+++||||+++++++......+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999654 4679999999877544332 3456999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++++|.+++. ....+++..+..++.|+++||.+||+.+ ++|+||||+||++++++.++|+|||.+.... ...
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence 9999999985 3456899999999999999999999986 9999999999999999999999999997541 112
Q ss_pred cccccccccCCcccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVK-KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~-~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
.......++..|+|||.+. +..++.++||||+|+++|+|++|+.|+................. . ........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~---~----~~~~~~~~ 225 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK---R----PLPSSSQQ 225 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH---T----HHHHHTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc---c----cccccccc
Confidence 2333456788999999998 88899999999999999999999988864311111111111110 0 00000000
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.......+.+++..||+.||++||++.++++
T Consensus 226 ---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 ---SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ---cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001257889999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=282.77 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=200.3
Q ss_pred HhcCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccCC-----h---hhHHHHHHHHHHHhcC-CCCceeeeeeeeec
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATS-----T---QGLEEFKNEVSLTARL-QHVNLLRVLGYCTE 502 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-----~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 502 (755)
--++|+..+.||.|..++|-++. .++|+.+|+|++.... + .-.+.-.+|+.+|+++ .||+|+.+.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 34578888999999999999884 4568999999885431 1 2244567899999999 69999999999999
Q ss_pred CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecC
Q 004402 503 RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG 582 (755)
Q Consensus 503 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg 582 (755)
+...++|+|.|+.|.|.++|.. .-.++++...+|+.|+..|+.|||..+ |+||||||+|||+|++.++||+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence 9999999999999999999943 456899999999999999999999987 9999999999999999999999999
Q ss_pred CccccccCCcccccccccccCCccccccccC------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHH
Q 004402 583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKK------GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFE 656 (755)
Q Consensus 583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 656 (755)
+++.+.+.. .....+||++|+|||.+.. ..|+..+|+|+.|||||.|+.|.+||... ..+.++..
T Consensus 169 Fa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR---kQmlMLR~--- 239 (411)
T KOG0599|consen 169 FACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR---KQMLMLRM--- 239 (411)
T ss_pred eeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH---HHHHHHHH---
Confidence 999876543 3335799999999999853 35788999999999999999999998421 11111111
Q ss_pred HhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 657 QWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 657 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+.++. -++-.|. ..+......+|+.+||+.||.+|.|++|++.
T Consensus 240 -ImeGk-yqF~spe-----Wadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 240 -IMEGK-YQFRSPE-----WADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred -HHhcc-cccCCcc-----hhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11111 1111221 1223345678999999999999999999873
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=316.38 Aligned_cols=259 Identities=20% Similarity=0.266 Sum_probs=198.3
Q ss_pred HHHHHHHhcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeec
Q 004402 427 FSDIKAATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE 502 (755)
Q Consensus 427 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 502 (755)
+.++....++|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++..++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3444555689999999999999999999654 5889999998643 22234567889999999999999999999999
Q ss_pred CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecC
Q 004402 503 RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG 582 (755)
Q Consensus 503 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg 582 (755)
....++||||+++|+|..++.. ..++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999988843 24788888999999999999999987 9999999999999999999999999
Q ss_pred CccccccCCcccccccccccCCccccccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHh
Q 004402 583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG----IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQW 658 (755)
Q Consensus 583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 658 (755)
+++....... .......||+.|+|||++... .++.++|||||||++|||++|+.|+...... .. ...+
T Consensus 188 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~----~~~i 259 (371)
T cd05622 188 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GT----YSKI 259 (371)
T ss_pred ceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH---HH----HHHH
Confidence 9986543211 122345789999999998653 3789999999999999999999998532211 11 1111
Q ss_pred cc-CCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 004402 659 KD-SKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPED--RPSMLEVSSM 707 (755)
Q Consensus 659 ~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 707 (755)
.. .....+.+ .......+.+++..|++.++.+ ||++.|+++.
T Consensus 260 ~~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 260 MNHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HcCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 11 11011111 1122346778999999844433 7899988874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=309.58 Aligned_cols=264 Identities=22% Similarity=0.328 Sum_probs=195.4
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
++|...+.||+|+||.||+|... +++.||+|+++.... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46788899999999999999654 588999999875432 2334678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++ +|..++... ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 777776432 335788999999999999999999986 99999999999999999999999999975432211
Q ss_pred ccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHH--------HHHhccCC-
Q 004402 593 EANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYA--------FEQWKDSK- 662 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~- 662 (755)
......++..|+|||.+.+ ..++.++|||||||++|||+||+.|+......+........ +..+....
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1223467899999998865 56899999999999999999999998654332221111110 00000000
Q ss_pred CccccCCCCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 663 GKEFIDPSLDD----SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 663 ~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
....-.+.... ...+.....+.+++.+|++.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000 000112335679999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=299.01 Aligned_cols=238 Identities=25% Similarity=0.425 Sum_probs=186.8
Q ss_pred CcccccCCeeEEEEEcCCCC-----------EEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 441 NKLGEGGFGPVYKGNLPRGQ-----------EFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
+.||+|+||.||+|...+.. .+++|.+...... ...|.+|+.++++++|||++++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999764432 5788887655433 5788999999999999999999999988 778999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC-------CeEEEecC
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-------NPKISDFG 582 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~-------~~kl~Dfg 582 (755)
+||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ ++||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999986432 25889999999999999999999876 99999999999999888 79999999
Q ss_pred CccccccCCcccccccccccCCccccccccCC--CCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCcccchHHHHHHHhc
Q 004402 583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG--IYSMKYDVYSFGVLLLQIISS-KRNARYYGTSENLNFLEYAFEQWK 659 (755)
Q Consensus 583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDVwS~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~ 659 (755)
++..... .....++..|+|||++... .++.++|||||||++|||++| ..|+....... .... +.
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~----~~ 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERF----YQ 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHH----Hh
Confidence 9986433 1123456789999999876 789999999999999999995 54543322111 1110 01
Q ss_pred cCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 004402 660 DSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709 (755)
Q Consensus 660 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 709 (755)
... ....+ ....+.+++.+||+.+|++|||+.++++.|+
T Consensus 221 ~~~--~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQH--RLPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCC--CCCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 00000 1147889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=297.52 Aligned_cols=250 Identities=29% Similarity=0.463 Sum_probs=198.7
Q ss_pred CCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCC
Q 004402 436 NFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
+|+..+.||+|+||.||++...+++.+|+|.+..... ....|.+|++++++++|||++++++++......++++||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 5667789999999999999877788999999865432 235788999999999999999999999998899999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
++|.+++... ...+++..+..++.+++.++.|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~- 157 (256)
T cd05112 84 GCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS- 157 (256)
T ss_pred CcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc-
Confidence 9999988542 235788999999999999999999886 9999999999999999999999999998654322111
Q ss_pred cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS 674 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 674 (755)
.....++..|+|||.+.++.++.++||||||+++|||++ |+.|+...... ... ...... .....+..
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~~~--~~~~~~~~--- 225 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVV----ETINAG--FRLYKPRL--- 225 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHH----HHHhCC--CCCCCCCC---
Confidence 112234678999999998899999999999999999998 88777432211 111 111111 11111211
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 004402 675 SSPCKLLNCMQVALLCVQENPEDRPSMLEVSSML 708 (755)
Q Consensus 675 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 708 (755)
....+.+++.+||+.+|++|||+.|+++.|
T Consensus 226 ----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ----ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ----CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 124688999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=303.65 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=201.2
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
..+|+..+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|||++++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 35788899999999999999964 57999999999766555567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++||||||+|||++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998742 34788999999999999999999986 99999999999999999999999999976543221
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.|+........... ..... .+.+
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~------~~~~- 235 (297)
T cd06656 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG------TPEL- 235 (297)
T ss_pred --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC------CCCC-
Confidence 12234678899999999999999999999999999999999998854322111000 00000 0000
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.........+.+++.+||+.+|++||++.++++
T Consensus 236 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 -QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011122345778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=302.43 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=199.9
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCC----EEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQ----EFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
.+|...+.||+|+||.||+|... +|+ .+|+|.+.... ......+.+|+.++.+++|||+++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45677899999999999999653 233 68999887654 3445678999999999999999999999987 78899
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
|+||+++|+|.+++... ...+++.....++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998643 234889999999999999999999976 9999999999999999999999999998765
Q ss_pred cCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
............++..|+|||.+....++.++|||||||++|||++ |+.|+...... ... ....... ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~~~~--~~~ 231 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIP----DLLEKGE--RLP 231 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHH----HHHhCCC--CCC
Confidence 3322222222233568999999988899999999999999999999 88887532211 111 1111110 001
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
. +......+.+++.+||..+|++||++.++++.|++.
T Consensus 232 ~-------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 232 Q-------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred C-------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1 111223678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=316.95 Aligned_cols=262 Identities=18% Similarity=0.224 Sum_probs=197.9
Q ss_pred hcCCCccCcccccCCeeEEEEEc---CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL---PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
..+|...+.||+|+||.||++.. ..++.||+|.+... +.+.+|++++++++||||+++++++......+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 45799999999999999999854 23678999988653 23467999999999999999999999888999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
|++. ++|..++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||+++.....
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9986 57777772 3346899999999999999999999986 999999999999999999999999999866543
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC-------
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG------- 663 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 663 (755)
..........||+.|+|||++....++.++|||||||++|||++|+.|+...........+....+.......
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 3333333467899999999999999999999999999999999999998544332221111111111110000
Q ss_pred ----------ccccCCCCCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 664 ----------KEFIDPSLDDS---SSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 664 ----------~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
.....+..... ........+.+++.+||+.||++|||+.|++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 000112356789999999999999999999864
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.36 Aligned_cols=255 Identities=25% Similarity=0.452 Sum_probs=197.2
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCC----EEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQ----EFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
++|+..+.||+|+||.||+|.. .+|+ .||+|.+.... ......+.+|+.+++.++||||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 4567788999999999999965 3444 57999886543 23345788999999999999999999998754 4679
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
++||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999988542 235788999999999999999999986 9999999999999999999999999998764
Q ss_pred cCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
............++..|+|||.+.+..++.++|||||||++|||++ |+.|+...... ..... ..... ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~--~~~ 231 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIPDL----LEKGE--RLP 231 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHCCC--CCC
Confidence 3322222223345678999999998999999999999999999997 78777432111 11111 11110 010
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
. .......+.+++..||..+|++||++.++++.|+..
T Consensus 232 ~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 232 Q-------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 111234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=298.42 Aligned_cols=254 Identities=25% Similarity=0.426 Sum_probs=201.1
Q ss_pred hcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
.++|...+.||+|+||.||++....+..+|+|.+.... ...+.+.+|++++++++|+|++++.+++.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 35678889999999999999987778889999887543 335678999999999999999999999877 7789999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++++|.+++.... ...+++..++.++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999985432 345788899999999999999999876 999999999999999999999999999865432211
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
......++..|+|||.+....++.++|||||||+++|++| |+.|+...... .... ........ +
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~----~~~~~~~~----~--- 223 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIR----ALERGYRM----P--- 223 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHhCCCCC----C---
Confidence 1122345678999999998889999999999999999999 78777532211 1111 11111100 0
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
........+.+++.+||+.+|++||++.++.+.|++
T Consensus 224 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 --RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011223468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=302.61 Aligned_cols=252 Identities=21% Similarity=0.349 Sum_probs=198.1
Q ss_pred CCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
+|+..+.||+|+||.||++... +++.||+|.+... .......+.+|++++.+++||||+++++++......++|+||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5777899999999999999764 6899999988654 3344567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++++|..++........+++..+..++.+++.||.|||+.. +++||||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 99999988865333346899999999999999999999743 49999999999999999999999999997653221
Q ss_pred cccccccccCCccccccccCCC------CCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGI------YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~------~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
.....++..|+|||.+.+.. ++.++|||||||++|||++|+.|+........ .. .........
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~-~~~~~~~~~----- 226 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FA-QLSAIVDGD----- 226 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HH-HHHHHhhcC-----
Confidence 22235778999999985543 58899999999999999999999854221111 11 111111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+.+ .......+.+++.+||+.+|++||++.++++
T Consensus 227 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 PPTL----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCCC----CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1111 1123346789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=301.90 Aligned_cols=250 Identities=21% Similarity=0.307 Sum_probs=195.5
Q ss_pred CCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
|+..+.||+|+||+||++.. .+++.||+|.+.... ......+.+|++++.+++|+|++++.+++...+..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678899999999999965 468999999986542 22334578899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 9999999887542 2335899999999999999999999886 9999999999999999999999999997543221
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
......|+..|+|||.+.+..++.++|||||||++|||++|+.|+.......... .......... ....
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~---~~~~~~~~~~------~~~~ 225 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE---EVDRRVLETE------EVYS 225 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhhhccc------cccC
Confidence 1123468999999999998899999999999999999999999985432211111 1111111100 0111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPS-----MLEVSS 706 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 706 (755)
. .....+.+++..||+.||++||+ +.++++
T Consensus 226 ~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 226 A----KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred c----cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 1 12235778999999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=304.14 Aligned_cols=249 Identities=24% Similarity=0.361 Sum_probs=200.1
Q ss_pred cCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
.+|+..+.||.|++|.||+|. ..+++.|++|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 468888999999999999995 4578999999987665555678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++++|..++.. ..+++.++..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 99999988742 34889999999999999999999986 99999999999999999999999999886543221
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
......++..|+|||.+.+..++.++|||||||++|||++|+.|+........ ..... . ..... +.
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~---~~~~~---~-~~~~~-----~~- 236 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIA---T-NGTPE-----LQ- 236 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH---h-cCCcc-----cC-
Confidence 12234678899999999988899999999999999999999998854322110 00000 0 00000 00
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
........+.+++.+||+.||++||++.++++
T Consensus 237 -~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 237 -NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 01112235778999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=298.63 Aligned_cols=249 Identities=22% Similarity=0.357 Sum_probs=196.2
Q ss_pred CCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCC
Q 004402 437 FSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
|+..+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|||++++++++......++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 456688999999999999654 4788999999776666677899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
++|..++... ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~ 159 (282)
T cd06643 87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 159 (282)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence 9998887532 345899999999999999999999986 9999999999999999999999999997643221 12
Q ss_pred cccccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 596 TGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
.....++..|+|||++. +..++.++|||||||++|||++|+.|+...... .. ... ...........
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~---~~~-~~~~~~~~~~~-- 230 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM---RV---LLK-IAKSEPPTLAQ-- 230 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH---HH---HHH-HhhcCCCCCCC--
Confidence 23346789999999884 455788999999999999999999887432211 11 111 11111001111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+......+.+++.+||+.+|++||++.++++
T Consensus 231 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 231 -----PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112346789999999999999999998864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=331.75 Aligned_cols=261 Identities=23% Similarity=0.310 Sum_probs=199.0
Q ss_pred HHhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--Ccc
Q 004402 432 AATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DEN 506 (755)
Q Consensus 432 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 506 (755)
...++|.+.+.||+|+||+||++.. ..++.||+|.+... .......|..|+.++.+++||||+++++++... ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3456889999999999999999965 45778999998654 334456789999999999999999999988543 458
Q ss_pred EEEEeecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCceecccCCCCEEEcCC--------
Q 004402 507 MLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSN----FRVIHRDLKASNILLDNE-------- 573 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~----~~iiHrDlk~~NIll~~~-------- 573 (755)
++||||+++|+|..+|.... ....+++..++.|+.||+.||.|||..+. .+||||||||+||||+.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999886422 23468999999999999999999998542 359999999999999642
Q ss_pred ---------CCeEEEecCCccccccCCcccccccccccCCccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004402 574 ---------LNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSKRNARYY 642 (755)
Q Consensus 574 ---------~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvil~elltg~~p~~~~ 642 (755)
..+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||+||||+||+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 348999999998653321 1224578999999999854 45899999999999999999999998532
Q ss_pred CCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH--HHhhcC
Q 004402 643 GTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVS--SMLKDD 711 (755)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl--~~L~~~ 711 (755)
... . .....+... +.+.. ......+.+|+..||+.+|.+||++.|++ ..+...
T Consensus 247 ~~~--~----qli~~lk~~-------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 247 NNF--S----QLISELKRG-------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CcH--H----HHHHHHhcC-------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 211 1 111111111 11100 01124678999999999999999999998 455543
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=302.97 Aligned_cols=261 Identities=26% Similarity=0.330 Sum_probs=194.7
Q ss_pred CCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
+|+..+.||+|++|.||+|... +++.||+|.++... ....+.+.+|+.++.+++|||++++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677889999999999999754 68999999986542 22346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
++ ++|.+++........+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 688888754433456899999999999999999999986 99999999999999999999999999976543211
Q ss_pred ccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccC----------
Q 004402 593 EANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDS---------- 661 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 661 (755)
......+++.|+|||.+.+ ..++.++|||||||++|||+||+.|+........ .......+...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ---LFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHhCCCChhhhhcchh
Confidence 1122356889999998865 4578999999999999999999988753221110 00000000000
Q ss_pred ------CCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 662 ------KGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 662 ------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.........+.. .......++.+++.+||+.||++|||+.+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hHHHHhhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000 00112346679999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=295.81 Aligned_cols=251 Identities=25% Similarity=0.410 Sum_probs=197.7
Q ss_pred CCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCC------hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 436 NFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATS------TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
+|...+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 466788999999999999988789999999886432 22335688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999998532 34788999999999999999999886 99999999999999999999999999986432
Q ss_pred CC----cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcc
Q 004402 590 DV----DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665 (755)
Q Consensus 590 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (755)
.. .........++..|+|||.+.+..++.++|||||||+++||++|+.|+....... ..... ... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~----~~~--~~ 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA---AMFYI----GAH--RG 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH---HHHHh----hhc--cC
Confidence 11 1111223467889999999998889999999999999999999999885322111 00000 000 00
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 666 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..+.+... ....+.+++.+||+.+|++||++.|+++
T Consensus 226 -~~~~~~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 -LMPRLPDS----FSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -CCCCCCCC----CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11112122 2346789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=292.41 Aligned_cols=248 Identities=24% Similarity=0.400 Sum_probs=205.9
Q ss_pred CCCccCcccccCCeeEEEE-EcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecC
Q 004402 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 514 (755)
-|+.+++||+|+||.||++ ....|+.+|||.+... ...+++.+|+.+|.++..|++|+.+|.+.....+++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3567889999999999999 4457999999998654 346789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 594 (755)
.|+..+.+.. ++..+.+.++..++...++||+|||... -||||||+.||||+-+|.+||+|||.+..+.... .
T Consensus 112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--A 184 (502)
T KOG0574|consen 112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--A 184 (502)
T ss_pred CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--H
Confidence 9999999853 4567999999999999999999999986 8999999999999999999999999998765433 2
Q ss_pred ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS 674 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 674 (755)
....+.||+.|||||++..-.|..++||||||+...||..|++|+........+.++ ..-..|.+ .
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI------------PT~PPPTF--~ 250 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI------------PTKPPPTF--K 250 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec------------cCCCCCCC--C
Confidence 344578999999999999999999999999999999999999988543322211110 00011111 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 675 SSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 675 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+.....++-+++..||-+.|++|-|+.++++
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 23455667889999999999999999988875
|
|
| >cd00598 GH18_chitinase-like The GH18 (glycosyl hydrolase, family 18) type II chitinases hydrolyze chitin, an abundant polymer of beta-1,4-linked N-acetylglucosamine (GlcNAc) which is a major component of the cell wall of fungi and the exoskeleton of arthropods | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=291.70 Aligned_cols=204 Identities=26% Similarity=0.410 Sum_probs=174.6
Q ss_pred EEEEecCCCCCC---CCCCCCCCcceEEEEEEEecCCCcEEecCCchhhHHHHHHHHHHhhCCCceEEEEecCCCCCccc
Q 004402 29 KAGYWLAGREFP---LSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQ 105 (755)
Q Consensus 29 ~~gY~~~~~~~~---~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg~~~~~~~ 105 (755)
++|||..|.... +..++.+.||||+|+|+.+++++................++.+|+++|++|+++||||+.
T Consensus 1 vv~y~~~w~~~~~~~~~~~~~~~~thvi~~f~~v~~~~~~~~~~~~~~~~~~~~i~~l~~~~~g~kv~~sigg~~----- 75 (210)
T cd00598 1 VICYYDGWSSGRGPDPTDIPLSLCTHIIYAFAEISSDGSLNLFGDKSEEPLKGALEELASKKPGLKVLISIGGWT----- 75 (210)
T ss_pred CEEEEccccccCCCChhhCCcccCCEEEEeeEEECCCCCEecccCcccHHHHHHHHHHHHhCCCCEEEEEEcCCC-----
Confidence 589998877754 489999999999999999998776554222333344455578888889999999995544
Q ss_pred cccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCCC---cccHHHHHHHHHHHccCCCccEEE
Q 004402 106 SILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTD---LNSLGILLDEWKASASDQPELTLS 182 (755)
Q Consensus 106 ~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~~---~~~~~~~l~~lr~~l~~~~~~~ls 182 (755)
.+.. + .++++++.|++|++++++++++|+|||||||||+|...+ +++|+.|+++||++|++. +++||
T Consensus 76 -------~~~~-~-~~~~~~~~~~~f~~~~~~~v~~~~~DGidiD~E~~~~~~~~~~~~~~~ll~~lr~~l~~~-~~~ls 145 (210)
T cd00598 76 -------DSSP-F-TLASDPASRAAFANSLVSFLKTYGFDGVDIDWEYPGAADNSDRENFITLLRELRSALGAA-NYLLT 145 (210)
T ss_pred -------CCCC-c-hhhcCHHHHHHHHHHHHHHHHHcCCCceEEeeeCCCCcCccHHHHHHHHHHHHHHHhccc-CcEEE
Confidence 3322 3 889999999999999999999999999999999998765 899999999999999865 79999
Q ss_pred eeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHHHHHHCCCCCCceeecccc
Q 004402 183 MAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGARA 262 (755)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~~~~~~g~p~~KlvlG~p~ 262 (755)
+++|+.+.....+|+++++++++||+|+|+|| |+||+|+
T Consensus 146 ~a~~~~~~~~~~~~~~~~l~~~vD~v~vm~Yd-----------------------------------------l~~g~~~ 184 (210)
T cd00598 146 IAVPASYFDLGYAYDVPAIGDYVDFVNVMTYD-----------------------------------------LVLGVPF 184 (210)
T ss_pred EEecCChHHhhccCCHHHHHhhCCEEEEeeec-----------------------------------------ccccchh
Confidence 99998776554458999999999999999998 8999999
Q ss_pred cCCCcccCCCcchHHHHHHHhhcCCCcccccccceeeeeeecCcEEEeeCCcchhhhhhhcccccCcccccccccccc
Q 004402 263 SGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSND 340 (755)
Q Consensus 263 yG~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~d 340 (755)
| |++.|++|++++++||+|+|++++|
T Consensus 185 ~----------------------------------------------------s~~~k~~~~~~~~~gGv~~w~~~~d 210 (210)
T cd00598 185 Y----------------------------------------------------SLGAKAKYAKQKGLGGVMIWELDQD 210 (210)
T ss_pred h----------------------------------------------------hHHHHHHHHHHcCCceEEEEeccCC
Confidence 8 9999999999999999999999876
|
Chitinases have been identified in viruses, bacteria, fungi, protozoan parasites, insects, and plants. The structure of the GH18 domain is an eight-stranded beta/alpha barrel with a pronounced active-site cleft at the C-terminal end of the beta-barrel. The GH18 family includes chitotriosidase, chitobiase, hevamine, zymocin-alpha, narbonin, SI-CLP (stabilin-1 interacting chitinase-like protein), IDGF (imaginal disc growth factor), CFLE (cortical fragment-lytic enzyme) spore hydrolase, the type III and type V plant chitinases, the endo-beta-N-acetylglucosaminidases, and the chitolectins. The GH85 (glycosyl hydrolase, family 85) ENGases (endo-beta-N-acetylglucosaminidases) are closely related to the GH18 chitinases and are inclu |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=298.82 Aligned_cols=251 Identities=24% Similarity=0.390 Sum_probs=198.5
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
++|+..+.||+|+||.||+|... +++.|++|.+........+.+.+|+.+++.++|||++++++++......++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56778899999999999999664 58999999998777777788999999999999999999999999888999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++++|..++... ...+++..+..++.|++++|.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 999998877432 235889999999999999999999876 9999999999999999999999999987543221
Q ss_pred cccccccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 594 ANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
.......++..|+|||.+. ...++.++|||||||++|||++|+.|+...... .... .......
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~-~~~~~~~----- 232 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLL-KIAKSEP----- 232 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHH-HHhcCCC-----
Confidence 1122346788999999884 345788999999999999999999887432211 1111 1111110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+... ........+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 PTLS--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ccCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1110 01122336788999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.42 Aligned_cols=241 Identities=22% Similarity=0.295 Sum_probs=189.7
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCccEEEE
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ 510 (755)
+|+..+.||+|+||.||++.. .+|+.||+|++... .....+.+..|..++..+. |++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 366778999999999999964 46899999998754 2233456788888988885 577888999999888999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|+|..++.. ...+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999988743 235889999999999999999999986 999999999999999999999999998754322
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ....... ..... .
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i----~~~~~------~ 219 (323)
T cd05615 155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQSI----MEHNV------S 219 (323)
T ss_pred C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHH----HhCCC------C
Confidence 1 122235689999999999999999999999999999999999999853221 1111111 11110 1
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSM 701 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 701 (755)
... .....+.+++.+||+.+|.+|++.
T Consensus 220 ~p~----~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 YPK----SLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCc----cCCHHHHHHHHHHcccCHhhCCCC
Confidence 111 122367889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.93 Aligned_cols=262 Identities=21% Similarity=0.276 Sum_probs=193.2
Q ss_pred HhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC-----
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD----- 504 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 504 (755)
..++|+..+.||+|+||.||++.. .+|+.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 347899999999999999999965 45899999998654 2334567889999999999999999999886543
Q ss_pred -ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCC
Q 004402 505 -ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM 583 (755)
Q Consensus 505 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl 583 (755)
..++||||+++ +|...+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46999999976 4544442 23778889999999999999999987 99999999999999999999999999
Q ss_pred ccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccc------------hH
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLN------------FL 651 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~------------~~ 651 (755)
++..... .......+|+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ..
T Consensus 170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 9754322 12223467899999999999999999999999999999999999986432211000 00
Q ss_pred HH---HHHHhccC--C-----CccccCCCC-C--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 652 EY---AFEQWKDS--K-----GKEFIDPSL-D--DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 652 ~~---~~~~~~~~--~-----~~~~~d~~l-~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.. ....+... . ..+...... . ..........+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 00000000 0 000000000 0 0001112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=301.22 Aligned_cols=263 Identities=22% Similarity=0.302 Sum_probs=201.0
Q ss_pred cCHHHHHHHhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeeeee-
Q 004402 425 FSFSDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCT- 501 (755)
Q Consensus 425 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~- 501 (755)
+.++.+..+.++|+..+.||+|+||.||++.. .+++.+|+|++..... ....+.+|+.++.++ +|||++++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 44566667788999999999999999999955 4588999998865322 235678899999999 6999999999884
Q ss_pred ----cCCccEEEEeecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCe
Q 004402 502 ----ERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP 576 (755)
Q Consensus 502 ----~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~ 576 (755)
.....++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 3345899999999999998875322 2345788999999999999999999976 9999999999999999999
Q ss_pred EEEecCCccccccCCcccccccccccCCccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchH
Q 004402 577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK-----GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFL 651 (755)
Q Consensus 577 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~ 651 (755)
||+|||+++...... .......|+..|+|||.+.. ..++.++|||||||++|||++|+.|+.......
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~----- 236 (286)
T cd06638 164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR----- 236 (286)
T ss_pred EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----
Confidence 999999998654321 12223468899999998753 457899999999999999999999875322111
Q ss_pred HHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 652 EYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 652 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
... ...........++. .....+.+++.+||+.||++|||+.|+++.
T Consensus 237 -~~~-~~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 237 -ALF-KIPRNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred -HHh-hccccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000 00111001111111 112357899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.67 Aligned_cols=241 Identities=20% Similarity=0.255 Sum_probs=185.7
Q ss_pred CcccccCCeeEEEEEcC-CCCEEEEEEeccCC---hhhHHHHHHHH-HHHhcCCCCceeeeeeeeecCCccEEEEeecCC
Q 004402 441 NKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEV-SLTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
+.||+|+||+||++... +++.||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999654 57899999986532 12223444444 456788999999999999999999999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
|+|..++.. ...+.......++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 999988853 234677888889999999999999987 9999999999999999999999999997532211 12
Q ss_pred cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSS 675 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 675 (755)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ........ .... .+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~----~~~~------~~~--- 216 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYDNIL----NKPL------QLK--- 216 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH---HHHHHHHH----hCCc------CCC---
Confidence 2345789999999999999999999999999999999999999853221 11111111 1100 011
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 676 SPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 676 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+.....+.+++.+|++.||.+||++.+.+.
T Consensus 217 -~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 217 -PNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred -CCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 112336788999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=302.38 Aligned_cols=256 Identities=22% Similarity=0.351 Sum_probs=201.1
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
++|+..+.||+|+||+||++.. .+++.||+|++.... ....+.+.+|++++..++||||+++++++......++|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 4567778999999999999965 458899999886543 34457889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++++|..++.. ...+++.....++.+++.+|.|||+.+ +++||||+|+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 999999988743 235889999999999999999999753 4999999999999999999999999998754221
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccc-----chHHHHHHHhccCCCcccc
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL-----NFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 667 (755)
......|+..|+|||.+.+..++.++|||||||++|||++|+.|+......... ........ .....
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~----- 229 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ-IVQEP----- 229 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH-Hhhcc-----
Confidence 122356889999999998889999999999999999999999998643322110 11111111 11000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSML 708 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 708 (755)
.+.+.. ......+.+++.+||+.||++|||+.|+++..
T Consensus 230 ~~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 PPRLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 111111 11334678999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=300.05 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=197.6
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
++|...+.||+|+||.||++.. .+++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++++||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4666778999999999999964 468999999987665555567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++++|.+++.. ...+++.+...++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 99999998743 335889999999999999999999986 9999999999999999999999999987654321
Q ss_pred cccccccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
.......|+..|+|||.+. ...++.++|||||||++|||++|+.|+........ . ... ... ....+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~----~~~-~~~---~~~~~~ 230 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--L----FLM-TKS---NFQPPK 230 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--H----Hhh-hcc---CCCCCc
Confidence 1223356889999999874 45688999999999999999999988743221110 0 000 000 000111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.... ......+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 1110 011235789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=305.63 Aligned_cols=196 Identities=24% Similarity=0.411 Sum_probs=158.4
Q ss_pred cCcccccCCeeEEEEEcC---CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeec--CCccEEEEeecC
Q 004402 440 ANKLGEGGFGPVYKGNLP---RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE--RDENMLIYEYLP 514 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~~ 514 (755)
.++||+|+||+||+|... +++.||+|.+..... ...+.+|+.++++++||||+++++++.. ....++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999653 467999999865432 2457889999999999999999998854 345789999986
Q ss_pred CCChhhhhcCCC------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE----cCCCCeEEEecCCc
Q 004402 515 NKSLDLYLFDPI------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL----DNELNPKISDFGMA 584 (755)
Q Consensus 515 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll----~~~~~~kl~Dfgla 584 (755)
+ +|..++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 6766653211 1235888999999999999999999987 9999999999999 45678999999999
Q ss_pred cccccCCcc-cccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004402 585 KLFRKDVDE-ANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARY 641 (755)
Q Consensus 585 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~ 641 (755)
+.+...... .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.|+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 876433221 12234578999999999876 4589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=300.79 Aligned_cols=240 Identities=25% Similarity=0.395 Sum_probs=187.4
Q ss_pred CcccccCCeeEEEEEcCC--------CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 441 NKLGEGGFGPVYKGNLPR--------GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.+++.++|||++++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999996432 235889988665555567889999999999999999999999998899999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC--------eEEEecCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN--------PKISDFGMA 584 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~--------~kl~Dfgla 584 (755)
+++|+|..++... +..+++..+..++.||+.||.|||+.+ ++||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998643 235789999999999999999999986 999999999999987765 599999998
Q ss_pred cccccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCC-CCCCCCCcccchHHHHHHHhccCC
Q 004402 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRN-ARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|..+ +..... ..... . .. ..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~---~~~~~-~---~~-~~ 221 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS---QKKLQ-F---YE-DR 221 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH---HHHHH-H---HH-cc
Confidence 65432 122456789999999976 4579999999999999999999643 321111 11000 0 00 00
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 004402 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709 (755)
Q Consensus 663 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 709 (755)
..+... ....+.+++.+||+.+|++|||++++++.|+
T Consensus 222 ------~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ------HQLPAP----KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------ccCCCC----CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011111 1236789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=303.41 Aligned_cols=260 Identities=23% Similarity=0.350 Sum_probs=189.2
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCCh--hhHHHHHHHHHHHhcC---CCCceeeeeeeeecC-----C
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST--QGLEEFKNEVSLTARL---QHVNLLRVLGYCTER-----D 504 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~-----~ 504 (755)
+|+..+.||+|+||+||++.. .+++.||+|.++.... .....+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 477889999999999999965 4689999999865421 1223455677666655 799999999987642 3
Q ss_pred ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCc
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla 584 (755)
..++++||+++ +|..++... ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 47899999974 787777432 2335889999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC-
Q 004402 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG- 663 (755)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 663 (755)
+...... ......+|..|+|||.+.+..++.++|||||||++|||++|+.|+........ .............
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~ 229 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDLIGLPPED 229 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH---HHHHHHHhCCCChh
Confidence 8654321 12234678999999999988999999999999999999999988754322111 1111111000000
Q ss_pred ---------ccccCCCCC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 664 ---------KEFIDPSLD---DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 664 ---------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.....+... ....+.....+.+++.+|++.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000 0001122345789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=298.81 Aligned_cols=256 Identities=24% Similarity=0.385 Sum_probs=196.1
Q ss_pred CCccCcccccCCeeEEEEEcC----CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC------
Q 004402 437 FSSANKLGEGGFGPVYKGNLP----RGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD------ 504 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 504 (755)
|...+.||+|+||.||+|... +++.||||++... .....+++.+|+.++++++|||++++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999642 4689999998654 3344667899999999999999999999886532
Q ss_pred ccEEEEeecCCCChhhhhcCCC---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEec
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPI---RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDF 581 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Df 581 (755)
..++++||+++|+|..++.... ....+++.....++.|++.||+|||+.+ ++||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999988874321 2235788999999999999999999886 999999999999999999999999
Q ss_pred CCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhcc
Q 004402 582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKD 660 (755)
Q Consensus 582 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 660 (755)
|+++...............++..|++||.+....++.++|||||||++|||++ |+.|+..... ...... ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~----~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNY----LIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHH----HHc
Confidence 99986543322222222345678999999998889999999999999999999 7776642211 111111 111
Q ss_pred CCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 661 SKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 661 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
.. . ... .......+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 231 ~~--~---~~~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GN--R---LKQ----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CC--c---CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 0 000 112234788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=301.19 Aligned_cols=246 Identities=24% Similarity=0.382 Sum_probs=196.7
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++......++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 355567899999999999965 457899999987543 344567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++++|.+++. ...+++..+..++.++++|+.|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence 9999998874 235788999999999999999999876 9999999999999999999999999997654321
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
.......++..|+|||.+.+..++.++|||||||++|||++|+.|+....... ... ..... ..+.+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~----~~~~~-----~~~~~~~ 223 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLF----LIPKN-----SPPTLEG 223 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHh----hhhcC-----CCCCCCc
Confidence 11223457889999999999899999999999999999999998874321111 000 00111 0111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.....+.+++.+||+.+|++||++.++++
T Consensus 224 ----~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 224 ----QYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred ----ccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 22346789999999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=295.57 Aligned_cols=248 Identities=27% Similarity=0.433 Sum_probs=196.4
Q ss_pred CCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCCh---------hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcc
Q 004402 437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST---------QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN 506 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 506 (755)
|.....||+|++|.||+|.. .+++.+|+|.+..... +..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 56678999999999999965 4588999998865422 1235688999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
++++||+++++|..++.. ...+++..+..++.+++.||.|||+.+ ++||||+|+||++++++.++|+|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999843 245788899999999999999999886 99999999999999999999999999987
Q ss_pred cccCCccc----ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC
Q 004402 587 FRKDVDEA----NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 587 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
........ ......++..|+|||.+.+..++.++|||||||++|||++|+.|+...... ... .. ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~---~~-~~~-- 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QAI---FK-IGE-- 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HHH---HH-Hhc--
Confidence 65321111 112345788999999999889999999999999999999999998542211 111 11 011
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 663 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
...+.+.. .....+.+++.+||+.||.+||++.|+++
T Consensus 227 ---~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 ---NASPEIPS----NISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---cCCCcCCc----ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11111111 22346789999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=308.98 Aligned_cols=246 Identities=25% Similarity=0.402 Sum_probs=200.5
Q ss_pred cccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCCChhh
Q 004402 442 KLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDL 520 (755)
Q Consensus 442 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 520 (755)
+||+|.||+||.|+. .+...+|||.+.....+..+.+.+|+.+-++|+|.|||+.+|.|.+.+..-+.||-+++|||..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 699999999999965 4466899999988777777889999999999999999999999999999999999999999999
Q ss_pred hhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc-CCCCeEEEecCCccccccCCcccccccc
Q 004402 521 YLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRI 599 (755)
Q Consensus 521 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 599 (755)
+|...=+.-.-++.+.-...+||++||.|||++. |||||||-+|||++ -.|.+||+|||-++.+.. -...+..+
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence 9954322222367778888999999999999998 99999999999996 578999999999986532 23345567
Q ss_pred cccCCccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCH
Q 004402 600 VGTYGYVPPEYVKKG--IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSP 677 (755)
Q Consensus 600 ~gt~~y~aPE~~~~~--~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 677 (755)
.||..|||||++..+ .|+.++|||||||.+.||.||++||-..+.+... .++-+..+ + ....+.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--------MFkVGmyK--v----HP~iPe 802 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--------MFKVGMYK--V----HPPIPE 802 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--------hhhhccee--c----CCCCcH
Confidence 899999999999765 4889999999999999999999999765554311 11111110 1 122344
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 678 CKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 678 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+...++..++++|+..||.+||+++++++
T Consensus 803 elsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 55667889999999999999999999984
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=309.14 Aligned_cols=196 Identities=26% Similarity=0.366 Sum_probs=167.4
Q ss_pred CCCccCcccccCCeeEEEE-EcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CC-----ceeeeeeeeecCCccEE
Q 004402 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HV-----NLLRVLGYCTERDENML 508 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~~~~~~~~l 508 (755)
+|++.+.||+|+||.|-+| +..+++.||||+++... ....+...|+.+|..|+ |. |+|++++||...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7889999999999999999 45679999999997653 34456688999999996 43 89999999999999999
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC--CCeEEEecCCccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE--LNPKISDFGMAKL 586 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~--~~~kl~Dfgla~~ 586 (755)
|+|.++. +|.+++....- ..++...++.|+.||+.||.+||..+ |||+||||+||||.+- ..+||+|||.++.
T Consensus 266 VfELL~~-NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhhh-hHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999854 89999865433 34889999999999999999999887 9999999999999653 3699999999997
Q ss_pred cccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004402 587 FRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY 642 (755)
Q Consensus 587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~ 642 (755)
....... ..-+..|.|||++.+.+|+.+.||||||||+.||++|.+.|+..
T Consensus 341 ~~q~vyt-----YiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 341 ESQRVYT-----YIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred cCCccee-----eeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 6544332 24467899999999999999999999999999999998766543
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=306.14 Aligned_cols=250 Identities=24% Similarity=0.324 Sum_probs=206.5
Q ss_pred hcCCCccCcccccCCeeEEEEEcCC-CCEEEEEEeccCCh---hhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCccEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATST---QGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENML 508 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 508 (755)
...|+..+.||+|.||.||++..+. |+.+|+|.+.+... ...+.+.+|+.+|++++ |||||.+.+.++.....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4567788999999999999996554 99999999976543 23468899999999998 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC----CCeEEEecCCc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE----LNPKISDFGMA 584 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~----~~~kl~Dfgla 584 (755)
|||+|.+|.|.+.+... . +++.....++.||+.++.|||+.+ ++||||||+|+|+... +.+|++|||++
T Consensus 114 vmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999988654 2 899999999999999999999987 9999999999999643 47999999999
Q ss_pred cccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCc
Q 004402 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664 (755)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (755)
..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||......... . .+..+..
T Consensus 187 ~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~--~-----~i~~~~~- 255 (382)
T KOG0032|consen 187 KFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF--L-----AILRGDF- 255 (382)
T ss_pred eEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH--H-----HHHcCCC-
Confidence 98765 33455689999999999999999999999999999999999999998644332211 1 1111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 665 EFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 665 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
...............+++..|+..||..|+|+.++++
T Consensus 256 -----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 -----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred -----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1222223333456778999999999999999999998
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=298.01 Aligned_cols=256 Identities=21% Similarity=0.365 Sum_probs=199.9
Q ss_pred cCCCccCcccccCCeeEEEEEcCC----CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
++|...+.||+|+||.||+|...+ ...||||...... .+..+.+.+|+.++++++|||++++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457778999999999999996533 3479999887654 4556789999999999999999999998875 567899
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||+++|+|.+++... ...+++..++.++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999998542 235899999999999999999999876 99999999999999999999999999986543
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
... .......++..|+|||.+....++.++|||||||+++||++ |..|+...... ..... ..... ..
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~----~~~~~--~~-- 227 (270)
T cd05056 160 ESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGR----IENGE--RL-- 227 (270)
T ss_pred ccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHH----HHcCC--cC--
Confidence 321 11112234568999999988889999999999999999986 88887533221 11111 11111 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
.. ....+..+.+++.+|+..+|++|||+.++++.|++...
T Consensus 228 -~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 -PM----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 01 11223468899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=308.51 Aligned_cols=255 Identities=18% Similarity=0.232 Sum_probs=192.0
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4688899999999999999965 45899999998643 2233456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999998532 335788999999999999999999987 999999999999999999999999998765432
Q ss_pred CcccccccccccCCccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcc
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKK-----GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (755)
.. .......||+.|+|||++.. ..++.++|||||||++|||++|+.|+...... .... ..........
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~---~~~~---~i~~~~~~~~ 228 (331)
T cd05597 156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYG---KIMNHKEHFQ 228 (331)
T ss_pred CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH---HHHH---HHHcCCCccc
Confidence 21 12223468999999999863 45788999999999999999999998532111 1111 1111111011
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHH
Q 004402 666 FIDPSLDDSSSPCKLLNCMQVALLCVQE--NPEDRPSMLEVSSM 707 (755)
Q Consensus 666 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPt~~evl~~ 707 (755)
+ .+. .. .....+.+++.+|+.. ++..||++.++++.
T Consensus 229 ~-~~~-~~----~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 F-PPD-VT----DVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred C-CCc-cC----CCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1 010 01 1223566777776654 33447899888865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=295.91 Aligned_cols=248 Identities=26% Similarity=0.374 Sum_probs=200.0
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
++|+..+.||.|++|.||+|... +++.||+|++.... ......+.+|+.+++.++|+|++++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35777889999999999999654 68999999986543 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++++|.+++... .+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 9999999988532 6899999999999999999999886 9999999999999999999999999998765432
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
.......++..|+|||.+.+..++.++|||||||++|||+||+.|+....... .. ...... ..+.+.
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~~----~~~~~~-----~~~~~~ 219 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VL----FLIPKN-----NPPSLE 219 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---HH----HHhhhc-----CCCCCc
Confidence 12223467889999999998889999999999999999999999885332111 11 011111 111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.. .....+.+++.+||..+|++|||++++++
T Consensus 220 ~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 GN---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11 02336789999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=295.77 Aligned_cols=250 Identities=24% Similarity=0.322 Sum_probs=198.9
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
+|+..+.||+|+||.||++.. .+++.+|+|.++.. .....+.+.+|+.+++.++|||++++++.+...+..++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 467789999999999999965 46899999998643 3344567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++++|.+++... ....++......++.+++.||.|||+.+ ++|+||||+||++++++.++++|||++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999998887532 2345788999999999999999999986 99999999999999999999999999976543211
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
......++..|+|||.+.+..++.++||||||+++|+|++|+.|+..... .... .......... +..
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~---~~~~----~~~~~~~~~~-----~~~ 222 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW---KNLI----LKVCQGSYKP-----LPS 222 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH---HHHH----HHHhcCCCCC-----CCc
Confidence 12235678899999999988899999999999999999999998853211 1111 1111111110 111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
.....+.+++.+||+.||++|||+.|++..
T Consensus 223 ----~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 ----HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 122357789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.65 Aligned_cols=260 Identities=22% Similarity=0.269 Sum_probs=193.8
Q ss_pred HhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC------
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER------ 503 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 503 (755)
..++|...+.||+|+||.||++.. ..++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 456899999999999999999964 45889999998754 233446788999999999999999999987543
Q ss_pred CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCC
Q 004402 504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM 583 (755)
Q Consensus 504 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl 583 (755)
...++||||+++ +|...+. ..+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 246899999975 5555542 23788889999999999999999986 99999999999999999999999999
Q ss_pred ccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHH------
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQ------ 657 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~------ 657 (755)
++...... ......+|..|+|||.+.+..++.++|||||||++|||++|+.||........ .......
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~ 239 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ---WNKVIEQLGTPCP 239 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCH
Confidence 98643221 12234689999999999999999999999999999999999999854321111 0000000
Q ss_pred ------------hcc--CCCcccc------CCCC--CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 658 ------------WKD--SKGKEFI------DPSL--DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 658 ------------~~~--~~~~~~~------d~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
+.. .....+. +... ...........+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 0000000 0000 000111123467899999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=296.07 Aligned_cols=247 Identities=26% Similarity=0.421 Sum_probs=195.7
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecC
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 514 (755)
++|...+.||+|+||.||++.. .++.||+|.++... ..+.+.+|+.++.+++|||++++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3577889999999999999975 78899999986543 236789999999999999999999998654 5799999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 594 (755)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 99999998543 2335789999999999999999999876 9999999999999999999999999997543221
Q ss_pred ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
.....+..|+|||.+.+..++.++|||||||++|||++ |+.|+....... .. ........ .+ .
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~~~---~~--~-- 218 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---VK----ECVEKGYR---ME--P-- 218 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH---HH----HHHhCCCC---CC--C--
Confidence 12233568999999998899999999999999999998 887774322111 11 11111100 01 1
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
....+..+.+++.+||+.+|++||++.++++.|++
T Consensus 219 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 --PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11223467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=294.46 Aligned_cols=253 Identities=23% Similarity=0.371 Sum_probs=202.1
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
++|+..+.||+|+||.||++.. .+++.+++|.+........+.+.+|++++++++|||++++++++......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 5688889999999999999965 457899999998766666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++++|.+++... ...++......++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 999999987542 245889999999999999999999876 99999999999999999999999999986543211
Q ss_pred cccccccccCCccccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKG---IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~---~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
......++..|+|||.+... .++.++|||||||++|||+||+.|+........ ... .... .+..+.
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~-----~~~~---~~~~~~ 225 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFL-----ISKS---NFPPPK 225 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-----HHhc---cCCCcc
Confidence 12234678899999998776 889999999999999999999988753221111 000 0000 001111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+. ........+.+++.+||+.+|.+|||+.++++
T Consensus 226 ~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 LK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11 11223456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=294.25 Aligned_cols=251 Identities=20% Similarity=0.304 Sum_probs=201.0
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
+|+..+.||+|+||.||.++. .+++.+++|.+... .....+.+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999998854 56899999998654 344556789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999885432 345889999999999999999999886 99999999999999999999999999986543321
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
......+++.|+|||.+.+..++.++||||||+++|||++|+.|+...... .... .........
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~~----~~~~~~~~~------- 220 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVV----KIVQGNYTP------- 220 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH---HHHH----HHHcCCCCC-------
Confidence 222346789999999998888999999999999999999999887532211 1111 111111110
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSML 708 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 708 (755)
........+.+++.+||+.+|++||++.++++.+
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 --VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0112234678999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=299.93 Aligned_cols=264 Identities=21% Similarity=0.318 Sum_probs=197.1
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
++|+..+.||+|++|.||++... +|+.||+|++.... ....+.+.+|+.++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36788899999999999999765 58999999986542 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999988877632 235899999999999999999999976 9999999999999999999999999998764332
Q ss_pred cccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHH--------hccCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQ--------WKDSK 662 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~~~ 662 (755)
. ......++..|+|||.+.+ ..++.++|||||||++|||++|+.|+......+........... +....
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1222356789999998865 56889999999999999999999888543322111100000000 00000
Q ss_pred -CccccCCCCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 663 -GKEFIDPSLDDSSS-----PCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 663 -~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
......+....... ......+.+++.+||+.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000010000000 112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=304.02 Aligned_cols=261 Identities=24% Similarity=0.320 Sum_probs=195.1
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
++|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++......++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999654 58899999986543 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
++ ++|..++... ...+++.....++.|+++||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 5888877542 335788999999999999999999986 99999999999999999999999999975432211
Q ss_pred ccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhcc---CCCcc---
Q 004402 593 EANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKD---SKGKE--- 665 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~--- 665 (755)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.|+......+ ........... .....
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhhc
Confidence 1223356889999998865 457899999999999999999998886433211 11111111000 00000
Q ss_pred ---cc---CCCCCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 666 ---FI---DPSLDDS----SSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 666 ---~~---d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.. .+..... ........+.+++.+|++.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 0000000 00112335779999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.35 Aligned_cols=201 Identities=23% Similarity=0.359 Sum_probs=171.9
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3678889999999999999965 468999999986532 233557888999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|+|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999998853 345888999999999999999999987 999999999999999999999999998754321
Q ss_pred Ccc---------------------------------cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCC
Q 004402 591 VDE---------------------------------ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637 (755)
Q Consensus 591 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~ 637 (755)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 000 00113478999999999999999999999999999999999999
Q ss_pred CCCC
Q 004402 638 NARY 641 (755)
Q Consensus 638 p~~~ 641 (755)
||..
T Consensus 235 Pf~~ 238 (360)
T cd05627 235 PFCS 238 (360)
T ss_pred CCCC
Confidence 9854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=306.20 Aligned_cols=199 Identities=17% Similarity=0.250 Sum_probs=163.7
Q ss_pred ccCccccc--CCeeEEEEEc-CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 439 SANKLGEG--GFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 439 ~~~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
..++||+| +|++||++.. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 7889999954 568999999987542 334456788999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999885432 234889999999999999999999986 999999999999999999999999876543211110
Q ss_pred c-----ccccccccCCccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004402 594 A-----NTGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSKRNARY 641 (755)
Q Consensus 594 ~-----~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvil~elltg~~p~~~ 641 (755)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.|+..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0 1112346778999999876 4589999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.75 Aligned_cols=192 Identities=22% Similarity=0.317 Sum_probs=163.0
Q ss_pred HhcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
...+|...+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++......++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3568999999999999999999654 5789999975432 23568999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
++. ++|..++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 995 578777743 2345899999999999999999999986 999999999999999999999999999753221
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNA 639 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~ 639 (755)
.......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1122356899999999999999999999999999999999876554
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=283.52 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=197.5
Q ss_pred hcCCCccCcccccCCeeEEEE-EcCCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
+++|+.-++||+|.|+.|+++ ..++|+.+|+|++... .....+.+.+|+.+...|+||||+++...+.+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 345667789999999999998 5667999999987543 3335678899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC---CCeEEEecCCcccc
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE---LNPKISDFGMAKLF 587 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~---~~~kl~Dfgla~~~ 587 (755)
|+|.+++|..-+. .+...++...-+.+.||+++|.|.|.++ |||||+||+|+||-.. --+||+|||++..+
T Consensus 90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999865442 3355777888899999999999999997 9999999999999543 34899999999987
Q ss_pred ccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
. ........+|||+|||||++...+|+..+|||+.||+||-|+.|..||...... . ..+.+..+.. + +
T Consensus 164 ~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---r----lye~I~~g~y-d-~ 231 (355)
T KOG0033|consen 164 N---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---R----LYEQIKAGAY-D-Y 231 (355)
T ss_pred C---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---H----HHHHHhcccc-C-C
Confidence 6 223334568999999999999999999999999999999999999998432211 1 2222222211 1 1
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVS 705 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 705 (755)
++... +....+..+|+.+||..||.+|.|+.|.+
T Consensus 232 ~~~~w----~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 232 PSPEW----DTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred CCccc----CcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 12111 12223567899999999999999998766
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=295.36 Aligned_cols=248 Identities=22% Similarity=0.330 Sum_probs=199.4
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
..|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++|||++++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 3566778999999999999965 458899999987543 34456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++++|.+++.. ..+++.....++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999988742 34788899999999999999999876 99999999999999999999999999976543221
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
......++..|+|||.+.+..++.++|||||||++|||+||+.|+........ . ...... ..
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~----~~~~~~---------~~ 218 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV---L----FLIPKN---------NP 218 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH---h----hhhhcC---------CC
Confidence 12234578899999999988899999999999999999999988753221110 0 000000 01
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
..........+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11122345578899999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.63 Aligned_cols=240 Identities=23% Similarity=0.284 Sum_probs=183.3
Q ss_pred ccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcC---CCCceeeeeeeeecCCccEEEEeecCC
Q 004402 443 LGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARL---QHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 443 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
||+|+||+||++.. .+++.||||++.... ......+..|..++.+. +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999965 458999999986532 12233455666676655 699999999999999999999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 999888753 345889999999999999999999987 9999999999999999999999999997533221 12
Q ss_pred cccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS 674 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 674 (755)
.....||..|+|||.+.+. .++.++|||||||++|||++|+.|+...... . ....+..+.. .+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~---~----~~~~i~~~~~-~~~~~----- 219 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ---Q----MYRNIAFGKV-RFPKN----- 219 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH---H----HHHHHHcCCC-CCCCc-----
Confidence 2345789999999998754 4899999999999999999999998432211 1 1111111110 11110
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC----CHHHHHH
Q 004402 675 SSPCKLLNCMQVALLCVQENPEDRP----SMLEVSS 706 (755)
Q Consensus 675 ~~~~~~~~l~~l~~~Cl~~dP~~RP----t~~evl~ 706 (755)
.....+.+++.+||+.||.+|| ++.++++
T Consensus 220 ---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 ---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1123677899999999999998 4555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=309.02 Aligned_cols=259 Identities=21% Similarity=0.253 Sum_probs=193.3
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC------C
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER------D 504 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 504 (755)
.++|...+.||+|+||.||++.. ..++.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 56899999999999999999964 45889999998754 233446788999999999999999999987543 2
Q ss_pred ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCc
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla 584 (755)
..++||||+++ +|...+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 46999999975 5655552 23778889999999999999999986 999999999999999999999999999
Q ss_pred cccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhc-----
Q 004402 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWK----- 659 (755)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 659 (755)
+...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||........ .........
T Consensus 174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~ 247 (364)
T cd07875 174 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ---WNKVIEQLGTPCPE 247 (364)
T ss_pred cccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHH
Confidence 8653321 12234689999999999999999999999999999999999999854322111 111110000
Q ss_pred -------------cC--CC-----ccccCCCC---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 660 -------------DS--KG-----KEFIDPSL---DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 660 -------------~~--~~-----~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
.. .. ..+..... ...........+.+++.+|++.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 00 00000000 000011122467899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=292.47 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=203.1
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
++|+..+.||.|+||+||+|.. .++..+|+|++.... ....+.+.+|++.++.++|+|++++++.+...+..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688889999999999999964 468899999986543 23567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++++|.+++........+++.....++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865333346889999999999999999999886 99999999999999999999999999987654322
Q ss_pred cc--ccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 593 EA--NTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 593 ~~--~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
.. ......++..|+|||.+... .++.++|||||||++|||++|+.|+....... .... .... ..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~----~~~~------~~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLML----TLQN------DPP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHH----HhcC------CCC
Confidence 21 22334688999999998776 78999999999999999999999985332211 1111 1111 011
Q ss_pred CCCCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 670 SLDDSS-SPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 670 ~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+.... .......+.+++..||+.||++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111111 1123346789999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=308.50 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=202.1
Q ss_pred CCccCcccccCCeeEEEEEcCC-CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCC
Q 004402 437 FSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
++++..||.|+||.||++..+. +-..|-|++.....+..+.|+-|+++|..+.||+||+|++.|...+.+++..|||.+
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 3456789999999999996544 445678888888888899999999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
|-.+..+... ...+.+.++.-++.+++.||.|||++. |||||||+.|||++-+|.++|+|||.+..... ....
T Consensus 114 GAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qk 186 (1187)
T KOG0579|consen 114 GAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQK 186 (1187)
T ss_pred chHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HHhh
Confidence 9999887543 346899999999999999999999987 99999999999999999999999999864332 2233
Q ss_pred cccccccCCccccccc-----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 596 TGRIVGTYGYVPPEYV-----KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~-----~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
...+.||++|||||+. ...+|+.++||||||+.|.||..+.+|-..... .++.-.+.......++.|
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-------MRVllKiaKSePPTLlqP- 258 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEPPTLLQP- 258 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-------HHHHHHHhhcCCCcccCc-
Confidence 4567999999999986 456799999999999999999998876532211 122222232322222222
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..+...+.+++..||..||..||++.++++
T Consensus 259 ------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 259 ------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ------chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 234557889999999999999999999874
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=298.64 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=200.4
Q ss_pred hcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
.++|+..+.||+|+||.||++... +++.+|+|.+........+.|.+|++++++++|||++++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356788899999999999999764 5889999999877666677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++++|..++... ...+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999999988542 235889999999999999999999987 99999999999999999999999999876433211
Q ss_pred ccccccccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 593 EANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
......++..|+|||.+. ...++.++|||||||++|||++|+.|+....... .. ..+.....
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~~~~---- 225 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR---VL----LKILKSEP---- 225 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH---HH----HHHhcCCC----
Confidence 222346788999999874 3457789999999999999999998875332111 11 11111110
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+.+.. +......+.+++..||+.+|++||++.++++
T Consensus 226 -~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 226 -PTLDQ--PSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred -CCcCC--cccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 11100 1112336788999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=294.19 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=195.9
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCCh----------hhHHHHHHHHHHHhcCCCCceeeeeeeeecCC
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST----------QGLEEFKNEVSLTARLQHVNLLRVLGYCTERD 504 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 504 (755)
+|...+.||+|+||.||+|.. .+|+.||+|.++.... ...+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 456678999999999999954 4689999998854211 12346788999999999999999999999999
Q ss_pred ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCc
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla 584 (755)
..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999988543 45888999999999999999999976 999999999999999999999999999
Q ss_pred cccccCCcccccccccccCCccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC
Q 004402 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGI--YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
+...............++..|+|||.+.... ++.++||||||+++||+++|..|+..... . ........ ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~---~~~~~~~~-~~ 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---I---AAMFKLGN-KR 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch---H---HHHHHhhc-cc
Confidence 8654322222223346788999999987654 88999999999999999999988742111 1 11111111 11
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 663 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
....+.+. ........+.+++.+||+.+|++|||+.++++
T Consensus 229 ~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 SAPPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 11111111 11123357889999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=294.57 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=191.4
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC-----hhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--Ccc
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-----TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DEN 506 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 506 (755)
.+|+..+.||+|+||.||++.. .+++.||+|++.... .+..+.+.+|+.++++++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688889999999999999965 468999999886432 23345788999999999999999999988653 457
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
++++||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999998853 234788999999999999999999876 99999999999999999999999999986
Q ss_pred cccCCc-ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcc
Q 004402 587 FRKDVD-EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665 (755)
Q Consensus 587 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (755)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.|+...... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~---- 225 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQP---- 225 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCC----
Confidence 532111 11112345788999999999888999999999999999999999988532111 1111110000
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 666 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..+.+.. .....+.+++ +||..+|++||+++||++
T Consensus 226 -~~~~~~~----~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 -TNPQLPS----HISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CCCCCch----hcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1111111 1122344555 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=323.60 Aligned_cols=271 Identities=20% Similarity=0.268 Sum_probs=192.1
Q ss_pred HHHHHHhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCC------Cceeeeeeee
Q 004402 428 SDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH------VNLLRVLGYC 500 (755)
Q Consensus 428 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~ 500 (755)
+++...+++|...++||+|+||+||++.. ..++.||||+++... ...+.+..|+.++..++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 44455678899999999999999999965 458899999986532 223345566766666654 4688999988
Q ss_pred ecC-CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC-----
Q 004402 501 TER-DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL----- 574 (755)
Q Consensus 501 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~----- 574 (755)
... ...++|||++ +++|.+++.. ...+++..+..++.||+.||.|||+.. +||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccccc
Confidence 764 4678999988 6678777743 345889999999999999999999742 399999999999998765
Q ss_pred -----------CeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004402 575 -----------NPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG 643 (755)
Q Consensus 575 -----------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~ 643 (755)
.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999886422 12234678999999999999999999999999999999999999986543
Q ss_pred CCcccchHHHHHH----Hhc----cCCCcccc------CCCCCC-----------CCCHHHHHHHHHHHHHcccCCCCCC
Q 004402 644 TSENLNFLEYAFE----QWK----DSKGKEFI------DPSLDD-----------SSSPCKLLNCMQVALLCVQENPEDR 698 (755)
Q Consensus 644 ~~~~~~~~~~~~~----~~~----~~~~~~~~------d~~l~~-----------~~~~~~~~~l~~l~~~Cl~~dP~~R 698 (755)
..+....+..... .+. .....+++ .+.... .........+++|+..||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 3221111111000 000 00000000 000000 0000112356799999999999999
Q ss_pred CCHHHHHH--Hhhc
Q 004402 699 PSMLEVSS--MLKD 710 (755)
Q Consensus 699 Pt~~evl~--~L~~ 710 (755)
||+.|+++ .+.+
T Consensus 430 ~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 430 LNARQMTTHPYVLK 443 (467)
T ss_pred CCHHHHhcCccccc
Confidence 99999996 4443
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=291.41 Aligned_cols=247 Identities=27% Similarity=0.408 Sum_probs=197.2
Q ss_pred CCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC-----hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS-----TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|+.+++.++|+|++++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999765 78999999986543 23456789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
+||+++++|.+++... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998532 34788999999999999999999986 99999999999999999999999999886543
Q ss_pred CCcccccccccccCCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
.. ......++..|++||.+.... ++.++|+|||||++|||++|+.|+..... .. ...........
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---~~---~~~~~~~~~~~----- 220 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---VA---AVFKIGRSKEL----- 220 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---HH---HHHHHHhcccC-----
Confidence 22 222346788999999987776 89999999999999999999999754321 11 11111000000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+.+ +......+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 PPI----PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCc----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 011 1112346778999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.55 Aligned_cols=195 Identities=25% Similarity=0.415 Sum_probs=157.5
Q ss_pred CcccccCCeeEEEEEcC---CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeec--CCccEEEEeecCC
Q 004402 441 NKLGEGGFGPVYKGNLP---RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE--RDENMLIYEYLPN 515 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~~~ 515 (755)
.+||+|+||.||+|... ++..||+|.+..... ...+.+|++++++++||||+++++++.. ....++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999754 457899999865432 2457889999999999999999998854 4567899999875
Q ss_pred CChhhhhcCC------CccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE----cCCCCeEEEecCCcc
Q 004402 516 KSLDLYLFDP------IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL----DNELNPKISDFGMAK 585 (755)
Q Consensus 516 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll----~~~~~~kl~Dfgla~ 585 (755)
+|.+++... .....+++..+..++.||+.||.|||+.+ ++||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 665555321 12235788999999999999999999986 9999999999999 566789999999998
Q ss_pred ccccCCcc-cccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004402 586 LFRKDVDE-ANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARY 641 (755)
Q Consensus 586 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~ 641 (755)
........ .......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.|+..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 76443221 12234578999999999876 4589999999999999999999998854
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=291.23 Aligned_cols=249 Identities=21% Similarity=0.344 Sum_probs=196.8
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC-ccEEEEe
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD-ENMLIYE 511 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e 511 (755)
+|+..+.||+|++|.||++.. .+++.||+|.+... .....+.+.+|++++++++|+|++++++.+...+ ..+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 477889999999999999965 45789999998653 2334567889999999999999999998876444 5789999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++++|.+++... ....+++.++..++.+++.|+.+||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999988643 2345899999999999999999999987 9999999999999999999999999998664322
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
. ......+++.|+|||.+.+..++.++|||||||+++||++|+.|+..... . .... ....+.. +.+
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~---~---~~~~-~~~~~~~-----~~~ 222 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---N---SLVY-RIIEGKL-----PPM 222 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---H---HHHH-HHHhcCC-----CCC
Confidence 1 22334678899999999999999999999999999999999988753211 1 1111 1111111 011
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.......+.+++.+||+.+|++|||+.++++
T Consensus 223 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 223 ----PKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ----ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1123346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=293.38 Aligned_cols=253 Identities=27% Similarity=0.446 Sum_probs=198.8
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC------hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS------TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
+|+..+.||+|++|.||++.. .+++.||+|.+.... ....+.+.+|++++++++|+|++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467788999999999999964 568999999986543 1234678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC-CeEEEecCCcccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDFGMAKLF 587 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~-~~kl~Dfgla~~~ 587 (755)
|+||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999998853 235788999999999999999999986 99999999999998776 5999999999876
Q ss_pred ccCCcc--cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcc
Q 004402 588 RKDVDE--ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665 (755)
Q Consensus 588 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (755)
...... .......++..|+|||.+.+..++.++||||+|++++||++|+.|+......... ...... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~-~~~---- 226 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFKI-ASA---- 226 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHHH-hcc----
Confidence 543211 1122346788999999998888999999999999999999999887533222111 111110 000
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 666 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
...+ ..+......+.+++.+|++.+|++||++.|+++
T Consensus 227 ~~~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 TTAP----SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCC----CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0011 112223356889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=300.63 Aligned_cols=248 Identities=25% Similarity=0.344 Sum_probs=197.2
Q ss_pred CCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCC
Q 004402 437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
|.....||+|+||.||++.. .+++.||||.+........+.+.+|+..++.++|||++++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 33446799999999999965 46889999998766656667789999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
++|.+++.. ..+++.....++.+|+.||.|||+.+ ++||||||+||++++++.++|+|||++........ .
T Consensus 104 ~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~ 174 (292)
T cd06658 104 GALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--K 174 (292)
T ss_pred CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--c
Confidence 999988732 34788999999999999999999986 99999999999999999999999999976543221 1
Q ss_pred cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSS 675 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 675 (755)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ..... ... ...+.+...
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~----~~~-----~~~~~~~~~- 241 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAMRR----IRD-----NLPPRVKDS- 241 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH----HHh-----cCCCccccc-
Confidence 22346789999999998888999999999999999999999987532211 11111 110 011111110
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 676 SPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 676 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
......+.+++..||+.||++|||++|+++.
T Consensus 242 -~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 -HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0122357789999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=305.25 Aligned_cols=254 Identities=16% Similarity=0.217 Sum_probs=192.8
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|...+.||+|+||.||++... +++.||+|++... .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999654 5889999998653 2223456888999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|+|..++... ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998542 235788899999999999999999986 999999999999999999999999999865432
Q ss_pred CcccccccccccCCccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcc
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKK-----GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (755)
.. .......||+.|+|||++.+ +.++.++|||||||++|||++|+.|+...... .. ..........-
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~----~~~i~~~~~~~ 227 (331)
T cd05624 156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---ET----YGKIMNHEERF 227 (331)
T ss_pred Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH---HH----HHHHHcCCCcc
Confidence 21 12223568999999999875 56789999999999999999999998532211 11 11111100000
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 004402 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPED--RPSMLEVSS 706 (755)
Q Consensus 666 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~ 706 (755)
-+.+.. ......+.+++.+|+...+++ |++++++++
T Consensus 228 ~~p~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 228 QFPSHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred cCCCcc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 011111 112346778888888865544 467877764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=297.73 Aligned_cols=260 Identities=24% Similarity=0.361 Sum_probs=200.4
Q ss_pred cCHHHHHHHhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeeeeec
Q 004402 425 FSFSDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTE 502 (755)
Q Consensus 425 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 502 (755)
.++.++....+.|+..+.||+|+||.||+|.. .+++.+|+|++..... ....+..|+.++.++ +|||++++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 35566667778899999999999999999965 5688999999865432 345688899999998 79999999999853
Q ss_pred ------CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCe
Q 004402 503 ------RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP 576 (755)
Q Consensus 503 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~ 576 (755)
....+++|||+++|+|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 34679999999999999988542 2345788889999999999999999986 9999999999999999999
Q ss_pred EEEecCCccccccCCcccccccccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchH
Q 004402 577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFL 651 (755)
Q Consensus 577 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~ 651 (755)
+|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.|+.........
T Consensus 161 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~--- 235 (282)
T cd06636 161 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL--- 235 (282)
T ss_pred EEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh---
Confidence 9999999876532211 122356889999999875 346788999999999999999999988532211110
Q ss_pred HHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 652 EYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 652 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.. ... ...+.+. .......+.+++.+||+.||.+|||+.|+++
T Consensus 236 ---~~-~~~-----~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 ---FL-IPR-----NPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---hh-Hhh-----CCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 000 0011111 1112346889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=306.36 Aligned_cols=255 Identities=18% Similarity=0.232 Sum_probs=192.5
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..++||+|+||.||++... +++.+|+|++... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888899999999999999754 4788999998643 2223445888999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|+|.+++... ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999998542 235788899999999999999999987 999999999999999999999999999754332
Q ss_pred CcccccccccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcc
Q 004402 591 VDEANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (755)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.|+..... ..... ...... ..
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~---~~~~~----~i~~~~-~~ 226 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYG----KIMNHK-ER 226 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH---HHHHH----HHhCCC-cc
Confidence 11 1223357899999999986 34688999999999999999999999853221 11111 111110 00
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCC--CCCCHHHHHHH
Q 004402 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPE--DRPSMLEVSSM 707 (755)
Q Consensus 666 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~--~RPt~~evl~~ 707 (755)
..-+... ......+.+++.+|+..+++ .||++.|+++.
T Consensus 227 ~~~p~~~----~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 FQFPAQV----TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccCCCcc----ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0001000 11223567788887755444 36899888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=289.21 Aligned_cols=250 Identities=34% Similarity=0.511 Sum_probs=197.0
Q ss_pred CccCcccccCCeeEEEEEcCC-----CCEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 438 SSANKLGEGGFGPVYKGNLPR-----GQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 438 ~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
+..+.||.|+||.||++.... +..||+|++...... ..+.+..|+.++..++|+|++++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456889999999999996643 388999999765433 56789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999854222 12899999999999999999999986 9999999999999999999999999998765432
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
... .....++..|+|||.+....++.++||||+|++++||++ |..|+... ........ ....... .
T Consensus 158 ~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~---~~~~~~~~----~~~~~~~-----~ 224 (258)
T smart00219 158 YYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM---SNEEVLEY----LKKGYRL-----P 224 (258)
T ss_pred ccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHH----HhcCCCC-----C
Confidence 211 112236789999999988889999999999999999998 56665321 11111111 1111110 0
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSML 708 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 708 (755)
... .....+.+++.+|++.+|++|||+.|+++.|
T Consensus 225 ~~~----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 KPE----NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCC----cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111 1234688899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=298.12 Aligned_cols=261 Identities=21% Similarity=0.304 Sum_probs=196.4
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChh-----hHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQ-----GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
+|+..+.||+|++|.||+|.. .+++.||||.+...... ....+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 467788999999999999965 46899999999765322 234577899999999999999999999998899999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||+ +++|..++.... ..+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999985432 35899999999999999999999987 99999999999999999999999999987644
Q ss_pred CCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccC-------
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDS------- 661 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 661 (755)
.... .....++..|+|||.+.+ ..++.++|||||||+++||++|..++...... .............
T Consensus 155 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 155 PNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---DQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---HHHHHHHHHcCCCchhhhhh
Confidence 3211 122345778999998854 46789999999999999999997666432221 1111111111000
Q ss_pred --CCccccCCCCCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 662 --KGKEFIDPSLDDSS-----SPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 662 --~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
.............. .......+.+++.+||+.+|++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000000 11223567899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=290.30 Aligned_cols=253 Identities=25% Similarity=0.385 Sum_probs=204.6
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
++|+..+.||+|++|.||++... +++.|++|++..... ...+.+.+|+..+.+++|+|++++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999765 499999999877644 4457899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE-YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~-~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
+++++|.+++... ..+++.....++.|+++|+.|||+ .+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998542 468999999999999999999999 76 9999999999999999999999999998664332
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
.. .....++..|+|||.+....++.++||||||+++|||+||+.|+............... ..... +.+
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~----~~~~~-----~~~ 223 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI----CDGPP-----PSL 223 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH----hcCCC-----CCC
Confidence 22 12346788999999999989999999999999999999999998654431211222111 11111 111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
... .....+.+++.+||+.+|++||++.|+++.
T Consensus 224 ~~~---~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAE---EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred Ccc---cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 023478899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=300.86 Aligned_cols=261 Identities=21% Similarity=0.297 Sum_probs=196.1
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
++|+..+.||+|+||.||++... +++.||+|++..... ...+.+.+|+++++.++||||+++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46788899999999999999764 589999998765422 234578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++++|..+... ...+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999877642 234899999999999999999999986 9999999999999999999999999998654322
Q ss_pred cccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhcc----------
Q 004402 592 DEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKD---------- 660 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 660 (755)
.......++..|+|||.+.+ ..++.++|||||||++|||++|+.|+......+ ...........
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID---QLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHHHhCCCchhhHHHhc
Confidence 11223457889999998865 457889999999999999999998775322111 11000000000
Q ss_pred -CC-CccccCCCCCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 661 -SK-GKEFIDPSLDDS-----SSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 661 -~~-~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.. ......+..... ..+.....+.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 000000000000 01122356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=293.39 Aligned_cols=258 Identities=24% Similarity=0.360 Sum_probs=199.4
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCceeeeeeeeecC--CccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~ 510 (755)
++|+..+.||.|++|.||++.. .+++.+|+|.+..... .....+.+|++++++++||||++++++|... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3678889999999999999976 4588999999875432 3456789999999999999999999998654 3579999
Q ss_pred eecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 511 EYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
||+++++|.+++.... ....++......++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999988864322 2345788999999999999999999986 99999999999999999999999999875432
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC--cccchHHHHHHHhccCCCcccc
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS--ENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
... ....++..|+|||.+.+..++.++|||||||++|||++|+.|+...... .......+. .......+
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~- 228 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI----VNMPNPEL- 228 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH----hcCCchhh-
Confidence 211 1335678999999999999999999999999999999999998654321 111111111 11111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..... ........+.+++.+||+.+|++|||+.|+++
T Consensus 229 ~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 229 KDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ccCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 10000 01123457889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=309.52 Aligned_cols=257 Identities=21% Similarity=0.289 Sum_probs=191.6
Q ss_pred HhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecC------
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER------ 503 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 503 (755)
..++|...+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 456889999999999999999964 568899999987542 22345678899999999999999999987543
Q ss_pred CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCC
Q 004402 504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM 583 (755)
Q Consensus 504 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl 583 (755)
...++++|++ +++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3468999987 778887763 235889999999999999999999987 99999999999999999999999999
Q ss_pred ccccccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHH-----
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQ----- 657 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~----- 657 (755)
++..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.|+....... ........
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~ 236 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVVGTPS 236 (343)
T ss_pred ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCCC
Confidence 9865322 223468999999999876 568999999999999999999999885432111 11111000
Q ss_pred ------hccCCCccccCCCCCCCCC-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 658 ------WKDSKGKEFIDPSLDDSSS-------PCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 658 ------~~~~~~~~~~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
........... .+..... ......+.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 237 PEVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000 0000000 001124678999999999999999999984
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=298.85 Aligned_cols=265 Identities=21% Similarity=0.315 Sum_probs=198.7
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
++|+..+.||+|+||.||+|... +++.||+|+++.. .....+.+.+|++++++++|+||+++++++...+..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36788899999999999999664 5889999998654 23345678999999999999999999999999889999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|++++.+..+... ...+++..+..++.+|+.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9998877765532 234889999999999999999999986 9999999999999999999999999998765432
Q ss_pred cccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHH--------Hhc-cC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFE--------QWK-DS 661 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~-~~ 661 (755)
.. ......++..|+|||++... .++.++||||||+++|||++|+.|+......+.......... .+. ..
T Consensus 155 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 AS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred cc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 21 22234678899999999887 889999999999999999999988753322111000000000 000 00
Q ss_pred CC--ccccCCCC----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 662 KG--KEFIDPSL----DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 662 ~~--~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.. .++.+... ...........+.+++.+||+.+|++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 00000000 00011112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=300.25 Aligned_cols=246 Identities=25% Similarity=0.358 Sum_probs=196.0
Q ss_pred ccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCCC
Q 004402 439 SANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKS 517 (755)
Q Consensus 439 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 517 (755)
....||+|+||.||++.. .+++.||+|++........+.+.+|+.++..++|||++++++++...+..++++||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 345799999999999965 4689999999876555555678899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccccc
Q 004402 518 LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597 (755)
Q Consensus 518 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 597 (755)
|..++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+..... ...
T Consensus 105 L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~ 175 (297)
T cd06659 105 LTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRK 175 (297)
T ss_pred HHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccc
Confidence 9887632 35789999999999999999999886 99999999999999999999999999976543221 122
Q ss_pred cccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCH
Q 004402 598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSP 677 (755)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 677 (755)
...++..|+|||.+.+..++.++|||||||+++||++|+.|+...... ..... +.... .+.... ..
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~----~~~~~-----~~~~~~--~~ 241 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKR----LRDSP-----PPKLKN--AH 241 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH----HhccC-----CCCccc--cC
Confidence 356789999999999888999999999999999999999988532211 11111 11110 000000 01
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 678 CKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 678 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
.....+.+++.+||+.+|++||++.++++.
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 122357789999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=298.25 Aligned_cols=262 Identities=23% Similarity=0.307 Sum_probs=201.5
Q ss_pred cCHHHHHHHhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeeeeec
Q 004402 425 FSFSDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTE 502 (755)
Q Consensus 425 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 502 (755)
++..++..++++|+..+.||+|+||.||++.. .+++.+|+|++..... ....+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 45566667788999999999999999999965 5688999999865432 235678899999999 89999999999875
Q ss_pred CC-----ccEEEEeecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCe
Q 004402 503 RD-----ENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP 576 (755)
Q Consensus 503 ~~-----~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~ 576 (755)
.+ ..++|+||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 43 4799999999999998875322 2345889999999999999999999876 9999999999999999999
Q ss_pred EEEecCCccccccCCcccccccccccCCccccccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchH
Q 004402 577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG-----IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFL 651 (755)
Q Consensus 577 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~ 651 (755)
||+|||++........ ......++..|+|||.+... .++.++|||||||++|||++|+.|+.......
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~----- 240 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK----- 240 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-----
Confidence 9999999986543221 12234678899999988643 36899999999999999999998875322111
Q ss_pred HHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 652 EYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 652 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.... +.......+.+ .......+.+++.+||+.+|++||++.|+++
T Consensus 241 -~~~~-~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 241 -TLFK-IPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred -HHHH-HhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111 11111111111 1112346889999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=298.12 Aligned_cols=257 Identities=18% Similarity=0.267 Sum_probs=199.9
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||+|+||.||++.. ..++.|++|.+.... ....+.+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3678889999999999999965 457899999987653 233457889999999999999999999999988999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++++|..++.. ...+++.....++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999843 235888999999999999999999876 999999999999999999999999998742111
Q ss_pred Cc-------------ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHH
Q 004402 591 VD-------------EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQ 657 (755)
Q Consensus 591 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 657 (755)
.. ........++..|+|||.+.+..++.++|||||||++|||++|+.|+..... .... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~---~~~~----~~ 227 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELF----GQ 227 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHH----HH
Confidence 00 0011123567899999999888899999999999999999999998743211 1111 11
Q ss_pred hccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 658 WKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 658 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
..... ...+.... .....+.+++.+||+.+|++||++.++.+.|+..
T Consensus 228 ~~~~~---~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 228 VISDD---IEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HHhcc---cCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 11110 11111111 1234678999999999999999988888888763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=292.90 Aligned_cols=252 Identities=24% Similarity=0.348 Sum_probs=199.6
Q ss_pred CCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
+|+..+.||+|++|.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++.+......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777889999999999999664 58999999987653 344567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE-YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~-~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
++++|.+++.... ..++......++.+++.+|.|||+ .+ ++|+||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999885432 468889999999999999999998 65 99999999999999999999999999876533221
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
. ...++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... ...... ........ .+.+.
T Consensus 157 ~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~-~~~~~~~~-----~~~~~ 225 (265)
T cd06605 157 K----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFEL-LQYIVNEP-----PPRLP 225 (265)
T ss_pred h----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHH-HHHHhcCC-----CCCCC
Confidence 1 1567889999999999999999999999999999999999885432211 111111 11111111 11111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.. .....+.+++.+||..+|++|||+.++++
T Consensus 226 ~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 226 SG---KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hh---hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11 12346789999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=295.76 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=200.5
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
.+|...+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788889999999999999964 468899999987655555677899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 99999998843 34788899999999999999999886 99999999999999999999999999875543221
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
......+++.|+|||.+....++.++|||||||++||+++|+.|+........... . .... .+..
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~---~---~~~~------~~~~-- 235 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---I---ATNG------TPEL-- 235 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee---h---hcCC------CCCC--
Confidence 22234678899999999888899999999999999999999999854322111000 0 0000 0001
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
.........+.+++.+||+.+|++||++.++++.
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111223467889999999999999999999954
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=290.19 Aligned_cols=249 Identities=21% Similarity=0.367 Sum_probs=198.5
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
+|+..+.||+|+||.||++.. .+|+.||+|++... .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999954 46899999998653 233456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++++|.+++... ....+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999888542 2235788999999999999999999976 99999999999999999999999999986543221
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
......++..|+|||.+.+..++.++|||||||+++||++|+.|+..... .... .. ...+... ..
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---~~~~---~~-~~~~~~~-----~~- 221 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM---KNLV---LK-IIRGSYP-----PV- 221 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH---HHHH---HH-HhcCCCC-----CC-
Confidence 12234578899999999988999999999999999999999988753211 1111 11 1111110 01
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+......+.+++.+||+.+|++||++.+|++
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 222 ---SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ---cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1122346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=295.51 Aligned_cols=261 Identities=23% Similarity=0.309 Sum_probs=192.9
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
+|+..+.||+|+||.||++.. .+|+.||+|++.... ......+.+|++++++++|||++++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 467788999999999999965 468999999986542 22235678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
++ ++|..++... ...+++.....++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 4777766432 235899999999999999999999986 99999999999999999999999999986543221
Q ss_pred ccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC------Ccc
Q 004402 593 EANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK------GKE 665 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 665 (755)
......++..|+|||.+.+. .++.++|||||||++|||+||+.|+..... ................ ...
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC--HHHHHHHHHHHhCCCChHHhHHhhh
Confidence 12233568899999988664 478999999999999999999988632221 1111111111110000 000
Q ss_pred ccC----CCCCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 666 FID----PSLDD-----SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 666 ~~d----~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..+ +.... ...+.....+.+++.+||+.||.+|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 00000 001122346779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=290.67 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=193.0
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC-----ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--Ccc
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-----STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DEN 506 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 506 (755)
++|+..+.||+|+||.||+|.. .+++.||||.+... .....+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688889999999999999965 45899999987532 123356788999999999999999999988664 457
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
++++||+++++|.+++... ..+++....+++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999988532 34788889999999999999999887 99999999999999999999999999986
Q ss_pred cccCCc-ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcc
Q 004402 587 FRKDVD-EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665 (755)
Q Consensus 587 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (755)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.|+...... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~---- 225 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQP---- 225 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------HHHHHHhcCC----
Confidence 532211 11122345788999999998888999999999999999999999987432111 1111110000
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 666 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..+ ..+......+.+++.+|+. +|++||+++|+++
T Consensus 226 -~~~----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 -TNP----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -CCC----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 011 1122233467788889985 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=323.96 Aligned_cols=263 Identities=25% Similarity=0.371 Sum_probs=204.3
Q ss_pred HHHhcCCCccCcccccCCeeEEEEEcC--------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCceeeeeeee
Q 004402 431 KAATNNFSSANKLGEGGFGPVYKGNLP--------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYC 500 (755)
Q Consensus 431 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 500 (755)
+...++....+.||+|.||.|++|... ....||||.++... ....+.+..|+++|+.+ +|+|++.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 334445556679999999999999532 14579999997653 34567899999999999 799999999999
Q ss_pred ecCCccEEEEeecCCCChhhhhcCCC-----c------c--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCC
Q 004402 501 TERDENMLIYEYLPNKSLDLYLFDPI-----R------R--YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASN 567 (755)
Q Consensus 501 ~~~~~~~lv~e~~~~gsL~~~l~~~~-----~------~--~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~N 567 (755)
......++|.||++.|+|..+|...+ . . ..++....+.++.|||.||+||++.. +|||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhh
Confidence 99899999999999999999997544 0 0 23888999999999999999999986 9999999999
Q ss_pred EEEcCCCCeEEEecCCccccccCCccc-ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCC-CCCCCCCC
Q 004402 568 ILLDNELNPKISDFGMAKLFRKDVDEA-NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR-NARYYGTS 645 (755)
Q Consensus 568 Ill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~-p~~~~~~~ 645 (755)
||++++..+||+|||+++......... ..+...-+..|||||.+....|+.+||||||||+||||+|... |++ +..
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp--~~~ 526 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP--GIP 526 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC--CCC
Confidence 999999999999999999654433222 1111113567999999999999999999999999999999553 332 211
Q ss_pred cccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 646 ENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
...++. +.++++... ..+..+..+++++|..||+.+|++||++.++++.|+..
T Consensus 527 ~~~~l~----~~l~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 PTEELL----EFLKEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred cHHHHH----HHHhcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 111222 222332211 11222345788999999999999999999999999884
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=299.25 Aligned_cols=253 Identities=22% Similarity=0.269 Sum_probs=198.6
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST---QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||+|++|.||++... +++.||+|.+..... ...+.+.+|++++..++||||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999664 489999999876532 24567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+.+++|.+++... ....+++.....++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999988532 2346889999999999999999999986 999999999999999999999999998754322
Q ss_pred Ccc---------------------------cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004402 591 VDE---------------------------ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG 643 (755)
Q Consensus 591 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~ 643 (755)
... .......|+..|+|||++.+..++.++||||||+++|||++|+.|+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 01123467889999999999889999999999999999999999985332
Q ss_pred CCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 004402 644 TSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPS----MLEVSS 706 (755)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt----~~evl~ 706 (755)
... .. . ...... ............+.+++.+||+.+|++||| +.|+++
T Consensus 237 ~~~---~~---~-~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDE---TF---S-NILKKE--------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHH---HH---H-HHhcCC--------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 211 01 0 001000 000001113457889999999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=291.73 Aligned_cols=247 Identities=22% Similarity=0.329 Sum_probs=205.0
Q ss_pred cCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.-|+..+.||+|.|.+|-+++ .-+|+.||||++.+... -....+.+|+.-|+.++|||||+|+.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 456777899999999999994 34799999999987643 334568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc-CCCCeEEEecCCccccccC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~-~~~~~kl~Dfgla~~~~~~ 590 (755)
.-.+|+|.+|+..... -+.+....+.+.||..|+.|.|..+ +|||||||+||.+- .-|-+||+|||++-.+.+.
T Consensus 98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999976443 4788889999999999999999998 99999999999875 5678999999999877654
Q ss_pred CcccccccccccCCccccccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYS-MKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
. .....+|...|-|||++.+..|+ +++||||||||||.|++|+.||....+.+...++ +|=
T Consensus 173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI---------------mDC 234 (864)
T KOG4717|consen 173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI---------------MDC 234 (864)
T ss_pred c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh---------------hcc
Confidence 3 33456899999999999999986 6899999999999999999999655444332211 111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.-..+.....+|.+|+..||..||.+|.+.+||+.
T Consensus 235 --KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 235 --KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 11223344568999999999999999999999984
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=299.45 Aligned_cols=267 Identities=21% Similarity=0.301 Sum_probs=194.5
Q ss_pred CCCccCcccccCCeeEEEEEcC---CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--CccE
Q 004402 436 NFSSANKLGEGGFGPVYKGNLP---RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DENM 507 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 507 (755)
+|+..+.||+|+||.||+|... .++.||+|.+.... ....+.+.+|+.++.+++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4677889999999999999754 47899999997643 33346678899999999999999999999887 7799
Q ss_pred EEEeecCCCChhhhhcCCC--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC----CCCeEEEec
Q 004402 508 LIYEYLPNKSLDLYLFDPI--RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN----ELNPKISDF 581 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~----~~~~kl~Df 581 (755)
+||||+++ +|..++.... ....++......++.|++.||.|||+.+ ++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999976 5555553222 1236888999999999999999999987 999999999999999 999999999
Q ss_pred CCccccccCCc-ccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccc------chHHH
Q 004402 582 GMAKLFRKDVD-EANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL------NFLEY 653 (755)
Q Consensus 582 gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~------~~~~~ 653 (755)
|++........ ........++..|+|||.+.+ ..++.++|||||||+++||++|+.|+......... .....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 112233567889999998765 45899999999999999999999988644332200 00111
Q ss_pred HHHHhccC------------CCccccCCCCCCCCC---H--------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 654 AFEQWKDS------------KGKEFIDPSLDDSSS---P--------CKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 654 ~~~~~~~~------------~~~~~~d~~l~~~~~---~--------~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
....+... ......+........ . .....+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11111000 000000000000000 0 12236789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=294.81 Aligned_cols=252 Identities=23% Similarity=0.344 Sum_probs=190.9
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC-hhhHHHHHHHHHH-HhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSL-TARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
++|+..+.||+|+||.||++.. .+|+.||+|++.... .+....+..|+.. ++.++|||++++++++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 3678889999999999999965 469999999987653 2233455666665 566689999999999999899999999
Q ss_pred ecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 512 YLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 512 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
|++ |+|..++... .....+++..++.++.||+.||.|||+.. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6887776432 23346899999999999999999999862 3999999999999999999999999999865322
Q ss_pred CcccccccccccCCccccccccC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccc
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKK----GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (755)
. ......++..|+|||.+.+ ..++.++|+|||||++|||++|+.|+...... .... .... ...
T Consensus 158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~---~~~~-~~~---- 224 (283)
T cd06617 158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQQL---KQVV-EEP---- 224 (283)
T ss_pred c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HHHH---HHHH-hcC----
Confidence 1 1122457889999998864 45688999999999999999999987532211 1111 1111 110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 667 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+.+.. ......+.+++.+||+.+|++||++.++++
T Consensus 225 -~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 -SPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -CCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111 112346789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=291.06 Aligned_cols=247 Identities=26% Similarity=0.411 Sum_probs=196.1
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCC---CCceeeeeeeeecCCccEEEE
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQ---HVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~ 510 (755)
.|+..+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466778999999999999965 56899999998654 3344567889999999986 999999999999888999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++++|.+++.. ..+++.....++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988743 26889999999999999999999987 999999999999999999999999999866443
Q ss_pred CcccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
.. ......|+..|+|||.+.++ .++.++|||||||++|||++|+.|+........ . ..... ...+
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~-~~~~~-----~~~~ 220 (277)
T cd06917 155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------M-MLIPK-----SKPP 220 (277)
T ss_pred cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------h-hcccc-----CCCC
Confidence 21 12234688899999988654 468999999999999999999998853221110 0 00000 0111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+... .....+.+++.+||+.||++||++.|+++
T Consensus 221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11111 12346789999999999999999999985
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=288.18 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=197.4
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
+|+..+.||+|++|.||++.. .+++.+|+|++... .....+.+.+|++++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999854 46889999998654 234456889999999999999999999999888899999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC-CeEEEecCCccccccCC
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDFGMAKLFRKDV 591 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~-~~kl~Dfgla~~~~~~~ 591 (755)
+++++|.+++.... ...+++..+..++.+++++|.|||+.+ ++|+||+|+||++++++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999985432 335789999999999999999999986 99999999999998654 58999999998654322
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
......++..|+|||.+.+..++.++||||||+++|+|++|+.|+...... ...... ....... +
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~----~~~~~~~-----~ 221 (256)
T cd08220 157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVLKI----MSGTFAP-----I 221 (256)
T ss_pred ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHHHH----HhcCCCC-----C
Confidence 122346788999999999888999999999999999999999887533211 111111 1111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.. .....+.+++.+||+.+|++|||+.|+++
T Consensus 222 ~~----~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 SD----RYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CC----CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 12336789999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=294.29 Aligned_cols=261 Identities=20% Similarity=0.297 Sum_probs=198.0
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
+|+..+.||+|++|.||+|.. .+|+.||+|++.... ....+.+.+|+.++++++|||++++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 467788999999999999975 468999999987653 33456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+ +++|.+++.... ..+++.+++.++.||+++|.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999885432 45899999999999999999999986 99999999999999999999999999987644321
Q ss_pred ccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC--------
Q 004402 593 EANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG-------- 663 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 663 (755)
.......++..|+|||.+.+. .++.++||||+||+++||++|..++..... ................
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhccC
Confidence 112234678899999988654 468999999999999999999766643221 1111222111111000
Q ss_pred ----ccccCCCCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 664 ----KEFIDPSLDD----SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 664 ----~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..+..+.... ...+.....+.+++.+|++.+|++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000000 000122357889999999999999999999886
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=290.57 Aligned_cols=247 Identities=24% Similarity=0.369 Sum_probs=197.5
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
-|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+..+.+++|||++++++++......++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 466778999999999999964 468899999986543 334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++++|..++.. ..+++.....++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 99999988742 35789999999999999999999876 99999999999999999999999999876543211
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
......++..|+|||.+.+..++.++|||||||++|||++|..|+...... .... ...... .+.+..
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~----~~~~~~-----~~~~~~ 223 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM---KVLF----LIPKNN-----PPTLEG 223 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH---HHHH----HHhcCC-----CCCCCc
Confidence 122345788999999998888999999999999999999999887432211 1110 111111 111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
.....+.+++.+||+.+|++||++.++++.
T Consensus 224 ----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 224 ----NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 223467899999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=289.41 Aligned_cols=254 Identities=24% Similarity=0.347 Sum_probs=199.3
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--CccEEEE
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DENMLIY 510 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~ 510 (755)
+|+..+.||.|+||.||++.. .+++.||+|++... .....+.+..|++++++++|||++++++++... ...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 467788999999999999954 56889999998653 334456788999999999999999999987643 4578999
Q ss_pred eecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCceecccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 511 EYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYS--NFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~--~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
||+++++|.+++.... ....+++...+.++.+++.||.|||..+ ..+++|+||+|+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999985432 2356899999999999999999999443 345999999999999999999999999999876
Q ss_pred ccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
...... .....++..|+|||.+....++.++||||||+++++|++|+.|+..... .... ........
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~----~~~~~~~~---- 227 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLA----SKIKEGKF---- 227 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHH----HHHhcCCC----
Confidence 543211 2234678999999999988899999999999999999999998854321 1111 11111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
+.+ +......+.+++.+|++.+|++||++.+|++.
T Consensus 228 -~~~----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 -RRI----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -CCC----ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111 11233468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=295.45 Aligned_cols=262 Identities=24% Similarity=0.335 Sum_probs=193.2
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
++|+..+.||+|++|.||+|... +++.||||.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999754 689999999865432 2234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++ +|.+++... ...+++.....++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 888887543 235788999999999999999999986 99999999999999999999999999875432111
Q ss_pred ccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC--------
Q 004402 593 EANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG-------- 663 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 663 (755)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.|+..... .................
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhhhhhh
Confidence 1112346788999998865 5589999999999999999999988853321 11111111111100000
Q ss_pred -ccccC--------CCCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 664 -KEFID--------PSLDDS-SSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 664 -~~~~d--------~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..... ..+... ........+.+++.+|++.+|++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 000000 00011146678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=287.32 Aligned_cols=252 Identities=25% Similarity=0.416 Sum_probs=198.5
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
+|...+.||+|+||.||+|.. .+++.|++|.+..... ...+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 467789999999999999965 4689999999876544 3567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999854 234788899999999999999999987 99999999999999999999999999987643322
Q ss_pred ccc--cccccccCCccccccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 593 EAN--TGRIVGTYGYVPPEYVKKGI---YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 593 ~~~--~~~~~gt~~y~aPE~~~~~~---~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
... .....++..|+|||.+.... ++.++||||||+++||+++|+.|+....... . .... .... .
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~--~---~~~~-~~~~-----~ 223 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF--Q---IMFH-VGAG-----H 223 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH--H---HHHH-HhcC-----C
Confidence 111 11345788999999998766 8899999999999999999999985332111 0 0100 0000 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+.+... ......+.+++.+||+.+|++|||+.+++.
T Consensus 224 ~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 KPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111111 111335678999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=294.24 Aligned_cols=261 Identities=21% Similarity=0.293 Sum_probs=195.0
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCceeeeeeeeecC--CccEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DENMLI 509 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv 509 (755)
++|+..+.||+|+||.||+|... +++.+|+|.++.... .....+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46778899999999999999764 588999999875432 2234567899999999999999999998777 789999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
+||++ ++|.+++... ...+++.....++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 4888877532 235899999999999999999999986 99999999999999999999999999986644
Q ss_pred CCcccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhc---------
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWK--------- 659 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------- 659 (755)
... ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+........ .......+.
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ---LNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchHHHHH
Confidence 321 12234568899999988654 468999999999999999999988864332211 111111100
Q ss_pred --c------CCCccccCCCCCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 660 --D------SKGKEFIDPSLDDSSSPC-KLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 660 --~------~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. ..........+....... ....+.+++.+||+.+|++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 000000000111111111 2345778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=294.12 Aligned_cols=246 Identities=28% Similarity=0.392 Sum_probs=192.4
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
+.|...+.||+|+||.||+|.. .+++.||+|.+.... .+..+.+.+|+++++.++|||++++.++|...+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4577889999999999999965 468999999986432 234457889999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||++ |++.+++... ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 5666665322 235899999999999999999999886 999999999999999999999999998754322
Q ss_pred CcccccccccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 591 VDEANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
....++..|+|||.+. .+.++.++||||||+++|||+||+.|+....... .... .....
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~-~~~~~----- 230 (307)
T cd06607 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYH-IAQND----- 230 (307)
T ss_pred ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHH-HhcCC-----
Confidence 1245778999999874 4668899999999999999999998874321110 0110 00000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
.+.+ ........+.+++.+||+.+|++||++.++++.
T Consensus 231 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 231 SPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0111 111233468899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=291.59 Aligned_cols=247 Identities=23% Similarity=0.347 Sum_probs=197.3
Q ss_pred CCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCC
Q 004402 437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++|||++++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999964 56889999998766555566789999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
++|.+++.. ..+++..+..++.+++.||+|||+.+ ++||||+|+||+++.++.++|+|||++........ .
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~ 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence 999998854 34788999999999999999999986 99999999999999999999999999875543221 1
Q ss_pred cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSS 675 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 675 (755)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.|+..... ...... ..... .+....
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~---~~~~~~----~~~~~-----~~~~~~-- 237 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---LQAMKR----IRDNL-----PPKLKN-- 237 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH---HHHHHH----HHhcC-----CCCCcc--
Confidence 2234578899999999888899999999999999999999998743211 111111 11110 111111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 676 SPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 676 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.......+.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1112246889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=291.57 Aligned_cols=261 Identities=26% Similarity=0.369 Sum_probs=196.8
Q ss_pred CCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
+|+..+.||+|++|.||+|... +|+.||||+++.... ...+.+.+|+.++++++|||++++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999764 588999999876532 23456788999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++ +|.+++........+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 78887755444456899999999999999999999886 99999999999999999999999999976533211
Q ss_pred cccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccC---------CC
Q 004402 594 ANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDS---------KG 663 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~ 663 (755)
......++..|++||.+.+ ..++.++|||||||++|||++|+.|+......+ ............ ..
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED---QLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCChhhHHHHhcC
Confidence 1122356889999998865 457899999999999999999998875433221 111111111000 00
Q ss_pred ccccCCCCCC-------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 664 KEFIDPSLDD-------SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 664 ~~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..+. ..... ...+.....+.+++..|++.||++||++.|+++
T Consensus 232 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYK-PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhc-ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 00000 000112345779999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=290.80 Aligned_cols=243 Identities=23% Similarity=0.323 Sum_probs=196.2
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 3678889999999999999965 458999999986542 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++++|.+++... ..++...+..++.|+++||.|||+.+ ++|+||+|+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999988532 45889999999999999999999976 999999999999999999999999999865433
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
.....+++.|+|||.+.+...+.++||||||++++||++|+.|+..... ... ........ ..
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~----~~~~~~~~------~~ 216 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---IQI----YEKILEGK------VR 216 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHH----HHHHhcCC------cc
Confidence 2234678999999999888899999999999999999999998753221 111 11111111 01
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRP-----SMLEVS 705 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl 705 (755)
+... ....+.+++.+||+.||.+|| +++|++
T Consensus 217 ~~~~----~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 217 FPSF----FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred CCcc----CCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 1111 134678999999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=290.62 Aligned_cols=254 Identities=26% Similarity=0.366 Sum_probs=197.7
Q ss_pred HhcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCC------
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERD------ 504 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~------ 504 (755)
.+++|+..+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+.+++++ +|+|++++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999764 578999999876543 346789999999999 7999999999997644
Q ss_pred ccEEEEeecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCC
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM 583 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl 583 (755)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 3799999999999998875422 2346889999999999999999999886 99999999999999999999999999
Q ss_pred ccccccCCcccccccccccCCccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHh
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKK-----GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQW 658 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 658 (755)
+........ ......++..|+|||.+.. ..++.++|||||||+++||++|+.|+....... . ... .
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~---~~~-~ 230 (275)
T cd06608 160 SAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR---A---LFK-I 230 (275)
T ss_pred ceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH---H---HHH-h
Confidence 976543221 1223467889999998753 346789999999999999999999985321111 1 111 1
Q ss_pred ccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 659 KDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 659 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.... .+.+. ........+.+++.+||..||++|||+.++++
T Consensus 231 ~~~~-----~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 PRNP-----PPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hccC-----CCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111 11111 11123346889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=292.86 Aligned_cols=260 Identities=22% Similarity=0.333 Sum_probs=193.8
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
+|+..+.||+|++|.||+|.. .+|+.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 477889999999999999965 468999999986542 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+. ++|..++... ....+++.....++.+++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 6888877542 2346899999999999999999999886 99999999999999999999999999976543221
Q ss_pred ccccccccccCCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC---------
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK--------- 662 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 662 (755)
......++..|+|||.+.+.. ++.++|||||||++|||+||+.|+....... ... ..........
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLF-RIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHH-HHHHHhCCCChhhhhhhhH
Confidence 122234678899999886644 6889999999999999999999885432111 111 1111000000
Q ss_pred -------CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 663 -------GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 663 -------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
........+.. ..+.....+.+++.+||+.||++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 00112235678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=297.22 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=201.1
Q ss_pred HhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEec--cCChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEE
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLS--ATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 509 (755)
....|+++++||+||.+.||++...+.+.+|+|++. ..+.+...-|.+|+..|.+| .|.+||.|++|-..++.+|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 446788899999999999999988788899998764 34667788899999999999 599999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||- ..+|..+|..... ....| .++.+..|++.++.++|..+ |||.||||.|.|+-. |.+||+|||+|..+..
T Consensus 439 mE~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 9975 5689888864322 23334 77889999999999999987 999999999999974 5899999999999888
Q ss_pred CCcccccccccccCCccccccccCCC-----------CCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHh
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGI-----------YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQW 658 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 658 (755)
+.........+||+.||+||.+.... .+.+|||||+|||||+|+-|+.||..... . +.
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~----~a-- 580 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----Q----IA-- 580 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----H----HH--
Confidence 77776677789999999999885432 46789999999999999999999853211 1 11
Q ss_pred ccCCCccccCCCCCCCCCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 659 KDSKGKEFIDPSLDDSSSP-CKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 659 ~~~~~~~~~d~~l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
++..+.+|.-.-.++. ....++++++..||+.||.+|||..||++
T Consensus 581 ---Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 ---KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ---HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1123334422111110 11123889999999999999999999985
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=282.08 Aligned_cols=251 Identities=24% Similarity=0.381 Sum_probs=201.8
Q ss_pred CCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCceeeeeeeeecC--CccEEEE
Q 004402 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DENMLIY 510 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~ 510 (755)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999765 689999999876542 4567899999999999999999999999888 7899999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++++|.+++... ..+++..+..++.+++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999998542 26899999999999999999999976 999999999999999999999999999876544
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
..........++..|+|||.+.....+.++||||||+++++|++|+.|+..... ..............
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~------- 222 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGSSGEP------- 222 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccccCCC-------
Confidence 321112335678899999999888899999999999999999999999864431 11111111000000
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
...+......+.+++.+|++.+|++||++.++++
T Consensus 223 --~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 --PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred --cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 0111122357889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=303.22 Aligned_cols=212 Identities=27% Similarity=0.457 Sum_probs=180.7
Q ss_pred CCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC------CccE
Q 004402 436 NFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER------DENM 507 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~ 507 (755)
.+...+.||+|+||.||+|+ ...|+.||||.++.. .....+...+|+++|++++|+|||++++.-.+. +...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 34567889999999999997 567999999999764 334456778999999999999999999875543 3578
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc--CCC--CeEEEecCC
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD--NEL--NPKISDFGM 583 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~--~~~--~~kl~Dfgl 583 (755)
+|||||.+|||...|.++.+..-|++.+.+.++.+++.||.|||+++ |+||||||.||++- ++| .-||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999999888888999999999999999999999876 99999999999993 334 369999999
Q ss_pred ccccccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHH
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEY 653 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~ 653 (755)
|+.+.... .....+||..|++||+... +.|+..+|.|||||++||..||..||.+.+.........|
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~ 238 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMW 238 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhh
Confidence 99765432 4556899999999999984 8899999999999999999999999988777654333333
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=289.57 Aligned_cols=263 Identities=22% Similarity=0.297 Sum_probs=192.7
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
+++|...+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.++|+||+++.+++...+..++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46788899999999999999964 4689999999865432 223467889999999999999999999999889999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+. ++|..++... ...+.+..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 84 YMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred ccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 996 6676665432 234778888999999999999999986 9999999999999999999999999997543221
Q ss_pred cccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhcc----------
Q 004402 592 DEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKD---------- 660 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 660 (755)
. ......++..|+|||.+.+ ..++.++|||||||++|||++|+.|+...... ...+...+.....
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 158 Q--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred C--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhhh
Confidence 1 1122356889999999875 45789999999999999999999988533221 1111111110000
Q ss_pred ---CCCccccCCCCCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 661 ---SKGKEFIDPSLDDS-----SSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 661 ---~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
....+......... ........+.+++.+|++.||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000000 00011346778999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=301.98 Aligned_cols=268 Identities=21% Similarity=0.330 Sum_probs=195.5
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC-----cc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD-----EN 506 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~ 506 (755)
.++|+..+.||+|+||.||+|.. .+|+.||+|++... .......+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46788999999999999999954 56899999998643 2334466889999999999999999998875443 47
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
++++||+++ +|..++. ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 7766653 235889999999999999999999987 99999999999999999999999999986
Q ss_pred cccCCccc-ccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccC---
Q 004402 587 FRKDVDEA-NTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDS--- 661 (755)
Q Consensus 587 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 661 (755)
........ ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.|+....... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHH
Confidence 54322111 1223467899999998654 568999999999999999999998885322111 111111100000
Q ss_pred --------CCccccCC-CCCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcCc
Q 004402 662 --------KGKEFIDP-SLDDSS-----SPCKLLNCMQVALLCVQENPEDRPSMLEVSSM--LKDDS 712 (755)
Q Consensus 662 --------~~~~~~d~-~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~ 712 (755)
...+.... ...... .+.....+.+++.+||+.+|++|||+.|+++. ++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00000000 000000 01113467899999999999999999999975 65543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=279.77 Aligned_cols=249 Identities=27% Similarity=0.412 Sum_probs=201.2
Q ss_pred CCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecC
Q 004402 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 514 (755)
.|+..+.||+|++|.||++... +++.+++|++........+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3667789999999999999764 688999999987665566789999999999999999999999999899999999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 594 (755)
+++|.+++.... ..+++..+..++.+++++|.+||..+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999885422 45899999999999999999999976 99999999999999999999999999987654321
Q ss_pred ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS 674 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 674 (755)
.....++..|+|||.+....++.++||||||+++++|++|+.|+....... .... . ..........+
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~---~-~~~~~~~~~~~----- 220 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK---ALFK---I-ATNGPPGLRNP----- 220 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH---HHHH---H-HhcCCCCcCcc-----
Confidence 234567889999999988889999999999999999999998875332111 1111 0 10111111111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 675 SSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 675 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
......+.+++.+||+.||++|||+.|+++
T Consensus 221 --~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 --EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred --cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011346889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=301.83 Aligned_cols=247 Identities=26% Similarity=0.390 Sum_probs=192.7
Q ss_pred cCcccccCCeeEEEEEc-CCCCEEEEEEecc----CChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc--cEEEEee
Q 004402 440 ANKLGEGGFGPVYKGNL-PRGQEFAVKRLSA----TSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE--NMLIYEY 512 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lv~e~ 512 (755)
..+||+|+|-+||||-. .+|-.||=-.++. ..++..++|..|+.+|+.|+||||++++.+..+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 46799999999999944 4577776333221 244556889999999999999999999998877655 6789999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC-CCeEEEecCCccccccCC
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~-~~~kl~Dfgla~~~~~~~ 591 (755)
+..|+|..|+... ..++...+.+++.||++||.|||++. +||||||||-+||+|+.+ |.|||+|+|||......
T Consensus 125 ~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred ccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence 9999999998543 34788899999999999999999975 699999999999999865 79999999999976543
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
....+.|||.|||||+.. ..|++.+||||||+.++||+|+.-|+.-..... .....+........+..+-|
T Consensus 200 ---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A--QIYKKV~SGiKP~sl~kV~d--- 270 (632)
T KOG0584|consen 200 ---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA--QIYKKVTSGIKPAALSKVKD--- 270 (632)
T ss_pred ---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH--HHHHHHHcCCCHHHhhccCC---
Confidence 223378999999999887 789999999999999999999998875433222 11222222222222222222
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhhc
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKD 710 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~ 710 (755)
.++.+++.+|+.. .++|||+.|+++ +|..
T Consensus 271 ---------Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 271 ---------PEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred ---------HHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 2678999999999 999999999994 5543
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=289.53 Aligned_cols=252 Identities=25% Similarity=0.365 Sum_probs=201.0
Q ss_pred HhcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.+++|+..+.||+|++|.||++... +++.|++|++..... ..+.+.+|+++++.++|+|++++++++......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 3556778889999999999999765 588999999976554 45678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++++|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999986432 36899999999999999999999976 9999999999999999999999999987543321
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
. ......++..|++||.+.+..++.++|||||||++|||++|+.|+....... ... ...........
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~---~~~----~~~~~~~~~~~---- 237 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR---ALF----LITTKGIPPLK---- 237 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHhcCCCCCc----
Confidence 1 1123356789999999988889999999999999999999998874322111 111 01111100100
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
........+.+++.+||+.+|.+||++.++++
T Consensus 238 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 238 ---NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ---chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 01112346889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=291.05 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=191.9
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCccEEEEee
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
+|...+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++.++. ||||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 344567899999999999965 458999999987543 334567899999999996 99999999999988889999999
Q ss_pred cCCCChhhhhcC--CCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 513 LPNKSLDLYLFD--PIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 513 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
+.. ++.++... ......+++.....++.+++.||+|||+.. +++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 55443211 112346889999999999999999999753 4999999999999999999999999999765432
Q ss_pred CcccccccccccCCccccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKG---IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
.. .....++..|+|||.+... .++.++|||||||++|||++|+.|+.... ......... ....
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~-~~~~----- 227 (288)
T cd06616 162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQV-VKGD----- 227 (288)
T ss_pred Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhh-cCCC-----
Confidence 21 1223578899999998776 68999999999999999999999985432 111111111 1010
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
.+.+...........+.+++.+||+.+|++|||+.+|++.
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111112234468899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=287.53 Aligned_cols=247 Identities=22% Similarity=0.289 Sum_probs=198.2
Q ss_pred CCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
+|+..+.||.|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999764 58999999987542 2345789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++++|..++... ..+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999988532 46889999999999999999999886 9999999999999999999999999998654332
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
......++..|+|||.+....++.++||||||+++|+|++|+.|+........ ......... ...
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~--~~~------ 219 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQET--ADV------ 219 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHhcc--ccc------
Confidence 12234578899999999988899999999999999999999999864433211 111111110 000
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSM--LEVS 705 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~--~evl 705 (755)
..+......+.+++.+||+.||.+||++ +|++
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 --LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1111223578899999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=290.48 Aligned_cols=260 Identities=24% Similarity=0.347 Sum_probs=194.6
Q ss_pred CCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--CccEEEEe
Q 004402 437 FSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DENMLIYE 511 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e 511 (755)
|+..+.||+|++|.||+|... +++.+|+|++.... ......+.+|++++++++|||++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456789999999999999764 58899999997663 33446788999999999999999999999887 78999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++ +|..++... ...+++..++.++.+|+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 887777432 236889999999999999999999986 9999999999999999999999999998664432
Q ss_pred cccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCc---cc-
Q 004402 592 DEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK---EF- 666 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~- 666 (755)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... ............... ..
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccc
Confidence 11 1222356788999997764 467999999999999999999998875433221 111111111100000 00
Q ss_pred -------c------CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 667 -------I------DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 667 -------~------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. ...+...........+.+++.+||+.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 000000000011446789999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=291.79 Aligned_cols=263 Identities=21% Similarity=0.277 Sum_probs=192.2
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCc-----
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDE----- 505 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~----- 505 (755)
++|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++++ +|||++++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688889999999999999965 468999999876542 22345788899999999 46999999999877655
Q ss_pred cEEEEeecCCCChhhhhcCCCc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC-CCCeEEEecC
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIR--RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-ELNPKISDFG 582 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~-~~~~kl~Dfg 582 (755)
.++||||+++ +|..++..... ...+++..++.++.||++||.|||+.+ ++||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 78777754222 345899999999999999999999986 999999999999998 8899999999
Q ss_pred CccccccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccC
Q 004402 583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDS 661 (755)
Q Consensus 583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 661 (755)
+++.+...... .....+++.|+|||.+.+ ..++.++||||||+++|||++|..|+....... ............
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ---QLLHIFKLLGTP 231 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHhCCC
Confidence 99865332211 112356788999998865 457999999999999999999998875422111 111111111100
Q ss_pred CCcc---c---c----CCCCC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 662 KGKE---F---I----DPSLD----DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 662 ~~~~---~---~----d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.... . . -+... ....+.....+.+++.+||+.||.+||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 0 0 00000 0000122346789999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=292.63 Aligned_cols=262 Identities=23% Similarity=0.334 Sum_probs=192.4
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCceeeeeeeeecC--CccEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DENML 508 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 508 (755)
.++|+..+.||+|+||.||+|.. .+|+.||+|+++.... .....+.+|+.++.+++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 45788899999999999999965 4589999999865422 2223567899999999999999999998755 45799
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
||||+.+ +|.+++... ...+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 787777432 245899999999999999999999987 9999999999999999999999999998764
Q ss_pred cCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC----
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG---- 663 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 663 (755)
.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.|+...... ...............
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI---EQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCChhhch
Confidence 3321 1122345788999998865 56799999999999999999999888533221 111111111110000
Q ss_pred --------ccc-cC-CCCCC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 664 --------KEF-ID-PSLDD--SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 664 --------~~~-~d-~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..+ .. ..... .........+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 00 00000 000011345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=296.89 Aligned_cols=262 Identities=22% Similarity=0.278 Sum_probs=194.2
Q ss_pred HhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC-----
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD----- 504 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 504 (755)
..++|+..+.||+|+||.||++.. .+++.||+|++... .......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 357899999999999999999964 46899999998643 2334456788999999999999999999886432
Q ss_pred -ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCC
Q 004402 505 -ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM 583 (755)
Q Consensus 505 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl 583 (755)
..++||||+. ++|...+.. .++...+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 4699999996 477776632 2788899999999999999999986 99999999999999999999999999
Q ss_pred ccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchH------------
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFL------------ 651 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~------------ 651 (755)
++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.|+...........+
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 986543211 22345788999999999999999999999999999999999988543211100000
Q ss_pred ---HHHHHHhccCC-------CccccCCCC----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 652 ---EYAFEQWKDSK-------GKEFIDPSL----DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 652 ---~~~~~~~~~~~-------~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
........... ..+.....+ ...........+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000000000 001111100 00011123446789999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=284.99 Aligned_cols=242 Identities=24% Similarity=0.290 Sum_probs=184.3
Q ss_pred cccccCCeeEEEEEc-CCCCEEEEEEeccCCh---hhHHHHHHHHHHH---hcCCCCceeeeeeeeecCCccEEEEeecC
Q 004402 442 KLGEGGFGPVYKGNL-PRGQEFAVKRLSATST---QGLEEFKNEVSLT---ARLQHVNLLRVLGYCTERDENMLIYEYLP 514 (755)
Q Consensus 442 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 514 (755)
.||+|+||.||++.. .+++.+|+|.+..... .....+.+|..++ ...+|||++.+.+++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999965 4589999998865421 1222344454433 34479999999999998889999999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 594 (755)
+|+|..++.. ...+++.....++.|++.||.|||+.+ ++||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999988753 335899999999999999999999987 9999999999999999999999999997543221
Q ss_pred ccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
.....|+..|+|||.+.. ..++.++|||||||+++||++|+.|+.......... .... .. .....+.
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~----~~-----~~~~~~~- 219 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRM----TL-----TVNVELP- 219 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHH----hh-----cCCcCCc-
Confidence 122468899999998864 568999999999999999999999986433222111 1100 00 0111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRP-----SMLEVSSM 707 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 707 (755)
......+.+++..||+.||++|| |++|+++.
T Consensus 220 ---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 ---DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 12234678999999999999999 59988874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=290.03 Aligned_cols=259 Identities=24% Similarity=0.344 Sum_probs=193.3
Q ss_pred CCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
|+..+.||+|++|.||+|.. .+|+.||+|++.... ......+.+|++++++++|||++++++++.+.+..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 55678999999999999965 469999999986543 223456889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
+ ++|..++.... ...+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 68888875322 235899999999999999999999976 99999999999999999999999999976533211
Q ss_pred cccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccC-----------
Q 004402 594 ANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDS----------- 661 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 661 (755)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....... .... ..+.....
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFR-IFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCCChHHhhhhhhc
Confidence 11223567899999987654 57899999999999999999998875432211 0000 11100000
Q ss_pred -C----CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 662 -K----GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 662 -~----~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. .......... ...+.....+.+++.+||+.+|++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 0000000000 001112246789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=290.94 Aligned_cols=264 Identities=23% Similarity=0.324 Sum_probs=195.0
Q ss_pred HHhcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC----
Q 004402 432 AATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD---- 504 (755)
Q Consensus 432 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 504 (755)
...++|+..+.||+|+||.||+|... +|+.||+|+++... ......+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578889999999999999999764 58899999986543 223356788999999999999999999987654
Q ss_pred ------ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEE
Q 004402 505 ------ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI 578 (755)
Q Consensus 505 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl 578 (755)
..++|+||+++ ++...+... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 68999999986 565655432 335899999999999999999999986 999999999999999999999
Q ss_pred EecCCccccccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHH
Q 004402 579 SDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQ 657 (755)
Q Consensus 579 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 657 (755)
+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.|+..... ..........
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~---~~~~~~~~~~ 233 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE---LAQLELISRL 233 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHH
Confidence 999999866433221 1122345778999998764 4578999999999999999999988753221 1122222221
Q ss_pred hccCCC---cccc--------C------CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 658 WKDSKG---KEFI--------D------PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 658 ~~~~~~---~~~~--------d------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
...... ..+. + ....... ...+..+.+++..||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111100 0000 0 0000000 012346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=285.13 Aligned_cols=249 Identities=23% Similarity=0.384 Sum_probs=197.0
Q ss_pred CCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
+|+..+.||+|+||.||++... +|..+|+|.+.... ....+.+.+|+.+++.++|+|++++++.+......++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999654 58899999986542 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC-eEEEecCCccccccCC
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN-PKISDFGMAKLFRKDV 591 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~-~kl~Dfgla~~~~~~~ 591 (755)
+++++|.+++... ....+++..+..++.++++||.|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999988542 2235789999999999999999999986 999999999999998864 6999999998654322
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+..... ....... .... ..+ .
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~-~~~~----~~~-~ 222 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKI-CQGY----FAP-I 222 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHH-hccc----CCC-C
Confidence 1 12234578899999999888899999999999999999999988743211 1111111 1111 111 1
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+.....+.+++.+||+.+|++|||+.|+++
T Consensus 223 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 ----SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ----CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112246889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=298.06 Aligned_cols=263 Identities=24% Similarity=0.335 Sum_probs=194.6
Q ss_pred hcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCC--ccE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT--STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERD--ENM 507 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~--~~~ 507 (755)
.++|+..+.||+|+||.||+|... +++.+|+|++... .......+.+|+.++.++ +||||++++++|...+ ..+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 467888899999999999999754 5889999988543 233345677899999999 9999999999986543 579
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
+||||++ ++|..++.. ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 588877743 26788999999999999999999976 999999999999999999999999999866
Q ss_pred ccCCcc---cccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHH------
Q 004402 588 RKDVDE---ANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQ------ 657 (755)
Q Consensus 588 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~------ 657 (755)
...... .......++..|+|||.+.+ ..++.++||||||+++|||+||+.|+........ .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~ 234 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ---LEKIIEVIGPPSA 234 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCH
Confidence 443221 12233567889999998754 5678999999999999999999998854322111 1110000
Q ss_pred -----hccCCCccccCC----CCC--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 658 -----WKDSKGKEFIDP----SLD--DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 658 -----~~~~~~~~~~d~----~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
+.......+++. ... ....+.....+.+++.+||+.+|++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000001100 000 00001123467899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=290.27 Aligned_cols=247 Identities=28% Similarity=0.390 Sum_probs=192.7
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.|+..+.||+|+||.||++.. .+++.||+|++.... .+....+.+|++++++++|||++++++++.+....++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 366778999999999999965 468999999986442 2334578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+. |+|.+.+... ...+++.++..++.+++.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 997 4776666432 345899999999999999999999986 999999999999999999999999998754321
Q ss_pred cccccccccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 592 DEANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
....++..|+|||.+. .+.++.++|||||||++|||++|+.|+..... ...... +.....
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~----~~~~~~----- 241 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYH----IAQNES----- 241 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH---HHHHHH----HHhccC-----
Confidence 2245788999999873 45689999999999999999999988743211 111110 010000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 709 (755)
+.. ........+.+++.+||+.+|++||++.++++.+-
T Consensus 242 ~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 242 PTL---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred CCC---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 000 11122346789999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=285.08 Aligned_cols=244 Identities=22% Similarity=0.313 Sum_probs=189.7
Q ss_pred ccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCCCh
Q 004402 443 LGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL 518 (755)
Q Consensus 443 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 518 (755)
||+|+||+||++.. .+|+.||+|.+.... ......+..|++++++++|||++++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999954 468999999986542 22344678899999999999999999999998999999999999999
Q ss_pred hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccccccc
Q 004402 519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598 (755)
Q Consensus 519 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 598 (755)
.+++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++...... .....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence 998854322 35889999999999999999999986 999999999999999999999999998765431 11223
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHH
Q 004402 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPC 678 (755)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 678 (755)
..++..|+|||.+.+..++.++|||||||++++|++|+.|+...........+ ..... .. ... .+..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~-~~-----~~~----~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL---KRRTL-EM-----AVE----YPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH---Hhccc-cc-----ccc----CCcc
Confidence 45678999999998888999999999999999999999998543321111110 00000 00 001 1111
Q ss_pred HHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004402 679 KLLNCMQVALLCVQENPEDRP-----SMLEVSS 706 (755)
Q Consensus 679 ~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 706 (755)
....+.+++.+||+.+|++|| ++.++++
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 234678999999999999999 5555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=292.39 Aligned_cols=266 Identities=19% Similarity=0.302 Sum_probs=190.3
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc------
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE------ 505 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------ 505 (755)
++|+..+.||+|+||.||++.. .+++.||||.+.... ......+.+|+.++++++||||++++++|.....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 4688899999999999999965 468999999986542 2223456789999999999999999999876543
Q ss_pred --cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCC
Q 004402 506 --NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM 583 (755)
Q Consensus 506 --~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl 583 (755)
.++||||+.+ +|..++... ...+++.+...++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 4999999975 777766432 235889999999999999999999986 99999999999999999999999999
Q ss_pred ccccccCCcc--cccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhcc
Q 004402 584 AKLFRKDVDE--ANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKD 660 (755)
Q Consensus 584 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 660 (755)
+......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...........+.........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9865432221 112234567889999988664 4789999999999999999999887533221111111111000000
Q ss_pred CC-----CccccCC-CCCCCC---------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 661 SK-----GKEFIDP-SLDDSS---------SPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 661 ~~-----~~~~~d~-~l~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.. .....+. .+.... .......+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 0000000 000000 0001235678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=281.38 Aligned_cols=242 Identities=24% Similarity=0.328 Sum_probs=191.8
Q ss_pred ccccCCeeEEEEEcC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCCCh
Q 004402 443 LGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL 518 (755)
Q Consensus 443 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 518 (755)
||+|++|.||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++.+.+....++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999764 48999999986542 23446789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccccccc
Q 004402 519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598 (755)
Q Consensus 519 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 598 (755)
.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 9998532 34788999999999999999999976 9999999999999999999999999998664332 1223
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHH
Q 004402 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPC 678 (755)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 678 (755)
..++..|++||.+....++.++|+||||+++|||++|..|+....... .... ........ .. ..+..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~----~~~~~~~~----~~----~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIY----NDILKGNG----KL----EFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHH----HHHhccCC----CC----CCCcc
Confidence 467889999999988889999999999999999999999885443211 1111 11110000 00 01111
Q ss_pred HHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 004402 679 KLLNCMQVALLCVQENPEDRPS-----MLEVSS 706 (755)
Q Consensus 679 ~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 706 (755)
....+.+++.+||+.+|++||+ ++|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 1347889999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=265.35 Aligned_cols=247 Identities=22% Similarity=0.357 Sum_probs=192.2
Q ss_pred ccCcccccCCeeEEEEEcC-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCccEEEEeecCC
Q 004402 439 SANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 439 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
.+..||.|+.|+|++.+.. .|..+|||..... +.+..++++..+.++.+-+ .|.||+.+|||..+....+.||.|..
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 4567999999999999654 5899999998765 4556678888888887765 89999999999999889999998844
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
.++.+|.. -...+++..+-++...+..||.||.+.+ +|||||+||+|||+|+.|++|+||||++..+-.....
T Consensus 176 -C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-- 248 (391)
T KOG0983|consen 176 -CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-- 248 (391)
T ss_pred -HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc--
Confidence 44555532 2345788888899999999999999887 6999999999999999999999999999866543333
Q ss_pred cccccccCCccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKK---GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
++..|-+.|||||.+.- ..|+.++||||||+.|+||.||+-|+..... ....+..+... ..|.+.
T Consensus 249 -trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t--dFe~ltkvln~---------ePP~L~ 316 (391)
T KOG0983|consen 249 -TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT--DFEVLTKVLNE---------EPPLLP 316 (391)
T ss_pred -ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc--cHHHHHHHHhc---------CCCCCC
Confidence 34467889999999853 4688999999999999999999998864332 22222222211 113332
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
... .....+++++..||++|+.+||...++++
T Consensus 317 ~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 317 GHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ccc--CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 221 13346889999999999999999998875
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=298.18 Aligned_cols=268 Identities=20% Similarity=0.312 Sum_probs=195.7
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC-----Cc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER-----DE 505 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 505 (755)
.++|...+.||+|+||+||++.. .+++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35788899999999999999964 56899999998653 223345678899999999999999999987654 24
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
.++++||+. ++|..++.. ...+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 678777743 235889999999999999999999986 9999999999999999999999999998
Q ss_pred ccccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHH--------H
Q 004402 586 LFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAF--------E 656 (755)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~--------~ 656 (755)
...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.|+................ .
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 654322 11223457889999998765 568999999999999999999999885332111000000000 0
Q ss_pred HhccCCCcccc-------CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcC
Q 004402 657 QWKDSKGKEFI-------DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM--LKDD 711 (755)
Q Consensus 657 ~~~~~~~~~~~-------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~ 711 (755)
..........+ ++.... ..+.....+.+++.+||+.+|++|||++|+++. ++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00000000000 000000 011223467899999999999999999999866 6543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=286.64 Aligned_cols=257 Identities=20% Similarity=0.293 Sum_probs=189.0
Q ss_pred CCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCC-CCceeeeeeeeecC--CccEEEEe
Q 004402 437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTER--DENMLIYE 511 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lv~e 511 (755)
|+..+.||+|+||.||++.. .+++.||+|+++... ........+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 45678899999999999964 468999999987542 222234457888898885 99999999999887 78999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|++ ++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 5777766432 246899999999999999999999986 999999999999999 999999999998654322
Q ss_pred cccccccccccCCcccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHH-----------Hhc
Q 004402 592 DEANTGRIVGTYGYVPPEYVK-KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFE-----------QWK 659 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~ 659 (755)
.. ....++..|+|||.+. +..++.++|||||||++|||++|..|+......+ ....... ...
T Consensus 154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhc
Confidence 21 2245788999999764 4567899999999999999999998885432211 1111111 000
Q ss_pred cCCCccccCCCCCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 660 DSKGKEFIDPSLDDS----SSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 660 ~~~~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.........+..... ........+.+++.+||+.+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000001100000000 01123457889999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=285.97 Aligned_cols=257 Identities=16% Similarity=0.184 Sum_probs=181.8
Q ss_pred cCCCccCcccccCCeeEEEEEcCC----CCEEEEEEeccCChhhH-----------HHHHHHHHHHhcCCCCceeeeeee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSATSTQGL-----------EEFKNEVSLTARLQHVNLLRVLGY 499 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~g~ 499 (755)
++|...++||+|+||.||+|...+ +..+|+|.......... .....+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 578889999999999999997544 34667775432221110 112234445667789999999998
Q ss_pred eecCC----ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC
Q 004402 500 CTERD----ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN 575 (755)
Q Consensus 500 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~ 575 (755)
+.... ..++++|++.. ++.+.+.. ....++..+..++.|++.||.|||+.+ ++||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 76543 23677777643 45444422 123567888999999999999999986 999999999999999999
Q ss_pred eEEEecCCccccccCCcc-----cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccch
Q 004402 576 PKISDFGMAKLFRKDVDE-----ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNF 650 (755)
Q Consensus 576 ~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~ 650 (755)
++|+|||+++.+...... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||...........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 999999999876432111 112234689999999999999999999999999999999999999865433221111
Q ss_pred -HH-HHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 004402 651 -LE-YAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709 (755)
Q Consensus 651 -~~-~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 709 (755)
.. ........+. +.. ......+.+++..|++.+|++||++.++.+.|+
T Consensus 245 ~~~~~~~~~~~~~~--------~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 245 AAKCDFIKRLHEGK--------IKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HhHHHHHHHhhhhh--------hcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 00 0111111110 000 111346889999999999999999999999873
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=288.69 Aligned_cols=262 Identities=22% Similarity=0.307 Sum_probs=192.0
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
++|+..+.||+|++|.||+|... +|+.||+|.+.... ....+.+.+|++++++++|||++++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999654 68999999986542 2334578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC-CCCeEEEecCCccccccC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-ELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~-~~~~kl~Dfgla~~~~~~ 590 (755)
|++ ++|..++... ....+++.....++.||+.||+|||+.+ ++||||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 4776666332 2234678888899999999999999986 999999999999985 557999999999765432
Q ss_pred CcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC-------
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK------- 662 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 662 (755)
.. ......+++.|+|||.+.+ ..++.++|||||||++|||+||+.|+......+ .............
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID---ELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChhhcccc
Confidence 11 1123456889999998866 457899999999999999999998885432211 1111111100000
Q ss_pred --Ccccc--CCCCCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 663 --GKEFI--DPSLDDS----SSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 663 --~~~~~--d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..... .+..... ..+.....+.+++.+|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 0000000 01112335788999999999999999999986
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=287.53 Aligned_cols=244 Identities=23% Similarity=0.325 Sum_probs=194.7
Q ss_pred cCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCCCh
Q 004402 440 ANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL 518 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 518 (755)
...||+|+||.||++.. .+++.||||.+..........+.+|+.+++.++|+|++++++++...+..+++|||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35799999999999965 46899999998765555567799999999999999999999999999999999999999999
Q ss_pred hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccccccc
Q 004402 519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598 (755)
Q Consensus 519 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 598 (755)
.+++.. ..+++.....++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~ 175 (292)
T cd06657 105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS 175 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence 987732 34788999999999999999999986 99999999999999999999999999876543221 1223
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHH
Q 004402 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPC 678 (755)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 678 (755)
..++..|+|||.+.+..++.++||||||+++|||++|..|+...... ......... ..+.+... ..
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~~---------~~~~~~~~--~~ 241 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDN---------LPPKLKNL--HK 241 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhh---------CCcccCCc--cc
Confidence 46788999999998888999999999999999999999987532111 111111110 01111100 01
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 679 KLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 679 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
....+.+++.+||+.+|.+||++.++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 2235778999999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=284.31 Aligned_cols=247 Identities=22% Similarity=0.320 Sum_probs=195.3
Q ss_pred ccccCCeeEEEEEcC-CCCEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCCCh
Q 004402 443 LGEGGFGPVYKGNLP-RGQEFAVKRLSATST---QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL 518 (755)
Q Consensus 443 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 518 (755)
||+|+||.||++... +|+.+++|.+..... ...+.+.+|++++.+++|||++++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999765 499999999865533 3456789999999999999999999999988999999999999999
Q ss_pred hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc------
Q 004402 519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD------ 592 (755)
Q Consensus 519 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~------ 592 (755)
.+++... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9988542 25899999999999999999999886 99999999999999999999999999886433211
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
........++..|+|||.+.....+.++||||||++++||++|+.|+...... ... ........ . ..
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~----~~~~~~~~----~--~~ 221 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIF----QNILNGKI----E--WP 221 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHhcCCc----C--CC
Confidence 11223346788999999998888999999999999999999999887532211 111 11111110 0 00
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
... .....+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 222 ~~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 222 EDV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred ccc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 000 013467899999999999999999888777764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=307.90 Aligned_cols=267 Identities=21% Similarity=0.271 Sum_probs=184.3
Q ss_pred HhcCCCccCcccccCCeeEEEEEcCC--CCEEEEE------------------EeccCChhhHHHHHHHHHHHhcCCCCc
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNLPR--GQEFAVK------------------RLSATSTQGLEEFKNEVSLTARLQHVN 492 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~H~n 492 (755)
..++|+..+.||+|+||+||++.... +...++| .+. ........+.+|+.+|.+++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 35789999999999999999985432 2222222 111 11223456889999999999999
Q ss_pred eeeeeeeeecCCccEEEEeecCCCChhhhhcCCCc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE
Q 004402 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR--RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL 570 (755)
Q Consensus 493 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll 570 (755)
|+++++++...+..++++|++.. +|..++..... ...........++.||+.||.|||+.+ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 99999999999999999999854 56565543211 112335667789999999999999986 9999999999999
Q ss_pred cCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccch
Q 004402 571 DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNF 650 (755)
Q Consensus 571 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~ 650 (755)
+.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|+.++...........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 9999999999999987643222 122235789999999999999999999999999999999998754322221111111
Q ss_pred HHHHHHHhccCCCccccC----------CC-CC---CCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 651 LEYAFEQWKDSKGKEFID----------PS-LD---DSSS-----PCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 651 ~~~~~~~~~~~~~~~~~d----------~~-l~---~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+......+.. ...++.+ .. +. .... ......+.+++.+||+.||++|||+.|+++
T Consensus 380 ~~~~~~~~~~-~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 380 LLKIIDSLSV-CDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHhccc-ChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1111111000 0000000 00 00 0000 001124567789999999999999999986
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=295.10 Aligned_cols=266 Identities=18% Similarity=0.301 Sum_probs=195.2
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeec----CCcc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTE----RDEN 506 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~ 506 (755)
..+|+..+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36788899999999999999964 469999999987542 2345677889999999999999999998753 3457
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
++|+||+. ++|..++.. ...+++.....++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 688888743 234899999999999999999999986 99999999999999999999999999986
Q ss_pred cccCCcc--cccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHH--------HH
Q 004402 587 FRKDVDE--ANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEY--------AF 655 (755)
Q Consensus 587 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~--------~~ 655 (755)
....... .......++..|+|||.+.. ..++.++|||||||++|||++|+.|+.............. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5432211 11123467889999998865 5689999999999999999999999854322111100000 00
Q ss_pred HHhccCCCccccCCC-CCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 656 EQWKDSKGKEFIDPS-LDDSS-----SPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 656 ~~~~~~~~~~~~d~~-l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.........+..+.. ..... .+.....+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000000000000000 00000 0122456889999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=281.51 Aligned_cols=245 Identities=18% Similarity=0.234 Sum_probs=187.8
Q ss_pred CcccccCCeeEEEEEc-CCCCEEEEEEeccCCh---hhHHHHHHHHHHH-hcCCCCceeeeeeeeecCCccEEEEeecCC
Q 004402 441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST---QGLEEFKNEVSLT-ARLQHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
+.||+|+||.||+|.. .+++.||+|++..... .....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999965 4589999999875432 2223345555444 445899999999999999999999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
++|..++.. ...+++..+..++.|+++||.|||+.+ ++||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999998853 235788999999999999999999986 99999999999999999999999999875432
Q ss_pred cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSS 675 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 675 (755)
.....++..|+|||.+.+..++.++||||||++++||++|..|+...... ... ......... .....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~~~~~--~~~~~---- 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---AVF----DNILSRRIN--WPEEV---- 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHhcccC--CCCcc----
Confidence 22345788999999998888999999999999999999999998532211 111 111111100 00111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 676 SPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 676 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
.......+.+++.+||+.+|++||++.++.+.|..
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 11223467899999999999999988777776643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=279.27 Aligned_cols=249 Identities=22% Similarity=0.278 Sum_probs=188.4
Q ss_pred HHHHHHhcCCCccCcc--cccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecC
Q 004402 428 SDIKAATNNFSSANKL--GEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER 503 (755)
Q Consensus 428 ~~l~~~~~~f~~~~~l--G~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 503 (755)
.+.....++|+..+.+ |+|+||.||++.. .+++.+|+|.+........ |+.....+ +|||++++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444445677777776 9999999999964 4688999999865422211 22222222 799999999999999
Q ss_pred CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC-CeEEEecC
Q 004402 504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDFG 582 (755)
Q Consensus 504 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~-~~kl~Dfg 582 (755)
+..++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 9999999999999999998532 36899999999999999999999987 99999999999999998 99999999
Q ss_pred CccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC
Q 004402 583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
+++..... ....++..|+|||.+.+..++.++|||||||+++||++|+.|+...... ......+.... ..
T Consensus 156 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~---~~ 225 (267)
T PHA03390 156 LCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ---QK 225 (267)
T ss_pred cceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh---cc
Confidence 98764322 1235788999999999989999999999999999999999998633221 11111111110 00
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 004402 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPS-MLEVSS 706 (755)
Q Consensus 663 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~evl~ 706 (755)
... . .......+.+++.+||+.+|.+||+ ++|+++
T Consensus 226 ~~~-----~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 KLP-----F----IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cCC-----c----ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 000 0 1122346789999999999999995 688873
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=286.62 Aligned_cols=259 Identities=22% Similarity=0.312 Sum_probs=195.9
Q ss_pred CCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 437 FSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
|+..+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+|++++++++......++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456688999999999999654 688999999865532 24567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++ +|..++... ...+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 75 777776442 246899999999999999999999987 99999999999999999999999999987654321
Q ss_pred cccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC---Ccccc--
Q 004402 594 ANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK---GKEFI-- 667 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-- 667 (755)
......++..|+|||.+.+. .++.++||||||+++|+|+||+.|+......+ ............. ...+.
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCchHhcccchhh
Confidence 11223567889999998776 78999999999999999999998875432211 1111111111100 00000
Q ss_pred ---------CCCCC--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 668 ---------DPSLD--DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 668 ---------d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+.... ....+.....+.+++.+||+.||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000 0011123457889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=281.34 Aligned_cols=248 Identities=26% Similarity=0.370 Sum_probs=199.6
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
+|+..+.||+|++|.||++.. .+++.+|+|.+... .......+.+|++++++++|+||+++.+++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 467789999999999999954 46889999998654 233456788999999999999999999999988999999999
Q ss_pred cCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 513 LPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 513 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
+++++|..++.... ....+++..++.++.++++||.|||+.+ ++|+||+|.||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999875422 2346889999999999999999999886 9999999999999999999999999998765431
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
.....++..|++||.+.+..++.++|+||||+++|||++|+.|+...... .... ........
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~----~~~~~~~~------- 219 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRY----KVQRGKYP------- 219 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHhcCCCC-------
Confidence 12245788999999999999999999999999999999999988543211 1111 11111110
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.........+.+++.+|++.+|++||++.++++
T Consensus 220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 --PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred --CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111123446889999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=290.21 Aligned_cols=260 Identities=22% Similarity=0.296 Sum_probs=189.5
Q ss_pred Cccccc--CCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCC
Q 004402 441 NKLGEG--GFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 441 ~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
..||+| +||+||++.. ..|+.||+|++... ..+..+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456777 8999999965 57999999998654 233456789999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc-
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA- 594 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 594 (755)
++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999885432 234788999999999999999999876 9999999999999999999999998654322111100
Q ss_pred ----ccccccccCCccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHH-------------
Q 004402 595 ----NTGRIVGTYGYVPPEYVKKG--IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAF------------- 655 (755)
Q Consensus 595 ----~~~~~~gt~~y~aPE~~~~~--~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~------------- 655 (755)
......++..|+|||++.+. .++.++|||||||++|||++|+.|+........ ......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccc
Confidence 01112345679999998764 478999999999999999999998854321110 000000
Q ss_pred ---HHhcc----------------CCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 656 ---EQWKD----------------SKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 656 ---~~~~~----------------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..... .......+..+...........+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000 0000011111111122234557889999999999999999999973
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=276.31 Aligned_cols=247 Identities=27% Similarity=0.411 Sum_probs=199.1
Q ss_pred CCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
+|+..+.||+|++|.||++... +++.|++|.+..... ...+.+.+|++++.+++|||++++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677899999999999999654 588999999976643 4567899999999999999999999999988899999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++++|.+++... ..+++..+..++.+++.+|.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999988532 46899999999999999999999886 99999999999999999999999999987654322
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
. .....++..|+|||.+.+..++.++||||+|++++||++|+.|+..... . ........ .. .+.+.
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---~---~~~~~~~~-~~-----~~~~~ 220 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---M---AALFRIVQ-DD-----HPPLP 220 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---H---HHHHHHhc-cC-----CCCCC
Confidence 1 2234678899999999888889999999999999999999988753221 1 11111100 00 01111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. .....+.+++.+||+.+|++|||+.+++.
T Consensus 221 ~----~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 E----GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred C----CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1 12346789999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=284.16 Aligned_cols=248 Identities=24% Similarity=0.327 Sum_probs=197.2
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST---QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
.+.|..-++||+|+||.||-++. .+|+.+|.|.+.+... +.....++|-.+|.+++.+.||.+--.++..+.+|+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 35677789999999999999965 4699999998865432 2334578899999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
+..|.+|+|.-+|.+... ..++++..+..+.+|+.||.+||... ||.||+||+|||||+.|+++|+|+|||..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999998876544 56899999999999999999999987 99999999999999999999999999997754
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
.... ...+||.+|||||++.++.|+...|.||+||+||||+.|+.||.......-..-++.-. .. ++
T Consensus 340 g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~----~~------~~ 406 (591)
T KOG0986|consen 340 GKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT----LE------DP 406 (591)
T ss_pred CCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH----hc------ch
Confidence 3322 23389999999999999999999999999999999999999997554332211111100 00 00
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSM 701 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 701 (755)
..++.....+..++....|+.||++|-..
T Consensus 407 ---~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 407 ---EEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred ---hhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 11222233356677777889999988543
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=285.72 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=190.6
Q ss_pred cCCCccCcccccCCeeEEEEEcCC-CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCccEEEEe
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e 511 (755)
++|+..+.||+|+||.||+|.... ++.||||++.... ......+..|+.++.+.. ||||++++++|......+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 457778999999999999997754 8999999987543 233456777887777774 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++ +|..++... ...+++..+..++.+++.||+|||+.. +++||||+|+||++++++.+||+|||++..+....
T Consensus 95 ~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 9854 666655332 236889999999999999999999743 49999999999999999999999999997654322
Q ss_pred cccccccccccCCccccccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGI----YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
.. ....++..|+|||.+.+.. ++.++||||||+++|||++|+.|+..... ........ .. .....
T Consensus 170 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~---~~-~~~~~-- 238 (296)
T cd06618 170 AK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--EFEVLTKI---LQ-EEPPS-- 238 (296)
T ss_pred cc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh--HHHHHHHH---hc-CCCCC--
Confidence 11 2235678999999987554 78999999999999999999998743211 11111111 11 11001
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
+.. .......+.+++.+||+.||++||++.++++.
T Consensus 239 ---~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 ---LPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ---CCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 110 00123468899999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=286.22 Aligned_cols=259 Identities=20% Similarity=0.220 Sum_probs=188.7
Q ss_pred CcccccCCeeEEEEEcCCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCCCh
Q 004402 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL 518 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 518 (755)
+.+|.|+++.|+++.. +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3445555666666654 7999999998754 344567899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc-----
Q 004402 519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE----- 593 (755)
Q Consensus 519 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~----- 593 (755)
.+++.... ...+++.....++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||.+.........
T Consensus 87 ~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 87 EDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99986432 234788899999999999999999986 999999999999999999999999998755322110
Q ss_pred cccccccccCCccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhc-----------c
Q 004402 594 ANTGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWK-----------D 660 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~ 660 (755)
.......++..|+|||.+.. ..++.++|||||||++|||++|+.|+....... ........... .
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhc
Confidence 11123356778999999876 358899999999999999999999985422111 11111000000 0
Q ss_pred CCCcc----ccCCCC----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 661 SKGKE----FIDPSL----DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 661 ~~~~~----~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..... ..++.. ...........+.+++.+||+.||++|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000 000000 01111122346778999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=294.23 Aligned_cols=263 Identities=22% Similarity=0.319 Sum_probs=192.8
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC------
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD------ 504 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 504 (755)
.++|...+.||+|+||.||+|.. .+|+.||||++... .......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36888899999999999999965 46899999998653 2223456889999999999999999999886543
Q ss_pred ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCc
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla 584 (755)
..++|+||+.. +|..++ ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 35899999964 665554 224788999999999999999999986 999999999999999999999999999
Q ss_pred cccccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHH------
Q 004402 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQ------ 657 (755)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~------ 657 (755)
+..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.|+....... ........
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 236 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGP 236 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence 754321 123456889999999876 468999999999999999999999985432111 11111100
Q ss_pred -----hccCCCccccC--CCCC-CCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHH--HHhhcCcc
Q 004402 658 -----WKDSKGKEFID--PSLD-DSS---SPCKLLNCMQVALLCVQENPEDRPSMLEVS--SMLKDDSM 713 (755)
Q Consensus 658 -----~~~~~~~~~~d--~~l~-~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl--~~L~~~~~ 713 (755)
+.......... +... ... .+.....+.+++.+||+.||++||++.|++ ..+++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000000000 0000 000 001223577999999999999999999999 44666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=276.15 Aligned_cols=250 Identities=22% Similarity=0.357 Sum_probs=201.5
Q ss_pred CCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
+|+..+.||+|+||.||++... +++.|++|++..... ...+.+.+|+++++.++|||++++++.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677889999999999999654 589999999876532 4566789999999999999999999999988999999999
Q ss_pred cCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 513 LPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 513 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999886432 1356899999999999999999999986 9999999999999999999999999998654432
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
.......+++.|+|||.+....++.++||||+|+++++|++|+.|+...... .. .......... .+
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~----~~~~~~~~~~-----~~ 223 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---EL----ALKILKGQYP-----PI 223 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HH----HHHHhcCCCC-----CC
Confidence 1222346788999999998888999999999999999999999887543211 11 1111111111 11
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.. .....+.+++.+||+.+|++|||+.|+++
T Consensus 224 ~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 PS----QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CC----CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11 22346789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=283.64 Aligned_cols=255 Identities=22% Similarity=0.315 Sum_probs=197.6
Q ss_pred CCCccCcccccCCeeEEEEEc----CCCCEEEEEEeccCC----hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCcc
Q 004402 436 NFSSANKLGEGGFGPVYKGNL----PRGQEFAVKRLSATS----TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDEN 506 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 506 (755)
+|+..+.||+|++|.||++.. .+++.||||++.... ....+.+.+|+.++.++ +|||++++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 366778999999999999863 357899999986532 22345688999999999 699999999999888899
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
++||||+++|+|.+++.. +..+++.....++.|++++|.|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999988853 235788999999999999999999876 99999999999999999999999999886
Q ss_pred cccCCcccccccccccCCccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCc
Q 004402 587 FRKDVDEANTGRIVGTYGYVPPEYVKKGI--YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664 (755)
Q Consensus 587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (755)
+...... ......++..|+|||.+.+.. .+.++||||||+++|||++|..|+...+...... . ........
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--~-~~~~~~~~--- 227 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS--E-ISRRILKS--- 227 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHH--H-HHHHHHcc---
Confidence 5433211 122345788999999987665 7889999999999999999999985432221111 1 11111000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 665 EFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 665 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
.+.... .....+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 228 ---~~~~~~----~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 ---KPPFPK----TMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ---CCCCCc----ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 011111 122367889999999999999999999888865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=279.36 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=193.5
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC-----ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--Ccc
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-----STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DEN 506 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 506 (755)
.+|+..+.||+|+||.||++.. .+++.||+|++... ..+....+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688889999999999999965 45899999987432 233456789999999999999999999998664 357
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
++++||+++++|.+++.. ...+++.....++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999988853 234788899999999999999999886 99999999999999999999999999986
Q ss_pred cccCCc-ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcc
Q 004402 587 FRKDVD-EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665 (755)
Q Consensus 587 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (755)
...... ........++..|+|||.+.+..++.++|||||||+++||++|+.|+..... . ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~---~~~~~~~~~~---- 225 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA---M---AAIFKIATQP---- 225 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH---H---HHHHHHHcCC----
Confidence 532211 1112234678899999999988899999999999999999999999743211 1 1111111110
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 666 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..+.+ +......+.+++.+||+ +|..||+..++++
T Consensus 226 -~~~~~----p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 -TKPML----PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -CCCCC----CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 01111 11223467899999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=293.09 Aligned_cols=266 Identities=22% Similarity=0.312 Sum_probs=199.5
Q ss_pred CCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC-----ccE
Q 004402 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD-----ENM 507 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 507 (755)
+|...+.||+|++|.||++... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4777899999999999999764 48999999987653 344567899999999999999999999987765 689
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
++|||++ ++|..++.. ...+++..+..++.+++.||.|||+.+ ++||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 478877743 236899999999999999999999986 999999999999999999999999999876
Q ss_pred ccCCcc-cccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHh-------
Q 004402 588 RKDVDE-ANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQW------- 658 (755)
Q Consensus 588 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~------- 658 (755)
...... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.|+......... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~ 230 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL---NLIVEVLGTPSEED 230 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHhcCCCChhH
Confidence 543210 112234578899999999887 7899999999999999999999988543321111 1111100
Q ss_pred ----ccCCCccccCCCC-CC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcC
Q 004402 659 ----KDSKGKEFIDPSL-DD-----SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM--LKDD 711 (755)
Q Consensus 659 ----~~~~~~~~~d~~l-~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~ 711 (755)
......+.+...- .. ...+.....+.+++.+||+.+|++||++.++++. +++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 0000001110000 00 0001123467899999999999999999999973 5543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=282.02 Aligned_cols=262 Identities=22% Similarity=0.267 Sum_probs=192.2
Q ss_pred CCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCccEEEEeec
Q 004402 437 FSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST-QGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
|...+.||+|++|.||+|... +++.|+||++..... .......+|+..+.+++ |||++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456789999999999999764 478999999865432 22234567899999998 999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
+|+|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 888988875432 246899999999999999999999986 99999999999999999999999999986543221
Q ss_pred cccccccccCCcccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHH----------HHHHHhccCC
Q 004402 594 ANTGRIVGTYGYVPPEYVK-KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLE----------YAFEQWKDSK 662 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~-~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~----------~~~~~~~~~~ 662 (755)
.....++..|+|||.+. ...++.++||||||++++||++|+.|+......+...... +.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 12345788999999875 4567999999999999999999998875433211110000 0000000000
Q ss_pred CccccCCCCC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 663 GKEFIDPSLD---DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 663 ~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
....+..... ....+.....+.+++.+||+.+|++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000000 0000011346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-33 Score=320.66 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=198.3
Q ss_pred hcCCCccCcccccCCeeEEEE-EcCCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
+-++.....||.|.||.||-+ ...+|+..|+|.+.-. .........+|+.++..++|||+|+.+|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 345666788999999999998 5677999999987544 2334556789999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
|||++|+|.+.+.. ....++.....+..|++.|++|||+.+ ||||||||.||+|+.+|.+|++|||.|..+...
T Consensus 1314 EyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999842 334667777788899999999999987 999999999999999999999999999987654
Q ss_pred Cccc--ccccccccCCccccccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcc
Q 004402 591 VDEA--NTGRIVGTYGYVPPEYVKKGI---YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665 (755)
Q Consensus 591 ~~~~--~~~~~~gt~~y~aPE~~~~~~---~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (755)
.... ......||+.|||||++.+.. ..-+.||||+|||+.||+||++|+...+..-. +.+ ....+..
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a---IMy---~V~~gh~-- 1459 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA---IMY---HVAAGHK-- 1459 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH---HHh---HHhccCC--
Confidence 3111 123468999999999997643 45689999999999999999999965443211 111 1111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 666 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
|.+. .....+-.+++..|++.||++|.++.|+++.
T Consensus 1460 ---Pq~P----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 ---PQIP----ERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ---CCCc----hhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1111 1123355789999999999999998877654
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=285.47 Aligned_cols=246 Identities=28% Similarity=0.395 Sum_probs=191.1
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.|+..+.||+|+||.||+|.. .+++.+|+|.+... .....+++.+|+++++.++|+|++++.+++......++|+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 466678899999999999965 45889999998642 23345578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+. |+|.+++... ...+++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 96 YCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred ccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 996 5777666432 234788999999999999999999886 999999999999999999999999998764322
Q ss_pred cccccccccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 592 DEANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
....++..|+|||.+. .+.++.++|||||||++|||++|+.|+....... .. . .......
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~---~-~~~~~~~----- 231 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---AL---Y-HIAQNES----- 231 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---HH---H-HHhhcCC-----
Confidence 1245788999999874 3567889999999999999999998874321110 00 0 0011100
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSML 708 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 708 (755)
+.. ........+.+++.+||+.+|++||++.++++..
T Consensus 232 ~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 232 PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred CCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 111 1112334678999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=279.18 Aligned_cols=259 Identities=23% Similarity=0.352 Sum_probs=190.5
Q ss_pred CCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhcC---CCCceeeeeeeeecCCc-----
Q 004402 437 FSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST--QGLEEFKNEVSLTARL---QHVNLLRVLGYCTERDE----- 505 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 505 (755)
|+..+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++.++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 456789999999999999765 489999999975422 2234566777776655 69999999999988776
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
.+++|||+.+ +|.+++... ....+++..++.++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999974 788877432 2235899999999999999999999986 9999999999999999999999999998
Q ss_pred ccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCc-
Q 004402 586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK- 664 (755)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 664 (755)
....... .....++..|+|||.+.+..++.++|||||||++|||++|+.|+......+ ...............
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QLDKIFDVIGLPSEEE 229 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HHHHHHHHcCCCChHh
Confidence 6543211 122356889999999999999999999999999999999987775322211 111111111100000
Q ss_pred ---------cccCCCCC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 665 ---------EFIDPSLD---DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 665 ---------~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
........ ....+.....+.+++.+||+.||++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 0011122356678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=279.02 Aligned_cols=241 Identities=27% Similarity=0.309 Sum_probs=184.2
Q ss_pred cccccCCeeEEEEEc-CCCCEEEEEEeccCCh---hhHHHHHHHH---HHHhcCCCCceeeeeeeeecCCccEEEEeecC
Q 004402 442 KLGEGGFGPVYKGNL-PRGQEFAVKRLSATST---QGLEEFKNEV---SLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514 (755)
Q Consensus 442 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 514 (755)
.||+|+||.||++.. .+++.||+|.+..... .....+..|. ..+....|||++++.+++...+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999965 4589999999865421 1112233443 34455689999999999999999999999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 594 (755)
+|+|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 9999988743 345899999999999999999999986 9999999999999999999999999997553221
Q ss_pred ccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
.....|+..|+|||.+.++ .++.++|||||||++|||++|+.|+........... .. ... .....+..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-~~---~~~------~~~~~~~~ 220 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DR---MTL------TMAVELPD 220 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-HH---Hhh------ccCCCCCC
Confidence 1234688999999998754 689999999999999999999999854322221111 00 000 01111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRP-----SMLEVSS 706 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 706 (755)
. ....+.+++.+|++.+|++|| ++.++++
T Consensus 221 ~----~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 221 S----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred c----CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1 234688999999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=281.63 Aligned_cols=251 Identities=23% Similarity=0.311 Sum_probs=192.4
Q ss_pred CCCccCcccccCCeeEEEEEc----CCCCEEEEEEeccCC----hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCcc
Q 004402 436 NFSSANKLGEGGFGPVYKGNL----PRGQEFAVKRLSATS----TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDEN 506 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 506 (755)
+|+..+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|+.++.++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999964 468999999986532 12345688899999999 699999999999988889
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
++|+||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999998853 235788899999999999999999976 99999999999999999999999999986
Q ss_pred cccCCcccccccccccCCccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCc
Q 004402 587 FRKDVDEANTGRIVGTYGYVPPEYVKKG--IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664 (755)
Q Consensus 587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (755)
....... ......|+..|+|||.+... .++.++||||||+++|||++|+.|+......... .... ......
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~-~~~~~~--- 227 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ--AEIS-RRILKS--- 227 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH--HHHH-HHhhcc---
Confidence 5432211 12234678899999998753 4688999999999999999999988543222111 1111 110000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004402 665 EFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRP-----SMLEVSS 706 (755)
Q Consensus 665 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 706 (755)
.+.. +......+.+++.+||+.+|++|| ++.++++
T Consensus 228 ---~~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 ---EPPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---CCCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0111 111234677999999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=293.36 Aligned_cols=264 Identities=20% Similarity=0.272 Sum_probs=191.8
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC----------
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTER---------- 503 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---------- 503 (755)
.+|...+.||.|+||.||+|.. .+|+.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5788899999999999999965 56899999998776666667889999999999999999999876543
Q ss_pred ----CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc-CCCCeEE
Q 004402 504 ----DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-NELNPKI 578 (755)
Q Consensus 504 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~-~~~~~kl 578 (755)
...++|+||++ ++|..++. ...+++.....++.||+.||.|||+.+ ++||||||+||+++ +++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 34689999997 58877763 235788999999999999999999886 99999999999997 4567899
Q ss_pred EecCCccccccCCccc-ccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHH
Q 004402 579 SDFGMAKLFRKDVDEA-NTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFE 656 (755)
Q Consensus 579 ~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 656 (755)
+|||+++......... ......++..|+|||.+.. ..++.++|||||||++|||++|+.|+......... .....
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~---~~~~~ 233 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM---QLILE 233 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHH
Confidence 9999998654321111 1122357889999997654 56889999999999999999999998533211100 00000
Q ss_pred Hhcc-----------CCCccccCCCCCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHH--HHhh
Q 004402 657 QWKD-----------SKGKEFIDPSLDDSS-----SPCKLLNCMQVALLCVQENPEDRPSMLEVS--SMLK 709 (755)
Q Consensus 657 ~~~~-----------~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl--~~L~ 709 (755)
.... ............... .+.....+.+++.+||+.||++|||+.|++ ..++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~ 304 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence 0000 000000000000000 011224677999999999999999999998 4454
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=282.71 Aligned_cols=249 Identities=25% Similarity=0.372 Sum_probs=198.8
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCccEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv 509 (755)
++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|++++.+++ ||||+++++++...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46788899999999999999654 6999999998653 2333467889999999998 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999998853 236899999999999999999999986 99999999999999999999999999986543
Q ss_pred CCcc------------------cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchH
Q 004402 590 DVDE------------------ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFL 651 (755)
Q Consensus 590 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~ 651 (755)
.... .......++..|+|||.+....++.++||||||++++|+++|+.|+..... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~ 231 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLTF 231 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHHH
Confidence 3211 122334678899999999888899999999999999999999998864331 1111
Q ss_pred HHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 004402 652 EYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSM----LEVSS 706 (755)
Q Consensus 652 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~----~evl~ 706 (755)
... ... ...+ +......+.+++.+||+.+|++||++ +++++
T Consensus 232 ~~~----~~~------~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 QKI----LKL------EYSF----PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHH----Hhc------CCCC----CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111 100 0011 11123467899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=286.96 Aligned_cols=264 Identities=21% Similarity=0.302 Sum_probs=194.1
Q ss_pred HHHhcCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeec-CCcc
Q 004402 431 KAATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE-RDEN 506 (755)
Q Consensus 431 ~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 506 (755)
...+++|+..+.||+|+||.||++. ..+++.||+|++... .....+.+.+|++++.+++|||++++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 3467889999999999999999996 447999999988543 22334678899999999999999999998865 4578
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
++++||+ +++|..++. ...+++.....++.|+++||.|||+.+ ++||||+|+||++++++.++|+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 568887773 234778888899999999999999987 99999999999999999999999999975
Q ss_pred cccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHH--------HHHHH
Q 004402 587 FRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLE--------YAFEQ 657 (755)
Q Consensus 587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~--------~~~~~ 657 (755)
.... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.|+............. .....
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 4321 122356788999998765 568999999999999999999998885432211000000 00000
Q ss_pred hccCCCccccCC-CCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 658 WKDSKGKEFIDP-SLDDSSS-----PCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 658 ~~~~~~~~~~d~-~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
.......+++.. ......+ +.....+.+++.+||+.+|++|||+.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000011000 0000000 1123468899999999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=288.63 Aligned_cols=262 Identities=21% Similarity=0.282 Sum_probs=191.8
Q ss_pred cCCCc-cCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhh--------------HHHHHHHHHHHhcCCCCceeeeee
Q 004402 435 NNFSS-ANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQG--------------LEEFKNEVSLTARLQHVNLLRVLG 498 (755)
Q Consensus 435 ~~f~~-~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g 498 (755)
++|.. .+.||+|+||+||++.. ..++.||||.++...... ...+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 34543 46799999999999964 468999999986542211 124778999999999999999999
Q ss_pred eeecCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEE
Q 004402 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI 578 (755)
Q Consensus 499 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl 578 (755)
++...+..+++|||+. |+|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 688888743 335888999999999999999999886 999999999999999999999
Q ss_pred EecCCccccccCC------------cccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 004402 579 SDFGMAKLFRKDV------------DEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTS 645 (755)
Q Consensus 579 ~Dfgla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~ 645 (755)
+|||++....... .........++..|+|||.+.+. .++.++|||||||++|||++|+.|+......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999998654111 01111123467889999988764 4789999999999999999999888543322
Q ss_pred cccchHHHHHHHhccCCCc---cc--------cCCCCCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 646 ENLNFLEYAFEQWKDSKGK---EF--------IDPSLDD---SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~---~~--------~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. ............... .. ....... .........+.+++..||+.+|++|||+.|++.
T Consensus 241 ~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 D---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred H---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1 111121111111000 00 0000000 000112346789999999999999999999985
|
|
| >COG3858 Predicted glycosyl hydrolase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=280.70 Aligned_cols=234 Identities=19% Similarity=0.227 Sum_probs=188.8
Q ss_pred CceEEEEecCCCCCccccccC--CCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCCCcccHHHHH
Q 004402 89 SIKTLLSIWNGQNSTYQSILG--NKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILL 166 (755)
Q Consensus 89 ~lk~~isigg~~~~~~~~~~g--g~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~~~~~~~~~l 166 (755)
+++.++.+ +|.+ +.+++.+.++.++.|+..+.++++++++.++.+|+.||.||+|...+.|++.|..|+
T Consensus 160 ~i~~~~~i---------SN~~~~~~~f~~ela~~lL~net~~~~~i~~ii~~l~~~Gyrgv~iDfE~v~~~DR~~yt~fl 230 (423)
T COG3858 160 KIKPVPGI---------SNGTRPGANFGGELAQLLLNNETAKNRLINNIITLLDARGYRGVNIDFENVGPGDRELYTDFL 230 (423)
T ss_pred ccceeEEE---------ecCCccccccchHHHHHHHhcHHHHHHHHHHHHHHHHhcCcccEEechhhCCHHHHHHHHHHH
Confidence 46666666 2223 455667778999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHccCCCccEEEeeeecCCc-----ccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHH
Q 004402 167 DEWKASASDQPELTLSMAVRYSPT-----HETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDF 241 (755)
Q Consensus 167 ~~lr~~l~~~~~~~ls~~~~~~~~-----~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~ 241 (755)
+++|++|+++ ++.+++|+++... .|...||++.+++++|++.|||||.|.. + +.+|+.||.. +++.
T Consensus 231 R~~r~~l~~~-G~~~siAvaakt~~~~~G~W~~~~dy~a~Gkiad~v~lMtYd~h~~-g-G~PG~vA~i~------~vr~ 301 (423)
T COG3858 231 RQVRDALHSG-GYTVSIAVAAKTSDLQVGSWHGAYDYVALGKIADFVILMTYDWHYS-G-GPPGPVASIG------WVRK 301 (423)
T ss_pred HHHHHHhccC-CeEEEEEecCCCCCCcCccccchhhhhhhceeeeEEEEEEeccCcC-C-CCCCcccCch------hHhh
Confidence 9999999987 8999999998653 3445689999999999999999999833 3 4588888863 6666
Q ss_pred HHHHHHHCCCCCCceeecccccCCCcccCC----Cc----chHHHHHHHhhcCCCcccccccceeeeee----ecC-cEE
Q 004402 242 GIREWLRRGFPANKLVLGARASGPGITIDG----SM----GYKFIRAFIQNYGYGAAPVYNASYVVNLF----TSG-ATW 308 (755)
Q Consensus 242 ~v~~~~~~g~p~~KlvlG~p~yG~~~~~~~----~~----~y~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~-~~~ 308 (755)
.+++-+. -+|++||+||+|+||++|+... .. ...+. ......++.+..||..+..+++ .++ .|+
T Consensus 302 ~ieya~T-~iP~~Kv~mGip~YGYDW~~~y~~~g~~~~a~~~~~~--i~ia~~y~A~Iq~D~~~qsp~F~y~D~eg~~h~ 378 (423)
T COG3858 302 VIEYALT-VIPAEKVMMGIPLYGYDWTLPYDPLGYLARAISPDEA--IDIANRYNATIQYDATSQSPFFYYVDKEGRYHE 378 (423)
T ss_pred hhhhhhe-ecchHHeEEccccccccccCCCCCCcceeeecCcchh--hhhhcccCCccCcCccccCceEEEEcCCCceEE
Confidence 6555555 6999999999999999999872 22 22221 1123344566677766665554 244 799
Q ss_pred EeeCCcchhhhhhhcccccCccccccccccccchh
Q 004402 309 INFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNW 343 (755)
Q Consensus 309 i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~dd~~ 343 (755)
|||||.+|++.|.++++++||.||+.|.|+++++.
T Consensus 379 VWfeD~~s~~~k~~lik~ygl~GVs~W~Lg~e~p~ 413 (423)
T COG3858 379 VWFEDARSFQTKLDLIKEYGLRGVSYWVLGQEDPR 413 (423)
T ss_pred EEcCchHHHHHHHHHHHHcCCceEEEEEecCcchh
Confidence 99999999999999999999999999999998764
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=283.47 Aligned_cols=244 Identities=27% Similarity=0.382 Sum_probs=189.2
Q ss_pred CCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
|...+.||+|+||.||+|+. .+++.|++|++.... ....+.+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999965 468899999986432 23345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+. |+|.+++.. ....+++.++..++.|++.++.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 567666643 2345889999999999999999999886 99999999999999999999999999864221
Q ss_pred ccccccccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 593 EANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
.....|+..|+|||.+. ...++.++|||||||++|||++|..|+..... ....... .. .....
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~---~~~~~~~---~~-~~~~~---- 239 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHI---AQ-NDSPT---- 239 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHH---Hh-cCCCC----
Confidence 12346788999999874 46688999999999999999999988743221 1111111 00 01001
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
.. .......+.+++.+||+.+|++||++.++++.
T Consensus 240 -~~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 -LQ---SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 10 11122357889999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-33 Score=268.05 Aligned_cols=253 Identities=22% Similarity=0.328 Sum_probs=192.2
Q ss_pred ccCcccccCCeeEEEEE-cCCCCEEEEEEeccCCh-hhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEEEeecCC
Q 004402 439 SANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATST-QGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 439 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
.+..||.|+||+|+|-. .+.|+..|||+++.... ...++++.|.+...+- +.||||+++|.+..++..++.||.|.
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd- 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD- 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence 34789999999999984 45699999999987643 6677899998876555 79999999999999999999999994
Q ss_pred CChhhhhcC--CCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 516 KSLDLYLFD--PIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 516 gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
.||+.+-.. ...+..+++...-+|......||.||.... .|||||+||+||||+..|.+||||||++..+..+..
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA- 223 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA- 223 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHH-
Confidence 477655321 123445788888889999999999998765 599999999999999999999999999987654322
Q ss_pred cccccccccCCccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
.+.-.|-..|||||.+.. ..|+.+|||||||++|+|+.||+.|+..+.+ ..+.+. ....++...+..+
T Consensus 224 --kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~----~Vv~gdpp~l~~~-- 293 (361)
T KOG1006|consen 224 --KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLC----QVVIGDPPILLFD-- 293 (361)
T ss_pred --hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHH----HHHcCCCCeecCc--
Confidence 233467788999998864 3489999999999999999999998865443 111111 1122222222111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
.........+..++..|+.+|-+.||...++.++
T Consensus 294 --~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 --KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred --ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1111234468899999999999999999998753
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-32 Score=292.30 Aligned_cols=269 Identities=18% Similarity=0.250 Sum_probs=196.5
Q ss_pred cCHHHHHHHhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeee
Q 004402 425 FSFSDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501 (755)
Q Consensus 425 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 501 (755)
....++...+++|+..+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++.+++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34556777889999999999999999999964 568999999987542 223456888999999999999999999875
Q ss_pred cC------CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC
Q 004402 502 ER------DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN 575 (755)
Q Consensus 502 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~ 575 (755)
.. ...+++++++ +++|..++.. ..+++..+..++.|+++||.|||+.+ ++||||||+||++++++.
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCC
Confidence 43 2357788876 7788877632 34889999999999999999999986 999999999999999999
Q ss_pred eEEEecCCccccccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHH--
Q 004402 576 PKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLE-- 652 (755)
Q Consensus 576 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~-- 652 (755)
+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.|+.............
T Consensus 159 ~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (345)
T cd07877 159 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233 (345)
T ss_pred EEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999999999754321 223467889999998866 568899999999999999999998875332211110000
Q ss_pred ------HHHHHhccCCCc-------cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 653 ------YAFEQWKDSKGK-------EFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 653 ------~~~~~~~~~~~~-------~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
.....+...... .......... .......+.+++.+|++.||.+||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhh-cCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000000000 0000000000 00112357799999999999999999988843
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=284.43 Aligned_cols=264 Identities=22% Similarity=0.314 Sum_probs=190.8
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCceeeeeeeeecCC------
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERD------ 504 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 504 (755)
.++|+..+.||+|+||.||++.. .+++.+|||++..... .....+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46888999999999999999965 4589999999865422 22345778999999999999999999875433
Q ss_pred --ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecC
Q 004402 505 --ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG 582 (755)
Q Consensus 505 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg 582 (755)
..++|+||+.. +|...+... ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999975 566555432 345899999999999999999999987 9999999999999999999999999
Q ss_pred CccccccCCccc---------ccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHH
Q 004402 583 MAKLFRKDVDEA---------NTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLE 652 (755)
Q Consensus 583 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~ 652 (755)
+++......... ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.|+........ ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~---~~ 237 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ---LH 237 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH---HH
Confidence 998654322111 1123456888999998765 4588999999999999999999988753322211 11
Q ss_pred HHHHHhccC---------CCcc----ccCCCCCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 653 YAFEQWKDS---------KGKE----FIDPSLDDS---SSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 653 ~~~~~~~~~---------~~~~----~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
......... .... ......... ........+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111111000 0000 000000000 00011246789999999999999999998874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=278.09 Aligned_cols=259 Identities=25% Similarity=0.338 Sum_probs=194.6
Q ss_pred CCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 437 FSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
|+..+.||+|++|.||+|... +++.||+|.+.... ....+.+..|+.++++++|+|++++++++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999664 48999999987653 333467888999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
+ ++|.+++.... ..+++..+..++.+++.||.|||+.+ ++||||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 58988885432 35899999999999999999999986 99999999999999999999999999986543221
Q ss_pred cccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC------ccc
Q 004402 594 ANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG------KEF 666 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 666 (755)
......++..|+|||.+... .++.++|||||||++|||++|+.|+....... .............. ..+
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID---QLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHHHhCCCcHHHHHhhccc
Confidence 11223456789999998766 78999999999999999999988874422111 11111111000000 000
Q ss_pred --cCCCCC---C----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 667 --IDPSLD---D----SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 667 --~d~~l~---~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+.... . ...+.....+.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000 0 000111346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=289.74 Aligned_cols=266 Identities=20% Similarity=0.297 Sum_probs=194.0
Q ss_pred HhcCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC-----
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD----- 504 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 504 (755)
..++|+..+.||+|+||.||++. ..+++.||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 46789999999999999999995 456899999998643 2333456889999999999999999999886543
Q ss_pred -ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCC
Q 004402 505 -ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM 583 (755)
Q Consensus 505 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl 583 (755)
..++|+||+ +++|..++. ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 348999998 678887763 235889999999999999999999986 99999999999999999999999999
Q ss_pred ccccccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccch-H-------HHH
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNF-L-------EYA 654 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~-~-------~~~ 654 (755)
+...... .....+++.|+|||.+.+ ..++.++|||||||++++|++|+.|+........... . ...
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 165 ARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred ccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9864322 122356889999998876 4588999999999999999999998853321100000 0 000
Q ss_pred HHHhccCCCccccCC--CCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH--HHhhcC
Q 004402 655 FEQWKDSKGKEFIDP--SLDD----SSSPCKLLNCMQVALLCVQENPEDRPSMLEVS--SMLKDD 711 (755)
Q Consensus 655 ~~~~~~~~~~~~~d~--~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl--~~L~~~ 711 (755)
...+.......+... .... .........+.+++.+|++.||++|||+.+++ ..++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 000000000000000 0000 00011223578999999999999999999998 444443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=287.23 Aligned_cols=248 Identities=22% Similarity=0.320 Sum_probs=201.4
Q ss_pred HhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
....|.+...||+|.|+.|.+++. .++..||||.+.+.. ....+.+.+|+++|..++|||||+++.+......+++|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 456888999999999999999954 569999999998763 33445689999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||+.+|.+.+++.... .+.......++.|+..+++|+|+.+ |+|||||++||||+.+.++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999996533 3455788889999999999999998 99999999999999999999999999998753
Q ss_pred CCcccccccccccCCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
. ......+|++.|.|||++.+..| ++++|+||+|++||-|++|..||+...-..... ..+.. .
T Consensus 208 ~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~-----------rvl~g--k 271 (596)
T KOG0586|consen 208 G---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP-----------RVLRG--K 271 (596)
T ss_pred c---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc-----------hheee--e
Confidence 2 23345789999999999998877 589999999999999999999996433222111 00000 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
-++... ...+|-+++++++-.+|.+|++++++-+
T Consensus 272 ~rIp~~----ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 272 YRIPFY----MSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ecccce----eechhHHHHHHhhccCccccCCHHHhhh
Confidence 011111 1125678899999999999999988763
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=265.23 Aligned_cols=270 Identities=20% Similarity=0.299 Sum_probs=194.7
Q ss_pred cCCCccCcccccCCeeEEEEEc-C--C--CCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCceeeeeeeeec-CCcc
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-P--R--GQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTE-RDEN 506 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~--~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 506 (755)
..|+....||+|.+|.||++.- + + ...+|||.++.... .......+|+.+++.++|||++.+..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 4688889999999999999932 2 2 33799999976532 122456899999999999999999999887 6678
Q ss_pred EEEEeecCCCChhhhhc--CCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC----CCeEEEe
Q 004402 507 MLIYEYLPNKSLDLYLF--DPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE----LNPKISD 580 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~--~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~----~~~kl~D 580 (755)
++++||.+...+ ..++ .......++......|+.||..|+.|||++. |+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEhDL~-~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEHDLW-HIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhhhHH-HHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999988444 4442 2223357888899999999999999999998 9999999999999888 9999999
Q ss_pred cCCccccccCCcc-cccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC------cccchHH
Q 004402 581 FGMAKLFRKDVDE-ANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTS------ENLNFLE 652 (755)
Q Consensus 581 fgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~------~~~~~~~ 652 (755)
||+++.+...... .....++-|.+|.|||.+.+ ..||.+.|||+.|||+.||+|..+-|...... -..+.+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999988765332 24456778999999998876 46999999999999999999988766432211 0112222
Q ss_pred HHHHHhccCCCc------cccCC-C----CC-CCCCHH-----------HHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 004402 653 YAFEQWKDSKGK------EFIDP-S----LD-DSSSPC-----------KLLNCMQVALLCVQENPEDRPSMLEVSSML 708 (755)
Q Consensus 653 ~~~~~~~~~~~~------~~~d~-~----l~-~~~~~~-----------~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 708 (755)
+.+..+.-.... .+.+- . +. .....+ ....-++|...+|+.||-+|.|+++.++--
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 222222111100 00000 0 00 000000 011246789999999999999999988644
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=274.88 Aligned_cols=249 Identities=26% Similarity=0.353 Sum_probs=191.1
Q ss_pred CCCccCcccccCCeeEEEEEcCC-CCEEEEEEeccC-----ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 436 NFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSAT-----STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
+|...+.||+|+||.||++.... +..+++|.++.. .......+..|+.++++++|||++++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 46778899999999999996533 455666665432 122334577899999999999999999999988899999
Q ss_pred EeecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 510 YEYLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
+||+++++|..++... .....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++ +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999887542 22356899999999999999999999976 999999999999986 569999999998654
Q ss_pred cCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
.... ......++..|+|||.+.+..++.++||||||+++|+|++|..|+.... . ...... .... ..
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~---~---~~~~~~-~~~~-----~~ 222 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN---F---LSVVLR-IVEG-----PT 222 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---H---HHHHHH-HHcC-----CC
Confidence 3221 1223457889999999988889999999999999999999998874221 1 111111 1111 11
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+.+ +......+.+++.+||+.+|++||++.|+++
T Consensus 223 ~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 PSL----PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCC----cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 111 1233347889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=285.73 Aligned_cols=259 Identities=21% Similarity=0.288 Sum_probs=187.6
Q ss_pred CCCccCcccccCCeeEEEEEcC-C--CCEEEEEEeccC--ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecC----Cc
Q 004402 436 NFSSANKLGEGGFGPVYKGNLP-R--GQEFAVKRLSAT--STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER----DE 505 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 505 (755)
+|+..+.||+|+||.||++... . +..||+|++... .....+.+.+|+.++.++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999653 3 779999998653 222345688899999999 599999999875432 34
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
.++++||+. ++|..++.. ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888886 688887743 345889999999999999999999986 9999999999999999999999999998
Q ss_pred ccccCCcc--cccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHH------
Q 004402 586 LFRKDVDE--ANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFE------ 656 (755)
Q Consensus 586 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~------ 656 (755)
.+...... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.|+....... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~ 230 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPD 230 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCC
Confidence 65432211 11223568899999998765 568999999999999999999998875422111 1110000
Q ss_pred -----HhccCCCccc-------cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004402 657 -----QWKDSKGKEF-------IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVS 705 (755)
Q Consensus 657 -----~~~~~~~~~~-------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 705 (755)
.+........ ....+.. ..+.....+.+++.+|++.||++|||+.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0000000000 0000000 0011234678999999999999999999987
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=300.77 Aligned_cols=255 Identities=26% Similarity=0.384 Sum_probs=184.1
Q ss_pred HHhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC------
Q 004402 432 AATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER------ 503 (755)
Q Consensus 432 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 503 (755)
.-..+|+.++.||+||||.|||++. -+|+.+|||++... .......+.+|+.+|++|+|||+|+++....+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 3456788899999999999999954 37999999998655 334455788999999999999999976311000
Q ss_pred --------------------------------------------------------------------------------
Q 004402 504 -------------------------------------------------------------------------------- 503 (755)
Q Consensus 504 -------------------------------------------------------------------------------- 503 (755)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHH
Q 004402 504 ---------------------------------DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL 550 (755)
Q Consensus 504 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L 550 (755)
..+||-||||+..+|.+++...... -.....++++.+|++||+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHH
Confidence 1135677888877777666432111 13567889999999999999
Q ss_pred HhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc----------------cCCcccccccccccCCccccccccCC
Q 004402 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR----------------KDVDEANTGRIVGTYGYVPPEYVKKG 614 (755)
Q Consensus 551 h~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~ 614 (755)
|+++ +|||||||.||+||++..+||+|||+++... ........+..+||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9997 9999999999999999999999999998721 00111123456899999999999764
Q ss_pred ---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcc
Q 004402 615 ---IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCV 691 (755)
Q Consensus 615 ---~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl 691 (755)
.|+.|+|+||+|||++||+- ||. ...+ .. .....++.+.+..- +.+ .......-..++.+++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~--TsME---Ra-~iL~~LR~g~iP~~--~~f----~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFG--TSME---RA-SILTNLRKGSIPEP--ADF----FDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCC--chHH---HH-HHHHhcccCCCCCC--ccc----ccccchHHHHHHHHHh
Confidence 49999999999999999985 332 1111 11 12333343333222 111 1112223357899999
Q ss_pred cCCCCCCCCHHHHHH
Q 004402 692 QENPEDRPSMLEVSS 706 (755)
Q Consensus 692 ~~dP~~RPt~~evl~ 706 (755)
+.||.+|||+.|+++
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999875
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=264.17 Aligned_cols=241 Identities=23% Similarity=0.310 Sum_probs=192.9
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
-++|+.+++||+|.||.|-+++- ..++.+|+|++++.- .+....-+.|-.+|...+||.+..+--.+...+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 46888999999999999999954 569999999998763 33344567899999999999999998889999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||..+|.|.-+|. +...+++......-..|..||.|||+.+ ||.||||.+|.|||.+|++||+|||+++.-..
T Consensus 247 MeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999987773 3445777888888899999999999987 99999999999999999999999999985332
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
.......++||+.|+|||++....|..++|.|.+||++|||++|+.||-..+......++. .. |-
T Consensus 321 --~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl--~e-----------d~ 385 (516)
T KOG0690|consen 321 --YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL--ME-----------DL 385 (516)
T ss_pred --ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH--hh-----------hc
Confidence 2233456899999999999999999999999999999999999999985433332222211 00 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRP 699 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 699 (755)
++....++ +...|....|.+||.+|-
T Consensus 386 kFPr~ls~----eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 KFPRTLSP----EAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred cCCccCCH----HHHHHHHHHhhcChHhhc
Confidence 11112222 445677788999999994
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=289.18 Aligned_cols=258 Identities=20% Similarity=0.294 Sum_probs=192.8
Q ss_pred HhcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc----
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE---- 505 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---- 505 (755)
..++|+..+.||+|++|.||+|... +++.||||++... .....+.+.+|+.++++++|||++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567888999999999999999764 5889999998653 22334567889999999999999999998766554
Q ss_pred --cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCC
Q 004402 506 --NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM 583 (755)
Q Consensus 506 --~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl 583 (755)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5688887742 35899999999999999999999986 99999999999999999999999999
Q ss_pred ccccccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHH-----
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQ----- 657 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~----- 657 (755)
+...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.|+....... ........
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~~~ 236 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGTPD 236 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCC
Confidence 9865332 122356888999998865 467899999999999999999999885332211 11111111
Q ss_pred ------hccCCCccccCCCC---CCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 658 ------WKDSKGKEFIDPSL---DDSS---SPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 658 ------~~~~~~~~~~d~~l---~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+.......++.... .... .......+.+++.+||+.+|++|||+.||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000000000000 0000 0011346889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=265.75 Aligned_cols=236 Identities=24% Similarity=0.308 Sum_probs=189.5
Q ss_pred ccccCCeeEEEEEcC-CCCEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCCCh
Q 004402 443 LGEGGFGPVYKGNLP-RGQEFAVKRLSATST---QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL 518 (755)
Q Consensus 443 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 518 (755)
||+|+||.||++... +++.+|+|++..... ...+.+..|++++++++|||++++++.+......+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999764 589999999876532 2456789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccccccc
Q 004402 519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598 (755)
Q Consensus 519 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 598 (755)
.+++... ..+++.....++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 9988532 25889999999999999999999976 9999999999999999999999999998654321 12233
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHH
Q 004402 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPC 678 (755)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 678 (755)
..++..|++||.+.+...+.++|+||||+++|||++|+.|+..... ....... ... ...+...
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~----~~~------~~~~~~~---- 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKI----LKD------PLRFPEF---- 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH----hcC------CCCCCCC----
Confidence 4678899999999888899999999999999999999998853321 1111111 110 0111111
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHH
Q 004402 679 KLLNCMQVALLCVQENPEDRPSMLE 703 (755)
Q Consensus 679 ~~~~l~~l~~~Cl~~dP~~RPt~~e 703 (755)
....+.+++.+||..||++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1346789999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06544 GH18_narbonin Narbonin is a plant 2S protein from the globulin fraction of narbon bean (Vicia narbonensis L | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=263.38 Aligned_cols=203 Identities=15% Similarity=0.119 Sum_probs=143.1
Q ss_pred CCCCCCCCCC--cceEEEEEEE-ecC----CCcEEecCCchhhHHHHHHHHHHhhCCCceEEEEecCCCCCccccccCCC
Q 004402 39 FPLSDINSAL--FTHLICAFAE-VDS----STYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNK 111 (755)
Q Consensus 39 ~~~~~i~~~~--~thi~~~f~~-~~~----~~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg~~~~~~~~~~gg~ 111 (755)
.++++||... ||||||||+. .+. .++.+......+......+..+|++||++|||+|||||.. |+
T Consensus 13 ~~~~dip~~~~~~thii~aFa~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lK~~~p~lKvllSiGG~~~-------~~- 84 (253)
T cd06544 13 VTFSDVPINPKVEFHFILSFAIDYDTESNPTNGKFNPYWDTENLTPEAVKSIKAQHPNVKVVISIGGRGV-------QN- 84 (253)
T ss_pred ccccccCCCCCeeEEEEEEeeeecccccCCCCCccccccCccccCHHHHHHHHHhCCCcEEEEEeCCCCC-------CC-
Confidence 4688999999 9999999994 322 1344433333333344555889999999999999966663 11
Q ss_pred CCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCCCcccHHHHHHHHHHHccCCCccEEEeeeecCCcc
Q 004402 112 NINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTH 191 (755)
Q Consensus 112 ~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~~~~~~~~~l~~lr~~l~~~~~~~ls~~~~~~~~~ 191 (755)
+..+....+.+..|++||+++++++++|||||||||||||. .++++|+.|+++||++|++. ++++.+++.+....
T Consensus 85 ---~~~~~~~~~~~~~~~~fv~S~~~~l~~~~fDGiDiDwE~~~-~d~~~f~~ll~~l~~~l~~~-~~lt~a~vap~~~~ 159 (253)
T cd06544 85 ---NPTPFDPSNVDSWVSNAVSSLTSIIQTYNLDGIDIDYEHFP-ADPDTFVECIGQLITELKNN-GVIKVASIAPSEDA 159 (253)
T ss_pred ---CccccCchhhhhHHHHHHHHHHHHHHHhCCCceeeecccCC-cCHHHHHHHHHHHHHHhhhc-CCeEEEEecCCccc
Confidence 11233344555566777999999999999999999999994 67999999999999999875 44444444433322
Q ss_pred cccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHHHHHHCCCCCCceeecccccCCCcc
Q 004402 192 ETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGARASGPGIT 268 (755)
Q Consensus 192 ~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~~~~~~g~p~~KlvlG~p~yG~~~~ 268 (755)
. ..+..+.+.+++|++++|+||+++.+ ++ ...+ ......+.|. .++|++||++|+|+++++|.
T Consensus 160 ~-~~~y~~~~~~~~d~id~~~~qfy~~~-~~--~~~~---------~~~~~~~~~~-~~~p~~Kv~lGl~a~~~~~~ 222 (253)
T cd06544 160 E-QSHYLALYNAYGDYIDYVNYQFYNYG-VP--TTVA---------KYVEFYDEVA-NNYPGKKVLASFSTDGEDGA 222 (253)
T ss_pred c-ccccHHHHHHhhCceeEEEhhhhCCC-CC--CCHH---------HHHHHHHHHH-hCCCcccEEEEEecCCCccC
Confidence 2 33558888999999999999999542 21 1111 1112333343 47999999999999997764
|
) cotyledons with unknown function. Narbonin has a glycosyl hydrolase family 18 (GH18) domain without the conserved catalytic residues and with no known enzymatic activity. Narbonin amounts to up to 3% of the total seed globulins of mature seeds and was thought to be a storage protein but was found to degrade too slowly during germination. This family also includes the VfNOD32 nodulin from Vicia faba. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=288.89 Aligned_cols=260 Identities=23% Similarity=0.334 Sum_probs=207.6
Q ss_pred CHHHHHHHhcCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeeeeec-
Q 004402 426 SFSDIKAATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTE- 502 (755)
Q Consensus 426 ~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~- 502 (755)
.++.+...+..|++.++||.|.+|.||+++ .++++.+|+|+...... ..+++..|.++++.. .|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 344444556778899999999999999995 45689999998866533 346778899999988 79999999999854
Q ss_pred ----CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEE
Q 004402 503 ----RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI 578 (755)
Q Consensus 503 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl 578 (755)
.+.++||||||.+||..++..... ...+.|..+..|+..++.||.+||.+. ++|||||-.|||++.++.+||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 467899999999999999986654 567999999999999999999999987 999999999999999999999
Q ss_pred EecCCccccccCCcccccccccccCCccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHH
Q 004402 579 SDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK-----GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEY 653 (755)
Q Consensus 579 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~ 653 (755)
+|||.+.++.... .+.....||+.|||||++.. ..|+..+|+||||++..||--|.+|+....... .
T Consensus 165 vDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr------a 236 (953)
T KOG0587|consen 165 VDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR------A 236 (953)
T ss_pred eeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh------h
Confidence 9999998775543 34455789999999999864 347789999999999999999988874322211 1
Q ss_pred HHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 654 AFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 654 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+. -.-.|......+......+.+++..|+.+|-++||++.++++
T Consensus 237 LF~--------IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 LFL--------IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hcc--------CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 110 001122222234566778899999999999999999998874
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=297.48 Aligned_cols=145 Identities=27% Similarity=0.389 Sum_probs=128.9
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|...+.||+|+||.||+|... +++.||||+++... ....+.+..|+.++..++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888899999999999999654 68999999986542 333467889999999999999999999999889999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
||+++++|..++.. ...+++...+.++.||+.||.|||..+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999998853 234788899999999999999999976 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=267.35 Aligned_cols=257 Identities=27% Similarity=0.391 Sum_probs=194.8
Q ss_pred hcCCCccCcccccCCeeEEEE-EcCCCCEEEEEEeccC--Ch-----hhHHHHHHHHHHHhcCCCCceeeeeeeee-cCC
Q 004402 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--ST-----QGLEEFKNEVSLTARLQHVNLLRVLGYCT-ERD 504 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~--~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~ 504 (755)
.++|-++.+||+|+|+.||++ .+...+-||||+-..+ .. ...+...+|..+-+.|.||.||++++++. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 456777889999999999999 5667889999975332 11 12345678999999999999999999985 456
Q ss_pred ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc---CCCCeEEEec
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD---NELNPKISDF 581 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~---~~~~~kl~Df 581 (755)
..|-|+|||++.+|+.||.. ...+++++...|+.||+.||.||.+.. +||||-||||.||||- ..|.+||+||
T Consensus 542 sFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 78999999999999999953 456899999999999999999999864 6899999999999994 4578999999
Q ss_pred CCccccccCCcc-----cccccccccCCccccccccC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHH
Q 004402 582 GMAKLFRKDVDE-----ANTGRIVGTYGYVPPEYVKK----GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLE 652 (755)
Q Consensus 582 gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~ 652 (755)
|+++.+..+... ..++...||.+|++||.+.- ..++.++||||.|||+|+.+-|++||........+ +.
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI--Lq 695 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI--LQ 695 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH--Hh
Confidence 999987654332 22445689999999997743 35789999999999999999999999643322211 11
Q ss_pred HHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004402 653 YAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVS 705 (755)
Q Consensus 653 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 705 (755)
.. .--...++--| .-+....+...++.+||+.--++|....++.
T Consensus 696 eN----TIlkAtEVqFP-----~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 EN----TILKATEVQFP-----PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hh----chhcceeccCC-----CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 00 00000111000 0111123556899999999999999887775
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=266.67 Aligned_cols=262 Identities=20% Similarity=0.254 Sum_probs=199.5
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC--CC----ceeeeeeeeecCCcc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ--HV----NLLRVLGYCTERDEN 506 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--H~----niv~l~g~~~~~~~~ 506 (755)
+++|.+...+|+|.||.|-.+.. ..+..||||+++.- ....+..+-|+++|.++. .| -+|.+.+|+.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 67899999999999999999943 44789999998654 344566788999999993 23 378888999999999
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC--------------
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-------------- 572 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~-------------- 572 (755)
|+|+|.+ +-|+.++|..+ .-..++...+..|+.|++++++|||++. ++|.||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999988 55888888543 3345788999999999999999999997 999999999999932
Q ss_pred ------CCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 004402 573 ------ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646 (755)
Q Consensus 573 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~ 646 (755)
+..+||+|||.|+.-.. ..+.++.|..|.|||++.+-.++.++||||+||||.||.||...|....+.+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 34589999999986322 2346788999999999999999999999999999999999998886655444
Q ss_pred ccchHHHHHHHhcc--------------CCC-----------ccccCCCC----CCCCCHHHHHHHHHHHHHcccCCCCC
Q 004402 647 NLNFLEYAFEQWKD--------------SKG-----------KEFIDPSL----DDSSSPCKLLNCMQVALLCVQENPED 697 (755)
Q Consensus 647 ~~~~~~~~~~~~~~--------------~~~-----------~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~ 697 (755)
...+.+.....+.. +.+ ....++.. .......+..++.+|+..+|..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 44333333221110 000 00000000 00112244567899999999999999
Q ss_pred CCCHHHHHH
Q 004402 698 RPSMLEVSS 706 (755)
Q Consensus 698 RPt~~evl~ 706 (755)
|+|+.|++.
T Consensus 397 RiTl~EAL~ 405 (415)
T KOG0671|consen 397 RITLREALS 405 (415)
T ss_pred cccHHHHhc
Confidence 999999874
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=232.06 Aligned_cols=260 Identities=22% Similarity=0.289 Sum_probs=192.5
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
+|+..++||+|.+|+||+++. .+++.||+|+++..+ +..-...++|+-+++.++|.|||++++....+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 455678999999999999964 558999999987653 22345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
|.. +|..+.-. -...++.+....++.|+.+||.|.|+.+ +.|||+||.|.||+.+|++|++|||+++.+.-...
T Consensus 83 cdq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 954 67766532 2345888999999999999999999987 99999999999999999999999999997764322
Q ss_pred ccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCC-CCCCCCcccchHHHHHHHhccC------CCc
Q 004402 593 EANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNA-RYYGTSENLNFLEYAFEQWKDS------KGK 664 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~------~~~ 664 (755)
..+..+-|..|.+|.++.+. -|+...|+||-||++.|+....+|. +..+ ..+.+...++.+... .+.
T Consensus 157 --cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d---vddqlkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND---VDDQLKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred --eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc---HHHHHHHHHHHhCCCccccCCccc
Confidence 22234568999999998775 5899999999999999999765554 2222 222223333332221 122
Q ss_pred cccCCCCCCCCCHH-----HH----HHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 665 EFIDPSLDDSSSPC-----KL----LNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 665 ~~~d~~l~~~~~~~-----~~----~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+.|......++.. .. ..=.++....+..+|.+|.++++.++
T Consensus 232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 33332222211111 01 11246777788889999999887764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=292.39 Aligned_cols=206 Identities=21% Similarity=0.310 Sum_probs=179.6
Q ss_pred HHHHHHHhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeec
Q 004402 427 FSDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE 502 (755)
Q Consensus 427 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 502 (755)
..++....++|+++++||+|+||.|..++. .+++.+|+|++.+. .......|..|-.+|..-+.+-|+.+.-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 355666678999999999999999999976 45889999999763 22334579999999999999999999999999
Q ss_pred CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecC
Q 004402 503 RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG 582 (755)
Q Consensus 503 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg 582 (755)
...+|+|||||+||+|-.++.... .+++......+..|.-||..||+.+ +|||||||+|||||.+|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999885432 4888888889999999999999997 9999999999999999999999999
Q ss_pred CccccccCCcccccccccccCCcccccccc----C-CCCCchhhHHHHHHHHHHHHcCCCCC
Q 004402 583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVK----K-GIYSMKYDVYSFGVLLLQIISSKRNA 639 (755)
Q Consensus 583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~~sDVwS~Gvil~elltg~~p~ 639 (755)
.+-.+..+ ........+|||.|++||++. + +.|+..+|.||+||++|||+.|..||
T Consensus 221 sClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPF 281 (1317)
T KOG0612|consen 221 SCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPF 281 (1317)
T ss_pred hHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcc
Confidence 99876543 344556679999999999985 3 67999999999999999999999998
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=277.28 Aligned_cols=239 Identities=23% Similarity=0.317 Sum_probs=188.4
Q ss_pred hcCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEEEe
Q 004402 434 TNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 511 (755)
++.|+....+|.|+|+.|-++. ..+++..++|++..... +-.+|+.++... +|||++++.+.+.+....++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 4456667779999999999984 56789999999977622 224577666665 79999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE-cCCCCeEEEecCCccccccC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL-DNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll-~~~~~~kl~Dfgla~~~~~~ 590 (755)
.+.++-+.+.+.. ..... ..+..|+.+|+.++.|||+++ +|||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~---~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRS---KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHh---cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999887665532 22223 677789999999999999977 9999999999999 68999999999999976654
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
....+-|..|.|||++....|++++|+||||++||||++|+.|+...... .+.. ..+..+.
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~----~~i~~~~-------- 530 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIH----TRIQMPK-------- 530 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHH----HhhcCCc--------
Confidence 22235588999999999999999999999999999999999998654433 1111 1111111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+.+......+|+.+||+.||.+||+|.++..
T Consensus 531 ----~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 531 ----FSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ----cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 11233346678999999999999999999863
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=261.42 Aligned_cols=220 Identities=16% Similarity=0.121 Sum_probs=172.7
Q ss_pred cCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCCChhhhhcC
Q 004402 446 GGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFD 524 (755)
Q Consensus 446 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 524 (755)
|.+|.||++.. .+++.+|+|++..... +.+|...+....|||++++++++.+.+..+++|||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999954 5689999999976532 23445555556799999999999999999999999999999988853
Q ss_pred CCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccccccccccCC
Q 004402 525 PIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604 (755)
Q Consensus 525 ~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~ 604 (755)
...+++.....++.|++.||.|||+.+ ++||||||+||+++.++.++++|||.+....... ....++..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 234889999999999999999999986 9999999999999999999999999886543321 12345678
Q ss_pred ccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHH
Q 004402 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCM 684 (755)
Q Consensus 605 y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 684 (755)
|+|||.+....++.++||||+|++++||++|+.|+....... . ......+.. .....+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~-----~~~~~~~~~----~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------N-----THTTLNIPE----WVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------c-----cccccCCcc----cCCHHHH
Confidence 999999988889999999999999999999987653211100 0 000001111 1223678
Q ss_pred HHHHHcccCCCCCCCCHH
Q 004402 685 QVALLCVQENPEDRPSML 702 (755)
Q Consensus 685 ~l~~~Cl~~dP~~RPt~~ 702 (755)
+++.+|++.||++||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=261.96 Aligned_cols=241 Identities=23% Similarity=0.302 Sum_probs=187.2
Q ss_pred hcCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATS---TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 508 (755)
..+|..+.+||+|+||.|-++. ..+.+.+|||++++.- .+..+--+.|-.+|... +-|.++.+..++..-+.+++
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3467788999999999999994 4457789999998752 22233345566777665 57889999999999999999
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
||||+.+|+|--++++. ..+.+..+...|..||-||-+||+.+ ||.||||..|||||.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999997776532 23667788899999999999999987 9999999999999999999999999998432
Q ss_pred cCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
. ....+...+||+.|+|||++....|+..+|.|||||+||||+.|+.||+..+..+ +..... +..
T Consensus 502 ~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---lF~aI~----ehn------ 566 (683)
T KOG0696|consen 502 F--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQAIM----EHN------ 566 (683)
T ss_pred c--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHH----Hcc------
Confidence 2 2234456899999999999999999999999999999999999999996443322 222111 111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRP 699 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 699 (755)
-.++.....+...+...-+.+.|.+|-
T Consensus 567 ----vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 ----VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ----CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 112223334556777778888888883
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=252.28 Aligned_cols=255 Identities=22% Similarity=0.317 Sum_probs=195.9
Q ss_pred cCcccccCCeeEEEE-EcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEEEeecCCCC
Q 004402 440 ANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPNKS 517 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~gs 517 (755)
.+.||+|+++.|-.+ .+.+|..+|||++.+.....+.+..+|++++.+. .|+||+.|+.+|++++..|||||-|.+|+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 368999999999988 5778999999999888767778899999999999 59999999999999999999999999999
Q ss_pred hhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC---eEEEecCCccccccCC---
Q 004402 518 LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN---PKISDFGMAKLFRKDV--- 591 (755)
Q Consensus 518 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~---~kl~Dfgla~~~~~~~--- 591 (755)
|..+++. +..+++.+..++..+|+.||.|||..+ |.|||+||+|||...-.. +|||||.+...+....
T Consensus 163 lLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 163 LLSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 9888854 445889999999999999999999987 999999999999965544 7999999886543211
Q ss_pred --cccccccccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-------cccchH-HHHHH
Q 004402 592 --DEANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS-------ENLNFL-EYAFE 656 (755)
Q Consensus 592 --~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~-------~~~~~~-~~~~~ 656 (755)
........+|+..|||||+.. ...|+.++|.||||||||-|++|..||-..-.. +.-... ...+.
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 122233568899999999763 346889999999999999999999999643221 111111 11222
Q ss_pred HhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 657 QWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 657 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+.++. -++.|..+ .....+..+++...+..++.+|-++.++++
T Consensus 317 sIQEGk-YeFPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 317 SIQEGK-YEFPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHhccC-CcCChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 222222 12222221 112234456777888899999999988876
|
|
| >cd06546 GH18_CTS3_chitinase GH18 domain of CTS3 (chitinase 3), an uncharacterized protein from the human fungal pathogen Coccidioides posadasii | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=254.60 Aligned_cols=196 Identities=13% Similarity=0.200 Sum_probs=142.1
Q ss_pred EEEEEecCCCC--------CCCCCCCCCCcceEEEEEEEecCCCcEEecCCch--hh---HHHHHHHHHHhhCCCceEEE
Q 004402 28 IKAGYWLAGRE--------FPLSDINSALFTHLICAFAEVDSSTYQLSISSAN--QQ---YFSIFANSVRRKNPSIKTLL 94 (755)
Q Consensus 28 ~~~gY~~~~~~--------~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~--~~---~~~~~~~~~k~~~~~lk~~i 94 (755)
++||||..|+. +++..++..+||||+|+|+.++++|. +...+.. .. .+...++.+| ++++||++
T Consensus 1 r~v~y~~~~~~~~~~~~~~~~~~~~~~~~~THvi~af~~i~~~G~-l~~~d~~~~~~~~~~~~~~i~~~~--~~g~KVll 77 (256)
T cd06546 1 RLVIYYQTTHPSNGDPISSLLLVTEKGIALTHLIVAALHINDDGN-IHLNDHPPDHPRFTTLWTELAILQ--SSGVKVMG 77 (256)
T ss_pred CEEEEEccEECCCCCcccccccccCCCCCCceEEEEEEEECCCCe-EEECCCCCCcchhhHHHHHHHHHH--hCCCEEEE
Confidence 47899866533 22335678899999999999998654 4333221 11 2222223444 57999999
Q ss_pred EecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCCCcccHHHHHHHHHHHcc
Q 004402 95 SIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASAS 174 (755)
Q Consensus 95 sigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~~~~~~~~~l~~lr~~l~ 174 (755)
|||||. .+. |+.++++++.|++|++++.+++++|+|||||||||+|. +..+|+.|+++||+++.
T Consensus 78 SiGG~~------------~~~--fs~~a~~~~~r~~f~~s~~~~~~~~~~DGiDiDwE~p~--~~~~~~~ll~~Lr~~~~ 141 (256)
T cd06546 78 MLGGAA------------PGS--FSRLDDDDEDFERYYGQLRDMIRRRGLDGLDLDVEEPM--SLDGIIRLIDRLRSDFG 141 (256)
T ss_pred EECCCC------------CCC--cccccCCHHHHHHHHHHHHHHHHHhCCCceEEeeecCC--CHhHHHHHHHHHHHHhC
Confidence 995554 221 88888999999999999999999999999999999994 46799999999999995
Q ss_pred CCCccEEEeeeecCC----cccccccCcchhc----ccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHHHH
Q 004402 175 DQPELTLSMAVRYSP----THETVSYPIDSMK----KNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREW 246 (755)
Q Consensus 175 ~~~~~~ls~~~~~~~----~~~~~~~~~~~l~----~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~~~ 246 (755)
+++.||++++... ...-.++++.++. .++||+|+|.||.+|... . ......|
T Consensus 142 --~~~~lT~Ap~~~~~~~g~~~~~~~~~~~l~~~~~~~~Df~nvQfYn~~g~~~--------~----------~~~~~~~ 201 (256)
T cd06546 142 --PDFIITLAPVASALTGGEANLSGFDYRELEQARGDKIDFYNAQFYNGFGSMS--------S----------PSDYDAI 201 (256)
T ss_pred --CCcEEEECCccccccCCcccccccCHHHHHHhhCCceeEEEEcCcCCCCCcc--------C----------HHHHHHH
Confidence 3688998776431 1122346777665 499999999999763210 0 1133456
Q ss_pred HHCCCCCCceeecccc
Q 004402 247 LRRGFPANKLVLGARA 262 (755)
Q Consensus 247 ~~~g~p~~KlvlG~p~ 262 (755)
+..++|++||++|+|+
T Consensus 202 ~~~~~~~~Kv~iGlpa 217 (256)
T cd06546 202 VAQGWDPERIVIGLLT 217 (256)
T ss_pred HHcCCCcccEEEEEec
Confidence 6679999999999997
|
CTS3 has a chitinase-like glycosyl hydrolase family 18 (GH18) domain; and has homologs in bacteria as well as fungi. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=238.33 Aligned_cols=209 Identities=25% Similarity=0.379 Sum_probs=170.8
Q ss_pred HHHHhcCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCcc
Q 004402 430 IKAATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSAT-STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDEN 506 (755)
Q Consensus 430 l~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 506 (755)
++...+.......||+|++|.|-+-+ ..+|+..|+|++... ..+..++.+.|+.+..+. .+|.+|.++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 44445556667899999999998875 467999999999765 445667888999886665 799999999998888899
Q ss_pred EEEEeecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 507 MLIYEYLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
++.||.|. .||+.+-.+- .....+++..+-+|+..|.+||.|||++- .+||||+||+|||++.+|++|+||||++.
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999995 4787765322 23456888889999999999999999976 59999999999999999999999999998
Q ss_pred ccccCCcccccccccccCCccccccccC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004402 586 LFRKDVDEANTGRIVGTYGYVPPEYVKK----GIYSMKYDVYSFGVLLLQIISSKRNARYYGT 644 (755)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDVwS~Gvil~elltg~~p~~~~~~ 644 (755)
.+..+.... ...|-..|||||.+.. ..|+.+|||||||+.+.||.+++.|++.++.
T Consensus 198 ~L~dSiAkt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 198 YLVDSIAKT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred eehhhhHHH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 765433222 2356678999998853 4689999999999999999999999876554
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-30 Score=248.32 Aligned_cols=252 Identities=21% Similarity=0.278 Sum_probs=189.9
Q ss_pred hcCCCcc-CcccccCCeeEEEEE-cCCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecC----Ccc
Q 004402 434 TNNFSSA-NKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER----DEN 506 (755)
Q Consensus 434 ~~~f~~~-~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~~ 506 (755)
+++|.+. ++||-|-.|.|-.+. ..+|+.+|+|++.... ..++|+++--+. .|||||.+++++.+. ..+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 5556543 689999999999984 4569999999986542 346677764444 799999999988653 457
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC---CCCeEEEecCC
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGM 583 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~---~~~~kl~Dfgl 583 (755)
++|||.|++|.|...+.+. +...+++.+.-.|..||+.|+.|||+.+ |.||||||+|+|.+. |-.+||+|||+
T Consensus 135 LiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred EeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 8999999999998888653 4456899999999999999999999997 999999999999964 55699999999
Q ss_pred ccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG 663 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (755)
|+.-.. .......+.|+.|.|||++...+|+..+|+||+||++|-|++|.+||-.........-. ...++.+.
T Consensus 211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgM---k~rI~~gq- 283 (400)
T KOG0604|consen 211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KRRIRTGQ- 283 (400)
T ss_pred ccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhH---HhHhhccC-
Confidence 986432 22333467899999999999999999999999999999999999998322211110000 01111111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 664 KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 664 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
-++.++ ...+......++++..|+.+|.+|-|+.|+..
T Consensus 284 y~FP~p-----EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 284 YEFPEP-----EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ccCCCh-----hHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 112222 22234456678999999999999999999874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=275.97 Aligned_cols=265 Identities=23% Similarity=0.323 Sum_probs=177.9
Q ss_pred HhcCCCccCcccccCCeeEEEEEc-----------------CCCCEEEEEEeccCChhhHHHH--------------HHH
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNL-----------------PRGQEFAVKRLSATSTQGLEEF--------------KNE 481 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E 481 (755)
..++|+..++||+|+||+||+|.. ..++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999953 2356899999875543333333 346
Q ss_pred HHHHhcCCCCce-----eeeeeeeec--------CCccEEEEeecCCCChhhhhcCCCc---------------------
Q 004402 482 VSLTARLQHVNL-----LRVLGYCTE--------RDENMLIYEYLPNKSLDLYLFDPIR--------------------- 527 (755)
Q Consensus 482 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------- 527 (755)
+.++.+++|.++ ++++++|.. ....++||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777766554 677787753 3467999999999999998864211
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccccccccccCCccc
Q 004402 528 RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607 (755)
Q Consensus 528 ~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a 607 (755)
...+++..+..++.|++.+|.|||+.+ ++||||||+|||++.++.+||+|||+++........ ......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 123567788999999999999999986 999999999999999999999999999765432211 1112234789999
Q ss_pred cccccCCCC----------------------CchhhHHHHHHHHHHHHcCCC-CCCCCCCCc-ccchHHHHHHHhccCCC
Q 004402 608 PEYVKKGIY----------------------SMKYDVYSFGVLLLQIISSKR-NARYYGTSE-NLNFLEYAFEQWKDSKG 663 (755)
Q Consensus 608 PE~~~~~~~----------------------s~~sDVwS~Gvil~elltg~~-p~~~~~~~~-~~~~~~~~~~~~~~~~~ 663 (755)
||.+..... ..+.||||+||+++||+++.. |+....... ...........|+....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 998754321 124799999999999999874 442111000 00000011111111110
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCC---CCCCCHHHHHH
Q 004402 664 KEFIDPSLDDSSSPCKLLNCMQVALLCVQENP---EDRPSMLEVSS 706 (755)
Q Consensus 664 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPt~~evl~ 706 (755)
.. .+-.... .......+++.+++..+| .+|+|++|+++
T Consensus 459 ~~-~~~~~~d----~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QK-YDFSLLD----RNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cC-CCccccc----ccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 00 1111111 112356788889998765 78999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=252.78 Aligned_cols=238 Identities=25% Similarity=0.321 Sum_probs=190.1
Q ss_pred CCeeEEEEEcC-CCCEEEEEEeccCChhh-HHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCCChhhhhcC
Q 004402 447 GFGPVYKGNLP-RGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFD 524 (755)
Q Consensus 447 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 524 (755)
+||.||+|... +++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999775 48999999997765444 67899999999999999999999999998999999999999999998854
Q ss_pred CCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccccccccccCC
Q 004402 525 PIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604 (755)
Q Consensus 525 ~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~ 604 (755)
.. .+++..+..++.++++++.+||..+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 22 2788999999999999999999986 9999999999999999999999999998765432 2223467889
Q ss_pred ccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHH
Q 004402 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCM 684 (755)
Q Consensus 605 y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 684 (755)
|++||.+....++.++||||||+++++|++|..|+...... .... ......... ... ........+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~----~~~~~~~~~----~~~---~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELF----KKIGKPKPP----FPP---PEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHH----HHHhccCCC----Ccc---ccccCCHHHH
Confidence 99999999888999999999999999999999887432111 1111 111111100 000 0000234788
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 004402 685 QVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 685 ~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-31 Score=251.68 Aligned_cols=265 Identities=18% Similarity=0.341 Sum_probs=189.5
Q ss_pred CCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--------C
Q 004402 436 NFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--------D 504 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~ 504 (755)
.|+...+||+|.||.||+++.. .|+.||+|++--. .+..-...++|+++|..++|+|++.++..|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4556688999999999999654 4788999876432 222234568999999999999999999988542 2
Q ss_pred ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCc
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla 584 (755)
..++||.+|+. +|.-+|.+. ...++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 37899999976 666666443 245788999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCc--ccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccC
Q 004402 585 KLFRKDVD--EANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDS 661 (755)
Q Consensus 585 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 661 (755)
+.+..... ....+..+-|..|.+||.+.+ ..|+++.|||.-|||+.||+|+.+-+..........++......+..+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 87644322 222334456999999997765 679999999999999999999886654333333333333222211111
Q ss_pred CCccc--------c--CCCCCCCC--CHHH------HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 662 KGKEF--------I--DPSLDDSS--SPCK------LLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 662 ~~~~~--------~--d~~l~~~~--~~~~------~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
-..++ + .|.-...+ -++. ....++|+..++..||.+|+++.+++.
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 10000 0 00000000 0001 124568899999999999999998874
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=267.26 Aligned_cols=243 Identities=22% Similarity=0.321 Sum_probs=189.9
Q ss_pred cCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCC
Q 004402 440 ANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK 516 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 516 (755)
.++||+|.||+||-|.. ++|+.||||++.+- ..+....+++|+.+|..++||.||.+...|+..+..++|||-+.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 58999999999999955 56999999999654 2333467899999999999999999999999999999999999776
Q ss_pred ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC---CCCeEEEecCCccccccCCcc
Q 004402 517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 517 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~---~~~~kl~Dfgla~~~~~~~~~ 593 (755)
-|+-.|.. .+..+++.....+..||+.||.|||..+ |+|+||||+||||.+ --++||||||+|+.+....
T Consensus 649 MLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 649 MLEMILSS--EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred HHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 66666643 3445888888889999999999999997 999999999999954 3579999999999876432
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
....++||+.|+|||++....|...-|+||.|||+|--++|..||... ++..+.++. ..-+..+.
T Consensus 722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQN---------AaFMyPp~--- 786 (888)
T KOG4236|consen 722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQN---------AAFMYPPN--- 786 (888)
T ss_pred -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhc---------cccccCCC---
Confidence 233579999999999999999999999999999999999999888432 221111111 11111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVS 705 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 705 (755)
...+.....++++...|+..-++|-|..+.+
T Consensus 787 -PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 787 -PWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred -chhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 1122333566788888888888888876654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=282.12 Aligned_cols=261 Identities=20% Similarity=0.242 Sum_probs=165.1
Q ss_pred HhcCCCccCcccccCCeeEEEEEcC-C----CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeee------ee
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNLP-R----GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY------CT 501 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~ 501 (755)
..++|+..+.||+|+||.||+|... + +..||||++...... +....| .+....+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4568899999999999999999654 4 689999988654321 111111 1122222222222211 24
Q ss_pred cCCccEEEEeecCCCChhhhhcCCCcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccC
Q 004402 502 ERDENMLIYEYLPNKSLDLYLFDPIRR-----------------YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLK 564 (755)
Q Consensus 502 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk 564 (755)
.....++|+||+++++|.+++...... .......+..++.|++.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 556789999999999999888542210 01123345679999999999999986 9999999
Q ss_pred CCCEEEcC-CCCeEEEecCCccccccCCcccccccccccCCccccccccCC----------------------CCCchhh
Q 004402 565 ASNILLDN-ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG----------------------IYSMKYD 621 (755)
Q Consensus 565 ~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~sD 621 (755)
|+|||+++ ++.+||+|||+++.+..... .......+++.|||||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 57999999999986543322 222345789999999965322 2345679
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccC--CCccccCCCC----CCCCC--HHHHHHHHHHHHHcccC
Q 004402 622 VYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDS--KGKEFIDPSL----DDSSS--PCKLLNCMQVALLCVQE 693 (755)
Q Consensus 622 VwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~~l----~~~~~--~~~~~~l~~l~~~Cl~~ 693 (755)
||||||+||||+++..+.. .....+... ....... .....+.+.. ..... ........+|+.+||+.
T Consensus 362 VwSlGviL~el~~~~~~~~----~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSD----SNLIQFNRQ-LKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred cHHHHHHHHHHHhCcCCCc----hHHHHHHHH-HHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 9999999999998654431 111111000 0000000 0000011100 00000 00112345899999999
Q ss_pred CCCCCCCHHHHHH
Q 004402 694 NPEDRPSMLEVSS 706 (755)
Q Consensus 694 dP~~RPt~~evl~ 706 (755)
||++|||+.|+++
T Consensus 437 dP~kR~ta~e~L~ 449 (566)
T PLN03225 437 KGRQRISAKAALA 449 (566)
T ss_pred CcccCCCHHHHhC
Confidence 9999999999986
|
|
| >cd02871 GH18_chitinase_D-like GH18 domain of Chitinase D (ChiD) | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=256.30 Aligned_cols=209 Identities=22% Similarity=0.310 Sum_probs=145.3
Q ss_pred eEEEEEecCCCCC------CCCCCCCCCcceEEEEEEEecCCCc-EEe------cCCchhhHHHHHHHHHHhhCCCceEE
Q 004402 27 WIKAGYWLAGREF------PLSDINSALFTHLICAFAEVDSSTY-QLS------ISSANQQYFSIFANSVRRKNPSIKTL 93 (755)
Q Consensus 27 ~~~~gY~~~~~~~------~~~~i~~~~~thi~~~f~~~~~~~~-~~~------~~~~~~~~~~~~~~~~k~~~~~lk~~ 93 (755)
++++|||..|..+ +++. .++.||||+|+|+.+..++. .+. ........+...++.+|++ ++|||
T Consensus 1 k~~vgY~~~w~~~~~~~~~~~~~-~~~~yt~i~~AF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~q~~--G~KVl 77 (312)
T cd02871 1 KVLVGYWHNWDNGAGSGRQDLDD-VPSKYNVINVAFAEPTSDGGGEVTFNNGSSPGGYSPAEFKADIKALQAK--GKKVL 77 (312)
T ss_pred CeEEEecCcccCCCCCCCCCccc-CCCCCCEEEEcceeecCCCceeEeecccCCcccCChHHHHHHHHHHHHC--CCEEE
Confidence 5789999877553 2334 45899999999999987543 222 1222334555655677775 79999
Q ss_pred EEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCC-----CcccHHHHHHH
Q 004402 94 LSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNST-----DLNSLGILLDE 168 (755)
Q Consensus 94 isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~-----~~~~~~~~l~~ 168 (755)
+||||+.+ +..+++++.|++|++++++++++|||||||||||+|... ++++|+.||++
T Consensus 78 lSiGG~~~-----------------~~~~~~~~~~~~fa~sl~~~~~~~g~DGiDiD~E~~~~~~~~~~~~~~~~~~lk~ 140 (312)
T cd02871 78 ISIGGANG-----------------HVDLNHTAQEDNFVDSIVAIIKEYGFDGLDIDLESGSNPLNATPVITNLISALKQ 140 (312)
T ss_pred EEEeCCCC-----------------ccccCCHHHHHHHHHHHHHHHHHhCCCeEEEecccCCccCCcHHHHHHHHHHHHH
Confidence 99965541 224778899999999999999999999999999999654 56899999999
Q ss_pred HHHHccCCCccEEEeeeecCCcc--------ccccc--CcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCc
Q 004402 169 WKASASDQPELTLSMAVRYSPTH--------ETVSY--PIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNIS 238 (755)
Q Consensus 169 lr~~l~~~~~~~ls~~~~~~~~~--------~~~~~--~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~ 238 (755)
||+++.+ +++||+|+...... ....| ...++..++||+|||.||.++.. +.... .......+
T Consensus 141 lr~~~~~--~~~lT~AP~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~D~invqfYn~~~~~-----~~~~~-~~~~~~~~ 212 (312)
T cd02871 141 LKDHYGP--NFILTMAPETPYVQGGYAAYGGIWGAYLPLIDNLRDDLTWLNVQYYNSGGMG-----GCDGQ-SYSQGTAD 212 (312)
T ss_pred HHHHcCC--CeEEEECCCcccccCcccccccCCcchhHHHHHhhhheeEEEEeeccCCCcc-----ccccc-CCccchhH
Confidence 9999963 79999986532111 11123 35678889999999999987421 11111 00111112
Q ss_pred HHHHHHHHHHCC-----------CCCCceeeccccc
Q 004402 239 TDFGIREWLRRG-----------FPANKLVLGARAS 263 (755)
Q Consensus 239 ~~~~v~~~~~~g-----------~p~~KlvlG~p~y 263 (755)
...++...+..| +|++||++|+|+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~p~~Kv~iG~pa~ 248 (312)
T cd02871 213 FLVALADMLLTGFPIAGNDRFPPLPADKVVIGLPAS 248 (312)
T ss_pred HHHHHHHHHHcCCCccCCcccccCChhhEEEeccCC
Confidence 222333344444 8999999999996
|
ChiD, a chitinase found in Bacillus circulans, hydrolyzes the 1,4-beta-linkages of N-acetylglucosamine in chitin and chitodextrins. The domain architecture of ChiD includes a catalytic glycosyl hydrolase family 18 (GH18) domain, a chitin-binding domain, and a fibronectin type III domain. The chitin-binding and fibronectin type III domains are located either N-terminal or C-terminal to the catalytic domain. This family includes exochitinase Chi36 from Bacillus cereus. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=242.13 Aligned_cols=248 Identities=21% Similarity=0.337 Sum_probs=195.5
Q ss_pred hcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT---STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 508 (755)
.++|+.+++||+|++..|..+++. +.+.+|+|++++. ..+..+-.+.|-.+..+. +||.+|.+..|+..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467889999999999999999764 5789999998764 334445567777777776 79999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
|.||+++|+|--+++ ++..++++........|.-||.|||+.+ ||.||||..|||+|..|++||+|+|+++.-.
T Consensus 329 vieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999976653 4456899999999999999999999987 9999999999999999999999999998533
Q ss_pred cCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc-ccchHHHHHHHhccCCCcccc
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE-NLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 667 (755)
. ....++.++||+.|.|||++.+..|...+|.|++||+++||+.|+.||.--+... ..+.-++.++.+-+..+.
T Consensus 403 ~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir--- 477 (593)
T KOG0695|consen 403 G--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR--- 477 (593)
T ss_pred C--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc---
Confidence 2 2234556899999999999999999999999999999999999999998655332 223333444333222111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRP 699 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 699 (755)
+... .......+...-+++||.+|-
T Consensus 478 ---iprs----lsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 ---IPRS----LSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ---ccce----eehhhHHHHHHhhcCCcHHhc
Confidence 1111 112334677788999998884
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=258.02 Aligned_cols=204 Identities=24% Similarity=0.378 Sum_probs=170.6
Q ss_pred CCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 436 NFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATST---QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
-|..++.||-|+||+|.+++ .++...+|+|.+++.+. ........|-.||..-..+-||+|+-.|.+++.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 36677889999999999994 45577899999987642 223457789999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc--
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK-- 589 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~-- 589 (755)
|+++|++-.+|. +-..+.+...+..+..+++|+.+.|..+ +|||||||+|||||.+|++||+||||+.-+.=
T Consensus 710 YIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 710 YIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred ccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999988884 3446778888888899999999999987 99999999999999999999999999875310
Q ss_pred ------CCcccc--------------------------------cccccccCCccccccccCCCCCchhhHHHHHHHHHH
Q 004402 590 ------DVDEAN--------------------------------TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQ 631 (755)
Q Consensus 590 ------~~~~~~--------------------------------~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~e 631 (755)
..+..+ .-..+||+.|+|||++....|+..+|.||.||||+|
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 000000 001379999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCCC
Q 004402 632 IISSKRNARYYGTS 645 (755)
Q Consensus 632 lltg~~p~~~~~~~ 645 (755)
|+.|+.||......
T Consensus 864 m~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPG 877 (1034)
T ss_pred HhhCCCCccCCCCC
Confidence 99999999654433
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-29 Score=260.73 Aligned_cols=241 Identities=22% Similarity=0.277 Sum_probs=195.4
Q ss_pred CCCccCcccccCCeeEEEEEcCCCC-EEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 436 NFSSANKLGEGGFGPVYKGNLPRGQ-EFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
++..+..||-|+||.|-+.+..+.. .+|+|++++. +....+....|-.+|...+.|.||+++--|.+....|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 3445578999999999999775443 4899988664 33445667889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
-|-+|.|=..|.+ +..++..+...++.++.+|+.|||+.+ ||.|||||+|.+|+.+|-+||.|||+|+.+...
T Consensus 501 aClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g- 573 (732)
T KOG0614|consen 501 ACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG- 573 (732)
T ss_pred hhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence 9999999888854 445788888899999999999999997 999999999999999999999999999987643
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
..+..++||+.|.|||++.+...+.++|.||||++++||++|.+||...++....+++......+.
T Consensus 574 --~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~------------ 639 (732)
T KOG0614|consen 574 --RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE------------ 639 (732)
T ss_pred --CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh------------
Confidence 345568999999999999999999999999999999999999999976555444433322222111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPS 700 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 700 (755)
.+........++++..+..+|.+|-.
T Consensus 640 ---~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 640 ---FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ---cccccchhHHHHHHHHHhcCcHhhhc
Confidence 11112234567888888999999965
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-29 Score=243.06 Aligned_cols=263 Identities=21% Similarity=0.306 Sum_probs=189.7
Q ss_pred CccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC-----CccEEE
Q 004402 438 SSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER-----DENMLI 509 (755)
Q Consensus 438 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lv 509 (755)
+..+.||-|+||.||..+. .+|+.||+|++..- +-...+.+.+|+++|..++|.|++..++...-. .++|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 4567899999999999865 45999999987543 233456789999999999999999988765432 346788
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
.|.|.. +|...+.. .+.++.....-+..||.+||.|||+.+ |.||||||.|.|++.|..+||||||+++....
T Consensus 136 TELmQS-DLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQS-DLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHh-hhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 898854 67766643 445777788889999999999999987 99999999999999999999999999997665
Q ss_pred CCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHH--------HHhcc
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAF--------EQWKD 660 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~ 660 (755)
+.....+ ..+-|..|.|||++.+ ..|+.+.||||.|||+.||+.++..|...+..+..+++.... +.-.+
T Consensus 209 d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 209 RDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 5444333 3355889999999876 468999999999999999998887775544443333322111 11111
Q ss_pred CCCccccC-----CC---CCCCCC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 004402 661 SKGKEFID-----PS---LDDSSS-PCKLLNCMQVALLCVQENPEDRPSMLEVSSML 708 (755)
Q Consensus 661 ~~~~~~~d-----~~---l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 708 (755)
+....++. |. +..-.+ .....+-..+...++..||+.|.+..+.+..+
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11111111 11 100001 01112344677788999999999999888665
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-29 Score=270.47 Aligned_cols=246 Identities=24% Similarity=0.336 Sum_probs=184.9
Q ss_pred CCCccCcccccCCee-EEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEEEeec
Q 004402 436 NFSSANKLGEGGFGP-VYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
-|...+++|.|+.|+ ||+|.. .|+.||||++-... .....+|+..|+.- +|||||++++.-.++...|+..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 355567899999985 799988 78999999985432 24567899999988 7999999999988888999999999
Q ss_pred CCCChhhhhcCCCcc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC---C--CCeEEEecCCcccc
Q 004402 514 PNKSLDLYLFDPIRR-YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---E--LNPKISDFGMAKLF 587 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~---~--~~~kl~Dfgla~~~ 587 (755)
..+|++++...... ........+.+..|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++.+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 55999998653111 11111345788899999999999987 999999999999976 3 56899999999987
Q ss_pred ccCCcc-cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCcccchHHHHHHHhccCCCcc
Q 004402 588 RKDVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISS-KRNARYYGTSENLNFLEYAFEQWKDSKGKE 665 (755)
Q Consensus 588 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (755)
..+... .......||-+|+|||.+....-+.++||||+||++|..++| ..||...-..+ ..-+.......
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------~NIl~~~~~L~ 733 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------ANILTGNYTLV 733 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--------hhhhcCcccee
Confidence 665433 234567899999999999998888999999999999999987 67774321110 00000000000
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004402 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVS 705 (755)
Q Consensus 666 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 705 (755)
.+.+ ..++ +..+|+.+|++.+|..||++.+|+
T Consensus 734 ~L~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 734 HLEP------LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred eecc------CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 0111 1111 567899999999999999999986
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-26 Score=228.37 Aligned_cols=211 Identities=35% Similarity=0.551 Sum_probs=181.9
Q ss_pred ccccCCeeEEEEEcCC-CCEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCCChhh
Q 004402 443 LGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDL 520 (755)
Q Consensus 443 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 520 (755)
||+|.+|.||++.... ++.+++|++...... ..+.+.+|+..+..++|++++++++++......++++|++++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999997754 899999999766443 34678999999999999999999999999889999999999999999
Q ss_pred hhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC-CCCeEEEecCCccccccCCcccccccc
Q 004402 521 YLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-ELNPKISDFGMAKLFRKDVDEANTGRI 599 (755)
Q Consensus 521 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~ 599 (755)
++.... ..+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 885321 35788999999999999999999986 999999999999999 89999999999986543321 12224
Q ss_pred cccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHH
Q 004402 600 VGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPC 678 (755)
Q Consensus 600 ~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 678 (755)
.+...|++||.+... ..+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 567889999999877 888999999999999998
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 004402 679 KLLNCMQVALLCVQENPEDRPSMLEVSSML 708 (755)
Q Consensus 679 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 708 (755)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2577899999999999999999998643
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-27 Score=219.50 Aligned_cols=252 Identities=19% Similarity=0.348 Sum_probs=189.1
Q ss_pred hcCCCccCcccccCCeeEEEE-EcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCC--ccEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERD--ENMLI 509 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~lv 509 (755)
.++|++.+++|+|.++.||.| ...+.+.++||+++... .+.+.+|+++|..|. ||||+++++...+.. .+.+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 457888899999999999999 45678999999997654 356789999999996 999999999987654 46899
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC-CCeEEEecCCccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMAKLFR 588 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~-~~~kl~Dfgla~~~~ 588 (755)
+||+.+.+...+- ..++...+...+.+++.||.|.|+++ |+|||+||.|++||.. ..++|+|+|+|..+.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998876554 24677788899999999999999997 9999999999999865 569999999999876
Q ss_pred cCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchH------------HHHH
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFL------------EYAF 655 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~------------~~~~ 655 (755)
+..... ..+.+..|.-||.+.. ..|+..-|+|||||+|.+|+..+.||- .+......++ .++.
T Consensus 185 p~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF-hG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 185 PGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF-HGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc-CCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 654332 2356778899998865 567889999999999999999999873 2322211111 1111
Q ss_pred HHh--------------ccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004402 656 EQW--------------KDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVS 705 (755)
Q Consensus 656 ~~~--------------~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 705 (755)
... .......++.+.-... ...+.++++...|..|..+|||++|..
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl----~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHL----VSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCcccccc----CChHHHHHHHHHHhhccccccchHHHh
Confidence 100 0000111111111111 123567899999999999999999875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-25 Score=231.19 Aligned_cols=131 Identities=23% Similarity=0.310 Sum_probs=107.8
Q ss_pred cCCCccCcccccCCeeEEEE-EcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-----CC---ceeeeeeeeecC--
Q 004402 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-----HV---NLLRVLGYCTER-- 503 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~---niv~l~g~~~~~-- 503 (755)
.+|...++||+|.|++||++ ..++.+.||+|+.+.. ....+..+.|+++|++++ |+ .||+|++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 57888899999999999999 4567889999988543 345567889999999983 33 699999998653
Q ss_pred --CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE
Q 004402 504 --DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL 570 (755)
Q Consensus 504 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll 570 (755)
.+.|+|+|++ +.+|..++... .-+-++.....+|+.||+.||.|||..+ +|||.||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 4689999999 55666666432 2234888999999999999999999998 79999999999998
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-27 Score=252.91 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=198.8
Q ss_pred hcCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
.++|+..+++|.|.+|.|||++ ...++..|+|+++........-.++|+-+++..+||||+.++|-+...+..+++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 3467888999999999999995 456999999999887666677788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
|.+|+|++.-+- ...+++.++..+.....+||.|||+.+ =+|||||-.|||+++.+.+|++|||.+-.+.....
T Consensus 94 cgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred cCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhh
Confidence 999999887642 346888899999999999999999987 78999999999999999999999999987654433
Q ss_pred ccccccccccCCccccccc---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 593 EANTGRIVGTYGYVPPEYV---KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~---~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
+...+.||+.|||||+. ..+.|...+|||+.|+...|+--...|.-.... .++......+ .+-.+
T Consensus 168 --KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-------mr~l~LmTkS---~~qpp 235 (829)
T KOG0576|consen 168 --KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-------MRALFLMTKS---GFQPP 235 (829)
T ss_pred --hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-------HHHHHHhhcc---CCCCC
Confidence 33457899999999976 467799999999999999999765544311111 1111111111 11112
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVS 705 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 705 (755)
.+.+. ......+.++++.|+.++|++||+++.++
T Consensus 236 ~lkDk--~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 236 TLKDK--TKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred cccCC--ccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 22221 12334677899999999999999998765
|
|
| >KOG2091 consensus Predicted member of glycosyl hydrolase family 18 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=223.23 Aligned_cols=292 Identities=12% Similarity=0.176 Sum_probs=224.2
Q ss_pred ceEEEEEecCCCC--CCCCCCCCCCcceEEEEEEEecCCCcEEecCCchhhHHHHHHHHHHhhCCCceEEEEecCCCCCc
Q 004402 26 TWIKAGYWLAGRE--FPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNST 103 (755)
Q Consensus 26 ~~~~~gY~~~~~~--~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg~~~~~ 103 (755)
+..+.||...|+. |+++.|-.++.|||...+..+...|..+...+..+.. +.+++++|+++++++++..+
T Consensus 78 ~~~vLayVTPWNs~Gydvakifaskft~iSPVW~ql~~qgs~~~v~G~hdid-~gwiralRk~~~~l~ivPR~------- 149 (392)
T KOG2091|consen 78 GGTVLAYVTPWNSHGYDVAKIFASKFTYISPVWLQLKDQGSDVGVYGKHDID-PGWIRALRKSGKDLHIVPRF------- 149 (392)
T ss_pred CCceEEEecCcCccchhHHHHHhcccceecchheeehhcCcceEEeecccCC-hHHHHHHHHhCCCceeecee-------
Confidence 6789999988876 9999999999999999999999877555555444444 44558899999999998887
Q ss_pred cccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCccccc-ccCCCC-CCcccHHHHHHHHHHHccCCCccEE
Q 004402 104 YQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLF-WLWPNS-TDLNSLGILLDEWKASASDQPELTL 181 (755)
Q Consensus 104 ~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiD-we~p~~-~~~~~~~~~l~~lr~~l~~~~~~~l 181 (755)
.|..+. .+.|..++.+++.|++..+.++++++++||||+.|+ |..... -+-.....|+++|-+++++. .++.
T Consensus 150 ---~fd~~~--~~d~ke~l~ke~l~ekv~~tlv~~ck~~~fdGlVlevwsq~a~~i~d~~al~~v~hl~k~Lhkq-~l~~ 223 (392)
T KOG2091|consen 150 ---YFDEFT--SADLKEFLVKEALREKVGQTLVNFCKKHGFDGLVLEVWSQLADVIADKDALELVEHLGKALHKQ-ELQA 223 (392)
T ss_pred ---hhhhcc--chHHHHHhhhHHHHHHHHHHHHHHHHHcCCCeeeHHHHHHHHHHHhhhHHHHHHHHHHHHHHHh-heEE
Confidence 334433 334889999999999999999999999999999999 765422 11244567888899999875 4555
Q ss_pred EeeeecC--Ccccccc----cCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHHHHHHCCCCCCc
Q 004402 182 SMAVRYS--PTHETVS----YPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANK 255 (755)
Q Consensus 182 s~~~~~~--~~~~~~~----~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~~~~~~g~p~~K 255 (755)
-..+|+. +...... -++..|...+|.+.+|||||.+ ...+|++||++ +++.++....-...-+.|
T Consensus 224 iLvvPp~~~~e~~~~~~ft~ee~~~L~~~~d~fsLmTYd~s~---~~~pg~nap~~------wi~~~l~~l~~~s~~r~K 294 (392)
T KOG2091|consen 224 ILVVPPVIEEENGQLKFFTPEEFSKLVAVYDGFSLMTYDYSL---VQGPGPNAPLE------WIRHCLHHLGGSSAKRPK 294 (392)
T ss_pred EEEeCCCCcCCCCCcCcCCHHHHHHHHHhhhheeEEEeeccc---ccCCCCCCCHH------HHHHHHHHhCCccccccc
Confidence 5555553 2222221 2678899999999999999972 34579999975 888888887665566789
Q ss_pred eeecccccCCCccc---CCCcchHHHHHHHhhcCCCcccccccceeeeee-----ecCcEEEeeCCcchhhhhhhccccc
Q 004402 256 LVLGARASGPGITI---DGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLF-----TSGATWINFDGVETIKAKISYAKEK 327 (755)
Q Consensus 256 lvlG~p~yG~~~~~---~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~i~yd~~~S~~~K~~~a~~~ 327 (755)
+.+|+.|||.+|+. .+.++......+++... ..-.||+.+....+ .++++.|.|++..|+..++++|++.
T Consensus 295 iLlGlNFYG~d~~~gdg~~~IT~~rYL~lLk~~k--~~~~~Dees~EH~f~~k~n~~gkhivfyPTL~Sl~~Ri~lA~~~ 372 (392)
T KOG2091|consen 295 ILLGLNFYGNDFNLGDGGEAITAKRYLQLLKGEK--SVFKFDEESKEHFFEYKRNDDGKHIVFYPTLTSLELRIELAREL 372 (392)
T ss_pred eeEeeeccccccccCCCCCceeHHHHHHHHhccC--cceeeccccchhheeeeccCCCceEEEecchHhHHHHHHHHHHh
Confidence 99999999999998 25677776677776654 44556655544332 3468999999999999999999999
Q ss_pred Cccccccccccccchh
Q 004402 328 NLLGYKAFQLSNDDNW 343 (755)
Q Consensus 328 ~l~Gi~~W~l~~dd~~ 343 (755)
| .||++|++++.-++
T Consensus 373 g-vgISIWe~GqGLDY 387 (392)
T KOG2091|consen 373 G-VGISIWEYGQGLDY 387 (392)
T ss_pred C-CceEeeeccCchhh
Confidence 9 77999999976443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=225.42 Aligned_cols=260 Identities=22% Similarity=0.263 Sum_probs=188.6
Q ss_pred cCCCccCcccccCCeeEEEE-EcCCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC------Cc
Q 004402 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER------DE 505 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 505 (755)
.+|..+..+|.|.- .|..+ +.-.+++||+|.+... .....++..+|+..+..++|+|+++++.++.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666788899988 56555 3446899999987554 233456778999999999999999999998643 34
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
.++|||+|. .+|...++ -.++-.+...|..|+++|++|||+.+ |+||||||+||++..+..+||.|||+++
T Consensus 96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 689999995 47777664 23666788999999999999999997 9999999999999999999999999998
Q ss_pred ccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccc------------chHHH
Q 004402 586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL------------NFLEY 653 (755)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~------------~~~~~ 653 (755)
.-..+ -..+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.....-+.. .+...
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 54332 2334457789999999998888999999999999999999999777532211110 00000
Q ss_pred HH---HHhcc-------CCC-ccccCCCCCC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 654 AF---EQWKD-------SKG-KEFIDPSLDD--SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 654 ~~---~~~~~-------~~~-~~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
.. +.... -.. ..+.|..+.. ..++-......+++.+||-.||++|.+++++++.
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 00000 000 1111211111 1112233456789999999999999999999863
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=223.41 Aligned_cols=198 Identities=30% Similarity=0.466 Sum_probs=170.3
Q ss_pred CCccCcccccCCeeEEEEEcCC-CCEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecC
Q 004402 437 FSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 514 (755)
|+..+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4556889999999999997755 899999999876554 56789999999999999999999999998889999999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 594 (755)
+++|.+++..... .+++.....++.+++.++.+||..+ ++|+||+|.||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 9999998854221 1788999999999999999999986 999999999999999999999999999876543211
Q ss_pred ccccccccCCccccccc-cCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYV-KKGIYSMKYDVYSFGVLLLQIISSKRNAR 640 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~-~~~~~s~~sDVwS~Gvil~elltg~~p~~ 640 (755)
......++..|++||.+ ....++.++|||+||++++||++|+.|+.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 22234667889999998 67778889999999999999999999883
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=241.12 Aligned_cols=195 Identities=25% Similarity=0.386 Sum_probs=162.8
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChh--------hHHHHHHHHHHHhcCC---CCceeeeeeeeec
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQ--------GLEEFKNEVSLTARLQ---HVNLLRVLGYCTE 502 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---H~niv~l~g~~~~ 502 (755)
..|...+.+|+|+||.|+.+..+ +...|+||.+.+.+.- ..-..-.|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35888999999999999999554 4678999998765311 1112456999999996 9999999999999
Q ss_pred CCccEEEEeec-CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEec
Q 004402 503 RDENMLIYEYL-PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDF 581 (755)
Q Consensus 503 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Df 581 (755)
++..+|++|-. ++-+|.+++ ..+..+++.+...|+.||+.|+++||+.+ |||||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999976 444566665 23556899999999999999999999997 999999999999999999999999
Q ss_pred CCccccccCCcccccccccccCCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCC
Q 004402 582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNA 639 (755)
Q Consensus 582 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~elltg~~p~ 639 (755)
|.+....+.+ ...++||..|.|||++.+..| ...-|||++|++||.++-...|+
T Consensus 715 gsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 715 GSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 9998765443 345799999999999999887 56789999999999988766554
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=239.24 Aligned_cols=265 Identities=19% Similarity=0.239 Sum_probs=196.4
Q ss_pred HhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCC------CceeeeeeeeecCCc
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH------VNLLRVLGYCTERDE 505 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~~~~~~ 505 (755)
...+|......|+|-|++|.+|.. ..|+.||||+++.+..- .+.=+.|+++|++|+. -|+++++-.|....+
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 346788888899999999999954 45889999999876322 2344789999999953 378999999999999
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC-CeEEEecCCc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDFGMA 584 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~-~~kl~Dfgla 584 (755)
+|||+|-+. -+|.+.|.......-|........+.|+.-||..|...+ |+|.||||.|||+++.. .+||||||.|
T Consensus 509 LClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 999999874 488888877666667888899999999999999998876 99999999999998765 5899999999
Q ss_pred cccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHh-----c
Q 004402 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQW-----K 659 (755)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-----~ 659 (755)
-...... .+...-+..|.|||++.+-.|+...|+||.||.||||.||+..|+.......+.+...+...+ +
T Consensus 585 ~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR 660 (752)
T KOG0670|consen 585 SFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR 660 (752)
T ss_pred ccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence 7643221 111222457999999999999999999999999999999999886554433322221111110 0
Q ss_pred cCCC-ccc--------------------------cCCC------CC-----CCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 004402 660 DSKG-KEF--------------------------IDPS------LD-----DSSSPCKLLNCMQVALLCVQENPEDRPSM 701 (755)
Q Consensus 660 ~~~~-~~~--------------------------~d~~------l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 701 (755)
.+.. .+. +.|. +. ....+.....+.+|+..|+..||++|.|.
T Consensus 661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~ 740 (752)
T KOG0670|consen 661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV 740 (752)
T ss_pred hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence 0000 000 1110 00 01122345567889999999999999999
Q ss_pred HHHHH
Q 004402 702 LEVSS 706 (755)
Q Consensus 702 ~evl~ 706 (755)
.+.+.
T Consensus 741 nqAL~ 745 (752)
T KOG0670|consen 741 NQALK 745 (752)
T ss_pred HHHhc
Confidence 88764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=215.11 Aligned_cols=255 Identities=18% Similarity=0.316 Sum_probs=185.4
Q ss_pred hcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeee-eecCCccEEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGY-CTERDENMLIY 510 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lv~ 510 (755)
.+.|.+.+.||+|.||.+-++..+ ..+.+++|-+..... ..++|.+|...--.| .|.||+..+.. |...+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 356888899999999999999664 477899998866533 357899998876667 69999998865 55566778999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE-c-CCCCeEEEecCCccccc
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL-D-NELNPKISDFGMAKLFR 588 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll-~-~~~~~kl~Dfgla~~~~ 588 (755)
||++.|+|..-+. ..-+.+....+++.|++.|+.|+|+.+ +||||||.+|||| + +..++||||||+.+..+
T Consensus 102 E~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999976653 334667788899999999999999997 9999999999999 3 34579999999998654
Q ss_pred cCCcccccccccccCCccccccccC---C--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKK---G--IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG 663 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (755)
..... ..-+..|.+||.... + ...+.+|||.||++++..+||+.|+.... ...... |.+.+|.....
T Consensus 175 ~tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y--~~~~~w~~rk~ 246 (378)
T KOG1345|consen 175 TTVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPY--WEWEQWLKRKN 246 (378)
T ss_pred ceehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchH--HHHHHHhcccC
Confidence 43322 223567999997642 2 24678999999999999999999986322 222222 22333333322
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 664 KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 664 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
....+ .-...+ ..++++..+-+..+|++|--..++.++-..
T Consensus 247 ~~~P~--~F~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 247 PALPK--KFNPFS----EKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred ccCch--hhcccC----HHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 21111 111122 256677888899999999777777666544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.2e-25 Score=210.07 Aligned_cols=247 Identities=21% Similarity=0.346 Sum_probs=185.9
Q ss_pred ccCcccccCCeeEEEEEcCCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCC
Q 004402 439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK 516 (755)
Q Consensus 439 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 516 (755)
...+|.+...|..|+|++ .|..+++|++... .....+.|.+|.-.|+.+.||||++++|.|.....+.++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 345788999999999999 4556666776543 2333467999999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceec-ccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR-DLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 517 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHr-Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
||...|++.. ....+..+..+++.+||+|++|||+.. +++-| -|.+..+++|++.+++|+- +-.+.......
T Consensus 273 slynvlhe~t-~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarism-ad~kfsfqe~g--- 345 (448)
T KOG0195|consen 273 SLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQEVG--- 345 (448)
T ss_pred HHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheec-ccceeeeeccc---
Confidence 9999998643 345777899999999999999999987 44443 6889999999999988751 11111111111
Q ss_pred cccccccCCccccccccCCCC---CchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKGIY---SMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~---s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
..-.+.||+||.++..+- -.++|+|||+++||||.|...||......+..- .+.-+.++
T Consensus 346 ---r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm---------------kialeglr 407 (448)
T KOG0195|consen 346 ---RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM---------------KIALEGLR 407 (448)
T ss_pred ---cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---------------hhhhcccc
Confidence 122578999999987653 357999999999999999999987554433111 11111122
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
-..++.....+.+++.-|++.||.+||.+..++-.||+.
T Consensus 408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 222333444678899999999999999999999999864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-24 Score=219.25 Aligned_cols=200 Identities=24% Similarity=0.387 Sum_probs=164.0
Q ss_pred HHHhcCCCccCcccccCCeeEEEEEcC----CCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCc
Q 004402 431 KAATNNFSSANKLGEGGFGPVYKGNLP----RGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDE 505 (755)
Q Consensus 431 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 505 (755)
....+.|...++||+|.|++||++.+. ..+.||+|.+...+.. ..+.+|+++|..+ -+.||+++.+++...+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 344567888999999999999999543 4678999998765433 5688999999999 59999999999999999
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC-CCeEEEecCCc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMA 584 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~-~~~kl~Dfgla 584 (755)
.++|+||++.....+++.. ++...+...+..+..||.++|.++ ||||||||+|+|.+.. +.-.|.|||++
T Consensus 110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 9999999999998888743 667889999999999999999997 9999999999999865 56789999999
Q ss_pred cccccCC------c-------c-----------------------------cccccccccCCccccccccC-CCCCchhh
Q 004402 585 KLFRKDV------D-------E-----------------------------ANTGRIVGTYGYVPPEYVKK-GIYSMKYD 621 (755)
Q Consensus 585 ~~~~~~~------~-------~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~s~~sD 621 (755)
....... . . .......||++|.|||++.. ..-|+++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 8211000 0 0 00011369999999998754 56789999
Q ss_pred HHHHHHHHHHHHcCCCCCCC
Q 004402 622 VYSFGVLLLQIISSKRNARY 641 (755)
Q Consensus 622 VwS~Gvil~elltg~~p~~~ 641 (755)
|||-|||++-+++++.||-.
T Consensus 261 iws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred eeeccceeehhhcccccccc
Confidence 99999999999999998743
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=259.41 Aligned_cols=196 Identities=16% Similarity=0.219 Sum_probs=136.3
Q ss_pred cCCC-Cceeeeeeee-------ecCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 004402 487 RLQH-VNLLRVLGYC-------TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558 (755)
Q Consensus 487 ~l~H-~niv~l~g~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~i 558 (755)
.++| +||++++++| ...+..+.++|++ .++|.++|... ...+++.+++.++.||++||.|||+.+ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3456 5888888877 2334567788887 66999998543 345899999999999999999999986 9
Q ss_pred eecccCCCCEEEcC-------------------CCCeEEEecCCccccccCCc--------------ccccccccccCCc
Q 004402 559 IHRDLKASNILLDN-------------------ELNPKISDFGMAKLFRKDVD--------------EANTGRIVGTYGY 605 (755)
Q Consensus 559 iHrDlk~~NIll~~-------------------~~~~kl~Dfgla~~~~~~~~--------------~~~~~~~~gt~~y 605 (755)
+||||||+||||+. ++.+|++|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999965 44556666666653211000 0001123578899
Q ss_pred cccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHH
Q 004402 606 VPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQ 685 (755)
Q Consensus 606 ~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 685 (755)
||||++.+..++.++|||||||+||||++|..|+.... ... ..+.. ....+.. .........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~----~~~~~----~~~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTM----SSLRH----RVLPPQI-----LLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHH----HHHHH----hhcChhh-----hhcCHHHHH
Confidence 99999999999999999999999999999876642110 000 00000 0111111 011224567
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 004402 686 VALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 686 l~~~Cl~~dP~~RPt~~evl~ 706 (755)
++.+||+.+|.+||++.|+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 888999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.1e-23 Score=199.90 Aligned_cols=166 Identities=17% Similarity=0.129 Sum_probs=123.2
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccc
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
|+|.+++... +..+++.+++.++.||+.||.|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 6888888542 345899999999999999999999875 999999999999999 99998654321
Q ss_pred cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSS 675 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 675 (755)
..||+.|||||++.+..++.++|||||||++|||+||+.|+...... ............... +.. ...
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~------~~~-~~~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADD------PRD-RSN 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCC------ccc-ccc
Confidence 25789999999999999999999999999999999999987432211 111111111111100 000 001
Q ss_pred CHHHH--HHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 676 SPCKL--LNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 676 ~~~~~--~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
..... ..+.+++.+||+.+|++||++.|+++.+..
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 11112 258899999999999999999999998864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd06542 GH18_EndoS-like Endo-beta-N-acetylglucosaminidases are bacterial chitinases that hydrolyze the chitin core of various asparagine (N)-linked glycans and glycoproteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=206.95 Aligned_cols=228 Identities=13% Similarity=0.114 Sum_probs=161.8
Q ss_pred EEEEEecCCCC------CCCCCCCCCCcceEEEEEEEecCCCcEEecCCchhhHHHHHHHHHHhhCCCceEEEEecCCCC
Q 004402 28 IKAGYWLAGRE------FPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQN 101 (755)
Q Consensus 28 ~~~gY~~~~~~------~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg~~~ 101 (755)
+.+|||..|+. ..+.++| ..+++|++.++.++.++... ...........++.+|++ |+||++||||+..
T Consensus 2 ~~~~y~~~~~~~~~~~~~~l~~~p-ds~D~v~lf~~~~~~~~~~~--~~~~~~~~~~~i~~l~~k--G~KVl~sigg~~~ 76 (255)
T cd06542 2 ISFGYFEVWDDKGASLQESLLNLP-DSVDMVSLFAANINLDAATA--VQFLLTNKETYIRPLQAK--GTKVLLSILGNHL 76 (255)
T ss_pred eEEEEEEecCCcCcccccccccCC-CcceEEEEcccccCcccccc--hhhhhHHHHHHHHHHhhC--CCEEEEEECCCCC
Confidence 57899887764 4566775 67888887444444321100 122334445555666665 7999999966553
Q ss_pred CccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCC-------CCcccHHHHHHHHHHHcc
Q 004402 102 STYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-------TDLNSLGILLDEWKASAS 174 (755)
Q Consensus 102 ~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~-------~~~~~~~~~l~~lr~~l~ 174 (755)
... | ....+++.|++|++++++++++|||||||||||++.. .+.++|..|+++||++++
T Consensus 77 ------------~~~-~-~~~~~~~~~~~fa~~l~~~v~~yglDGiDiD~E~~~~~~~~~~~~~~~~~~~lv~~Lr~~~~ 142 (255)
T cd06542 77 ------------GAG-F-ANNLSDAAAKAYAKAIVDTVDKYGLDGVDFDDEYSGYGKNGTSQPSNEAFVRLIKELRKYMG 142 (255)
T ss_pred ------------CCC-c-cccCCHHHHHHHHHHHHHHHHHhCCCceEEeeeecccCCCCCCcchHHHHHHHHHHHHHHhC
Confidence 211 3 3466788999999999999999999999999999854 367899999999999997
Q ss_pred CCCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHHHHHHCCCCCC
Q 004402 175 DQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPAN 254 (755)
Q Consensus 175 ~~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~~~~~~g~p~~ 254 (755)
+. +++|++++++..... +.+++++++||+++|+||.+.. ..+. .......|+|++
T Consensus 143 ~~-~kllt~~~~~~~~~~----~~~~~~~~vDyv~~~~y~~~~~----~~~~----------------~~~~~~~g~~~~ 197 (255)
T cd06542 143 PT-DKLLTIDGYGQALSN----DGEEVSPYVDYVIYQYYGSSSS----STQR----------------NWNTNSPKIPPE 197 (255)
T ss_pred cC-CcEEEEEecCCchhc----CHHHHHHhCCEEEeeccCCCCc----cCCc----------------ccccccCCCCHH
Confidence 53 689999888654322 6789999999999999976421 1110 011124589999
Q ss_pred ceeecccccCCCcccCCCcchHHHHHHHhhcCCCcccccccceeeeeeecCcEEEeeCCcchhhhhhhccccc-Cccccc
Q 004402 255 KLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEK-NLLGYK 333 (755)
Q Consensus 255 KlvlG~p~yG~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~yd~~~S~~~K~~~a~~~-~l~Gi~ 333 (755)
|+++|+++++.... ....++...++++.+. +.||+|
T Consensus 198 k~i~~~~~~~~~~~-------------------------------------------~~~~~~~~~A~~~~~~~~~gG~~ 234 (255)
T cd06542 198 KMVYTESFEEENGG-------------------------------------------NSGSSAEQYARWTPAKGGKGGIG 234 (255)
T ss_pred HceeeeeeecccCC-------------------------------------------CcchhHHHHHhcCcccCceEEEE
Confidence 99999999873211 2455556666777766 899999
Q ss_pred cccccccch
Q 004402 334 AFQLSNDDN 342 (755)
Q Consensus 334 ~W~l~~dd~ 342 (755)
+|.+..|..
T Consensus 235 ~y~~~~dy~ 243 (255)
T cd06542 235 TYALDRDYY 243 (255)
T ss_pred EEecCCCcc
Confidence 999998863
|
The endo-beta-N-acetylglucosaminidases have a glycosyl hydrolase family 18 (GH18) catalytic domain. Some members also have an additional C-terminal glycosyl hydrolase family 20 (GH20) domain while others have an N-terminal domain of unknown function (pfam08522). Members of this family include endo-beta-N-acetylglucosaminidase S (EndoS) from Streptococcus pyogenes, EndoF1, EndoF2, EndoF3, and EndoH from Flavobacterium meningosepticum, and EndoE from Enterococcus faecalis. EndoS is a secreted endoglycosidase from Streptococcus pyogenes that specifically hydrolyzes the glycan on human IgG between two core N-acetylglucosamine residues. EndoE is a secreted endoglycosidase, encoded by the ndoE gene in Enterococcus faecalis, that hydrolyzes the glycan on human RNase B. |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=212.10 Aligned_cols=168 Identities=17% Similarity=0.209 Sum_probs=129.8
Q ss_pred HHHhcCCCccCcccccCCeeEEEEEcC--CCCEEEEEEeccC-----ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC
Q 004402 431 KAATNNFSSANKLGEGGFGPVYKGNLP--RGQEFAVKRLSAT-----STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER 503 (755)
Q Consensus 431 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 503 (755)
.....+|...+.||+|+||+||+|... +++.||||++... .....+.|.+|+++|++++|+|+++.+..+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 344568999999999999999999654 5778899987533 223356799999999999999998533322
Q ss_pred CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc-CCCCEEEcCCCCeEEEecC
Q 004402 504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDL-KASNILLDNELNPKISDFG 582 (755)
Q Consensus 504 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDl-k~~NIll~~~~~~kl~Dfg 582 (755)
...++||||+++++|.... . .. ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 4579999999999996321 1 01 1467889999999999986 999999 9999999999999999999
Q ss_pred CccccccCCcccc------cccccccCCccccccccCC
Q 004402 583 MAKLFRKDVDEAN------TGRIVGTYGYVPPEYVKKG 614 (755)
Q Consensus 583 la~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 614 (755)
+++.+........ .....+++.|+|||.+...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9997654322111 1245678899999998643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-20 Score=201.03 Aligned_cols=262 Identities=21% Similarity=0.230 Sum_probs=192.4
Q ss_pred CCCccCcccccCCeeEEEEEcCC--CCEEEEEEeccCChhhHHHHHHHHHHHhcCCC----Cceeeeeeee-ecCCccEE
Q 004402 436 NFSSANKLGEGGFGPVYKGNLPR--GQEFAVKRLSATSTQGLEEFKNEVSLTARLQH----VNLLRVLGYC-TERDENML 508 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l 508 (755)
+|...+.||+|+||.||++.... ...+|+|............+..|+.++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 78899999999999999997544 35889998765533322267788888888863 5788888888 46677899
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC-----CCeEEEecCC
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-----LNPKISDFGM 583 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~-----~~~kl~Dfgl 583 (755)
||+.+ +.+|.++..... ...++..+...|+.|+..+|.+||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 778988764333 456899999999999999999999987 9999999999999765 4699999999
Q ss_pred ccccc--cCCc------ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHH
Q 004402 584 AKLFR--KDVD------EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAF 655 (755)
Q Consensus 584 a~~~~--~~~~------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~ 655 (755)
++.+. .... ........||..|+++....+...+.+.|+||++.++.|++.|..|+................
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 99332 1111 111234569999999999999999999999999999999999998875433322211111110
Q ss_pred HHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 004402 656 EQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMA 714 (755)
Q Consensus 656 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 714 (755)
. ...... .....+..+.++...+-..+...+|....+.+.|++....
T Consensus 254 ---~----~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 254 ---R----KLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred ---h----hhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 0 011110 1112223455666666668999999999999998765444
|
|
| >cd06543 GH18_PF-ChiA-like PF-ChiA is an uncharacterized chitinase found in the hyperthermophilic archaeon Pyrococcus furiosus with a glycosyl hydrolase family 18 (GH18) catalytic domain as well as a cellulose-binding domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=7e-22 Score=203.62 Aligned_cols=149 Identities=13% Similarity=0.152 Sum_probs=115.7
Q ss_pred CCCcceEEEEEEEecCCCcEEecCCc---h-hhHHHHHHHHHHhhCCCceEEEEecCCCCCccccccCCCCCCccccccc
Q 004402 46 SALFTHLICAFAEVDSSTYQLSISSA---N-QQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSM 121 (755)
Q Consensus 46 ~~~~thi~~~f~~~~~~~~~~~~~~~---~-~~~~~~~~~~~k~~~~~lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~ 121 (755)
...|+|++++|+....++ ....... . ...+...++.+|++ ++||+||+|||.+ . ..
T Consensus 23 ~~g~~~v~lAFi~~~~~~-~~~w~g~~~~~~~~~~~~~i~~lk~~--G~kViiS~GG~~g------------~-----~~ 82 (294)
T cd06543 23 ATGVKAFTLAFIVASGGC-KPAWGGSYPLDQGGWIKSDIAALRAA--GGDVIVSFGGASG------------T-----PL 82 (294)
T ss_pred HcCCCEEEEEEEEcCCCC-cccCCCCCCcccchhHHHHHHHHHHc--CCeEEEEecCCCC------------C-----cc
Confidence 358999999999887433 3322221 1 33445555788888 4899999966652 1 12
Q ss_pred ccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCCCc---ccHHHHHHHHHHHccCCCccEEEeeeecCCcccc-cccC
Q 004402 122 VGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDL---NSLGILLDEWKASASDQPELTLSMAVRYSPTHET-VSYP 197 (755)
Q Consensus 122 ~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~~~---~~~~~~l~~lr~~l~~~~~~~ls~~~~~~~~~~~-~~~~ 197 (755)
..+.+.|++|++++.+++.+|+|||||||||++...++ +++..+|++|++++ +++.|++++|..+.-.. .+++
T Consensus 83 ~~~~~~~~~~~~a~~~~i~~y~~dgiDfDiE~~~~~d~~~~~~~~~al~~Lq~~~---p~l~vs~Tlp~~p~gl~~~g~~ 159 (294)
T cd06543 83 ATSCTSADQLAAAYQKVIDAYGLTHLDFDIEGGALTDTAAIDRRAQALALLQKEY---PDLKISFTLPVLPTGLTPDGLN 159 (294)
T ss_pred ccCcccHHHHHHHHHHHHHHhCCCeEEEeccCCccccchhHHHHHHHHHHHHHHC---CCcEEEEecCCCCCCCChhHHH
Confidence 33778999999999999999999999999999987775 78889999999887 47889999997765444 5577
Q ss_pred cchhcc----cCChhhhhhhhccC
Q 004402 198 IDSMKK----NLNWAHLVAYDYHM 217 (755)
Q Consensus 198 ~~~l~~----~vD~~~vm~Yd~~~ 217 (755)
+.+.++ .+|+||||||||++
T Consensus 160 ~l~~a~~~Gv~~d~VNiMtmDyg~ 183 (294)
T cd06543 160 VLEAAAANGVDLDTVNIMTMDYGS 183 (294)
T ss_pred HHHHHHHcCCCcceeeeeeecCCC
Confidence 788888 99999999999984
|
Members of this domain family are found not only in archaea but also in eukaryotes and prokaryotes. PF-ChiA exhibits hydrolytic activity toward both colloidal and crystalline (beta/alpha) chitins at high temperature. |
| >cd02877 GH18_hevamine_XipI_class_III This conserved domain family includes xylanase inhibitor Xip-I, and the class III plant chitinases such as hevamine, concanavalin B, and PPL2, all of which have a glycosyl hydrolase family 18 (GH18) domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=192.31 Aligned_cols=199 Identities=18% Similarity=0.161 Sum_probs=129.6
Q ss_pred EEEEecCCC-CCCCCCC-CCCCcceEEEEEEEecCCCcE--EecCCc--h-----hhHHHHHHHHHHhhCCCceEEEEec
Q 004402 29 KAGYWLAGR-EFPLSDI-NSALFTHLICAFAEVDSSTYQ--LSISSA--N-----QQYFSIFANSVRRKNPSIKTLLSIW 97 (755)
Q Consensus 29 ~~gY~~~~~-~~~~~~i-~~~~~thi~~~f~~~~~~~~~--~~~~~~--~-----~~~~~~~~~~~k~~~~~lk~~isig 97 (755)
++.||-... +-++.+- +...++-|+++|+..-.+++. +.+... . -..+...++.++++ ++|||||||
T Consensus 3 v~vyWGq~~~~~~L~~~C~~~~~dii~i~Fl~~~~~~~~p~~n~~~~c~~~~~~~c~~~~~dI~~cq~~--G~KVlLSIG 80 (280)
T cd02877 3 IAVYWGQNSDEGSLREYCDTGNYDIVNISFLNVFGSGGTPGLNFAGHCGGSTYPNCPQLGADIKHCQSK--GKKVLLSIG 80 (280)
T ss_pred eEEECCCCCCCCCHHHHhCCCCccEEEEEeEcccCCCCCcccCccccCcccccccchhHHHHHHHHHHC--CCEEEEEcc
Confidence 778984322 2222211 233588999999976654221 111111 1 12455555666665 799999996
Q ss_pred CCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHH------------HHcCCCcccccccCCCCCCcccHHHH
Q 004402 98 NGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTA------------RLYGFQGIDLFWLWPNSTDLNSLGIL 165 (755)
Q Consensus 98 g~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~------------~~~~~DGvdiDwe~p~~~~~~~~~~~ 165 (755)
||.+ +.. | ++++.|++|++++.++. .+++|||||||||+|.. .+|..|
T Consensus 81 G~~~------------~~~-~----~s~~~a~~Fa~~l~~~~~~~~~~~~~rp~g~~~lDGiD~D~E~~~~---~~~~~l 140 (280)
T cd02877 81 GAGG------------SYS-L----SSDADAKDFADYLWNAFGGGTDSGVPRPFGDAVVDGFDFDIEHGSP---ENYDAL 140 (280)
T ss_pred CCCC------------CcC-C----CCHHHHHHHHHHHHHHhCCccccccccccccccccceEEecccCCc---cCHHHH
Confidence 6552 211 2 67899999999998875 26789999999999964 789999
Q ss_pred HHHHHHHccCC--CccEEEeeeecCCcccccccCcchhc-ccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHH
Q 004402 166 LDEWKASASDQ--PELTLSMAVRYSPTHETVSYPIDSMK-KNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFG 242 (755)
Q Consensus 166 l~~lr~~l~~~--~~~~ls~~~~~~~~~~~~~~~~~~l~-~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~ 242 (755)
+++||+.+... +++.||+|++... ...+....+. .++||+|||.||..+. ....+.++ .....
T Consensus 141 ~~~LR~~~~~~~~~~~~LTaAPq~~~---~d~~~~~~i~~~~~D~i~vqfYn~~~c--~~~~~~~~---------~~~~~ 206 (280)
T cd02877 141 AKRLRSLFASDPSKKYYLTAAPQCPY---PDASLGDAIATGLFDFIFVQFYNNPCC--SYASGNAS---------GFNFN 206 (280)
T ss_pred HHHHHHHhhcccCCceEEEeccccCC---cchhHHHHHccCccCEEEEEEecCccc--cccccccc---------hhhhH
Confidence 99999999753 5799999966531 1223344555 4999999999997421 11011111 12235
Q ss_pred HHHHHHCCCCC---CceeecccccC
Q 004402 243 IREWLRRGFPA---NKLVLGARASG 264 (755)
Q Consensus 243 v~~~~~~g~p~---~KlvlG~p~yG 264 (755)
.+.|... ++. .||+||+|+.-
T Consensus 207 ~~~w~~~-~~~~~~~kv~lGlpas~ 230 (280)
T cd02877 207 WDTWTSW-AKATSNAKVFLGLPASP 230 (280)
T ss_pred HHHHHHh-cccCCCceEEEecccCC
Confidence 5667654 565 89999999864
|
Hevamine is a class III endochitinase that hydrolyzes the linear polysaccharide chains of chitin and peptidoglycan and is important for defense against pathogenic bacteria and fungi. PPL2 (Parkia platycephala lectin 2) is a class III chitinase from Parkia platycephala seeds that hydrolyzes beta(1-4) glycosidic bonds linking 2-acetoamido-2-deoxy-beta-D-glucopyranose units in chitin. |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.1e-19 Score=190.45 Aligned_cols=261 Identities=26% Similarity=0.352 Sum_probs=194.2
Q ss_pred CCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChh---hHHHHHHHHHHHhcCCCC-ceeeeeeeeecCCccEEEEee
Q 004402 437 FSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQ---GLEEFKNEVSLTARLQHV-NLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~e~ 512 (755)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|..++..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556788999999999999765 88999998765332 367899999999999988 799999999776678999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC-CeEEEecCCccccccCC
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDFGMAKLFRKDV 591 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~-~~kl~Dfgla~~~~~~~ 591 (755)
+.++++..++........+.......+..+++.++.|+|..+ ++|||+||+||+++..+ .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966643211125788999999999999999999987 99999999999999998 79999999998654433
Q ss_pred ccc----ccccccccCCccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-cccchHHHHHHHhccCCC
Q 004402 592 DEA----NTGRIVGTYGYVPPEYVKK---GIYSMKYDVYSFGVLLLQIISSKRNARYYGTS-ENLNFLEYAFEQWKDSKG 663 (755)
Q Consensus 592 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 663 (755)
... ......|+..|+|||.+.+ ..++...|+||+|++++++++|..|+...... ......... .....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~----~~~~~ 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII----LELPT 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHH----HhcCC
Confidence 221 2355689999999999987 57889999999999999999999885433321 001111111 11110
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 664 KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 664 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
. .................+.+++..|+..+|..|.+..+....
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000000001122356788999999999999998877754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9e-21 Score=214.72 Aligned_cols=253 Identities=23% Similarity=0.268 Sum_probs=185.4
Q ss_pred ccCcccccCCeeEEEEEc-CCCCEEEEEEec----cC-Ch-hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 439 SANKLGEGGFGPVYKGNL-PRGQEFAVKRLS----AT-ST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 439 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~----~~-~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
..+.+|.|++|.|+.... ......+.|..+ .. .. +....+..|+.+-..++|||++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 457899999997777633 233444444332 11 11 112236778888899999999988888877766666699
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
||++ +|..++... ..+...++-.++.|+..|+.|||+.+ +.|||+|++|++++.++.+||+|||.+..+....
T Consensus 402 ~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 998877432 35778889999999999999999997 9999999999999999999999999999876554
Q ss_pred cc--cccccccccCCccccccccCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 592 DE--ANTGRIVGTYGYVPPEYVKKGIYSM-KYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 592 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~-~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
.. ......+|...|+|||.+.+..|.+ ..||||.|+++..|++|+.|+......+.... ..... .+.-.
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~------~~~~~--~~~~~ 546 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK------TNNYS--DQRNI 546 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh------hhccc--ccccc
Confidence 44 4556678999999999999999975 68999999999999999999876544432210 00000 00000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..-........+.+...++.++|+.||.+|.|+++|++
T Consensus 547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000011123446678999999999999999999984
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-19 Score=194.41 Aligned_cols=217 Identities=25% Similarity=0.370 Sum_probs=163.6
Q ss_pred HhcCCCCceeeeeeeeecCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccC
Q 004402 485 TARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLK 564 (755)
Q Consensus 485 l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk 564 (755)
|+.+.|.|+.+++|.+.+....++|.+||+.|+|.+.+.. ....+++.-...+..+|+.||.|||... -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4568999999999999999999999999999999999965 3456899999999999999999999864 23999999
Q ss_pred CCCEEEcCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCC-------CCchhhHHHHHHHHHHHHcCCC
Q 004402 565 ASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI-------YSMKYDVYSFGVLLLQIISSKR 637 (755)
Q Consensus 565 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~s~~sDVwS~Gvil~elltg~~ 637 (755)
++|+++|....+||+|||+.................-..-|.|||.+.... .+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999998764211111111122345799999987631 4678999999999999999999
Q ss_pred CCCCCCCCcc-cchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 638 NARYYGTSEN-LNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 638 p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
|+........ ...+.++. . .....+.|.+.... +....+..++.+||..+|++||++.++-..++...
T Consensus 157 ~~~~~~~~~~~~eii~~~~----~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVK----K-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccccccccCChHHHHHHHH----h-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 9875433322 12222221 1 12233333332211 22236889999999999999999999999887543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.3e-20 Score=179.99 Aligned_cols=171 Identities=12% Similarity=0.158 Sum_probs=132.5
Q ss_pred HhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhh---HHH------HHHHHHHHhcCCCCceeeeeeeeecC
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQG---LEE------FKNEVSLTARLQHVNLLRVLGYCTER 503 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~------~~~E~~~l~~l~H~niv~l~g~~~~~ 503 (755)
..++|...++||.|+||.||.... ++..+|||.++...... ... +.+|+..+.++.||+|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 368999999999999999999866 57789999997553222 222 67899999999999999998875532
Q ss_pred --------CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC
Q 004402 504 --------DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN 575 (755)
Q Consensus 504 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~ 575 (755)
...+++|||+++.+|.++.. ++. ....+++.++..+|..+ ++|||++|+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999977631 222 24568999999999987 99999999999999988
Q ss_pred eEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHH
Q 004402 576 PKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633 (755)
Q Consensus 576 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ell 633 (755)
++|+|||.......+... ..+.....|..++|+||||+.+.-+.
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988754211110 11334455667899999999987664
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.7e-18 Score=171.66 Aligned_cols=259 Identities=20% Similarity=0.231 Sum_probs=186.5
Q ss_pred cCCCccCcccccCCeeEEEE-EcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
-+|...++||+|+||+.+.| .+-++++||||.-...++ .-++..|....+.| ..++|..++-+..+.....||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 46888999999999999999 466899999997533322 24567788888777 568888888887888888999998
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC-----CCeEEEecCCcccc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-----LNPKISDFGMAKLF 587 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~-----~~~kl~Dfgla~~~ 587 (755)
+ +-||+++.-- ....++.++...+|.|+..-++|+|+.+ +|.|||||+|.||..- ..+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 7788887532 2335888999999999999999999998 9999999999999643 34899999999987
Q ss_pred ccCCccc-----ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC
Q 004402 588 RKDVDEA-----NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 588 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
....... ......||.+||+--...+..-+.+.|.=|+|-+++..+-|..|+............ +++.+.+
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY----eKIGe~K 255 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY----EKIGETK 255 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH----HHhcccc
Confidence 6543221 233467999999999999999999999999999999999999998654443322221 2222221
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 663 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
...-++. |.... +.++..-+.-.-..+-++-|...-+...+.+
T Consensus 256 r~T~i~~-Lc~g~----P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~d 298 (449)
T KOG1165|consen 256 RSTPIEV-LCEGF----PEEFATYLRYVRRLDFFETPDYDYLRKLFDD 298 (449)
T ss_pred ccCCHHH-HHhcC----HHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1111111 11111 2233344444445566677877666555544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.9e-19 Score=173.81 Aligned_cols=139 Identities=18% Similarity=0.154 Sum_probs=106.3
Q ss_pred cCcccccCCeeEEEEEcCCCCEEEEEEeccCChh--h-------HH-----------------HHHHHHHHHhcCCCCce
Q 004402 440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQ--G-------LE-----------------EFKNEVSLTARLQHVNL 493 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~-----------------~~~~E~~~l~~l~H~ni 493 (755)
...||+|+||.||+|...+|+.||||+++..... . .. ....|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999998878999999998754211 0 01 22349999999987766
Q ss_pred eeeeeeeecCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCceecccCCCCEEEcC
Q 004402 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL-QEYSNFRVIHRDLKASNILLDN 572 (755)
Q Consensus 494 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L-h~~~~~~iiHrDlk~~NIll~~ 572 (755)
.....+.. ...++||||++++++..... ....++......++.|++.+|.+| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 33222221 23489999999887754432 223578899999999999999999 5665 99999999999998
Q ss_pred CCCeEEEecCCcccc
Q 004402 573 ELNPKISDFGMAKLF 587 (755)
Q Consensus 573 ~~~~kl~Dfgla~~~ 587 (755)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.9e-19 Score=165.99 Aligned_cols=259 Identities=21% Similarity=0.272 Sum_probs=188.9
Q ss_pred hcCCCccCcccccCCeeEEEE-EcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCC-CceeeeeeeeecCCccEEEEe
Q 004402 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH-VNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e 511 (755)
..+|..+++||.|+||.+|.| ...+|+.||||.-+..... ..+.-|.++.+.|+| ..|..+..|..+.....+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 467889999999999999999 5678999999986554322 356788899999975 567778888888889999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC---CCeEEEecCCccccc
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE---LNPKISDFGMAKLFR 588 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~---~~~kl~Dfgla~~~~ 588 (755)
.+ +.||++++.-. ...++.++.+-++.|+..-++|+|..+ +|||||||+|.|..-+ ..+.++|||+++.+.
T Consensus 92 LL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 88 77898876322 234778899999999999999999998 9999999999999654 458999999999765
Q ss_pred cCCcc-----cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC
Q 004402 589 KDVDE-----ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG 663 (755)
Q Consensus 589 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (755)
..... .......||.+|.+--...+-.-+.+.|+=|+|.+|..+--|..|+.......-.... +.+.+...
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy----EkI~EkK~ 241 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY----EKISEKKM 241 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH----HHHHHhhc
Confidence 42221 1223467999999988888778889999999999999999999998543322211111 11111111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 004402 664 KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709 (755)
Q Consensus 664 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 709 (755)
.-.+. .+.... +.++.-.+.-|-..--++-|...-+-+.++
T Consensus 242 s~~ie-~LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 242 STPIE-VLCKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred CCCHH-HHhCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 11111 111222 234556667788877888888766665554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-18 Score=168.35 Aligned_cols=140 Identities=20% Similarity=0.230 Sum_probs=109.3
Q ss_pred cCcccccCCeeEEEEEcCCCCEEEEEEeccCChh--------------------------hHHHHHHHHHHHhcCCCCce
Q 004402 440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQ--------------------------GLEEFKNEVSLTARLQHVNL 493 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~H~ni 493 (755)
...||+|++|.||+|...+|+.||||+++..... ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999998778999999998765211 01224678999999999887
Q ss_pred eeeeeeeecCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecccCCCCEEEcC
Q 004402 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE-YSNFRVIHRDLKASNILLDN 572 (755)
Q Consensus 494 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~-~~~~~iiHrDlk~~NIll~~ 572 (755)
.....+... ..++||||++++++..... ....++......++.+++.++.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 443333322 3489999999886543321 22346778889999999999999999 65 99999999999999
Q ss_pred CCCeEEEecCCccccc
Q 004402 573 ELNPKISDFGMAKLFR 588 (755)
Q Consensus 573 ~~~~kl~Dfgla~~~~ 588 (755)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.6e-19 Score=201.58 Aligned_cols=251 Identities=19% Similarity=0.207 Sum_probs=178.6
Q ss_pred CCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCC-hhhHHHHHHHHHH--HhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 436 NFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATS-TQGLEEFKNEVSL--TARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
++...+.||.+.|=+|.+++.+.|. |+||++-+.. .-..+.|.++++- ...++|||++++.-+-......|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4566789999999999999988887 9999986554 3344445444333 4445899999999887777778899999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
..+ +|.+.| ..+..+...+...|+.|+..|+.-.|..+ |+|+|||.+||||+.-.-+.|+||..-+...-..+
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 855 676666 34667888899999999999999999997 99999999999999999999999988875432211
Q ss_pred -ccccc----cccccCCccccccccCC-----------CCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCcccchHHHHH
Q 004402 593 -EANTG----RIVGTYGYVPPEYVKKG-----------IYSMKYDVYSFGVLLLQIISS-KRNARYYGTSENLNFLEYAF 655 (755)
Q Consensus 593 -~~~~~----~~~gt~~y~aPE~~~~~-----------~~s~~sDVwS~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~ 655 (755)
..... ....-..|+|||.+... ..+++-||||+||++.||++- +++|... .+..+
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aY-- 247 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAY-- 247 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhH--
Confidence 11111 11223579999977431 257889999999999999985 5555321 11111
Q ss_pred HHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 656 EQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 656 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
+.+. .......+..- +...++.+++.|++.||++|-++++.++--++
T Consensus 248 ---r~~~-~~~~e~~Le~I----ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 248 ---RSGN-ADDPEQLLEKI----EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred ---hccC-ccCHHHHHHhC----cCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 1110 00000000000 01156789999999999999999999988554
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.2e-17 Score=157.51 Aligned_cols=183 Identities=18% Similarity=0.147 Sum_probs=136.7
Q ss_pred ccCcccccCCeeEEEEEcCCCCEEEEEEeccCCh----hhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCccEEEEeec
Q 004402 439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST----QGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 439 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
....|++|+||+||.+.- .+.+++.+.+..... -....|.+|+++|.+++ |+++.+++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999998765 688888887765532 11235889999999995 5889999886 3469999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc-CCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDL-KASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDl-k~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
++.+|...+. . ....++.+++++|.++|..+ |+|||| ||+|||++.++.++|+|||++........
T Consensus 81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9988864331 0 12357789999999999987 999999 79999999999999999999986543221
Q ss_pred c----cc-------cccccccCCccccccccCC-CCC-chhhHHHHHHHHHHHHcCCCCC
Q 004402 593 E----AN-------TGRIVGTYGYVPPEYVKKG-IYS-MKYDVYSFGVLLLQIISSKRNA 639 (755)
Q Consensus 593 ~----~~-------~~~~~gt~~y~aPE~~~~~-~~s-~~sDVwS~Gvil~elltg~~p~ 639 (755)
. .. ......++.|++|+-..-- ..+ ...+.++-|+-+|.++|++.+.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 0 00 0112346777888744322 233 5679999999999999998765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.1e-17 Score=161.00 Aligned_cols=137 Identities=21% Similarity=0.271 Sum_probs=105.5
Q ss_pred CccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-----CCCceeeeeeeeecCC---c-cEE
Q 004402 438 SSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-----QHVNLLRVLGYCTERD---E-NML 508 (755)
Q Consensus 438 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~l 508 (755)
...+.||+|+||.||. ...++.. +||++........+.+.+|+.+++.+ .||||++++|++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4567899999999996 3333444 79988765444567899999999999 5799999999998764 2 237
Q ss_pred EEee--cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCceecccCCCCEEEcC----CCCeEEEec
Q 004402 509 IYEY--LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL-LYLQEYSNFRVIHRDLKASNILLDN----ELNPKISDF 581 (755)
Q Consensus 509 v~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l-~~Lh~~~~~~iiHrDlk~~NIll~~----~~~~kl~Df 581 (755)
|+|| +++|+|.+++.+. .+++. ..++.+++.++ .|||+++ |+||||||+|||++. +..++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 6689999999432 24444 35567777777 8999987 999999999999974 347999995
Q ss_pred CCcc
Q 004402 582 GMAK 585 (755)
Q Consensus 582 gla~ 585 (755)
+.+.
T Consensus 154 ~G~~ 157 (210)
T PRK10345 154 IGES 157 (210)
T ss_pred CCCc
Confidence 4443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5e-17 Score=187.48 Aligned_cols=199 Identities=19% Similarity=0.239 Sum_probs=160.9
Q ss_pred HHHHHhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC---CCceeeeeeeeecCCc
Q 004402 429 DIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ---HVNLLRVLGYCTERDE 505 (755)
Q Consensus 429 ~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~ 505 (755)
+++...+.|.+.+.||+|+||.||+|...+|+.||+|+-+.... -+|---.+++.+|+ -+-|..+..++.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 44455678888999999999999999887899999998766532 12222233444444 2344555556666778
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc-------CCCCeEE
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-------NELNPKI 578 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~-------~~~~~kl 578 (755)
.++|+||.+.|+|.+++. ....++|...+.++.|++..+..||..+ |||+||||+|.||. ++..++|
T Consensus 769 S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred ceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence 899999999999999985 4456899999999999999999999987 99999999999994 3456899
Q ss_pred EecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCC
Q 004402 579 SDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636 (755)
Q Consensus 579 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~ 636 (755)
+|||.+..+..-.........++|-.+-.+|+..+..++.+.|.|.|+-+++-|+.|+
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 9999998765544445566678899999999999999999999999999999999887
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.3e-17 Score=164.73 Aligned_cols=232 Identities=19% Similarity=0.239 Sum_probs=144.4
Q ss_pred CCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCC-----------Cceeeeeee--
Q 004402 437 FSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQH-----------VNLLRVLGY-- 499 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H-----------~niv~l~g~-- 499 (755)
+...+.||.|+++.||.++. .+|+.+|||++.... ....+++.+|.-....+.+ .-++++--.
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 34567899999999999965 459999999975432 2345667777655544332 112221111
Q ss_pred ------eecCC--------ccEEEEeecCCCChhhhhcC---CC-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceec
Q 004402 500 ------CTERD--------ENMLIYEYLPNKSLDLYLFD---PI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561 (755)
Q Consensus 500 ------~~~~~--------~~~lv~e~~~~gsL~~~l~~---~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHr 561 (755)
..... ..+++|+-+ .++|..++.. .. ....+....++.+..|+.+.+++||+.+ ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 11111 235677766 5678777531 11 1122344556777899999999999997 9999
Q ss_pred ccCCCCEEEcCCCCeEEEecCCccccccCCcccccccccccCCccccccccC--------CCCCchhhHHHHHHHHHHHH
Q 004402 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK--------GIYSMKYDVYSFGVLLLQII 633 (755)
Q Consensus 562 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDVwS~Gvil~ell 633 (755)
||+|+|++++.+|.++|+||+.....+..... ...+..|.+||.... -.+|.+.|.|++|+++|.|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999887654332111 233577999997643 24788999999999999999
Q ss_pred cCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 004402 634 SSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDR 698 (755)
Q Consensus 634 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 698 (755)
|++.|+........... .+ ..+. +.+..+..|+..+|+.||++|
T Consensus 245 C~~lPf~~~~~~~~~~~-------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW-------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG-------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc-------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999864322211110 11 1222 445678899999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.5e-18 Score=182.12 Aligned_cols=232 Identities=22% Similarity=0.248 Sum_probs=171.3
Q ss_pred cccccCCeeEEEEE----cCCCCEEEEEEeccCChhh--HHHHHHHHHHHhcCC-CCceeeeeeeeecCCccEEEEeecC
Q 004402 442 KLGEGGFGPVYKGN----LPRGQEFAVKRLSATSTQG--LEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIYEYLP 514 (755)
Q Consensus 442 ~lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~ 514 (755)
++|+|+||.|+++. .+.|..+|+|.+.+..... ......|..++..++ ||.+|++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999999863 3457789999886653211 114566788888886 9999999999999999999999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 594 (755)
+|.|-..+.+ ....+..........++-++.++|..+ ++|||+|++||+++.+|.+++.|||+++..-...
T Consensus 81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--- 151 (612)
T KOG0603|consen 81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--- 151 (612)
T ss_pred cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence 9999776643 233555566667778888999999987 9999999999999999999999999998643221
Q ss_pred ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS 674 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 674 (755)
..+||..|||||++. ....++|.||||++++||+||-.|+.. +....... . .-.
T Consensus 152 ---~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~------------~--~~~ 205 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILK------------A--ELE 205 (612)
T ss_pred ---hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhh------------h--ccC
Confidence 128899999999998 457789999999999999999988854 11111110 0 011
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCH--HHHHHHh
Q 004402 675 SSPCKLLNCMQVALLCVQENPEDRPSM--LEVSSML 708 (755)
Q Consensus 675 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~--~evl~~L 708 (755)
.+........++...+...+|.+|--. ..+.+.+
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 222333445567777777788777544 3444444
|
|
| >COG3469 Chitinase [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-15 Score=145.02 Aligned_cols=228 Identities=16% Similarity=0.222 Sum_probs=139.1
Q ss_pred cCCcceEEEEEecCCCC--------CCCCCCC----CCCcceEEEEEEEecCCCcEEecCCchhhHHHHHHHHHHhhCCC
Q 004402 22 SDAQTWIKAGYWLAGRE--------FPLSDIN----SALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPS 89 (755)
Q Consensus 22 ~~~~~~~~~gY~~~~~~--------~~~~~i~----~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~ 89 (755)
..+.+++.+|||..|.. .+..+|. ++.++.+..+|..-..+=-.+.+-...+..|..-+.+|.++ +
T Consensus 21 ~~~~~KvLvGyWHnw~sgaaDgyq~gs~adial~d~~~~ynvv~V~Fmk~~g~iptf~P~~~~daeFr~~v~aLnae--G 98 (332)
T COG3469 21 PDISNKVLVGYWHNWKSGAADGYQQGSSADIALADTPRNYNVVTVSFMKGAGDIPTFKPYNDPDAEFRAQVGALNAE--G 98 (332)
T ss_pred cccccceEEEeeecccccccccccccceeeeEeccCCcccceEEEEEeecCCCCcccCcCCCCHHHHHHHHHHhhcc--C
Confidence 34457899999975543 2333333 23466677777655432112222233344555554555554 6
Q ss_pred ceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCC---CCcccHHHHH
Q 004402 90 IKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS---TDLNSLGILL 166 (755)
Q Consensus 90 lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~---~~~~~~~~~l 166 (755)
--++||+||..+ +--+ ....-+.|+.+|++++++|||||+|||.|.-.. +...-.-..+
T Consensus 99 kavllsLGGAdg-----------------hIeL-~~~qE~~fv~eiirlietyGFDGLDiDLEq~ai~~~dnq~v~p~al 160 (332)
T COG3469 99 KAVLLSLGGADG-----------------HIEL-KAGQEQAFVNEIIRLIETYGFDGLDIDLEQSAILAADNQTVIPAAL 160 (332)
T ss_pred cEEEEEccCccc-----------------eEEe-ccchHHHHHHHHHHHHHHhCCCccccchhhhhhhhcCCeeehHHHH
Confidence 789999955441 2223 234478999999999999999999999998733 2333567888
Q ss_pred HHHHHHccC-CCccEEEeeeecCCccccccc--CcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHH
Q 004402 167 DEWKASASD-QPELTLSMAVRYSPTHETVSY--PIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGI 243 (755)
Q Consensus 167 ~~lr~~l~~-~~~~~ls~~~~~~~~~~~~~~--~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v 243 (755)
|.+|+.-+. ++++.||+++..+.-.....| -+.++..+.||++..-|+..|.+ ...+..+++.- +.+.-+....
T Consensus 161 k~vk~hyk~~Gk~f~itMAPEfPYl~~~gaY~pyin~l~~~yD~i~pQlYNqGGdg-~w~~~~nawi~--q~nd~~kesf 237 (332)
T COG3469 161 KAVKDHYKNQGKNFFITMAPEFPYLQGWGAYIPYINELRDYYDFIAPQLYNQGGDG-NWVTESNAWIA--QNNDMVKESF 237 (332)
T ss_pred HHHHHHHHhcCCceEEEecCCCceecCCcccchHHHHHhhHHhhhhHHHhcCCCCC-CCcCccccccc--cccHHHHHhH
Confidence 888887654 678999999876533322323 36788999999999999986421 11111222221 1111122222
Q ss_pred HHHHH----------CCCCCCceeecccccCCCcccCCCc
Q 004402 244 REWLR----------RGFPANKLVLGARASGPGITIDGSM 273 (755)
Q Consensus 244 ~~~~~----------~g~p~~KlvlG~p~yG~~~~~~~~~ 273 (755)
.+++. ..+|.+|+++|+|. +.+-...|..
T Consensus 238 ly~~~~slanGtr~f~~ipa~k~aiGLPs-n~daAatGyv 276 (332)
T COG3469 238 LYYLTFSLANGTRGFEKIPADKFAIGLPS-NVDAAATGYV 276 (332)
T ss_pred HHHhhhhhhcCcccceecccceeEEecCC-CcchhhcCcC
Confidence 23321 15899999999998 5554444443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.8e-16 Score=156.70 Aligned_cols=144 Identities=17% Similarity=0.167 Sum_probs=111.3
Q ss_pred hcCCCccCcccccCCeeEEEEE--cCCCCEEEEEEeccCChh------------------------hHHHHHHHHHHHhc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGN--LPRGQEFAVKRLSATSTQ------------------------GLEEFKNEVSLTAR 487 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~ 487 (755)
...|...+.||+|++|.||+|. ..+|+.||||+++..... ....+..|+..+.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3357788999999999999997 568999999998754210 11235689999999
Q ss_pred CCCC--ceeeeeeeeecCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCC
Q 004402 488 LQHV--NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKA 565 (755)
Q Consensus 488 l~H~--niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~ 565 (755)
+.+. .+.+++++ ...++||||+++++|...... ...........++.+++.++.+||+.+ +++||||||
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp 177 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSE 177 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCCh
Confidence 9753 33444443 235899999999888665422 223555667899999999999999875 499999999
Q ss_pred CCEEEcCCCCeEEEecCCcccc
Q 004402 566 SNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 566 ~NIll~~~~~~kl~Dfgla~~~ 587 (755)
+||+++ ++.++|+|||.+...
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhcc
Confidence 999999 889999999998753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.2e-16 Score=154.39 Aligned_cols=134 Identities=18% Similarity=0.300 Sum_probs=112.4
Q ss_pred CcccccCCeeEEEEEcCCCCEEEEEEeccCCh--h------hHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATST--Q------GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
+.||+|++|.||+|.. .|..|++|+...... . ....+.+|+.++..++|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 778899998654321 1 124578899999999999987777777777788999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
+++++|.+++... .. .+..++.+++.+|.+||..+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999887431 12 78899999999999999987 99999999999999 78999999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.7e-16 Score=151.70 Aligned_cols=144 Identities=18% Similarity=0.203 Sum_probs=111.1
Q ss_pred HHHHHhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChh----------------------hHHHHHHHHHHHh
Q 004402 429 DIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQ----------------------GLEEFKNEVSLTA 486 (755)
Q Consensus 429 ~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~ 486 (755)
++......|...+.||+|+||.||++...+|+.||||++...... ....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 344444447778999999999999998888999999987543210 1123677889999
Q ss_pred cCCCCc--eeeeeeeeecCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccC
Q 004402 487 RLQHVN--LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLK 564 (755)
Q Consensus 487 ~l~H~n--iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk 564 (755)
.+.|++ +...++. ...++||||+++++|...... .....++.+++.++.++|+.+ ++|||||
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 998774 4444432 356899999999998765320 234578899999999999976 9999999
Q ss_pred CCCEEEcCCCCeEEEecCCccccc
Q 004402 565 ASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 565 ~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
|+||++++++.++|+|||++....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.5e-17 Score=173.27 Aligned_cols=174 Identities=25% Similarity=0.374 Sum_probs=129.6
Q ss_pred ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCc
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla 584 (755)
.+++.|++|...+|.+||..+......++.....++.|++.++.| . +.+|||+||.||+...+.++||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 478999999999999999765555667888999999999999999 3 3999999999999999999999999999
Q ss_pred cccccCC----cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCCcccchHHHHHHHhc
Q 004402 585 KLFRKDV----DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK-RNARYYGTSENLNFLEYAFEQWK 659 (755)
Q Consensus 585 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~ 659 (755)
....... .....+..+||..||+||.+.+..|+.++||||||++|+||+.-. .++. . ......++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------r----~~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------R----IATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------H----HHhhhhhh
Confidence 8765443 223445568999999999999999999999999999999999611 1110 0 00111112
Q ss_pred cCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 004402 660 DSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLE 703 (755)
Q Consensus 660 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 703 (755)
++. ++|.....++ .-+.++.+++...|++||++.+
T Consensus 474 ~g~----ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 474 DGI----IPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred cCC----CChHHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence 222 2221111111 2246788999999999995444
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.8e-15 Score=149.99 Aligned_cols=130 Identities=22% Similarity=0.342 Sum_probs=105.3
Q ss_pred cccccCCeeEEEEEcCCCCEEEEEEeccCC--h------hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATS--T------QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 442 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
.||+|+||.||+|.. +|..|++|...... . ...+++.+|++++..++|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 67899999864321 1 11356788999999999887655555555666779999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
++++|.+++.... ..++.+++++|.+||..+ ++|+|++|+||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988763210 078999999999999987 99999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.5e-15 Score=173.24 Aligned_cols=137 Identities=19% Similarity=0.287 Sum_probs=111.3
Q ss_pred hcCCCccCcccccCCeeEEEEEcCCCCEEEEEEe-ccC-Ch------hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRL-SAT-ST------QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE 505 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~-~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 505 (755)
...|...+.||+|+||+||+|..... .+++|+. ... .. ...+.+.+|++++..++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 44556778999999999999977443 4444432 211 11 123568899999999999999888888777778
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
.++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ +++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999988773 35678999999999999987 9999999999999 67899999999997
Q ss_pred c
Q 004402 586 L 586 (755)
Q Consensus 586 ~ 586 (755)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.6e-14 Score=133.43 Aligned_cols=135 Identities=21% Similarity=0.254 Sum_probs=114.9
Q ss_pred ccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCC--CceeeeeeeeecCCccEEEEeecCCC
Q 004402 439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH--VNLLRVLGYCTERDENMLIYEYLPNK 516 (755)
Q Consensus 439 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~e~~~~g 516 (755)
..+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++.+++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999998744 7899999866543 4678899999999976 58899999888778899999999988
Q ss_pred ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 517 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
.+..+ +......++.++++++.+||.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77533 4566778899999999999997656799999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.1e-14 Score=143.13 Aligned_cols=198 Identities=22% Similarity=0.286 Sum_probs=131.4
Q ss_pred CCCceeeeeeeeecC---------------------------CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHH
Q 004402 489 QHVNLLRVLGYCTER---------------------------DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541 (755)
Q Consensus 489 ~H~niv~l~g~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 541 (755)
+|||||+++++|.+. ..+|+||.-.+ .+|..++.. ...+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence 699999998876432 23577887663 477777742 2345566777889
Q ss_pred HHHHHHHHHHhcCCCCceecccCCCCEEE--cCCC--CeEEEecCCccccccC----CcccccccccccCCccccccccC
Q 004402 542 GVTQGLLYLQEYSNFRVIHRDLKASNILL--DNEL--NPKISDFGMAKLFRKD----VDEANTGRIVGTYGYVPPEYVKK 613 (755)
Q Consensus 542 ~ia~~l~~Lh~~~~~~iiHrDlk~~NIll--~~~~--~~kl~Dfgla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~ 613 (755)
|+.+|+.|||.++ +.|||+|++|||+ |+|. .+.|+|||.+---... ......-..-|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999987 9999999999999 3333 4789999987532210 00011111245667899998753
Q ss_pred C--CC----CchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHH
Q 004402 614 G--IY----SMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVA 687 (755)
Q Consensus 614 ~--~~----s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~ 687 (755)
. .. -.++|.|+.|-+.||+++...||-..+.. ..+...+ ++..+ |.+.+..+ ..+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~Y-----qe~qL-----Palp~~vp----p~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRTY-----QESQL-----PALPSRVP----PVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhhh-----hhhhC-----CCCcccCC----hHHHHHH
Confidence 2 21 25899999999999999998887432211 1111111 11111 22222222 3577899
Q ss_pred HHcccCCCCCCCCHHHHHHHhh
Q 004402 688 LLCVQENPEDRPSMLEVSSMLK 709 (755)
Q Consensus 688 ~~Cl~~dP~~RPt~~evl~~L~ 709 (755)
...++.||++||+..-....|.
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 9999999999999877766664
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.4e-14 Score=138.53 Aligned_cols=136 Identities=20% Similarity=0.249 Sum_probs=96.6
Q ss_pred cCcccccCCeeEEEEEcCCCCEEEEEEeccCChh--hHHH----------------------HHHHHHHHhcCCCCc--e
Q 004402 440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQ--GLEE----------------------FKNEVSLTARLQHVN--L 493 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--i 493 (755)
.+.||+|+||.||++...+|+.||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999998878999999998654211 1111 134555555554332 3
Q ss_pred eeeeeeeecCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecccCCCCEEEcC
Q 004402 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE-YSNFRVIHRDLKASNILLDN 572 (755)
Q Consensus 494 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~-~~~~~iiHrDlk~~NIll~~ 572 (755)
.+.+++ ...++||||++++.+......... .. .....++.+++.++.++|. .+ ++||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 333333 246899999999654322111100 11 5677899999999999998 65 99999999999999
Q ss_pred CCCeEEEecCCcccc
Q 004402 573 ELNPKISDFGMAKLF 587 (755)
Q Consensus 573 ~~~~kl~Dfgla~~~ 587 (755)
++.++|+|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.4e-14 Score=163.88 Aligned_cols=209 Identities=20% Similarity=0.290 Sum_probs=138.6
Q ss_pred hcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
..+|+.++.|..|++|.||..+.. ..+++|+|+-+.+. +++- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l------ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch------hhhc--cccccCCccee------------------
Confidence 457888999999999999999764 36788885432211 1110 23333334333
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
|+-...+... . .++.. .+.+++|||+.+ |+|||+||+|.+|+.-|.+|++|||+++.......
T Consensus 136 ---gDc~tllk~~-g--~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLKNI-G--PLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhcccC-C--CCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 4444444221 1 12222 277899999987 99999999999999999999999999986432111
Q ss_pred -------------ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhc
Q 004402 593 -------------EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWK 659 (755)
Q Consensus 593 -------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 659 (755)
+-....++||+.|.|||++....|...+|.|++|+|+||.+-|+.||.....++ ++..+...
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---lfg~visd-- 273 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQVISD-- 273 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH---HHhhhhhh--
Confidence 111234689999999999999999999999999999999999999985432222 11111110
Q ss_pred cCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 004402 660 DSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRP 699 (755)
Q Consensus 660 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 699 (755)
..+..+. ......+..+++.+.|+.+|..|-
T Consensus 274 ---~i~wpE~------dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 274 ---DIEWPEE------DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ---hcccccc------CcCCCHHHHHHHHHHHHhChHhhc
Confidence 0011111 111223566788888999999884
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.7e-13 Score=137.58 Aligned_cols=135 Identities=22% Similarity=0.242 Sum_probs=104.3
Q ss_pred cCccc-ccCCeeEEEEEcCCCCEEEEEEeccCC-------------hhhHHHHHHHHHHHhcCCCCce--eeeeeeeecC
Q 004402 440 ANKLG-EGGFGPVYKGNLPRGQEFAVKRLSATS-------------TQGLEEFKNEVSLTARLQHVNL--LRVLGYCTER 503 (755)
Q Consensus 440 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~ 503 (755)
...|| .|+.|+||+... .+..++||++.... ......+.+|++++.+++|+++ +..++++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45788 899999999977 47889999885421 1123467889999999998774 6667665433
Q ss_pred Cc----cEEEEeecCC-CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEE
Q 004402 504 DE----NMLIYEYLPN-KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI 578 (755)
Q Consensus 504 ~~----~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl 578 (755)
.. .++|+|++++ .+|.+++.. ..++.. .+.+|++++.+||+.+ |+||||||+|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 22 3599999997 688887743 224433 3568999999999987 999999999999999999999
Q ss_pred EecCCccc
Q 004402 579 SDFGMAKL 586 (755)
Q Consensus 579 ~Dfgla~~ 586 (755)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.3e-14 Score=162.76 Aligned_cols=253 Identities=23% Similarity=0.316 Sum_probs=182.6
Q ss_pred CCCccCcccccCCeeEEEEEcCC--CCEEEEEEeccCC--hhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCccEEEE
Q 004402 436 NFSSANKLGEGGFGPVYKGNLPR--GQEFAVKRLSATS--TQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ 510 (755)
.|...+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++.+++...+.+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 45556779999999998875433 4466777665543 233345556777777776 999999999999999999999
Q ss_pred eecCCCChhhhhc-CCCccCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCceecccCCCCEEEcCCC-CeEEEecCCcccc
Q 004402 511 EYLPNKSLDLYLF-DPIRRYVLDWQKRVNIIEGVTQGLLYLQ-EYSNFRVIHRDLKASNILLDNEL-NPKISDFGMAKLF 587 (755)
Q Consensus 511 e~~~~gsL~~~l~-~~~~~~~l~~~~~~~i~~~ia~~l~~Lh-~~~~~~iiHrDlk~~NIll~~~~-~~kl~Dfgla~~~ 587 (755)
+|..++++...+. ... ...+....-..+.|+..++.|+| ..+ +.||||||+|.+++..+ .++++|||+|..+
T Consensus 101 ~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred CcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999977662 221 12444556678899999999999 655 99999999999999999 9999999999987
Q ss_pred cc-CCcccccccccc-cCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCc
Q 004402 588 RK-DVDEANTGRIVG-TYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664 (755)
Q Consensus 588 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (755)
.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......... ... +....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~-----~~~~~-- 247 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSS-----WKSNK-- 247 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-cee-----ecccc--
Confidence 66 444444445677 9999999998874 4567899999999999999999888654433311 010 11111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004402 665 EFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVS 705 (755)
Q Consensus 665 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 705 (755)
..... ...........++...|+..+|+.|.+.+++-
T Consensus 248 ~~~~~----~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 248 GRFTQ----LPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ccccc----CccccCChhhhhcccccccCCchhcccccccc
Confidence 00000 01111122455777888889999999977764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.4e-12 Score=140.83 Aligned_cols=144 Identities=20% Similarity=0.229 Sum_probs=99.9
Q ss_pred CCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHH---------------------------------------
Q 004402 436 NFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLE--------------------------------------- 476 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--------------------------------------- 476 (755)
.|+ .+.||.|++|.||+|++.+|+.||||+.+....+...
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 444 3679999999999999999999999998765211100
Q ss_pred -HHHHHHHHHhcC----CCCceeeeeeeee-cCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHH-HHHH
Q 004402 477 -EFKNEVSLTARL----QHVNLLRVLGYCT-ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ-GLLY 549 (755)
Q Consensus 477 -~~~~E~~~l~~l----~H~niv~l~g~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~l~~ 549 (755)
+|.+|...+.++ +|.+-+.+-..+. .....++||||+++++|.++...... .. .+..++..++. .+..
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQ 272 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHH
Confidence 244455544444 2333333333332 23457999999999999887632111 11 23456666665 4667
Q ss_pred HHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 550 Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
+|..+ ++|+|++|.||+++.+++++++|||++..+.
T Consensus 273 l~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 273 VLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 78765 9999999999999999999999999998654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.7e-12 Score=129.34 Aligned_cols=203 Identities=19% Similarity=0.245 Sum_probs=136.7
Q ss_pred HHHhcCCCCceeeeeeeeecC-----CccEEEEeecCCCChhhhhcCCCc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 004402 483 SLTARLQHVNLLRVLGYCTER-----DENMLIYEYLPNKSLDLYLFDPIR-RYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556 (755)
Q Consensus 483 ~~l~~l~H~niv~l~g~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~ 556 (755)
.-|-++-|.|||++..|..+. ....++.|||+.|++..+|..... ...+......+++.||..||.|||+. .+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 345556799999999987553 346899999999999999965332 34577777889999999999999995 57
Q ss_pred CceecccCCCCEEEcCCCCeEEEecCCccccccC---CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHH
Q 004402 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKD---VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQII 633 (755)
Q Consensus 557 ~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ell 633 (755)
+|+|+++.-+.|++..++-+|++--.-. ..... ..........+.++|.+||+=...+.+.++|||+||+..+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 8999999999999999998887521111 11110 0111122234578999999887777888999999999999998
Q ss_pred cCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 634 SSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 634 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
-+..-......... .+ ..+...+- .+... .-..++..|++..|..||+|++++.
T Consensus 277 ilEiq~tnseS~~~---~e--------e~ia~~i~-~len~-------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKVE---VE--------ENIANVII-GLENG-------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcceee---hh--------hhhhhhee-eccCc-------cccCcCcccccCCCCCCcchhhhhc
Confidence 76643211111100 00 00000000 00000 0124566799999999999998763
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.1e-11 Score=115.38 Aligned_cols=131 Identities=18% Similarity=0.175 Sum_probs=97.2
Q ss_pred cCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceee-eeeeeecCCccEEEEeecCCCCh
Q 004402 440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR-VLGYCTERDENMLIYEYLPNKSL 518 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lv~e~~~~gsL 518 (755)
.+.|+.|.++.||+++. .++.|++|....... ....+..|+..+..+.+.++++ ++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 35789999999999986 478899998755432 1234678999999886655543 44433 2346899999999887
Q ss_pred hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS--NFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 519 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~--~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
.... .....++.+++++|+.||... ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5320 111345678999999999876 23469999999999999 66899999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=3e-10 Score=124.38 Aligned_cols=168 Identities=15% Similarity=0.174 Sum_probs=126.7
Q ss_pred EcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCCChhhhhcCCCccCCCCHH
Q 004402 455 NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQ 534 (755)
Q Consensus 455 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~ 534 (755)
...++.+|.|...+.......+...+.++.|+.++||||++++.........|+|+|-+. .|..++.. +...
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~ 104 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKE 104 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHH
Confidence 445688899988876655445567788999999999999999999999999999999873 45656532 2245
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccccccccccCCccccccccCC
Q 004402 535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614 (755)
Q Consensus 535 ~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 614 (755)
.....+.||++||.|||+.+ .++|++|.-..|++++.|+.||++|.++........ ......--..|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 56677899999999999777 599999999999999999999999988864322111 00011112346667755433
Q ss_pred CCCchhhHHHHHHHHHHHHcCC
Q 004402 615 IYSMKYDVYSFGVLLLQIISSK 636 (755)
Q Consensus 615 ~~s~~sDVwS~Gvil~elltg~ 636 (755)
. -..|.|-|||+++|++.|.
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred c--cchhhhhHHHHHHHHhCcc
Confidence 3 2469999999999999983
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.7e-10 Score=128.72 Aligned_cols=147 Identities=18% Similarity=0.180 Sum_probs=92.8
Q ss_pred hcCCCccCcccccCCeeEEEEEcCC-CCEEEEEEeccCChh----------------------------------hHHH-
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQ----------------------------------GLEE- 477 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~~- 477 (755)
...|+. +.||+|++|.||+|++.+ |+.||||++++...+ ..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 446776 789999999999999877 999999999754211 0111
Q ss_pred -----HHHHHHHHhcC----CCCceeeeeeeeec-CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHH-
Q 004402 478 -----FKNEVSLTARL----QHVNLLRVLGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG- 546 (755)
Q Consensus 478 -----~~~E~~~l~~l----~H~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~- 546 (755)
|.+|...+.++ .+.+.+.+-.++.+ ....++||||++++.+.++-.- .....+.. .++...++.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l--~~~g~d~~---~la~~~v~~~ 272 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL--RAAGTDMK---LLAERGVEVF 272 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH--HhcCCCHH---HHHHHHHHHH
Confidence 33444444443 23333443333332 3457899999999999764211 11111111 122222211
Q ss_pred HHHHHhcCCCCceecccCCCCEEEcCCC----CeEEEecCCcccccc
Q 004402 547 LLYLQEYSNFRVIHRDLKASNILLDNEL----NPKISDFGMAKLFRK 589 (755)
Q Consensus 547 l~~Lh~~~~~~iiHrDlk~~NIll~~~~----~~kl~Dfgla~~~~~ 589 (755)
+.-+... +++|+|++|.||+++.++ ++++.|||+...+..
T Consensus 273 ~~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 273 FTQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 1222333 499999999999999988 999999999987643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1e-10 Score=127.14 Aligned_cols=248 Identities=20% Similarity=0.252 Sum_probs=173.3
Q ss_pred CCCccCcccc--cCCeeEEEEEc---CCCCEEEEEEeccCCh--hhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccE
Q 004402 436 NFSSANKLGE--GGFGPVYKGNL---PRGQEFAVKRLSATST--QGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENM 507 (755)
Q Consensus 436 ~f~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 507 (755)
.|.....+|. |.+|.||.+.. .++..+|+|.-+.... .....=.+|+..-.++ .|+|.++........+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556788999 99999999965 4578899998543322 2212224566666666 5999999888888888999
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCceecccCCCCEEEcCC-CCeEEEecC
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ----GLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFG 582 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~l~~Lh~~~~~~iiHrDlk~~NIll~~~-~~~kl~Dfg 582 (755)
+-+|.|. .+|..+.+.. ...++....+....+..+ ||.++|+.. ++|-|+||.||++..+ ..++++|||
T Consensus 195 iqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 9999885 6887777543 223566777778888888 999999987 9999999999999999 899999999
Q ss_pred CccccccCCcccc---cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhc
Q 004402 583 MAKLFRKDVDEAN---TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWK 659 (755)
Q Consensus 583 la~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 659 (755)
+...+....-... .....|...|++||.+. +.++..+|+|++|.++.|-.++.......-... |.+.+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------W~~~r 339 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS--------WSQLR 339 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC--------ccccc
Confidence 9987765431111 12235677899999874 457889999999999999988765443210000 00111
Q ss_pred cCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 660 DSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 660 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
... +...+... -...+..++.++++.+|-.|++.+.+..
T Consensus 340 ~~~----ip~e~~~~----~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 QGY----IPLEFCEG----GSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccc----CchhhhcC----cchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 100 11111111 1123445888999999999999877663
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.5e-09 Score=107.72 Aligned_cols=142 Identities=18% Similarity=0.262 Sum_probs=109.1
Q ss_pred CcccccCCeeEEEEEcCCCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCC--CceeeeeeeeecCC---ccEEEEeecC
Q 004402 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQH--VNLLRVLGYCTERD---ENMLIYEYLP 514 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lv~e~~~ 514 (755)
+.|+.|..+.||++...+|+.+++|....... .....+..|.+++..+.+ .++.+++.++.... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999876678999998765432 134578899999999965 44566777776543 5689999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS---------------------------------------- 554 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~---------------------------------------- 554 (755)
+.++...+.. ..++......++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988765421 23666777788888888888888521
Q ss_pred -------------CCCceecccCCCCEEEcC--CCCeEEEecCCccc
Q 004402 555 -------------NFRVIHRDLKASNILLDN--ELNPKISDFGMAKL 586 (755)
Q Consensus 555 -------------~~~iiHrDlk~~NIll~~--~~~~kl~Dfgla~~ 586 (755)
...++|+|+.|.||++++ ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 234799999999999998 56789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.02 E-value=5e-09 Score=101.62 Aligned_cols=136 Identities=17% Similarity=0.161 Sum_probs=97.3
Q ss_pred CcccccCCeeEEEEEcCC-------CCEEEEEEeccCC----------------------hhhHHHHH----HHHHHHhc
Q 004402 441 NKLGEGGFGPVYKGNLPR-------GQEFAVKRLSATS----------------------TQGLEEFK----NEVSLTAR 487 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~E~~~l~~ 487 (755)
..||.|.-+.||.|...+ +..+|||+.+... ....+.+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999996543 5799999875321 00122233 79999999
Q ss_pred CCC--CceeeeeeeeecCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCceecccC
Q 004402 488 LQH--VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL-QEYSNFRVIHRDLK 564 (755)
Q Consensus 488 l~H--~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L-h~~~~~~iiHrDlk 564 (755)
+.. -++...+++ ...++||||+.++.+.... .....++..+...+..++..+|..| |..+ +||+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~---Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK---LKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh---hhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 843 456666654 4578999999775442211 1112344456677889999999998 6665 9999999
Q ss_pred CCCEEEcCCCCeEEEecCCcccc
Q 004402 565 ASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 565 ~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
+.|||++ ++.+.|+|||.+...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 468999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.5e-10 Score=121.47 Aligned_cols=248 Identities=20% Similarity=0.205 Sum_probs=172.8
Q ss_pred HHhcCCCccCcccccCCeeEEEEEc--CCCCEEEEEEeccCChhhHH--HHHHHHHHHhcC-CCCceeeeeeeeecCCcc
Q 004402 432 AATNNFSSANKLGEGGFGPVYKGNL--PRGQEFAVKRLSATSTQGLE--EFKNEVSLTARL-QHVNLLRVLGYCTERDEN 506 (755)
Q Consensus 432 ~~~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 506 (755)
.-..+|..+..||.|.|+.|++... .++..+++|.+......... .-+.|+.+...+ .|.+++.........+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3456788899999999999999853 46889999988665332222 224566666666 588888877766667777
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC-CCeEEEecCCcc
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMAK 585 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~-~~~kl~Dfgla~ 585 (755)
++--|||+++++.... .....++...++++..+++.++.++|+.. ++|+|+||+||++..+ +..+++|||.+.
T Consensus 342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 8999999999987665 22345677788899999999999999876 9999999999999886 889999999987
Q ss_pred ccccCCcccccccccccCCcc--ccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC
Q 004402 586 LFRKDVDEANTGRIVGTYGYV--PPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG 663 (755)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (755)
.+.... ......-+++ +|+......+-.+.|++|||.-+.|.+++..-.+...... .+..+..
T Consensus 416 ~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~----------~i~~~~~ 480 (524)
T KOG0601|consen 416 RLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL----------TIRSGDT 480 (524)
T ss_pred ccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccccce----------eeecccc
Confidence 422110 0111222333 5666677788899999999999999998764322111000 0000100
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 664 KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 664 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
+.+. .....+..+..-+...++..||.+.++....+-
T Consensus 481 -----p~~~-----~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 481 -----PNLP-----GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred -----cCCC-----chHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 1111 111345566777889999999999988876654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.1e-08 Score=92.07 Aligned_cols=144 Identities=19% Similarity=0.283 Sum_probs=104.0
Q ss_pred ccCcccccCCeeEEEEEcCCCCEEEEEEe-ccC-C------hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 439 SANKLGEGGFGPVYKGNLPRGQEFAVKRL-SAT-S------TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 439 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~-~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
....|-+|+-+.|+++.. .|+...||.- .+. . .-..++..+|...|.+++--.|.--.-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 467889999999999987 6777777753 221 1 112446788999998886545444444555666778999
Q ss_pred eecCC-CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC---eEEEecCCccc
Q 004402 511 EYLPN-KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN---PKISDFGMAKL 586 (755)
Q Consensus 511 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~---~kl~Dfgla~~ 586 (755)
||+++ .++.+++........ ..+....++..|-+.+.-||.++ |||+||..+||+|..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 467777754333222 22333678889999999999998 999999999999966543 58999999975
Q ss_pred c
Q 004402 587 F 587 (755)
Q Consensus 587 ~ 587 (755)
.
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 3
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=3e-08 Score=92.73 Aligned_cols=131 Identities=21% Similarity=0.334 Sum_probs=98.3
Q ss_pred CcccccCCeeEEEEEcCCCCEEEEEEe-ccC--Chh-----hHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 441 NKLGEGGFGPVYKGNLPRGQEFAVKRL-SAT--STQ-----GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~--~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
..+++|+-+.+|.+.+ -|.++++|.- .+. .++ ..+.-.+|..++.+++--.|.--+-+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3578999999999976 4555777753 222 111 123567899999888655444444455567778999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
+++..|.+.+... ...++..+-..+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998888432 2566777888888899987 99999999999998875 99999999974
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.1e-07 Score=101.42 Aligned_cols=170 Identities=20% Similarity=0.289 Sum_probs=127.8
Q ss_pred CCeeEEEEE-cCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeec----CCccEEEEeecCC-CChhh
Q 004402 447 GFGPVYKGN-LPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE----RDENMLIYEYLPN-KSLDL 520 (755)
Q Consensus 447 ~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~e~~~~-gsL~~ 520 (755)
.-.+.||+. ..+|..|++|+++....+.......-++.++++.|+|+|++..++.. +..+++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 446789984 45799999999955544333333456788999999999999988763 3458999999876 45655
Q ss_pred hhcCC------------CccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 521 YLFDP------------IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 521 ~l~~~------------~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
+-+.. ......++..+|.++.|+..||.++|+.+ +.-+-|.+.+||++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 54321 12234677899999999999999999987 8889999999999999999999888887665
Q ss_pred cCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRN 638 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p 638 (755)
.+.... +.. -.+-|.=.||.+++.|.||...
T Consensus 445 ~d~~~~----------------le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPTEP----------------LES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCCcc----------------hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 443111 111 2356889999999999999644
|
|
| >KOG4701 consensus Chitinase [Cell wall/membrane/envelope biogenesis] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.7e-07 Score=94.67 Aligned_cols=219 Identities=17% Similarity=0.172 Sum_probs=120.3
Q ss_pred HHHHH-HHhhhchhccCCcceEEEEEecCC---CCCCCC-CCCCCCcceEEEEEEEecCCCcE--Eec----CCch----
Q 004402 8 VLFFI-FLSSFQLEFSDAQTWIKAGYWLAG---REFPLS-DINSALFTHLICAFAEVDSSTYQ--LSI----SSAN---- 72 (755)
Q Consensus 8 ~~~~~-~~~~~~~~~~~~~~~~~~gY~~~~---~~~~~~-~i~~~~~thi~~~f~~~~~~~~~--~~~----~~~~---- 72 (755)
+++|+ |+.+.........+-.+++||-.. ++-.+. --....+.-++++|..-=+.++. +.+ .+..
T Consensus 7 illF~~F~~l~lsk~~~~~~t~IA~YWGQN~aG~q~~Ls~yC~~~~yd~~~lsFL~~F~~~~Tp~LNfAn~Csd~~~~~l 86 (568)
T KOG4701|consen 7 LLLFVYFARLALSKLNLTNQTAIAGYWGQNLAGDQKRLSSYCQNTTYDAIILSFLIDFNVDGTPVLNFANLCSDSDTFSL 86 (568)
T ss_pred HHHHHHHHHccccccccccccceEEEeccccccchhhhhhhhccCccceeeeehhhhcCCCCCceeehhcccCccccccc
Confidence 33344 333333444455577799999542 221111 11233466677777632221111 111 1111
Q ss_pred --hhHHHHHHHHHHhhCCCceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHH----------
Q 004402 73 --QQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTAR---------- 140 (755)
Q Consensus 73 --~~~~~~~~~~~k~~~~~lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~---------- 140 (755)
--++...++....+ |+|||+|+||+.+ ...+.|.+..+.|++.+.+.--
T Consensus 87 ~~CTqi~~di~~CQS~--GiKVlLSLGG~~G-----------------nYs~~~d~dA~~fA~~LWn~Fg~G~~S~RPfg 147 (568)
T KOG4701|consen 87 KKCTQIETDIQVCQSN--GIKVLLSLGGYNG-----------------NYSLNNDDDATNFAFQLWNIFGSGEDSYRPFG 147 (568)
T ss_pred cccchhhhHHHHHHhc--CeEEEEeccCccc-----------------ceeeccchhHHHHHHHHHHHhcCCccccCccc
Confidence 11333343434443 8999999976663 3456777888899999887642
Q ss_pred HcCCCcccccccCCCCCCcccHHHHHHHHHHHccC-CCccEEEeeeecC-CcccccccCcchhc-ccCChhhhhhhhccC
Q 004402 141 LYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASD-QPELTLSMAVRYS-PTHETVSYPIDSMK-KNLNWAHLVAYDYHM 217 (755)
Q Consensus 141 ~~~~DGvdiDwe~p~~~~~~~~~~~l~~lr~~l~~-~~~~~ls~~~~~~-~~~~~~~~~~~~l~-~~vD~~~vm~Yd~~~ 217 (755)
+-=+||+|||.|... ...|..|.+.||+.|.. .+++-|+.|+..+ |+.... ..|. +-.||+-+.-|+--
T Consensus 148 ~AVvDGfDF~IE~g~---~~~ysaLA~~L~~~Fa~~~r~yYLsaAPQCP~PD~~~G----~aL~~~~fDf~~IQFYNN~- 219 (568)
T KOG4701|consen 148 KAVVDGFDFEIEKGT---NTAYSALAKRLLEIFASDPRRYYLSAAPQCPVPDHTLG----KALSENSFDFLSIQFYNNS- 219 (568)
T ss_pred chhccceeeeeecCC---cchHHHHHHHHHHHHccCCceEEeccCCCCCCCchhhh----hhhhccccceEEEEeecCC-
Confidence 222799999999763 46789999999999865 4568887776532 221111 1222 34688888888642
Q ss_pred CCCCcccccCCCCCCCCCCCcHHHHHHHHHHCCCCCCc---eeecccccC
Q 004402 218 PSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANK---LVLGARASG 264 (755)
Q Consensus 218 ~~~~~~~~~~a~l~~~~~~~~~~~~v~~~~~~g~p~~K---lvlG~p~yG 264 (755)
.-+.-.| ..+.+.+ +-..|.. .+.++| +.||+|.-.
T Consensus 220 -~CS~SsG--------~~Q~~fD-sW~~ya~-~~a~nKn~~lFLGLPg~~ 258 (568)
T KOG4701|consen 220 -TCSGSSG--------SRQSTFD-AWVEYAE-DSAYNKNTSLFLGLPGHQ 258 (568)
T ss_pred -CcccccC--------cccccHH-HHHHHHh-hhcccccceEEeeccCCc
Confidence 0010011 1112221 1122332 477788 999999743
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.6e-08 Score=115.77 Aligned_cols=250 Identities=17% Similarity=0.175 Sum_probs=159.0
Q ss_pred HhcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
..+.|.+.+-+-+|.++.++...-. .|...++|...... ....+....+-.++-..+||-++...--+.......|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3456667778889999999887432 24444444432221 1111222333333333445665555444455677899
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
+++|..+++|...|+... ..+..........+.+.+++||... +.|||++|.|+|...++..+++||+......
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999988887543 2344444555666788999999875 8999999999999999999999998433211
Q ss_pred cC---------------------Cc----c----cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004402 589 KD---------------------VD----E----ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNA 639 (755)
Q Consensus 589 ~~---------------------~~----~----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~ 639 (755)
.- .. . .......+|+.|.+||.+.+......+|.|++|++++|.++|..|+
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 00 0 0122357899999999999999999999999999999999999988
Q ss_pred CCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 004402 640 RYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSML 702 (755)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 702 (755)
....... ..+.+...... ... .......+..+++..-+..+|.+|-.+.
T Consensus 1036 na~tpq~-------~f~ni~~~~~~------~p~-g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQ-------IFENILNRDIP------WPE-GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhh-------hhhccccCCCC------CCC-CccccChhhhhhhhhhhccCchhccCcc
Confidence 5433222 11111111110 000 0111122445666677778888887665
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.8e-07 Score=90.58 Aligned_cols=125 Identities=27% Similarity=0.319 Sum_probs=81.1
Q ss_pred eEEEEEcCCCCEEEEEEeccCCh--------------------------hhHHHHHHHHHHHhcCCCC--ceeeeeeeee
Q 004402 450 PVYKGNLPRGQEFAVKRLSATST--------------------------QGLEEFKNEVSLTARLQHV--NLLRVLGYCT 501 (755)
Q Consensus 450 ~Vy~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~H~--niv~l~g~~~ 501 (755)
.||.|...+|..+|||+.+.... .......+|.+.|.++..- ++.+.+.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999888999999998754210 0123467899999999765 455666542
Q ss_pred cCCccEEEEeecC--CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCceecccCCCCEEEcCCCCeEE
Q 004402 502 ERDENMLIYEYLP--NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY-LQEYSNFRVIHRDLKASNILLDNELNPKI 578 (755)
Q Consensus 502 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~-Lh~~~~~~iiHrDlk~~NIll~~~~~~kl 578 (755)
..++||||++ +..+..+.... ++......++.++...+.. +|..+ ++|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 4589999998 55554432111 1123445667777775555 46665 9999999999999988 9999
Q ss_pred EecCCcccc
Q 004402 579 SDFGMAKLF 587 (755)
Q Consensus 579 ~Dfgla~~~ 587 (755)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.66 E-value=4e-07 Score=93.54 Aligned_cols=141 Identities=19% Similarity=0.172 Sum_probs=99.3
Q ss_pred CcccccCCeeEEEEEcCCCCEEEEEEeccCChh-hHH----------HHHHHHHHHhcCCCC--ceeeeeeeeec-----
Q 004402 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQ-GLE----------EFKNEVSLTARLQHV--NLLRVLGYCTE----- 502 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~E~~~l~~l~H~--niv~l~g~~~~----- 502 (755)
+.+-+.....|.+..+ +|+.+.||+....... ..+ .+.+|...+.++... .....+++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444455667766 6789999977443311 111 377888888887433 33444555433
Q ss_pred CCccEEEEeecCCC-ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC-------CC
Q 004402 503 RDENMLIYEYLPNK-SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-------EL 574 (755)
Q Consensus 503 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~-------~~ 574 (755)
....++|+|++++. +|.+++.+.. ....+......++.+++..+.-||..+ ++|+|++++|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 23468999999886 7888874321 123455677789999999999999997 999999999999975 46
Q ss_pred CeEEEecCCccc
Q 004402 575 NPKISDFGMAKL 586 (755)
Q Consensus 575 ~~kl~Dfgla~~ 586 (755)
.+.++||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998863
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=7e-07 Score=88.70 Aligned_cols=135 Identities=21% Similarity=0.256 Sum_probs=94.7
Q ss_pred CCccCcccccCCeeEEEEEcCCCCEEEEEEeccCCh----------------------hhHHHHHHHHHHHhcCCCC--c
Q 004402 437 FSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST----------------------QGLEEFKNEVSLTARLQHV--N 492 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~H~--n 492 (755)
..+.++||.|.-+.||.|..+.|.++|||.=+.... ..+....+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345689999999999999999999999995322110 1233568899999998644 5
Q ss_pred eeeeeeeeecCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC
Q 004402 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN 572 (755)
Q Consensus 493 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~ 572 (755)
+.+.+++ +...+||||+++-.|...- ++....-.++..|.+-+.-+-..+ +||+|+++-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 5555554 4568999999886664321 122333334444444444333444 999999999999999
Q ss_pred CCCeEEEecCCccc
Q 004402 573 ELNPKISDFGMAKL 586 (755)
Q Consensus 573 ~~~~kl~Dfgla~~ 586 (755)
+|.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999976653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=4.4e-06 Score=87.09 Aligned_cols=265 Identities=12% Similarity=0.116 Sum_probs=154.0
Q ss_pred ccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeee------eecC-CccEEEE
Q 004402 439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGY------CTER-DENMLIY 510 (755)
Q Consensus 439 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~------~~~~-~~~~lv~ 510 (755)
..+.||+|+-+.+|-.- .-...+-|+.......... +.+..|... .||-+-.=+.| .-+. ...-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45779999999999642 2223345777665443322 223444444 56643321111 1111 2255677
Q ss_pred eecCCCC-hhhhhcCC---CccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 511 EYLPNKS-LDLYLFDP---IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 511 e~~~~gs-L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
+.+++-- ...++.-. ..-...+|.-.++.+..+|.+.+.||..+ .+-+|+.++|+|+++++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 7665431 12222111 11234689999999999999999999987 88999999999999999999998655443
Q ss_pred cccCCcccccccccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCC--cccchHHHHH-HH
Q 004402 587 FRKDVDEANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISS-KRNARYYGTS--ENLNFLEYAF-EQ 657 (755)
Q Consensus 587 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~elltg-~~p~~~~~~~--~~~~~~~~~~-~~ 657 (755)
.. ........+|...|.+||.-. +-.-+...|-|.|||++++|+.| +.|+..-... .....-.... ..
T Consensus 167 ~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 167 NA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred cc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 32 222233457889999999754 33457789999999999999887 7777532211 1000000000 00
Q ss_pred hc--cCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCC--CCCCCCHHHHHHHhhcCcccc
Q 004402 658 WK--DSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQEN--PEDRPSMLEVSSMLKDDSMAI 715 (755)
Q Consensus 658 ~~--~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~d--P~~RPt~~evl~~L~~~~~~~ 715 (755)
+. ........ +.-....-......+..+..+|+... +.-|||++--+..|.....++
T Consensus 244 f~ya~~~~~g~~-p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 244 FAYASDQRRGLK-PPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred eeechhccCCCC-CCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 00 00000000 10011111112234556777888643 568999998887776544443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=6e-08 Score=107.12 Aligned_cols=153 Identities=17% Similarity=0.216 Sum_probs=102.9
Q ss_pred HHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc-------cccccccccCCccccccccC
Q 004402 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE-------ANTGRIVGTYGYVPPEYVKK 613 (755)
Q Consensus 541 ~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~ 613 (755)
.+++.||.|+|... .+||++|.|++|.++.++..||+.|+.+.-....... ....-......|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 44559999999866 6999999999999999999999999988754431111 11111233568999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHcCCCC-CCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHccc
Q 004402 614 GIYSMKYDVYSFGVLLLQIISSKRN-ARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQ 692 (755)
Q Consensus 614 ~~~s~~sDVwS~Gvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~ 692 (755)
...+.++|+||+||+++.+..|+.+ +...+.... +...... +..-...++...+.++.+-+.+.+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-----~~~~~~~--------~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-----YSFSRNL--------LNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcch-----hhhhhcc--------cccccccccccCcHHHHHHHHHHhc
Confidence 8889999999999999999954433 322221111 1111100 0000111223344577788889999
Q ss_pred CCCCCCCCHHHHHHHh
Q 004402 693 ENPEDRPSMLEVSSML 708 (755)
Q Consensus 693 ~dP~~RPt~~evl~~L 708 (755)
.++..||++.++....
T Consensus 251 ~~~~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLSIP 266 (700)
T ss_pred CCcccCcchhhhhccc
Confidence 9999999887776543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.24 E-value=6.8e-06 Score=81.61 Aligned_cols=105 Identities=25% Similarity=0.308 Sum_probs=81.5
Q ss_pred HHHHHHHHHHhcCCC--CceeeeeeeeecCC----ccEEEEeecCCC-ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHH
Q 004402 476 EEFKNEVSLTARLQH--VNLLRVLGYCTERD----ENMLIYEYLPNK-SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLL 548 (755)
Q Consensus 476 ~~~~~E~~~l~~l~H--~niv~l~g~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~ 548 (755)
....+|...+.++.. -...+.+++..... ..++|+|++++. +|.+++..... .+......++.+++..+.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence 356778888777743 34455666665532 348999999874 78888753211 455677899999999999
Q ss_pred HHHhcCCCCceecccCCCCEEEcCCC---CeEEEecCCccc
Q 004402 549 YLQEYSNFRVIHRDLKASNILLDNEL---NPKISDFGMAKL 586 (755)
Q Consensus 549 ~Lh~~~~~~iiHrDlk~~NIll~~~~---~~kl~Dfgla~~ 586 (755)
-||..+ ++|+|+++.|||++.+. .+.++||+.++.
T Consensus 133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999997 99999999999999887 899999998875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.8e-05 Score=77.17 Aligned_cols=138 Identities=14% Similarity=0.166 Sum_probs=100.7
Q ss_pred ccccCCeeEEEEEcCCCCEEEEEEeccCC------hhhHHHHHHHHHHHhcCCC--Cceeeeeeeee-cC----CccEEE
Q 004402 443 LGEGGFGPVYKGNLPRGQEFAVKRLSATS------TQGLEEFKNEVSLTARLQH--VNLLRVLGYCT-ER----DENMLI 509 (755)
Q Consensus 443 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~-~~----~~~~lv 509 (755)
-|+||-+-|++-.. +|+.+-+|+-...- +-....|.+|+..+.++.. -.+.+.+ ++. .. ...+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 35688888998876 45579999865211 2345689999999999853 3344444 332 21 235799
Q ss_pred EeecCC-CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC--eEEEecCCccc
Q 004402 510 YEYLPN-KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN--PKISDFGMAKL 586 (755)
Q Consensus 510 ~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~--~kl~Dfgla~~ 586 (755)
+|-+++ -+|.+++.+.. ....+...+..++.++++.+.-||+.+ +.|+|+.+.|||++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997653 57888874321 123566778899999999999999997 999999999999986667 99999987764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.3e-05 Score=89.43 Aligned_cols=146 Identities=18% Similarity=0.233 Sum_probs=95.0
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhh------------------------------HH--------
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQG------------------------------LE-------- 476 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~-------- 476 (755)
..|+ .+.|+.++-|.||+|++++|+.||||+.++.-.+. .+
T Consensus 126 ~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 3454 36799999999999999999999999987652110 01
Q ss_pred --HHHHHHHHHhcC----CCCceeeeeeeeec-CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHH-H
Q 004402 477 --EFKNEVSLTARL----QHVNLLRVLGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL-L 548 (755)
Q Consensus 477 --~~~~E~~~l~~l----~H~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l-~ 548 (755)
++.+|..-+.++ ++..-+.+=..+.+ .....|+|||++|-.+.+...-.. ...+ +..++..++++. .
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d---~k~ia~~~~~~f~~ 279 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGID---RKELAELLVRAFLR 279 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCC---HHHHHHHHHHHHHH
Confidence 133344444443 22222333333433 456799999999998887742211 2233 334444444432 2
Q ss_pred HHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 549 ~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
.+-.. +++|.|..|.||+++.++++.+.|||+...+..
T Consensus 280 q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 280 QLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 22223 499999999999999999999999999987643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.2e-05 Score=79.08 Aligned_cols=139 Identities=17% Similarity=0.238 Sum_probs=84.7
Q ss_pred CcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCc--eeeeeeeeecCCccEEEEeecCCCC-
Q 004402 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN--LLRVLGYCTERDENMLIYEYLPNKS- 517 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lv~e~~~~gs- 517 (755)
..||+|..+.||+. .|..+++|...... ......+|.+++..+..-. +.+.++++...+...+|||++++..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 35567888876543 2245688999998885433 4566777777777789999998863
Q ss_pred hhhhh---------------------cCCCccCCCCHHHHH-HHHH----------HHHH-HHHHHHhc-CCCCceeccc
Q 004402 518 LDLYL---------------------FDPIRRYVLDWQKRV-NIIE----------GVTQ-GLLYLQEY-SNFRVIHRDL 563 (755)
Q Consensus 518 L~~~l---------------------~~~~~~~~l~~~~~~-~i~~----------~ia~-~l~~Lh~~-~~~~iiHrDl 563 (755)
+...+ |.... ......... .+.. .+.+ ...+|... ....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 11000 001111100 0000 0111 12222221 1234789999
Q ss_pred CCCCEEEcCCCCeEEEecCCccc
Q 004402 564 KASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 564 k~~NIll~~~~~~kl~Dfgla~~ 586 (755)
.|.||++++++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999988 99999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd06547 GH85_ENGase Endo-beta-N-acetylglucosaminidase (ENGase) hydrolyzes the N-N'-diacetylchitobiosyl core of N-glycosylproteins | Back alignment and domain information |
|---|
Probab=98.10 E-value=9.5e-06 Score=85.87 Aligned_cols=154 Identities=14% Similarity=0.108 Sum_probs=99.5
Q ss_pred HHHHhhCCCceEEEEecCCCCCccccccCCCCCCcccccccccC-hhhHHHHHHHHHHHHHHcCCCcccccccCCC--CC
Q 004402 81 NSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGD-SSHRKSFIESSIRTARLYGFQGIDLFWLWPN--ST 157 (755)
Q Consensus 81 ~~~k~~~~~lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~-~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~--~~ 157 (755)
.++|++ ||||+-.|- +- +..+.+.++.++.+ ++.+..+|+.|+++++.|||||+.||+|... ++
T Consensus 53 daAHkn--GV~Vlgti~----------~e-~~~~~~~~~~lL~~~~~~~~~~a~kLv~lak~yGfDGw~iN~E~~~~~~~ 119 (339)
T cd06547 53 NAAHRN--GVPVLGTFI----------FE-WTGQVEWLEDFLKKDEDGSFPVADKLVEVAKYYGFDGWLINIETELGDAE 119 (339)
T ss_pred HHHHhc--CCeEEEEEE----------ec-CCCchHHHHHHhccCcccchHHHHHHHHHHHHhCCCceEeeeeccCCcHH
Confidence 557776 899998882 11 11223457888988 9999999999999999999999999999886 67
Q ss_pred CcccHHHHHHHHHHHccCC-CccEEE-eeee--cCCcccccccCcchhc-ccCChhhhh---hhhccCCCCCcccccCCC
Q 004402 158 DLNSLGILLDEWKASASDQ-PELTLS-MAVR--YSPTHETVSYPIDSMK-KNLNWAHLV---AYDYHMPSKENVTGIHAA 229 (755)
Q Consensus 158 ~~~~~~~~l~~lr~~l~~~-~~~~ls-~~~~--~~~~~~~~~~~~~~l~-~~vD~~~vm---~Yd~~~~~~~~~~~~~a~ 229 (755)
+++++..|+++|++++++. ++..+. -..- .+.-.++. +|. ....|+.+. --+|. |..
T Consensus 120 ~~~~l~~F~~~L~~~~~~~~~~~~v~WYDs~t~~G~l~wQn-----~Ln~~N~~ff~~~D~~FlNY~---W~~------- 184 (339)
T cd06547 120 KAKRLIAFLRYLKAKLHENVPGSLVIWYDSMTEDGKLSWQN-----ELNSKNKPFFDVCDGIFLNYW---WTE------- 184 (339)
T ss_pred HHHHHHHHHHHHHHHHhhcCCCcEEEEEecCCCCCccchhh-----hhhHHHHHHHhhhcceeEecC---CCc-------
Confidence 8999999999999999862 232221 1111 11111111 111 112222111 01221 222
Q ss_pred CCCCCCCCcHHHHHHHHHHCCCCCCceeecccccCCCccc
Q 004402 230 LYNPSSNISTDFGIREWLRRGFPANKLVLGARASGPGITI 269 (755)
Q Consensus 230 l~~~~~~~~~~~~v~~~~~~g~p~~KlvlG~p~yG~~~~~ 269 (755)
...+.+++.....|..+.+|.+|+-..||+...
T Consensus 185 -------~~l~~s~~~a~~~g~~~~dvy~GiDv~grg~~~ 217 (339)
T cd06547 185 -------ESLERSVQLAEGLGRSPYDVYVGVDVWGRGTKG 217 (339)
T ss_pred -------chHHHHHHHHHHcCCCHhHEEEEEEEEcCCccc
Confidence 122344555567788999999999999988653
|
The beta-1,4-glycosyl bond located between two N-acetylglucosamine residues is hydrolyzed such that N-acetylglucosamine 1 remains with the protein and N-acetylglucosamine 2 forms the reducing end of the released glycan. ENGase is a key enzyme in the processing of free oligosaccharides in the cytosol of eukaryotes. Oligosaccharides formed in the lumen of the endoplasmic reticulum are transported into the cytosol where they are catabolized by cytosolic ENGases and other enzymes, possibly to maximize the reutilization of the component sugars. ENGases have an eight-stranded alpha/beta barrel topology and are classified as a family 85 glycosyl hydrolase (GH85) domain. The GH85 ENGases are sequence-similar to the family 18 glycosyl hydrolases, also known as GH18 chitinases. An ENGase-like protein is also found in bacteria and is included in this alignment mod |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.04 E-value=6.9e-05 Score=74.08 Aligned_cols=152 Identities=19% Similarity=0.247 Sum_probs=98.3
Q ss_pred cCHHHHHHHhcCCCccC---cccccCCeeEEEEEcCCCCEEEEEEeccCChhh-------------------HH-----H
Q 004402 425 FSFSDIKAATNNFSSAN---KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQG-------------------LE-----E 477 (755)
Q Consensus 425 ~~~~~l~~~~~~f~~~~---~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~~-----~ 477 (755)
.+.+.+....++..+.+ .|+.|.-+.||+|...++..+|||+++...... .+ -
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 44555555555544444 456777889999988789999999986542111 01 1
Q ss_pred HHHHHHHHhcCC--CCceeeeeeeeecCCccEEEEeecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 004402 478 FKNEVSLTARLQ--HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYS 554 (755)
Q Consensus 478 ~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~ 554 (755)
..+|+.-|.++. +-.+.+-+++. ...|||||+....+- .+. ....+...+...+..++.+.+.-|-..+
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~p----AP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLP----APRLKDVPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCC----CCCcccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 345666666663 33344444443 347999999665221 111 1112233356667777888887776633
Q ss_pred CCCceecccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 555 ~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
++||+||+.-|||+. ++.+.|+||+-|...
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECcccccc
Confidence 499999999999999 889999999988643
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.95 E-value=7.9e-05 Score=76.22 Aligned_cols=140 Identities=16% Similarity=0.180 Sum_probs=85.1
Q ss_pred cccccCC-eeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCccEEEEeecCCCChh
Q 004402 442 KLGEGGF-GPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIYEYLPNKSLD 519 (755)
Q Consensus 442 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 519 (755)
.|-.|.. ..||+.... +..+.||+..... .....+|++++..+. +--+.+++++....+..++|||++++.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3455555 789999764 4788889875443 234667888888873 444556777776666789999999998876
Q ss_pred hhh-------------------cCCCc-cCCCC--HHHHHHH-HH-------------------HHHHHHHHHHhc----
Q 004402 520 LYL-------------------FDPIR-RYVLD--WQKRVNI-IE-------------------GVTQGLLYLQEY---- 553 (755)
Q Consensus 520 ~~l-------------------~~~~~-~~~l~--~~~~~~i-~~-------------------~ia~~l~~Lh~~---- 553 (755)
... |.... ..... ....... .. .+...+..|-..
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 11000 00111 0000000 00 011122222211
Q ss_pred CCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 554 ~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
....++|+|+.|.|||++++..+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 22348999999999999998778999999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.91 E-value=1.6e-06 Score=94.81 Aligned_cols=183 Identities=17% Similarity=0.150 Sum_probs=127.8
Q ss_pred ccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCc-eeeeeeeeecCCccEEEEeecCCC-
Q 004402 439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN-LLRVLGYCTERDENMLIYEYLPNK- 516 (755)
Q Consensus 439 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lv~e~~~~g- 516 (755)
....+++|+.+.++|.+--..+....+.+... ....-++++|.+++||| .+..++-+..++...++++++..+
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 34567899999999985433333445555433 34456889999999999 666666666677789999999887
Q ss_pred ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccccc
Q 004402 517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596 (755)
Q Consensus 517 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 596 (755)
+-..-. ......+...+...+...-++++++||+.. =+||| ||+..+ ...|..||+....+.... ..
T Consensus 321 s~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~ 387 (829)
T KOG0576|consen 321 SSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KP 387 (829)
T ss_pred cccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---cc
Confidence 221111 001112333344455556667888898764 47888 887776 578999999988765443 23
Q ss_pred ccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004402 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNA 639 (755)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~ 639 (755)
....+|+.|+|||+...+.+....|+|++|+--.++--|-.|.
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 3457899999999999999999999999998777776665543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00013 Score=71.44 Aligned_cols=138 Identities=14% Similarity=0.188 Sum_probs=91.8
Q ss_pred HhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHH---------HHHHHHHHhcCCC---Cceeeeeeee
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEE---------FKNEVSLTARLQH---VNLLRVLGYC 500 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~H---~niv~l~g~~ 500 (755)
..++|...+++-......|.+-.. +|+.+++|..+.......+. ..+++..+.+++. -....++.++
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 356788888888888888888777 67999999876653322222 2333444444422 2222222222
Q ss_pred ec-----CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC
Q 004402 501 TE-----RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN 575 (755)
Q Consensus 501 ~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~ 575 (755)
.. ....+++|||+++..|.++.. ++. .++..+.+.+.-||..+ +.|+|..|.|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 21 234568999999988865431 221 34566778899999987 99999999999999654
Q ss_pred eEEEecCCccc
Q 004402 576 PKISDFGMAKL 586 (755)
Q Consensus 576 ~kl~Dfgla~~ 586 (755)
+++.||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.91 E-value=7.7e-05 Score=75.46 Aligned_cols=144 Identities=24% Similarity=0.240 Sum_probs=84.0
Q ss_pred cCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCC--ceeeeeeeeecC---CccEEEEeecC
Q 004402 440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHV--NLLRVLGYCTER---DENMLIYEYLP 514 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~---~~~~lv~e~~~ 514 (755)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+.+++.++... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999998866 69999997655 3456777888888888432 345566644332 23689999999
Q ss_pred CCChhh----------------hh---cCCC-ccCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 004402 515 NKSLDL----------------YL---FDPI-RRYVLDWQK---------RVNI------------IEGVTQ-GLLYLQE 552 (755)
Q Consensus 515 ~gsL~~----------------~l---~~~~-~~~~l~~~~---------~~~i------------~~~ia~-~l~~Lh~ 552 (755)
+..+.. .+ +... ......+.. .... ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 1110 000011000 0000 111222 2333332
Q ss_pred ----cCCCCceecccCCCCEEEc-CCCCeEEEecCCccc
Q 004402 553 ----YSNFRVIHRDLKASNILLD-NELNPKISDFGMAKL 586 (755)
Q Consensus 553 ----~~~~~iiHrDlk~~NIll~-~~~~~kl~Dfgla~~ 586 (755)
.....++|+|+.|.|||++ +++.+.|.||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2334599999999999999 666668999998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.85 E-value=7.7e-05 Score=72.55 Aligned_cols=105 Identities=20% Similarity=0.148 Sum_probs=83.4
Q ss_pred HHHHHHHhcCCC-CceeeeeeeeecCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 004402 479 KNEVSLTARLQH-VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557 (755)
Q Consensus 479 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~ 557 (755)
..|.-+|..+++ +++.+++|.|- .+++.||...+++...-.....-...+|..+.+||.++.+.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888888976 69999999994 3789999987766321000011124689999999999999999999866666
Q ss_pred ceecccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 558 VIHRDLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 558 iiHrDlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
+.-.|++++|+-+++++++|++|.......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 889999999999999999999999877643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.0002 Score=79.57 Aligned_cols=145 Identities=17% Similarity=0.245 Sum_probs=90.9
Q ss_pred CCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhh-------------------------------HH------HH
Q 004402 436 NFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQG-------------------------------LE------EF 478 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~ 478 (755)
.|+ .+.||.-+.|.||++++++|+.||||+.++.-.+. .+ +|
T Consensus 163 ~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF 241 (538)
T KOG1235|consen 163 EFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF 241 (538)
T ss_pred hcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence 443 36899999999999999999999999887642110 01 13
Q ss_pred HHHHHHHhc----CCCCc---eeeeeeeeec-CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHH
Q 004402 479 KNEVSLTAR----LQHVN---LLRVLGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL 550 (755)
Q Consensus 479 ~~E~~~l~~----l~H~n---iv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L 550 (755)
.+|.+-..+ +.|-+ -|.+=.++.+ .....|+||||+|..+.+... ..+..++.. .++..+.++...+
T Consensus 242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~--i~~~gi~~~---~i~~~l~~~~~~q 316 (538)
T KOG1235|consen 242 TKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA--IDKRGISPH---DILNKLVEAYLEQ 316 (538)
T ss_pred HHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH--HHHcCCCHH---HHHHHHHHHHHHH
Confidence 444433222 23444 1112222322 346799999999998877642 122234444 3333333333221
Q ss_pred HhcCCCCceecccCCCCEEEcC----CCCeEEEecCCccccc
Q 004402 551 QEYSNFRVIHRDLKASNILLDN----ELNPKISDFGMAKLFR 588 (755)
Q Consensus 551 h~~~~~~iiHrDlk~~NIll~~----~~~~kl~Dfgla~~~~ 588 (755)
.-..+++|+|=.|.||+++. ++++.+-|||+...+.
T Consensus 317 --If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 317 --IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred --HHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 11124999999999999984 6789999999998653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00028 Score=66.05 Aligned_cols=128 Identities=23% Similarity=0.299 Sum_probs=86.3
Q ss_pred ccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceee-eeeeeecCCccEEEEeecCCCC
Q 004402 439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR-VLGYCTERDENMLIYEYLPNKS 517 (755)
Q Consensus 439 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lv~e~~~~gs 517 (755)
..+.|++|.+|.||+|.+ .|..+|+|+-+..+. ...+..|.++|..+.-.++.+ ++.|- ...+.|||+.+-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW-RGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeec-cCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence 347899999999999988 566899998766543 468899999999987766544 33332 2345599999888
Q ss_pred hhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccC-CCCEEEcCCCCeEEEecCCccc
Q 004402 518 LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLK-ASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 518 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk-~~NIll~~~~~~kl~Dfgla~~ 586 (755)
|.+.-.. .+.+.... +++.---|...+ |-|..|. |..++|.++..+.|+||..|+.
T Consensus 99 L~~~~~~------~~rk~l~~----vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIG------GDRKHLLR----VLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhc------ccHHHHHH----HHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 8655421 12233333 333322333333 8888887 4444454555999999999873
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00051 Score=67.11 Aligned_cols=134 Identities=18% Similarity=0.281 Sum_probs=91.0
Q ss_pred ccCcccccCCeeEEEEEcCCCCEEEEEEeccCC----------------hhhHHHHHHHHHHHhcCC------CCceeee
Q 004402 439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLSATS----------------TQGLEEFKNEVSLTARLQ------HVNLLRV 496 (755)
Q Consensus 439 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l 496 (755)
....||+|+.-.||. ++++...+||+..... ....++..+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 456899999999995 5567788899887655 122345666666555554 7889999
Q ss_pred eeeeecCCccEEEEeecCC--C----ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE
Q 004402 497 LGYCTERDENMLIYEYLPN--K----SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL 570 (755)
Q Consensus 497 ~g~~~~~~~~~lv~e~~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll 570 (755)
+|+..++...-+|+|.+.+ | +|.+++. +..++. .. ...+-+-..||-+.+ |+.+|++|.||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~---~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-EL---RQALDEFKRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HH---HHHHHHHHHHHHHcC---CeecCCCcccEEE
Confidence 9999999899999998643 2 3555552 223443 22 333334455666665 9999999999999
Q ss_pred cCCC----CeEEEe-cCCcc
Q 004402 571 DNEL----NPKISD-FGMAK 585 (755)
Q Consensus 571 ~~~~----~~kl~D-fgla~ 585 (755)
..+. .+.|+| ||-..
T Consensus 152 ~~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred EecCCCceEEEEEeCCCCcc
Confidence 5432 477776 44443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.0005 Score=82.84 Aligned_cols=79 Identities=19% Similarity=0.421 Sum_probs=57.7
Q ss_pred cCcccccCCeeEEEEEcCCC---CEEEEEEeccCC-hhhHHHHHHHHHHHhcCC-CCce--eeeeeeeecC---CccEEE
Q 004402 440 ANKLGEGGFGPVYKGNLPRG---QEFAVKRLSATS-TQGLEEFKNEVSLTARLQ-HVNL--LRVLGYCTER---DENMLI 509 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lv 509 (755)
.+.|+.|.+..+|+.....+ ..+++|+..... ......+.+|+++|+.+. |+++ .+++.+|.+. ...++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999876553 467778764332 123356889999999995 6654 7788888764 357899
Q ss_pred EeecCCCCh
Q 004402 510 YEYLPNKSL 518 (755)
Q Consensus 510 ~e~~~~gsL 518 (755)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00063 Score=65.92 Aligned_cols=137 Identities=23% Similarity=0.420 Sum_probs=93.7
Q ss_pred CCCCccccCHHHHHHHhcCCCccCcccccCC-eeEEEEEcCCCCEEEEEEecc---CCh------------------hhH
Q 004402 418 DTPNLQVFSFSDIKAATNNFSSANKLGEGGF-GPVYKGNLPRGQEFAVKRLSA---TST------------------QGL 475 (755)
Q Consensus 418 ~~~~~~~~~~~~l~~~~~~f~~~~~lG~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~ 475 (755)
..|.+..|+.. +.+++.++.||.|.. |.||+.++ +|+.+|+|.++. ... ...
T Consensus 25 ~gPKL~~F~~h-----~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 98 (207)
T PF13095_consen 25 PGPKLEPFTHH-----GDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYA 98 (207)
T ss_pred CCCCcCCcCCC-----CCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhc
Confidence 34455666662 267888999999999 99999998 788999999321 100 112
Q ss_pred HHHHHHHHHHhcCC---CCce--eeeeeeeecCC------------------ccEEEEeecCCCChhhhhcCCCccCCCC
Q 004402 476 EEFKNEVSLTARLQ---HVNL--LRVLGYCTERD------------------ENMLIYEYLPNKSLDLYLFDPIRRYVLD 532 (755)
Q Consensus 476 ~~~~~E~~~l~~l~---H~ni--v~l~g~~~~~~------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~ 532 (755)
..|..|+....+|+ +.++ |+.+||..-.. ...||.||++... .+.
T Consensus 99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~ 166 (207)
T PF13095_consen 99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ 166 (207)
T ss_pred ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc
Confidence 35888998888885 3455 88888873220 1246777765532 112
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCc
Q 004402 533 WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584 (755)
Q Consensus 533 ~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla 584 (755)
..-+.+|.+-+..+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 167 ----~~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 167 ----IRDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ----hhHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 223445666677788876 999999999986 3489999864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0014 Score=69.05 Aligned_cols=78 Identities=18% Similarity=0.136 Sum_probs=56.9
Q ss_pred CccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCC---Cceeeeeeeeec---CCccEEEEe
Q 004402 438 SSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH---VNLLRVLGYCTE---RDENMLIYE 511 (755)
Q Consensus 438 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~---~~~~~lv~e 511 (755)
...+.||+|..+.||+....++ .+.+|..+... ....|..|.+.|+.+.. ..+.+++++|.. .+..++|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3457899999999999876555 46777754311 22578889999988843 367788887754 356899999
Q ss_pred ecCCCCh
Q 004402 512 YLPNKSL 518 (755)
Q Consensus 512 ~~~~gsL 518 (755)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00087 Score=68.09 Aligned_cols=73 Identities=18% Similarity=0.258 Sum_probs=45.2
Q ss_pred CcccccCCe-eEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCC---ceeeeeeeeecC---CccEEEEeec
Q 004402 441 NKLGEGGFG-PVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHV---NLLRVLGYCTER---DENMLIYEYL 513 (755)
Q Consensus 441 ~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~---~~~~lv~e~~ 513 (755)
+.|+.|+.. .||+. +..+++|..+... ....+.+|.+++..+... .+..+++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567777766 58875 2357778654422 235688899988877421 233334433322 2348899999
Q ss_pred CCCChh
Q 004402 514 PNKSLD 519 (755)
Q Consensus 514 ~~gsL~ 519 (755)
++.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00057 Score=70.44 Aligned_cols=139 Identities=17% Similarity=0.143 Sum_probs=79.3
Q ss_pred cccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCce-eeeeeeeecCCccEEEEeecCCCChhh
Q 004402 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL-LRVLGYCTERDENMLIYEYLPNKSLDL 520 (755)
Q Consensus 442 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e~~~~gsL~~ 520 (755)
.+..|-...+|+... +++.+++|+.........-...+|..+++.+....+ .++++.+. ..+|+||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 356688889999874 577888987654322211134678888888854333 23343332 378999999877642
Q ss_pred h-----------------hcCCC-ccCCCCHHHH-HHHHH---------HHHHHHHHHHhc-----CCCCceecccCCCC
Q 004402 521 Y-----------------LFDPI-RRYVLDWQKR-VNIIE---------GVTQGLLYLQEY-----SNFRVIHRDLKASN 567 (755)
Q Consensus 521 ~-----------------l~~~~-~~~~l~~~~~-~~i~~---------~ia~~l~~Lh~~-----~~~~iiHrDlk~~N 567 (755)
. +|... ....++.... ..... .+...+..+... ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 0111222111 11111 111122222211 12348999999999
Q ss_pred EEEcCCCCeEEEecCCccc
Q 004402 568 ILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 568 Ill~~~~~~kl~Dfgla~~ 586 (755)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.001 Score=67.47 Aligned_cols=142 Identities=18% Similarity=0.231 Sum_probs=81.9
Q ss_pred cCcccccCCeeEEEEEcCC--CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCce-eeeeeeeecCCccEEEEeecCCC
Q 004402 440 ANKLGEGGFGPVYKGNLPR--GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL-LRVLGYCTERDENMLIYEYLPNK 516 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e~~~~g 516 (755)
.+.|..|-...+|+....+ ++.|++|+........ -.-.+|+.++..+...++ .++++.+. ..++|||+++.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3567788888999998764 6789999775432211 122468888888853333 34444332 24899999987
Q ss_pred Chhhh-----------------hcCCCccC--------CCC-HHHHHHHHH----------------------HHHHHHH
Q 004402 517 SLDLY-----------------LFDPIRRY--------VLD-WQKRVNIIE----------------------GVTQGLL 548 (755)
Q Consensus 517 sL~~~-----------------l~~~~~~~--------~l~-~~~~~~i~~----------------------~ia~~l~ 548 (755)
++... +|...... ... +..+..+.. .+.+.+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 76322 11111110 111 112111111 1111112
Q ss_pred HH----Hhc-CCCCceecccCCCCEEEcC-CCCeEEEecCCccc
Q 004402 549 YL----QEY-SNFRVIHRDLKASNILLDN-ELNPKISDFGMAKL 586 (755)
Q Consensus 549 ~L----h~~-~~~~iiHrDlk~~NIll~~-~~~~kl~Dfgla~~ 586 (755)
.| ... ....++|+|+.+.|||+++ ++.+.++||..+..
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 22 111 2335999999999999998 57899999988853
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF02638 DUF187: Glycosyl hydrolase like GH101; InterPro: IPR003790 This entry describes proteins of unknown function | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.00041 Score=73.09 Aligned_cols=129 Identities=15% Similarity=0.185 Sum_probs=87.2
Q ss_pred cChhhHHHHHHHHHHHHHHcCCCccccc-ccCCC------------------------CCC-------cccHHHHHHHHH
Q 004402 123 GDSSHRKSFIESSIRTARLYGFQGIDLF-WLWPN------------------------STD-------LNSLGILLDEWK 170 (755)
Q Consensus 123 ~~~~~r~~fi~~i~~~~~~~~~DGvdiD-we~p~------------------------~~~-------~~~~~~~l~~lr 170 (755)
..|+.|+-.++-+.+++++|.+|||.|| .-||. ..| +++...|+++++
T Consensus 134 ~~PeVr~~i~~~v~Eiv~~YdvDGIhlDdy~yp~~~~g~~~~~~~~y~~~~g~~~~~~~~d~~W~~WRr~~I~~~V~~i~ 213 (311)
T PF02638_consen 134 GHPEVRDYIIDIVKEIVKNYDVDGIHLDDYFYPPPSFGYDFPDVAAYEKYTGKDPFSSPEDDAWTQWRRDNINNFVKRIY 213 (311)
T ss_pred CCHHHHHHHHHHHHHHHhcCCCCeEEecccccccccCCCCCccHHHHHHhcCcCCCCCccchHHHHHHHHHHHHHHHHHH
Confidence 3788999999999999999999999999 45541 133 667889999999
Q ss_pred HHccC-CCccEEEeeeecCC-ccccccc-Ccchhc--ccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHHH
Q 004402 171 ASASD-QPELTLSMAVRYSP-THETVSY-PIDSMK--KNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIRE 245 (755)
Q Consensus 171 ~~l~~-~~~~~ls~~~~~~~-~~~~~~~-~~~~l~--~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~~ 245 (755)
++.++ ++...+++++.+.. ..+..-| |..... .++|++..|.|-.. .+. ..+ ..+..+..
T Consensus 214 ~~ik~~kP~v~~sisp~g~~~~~y~~~~qD~~~W~~~G~iD~i~Pq~Y~~~---~~~---~~~---------~~~~~~~~ 278 (311)
T PF02638_consen 214 DAIKAIKPWVKFSISPFGIWNSAYDDYYQDWRNWLKEGYIDYIVPQIYWSD---FSH---FTA---------PYEQLAKW 278 (311)
T ss_pred HHHHHhCCCCeEEEEeecchhhhhhheeccHHHHHhcCCccEEEeeecccc---cch---hHH---------HHHHHHHH
Confidence 99976 55788888765443 2222212 333333 67999999999541 111 111 23455666
Q ss_pred HHHCCCCC-CceeecccccCCC
Q 004402 246 WLRRGFPA-NKLVLGARASGPG 266 (755)
Q Consensus 246 ~~~~g~p~-~KlvlG~p~yG~~ 266 (755)
|.+.-.+. -+|.+|+.+|-.+
T Consensus 279 w~~~~~~~~v~ly~G~~~y~~~ 300 (311)
T PF02638_consen 279 WAKQVKPTNVHLYIGLALYKVG 300 (311)
T ss_pred HHHhhcCCCceEEEccCcCCCC
Confidence 66554443 4899999998743
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0025 Score=69.15 Aligned_cols=76 Identities=17% Similarity=0.253 Sum_probs=53.6
Q ss_pred cCcccccCCeeEEEEEcCCC-CEEEEEEeccC-----C--hhhHHHHHHHHHHHhcCC---CCceeeeeeeeecCCccEE
Q 004402 440 ANKLGEGGFGPVYKGNLPRG-QEFAVKRLSAT-----S--TQGLEEFKNEVSLTARLQ---HVNLLRVLGYCTERDENML 508 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~l 508 (755)
.+.||.|.+..||+....+| +.|+||.-... . .-..+++..|.+.|..+. ..++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35799999999999988776 58999984311 1 123456777888887762 2356667766 3356789
Q ss_pred EEeecCCCC
Q 004402 509 IYEYLPNKS 517 (755)
Q Consensus 509 v~e~~~~gs 517 (755)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0026 Score=75.18 Aligned_cols=197 Identities=22% Similarity=0.193 Sum_probs=133.7
Q ss_pred HHHHHHHHHhcCCCCceeeeeeeeecCCcc----EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHh
Q 004402 477 EFKNEVSLTARLQHVNLLRVLGYCTERDEN----MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552 (755)
Q Consensus 477 ~~~~E~~~l~~l~H~niv~l~g~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~ 552 (755)
....|++.+.++.|+|++..++|..+.... .+..++|..-++...+.. -...+....+.+..+..+||.|+|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~---v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS---VGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh---ccccCHHHHHHHHHHHhhhHHHHHH
Confidence 345577788888999999999987665432 344577777777666633 3346778888889999999999999
Q ss_pred cCCCCceecccCCC---CEEEcCCCCeEEE--ecCCccccccCCcccccccccccCCccccccccCCCCCc--hhhHHHH
Q 004402 553 YSNFRVIHRDLKAS---NILLDNELNPKIS--DFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM--KYDVYSF 625 (755)
Q Consensus 553 ~~~~~iiHrDlk~~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--~sDVwS~ 625 (755)
.. ..|.-+..+ +--.+..+...++ ||+.++.+...... .....+..|.+||......+.. ..|+|.+
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHH
Confidence 85 556555555 5556677777777 89888765432211 1123356788899887766654 4799999
Q ss_pred HHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004402 626 GVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVS 705 (755)
Q Consensus 626 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 705 (755)
|..+..+..|..+........ .+.+ .... ....+....|+..++++|++..+++
T Consensus 379 gll~~~~~~~~~i~~~~~~~~------------------~~l~----~~~~----~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAVPV------------------SLLD----VLST----SELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCcccccccchh------------------hhhc----cccc----hhhhhhhhhhcchhhhhccchhhhh
Confidence 999999998765432211100 0011 0000 0345677789999999999999998
Q ss_pred HHh
Q 004402 706 SML 708 (755)
Q Consensus 706 ~~L 708 (755)
...
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 765
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 755 | ||||
| 3aqu_A | 356 | Crystal Structure Of A Class V Chitinase From Arabi | 3e-72 | ||
| 3alg_A | 353 | Crystal Structure Of Class V Chitinase (E115q Mutan | 2e-60 | ||
| 3alf_A | 353 | Crystal Structure Of Class V Chitinase From Nicotia | 2e-60 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-53 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-53 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-45 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-44 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-37 | ||
| 1hkk_A | 364 | High Resoultion Crystal Structure Of Human Chitinas | 6e-31 | ||
| 1waw_A | 445 | Specificity And Affinity Of Natural Product Cyclope | 6e-31 | ||
| 1hki_A | 365 | Crystal Structure Of Human Chitinase In Complex Wit | 6e-31 | ||
| 1lg1_A | 365 | Crystal Structure Of Human Chitotriosidase In Compl | 6e-31 | ||
| 1guv_A | 366 | Structure Of Human Chitotriosidase Length = 366 | 8e-31 | ||
| 1xhg_A | 361 | Crystal Structure Of A 40 Kda Signalling Protein Fr | 8e-26 | ||
| 1syt_A | 361 | Crystal Structure Of Signalling Protein From Goat S | 2e-25 | ||
| 1zbv_A | 361 | Crystal Structure Of The Goat Signalling Protein (S | 2e-25 | ||
| 1ljy_A | 361 | Crystal Structure Of A Novel Regulatory 40 Kda Mamm | 3e-25 | ||
| 2pi6_A | 361 | Crystal Structure Of The Sheep Signalling Glycoprot | 3e-25 | ||
| 1sr0_A | 361 | Crystal Structure Of Signalling Protein From Sheep( | 4e-25 | ||
| 1tfv_A | 361 | Crystal Structure Of A Buffalo Signaling Glycoprote | 5e-25 | ||
| 1hjv_A | 362 | Crystal Structure Of Hcgp-39 In Complex With Chitin | 2e-24 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-24 | ||
| 1owq_A | 361 | Crystal Structure Of A 40 Kda Signalling Protein (S | 9e-24 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-23 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-23 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-23 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-23 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-23 | ||
| 2esc_A | 361 | Crystal Structure Of A 40 Kda Protective Signalling | 2e-23 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-23 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-23 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-23 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-23 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-22 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-22 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-22 | ||
| 4ay1_A | 365 | Human Ykl-39 Is A Pseudo-Chitinase With Retained Ch | 7e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-22 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-22 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-21 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-21 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-21 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-21 | ||
| 3fxy_A | 395 | Acidic Mammalian Chinase, Catalytic Domain Length = | 9e-21 | ||
| 2ybt_A | 381 | Crystal Structure Of Human Acidic Chitinase In Comp | 1e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-20 | ||
| 1e9l_A | 377 | The Crystal Structure Of Novel Mammalian Lectin Ym1 | 3e-20 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-20 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-19 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-19 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-19 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-19 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-18 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-18 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-18 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-18 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-18 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-18 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-18 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-12 | ||
| 3g6l_A | 406 | The Crystal Structure Of A Chitinase Crchi1 From Th | 1e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-12 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-10 | ||
| 1wno_A | 395 | Crystal Structure Of A Native Chitinase From Asperg | 2e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-10 | ||
| 1w9p_A | 433 | Specificity And Affinity Of Natural Product Cyclope | 3e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-09 | ||
| 1jnd_A | 420 | Crystal Structure Of Imaginal Disc Growth Factor-2 | 4e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-09 | ||
| 1ll7_A | 392 | Structure Of The E171q Mutant Of C. Immitis Chitina | 6e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-09 | ||
| 1ll6_A | 392 | Structure Of The D169n Mutant Of C. Immitis Chitina | 7e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-09 | ||
| 1d2k_A | 392 | C. Immitis Chitinase 1 At 2.2 Angstroms Resolution | 8e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 3b9a_A | 584 | Crystal Structure Of Vibrio Harveyi Chitinase A Com | 3e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3b8s_A | 584 | Crystal Structure Of Wild-Type Chitinase A From Vib | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-06 | ||
| 3ars_A | 584 | Crystal Structure Analysis Of Chitinase A From Vibr | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-06 | ||
| 1itx_A | 419 | Catalytic Domain Of Chitinase A1 From Bacillus Circ | 4e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-06 | ||
| 1e6n_B | 499 | Chitinase B From Serratia Marcescens Inactive Mutan | 8e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-06 | ||
| 1ogb_A | 499 | Chitinase B From Serratia Marcescens Mutant D142n L | 8e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-06 | ||
| 1e6z_A | 498 | Chitinase B From Serratia Marcescens Wildtype In Co | 9e-06 | ||
| 1ur9_A | 499 | Interactions Of A Family 18 Chitinase With The Desi | 9e-06 | ||
| 1e15_A | 499 | Chitinase B From Serratia Marcescens Length = 499 | 9e-06 | ||
| 1h0g_A | 499 | Complex Of A Chitinase With The Natural Product Cyc | 9e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-05 | ||
| 1kfw_A | 435 | Structure Of Catalytic Domain Of Psychrophilic Chit | 2e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-04 |
| >pdb|3AQU|A Chain A, Crystal Structure Of A Class V Chitinase From Arabidopsis Thaliana Length = 356 | Back alignment and structure |
|
| >pdb|3ALG|A Chain A, Crystal Structure Of Class V Chitinase (E115q Mutant) From Nicotiana Tobaccum In Complex With Nag4 Length = 353 | Back alignment and structure |
|
| >pdb|3ALF|A Chain A, Crystal Structure Of Class V Chitinase From Nicotiana Tobaccum Length = 353 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1HKK|A Chain A, High Resoultion Crystal Structure Of Human Chitinase In Complex With Allosamidin Length = 364 | Back alignment and structure |
|
| >pdb|1WAW|A Chain A, Specificity And Affinity Of Natural Product Cyclopentapeptide Inhibitor Argadin Against Human Chitinase Length = 445 | Back alignment and structure |
|
| >pdb|1HKI|A Chain A, Crystal Structure Of Human Chitinase In Complex With Glucoallosamidin B Length = 365 | Back alignment and structure |
|
| >pdb|1LG1|A Chain A, Crystal Structure Of Human Chitotriosidase In Complex With Chitobiose Length = 365 | Back alignment and structure |
|
| >pdb|1GUV|A Chain A, Structure Of Human Chitotriosidase Length = 366 | Back alignment and structure |
|
| >pdb|1XHG|A Chain A, Crystal Structure Of A 40 Kda Signalling Protein From Porcine (spp-40) At 2.89a Resolution Length = 361 | Back alignment and structure |
|
| >pdb|1SYT|A Chain A, Crystal Structure Of Signalling Protein From Goat Spg-40 In The Presense Of N,n',n''-triacetyl-chitotriose At 2.6a Resolution Length = 361 | Back alignment and structure |
|
| >pdb|1ZBV|A Chain A, Crystal Structure Of The Goat Signalling Protein (Spg-40) Complexed With A Designed Peptide Trp-Pro-Trp At 3.2a Resolution Length = 361 | Back alignment and structure |
|
| >pdb|1LJY|A Chain A, Crystal Structure Of A Novel Regulatory 40 Kda Mammary Gland Protein (Mgp-40) Secreted During Involution Length = 361 | Back alignment and structure |
|
| >pdb|2PI6|A Chain A, Crystal Structure Of The Sheep Signalling Glycoprotein (Sps-40) Complex With 2-Methyl-2-4-Pentanediol At 1.65a Resolution Reveals Specific Binding Characteristics Of Sps-40 Length = 361 | Back alignment and structure |
|
| >pdb|1SR0|A Chain A, Crystal Structure Of Signalling Protein From Sheep(Sps-40) At 3.0a Resolution Using Crystal Grown In The Presence Of Polysaccharides Length = 361 | Back alignment and structure |
|
| >pdb|1TFV|A Chain A, Crystal Structure Of A Buffalo Signaling Glycoprotein (Spb-40) Secreted During Involution Length = 361 | Back alignment and structure |
|
| >pdb|1HJV|A Chain A, Crystal Structure Of Hcgp-39 In Complex With Chitin Tetramer Length = 362 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1OWQ|A Chain A, Crystal Structure Of A 40 Kda Signalling Protein (Spc-40) Secreted During Involution Length = 361 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2ESC|A Chain A, Crystal Structure Of A 40 Kda Protective Signalling Protein From Bovine (Spc-40) At 2.1 A Resolution Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AY1|A Chain A, Human Ykl-39 Is A Pseudo-Chitinase With Retained Chitooligosaccharide Binding Properties Length = 365 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXY|A Chain A, Acidic Mammalian Chinase, Catalytic Domain Length = 395 | Back alignment and structure |
|
| >pdb|2YBT|A Chain A, Crystal Structure Of Human Acidic Chitinase In Complex With Bisdionin C Length = 381 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1E9L|A Chain A, The Crystal Structure Of Novel Mammalian Lectin Ym1 Suggests A Saccharide Binding Site Length = 377 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3G6L|A Chain A, The Crystal Structure Of A Chitinase Crchi1 From The Nematophagous Fungus Clonostachys Rosea Length = 406 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1WNO|A Chain A, Crystal Structure Of A Native Chitinase From Aspergillus Fumigatus Yj- 407 Length = 395 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1W9P|A Chain A, Specificity And Affinity Of Natural Product Cyclopentapeptide Inhibitors Against Aspergillus Fumigatus, Human And Bacterial Chitinasefra Length = 433 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1JND|A Chain A, Crystal Structure Of Imaginal Disc Growth Factor-2 Length = 420 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1LL7|A Chain A, Structure Of The E171q Mutant Of C. Immitis Chitinase 1 Length = 392 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1LL6|A Chain A, Structure Of The D169n Mutant Of C. Immitis Chitinase 1 Length = 392 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1D2K|A Chain A, C. Immitis Chitinase 1 At 2.2 Angstroms Resolution Length = 392 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3B9A|A Chain A, Crystal Structure Of Vibrio Harveyi Chitinase A Complexed With Hexasaccharide Length = 584 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3B8S|A Chain A, Crystal Structure Of Wild-Type Chitinase A From Vibrio Harveyi Length = 584 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ARS|A Chain A, Crystal Structure Analysis Of Chitinase A From Vibrio Harveyi With Novel Inhibitors - Apo Structure Of Mutant W275g Length = 584 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1ITX|A Chain A, Catalytic Domain Of Chitinase A1 From Bacillus Circulans Wl-12 Length = 419 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1E6N|B Chain B, Chitinase B From Serratia Marcescens Inactive Mutant E144q In Complex With N-Acetylglucosamine-Pentamer Length = 499 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OGB|A Chain A, Chitinase B From Serratia Marcescens Mutant D142n Length = 499 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1E6Z|A Chain A, Chitinase B From Serratia Marcescens Wildtype In Complex With Catalytic Intermediate Length = 498 | Back alignment and structure |
|
| >pdb|1UR9|A Chain A, Interactions Of A Family 18 Chitinase With The Designed Inhibitor Hm508, And Its Degradation Product, Chitobiono-Delta-Lactone Length = 499 | Back alignment and structure |
|
| >pdb|1E15|A Chain A, Chitinase B From Serratia Marcescens Length = 499 | Back alignment and structure |
|
| >pdb|1H0G|A Chain A, Complex Of A Chitinase With The Natural Product Cyclopentapeptide Argadin From Clonostachys Length = 499 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1KFW|A Chain A, Structure Of Catalytic Domain Of Psychrophilic Chitinase B From Arthrobacter Tad20 Length = 435 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 383 bits (985), Expect = e-128
Identities = 119/314 (37%), Positives = 178/314 (56%), Gaps = 11/314 (3%)
Query: 408 STPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRL 467
PA E + L+ FS +++ A++NFS+ N LG GGFG VYKG L G AVKRL
Sbjct: 3 DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 62
Query: 468 SATSTQGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI 526
TQG E +F+ EV + + H NLLR+ G+C E +L+Y Y+ N S+ L +
Sbjct: 63 KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122
Query: 527 R-RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585
+ LDW KR I G +GL YL ++ + ++IHRD+KA+NILLD E + DFG+AK
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 586 LFRKDVDEANTG---RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY 642
L D +T + GT G++ PEY+ G S K DV+ +GV+LL++I+ +R
Sbjct: 183 LM----DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 238
Query: 643 GTS--ENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPS 700
+ +++ L++ K+ K + +D L + ++ +QVALLC Q +P +RP
Sbjct: 239 RLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPK 298
Query: 701 MLEVSSMLKDDSMA 714
M EV ML+ D +A
Sbjct: 299 MSEVVRMLEGDGLA 312
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 380 bits (979), Expect = e-127
Identities = 107/313 (34%), Positives = 165/313 (52%), Gaps = 19/313 (6%)
Query: 413 EYFDSDTPNLQVFSFSDIKAATNNFSS------ANKLGEGGFGPVYKGNLPRGQEFAVKR 466
+ + FSF ++K TNNF NK+GEGGFG VYKG + AVK+
Sbjct: 3 KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKK 61
Query: 467 LSA----TSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL 522
L+A T+ + ++F E+ + A+ QH NL+ +LG+ ++ D+ L+Y Y+PN SL L
Sbjct: 62 LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
Query: 523 FDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG 582
L W R I +G G+ +L E IHRD+K++NILLD KISDFG
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFG 178
Query: 583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY 642
+A+ K T RIVGT Y+ PE + +G + K D+YSFGV+LL+II+ +
Sbjct: 179 LARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEH 237
Query: 643 GTSENLNFLEYAFEQWKDSKG-KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSM 701
+ L L+ E + K +++ID ++D+ S + VA C+ E RP +
Sbjct: 238 REPQLL--LDIKEEIEDEEKTIEDYIDKKMNDADST-SVEAMYSVASQCLHEKKNKRPDI 294
Query: 702 LEVSSMLKDDSMA 714
+V +L++ + +
Sbjct: 295 KKVQQLLQEMTAS 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 342 bits (879), Expect = e-112
Identities = 107/319 (33%), Positives = 170/319 (53%), Gaps = 10/319 (3%)
Query: 397 LGRRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNL 456
+G + + + A D++ ATNNF +G G FG VYKG L
Sbjct: 1 MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60
Query: 457 PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK 516
G + A+KR + S+QG+EEF+ E+ + +H +L+ ++G+C ER+E +LIY+Y+ N
Sbjct: 61 RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 517 SLDLYLFDPIR-RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN 575
+L +L+ + W++R+ I G +GL YL + +IHRD+K+ NILLD
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFV 177
Query: 576 PKISDFGMAKLFRKDVDEANTG---RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQI 632
PKI+DFG++K + T + GT GY+ PEY KG + K DVYSFGV+L ++
Sbjct: 178 PKITDFGISKKG---TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234
Query: 633 ISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQ 692
+ ++ E +N E+A E + + ++ +DP+L D P L A+ C+
Sbjct: 235 LCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLA 294
Query: 693 ENPEDRPSMLEVSSMLKDD 711
+ EDRPSM +V L+
Sbjct: 295 LSSEDRPSMGDVLWKLEYA 313
|
| >3aqu_A AT4G19810; stress response, TIM barrel, hydrolase, chitin; HET: FLC; 2.01A {Arabidopsis thaliana} Length = 356 | Back alignment and structure |
|---|
Score = 301 bits (774), Expect = 3e-96
Identities = 151/355 (42%), Positives = 214/355 (60%), Gaps = 45/355 (12%)
Query: 25 QTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVR 84
QT +KA YW EFP++DI+S+LFTHL CAFA+++S T Q+++SSANQ FS F +V+
Sbjct: 2 QTVVKASYWFPASEFPVTDIDSSLFTHLFCAFADLNSQTNQVTVSSANQPKFSTFTQTVQ 61
Query: 85 RKNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLY 142
R+NPS+KTLLSI + Y +SM + + RKSFI+SSIR AR Y
Sbjct: 62 RRNPSVKTLLSIGGGIADKTAY--------------ASMASNPTSRKSFIDSSIRVARSY 107
Query: 143 GFQGIDLFWLWPNS-TDLNSLGILLDEWK------ASASDQPELTLSMAVRYSPTHETVS 195
GF G+DL W +P+S T++ + G LL EW+ AS+S +P L L+ AV YS + +V
Sbjct: 108 GFHGLDLDWEYPSSATEMTNFGTLLREWRSAVVAEASSSGKPRLLLAAAVFYSNNYYSVL 167
Query: 196 YPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN-ISTDFGIREWLRRGFPAN 254
YP+ ++ +L+W +L+AYD++ P VTG AAL++PS+ S D G R W++ G PA
Sbjct: 168 YPVSAVASSLDWVNLMAYDFYGPGWSRVTGPPAALFDPSNAGPSGDAGTRSWIQAGLPAK 227
Query: 255 KLVLG-------------------ARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNA 295
K VLG A +G I+ DGS+GY IR FI + GA VYN+
Sbjct: 228 KAVLGFPYYGYAWRLTNANSHSYYAPTTGAAISPDGSIGYGQIRKFIVD--NGATTVYNS 285
Query: 296 SYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAAQ 350
+ V + +G WI +D ++I K+ YAK++ LLGY ++ + DDN LSRAA
Sbjct: 286 TVVGDYCYAGTNWIGYDDNQSIVTKVRYAKQRGLLGYFSWHVGADDNSGLSRAAS 340
|
| >3alf_A Chitinase, class V; hydrolase; 1.20A {Nicotiana tabacum} PDB: 3alg_A* Length = 353 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 8e-93
Identities = 136/352 (38%), Positives = 194/352 (55%), Gaps = 44/352 (12%)
Query: 28 IKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKN 87
+K GYW L++I+S LFTHL CAFA+++ QL IS NQ F F ++V+RKN
Sbjct: 4 VKGGYWFKDSGLALNNIDSTLFTHLFCAFADLNPQLNQLIISPENQDSFRQFTSTVQRKN 63
Query: 88 PSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGI 147
PS+KT LSI N + M + RKSFI+SSIR AR GF G+
Sbjct: 64 PSVKTFLSI------------AGGRANSTAYGIMARQPNSRKSFIDSSIRLARQLGFHGL 111
Query: 148 DLFWLWPNS-TDLNSLGILLDEWK------ASASDQPELTLSMAVRYSPTHETVSYPIDS 200
DL W +P S D+ +LG LL+EW+ A S + L L+ AV SP ++YP++S
Sbjct: 112 DLDWEYPLSAADMTNLGTLLNEWRTAINTEARNSGRAALLLTAAVSNSPRVNGLNYPVES 171
Query: 201 MKKNLNWAHLVAYDYHMPSKE-NVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLG 259
+ +NL+W +L+AYD++ P+ + T HA L++P +++S GI W++ G P KLVLG
Sbjct: 172 LARNLDWINLMAYDFYGPNWSPSQTNSHAQLFDPVNHVSGSDGINAWIQAGVPTKKLVLG 231
Query: 260 -------------------ARASGPGIT---IDGSMGYKFIRAFIQNYGYGAAPVYNASY 297
A A+G DGSM Y IR +I A VYNA+
Sbjct: 232 IPFYGYAWRLVNANIHGLRAPAAGKSNVGAVDDGSMTYNRIRDYIVE--SRATTVYNATI 289
Query: 298 VVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAA 349
V + SG+ WI++D +T++ K++Y K + LLGY A+ ++ D NW LSR A
Sbjct: 290 VGDYCYSGSNWISYDDTQTVRNKVNYVKGRGLLGYFAWHVAGDQNWGLSRTA 341
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 2e-87
Identities = 69/308 (22%), Positives = 119/308 (38%), Gaps = 28/308 (9%)
Query: 425 FSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSL 484
++ + G FG V+K + AVK Q + + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 485 TARLQHVNLLRVLGYCTERD----ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNII 540
++H N+L+ +G + LI + SL +L + V+ W + +I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 541 EGVTQGLLYL-------QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593
E + +GL YL ++ + HRD+K+ N+LL N L I+DFG+A F
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 594 ANTGRIVGTYGYVPPEYVKKGI-----YSMKYDVYSFGVLLLQIISSKRNARYYGTSENL 648
+T VGT Y+ PE ++ I ++ D+Y+ G++L ++ S A L
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 649 NFLEY-----AFEQWKDSKGKEFIDPSLDDSSSPCKLLNCM-QVALLCVQENPEDRPSML 702
F E + E ++ + P L D + + + C + E R S
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 703 EVSSMLKD 710
V +
Sbjct: 308 CVGERITQ 315
|
| >4ay1_A Chitinase-3-like protein 2; chilectin, lectin, chitooligosaccharide, pseudochitinase, HY; HET: NAG; 1.95A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 3e-71
Identities = 80/354 (22%), Positives = 149/354 (42%), Gaps = 60/354 (16%)
Query: 26 TWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRR 85
W + +F +I+ L +HLI +FA ++++ + I ++ NS++
Sbjct: 10 NW--SQDRQEPGKFTPENIDPFLCSHLIYSFASIENNK--VIIKDKSEVMLYQTINSLKT 65
Query: 86 KNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG 143
KNP +K LLSI + + + MV S+ R FI S I R +
Sbjct: 66 KNPKLKILLSIGGYLFGSKGF--------------HPMVDSSTSRLEFINSIILFLRNHN 111
Query: 144 FQGIDLFWLWPNSTDLNSLGILLDEWK------ASASDQPELTLSMAVRYSPTHETVSYP 197
F G+D+ W++P+ + +L+ E + S + L L+ V SY
Sbjct: 112 FDGLDVSWIYPDQKENTHFTVLIHELAEAFQKDFTKSTKERLLLTAGVSAGRQMIDNSYQ 171
Query: 198 IDSMKKNLNWAHLVAYDYHMP-SKENVTGIHAALYNPSSN------ISTDFGIREWLRRG 250
++ + K+L++ +L+++D+H K +TG ++ L + + ++ + W+ +G
Sbjct: 172 VEKLAKDLDFINLLSFDFHGSWEKPLITGHNSPLSKGWQDRGPSSYYNVEYAVGYWIHKG 231
Query: 251 FPANKLVLG------------------ARASGPGIT-----IDGSMGYKFIRAFIQNYGY 287
P+ K+V+G A ASGPG G + Y I F++
Sbjct: 232 MPSEKVVMGIPTYGHSFTLASAETTVGAPASGPGAAGPITESSGFLAYYEICQFLKGAKI 291
Query: 288 GAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
Y V G W+ +D V++++ K+ + K NL G + + DD
Sbjct: 292 TRLQDQQVPYAVK----GNQWVGYDDVKSMETKVQFLKNLNLGGAMIWSIDMDD 341
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 6e-68
Identities = 72/336 (21%), Positives = 127/336 (37%), Gaps = 49/336 (14%)
Query: 425 FSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNE--V 482
+ S+ +N +G G +G VYKG+L + AVK S + Q F NE +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 483 SLTARLQHVNLLRVLGYCTERDEN-----MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRV 537
++H N+ R + + +L+ EY PN SL YL + DW
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSC 114
Query: 538 NIIEGVTQGLLYL------QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF---- 587
+ VT+GL YL ++ + HRDL + N+L+ N+ ISDFG++
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 588 --RKDVDEANTGRIVGTYGYVPPEYVKKGI-------YSMKYDVYSFGVLLLQIISSKRN 638
R ++ VGT Y+ PE ++ + + D+Y+ G++ +I +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 639 ARYYGTSE-------NLNFLEYAFEQWKDSKGKEFIDPSL-----DDSSSPCKLLNCMQV 686
+ FE + +E P ++S + L ++
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE- 293
Query: 687 ALLCVQENPEDRPSMLEVSSMLKDDSMAIAAPKRPA 722
C ++ E R + + + M K +
Sbjct: 294 --DCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >1vf8_A YM1, secretory protein; chitinase, CHI-lectin, structural plasticity, functional versatility, immune system; 1.31A {Mus musculus} SCOP: c.1.8.5 d.26.3.1 PDB: 1e9l_A Length = 377 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 4e-66
Identities = 87/359 (24%), Positives = 141/359 (39%), Gaps = 65/359 (18%)
Query: 26 TWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRR 85
+W A F +I+ L THLI AFA + ++ ++ + N ++
Sbjct: 9 SW--AKDRPIEGSFKPGNIDPCLCTHLIYAFAGMQNNE--ITYTHEQDLRDYEALNGLKD 64
Query: 86 KNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG 143
KN +KTLL+I W + + S+MV +R+ FI+S IR R Y
Sbjct: 65 KNTELKTLLAIGGWKFGPAPF--------------SAMVSTPQNRQIFIQSVIRFLRQYN 110
Query: 144 FQGIDLFWLWPNS-----TDLNSLGILLDEWK------ASASDQPELTLSMAVRYSPTHE 192
F G++L W +P S D + +L+ E + + D P L L+
Sbjct: 111 FDGLNLDWQYPGSRGSPPKDKHLFSVLVKEMRKAFEEESVEKDIPRLLLTSTGAGIIDVI 170
Query: 193 TVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNI------STDFGIREW 246
Y I + ++L++ ++ YD H P + TG ++ LY +I + D I W
Sbjct: 171 KSGYKIPELSQSLDYIQVMTYDLHDPK-DGYTGENSPLYKSPYDIGKSADLNVDSIISYW 229
Query: 247 LRRGFPANKLVLG-------------------ARASGPGIT-----IDGSMGYKFIRAFI 282
G + KL++G A G G + Y + F+
Sbjct: 230 KDHGAASEKLIVGFPAYGHTFILSDPSKTGIGAPTISTGPPGKYTDESGLLAYYEVCTFL 289
Query: 283 QNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
GA V++A V G W+ +D V + K K + K+ NL G + L DD
Sbjct: 290 NE---GATEVWDAPQEVPYAYQGNEWVGYDNVRSFKLKAQWLKDNNLGGAVVWPLDMDD 345
|
| >3fy1_A Amcase, TSA1902, acidic mammalian chitinase; structure, crystallography, asthma,inhibitor, chitin degradation, methylallosamidin; HET: NA1 NAA AMI; 1.70A {Homo sapiens} PDB: 3fxy_A* 3rm4_A* 3rm8_A* 3rm9_A* 3rme_A* 2ybt_A* 2ybu_A* Length = 395 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 2e-65
Identities = 92/359 (25%), Positives = 148/359 (41%), Gaps = 65/359 (18%)
Query: 26 TWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRR 85
W A Y F DIN L THLI AFA + ++ I + + F N ++
Sbjct: 9 NW--AQYRPGLGRFMPDDINPCLCTHLIYAFAGMQNNEITT-IEWNDVTLYQAF-NGLKN 64
Query: 86 KNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG 143
KN +KTLL+I WN + + ++MV +R++FI S I+ R Y
Sbjct: 65 KNSQLKTLLAIGGWNFGTAPF--------------TAMVSTPENRQTFITSVIKFLRQYE 110
Query: 144 FQGIDLFWLWPNS-----TDLNSLGILLDEWK------ASASDQPELTLSMAVRYSPTHE 192
F G+D W +P S D + +L+ E + A ++P L ++ AV ++
Sbjct: 111 FDGLDFDWEYPGSRGSPPQDKHLFTVLVQEMREAFEQEAKQINKPRLMVTAAVAAGISNI 170
Query: 193 TVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN------ISTDFGIREW 246
Y I + + L++ H++ YD H E TG ++ LY ++ ++ D+ + W
Sbjct: 171 QSGYEIPQLSQYLDYIHVMTYDLHGSW-EGYTGENSPLYKYPTDTGSNAYLNVDYVMNYW 229
Query: 247 LRRGFPANKLVLG-------------------ARASGPGIT-----IDGSMGYKFIRAFI 282
G PA KL++G A SG G G Y I F+
Sbjct: 230 KDNGAPAEKLIVGFPTYGHNFILSNPSNTGIGAPTSGAGPAGPYAKESGIWAYYEICTFL 289
Query: 283 QNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
+N GA ++A V G W+ +D V++ K + K G + + DD
Sbjct: 290 KN---GATQGWDAPQEVPYAYQGNVWVGYDNVKSFDIKAQWLKHNKFGGAMVWAIDLDD 345
|
| >2pi6_A Chitinase-3-like protein 1; complex, signaling protein; HET: NAG MAN; 1.65A {Ovis aries} SCOP: c.1.8.5 d.26.3.1 PDB: 2dpe_A* 1sr0_A* 1zl1_A* 1zbk_A* 2dsu_A* 2dsv_A* 2dsw_A* 2fdm_A* 2g41_A* 2g8z_A* 2dt1_A* 1zbv_A* 1zu8_A* 2aos_A* 2b31_A* 1zbw_A* 2dt0_A* 2dsz_A* 2dt2_A* 2dt3_A* ... Length = 361 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 2e-65
Identities = 90/351 (25%), Positives = 142/351 (40%), Gaps = 58/351 (16%)
Query: 26 TWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRR 85
+W + Y I+ L TH+I FA + ++ + Y ++ N+++
Sbjct: 9 SW--SQYREGDGSCFPDAIDPFLCTHVIYTFANISNNEIDTWEWNDVTLYDTL--NTLKN 64
Query: 86 KNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG 143
+NP +KTLLS+ WN + S + + R++FI+S R +G
Sbjct: 65 RNPKLKTLLSVGGWNFGPERF--------------SKIASKTQSRRTFIKSVPPFLRTHG 110
Query: 144 FQGIDLFWLWPNSTDLNSLGILLDEWKA-----SASDQPELTLSMAVRYSPTHETVSYPI 198
F G+DL WL+P D L L+ E KA + + +L LS AV Y I
Sbjct: 111 FDGLDLAWLYPGRRDKRHLTTLVKEMKAEFIREAQAGTEQLLLSAAVSAGKIAIDRGYDI 170
Query: 199 DSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN-----ISTDFGIREWLRRGFPA 253
+ ++L++ L+ YD+H G H+ L+ + + + D+ + LR G PA
Sbjct: 171 AQISRHLDFISLLTYDFHGAW-RQTVGHHSPLFRGNEDASSRFSNADYAVSYMLRLGAPA 229
Query: 254 NKLVLG------------------ARASGPGIT-----IDGSMGYKFIRAFIQNYGYGAA 290
NKLV+G A SGPGI G + Y I F+
Sbjct: 230 NKLVMGIPTFGRSFTLASSKTDVGAPVSGPGIPGRFTKEKGILAYYEICDFLHGATTHRF 289
Query: 291 PVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
Y G W+ +D E++K K Y K + L G + L DD
Sbjct: 290 RDQQVPYATK----GNQWVAYDDQESVKNKARYLKNRQLAGAMVWALDLDD 336
|
| >1wb0_A Chitinase 1, chitotriosidase 1; cyclopentapeptide inhibitors, chitinase inhibitors, carbohyd metabolism, chitin degradation, chitin-binding; HET: VR0 MEA; 1.65A {Homo sapiens} SCOP: c.1.8.5 d.26.3.1 PDB: 1waw_A* 1guv_A 1lg2_A 1lg1_A 1lq0_A 1hki_A* 1hkj_A* 1hkm_A* 1hkk_A* Length = 445 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 1e-63
Identities = 101/359 (28%), Positives = 157/359 (43%), Gaps = 67/359 (18%)
Query: 26 TWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRR 85
W A Y F D++ +L THLI AFA + + S + N + N +++
Sbjct: 9 NW--AQYRQGEARFLPKDLDPSLCTHLIYAFAGMTNHQL--STTEWNDETLYQEFNGLKK 64
Query: 86 KNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG 143
NP +KTLL+I WN + + MV +++R++F+ S+IR R Y
Sbjct: 65 MNPKLKTLLAIGGWNFGTQKF--------------TDMVATANNRQTFVNSAIRFLRKYS 110
Query: 144 FQGIDLFWLWPNS-----TDLNSLGILLDEWK------ASASDQPELTLSMAVRYSPTHE 192
F G+DL W +P S D L+ + A S + L LS AV T+
Sbjct: 111 FDGLDLDWEYPGSQGSPAVDKERFTTLVQDLANAFQQEAQTSGKERLLLSAAVPAGQTYV 170
Query: 193 TVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN------ISTDFGIREW 246
Y +D + +NL++ +L+AYD+H E VTG ++ LY ++ D +++W
Sbjct: 171 DAGYEVDKIAQNLDFVNLMAYDFHGSW-EKVTGHNSPLYKRQEESGAAASLNVDAAVQQW 229
Query: 247 LRRGFPANKLVLG-------------------ARASGPGIT-----IDGSMGYKFIRAFI 282
L++G PA+KL+LG A A+G G G + Y + ++
Sbjct: 230 LQKGTPASKLILGMPTYGRSFTLASSSDTRVGAPATGSGTPGPFTKEGGMLAYYEVCSWK 289
Query: 283 QNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
GA V W+ FD VE+ K K+SY K+K L G + L DD
Sbjct: 290 -----GATKQRIQDQKVPYIFRDNQWVGFDDVESFKTKVSYLKQKGLGGAMVWALDLDD 343
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-56
Identities = 73/272 (26%), Positives = 132/272 (48%), Gaps = 21/272 (7%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRL--SATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
K+G G FG V++ G + AVK L + + EF EV++ RL+H N++ +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
T+ ++ EYL SL L R LD ++R+++ V +G+ YL N +
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
+HR+LK+ N+L+D + K+ DFG+++L K ++ GT ++ PE ++ +
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 619 KYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPC 678
K DVYSFGV+L ++ + + + + NLN + G + + + +P
Sbjct: 219 KSDVYSFGVILWELATLQ---QPW---GNLNPAQVVAA-----VGFKCKRLEIPRNLNP- 266
Query: 679 KLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
++ ++ C P RPS + +L+
Sbjct: 267 QVAAIIE---GCWTNEPWKRPSFATIMDLLRP 295
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 9e-54
Identities = 72/311 (23%), Positives = 123/311 (39%), Gaps = 31/311 (9%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
+G G FG V K R ++ A+K++ + S + F E+ +R+ H N++++ G C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
+ L+ EY SL L ++ +QG+ YL +IH
Sbjct: 71 L--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 561 RDLKASNILLDNELN-PKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
RDLK N+LL KI DFG A D+ T G+ ++ PE + YS K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNN-KGSAAWMAPEVFEGSNYSEK 183
Query: 620 YDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCK 679
DV+S+G++L ++I+ + + + + + + W G P L +
Sbjct: 184 CDVFSWGIILWEVITRR---KPF---DEIGGPAFRIM-WAVHNGTR---PPLIKNLPK-P 232
Query: 680 LLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAPKRP------AFSAKGDENAET 733
+ + M C ++P RPSM E+ ++ P G++
Sbjct: 233 IESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVE 289
Query: 734 SSTSRQEIYSF 744
E Y
Sbjct: 290 PYVDFAEFYRL 300
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-53
Identities = 64/285 (22%), Positives = 134/285 (47%), Gaps = 38/285 (13%)
Query: 441 NKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQG-------LEEFKNEVSLTARLQHVN 492
++G+GGFG V+KG + A+K L ++G +EF+ EV + + L H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
++++ G ++ E++P L L D + + + W ++ ++ + G+ Y+Q
Sbjct: 85 IVKLYGLMHN--PPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 553 YSNFRVIHRDLKASNILLDN-----ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
N ++HRDL++ NI L + + K++DFG+++ ++G + ++
Sbjct: 141 -QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMA 194
Query: 608 PE--YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665
PE ++ Y+ K D YSF ++L I++ + + + ++ + F +G
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGE---GPF---DEYSYGKIKFINMIREEGLR 248
Query: 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P++ + P +L N ++ LC +P+ RP + L +
Sbjct: 249 ---PTIPEDCPP-RLRNVIE---LCWSGDPKKRPHFSYIVKELSE 286
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 6e-53
Identities = 70/296 (23%), Positives = 120/296 (40%), Gaps = 34/296 (11%)
Query: 441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
LG+G FG K G+ +K L + F EV + L+H N+L+ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
+ I EY+ +L + + W +RV+ + + G+ YL + +I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYL---HSMNII 130
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR------------IVGTYGYVP 607
HRDL + N L+ N ++DFG+A+L + + R +VG ++
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667
PE + Y K DV+SFG++L +II A ++F + F+
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVN-ADPDYLPRTMDFGLNV---------RGFL 240
Query: 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD--DSMAIAAPKRP 721
D + P + + C +PE RPS +++ L+ +A P P
Sbjct: 241 DRYCPPNCPP-SFF---PITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGP 292
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 5e-52
Identities = 71/282 (25%), Positives = 122/282 (43%), Gaps = 36/282 (12%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRL----SATSTQGLEEFKNEVSLTARLQHVNLLRV 496
+G GGFG VY+ G E AVK +Q +E + E L A L+H N++ +
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
G C + L+ E+ L+ L + VN + +G+ YL + +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 557 RVIHRDLKASNILLDNELNP--------KISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
+IHRDLK+SNIL+ ++ KI+DFG+A+ + + + G Y ++ P
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAP 183
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668
E ++ ++S DV+S+GVLL ++++ + + ++ L A+
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE---VPF---RGIDGLAVAY--GVAMNKLALPI 235
Query: 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P S+ P M+ C +P RPS + L
Sbjct: 236 P----STCPEPFAKLME---DCWNPDPHSRPSFTNILDQLTT 270
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-50
Identities = 62/277 (22%), Positives = 116/277 (41%), Gaps = 32/277 (11%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSA--TSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
KL E G ++KG +G + VK L ST+ +F E H N+L VLG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 499 YCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
C LI ++P SL L + +V+D + V + +G+ +L
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHT-LEP 132
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK--- 613
+ L + ++++D ++ +IS + F + GR+ +V PE ++K
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRM-YAPAWVAPEALQKKPE 185
Query: 614 GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673
D++SF VLL ++++ + + +L+ +E E + P++
Sbjct: 186 DTNRRSADMWSFAVLLWELVTRE---VPF---ADLSNMEIGM-----KVALEGLRPTIPP 234
Query: 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
SP + M+ +C+ E+P RP + +L+
Sbjct: 235 GISP-HVSKLMK---ICMNEDPAKRPKFDMIVPILEK 267
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 6e-50
Identities = 76/278 (27%), Positives = 135/278 (48%), Gaps = 30/278 (10%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLG 498
++G G FG VYKG G + AVK L+ T + Q L+ FKNEV + + +HVN+L +G
Sbjct: 30 QRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 499 YCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
Y T + ++ ++ SL +L + +K ++I +G+ YL +
Sbjct: 88 YSTA--PQLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYL-HAKSI- 141
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE---YVKKG 614
IHRDLK++NI L + KI DFG+A + ++ G+ ++ PE
Sbjct: 142 -IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 615 IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS 674
YS + DVY+FG++L ++++ + Y N+N + E G+ + P L
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLP--Y----SNINNRDQIIEM----VGRGSLSPDLSKV 250
Query: 675 SSPC--KLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
S C ++ M C+++ ++RPS + + +++
Sbjct: 251 RSNCPKRMKRLMA---ECLKKKRDERPSFPRILAEIEE 285
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 6e-50
Identities = 65/298 (21%), Positives = 117/298 (39%), Gaps = 40/298 (13%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNE--VSLTARLQHVNLLRVLG 498
+G+G +G V++G+ +G+ AVK S ++ + + E + T L+H N+L +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 499 YCTERDEN----MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL---- 550
+ LI Y SL +D ++ LD + I+ + GL +L
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 551 -QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF---RKDVDEANTGRIVGTYGYV 606
+ HRDLK+ NIL+ I+D G+A + +D N R VGT Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKRYM 184
Query: 607 PPE------YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS----ENLNFLEYAFE 656
PE V + D+++FG++L ++ + ++ + +FE
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 657 QWKDSKGKE----FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
+ + I + L M+ C +NP R + L + L
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 1e-49
Identities = 73/296 (24%), Positives = 120/296 (40%), Gaps = 36/296 (12%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNE--VSLTARLQHVNLLRVLG 498
++G+G +G V+ G RG++ AVK T + E + T ++H N+L +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 499 YCTERDEN----MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL---- 550
+ + LI +Y N SL YL + LD + + + GL +L
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 551 -QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF---RKDVDEANTGRIVGTYGYV 606
+ HRDLK+ NIL+ I+D G+A F +VD R VGT Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR-VGTKRYM 213
Query: 607 PPE------YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT----SENLNFLEYAFE 656
PPE + D+YSFG++L ++ + +L + ++E
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 657 QWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALL--CVQENPEDRPSMLEVSSMLKD 710
++ + + PS + S + L M L+ C NP R + L V L
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQM-GKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 4e-49
Identities = 68/296 (22%), Positives = 122/296 (41%), Gaps = 36/296 (12%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNE--VSLTARLQHVNLLRVLG 498
+G+G FG V++G RG+E AVK S ++ + E + T L+H N+L +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 499 YCTERDEN----MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
+ + L+ +Y + SL FD + RY + + + + GL +L
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 555 NFR-----VIHRDLKASNILLDNELNPKISDFGMAKLFR---KDVDEANTGRIVGTYGYV 606
+ HRDLK+ NIL+ I+D G+A +D A R VGT Y+
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR-VGTKRYM 218
Query: 607 PPE------YVKKGIYSMKYDVYSFGVLLLQIIS----SKRNARYYGTSENLNFLEYAFE 656
PE +K + D+Y+ G++ +I + Y +L + + E
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 657 QWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALL--CVQENPEDRPSMLEVSSMLKD 710
+ + ++ + P++ + C+ L M ++ C N R + L + L
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVM-AKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >1jnd_A Imaginal DISC growth factor-2; IDGF, chitinase, insulin recep heparin, hormone-growth factor complex; HET: NAG BMA MAN; 1.30A {Drosophila melanogaster} SCOP: c.1.8.5 d.26.3.1 PDB: 1jne_A* Length = 420 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 4e-47
Identities = 73/387 (18%), Positives = 129/387 (33%), Gaps = 101/387 (26%)
Query: 43 DINSALFTHLICAFAEVDSSTYQLSI----SSANQQYFSIFANSVRRKNPSIKTLLSI-- 96
+I +HL+ +A + Q + FS S++RK P +K LLS+
Sbjct: 27 EIALQFCSHLVYGYAGLRGENLQAYSMNENLDIYKHQFSEV-TSLKRKYPHLKVLLSVGG 85
Query: 97 WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS 156
+ + + + + + G+ + FI S+ + YGF G+DL + +P +
Sbjct: 86 DHDIDPDHPN---------KYIDLLEGEKVRQIGFIRSAYELVKTYGFDGLDLAYQFPKN 136
Query: 157 TDLNSLGILLDEWKASAS------------------------------DQPELTLSMAVR 186
G L WK+ LS+ V
Sbjct: 137 KPRKVHGDLGLAWKSIKKLFTGDFIVDPHAALHKEQFTALVRDVKDSLRADGFLLSLTVL 196
Query: 187 YSPTHETVSYPIDSMKKNLNWAHLVAYDYHMP-SKENVTGIHAALYNPSSN------IST 239
+ T + I ++ +++ +L +D+ P A +Y+P + ++
Sbjct: 197 PNVNS-TWYFDIPALNGLVDFVNLATFDFLTPARNPEEADYSAPIYHPDGSKDRLAHLNA 255
Query: 240 DFGIREWLRRGFPANKLVLG----------------------ARASGPGIT-----IDGS 272
DF + WL +GFP+NK+ LG SGP G
Sbjct: 256 DFQVEYWLSQGFPSNKINLGVATYGNAWKLTKDSGLEGVPVVPETSGPAPEGFQSQKPGL 315
Query: 273 MGYKFIRAFIQNYGYGA------------------APVYNASYVVNLFTSGATWINFDGV 314
+ Y I + N + + W+++D
Sbjct: 316 LSYAEICGKLSNPQNQFLKGNESPLRRVSDPTKRFGGIAYRPVDGQ--ITEGIWVSYDDP 373
Query: 315 ETIKAKISYAKEKNLLGYKAFQLSNDD 341
++ K +YA+ KNL G F LS DD
Sbjct: 374 DSASNKAAYARVKNLGGVALFDLSYDD 400
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 4e-47
Identities = 60/284 (21%), Positives = 116/284 (40%), Gaps = 37/284 (13%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLG 498
+G+G FG VY G G E A++ + + L+ FK EV + +H N++ +G
Sbjct: 39 ELIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
C +I ++L + D + VLD K I + + +G+ YL +
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYL-HAKG--I 151
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI---VGTYGYVPPEYVK--- 612
+H+DLK+ N+ DN I+DFG+ + ++ G ++ PE ++
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 613 ------KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666
K +S DV++ G + ++ + R + + W+ G +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHA--REWPF----KTQPAEAII---WQMGTGMK- 260
Query: 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P+L ++ + + C E+RP+ ++ ML+
Sbjct: 261 --PNLSQIGMGKEISDILL---FCWAFEQEERPTFTKLMDMLEK 299
|
| >1w9p_A Chitinase; peptide inhibitors, argifin, argadin, glycosidase, hydrolase; 1.7A {Aspergillus fumigatus} SCOP: c.1.8.5 d.26.3.1 PDB: 1w9u_A* 1w9v_A* 2a3a_A* 2a3b_A* 2a3c_A* 2a3e_A* 2iuz_A* 3ch9_A 3chc_A* 3chd_A* 3che_A* 3chf_A* 1wno_A* Length = 433 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 8e-47
Identities = 76/357 (21%), Positives = 136/357 (38%), Gaps = 71/357 (19%)
Query: 36 GREFPLSDINSALFTHLICAFAEVDSSTYQLSIS-------------SANQQYFSIFAN- 81
GR D+ TH++ AFA V T ++ ++ S + +++
Sbjct: 56 GRNHNPQDLPVERLTHVLYAFANVRPETGEVYMTDSWADIEKHYPGDSWSDTGNNVYGCI 115
Query: 82 ----SVRRKNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESS 135
++++N ++K LLSI W S + + RK+F +++
Sbjct: 116 KQLYLLKKQNRNLKVLLSIGGWTY--SPN-------------FAPAASTDAGRKNFAKTA 160
Query: 136 IRTARLYGFQGIDLFWLWPNSTD--------LNSLGILLDEWKASASDQPELTLSMAVRY 187
++ + GF G+D+ W +P + L + LD + A+ + L++A
Sbjct: 161 VKLLQDLGFDGLDIDWEYPENDQQANDFVLLLKEVRTALDSYSAANAGGQHFLLTVASPA 220
Query: 188 SPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN-----ISTDFG 242
P + M + L++ +L+AYDY S +++G A +YN +SN +T
Sbjct: 221 GPDK-IKVLHLKDMDQQLDFWNLMAYDYAG-SFSSLSGHQANVYNDTSNPLSTPFNTQTA 278
Query: 243 IREWLRRGFPANKLVLG-----------------ARASGPGITIDGSMGYKFIRAFIQNY 285
+ + G PANK+VLG G G +G YK +
Sbjct: 279 LDLYRAGGVPANKIVLGMPLYGRSFANTDGPGKPYNGVGQGSWENGVWDYKALPQ--AGA 336
Query: 286 GYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDN 342
P ASY + + I++D + K Y K L G + S+D
Sbjct: 337 TEHVLPDIMASYSYD--ATNKFLISYDNPQVANLKSGYIKSLGLGGAMWWDSSSDKT 391
|
| >3g6m_A Chitinase, crchi1; inhibitor, caffeine, glycosidase, hydrolas hydrolase inhibitor complex; HET: CFF; 1.65A {Bionectria ochroleuca} PDB: 3g6l_A* Length = 406 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-46
Identities = 78/356 (21%), Positives = 138/356 (38%), Gaps = 70/356 (19%)
Query: 36 GREFPLSDINSALFTHLICAFAEVDSS------------TYQLSISSANQQYFSIFAN-- 81
GR F +D+ ++ H++ +F + S S N + +
Sbjct: 34 GRNFQPADLQASKILHVLYSFMNLRVDGTVYSGDTYADLEKHYSDDSWNDIGTNAYGCVK 93
Query: 82 ---SVRRKNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSI 136
+++ N S+K +LSI W ST + + R +F ++++
Sbjct: 94 QLYKLKKANRSLKIMLSIGGWTW--STN-------------FPAAASTEATRATFAKTAV 138
Query: 137 RTARLYGFQGIDLFWLWPNSTD--------LNSLGILLDEWKASASDQPELTLSMAVRYS 188
+ +GF GID+ W +P S L + LD + A+ ++ LS+A
Sbjct: 139 EFMKDWGFDGIDVDWEYPASETDANNMVLLLQRVRQELDSYSATYANGYHFQLSIAAPAG 198
Query: 189 PTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN-----ISTDFGI 243
P+H + + L+ +L+AYDY S ++V+G LY +SN ST +
Sbjct: 199 PSH-YNVLKLAQLGSVLDNINLMAYDYAG-SWDSVSGHQTNLYPSTSNPSSTPFSTKAAV 256
Query: 244 REWLRRGFPANKLVLG-----------------ARASGPGITIDGSMGYKFIRAFIQNYG 286
++ G PA+K++LG G G G YK +
Sbjct: 257 DAYIAAGVPASKIILGMPIYGRAFVGTDGPGKPYSTIGEGSWESGIWDYKVLPKAGATVI 316
Query: 287 YGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDN 342
A+Y + +S T I++D + ++ K+SYAK L G ++ S D
Sbjct: 317 TD--SAAGATYSYD--SSSRTMISYDTPDMVRTKVSYAKGLGLGGSMFWEASADKT 368
|
| >1ll7_A Chitinase 1; beta-alpha barrel, hydrolase; 2.00A {Coccidioides immitis} SCOP: c.1.8.5 d.26.3.1 PDB: 1d2k_A 1ll4_A* 1ll6_A Length = 392 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 2e-46
Identities = 74/355 (20%), Positives = 137/355 (38%), Gaps = 70/355 (19%)
Query: 36 GREFPLSDINSALFTHLICAFAEVDSS------------TYQLSISSANQQYFSIFAN-- 81
GR D+ + FTH++ AFA + S ++ +++
Sbjct: 16 GRGHNPQDLKADQFTHILYAFANIRPSGEVYLSDTWADTDKHYPGDKWDEPGNNVYGCIK 75
Query: 82 ---SVRRKNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSI 136
+++ N ++KTLLSI W S + RK F ++S+
Sbjct: 76 QMYLLKKNNRNLKTLLSIGGWT--YSPN-------------FKTPASTEEGRKKFADTSL 120
Query: 137 RTARLYGFQGIDLFWLWPNSTD--------LNSLGILLDEWKASASDQPELTLSMAVRYS 188
+ + GF GID+ W +P L + LD + A + + L++A
Sbjct: 121 KLMKDLGFDGIDIDWQYPEDEKQANDFVLLLKACREALDAYSAKHPNGKKFLLTIASPAG 180
Query: 189 PTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN-----ISTDFGI 243
P + + M K L++ +L+AYD+ S + V+G + ++ ++ S+D +
Sbjct: 181 PQN-YNKLKLAEMDKYLDFWNLMAYDFSG-SWDKVSGHMSNVFPSTTKPESTPFSSDKAV 238
Query: 244 REWLRRGFPANKLVLG-----------------ARASGPGITIDGSMGYKFIRAFIQNYG 286
+++++ G PANK+VLG G G +G YK + Q
Sbjct: 239 KDYIKAGVPANKIVLGMPLYGRAFASTDGIGTSFNGVGGGSWENGVWDYKDMPQ--QGAQ 296
Query: 287 YGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
ASY + + I++D V+ K Y + + G ++ S+D
Sbjct: 297 VTELEDIAASYSYD--KNKRYLISYDTVKIAGKKAEYITKNGMGGGMWWESSSDK 349
|
| >3qok_A Putative chitinase II; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, glycosyl hydrolases family 18; 2.60A {Klebsiella pneumoniae subsp} Length = 420 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 7e-46
Identities = 68/428 (15%), Positives = 131/428 (30%), Gaps = 108/428 (25%)
Query: 7 RVLFFIFLSSFQLEFSDAQTWIKAGYW------LAGREFPLSDINSALFTHLICAFAEVD 60
R+ L AQ + GY+ AG + ++ THL +F +
Sbjct: 6 RLPLLAALPLLCASALSAQPLMSVGYFNGGGDVTAGPGGDIDKLDVRQITHLNYSFGLIY 65
Query: 61 SSTYQLSISSAN-----------QQYFSIFA--NSVRRKNPSIKTLLSI--WNGQNSTYQ 105
+ + ++ + + ++R++NP +K LLS+ W +
Sbjct: 66 NDEKDETNAALKDPAHLHEIWLSPKVQADLQKLPALRKQNPDLKVLLSVGGWGARG---- 121
Query: 106 SILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLG-- 163
S + R FI S+ + + YG GIDL W +P + +
Sbjct: 122 ------------FSGAAATAESRAVFIRSAQKIIQQYGLDGIDLDWEFPVNGAWGLVASQ 169
Query: 164 --------ILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDY 215
LL + + + +++AV + + ++ LN+ +L+ YD
Sbjct: 170 PADRDNFTALLKSLREAV--GEQKLVTIAVGANAESPKSWVDVKAVAPVLNYINLMTYDM 227
Query: 216 HMPSKENVTGIHAALYNPSSN--------ISTDFGIREWLRRGFPANKLVLG-------- 259
++ LY+ S S DF + +L G +++ LG
Sbjct: 228 AYG----TQYFNSNLYDSSHWPTVAAADKYSADFVVNNYLAAGLKPSQMNLGIGFYGRVP 283
Query: 260 ---------------------ARASGPGITI-----------DGSMGYKFIRAFIQNYGY 287
GP D + Y I + N
Sbjct: 284 KRAVEPGIDWTKADAQNNPVTQPYFGPQQIALFASLGYDLSKDTYVKYNDIVGKLLNDPQ 343
Query: 288 GAAPVY-----NASYVVN--LFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSND 340
+ ++ ++++ ++ K Y K K L G ++ D
Sbjct: 344 KRFTEHWDDEAKVPWLSVQSAEGKPLFALSYENPRSVAIKADYIKAKGLAGAMFWEYGAD 403
Query: 341 DNWALSRA 348
D L+R
Sbjct: 404 DQNQLARQ 411
|
| >3fnd_A Chitinase; TIM-barrel, structural genomics, PSI-2, P structure initiative, NEW YORK SGX research center for STRU genomics, nysgxrc; 1.90A {Bacteroides thetaiotaomicron} PDB: 3co4_A Length = 312 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 51/326 (15%), Positives = 105/326 (32%), Gaps = 63/326 (19%)
Query: 31 GY---WLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKN 87
GY E I TH+ +FA V + L+I+ ++ S+
Sbjct: 8 GYLALDDWEFESLFPTIEWKYLTHINASFARVKADG-TLNINPVRKRIESVRE---TAHK 63
Query: 88 PSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQ 145
++K L+S+ + ++ + D RK I+ I + Y
Sbjct: 64 HNVKILISLAKNSP----------------GEFTTAINDPKARKELIQQIIAFTKEYKLD 107
Query: 146 GIDLFWLWPNSTDLNSLGILLDEWK-ASASDQPELTLSMAVRYSPTHETVSYPIDSMKKN 204
G D+ + ++ D N LL + + + + ++ AV + ++
Sbjct: 108 GFDIDYEEYDNWDKN-FPSLLVFARGLYLAKEKNMLMTCAVNSRWLNYGT-----EWEQY 161
Query: 205 LNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRR-GFPANKLVLG---- 259
++ +L++YD + + HA+ + ++ W + +K+V G
Sbjct: 162 FDYINLMSYDRGAFT--DKPVQHASYDD------FVKDLKYWNEQCRASKSKIVGGLPFY 213
Query: 260 AR----ASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVE 315
+ + + Y I + N ++G
Sbjct: 214 GYSWEESLQGAVDDVRGIRYSGILKHLGNEAA--------------DKDNIGKTYYNGRP 259
Query: 316 TIKAKISYAKEKNLLGYKAFQLSNDD 341
TI K + KE + G +QL D
Sbjct: 260 TIANKCKFIKENDYAGVMIWQLFQDA 285
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-41
Identities = 74/280 (26%), Positives = 110/280 (39%), Gaps = 40/280 (14%)
Query: 442 KLGEGGFGPVYKGNL-PRGQEFAVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
++G G FG V+ G L AVK +F E + + H N++R++G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
CT++ ++ E + +L L + + ++ G+ YL E I
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYL-ESKCC--I 235
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKG 614
HRDL A N L+ + KISDFGM++ V A+ G VP PE + G
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL-----RQVPVKWTAPEALNYG 290
Query: 615 IYSMKYDVYSFGVLLLQIISSKRNAR--YYGTS--ENLNFLEYAFEQWKDSKGKEFIDPS 670
YS + DV+SFG+LL + S Y S + F+E KG P
Sbjct: 291 RYSSESDVWSFGILLWETFS---LGASPYPNLSNQQTREFVE---------KGGRLPCPE 338
Query: 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
L P + M C P RPS + L+
Sbjct: 339 L----CPDAVFRLM---EQCWAYEPGQRPSFSTIYQELQS 371
|
| >1goi_A Chitinase B; chitin degradation, hydrolase, glycosidase; 1.45A {Serratia marcescens} SCOP: b.72.2.1 c.1.8.5 d.26.3.1 PDB: 1o6i_A* 1e6r_A* 1e15_A 1gpf_A* 1ur8_A* 1w1p_A* 1w1t_A* 1w1v_A* 1w1y_A* 1e6p_A 1e6n_A 1h0g_A* 1h0i_A* 1ogb_A 1ogg_A* 1e6z_A* 1ur9_A* Length = 499 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-41
Identities = 66/400 (16%), Positives = 137/400 (34%), Gaps = 100/400 (25%)
Query: 30 AGYWLAGREFPLSDINSAL---FTHLICAFAEVDSSTY-QLSISSANQQYFSIFA--NSV 83
+ FP+S+I A TH+ +F +++S+ ++ + + + ++
Sbjct: 22 TETDTSVVPFPVSNITPAKAKQLTHINFSFLDINSNLECAWDPATNDAKARDVVNRLTAL 81
Query: 84 RRKNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARL 141
+ NPS++ + SI W S + + V + R F +S +R +
Sbjct: 82 KAHNPSLRIMFSIGGWY--YSNDLGVSHAN------YVNAVKTPASRAKFAQSCVRIMKD 133
Query: 142 YGFQGIDLFWLWPNSTDLNSLGILLDEWKA--------SASDQPELTLSMAVRYSPTH-E 192
YGF G+++ W +P + +++ L E + L++A
Sbjct: 134 YGFDGVNIDWEYPQAAEVDGFIAALQEIRTLLNQQTITDGRQALPYQLTIAGAGGAFFLS 193
Query: 193 TVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN---------------- 236
+ + L++ +L+ YD E VT AAL+ ++
Sbjct: 194 RYYSKLAQIVAPLDYINLMTYDLAG-PWEKVTNHQAALFGDAAGPTFYNALREANLGWSW 252
Query: 237 ------------ISTDFGIRE-WLRRGFPANKLVLG-------------------ARASG 264
++ D +++ + G P+ K+V+G + S
Sbjct: 253 EELTRAFPSPFSLTVDAAVQQHLMMEGVPSAKIVMGVPFYGRAFKGVSGGNGGQYSSHST 312
Query: 265 PGITI-------------------DGSMGYKFIRAFIQNYGYGAAPVYN----ASYVVNL 301
PG Y+ + +Q YG ++N Y+ +
Sbjct: 313 PGEDPYPSTDYWLVGCEECVRDKDPRIASYRQLEQMLQG-NYGYQRLWNDKTKTPYLYH- 370
Query: 302 FTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
++ +D E+ K K Y K++ L G + L D+
Sbjct: 371 -AQNGLFVTYDDAESFKYKAKYIKQQQLGGVMFWHLGQDN 409
|
| >1edq_A Chitinase A; beta-alpha (TIM) barrel, hydrolase; 1.55A {Serratia marcescens} SCOP: b.1.18.2 c.1.8.5 d.26.3.1 PDB: 1ffq_A* 1ffr_A* 1ehn_A* 1ctn_A 1k9t_A* 1eib_A* 2wlz_A* 2wly_A* 2wm0_A* 2wk2_A* 1nh6_A* 1x6l_A 1rd6_A 1x6n_A* Length = 540 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 5e-41
Identities = 65/379 (17%), Positives = 119/379 (31%), Gaps = 75/379 (19%)
Query: 36 GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLS 95
GR F + I + THL+ F + + F S + + ++
Sbjct: 148 GRNFTVDKIPAQNLTHLLYGFIPICGGNGINDSLKEIEGSFQALQRSCQGREDFKVSIHD 207
Query: 96 IWNGQNSTY-------QSILGN-------KNINPSV---LS----------SMVGDSSHR 128
+ GN K +P + S +GD R
Sbjct: 208 PFAALQKAQKGVTAWDDPYKGNFGQLMALKQAHPDLKILPSIGGWTLSDPFFFMGDKVKR 267
Query: 129 KSFIESSIRTARLYG-FQGIDLFWLWPNSTDLNSLG----------ILLDEWKA-----S 172
F+ S + + F G+D+ W +P N +L+ E +A S
Sbjct: 268 DRFVGSVKEFLQTWKFFDGVDIDWEFPGGKGANPNLGSPQDGETYVLLMKELRAMLDQLS 327
Query: 173 ASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALY- 231
+ L+ A+ + + +++ L++YD++ G AL
Sbjct: 328 VETGRKYELTSAISAGKDK-IDKVAYNVAQNSMDHIFLMSYDFYGAFDLKNLGHQTALNA 386
Query: 232 ---NPSSNISTDFGIREWLRRGFPANKLVLG-----------------------ARASGP 265
P + +T G+ L +G K+V+G A
Sbjct: 387 PAWKPDTAYTTVNGVNALLAQGVKPGKIVVGTAMYGRGWTGVNGYQNNIPFTGTATGPVK 446
Query: 266 GITIDGSMGYKFIRAFIQNYGYGAA--PVYNASYVVNLFTSGATWINFDGVETIKAKISY 323
G +G + Y+ I + + A YV S I FD +++AK Y
Sbjct: 447 GTWENGIVDYRQIAGQFMSGEWQYTYDATAEAPYVFK--PSTGDLITFDDARSVQAKGKY 504
Query: 324 AKEKNLLGYKAFQLSNDDN 342
+K L G ++++ D+
Sbjct: 505 VLDKQLGGLFSWEIDADNG 523
|
| >3oa5_A CHI1; TIM barrel, hydrolase; HET: 2PE; 1.74A {Yersinia} PDB: 4a5q_A Length = 574 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 8e-41
Identities = 50/369 (13%), Positives = 111/369 (30%), Gaps = 77/369 (20%)
Query: 30 AGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFA--NSVRRKN 87
+ D + A+ + C F + ++ + ++ + + +
Sbjct: 178 DAIANHKGKTIPVDPDGAVLASINCGFTKWEAG--DANERYNQEKAKGLLGGFRLLHEAD 235
Query: 88 PSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG-F 144
++ LSI W+ S S + D R +F+E + + F
Sbjct: 236 KELEFSLSIGGWSM--SGL-------------FSEIAKDEILRTNFVEGIKDFFQRFPMF 280
Query: 145 QGIDLFWLWPNSTDLNSLG---------ILLDEWKASASDQPELTLSMAVRYSPTHETVS 195
+D+ W +P S + IL+ + A +S+A P +
Sbjct: 281 SHLDIDWEYPGSIGAGNPNSPDDGANFAILIQQITD-AKISNLKGISIASSADPAKIDAA 339
Query: 196 YPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALY----NPSSNISTDFGIREWLRR-G 250
M + +L+ YD+ + H +Y + S S D + +
Sbjct: 340 NIPALMDAGVTGINLMTYDFFTLG-DGKLSHHTNIYRDPSDVYSKYSIDDAVTHLIDEKK 398
Query: 251 FPANKLVLG---------------ARASGPGIT-----IDGSMGY-------------KF 277
+ +G + S + + ++G +
Sbjct: 399 VDPKAIFIGYAGYTRNAKNATITTSIPSEEALKGTYTDANQTLGSFEYSVLEWTDIICHY 458
Query: 278 IRAFIQNYGYGAAPVYN----ASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYK 333
+ G V++ A Y+ + + +I+ D +++ K Y K+K L G
Sbjct: 459 MDFEKGEGRNGYKLVHDKVAKADYLYS--EATKVFISLDTPRSVRDKGRYVKDKGLGGLF 516
Query: 334 AFQLSNDDN 342
+ D+
Sbjct: 517 IWSGDQDNG 525
|
| >1itx_A Chitinase A1, glycosyl hydrolase; alpha-beta (TIM) barrel; 1.10A {Bacillus circulans} SCOP: c.1.8.5 d.26.3.1 Length = 419 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-40
Identities = 81/411 (19%), Positives = 147/411 (35%), Gaps = 117/411 (28%)
Query: 36 GREFPLSDINSALFTHLICAFAEVDSSTYQLSIS-------------------------- 69
GR + ++DI+ TH+ AFA++ + +
Sbjct: 25 GRNYNVADIDPTKVTHINYAFADICWNGIHGNPDPSGPNPVTWTCQNEKSQTINVPNGTI 84
Query: 70 ----------------SANQQYFSIFA--NSVRRKNPSIKTLLSI--WNGQNSTYQSILG 109
+ +Q N +++ NP++KT++S+ W S
Sbjct: 85 VLGDPWIDTGKTFAGDTWDQPIAGNINQLNKLKQTNPNLKTIISVGGWTW--SNR----- 137
Query: 110 NKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLG------ 163
S + ++ R+ F S++ R Y F G+DL W +P S L+
Sbjct: 138 --------FSDVAATAATREVFANSAVDFLRKYNFDGVDLDWEYPVSGGLDGNSKRPEDK 189
Query: 164 ----ILLDEWKA-----SASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYD 214
+LL + + A D + L++A S T+ + + + ++W +++ YD
Sbjct: 190 QNYTLLLSKIREKLDAAGAVDGKKYLLTIASGASATYAA-NTELAKIAAIVDWINIMTYD 248
Query: 215 YHMPSKENVTGIHAALY----------NPSSNISTDFGIREWLRRGFPANKLVLGA---- 260
++ + + ++ +A L ++ + G + L G PA KLVLG
Sbjct: 249 FNG-AWQKISAHNAPLNYDPAASAAGVPDANTFNVAAGAQGHLDAGVPAAKLVLGVPFYG 307
Query: 261 RA------------------SGPGITIDGSMGYKFIRAFIQNYGYGAAPVYN----ASYV 298
R S G GS + + A N G +N Y+
Sbjct: 308 RGWDGCAQAGNGQYQTCTGGSSVGTWEAGSFDFYDLEANYINKN-GYTRYWNDTAKVPYL 366
Query: 299 VNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAA 349
N S +I++D E++ K +Y K K L G ++LS D N L
Sbjct: 367 YN--ASNKRFISYDDAESVGYKTAYIKSKGLGGAMFWELSGDRNKTLQNKL 415
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 82/319 (25%), Positives = 134/319 (42%), Gaps = 42/319 (13%)
Query: 441 NKLGEGGFGPVYKG-----NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
++LG+G FG V G AVK+L + +F+ E+ + L +++
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 496 VLGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
G L+ EYLP+ L +L R LD + + + +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----P 608
R +HRDL A NIL+++E + KI+DFG+AKL D D +V G P P
Sbjct: 147 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAP 199
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT---SENLNFLEYAFEQWKDSKGKE 665
E + I+S + DV+SFGV+L ++ + Y S + FL +
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT-------YCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 666 FIDPSLDD-------SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAP 718
++ L++ + P ++ M LC +P+DRPS + L
Sbjct: 253 LLE-LLEEGQRLPAPPACPAEVHELM---KLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308
Query: 719 KRPAFSAKGDENAETSSTS 737
+ AF+A + + S S
Sbjct: 309 ETHAFTAHPEGKHHSLSFS 327
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-40
Identities = 78/271 (28%), Positives = 122/271 (45%), Gaps = 22/271 (8%)
Query: 441 NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
+KLG G +G VY+G AVK L + + +EEF E ++ ++H NL+++LG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
CT +I E++ +L YL + R + + + ++ + YL E NF I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL-EKKNF--I 340
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMK 619
HR+L A N L+ K++DFG+++L D A+ G + PE + +S+K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 399
Query: 620 YDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCK 679
DV++FGVLL +I + + Y G E K P P K
Sbjct: 400 SDVWAFGVLLWEIATYGMSP-YPGID-LSQVYELL------EKDYRMERPEG----CPEK 447
Query: 680 LLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
+ M C Q NP DRPS E+ +
Sbjct: 448 VYELM---RACWQWNPSDRPSFAEIHQAFET 475
|
| >1kfw_A Chitinase B; TIM barrel, hydrolase; 1.74A {Arthrobacter SP} SCOP: c.1.8.5 d.26.3.1 Length = 435 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-40
Identities = 69/421 (16%), Positives = 130/421 (30%), Gaps = 134/421 (31%)
Query: 36 GREFPLSDINS----ALFTHLICAFAEVDSSTYQLSISSANQQYFSIFA----------- 80
GR F ++ TH+ +F +++ T +++ Q +
Sbjct: 22 GRAFQAKQLDVSGTAKNLTHINYSFGNINNQTLTCFMANKAQGTGPNGSDGAGDAWADFG 81
Query: 81 ---------------------------NSVRRKNPSIKTLLSI--WNGQNSTYQSILGNK 111
++ KNP +K ++S+ W +
Sbjct: 82 MGYAADKSVSGKADTWDQPLAGSFNQLKQLKAKNPKLKVMISLGGWTWSKN--------- 132
Query: 112 NINPSVLSSMVGDSSHRKSFIESSIRTARLYG----------------FQGIDLFWLWPN 155
S + R+ + S I F GID+ W WP
Sbjct: 133 ------FSKAAATEASRQKLVSSCIDLYIKGNLPNFEGRGGAGAAAGIFDGIDIDWEWPG 186
Query: 156 STDLNSLG------------ILLDEWKA-----SASDQPELTLSMAVRYSPTH-ETVSYP 197
+ + LL E++ +++ + LS + +P + +
Sbjct: 187 TNSGLAGNGVDTVNDRANFKALLAEFRKQLDAYGSTNNKKYVLSAFLPANPADIDAGGWD 246
Query: 198 IDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN-------ISTDFGIREWLRRG 250
+ K+L++ + YD H +TG A LY+ ++ S D ++++L G
Sbjct: 247 DPANFKSLDFGSIQGYDLHGAWNPTLTGHQANLYDDPADPRAPSKKFSADKAVKKYLAAG 306
Query: 251 FPANKLVLG-------------------ARASGPGITIDGSMGYKFIRAFIQNYGYGAAP 291
+L LG A PG + Y ++
Sbjct: 307 IDPKQLGLGLAAYGRGWTGAKNVSPWGPATDGAPGTYETANEDYDKLKT-------LGTD 359
Query: 292 VYN----ASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSR 347
Y+ +++ + G W ++D + T K K Y K L G ++LS D N L
Sbjct: 360 HYDAATGSAWRYD----GTQWWSYDNIATTKQKTDYIVSKGLGGGMWWELSGDRNGELVG 415
Query: 348 A 348
A
Sbjct: 416 A 416
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 71/297 (23%), Positives = 119/297 (40%), Gaps = 53/297 (17%)
Query: 441 NKLGEGGFGPVYKG---NLPRGQEF--AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLL 494
LGEG FG V G AVK L + Q +K E+ + L H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 495 RVLGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
+ G C + L+ EY+P SL YL R+ + + + + + +G+ YL
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP----- 607
++ IHRDL A N+LLDN+ KI DFG+AK + + V G P
Sbjct: 153 -QHY--IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYA 205
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667
PE +K+ + DV+SFGV L ++++ + S + ++ + G
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLT-------HCDSS-----QSPPTKFLELIGIAQG 253
Query: 668 DPSLDD--------------SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
++ P ++ + M C + RP+ + +LK
Sbjct: 254 QMTVLRLTELLERGERLPRPDKCPAEVYHLM---KNCWETEASFRPTFENLIPILKT 307
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 73/302 (24%), Positives = 129/302 (42%), Gaps = 36/302 (11%)
Query: 416 DSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGL 475
+ P+ + + + + +LG G FG V G + A+K + S
Sbjct: 5 SKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-E 63
Query: 476 EEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQK 535
+EF E + L H L+++ G CT++ +I EY+ N L YL + R+ Q+
Sbjct: 64 DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQ 121
Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
+ + + V + + YL E F +HRDL A N L++++ K+SDFG+++ D ++
Sbjct: 122 LLEMCKDVCEAMEYL-ESKQF--LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178
Query: 596 TGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS--ENL 648
G P PE + +S K D+++FGVL+ +I S + Y + E
Sbjct: 179 VG------SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP-YERFTNSETA 231
Query: 649 NFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSML 708
+ +G P L + K+ M C E ++RP+ + S +
Sbjct: 232 EHIA---------QGLRLYRPHL----ASEKVYTIM---YSCWHEKADERPTFKILLSNI 275
Query: 709 KD 710
D
Sbjct: 276 LD 277
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-39
Identities = 69/275 (25%), Positives = 125/275 (45%), Gaps = 32/275 (11%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
KLG+G FG V+ G A+K L + E F E + +L+H L+++
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
+E + ++ EY+ SL +L L + V++ + G+ Y+ E N+ +H
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VH 303
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKY 620
RDL+A+NIL+ L K++DFG+A+L + A G + PE G +++K
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 362
Query: 621 DVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID-----PSLDDSS 675
DV+SFG+LL ++ + G + + + + ++ P +
Sbjct: 363 DVWSFGILLTELTT-------KG--------RVPYPGMVNREVLDQVERGYRMPCPPE-- 405
Query: 676 SPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P L + M C ++ PE+RP+ + + L+D
Sbjct: 406 CPESLHDLM---CQCWRKEPEERPTFEYLQAFLED 437
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 9e-39
Identities = 69/275 (25%), Positives = 125/275 (45%), Gaps = 32/275 (11%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
KLG+G FG V+ G A+K L + E F E + +L+H L+++
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
+E + ++ EY+ SL +L L + V++ + G+ Y+ E N+ +H
Sbjct: 332 SE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VH 386
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKY 620
RDL+A+NIL+ L K++DFG+A+L + A G + PE G +++K
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 445
Query: 621 DVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID-----PSLDDSS 675
DV+SFG+LL ++ + G + + + + ++ P +
Sbjct: 446 DVWSFGILLTELTT-------KG--------RVPYPGMVNREVLDQVERGYRMPCPPE-- 488
Query: 676 SPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P L + M C ++ PE+RP+ + + L+D
Sbjct: 489 CPESLHDLM---CQCWRKEPEERPTFEYLQAFLED 520
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 74/277 (26%), Positives = 118/277 (42%), Gaps = 36/277 (12%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
++G G FG V+ G + A+K + + E+F E + +L H L+++ G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
E+ L+ E++ + L YL +R + + + + V +G+ YL E + IH
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYL-EEACV--IH 127
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGI 615
RDL A N L+ K+SDFGM + D ++TG P PE
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG------TKFPVKWASPEVFSFSR 181
Query: 616 YSMKYDVYSFGVLLLQIISSKRNARYYGTS--ENLNFLEYAFEQWKDSKGKEFIDPSLDD 673
YS K DV+SFGVL+ ++ S + Y S E + + G P L
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIP-YENRSNSEVVEDIS---------TGFRLYKPRL-- 229
Query: 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
+ + M C +E PEDRP+ + L +
Sbjct: 230 --ASTHVYQIM---NHCWRERPEDRPAFSRLLRQLAE 261
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 75/289 (25%), Positives = 120/289 (41%), Gaps = 35/289 (12%)
Query: 441 NKLGEGGFGPVYKGNLP-----RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
+LG+G FG V G+ AVK+L ++ + L +F+ E+ + LQH N+++
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 496 VLGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
G C LI EYLP SL YL + +D K + + +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT- 132
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----P 608
+ IHRDL NIL++NE KI DFG+ K+ +D + V G P P
Sbjct: 133 KRY--IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPIFWYAP 186
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668
E + + +S+ DV+SFGV+L ++ + ++ Q E +
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246
Query: 669 -------PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P P ++ M C N RPS +++ +
Sbjct: 247 NNGRLPRP----DGCPDEIYMIM---TECWNNNVNQRPSFRDLALRVDQ 288
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 81/279 (29%), Positives = 125/279 (44%), Gaps = 38/279 (13%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEF--AVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
+KLG G +G VY+G + AVK L + + +EEF E ++ ++H NL+++LG
Sbjct: 19 HKLGGGQYGEVYEGVW-KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
CT +I E++ +L YL + R + + + ++ + YL E NF
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL-EKKNF-- 132
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKK 613
IHRDL A N L+ K++DFG+++L D A+ G P PE +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG------AKFPIKWTAPESLAY 186
Query: 614 GIYSMKYDVYSFGVLLLQIISSKRNARYYGTS--ENLNFLEYAFEQWKDSKGKEFIDPSL 671
+S+K DV++FGVLL +I + + Y G + LE K P
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLE---------KDYRMERPEG 236
Query: 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P K+ M C Q NP DRPS E+ +
Sbjct: 237 ----CPEKVYELM---RACWQWNPSDRPSFAEIHQAFET 268
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-38
Identities = 75/289 (25%), Positives = 120/289 (41%), Gaps = 35/289 (12%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEF-----AVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
+LG+G FG V Q+ AVK+L ++ + L +F+ E+ + LQH N+++
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 496 VLGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
G C LI EYLP SL YL + +D K + + +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT- 163
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----P 608
+ IHRDL NIL++NE KI DFG+ K+ +D + V G P P
Sbjct: 164 KRY--IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAP 217
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668
E + + +S+ DV+SFGV+L ++ + ++ Q E +
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277
Query: 669 -------PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P P ++ M C N RPS +++ +
Sbjct: 278 NNGRLPRP----DGCPDEIYMIM---TECWNNNVNQRPSFRDLALRVDQ 319
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-38
Identities = 74/280 (26%), Positives = 130/280 (46%), Gaps = 42/280 (15%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
KLG G FG V+ + + AVK + S +E F E ++ LQH L+++
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
T+ + +I E++ SL +L K ++ + +G+ ++ E N+ IH
Sbjct: 253 TK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI-EQRNY--IH 307
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGI 615
RDL+A+NIL+ L KI+DFG+A++ + A G P PE + G
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG------AKFPIKWTAPEAINFGS 361
Query: 616 YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID-----PS 670
+++K DV+SFG+LL++I++ YG + + + ++ P
Sbjct: 362 FTIKSDVWSFGILLMEIVT-------YG--------RIPYPGMSNPEVIRALERGYRMPR 406
Query: 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
++ P +L N M + C + PE+RP+ + S+L D
Sbjct: 407 PEN--CPEELYNIM---MRCWKNRPEERPTFEYIQSVLDD 441
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 9e-38
Identities = 69/293 (23%), Positives = 121/293 (41%), Gaps = 43/293 (14%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEF-----AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLL 494
LGEG FG V + AVK L + + + K E+ + L H N++
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 495 RVLGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
+ G CTE N LI E+LP+ SL YL P + ++ ++++ + +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP----- 607
+ +HRDL A N+L+++E KI DFG+ K D + V P
Sbjct: 145 -RQY--VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT----VKDDRDSPVFWYA 197
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWK---DSKGK 664
PE + + + + DV+SFGV L ++++ Y S++ +
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLT-------YCDSDSSPMALFLKMIGPTHGQMTVT 250
Query: 665 EFIDPSLDD-------SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
++ +L + + P ++ M C + P +R S + +
Sbjct: 251 RLVN-TLKEGKRLPCPPNCPDEVYQLM---RKCWEFQPSNRTSFQNLIEGFEA 299
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 42/279 (15%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
+LG G FG V G + AVK + S +EF E +L H L++ G C+
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
+ ++ EY+ N L YL L+ + + + V +G+ +L E F IHR
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFL-ESHQF--IHR 128
Query: 562 DLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGIY 616
DL A N L+D +L K+SDFGM + D ++ G P PE Y
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG------TKFPVKWSAPEVFHYFKY 182
Query: 617 SMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID-----PSL 671
S K DV++FG+L+ ++ S G + ++ + +S+ +
Sbjct: 183 SSKSDVWAFGILMWEVFS-------LG--------KMPYDLYTNSEVVLKVSQGHRLYRP 227
Query: 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
+ + M C E PE RP+ ++ S ++
Sbjct: 228 HL--ASDTIYQIM---YSCWHELPEKRPTFQQLLSSIEP 261
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 78/295 (26%), Positives = 133/295 (45%), Gaps = 50/295 (16%)
Query: 441 NKLGEGGFGPVYKG---NLPRGQEF---AVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
+LGEG FG V+ NL Q+ AVK L S ++F+ E L LQH +++
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYL------------FDPIRRYVLDWQKRVNIIEG 542
R G CTE ++++EY+ + L+ +L + + L + + +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
V G++YL + +HRDL N L+ L KI DFGM+ +D+ + R VG
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMS----RDIYSTDYYR-VGG 218
Query: 603 YGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR--YYGTSENLNFLEYAF 655
+P PE + ++ + DV+SFGV+L +I + + +Y S N ++
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTY---GKQPWYQLS-NTEAIDCI- 273
Query: 656 EQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
++G+E P + P ++ M C Q P+ R S+ +V + L+
Sbjct: 274 -----TQGRELERP----RACPPEVYAIM---RGCWQREPQQRHSIKDVHARLQA 316
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 62/293 (21%), Positives = 104/293 (35%), Gaps = 59/293 (20%)
Query: 442 KLGEGGFGPVYKGNL--------PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
LG+G F ++KG E +K L E F S+ ++L H +L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
+ G C DEN+L+ E++ SLD YL + ++ ++ + + + + +L E
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFL-EE 131
Query: 554 SNFRVIHRDLKASNILLDNELNP--------KISDFGMAKLFRKDVDEANTGRIVGTYGY 605
+ IH ++ A NILL E + K+SD G++
Sbjct: 132 NTL--IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-----------DILQ 178
Query: 606 VP-----PEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTS--ENLNFLEYAFEQ 657
PE ++ ++ D +SFG L +I S L F E
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQFYE----- 232
Query: 658 WKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
+ P +L N + C+ P+ RPS + L
Sbjct: 233 ----DRHQLPAP------KAAELANLI---NNCMDYEPDHRPSFRAIIRDLNS 272
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-37
Identities = 78/278 (28%), Positives = 124/278 (44%), Gaps = 42/278 (15%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
+G+G FG V G+ RG + AVK + +T + F E S+ +L+H NL+++LG
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 501 TERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
E ++ EY+ SL YL R VL + V + + YL E +NF +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL-EGNNF--V 311
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKG 614
HRDL A N+L+ + K+SDFG+ K+ G +P PE +++
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLT----KEASSTQDT------GKLPVKWTAPEALREK 361
Query: 615 IYSMKYDVYSFGVLLLQIISSKRNARYYGTS--ENLNFLEYAFEQWKDSKGKEFIDPSLD 672
+S K DV+SFG+LL +I S R Y + + +E KG + P
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVP-YPRIPLKDVVPRVE---------KGYKMDAPDG- 410
Query: 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P + + M C + RP+ L++ L+
Sbjct: 411 ---CPPAVYDVM---KNCWHLDAATRPTFLQLREQLEH 442
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 79/278 (28%), Positives = 123/278 (44%), Gaps = 42/278 (15%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
+G+G FG V G+ RG + AVK + +T + F E S+ +L+H NL+++LG
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 501 TERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
E ++ EY+ SL YL R VL + V + + YL E +NF +
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL-EGNNF--V 139
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKG 614
HRDL A N+L+ + K+SDFG+ K+ G +P PE +++
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLT----KEASSTQDT------GKLPVKWTAPEALREK 189
Query: 615 IYSMKYDVYSFGVLLLQIISSKRNARYYGTS--ENLNFLEYAFEQWKDSKGKEFIDPSLD 672
+S K DV+SFG+LL +I S R Y + + +E KG + P
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVP-YPRIPLKDVVPRVE---------KGYKMDAPDG- 238
Query: 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P + M C + RPS L++ L+
Sbjct: 239 ---CPPAVYEVM---KNCWHLDAAMRPSFLQLREQLEH 270
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 76/304 (25%), Positives = 138/304 (45%), Gaps = 53/304 (17%)
Query: 441 NKLGEGGFGPVYKG---NLPRGQEF---AVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
+LGEG FG V+ NL ++ AVK L + ++F+ E L LQH +++
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYL-------------FDPIRRYVLDWQKRVNIIE 541
+ G C + D ++++EY+ + L+ +L + L + ++I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
+ G++YL ++ +HRDL N L+ L KI DFGM+ +DV + R VG
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS----RDVYSTDYYR-VG 192
Query: 602 TYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR--YYGTSENLNFLEYA 654
+ +P PE + ++ + DV+SFGV+L +I + + ++ S N +E
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT---YGKQPWFQLS-NTEVIECI 248
Query: 655 FEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMA 714
++G+ P P ++ + M L C Q P+ R ++ E+ +L ++
Sbjct: 249 ------TQGRVLERP----RVCPKEVYDVM---LGCWQREPQQRLNIKEIYKIL--HALG 293
Query: 715 IAAP 718
A P
Sbjct: 294 KATP 297
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 88/277 (31%), Positives = 138/277 (49%), Gaps = 36/277 (12%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
+LG G FG V+ G + AVK L S + F E +L +LQH L+R+
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
T+ + +I EY+ N SL +L P L K +++ + +G+ ++ E N+ IH
Sbjct: 78 TQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFI-EERNY--IH 132
Query: 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGI 615
RDL+A+NIL+ + L+ KI+DFG+A+L + A G P PE + G
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG------AKFPIKWTAPEAINYGT 186
Query: 616 YSMKYDVYSFGVLLLQIISSKRNARYYGTS--ENLNFLEYAFEQWKDSKGKEFIDPSLDD 673
+++K DV+SFG+LL +I++ R Y G + E + LE +G + P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIP-YPGMTNPEVIQNLE---------RGYRMVRPDN-- 234
Query: 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P +L M LC +E PEDRP+ + S+L+D
Sbjct: 235 --CPEELYQLM---RLCWKERPEDRPTFDYLRSVLED 266
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 52/297 (17%)
Query: 441 NKLGEGGFGPVYKG---NLPRGQEF---AVKRLSATST-QGLEEFKNEVSLTARLQHVNL 493
+LGE FG VYKG G++ A+K L + EEF++E L ARLQH N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYL-------------FDPIRRYVLDWQKRVNII 540
+ +LG T+ +I+ Y + L +L D + L+ V+++
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
+ G+ YL S+ V+H+DL N+L+ ++LN KISD G+ ++V A+ ++
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLF----REVYAADYYKL- 186
Query: 601 GTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS--ENLNFLEY 653
+P PE + G +S+ D++S+GV+L ++ S Y G S + + +
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-YCGYSNQDVVEMIR- 244
Query: 654 AFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
+ P P + M + C E P RP ++ S L+
Sbjct: 245 --------NRQVLPCP----DDCPAWVYALM---IECWNEFPSRRPRFKDIHSRLRA 286
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 69/288 (23%), Positives = 120/288 (41%), Gaps = 51/288 (17%)
Query: 441 NKLGEGGFGPVYKGNL-PRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLL 494
LG G FG VYKG P G++ A+K L ATS + +E +E + A + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
R+LG C LI + +P L Y+ + + + Q +N + +G+ YL++
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLED-R 136
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PE 609
+HRDL A N+L+ + KI+DFG+AKL + E + G VP E
Sbjct: 137 RL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALE 189
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669
+ IY+ + DV+S+GV + ++++ +G+ + + E
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT-------FGS-----------KPYDGIPASEISS- 230
Query: 670 SLDD-------SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
L+ + M C + + RP E+
Sbjct: 231 ILEKGERLPQPPICTIDVYMIM---RKCWMIDADSRPKFRELIIEFSK 275
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-37
Identities = 72/285 (25%), Positives = 134/285 (47%), Gaps = 45/285 (15%)
Query: 442 KLGEGGFGPVYKG--NLPRGQEF---AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLR 495
+G G FG VYKG G++ A+K L + + + +F E + + H N++R
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
+ G ++ M+I EY+ N +LD +L + + + V ++ G+ G+ YL N
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLAN-MN 167
Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEY 610
+ +HRDL A NIL+++ L K+SDFG++++ D + T G G +P PE
Sbjct: 168 Y--VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS--G--GKIPIRWTAPEA 221
Query: 611 VKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID-- 668
+ ++ DV+SFG+++ ++++ YG E + + + + + I+
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMT-------YG--------ERPYWELSNHEVMKAINDG 266
Query: 669 ---PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P+ D P + M + C Q+ RP ++ S+L
Sbjct: 267 FRLPTPMD--CPSAIYQLM---MQCWQQERARRPKFADIVSILDK 306
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 76/285 (26%), Positives = 129/285 (45%), Gaps = 44/285 (15%)
Query: 441 NKLGEGGFGPVYKG--NLPRGQEF--AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLR 495
+G G FG V G LP +E A+K L + + +F E S+ + H N++R
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
+ G T+ M++ EY+ N SLD +L + V ++ G+ G+ YL
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYL-SDMG 167
Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEY 610
+ +HRDL A NIL+++ L K+SDFG+ ++ D + A T G +P PE
Sbjct: 168 Y--VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT----TRGGKIPIRWTSPEA 221
Query: 611 VKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID-- 668
+ ++ DV+S+G++L +++S YG E + + + + +D
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMS-------YG--------ERPYWEMSNQDVIKAVDEG 266
Query: 669 ---PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P D P L M L C Q++ +RP ++ S+L
Sbjct: 267 YRLPPPMD--CPAALYQLM---LDCWQKDRNNRPKFEQIVSILDK 306
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 72/285 (25%), Positives = 125/285 (43%), Gaps = 42/285 (14%)
Query: 441 NKLGEGGFGPVYKGNL--PRGQEF--AVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLR 495
+G G FG VY G L G++ AVK L+ + G + +F E + H N+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 496 VLGYCTERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
+LG C + + +++ Y+ + L ++ + + + + V +G+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLAS-K 147
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG-TYGYVP-----P 608
F +HRDL A N +LD + K++DFG+A +D+ + + T +P
Sbjct: 148 KF--VHRDLAARNCMLDEKFTVKVADFGLA----RDMYDKEYYSVHNKTGAKLPVKWMAL 201
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR-YYGTS--ENLNFLEYAFEQWKDSKGKE 665
E ++ ++ K DV+SFGVLL ++++ R A Y + + +L +G+
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL---------QGRR 250
Query: 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
+ P P L M L C E RPS E+ S +
Sbjct: 251 LLQP----EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 288
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 75/285 (26%), Positives = 127/285 (44%), Gaps = 44/285 (15%)
Query: 441 NKLGEGGFGPVYKGNL--PRGQEF--AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLR 495
+G G G V G L P ++ A+K L + + + +F +E S+ + H N++R
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
+ G T M++ EY+ N SLD +L + V ++ GV G+ YL
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYL-SDLG 171
Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEY 610
+ +HRDL A N+L+D+ L K+SDFG++++ D D A T T G +P PE
Sbjct: 172 Y--VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT----TTGGKIPIRWTAPEA 225
Query: 611 VKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID-- 668
+ +S DV+SFGV++ ++++ YG E + + ++
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA-------YG--------ERPYWNMTNRDVISSVEEG 270
Query: 669 ---PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P+ P L M L C ++ RP ++ S+L
Sbjct: 271 YRLPAPMG--CPHALHQLM---LDCWHKDRAQRPRFSQIVSVLDA 310
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 80/291 (27%), Positives = 119/291 (40%), Gaps = 46/291 (15%)
Query: 441 NKLGEGGFGPVYKG---NLPRGQEF---AVKRLSATST-QGLEEFKNEVSLTARLQHVNL 493
LG G FG VY+G +P AVK L + Q +F E + ++ H N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYL----FDPIRRYVLDWQKRVNIIEGVTQGLLY 549
+R +G + ++ E + L +L P + L +++ + G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 550 LQEYSNFRVIHRDLKASNILLDNE---LNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
L E ++F IHRD+ A N LL KI DFGMA +D+ A+ R G +
Sbjct: 156 L-EENHF--IHRDIAARNCLLTCPGPGRVAKIGDFGMA----RDIYRASYYR-KGGCAML 207
Query: 607 P-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS--ENLNFLEYAFEQWK 659
P PE +GI++ K D +SFGVLL +I S Y S E L F+
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLEFVT------- 259
Query: 660 DSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
G P + P + M C Q PEDRP+ + ++
Sbjct: 260 --SGGRMDPP----KNCPGPVYRIM---TQCWQHQPEDRPNFAIILERIEY 301
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 75/285 (26%), Positives = 119/285 (41%), Gaps = 48/285 (16%)
Query: 442 KLGEGGFGPVYKGNLPRGQEF---AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLRVL 497
+LG G FG V +G ++ A+K L T EE E + +L + ++R++
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
G C + ML+ E L +L +R + ++ V+ G+ YL E NF
Sbjct: 77 GVCQA-EALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL-EEKNF- 131
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGRIVGTYGYVP-----PEY 610
+HRDL A N+LL N KISDFG++K D A + G P PE
Sbjct: 132 -VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA------GKWPLKWYAPEC 184
Query: 611 VKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID-- 668
+ +S + DV+S+GV + + +S YG + +++ K + FI+
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALS-------YG--------QKPYKKMKGPEVMAFIEQG 229
Query: 669 ---PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
+ P +L M C EDRP L V ++
Sbjct: 230 KRMECPPE--CPPELYALM---SDCWIYKWEDRPDFLTVEQRMRA 269
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 77/284 (27%), Positives = 122/284 (42%), Gaps = 46/284 (16%)
Query: 442 KLGEGGFGPVYKGNLPRGQEF---AVKRL--SATSTQGLEEFKNEVSLTARLQHVNLLRV 496
+LG G FG V KG + AVK L A +E E ++ +L + ++R+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
+G C + ML+ E L+ YL + + + + ++ V+ G+ YL E SNF
Sbjct: 84 IGICEA-ESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL-EESNF 138
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYV 611
+HRDL A N+LL + KISDFG++K R D + G P PE +
Sbjct: 139 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH----GKWPVKWYAPECI 192
Query: 612 KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID--- 668
+S K DV+SFGVL+ + S YG + + K S+ ++
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFS-------YG--------QKPYRGMKGSEVTAMLEKGE 237
Query: 669 --PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P ++ + M LC + E+RP V L++
Sbjct: 238 RMGCPAG--CPREMYDLM---NLCWTYDVENRPGFAAVELRLRN 276
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 75/289 (25%), Positives = 112/289 (38%), Gaps = 52/289 (17%)
Query: 442 KLGEGGFGPVYKG--NLPRGQEF--AVKRL---SATSTQGLEEFKNEVSLTARLQHVNLL 494
KLG+G FG V +G + P G+ AVK L + + +++F EV+ L H NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
R+ G ++ E P SL L + V +G+ YL E
Sbjct: 85 RLYGVVLT-PPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYL-ESK 140
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PE 609
F IHRDL A N+LL KI DFG+ + ++ D VP PE
Sbjct: 141 RF--IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH----RKVPFAWCAPE 194
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669
+K +S D + FGV L ++ + Y E W G + +
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFT------------------YGQEPWIGLNGSQILH- 235
Query: 670 SLDDS--------SSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
+D P + N M + C PEDRP+ + + L +
Sbjct: 236 KIDKEGERLPRPEDCPQDIYNVM---VQCWAHKPEDRPTFVALRDFLLE 281
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 77/332 (23%), Positives = 138/332 (41%), Gaps = 57/332 (17%)
Query: 441 NKLGEGGFGPVYKGNL-PRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLL 494
LG G FG VYKG P G++ A+K L ATS + +E +E + A + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
R+LG C LI + +P L Y+ + + + Q +N + +G+ YL++
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLED-R 136
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PE 609
+HRDL A N+L+ + KI+DFG+AKL + E + G VP E
Sbjct: 137 RL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALE 189
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669
+ IY+ + DV+S+GV + ++++ +G+ + E
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT-------FGSKP-----------YDGIPASEISS- 230
Query: 670 SLDD-------SSSPCKLLNCMQVALLCVQENPEDRPS----MLEVSSMLKDDS--MAIA 716
L+ + M + C + + RP ++E S M +D + I
Sbjct: 231 ILEKGERLPQPPICTIDVYMIM---VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 287
Query: 717 APKRPAFSAKGDENAETSSTSRQEIYSFNDPE 748
+R + D N + +++ D +
Sbjct: 288 GDERMHLPSPTDSNFYRALMDEEDMDDVVDAD 319
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-35
Identities = 87/349 (24%), Positives = 131/349 (37%), Gaps = 48/349 (13%)
Query: 383 YFRRTAIKSKVMIILGRRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANK 442
YF+ LRT T + + ++ N +
Sbjct: 21 YFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPR--KNITLIRG 78
Query: 443 LGEGGFGPVYKG---NLPRGQEF---AVKRLSATST-QGLEEFKNEVSLTARLQHVNLLR 495
LG G FG VY+G +P AVK L + Q +F E + ++ H N++R
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYL----FDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
+G + ++ E + L +L P + L +++ + G YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197
Query: 552 EYSNFRVIHRDLKASNILLDNE---LNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP- 607
E ++F IHRD+ A N LL KI DFGMA +D+ A R G +P
Sbjct: 198 EENHF--IHRDIAARNCLLTCPGPGRVAKIGDFGMA----RDIYRAGYYR-KGGCAMLPV 250
Query: 608 ----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS--ENLNFLEYAFEQWKDS 661
PE +GI++ K D +SFGVLL +I S Y S E L F+
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLEFVT--------- 300
Query: 662 KGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
G P + P + M C Q PEDRP+ + ++
Sbjct: 301 SGGRMDPP----KNCPGPVYRIM---TQCWQHQPEDRPNFAIILERIEY 342
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 78/292 (26%), Positives = 132/292 (45%), Gaps = 46/292 (15%)
Query: 441 NKLGEGGFGPVYKG---NLPRGQEF---AVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
+LG+G FG VY+G + + + A+K ++ ++ EF NE S+ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYL-------FDPIRRYVLDWQKRVNIIEGVTQG 546
+R+LG ++ ++I E + L YL + K + + + G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
+ YL + + +HRDL A N ++ + KI DFGM +D+ E + R G G +
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMT----RDIYETDYYR-KGGKGLL 202
Query: 607 P-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS--ENLNFLEYAFEQWK 659
P PE +K G+++ DV+SFGV+L +I + Y G S + L F+
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVM------- 254
Query: 660 DSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711
+G P + P L M +C Q NP+ RPS LE+ S +K++
Sbjct: 255 --EGGLLDKP----DNCPDMLFELM---RMCWQYNPKMRPSFLEIISSIKEE 297
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 66/284 (23%), Positives = 116/284 (40%), Gaps = 40/284 (14%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEF----AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLR 495
+G+G FG VY G + A+K L T Q +E F E L L H N+L
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 496 VLGYCTERDE-NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
++G + ++ Y+ + L ++ P + + ++ V +G+ YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYL-AEQ 143
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN-TGRIVGTYGYVP-----P 608
F +HRDL A N +LD K++DFG+A +D+ + + +P
Sbjct: 144 KF--VHRDLAARNCMLDESFTVKVADFGLA----RDILDREYYSVQQHRHARLPVKWTAL 197
Query: 609 EYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS--ENLNFLEYAFEQWKDSKGKEF 666
E ++ ++ K DV+SFGVLL ++++ Y + +FL +G+
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPP-YRHIDPFDLTHFLA---------QGRRL 247
Query: 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P P L M C + +P RP+ + ++
Sbjct: 248 PQP----EYCPDSLYQVM---QQCWEADPAVRPTFRVLVGEVEQ 284
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-35
Identities = 78/328 (23%), Positives = 138/328 (42%), Gaps = 42/328 (12%)
Query: 398 GRRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNL- 456
G NL G +T + + +Q I ++ +G G FG VY G L
Sbjct: 52 GSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLL 111
Query: 457 -PRGQEF--AVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVLGYCTERDEN-MLIYE 511
G++ AVK L+ + G + +F E + H N+L +LG C + + +++
Sbjct: 112 DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171
Query: 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD 571
Y+ + L ++ + + + + V +G+ +L F +HRDL A N +LD
Sbjct: 172 YMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLAS-KKF--VHRDLAARNCMLD 226
Query: 572 NELNPKISDFGMAKLFRKDVDEANTGRIV-GTYGYVP-----PEYVKKGIYSMKYDVYSF 625
+ K++DFG+A +D+ + + T +P E ++ ++ K DV+SF
Sbjct: 227 EKFTVKVADFGLA----RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 282
Query: 626 GVLLLQIISSKRNAR-YYGTS--ENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLN 682
GVLL ++++ R A Y + + +L +G+ + P P L
Sbjct: 283 GVLLWELMT--RGAPPYPDVNTFDITVYLL---------QGRRLLQP----EYCPDPLYE 327
Query: 683 CMQVALLCVQENPEDRPSMLEVSSMLKD 710
M L C E RPS E+ S +
Sbjct: 328 VM---LKCWHPKAEMRPSFSELVSRISA 352
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 66/284 (23%), Positives = 112/284 (39%), Gaps = 47/284 (16%)
Query: 442 KLGEGGFGPVYKG--NLPRGQEF--AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLRV 496
LGEG FG VY+G +G++ AVK + E+F +E + L H +++++
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
+G E + +I E P L YL + L V + + + YL E N
Sbjct: 79 IGIIEE-EPTWIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYL-ESINC 134
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYV 611
+HRD+ NIL+ + K+ DFG+++ + + +P PE +
Sbjct: 135 --VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV------TRLPIKWMSPESI 186
Query: 612 KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID--- 668
++ DV+ F V + +I+S +G + F ++ ++
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILS-------FG--------KQPFFWLENKDVIGVLEKGD 231
Query: 669 --PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P D P L M C +P DRP E+ L D
Sbjct: 232 RLPKPDL--CPPVLYTLM---TRCWDYDPSDRPRFTELVCSLSD 270
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-35
Identities = 66/284 (23%), Positives = 113/284 (39%), Gaps = 47/284 (16%)
Query: 442 KLGEGGFGPVYKGNL--PRGQEF--AVKRLSA-TSTQGLEEFKNEVSLTARLQHVNLLRV 496
+GEG FG V++G P A+K TS E+F E + H +++++
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
+G TE + +I E L +L R+Y LD + ++ L YL E F
Sbjct: 82 IGVITE-NPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYL-ESKRF 137
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYV 611
+HRD+ A N+L+ + K+ DFG+++ + G +P PE +
Sbjct: 138 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK------GKLPIKWMAPESI 189
Query: 612 KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID--- 668
++ DV+ FGV + +I+ +G F+ K++ I+
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILM-------HG--------VKPFQGVKNNDVIGRIENGE 234
Query: 669 --PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P + P L + M C +P RP E+ + L
Sbjct: 235 RLPMPPN--CPPTLYSLM---TKCWAYDPSRRPRFTELKAQLST 273
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 48/292 (16%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEF----AVKRL--SATSTQGLEEFKNEVSLTARLQHVNLL 494
LGEG FG V +GNL + AVK + +S + +EEF +E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 495 RVLGYCTERD-----ENMLIYEYLPNKSLDLYL---FDPIRRYVLDWQKRVNIIEGVTQG 546
R+LG C E + M+I ++ L YL + Q + + + G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
+ YL SN +HRDL A N +L +++ ++DFG++ K + + R G +
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLS----KKIYSGDYYR-QGRIAKM 211
Query: 607 P-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR-YYGTS--ENLNFLEYAFEQW 658
P E + +Y+ K DV++FGV + +I + R Y G E ++L
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGMTPYPGVQNHEMYDYLL------ 263
Query: 659 KDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
G P +L M C + +P DRP+ + L+
Sbjct: 264 ---HGHRLKQP----EDCLDELYEIM---YSCWRTDPLDRPTFSVLRLQLEK 305
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 65/292 (22%), Positives = 117/292 (40%), Gaps = 47/292 (16%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEF----AVKRL--SATSTQGLEEFKNEVSLTARLQHVNLL 494
LG+G FG V + L + AVK L ++ +EEF E + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 495 RVLGYCTERDEN------MLIYEYLPNKSLDLYLFD---PIRRYVLDWQKRVNIIEGVTQ 545
+++G M+I ++ + L +L + L Q V + +
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
G+ YL NF IHRDL A N +L ++ ++DFG++ + + + R G
Sbjct: 149 GMEYL-SSRNF--IHRDLAARNCMLAEDMTVCVADFGLS----RKIYSGDYYR-QGCASK 200
Query: 606 VP-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS--ENLNFLEYAFEQW 658
+P E + +Y++ DV++FGV + +I++ + Y G E N+L
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP-YAGIENAEIYNYLI------ 253
Query: 659 KDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
G P ++ + M C +P+ RPS + L++
Sbjct: 254 ---GGNRLKQP----PECMEEVYDLM---YQCWSADPKQRPSFTCLRMELEN 295
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 3e-34
Identities = 74/287 (25%), Positives = 117/287 (40%), Gaps = 52/287 (18%)
Query: 442 KLGEGGFGPVYKGNLPRGQEF---AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLRVL 497
+LG G FG V +G ++ A+K L T EE E + +L + ++R++
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
G C + ML+ E L +L +R + ++ V+ G+ YL E NF
Sbjct: 403 GVCQ-AEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL-EEKNF- 457
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE--ANTGRIVGTYGYVP-----PEY 610
+HR+L A N+LL N KISDFG++K D A + G P PE
Sbjct: 458 -VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA------GKWPLKWYAPEC 510
Query: 611 VKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670
+ +S + DV+S+GV + + +S Y + +K KG E +
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALS------------------YGQKPYKKMKGPEVMA-F 551
Query: 671 LDD-------SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
++ P +L M C EDRP L V ++
Sbjct: 552 IEQGKRMECPPECPPELYALM---SDCWIYKWEDRPDFLTVEQRMRA 595
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEF-----AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLL 494
LG G FG V+KG E +K + + Q + + + L H +++
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
R+LG C L+ +YLP SL ++ R L Q +N + +G+ YL E
Sbjct: 79 RLLGLCPG-SSLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYL-EEH 134
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PE 609
+HR+L A N+LL + +++DFG+A L D + P E
Sbjct: 135 GM--VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKWMALE 187
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIIS 634
+ G Y+ + DV+S+GV + ++++
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 68/307 (22%), Positives = 124/307 (40%), Gaps = 27/307 (8%)
Query: 403 RTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQE 461
++ G P F ++ + NF K+G G F VY+ L G
Sbjct: 4 QSQGMQGPPVPQFQPQKALRPDMGYNTL----ANFRIEKKIGRGQFSEVYRAACLLDGVP 59
Query: 462 FAVKRL---SATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSL 518
A+K++ + + E+ L +L H N+++ E +E ++ E L
Sbjct: 60 VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDL 119
Query: 519 DLYLFDPIRRYVLDWQKRV-NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPK 577
+ ++ L ++ V + L ++ RV+HRD+K +N+ + K
Sbjct: 120 SRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVK 176
Query: 578 ISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637
+ D G+ + F A++ +VGT Y+ PE + + Y+ K D++S G LL ++ + +
Sbjct: 177 LGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234
Query: 638 NARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPED 697
+YG NL L K + P D S Q+ +C+ +PE
Sbjct: 235 P--FYGDKMNLYSLCK-----KIEQCD--YPPLPSDHYSE----ELRQLVNMCINPDPEK 281
Query: 698 RPSMLEV 704
RP + V
Sbjct: 282 RPDVTYV 288
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 69/298 (23%), Positives = 122/298 (40%), Gaps = 50/298 (16%)
Query: 441 NKLGEGGFGPVYKG---NLPRGQEF---AVKRL-SATSTQGLEEFKNEVSLTARL-QHVN 492
LG G FG V + L + AVK L + E +E+ + + L H+N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL---------------FDPIRRYVLDWQKRV 537
++ +LG CT ++I EY L +L LD + +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
+ V +G+ +L ++ IHRDL A NILL + KI DFG+A +D+ +
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA----RDIKNDSNY 201
Query: 598 RIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLE 652
V +P PE + +Y+ + DV+S+G+ L ++ S + Y G + F +
Sbjct: 202 V-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-YPGMPVDSKFYK 259
Query: 653 YAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
+G + P +P ++ + M C +P RP+ ++ +++
Sbjct: 260 MI------KEGFRMLSP----EHAPAEMYDIM---KTCWDADPLKRPTFKQIVQLIEK 304
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 67/277 (24%), Positives = 120/277 (43%), Gaps = 51/277 (18%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
++G G F VYKG + E A + + + FK E + LQH N++R
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 499 YC--TERDENML--IYEYLPNKSLDLYLFDPIRRY-VLDWQKRVNIIEGVTQGLLYLQEY 553
T + + + + E + + +L YL +R+ V+ + + + +GL +L
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHT- 147
Query: 554 SNFRVIHRDLKASNILLDNEL-NPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
+IHRDLK NI + + KI D G+A L R +A ++GT ++ PE +
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEMYE 203
Query: 613 KGIYSMKYDVYSFGVLLLQIISSK------RNAR---YYGTSENLNFLEYAFEQWKDSKG 663
+ Y DVY+FG+ +L++ +S+ +NA TS +F++ +
Sbjct: 204 EK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV---KPASFDKVAIPEV 259
Query: 664 KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPS 700
KE I+ C+++N ++R S
Sbjct: 260 KEIIE--------------------GCIRQNKDERYS 276
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 71/297 (23%), Positives = 120/297 (40%), Gaps = 49/297 (16%)
Query: 441 NKLGEGGFGPVYKG---NLPRGQEF---AVKRL-SATSTQGLEEFKNEVSLTARL-QHVN 492
LG G FG V + + + AVK L + +E+ + + H+N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 493 LLRVLGYCTERDE-NMLIYEYLPNKSLDLYL-------------FDPIRRYVLDWQKRVN 538
++ +LG CT+ M+I E+ +L YL + + + L + +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 539 IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598
V +G+ +L ++ + IHRDL A NILL + KI DFG+A +D+ +
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA----RDIYKDPDYV 205
Query: 599 IVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEY 653
+P PE + +Y+++ DV+SFGVLL +I S + Y G + F
Sbjct: 206 -RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRR 263
Query: 654 AFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
+G P + ++ M L C P RP+ E+ L +
Sbjct: 264 L------KEGTRMRAP----DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 307
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-33
Identities = 77/381 (20%), Positives = 135/381 (35%), Gaps = 63/381 (16%)
Query: 364 LLILLPIGLVLILIASLI-CYFRRTAIKSKVMIILGRRNLRTPGTSTPAAEYFDSDTPNL 422
L + P + +A LI Y R ++ II ++ S P +
Sbjct: 297 LTVTAPSLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRS 356
Query: 423 QVFSFSDIKAAT---------------------NNFSSANKLGEGGFGPVYKGNL--PRG 459
S S+ +GEG FG V++G P
Sbjct: 357 HTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPEN 416
Query: 460 QEF--AVKRL-SATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNK 516
A+K + TS E+F E + H ++++++G TE + +I E
Sbjct: 417 PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLG 475
Query: 517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP 576
L +L R++ LD + ++ L YL E F +HRD+ A N+L+ +
Sbjct: 476 ELRSFLQV--RKFSLDLASLILYAYQLSTALAYL-ESKRF--VHRDIAARNVLVSSNDCV 530
Query: 577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQ 631
K+ DFG+++ + G +P PE + ++ DV+ FGV + +
Sbjct: 531 KLGDFGLSRYMEDSTYYKASK------GKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 584
Query: 632 IISSKRNARYYGTS--ENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALL 689
I+ + G + + +E G+ P + P L + M
Sbjct: 585 ILMHGVKP-FQGVKNNDVIGRIE---------NGERLPMP----PNCPPTLYSLM---TK 627
Query: 690 CVQENPEDRPSMLEVSSMLKD 710
C +P RP E+ + L
Sbjct: 628 CWAYDPSRRPRFTELKAQLST 648
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 73/305 (23%), Positives = 126/305 (41%), Gaps = 60/305 (19%)
Query: 441 NKLGEGGFGPVYKG---NLPRGQEF---AVKRLSATST-QGLEEFKNEVSLTARLQHVNL 493
+GEG FG V++ L + F AVK L ++ +F+ E +L A + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYL---------------------FDPIRRYVLD 532
+++LG C L++EY+ L+ +L L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 533 WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592
+++ I V G+ YL S + +HRDL N L+ + KI+DFG++ +++
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLS----RNIY 225
Query: 593 EANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNAR--YYGTS 645
A+ + +P PE + Y+ + DV+++GV+L +I S YYG +
Sbjct: 226 SADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY---GLQPYYGMA 281
Query: 646 ENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVS 705
+ + Y G P + P +L N M LC + P DRPS +
Sbjct: 282 -HEEVIYYV------RDGNILACP----ENCPLELYNLM---RLCWSKLPADRPSFCSIH 327
Query: 706 SMLKD 710
+L+
Sbjct: 328 RILQR 332
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 76/300 (25%), Positives = 121/300 (40%), Gaps = 63/300 (21%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEF---AVKRL--SATSTQGLEEFKNEVSLTARL-QHVNLL 494
+ +GEG FG V K + + A+KR+ A+ +F E+ + +L H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-HRDFAGELEVLCKLGHHPNII 89
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYL-------------FDPIRRYVLDWQKRVNIIE 541
+LG C R L EY P+ +L +L L Q+ ++
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
V +G+ YL S + IHRDL A NIL+ KI+DFG++ + + +
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVY----VKK 198
Query: 602 TYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS--ENLNFLEYA 654
T G +P E + +Y+ DV+S+GVLL +I+S Y G + E L
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-YCGMTCAELYEKLP-- 255
Query: 655 FEQWKDSKGKEFIDPSLDDSSSPCKLLNCM----QVALLCVQENPEDRPSMLEVSSMLKD 710
+G P NC + C +E P +RPS ++ L
Sbjct: 256 -------QGYRLEKPL-----------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 72/302 (23%), Positives = 116/302 (38%), Gaps = 56/302 (18%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN 492
++F LG+G FG V K N + +A+K++ T + L +EV L A L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLY----------LFDPIRRYVLDWQKRV--NII 540
++R N + K L+ L+D I L+ Q+ +
Sbjct: 64 VVRYYA-AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI- 599
+ + L Y+ +S +IHRDLK NI +D N KI DFG+AK + +D
Sbjct: 123 RQILEALSYI--HSQ-GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 600 -----------VGTYGYVPPEYVK-KGIYSMKYDVYSFGVLLLQIISSKRNARYYG--TS 645
+GT YV E + G Y+ K D+YS G++ ++I Y T
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--------YPFSTG 231
Query: 646 ENLNFLEYAFEQWKDSKGKEF-IDPSLDDSSSP--CKLLNCMQVALLCVQENPEDRPSML 702
+ K + P DD+ K++ + + +P RP
Sbjct: 232 MERVNI------LKKLRSVSIEFPPDFDDNKMKVEKKIIRLL----IDH--DPNKRPGAR 279
Query: 703 EV 704
+
Sbjct: 280 TL 281
|
| >3arx_A Chitinase A; TIM barrel, inhibitor complex, glycosidase, hydrolase, hydro hydrolase inhibitor complex; HET: POY; 1.16A {Vibrio harveyi} PDB: 3aro_A* 3arp_A* 3arr_A* 3arv_A* 3arw_A* 3arq_A* 3ary_A* 3arz_A* 3b8s_A 3b9e_A 3b9a_A* 3b9d_A 3as2_A* 3ars_A* 3art_A* 3as0_A* 3as1_A* 3aru_A* 3as3_A* Length = 584 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-32
Identities = 74/426 (17%), Positives = 131/426 (30%), Gaps = 139/426 (32%)
Query: 36 GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFA--------------- 80
GR++ + ++ TH++ F + + N A
Sbjct: 151 GRDYTVDNMPVDNLTHILYGFIPICGPNESVKSVGGNSFNALQTACRGVNDYEVVIHDPW 210
Query: 81 -------------------------NSVRRKNPSIKTLLSI--WNGQNSTYQSILGNKNI 113
+++++NP +K + SI W S
Sbjct: 211 AAYQKSFPQAGHEYSTPIKGNYAMLMALKQRNPDLKIIPSIGGWTL--SDP--------- 259
Query: 114 NPSVLSSMVGDSSHRKSFIESSIRTARLYGFQ-GIDLFWLWPNS-----------TDLNS 161
V D +R +F+ S + + + F G+D+ W +P D +
Sbjct: 260 ----FYDFV-DKKNRDTFVASVKKFLKTWKFYDGVDIDWEFPGGGGAAADKGDPVNDGPA 314
Query: 162 LGILLDEWKA-----SASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYH 216
L+ E + A L+ A+ + +++ + YD++
Sbjct: 315 YIALMRELRVMLDELEAETGRTYELTSAIGVGYDK-IEDVDYADAVQYMDYIFAMTYDFY 373
Query: 217 MPSKENVTGIHAALYNPSSNI---------------------STDFGIREWLRRGFPANK 255
NV G ALY S + D GI+ L +G PANK
Sbjct: 374 G-GWNNVPGHQTALYCGSFMRPGQCDGGGVDENGEPYKGPAYTADNGIQLLLAQGVPANK 432
Query: 256 LVLG-------------------------------ARASGPGITIDGSMGYKFIRAFIQN 284
LVLG ++ G+ DG + YK I++F+
Sbjct: 433 LVLGTAMYGRGWEGVTPDTLTDPNDPMTGTATGKLKGSTAQGVWEDGVIDYKGIKSFMLG 492
Query: 285 YGYGAAPVYN--------ASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQ 336
+ A +V N S I FD ++ AK +YAK L G +++
Sbjct: 493 ANNTGINGFEYGYDAQAEAPWVWN--RSTGELITFDDHRSVLAKGNYAKSLGLAGLFSWE 550
Query: 337 LSNDDN 342
+ D+
Sbjct: 551 IDADNG 556
|
| >3cz8_A Putative sporulation-specific glycosylase YDHD; structural genomics, uncharacterized protein, protein struct initiative, PSI-2; 2.20A {Bacillus subtilis subsp} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 43/334 (12%), Positives = 110/334 (32%), Gaps = 50/334 (14%)
Query: 31 GYWLAGREFP----LSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRK 86
+++ ++D + I + + ++ A + + +R+
Sbjct: 12 SFYVLRNPDLDRELINDYAPYSSSISIFEYHIAPNGDIANQLNDA-----AAIETTWQRR 66
Query: 87 NPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQG 146
+ T+ ++ + + ++ ++ + + R + + + G+ G
Sbjct: 67 VTPLATITNL------------TSGGFSTEIVHQVLNNPTARTNLVNNIYDLVSTRGYGG 114
Query: 147 IDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAV---RYSPTHETVSYPIDSMKK 203
+ + + ++ D + L + + L++AV Y +
Sbjct: 115 VTIDFEQVSAADRDLFTGFLRQLRD-RLQAGGYVLTIAVPAKTSDNIPWLRGYDYGGIGA 173
Query: 204 NLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGA--- 260
+N+ ++AYD+H E G A + I E+ P+ K+++G
Sbjct: 174 VVNYMFIMAYDWHHAGSE--PGPVAPITEIRRTI-------EFTIAQVPSRKIIIGVPLY 224
Query: 261 ----RASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFT-----SGATWINF 311
T+ ++ + Y A Y+A Y F + F
Sbjct: 225 GYDWIIPYQPGTVASAISNQNAIERAMR--YQAPIQYSAEYQSPFFRYSDQQGRTHEVWF 282
Query: 312 DGVETIKAKISYAKEKNLLGYKAFQLSNDD--NW 343
+GV ++ K+ +E L A+QL+ + +
Sbjct: 283 EGVRSMSRKMQIVREYRLQAIGAWQLTLAEGHHH 316
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 4e-32
Identities = 76/294 (25%), Positives = 122/294 (41%), Gaps = 46/294 (15%)
Query: 441 NKLGEGGFGPVYKG---NLPRGQEF---AVKRL-SATSTQGLEEFKNEVSLTARL-QHVN 492
LG G FG V + L + AVK L S E +E+ + + L QH N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYL-----------FDPIRRYVLDWQKRVNIIE 541
++ +LG CT ++I EY L +L I + ++
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
V QG+ +L ++ IHRD+ A N+LL N KI DFG+A +D+ + V
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA----RDIMNDSNYI-VK 223
Query: 602 TYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFE 656
+P PE + +Y+++ DV+S+G+LL +I S N Y G N F +
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP-YPGILVNSKFYKLV-- 280
Query: 657 QWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
G + P + +P + + M C P RP+ ++ S L++
Sbjct: 281 ----KDGYQMAQP----AFAPKNIYSIM---QACWALEPTHRPTFQQICSFLQE 323
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 71/300 (23%), Positives = 125/300 (41%), Gaps = 55/300 (18%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEF--------AVKRL-SATSTQGLEEFKNEVSLTARL-QH 490
LGEG FG V + AVK L + + L + +E+ + + +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYL-------------FDPIRRYVLDWQKRV 537
N++ +LG CT+ +I EY +L YL + + + ++ V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
+ + +G+ YL ++ + IHRDL A N+L+ KI+DFG+A +D++ +
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA----RDINNIDYY 213
Query: 598 RIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS--ENLNF 650
+ T G +P PE + +Y+ + DV+SFGVL+ +I + + Y G E
Sbjct: 214 K-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKL 271
Query: 651 LEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
L+ +G P ++ +L M C P RP+ ++ L
Sbjct: 272 LK---------EGHRMDKP----ANCTNELYMMM---RDCWHAVPSQRPTFKQLVEDLDR 315
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 58/294 (19%), Positives = 112/294 (38%), Gaps = 45/294 (15%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS-ATSTQGLEEFKNEVSLTARLQHVN 492
+F LG GGFG V++ N +A+KR+ E+ EV A+L+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 493 LLRVLGYCTERDE---------NMLIY---EYLPNKSLDLYLFDPIRRYVLDWQKRVNII 540
++R E++ + +Y + ++L ++ + ++I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR-- 598
+ + + +L ++HRDLK SNI + K+ DFG+ +D +E
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 599 --------IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNF 650
VGT Y+ PE + YS K D++S G++L +++ + E +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-----PFSTQMERV-- 234
Query: 651 LEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
D + +F ++ M + +P +RP + +
Sbjct: 235 -----RTLTDVRNLKFPPLFTQKYPCEYVMVQDM------LSPSPMERPEAINI 277
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 71/300 (23%), Positives = 125/300 (41%), Gaps = 55/300 (18%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEF--------AVKRL-SATSTQGLEEFKNEVSLTARL-QH 490
LGEG FG V + AVK L + + L + +E+ + + +H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYL-------------FDPIRRYVLDWQKRV 537
N++ +LG CT+ +I EY +L YL + + + ++ V
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
+ + +G+ YL ++ + IHRDL A N+L+ KI+DFG+A +D++ +
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA----RDINNIDYY 259
Query: 598 RIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS--ENLNF 650
+ T G +P PE + +Y+ + DV+SFGVL+ +I + + Y G E
Sbjct: 260 K-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKL 317
Query: 651 LEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
L+ +G P ++ +L M C P RP+ ++ L
Sbjct: 318 LK---------EGHRMDKP----ANCTNELYMMM---RDCWHAVPSQRPTFKQLVEDLDR 361
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 77/307 (25%), Positives = 132/307 (42%), Gaps = 64/307 (20%)
Query: 441 NKLGEGGFGPVYKG---NLPRGQEF---AVKRLSATSTQG-LEEFKNEVSLTARLQHVNL 493
LGEG FG V K +L + AVK L ++ L + +E ++ ++ H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYL---------------------FDPIRRYVLD 532
+++ G C++ +LI EY SL +L D L
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 533 WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592
++ ++QG+ YL + +++HRDL A NIL+ KISDFG++ +DV
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLS----RDVY 201
Query: 593 EANTGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS-- 645
E ++ + G +P E + IY+ + DV+SFGVLL +I++ N Y G
Sbjct: 202 EEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-YPGIPPE 259
Query: 646 ENLNFLE--YAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLE 703
N L+ + E+ P + ++ M L C ++ P+ RP +
Sbjct: 260 RLFNLLKTGHRMER-----------P----DNCSEEMYRLM---LQCWKQEPDKRPVFAD 301
Query: 704 VSSMLKD 710
+S L+
Sbjct: 302 ISKDLEK 308
|
| >3sim_A Protein, family 18 chitinase; family 18 plant chitinase, TIM barrel, chitin binding, glyco hydrolase, hydrolase; 2.10A {Crocus vernus} Length = 275 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 32/241 (13%), Positives = 79/241 (32%), Gaps = 27/241 (11%)
Query: 30 AGY-WLAGREFPLSDINSALFT-HLICAFAEVDSSTYQLSISSANQQYFSIFA------- 80
GY +G +F IN + + +FA +++ + ++ F +
Sbjct: 7 IGYPLFSGVKFSDVPINPHITKFQFVLSFAVDYTASSPHTSTNGKFNVFWDSSILGPDQI 66
Query: 81 NSVRRKNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRT 138
++++ +P+++ +S+ + ++T Q S + + S R
Sbjct: 67 SAIKSSHPNVRVAVSLGGASVGSNTVQF-------------QAASVDSWVSNAVTSLTRI 113
Query: 139 ARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPI 198
+ Y GID+ + +TD N+ + + + ++ SP Y +
Sbjct: 114 IQRYNLDGIDIDYEHFQNTDKNTFAECIGRLIT-TLKKNGVISFASI--SPFPSVDEYYL 170
Query: 199 DSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVL 258
+ N + + Y + YN +++ + G L +
Sbjct: 171 ALFNEYKNAINHINYQFKAYDSSTSVDKFLGYYNNAASKYKGGNVLISFSTGPHPGGLPV 230
Query: 259 G 259
Sbjct: 231 D 231
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 70/308 (22%), Positives = 113/308 (36%), Gaps = 59/308 (19%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
KLGEGGF V L G +A+KR+ Q EE + E + H N+LR++ YC
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 501 TERDENM----LIYEYLPNKSLDLYLFDPIRRYVLDWQ----KRV-NIIEGVTQGLLYLQ 551
L+ + +L ++ I R ++ ++ G+ +GL +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTL----WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH 151
Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV-------GTYG 604
HRDLK +NILL +E P + D G V+ + + T
Sbjct: 152 AK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 605 YVPPEYVKKGIYSM---KYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDS 661
Y PE + + + DV+S G +L Y + F E ++
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVL-----------YA-----MMFGEGPYDMVFQK 252
Query: 662 KG-------KEFIDPSLDDSSSPCK-LLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713
+ P SS LLN M + +P RP + + S L +++
Sbjct: 253 GDSVALAVQNQLSIPQSPRHSSALWQLLNSM------MTVDPHQRPHIPLLLSQL--EAL 304
Query: 714 AIAAPKRP 721
AP +
Sbjct: 305 QPPAPGQH 312
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-31
Identities = 77/300 (25%), Positives = 123/300 (41%), Gaps = 55/300 (18%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEF--------AVKRL-SATSTQGLEEFKNEVSLTARL-QH 490
LGEG FG V + AVK L S + + L + +E+ + + +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYL-------------FDPIRRYVLDWQKRV 537
N++ +LG CT+ +I EY +L YL L + V
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 538 NIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
+ V +G+ YL ++ + IHRDL A N+L+ + KI+DFG+A +D+ +
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RDIHHIDYY 247
Query: 598 RIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS--ENLNF 650
+ T G +P PE + IY+ + DV+SFGVLL +I + + Y G E
Sbjct: 248 K-KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFKL 305
Query: 651 LEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
L+ +G P S+ +L M C P RP+ ++ L
Sbjct: 306 LK---------EGHRMDKP----SNCTNELYMMM---RDCWHAVPSQRPTFKQLVEDLDR 349
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-31
Identities = 73/300 (24%), Positives = 120/300 (40%), Gaps = 49/300 (16%)
Query: 441 NKLGEGGFGPVYKG---NLPRGQEF---AVKRL-SATSTQGLEEFKNEVSLTARL-QHVN 492
LG G FG V + + AVK L + E +E+ + +L H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLF---DPIRRYVLDWQKRVNIIEGVTQGLLY 549
++ +LG CT LI+EY L YL + ++++ + + E +L
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 550 LQEYSNF--------------RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
++ F +HRDL A N+L+ + KI DFG+A +D+ +
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA----RDIMSDS 226
Query: 596 TGRIVGTYGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNF 650
V +P PE + +GIY++K DV+S+G+LL +I S N Y G + NF
Sbjct: 227 NYV-VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-YPGIPVDANF 284
Query: 651 LEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
+ G + P + ++ M C + RPS ++S L
Sbjct: 285 YKLI------QNGFKMDQP----FYATEEIYIIM---QSCWAFDSRKRPSFPNLTSFLGC 331
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 65/262 (24%), Positives = 112/262 (42%), Gaps = 23/262 (8%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
LG+G +G VY G +L A+K + ++ + E++L L+H N+++ LG +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHR 561
E + E +P SL L + Q + + +GL YL + +++HR
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146
Query: 562 DLKASNILLDNEL-NPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI--YSM 618
D+K N+L++ KISDFG +K T GT Y+ PE + KG Y
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYGK 204
Query: 619 KYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPC 678
D++S G ++++ + K +Y E + +K K P + +S S
Sbjct: 205 AADIWSLGCTIIEMATGKPP--FYELGEPQAAM------FKVGMFKV--HPEIPESMSA- 253
Query: 679 KLLNCMQVALLCVQENPEDRPS 700
L C + +P+ R
Sbjct: 254 ---EAKAFILKCFEPDPDKRAC 272
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-30
Identities = 62/284 (21%), Positives = 115/284 (40%), Gaps = 42/284 (14%)
Query: 436 NFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLL 494
+F + LG G G + + ++ AVKR+ + EV L +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVI 81
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLY---LFDPI--RRYVLDWQKRVNIIEGVTQGLLY 549
R +CTE+D Y+ +++L L + + + + + + +++ T GL +
Sbjct: 82 RY--FCTEKDRQFQ---YI---AIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 550 LQEYSNFRVIHRDLKASNILLDN-----ELNPKISDFGMAKLFRKDVDE-ANTGRIVGTY 603
L ++HRDLK NIL+ ++ ISDFG+ K + + GT
Sbjct: 134 LHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 604 GYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKD 660
G++ PE + K + D++S G + +IS + N L A
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS---- 246
Query: 661 SKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
+ + P + +L+ M + + +P+ RPS V
Sbjct: 247 ---LDCLHPEKHEDVIARELIEKM----IAM--DPQKRPSAKHV 281
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 69/286 (24%), Positives = 118/286 (41%), Gaps = 47/286 (16%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
+F +G GGFG V+K + G+ + +KR+ + E+ + EV A+L HVN+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLD--LY----------LFDPIRRY---VLDWQKRVN 538
+ G D + ++S L+ L I + LD +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 539 IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598
+ E +T+G+ Y+ ++I+RDLK SNI L + KI DFG+ + D +
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKRTR-- 180
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQW 658
GT Y+ PE + Y + D+Y+ G++L +++ A + TS+
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA--FETSKFFT--------- 229
Query: 659 KDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
G I LL + + + PEDRP+ E+
Sbjct: 230 DLRDGI--ISDIF--DKKEKTLLQKL------LSKKPEDRPNTSEI 265
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-30
Identities = 60/280 (21%), Positives = 120/280 (42%), Gaps = 39/280 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHV 491
+ K+GEG FG + G+++ +K +S S++ EE + EV++ A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYL----FDPIR-RYVLDW--QKRVNIIEGVT 544
N+++ E ++ +Y L + + +LDW Q +
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ--------IC 135
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
L ++ + +++HRD+K+ NI L + ++ DFG+A++ V+ A +GT
Sbjct: 136 LALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPY 190
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664
Y+ PE + Y+ K D+++ G +L ++ + K + ++ L K G
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHA--FEAG--SMKNLVL-----KIISGS 241
Query: 665 EFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
P + S + + + NP DRPS+ +
Sbjct: 242 F---PPVSLHYSY----DLRSLVSQLFKRNPRDRPSVNSI 274
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 62/273 (22%), Positives = 107/273 (39%), Gaps = 30/273 (10%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
+G G +G K G+ K + + + +EV+L L+H N++R
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 499 YCTERDENML--IYEYLPNKSLDLYLFDPIRRYVLDWQKRV-NIIEGVTQGLLYL--QEY 553
+R L + EY L + + ++ V ++ +T L +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
V+HRDLK +N+ LD + N K+ DFG+A++ D A T VGT Y+ PE + +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNR 190
Query: 614 GIYSMKYDVYSFGVLLLQIISSKR--NARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671
Y+ K D++S G LL ++ + A + L K +GK
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAF------SQKELAG-----KIREGK--FRRIP 237
Query: 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
S ++ + RPS+ E+
Sbjct: 238 YRYSDELN-----EIITRMLNLKDYHRPSVEEI 265
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 61/297 (20%), Positives = 116/297 (39%), Gaps = 43/297 (14%)
Query: 426 SFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKR--LSATSTQGLEEFKNEVS 483
F + +S ++G GG V++ + Q +A+K L Q L+ ++NE++
Sbjct: 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 78
Query: 484 LTARLQHVNL--LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRY-VLDWQKRVNII 540
+LQ + +R+ Y ++ E N L +++ +D +R +
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDL----NSWLKKKKSIDPWERKSYW 133
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
+ + + + + ++ ++H DLK +N L+ + K+ DFG+A + D V
Sbjct: 134 KNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 189
Query: 601 GTYGYVPPE-----------YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLN 649
GT Y+PPE K S K DV+S G +L + K + ++
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQIS 247
Query: 650 FLEYAFEQWKDSKGKEFIDPSLDDSSSPCK--LLNCMQVALLCVQENPEDRPSMLEV 704
L E P D + L C++ +P+ R S+ E+
Sbjct: 248 KLHA-----IIDPNHEIEFP--DIPEKDLQDVLKCCLKR-------DPKQRISIPEL 290
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 24/197 (12%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEE-FKNEVSLTARLQHVNLLRVLG 498
LG+GGF ++ + + FA K + S E E+S+ L H +++ G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN------IIEGVTQGLLYLQE 552
+ + D ++ E +SL + +R +K + + + G YL
Sbjct: 109 FFEDNDFVFVVLELCRRRSL----LELHKR-----RKALTEPEARYYLRQIVLGCQYLHR 159
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
RVIHRDLK N+ L+ +L KI DFG+A D + + GT Y+ PE +
Sbjct: 160 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLS 214
Query: 613 KGIYSMKYDVYSFGVLL 629
K +S + DV+S G ++
Sbjct: 215 KKGHSFEVDVWSIGCIM 231
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 24/197 (12%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEE-FKNEVSLTARLQHVNLLRVLG 498
LG+GGF ++ + + FA K + S E E+S+ L H +++ G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN------IIEGVTQGLLYLQE 552
+ + D ++ E +SL + +R +K + + + G YL
Sbjct: 83 FFEDNDFVFVVLELCRRRSL----LELHKR-----RKALTEPEARYYLRQIVLGCQYLHR 133
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
RVIHRDLK N+ L+ +L KI DFG+A D + + GT Y+ PE +
Sbjct: 134 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLS 188
Query: 613 KGIYSMKYDVYSFGVLL 629
K +S + DV+S G ++
Sbjct: 189 KKGHSFEVDVWSIGCIM 205
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 17/209 (8%)
Query: 428 SDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEE-FKNEVS 483
+ I +F N LG+G F VY+ ++ G E A+K + A G+ + +NEV
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63
Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIR---RYVLDWQKRVNII 540
+ +L+H ++L + Y + + L+ E N + ++ + + + R + +
Sbjct: 64 IHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEAR-HFM 118
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
+ G+LYL ++HRDL SN+LL +N KI+DFG+A + ++ T +
Sbjct: 119 HQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LC 173
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
GT Y+ PE + + ++ DV+S G +
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMF 202
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 64/324 (19%), Positives = 121/324 (37%), Gaps = 46/324 (14%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKR--LSATSTQGLEEFKNEVSLTARLQHVNL--LRV 496
++G GG V++ + Q +A+K L Q L+ ++NE++ +LQ + +R+
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRY-VLDWQKRVNIIEGVTQGLLYLQEYSN 555
Y ++ E N L +++ +D +R + + + + + + ++
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDL----NSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH-- 127
Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE------ 609
++H DLK +N L+ + K+ DFG+A + D VGT Y+PPE
Sbjct: 128 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 610 -----YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664
K S K DV+S G +L + K + ++ L
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKLHA-----IIDPNH 238
Query: 665 EFIDPSLDDSSSPCK--LLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAPKRPA 722
E P D + L C++ +P+ R S+ E+ L + I
Sbjct: 239 EIEFP--DIPEKDLQDVLKCCLKR-------DPKQRISIPEL---LAHPYVQIQTHPVNQ 286
Query: 723 FSAKGDENAETSSTSRQEIYSFND 746
+ E + + S N
Sbjct: 287 MAKGTTEEMKYVLGQLVGLNSPNS 310
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-29
Identities = 66/322 (20%), Positives = 126/322 (39%), Gaps = 42/322 (13%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKR--LSATSTQGLEEFKNEVSLTARLQHVNL--LRV 496
++G GG V++ + Q +A+K L Q L+ ++NE++ +LQ + +R+
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
Y ++ E N L+ +L ++ +D +R + + + + + + ++
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH--- 174
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK---- 612
++H DLK +N L+ + K+ DFG+A + D VG Y+PPE +K
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 613 -------KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665
K S K DV+S G +L + K + ++ L E
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKLHA-----IIDPNHE 286
Query: 666 FIDPSLDDSSSPCK-LLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAPKRPAFS 724
P D + +L C C++ +P+ R S+ E+ L + I +
Sbjct: 287 IEFP--DIPEKDLQDVLKC------CLKRDPKQRISIPEL---LAHPYVQIQTHPVNQMA 335
Query: 725 AKGDENAETSSTSRQEIYSFND 746
E + + S N
Sbjct: 336 KGTTEEMKYVLGQLVGLNSPNS 357
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 2e-28
Identities = 43/360 (11%), Positives = 85/360 (23%), Gaps = 54/360 (15%)
Query: 382 CYFRRTAIKSKVMIILGRRNLRTPGTSTPAAEYFDSDTPNLQVFSF-SDIKAATNNFSSA 440
F R +K + +I R + + P + S +
Sbjct: 8 DSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLV 67
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRL---SATSTQGLEEFKNEVSLTARLQHVNLLRV 496
L G V+ ++ R ++FA+K + S LE ARL +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 497 LGYC-------------------------TERDENMLIYEYLPNKSL----DLYLFDPIR 527
N L+ + L F +
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 528 RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587
R + + + LQ ++H N+ + + + D
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSAL--- 241
Query: 588 RKDVDEANTGRIVGTYGYVPPEYV--KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS 645
K Y P E++ ++ + + G+ + ++ +G
Sbjct: 242 WKVGTRGPA--SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP---FGLV 296
Query: 646 ENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCK-LLNCMQVALLCVQENPEDRPSMLEV 704
+ + S K L+ L + R LE
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF----LNF--DRRRRLLPLEA 350
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 72/327 (22%), Positives = 120/327 (36%), Gaps = 56/327 (17%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGY 499
L EGGF VY+ ++ G+E+A+KRL + + EV +L H N+++
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 500 CTERDENM-------LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
+ E L+ L L +L R L + I + + ++
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI----------VGT 602
+IHRDLK N+LL N+ K+ DFG A D + + + T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 603 YGYVPPEYV---KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWK 659
Y PE + K D+++ G +L Y L F ++ FE
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCIL-----------YL-----LCFRQHPFED-- 255
Query: 660 DSKGK----EFIDPSLDDSSSPCK-LLNCMQVALLCVQENPEDRPSMLEV----SSMLKD 710
+K + ++ P D + L+ M +Q NPE+R S+ EV +
Sbjct: 256 GAKLRIVNGKYSIPPHDTQYTVFHSLIRAM------LQVNPEERLSIAEVVHQLQEIAAA 309
Query: 711 DSMAIAAPKRPAFSAKGDENAETSSTS 737
++ +P G + T S
Sbjct: 310 RNVNPKSPITELLEQNGGYGSATLSRG 336
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 60/339 (17%), Positives = 108/339 (31%), Gaps = 90/339 (26%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS-ATSTQGLEEFKNEVSLTARLQHVN 492
+F +G GGFG V++ N +A+KR+ E+ EV A+L+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 493 LLRVLGYCTERDENMLIYEYLP------------------------NKSLDLYLFDPIRR 528
++R E E + +D +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 529 YVL---------------------DWQKRVN------------IIEGVTQGLLYLQEYSN 555
+ DW R I + + + +L +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL---HS 182
Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG----------RIVGTYGY 605
++HRDLK SNI + K+ DFG+ +D +E VGT Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665
+ PE + YS K D++S G++L +++ + T + D + +
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLY------SFSTQMERVRI------ITDVRNLK 290
Query: 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
F ++ M + +P +RP ++
Sbjct: 291 FPLLFTQKYPQEHMMVQDM------LSPSPTERPEATDI 323
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 71/283 (25%), Positives = 119/283 (42%), Gaps = 49/283 (17%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEE-FKNEVSLTARLQH 490
+F LG+G FG VY A+K L + G+E + EV + + L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN------IIEGVT 544
N+LR+ GY + LI EY P ++ + +++ + + I +
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTV----YRELQK-----LSKFDEQRTATYITELA 119
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
L Y RVIHRD+K N+LL + KI+DFG + + + GT
Sbjct: 120 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRTDLCGTLD 172
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK---RNARYYGTSENLNFLEYAFEQWKDS 661
Y+PPE ++ ++ K D++S GVL + + K Y T + ++ +E+ F +
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 232
Query: 662 KGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
++ I +LL + NP RP + EV
Sbjct: 233 GARDLI----------SRLL----------KHNPSQRPMLREV 255
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 56/280 (20%), Positives = 107/280 (38%), Gaps = 34/280 (12%)
Query: 428 SDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFK-NEVSLT 485
+ + + + ++G G FG V++ + G + AVK++ LE F+ E+
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVAC 104
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRY-VLDWQKRVNIIEGVT 544
A L ++ + G E + E L SL I++ L + + +
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG----QLIKQMGCLPEDRALYYLGQAL 160
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANTGR---IV 600
+GL YL R++H D+KA N+LL ++ + + DFG A + D + I
Sbjct: 161 EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKD 660
GT ++ PE V K D++S ++L +++ + + +
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP--WT----QYFRGPLCLKIASE 271
Query: 661 SKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPS 700
+ S +P Q +++ P R S
Sbjct: 272 PP----PIREIPPSCAP----LTAQAIQEGLRKEPVHRAS 303
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 56/299 (18%), Positives = 110/299 (36%), Gaps = 50/299 (16%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVLGY 499
LG+G V++G + G FA+K + S ++ E + +L H N++++
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA- 74
Query: 500 CTERDENMLIY---EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
E E+ P SL L +P Y L + + ++ V G+ +L+E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--- 131
Query: 557 RVIHRDLKASNILL----DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
++HR++K NI+ D + K++DFG A+ D ++ + + GT Y+ P+ +
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVS--LYGTEEYLHPDMYE 188
Query: 613 KGI--------YSMKYDVYSFGVLL-------------------LQIISSKRNARYYGTS 645
+ + Y D++S GV +++ + G
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248
Query: 646 ENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
+ E W P S ++L V ++ + E +
Sbjct: 249 SGVQKAENGPIDW------SGDMPVSCSLSRGLQVL-LTPVLANILEADQEKCWGFDQF 300
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 4e-26
Identities = 63/283 (22%), Positives = 106/283 (37%), Gaps = 28/283 (9%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARLQHVNLLRVL-- 497
+LG GGFG V + + G++ A+K+ + E + E+ + +L H N++
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 498 ----GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
D +L EY L YL L ++ ++ L YL E
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 554 SNFRVIHRDLKASNILLD---NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
R+IHRDLK NI+L L KI D G AK + + VGT Y+ PE
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTE--FVGTLQYLAPEL 194
Query: 611 VKKGIYSMKYDVYSFGVLL-------LQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG 663
+++ Y++ D +SFG L + + + +++G + + D G
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV--YDDLTG 252
Query: 664 KEFIDPSLDDSSSPCKLLNCMQVALLCV--QENPEDRPSMLEV 704
L + +L L + R + +
Sbjct: 253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295
|
| >3bxw_B Chitinase domain-containing protein 1; TIM barrel, lysosome, secreted, hydrolase; 2.70A {Homo sapiens} Length = 393 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 4e-26
Identities = 36/329 (10%), Positives = 105/329 (31%), Gaps = 51/329 (15%)
Query: 39 FPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWN 98
+ ++ + + FT + + ++ ++ + + +VR+ + + +
Sbjct: 93 YDVTKVFGSKFTQISPVWLQLKRRGREMFEVTGLHDVDQGWMRAVRKHAKGLHIVPRLLF 152
Query: 99 GQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWP-NST 157
+ +++ + ++ ++ A+ F G + S
Sbjct: 153 E------------DWTYDDFRNVLDSEDEIEELSKTVVQVAKNQHFDGFVVEVWNQLLSQ 200
Query: 158 DLNSLGILLDEWKASASDQ-PELTLSMAVRYSPTHETVS----YPIDSMKKNLNWAHLVA 212
L +L + L + +P + + + + L+ L+
Sbjct: 201 KRVGLIHMLTHLAEALHQARLLALLVIPPAITPGTDQLGMFTHKEFEQLAPVLDGFSLMT 260
Query: 213 YDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGARASG-----PGI 267
YDY + G +A L ++ + +K++LG G
Sbjct: 261 YDYSTAHQ---PGPNAPLSW------VRACVQVLDPKSKWRSKILLGLNFYGMDYATSKD 311
Query: 268 TIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFT-----SGATWINFDGVETIKAKIS 322
+ +G ++I+ + V+++ + F SG + + +++++ ++
Sbjct: 312 AREPVVGARYIQTLKD---HRPRMVWDSQASEHFFEYKKSRSGRHVVFYPTLKSLQVRLE 368
Query: 323 YAKEKNL------LGYKAFQLSNDDNWAL 345
A+E + LG D + L
Sbjct: 369 LARELGVGVSIWELGQ-----GLDYFYDL 392
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 54/198 (27%), Positives = 100/198 (50%), Gaps = 10/198 (5%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
++ K+G+G G VY ++ GQE A+++++ E NE+ + ++ N++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
L DE ++ EYL SL D + +D + + Q L +L +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLH---S 134
Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI 615
+VIHRD+K+ NILL + + K++DFG + + +T +VGT ++ PE V +
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 192
Query: 616 YSMKYDVYSFGVLLLQII 633
Y K D++S G++ +++I
Sbjct: 193 YGPKVDIWSLGIMAIEMI 210
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-26
Identities = 67/306 (21%), Positives = 117/306 (38%), Gaps = 63/306 (20%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVS-LTARLQHVNL 493
N S LG G G V +G+ AVKR+ + E+ LT H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNV 71
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLY---LFDPI--------RRYVLDWQKRVNIIEG 542
+R YC+E + L Y+ +L+L L D + + ++++
Sbjct: 72 IRY--YCSETTDRFL---YI---ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNE-------------LNPKISDFGMAKLFRK 589
+ G+ +L ++IHRDLK NIL+ L ISDFG+ K
Sbjct: 124 IASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 590 DVD--EANTGRIVGTYGYVPPEYVKKGI-------YSMKYDVYSFGVLLLQIISSKRNAR 640
N GT G+ PE +++ + D++S G + I+S ++
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 641 YYGTSENLNFL--EYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDR 698
S N + ++ ++ K + I + D L++ M + +P R
Sbjct: 241 GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATD-------LISQM----IDH--DPLKR 287
Query: 699 PSMLEV 704
P+ ++V
Sbjct: 288 PTAMKV 293
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 57/198 (28%), Positives = 100/198 (50%), Gaps = 10/198 (5%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
S K+GEG G V G++ AVK + Q E NEV + QH N++
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
+ +E ++ E+L +L D + + L+ ++ + E V Q L YL
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLH---A 159
Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI 615
VIHRD+K+ +ILL + K+SDFG KDV + + +VGT ++ PE + + +
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSL 217
Query: 616 YSMKYDVYSFGVLLLQII 633
Y+ + D++S G+++++++
Sbjct: 218 YATEVDIWSLGIMVIEMV 235
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 60/298 (20%), Positives = 114/298 (38%), Gaps = 36/298 (12%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARLQHVNLLRVLGY 499
LG+G V++G + G FA+K + S + E + +L H N++++
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA- 74
Query: 500 CTERDENMLIY---EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
E E+ P SL L +P Y L + + ++ V G+ +L+E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--- 131
Query: 557 RVIHRDLKASNILL----DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
++HR++K NI+ D + K++DFG A+ D ++ + + GT Y+ P+ +
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVS--LYGTEEYLHPDMYE 188
Query: 613 KGI--------YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664
+ + Y D++S GV + R + + Y K S
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248
Query: 665 EFIDPSLD-------DSSSPCKLLNCMQVAL-----LCVQENPEDRPSMLEVSSMLKD 710
+ + + D C L +QV L ++ + E + + D
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 29/218 (13%)
Query: 435 NNFSSANKLGEGGFGPVY---------------KGNLPRGQEFAVKRLSATSTQGLEE-F 478
N++ L +G F + K L + ++F S + + F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 479 KNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL-----FDPIRRYVLDW 533
KNE+ + +++ L G T DE +IYEY+ N S+ + D +
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150
Query: 534 QKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593
Q II+ V Y+ ++ + HRD+K SNIL+D K+SDFG ++ +
Sbjct: 151 QVIKCIIKSVLNSFSYI--HNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD--KK 206
Query: 594 ANTGRIVGTYGYVPPEYV--KKGIYSMKYDVYSFGVLL 629
GTY ++PPE+ + K D++S G+ L
Sbjct: 207 IKG--SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 52/239 (21%), Positives = 95/239 (39%), Gaps = 19/239 (7%)
Query: 400 RNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSS----ANKLGEGGFGPVYKG- 454
+R +Y + + ++ + +LG G FG V++
Sbjct: 12 SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71
Query: 455 NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514
G+ F K ++ KNE+S+ +L H L+ + ++ E +LI E+L
Sbjct: 72 EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131
Query: 515 NKSLDLYLFDPI--RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN 572
LFD I Y + + +N + +GL ++ E+ ++H D+K NI+ +
Sbjct: 132 GGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCET 184
Query: 573 ELNP--KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
+ KI DFG+A D + T + PE V + D+++ GVL
Sbjct: 185 KKASSVKIIDFGLATKLNPD-EIVKV--TTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 54/193 (27%), Positives = 90/193 (46%), Gaps = 13/193 (6%)
Query: 442 KLGEGGFGPVYKGNLPR-GQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQHVNLLRVL 497
KLG GG VY + A+K + + L+ F+ EV +++L H N++ ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS-NF 556
E D L+ EY+ +L Y+ L +N + G+ +++ +
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGI----KHAHDM 130
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
R++HRD+K NIL+D+ KI DFG+AK + T ++GT Y PE K
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 617 SMKYDVYSFGVLL 629
D+YS G++L
Sbjct: 190 DECTDIYSIGIVL 202
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 60/238 (25%), Positives = 101/238 (42%), Gaps = 21/238 (8%)
Query: 403 RTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSS------ANKLGEGGFGPVYKG-N 455
R P S + F + A +S LG G FG V+K
Sbjct: 51 RMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEE 110
Query: 456 LPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515
G + A K + + EE KNE+S+ +L H NL+++ +++ +L+ EY+
Sbjct: 111 TATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170
Query: 516 KSLDLYLFDPI--RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE 573
LFD I Y L + ++ + +G+ ++ + ++H DLK NIL N
Sbjct: 171 GE----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNR 223
Query: 574 LNP--KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
KI DFG+A+ ++ ++ GT ++ PE V S D++S GV+
Sbjct: 224 DAKQIKIIDFGLARRYKPR-EKLKV--NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 26/197 (13%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEE-FKNEVSLTARLQHVNLLRVLG 498
LG+G FG VY A+K L S +G+E + E+ + + L+H N+LR+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN------IIEGVTQGLLYLQE 552
Y +R L+ E+ P L + +++ R + +E + L Y E
Sbjct: 82 YFHDRKRIYLMLEFAPRGEL----YKELQK-----HGRFDEQRSATFMEELADALHYCHE 132
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
+VIHRD+K N+L+ + KI+DFG + + GT Y+PPE ++
Sbjct: 133 R---KVIHRDIKPENLLMGYKGELKIADFGWSVH----APSLRRRTMCGTLDYLPPEMIE 185
Query: 613 KGIYSMKYDVYSFGVLL 629
+ K D++ GVL
Sbjct: 186 GKTHDEKVDLWCAGVLC 202
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 54/193 (27%), Positives = 97/193 (50%), Gaps = 11/193 (5%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLL 494
F+ K+G+G FG V+KG + + A+K + + +E+ + E+++ ++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
+ G + + +I EYL S D + LD + I+ + +GL YL
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH--- 136
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
+ + IHRD+KA+N+LL K++DFG+A + NT VGT ++ PE +K+
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 194
Query: 615 IYSMKYDVYSFGV 627
Y K D++S G+
Sbjct: 195 AYDSKADIWSLGI 207
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-25
Identities = 72/288 (25%), Positives = 125/288 (43%), Gaps = 39/288 (13%)
Query: 430 IKAATNNFSSA----NKLGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEEFKNEV 482
I + + S KLG G +G V + E A+K + ++ ST + EV
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIE 541
++ L H N++++ + ++ L+ E L FD I R + II+
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAAVIIK 143
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGMAKLFRKDVDEANTGR 598
V G+ YL +++ ++HRDLK N+LL++ + KI DFG++ +F
Sbjct: 144 QVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKE 197
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQW 658
+GT Y+ PE V + Y K DV+S GV+L +++ + G ++ + +
Sbjct: 198 RLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYP--PFGGQTD-----QEILRKV 249
Query: 659 KDSKGK-EFIDPSLDDSSSPCK-LLNCMQVALLCVQENPEDRPSMLEV 704
+ KGK F P + S K L+ M L + + R S +
Sbjct: 250 E--KGKYTFDSPEWKNVSEGAKDLIKQM----LQF--DSQRRISAQQA 289
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-25
Identities = 48/240 (20%), Positives = 93/240 (38%), Gaps = 19/240 (7%)
Query: 399 RRNLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSS----ANKLGEGGFGPVYKG 454
+ G T ++ Y + + + ++ ++ +LG G FG V++
Sbjct: 117 EQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV 176
Query: 455 -NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513
G FA K + E + E+ + L+H L+ + + +E ++IYE++
Sbjct: 177 TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236
Query: 514 PNKSLDLYLFDPI--RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD 571
LF+ + + + V + V +GL ++ E + +H DLK NI+
Sbjct: 237 SGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFT 289
Query: 572 NELNP--KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
+ + K+ DFG+ GT + PE + D++S GVL
Sbjct: 290 TKRSNELKLIDFGLTAHLDPK-QSVKV--TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 63/319 (19%), Positives = 120/319 (37%), Gaps = 53/319 (16%)
Query: 416 DSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG 474
T +V D ++F ++LG G G V+K + P G A K +
Sbjct: 19 AFLTQKQKVGELKD-----DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP- 72
Query: 475 LEEFK---NEVSLTARLQHVNLLRVLG-YCTERDENMLIYEYLPNKSLDLYL--FDPIRR 528
E+ + ++ G + ++ + ++ + E++ SLD L I
Sbjct: 73 -AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPE 130
Query: 529 YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588
+L + V +GL YL +++HRD+K SNIL+++ K+ DFG++
Sbjct: 131 QIL-----GKVSIAVIKGLTYL--REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183
Query: 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQI------ISSKRNARYY 642
+ AN+ VGT Y+ PE ++ YS++ D++S G+ L+++ I
Sbjct: 184 DSM--ANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 239
Query: 643 GTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVAL-------------- 688
+ A + ++ DS P + + +
Sbjct: 240 LMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSL 299
Query: 689 -------LCVQENPEDRPS 700
C+ +NP +R
Sbjct: 300 EFQDFVNKCLIKNPAERAD 318
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 68/288 (23%), Positives = 116/288 (40%), Gaps = 59/288 (20%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVK-----RLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
+G+G F V + N GQ+FAVK + +++ E+ K E S+ L+H +++
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQK---RV--NIIEGVTQGLLYL 550
+L + +++E++ L I + V + + + + L Y
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADL----CFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 551 QEYSNFRVIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
+ +IHRD+K +LL ++ N K+ FG+A + A VGT ++
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMA 201
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY---------YGTSENLNFLEYAFEQW 658
PE VK+ Y DV+ GV+L + YGT E L FE
Sbjct: 202 PEVVKREPYGKPVDVWGCGVIL-----------FILLSGCLPFYGTKERL------FEGI 244
Query: 659 KDSKGK-EFIDPSLDDSSSPCK-LLNCMQVALLCVQENPEDRPSMLEV 704
KGK + S K L+ M L + +P +R ++ E
Sbjct: 245 I--KGKYKMNPRQWSHISESAKDLVRRM----LML--DPAERITVYEA 284
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 80/289 (27%), Positives = 120/289 (41%), Gaps = 40/289 (13%)
Query: 430 IKAATNNFSSA----NKLGEGGFGPVYKG-NLPRGQEFAVKRLS---ATSTQGLEEFKNE 481
++ +T FS LG+G FG V + GQE AVK +S E E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 482 VSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNII 540
V L +L H N++++ + ++ L+ E L FD I R II
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARII 132
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGMAKLFRKDVDEANTG 597
V G+ Y+ + ++HRDLK N+LL++ + N +I DFG++ F
Sbjct: 133 RQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMK 186
Query: 598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQ 657
+GT Y+ PE V G Y K DV+S GV+L ++S + G +E ++
Sbjct: 187 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCP--PFNGANE-----YDILKK 238
Query: 658 WKDSKGK-EFIDPSLDDSSSPCK-LLNCMQVALLCVQENPEDRPSMLEV 704
+ KGK F P S K L+ M L P R S +
Sbjct: 239 VE--KGKYTFELPQWKKVSESAKDLIRKM----LTY--VPSMRISARDA 279
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 51/271 (18%), Positives = 91/271 (33%), Gaps = 48/271 (17%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARL-QHVNLLRVL 497
+LG G +G V+K + G+ +AVK + EV ++ QH +R+
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 498 GYCTERDENMLIYEYLPNKSLDLYL------F--DPIRRYVLDWQKRVNIIEGVTQGLLY 549
E L E SL + + Y+ D L +
Sbjct: 124 QAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRD----------TLLALAH 172
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
L ++H D+K +NI L K+ DFG+ G Y+ PE
Sbjct: 173 LHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGEV--QEGDPRYMAPE 226
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669
++ Y DV+S G+ +L++ + E W+ +
Sbjct: 227 LLQGS-YGTAADVFSLGLTILEVACNMELPHGG-------------EGWQQLRQGYLPPE 272
Query: 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPS 700
SS + V ++ ++ +P+ R +
Sbjct: 273 FTAGLSSELR-----SVLVMMLEPDPKLRAT 298
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 48/198 (24%), Positives = 79/198 (39%), Gaps = 17/198 (8%)
Query: 442 KLGEGGFGPVYKGNLPR-GQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQHVNLLRVL 497
LG GG V+ R ++ AVK L A F+ E A L H ++ V
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 498 GYCTERDENMLIY----EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
+ EY+ +L + + ++ + +I Q L +
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQAL----NF 131
Query: 554 S-NFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDEANTGRIVGTYGYVPPEYV 611
S +IHRD+K +NI++ K+ DFG+A+ + T ++GT Y+ PE
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 612 KKGIYSMKYDVYSFGVLL 629
+ + DVYS G +L
Sbjct: 192 RGDSVDARSDVYSLGCVL 209
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 41/259 (15%), Positives = 87/259 (33%), Gaps = 32/259 (12%)
Query: 401 NLRTPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG------ 454
L P +S P F+ + ++ + + + LGEG F VY+
Sbjct: 33 GLSKPVSSYP--NTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLN 90
Query: 455 NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ---HVNLLRVLGYCTERDENMLIYE 511
+ Q+F +K + EF L RL+ ++ ++ ++L+ E
Sbjct: 91 DAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGE 147
Query: 512 YLPNKSLDLYLFDPIRRYVLDWQKRVN---IIEGVTQGLLYLQEYSNFRVIHRDLKASNI 568
+L + I Y +K + +I + L +++ + +IH D+K N
Sbjct: 148 LYSYGTL----LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNF 203
Query: 569 LLDNELNP-----------KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYS 617
+L N + D G + + T G+ E + ++
Sbjct: 204 ILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN 263
Query: 618 MKYDVYSFGVLLLQIISSK 636
+ D + + ++
Sbjct: 264 YQIDYFGVAATVYCMLFGT 282
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 57/196 (29%), Positives = 100/196 (51%), Gaps = 12/196 (6%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN 492
F KLGEG +G VYK + GQ A+K++ L+E E+S+ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
+++ G + + ++ EY S+ D+ +R L + I++ +GL YL
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV 611
R IHRD+KA NILL+ E + K++DFG+A + + NT ++GT ++ PE +
Sbjct: 143 ---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVI 197
Query: 612 KKGIYSMKYDVYSFGV 627
++ Y+ D++S G+
Sbjct: 198 QEIGYNCVADIWSLGI 213
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 42/198 (21%), Positives = 77/198 (38%), Gaps = 23/198 (11%)
Query: 442 KLGEGGFGPVYKGN---LPRGQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQHVNLLR 495
+G GG G VY+ R A+K +S ++ + E RLQ +++
Sbjct: 41 LVGRGGMGDVYEAEDTVRER--IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
+ + + + + L L R+ L + V I+ + L + ++
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSAL----DAAH 151
Query: 556 FR-VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN---TGRIVGTYGYVPPEYV 611
HRD+K NIL+ + + DFG+A + G VGT Y+ PE
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASA----TTDEKLTQLGNTVGTLYYMAPERF 207
Query: 612 KKGIYSMKYDVYSFGVLL 629
+ + + D+Y+ +L
Sbjct: 208 SESHATYRADIYALTCVL 225
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 47/307 (15%), Positives = 92/307 (29%), Gaps = 75/307 (24%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG---LEEFKNEVSLTARLQHV------- 491
LG+ + + G+ F V T +++ K EV L+ +
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 492 ---------NLLRVLG-------YCTERDENM----LIYEYLPNKSLDL--YLFDPIRRY 529
+L++ ERD + +Y + + L +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 530 -VLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588
L R+ + V + L L Y ++H L+ +I+LD ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL---- 253
Query: 589 KDVDEANTGRIVGTYGYVPPEYVK-----------KGIYSMKYDVYSFGVLLLQIISSKR 637
V + + G+ PPE + + + +D ++ G+++ I +
Sbjct: 254 --VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD- 310
Query: 638 NARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPED 697
+ G E+I S + P + L L ED
Sbjct: 311 ---------------LPITKDAALGGSEWIFRSCKNIPQPVRALLE---GFLRY--PKED 350
Query: 698 RPSMLEV 704
R L+
Sbjct: 351 RLLPLQA 357
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 41/193 (21%), Positives = 83/193 (43%), Gaps = 16/193 (8%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
LG G FG V++ + + K + K E+S+ +H N+L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPI--RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
+E ++I+E++ + F+ I + L+ ++ V+ + V + L +L ++ +
Sbjct: 71 ESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFLHSHN---I 123
Query: 559 IHRDLKASNILLDNELNP--KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
H D++ NI+ + KI +FG A+ + D + Y PE + +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRL--LFTAPEYYAPEVHQHDVV 180
Query: 617 SMKYDVYSFGVLL 629
S D++S G L+
Sbjct: 181 STATDMWSLGTLV 193
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 32/234 (13%), Positives = 71/234 (30%), Gaps = 53/234 (22%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHV------- 491
LG+ + + G+ F V T + +++ K EV L+ +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 492 ---------NLLRVLGYCTERDEN--------MLIYEYLPNKSLDLY-LFDPIRRYV--- 530
+L++ + + P +L + + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 531 --LDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588
L R+ + V + L L Y ++H L+ +I+LD ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-- 260
Query: 589 KDVDEANTGRIVGTYGYVPPEYV----------KKGIYSMKYDVYSFGVLLLQI 632
+ + G+ PPE + + +D ++ G+ + I
Sbjct: 261 ----DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVN 492
+++ +G G V P+ ++ A+KR++ Q ++E E+ ++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSL-DL----YLFDPIRRYVLDWQKRVNIIEGVTQGL 547
++ +DE L+ + L S+ D+ + VLD I+ V +GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM-AKLFRKDVDEANTGR--IVGTYG 604
YL + IHRD+KA NILL + + +I+DFG+ A L N R VGT
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 605 YVPPEYVKKGI-YSMKYDVYSFGV 627
++ PE +++ Y K D++SFG+
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGI 215
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-23
Identities = 74/273 (27%), Positives = 123/273 (45%), Gaps = 35/273 (12%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEEFKNEVSLTARLQHVNLLRVL 497
LG+G FG V K + QE+AVK + ++ + EV L +L H N++++
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
+ ++ E L FD I +R II+ V G+ Y+ ++
Sbjct: 88 EILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH--- 140
Query: 557 RVIHRDLKASNILLDN---ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
++HRDLK NILL++ + + KI DFG++ F+++ + +GT Y+ PE V +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKD--RIGTAYYIAPE-VLR 196
Query: 614 GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK-EFIDPSLD 672
G Y K DV+S GV+L ++S +YG +E ++ + GK F P
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTP--PFYGKNE-----YDILKRVE--TGKYAFDLPQWR 247
Query: 673 DSSSPCK-LLNCMQVALLCVQENPEDRPSMLEV 704
S K L+ M L +P R + +
Sbjct: 248 TISDDAKDLIRKM----LTF--HPSLRITATQC 274
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 73/283 (25%), Positives = 121/283 (42%), Gaps = 44/283 (15%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLS-------------ATSTQGLEEFKNEVSLTA 486
KLG G +G V E A+K + + EE NE+SL
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 487 RLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQ 545
L H N++++ ++ L+ E+ L F+ I R+ D NI++ +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAANIMKQILS 157
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
G+ YL +++ ++HRD+K NILL+N LN KI DFG++ F KD + +GT
Sbjct: 158 GICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRD--RLGT 211
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662
Y+ PE V K Y+ K DV+S GV++ ++ + G ++ + ++ + K
Sbjct: 212 AYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP--PFGGQND-----QDIIKKVEKGK 263
Query: 663 GKEFIDPSLDDSSSPCK-LLNCMQVALLCVQENPEDRPSMLEV 704
F + S K L+ M L + R + E
Sbjct: 264 Y-YFDFNDWKNISDEAKELIKLM----LTY--DYNKRCTAEEA 299
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 15/198 (7%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
+ +LG+G FG VYK N G A K + S + LE++ E+ + A H +++
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 496 VLGYCTERDENMLIYEYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
+LG + ++ E+ P ++ + L L + + + + L +L
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIML---ELDRGLTEPQIQVVCRQMLEALNFL---H 134
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV--- 611
+ R+IHRDLKA N+L+ E + +++DFG++ K + + ++ +GT ++ PE V
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCE 192
Query: 612 --KKGIYSMKYDVYSFGV 627
K Y K D++S G+
Sbjct: 193 TMKDTPYDYKADIWSLGI 210
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 1e-22
Identities = 57/330 (17%), Positives = 108/330 (32%), Gaps = 45/330 (13%)
Query: 412 AEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEG--GFGPVYKG-NLPRGQEFAVKR-- 466
A + NL S + +G+G V P G+ V+R
Sbjct: 2 AHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN 61
Query: 467 LSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI 526
L A S + + + E+ ++ H N++ +E ++ ++ S L
Sbjct: 62 LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTH 120
Query: 527 RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG-MAK 585
++ I++GV + L Y+ +HR +KAS+IL+ + +S
Sbjct: 121 FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS 177
Query: 586 LF----RKDVDEANTGRIVGTYGYVPPEYVKKGI--YSMKYDVYSFG------------- 626
+ R+ V V ++ PE +++ + Y K D+YS G
Sbjct: 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
Query: 627 -------VLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCK 679
+LL ++ + T +S + + S S+
Sbjct: 238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDS 297
Query: 680 LLNCMQVAL---------LCVQENPEDRPS 700
+ C+Q NP+ RPS
Sbjct: 298 PSHPYHRTFSPHFHHFVEQCLQRNPDARPS 327
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 59/195 (30%), Positives = 97/195 (49%), Gaps = 18/195 (9%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
LG+G FG V K + QE+AVK + ++ + EV L +L H N++++
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
+ ++ E L FD I +R II+ V G+ Y+ +++
Sbjct: 89 ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 558 VIHRDLKASNILL---DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
++HRDLK NILL + + + KI DFG++ F+++ + +GT Y+ PE V +G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKD--RIGTAYYIAPE-VLRG 197
Query: 615 IYSMKYDVYSFGVLL 629
Y K DV+S GV+L
Sbjct: 198 TYDEKCDVWSAGVIL 212
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 33/202 (16%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARLQHVNLLRVLGYC 500
LGEG +G V N + AVK + E K E+ + L H N+++ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPI-----------RRYVLDWQKRVNIIEGVTQGLLY 549
E + L EY L FD I +R+ Q ++ GV
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQ----LMAGV------ 118
Query: 550 LQEYS-NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
Y + HRD+K N+LLD N KISDFG+A +FR + E ++ GT YV P
Sbjct: 119 --VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 609 EYVKKGIYS-MKYDVYSFGVLL 629
E +K+ + DV+S G++L
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVL 198
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 49/193 (25%), Positives = 82/193 (42%), Gaps = 16/193 (8%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
+G G +G V A K++ + ++ FK E+ + L H N++R+
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
+ + L+ E LF+ + + V I++ V + Y + V
Sbjct: 76 EDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVA 128
Query: 560 HRDLKASNILLDN---ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
HRDLK N L + K+ DFG+A F+ T VGT YV P+ V +G+Y
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRT--KVGTPYYVSPQ-VLEGLY 184
Query: 617 SMKYDVYSFGVLL 629
+ D +S GV++
Sbjct: 185 GPECDEWSAGVMM 197
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 22/200 (11%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG------LEEFKNEVSLTARLQHVNLL 494
+LG G F V K G E+A K + ++ EE + EVS+ ++ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEY 553
+ R + +LI E + L FD + ++ L ++ + I+ + G+ YL
Sbjct: 79 TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 554 SNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
+ H DLK NI+L ++ P K+ DFG+A +D E I GT +V PE
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKN--IFGTPEFVAPE 188
Query: 610 YVKKGIYSMKYDVYSFGVLL 629
V ++ D++S GV+
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 3e-22
Identities = 58/324 (17%), Positives = 101/324 (31%), Gaps = 89/324 (27%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVK-----RLSATSTQGLEEFKNEVSLTARLQHVNLLR 495
+G+G +G V A+K ++ + + +E K EV L +L H N+ R
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
+ + L+ E L D + ++ D + + TQ +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHL----LDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 556 FR--------------------------------------VIHRDLKASNILL--DNELN 575
+ HRD+K N L +
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFE 208
Query: 576 PKISDFGMAKLFR--KDVDEANTGRIVGTYGYVPPEYVKKGI--YSMKYDVYSFGVLLLQ 631
K+ DFG++K F + + GT +V PE + Y K D +S GVLL
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL-- 266
Query: 632 IISSKRNARY---------YGTSENLNFLEYAFEQWKDSKGK-EFIDPSLDDSSSPCK-L 680
+ G ++ Q K F +P+ + S + L
Sbjct: 267 ---------HLLLMGAVPFPGVNDA-----DTISQVL--NKKLCFENPNYNVLSPLARDL 310
Query: 681 LNCMQVALLCVQENPEDRPSMLEV 704
L+ + L N ++R +
Sbjct: 311 LSNL----LNR--NVDERFDAMRA 328
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 4e-22
Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 17/195 (8%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
+LG+G F V + + G EFA K + S + ++ + E + +LQH N++R+
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
E + L+++ + L F+ I R + I+ + + + Y
Sbjct: 73 SIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAYCHSN---G 125
Query: 558 VIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
++HR+LK N+LL ++ K++DFG+A D + + GT GY+ PE +KK
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHG--FAGTPGYLSPEVLKKD 182
Query: 615 IYSMKYDVYSFGVLL 629
YS D+++ GV+L
Sbjct: 183 PYSKPVDIWACGVIL 197
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-22
Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 22/200 (11%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG------LEEFKNEVSLTARLQHVNLL 494
+LG G F V K G E+A K + ++ EE + EVS+ ++ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEY 553
+ R + +LI E + L FD + ++ L ++ + I+ + G+ YL
Sbjct: 79 TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 554 SNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
+ H DLK NI+L ++ P K+ DFG+A +D E I GT +V PE
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKN--IFGTPEFVAPE 188
Query: 610 YVKKGIYSMKYDVYSFGVLL 629
V ++ D++S GV+
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 81/333 (24%), Positives = 128/333 (38%), Gaps = 58/333 (17%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARLQHVNLLRVLGYC 500
LGEG +G V N + AVK + E K E+ + L H N+++ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPI-----------RRYVLDWQKRVNIIEGVTQGLLY 549
E + L EY L FD I +R+ Q ++ GV
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQ----LMAGV------ 118
Query: 550 LQEYS-NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
Y + HRD+K N+LLD N KISDFG+A +FR + E ++ GT YV P
Sbjct: 119 --VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 609 EYVKKGIYS-MKYDVYSFGVLLLQIISSKRNARYY---GTSENLNFLEYAFEQWKDSKGK 664
E +K+ + DV+S G++L ++ A S++ + K
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAML-----AGELPWDQPSDSCQEYS------DWKEKK 225
Query: 665 EFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS---MLKDDSMAIAAPKRP 721
+++P S+P LL+ + L NP R ++ ++ K P+
Sbjct: 226 TYLNPWKKIDSAPLALLHKI----LVE--NPSARITIPDIKKDRWYNKPLKKGAKRPRVT 279
Query: 722 AFSAKGDENAETSSTSRQEIYSFNDPELSQLEP 754
S E+ S Q F+ + P
Sbjct: 280 --SGGVSESPSGFSKHIQSNLDFSPVNSASRTP 310
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 21/198 (10%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVLGY 499
KLG G FG V+ G E +K ++ +Q +E+ + E+ + L H N++++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDW-----QKRVNIIEGVTQGLLYLQEYS 554
+ ++ E L + I +++ + L Y
Sbjct: 89 FEDYHNMYIVMETCEGGEL----LERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ- 143
Query: 555 NFRVIHRDLKASNILLDN---ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV 611
V+H+DLK NIL + KI DFG+A+LF+ D + + GT Y+ PE V
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTN--AAGTALYMAPE-V 197
Query: 612 KKGIYSMKYDVYSFGVLL 629
K + K D++S GV++
Sbjct: 198 FKRDVTFKCDIWSAGVVM 215
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 7e-22
Identities = 50/193 (25%), Positives = 84/193 (43%), Gaps = 16/193 (8%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
LG G F V+ G+ FA+K + + +NE+++ +++H N++ +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
L+ + + L FD I R V + +I+ V + YL E ++
Sbjct: 76 ESTTHYYLVMQLVSGGEL----FDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIV 128
Query: 560 HRDLKASNILL---DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
HRDLK N+L + I+DFG++K+ GT GYV PE + + Y
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKME----QNGIMSTACGTPGYVAPEVLAQKPY 184
Query: 617 SMKYDVYSFGVLL 629
S D +S GV+
Sbjct: 185 SKAVDCWSIGVIT 197
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 1e-21
Identities = 44/197 (22%), Positives = 80/197 (40%), Gaps = 26/197 (13%)
Query: 442 KLGEGGFGPVYKG---NLPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARLQHVNLLRVL 497
+ GG G +Y N+ G+ +K L + + E A + H +++++
Sbjct: 87 CIAHGGLGWIYLALDRNVN-GRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 498 --GYCTERDENMLIY---EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
T+R + + Y EY+ +SL L + + + + L YL
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLHS 200
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
+++ DLK NI+L E K+ D G ++ G + GT G+ PE V+
Sbjct: 201 I---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR----INS--FGYLYGTPGFQAPEIVR 250
Query: 613 KGIYSMKYDVYSFGVLL 629
G ++ D+Y+ G L
Sbjct: 251 TGP-TVATDIYTVGRTL 266
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 60/294 (20%), Positives = 106/294 (36%), Gaps = 57/294 (19%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKR--LSATSTQGLEEFKNEVSLTARL-Q 489
T F K+G G FG V+K G +A+KR + + EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 490 HVNLLRVLGYCTERDENMLIY-EYLPNKSL-DLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
H +++R E D +MLI EY SL D + + +++ V +GL
Sbjct: 70 HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNP-------------------KISDFGMAKLFR 588
Y+ ++H D+K SNI + P KI D G
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR-- 183
Query: 589 KDVDEANTGRIVGTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYYGTSEN 647
+ G ++ E +++ + K D+++ + ++ ++
Sbjct: 184 --ISSPQV--EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP---------- 229
Query: 648 LNFLEYAFEQWKD-SKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPS 700
L +QW + +G+ P + S ++ + + +PE RPS
Sbjct: 230 ---LPRNGDQWHEIRQGRL---PRIPQVLSQ----EFTELLKVMIHPDPERRPS 273
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 19/198 (9%)
Query: 437 FSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG---LEEFKNEVSLTARLQHVN 492
FS ++G G FG VY ++ + A+K++S + Q ++ EV +L+H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
++ G L+ EY + DL + + L + + G QGL YL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLH- 171
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV- 611
+ +IHRD+KA NILL K+ DFG A + AN+ VGT ++ PE +
Sbjct: 172 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANS--FVGTPYWMAPEVIL 223
Query: 612 --KKGIYSMKYDVYSFGV 627
+G Y K DV+S G+
Sbjct: 224 AMDEGQYDGKVDVWSLGI 241
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 73/286 (25%), Positives = 108/286 (37%), Gaps = 69/286 (24%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRL------SATSTQGLEEFKNEVSLTARLQHV--NL 493
LG GGFG VY G + A+K + EV L ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-----------RRYVLDWQKRVNIIEG 542
+R+L + D +LI E P DL FD I R + WQ ++E
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQDL--FDFITERGALQEELARSFF--WQ----VLEA 161
Query: 543 VTQGLLYLQEYS-NFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEA-NTGRI 599
V + N V+HRD+K NIL+D N K+ DFG L + D
Sbjct: 162 V--------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTD--F 208
Query: 600 VGTYGYVPPEYVKKGIYS-MKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQW 658
GT Y PPE+++ Y V+S G+LL ++ G + F
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV--------CGD---IPF----EHDE 253
Query: 659 KDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
+ +G+ F + SS L+ L + P DRP+ E+
Sbjct: 254 EIIRGQVFFRQRV--SSECQHLIRWC----LAL--RPSDRPTFEEI 291
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 48/225 (21%), Positives = 88/225 (39%), Gaps = 23/225 (10%)
Query: 419 TPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATS-TQGLE 476
+ L++ + ++G G +G V K + P GQ AVKR+ +T + +
Sbjct: 6 SGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK 65
Query: 477 EFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQK 535
+ ++ + R +++ G + + E + Y +
Sbjct: 66 QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFY-----KYVYSVLDD 120
Query: 536 RVN------IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589
+ I + L +L N ++IHRD+K SNILLD N K+ DFG++
Sbjct: 121 VIPEEILGKITLATVKALNHL--KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178
Query: 590 DVDEANTGRIVGTYGYVPPE----YVKKGIYSMKYDVYSFGVLLL 630
+ + G Y+ PE + Y ++ DV+S G+ L
Sbjct: 179 SIAKTRD---AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY 220
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 51/211 (24%), Positives = 81/211 (38%), Gaps = 44/211 (20%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLS----ATSTQGLEEFKNEVSLTARLQHVNLLR-- 495
LGEG +G V + + AVK L G K E+ L RL+H N+++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 496 -VLGYCTERDENMLIY---EYLPNKSLDLYLFDPI----------RRYVLDWQKRVNIIE 541
VL ++ +Y EY ++ D + Y Q +I+
Sbjct: 73 DVLYNEEKQK----MYMVMEYCVCGMQEM--LDSVPEKRFPVCQAHGYF--CQ----LID 120
Query: 542 GVTQGLLYLQEYS-NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
G+ EY + ++H+D+K N+LL KIS G+A+ +
Sbjct: 121 GL--------EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 601 GTYGYVPPEYV--KKGIYSMKYDVYSFGVLL 629
G+ + PPE K D++S GV L
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 22/200 (11%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVK-----RLSATSTQG-LEEFKNEVSLTARLQHVNLL 494
+LG G F V K G+E+A K RLS++ EE + EV++ ++H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEY 553
+ + + +LI E + L FD + + L + ++ + G+ YL
Sbjct: 72 TLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILDGVHYLHSK 127
Query: 554 SNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
R+ H DLK NI+L ++ P K+ DFG+A +E I GT +V PE
Sbjct: 128 ---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKN--IFGTPEFVAPE 181
Query: 610 YVKKGIYSMKYDVYSFGVLL 629
V ++ D++S GV+
Sbjct: 182 IVNYEPLGLEADMWSIGVIT 201
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 4e-21
Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 17/195 (8%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
+LG+G F V + + G EFA K + S + ++ + E + +LQH N++R+
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
E + L+++ + L F+ I R + I+ + + + Y
Sbjct: 96 SIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAYCHSNG--- 148
Query: 558 VIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
++HR+LK N+LL ++ K++DFG+A D GT GY+ PE +KK
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---DSEAWHGFAGTPGYLSPEVLKKD 205
Query: 615 IYSMKYDVYSFGVLL 629
YS D+++ GV+L
Sbjct: 206 PYSKPVDIWACGVIL 220
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 5e-21
Identities = 51/237 (21%), Positives = 93/237 (39%), Gaps = 25/237 (10%)
Query: 406 GTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAV 464
G+S + + T Q + N+ + ++G G G V+K G AV
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEI-----NDLENLGEMGSGTCGQVWKMRFRKTGHVIAV 55
Query: 465 KRLSATST-QGLEEFKNEVS-LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL 522
K++ + + + ++ + +++ G + + E + + L
Sbjct: 56 KQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKK 115
Query: 523 --FDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISD 580
PI +L + + + L YL VIHRD+K SNILLD K+ D
Sbjct: 116 RMQGPIPERIL-----GKMTVAIVKALYYL--KEKHGVIHRDVKPSNILLDERGQIKLCD 168
Query: 581 FGMAKLFRKDVDEANTGRIVGTYGYVPPE-----YVKKGIYSMKYDVYSFGVLLLQI 632
FG++ D + + G Y+ PE K Y ++ DV+S G+ L+++
Sbjct: 169 FGISGRLVDDKAKDRS---AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 26/204 (12%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVL 497
+LG G +G V K ++P GQ AVKR+ AT +Q + ++ ++ R +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN------IIEGVTQGLLYLQ 551
G + + E + + SLD + + V+D + + I + + L +L
Sbjct: 73 GALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVKALEHL- 125
Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGM-AKLFRKDVDEANTGRIVGTYGYVPPE- 609
+S VIHRD+K SN+L++ K+ DFG+ L VD+ G Y+ PE
Sbjct: 126 -HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVAKDIDAGCKPYMAPER 180
Query: 610 ---YVKKGIYSMKYDVYSFGVLLL 630
+ + YS+K D++S G+ ++
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMI 204
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 8e-21
Identities = 50/195 (25%), Positives = 94/195 (48%), Gaps = 16/195 (8%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
+LG+G F V + + GQE+A + S + ++ + E + L+H N++R+
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
+E + LI++ + L F+ I R + I+ + + +L+ +
Sbjct: 78 SISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEAVLHCHQMG--- 130
Query: 558 VIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
V+HR+LK N+LL ++L K++DFG+A + GT GY+ PE ++K
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKD 188
Query: 615 IYSMKYDVYSFGVLL 629
Y D+++ GV+L
Sbjct: 189 PYGKPVDLWACGVIL 203
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 22/200 (11%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRL------SATSTQGLEEFKNEVSLTARLQHVNLL 494
+LG G F V K G ++A K + S+ E+ + EVS+ +QH N++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEY 553
+ + + +LI E + L FD + + L ++ ++ + G+ YL
Sbjct: 78 TLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 554 SNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
+ H DLK NI+L + P KI DFG+A + N I GT +V PE
Sbjct: 134 Q---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVAPE 187
Query: 610 YVKKGIYSMKYDVYSFGVLL 629
V ++ D++S GV+
Sbjct: 188 IVNYEPLGLEADMWSIGVIT 207
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 70/288 (24%), Positives = 114/288 (39%), Gaps = 71/288 (24%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRL------SATSTQGLEEFKNEVSLTARL----QHV 491
LG+GGFG V+ G L + A+K + + EV+L ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-----------RRYVLDWQKRVNII 540
++R+L + ++ ML+ E P + DL FD I R + Q ++
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQDL--FDYITEKGPLGEGPSRCFF--GQ----VV 149
Query: 541 EGVTQGLLYLQEYS-NFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEA-NTG 597
+ ++ + V+HRD+K NIL+D K+ DFG L DE
Sbjct: 150 AAI--------QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYTD- 197
Query: 598 RIVGTYGYVPPEYVKKGIYS-MKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFE 656
GT Y PPE++ + Y + V+S G+LL ++ G + FE
Sbjct: 198 -FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMV--------CG--------DIPFE 240
Query: 657 QWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
+ ++ E P+ S C L+ L P RPS+ E+
Sbjct: 241 RDQEILEAELHFPA-HVSPDCCALIRRC----LAP--KPSSRPSLEEI 281
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 22/226 (9%)
Query: 416 DSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG 474
DS +L S ++ F +G G +G VYKG ++ GQ A+K + T
Sbjct: 5 DSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DE 63
Query: 475 LEEFKNEVSLTARL-QHVNLLRVLG------YCTERDENMLIYEYLPNKSL-DLYLFDPI 526
EE K E+++ + H N+ G D+ L+ E+ S+ DL
Sbjct: 64 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNT 121
Query: 527 RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586
+ L + I + +GL +L + +VIHRD+K N+LL K+ DFG++
Sbjct: 122 KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178
Query: 587 FRKDVDEANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGV 627
+ V NT +GT ++ PE + Y K D++S G+
Sbjct: 179 LDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGI 222
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 51/201 (25%), Positives = 85/201 (42%), Gaps = 32/201 (15%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGY 499
LGEG F K + Q FAVK +S + + E++ + H N++++
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN--------IIEGVTQGLLYLQ 551
++ L+ E L L F+ I +K+ + I+ + + ++
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FERI-------KKKKHFSETEASYIMRKLVSAVSHMH 123
Query: 552 EYSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
+ V+HRDLK N+L ++ L KI DFG A+L D T T Y P
Sbjct: 124 DVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAP 178
Query: 609 EYVKKGIYSMKYDVYSFGVLL 629
E + + Y D++S GV+L
Sbjct: 179 ELLNQNGYDESCDLWSLGVIL 199
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 47/206 (22%), Positives = 92/206 (44%), Gaps = 28/206 (13%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGL---------EEFKNEVSLTARL-QH 490
LG G V + + P +E+AVK + T E EV + ++ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLY 549
N++++ L+++ + L FD + + L ++ I+ + + +
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMRALLEVICA 139
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
L + ++HRDLK NILLD+++N K++DFG + ++ + GT Y+ PE
Sbjct: 140 LHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLRE--VCGTPSYLAPE 193
Query: 610 YVKKGI------YSMKYDVYSFGVLL 629
++ + Y + D++S GV++
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 51/196 (26%), Positives = 84/196 (42%), Gaps = 20/196 (10%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLG 498
+G G + + + EFAVK + + EE + + R QH N++ +
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHPNIITLKD 83
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
+ ++ E + L D I R+ ++ ++ +T+ + YL
Sbjct: 84 VYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREASAVLFTITKTVEYLHAQ---G 136
Query: 558 VIHRDLKASNILL----DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
V+HRDLK SNIL N + +I DFG AK R + T T +V PE +++
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFVAPEVLER 194
Query: 614 GIYSMKYDVYSFGVLL 629
Y D++S GVLL
Sbjct: 195 QGYDAACDIWSLGVLL 210
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-20
Identities = 68/318 (21%), Positives = 114/318 (35%), Gaps = 62/318 (19%)
Query: 419 TPNLQVFSFSDIKAATNNFSSAN---------KLGEGGFGPVYKG-NLPRGQEFAVKRLS 468
+VF F D+ + LG G G V ++ A++ +S
Sbjct: 110 LSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS 169
Query: 469 --------ATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDL 520
A + E+ + +L H ++++ + D ++ E + L
Sbjct: 170 KRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGEL-- 226
Query: 521 YLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL---DNELNP 576
FD + L + + YL E +IHRDLK N+LL + +
Sbjct: 227 --FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLI 281
Query: 577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE---YVKKGIYSMKYDVYSFGVLLLQII 633
KI+DFG +K+ + T + GT Y+ PE V Y+ D +S GV+L +
Sbjct: 282 KITDFGHSKIL-GETSLMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338
Query: 634 S-----SKRNARYYGTSENLNFLEYAFEQWKDSKGK-EFIDPSLDDSSSPCK-LLNCMQV 686
S S+ T +L +Q GK FI + S L+ +
Sbjct: 339 SGYPPFSEHR-----TQVSL------KDQIT--SGKYNFIPEVWAEVSEKALDLVKKL-- 383
Query: 687 ALLCVQENPEDRPSMLEV 704
L V +P+ R + E
Sbjct: 384 --LVV--DPKARFTTEEA 397
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 7e-20
Identities = 51/243 (20%), Positives = 104/243 (42%), Gaps = 27/243 (11%)
Query: 404 TPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEF 462
YF S P ++ ++ K + + +G G V + + G EF
Sbjct: 63 DAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEF 122
Query: 463 AVKRLSATSTQG--------LEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYL 513
AVK + T+ + E + E + ++ H +++ ++ L+++ +
Sbjct: 123 AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLM 182
Query: 514 PNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN 572
L FD + + L ++ +I+ + + + +L ++HRDLK NILLD+
Sbjct: 183 RKGEL----FDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDD 235
Query: 573 ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI------YSMKYDVYSFG 626
+ ++SDFG + ++ + GT GY+ PE +K + Y + D+++ G
Sbjct: 236 NMQIRLSDFGFSCHLEPG-EKLRE--LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292
Query: 627 VLL 629
V+L
Sbjct: 293 VIL 295
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 68/314 (21%), Positives = 118/314 (37%), Gaps = 96/314 (30%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLS--------------------------ATSTQGL 475
+G+G +G V N +A+K LS +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 476 EEFKNEVSLTARLQHVNLLR---VLGYCTERDENMLIYEYLPNKSLDLYLFDPI------ 526
E+ E+++ +L H N+++ VL E D +++E + + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNE-DHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 527 ----RRYVLDWQKRVNIIEGVTQGLLYLQEYS-NFRVIHRDLKASNILLDNELNPKISDF 581
R Y D +I+G+ EY ++IHRD+K SN+L+ + + KI+DF
Sbjct: 136 EDQARFYFQD------LIKGI--------EYLHYQKIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYV--KKGIYS-MKYDVYSFGVLLLQIISSKRN 638
G++ F+ + VGT ++ PE + + I+S DV++ GV L
Sbjct: 182 GVSNEFKGSDALLSN--TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL--------- 230
Query: 639 ARY---YGT----SENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCK-LLNCMQVALLC 690
Y +G E + L ++ K P D + K L+ M L
Sbjct: 231 --YCFVFGQCPFMDERIMCL-HS----KIKSQ-ALEFPDQPDIAEDLKDLITRM----LD 278
Query: 691 VQENPEDRPSMLEV 704
NPE R + E+
Sbjct: 279 K--NPESRIVVPEI 290
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 55/210 (26%), Positives = 86/210 (40%), Gaps = 37/210 (17%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYC 500
LGEG V NL QE+AVK + EV + + Q H N+L ++ +
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN--------IIEGVTQGLLYLQE 552
E D L++E + S+ I KR + +++ V L +L
Sbjct: 81 EEEDRFYLVFEKMRGGSI----LSHI-------HKRRHFNELEASVVVQDVASALDFLH- 128
Query: 553 YSNFRVIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGR-----IVGTYG 604
N + HRDLK NIL ++ KI DF + + + D + G+
Sbjct: 129 --NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 605 YVPPEYVKKG-----IYSMKYDVYSFGVLL 629
Y+ PE V+ IY + D++S GV+L
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 58/214 (27%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVK---RLSATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
LG G FG V G + G + AVK R S + + K E+ +H ++++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK--- 75
Query: 499 YCTERDENMLIYEYLPNKSLDLY----------LFDPI-----------RRYVLDWQKRV 537
+Y+ + + D + LFD I RR Q
Sbjct: 76 ----------LYQVISTPT-DFFMVMEYVSGGELFDYICKHGRVEEMEARRLF--QQ--- 119
Query: 538 NIIEGVTQGLLYLQEYS-NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
I+ V +Y V+HRDLK N+LLD +N KI+DFG++ + + T
Sbjct: 120 -ILSAV--------DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRT 169
Query: 597 GRIVGTYGYVPPEYVKKGIYS-MKYDVYSFGVLL 629
G+ Y PE + +Y+ + D++S GV+L
Sbjct: 170 --SCGSPNYAAPEVISGRLYAGPEVDIWSCGVIL 201
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 43/206 (20%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQH---VNLLRV 496
+G+G F V ++ G+E A+K + T + L++ EV + L H V L V
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPI-----------RRYVLDWQKRVNIIEGVTQ 545
+ TE+ + I EY + FD + R Q I+ V
Sbjct: 83 IE--TEKTLYL-IMEYASGGEV----FDYLVAHGRMKEKEARSKF--RQ----IVSAV-- 127
Query: 546 GLLYLQEYS-NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
+Y R++HRDLKA N+LLD ++N KI+DFG + F + + G
Sbjct: 128 ------QYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDA--FCGAPP 178
Query: 605 YVPPEYVKKGIYS-MKYDVYSFGVLL 629
Y PE + Y + DV+S GV+L
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVIL 204
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 46/201 (22%), Positives = 85/201 (42%), Gaps = 26/201 (12%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHV-NLLRVL 497
+LG G F V + + GQE+A K + E +E+++ + ++ +
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKR------VNIIEGVTQGLLYLQ 551
E +LI EY + F + + + + +I+ + +G+ YL
Sbjct: 96 EVYENTSEIILILEYAAGGEI----FSLC---LPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 552 EYSNFRVIHRDLKASNILLDN--ELNP-KISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
+ ++H DLK NILL + L KI DFGM++ E I+GT Y+ P
Sbjct: 149 QN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELRE--IMGTPEYLAP 202
Query: 609 EYVKKGIYSMKYDVYSFGVLL 629
E + + D+++ G++
Sbjct: 203 EILNYDPITTATDMWNIGIIA 223
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 57/213 (26%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVK---RLSATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
LGEG FG V + Q+ A+K R + + E+S L+H ++++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK--- 73
Query: 499 YCTERDENMLIYEYLPNKSLDLY---------LFDPI-----------RRYVLDWQKRVN 538
+Y+ + + D+ LFD I RR+ Q
Sbjct: 74 ----------LYDVITTPT-DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFF--QQ---- 116
Query: 539 IIEGVTQGLLYLQEYS-NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG 597
II + EY +++HRDLK N+LLD+ LN KI+DFG++ + + T
Sbjct: 117 IICAI--------EYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKT- 166
Query: 598 RIVGTYGYVPPEYVKKGIYS-MKYDVYSFGVLL 629
G+ Y PE + +Y+ + DV+S G++L
Sbjct: 167 -SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVL 198
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 5e-19
Identities = 56/190 (29%), Positives = 91/190 (47%), Gaps = 34/190 (17%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN--------EVSLT 485
NF K+GEG +G VYK N G+ A+K++ L+ E+SL
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
L H N++++L ++ L++E+L DL +++ +D I + +
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFL---HQDL------KKF-MDASALTGIPLPLIK 106
Query: 546 GLLY--LQ--EY--SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRI 599
L+ LQ + S+ RV+HRDLK N+L++ E K++DFG+A+ F V T +
Sbjct: 107 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEV 164
Query: 600 VGTYGYVPPE 609
V T Y PE
Sbjct: 165 V-TLWYRAPE 173
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 5e-19
Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 45/216 (20%)
Query: 431 KAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKN--------EV 482
+ + K+GEG +G VYK +G+ A+KR+ L+ E+
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREI 70
Query: 483 SLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDL--YL------FDP--IRRYVLD 532
SL L H N++ ++ L++E++ DL L I+ Y+
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERCLTLVFEFME---KDLKKVLDENKTGLQDSQIKIYL-- 125
Query: 533 WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592
+Q + +G+ + + + R++HRDLK N+L++++ K++DFG+A+ F V
Sbjct: 126 YQ--------LLRGVAHC--HQH-RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV- 173
Query: 593 EANTGRIVGTYGYVPPEYVKKG--IYSMKYDVYSFG 626
+ T +V T Y P+ V G YS D++S G
Sbjct: 174 RSYTHEVV-TLWYRAPD-VLMGSKKYSTSVDIWSIG 207
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 91.1 bits (225), Expect = 6e-19
Identities = 99/656 (15%), Positives = 194/656 (29%), Gaps = 196/656 (29%)
Query: 116 SVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASD 175
S+LS D I S + LFW + + + ++E +
Sbjct: 44 SILSKEEIDH-----IIMSKDAVSGTL-----RLFWTLLSKQE-EMVQKFVEE--VLRIN 90
Query: 176 QPELTLSMAVRY-SPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPS 234
L + P+ T Y I+ + N + A Y++ + + AL
Sbjct: 91 YKFLMSPIKTEQRQPSMMTRMY-IEQRDRLYNDNQVFA-KYNVSRLQPYLKLRQALLE-- 146
Query: 235 SNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYG----AA 290
LR + IDG + G G A
Sbjct: 147 ------------LR--------------PAKNVLIDG-VL-----------GSGKTWVAL 168
Query: 291 PVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAAQ 350
V + V W+N + + + + LL +Q+ + ++
Sbjct: 169 DVCLSYKVQCKMDFKIFWLNLKNCNSPETVL--EMLQKLL----YQIDPNWTSRSDHSSN 222
Query: 351 IEENNDKDKQRLLLLIL---LPIGLVLIL----IASLICYFRRTAIKSKVMIILGRRNLR 403
I+ + L L+ L L+L A F + K+++
Sbjct: 223 IKLRIHSIQAELRRLLKSKPYENCL-LVLLNVQNAKAWNAF---NLSCKILLT------- 271
Query: 404 TPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGP------------V 451
T QV F + AAT S + P
Sbjct: 272 ---------------TRFKQVTDF--LSAATTTHISLDHH-SMTLTPDEVKSLLLKYLDC 313
Query: 452 YKGNLPR----GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN---LLRVLGYCTERD 504
+LPR + ++ ++ ++ +HVN L ++
Sbjct: 314 RPQDLPREVLTTNPRRLSIIAE-------SIRDGLATWDNWKHVNCDKLTTIIESSLNVL 366
Query: 505 ENMLIYEYLPNKSLDLYLFD-----PIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
E + L +F P L W ++I+ + + + + ++
Sbjct: 367 EPAEYRKMF----DRLSVFPPSAHIPTILLSLIWF---DVIKSDVM--VVVNKLHKYSLV 417
Query: 560 HRDLKASNILLDN---ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE---YVKK 613
+ K S I + + EL K+ + L R VD N + + +PP Y
Sbjct: 418 EKQPKESTISIPSIYLELKVKLEN--EYALHRSIVDHYNIPKTFDSDDLIPPYLDQY--- 472
Query: 614 GIYSMKYDVY------------SFGVLLLQI--ISSKRNARYYGTSEN-----LNFLE-- 652
YS + + F ++ L + K R+ T+ N LN L+
Sbjct: 473 -FYS--HIGHHLKNIEHPERMTLFRMVFLDFRFLEQK--IRHDSTAWNASGSILNTLQQL 527
Query: 653 --Y---------AFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPED 697
Y +E+ ++ +F+ P ++++ K + +++AL+ ++
Sbjct: 528 KFYKPYICDNDPKYERLVNAI-LDFL-PKIEENLICSKYTDLLRIALM----AEDE 577
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 4e-08
Identities = 58/427 (13%), Positives = 116/427 (27%), Gaps = 96/427 (22%)
Query: 351 IEENNDKDKQRLLLLILLPIGLVLILIASLICYFRRTAIKSKVMIILGRRNLRTPGTSTP 410
I + L LL ++ F ++ ++ S
Sbjct: 55 IMSKDAVSGTLRLFWTLLSKQ------EEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMM 108
Query: 411 AAEYFDSDTP---NLQVFS---------FSDIKAATNNFSSANKL---GEGGFGPVYKGN 455
Y + + QVF+ + ++ A A + G G G K
Sbjct: 109 TRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTW 165
Query: 456 LPRGQEFAVKRLSATSTQGLEEFKNEVS-LTARLQHVNLLRVLGYCTERDENMLIYEYLP 514
+ A+ + Q + ++ L L C + + + + L
Sbjct: 166 V------ALDVCLSYKVQ--CKMDFKIFWLN-----------LKNCNSPETVLEMLQKL- 205
Query: 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL 574
LY DP +W R + + + +Q + + + ++L N
Sbjct: 206 -----LYQIDP------NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQ 254
Query: 575 NPKIS---DFGMAKLF--RK-----DVDEANTGRIV---GTYGYVPPE-------YVKKG 614
N K + L R + A T I + P E Y+
Sbjct: 255 NAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCR 314
Query: 615 IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS 674
+ +V + L II+ + L + ++ K I+ SL +
Sbjct: 315 PQDLPREVLTTNPRRLSIIAES-------IRDGLATWDN-WKHVNCDKLTTIIESSL-NV 365
Query: 675 SSPCKLLNC-MQVALLCVQENPEDRPSMLEVSSML-----KDDSMAIAAPKRPAFSAKGD 728
P + ++++ P + S++ K D M + +
Sbjct: 366 LEPAEYRKMFDRLSVF-----PPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ 420
Query: 729 ENAETSS 735
T S
Sbjct: 421 PKESTIS 427
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 7e-19
Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 40/200 (20%)
Query: 429 DIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN------- 480
D+K+ + + LGEG F VYK + Q A+K++ E K+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHR---SEAKDGINRTAL 60
Query: 481 -EVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDL--YL------FDP--IRRY 529
E+ L L H N++ +L + L+++++ DL + P I+ Y
Sbjct: 61 REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME---TDLEVIIKDNSLVLTPSHIKAY 117
Query: 530 VLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589
+ QGL YL + + ++HRDLK +N+LLD K++DFG+AK F
Sbjct: 118 M--LM--------TLQGLEYL--HQH-WILHRDLKPNNLLLDENGVLKLADFGLAKSF-G 163
Query: 590 DVDEANTGRIVGTYGYVPPE 609
+ A T ++V T Y PE
Sbjct: 164 SPNRAYTHQVV-TRWYRAPE 182
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 9e-19
Identities = 45/219 (20%), Positives = 77/219 (35%), Gaps = 62/219 (28%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVK--------RLSATSTQGLEEFKNEVSLTARLQHVNL 493
LG G FG V+ + + +E VK L + E+++ +R++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLY-----------LFDPI-----------RRYVL 531
++ + + N+ LF I
Sbjct: 92 IK-------------VLDIFENQG-FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF- 136
Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
Q ++ V YL+ +IHRD+K NI++ + K+ DFG A +
Sbjct: 137 -RQ----LVSAVG----YLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG- 183
Query: 592 DEANTGRIVGTYGYVPPEYVKKGIYS-MKYDVYSFGVLL 629
T GT Y PE + Y + +++S GV L
Sbjct: 184 KLFYT--FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 9e-19
Identities = 52/193 (26%), Positives = 87/193 (45%), Gaps = 42/193 (21%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKN--------EVSLTA 486
+ K+GEG +G VYK G+ FA+K++ LE+ E+S+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 487 RLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDL--YL------FDP--IRRYVLDWQKR 536
L+H N++++ + +L++E+L DL L + + ++ Q
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHL---DQDLKKLLDVCEGGLESVTAKSFL--LQ-- 108
Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
+ G+ Y + RV+HRDLK N+L++ E KI+DFG+A+ F V T
Sbjct: 109 ------LLNGIAYC--HDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYT 158
Query: 597 GRIVGTYGYVPPE 609
IV T Y P+
Sbjct: 159 HEIV-TLWYRAPD 170
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 1e-18
Identities = 48/194 (24%), Positives = 87/194 (44%), Gaps = 43/194 (22%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN--------EVSLT 485
+ K+GEG +G V+K N + A+KR+ L++ E+ L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDL--YL------FDP--IRRYVLDWQK 535
L+H N++R+ + L++E+ DL Y DP ++ ++ +Q
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFL--FQ- 109
Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
+ +GL + +S V+HRDLK N+L++ K+++FG+A+ F V
Sbjct: 110 -------LLKGLGFC--HSR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCY 158
Query: 596 TGRIVGTYGYVPPE 609
+ +V T Y PP+
Sbjct: 159 SAEVV-TLWYRPPD 171
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-18
Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 58/214 (27%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVK---RLSATSTQGLEEFKNEVSLTARLQHVNLLRVLG 498
LG G FG V G + G + AVK R S + + + E+ +H ++++
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK--- 80
Query: 499 YCTERDENMLIYEYLPNKSLDLY----------LFDPI-----------RRYVLDWQKRV 537
+Y+ + S D++ LFD I RR Q
Sbjct: 81 ----------LYQVISTPS-DIFMVMEYVSGGELFDYICKNGRLDEKESRRLF--QQ--- 124
Query: 538 NIIEGVTQGLLYLQEYS-NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
I+ GV +Y V+HRDLK N+LLD +N KI+DFG++ + + T
Sbjct: 125 -ILSGV--------DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRT 174
Query: 597 GRIVGTYGYVPPEYVKKGIYS-MKYDVYSFGVLL 629
G+ Y PE + +Y+ + D++S GV+L
Sbjct: 175 --SCGSPNYAAPEVISGRLYAGPEVDIWSSGVIL 206
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 49/204 (24%), Positives = 81/204 (39%), Gaps = 27/204 (13%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLS--------ATSTQGLEEFKNEVSLTARLQHVN 492
LG G G V ++ A+K +S A + E+ + +L H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQ 551
++++ + D ++ E + L FD + L + + YL
Sbjct: 77 IIKIKNFFDAEDYY-IVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131
Query: 552 EYSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP 608
E +IHRDLK N+LL + + KI+DFG +K+ + T + GT Y+ P
Sbjct: 132 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRT--LCGTPTYLAP 185
Query: 609 E---YVKKGIYSMKYDVYSFGVLL 629
E V Y+ D +S GV+L
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 49/197 (24%), Positives = 96/197 (48%), Gaps = 37/197 (18%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN--------EVSLT 485
+ + K+G+G FG V+K + GQ+ A+K++ +E K E+ +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70
Query: 486 ARLQHVNLLRVLGYCTERDENM--------LIYEYLPNKSLDL--YLFDPIRRYVLDWQK 535
L+H N++ ++ C + L++++ DL L + + ++ L K
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC---EHDLAGLLSNVLVKFTLSEIK 127
Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
+++ + GL Y+ + N +++HRD+KA+N+L+ + K++DFG+A+ F +
Sbjct: 128 --RVMQMLLNGLYYI--HRN-KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 596 ---TGRIVGTYGYVPPE 609
T R+V T Y PPE
Sbjct: 183 NRYTNRVV-TLWYRPPE 198
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-18
Identities = 49/211 (23%), Positives = 86/211 (40%), Gaps = 38/211 (18%)
Query: 434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHVN 492
+++ +G G FG V++ L E A+K++ + FKN E+ + ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93
Query: 493 LLRVLGYCTERDENM------LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT-- 544
++ + + + L+ EY+P +Y R + K + +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP---ETVY------RASRHYAKLKQTMPMLLIK 144
Query: 545 -------QGLLYLQEYSNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEANT 596
+ L Y+ + + HRD+K N+LLD K+ DFG AK+ E N
Sbjct: 145 LYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA--GEPNV 199
Query: 597 GRIVGTYGYVPPEYVKKGI-YSMKYDVYSFG 626
I Y Y PE + Y+ D++S G
Sbjct: 200 SYICSRY-YRAPELIFGATNYTTNIDIWSTG 229
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 55/292 (18%), Positives = 106/292 (36%), Gaps = 71/292 (24%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGY 499
LG G G V + + GQ+ A+K L + + + EV + +++ +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILD- 89
Query: 500 CTERDENMLIYEYLPNKSLDLY----------LFDPIRRYVLDW---QKRVNIIEGVTQG 546
+YE + + L LF I+ ++ I+ +
Sbjct: 90 ---------VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 547 LLYLQEYSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
+ +L ++ + HRD+K N+L + + K++DFG AK ++ T T
Sbjct: 141 IQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN--ALQT--PCYTP 193
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARY---------YGTSENLNFLEYA 654
YV PE + Y D++S GV++ Y Y +
Sbjct: 194 YYVAPEVLGPEKYDKSCDMWSLGVIM-----------YILLCGFPPFYSNTGQAIS-PGM 241
Query: 655 FEQWKDSKGK-EFIDPSLDDSSSPCK-LLNCMQVALLCVQENPEDRPSMLEV 704
+ + G+ F +P + S K L+ + L +P +R ++ +
Sbjct: 242 KRRIR--LGQYGFPNPEWSEVSEDAKQLIRLL----LKT--DPTERLTITQF 285
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 7e-18
Identities = 71/287 (24%), Positives = 109/287 (37%), Gaps = 50/287 (17%)
Query: 404 TPGTSTPAAEYFDSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVY----KGNLPRG 459
T P A P Q K +F LGEG F V
Sbjct: 4 TAAEPRPGAGSLQHAQPPPQ-----PRKKRPEDFKFGKILGEGSFSTVVLARELAT---S 55
Query: 460 QEFAVKRLSATSTQGLEEF---KNEVSLTARLQH---VNLLRVLGYCTERDENML--IYE 511
+E+A+K L + E + +RL H V L Y T +D+ L
Sbjct: 56 REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-----YFTFQDDEKLYFGLS 110
Query: 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ--------GLLYLQEYSNFRVIHRDL 563
Y N L IR+ + E T+ L YL +IHRDL
Sbjct: 111 YAKNGEL----LKYIRK-----IGSFD--ETCTRFYTAEIVSALEYLHGKG---IIHRDL 156
Query: 564 KASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVY 623
K NILL+ +++ +I+DFG AK+ + +A VGT YV PE + + D++
Sbjct: 157 KPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLW 216
Query: 624 SFGVLLLQIISSK---RNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667
+ G ++ Q+++ R Y + + LEY F + K ++ +
Sbjct: 217 ALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLV 263
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 9e-18
Identities = 56/198 (28%), Positives = 83/198 (41%), Gaps = 47/198 (23%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN--------EVSLT 485
+ + KLGEG +G VYK + + A+KR+ LE + EVSL
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDL--YL-----FDP--IRRYVLDWQKR 536
LQH N++ + LI+EY DL Y+ I+ ++ +Q
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYA---ENDLKKYMDKNPDVSMRVIKSFL--YQ-- 140
Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP-----KISDFGMAKLFRKDV 591
+ G+ + +S R +HRDLK N+LL KI DFG+A+ F +
Sbjct: 141 ------LINGVNFC--HSR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191
Query: 592 DEANTGRIVGTYGYVPPE 609
T I+ T Y PPE
Sbjct: 192 -RQFTHEII-TLWYRPPE 207
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 47/193 (24%), Positives = 87/193 (45%), Gaps = 17/193 (8%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
+LG G VY+ + +A+K L T + + E+ + RL H N++++
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
E L+ E + L FD I + + + ++ + + + YL E ++
Sbjct: 118 ETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIV 170
Query: 560 HRDLKASNILL---DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
HRDLK N+L + KI+DFG++K+ + + GT GY PE ++ Y
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVE---HQVLMKTVCGTPGYCAPEILRGCAY 227
Query: 617 SMKYDVYSFGVLL 629
+ D++S G++
Sbjct: 228 GPEVDMWSVGIIT 240
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 51/214 (23%), Positives = 83/214 (38%), Gaps = 55/214 (25%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGY 499
LG G G V + N ++FA+K L + + EV L R +++R++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD- 122
Query: 500 CTERDENMLIYEYLPNKSLDLY----------LFDPIRRYVLDWQKRVN----------I 539
+YE L L LF I Q R + I
Sbjct: 123 ---------VYENLYAGRKCLLIVMECLDGGELFSRI-------QDRGDQAFTEREASEI 166
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRKDVDEAN 595
++ + + + YL + + HRD+K N+L ++ P K++DFG AK +
Sbjct: 167 MKSIGEAIQYLHSIN---IAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSH-NSLT 221
Query: 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
T T YV PE + Y D++S GV++
Sbjct: 222 T--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 61/303 (20%), Positives = 107/303 (35%), Gaps = 64/303 (21%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTA------- 486
+ + +GEG +G V K N G+ A+K+ + V A
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL------ESDDDKMVKKIAMREIKLL 78
Query: 487 -RLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
+L+H NL+ +L C ++ L++E++ + + LD+Q + +
Sbjct: 79 KQLRHENLVNLLEVCKKKKRWYLVFEFV---DHTILDDLELFPNGLDYQVVQKYLFQIIN 135
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
G+ + +S+ +IHRD+K NIL+ K+ DFG A+ + + T Y
Sbjct: 136 GIGFC--HSH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYDDEVA-TRWY 190
Query: 606 VPPEY-VKKGIYSMKYDVYSFGVLL------------------LQIISSKRNARYYGT-- 644
PE V Y DV++ G L+ L I G
Sbjct: 191 RAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM-----MCLGNLI 245
Query: 645 -------SENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPED 697
++N F + K+ + E P L + L + +P+
Sbjct: 246 PRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVV--IDLAKKC------LHIDPDK 297
Query: 698 RPS 700
RP
Sbjct: 298 RPF 300
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 23/189 (12%)
Query: 432 AATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN-----EVSLT 485
++++ F KLG G + VYKG N G A+K + S +G E+SL
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISLM 57
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDL--YLFDPIRRYVLDWQKRVNI---I 540
L+H N++R+ ++ L++E++ DL Y+ + +
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFM---DNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
+ QGL + + N +++HRDLK N+L++ K+ DFG+A+ F V + +V
Sbjct: 115 WQLLQGLAFC--HEN-KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV-NTFSSEVV 170
Query: 601 GTYGYVPPE 609
T Y P+
Sbjct: 171 -TLWYRAPD 178
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 44/194 (22%), Positives = 71/194 (36%), Gaps = 43/194 (22%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN--------EVSLT 485
+ K+GEG +G V+K N GQ A+K+ E E+ +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56
Query: 486 ARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLY--------LFDP--IRRYVLDWQK 535
+L+H NL+ +L + L++EY + ++ WQ
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYC---DHTVLHELDRYQRGVPEHLVKSIT--WQ- 110
Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
Q + + + + IHRD+K NIL+ K+ DFG A+L D
Sbjct: 111 -------TLQAVNFC--HKH-NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YY 159
Query: 596 TGRIVGTYGYVPPE 609
+ T Y PE
Sbjct: 160 DDEVA-TRWYRSPE 172
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 50/191 (26%), Positives = 88/191 (46%), Gaps = 36/191 (18%)
Query: 442 KLGEGGFGPVYKG---NLPRGQEFAVKR-----LSATSTQGLEEFKNEVSLTARLQHVNL 493
K+G G +G VYK + +++A+K+ +S ++ + E++L L+H N+
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-------EIALLRELKHPNV 80
Query: 494 LRVLGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT------- 544
+ + + L+++Y DL+ R +K V + G+
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 545 -QGLLYLQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRKDVDE-ANTGR 598
G+ YL ++N V+HRDLK +NIL+ E KI+D G A+LF + A+
Sbjct: 138 LDGIHYL--HAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
Query: 599 IVGTYGYVPPE 609
+V T+ Y PE
Sbjct: 195 VVVTFWYRAPE 205
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 4e-17
Identities = 56/235 (23%), Positives = 96/235 (40%), Gaps = 26/235 (11%)
Query: 409 TPAAEYFDSDTPN--LQVFSFSDIKAATNNFSSANKLGEGGFGPVY----KGNLPRGQEF 462
P E+ DS LQ + F LG GGFG V+ K G+ +
Sbjct: 157 APFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKAT---GKLY 213
Query: 463 AVKRLS---ATSTQGLEEFKNEVSLTARLQH---VNLLRVLGYCTERDENM-LIYEYLPN 515
A K+L+ +G + E + A++ V+L Y E ++ L+ +
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA----YAFETKTDLCLVMTIMNG 269
Query: 516 KSLDLYLFDPIRRYVLDWQKRVNI-IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL 574
+ ++++ + R + GL +L + +I+RDLK N+LLD++
Sbjct: 270 GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDG 326
Query: 575 NPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
N +ISD G+A + + GT G++ PE + Y D ++ GV L
Sbjct: 327 NVRISDLGLAVELKAGQTKTKG--YAGTPGFMAPELLLGEEYDFSVDYFALGVTL 379
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 5e-17
Identities = 51/173 (29%), Positives = 76/173 (43%), Gaps = 27/173 (15%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
V +G+ +L ++ + IHRDL A NILL + KI DFG+A+ KD D G
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD---- 254
Query: 603 YGYVP-----PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQ 657
+P PE + +Y+++ DV+SFGVLL +I S + Y G + F E
Sbjct: 255 -ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRRLKE- 311
Query: 658 WKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
G P + ++ M L C P RP+ E+ L +
Sbjct: 312 -----GTRMRAPD----YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 352
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 7e-17
Identities = 52/214 (24%), Positives = 89/214 (41%), Gaps = 43/214 (20%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHV 491
+++ +G G FG VY+ G+ A+K++ + FKN E+ + +L H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 492 NLLRVLGYCTERDENM------LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT- 544
N++R+ + E L+ +Y+P +Y R + + + +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP---ETVY------RVARHYSRAKQTLPVIYV 158
Query: 545 --------QGLLYLQEYSNFRVIHRDLKASNILLDNELNP-KISDFGMAKLFRKDVDEAN 595
+ L Y+ +F + HRD+K N+LLD + K+ DFG AK + E N
Sbjct: 159 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPN 213
Query: 596 TGRIVGTYGYVPPEYV---KKGIYSMKYDVYSFG 626
I Y Y PE + Y+ DV+S G
Sbjct: 214 VSYICSRY-YRAPELIFGATD--YTSSIDVWSAG 244
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 7e-17
Identities = 62/230 (26%), Positives = 97/230 (42%), Gaps = 21/230 (9%)
Query: 410 PAAEYFDSDTPN--LQVFSFSDIKAATNNFSSANKLGEGGFGPVY----KGNLPRGQEFA 463
P A+Y DS N LQ N F LG+GGFG V + G+ +A
Sbjct: 157 PFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRAT---GKMYA 213
Query: 464 VKRLS---ATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM-LIYEYLPNKSLD 519
K+L +G NE + ++ ++ L Y E + + L+ + L
Sbjct: 214 CKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LAYAYETKDALCLVLTLMNGGDLK 272
Query: 520 LYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKIS 579
+++ + + + E + GL L R+++RDLK NILLD+ + +IS
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAE-ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRIS 328
Query: 580 DFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
D G+A + VGT GY+ PE VK Y+ D ++ G LL
Sbjct: 329 DLGLAVHVPEG-QTIKG--RVGTVGYMAPEVVKNERYTFSPDWWALGCLL 375
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 9e-17
Identities = 49/191 (25%), Positives = 81/191 (42%), Gaps = 38/191 (19%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKN-----EVSLTARL 488
+ +KLGEG + VYKG A+K + +G EVSL L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAIREVSLLKDL 57
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDL--YL------FDP--IRRYVLDWQKRVN 538
+H N++ + L++EYL DL YL + ++ ++ +Q
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYL---DKDLKQYLDDCGNIINMHNVKLFL--FQ---- 108
Query: 539 IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598
+ +GL Y +V+HRDLK N+L++ K++DFG+A+ +
Sbjct: 109 ----LLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYDNE 160
Query: 599 IVGTYGYVPPE 609
+V T Y PP+
Sbjct: 161 VV-TLWYRPPD 170
|
| >3n12_A Chitinase A, chinctu2; zinc atoms, complex, hydrolase; 1.20A {Bacillus cereus} PDB: 3n11_A 3n15_A* 3n13_A* 3n17_A* 3n18_A* 3n1a_A* Length = 333 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 57/325 (17%), Positives = 98/325 (30%), Gaps = 67/325 (20%)
Query: 31 GYWLAGRE----FPLSDINSALFTHLICAFAEV--DSSTYQLSISSANQQYFSIFANSVR 84
GYW L D++ + + +F E D ST + S F + ++
Sbjct: 11 GYWHNFDNGTGIIKLKDVSPK-WDVINVSFGETGGDRSTVEFSPVYGTDADFKSDISYLK 69
Query: 85 RKNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLY 142
K K +LSI NG ++ D++ + FI S Y
Sbjct: 70 SKG--KKVVLSIGGQNG-------------------VVLLPDNAAKDRFINSIQSLIDKY 108
Query: 143 GFQGIDLFWLWPNS-------------TDLNSLGILLDEWKASASDQPELTLSMA----- 184
GF GID+ + +L + P+ LSMA
Sbjct: 109 GFDGIDIDLESGIYLNGNDTNFKNPTTPQIVNLISAIRTISDHYG--PDFLLSMAPETAY 166
Query: 185 -----VRYSPTHETVSYPIDSMKKNLNWAHLVAYDYH--MPSKENVTGIHAALYNPSSNI 237
Y I +K L + H+ Y+ + N A Y +
Sbjct: 167 VQGGYSAYGSIWGAYLPIIYGVKDKLTYIHVQHYNAGSGIGMDGNNYNQGTADYEVAMAD 226
Query: 238 -----STDFGIREWLRRGFPANKLVLGARASGP----GITIDGSMGYKFIRAFIQNYGYG 288
G + ++++++G A+ G I + K + I+ +G
Sbjct: 227 MLLHGFPVGGNANNIFPALRSDQVMIGLPAAPAAAPSGGYISPTEMKKALNYIIKGVPFG 286
Query: 289 AAPVYNASYVVNLFTSGATW-INFD 312
+ F +W IN+D
Sbjct: 287 GKYKLSNQSGYPAFRGLMSWSINWD 311
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 51/213 (23%), Positives = 78/213 (36%), Gaps = 58/213 (27%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
+G G FG + + AVK + + E + E+ L+H N++R
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAID-ENVQREIINHRSLRHPNIVR------ 80
Query: 502 ERDENMLIYEYLPNKSLDLY----------LFDPI-----------RRYVLDWQKRVNII 540
E + + L L++ I R + Q ++
Sbjct: 81 -------FKEVILTPT-HLAIIMEYASGGELYERICNAGRFSEDEARFFF--QQ----LL 126
Query: 541 EGVTQGLLYLQEYS-NFRVIHRDLKASNILLDNELNP--KISDFGMAKLFRKDVDEANTG 597
GV Y + ++ HRDLK N LLD P KI DFG +K + +
Sbjct: 127 SGV--------SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS- 176
Query: 598 RIVGTYGYVPPEYVKKGIYS-MKYDVYSFGVLL 629
VGT Y+ PE + + Y DV+S GV L
Sbjct: 177 -TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTL 208
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 34/214 (15%)
Query: 433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS-ATSTQGLEEFKN----EVSLTA 486
AT+ + ++G G +G VYK + G A+K + G EV+L
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 487 RLQ---HVNLLRVLGYCTERDEN-----MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVN 538
RL+ H N++R++ C + L++E++ DL R LD
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV---DQDL-------RTYLDKAPPPG 116
Query: 539 IIEGVTQGLLY--LQ--EY--SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592
+ + L+ L+ ++ +N ++HRDLK NIL+ + K++DFG+A+++
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGTVKLADFGLARIY--SYQ 173
Query: 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFG 626
A T +V T Y PE + + Y+ D++S G
Sbjct: 174 MALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVG 206
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 52/216 (24%), Positives = 95/216 (43%), Gaps = 44/216 (20%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR--GQEFAVKRLSATSTQGLEEFKN--------EVSL 484
+ ++GEG +G V+K + G+ A+KR+ ++ + EV++
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64
Query: 485 TARLQ---H---VNLLRVLGYCTERDEN--MLIYEYLPNKSLDLYLFDPIRRYVLDWQKR 536
L+ H V L V E L++E++ DL LD
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV---DQDL-------TTYLDKVPE 114
Query: 537 VNIIEGVTQGLLY--LQ--EY--SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590
+ + +++ L+ ++ S+ RV+HRDLK NIL+ + K++DFG+A+++
Sbjct: 115 PGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIY--S 171
Query: 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFG 626
A T +V T Y PE + + Y+ D++S G
Sbjct: 172 FQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVG 206
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 1e-15
Identities = 56/241 (23%), Positives = 96/241 (39%), Gaps = 37/241 (15%)
Query: 408 STPAAEYFDSDTPNLQVFSF---SDIKAATNNFSSANKLGEGGFGPVY----KGNLPRGQ 460
++ +SD +I N+FS +G GGFG VY G+
Sbjct: 159 GDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADT---GK 215
Query: 461 EFAVKRLSATSTQGLEEFKNEVSLTAR----LQHVNLLRV-----LGYCTERDENM-LIY 510
+A+K L + K +L L V+ + Y + + I
Sbjct: 216 MYAMKCLDKKRIKM----KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 271
Query: 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNI-IEGVTQGLLYLQEYSNFRVIHRDLKASNIL 569
+ + L + ++ + + + + GL ++ V++RDLK +NIL
Sbjct: 272 DLMNGGDL----HYHLSQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANIL 324
Query: 570 LDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI-YSMKYDVYSFGVL 628
LD + +ISD G+A D + VGT+GY+ PE ++KG+ Y D +S G +
Sbjct: 325 LDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 380
Query: 629 L 629
L
Sbjct: 381 L 381
|
| >1edt_A Endo-beta-N-acetylglucosaminidase H, endo H; hydrolase (glucosidase); 1.90A {Streptomyces plicatus} SCOP: c.1.8.5 PDB: 1c90_A 1c8x_A 1c91_A 1c3f_A 1c92_A 1c8y_A 1c93_A Length = 271 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 33/247 (13%), Positives = 72/247 (29%), Gaps = 43/247 (17%)
Query: 38 EFPLSDINSALFTHLICAFAEVDSSTY-QLSISSANQQYFSIFANSVRR----KNPSIKT 92
++ L+D F + A ++ T + + N+ + N+V + + IK
Sbjct: 27 KYTLADGGGNAFDVAVIFAANINYDTGTKTAYLHFNENVQRVLDNAVTQIRPLQQQGIKV 86
Query: 93 LLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLF 150
LLS+ + +F + YG G+D
Sbjct: 87 LLSVLGNHQGAGFAN----------------FPSQQAASAFAKQLSDAVAKYGLDGVDFD 130
Query: 151 WLWPN-------STDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKK 203
+ + +S L+ +A+ P+ +S+ P +SY +
Sbjct: 131 DEYAEYGNNGTAQPNDSSFVHLVTALRAN---MPDKIISLYN-IGPAASRLSYGGVDVSD 186
Query: 204 NLNWAHLVAYDYHMPSKENVTGIHAALYNPSS------NISTDFGIREWLRRGFPANKLV 257
++A Y+ + + A +P++ + ST + L
Sbjct: 187 KFDYA---WNPYYGTWQVPGIALPKAQLSPAAVEIGRTSRSTVADLARRTVDEGYGVYLT 243
Query: 258 LGARASG 264
Sbjct: 244 YNLDGGD 250
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 55/234 (23%), Positives = 82/234 (35%), Gaps = 47/234 (20%)
Query: 419 TPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEE 477
+ N + + + F G+G FG V G G A+K++
Sbjct: 7 SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----- 61
Query: 478 FKN----EVSLTARLQHVN---LLRVLGYCTERDEN----MLIYEYLPNKSLDLYLFDPI 526
F+N + A L H N L ERD ++ EY+P L+
Sbjct: 62 FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRC--C 116
Query: 527 RRYVLDWQKRVNI-----IEGVTQGLLYLQEYSNFRVIHRDLKASNILLD---NELNPKI 578
R Y I + + + + L S V HRD+K N+L++ L K+
Sbjct: 117 RNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTL--KL 173
Query: 579 SDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI------YSMKYDVYSFG 626
DFG AK E N I Y Y PE + Y+ D++S G
Sbjct: 174 CDFGSAKKLSP--SEPNVAYICSRY-YRAPE-----LIFGNQHYTTAVDIWSVG 219
|
| >2y8v_A CHIC, class III chitinase, putative; afchic, hydrolase; 1.99A {Aspergillus fumigatus} Length = 290 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 36/254 (14%), Positives = 75/254 (29%), Gaps = 38/254 (14%)
Query: 25 QTWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQ--LSISSANQQYFSIFANS 82
QT PL N+ TH+I A ++ L+ + + ++
Sbjct: 20 QTLCPNRGD-YVSVLPL-VKNNTGVTHIIIAAFHLNEDPGHITLNDDPPDHEMYNPLWAE 77
Query: 83 VRR-KNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARL 141
V K +K + + +Y + GD + + + + R
Sbjct: 78 VPVLKRSGVKVMGMLGGAAQGSY--------------RCLDGDQEKFERYYQPLLAMVRR 123
Query: 142 YGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSM 201
+ G+DL L + L+D K + +++A + ++
Sbjct: 124 HQLDGLDLDV--EEEMSLPGIIRLIDRLKLDLG--DDFIITLAPVAA-----------AL 168
Query: 202 KKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGAR 261
N + ++ +A YN + +G+ ++V G
Sbjct: 169 LGIGNLSGFDYRQLEQQRGSKISWYNAQFYNGWGLAEDPRMYAAIVAQGWSPQRVVYGL- 227
Query: 262 ASGPGITIDGSMGY 275
+GS GY
Sbjct: 228 ---LTNPGNGSQGY 238
|
| >1nar_A Narbonin; plant SEED protein; 1.80A {Vicia narbonensis} SCOP: c.1.8.5 Length = 290 | Back alignment and structure |
|---|
Score = 74.4 bits (182), Expect = 1e-14
Identities = 44/257 (17%), Positives = 82/257 (31%), Gaps = 43/257 (16%)
Query: 37 REFPLSDINSALFT-HLICAFA-----EVDSSTYQLSISSANQQYFSIFANSVRRKNPSI 90
+FP IN+ H I FA E T S + + +++R++P +
Sbjct: 19 HDFPTEIINTETLEFHYILGFAIESYYESGKGTGTFEESWDVELFGPEKVKNLKRRHPEV 78
Query: 91 KTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGID 148
K ++SI N +P+ + V ++ I GID
Sbjct: 79 KVVISIGGRGV----------NTPFDPAEENVWVSNAKESLKLIIQKYSDDSGNLIDGID 128
Query: 149 LFWLWPNSTD--LNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLN 206
+ + S + +G L+ E K D +S+A P+ S+ +
Sbjct: 129 IHYEHIRSDEPFATLMGQLITELKKD-DDLNINVVSIA----PSENNSSHYQKLYNAKKD 183
Query: 207 WAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIR---EWLRRGFPANKLVLGARAS 263
+ + V Y + N +STD + L + + +K++ G
Sbjct: 184 YINWVDYQF---------------SNQQKPVSTDDAFVEIFKSLEKDYHPHKVLPGFSTD 228
Query: 264 GPGITIDGSMGYKFIRA 280
+ FI
Sbjct: 229 PLDTKHNKITRDIFIGG 245
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 46/209 (22%)
Query: 443 LGEGGFGPVY----KGNLPRGQEFAVKRLSATSTQGLEEFKN---EVSLTARLQH---VN 492
+G+G FG V + +A+K ++ E +N E+ + L+H VN
Sbjct: 23 IGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79
Query: 493 LLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ------ 545
L Y + +E+M ++ + L L RY L Q+ V+ E +
Sbjct: 80 LW----YSFQDEEDMFMVVDLLLGGDL---------RYHL--QQNVHFKEETVKLFICEL 124
Query: 546 --GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
L YLQ R+IHRD+K NILLD + I+DF +A + ++ + T + GT
Sbjct: 125 VMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITT--MAGTK 178
Query: 604 GYVPPEYVKKGI---YSMKYDVYSFGVLL 629
Y+ PE YS D +S GV
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTA 207
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 42/303 (13%), Positives = 86/303 (28%), Gaps = 60/303 (19%)
Query: 442 KLGEGGFGPVYKG---NLPRGQEFAVKRL---SATSTQGLEEFKNEVSLTARLQHVNLLR 495
G ++ L R + A+ + L+E + +R+ + R
Sbjct: 38 FHGGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
VL R +++ E++ SL + ++ +
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHR--- 147
Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI 615
V S + +S G L +P
Sbjct: 148 AGVALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPDA------ 179
Query: 616 YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSS 675
+ + D+ G L ++ ++ + + L A + I+P+ D
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWP---LPEAGVRSGLAPAERDTAG----QPIEPADIDRD 231
Query: 676 SPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAPKRPAFSAKGDENAETSS 735
P ++ VA VQ + R + + ++++ A A R DE A S+
Sbjct: 232 IPFQISA---VAARSVQGDGGIRSAS-TLLNLMQQ---ATAVADRTEVLGPIDE-APVSA 283
Query: 736 TSR 738
R
Sbjct: 284 APR 286
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 31/84 (36%), Positives = 47/84 (55%), Gaps = 5/84 (5%)
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
L +L +I+RDLK NILLD E + K++DFG++K +A + GT Y
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 192
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLL 629
+ PE V + ++ D +SFGVL+
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLM 216
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 26/84 (30%), Positives = 46/84 (54%), Gaps = 5/84 (5%)
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
L +L + +I+RDLK NI+L+++ + K++DFG+ K D +T GT Y
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEY 187
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLL 629
+ PE + + ++ D +S G L+
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALM 211
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 4e-12
Identities = 42/286 (14%), Positives = 75/286 (26%), Gaps = 64/286 (22%)
Query: 423 QVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST--------QG 474
FS T K+GEG FG V++ A+K ++ +
Sbjct: 9 GPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKT 66
Query: 475 LEEFKNEVSLTARLQ---------HVNLLRVLGYC-------------------TERDEN 506
EE E+ ++ L + + T+ N
Sbjct: 67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAN 126
Query: 507 MLIYEYLPNK-------SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
+ ++ + +R + +I+ +T L + F
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRF--E 184
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFR-----KDVDEANTGRIVGTYG-------YVP 607
HRDL N+LL K+ K V +
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSM 244
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEY 653
E + G ++D+Y L + Y N+ +L Y
Sbjct: 245 DEDLFTGDGDYQFDIYR-----LMKKENNNRWGEYHPYSNVLWLHY 285
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 5/87 (5%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
+ L++L + +I+RDLK N+LLD+E + K++DFGM K + T GT
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGT 187
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLL 629
Y+ PE +++ +Y D ++ GVLL
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLL 214
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 27/84 (32%), Positives = 42/84 (50%), Gaps = 5/84 (5%)
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
L YL V++RD+K N++LD + + KI+DFG+ K D T GT Y
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEY 171
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLL 629
+ PE ++ Y D + GV++
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVM 195
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 27/84 (32%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
L YL + +++RDLK NILLD++ + ++DFG+ K + +T GT Y
Sbjct: 151 ALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEY 205
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLL 629
+ PE + K Y D + G +L
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVL 229
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 8e-12
Identities = 30/84 (35%), Positives = 45/84 (53%), Gaps = 4/84 (4%)
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
L YL +S V++RDLK N++LD + + KI+DFG+ K KD T GT Y
Sbjct: 260 ALDYL--HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEY 315
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLL 629
+ PE ++ Y D + GV++
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVM 339
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 31/84 (36%), Positives = 47/84 (55%), Gaps = 5/84 (5%)
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
L YL E +I+RDLK N+LLD+E + K++D+GM K + D +T GT Y
Sbjct: 122 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNY 176
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLL 629
+ PE ++ Y D ++ GVL+
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLM 200
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 67.4 bits (164), Expect = 1e-11
Identities = 34/87 (39%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
+ GL +LQ +I+RDLK N++LD+E + KI+DFGM K D T GT
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGT 505
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLL 629
Y+ PE + Y D ++FGVLL
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLL 532
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 34/87 (39%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
+ GL +LQ +I+RDLK N++LD+E + KI+DFGM K D T GT
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGT 184
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLL 629
Y+ PE + Y D ++FGVLL
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLL 211
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 51/211 (24%), Positives = 85/211 (40%), Gaps = 31/211 (14%)
Query: 431 KAATNNFSSANKLGEGGFGPVY----KGNLPRGQEFAVKRLSAT---STQGLEEFKNEVS 483
A + F LG G FG V K + G +A+K L + +E NE
Sbjct: 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 484 LTARLQH---VNLLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRYVLDWQKRVN 538
+ + V L + +D + L + EY+ + +L I R+ R
Sbjct: 94 ILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEP-HARFY 146
Query: 539 IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598
+ + YL +I+RDLK N+L+D + +++DFG AK + T
Sbjct: 147 AAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWT-- 197
Query: 599 IVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
+ GT + PE + Y+ D ++ GVL+
Sbjct: 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLI 228
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 47/220 (21%), Positives = 97/220 (44%), Gaps = 41/220 (18%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH-- 490
+++ KLG G + V++ N+ ++ VK L + + K E+ + L++
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKI---LENLR 88
Query: 491 -----VNLLRVLGYCTERDENMLIYEYLPNKSLDLY-LFDP-----IRRYVLDWQKRVNI 539
+ L ++ R L++E++ N D L+ IR Y+ ++
Sbjct: 89 GGPNIITLADIVKDPVSRTP-ALVFEHVNN--TDFKQLYQTLTDYDIRFYM--YE----- 138
Query: 540 IEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDFGMAKLFRKDVDEANTGR 598
+ + L Y +S ++HRD+K N+++D+E ++ D+G+A+ + + R
Sbjct: 139 ---ILKALDYC--HSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPGQEYNVR 190
Query: 599 IVGTYGYVPPE-YVKKGIYSMKYDVYSFGVLLLQIISSKR 637
+ Y + PE V +Y D++S G +L +I K
Sbjct: 191 VASRY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 34/87 (39%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
+ GL +L +++RDLK NILLD + + KI+DFGM K + NT GT
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 181
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLL 629
Y+ PE + Y+ D +SFGVLL
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLL 208
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 50/218 (22%), Positives = 84/218 (38%), Gaps = 29/218 (13%)
Query: 428 SDIKAATNNFSSANKLGEGGFGPVY----KGNLPRGQEFAVKRLSATSTQGLEE---FKN 480
++ +F +G G FG V K + FA+K L+ E F+
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFRE 123
Query: 481 EVSLTARLQH---VNLLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKR 536
E + L Y + D N+ L+ +Y L L R + R
Sbjct: 124 ERDVLVNGDSKWITTLH----YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-AR 178
Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
+ E + + + + +HRD+K NIL+D + +++DFG +D +
Sbjct: 179 FYLAE-MVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQS 233
Query: 597 GRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLL 629
VGT Y+ PE ++ KG Y + D +S GV +
Sbjct: 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCM 271
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 31/84 (36%), Positives = 47/84 (55%), Gaps = 5/84 (5%)
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
L YL E +I+RDLK N+LLD+E + K++D+GM K + D +T GT Y
Sbjct: 165 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNY 219
Query: 606 VPPEYVKKGIYSMKYDVYSFGVLL 629
+ PE ++ Y D ++ GVL+
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLM 243
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 47/243 (19%), Positives = 92/243 (37%), Gaps = 69/243 (28%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN-EVSLTARLQHV 491
+ +S LG G FG V + ++ G+ FA+K++ +KN E+ + L HV
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHV 60
Query: 492 NLLRVLGYCTERDENM--------------------------------------LIYEYL 513
N+++++ Y + +I EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ--------GLLYLQEYSNFRVIHRDLKA 565
P L+ ++ ++ + I + + ++ + + HRD+K
Sbjct: 121 P---DTLHKV--LKSFIRSGRS---IPMNLISIYIYQLFRAVGFIH---SLGICHRDIKP 169
Query: 566 SNILLDNELNP-KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI-YSMKYDVY 623
N+L++++ N K+ DFG AK E + I + Y PE + Y+ D++
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKLIP--SEPSVAYICSRF-YRAPELMLGATEYTPSIDLW 226
Query: 624 SFG 626
S G
Sbjct: 227 SIG 229
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 46/205 (22%), Positives = 74/205 (36%), Gaps = 31/205 (15%)
Query: 443 LGEGGFGPVY----KGNLPRGQEFAVKRLSATSTQGLEE---FKNEVSLTARLQH---VN 492
+G G F V K GQ +A+K ++ E F+ E +
Sbjct: 69 IGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 493 LLRVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
L + + + + L+ EY L L R + R + E + + +
Sbjct: 126 LH----FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLAE-IVMAIDSVH 179
Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE-- 609
+HRD+K NILLD + +++DFG R D + VGT Y+ PE
Sbjct: 180 RLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD-GTVRSLVAVGTPDYLSPEIL 235
Query: 610 -----YVKKGIYSMKYDVYSFGVLL 629
G Y + D ++ GV
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFA 260
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 7e-11
Identities = 56/207 (27%), Positives = 86/207 (41%), Gaps = 47/207 (22%)
Query: 443 LGEGGFGPVY----KGNLPRGQEFAVKRLSATSTQGLEEF---KNEVSLTARLQH---VN 492
LG G FG V+ + N G+ +A+K L L++ +E + + + H +
Sbjct: 14 LGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 493 LLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ----- 545
+ + T +D + I +Y+ L L +K V +
Sbjct: 71 M-----WGTFQDAQQIFMIMDYIEGGELFSLL-----------RKSQRFPNPVAKFYAAE 114
Query: 546 ---GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
L YL +I+RDLK NILLD + KI+DFG AK D T + GT
Sbjct: 115 VCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVTYT--LCGT 166
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLL 629
Y+ PE V Y+ D +SFG+L+
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILI 193
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 43/206 (20%), Positives = 75/206 (36%), Gaps = 60/206 (29%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGY 499
LG G G V + N ++FA+K L + + EV L R Q +++R++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD- 78
Query: 500 CTERDENMLIYEYLPNKSLDLY----------LFDPIRRYVLDW---QKRVNIIEGVTQG 546
+YE L L LF I+ ++ I++ + +
Sbjct: 79 ---------VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNE---LNPKISDFGMAKLFRKDVDEANTGRIVGTY 603
+ YL + + HRD+K N+L ++ K++DFG A
Sbjct: 130 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA------------------- 167
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLL 629
E Y D++S GV++
Sbjct: 168 ----KE-TTGEKYDKSCDMWSLGVIM 188
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 9e-11
Identities = 34/199 (17%), Positives = 77/199 (38%), Gaps = 45/199 (22%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---------EVS 483
+ + + +G G +G V + + + A+K++ F++ E++
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104
Query: 484 LTARLQHVNLLRVLG-YCTERDENM----LIYEYLPNKSLDLY--------LFDPIRRYV 530
+ RL H ++++VL + E ++ E D L + + +
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD---SDFKKLFRTPVYLTELHIKTL 161
Query: 531 LDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590
L + + G+ Y+ S ++HRDLK +N L++ + + K+ DFG+A+
Sbjct: 162 L-YN--------LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209
Query: 591 VDEANTGRIVGTYGYVPPE 609
+ + I +
Sbjct: 210 ENGNSQLPISPREDDMNLV 228
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 27/76 (35%), Positives = 41/76 (53%), Gaps = 7/76 (9%)
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE-ANTGRIVGTYGYVPPE---YVKK 613
+I+RD+K NILLD+ + ++DFG++K F D E A GT Y+ P+
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD--FCGTIEYMAPDIVRGGDS 237
Query: 614 GIYSMKYDVYSFGVLL 629
G + D +S GVL+
Sbjct: 238 G-HDKAVDWWSLGVLM 252
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 55/220 (25%), Positives = 89/220 (40%), Gaps = 36/220 (16%)
Query: 428 SDIKAATNNFSSANKLGEGGFGPVY----KGNLPRGQEFAVKRLSATSTQGLEE---FKN 480
D++ ++ +G G FG V K + +A+K LS + F
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWE 118
Query: 481 EVSLTARLQH---VNLLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIRRYVLDWQK 535
E + A V L + +D+ L + EY+P L + + Y + +
Sbjct: 119 ERDIMAFANSPWVVQL-----FYAFQDDRYLYMVMEYMPGGDL----VNLMSNYDVPEKW 169
Query: 536 -RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK-LFRKDVDE 593
R E V L + IHRD+K N+LLD + K++DFG + ++ +
Sbjct: 170 ARFYTAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225
Query: 594 ANTGRIVGTYGYVPPEYVK----KGIYSMKYDVYSFGVLL 629
+T VGT Y+ PE +K G Y + D +S GV L
Sbjct: 226 CDT--AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 263
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 53/222 (23%), Positives = 86/222 (38%), Gaps = 41/222 (18%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---------EVS 483
+ + +G G G V + + A+K+LS F+N E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76
Query: 484 LTARLQHVN---LLRVLGYCTERDENMLIYEYLPNKSLDLY------LFDPIRRYVLDWQ 534
L + H N LL V +E +Y + +L L Y+L +Q
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL-YQ 135
Query: 535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594
+ G+ +L +S +IHRDLK SNI++ ++ KI DFG+A R
Sbjct: 136 --------MLCGIKHL--HSA-GIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSF 181
Query: 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
V T Y PE + Y D++S G ++ ++I
Sbjct: 182 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3ebv_A Chinitase A; chitinase A, CHIA, glycosidase, structural genomics, unknown function, hydrolase, PSI-2, protein structure initiative; 1.50A {Streptomyces coelicolor} Length = 302 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 44/246 (17%), Positives = 85/246 (34%), Gaps = 39/246 (15%)
Query: 30 AGYWLAGRE----FPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRR 85
GYW +SD+ SA + + AFA+ ++ ++ + + + +
Sbjct: 8 TGYWQNFNNGATVQKISDVPSA-YDIIAVAFADATTTPGAVTFNLDSAGLGGYTVDQFKA 66
Query: 86 -----KNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTAR 140
+ K ++S+ G+ T ++S S+ +F S R
Sbjct: 67 DVRAKQAAGKKVIISV-GGEKGTVS------------VNS----SASATNFANSVYSVMR 109
Query: 141 LYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVR---YSPTHETVSYP 197
YGF G+D+ N + + L A A P++ L+MA + T
Sbjct: 110 EYGFDGVDIDLE--NGLNPTYMTQALRALSAKAG--PDMILTMAPQTIDMQSTQGGYFQT 165
Query: 198 IDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLV 257
++K L ++ Y+ + G +Y + L G +++
Sbjct: 166 ALNVKDILTVVNMQYYNSG-----TMLGCDGKVYAQGTVDFLTALACIQLEGGLAPSQVG 220
Query: 258 LGARAS 263
LG AS
Sbjct: 221 LGLPAS 226
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 42/229 (18%), Positives = 88/229 (38%), Gaps = 42/229 (18%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---------EVS 483
+ + LG GG G V+ + + A+K++ + E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDP---------IRRYVLDWQ 534
+ RL H N+++V + + +Y+ + + L +
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120
Query: 535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMAKLFRKDVDE 593
+ + +GL Y+ + V+HRDLK +N+ ++ E L KI DFG+A++
Sbjct: 121 HARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
Query: 594 AN--TGRIVGTYGYVPPEYVKKGIYSMKY----DVYSFGVLLLQIISSK 636
+ +V T Y P + + Y D+++ G + ++++ K
Sbjct: 178 KGHLSEGLV-TKWYRSPRLL---LSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 13/159 (8%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH-VN 492
N + K+G G FG +Y G ++ G+E A+K + E + +Q V
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
+ + E D N+++ E L SL+ R++ L K V ++ Q + ++
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSL---KTVLLL--ADQMISRIEY 120
Query: 553 YSNFRVIHRDLKASNILLDNELNPK---ISDFGMAKLFR 588
+ IHRD+K N L+ I DFG+AK +R
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 49/229 (21%), Positives = 87/229 (37%), Gaps = 44/229 (19%)
Query: 434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEE--FKN---------EV 482
+ ++ + G +G V G G A+KR+ T + G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 483 SLTARLQHVNLLRVLG-YCTERDENM----LIYEYLPN------KSLDLYLFDPIRRYVL 531
L H N+L + + + M L+ E + + + +Y +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
+ + GL L E + V+HRDL NILL + + I DF +A R+D
Sbjct: 141 -YH--------ILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLA---REDT 185
Query: 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKY----DVYSFGVLLLQIISSK 636
+AN V Y PE V + + D++S G ++ ++ + K
Sbjct: 186 ADANKTHYVTHRWYRAPELV---MQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 50/216 (23%), Positives = 89/216 (41%), Gaps = 29/216 (13%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---------EVS 483
+ + +G G G V + + A+K+LS F+N E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113
Query: 484 LTARLQHVN---LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNII 540
L + H N LL V +E +Y + +L + + LD ++ ++
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC---QVIQMELDHERMSYLL 170
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
+ G+ +L + +IHRDLK SNI++ ++ KI DFG+A+ T V
Sbjct: 171 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPY-V 224
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
T Y PE + Y D++S G ++ +++ K
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 57/231 (24%), Positives = 102/231 (44%), Gaps = 55/231 (23%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---------EVS 483
+++ + +GEG +G V + A+K++S F++ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 484 LTARLQHVNLLRVLGYCT-ERDENM----LIYEYLPNKSLDLY-------LFDPIRRYVL 531
+ R +H N++ + E M ++ + + DLY L + Y L
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSNDHICYFL 134
Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
+Q + +GL Y+ +N V+HRDLK SN+LL+ + KI DFG+A++ D
Sbjct: 135 -YQ--------ILRGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
Query: 592 DEAN--TGRIVGTYGYVPPEYVKKGIYSMKY----DVYSFGVLLLQIISSK 636
D T V T Y PE + + S Y D++S G +L +++S++
Sbjct: 183 DHTGFLTEY-VATRWYRAPEIM---LNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 37/160 (23%), Positives = 60/160 (37%), Gaps = 13/160 (8%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
NF K+G G FG + G NL + A+K S + +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-YKQLGSGDGI 67
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
+V + N ++ E L SL+ R + L K V +I Q + ++
Sbjct: 68 PQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSL---KTVLMI--AIQLISRMEYV 121
Query: 554 SNFRVIHRDLKASNILLDNELNPK-----ISDFGMAKLFR 588
+ +I+RD+K N L+ N I DF +AK +
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 37/160 (23%), Positives = 66/160 (41%), Gaps = 13/160 (8%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
++ ++GEG FG +++G NL Q+ A+K S + +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT-YKLLAGCTGI 68
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
V + E N+L+ + L SL+ L R++ + K V + Q L +Q
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLG-PSLEDLLDLCGRKFSV---KTVAMA--AKQMLARVQSI 122
Query: 554 SNFRVIHRDLKASNILLDNELNPK-----ISDFGMAKLFR 588
+++RD+K N L+ + + DFGM K +R
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162
|
| >2ebn_A Endo-beta-N-acetylglucosaminidase F1; hydrolase(glucosidase); 2.00A {Elizabethkingia meningoseptica} SCOP: c.1.8.5 Length = 289 | Back alignment and structure |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 35/239 (14%), Positives = 77/239 (32%), Gaps = 41/239 (17%)
Query: 38 EFPLSDINSALFTHLICAFAEV--DSSTYQLSIS-SANQQYFSIFANSVRR--KNPSIKT 92
F L + L ++ A + D++ ++ +S + N Q+ + ++ IK
Sbjct: 28 NFTLKNSGKPLVDMVVLFSANINYDAANDKVFVSNNPNVQHLLTNRAKYLKPLQDKGIKV 87
Query: 93 LLSIW-NGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFW 151
+LSI N S ++ ++ K+F + T LY G+
Sbjct: 88 ILSILGNHDRSGIANL----------------STARAKAFAQELKNTCDLYNLDGVFFDD 131
Query: 152 LWPN----------STDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSM 201
+ + N+ L E K + P +++ V + + +
Sbjct: 132 EYSAYQTPPPSGFVTPSNNAAARLAYETKQA---MPNKLVTVYVYSRTSSFPTAVDGVNA 188
Query: 202 KKNLNWAHLVAYDYHMPSKENVTGIHAALYN-PSSNISTDFGIREWLRRGFPANKLVLG 259
+++A +DY ++ + L S +F + N + G
Sbjct: 189 GSYVDYA---IHDYGGSY--DLATNYPGLAKSGMVMSSQEFNQGRYATAQALRNIVTKG 242
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 42/159 (26%), Positives = 68/159 (42%), Gaps = 13/159 (8%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVN 492
N F K+G G FG +Y G N+ +E A+K + + E + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTG 64
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
+ V + E D N+L+ + L SL+ R+ L K V ++ Q + ++
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL---KTVLML--ADQMINRVEF 118
Query: 553 YSNFRVIHRDLKASNILLDNELNPK---ISDFGMAKLFR 588
+ +HRD+K N L+ I DFG+AK +R
Sbjct: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 52/226 (23%), Positives = 95/226 (42%), Gaps = 50/226 (22%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---------EVS 483
+ S +G G +G V + G++ A+K+LS F++ E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELL 75
Query: 484 LTARLQHVNLLRVLG--YCTERDENM----LIYEYLPNKSLDLY------LFDPIRRYVL 531
L +QH N++ +L N L+ ++ DL + +Y++
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT---DLQKIMGLKFSEEKIQYLV 132
Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
+Q + +GL Y+ V+HRDLK N+ ++ + KI DFG+A+
Sbjct: 133 -YQ--------MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH----A 176
Query: 592 DEANTGRIVGTYGYVPPEYV-KKGIYSMKYDVYSFGVLLLQIISSK 636
D TG V T Y PE + Y+ D++S G ++ ++++ K
Sbjct: 177 DAEMTGY-VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 46/223 (20%), Positives = 91/223 (40%), Gaps = 43/223 (19%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---------EVS 483
+ +G G +G V + G + A+K+L F++ E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELR 76
Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDP---------IRRYVLDWQ 534
L ++H N++ +L ++ + + D YL P ++ L
Sbjct: 77 LLKHMRHENVIGLL--------DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED 128
Query: 535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594
+ ++ + +GL Y+ +IHRDLK N+ ++ + KI DFG+A+ ++
Sbjct: 129 RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY 185
Query: 595 NTGRIVGTYGYVPPEYV-KKGIYSMKYDVYSFGVLLLQIISSK 636
V T Y PE + Y+ D++S G ++ ++I+ K
Sbjct: 186 -----VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3ian_A Chitinase; structural genomics, hydrolase, glycosidase, PSI-2, protein structure initiative; 1.75A {Lactococcus lactis subsp} Length = 321 | Back alignment and structure |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 36/301 (11%), Positives = 87/301 (28%), Gaps = 40/301 (13%)
Query: 30 AGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPS 89
GY + + +F + + N+ A +
Sbjct: 20 DGYKGGSSADFNLSSTQEGYNVINVSFMKTPEGQTLPTFKPYNKTDTEFRAEISKLNAEG 79
Query: 90 IKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDL 149
L+++ G ++ + S F+ IR YGF G+D+
Sbjct: 80 KSVLIAL-GGADAHIEL-----------------KKSQESDFVNEIIRLVDTYGFDGLDI 121
Query: 150 FW------LWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYP--IDSM 201
N T + S + + ++MA + + Y I+++
Sbjct: 122 DLEQAAIEAADNQTVIPSALKKVKDHYRKDG--KNFMITMAPEFPYLTSSGKYAPYINNL 179
Query: 202 KKNLNWAHLVAYDYH-MPSKENVTGIHAALYNPSSNISTDFGIREWL------RRGFPAN 254
++ + Y+ ++ + + N +G+ + L PA+
Sbjct: 180 DSYYDFINPQYYNQGGDGFWDSDLNMWISQSNDEKKEDFLYGLTQRLVTGTDGFIKIPAS 239
Query: 255 KLVLGARAS----GPGITIDGSMGYKFIRAFIQNY-GYGAAPVYNASYVVNLFTSGATWI 309
K V+G ++ G D + + + ++ ++ ++G +
Sbjct: 240 KFVIGLPSNNDAAATGYVKDPNAVKNALNRLKASGNEIKGLMTWSVNWDAGTNSNGEKYN 299
Query: 310 N 310
N
Sbjct: 300 N 300
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 3e-08
Identities = 51/234 (21%), Positives = 98/234 (41%), Gaps = 54/234 (23%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---------EVS 483
+++F + LGEG +G V + P G+ A+K++ F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 484 LTARLQHVNLLRVLG-YCTERDENM----LIYEYLPNKSLDLY-------LFDPIRRYVL 531
+ +H N++ + + EN +I E + DL+ L D +Y +
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT---DLHRVISTQMLSDDHIQYFI 118
Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
+Q + + L + + VIHRDLK SN+L+++ + K+ DFG+A++ +
Sbjct: 119 -YQ--------TLRAVKVL--HGS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 592 DEANTGRIVGTY--GYV------PPEYV-KKGIYSMKYDVYSFGVLLLQIISSK 636
+ + + +V PE + YS DV+S G +L ++ +
Sbjct: 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 33/179 (18%), Positives = 68/179 (37%), Gaps = 29/179 (16%)
Query: 435 NNFSSANKLGEGGFGPVYKG---------NLPRGQEFAVKRLSATSTQGLEEFK------ 479
+ + G +Y+ + P+ Q+F++K L A + E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 480 --NEVSLTARLQHVNLL---RVLGYCTERDE-NMLIYEYLPNKSLDLYLFDPIRRYVLDW 533
+V+ +L LL +G+ +D+ L+ L +SL D ++VL
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQ-SALDVSPKHVLS- 157
Query: 534 QKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI--SDFGMAKLFRKD 590
++ V + + L L+ +H ++ A NI +D E ++ + +G A +
Sbjct: 158 ERSVLQV--ACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 48/223 (21%), Positives = 94/223 (42%), Gaps = 43/223 (19%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---------EVS 483
+ + + +G G +G V + G AVK+LS F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80
Query: 484 LTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDP---------IRRYVLDWQ 534
L ++H N++ +L ++ + D+YL ++ L
Sbjct: 81 LLKHMKHENVIGLL--------DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 132
Query: 535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594
+I + +GL Y+ +S +IHRDLK SN+ ++ + KI DFG+A+ ++
Sbjct: 133 HVQFLIYQILRGLKYI--HSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189
Query: 595 NTGRIVGTYGYVPPEYV-KKGIYSMKYDVYSFGVLLLQIISSK 636
V T Y PE + Y+ D++S G ++ ++++ +
Sbjct: 190 -----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 47/212 (22%), Positives = 80/212 (37%), Gaps = 36/212 (16%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATST---QGLEEFK-----NEVSLTARLQH-- 490
KLG G F V+ ++ A+K + +E K N+ T
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 491 ---VNLLRVLGYCTERDENM-LIYEYLPNKSLDLYLF---DPIRRYVLDWQKRVNIIEGV 543
+ LL + ++ +++E L +L R L + K+ I + +
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVL---GENLLALIKKYEHRGIPLIYVKQ--ISKQL 140
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNP------KISDFGMAKLFRKDVDEANTG 597
GL Y+ + +IH D+K N+L++ +P KI+D G A DE T
Sbjct: 141 LLGLDYM--HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYTN 194
Query: 598 RIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLL 629
I T Y PE + + D++S L+
Sbjct: 195 SIQ-TREYRSPEVLLGAPWGCGADIWSTACLI 225
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 29/170 (17%), Positives = 60/170 (35%), Gaps = 28/170 (16%)
Query: 442 KLGEGGFGPVYKG-NLPRGQE---FAVKRLSATSTQGLEEFK-----------NEVSLTA 486
K+G GGFG +Y + ++ VK + E K +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 487 RLQHVNLLRVLGY----CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEG 542
+L ++ + G R ++ E L L + + V +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ-KISGQNGTFKK---STVLQL-- 156
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI--SDFGMAKLFRKD 590
+ L L+ +H D+KA+N+LL + ++ +D+G++ + +
Sbjct: 157 GIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 39/196 (19%), Positives = 77/196 (39%), Gaps = 45/196 (22%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKN---------EVSLTARLQHV 491
+G G +G VY + + A+K+++ F++ E+++ RL+
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILREITILNRLKSD 85
Query: 492 NLLRVL-----GYCTERDENMLIYEYLPNKSLDLY--------LFDPIRRYVLDWQKRVN 538
++R+ + DE ++ E + DL L + + +L +
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIADS---DLKKLFKTPIFLTEEHIKTIL-YN---- 137
Query: 539 IIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR 598
+ G ++ E S +IHRDLK +N LL+ + + K+ DFG+A+ + D
Sbjct: 138 ----LLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 599 IVGTYGYVPPEYVKKG 614
+ P K
Sbjct: 191 LEENEEPGPHNKNLKK 206
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 31/172 (18%), Positives = 60/172 (34%), Gaps = 29/172 (16%)
Query: 442 KLGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQGLEEFK-----NEVSLTARLQH 490
+G+GGFG +Y ++ VK + + E K + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 491 VNLLRVLGYCT----------ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNII 540
L+ LG + +I + L +R+ K V +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSR---KTVLQL 157
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI--SDFGMAKLFRKD 590
+ L L+ +H D+KASN+LL+ + ++ D+G+A + +
Sbjct: 158 --SLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 48/207 (23%), Positives = 79/207 (38%), Gaps = 36/207 (17%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVK---RLSATSTQGLEEFKNEVSLTARLQHV----- 491
+ +G+G FG V K + + A+K A Q EV L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMK 115
Query: 492 -NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKR---VNIIEGVTQGL 547
++ + + R+ L++E L S +LY D +R R +N+ Q +
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEML---SYNLY--DLLRNT----NFRGVSLNLTRKFAQQM 166
Query: 548 LY---LQEYSNFRVIHRDLKASNILLDNELNP--KISDFGMAKLFRKDVDEANTGRIVGT 602
+IH DLK NILL N KI DFG + + + + + +
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQS 221
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLL 629
Y PE + Y + D++S G +L
Sbjct: 222 RFYRSPEVLLGMPYDLAIDMWSLGCIL 248
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 18/62 (29%), Positives = 30/62 (48%), Gaps = 8/62 (12%)
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPP--------E 609
++HRD+K SNILL+ E + K++DFG+++ F N + +
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 610 YV 611
YV
Sbjct: 190 YV 191
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 51/211 (24%), Positives = 82/211 (38%), Gaps = 50/211 (23%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRL---SATSTQGLEEFKNEVSLTARLQHV------N 492
+G+G FG V K + Q A+K + Q EE + + L+ N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEHLRKQDKDNTMN 160
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKR-------VNIIEGVTQ 545
++ +L T R+ + +E L S++LY + K+ + ++
Sbjct: 161 VIHMLENFTFRNHICMTFELL---SMNLY----------ELIKKNKFQGFSLPLVRKFAH 207
Query: 546 GLLY-LQEYSNFRVIHRDLKASNILLDNELNP--KISDFGMAKLFRKDVDEANTGRIVGT 602
+L L R+IH DLK NILL + K+ DFG + + V T
Sbjct: 208 SILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---------EHQRVYT 258
Query: 603 Y----GYVPPEYVKKGIYSMKYDVYSFGVLL 629
Y Y PE + Y M D++S G +L
Sbjct: 259 YIQSRFYRAPEVILGARYGMPIDMWSLGCIL 289
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 755 | |||
| 3alf_A | 353 | Chitinase, class V; hydrolase; 1.20A {Nicotiana ta | 100.0 | |
| 3aqu_A | 356 | AT4G19810; stress response, TIM barrel, hydrolase, | 100.0 | |
| 4ay1_A | 365 | Chitinase-3-like protein 2; chilectin, lectin, chi | 100.0 | |
| 3fy1_A | 395 | Amcase, TSA1902, acidic mammalian chitinase; struc | 100.0 | |
| 1vf8_A | 377 | YM1, secretory protein; chitinase, CHI-lectin, str | 100.0 | |
| 2pi6_A | 361 | Chitinase-3-like protein 1; complex, signaling pro | 100.0 | |
| 1itx_A | 419 | Chitinase A1, glycosyl hydrolase; alpha-beta (TIM) | 100.0 | |
| 1wb0_A | 445 | Chitinase 1, chitotriosidase 1; cyclopentapeptide | 100.0 | |
| 3qok_A | 420 | Putative chitinase II; structural genomics, PSI-bi | 100.0 | |
| 3g6m_A | 406 | Chitinase, crchi1; inhibitor, caffeine, glycosidas | 100.0 | |
| 1kfw_A | 435 | Chitinase B; TIM barrel, hydrolase; 1.74A {Arthrob | 100.0 | |
| 1edq_A | 540 | Chitinase A; beta-alpha (TIM) barrel, hydrolase; 1 | 100.0 | |
| 1jnd_A | 420 | Imaginal DISC growth factor-2; IDGF, chitinase, in | 100.0 | |
| 1ll7_A | 392 | Chitinase 1; beta-alpha barrel, hydrolase; 2.00A { | 100.0 | |
| 1w9p_A | 433 | Chitinase; peptide inhibitors, argifin, argadin, g | 100.0 | |
| 1goi_A | 499 | Chitinase B; chitin degradation, hydrolase, glycos | 100.0 | |
| 3arx_A | 584 | Chitinase A; TIM barrel, inhibitor complex, glycos | 100.0 | |
| 3oa5_A | 574 | CHI1; TIM barrel, hydrolase; HET: 2PE; 1.74A {Yers | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3cz8_A | 319 | Putative sporulation-specific glycosylase YDHD; st | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3bxw_B | 393 | Chitinase domain-containing protein 1; TIM barrel, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fnd_A | 312 | Chitinase; TIM-barrel, structural genomics, PSI-2, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1nar_A | 290 | Narbonin; plant SEED protein; 1.80A {Vicia narbone | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3sim_A | 275 | Protein, family 18 chitinase; family 18 plant chit | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3n12_A | 333 | Chitinase A, chinctu2; zinc atoms, complex, hydrol | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2y8v_A | 290 | CHIC, class III chitinase, putative; afchic, hydro | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4axn_A | 328 | Chitinase C1; hydrolase; 1.68A {Serratia marcescen | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3ebv_A | 302 | Chinitase A; chitinase A, CHIA, glycosidase, struc | 100.0 | |
| 3ian_A | 321 | Chitinase; structural genomics, hydrolase, glycosi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4ac1_X | 283 | Endo-N-acetyl-beta-D-glucosaminidase; hydrolase, g | 99.96 | |
| 2gsj_A | 271 | Protein PPL-2; mimosoideae, chimerolectin, endochi | 99.96 | |
| 2hvm_A | 273 | Hevamine; hydrolase, chitinase/lysozyme; 1.80A {He | 99.96 | |
| 2uy2_A | 294 | Endochitinase; carbohydrate metabolism, polysaccha | 99.95 | |
| 1edt_A | 271 | Endo-beta-N-acetylglucosaminidase H, endo H; hydro | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 1cnv_A | 299 | Concanavalin B; plant chitinase, chitin binding pr | 99.93 | |
| 1eok_A | 290 | Endo-beta-N-acetylglucosaminidase F3; alpha/beta-b | 99.93 | |
| 2xtk_A | 310 | CHIA1, class III chitinase CHIA1; hydrolase, GH18; | 99.92 | |
| 2ebn_A | 289 | Endo-beta-N-acetylglucosaminidase F1; hydrolase(gl | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1ta3_A | 274 | XIP-1, xylanase inhibitor protein I; beta alpha ba | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 3poh_A | 451 | Endo-beta-N-acetylglucosaminidase F1; TIM barrel, | 99.79 | |
| 3mu7_A | 273 | XAIP-II, xylanase and alpha-amylase inhibitor prot | 99.79 | |
| 2dsk_A | 311 | Chitinase; catalytic domain, active domain, crysta | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.72 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.57 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.02 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.86 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.72 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.41 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.25 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.19 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.09 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.0 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.95 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.64 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.62 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.43 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.31 | |
| 2vtf_A | 626 | Endo-beta-N-acetylglucosaminidase; hydrolase, fami | 97.3 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.1 | |
| 2w91_A | 653 | Endo-beta-N-acetylglucosaminidase D; hydrolase, N- | 97.02 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.8 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.7 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.7 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.68 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.65 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.62 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.42 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.91 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.89 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.59 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.23 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 94.84 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 93.23 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.93 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 91.51 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.65 | |
| 3k1d_A | 722 | 1,4-alpha-glucan-branching enzyme; mycobacterium t | 86.95 | |
| 3gdb_A | 937 | Endo-D, putative uncharacterized protein SPR0440; | 81.74 |
| >3alf_A Chitinase, class V; hydrolase; 1.20A {Nicotiana tabacum} PDB: 3alg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-62 Score=523.35 Aligned_cols=312 Identities=42% Similarity=0.768 Sum_probs=277.9
Q ss_pred ceEEEEEecCCCCCCCCCCCCCCcceEEEEEEEecCCCcEEecCCchhhHHHHHHHHHHhhCCCceEEEEecCCCCCccc
Q 004402 26 TWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQ 105 (755)
Q Consensus 26 ~~~~~gY~~~~~~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg~~~~~~~ 105 (755)
+++++|||...+.|++++|++++||||+|+|+.++++++.+...+..+..+..+++.+|++||++|+++||
T Consensus 2 ~~~~~gY~~~~~~~~~~~i~~~~~THi~yaF~~i~~~~~~v~~~~~~~~~~~~~~~~lk~~~~~lkvllsi--------- 72 (353)
T 3alf_A 2 QNVKGGYWFKDSGLALNNIDSTLFTHLFCAFADLNPQLNQLIISPENQDSFRQFTSTVQRKNPSVKTFLSI--------- 72 (353)
T ss_dssp CCEEEEEEEGGGCCCGGGCCGGGCSEEEEEEEEEETTTTEEECCHHHHHHHHHHHHHHHHHCTTCEEEEEE---------
T ss_pred CceEEEEEecCCCCCHhHCCcccCCEEEEEEEEeeCCCCEEEeCCccHHHHHHHHHHHHhhCCCCeEEEEE---------
Confidence 47899999655679999999999999999999999987777776655667788878899999999999999
Q ss_pred cccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCC-CCCCcccHHHHHHHHHHHccC------CCc
Q 004402 106 SILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWP-NSTDLNSLGILLDEWKASASD------QPE 178 (755)
Q Consensus 106 ~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p-~~~~~~~~~~~l~~lr~~l~~------~~~ 178 (755)
|||+.++..|+.+++|++.|++||+++++++++||||||||||||| .++|+++|+.||++||++|++ +++
T Consensus 73 ---GG~~~~~~~f~~~~~~~~~r~~fi~siv~~~~~~~fDGiDiDwE~p~~~~d~~n~~~ll~eLr~~l~~~~~~~~~~~ 149 (353)
T 3alf_A 73 ---AGGRANSTAYGIMARQPNSRKSFIDSSIRLARQLGFHGLDLDWEYPLSAADMTNLGTLLNEWRTAINTEARNSGRAA 149 (353)
T ss_dssp ---ECTTSCHHHHHHHHHSHHHHHHHHHHHHHHHHHHTCSEEEEECCCCCSHHHHHHHHHHHHHHHHHHHHHHHHHCSCC
T ss_pred ---CCCCCCchhHHHHhcCHHHHHHHHHHHHHHHHHcCCCeEEEEeeecCChhHHHHHHHHHHHHHHHHHHhhhhcCCCc
Confidence 5665566679999999999999999999999999999999999999 567999999999999999964 236
Q ss_pred cEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCC-cccccCCCCCCCCCCCcHHHHHHHHHHCCCCCCcee
Q 004402 179 LTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKE-NVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLV 257 (755)
Q Consensus 179 ~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~-~~~~~~a~l~~~~~~~~~~~~v~~~~~~g~p~~Klv 257 (755)
++||+++|+.+.....+||+++|++++||||||+||+||+.|+ ..+||+|||+++....+++.+|++|++.|+|++||+
T Consensus 150 ~~Ls~a~~~~~~~~~~~~d~~~l~~~vD~invMtYD~~g~~w~~~~~g~~a~l~~~~~~~~~~~~v~~~~~~gvp~~Klv 229 (353)
T 3alf_A 150 LLLTAAVSNSPRVNGLNYPVESLARNLDWINLMAYDFYGPNWSPSQTNSHAQLFDPVNHVSGSDGINAWIQAGVPTKKLV 229 (353)
T ss_dssp CEEEEEEESSSEETTEECCHHHHHHHCSEEEEECCCSSCTTTSTTBCCCSSCSCCTTTCCSHHHHHHHHHHTTCCGGGEE
T ss_pred eEEEEecccCchhhhcCCCHHHHhhhccEEEEEEeeccCCCCCCCCCCCCCcCcCCCCCccHHHHHHHHHHcCCChHHEE
Confidence 8999999987665556699999999999999999999976466 789999999987778899999999999999999999
Q ss_pred ecccccCCCcccC----------------------CCcchHHHHHHHhhcCCCcccccccceeeeeeecCcEEEeeCCcc
Q 004402 258 LGARASGPGITID----------------------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVE 315 (755)
Q Consensus 258 lG~p~yG~~~~~~----------------------~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~yd~~~ 315 (755)
||+|+|||+|++. |.++|.++|+++...+ +...||+....+|...+.+||+|||++
T Consensus 230 lGip~YGr~~~~~~~~~~~~~~~~~g~~~~~~~~~g~~~y~ei~~~~~~~g--~~~~~D~~~~~~y~y~~~~~v~ydd~~ 307 (353)
T 3alf_A 230 LGIPFYGYAWRLVNANIHGLRAPAAGKSNVGAVDDGSMTYNRIRDYIVESR--ATTVYNATIVGDYCYSGSNWISYDDTQ 307 (353)
T ss_dssp EEEESEEEEEEESCTTCCSTTCBEEEECTTSCTTTCEEEHHHHHHHHHHHT--CEEEEETTTTEEEEEETTEEEEECCHH
T ss_pred EEeCCceeeeeccCCcCCCCCCCCCCCCCCCCCCCCeEcHHHHHHHHhhCC--CeEEEccccceEEEEeCCEEEEcCCHH
Confidence 9999999999742 5689999999887665 788899888888888888999999999
Q ss_pred hhhhhhhcccccCccccccccccccchhhhhhhhhh
Q 004402 316 TIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAAQI 351 (755)
Q Consensus 316 S~~~K~~~a~~~~l~Gi~~W~l~~dd~~~~~~~~~~ 351 (755)
|++.|++||+++||||+|+|+++.|+.|.+..+...
T Consensus 308 Si~~K~~~~~~~gLgGv~~W~l~~Dd~~~ll~a~~~ 343 (353)
T 3alf_A 308 TVRNKVNYVKGRGLLGYFAWHVAGDQNWGLSRTASQ 343 (353)
T ss_dssp HHHHHHHHHHHTTCSEEEEECGGGSSTTHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCEEEEEeccCCCCchHHHHHHH
Confidence 999999999999999999999999998888776643
|
| >3aqu_A AT4G19810; stress response, TIM barrel, hydrolase, chitin; HET: FLC; 2.01A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-61 Score=520.91 Aligned_cols=312 Identities=46% Similarity=0.811 Sum_probs=276.5
Q ss_pred ceEEEEEecCCCCCCCCCCCCCCcceEEEEEEEecCCCcEEecCCchhhHHHHHHHHHHhhCCCceEEEEecCCCCCccc
Q 004402 26 TWIKAGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQ 105 (755)
Q Consensus 26 ~~~~~gY~~~~~~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg~~~~~~~ 105 (755)
.++++|||...+.|++++|++++||||+|+|+.++++++.+...+..+..+..+++.+|++||++|+++||
T Consensus 3 ~~~~~gY~~~~~~~~~~~i~~~~~THi~yaF~~i~~~~~~v~~~~~~~~~~~~~~~~lk~~~~~lkvllsi--------- 73 (356)
T 3aqu_A 3 TVVKASYWFPASEFPVTDIDSSLFTHLFCAFADLNSQTNQVTVSSANQPKFSTFTQTVQRRNPSVKTLLSI--------- 73 (356)
T ss_dssp CCEEEEEECGGGCCCGGGSCGGGCSEEEEEEEEEETTTTEEECCTTTHHHHHHHHHHHTTTCTTCEEEEEE---------
T ss_pred ceEEEEEEeCCCCCCHHHCCcccCCEEEEEEEEecCCCCEEEeCCccHHHHHHHHHHHHhhCCCceEEEEE---------
Confidence 47899999555669999999999999999999999987778777666667888888899999999999999
Q ss_pred cccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCC-CCCCcccHHHHHHHHHHHccC------CCc
Q 004402 106 SILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWP-NSTDLNSLGILLDEWKASASD------QPE 178 (755)
Q Consensus 106 ~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p-~~~~~~~~~~~l~~lr~~l~~------~~~ 178 (755)
|||+.++..|+.+++|++.|++||+++++++++||||||||||||| .++|+++|+.||++||++|++ +++
T Consensus 74 ---GGw~~~~~~f~~~~~~~~~r~~fi~siv~~~~~~~fDGiDiDwE~p~~~~d~~n~~~ll~eLr~~l~~~~~~~g~~~ 150 (356)
T 3aqu_A 74 ---GGGIADKTAYASMASNPTSRKSFIDSSIRVARSYGFHGLDLDWEYPSSATEMTNFGTLLREWRSAVVAEASSSGKPR 150 (356)
T ss_dssp ---ECTTSCHHHHHHHHHSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCSHHHHHHHHHHHHHHHHHHHHHHHHHCSCC
T ss_pred ---CCCCCCcchHHHHhcCHHHHHHHHHHHHHHHHHhCCCeEEEEEeecCChhHHHHHHHHHHHHHHHHHHhhhhcCCCc
Confidence 5565556679999999999999999999999999999999999999 567899999999999999964 136
Q ss_pred cEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCC-CCcHHHHHHHHHHCCCCCCcee
Q 004402 179 LTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSS-NISTDFGIREWLRRGFPANKLV 257 (755)
Q Consensus 179 ~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~-~~~~~~~v~~~~~~g~p~~Klv 257 (755)
++||+++|+.+.....+||+++|++++||||||+||+||+.|+..+||+|||+.+.. ..+++.+|++|++.|+|++||+
T Consensus 151 ~~Ls~av~~~~~~~~~~~d~~~l~~~vD~inlMtYD~~g~~w~~~~g~~apl~~~~~~~~~v~~~v~~~~~~gvp~~Klv 230 (356)
T 3aqu_A 151 LLLAAAVFYSNNYYSVLYPVSAVASSLDWVNLMAYDFYGPGWSRVTGPPAALFDPSNAGPSGDAGTRSWIQAGLPAKKAV 230 (356)
T ss_dssp CEEEEEEESSSEETTEECCHHHHHHHCSEEEEECCCCCCTTTCSBCCCTTCSCCTTCSSCCHHHHHHHHHHTTCCGGGEE
T ss_pred eEEEEeccCCchhhhccCCHHHHhhhccEEEEEeeecccCCCCCCcCCCCcCCCCCCCCccHHHHHHHHHHcCCCHHHEE
Confidence 899999998766555669999999999999999999997647788999999996543 5799999999999999999999
Q ss_pred ecccccCCCcccC-------------------CCcchHHHHHHHhhcCCCcccccccceeeeeeecCcEEEeeCCcchhh
Q 004402 258 LGARASGPGITID-------------------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIK 318 (755)
Q Consensus 258 lG~p~yG~~~~~~-------------------~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~yd~~~S~~ 318 (755)
||+|+|||+|++. |.++|.++|+++...+ +...||+....+|...+.+||+|||++|++
T Consensus 231 lGip~YGr~~~~~~~~~~~~~~p~~g~~~~~~g~~~y~ei~~~l~~~g--~~~~~D~~~~~~y~y~~~~~v~ydd~~Si~ 308 (356)
T 3aqu_A 231 LGFPYYGYAWRLTNANSHSYYAPTTGAAISPDGSIGYGQIRKFIVDNG--ATTVYNSTVVGDYCYAGTNWIGYDDNQSIV 308 (356)
T ss_dssp EEEESEEEEEEESCTTCCSTTCBEEEECSSTTCEEEHHHHHHHHHHHT--CEEEEETTTTEEEEEETTEEEEECCHHHHH
T ss_pred EEeccceeeeEecCCcCCCCCCCCCCCCCCCCCeeeHHHHHHHHhcCC--CeEEEchhhceEEEEeCCEEEEeCCHHHHH
Confidence 9999999999743 5689999999887665 788899888888888888999999999999
Q ss_pred hhhhcccccCccccccccccccchhhhhhhhhh
Q 004402 319 AKISYAKEKNLLGYKAFQLSNDDNWALSRAAQI 351 (755)
Q Consensus 319 ~K~~~a~~~~l~Gi~~W~l~~dd~~~~~~~~~~ 351 (755)
.|++||+++||||+|+|+++.|+.|.+..+...
T Consensus 309 ~K~~~~~~~gLgGv~~W~l~~Dd~~~ll~a~~~ 341 (356)
T 3aqu_A 309 TKVRYAKQRGLLGYFSWHVGADDNSGLSRAASQ 341 (356)
T ss_dssp HHHHHHHHTTCCEEEEECGGGSSTTHHHHHHHH
T ss_pred HHHHHHHhCCCCeEEEEeccCCCCchHHHHHHH
Confidence 999999999999999999999998877766543
|
| >4ay1_A Chitinase-3-like protein 2; chilectin, lectin, chitooligosaccharide, pseudochitinase, HY; HET: NAG; 1.95A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-61 Score=517.51 Aligned_cols=300 Identities=25% Similarity=0.456 Sum_probs=255.8
Q ss_pred eEEEEEecCCC-------CCCCCCCCCCCcceEEEEEEEecCCCcEEecCCchhhHHHHHHHHHHhhCCCceEEEEecCC
Q 004402 27 WIKAGYWLAGR-------EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNG 99 (755)
Q Consensus 27 ~~~~gY~~~~~-------~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg~ 99 (755)
+++||||..|. .|.|++||+++||||+|||+.+++++. ... +..+..+...+.++|++||++|+||||
T Consensus 2 ~rvV~Yy~~W~~~r~~~~~~~~~~i~~~~~THi~yaFa~i~~~~~-~~~-~~~~~~~~~~~~~lK~~~p~lKvllSi--- 76 (365)
T 4ay1_A 2 YKLVCYFTNWSQDRQEPGKFTPENIDPFLCSHLIYSFASIENNKV-IIK-DKSEVMLYQTINSLKTKNPKLKILLSI--- 76 (365)
T ss_dssp CEEEEEEESGGGGSCTTSCCCGGGCCTTTCSEEEEEEEEEETTEE-ECC-CTTHHHHHHHHHHHHHHCTTCEEEEEE---
T ss_pred eEEEEEECCccccCCCCCCCChhHCCcccCCEEEEEeEEecCCee-EEC-CccHHHHHHHHHHHHHHCCCCEEEEEE---
Confidence 57899987653 478999999999999999999997543 333 334444444558899999999999999
Q ss_pred CCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCCCcccHHHHHHHHHHHccC----
Q 004402 100 QNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASD---- 175 (755)
Q Consensus 100 ~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~~~~~~~~~l~~lr~~l~~---- 175 (755)
|||++++..|+.+++|+++|++||+++++|+++|||||||||||||..+++.+|+.|+++||+++++
T Consensus 77 ---------GGw~~~s~~Fs~~~~~~~~R~~Fi~siv~~~~~~~fDGiDiDWEyP~~~d~~~~~~ll~elr~~~~~~~~~ 147 (365)
T 4ay1_A 77 ---------GGYLFGSKGFHPMVDSSTSRLEFINSIILFLRNHNFDGLDVSWIYPDQKENTHFTVLIHELAEAFQKDFTK 147 (365)
T ss_dssp ---------EETTTTTGGGTTGGGSHHHHHHHHHHHHHHHHHTTCCEEEEEESCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred ---------eCCCCCCchHHHHHcCHHHHHHHHHHHHHHHHhcCCceEEEeeecCCcccccccHHHHHHHHHHHHHHHhh
Confidence 5666556679999999999999999999999999999999999999999999999999999998742
Q ss_pred --CCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCc-ccccCCCCCCCC------CCCcHHHHHHHH
Q 004402 176 --QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKEN-VTGIHAALYNPS------SNISTDFGIREW 246 (755)
Q Consensus 176 --~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~-~~~~~a~l~~~~------~~~~~~~~v~~~ 246 (755)
++.++||+++|+.+.....+||+++|+++||||||||||+||+|..+ .+||+|||+... ...+++.+|++|
T Consensus 148 ~~~~~~~lt~a~~~~~~~~~~~~d~~~i~~~vD~inlMtYD~~g~w~~~~~tg~~apL~~~~~~~~~~~~~~v~~av~~~ 227 (365)
T 4ay1_A 148 STKERLLLTAGVSAGRQMIDNSYQVEKLAKDLDFINLLSFDFHGSWEKPLITGHNSPLSKGWQDRGPSSYYNVEYAVGYW 227 (365)
T ss_dssp CSSCCCEEEEEEECCHHHHHHHCCHHHHHHHCSEEEEECCCSSCTTCSSCBCCCSSCSSCCTTCCGGGGGSSHHHHHHHH
T ss_pred hccCceEEEeecCCChhhhhhhcchhhhhhcccEEEEEcccccCcccCCCcCCCCCCCCCCccccCccccccHHHHHHHH
Confidence 34799999999988777777999999999999999999999776554 589999999643 236899999999
Q ss_pred HHCCCCCCceeecccccCCCcccC-----------------------CCcchHHHHHHHhhcCCCcccccccceeeeeee
Q 004402 247 LRRGFPANKLVLGARASGPGITID-----------------------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFT 303 (755)
Q Consensus 247 ~~~g~p~~KlvlG~p~yG~~~~~~-----------------------~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (755)
+++|+|++|||||+|+|||+|++. |.+.|.++|..+... ...++.....+|..
T Consensus 228 ~~~gvp~~KlvlGip~YGr~~~~~~~~~~~~~~~~~~~~~g~~t~~~g~~~y~e~~~~~~~~----~~~~~~~~~~~y~~ 303 (365)
T 4ay1_A 228 IHKGMPSEKVVMGIPTYGHSFTLASAETTVGAPASGPGAAGPITESSGFLAYYEICQFLKGA----KITRLQDQQVPYAV 303 (365)
T ss_dssp HHTTCCGGGEEEEEESEEEEEEESSSCCSTTCBEEEECCCCTTTCCTTEEEHHHHHHHHTTC----EEEECTTTCCEEEE
T ss_pred HHcCCCHHHeeeccCccceeeeecCCCCCCCCcccCCCCCccccccCCeeeHHHHHHHhcCC----ceEEecCCeeEEEE
Confidence 999999999999999999999743 567899999877543 33444455567778
Q ss_pred cCcEEEeeCCcchhhhhhhcccccCccccccccccccchhh
Q 004402 304 SGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWA 344 (755)
Q Consensus 304 ~~~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~dd~~~ 344 (755)
.+++||+|||++|+++|++||+++||||+|+|++++||..+
T Consensus 304 ~~~~~vsydd~~Si~~K~~y~~~~~LgGv~~W~l~~DD~~G 344 (365)
T 4ay1_A 304 KGNQWVGYDDVKSMETKVQFLKNLNLGGAMIWSIDMDDFTG 344 (365)
T ss_dssp ETTEEEECCCHHHHHHHHHHHHHTTCSEEEEECGGGSCTTS
T ss_pred ECCEEEEeCCHHHHHHHHHHHHhcCCCEEEEEeCCCcCCCC
Confidence 88999999999999999999999999999999999998654
|
| >3fy1_A Amcase, TSA1902, acidic mammalian chitinase; structure, crystallography, asthma,inhibitor, chitin degradation, methylallosamidin; HET: NA1 NAA AMI; 1.70A {Homo sapiens} PDB: 3fxy_A* 3rm4_A* 3rm8_A* 3rm9_A* 3rme_A* 2ybt_A* 2ybu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-59 Score=507.70 Aligned_cols=300 Identities=29% Similarity=0.500 Sum_probs=258.6
Q ss_pred eEEEEEecCCC-------CCCCCCCCCCCcceEEEEEEEecCCCcEEecCCchhhHHHHHHHHHHhhCCCceEEEEecCC
Q 004402 27 WIKAGYWLAGR-------EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNG 99 (755)
Q Consensus 27 ~~~~gY~~~~~-------~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg~ 99 (755)
++++|||..|. .|.+++||+++||||+|+|+.++ ++ .+...+..+......+..+|++||++|+++||
T Consensus 1 ~~~v~Yy~~W~~~r~~~~~~~~~~i~~~~~THi~yaFa~i~-~~-~i~~~~~~d~~~~~~~~~lK~~~p~lKvllSi--- 75 (395)
T 3fy1_A 1 YQLTCYFTNWAQYRPGLGRFMPDDINPCLCTHLIYAFAGMQ-NN-EITTIEWNDVTLYQAFNGLKNKNSQLKTLLAI--- 75 (395)
T ss_dssp CEEEEEEETTGGGSCGGGCCCGGGSCTTTCSEEEEEEEEEE-TT-EEECCSTTHHHHHHHHHHGGGSCTTCEEEEEE---
T ss_pred CEEEEEECcccccCCCCCCCChhHCCcccCCEEEEEEEEee-CC-eeEecccccHHHHHHHHHHHHhCCCCEEEEEE---
Confidence 46899987664 36899999999999999999999 44 44443333333333347899999999999999
Q ss_pred CCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCC-----CCcccHHHHHHHHHHHcc
Q 004402 100 QNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-----TDLNSLGILLDEWKASAS 174 (755)
Q Consensus 100 ~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~-----~~~~~~~~~l~~lr~~l~ 174 (755)
|||++++..|+.++++++.|++||+++++++++|||||||||||||.. +|+++|+.||++||++|+
T Consensus 76 ---------GGw~~~s~~f~~~~~~~~~R~~fi~siv~~l~~~gfDGiDiDwEyP~~~g~~~~d~~nf~~ll~eLr~~l~ 146 (395)
T 3fy1_A 76 ---------GGWNFGTAPFTAMVSTPENRQTFITSVIKFLRQYEFDGLDFDWEYPGSRGSPPQDKHLFTVLVQEMREAFE 146 (395)
T ss_dssp ---------ECGGGCSHHHHHHHTSHHHHHHHHHHHHHHHHHHTCSEEEEECSCTTSTTCCTTHHHHHHHHHHHHHHHHH
T ss_pred ---------cCCCCCCchhhHHhCCHHHHHHHHHHHHHHHHhcCCCeEEEEeEcCCCCCCChhHHHHHHHHHHHHHHHHH
Confidence 666666677999999999999999999999999999999999999965 489999999999999996
Q ss_pred CC------CccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCC------CcHHHH
Q 004402 175 DQ------PELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN------ISTDFG 242 (755)
Q Consensus 175 ~~------~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~------~~~~~~ 242 (755)
+. +.++||+++|+.+.....+||+++|++++||||||+||+|| .|+..+||+||||..... .+++.+
T Consensus 147 ~~~~~~~~~~~~Lt~av~~~~~~~~~~~d~~~l~~~vD~inlMtYD~~g-~w~~~~g~~apl~~~~~~~~~~~~~~v~~~ 225 (395)
T 3fy1_A 147 QEAKQINKPRLMVTAAVAAGISNIQSGYEIPQLSQYLDYIHVMTYDLHG-SWEGYTGENSPLYKYPTDTGSNAYLNVDYV 225 (395)
T ss_dssp HHHHHHTSCCCEEEEEECCSHHHHHHHCCHHHHHHHCSEEEECCCCCSC-GGGSBCCCSSCSSCCTTCCGGGGGCSHHHH
T ss_pred HhhhccCCCceEEEEEecCChhHhhcchhHHHHHhhcceeeeecccccC-CCCCCCCCCCcCcCCCCCccccccccHHHH
Confidence 42 24899999999876666679999999999999999999995 567789999999965543 689999
Q ss_pred HHHHHHCCCCCCceeecccccCCCcccC------------------------CCcchHHHHHHHhhcCCCccccccccee
Q 004402 243 IREWLRRGFPANKLVLGARASGPGITID------------------------GSMGYKFIRAFIQNYGYGAAPVYNASYV 298 (755)
Q Consensus 243 v~~~~~~g~p~~KlvlG~p~yG~~~~~~------------------------~~~~y~~~~~~~~~~~~~~~~~~~~~~~ 298 (755)
|++|++.|+|++|||||+|+|||+|++. |.++|.+||..++. ++...||+...
T Consensus 226 v~~~~~~gvp~~KlvlGip~YGr~~~~~~~~~~~~g~p~~g~~~~G~~t~~~G~~~y~ei~~~~~~---g~~~~~D~~~~ 302 (395)
T 3fy1_A 226 MNYWKDNGAPAEKLIVGFPTYGHNFILSNPSNTGIGAPTSGAGPAGPYAKESGIWAYYEICTFLKN---GATQGWDAPQE 302 (395)
T ss_dssp HHHHHHTTCCGGGEEEEEESEEEEEEESSTTCCSTTCBEEEECCCCTTTCCTTEEEHHHHHHHHHT---TCEEEEETTTT
T ss_pred HHHHHHcCCCHHHEEEEeccccceeEecCCCCCCCCCcccCCCCCCcccCCCceeeHHHHHHHhcc---CCeEEEecccc
Confidence 9999999999999999999999999753 45789999987753 46788999888
Q ss_pred eeeeecCcEEEeeCCcchhhhhhhcccccCccccccccccccchhh
Q 004402 299 VNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWA 344 (755)
Q Consensus 299 ~~~~~~~~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~dd~~~ 344 (755)
.+|...+++||+|||++|++.|++|++++||||+|+|+++.||..+
T Consensus 303 ~~y~~~~~~~v~ydd~~Si~~K~~~~~~~gLgG~~~W~ld~DD~~g 348 (395)
T 3fy1_A 303 VPYAYQGNVWVGYDNVKSFDIKAQWLKHNKFGGAMVWAIDLDDFTG 348 (395)
T ss_dssp EEEEEETTEEEECCCHHHHHHHHHHHHHTTCSEEEEECGGGSCSSS
T ss_pred eEEEEECCEEEEeCCHHHHHHHHHHHHhCCCCEEEEEccccCccCC
Confidence 9999889999999999999999999999999999999999998544
|
| >1vf8_A YM1, secretory protein; chitinase, CHI-lectin, structural plasticity, functional versatility, immune system; 1.31A {Mus musculus} SCOP: c.1.8.5 d.26.3.1 PDB: 1e9l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-58 Score=499.46 Aligned_cols=299 Identities=29% Similarity=0.515 Sum_probs=257.8
Q ss_pred eEEEEEecCCC-------CCCCCCCCCCCcceEEEEEEEecCCCcEEecCCchhh-HHHHHHHHHHhhCCCceEEEEecC
Q 004402 27 WIKAGYWLAGR-------EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQ-YFSIFANSVRRKNPSIKTLLSIWN 98 (755)
Q Consensus 27 ~~~~gY~~~~~-------~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~-~~~~~~~~~k~~~~~lk~~isigg 98 (755)
++++|||..|. .|.+++|++++||||+|+|+.++++ .+...+..+. .+..+ .++|++||++|+++||
T Consensus 1 ~~vv~Y~~~w~~~~~~~~~~~~~~i~~~~~Thi~~aF~~i~~~--~~~~~d~~d~~~~~~~-~~lk~~~~~lkvllsi-- 75 (377)
T 1vf8_A 1 YQLMCYYTSWAKDRPIEGSFKPGNIDPCLCTHLIYAFAGMQNN--EITYTHEQDLRDYEAL-NGLKDKNTELKTLLAI-- 75 (377)
T ss_dssp CEEEEEEEGGGGGSCGGGCCCGGGSCTTTCSEEEEEEEEEETT--EEECSSTTHHHHHHHH-HHGGGTCTTCEEEEEE--
T ss_pred CeEEEEECcchhcCCcCCCCChHHCCcccCCEEEEEeEeeccC--ceeecchhHHHHHHHH-HHHHhhCCCCeEEEEE--
Confidence 36899987664 4789999999999999999999976 4444443333 34444 7899999999999999
Q ss_pred CCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCC-----CCcccHHHHHHHHHHHc
Q 004402 99 GQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-----TDLNSLGILLDEWKASA 173 (755)
Q Consensus 99 ~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~-----~~~~~~~~~l~~lr~~l 173 (755)
|||+.++..|+.+++|++.|++||+++++++++|||||||||||||.. +|+++|+.||++||++|
T Consensus 76 ----------GG~~~~s~~fs~~~~~~~~R~~fi~si~~~~~~~~fDGiDiDwEyp~~~g~~~~d~~n~~~ll~eLr~~l 145 (377)
T 1vf8_A 76 ----------GGWKFGPAPFSAMVSTPQNRQIFIQSVIRFLRQYNFDGLNLDWQYPGSRGSPPKDKHLFSVLVKEMRKAF 145 (377)
T ss_dssp ----------ECTTTCSHHHHHHHTSHHHHHHHHHHHHHHHHHTTCCEEEEECSCTTSTTCCTHHHHHHHHHHHHHHHHH
T ss_pred ----------CCCCCCCchHhHHhcCHHHHHHHHHHHHHHHHHcCCCeEEEeeeCCCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 666555667999999999999999999999999999999999999953 47899999999999999
Q ss_pred cC------CCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCC------CcHHH
Q 004402 174 SD------QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN------ISTDF 241 (755)
Q Consensus 174 ~~------~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~------~~~~~ 241 (755)
++ .++++||+++|+.+.....+||+++|++++||||||+||+||+ |+..+||+|||+..... .+++.
T Consensus 146 ~~~~~~~~~~~~~Ls~a~~~~~~~~~~~~d~~~l~~~vD~inlMtYD~~g~-w~~~~g~~apl~~~~~~~~~~~~~~v~~ 224 (377)
T 1vf8_A 146 EEESVEKDIPRLLLTSTGAGIIDVIKSGYKIPELSQSLDYIQVMTYDLHDP-KDGYTGENSPLYKSPYDIGKSADLNVDS 224 (377)
T ss_dssp HHHHHHHTSCCCEEEEEECSSHHHHHHHCCHHHHHHHCSEEEECCCCCSCG-GGSBCCCSSCSSCCTTCCGGGGGCSHHH
T ss_pred HhhhhccCCCceEEEEEccCCHHHHhccCCHHHHHhhCcEEEEEeecccCC-CCCCCCCCCCCCCCCCCccccccccHHH
Confidence 73 2479999999998766555699999999999999999999954 67789999999976543 58999
Q ss_pred HHHHHHHCCCCCCceeecccccCCCcccC------------------------CCcchHHHHHHHhhcCCCcccccccce
Q 004402 242 GIREWLRRGFPANKLVLGARASGPGITID------------------------GSMGYKFIRAFIQNYGYGAAPVYNASY 297 (755)
Q Consensus 242 ~v~~~~~~g~p~~KlvlG~p~yG~~~~~~------------------------~~~~y~~~~~~~~~~~~~~~~~~~~~~ 297 (755)
+|++|+++|+|++|||||+|+|||+|++. |.++|.++|..+.. ++...||+..
T Consensus 225 ~v~~~~~~gvp~~KlvlGip~YGr~~~~~~~~~~~~g~p~~g~~~~g~~t~~~G~~~y~ei~~~~~~---g~~~~~D~~~ 301 (377)
T 1vf8_A 225 IISYWKDHGAASEKLIVGFPAYGHTFILSDPSKTGIGAPTISTGPPGKYTDESGLLAYYEVCTFLNE---GATEVWDAPQ 301 (377)
T ss_dssp HHHHHHHTTCCGGGEEEEEESEEEEEEESCTTCCSTTCBEEEECCCCTTTCCTTEEEHHHHHHHHHT---TCEEEEETTT
T ss_pred HHHHHHHcCCCHHHEEEEecccceeeEcccCCCCCCCCcCCCCCCCCCccCcCceecHHHHHHHHhc---CCeEEecccc
Confidence 99999999999999999999999999753 33689999987642 4888999888
Q ss_pred eeeeeecCcEEEeeCCcchhhhhhhcccccCccccccccccccchhh
Q 004402 298 VVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWA 344 (755)
Q Consensus 298 ~~~~~~~~~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~dd~~~ 344 (755)
..+|...+++||+|||++|++.|++||+++||||+|+|+++.||..+
T Consensus 302 ~~~y~y~~~~~v~ydd~~Si~~K~~~~~~~gLgGv~~W~l~~Dd~~g 348 (377)
T 1vf8_A 302 EVPYAYQGNEWVGYDNVRSFKLKAQWLKDNNLGGAVVWPLDMDDFSG 348 (377)
T ss_dssp TEEEEEETTEEEECCCHHHHHHHHHHHHHTTCCEEEEETGGGSCTTS
T ss_pred ceeEEEeCCEEEEecCHHHHHHHHHHHHhCCCceEEEEeeecccCCC
Confidence 88888888999999999999999999999999999999999998544
|
| >2pi6_A Chitinase-3-like protein 1; complex, signaling protein; HET: NAG MAN; 1.65A {Ovis aries} SCOP: c.1.8.5 d.26.3.1 PDB: 2dpe_A* 1sr0_A* 1zl1_A* 1zbk_A* 2dsu_A* 2dsv_A* 2dsw_A* 2fdm_A* 2g41_A* 2g8z_A* 2dt1_A* 1zbv_A* 1zu8_A* 2aos_A* 2b31_A* 1zbw_A* 2dt0_A* 2dsz_A* 2dt2_A* 2dt3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=498.21 Aligned_cols=298 Identities=30% Similarity=0.498 Sum_probs=258.6
Q ss_pred eEEEEEecCCC-------CCCCCCCCCCCcceEEEEEEEecCCCcEEecCCchhh-HHHHHHHHHHhhCCCceEEEEecC
Q 004402 27 WIKAGYWLAGR-------EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQ-YFSIFANSVRRKNPSIKTLLSIWN 98 (755)
Q Consensus 27 ~~~~gY~~~~~-------~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~-~~~~~~~~~k~~~~~lk~~isigg 98 (755)
++++|||..|. .|++++|++++||||+|+|+.++ ++ .+...+..+. .+..+ .++|++||++|+++||
T Consensus 1 ~~vvgY~~~w~~~~~~~~~~~~~~i~~~~~Thi~~af~~i~-~g-~~~~~~~~d~~~~~~~-~~lk~~~p~lkvllsi-- 75 (361)
T 2pi6_A 1 YKLICYYTSWSQYREGDGSCFPDAIDPFLCTHVIYTFANIS-NN-EIDTWEWNDVTLYDTL-NTLKNRNPKLKTLLSV-- 75 (361)
T ss_dssp CEEEEEEEGGGGGSSGGGCCCGGGSCTTTCSEEEEEEEEEE-TT-EEECCSTTHHHHHHHH-HHHHHHCTTCEEEEEE--
T ss_pred CeEEEEECcccccCCCCCCCChHHCCcccCCEEEEEEEecc-CC-eEEeccHHHHHHHHHH-HHHHhcCCCCeEEEEE--
Confidence 47999987765 37899999999999999999999 54 5555443332 34554 6799999999999999
Q ss_pred CCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCCCcccHHHHHHHHHHHccCC--
Q 004402 99 GQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQ-- 176 (755)
Q Consensus 99 ~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~~~~~~~~~l~~lr~~l~~~-- 176 (755)
|||+.++..|+.+++|++.|++||+++++++++|||||||||||+|...|+++|+.|+++||++|++.
T Consensus 76 ----------GG~~~~s~~f~~~~~~~~~r~~fi~si~~~~~~~~fDGiDiDwE~p~~~d~~~~~~ll~eLr~~l~~~~~ 145 (361)
T 2pi6_A 76 ----------GGWNFGPERFSKIASKTQSRRTFIKSVPPFLRTHGFDGLDLAWLYPGRRDKRHLTTLVKEMKAEFIREAQ 145 (361)
T ss_dssp ----------ETTTSCHHHHHHHHTSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCGGGHHHHHHHHHHHHHHHHHHHT
T ss_pred ----------CCCCCCchhHHHHhcCHHHHHHHHHHHHHHHHHcCCCeEEEeeecCCchHHHHHHHHHHHHHHHHhhhhc
Confidence 55655566799999999999999999999999999999999999999889999999999999999642
Q ss_pred ---CccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCC-----CCCcHHHHHHHHHH
Q 004402 177 ---PELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPS-----SNISTDFGIREWLR 248 (755)
Q Consensus 177 ---~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~-----~~~~~~~~v~~~~~ 248 (755)
++++||+++|+.+.....+||+++|++++||||||+||+|| .|++.+||+|||+... ...+++.+|++|++
T Consensus 146 ~~~~~~~Ls~a~~~~~~~~~~~~d~~~l~~~vD~inlMtYD~~g-~w~~~~g~~apl~~~~~~~~~~~~~v~~~v~~~~~ 224 (361)
T 2pi6_A 146 AGTEQLLLSAAVSAGKIAIDRGYDIAQISRHLDFISLLTYDFHG-AWRQTVGHHSPLFRGNEDASSRFSNADYAVSYMLR 224 (361)
T ss_dssp TSSCCCEEEEEEECCHHHHHHHCCHHHHHHHCSEEEEETTCCSC-TTCCBCCCSSCSSCCSSSCSCTTSSHHHHHHHHHH
T ss_pred ccCCceEEEEEecCCHHHHhccCCHHHHHhhccEEEEEeeeccC-CCCCCCCCCCCCCCCCCCccccCccHHHHHHHHHH
Confidence 36799999999876555569999999999999999999995 5677899999999743 34689999999999
Q ss_pred CCCCCCceeecccccCCCcccC-----------------------CCcchHHHHHHHhhcCCCcccccccceeeeeeecC
Q 004402 249 RGFPANKLVLGARASGPGITID-----------------------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSG 305 (755)
Q Consensus 249 ~g~p~~KlvlG~p~yG~~~~~~-----------------------~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (755)
.|+|++||+||+|+|||+|++. |.++|.++|+.+. +|...||+....+|...+
T Consensus 225 ~g~p~~KlvlGip~YGr~~~~~~~~~~~~~~~~g~~~~g~~t~~~g~~~y~ei~~~~~----g~~~~~D~~~~~~y~~~~ 300 (361)
T 2pi6_A 225 LGAPANKLVMGIPTFGRSFTLASSKTDVGAPVSGPGIPGRFTKEKGILAYYEICDFLH----GATTHRFRDQQVPYATKG 300 (361)
T ss_dssp TTCCGGGEEEEEESEEEEEEESSSCCSTTCBEEEECCCCTTTCCTTEEEHHHHHHHTT----TCEEEEETTTTEEEEEET
T ss_pred cCCCHHHEEEEecccceeeecCCCCCCCCCcCCCCCCCCCcCCCCceeeHHHHHHHhc----CCEEEecccccceEEEEC
Confidence 9999999999999999999764 3468999998653 488889998888888888
Q ss_pred cEEEeeCCcchhhhhhhcccccCccccccccccccchhh
Q 004402 306 ATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWA 344 (755)
Q Consensus 306 ~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~dd~~~ 344 (755)
++||+|||++|++.|++||+++||||+|+|++++||..+
T Consensus 301 ~~~v~ydd~~Si~~K~~~~~~~gLgGv~~W~l~~Dd~~g 339 (361)
T 2pi6_A 301 NQWVAYDDQESVKNKARYLKNRQLAGAMVWALDLDDFRG 339 (361)
T ss_dssp TEEEECCCHHHHHHHHHHHHHTTCSEEEEECGGGSCSSS
T ss_pred CEEEEeCCHHHHHHHHHHHHhCCCcEEEEEcccccccCC
Confidence 999999999999999999999999999999999998543
|
| >1itx_A Chitinase A1, glycosyl hydrolase; alpha-beta (TIM) barrel; 1.10A {Bacillus circulans} SCOP: c.1.8.5 d.26.3.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-58 Score=503.19 Aligned_cols=309 Identities=24% Similarity=0.390 Sum_probs=253.3
Q ss_pred ccCCcceEEEEEecCCC----CCCCCCCCCCCcceEEEEEEEecCCCc-----------------------------EEe
Q 004402 21 FSDAQTWIKAGYWLAGR----EFPLSDINSALFTHLICAFAEVDSSTY-----------------------------QLS 67 (755)
Q Consensus 21 ~~~~~~~~~~gY~~~~~----~~~~~~i~~~~~thi~~~f~~~~~~~~-----------------------------~~~ 67 (755)
.+.+..++++|||..|. .|.+++|++++||||+|||+.+..++. .+.
T Consensus 6 ~~~~~~~~vvgY~~~W~~y~~~~~~~~i~~~~~THi~yaFa~i~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~ 85 (419)
T 1itx_A 6 AEAADSYKIVGYYPSWAAYGRNYNVADIDPTKVTHINYAFADICWNGIHGNPDPSGPNPVTWTCQNEKSQTINVPNGTIV 85 (419)
T ss_dssp CCGGGGCEEEEEEEGGGGTTTCCCGGGCCGGGCSEEEEEEEEECBTTEEEECCTTSSCCEEEECBCTTSCBCCCCTTCEE
T ss_pred cccCCCCEEEEEECchhhcCCCCChhhCCHhhCcEEEEEeecccccccccccccccccccccccccccccccccCCCcee
Confidence 34455789999987764 478999999999999999999963221 122
Q ss_pred cCCch----------------hhHHHHHHHHHHhhCCCceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHHH
Q 004402 68 ISSAN----------------QQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSF 131 (755)
Q Consensus 68 ~~~~~----------------~~~~~~~~~~~k~~~~~lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~f 131 (755)
..+.+ ...+.++ .++|++||++|++||||||. . +..|+.|+++++.|++|
T Consensus 86 ~~D~~~d~~~~~~~~~w~~~~~g~~~~l-~~lk~~~p~lKvllsiGGw~------------~-s~~fs~~~~~~~~R~~F 151 (419)
T 1itx_A 86 LGDPWIDTGKTFAGDTWDQPIAGNINQL-NKLKQTNPNLKTIISVGGWT------------W-SNRFSDVAATAATREVF 151 (419)
T ss_dssp ESSHHHHHTSCCTTCCSSSSCCHHHHHH-HHHHHHSTTCEEEEEEECSS------------S-CTTHHHHHTSHHHHHHH
T ss_pred ecchhhhhhcccCccccchhhhHHHHHH-HHHHHhCCCCEEEEEEcCCC------------C-cchhhHHhcCHHHHHHH
Confidence 21111 1234444 67999999999999995554 3 23499999999999999
Q ss_pred HHHHHHHHHHcCCCcccccccCCC----------CCCcccHHHHHHHHHHHccC-----CCccEEEeeeecCCccccccc
Q 004402 132 IESSIRTARLYGFQGIDLFWLWPN----------STDLNSLGILLDEWKASASD-----QPELTLSMAVRYSPTHETVSY 196 (755)
Q Consensus 132 i~~i~~~~~~~~~DGvdiDwe~p~----------~~~~~~~~~~l~~lr~~l~~-----~~~~~ls~~~~~~~~~~~~~~ 196 (755)
|+++++++++|||||||||||||. ++|+++|+.||++||++|++ ++.++||+++|+.+... .+|
T Consensus 152 i~s~v~~l~~~~fDGiDiDwEyP~~~~~~g~~~~~~d~~nf~~ll~eLr~~l~~~~~~~g~~~~Lt~a~~~~~~~~-~~~ 230 (419)
T 1itx_A 152 ANSAVDFLRKYNFDGVDLDWEYPVSGGLDGNSKRPEDKQNYTLLLSKIREKLDAAGAVDGKKYLLTIASGASATYA-ANT 230 (419)
T ss_dssp HHHHHHHHHHHTCSEEEEECSCSSSCSCTTSCCCTTHHHHHHHHHHHHHHHHHHHHHHHTSCCEEEEEECCSHHHH-HTS
T ss_pred HHHHHHHHHHcCCCceEEeeecCCCCCCCCCCCChhHHHHHHHHHHHHHHHHHhhhcccCCceEEEEeccCCHHHh-hcC
Confidence 999999999999999999999995 36789999999999999975 45799999999876544 358
Q ss_pred CcchhcccCChhhhhhhhccCCCCCcccccCCCCCCC----------CCCCcHHHHHHHHHHCCCCCCceeecccccCCC
Q 004402 197 PIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNP----------SSNISTDFGIREWLRRGFPANKLVLGARASGPG 266 (755)
Q Consensus 197 ~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~----------~~~~~~~~~v~~~~~~g~p~~KlvlG~p~yG~~ 266 (755)
|+++|++++|||||||||+|| .|+..+||+||||.. ...++++.+|++|++.|+|++|||||+|+|||+
T Consensus 231 d~~~l~~~vD~inlMtYD~~g-~w~~~~g~~apL~~~~~~~~~~~~~~~~~~v~~~v~~~~~~gvp~~KlvlGip~YGr~ 309 (419)
T 1itx_A 231 ELAKIAAIVDWINIMTYDFNG-AWQKISAHNAPLNYDPAASAAGVPDANTFNVAAGAQGHLDAGVPAAKLVLGVPFYGRG 309 (419)
T ss_dssp CHHHHHHHSSEEEECCCCSSC-TTSSBCCCSSCSSCCHHHHHTTCTTTTTCSHHHHHHHHHHHTCCGGGEEEEEESEEEE
T ss_pred CHHHHHHhhheeeeecccccC-CCCCCCCCCCcCcCCCCccccCCcccccccHHHHHHHHHHcCCCchhEEEEecccccc
Confidence 999999999999999999995 567789999999953 245799999999999999999999999999999
Q ss_pred cccC----------------------CCcchHHHHHHHhhcCCCcccccccceeeeeeec--CcEEEeeCCcchhhhhhh
Q 004402 267 ITID----------------------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTS--GATWINFDGVETIKAKIS 322 (755)
Q Consensus 267 ~~~~----------------------~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~i~yd~~~S~~~K~~ 322 (755)
|+.. |.++|.++|...... .++...||+....+|... +++||+|||++|++.|++
T Consensus 310 w~~~~~~~~g~~~~~~g~~~~G~~~~G~~~y~ei~~~~~~~-~g~~~~~D~~~~~~y~y~~~~~~~v~ydd~~Si~~K~~ 388 (419)
T 1itx_A 310 WDGCAQAGNGQYQTCTGGSSVGTWEAGSFDFYDLEANYINK-NGYTRYWNDTAKVPYLYNASNKRFISYDDAESVGYKTA 388 (419)
T ss_dssp EESCCSGGGGTTCBCSEECSCCSSSTTEEEHHHHHHHTTTC-TTEEEEEETTTTEEEEEETTTCCEEECCCHHHHHHHHH
T ss_pred eeecCCCCCCCCCCCCCCCCCCcccCCeeeHHHHHHhhccc-CCcEEEeccccccceEEeCCCCEEEEeCCHHHHHHHHH
Confidence 9753 346789998643221 258888888888887753 579999999999999999
Q ss_pred cccccCccccccccccccchhhhh
Q 004402 323 YAKEKNLLGYKAFQLSNDDNWALS 346 (755)
Q Consensus 323 ~a~~~~l~Gi~~W~l~~dd~~~~~ 346 (755)
||+++||||+|+|+++.|+...++
T Consensus 389 y~~~~gLgGv~~W~l~~D~~~~Ll 412 (419)
T 1itx_A 389 YIKSKGLGGAMFWELSGDRNKTLQ 412 (419)
T ss_dssp HHHHHTCCEEEEECGGGCTTCHHH
T ss_pred HHHhCCCCeEEEEeecCCCCcHHH
Confidence 999999999999999999754433
|
| >1wb0_A Chitinase 1, chitotriosidase 1; cyclopentapeptide inhibitors, chitinase inhibitors, carbohyd metabolism, chitin degradation, chitin-binding; HET: VR0 MEA; 1.65A {Homo sapiens} SCOP: c.1.8.5 d.26.3.1 PDB: 1waw_A* 1guv_A 1lg2_A 1lg1_A 1lq0_A 1hki_A* 1hkj_A* 1hkm_A* 1hkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-58 Score=506.68 Aligned_cols=297 Identities=33% Similarity=0.544 Sum_probs=256.1
Q ss_pred EEEEEecCCC-------CCCCCCCCCCCcceEEEEEEEecCCCcEEecCCchhhHHHHHHHHHHhhCCCceEEEEecCCC
Q 004402 28 IKAGYWLAGR-------EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQ 100 (755)
Q Consensus 28 ~~~gY~~~~~-------~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg~~ 100 (755)
+++|||..|. .|.+++|++++||||+|+|+.++++ .+...+..+..+...+.++|++||++|++|||
T Consensus 2 kvv~Y~~~w~~~r~~~~~~~~~~i~~~~~THi~yaF~~i~~~--~~~~~d~~d~~~~~~~~~lk~~~p~lKvllsi---- 75 (445)
T 1wb0_A 2 KLVCYFTNWAQYRQGEARFLPKDLDPSLCTHLIYAFAGMTNH--QLSTTEWNDETLYQEFNGLKKMNPKLKTLLAI---- 75 (445)
T ss_dssp EEEEEEETTGGGSCGGGCCCGGGCCTTTCSEEEEEEEEEETT--EEECSSTTHHHHHHHHHHGGGTCTTCEEEEEE----
T ss_pred eEEEEECcccccCCCCCCCCHHHCCcccCCEEEEEEEeeccC--ceeecChhHHHHHHHHHHHHHhCCCCeEEEEE----
Confidence 4899987764 4789999999999999999999976 44444433333333347899999999999999
Q ss_pred CCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCC-----CCcccHHHHHHHHHHHccC
Q 004402 101 NSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-----TDLNSLGILLDEWKASASD 175 (755)
Q Consensus 101 ~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~-----~~~~~~~~~l~~lr~~l~~ 175 (755)
|||++++..|+.+++|++.|++||+++++++++|||||||||||||.. +|+++|+.||++||++|++
T Consensus 76 --------GGw~~~s~~fs~~~~~~~~R~~fi~siv~~l~~~gfDGiDiDwEyP~~~g~~~~d~~nf~~ll~eLr~~l~~ 147 (445)
T 1wb0_A 76 --------GGWNFGTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQGSPAVDKERFTTLVQDLANAFQQ 147 (445)
T ss_dssp --------ECTTTCSHHHHHHHTSHHHHHHHHHHHHHHHHHTTCCEEEEECSCTTSTTCCTTHHHHHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCchHHHHHcCHHHHHHHHHHHHHHHHHcCCCeEEEeCccCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 666555667999999999999999999999999999999999999953 5789999999999999973
Q ss_pred ------CCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCC------CcHHHHH
Q 004402 176 ------QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN------ISTDFGI 243 (755)
Q Consensus 176 ------~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~------~~~~~~v 243 (755)
.++++||+++|+.+.....+||+++|++++||||||+||+||+ |+..+||+||||..... .+++.+|
T Consensus 148 ~~~~~~~~~~~Ls~av~~~~~~~~~~~d~~~l~~~vD~inlMtYD~~g~-w~~~~g~~apL~~~~~~~~~~~~~~v~~av 226 (445)
T 1wb0_A 148 EAQTSGKERLLLSAAVPAGQTYVDAGYEVDKIAQNLDFVNLMAYDFHGS-WEKVTGHNSPLYKRQEESGAAASLNVDAAV 226 (445)
T ss_dssp HHHHHCSCCCEEEEEECCCHHHHHHHCCHHHHHHHCSEEEECCCCSSCT-TSSBCCCSSCSSCCTTCCGGGGGCSHHHHH
T ss_pred hhhccCCCceEEEEEecCCHHHHHccCCHHHHHHhcceeeeeeeeccCC-CcCCCCCCCCCCCCCCCccccccccHHHHH
Confidence 2489999999998766555699999999999999999999954 67889999999975543 5899999
Q ss_pred HHHHHCCCCCCceeecccccCCCcccC------------------------CCcchHHHHHHHhhcCCCcccccccceee
Q 004402 244 REWLRRGFPANKLVLGARASGPGITID------------------------GSMGYKFIRAFIQNYGYGAAPVYNASYVV 299 (755)
Q Consensus 244 ~~~~~~g~p~~KlvlG~p~yG~~~~~~------------------------~~~~y~~~~~~~~~~~~~~~~~~~~~~~~ 299 (755)
++|+++|+|++|||||+|+|||+|++. |.++|.+++.. .++...||+....
T Consensus 227 ~~~~~~gvp~~KlvlGip~YGr~~~~~~~~~~~~g~p~~g~~~~g~~t~~~G~~~y~ei~~~-----~g~~~~~D~~~~~ 301 (445)
T 1wb0_A 227 QQWLQKGTPASKLILGMPTYGRSFTLASSSDTRVGAPATGSGTPGPFTKEGGMLAYYEVCSW-----KGATKQRIQDQKV 301 (445)
T ss_dssp HHHHHTTCCGGGEEEEEESEEEEEEESCTTCCSTTCBEEEECCCCTTTCCTTEEEHHHHTTC-----TTCEEEEETTTTE
T ss_pred HHHHHcCCChhHEEEEecccceeeEccCCCCCCCCCcccCCCCCCCccCcCCcccHHHHhhc-----CCcEEEeccccce
Confidence 999999999999999999999999753 23578888864 2588999998888
Q ss_pred eeeecCcEEEeeCCcchhhhhhhcccccCccccccccccccchhh
Q 004402 300 NLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWA 344 (755)
Q Consensus 300 ~~~~~~~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~dd~~~ 344 (755)
+|...+++||+|||++|++.|++||+++||||+|+|+++.||..+
T Consensus 302 ~y~y~~~~~v~ydd~~Si~~K~~~~~~~gLgGv~~W~l~~Dd~~g 346 (445)
T 1wb0_A 302 PYIFRDNQWVGFDDVESFKTKVSYLKQKGLGGAMVWALDLDDFAG 346 (445)
T ss_dssp EEEEETTEEEECCCHHHHHHHHHHHHHTTCCEEEEECGGGSCTTC
T ss_pred eEEEeCCEEEEeCCHHHHHHHHHHHHHCCCceEEEecccccccCC
Confidence 888888999999999999999999999999999999999998544
|
| >3qok_A Putative chitinase II; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, glycosyl hydrolases family 18; 2.60A {Klebsiella pneumoniae subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-57 Score=499.71 Aligned_cols=309 Identities=21% Similarity=0.329 Sum_probs=249.7
Q ss_pred chhccCCcceEEEEEecCCCC------CCCCCCCCCCcceEEEEEEEecCCCcEEecCCch-hhHHHH------------
Q 004402 18 QLEFSDAQTWIKAGYWLAGRE------FPLSDINSALFTHLICAFAEVDSSTYQLSISSAN-QQYFSI------------ 78 (755)
Q Consensus 18 ~~~~~~~~~~~~~gY~~~~~~------~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~-~~~~~~------------ 78 (755)
+.....+..++++|||..|.. +.++++++++||||+|+|+.+++++......... ...+..
T Consensus 17 ~~~~~~~~~~~vvgYy~~~~~~r~~~~~~~~~i~~~~~THi~~af~~i~~~g~~~~~~~~~d~~~~~~~w~~~~~~~~~~ 96 (420)
T 3qok_A 17 CASALSAQPLMSVGYFNGGGDVTAGPGGDIDKLDVRQITHLNYSFGLIYNDEKDETNAALKDPAHLHEIWLSPKVQADLQ 96 (420)
T ss_dssp --------CCEEEEEEECSCCSSSCSCCCGGGCCCTTCSEEEEEEEEECCCCTTCCCGGGGCGGGTTSEECCHHHHHHHT
T ss_pred ccCCccCCCCEEEEEEcCccccCCCCCCCcccCCcccceEEEEEeEEECCCCcEEecCcccchhhhhhcccccchhhhHH
Confidence 334445668999999987775 6889999999999999999999866432212111 112221
Q ss_pred HHHHHHhhCCCceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCC---
Q 004402 79 FANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN--- 155 (755)
Q Consensus 79 ~~~~~k~~~~~lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~--- 155 (755)
.+..+|++||++||++|| |||+ +..|+.+++|++.|++||+++++++++|||||||||||||.
T Consensus 97 ~~~~lk~~~p~lkvllsi------------GG~~--s~~f~~~~~~~~~r~~fi~si~~~~~~~gfDGiDiDwE~p~~~~ 162 (420)
T 3qok_A 97 KLPALRKQNPDLKVLLSV------------GGWG--ARGFSGAAATAESRAVFIRSAQKIIQQYGLDGIDLDWEFPVNGA 162 (420)
T ss_dssp THHHHHHHCTTCEEEEEE------------ECTT--CCCHHHHTSSHHHHHHHHHHHHHHHHHHTCSEEEEECSCTTTHH
T ss_pred HHHHHHHhCCCCEEEEEE------------CCCC--CcchhhhhCCHHHHHHHHHHHHHHHHhcCCCceEEEEeCCCCCC
Confidence 147799999999999999 5554 34599999999999999999999999999999999999995
Q ss_pred -------CCCcccHHHHHHHHHHHccCCCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCC
Q 004402 156 -------STDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHA 228 (755)
Q Consensus 156 -------~~~~~~~~~~l~~lr~~l~~~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a 228 (755)
++|+++|+.||++||++|+ ++++||+++|+.+.....+||++++++++||||||+||+||+ |++ |+|
T Consensus 163 ~~~~~~~~~d~~~~~~ll~eLr~~l~--~~~~Ls~a~~~~~~~~~~~~d~~~l~~~~D~inlMtYD~~g~-w~~---~~a 236 (420)
T 3qok_A 163 WGLVASQPADRDNFTALLKSLREAVG--EQKLVTIAVGANAESPKSWVDVKAVAPVLNYINLMTYDMAYG-TQY---FNS 236 (420)
T ss_dssp HHTSCCCTTHHHHHHHHHHHHHHHHC--SSSEEEEEECSCTHHHHHTSCHHHHGGGCSEEEECCCCCCCT-TCC---CSS
T ss_pred CCCCCCChhHHHHHHHHHHHHHHHhC--CCcEEEEEecCccccccccccHHHHHhhCCEEEEecccCCCC-CCC---CCC
Confidence 6788999999999999997 479999999998655133699999999999999999999965 444 999
Q ss_pred CCCCCC--------CCCcHHHHHHHHHHCCCCCCceeecccccCCC----------cccCC-------------------
Q 004402 229 ALYNPS--------SNISTDFGIREWLRRGFPANKLVLGARASGPG----------ITIDG------------------- 271 (755)
Q Consensus 229 ~l~~~~--------~~~~~~~~v~~~~~~g~p~~KlvlG~p~yG~~----------~~~~~------------------- 271 (755)
||+... ...+++.+|++|++.|+|++||+||+|+|||+ |+...
T Consensus 237 pL~~~~~~~~~~~~~~~~~~~~v~~~~~~g~p~~KlvlGip~YGr~~~~~~~~~~~w~~~~~~~~g~~~~~~g~~~~~~~ 316 (420)
T 3qok_A 237 NLYDSSHWPTVAAADKYSADFVVNNYLAAGLKPSQMNLGIGFYGRVPKRAVEPGIDWTKADAQNNPVTQPYFGPQQIALF 316 (420)
T ss_dssp CSSCCSSSCCCSGGGCCCHHHHHHHHHHHTCCGGGEEEEEESEEECCGGGTSCBCCTTSTTGGGSCSBCCCCCHHHHHHH
T ss_pred cccCCCcccccCCcccccHHHHHHHHHHcCCCHHHeEEEecccccccccccccccceecCCcccCCCCCCccCCCCCCCC
Confidence 999654 24689999999999999999999999999999 97641
Q ss_pred -----------CcchHHHHHHH-hhcCCCcccccccceeeeeeecC------cEEEeeCCcchhhhhhhcccccCccccc
Q 004402 272 -----------SMGYKFIRAFI-QNYGYGAAPVYNASYVVNLFTSG------ATWINFDGVETIKAKISYAKEKNLLGYK 333 (755)
Q Consensus 272 -----------~~~y~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~------~~~i~yd~~~S~~~K~~~a~~~~l~Gi~ 333 (755)
.++|.++|... ...+..|...||+....+|.... ++||+|||++|++.|++||+++||||+|
T Consensus 317 ~~~G~~~~~~g~~~y~ei~~~~~~~~g~~~~~~~D~~~~~~y~~~~~~~g~~~~~v~ydd~~Si~~K~~~~~~~gLgGv~ 396 (420)
T 3qok_A 317 ASLGYDLSKDTYVKYNDIVGKLLNDPQKRFTEHWDDEAKVPWLSVQSAEGKPLFALSYENPRSVAIKADYIKAKGLAGAM 396 (420)
T ss_dssp HHTTCCTTTCCEEEHHHHHHHTTTCTTCCEEEEEETTTTEEEEEEECTTSCEEEEEECCCHHHHHHHHHHHHHHTCSEEE
T ss_pred CCCCccccCCCccCHHHHHHHhhccCCCceEEEECccccccEEEeCCCCCccceEEEcCCHHHHHHHHHHHHhCCCcEEE
Confidence 16788998763 33333388889988888887543 4599999999999999999999999999
Q ss_pred cccccccchhhhh
Q 004402 334 AFQLSNDDNWALS 346 (755)
Q Consensus 334 ~W~l~~dd~~~~~ 346 (755)
+|+++.||+..+.
T Consensus 397 ~W~l~~Dd~~~Ll 409 (420)
T 3qok_A 397 FWEYGADDQNQLA 409 (420)
T ss_dssp EECGGGSSTTHHH
T ss_pred EEccccCCccHHH
Confidence 9999999854443
|
| >3g6m_A Chitinase, crchi1; inhibitor, caffeine, glycosidase, hydrolas hydrolase inhibitor complex; HET: CFF; 1.65A {Bionectria ochroleuca} PDB: 3g6l_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-57 Score=494.03 Aligned_cols=299 Identities=24% Similarity=0.388 Sum_probs=248.7
Q ss_pred ccCCcceEEEEEecCCC----CCCCCCCCCCCcceEEEEEEEecCCCcEEecCCchh-------------------hHHH
Q 004402 21 FSDAQTWIKAGYWLAGR----EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQ-------------------QYFS 77 (755)
Q Consensus 21 ~~~~~~~~~~gY~~~~~----~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~-------------------~~~~ 77 (755)
.+.+..++++|||..|. .|.+++|++++||||+|+|+.+++++. +...+... ..+.
T Consensus 15 ~~~~~~~~~v~Y~~~W~~y~~~~~~~~i~~~~~THi~yaF~~i~~~g~-v~~~d~~~d~~~~~~~~~~~~~~~~~~g~~~ 93 (406)
T 3g6m_A 15 STRATGSINAVYFTNWGIYGRNFQPADLQASKILHVLYSFMNLRVDGT-VYSGDTYADLEKHYSDDSWNDIGTNAYGCVK 93 (406)
T ss_dssp ----CCBEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEEEECTTSC-EEESCHHHHHTCCCTTCCSCCSSSCCCHHHH
T ss_pred CcCCCCCEEEEEEChhhccCCCCChhhCChhhCCEEEEEEEEECCCCc-EEecChhhhhhhcccccccccccchhhHHHH
Confidence 34455899999987765 478999999999999999999998764 44333221 1233
Q ss_pred HHHHHHHhhCCCceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCC-
Q 004402 78 IFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS- 156 (755)
Q Consensus 78 ~~~~~~k~~~~~lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~- 156 (755)
.+ ..+|++||++||++|||||. . +..|+.++++++.|++||+++++++++|||||||||||||..
T Consensus 94 ~~-~~lk~~~~~lKvllsiGGw~------------~-s~~fs~~~~~~~~R~~fi~siv~~l~~~gfDGiDiDwE~p~~~ 159 (406)
T 3g6m_A 94 QL-YKLKKANRSLKIMLSIGGWT------------W-STNFPAAASTEATRATFAKTAVEFMKDWGFDGIDVDWEYPASE 159 (406)
T ss_dssp HH-HHHHHHCTTCEEEEEEECSS------------S-CTTHHHHTSSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCSH
T ss_pred HH-HHHHHHCCCCeEEEEEcCCC------------C-CchHHHHhCCHHHHHHHHHHHHHHHHHcCCcEEEEEEECCCcc
Confidence 33 67999999999999995554 3 234999999999999999999999999999999999999975
Q ss_pred CCcccHHHHHHHHHHHccC-------CCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCC
Q 004402 157 TDLNSLGILLDEWKASASD-------QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAA 229 (755)
Q Consensus 157 ~~~~~~~~~l~~lr~~l~~-------~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~ 229 (755)
+|+++|+.||++||++|++ +++++||+++|+.+.... +||+++|++++||||||+||+|| .|+..+||+||
T Consensus 160 ~d~~n~~~ll~eLr~~l~~~~~~~~~~~~~~Lsia~p~~~~~~~-~~d~~~l~~~vD~inlMtYD~~g-~w~~~~g~~a~ 237 (406)
T 3g6m_A 160 TDANNMVLLLQRVRQELDSYSATYANGYHFQLSIAAPAGPSHYN-VLKLAQLGSVLDNINLMAYDYAG-SWDSVSGHQTN 237 (406)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHSTTCCCEEEEEEECSHHHHT-TSCHHHHHHHCSEEEEECCCCSS-TTSSSCCCSSC
T ss_pred chhhHHHHHHHHHHHHHHHhhhhccCCCCeEEEEEecCCHHHhc-cCCHHHHHhhCCEEEEEcccCCC-CCCCCCCCCCc
Confidence 5789999999999999964 458999999998776654 59999999999999999999995 47778999999
Q ss_pred CCCCCC-----CCcHHHHHHHHHHCCCCCCceeecccccCCCcccC-----------------CCcchHHHHHHHhhcCC
Q 004402 230 LYNPSS-----NISTDFGIREWLRRGFPANKLVLGARASGPGITID-----------------GSMGYKFIRAFIQNYGY 287 (755)
Q Consensus 230 l~~~~~-----~~~~~~~v~~~~~~g~p~~KlvlG~p~yG~~~~~~-----------------~~~~y~~~~~~~~~~~~ 287 (755)
|+.... .++++.+|++|++.|+|++|||||+|+|||+|+.. |.+.|.+++. .
T Consensus 238 l~~~~~~~~~~~~~~~~~v~~~~~~g~p~~KlvlGip~YGr~~~~~~~~g~~~~g~~~~t~~~g~~~y~~l~~------~ 311 (406)
T 3g6m_A 238 LYPSTSNPSSTPFSTKAAVDAYIAAGVPASKIILGMPIYGRAFVGTDGPGKPYSTIGEGSWESGIWDYKVLPK------A 311 (406)
T ss_dssp SSCCSSCGGGCSCCHHHHHHHHHHTTCCGGGEEEEEESEEEEEESCSSTTSCCSBCCCCSSBTTEEEGGGCSC------T
T ss_pred ccCCCCCCcCCchhHHHHHHHHHHcCCCHHHEEEEecccceeeecCCCCCCCCcCCCCCcCcccceeHHHHHh------c
Confidence 996543 35899999999999999999999999999999864 1234655432 3
Q ss_pred Ccccccccceeeeeee--cCcEEEeeCCcchhhhhhhcccccCccccccccccccch
Q 004402 288 GAAPVYNASYVVNLFT--SGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDN 342 (755)
Q Consensus 288 ~~~~~~~~~~~~~~~~--~~~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~dd~ 342 (755)
++...||+....+|.. .+++||+|||++|++.|++||+++||||+|+|++++|++
T Consensus 312 g~~~~~D~~~~~~y~y~~~~~~~v~ydd~~Si~~K~~~~~~~gLgGv~~W~l~~Dd~ 368 (406)
T 3g6m_A 312 GATVITDSAAGATYSYDSSSRTMISYDTPDMVRTKVSYAKGLGLGGSMFWEASADKT 368 (406)
T ss_dssp TCEEEEETTTTEEEEEETTTTEEEECCCHHHHHHHHHHHHHHTCCEEEEECGGGCCS
T ss_pred CCeEEEecCcccceEEeCCCCEEEEeCCHHHHHHHHHHHHhCCCceEEEEecccCCC
Confidence 5777888877777764 367999999999999999999999999999999999984
|
| >1kfw_A Chitinase B; TIM barrel, hydrolase; 1.74A {Arthrobacter SP} SCOP: c.1.8.5 d.26.3.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-57 Score=492.14 Aligned_cols=297 Identities=24% Similarity=0.378 Sum_probs=246.2
Q ss_pred CcceEEEEEecCCC----CCCCCCCCC----CCcceEEEEEEEecCCCcEEecC---------------Cc---------
Q 004402 24 AQTWIKAGYWLAGR----EFPLSDINS----ALFTHLICAFAEVDSSTYQLSIS---------------SA--------- 71 (755)
Q Consensus 24 ~~~~~~~gY~~~~~----~~~~~~i~~----~~~thi~~~f~~~~~~~~~~~~~---------------~~--------- 71 (755)
...++++|||..|. .|.+++|+. .+||||+|+|+.++++++.+... +.
T Consensus 6 ~~~~~vvgY~~~W~~y~~~~~~~~i~~~~~~~~~THi~yaFa~i~~~~g~~~~~~~~~~~~~~~~~~~~D~~~d~~~~~~ 85 (435)
T 1kfw_A 6 VNGYRNVGYFAQWGVYGRAFQAKQLDVSGTAKNLTHINYSFGNINNQTLTCFMANKAQGTGPNGSDGAGDAWADFGMGYA 85 (435)
T ss_dssp BTTBEEEEEEEGGGGSTTCCCHHHHHHTSCGGGCSEEEEEEECBCTTTCSBCCCEECCCSSTTTTTTCEEHHHHHTCCCC
T ss_pred CCCcEEEEEECchhhcCCCCChhhCCcccccccCCEEEEEEEeecCCCCeEEeeccccccccccccccccchhhhhcccc
Confidence 45788999987764 467888984 59999999999999833322211 10
Q ss_pred ---------------hhhHHHHHHHHHHhhCCCceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHH
Q 004402 72 ---------------NQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSI 136 (755)
Q Consensus 72 ---------------~~~~~~~~~~~~k~~~~~lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~ 136 (755)
....+.++ .++|++||++|||+|||||.. +..|+.|+++++.|++||++++
T Consensus 86 ~~~~~~g~~d~~~~~~~g~~~~l-~~lK~~~p~lKvllSiGGw~~-------------s~~fs~~~~~~~~R~~Fi~siv 151 (435)
T 1kfw_A 86 ADKSVSGKADTWDQPLAGSFNQL-KQLKAKNPKLKVMISLGGWTW-------------SKNFSKAAATEASRQKLVSSCI 151 (435)
T ss_dssp TTTSSSSSCCCTTCSCCHHHHHH-HHHHTTCTTCEEEEEEECSSS-------------CTTHHHHTSSHHHHHHHHHHHH
T ss_pred ccccccccccccchhhHHHHHHH-HHHHHhCCCCEEEEEEcCCCC-------------cchhhHHhCCHHHHHHHHHHHH
Confidence 01235555 679999999999999955543 2349999999999999999999
Q ss_pred HHHHHc----------------CCCcccccccCCCC------------CCcccHHHHHHHHHHHccC-----CCccEEEe
Q 004402 137 RTARLY----------------GFQGIDLFWLWPNS------------TDLNSLGILLDEWKASASD-----QPELTLSM 183 (755)
Q Consensus 137 ~~~~~~----------------~~DGvdiDwe~p~~------------~~~~~~~~~l~~lr~~l~~-----~~~~~ls~ 183 (755)
+++++| +|||||||||||.. +|+++|+.||++||++|++ +++++||+
T Consensus 152 ~~l~~~~l~~~~~~g~~g~~~~~fDGiDiDwEyP~~~~g~~g~~~~p~~d~~nf~~ll~eLr~~l~~~~~~~g~~~~Ls~ 231 (435)
T 1kfw_A 152 DLYIKGNLPNFEGRGGAGAAAGIFDGIDIDWEWPGTNSGLAGNGVDTVNDRANFKALLAEFRKQLDAYGSTNNKKYVLSA 231 (435)
T ss_dssp HHHTSCCEEEETTEEETTTTTTTCCEEEEECSCTTSSCSSTTCCCCTTTHHHHHHHHHHHHHHHHHHHHHHTTCCCEEEE
T ss_pred HHHHhhcccccccccccccccCCCCceEEeeeCCCCCCCCCCCCCCcHHHHHHHHHHHHHHHHhhhhhhcccCCceEEEE
Confidence 999765 79999999999963 6789999999999999974 35799999
Q ss_pred eeecCCcccccc-cCcchhcccCChhhhhhhhccCCCCCcc-cccCCCCCCCCC-------CCcHHHHHHHHHHCCCCCC
Q 004402 184 AVRYSPTHETVS-YPIDSMKKNLNWAHLVAYDYHMPSKENV-TGIHAALYNPSS-------NISTDFGIREWLRRGFPAN 254 (755)
Q Consensus 184 ~~~~~~~~~~~~-~~~~~l~~~vD~~~vm~Yd~~~~~~~~~-~~~~a~l~~~~~-------~~~~~~~v~~~~~~g~p~~ 254 (755)
++|+.+.....+ ||+++|++++||||||+||+||+ |+.. +||+|||+.... .++++.+|++|++.|+|++
T Consensus 232 Avp~~~~~~~~g~~d~~~l~~~vD~invMtYD~~g~-w~~~~tg~~apL~~~~~~~~~~~~~~~v~~av~~~~~~gvp~~ 310 (435)
T 1kfw_A 232 FLPANPADIDAGGWDDPANFKSLDFGSIQGYDLHGA-WNPTLTGHQANLYDDPADPRAPSKKFSADKAVKKYLAAGIDPK 310 (435)
T ss_dssp EECSSHHHHHHHTTTCGGGGGTCSEEEECCSCSSCT-TSTTBCCCSSCSSCCTTCCSCGGGCCCHHHHHHHHHHTTCCGG
T ss_pred EccCChhhhccCcccHHHHHhhhheeeeeeecccCC-CCCCCCCCCCcCCCCCCCcccccccccHHHHHHHHHHcCCCHH
Confidence 999887655545 99999999999999999999954 6666 999999996543 4589999999999999999
Q ss_pred ceeecccccCCCcccC-------------------CCcchHHHHHHHhhcCCCcccccccceeeeeeecCcEEEeeCCcc
Q 004402 255 KLVLGARASGPGITID-------------------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVE 315 (755)
Q Consensus 255 KlvlG~p~yG~~~~~~-------------------~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~yd~~~ 315 (755)
|||||||+|||+|++. |.+.|.++ . .++...||+....+|...+++||+|||++
T Consensus 311 KlvlGip~YGr~w~~~~~~~~g~~~~~~~~~t~~~G~~~y~ei-----~--~~~~~~~D~~~~~~y~y~~~~~vsydd~~ 383 (435)
T 1kfw_A 311 QLGLGLAAYGRGWTGAKNVSPWGPATDGAPGTYETANEDYDKL-----K--TLGTDHYDAATGSAWRYDGTQWWSYDNIA 383 (435)
T ss_dssp GEEEEEESEEEEEESCCCSSSSCBCSEECCCSSBTTEEEHHHH-----T--TSSEEEEETTTTEEEEECSSCEEEECCHH
T ss_pred HEEEEecccceeeecCCCCCCCCCCCCCCCCCCcCCceeHHHh-----c--CCCeEEEccccceeEEEECCEEEEecCHH
Confidence 9999999999999864 34678777 2 23678888888888887889999999999
Q ss_pred hhhhhhhcccccCccccccccccccch
Q 004402 316 TIKAKISYAKEKNLLGYKAFQLSNDDN 342 (755)
Q Consensus 316 S~~~K~~~a~~~~l~Gi~~W~l~~dd~ 342 (755)
|++.|++||+++||||+|+|+++.|..
T Consensus 384 Si~~K~~y~~~~gLgGv~~W~l~~D~~ 410 (435)
T 1kfw_A 384 TTKQKTDYIVSKGLGGGMWWELSGDRN 410 (435)
T ss_dssp HHHHHHHHHHHTTCCEEEEECGGGCTT
T ss_pred HHHHHHHHHHhCCCCEEEEEecCCCCC
Confidence 999999999999999999999999543
|
| >1edq_A Chitinase A; beta-alpha (TIM) barrel, hydrolase; 1.55A {Serratia marcescens} SCOP: b.1.18.2 c.1.8.5 d.26.3.1 PDB: 1ffq_A* 1ffr_A* 1ehn_A* 1ctn_A 1k9t_A* 1eib_A* 2wlz_A* 2wly_A* 2wm0_A* 2wk2_A* 1nh6_A* 1x6l_A 1rd6_A 1x6n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=495.50 Aligned_cols=299 Identities=21% Similarity=0.354 Sum_probs=248.6
Q ss_pred cceEEEEEecCCC----CCCCCCCCCCCcceEEEEEEEecCC-------------------------CcEEecCCch---
Q 004402 25 QTWIKAGYWLAGR----EFPLSDINSALFTHLICAFAEVDSS-------------------------TYQLSISSAN--- 72 (755)
Q Consensus 25 ~~~~~~gY~~~~~----~~~~~~i~~~~~thi~~~f~~~~~~-------------------------~~~~~~~~~~--- 72 (755)
..++++|||..|. .|.+++||+++||||+|+|+.+..+ ++.+...+.+
T Consensus 133 ~~~~v~~Y~~~W~~y~~~~~~~~i~~~~~THi~yaF~~i~~~~~~n~~l~~~~g~~~~~~~~c~~~~~~~v~~~D~~ad~ 212 (540)
T 1edq_A 133 SGKVVGSYFVEWGVYGRNFTVDKIPAQNLTHLLYGFIPICGGNGINDSLKEIEGSFQALQRSCQGREDFKVSIHDPFAAL 212 (540)
T ss_dssp SSCEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEECBCCCTTTSGGGGGSTTHHHHHHHHTTTCCTTSBCCSCHHHHH
T ss_pred CCcEEEEEECcccccCCCCChhHCCHhhCCEEEEeeecccCcccccccccccccchhhhhcccccccCcceEecChhHhh
Confidence 4689999987763 4899999999999999999998641 1122211110
Q ss_pred --------------hhHHHHHHHHHHhhCCCceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHH
Q 004402 73 --------------QQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRT 138 (755)
Q Consensus 73 --------------~~~~~~~~~~~k~~~~~lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~ 138 (755)
...|..+ .++|++||++|+|+|||||. .+ ..|+.| ++++.|++||+++++|
T Consensus 213 ~~~~~g~~~~~~~~~g~~~~l-~~lK~~~p~lKvllSiGGw~------------~s-~~F~~~-~~~~~R~~Fi~siv~~ 277 (540)
T 1edq_A 213 QKAQKGVTAWDDPYKGNFGQL-MALKQAHPDLKILPSIGGWT------------LS-DPFFFM-GDKVKRDRFVGSVKEF 277 (540)
T ss_dssp TSCBTTBCSTTCSSCHHHHHH-HHHHHHCTTCEEEEEEECSS------------SC-GGGGGT-TSHHHHHHHHHHHHHH
T ss_pred ccccCCcccccccchhhHHHH-HHHHHhCCCCeEEEEEeCCc------------CC-Ccchhh-cCHHHHHHHHHHHHHH
Confidence 1234444 77999999999999995554 32 338887 6999999999999999
Q ss_pred HHHcC-CCcccccccCCC----------CCCcccHHHHHHHHHHHccC-----CCccEEEeeeecCCcccccccCcchhc
Q 004402 139 ARLYG-FQGIDLFWLWPN----------STDLNSLGILLDEWKASASD-----QPELTLSMAVRYSPTHETVSYPIDSMK 202 (755)
Q Consensus 139 ~~~~~-~DGvdiDwe~p~----------~~~~~~~~~~l~~lr~~l~~-----~~~~~ls~~~~~~~~~~~~~~~~~~l~ 202 (755)
+++|| |||||||||||. ++|+++|+.||++||++|++ +++++||+++|+...... .+|+++|+
T Consensus 278 l~~yg~fDGIDIDWEyP~~~g~~~~~g~~~D~~nf~~ll~eLr~~l~~~~~~~g~~~~LT~Av~a~~~~~~-~~d~~~l~ 356 (540)
T 1edq_A 278 LQTWKFFDGVDIDWEFPGGKGANPNLGSPQDGETYVLLMKELRAMLDQLSVETGRKYELTSAISAGKDKID-KVAYNVAQ 356 (540)
T ss_dssp HHHCTTCCEEEEECSCTTSCSSCTTCCCTTHHHHHHHHHHHHHHHHHHHHHHHTCCCEEEEEEECSHHHHT-TSCHHHHG
T ss_pred HHHcCCCceEEEEEEccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhhhccCCceEEEEEecCChhHhh-cccHHHHH
Confidence 99999 999999999994 56789999999999999964 457999999998765544 48999999
Q ss_pred ccCChhhhhhhhccCCCCCcc-cccCCCCCCCC----CCCcHHHHHHHHHHCCCCCCceeecccccCCCcccC-------
Q 004402 203 KNLNWAHLVAYDYHMPSKENV-TGIHAALYNPS----SNISTDFGIREWLRRGFPANKLVLGARASGPGITID------- 270 (755)
Q Consensus 203 ~~vD~~~vm~Yd~~~~~~~~~-~~~~a~l~~~~----~~~~~~~~v~~~~~~g~p~~KlvlG~p~yG~~~~~~------- 270 (755)
+++||||||+|||||+ |+.. +||+||||.+. ..++++.+|++|++.|+|++||+||+|+|||+|++.
T Consensus 357 ~~vD~inlMtYD~~G~-W~~~~~G~~apLy~~~~~~~~~~~v~~av~~~~~~gvp~~KivlGip~YGr~w~~~~~~~~~~ 435 (540)
T 1edq_A 357 NSMDHIFLMSYDFYGA-FDLKNLGHQTALNAPAWKPDTAYTTVNGVNALLAQGVKPGKIVVGTAMYGRGWTGVNGYQNNI 435 (540)
T ss_dssp GGCSEEEEECCCSSCT-TCSSSCCCSSCSSCCTTCTTCSCCHHHHHHHHHHHTCCGGGEEEEEESEEEEEESCBSCSTTC
T ss_pred hhccEEEEeccccCCC-CCCCCCCCcCCCCCCccCCCCCcCHHHHHHHHHHcCCCHHHEEEEeeccceeEeeccCCCCCC
Confidence 9999999999999965 5555 99999999654 357899999999999999999999999999999853
Q ss_pred ----------------CCcchHHHHHHHhhcCCCcccccccceeeeeeec--CcEEEeeCCcchhhhhhhcccccCcccc
Q 004402 271 ----------------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTS--GATWINFDGVETIKAKISYAKEKNLLGY 332 (755)
Q Consensus 271 ----------------~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~i~yd~~~S~~~K~~~a~~~~l~Gi 332 (755)
|.++|.++|+.+... +|...||+....+|... +++||+|||++|++.|++|++++||||+
T Consensus 436 ~~~g~~~G~~~Gt~e~G~~~y~ei~~~~~~~--g~~~~~D~~~~~~y~y~~~~~~~vsydd~~Si~~K~~y~k~~gLgGv 513 (540)
T 1edq_A 436 PFTGTATGPVKGTWENGIVDYRQIAGQFMSG--EWQYTYDATAEAPYVFKPSTGDLITFDDARSVQAKGKYVLDKQLGGL 513 (540)
T ss_dssp GGGSBCSEECCCSSBTTEEEHHHHHHHSSST--TCEEEEETTTTEEEEEETTTTEEEECCCHHHHHHHHHHHHHHTCCEE
T ss_pred cccccCCCCccccccCCcccHHHHHHHhhcC--CceEEECCccccceEEECCCCEEEEECCHHHHHHHHHHHHhCCCCEE
Confidence 236799999876543 58888888888887754 4799999999999999999999999999
Q ss_pred ccccccccch
Q 004402 333 KAFQLSNDDN 342 (755)
Q Consensus 333 ~~W~l~~dd~ 342 (755)
|+|+++.|+.
T Consensus 514 ~~W~l~~Dd~ 523 (540)
T 1edq_A 514 FSWEIDADNG 523 (540)
T ss_dssp EEECGGGCCS
T ss_pred EEEeccCCCH
Confidence 9999999973
|
| >1jnd_A Imaginal DISC growth factor-2; IDGF, chitinase, insulin recep heparin, hormone-growth factor complex; HET: NAG BMA MAN; 1.30A {Drosophila melanogaster} SCOP: c.1.8.5 d.26.3.1 PDB: 1jne_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-56 Score=489.42 Aligned_cols=308 Identities=24% Similarity=0.427 Sum_probs=249.2
Q ss_pred eEEEEEecCCC-------CCCCCCCC--CCCcceEEEEEEEecCCCcEEecCCch----hhHHHHHHHHHHhhCCCceEE
Q 004402 27 WIKAGYWLAGR-------EFPLSDIN--SALFTHLICAFAEVDSSTYQLSISSAN----QQYFSIFANSVRRKNPSIKTL 93 (755)
Q Consensus 27 ~~~~gY~~~~~-------~~~~~~i~--~~~~thi~~~f~~~~~~~~~~~~~~~~----~~~~~~~~~~~k~~~~~lk~~ 93 (755)
++++|||..|. .|.+++|+ .++||||+|+|+.++++++.+...+.+ ...+..+ .++|++||++||+
T Consensus 2 ~~vvgYy~~w~~~r~~~~~~~~~~i~~~~~~~THi~yaFa~i~~~~~~~~~~d~~~d~~~~~~~~~-~~lk~~~p~lKvl 80 (420)
T 1jnd_A 2 SNLVCYYDSSSYTREGLGKLLNPDLEIALQFCSHLVYGYAGLRGENLQAYSMNENLDIYKHQFSEV-TSLKRKYPHLKVL 80 (420)
T ss_dssp CEEEEEEEGGGGGCSSTTCCCHHHHHHHGGGCSEEEEEEEEECTTTCCEEETTHHHHTTTCHHHHH-HGGGGTSTTCEEE
T ss_pred CeEEEEEccchhcCCCCCCcCHhHcCCccccCCEEEEEEEEecCCCCEEEecCccchhhhHHHHHH-HHHHhhCCCceEE
Confidence 57999987664 46778887 478999999999999886666544321 2345555 6799999999999
Q ss_pred EEecCCCCCccccccCCCCCCcccccccccChhhH-HHHHHHHHHHHHHcCCCcccccccCCCC----------------
Q 004402 94 LSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHR-KSFIESSIRTARLYGFQGIDLFWLWPNS---------------- 156 (755)
Q Consensus 94 isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r-~~fi~~i~~~~~~~~~DGvdiDwe~p~~---------------- 156 (755)
+|||||..+. ..++..|+.++++++.| ++||+++++++++|||||||||||||..
T Consensus 81 lsiGGw~~~~--------~~~s~~f~~~~~~~~~R~~~Fi~s~v~~~~~~gfDGiDiDwEyP~~~~~~~~g~~g~~~~~~ 152 (420)
T 1jnd_A 81 LSVGGDHDID--------PDHPNKYIDLLEGEKVRQIGFIRSAYELVKTYGFDGLDLAYQFPKNKPRKVHGDLGLAWKSI 152 (420)
T ss_dssp EEEETTCCCC--------TTSTTHHHHHHTCCHHHHHHHHHHHHHHHHHTTCSEEEEECCCCCCCCCCC-----------
T ss_pred EEeCCCcCCC--------CccchhhhHhhcChHHHHHHHHHHHHHHHHHcCCCceEEeeecCCccccccccccccccccc
Confidence 9997766321 11245699999999999 9999999999999999999999999963
Q ss_pred ---------------CCcccHHHHHHHHHHHccCCCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCC
Q 004402 157 ---------------TDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKE 221 (755)
Q Consensus 157 ---------------~~~~~~~~~l~~lr~~l~~~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~ 221 (755)
+|+++|+.||++||++|++. +++||+++++.... ...||+++|++++|||||||||+||+|..
T Consensus 153 ~~~~~g~~~~~~~~~~d~~nf~~ll~eLr~~l~~~-~~~Ls~av~~~~~~-~~~~d~~~l~~~vD~inlMtYD~~g~~~~ 230 (420)
T 1jnd_A 153 KKLFTGDFIVDPHAALHKEQFTALVRDVKDSLRAD-GFLLSLTVLPNVNS-TWYFDIPALNGLVDFVNLATFDFLTPARN 230 (420)
T ss_dssp --------CCCTTHHHHHHHHHHHHHHHHHHHHTT-TCEEEEEECTTCCH-HHHCCHHHHHTTCSEEEECCCCSSCTTTC
T ss_pred cccccCCcccccCChhHHHHHHHHHHHHHHHHhhc-CcEEEEEEeCCcch-hhccCHHHHHhhCcEEEEeeeecCCCcCC
Confidence 35789999999999999875 79999999876433 23589999999999999999999977654
Q ss_pred -cccccCCCCCCCC------CCCcHHHHHHHHHHCCCCCCceeecccccCCCcccC------------------------
Q 004402 222 -NVTGIHAALYNPS------SNISTDFGIREWLRRGFPANKLVLGARASGPGITID------------------------ 270 (755)
Q Consensus 222 -~~~~~~a~l~~~~------~~~~~~~~v~~~~~~g~p~~KlvlG~p~yG~~~~~~------------------------ 270 (755)
..+||+|||+... ...+++.+|++|+++|+|++|||||+|+|||+|++.
T Consensus 231 ~~~~g~~apl~~~~~~~~~~~~~~v~~~v~~~~~~gvp~~KlvlGip~YGr~w~~~~~~~~~g~~~~~~~~g~~~~g~~t 310 (420)
T 1jnd_A 231 PEEADYSAPIYHPDGSKDRLAHLNADFQVEYWLSQGFPSNKINLGVATYGNAWKLTKDSGLEGVPVVPETSGPAPEGFQS 310 (420)
T ss_dssp TTCBCCSSCSSCCTTSTTCCTTCSHHHHHHHHHHTTCCGGGEEEEEESEEEEEECCGGGCSCCSSCBCSCCSBCCCCTTT
T ss_pred CCccccCCcccCCccccCccccccHHHHHHHHHHcCCCHHHEEEEecccceeeEecCCCCCCCCCcccccCCCCCCCCCC
Confidence 4689999999654 357899999999999999999999999999999742
Q ss_pred ---CCcchHHHHHHHhhcCC--------Ccccccccce-eeeeee-------cCcEEEeeCCcchhhhhhhcccccCccc
Q 004402 271 ---GSMGYKFIRAFIQNYGY--------GAAPVYNASY-VVNLFT-------SGATWINFDGVETIKAKISYAKEKNLLG 331 (755)
Q Consensus 271 ---~~~~y~~~~~~~~~~~~--------~~~~~~~~~~-~~~~~~-------~~~~~i~yd~~~S~~~K~~~a~~~~l~G 331 (755)
|.++|.++|..+...+. .+...||+.. ..+|.. .++.||+|||++|++.|++||+++||||
T Consensus 311 ~~~G~~~y~ei~~~~~~~~~~~~~g~~~~~~~~~D~~~~~~~y~y~~~d~~~~~~~wvsydd~~Si~~K~~y~~~~gLgG 390 (420)
T 1jnd_A 311 QKPGLLSYAEICGKLSNPQNQFLKGNESPLRRVSDPTKRFGGIAYRPVDGQITEGIWVSYDDPDSASNKAAYARVKNLGG 390 (420)
T ss_dssp CCTTEEEHHHHHHHBCCTTTTTCCGGGSCBEEECCTTCCSCEEEEECSBTTBCCCEEEEECCHHHHHHHHHHHHHTTCSE
T ss_pred CCCceeeHHHHHHhhcccCcccccccccceeEEechhhccceeEEEecccCCCCCEEEEcCCHHHHHHHHHHHHhCCCce
Confidence 23689999998765432 2445566532 223332 3579999999999999999999999999
Q ss_pred cccccccccchhhh
Q 004402 332 YKAFQLSNDDNWAL 345 (755)
Q Consensus 332 i~~W~l~~dd~~~~ 345 (755)
+|+|+++.||..+.
T Consensus 391 v~~W~l~~Dd~~g~ 404 (420)
T 1jnd_A 391 VALFDLSYDDFRGQ 404 (420)
T ss_dssp EEEECGGGSCTTCT
T ss_pred EEEEeeccCCCCCc
Confidence 99999999986553
|
| >1ll7_A Chitinase 1; beta-alpha barrel, hydrolase; 2.00A {Coccidioides immitis} SCOP: c.1.8.5 d.26.3.1 PDB: 1d2k_A 1ll4_A* 1ll6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-56 Score=482.40 Aligned_cols=293 Identities=23% Similarity=0.376 Sum_probs=245.3
Q ss_pred ceEEEEEecCCC----CCCCCCCCCCCcceEEEEEEEecCCCcEEecCCch-------------------hhHHHHHHHH
Q 004402 26 TWIKAGYWLAGR----EFPLSDINSALFTHLICAFAEVDSSTYQLSISSAN-------------------QQYFSIFANS 82 (755)
Q Consensus 26 ~~~~~gY~~~~~----~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~ 82 (755)
+++++|||..|. .|.+++|+.++||||+|+|+.+++++. +...+.. ...+..+ .+
T Consensus 2 ~~~vvgY~~~W~~y~~~~~~~~i~~~~~THi~yaF~~i~~~g~-v~~~d~~~d~~~~~~~~~w~~~~~~~~~~~~~l-~~ 79 (392)
T 1ll7_A 2 GFRSVVYFVNWAIYGRGHNPQDLKADQFTHILYAFANIRPSGE-VYLSDTWADTDKHYPGDKWDEPGNNVYGCIKQM-YL 79 (392)
T ss_dssp CBEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEEEECTTSC-EEESCHHHHTTCCCTTCCSSCSSCCCCHHHHHH-HH
T ss_pred CcEEEEEECchhhcCCCCChhhCCcccCCEEEEEEEEECCCCe-EEecChhhhhhcccCCccccccchhhhHHHHHH-HH
Confidence 478999987764 578999999999999999999998754 3332211 1124444 67
Q ss_pred HHhhCCCceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCC-CCCccc
Q 004402 83 VRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN-STDLNS 161 (755)
Q Consensus 83 ~k~~~~~lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~-~~~~~~ 161 (755)
+|++||++||++||| ||+.+ ..|+.++++++.|++||+++++++++|||||||||||||. ++|+++
T Consensus 80 lk~~~~~lKvllsiG------------G~~~s-~~f~~~~~~~~~r~~fi~siv~~l~~~~fDGiDiDwE~p~~~~d~~~ 146 (392)
T 1ll7_A 80 LKKNNRNLKTLLSIG------------GWTYS-PNFKTPASTEEGRKKFADTSLKLMKDLGFDGIDIDWQYPEDEKQAND 146 (392)
T ss_dssp HHHHCTTCEEEEEEE------------HHHHG-GGSHHHHTSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCSHHHHHH
T ss_pred HHHhCCCCeEEEEEe------------CCCCC-chHhHHhCCHHHHHHHHHHHHHHHHhcCCCcEEEEeeCCCChHHHHH
Confidence 999999999999994 44432 3499999999999999999999999999999999999997 468999
Q ss_pred HHHHHHHHHHHccC-------CCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCC
Q 004402 162 LGILLDEWKASASD-------QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPS 234 (755)
Q Consensus 162 ~~~~l~~lr~~l~~-------~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~ 234 (755)
|+.||++||++|++ +++++||+++|+.+.... .||+++|++++||||||+||+|| .|+..+||+|||+...
T Consensus 147 ~~~ll~eLr~~l~~~~~~~~~~~~~~Ls~av~~~~~~~~-~~d~~~l~~~vD~inlMtYD~~g-~w~~~~g~~apl~~~~ 224 (392)
T 1ll7_A 147 FVLLLKACREALDAYSAKHPNGKKFLLTIASPAGPQNYN-KLKLAEMDKYLDFWNLMAYDFSG-SWDKVSGHMSNVFPST 224 (392)
T ss_dssp HHHHHHHHHHHHHHHHHTSTTSCCCEEEEEEECSHHHHT-TSCHHHHHTTCSEEEEECCCSSS-TTSSBCCCSSCSSCCS
T ss_pred HHHHHHHHHHHHHhhhhcccCCCceEEEEEecCCHHHhc-cCCHHHHHHhhheeeEEeecccC-CCCCCCCCCCcCCCCC
Confidence 99999999999974 358999999998776555 49999999999999999999995 5677899999999654
Q ss_pred C-----CCcHHHHHHHHHHCCCCCCceeecccccCCCcccCC-----------------CcchHHHHHHHhhcCCCcccc
Q 004402 235 S-----NISTDFGIREWLRRGFPANKLVLGARASGPGITIDG-----------------SMGYKFIRAFIQNYGYGAAPV 292 (755)
Q Consensus 235 ~-----~~~~~~~v~~~~~~g~p~~KlvlG~p~yG~~~~~~~-----------------~~~y~~~~~~~~~~~~~~~~~ 292 (755)
. .++++.+|++|++.|+|++||+||+|+|||+|+... .+.|.+++ ..++...
T Consensus 225 ~~~~~~~~~v~~~v~~~~~~gvp~~KlvlGip~YGr~~~~~~~~g~~~~g~~~g~~~~g~~~y~~l~------~~g~~~~ 298 (392)
T 1ll7_A 225 TKPESTPFSSDKAVKDYIKAGVPANKIVLGMPLYGRAFASTDGIGTSFNGVGGGSWENGVWDYKDMP------QQGAQVT 298 (392)
T ss_dssp SCGGGCSCCHHHHHHHHHHTTCCGGGEEEEEESEEEEECSCSSTTSBCCCCCCBSSSTTEEEGGGCS------CTTCEEE
T ss_pred CCCccccccHHHHHHHHHHcCCChhHEEEEecccceeeeccCCCCCcCCCCCCCCCccccccHHHHh------hCCCeEE
Confidence 2 358999999999999999999999999999998652 22344332 1247778
Q ss_pred cccceeeeeee--cCcEEEeeCCcchhhhhhhcccccCccccccccccccc
Q 004402 293 YNASYVVNLFT--SGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341 (755)
Q Consensus 293 ~~~~~~~~~~~--~~~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~dd 341 (755)
||+....+|.. .+++||+|||++|++.|++||+++||||+|+|+++.|+
T Consensus 299 ~D~~~~~~y~y~~~~~~~v~ydd~~Si~~K~~~~~~~gLgGv~~W~l~~Dd 349 (392)
T 1ll7_A 299 ELEDIAASYSYDKNKRYLISYDTVKIAGKKAEYITKNGMGGGMWWESSSDK 349 (392)
T ss_dssp EETTTTEEEEEETTTTEEEECCCHHHHHHHHHHHHHTTCCEEEEECTTSCC
T ss_pred EecccceeEEEECCCCEEEEeCCHHHHHHHHHHHHhCCCCeEEEEeecCCC
Confidence 88877777765 47899999999999999999999999999999999998
|
| >1w9p_A Chitinase; peptide inhibitors, argifin, argadin, glycosidase, hydrolase; 1.7A {Aspergillus fumigatus} SCOP: c.1.8.5 d.26.3.1 PDB: 1w9u_A* 1w9v_A* 2a3a_A* 2a3b_A* 2a3c_A* 2a3e_A* 2iuz_A* 3ch9_A 3chc_A* 3chd_A* 3che_A* 3chf_A* 1wno_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=484.27 Aligned_cols=295 Identities=23% Similarity=0.357 Sum_probs=246.5
Q ss_pred cceEEEEEecCCC----CCCCCCCCCCCcceEEEEEEEecCCCcEEecCCchh-------------------hHHHHHHH
Q 004402 25 QTWIKAGYWLAGR----EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQ-------------------QYFSIFAN 81 (755)
Q Consensus 25 ~~~~~~gY~~~~~----~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~-------------------~~~~~~~~ 81 (755)
..++++|||..|. .|.+++|+.++||||+|+|+.++++++.+...+... ..+..+ .
T Consensus 41 ~~~~vvgYy~~W~~y~r~~~~~~i~~~~~THI~yaF~~i~~~~g~v~~~d~~~d~~~~~~~~~w~~~~~~~~~~~~~l-~ 119 (433)
T 1w9p_A 41 SGYRSVVYFVNWAIYGRNHNPQDLPVERLTHVLYAFANVRPETGEVYMTDSWADIEKHYPGDSWSDTGNNVYGCIKQL-Y 119 (433)
T ss_dssp CCBEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEEEECTTTCCEEESCHHHHHTCCCTTCCSSCCSSCCCHHHHHH-H
T ss_pred CCCEEEEEECchhhcCCCCChhHCCHhhCCEEEEEEEEecCCCCeeeecCchhhhhcccCCccccccchhhhHHHHHH-H
Confidence 4789999987664 478999999999999999999998444454433211 123444 6
Q ss_pred HHHhhCCCceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCC-CCCcc
Q 004402 82 SVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN-STDLN 160 (755)
Q Consensus 82 ~~k~~~~~lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~-~~~~~ 160 (755)
.+|++||++||++|||||. .+ ..|+.++++++.|++||+++++++++|||||||||||||. ++|++
T Consensus 120 ~lK~~~~~lKvllsiGGw~------------~s-~~fs~~~~~~~~R~~fi~siv~~l~~~gfDGIDiDwEyP~~~~d~~ 186 (433)
T 1w9p_A 120 LLKKQNRNLKVLLSIGGWT------------YS-PNFAPAASTDAGRKNFAKTAVKLLQDLGFDGLDIDWEYPENDQQAN 186 (433)
T ss_dssp HHHHHCTTCEEEEEEECTT------------TG-GGHHHHHTSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCSHHHHH
T ss_pred HHHHhCCCCEEEEEEeCCC------------CC-cchhhHhcCHHHHHHHHHHHHHHHHhcCcCceeEEEEeccChhHHH
Confidence 7999999999999995554 22 3499999999999999999999999999999999999997 46899
Q ss_pred cHHHHHHHHHHHccC-------CCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCC
Q 004402 161 SLGILLDEWKASASD-------QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNP 233 (755)
Q Consensus 161 ~~~~~l~~lr~~l~~-------~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~ 233 (755)
+|+.||++||++|++ +++++||+++|+.+..+. +||+++|++++||||||+||+|| .|+..+||+||||..
T Consensus 187 nf~~ll~eLr~~l~~~~~~~~~~~~~~Ls~avp~~~~~~~-~~d~~~l~~~vD~inlMtYD~~G-~w~~~~g~~apL~~~ 264 (433)
T 1w9p_A 187 DFVLLLKEVRTALDSYSAANAGGQHFLLTVASPAGPDKIK-VLHLKDMDQQLDFWNLMAYDYAG-SFSSLSGHQANVYND 264 (433)
T ss_dssp HHHHHHHHHHHHHHHHHHHHSTTCCCEEEEEECCSHHHHH-HSCHHHHHTTCSEEEECCCCCSS-TTSSSCCCSSCSSCC
T ss_pred HHHHHHHHHHHHHHhhhhcccCCCceEEEEEccCCHHHhh-hCCHHHHHHhhheeeeeccccCC-CCCCCCCCCCcCCCC
Confidence 999999999999974 458999999998766554 48999999999999999999995 577789999999965
Q ss_pred CC-----CCcHHHHHHHHHHCCCCCCceeecccccCCCcccCC-----------------CcchHHHHHHHhhcCCCccc
Q 004402 234 SS-----NISTDFGIREWLRRGFPANKLVLGARASGPGITIDG-----------------SMGYKFIRAFIQNYGYGAAP 291 (755)
Q Consensus 234 ~~-----~~~~~~~v~~~~~~g~p~~KlvlG~p~yG~~~~~~~-----------------~~~y~~~~~~~~~~~~~~~~ 291 (755)
.. .++++.+|++|++.|+|++||+||+|+|||+|+... .+.|.+++ ..++..
T Consensus 265 ~~~~~~~~~~v~~~v~~~~~~Gvp~~KlvlGip~YGr~w~~~~~~g~~~~g~~~g~~~~g~~~y~~l~------~~g~~~ 338 (433)
T 1w9p_A 265 TSNPLSTPFNTQTALDLYRAGGVPANKIVLGMPLYGRSFANTDGPGKPYNGVGQGSWENGVWDYKALP------QAGATE 338 (433)
T ss_dssp TTCGGGCSCCHHHHHHHHHHTTCCGGGEEEEEESEEEEESSCSSTTSCCCCCCCCSSBTTEEEGGGCS------CTTCEE
T ss_pred CCCCCCCcccHHHHHHHHHHcCCChhHEEEEecccceeeeccCCCCCcccCCCCCCCccceeeHHHHH------hCCCEE
Confidence 42 368999999999999999999999999999998651 23344432 124777
Q ss_pred ccccceeeeeee--cCcEEEeeCCcchhhhhhhcccccCccccccccccccc
Q 004402 292 VYNASYVVNLFT--SGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341 (755)
Q Consensus 292 ~~~~~~~~~~~~--~~~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~dd 341 (755)
.||+....+|.. .+++||+|||++|++.|++|++++||||+|+|+++.|+
T Consensus 339 ~~D~~~~~~y~yd~~~~~~v~ydd~~Si~~K~~~~~~~gLgGv~~W~l~~Dd 390 (433)
T 1w9p_A 339 HVLPDIMASYSYDATNKFLISYDNPQVANLKSGYIKSLGLGGAMWWDSSSDK 390 (433)
T ss_dssp EEEGGGTEEEEEETTTTEEEECCCHHHHHHHHHHHHHHTCCEEEEECGGGSC
T ss_pred EeccccCcceEEECCCCEEEEcCCHHHHHHHHHHHHhCCCCEEEEEeccCCC
Confidence 888877777765 47899999999999999999999999999999999998
|
| >1goi_A Chitinase B; chitin degradation, hydrolase, glycosidase; 1.45A {Serratia marcescens} SCOP: b.72.2.1 c.1.8.5 d.26.3.1 PDB: 1o6i_A* 1e6r_A* 1e15_A 1gpf_A* 1ur8_A* 1w1p_A* 1w1t_A* 1w1v_A* 1w1y_A* 1e6p_A 1e6n_A 1h0g_A* 1h0i_A* 1ogb_A 1ogg_A* 1e6z_A* 1ur9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-56 Score=495.00 Aligned_cols=307 Identities=21% Similarity=0.400 Sum_probs=256.6
Q ss_pred cceEEEEEec--C--------CC----CCCCCCCC---CCCcceEEEEEEEecCCCcEEecCCc-----hhhHHHHHHHH
Q 004402 25 QTWIKAGYWL--A--------GR----EFPLSDIN---SALFTHLICAFAEVDSSTYQLSISSA-----NQQYFSIFANS 82 (755)
Q Consensus 25 ~~~~~~gY~~--~--------~~----~~~~~~i~---~~~~thi~~~f~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 82 (755)
..++++|||. . ++ .|.+++|+ .++||||+|+|+.+++++. +...+. ....+..+ .+
T Consensus 3 ~~~~vvgYy~~~~~~w~~~~~~~~~~~~~~~~~i~~~q~~~~THi~yaF~~i~~~g~-~~~~~~~~d~~~~~~~~~l-~~ 80 (499)
T 1goi_A 3 TRKAVIGYYFIPTNQINNYTETDTSVVPFPVSNITPAKAKQLTHINFSFLDINSNLE-CAWDPATNDAKARDVVNRL-TA 80 (499)
T ss_dssp CCCEEEEEEECCHHHHHTCCSSCTTTCSSCGGGSCHHHHHHCSEEEEEEEEECTTSS-EECCTTCCHHHHHHHHHHH-HH
T ss_pred CCCEEEEEEccCccccccccccCCccCcCCHhHCCCccccCCCEEEEEeEEECCCCe-EEecCcccchhhHHHHHHH-HH
Confidence 4688999998 5 33 58899999 9999999999999998654 444331 12344554 67
Q ss_pred HHhhCCCceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCCCcccH
Q 004402 83 VRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSL 162 (755)
Q Consensus 83 ~k~~~~~lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~~~~~~ 162 (755)
+|++||++|+|+|||||..++. .......|+.++++++.|++||+++++++++|||||||||||+|.++|+++|
T Consensus 81 lk~~~p~lKvllSiGGw~~s~~------~~~~~~~f~~~~~~~~~r~~fi~siv~~~~~~gfDGiDiDwE~p~~~d~~~~ 154 (499)
T 1goi_A 81 LKAHNPSLRIMFSIGGWYYSND------LGVSHANYVNAVKTPASRAKFAQSCVRIMKDYGFDGVNIDWEYPQAAEVDGF 154 (499)
T ss_dssp GGGGCTTCEEEEEEECHHHHST------TSTTHHHHHHHTSSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCHHHHHHH
T ss_pred HHHhCCCCeEEEEECCCCCCCC------cccccchhhHhhCCHHHHHHHHHHHHHHHHHcCCCeEEEecccCChhhHHHH
Confidence 8999999999999976653211 1112256999999999999999999999999999999999999998999999
Q ss_pred HHHHHHHHHHccC-----CC---ccEEEeeeecCCccccccc-CcchhcccCChhhhhhhhccCCCCCcccccCCCCCCC
Q 004402 163 GILLDEWKASASD-----QP---ELTLSMAVRYSPTHETVSY-PIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNP 233 (755)
Q Consensus 163 ~~~l~~lr~~l~~-----~~---~~~ls~~~~~~~~~~~~~~-~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~ 233 (755)
+.||++||++|++ ++ +++||+++|+.+......| |+++|++++||||||+||+|| .|+..+||+||||..
T Consensus 155 ~~ll~eLr~~l~~~~~~~g~~~~~~~Ls~a~~~~~~~~~~~y~d~~~l~~~vD~inlMtYD~~g-~w~~~tg~~apL~~~ 233 (499)
T 1goi_A 155 IAALQEIRTLLNQQTITDGRQALPYQLTIAGAGGAFFLSRYYSKLAQIVAPLDYINLMTYDLAG-PWEKVTNHQAALFGD 233 (499)
T ss_dssp HHHHHHHHHHHHHHHHHTTCTTSCCEEEEEEESSHHHHTTTGGGHHHHHTTCSEEEEECCCSSC-TTSSSCCCTTCSSBC
T ss_pred HHHHHHHHHHhhhhhhhcccccCceEEEEeccCCHHHHhhhhhhHHHHhhcCCEEEEEeeeccC-CCCCCCCCCCcCcCC
Confidence 9999999999974 23 7999999998876555544 999999999999999999995 467789999999854
Q ss_pred CC----------------------------CCcHHHHHHHHHH-CCCCCCceeecccccCCCcccCC-------------
Q 004402 234 SS----------------------------NISTDFGIREWLR-RGFPANKLVLGARASGPGITIDG------------- 271 (755)
Q Consensus 234 ~~----------------------------~~~~~~~v~~~~~-~g~p~~KlvlG~p~yG~~~~~~~------------- 271 (755)
.. ..+++.+|++|++ .|+|++|||||||+|||+|++..
T Consensus 234 ~~~~~~~n~l~~~~~~~~~~~~~~~~~~~~~~~v~~av~~~~~~~Gvp~~KlvlGip~YGr~w~~~~~~~~g~~~~~~~~ 313 (499)
T 1goi_A 234 AAGPTFYNALREANLGWSWEELTRAFPSPFSLTVDAAVQQHLMMEGVPSAKIVMGVPFYGRAFKGVSGGNGGQYSSHSTP 313 (499)
T ss_dssp TTSCCBCCGGGGSSCCCCHHHHHHHCCSSBCCCHHHHHHHHHTSTTCCGGGEEEEEESEEEEEESCCSSSTTTTCCCCCC
T ss_pred CCCccccccccccccccccccccccccccccccHHHHHHHHHHhcCCCHHHeEEEecccceeeEecCCCCCCCCCcccCC
Confidence 32 3589999999999 99999999999999999997641
Q ss_pred -------------------------CcchHHHHHHHhhcCCCcccccccceeeeeee--cCcEEEeeCCcchhhhhhhcc
Q 004402 272 -------------------------SMGYKFIRAFIQNYGYGAAPVYNASYVVNLFT--SGATWINFDGVETIKAKISYA 324 (755)
Q Consensus 272 -------------------------~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~i~yd~~~S~~~K~~~a 324 (755)
.++|.+++..+.. ..++...||+....+|.. .+++||+|||++|++.|++||
T Consensus 314 ~~~~~~~~~~~~~g~~~c~~~~~~g~~~y~ei~~~~~~-~~g~~~~~D~~~~~~y~y~~~~~~~vsydd~~Si~~K~~y~ 392 (499)
T 1goi_A 314 GEDPYPSTDYWLVGCEECVRDKDPRIASYRQLEQMLQG-NYGYQRLWNDKTKTPYLYHAQNGLFVTYDDAESFKYKAKYI 392 (499)
T ss_dssp CCSSCSSSCCCSTTCHHHHHHTCTTEEEHHHHHHHHHT-TSSEEEEEETTTTEEEEEETTTTEEEECCCHHHHHHHHHHH
T ss_pred CCCccccccccccccccccccCCCCcccHHHHHHhhhc-CCCceEEEccccceEEEEECCCCEEEEeeCHHHHHHHHHHH
Confidence 4678999886653 235888888888888775 678999999999999999999
Q ss_pred cccCccccccccccccc
Q 004402 325 KEKNLLGYKAFQLSNDD 341 (755)
Q Consensus 325 ~~~~l~Gi~~W~l~~dd 341 (755)
+++||||+|+|+++.||
T Consensus 393 ~~~gLgGv~~W~l~~Dd 409 (499)
T 1goi_A 393 KQQQLGGVMFWHLGQDN 409 (499)
T ss_dssp HHTTCCEEEEECGGGSC
T ss_pred HhcCCCceEEEeeccCC
Confidence 99999999999999998
|
| >3arx_A Chitinase A; TIM barrel, inhibitor complex, glycosidase, hydrolase, hydro hydrolase inhibitor complex; HET: POY; 1.16A {Vibrio harveyi} PDB: 3aro_A* 3arp_A* 3arr_A* 3arv_A* 3arw_A* 3arq_A* 3ary_A* 3arz_A* 3b8s_A 3b9e_A 3b9a_A* 3b9d_A 3as2_A* 3ars_A* 3art_A* 3as0_A* 3as1_A* 3aru_A* 3as3_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-55 Score=495.25 Aligned_cols=301 Identities=22% Similarity=0.379 Sum_probs=248.4
Q ss_pred CcceEEEEEecCCC----CCCCCCCCCCCcceEEEEEEEecCCC-----------------------cEEecCCch----
Q 004402 24 AQTWIKAGYWLAGR----EFPLSDINSALFTHLICAFAEVDSST-----------------------YQLSISSAN---- 72 (755)
Q Consensus 24 ~~~~~~~gY~~~~~----~~~~~~i~~~~~thi~~~f~~~~~~~-----------------------~~~~~~~~~---- 72 (755)
...++++|||..|. .|.+++||.++||||+|+|+.++.++ +.+...+.+
T Consensus 135 ~~~~~v~~Y~~~W~~y~~~~~~~~i~~~~~THI~yaF~~i~~~~~~l~~~~~~~~~~~~~~c~~~~~~~v~~~D~~~d~~ 214 (584)
T 3arx_A 135 DPSIVMGTYFVEWGIYGRDYTVDNMPVDNLTHILYGFIPICGPNESVKSVGGNSFNALQTACRGVNDYEVVIHDPWAAYQ 214 (584)
T ss_dssp CTTSEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEECBSSCCGGGGGGCTTHHHHHHHHTTTCCTTCBCCSCHHHHHT
T ss_pred CCCcEEEEEECcccccCCCCChhHCCHhhCCEEEEEEEEecCCCccccccCccchhhhhhhcccCCCcceEecCchHhhh
Confidence 35689999987764 58999999999999999999987421 122222211
Q ss_pred --------------hhHHHHHHHHHHhhCCCceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHH
Q 004402 73 --------------QQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRT 138 (755)
Q Consensus 73 --------------~~~~~~~~~~~k~~~~~lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~ 138 (755)
...+..+ .++|++||++|||+|||||. .+ ..|+.| ++++.|++||+++++|
T Consensus 215 ~~~~~~g~~w~~~~~g~~~~l-~~lK~~np~lKvllSiGGw~------------~s-~~F~~~-~~~~~R~~Fi~siv~~ 279 (584)
T 3arx_A 215 KSFPQAGHEYSTPIKGNYAML-MALKQRNPDLKIIPSIGGWT------------LS-DPFYDF-VDKKNRDTFVASVKKF 279 (584)
T ss_dssp SCCGGGTCCTTCSSCHHHHHH-HHHHHHCTTCEEEEEEEESS------------SC-GGGGGG-GSHHHHHHHHHHHHHH
T ss_pred hccccCCccccccccchHHHH-HHHHHhCCCCEEEEEEcCCc------------CC-cchhhh-hCHHHHHHHHHHHHHH
Confidence 1234444 78999999999999995555 32 238887 6999999999999999
Q ss_pred HHHcC-CCcccccccCCC----------C-CCcccHHHHHHHHHHHccC-----CCccEEEeeeecCCcccccccCcchh
Q 004402 139 ARLYG-FQGIDLFWLWPN----------S-TDLNSLGILLDEWKASASD-----QPELTLSMAVRYSPTHETVSYPIDSM 201 (755)
Q Consensus 139 ~~~~~-~DGvdiDwe~p~----------~-~~~~~~~~~l~~lr~~l~~-----~~~~~ls~~~~~~~~~~~~~~~~~~l 201 (755)
+++|| |||||||||||. + +|+++|+.||++||++|++ ++.++||+++|+...... .+|+++|
T Consensus 280 l~~yg~fDGIDIDWEyP~~~g~~~~~g~p~~D~~nf~~ll~eLr~~l~~~~~~~g~~~~LT~Av~a~~~~~~-~~d~~~l 358 (584)
T 3arx_A 280 LKTWKFYDGVDIDWEFPGGGGAAADKGDPVNDGPAYIALMRELRVMLDELEAETGRTYELTSAIGVGYDKIE-DVDYADA 358 (584)
T ss_dssp HHHCTTCCEEEEEESCTTSCSSCTTCCCTTTHHHHHHHHHHHHHHHHHHHHHHHSCCCEEEEEECCSHHHHT-TSCHHHH
T ss_pred HHHcCCcceEeecccCccccCCCCCCCCchHHHHHHHHHHHHHHHhHHhhhhccCCceEEEEEecCChHHhh-ccCHHHH
Confidence 99999 999999999995 2 3789999999999999964 457999999998765544 4899999
Q ss_pred cccCChhhhhhhhccCCCCCcccccCCCCCCCC---------------------CCCcHHHHHHHHHHCCCCCCceeecc
Q 004402 202 KKNLNWAHLVAYDYHMPSKENVTGIHAALYNPS---------------------SNISTDFGIREWLRRGFPANKLVLGA 260 (755)
Q Consensus 202 ~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~---------------------~~~~~~~~v~~~~~~g~p~~KlvlG~ 260 (755)
++++||||||+||||| .|+..+||+||||... ..++++.+|++|+++|+|++||||||
T Consensus 359 ~~~vD~inlMtYD~hG-~W~~~tG~~apLy~~~~~~~~~c~~~~v~~~~~~~~~~~~~v~~av~~~~~~Gvp~~KivLGi 437 (584)
T 3arx_A 359 VQYMDYIFAMTYDFYG-GWNNVPGHQTALYCGSFMRPGQCDGGGVDENGEPYKGPAYTADNGIQLLLAQGVPANKLVLGT 437 (584)
T ss_dssp GGGCSEEEECCCCSSC-TTSSCCCCSSCSSCCTTSCTTTTTSCSBCTTSCBCCSCCSCHHHHHHHHHHTTCCGGGEEEEE
T ss_pred HhhCCEEEEecccccC-CCCCCcCCCCCCCCCCCCccccccccccccccccccccceeHHHHHHHHHHcCCCHHHEEEEE
Confidence 9999999999999995 4667799999999643 24689999999999999999999999
Q ss_pred cccCCCcccC-------------------------------CCcchHHHHHHHhhc----CCCcccccccceeeeeeec-
Q 004402 261 RASGPGITID-------------------------------GSMGYKFIRAFIQNY----GYGAAPVYNASYVVNLFTS- 304 (755)
Q Consensus 261 p~yG~~~~~~-------------------------------~~~~y~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~- 304 (755)
|+|||+|++. |.+.|.+||..+... -.+|...||+....+|...
T Consensus 438 p~YGr~w~~~~~~~~~~~~~~~~g~~~G~~~gt~~~~~~~~G~~~y~ei~~~~~~~~~~g~~g~~~~~D~~a~~py~y~~ 517 (584)
T 3arx_A 438 AMYGRGWEGVTPDTLTDPNDPMTGTATGKLKGSTAQGVWEDGVIDYKGIKSFMLGANNTGINGFEYGYDAQAEAPWVWNR 517 (584)
T ss_dssp ESEEEEEECCCGGGCSSTTCGGGSCCSEECCCCGGGTCSBTTEEEHHHHHHHTTTTTTSCCTTEEEEEETTTTEEEEEET
T ss_pred ccccceeeecccccccCCCCccccCCCCCcCCccccccccCCceeHHHHHHHhhcccccccCCcEEEECCccceeEEEEC
Confidence 9999999753 125799999876442 1358888998888887754
Q ss_pred -CcEEEeeCCcchhhhhhhcccccCccccccccccccc
Q 004402 305 -GATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341 (755)
Q Consensus 305 -~~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~dd 341 (755)
+++||+|||++|++.|++||+++||||+|+|+++.|+
T Consensus 518 ~~~~~vsyDd~~Si~~K~~y~k~~gLgGv~~W~l~~Dd 555 (584)
T 3arx_A 518 STGELITFDDHRSVLAKGNYAKSLGLAGLFSWEIDADN 555 (584)
T ss_dssp TTTEEEECCCHHHHHHHHHHHHHHTCCEEEEECGGGCC
T ss_pred CCCEEEEeCCHHHHHHHHHHHHhCCCCEEEEEeccCCc
Confidence 5799999999999999999999999999999999987
|
| >3oa5_A CHI1; TIM barrel, hydrolase; HET: 2PE; 1.74A {Yersinia} PDB: 4a5q_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=473.19 Aligned_cols=299 Identities=16% Similarity=0.242 Sum_probs=247.2
Q ss_pred CcceEEEEEecCCC-----------------CCCCCCC---CCCCcceEEEEEEEecCCC--------------------
Q 004402 24 AQTWIKAGYWLAGR-----------------EFPLSDI---NSALFTHLICAFAEVDSST-------------------- 63 (755)
Q Consensus 24 ~~~~~~~gY~~~~~-----------------~~~~~~i---~~~~~thi~~~f~~~~~~~-------------------- 63 (755)
+..++|+|||..|. .|++++| ++..||||+|+|+++..+.
T Consensus 97 ~~~~~v~~Y~~~W~~yd~r~~~~~~~~~~gr~~d~~~l~~~~p~~~t~ii~~F~~i~gd~~~g~~~~~i~~~~~~~~~d~ 176 (574)
T 3oa5_A 97 DDDFNVLCYFTDWSQYDPRIINKEIRDTGGRSADILRLNTPDGRPFKRLIYSFGGLIGDKKYSADGNASIAVRLGVATDP 176 (574)
T ss_dssp CSSCEEEEEEETTTTCCGGGTCSSCCSSCCCCCCGGGGCCSSSCSCSEEEEEEEEETTCTTTCTTTTHHHHHHHTSCSSH
T ss_pred CCCceEEEEEcchhhcccccccccccccCCCccCHhhhccCCCccccEEEEEEEeecCCcccCchHHHHHHHHhhhcccc
Confidence 56899999986653 4588899 8999999999999999765
Q ss_pred --------cEEecCCch----------------------------hhHHHHHHHHHHhhCCCceEEEEecCCCCCccccc
Q 004402 64 --------YQLSISSAN----------------------------QQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSI 107 (755)
Q Consensus 64 --------~~~~~~~~~----------------------------~~~~~~~~~~~k~~~~~lk~~isigg~~~~~~~~~ 107 (755)
+.+...+.+ ...+.++ ..+|++||+||||+||||
T Consensus 177 ~~~~~~~~g~v~~~D~wad~~~~~n~g~~~~~~~~~~~~~~~~~~~G~~~~l-~~LK~~np~LKvllSIGG--------- 246 (574)
T 3oa5_A 177 DDAIANHKGKTIPVDPDGAVLASINCGFTKWEAGDANERYNQEKAKGLLGGF-RLLHEADKELEFSLSIGG--------- 246 (574)
T ss_dssp HHHHHHHTTCEEESCHHHHHTCCTTTTCCSCCCCCHHHHCSTTTCCHHHHHH-HHHHHHCTTCEEEEEEEC---------
T ss_pred cccccCcCCeEeecCchhhhcccccccccccccCCccccccCccchhHHHHH-HHHHHHCCCCEEEEEECC---------
Confidence 223222221 1123333 789999999999999954
Q ss_pred cCCCCCCcccccccccChhhHHHHHHHHHHHHHHcC-CCcccccccCCC---------CCCcccHHHHHHHHHHHccCCC
Q 004402 108 LGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG-FQGIDLFWLWPN---------STDLNSLGILLDEWKASASDQP 177 (755)
Q Consensus 108 ~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~-~DGvdiDwe~p~---------~~~~~~~~~~l~~lr~~l~~~~ 177 (755)
|+. +..|+.|+++++.|++||+++++++++|| |||||||||||. ++|+++|+.||++||+++. +
T Consensus 247 ---w~~-S~~Fs~~~s~~~~R~~Fi~siv~~l~~yg~fDGIDIDWEyP~~~g~~n~~~~~D~~nf~~LLkeLR~~~~--~ 320 (574)
T 3oa5_A 247 ---WSM-SGLFSEIAKDEILRTNFVEGIKDFFQRFPMFSHLDIDWEYPGSIGAGNPNSPDDGANFAILIQQITDAKI--S 320 (574)
T ss_dssp ---GGG-CTTHHHHHHCHHHHHHHHHHHHHHHHHCTTCCEEEEECSCTTSCTTTCCCCTTHHHHHHHHHHHHHHTCC--T
T ss_pred ---CCC-cchhHHHhCCHHHHHHHHHHHHHHHHHcCCCceEEEEEEeccccccCCCCCHHHHHHHHHHHHHHHHhcc--C
Confidence 444 23499999999999999999999999998 999999999994 5678999999999999653 3
Q ss_pred ccE-EEeeeecCCcccccccCcchhc-ccCChhhhhhhhccCCCCCcccccCCCCCCCC----CCCcHHHHHHHHHH-CC
Q 004402 178 ELT-LSMAVRYSPTHETVSYPIDSMK-KNLNWAHLVAYDYHMPSKENVTGIHAALYNPS----SNISTDFGIREWLR-RG 250 (755)
Q Consensus 178 ~~~-ls~~~~~~~~~~~~~~~~~~l~-~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~----~~~~~~~~v~~~~~-~g 250 (755)
+++ ||+++|+.+..... ||+++|. ++||||||||||||| .|+..+||+|||+... ..++++.+|++|++ .|
T Consensus 321 ~~~~LSiAvpa~~~~~~~-~d~~~l~~~~vD~InlMtYD~~G-~W~~~tG~~apL~~~~~d~~~~~svd~aV~~~l~~~G 398 (574)
T 3oa5_A 321 NLKGISIASSADPAKIDA-ANIPALMDAGVTGINLMTYDFFT-LGDGKLSHHTNIYRDPSDVYSKYSIDDAVTHLIDEKK 398 (574)
T ss_dssp TCCEEEEEECSSHHHHHH-HTHHHHHHTTCCEEEECCCCCCC-TTSSBCCCSSCSCCCTTCSSSCCCHHHHHHHHHHTTC
T ss_pred CceEEEEEccCccccccc-cCHHHHHhhhCCEEEEEccccCC-CCCCCCCCCCCCCCCCCCccccccHHHHHHHHHHhcC
Confidence 677 99999998766544 8999986 699999999999995 5677899999999754 35789999999999 99
Q ss_pred CCCCceeecccccCCCcccC----------------------------CCcchHHHHHHHh-----hcCCCcccccccce
Q 004402 251 FPANKLVLGARASGPGITID----------------------------GSMGYKFIRAFIQ-----NYGYGAAPVYNASY 297 (755)
Q Consensus 251 ~p~~KlvlG~p~yG~~~~~~----------------------------~~~~y~~~~~~~~-----~~~~~~~~~~~~~~ 297 (755)
+|++|||||+|+|||+|++. |.++|.++|.... ....+|...||+..
T Consensus 399 vP~~KLvLGip~YGR~w~~~~~~~~~~~~~p~~G~~~~~g~~~Gt~e~G~l~y~eI~~~~l~~~~~~~~~g~~~~wD~~a 478 (574)
T 3oa5_A 399 VDPKAIFIGYAGYTRNAKNATITTSIPSEEALKGTYTDANQTLGSFEYSVLEWTDIICHYMDFEKGEGRNGYKLVHDKVA 478 (574)
T ss_dssp CCGGGEEEEEESBCEEESSEEECCSSTTTSCCCEEESCCTTCCBSSBTTBCBHHHHHHHTEETTTTEESTTCEEEEETTT
T ss_pred CCHHHEEEEeCccceeeecCCCCcccccCCCCCCccccCCCCCCcccCCceeHHHHHHHhhhhhhhhccCCceEEEchhc
Confidence 99999999999999999642 3467888876432 12346888999888
Q ss_pred eeeeeec--CcEEEeeCCcchhhhhhhcccccCcccccccccccc
Q 004402 298 VVNLFTS--GATWINFDGVETIKAKISYAKEKNLLGYKAFQLSND 340 (755)
Q Consensus 298 ~~~~~~~--~~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~d 340 (755)
..+|..+ +++||+|||++|+++|++||+++||||+|+|+++.|
T Consensus 479 ~~pY~y~~~~~~~VsYDD~~Si~~K~~yak~~gLGGv~iW~ld~D 523 (574)
T 3oa5_A 479 KADYLYSEATKVFISLDTPRSVRDKGRYVKDKGLGGLFIWSGDQD 523 (574)
T ss_dssp TEEEEECTTTCCEEEECCHHHHHHHHHHHHHHTCCEEEEETGGGC
T ss_pred CceEEEECCCCEEEEeCCHHHHHHHHHHHHhcCCCEEEEEeccCC
Confidence 8888754 568999999999999999999999999999999999
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=443.84 Aligned_cols=260 Identities=25% Similarity=0.404 Sum_probs=213.5
Q ss_pred cCCCccCcccccCCeeEEEEEcC------CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
++|...+.||+|+||+||+|.+. +++.||||+++....+..++|.+|+++|++++|||||+++|+|.+.+..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45677899999999999999753 477899999988777778899999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhcCCC----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEE
Q 004402 509 IYEYLPNKSLDLYLFDPI----------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI 578 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl 578 (755)
|||||++|+|.++|+... ....++|.+++.++.||++||.|||+.+ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999996432 2346999999999999999999999986 999999999999999999999
Q ss_pred EecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHH
Q 004402 579 SDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQ 657 (755)
Q Consensus 579 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 657 (755)
+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||.... ........
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~---~~~~~~~i--- 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---NNEVIECI--- 243 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHHHH---
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH---
Confidence 99999987654433333445679999999999999999999999999999999999 898885432 12222222
Q ss_pred hccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 658 WKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 658 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
..+.... . +...+..+.+|+.+||+.||++||||+||+++|++...
T Consensus 244 -~~~~~~~-----~----p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 244 -TQGRVLQ-----R----PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp -HHTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HcCCCCC-----C----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 2121111 1 11233478899999999999999999999999987543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=445.08 Aligned_cols=260 Identities=26% Similarity=0.396 Sum_probs=206.5
Q ss_pred cCCCccCcccccCCeeEEEEEcC------CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
++|...++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667789999999999999753 478999999988877778899999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCc------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCe
Q 004402 509 IYEYLPNKSLDLYLFDPIR------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP 576 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~ 576 (755)
|||||++|+|.++++.... ...++|.+++.|+.|||+||.|||+.+ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999965321 246899999999999999999999986 9999999999999999999
Q ss_pred EEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHH
Q 004402 577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAF 655 (755)
Q Consensus 577 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 655 (755)
||+|||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.||.... .........
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~---~~~~~~~i~ 274 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS---NTEAIDCIT 274 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC---HHHHHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC---HHHHHHHHH
Confidence 9999999997654433334445689999999999999999999999999999999999 898885332 122222221
Q ss_pred HHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 656 EQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 656 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
.+.. +.... ..+..+.+|+.+||+.||++||||.||++.|+....
T Consensus 275 ----~g~~-----~~~p~----~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 275 ----QGRE-----LERPR----ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp ----HTCC-----CCCCT----TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----cCCC-----CCCcc----cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 1111 11111 223478899999999999999999999999987643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-53 Score=442.31 Aligned_cols=256 Identities=27% Similarity=0.414 Sum_probs=208.9
Q ss_pred CCccCcccccCCeeEEEEEc------CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 437 FSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
+...++||+|+||+||+|.+ .+++.||||+++... ....++|.+|+.+|++++|||||+++|+|.+.+..++|
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 44568899999999999975 246799999997543 34467899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCe
Q 004402 510 YEYLPNKSLDLYLFDPI-------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP 576 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~ 576 (755)
||||++|+|.++|.... .+..++|.++++|+.|||+||.|||+.+ ||||||||+||||++++.+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCE
Confidence 99999999999996432 1346899999999999999999999986 9999999999999999999
Q ss_pred EEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHH
Q 004402 577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAF 655 (755)
Q Consensus 577 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 655 (755)
||+|||+++...............||+.|||||++.++.|+.++|||||||+||||+| |+.||..... .....
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~~--- 258 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVVE--- 258 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHHH---
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHHH---
Confidence 9999999997655444444455689999999999999999999999999999999999 7888754321 22222
Q ss_pred HHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 656 EQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 656 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
.+..+.... .+..++..+.+|+.+||+.||++||||.||++.|+..
T Consensus 259 -~i~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 -MIRNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp -HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -HHHcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 222221111 1223345788999999999999999999999999853
|
| >3cz8_A Putative sporulation-specific glycosylase YDHD; structural genomics, uncharacterized protein, protein struct initiative, PSI-2; 2.20A {Bacillus subtilis subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-53 Score=445.89 Aligned_cols=291 Identities=14% Similarity=0.201 Sum_probs=237.7
Q ss_pred CcceEEEEEecCCC---CCCCCCCCCCCcceEEEEEEEecCCCcEEecCCchhhHHHHHHHHHHhhCCCceEEEEecCCC
Q 004402 24 AQTWIKAGYWLAGR---EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQ 100 (755)
Q Consensus 24 ~~~~~~~gY~~~~~---~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg~~ 100 (755)
...++++|||..|+ .+...+.+..+||||+++|+.+++++. +..... +. .+++.+|+ +++|+++|||||+
T Consensus 5 ~~~~~vvgYy~~w~~~~~~~~l~~~~~~lthi~~~~~~i~~~g~-l~~~~~-~~---~~~~~~~~--~~~kv~lsigg~~ 77 (319)
T 3cz8_A 5 NYIAGTLSFYVLRNPDLDRELINDYAPYSSSISIFEYHIAPNGD-IANQLN-DA---AAIETTWQ--RRVTPLATITNLT 77 (319)
T ss_dssp CSCCEEEEEEEEECGGGC------CCCCCCEEEEEEEEBCTTSC-BCCCCS-CH---HHHHHHHH--TTCEEEEEEECEE
T ss_pred CCCceEEEEEecCCCccCHHHHHHhhCCCCEEEEeEEEECCCCC-EecCcC-CH---HHHHHHHH--CCCeEEEEEecCC
Confidence 34678999998765 345555668899999999999998664 332221 22 23344554 4899999997765
Q ss_pred CCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCCCcccHHHHHHHHHHHccCCCccE
Q 004402 101 NSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELT 180 (755)
Q Consensus 101 ~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~~~~~~~~~l~~lr~~l~~~~~~~ 180 (755)
+ +++++..|+.+++|++.|++||+++++++++|||||||||||+|.++|+++|+.||++||++|++. +++
T Consensus 78 ~---------~~~~~~~~~~~~~~~~~r~~fi~si~~~~~~~gfDGiDiDwE~p~~~d~~~~~~ll~eLr~~l~~~-~~~ 147 (319)
T 3cz8_A 78 S---------GGFSTEIVHQVLNNPTARTNLVNNIYDLVSTRGYGGVTIDFEQVSAADRDLFTGFLRQLRDRLQAG-GYV 147 (319)
T ss_dssp T---------TEECHHHHHHHHTCHHHHHHHHHHHHHHHHHHTCSEEEEECCSCCGGGHHHHHHHHHHHHHHHHHT-TCE
T ss_pred C---------CCcCHHHHHHHHcCHHHHHHHHHHHHHHHHHhCCCeEEEeccCCCHHHHHHHHHHHHHHHHHHhhc-CcE
Confidence 2 234566799999999999999999999999999999999999999999999999999999999865 799
Q ss_pred EEeeeecCCcc---cccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHHHHHHCCCCCCcee
Q 004402 181 LSMAVRYSPTH---ETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLV 257 (755)
Q Consensus 181 ls~~~~~~~~~---~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~~~~~~g~p~~Klv 257 (755)
||+++|+.... +..+||++++++++||||||+||+||+ |+ .+||+||++ +++.++++|++ ++|++||+
T Consensus 148 Ls~av~~~~~~~~~~~~~~d~~~l~~~vD~i~vMtYD~~g~-~~-~~g~~apl~------~v~~~v~~~~~-~vp~~Klv 218 (319)
T 3cz8_A 148 LTIAVPAKTSDNIPWLRGYDYGGIGAVVNYMFIMAYDWHHA-GS-EPGPVAPIT------EIRRTIEFTIA-QVPSRKII 218 (319)
T ss_dssp EEEEEECCSCSCCGGGTTCCHHHHHHHCSEEEEECCCSSCT-TS-CSCCSSCHH------HHHHHHHHHTT-TSCGGGEE
T ss_pred EEEEecCCcccccchhcccCHHHHHhhCCEEEEEeeccCCC-CC-CCCCCCChH------HHHHHHHHHHh-cCCHHHEE
Confidence 99999987642 345699999999999999999999954 43 489999985 68889998876 49999999
Q ss_pred ecccccCCCcccC-------CCcchHHHHHHHhhcCCCcccccccceeeeeee-----cCcEEEeeCCcchhhhhhhccc
Q 004402 258 LGARASGPGITID-------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFT-----SGATWINFDGVETIKAKISYAK 325 (755)
Q Consensus 258 lG~p~yG~~~~~~-------~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~i~yd~~~S~~~K~~~a~ 325 (755)
||+|+|||+|++. +.++|.++|+.+...+ +...||+....+|.. +..+||||||++|++.|++||+
T Consensus 219 lGip~YGr~w~~~~~~g~~~~~~~~~ei~~~~~~~g--~~~~~D~~~~~~y~~~~d~~g~~~~v~ydd~~Si~~K~~~~~ 296 (319)
T 3cz8_A 219 IGVPLYGYDWIIPYQPGTVASAISNQNAIERAMRYQ--APIQYSAEYQSPFFRYSDQQGRTHEVWFEGVRSMSRKMQIVR 296 (319)
T ss_dssp EECCSCEEEEESSCCTTCCCEEECHHHHHHHHHHTT--CCCEEETTTTEEEEEEECTTSCEEEEECCCHHHHHHHHHHHH
T ss_pred EEecCcCCcccccCCCCCCCCccCHHHHHHHHHHcC--CeEEechhhCCcEEEEEcCCCCEEEEEecCHHHHHHHHHHHH
Confidence 9999999999863 5689999999887755 788888888887763 2358999999999999999999
Q ss_pred ccCccccccccccccch
Q 004402 326 EKNLLGYKAFQLSNDDN 342 (755)
Q Consensus 326 ~~~l~Gi~~W~l~~dd~ 342 (755)
++||||+|+|++++|+.
T Consensus 297 ~~~LgGv~~W~l~~dd~ 313 (319)
T 3cz8_A 297 EYRLQAIGAWQLTLAEG 313 (319)
T ss_dssp HTTCSEEEEEEEEEC--
T ss_pred hcCCCeEEEEECCCCCc
Confidence 99999999999999984
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=430.90 Aligned_cols=262 Identities=25% Similarity=0.439 Sum_probs=203.2
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
+++...++||+|+||+||+|++. ..||||+++.. ..+..+.|.+|+.+|++++|||||+++|+|.+ +..++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 46677889999999999999874 36999998654 34556789999999999999999999999865 568999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
|++|+|.++|+.. +..+++.++..|+.|||+||.|||+.+ ||||||||+||||++++.+||+|||+|+.......
T Consensus 113 ~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999999653 345999999999999999999999986 99999999999999999999999999987654333
Q ss_pred ccccccccccCCccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKK---GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
.......+||+.|||||++.+ +.|+.++|||||||+||||+||+.||....... .+... ...+ ...+
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~---~~~~~---~~~~----~~~p 257 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD---QIIFM---VGRG----YASP 257 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHH---HHTT----CCCC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH---HHHHH---HhcC----CCCC
Confidence 334445689999999999863 468999999999999999999999985432211 11111 1111 1111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccc
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAI 715 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 715 (755)
.+. ......+..+.+|+.+||+.||++||||.||++.|+....++
T Consensus 258 ~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 258 DLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp CST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred Ccc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 111 111223457889999999999999999999999998655444
|
| >3bxw_B Chitinase domain-containing protein 1; TIM barrel, lysosome, secreted, hydrolase; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-53 Score=455.82 Aligned_cols=289 Identities=12% Similarity=0.157 Sum_probs=240.3
Q ss_pred ceEEEEEecCCCC--CCCCCCCCCCcceEEEEEEEecCCC-cEEecCCchhhHHHHHHHHHHhhCCCceEEE--EecCCC
Q 004402 26 TWIKAGYWLAGRE--FPLSDINSALFTHLICAFAEVDSST-YQLSISSANQQYFSIFANSVRRKNPSIKTLL--SIWNGQ 100 (755)
Q Consensus 26 ~~~~~gY~~~~~~--~~~~~i~~~~~thi~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~i--sigg~~ 100 (755)
..+++|||..|+. |.+.+++.++||||+|+|+.+++++ +.+...+..+.. ...++.+|++||++||++ ||
T Consensus 78 ~~~vvgY~~~W~~~~~~~~~~~~~~lThi~~af~~i~~~g~~~l~~~~~~d~~-~~~~~~lk~~~~~lkvl~~isi---- 152 (393)
T 3bxw_B 78 AGDVLGYVTPWNSHGYDVTKVFGSKFTQISPVWLQLKRRGREMFEVTGLHDVD-QGWMRAVRKHAKGLHIVPRLLF---- 152 (393)
T ss_dssp CSCEEEEEBTTBTHHHHHHHHHGGGCSEEEECCEEEEEEETTEEEEECGGGCC-HHHHHHHHHHSSSCEECCEEEE----
T ss_pred CCcEEEEECCccCCCCChhhcCHhhCCEEEEEEEEEecCCCceEEecCCCccC-HHHHHHHHhhCCCCEEEEEEeE----
Confidence 6789999999886 7888999999999999999999876 445443333222 344578999999999995 77
Q ss_pred CCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCccccc-ccCCCCCCcccHHHHHHHHHHHccCCCcc
Q 004402 101 NSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLF-WLWPNSTDLNSLGILLDEWKASASDQPEL 179 (755)
Q Consensus 101 ~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiD-we~p~~~~~~~~~~~l~~lr~~l~~~~~~ 179 (755)
|||+ .+.|+.+++|++.|++||+++++++++||||||||| ||+|.++++++|+.||++||++|++. ++
T Consensus 153 --------GGw~--~~~f~~~~~~~~~R~~fi~siv~~~~~~gfDGidiDfWE~p~~~d~~~~~~ll~eLr~~l~~~-~~ 221 (393)
T 3bxw_B 153 --------EDWT--YDDFRNVLDSEDEIEELSKTVVQVAKNQHFDGFVVEVWNQLLSQKRVGLIHMLTHLAEALHQA-RL 221 (393)
T ss_dssp --------CSCC--HHHHHHHHTCHHHHHHHHHHHHHHHHHHTCCEEEEECGGGCCC-CHHHHHHHHHHHHHHHHHT-TC
T ss_pred --------CCCC--HHHHHHHhcCHHHHHHHHHHHHHHHHHhCCCCEEecccccCChhhHHHHHHHHHHHHHHHhhc-Cc
Confidence 5554 235999999999999999999999999999999999 99999999999999999999999865 79
Q ss_pred EEEeeeecCCc----c--cccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHHHHHHCCCCC
Q 004402 180 TLSMAVRYSPT----H--ETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPA 253 (755)
Q Consensus 180 ~ls~~~~~~~~----~--~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~~~~~~g~p~ 253 (755)
+||+++|+... . +-.+||+++|++++||+|||+||+||+ ..+||+|||+ +++.+|++|++.|+|+
T Consensus 222 ~Lsiav~~~~~~~~~~~~~~~~~d~~~l~~~vD~inlMtYD~~g~---~~~G~~apL~------~v~~~v~~~~~~gvp~ 292 (393)
T 3bxw_B 222 LALLVIPPAITPGTDQLGMFTHKEFEQLAPVLDGFSLMTYDYSTA---HQPGPNAPLS------WVRACVQVLDPKSKWR 292 (393)
T ss_dssp EEEEEECCSBCTTTSSBCSSCHHHHHHHTTTCSEEEECCCCCCBT---TBCCCSSCHH------HHHHHHHHHSTTCSSG
T ss_pred EEEEEEcccccccccccccccccCHHHHHhhccEEEEEeeecCCC---CCCCCcCCHH------HHHHHHHHHHHcCCCH
Confidence 99999998631 1 123479999999999999999999952 6799999996 6999999999999999
Q ss_pred CceeecccccCCCcccC----CCcchHHHHHHHhhcCCCcccccccceeeeee-e----cCcEEEeeCCcchhhhhhhcc
Q 004402 254 NKLVLGARASGPGITID----GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLF-T----SGATWINFDGVETIKAKISYA 324 (755)
Q Consensus 254 ~KlvlG~p~yG~~~~~~----~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~-~----~~~~~i~yd~~~S~~~K~~~a 324 (755)
+||+||+|+|||+|+.. +.+++.+..++.... ++...||+....+|. . ++++||||||++|++.|++||
T Consensus 293 ~KivlGip~YGr~w~~~~~~g~~~t~~~y~~i~~~~--g~~~~~D~~~~~~~~~y~d~~~~~~~v~ydd~~Si~~K~~~~ 370 (393)
T 3bxw_B 293 SKILLGLNFYGMDYATSKDAREPVVGARYIQTLKDH--RPRMVWDSQASEHFFEYKKSRSGRHVVFYPTLKSLQVRLELA 370 (393)
T ss_dssp GGEEEEEESSEEEEETTTTEEEEECHHHHHHHHHHH--CCBCEEETTTTEEEEEEEETTTEEEEEECCCHHHHHHHHHHH
T ss_pred HHEEEEecccccccccCCCCCCccCHHHHHHHHHhc--CCceEEccccCCceEEEEecCCCCEEEEeCCHHHHHHHHHHH
Confidence 99999999999999865 233333444444343 377788887776542 2 568999999999999999999
Q ss_pred cccCccccccccccccch
Q 004402 325 KEKNLLGYKAFQLSNDDN 342 (755)
Q Consensus 325 ~~~~l~Gi~~W~l~~dd~ 342 (755)
+++|| |+|+|++++|++
T Consensus 371 ~~~gL-Gv~~W~l~~d~~ 387 (393)
T 3bxw_B 371 RELGV-GVSIWELGQGLD 387 (393)
T ss_dssp HHHTC-EEEEECTTSSCG
T ss_pred HHcCC-EEEEEECCCCch
Confidence 99999 999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=431.24 Aligned_cols=268 Identities=27% Similarity=0.390 Sum_probs=215.6
Q ss_pred CHHHHHHHhcCCCccCcccccCCeeEEEEEcC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCC-Cceeeee
Q 004402 426 SFSDIKAATNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQH-VNLLRVL 497 (755)
Q Consensus 426 ~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H-~niv~l~ 497 (755)
..++++...++|+..+.||+|+||+||+|... .++.||||++.... ....+.|.+|+++|.+++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 34455556778999999999999999999643 23689999997654 3445789999999999965 9999999
Q ss_pred eeeecC-CccEEEEeecCCCChhhhhcCCCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc
Q 004402 498 GYCTER-DENMLIYEYLPNKSLDLYLFDPIR-------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDL 563 (755)
Q Consensus 498 g~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDl 563 (755)
|+|.+. +..++|||||++|+|.++|+.... +..+++.+++.++.|||+||.|||+.+ ||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 999765 568999999999999999964321 345899999999999999999999987 999999
Q ss_pred CCCCEEEcCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004402 564 KASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY 642 (755)
Q Consensus 564 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~ 642 (755)
||+|||+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999997765544445556789999999999999999999999999999999998 89888543
Q ss_pred CCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 643 GTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
.... .+.... ..+.. +..... ...++.+++.+||+.||++|||+.||++.|++.
T Consensus 292 ~~~~--~~~~~i----~~g~~-----~~~p~~----~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 292 KIDE--EFCRRL----KEGTR-----MRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCSH--HHHHHH----HHTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHH--HHHHHH----HcCCC-----CCCCcc----CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 2221 112211 11111 111122 234688999999999999999999999999864
|
| >3fnd_A Chitinase; TIM-barrel, structural genomics, PSI-2, P structure initiative, NEW YORK SGX research center for STRU genomics, nysgxrc; 1.90A {Bacteroides thetaiotaomicron} PDB: 3co4_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=423.77 Aligned_cols=269 Identities=19% Similarity=0.230 Sum_probs=222.8
Q ss_pred ceEEEEEecCCCC--CC-CCCCCCCCcceEEEEEEEecCCCcEEecCCchhhHHHHHHHHHHhhCCCceEEEEecCCCCC
Q 004402 26 TWIKAGYWLAGRE--FP-LSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNS 102 (755)
Q Consensus 26 ~~~~~gY~~~~~~--~~-~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg~~~~ 102 (755)
+++++|||.+++. .. +++|++++||||+|+|+.+++++..... + ....+..+++ |+++|++||++|||||.
T Consensus 3 ~krvvgY~~~~~~~~~~~~~~i~~~~~Thi~~af~~i~~~g~~~~~-~-~~~~~~~~~~--k~~~~~lkvllsiGG~~-- 76 (312)
T 3fnd_A 3 LKVVIGYLALDDWEFESLFPTIEWKYLTHINASFARVKADGTLNIN-P-VRKRIESVRE--TAHKHNVKILISLAKNS-- 76 (312)
T ss_dssp CCEEEEEEETTCTTHHHHGGGCCGGGCSEEEEEEEEECTTSCEECT-T-TTTTHHHHHH--HHHHTTCEEEEEEEESS--
T ss_pred CceEEEEEeccccccCCChhhCCcccCCEEEEEEEEECCCCeEEec-C-cHHHHHHHHH--HHHcCCCEEEEEEcCCC--
Confidence 5789999976653 23 6999999999999999999987654333 2 3345666644 67788999999995443
Q ss_pred ccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCccccccc-CCCCCCcccHHHHHHHHHH-Hc-cCCCcc
Q 004402 103 TYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWL-WPNSTDLNSLGILLDEWKA-SA-SDQPEL 179 (755)
Q Consensus 103 ~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe-~p~~~~~~~~~~~l~~lr~-~l-~~~~~~ 179 (755)
.+.|+.++++++.|++||+++++++++||||||||||| +|... ++|+.|+++||+ +| +. +++
T Consensus 77 ------------~~~~~~~~~~~~~r~~fi~si~~~~~~~~~DGiDiDwE~~p~~~--~~~~~ll~eLr~~~l~~~-~~~ 141 (312)
T 3fnd_A 77 ------------PGEFTTAINDPKARKELIQQIIAFTKEYKLDGFDIDYEEYDNWD--KNFPSLLVFARGLYLAKE-KNM 141 (312)
T ss_dssp ------------TTHHHHHHHSHHHHHHHHHHHHHHHHHTTCSEEEECCCCCTTHH--HHHHHHHHHHHHHHHHSC-TTC
T ss_pred ------------CchhhHHhCCHHHHHHHHHHHHHHHHHcCCCeEEEeeeeCCCch--HHHHHHHHHHHHHHhccc-CCc
Confidence 22388999999999999999999999999999999999 99644 899999999999 99 54 489
Q ss_pred EEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHHHHH-HCCCCCCceee
Q 004402 180 TLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWL-RRGFPANKLVL 258 (755)
Q Consensus 180 ~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~~~~-~~g~p~~Klvl 258 (755)
+||+++|+.+. .|+ .++.+++||||||+||+ |+ |+..+||+||++ +++.++++|+ ..|+|++||+|
T Consensus 142 ~ls~av~~~~~----~~~-~~~~~~~D~i~vm~YD~-g~-~~~~~g~~apl~------~~~~~v~~~~~~~g~p~~Klvl 208 (312)
T 3fnd_A 142 LMTCAVNSRWL----NYG-TEWEQYFDYINLMSYDR-GA-FTDKPVQHASYD------DFVKDLKYWNEQCRASKSKIVG 208 (312)
T ss_dssp EEEEEECCSSS----CCT-TTSGGGCSEEEECCCCT-TC-SSSSCCCSSCHH------HHHHHHHHHHHTSCCCGGGEEE
T ss_pred EEEEEecCCcc----ccc-HHHHhhCCEEEEeeccC-CC-CCCCCCCCCchH------HHHHHHHHHHHHcCCCHHHEEE
Confidence 99999998432 355 78999999999999999 54 577899999985 6888999999 89999999999
Q ss_pred cccccCCCcccC--------CCcchHHHHHHHhhcCCCcccccccceeeeeeecCcEEEeeCCcchhhhhhhcccccCcc
Q 004402 259 GARASGPGITID--------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLL 330 (755)
Q Consensus 259 G~p~yG~~~~~~--------~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~yd~~~S~~~K~~~a~~~~l~ 330 (755)
|+|+|||+|+.. +.++|.++|+..... . .+ .++..||||||++|++.|++|++++|||
T Consensus 209 Gip~YGr~w~~~~~g~~~~~~~~~y~ei~~~~~~~----~-~~---------~d~~~~v~ydd~~Si~~K~~~~~~~gLg 274 (312)
T 3fnd_A 209 GLPFYGYSWEESLQGAVDDVRGIRYSGILKHLGNE----A-AD---------KDNIGKTYYNGRPTIANKCKFIKENDYA 274 (312)
T ss_dssp EEESEEEECCGGGTTSSCTTSEEEHHHHHHHHCGG----G-GG---------CSEETTEECCCHHHHHHHHHHHHHTTCC
T ss_pred EEcccCceeecCCCCCCCCCCceeHHHHHHhcCCc----e-EE---------ecCCeEEEcCCHHHHHHHHHHHHhcCCc
Confidence 999999999873 678999998854321 0 11 1123469999999999999999999999
Q ss_pred ccccccccccch
Q 004402 331 GYKAFQLSNDDN 342 (755)
Q Consensus 331 Gi~~W~l~~dd~ 342 (755)
|+|+|++++||.
T Consensus 275 Gv~~W~l~~Dd~ 286 (312)
T 3fnd_A 275 GVMIWQLFQDAH 286 (312)
T ss_dssp EEEEECGGGSCC
T ss_pred EEEEEeCcCCCC
Confidence 999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=416.77 Aligned_cols=268 Identities=23% Similarity=0.299 Sum_probs=201.1
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC----ccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD----ENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lv~ 510 (755)
++|...++||+|+||+||+|++ +|+.||||+++..... ...+..|+..+.+++|||||+++|+|.+.+ ..++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3466778999999999999987 6899999999754322 123345666677889999999999998654 479999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY-----SNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~-----~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
|||++|+|.++|+. ..++|..+.+++.|+++||+|||+. +.++||||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999953 3589999999999999999999986 24469999999999999999999999999998
Q ss_pred ccccCCcc--cccccccccCCccccccccCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc--------ccc
Q 004402 586 LFRKDVDE--ANTGRIVGTYGYVPPEYVKKG------IYSMKYDVYSFGVLLLQIISSKRNARYYGTSE--------NLN 649 (755)
Q Consensus 586 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~--------~~~ 649 (755)
........ ......+||+.|||||++.+. .++.++|||||||+||||+||+.|+....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76543322 123346899999999998754 46889999999999999999987764322211 001
Q ss_pred hHHHHHHHhccCCCccccCCCCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 650 FLEYAFEQWKDSKGKEFIDPSLDDS-SSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
........... +..+|.+... ...+....+.+|+.+||+.||++||||.||++.|++..
T Consensus 237 ~~~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 237 SVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CHHHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 11111111111 1122333221 12245567889999999999999999999999998754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=420.33 Aligned_cols=249 Identities=24% Similarity=0.332 Sum_probs=206.3
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
+.|+..++||+|+||+||+|.. .+|+.||||++........+.+.+|+++|++++|||||++++++.+.+..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4688899999999999999965 569999999997665555567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++|+|.+++.. ..+++.++..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 99999998842 35899999999999999999999987 99999999999999999999999999987654322
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ........ .... .+.+.
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i----~~~~-----~~~~~- 291 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMI----RDNL-----PPRLK- 291 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHH----HHSS-----CCCCS-
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHH----HcCC-----CCCCC-
Confidence 2345689999999999999999999999999999999999999985322 11112111 1111 11111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
........+.+|+.+||+.||++|||+.|+++
T Consensus 292 -~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp -CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11122346889999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=415.11 Aligned_cols=263 Identities=20% Similarity=0.215 Sum_probs=207.0
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
+.|...++||+|+||+||+|.. .+|+.||||+++.... ..+|+.+|++++|||||++++++.+.+..++|||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4577788999999999999965 5699999999976432 247999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC-CeEEEecCCccccccCCc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~ 592 (755)
++|+|.+++.. ...+++..+..++.||+.||.|||+++ ||||||||+||||+.++ .+||+|||+|+.+.....
T Consensus 133 ~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999953 346999999999999999999999987 99999999999999987 699999999997654321
Q ss_pred c---cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 593 E---ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 593 ~---~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
. ......+||+.|||||++.+..|+.++|||||||+||||+||+.||........ ....... .... .
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~i~~~--~~~~-----~ 276 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CLKIASE--PPPI-----R 276 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HHHHHHS--CCGG-----G
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHHHHcC--CCCc-----h
Confidence 1 122346899999999999999999999999999999999999999964433222 2211111 0000 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccccCCCCCCc
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAPKRPA 722 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~ 722 (755)
.+.. .....+.+++.+||+.||++|||+.|+++.|.........-..|.
T Consensus 277 ~~~~----~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw 325 (336)
T 4g3f_A 277 EIPP----SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPW 325 (336)
T ss_dssp GSCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCS
T ss_pred hcCc----cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCC
Confidence 1111 223467899999999999999999999998876544433333343
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=418.64 Aligned_cols=250 Identities=20% Similarity=0.349 Sum_probs=200.5
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
++|+..+.||+|+||+||+|.. .+|+.||||++... .....+.|.+|+++|++++|||||++++++.+.+..++|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5799999999999999999964 56999999999754 34456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
||++|+|.+++... +...+++.+.+.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999998532 2345788999999999999999999987 9999999999999999999999999998764321
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
......+||+.|||||++.+..|+.++|||||||+||||+||+.||.... ........ ..... +.+
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i----~~~~~-----~~~ 245 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS---MKNLVLKI----ISGSF-----PPV 245 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHH----HHTCC-----CCC
T ss_pred --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHH----HcCCC-----CCC
Confidence 12334689999999999999999999999999999999999999985322 11122111 11111 111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
... ....+.+|+.+||+.||++|||+.|+++
T Consensus 246 ~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 SLH----YSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Ccc----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112 2346889999999999999999999985
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=411.20 Aligned_cols=248 Identities=22% Similarity=0.307 Sum_probs=207.4
Q ss_pred cCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..++||+|+||+||++. ..+|+.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 469999999999999999996 456999999999754 2334578999999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
|||++|+|.+++.. ...+++.....++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999853 346899999999999999999999987 999999999999999999999999999987654
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
.........+||+.|||||++.+..|+.++||||+||+||||+||+.||.... ........ .... ..
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i----~~~~------~~ 252 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EGLIFAKI----IKLE------YD 252 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH----HHTC------CC
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH----HcCC------CC
Confidence 44444556789999999999999999999999999999999999999995322 11122111 1111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVS 705 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 705 (755)
+....+ ..+.+|+.+||+.||++|||++|++
T Consensus 253 ~p~~~s----~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 FPEKFF----PKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCTTCC----HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCcccC----HHHHHHHHHHccCCHhHCcChHHHc
Confidence 122222 3678999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=403.98 Aligned_cols=246 Identities=24% Similarity=0.384 Sum_probs=194.8
Q ss_pred CccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeec----CCccEEEE
Q 004402 438 SSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE----RDENMLIY 510 (755)
Q Consensus 438 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~ 510 (755)
...++||+|+||+||+|.. .+++.||||++... .....+.|.+|+++|++++|||||++++++.+ ....++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 3456799999999999964 56899999998654 34456789999999999999999999999865 34579999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC-CCCeEEEecCCcccccc
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-ELNPKISDFGMAKLFRK 589 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~-~~~~kl~Dfgla~~~~~ 589 (755)
|||++|+|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999953 346899999999999999999999874 35999999999999984 79999999999986432
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
. .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||..... ... .......+... +
T Consensus 185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~----~~~~i~~~~~~----~ 249 (290)
T 3fpq_A 185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQ----IYRRVTSGVKP----A 249 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHH----HHHHHTTTCCC----G
T ss_pred C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHH----HHHHHHcCCCC----C
Confidence 2 2335689999999998865 699999999999999999999999853221 111 11222211111 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+.... ...+.+|+.+||+.||++|||++|+++
T Consensus 250 ~~~~~~----~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 SFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111 235789999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=421.64 Aligned_cols=249 Identities=24% Similarity=0.336 Sum_probs=206.6
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
+.|+..++||+|+||.||+|.. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 5688999999999999999965 569999999997766555677899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++|+|.+++. ...+++.++..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 231 ~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-- 301 (423)
T 4fie_A 231 EGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 301 (423)
T ss_dssp TTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--
T ss_pred CCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--
Confidence 9999999884 235899999999999999999999987 9999999999999999999999999998765432
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ........ .... .+.+..
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i----~~~~-----~~~~~~ 369 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMI----RDNL-----PPRLKN 369 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHH----HHSC-----CCCCSC
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHH----HcCC-----CCCCcc
Confidence 22345789999999999999999999999999999999999999985322 11122111 1111 111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.......+.+|+.+||+.||++|||+.|+++
T Consensus 370 --~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 370 --LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp --TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1112246789999999999999999999876
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=393.15 Aligned_cols=245 Identities=24% Similarity=0.377 Sum_probs=188.9
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5899999999999999999965 56999999999754 2334567999999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||| +|+|.+++.. +..+++.+...++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6789888853 346999999999999999999999987 999999999999999999999999999865432
Q ss_pred CcccccccccccCCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
......+||+.|||||++.+..+ +.++||||+||++|||+||+.||.... ..... ..+.... .
T Consensus 166 ---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~---~~~~~----~~i~~~~------~ 229 (275)
T 3hyh_A 166 ---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES---IPVLF----KNISNGV------Y 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH----HHHHHTC------C
T ss_pred ---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC---HHHHH----HHHHcCC------C
Confidence 12234689999999999998876 579999999999999999999985321 11111 1111111 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+.... ...+.+++.+||+.||++|||++|+++
T Consensus 230 ~~p~~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 TLPKFL----SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCC----CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111222 236789999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=400.77 Aligned_cols=247 Identities=22% Similarity=0.287 Sum_probs=193.7
Q ss_pred cCCCccCcccccCCeeEEEEEc----CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL----PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
++|+..+.||+|+||+||+++. ..++.||||+++... ......+.+|+++|++++|||||++++++.+.+..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4688999999999999999964 247899999996542 2223468899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
|||||++|+|.+++.. ...+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999853 346899999999999999999999987 9999999999999999999999999998654
Q ss_pred cCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
... ......+||+.|||||++.+..|+.++|||||||+||||+||+.||..... ........ ...
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i~----~~~------ 242 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR---KETMTMIL----KAK------ 242 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH----HCC------
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH---HHHHHHHH----cCC------
Confidence 322 223346899999999999999999999999999999999999999853221 11221111 111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSM-----LEVSS 706 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~ 706 (755)
..+.... ...+.+|+.+||+.||++|||+ +|+++
T Consensus 243 ~~~p~~~----s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 243 LGMPQFL----SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCCCTTS----CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCCCcC----CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1111122 2367899999999999999984 56653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=392.69 Aligned_cols=251 Identities=22% Similarity=0.357 Sum_probs=187.6
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc-------
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE------- 505 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------- 505 (755)
++|+..+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 3588899999999999999964 569999999997553 3445689999999999999999999999865442
Q ss_pred -----cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEe
Q 004402 506 -----NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISD 580 (755)
Q Consensus 506 -----~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~D 580 (755)
.++|||||++|+|.+++.........++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 6899999999999999976544445677788999999999999999987 99999999999999999999999
Q ss_pred cCCccccccCCcc----------cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccch
Q 004402 581 FGMAKLFRKDVDE----------ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNF 650 (755)
Q Consensus 581 fgla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~ 650 (755)
||+|+.+...... ......+||+.|||||++.+..|+.++|||||||++|||++ |+.. . ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~--~---~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST--Q---MER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS--H---HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC--c---cHH
Confidence 9999976543211 11234579999999999999999999999999999999996 5421 1 111
Q ss_pred HHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 651 LEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 651 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.. ............ ........+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~-~~~~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VR-TLTDVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH-HHHHHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-HHHHHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 111111111000 01112234568999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=384.10 Aligned_cols=286 Identities=36% Similarity=0.610 Sum_probs=245.5
Q ss_pred ccCHHHHHHHhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC
Q 004402 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTER 503 (755)
Q Consensus 424 ~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 503 (755)
.+++.++...+++|+..+.||+|+||.||+|...+++.||||++........+.+.+|+.++++++||||+++++++.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 34556666778999999999999999999999888999999999877666778899999999999999999999999999
Q ss_pred CccEEEEeecCCCChhhhhcCCCc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecC
Q 004402 504 DENMLIYEYLPNKSLDLYLFDPIR-RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG 582 (755)
Q Consensus 504 ~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg 582 (755)
+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999865332 335899999999999999999999986 9999999999999999999999999
Q ss_pred CccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC
Q 004402 583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
+++...............||+.|+|||.+.+..++.++|||||||++|||+||+.|+.............+.........
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 99865433333333445789999999999989999999999999999999999999876555555556666555555666
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 663 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
....+++.+...........+.+++.+||+.||++|||+.|+++.|+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 66777777777777888889999999999999999999999999998653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=378.95 Aligned_cols=292 Identities=39% Similarity=0.649 Sum_probs=244.6
Q ss_pred CCccccCHHHHHHHhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCceeeeee
Q 004402 420 PNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQ-GLEEFKNEVSLTARLQHVNLLRVLG 498 (755)
Q Consensus 420 ~~~~~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g 498 (755)
.....+++.++....++|+..+.||+|+||.||+|...+|+.||||++...... ....+.+|++++..++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 345778999999999999999999999999999998888999999998765322 2336899999999999999999999
Q ss_pred eeecCCccEEEEeecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeE
Q 004402 499 YCTERDENMLIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPK 577 (755)
Q Consensus 499 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~k 577 (755)
++......++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+..+++||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 9999999999999999999999997643 234589999999999999999999998444599999999999999999999
Q ss_pred EEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC--CCCcccchHHHHH
Q 004402 578 ISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY--GTSENLNFLEYAF 655 (755)
Q Consensus 578 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~--~~~~~~~~~~~~~ 655 (755)
|+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.|+... ..........+..
T Consensus 175 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 175 VGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp ECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred eccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 999999987643322 2233456899999999999889999999999999999999999998532 1222334445554
Q ss_pred HHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 656 EQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 656 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
..........+.+..+...........+.+++.+||+.||++|||+.||++.|++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 445555666777777777778888889999999999999999999999999998743
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=388.18 Aligned_cols=266 Identities=19% Similarity=0.287 Sum_probs=200.6
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeec------CCc
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE------RDE 505 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 505 (755)
++|+..+.||+|+||+||+|.. .+|+.||||+++.. .....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5789999999999999999964 57999999999754 23445678999999999999999999998754 356
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
.|+|||||+ |+|.+++.. ...+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++
T Consensus 134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 678888853 346999999999999999999999987 9999999999999999999999999998
Q ss_pred ccccCC--cccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC
Q 004402 586 LFRKDV--DEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 586 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
.+.... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||...... ..+...........
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~---~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV---HQLQLIMMVLGTPS 283 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH---HHHHHHHHHHCCCC
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhcCCCC
Confidence 764332 22233457899999999998775 5699999999999999999999998543221 12222211111100
Q ss_pred Cc-----------cccCCCCCC--CCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhhcC
Q 004402 663 GK-----------EFIDPSLDD--SSS-----PCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKDD 711 (755)
Q Consensus 663 ~~-----------~~~d~~l~~--~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~ 711 (755)
.. ..+. .+.. ..+ +.....+.+|+.+||+.||++|||+.|+++ .+++.
T Consensus 284 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQ-SLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp GGGTC-----CHHHHHH-SSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hHHhhhhhhhhhhhhhh-cCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 00 0000 0000 000 011236789999999999999999999885 45443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=377.59 Aligned_cols=197 Identities=25% Similarity=0.354 Sum_probs=168.3
Q ss_pred HhcCCCccCcccccCCeeEEEEEc----CCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccE
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNL----PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENM 507 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 507 (755)
..++|+..++||+|+||+||+|+. ..++.||||++..... ...+.+|+++|..+ +||||+++++++.+.+..+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 357899999999999999999954 2468999999866543 35678999999998 6999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC-CCeEEEecCCccc
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMAKL 586 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~-~~~kl~Dfgla~~ 586 (755)
+|||||++|+|.+++. .+++.++..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999883 3889999999999999999999987 9999999999999877 7999999999986
Q ss_pred cccCCcc--------------------------cccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCC
Q 004402 587 FRKDVDE--------------------------ANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNA 639 (755)
Q Consensus 587 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~ 639 (755)
....... ......+||+.|||||++.+. .|+.++||||+||++|||+||+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 5432110 112234799999999998775 5899999999999999999999998
Q ss_pred C
Q 004402 640 R 640 (755)
Q Consensus 640 ~ 640 (755)
.
T Consensus 248 ~ 248 (361)
T 4f9c_A 248 Y 248 (361)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=359.72 Aligned_cols=286 Identities=35% Similarity=0.578 Sum_probs=232.3
Q ss_pred CccccCHHHHHHHhcCCCcc------CcccccCCeeEEEEEcCCCCEEEEEEeccC----ChhhHHHHHHHHHHHhcCCC
Q 004402 421 NLQVFSFSDIKAATNNFSSA------NKLGEGGFGPVYKGNLPRGQEFAVKRLSAT----STQGLEEFKNEVSLTARLQH 490 (755)
Q Consensus 421 ~~~~~~~~~l~~~~~~f~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H 490 (755)
....|++.++..++++|... +.||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45779999999999999887 8899999999999987 6899999998653 23446789999999999999
Q ss_pred CceeeeeeeeecCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE
Q 004402 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL 570 (755)
Q Consensus 491 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll 570 (755)
|||+++++++.+.+..++||||+++++|.+++........+++..++.++.|++.||.|||+.+ ++||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999876555567999999999999999999999986 9999999999999
Q ss_pred cCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccch
Q 004402 571 DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNF 650 (755)
Q Consensus 571 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~ 650 (755)
+.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.|+...........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 9999999999999987654333333344578999999998865 589999999999999999999999865443332222
Q ss_pred HHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 651 LEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 651 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
...... .........+++.+. .........+.+++.+||+.||++|||+.++++.|++...
T Consensus 246 ~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 246 IKEEIE-DEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHH-TTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHhh-hhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 111111 111222333444432 3345667789999999999999999999999999987543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=398.00 Aligned_cols=251 Identities=21% Similarity=0.284 Sum_probs=206.4
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
++|+..+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.+|+.++|||||++++++.+....++|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 5799999999999999999964 569999999998777666778999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC--CCeEEEecCCccccccCC
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE--LNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~--~~~kl~Dfgla~~~~~~~ 591 (755)
++|+|.+++... ...+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 237 ~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 999999988542 345899999999999999999999987 9999999999999854 899999999999765432
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ..... .+..... . +.+..
T Consensus 312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~---~~~~~----~i~~~~~-~-~~~~~ 379 (573)
T 3uto_A 312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLR----NVKSCDW-N-MDDSA 379 (573)
T ss_dssp ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHH----HHHTTCC-C-CCSGG
T ss_pred ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHH----HHHhCCC-C-CCccc
Confidence 22345899999999999999999999999999999999999999853221 11111 1111110 0 11111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.. .....+.+|+.+||+.||++|||+.|+++
T Consensus 380 ~~----~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 380 FS----GISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cc----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 12246789999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=387.65 Aligned_cols=248 Identities=25% Similarity=0.291 Sum_probs=197.5
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC------hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS------TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM 507 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 507 (755)
++|+..++||+|+||+||+++. .+|+.||||++.+.. .........++.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 4688899999999999999964 569999999996531 111223344577788889999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
+|||||++|+|..+|.. ...+++..+..++.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999853 346899999999999999999999987 999999999999999999999999999876
Q ss_pred ccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccc
Q 004402 588 RKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666 (755)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (755)
... .....+||+.|||||++.+ ..|+.++|||||||+||||++|+.||................ ..
T Consensus 343 ~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~----~~----- 409 (689)
T 3v5w_A 343 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----TM----- 409 (689)
T ss_dssp SSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH----HC-----
T ss_pred CCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc----CC-----
Confidence 432 2234689999999999965 579999999999999999999999996433322211111111 11
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 004402 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPS-----MLEVSS 706 (755)
Q Consensus 667 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 706 (755)
...+.... ...+.+|+.+||+.||++|++ ++||.+
T Consensus 410 -~~~~p~~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 410 -AVELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -CCCCCTTS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -CCCCCccC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11111222 236789999999999999998 677763
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=358.74 Aligned_cols=267 Identities=26% Similarity=0.408 Sum_probs=204.3
Q ss_pred HhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
..++|+..+.||+|+||+||+|.. +|+.||||++.... ....+.+.+|++++++++||||+++++++......++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 356788899999999999999976 68999999987653 444568999999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|+|.+++........+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 99999999999975444445899999999999999999999874 24999999999999999999999999999854332
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.|+...... ........ . .. ...
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~~~~~~--~-~~-----~~~ 259 (309)
T 3p86_A 193 F--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA---QVVAAVGF--K-CK-----RLE 259 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHHHHHH--S-CC-----CCC
T ss_pred c--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh--c-CC-----CCC
Confidence 1 1223457899999999999999999999999999999999999998543211 11111100 0 00 011
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccccCCC
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAP 718 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p 718 (755)
+.. .....+.+++.+||+.||++|||+.|+++.|+.......+|
T Consensus 260 ~~~----~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 260 IPR----NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp CCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred CCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 111 22346889999999999999999999999999876554444
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=357.39 Aligned_cols=260 Identities=24% Similarity=0.412 Sum_probs=211.6
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
++|...+.||+|+||+||++.. .+++.||+|++........+.|.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 4677889999999999999965 469999999998777777889999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++|+|.+++... ...+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 999999998542 345899999999999999999999987 999999999999999999999999999876433221
Q ss_pred c------------ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccc--chHHHHHHHhc
Q 004402 594 A------------NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL--NFLEYAFEQWK 659 (755)
Q Consensus 594 ~------------~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~ 659 (755)
. ......||+.|+|||.+.+..++.++|||||||++|||++|..|+......... ........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~--- 241 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD--- 241 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH---
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc---
Confidence 1 111457899999999999999999999999999999999999887654332211 11111111
Q ss_pred cCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccc
Q 004402 660 DSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAI 715 (755)
Q Consensus 660 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 715 (755)
....... ...+.+++.+||+.||++|||+.|+++.|+.....+
T Consensus 242 ---------~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 242 ---------RYCPPNC----PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp ---------HTCCTTC----CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---------ccCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111111 225788999999999999999999999999876544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=364.61 Aligned_cols=260 Identities=23% Similarity=0.344 Sum_probs=209.9
Q ss_pred hcCCCccCcccccCCeeEEEEEc--------CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecC
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL--------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER 503 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 503 (755)
.++|...+.||+|+||.||+|.. .++..||||+++... ....+.+.+|+.++.++ +||||++++++|...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 35788889999999999999964 235679999997653 34567899999999999 899999999999999
Q ss_pred CccEEEEeecCCCChhhhhcCCCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE
Q 004402 504 DENMLIYEYLPNKSLDLYLFDPIR-------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL 570 (755)
Q Consensus 504 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll 570 (755)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999864321 235889999999999999999999987 9999999999999
Q ss_pred cCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccc
Q 004402 571 DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLN 649 (755)
Q Consensus 571 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~ 649 (755)
+.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+| |+.|+...... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~ 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence 9999999999999987654333333334567889999999999999999999999999999999 88887543221 1
Q ss_pred hHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 650 FLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
..... ..... +.. +......+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 314 ~~~~~----~~~~~-----~~~----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 314 LFKLL----KEGHR-----MDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHHHH----HTTCC-----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHH----hcCCC-----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 22111 11110 111 1122346889999999999999999999999998754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=361.91 Aligned_cols=269 Identities=26% Similarity=0.325 Sum_probs=208.1
Q ss_pred hcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc----cEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE----NMLI 509 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----~~lv 509 (755)
.++|+..+.||+|+||.||+|+. .++.||||++...... ...+..|+.++.+++||||+++++++..... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 45788899999999999999987 4899999999765433 3456679999999999999999999987543 6999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhc-------CCCCceecccCCCCEEEcCCCCeEEEecC
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY-------SNFRVIHRDLKASNILLDNELNPKISDFG 582 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~-------~~~~iiHrDlk~~NIll~~~~~~kl~Dfg 582 (755)
|||+++|+|.+++.. ..+++..+..++.|++.||.|||+. ++.+|+||||||+|||++.++.+||+|||
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 999999999999843 3489999999999999999999987 11239999999999999999999999999
Q ss_pred CccccccCCcccccccccccCCccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHH-----
Q 004402 583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKK-----GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLE----- 652 (755)
Q Consensus 583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~----- 652 (755)
+++...............||+.|+|||.+.+ ..++.++|||||||++|||+||+.|+.............
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 9987655443333444678999999999976 356678999999999999999999986544332222111
Q ss_pred ----HHHHHhccCCCccccCCCCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 653 ----YAFEQWKDSKGKEFIDPSLDDS-SSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 653 ----~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
.......... ..+.+... ........+.+++.+||+.||++|||+.|+++.|++..
T Consensus 257 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 257 PSLEDMQEVVVHKK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp CCHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Cchhhhhhhhhccc----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111111111 11111111 11234556899999999999999999999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=351.17 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=205.5
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
.++|+..+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35789999999999999999964 56999999999766555667899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++|+|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999999843 35889999999999999999999987 99999999999999999999999999987654322
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
......||+.|+|||.+.+..++.++|||||||++|||++|+.|+...... ........ ... ...
T Consensus 172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~---~~~-~~~------ 236 (297)
T 3fxz_A 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYLIAT---NGT-PEL------ 236 (297)
T ss_dssp --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHH---HCS-CCC------
T ss_pred --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh---CCC-CCC------
Confidence 233457899999999999999999999999999999999999998532211 11111111 000 000
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..+......+.+++.+||+.||++|||+.|+++
T Consensus 237 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 011223346789999999999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=351.84 Aligned_cols=261 Identities=26% Similarity=0.375 Sum_probs=213.2
Q ss_pred cccCHHHHHHHhcC----------CCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCC
Q 004402 423 QVFSFSDIKAATNN----------FSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHV 491 (755)
Q Consensus 423 ~~~~~~~l~~~~~~----------f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ 491 (755)
..++.++++.+++. |+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45788888888765 666779999999999999765 6999999999877666678899999999999999
Q ss_pred ceeeeeeeeecCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc
Q 004402 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD 571 (755)
Q Consensus 492 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~ 571 (755)
||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 999999999999999999999999999998842 35899999999999999999999986 99999999999999
Q ss_pred CCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchH
Q 004402 572 NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFL 651 (755)
Q Consensus 572 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~ 651 (755)
.++.+||+|||++........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.|+..... ....
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---~~~~ 250 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAM 250 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH
T ss_pred CCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHH
Confidence 999999999999987654322 22345789999999999999999999999999999999999999853221 1111
Q ss_pred HHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 652 EYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 652 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.. +.... .+.+. ........+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~----~~~~~-----~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 251 KR----LRDSP-----PPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HH----HHHSS-----CCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HH----HhcCC-----CCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 11111 11111 01122346789999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=367.66 Aligned_cols=258 Identities=24% Similarity=0.363 Sum_probs=207.1
Q ss_pred hcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.++|...+.||+|+||.||+|... +++.||||+++... ....+.|.+|+++|++++||||++++++|...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 457788899999999999999765 68999999987653 3344578999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++|+|.+++... ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 99999999998532 335889999999999999999999987 9999999999999999999999999998654332
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
.........++..|+|||.+..+.++.++|||||||++|||+| |+.|+...... .... ...... ..
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~~----~~~~~~--~~---- 334 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTRE----FVEKGG--RL---- 334 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHHH----HHHTTC--CC----
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCC--CC----
Confidence 2222222345788999999998999999999999999999998 88887533211 1111 111111 00
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
..+...+..+.+++.+||+.||++|||+.++++.|++..
T Consensus 335 ---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 335 ---PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 111122346889999999999999999999999998653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=348.41 Aligned_cols=264 Identities=24% Similarity=0.377 Sum_probs=204.5
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecC
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 514 (755)
++|+..+.||+|+||.||++.. .++.||||++... ...+.|.+|+.++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 4677889999999999999987 5789999998654 345789999999999999999999999874 5899999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC-eEEEecCCccccccCCcc
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN-PKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~-~kl~Dfgla~~~~~~~~~ 593 (755)
+|+|.+++........+++..++.++.|+++||.|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999976544445789999999999999999999965456999999999999998887 799999999764322
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.|+........ ..... ...... +....
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~-~~~~~~-----~~~~~ 227 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMWA-VHNGTR-----PPLIK 227 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHHH-HHTTCC-----CCCBT
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHHH-HhcCCC-----CCccc
Confidence 1234689999999999999999999999999999999999999864332211 11111 111111 11111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccccCCCCCCc
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAPKRPA 722 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~ 722 (755)
. ....+.+++.+||+.||++|||+.|+++.|+.....++.+..|.
T Consensus 228 ~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~ 272 (307)
T 2eva_A 228 N----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272 (307)
T ss_dssp T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred c----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence 1 22367899999999999999999999999998766655544443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=354.74 Aligned_cols=259 Identities=26% Similarity=0.411 Sum_probs=206.0
Q ss_pred hcCCCccCcccccCCeeEEEEEcC----CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP----RGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
.++|...+.||+|+||.||+|... .+..||||++... .....+.|.+|+.++.+++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 356788899999999999999763 3456999999765 44456789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999998543 335899999999999999999999987 9999999999999999999999999998765
Q ss_pred cCCccc-ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccc
Q 004402 589 KDVDEA-NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666 (755)
Q Consensus 589 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (755)
...... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.|+...... ..... .....
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~----~~~~~---- 271 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVISS----VEEGY---- 271 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHH----HHTTC----
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHHHH----HHcCC----
Confidence 432221 2223355778999999998999999999999999999999 88887432211 11111 11110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 667 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
.. ..+......+.+++..||+.||++|||+.|+++.|+....
T Consensus 272 -~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 272 -RL----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp -CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CC----CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00 1111223478899999999999999999999999987643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=363.02 Aligned_cols=270 Identities=27% Similarity=0.398 Sum_probs=214.3
Q ss_pred cCHHHHHHHhcCCCccCcccccCCeeEEEEEc------CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCceeee
Q 004402 425 FSFSDIKAATNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRV 496 (755)
Q Consensus 425 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l 496 (755)
+...+++...++|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 44556666678999999999999999999962 346899999997653 34456799999999999 89999999
Q ss_pred eeeeecCCc-cEEEEeecCCCChhhhhcCCCc------------------------------------------------
Q 004402 497 LGYCTERDE-NMLIYEYLPNKSLDLYLFDPIR------------------------------------------------ 527 (755)
Q Consensus 497 ~g~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------ 527 (755)
++++.+.+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999999865432
Q ss_pred ---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 528 ---------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 528 ---------------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122889999999999999999999987 99999999999999999999999999987654433
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
........||+.|+|||.+.+..++.++|||||||++|||+| |+.|+....... ...... ..... ...
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~----~~~~~-----~~~ 317 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRL----KEGTR-----MRA 317 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHH----HHTCC-----CCC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHHHH----HcCCC-----CCC
Confidence 334445678899999999999999999999999999999998 998885433221 111111 11110 111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
... ....+.+++..||+.||++|||+.|+++.|++..
T Consensus 318 ~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 318 PDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 111 2236889999999999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=358.08 Aligned_cols=266 Identities=26% Similarity=0.381 Sum_probs=205.3
Q ss_pred cCCCccCcccccCCeeEEEEEc-----CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--CccE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-----PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DENM 507 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 507 (755)
++|+..+.||+|+||.||++.. .+++.||||++........+.+.+|++++.+++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5778889999999999999973 36889999999887777778899999999999999999999998654 4589
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
+||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 90 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 999999999999998543 234899999999999999999999986 999999999999999999999999999876
Q ss_pred ccCCcc-cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------Ccc-cchHHHHHHH
Q 004402 588 RKDVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGT--------SEN-LNFLEYAFEQ 657 (755)
Q Consensus 588 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~--------~~~-~~~~~~~~~~ 657 (755)
...... .......++..|+|||.+.+..++.++|||||||++|||+||..|+..... ... ..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 543221 122234567789999999999999999999999999999999987643210 000 0000111111
Q ss_pred hccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 004402 658 WKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMA 714 (755)
Q Consensus 658 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 714 (755)
..... ....+......+.+++.+||+.||++|||+.|+++.|++....
T Consensus 245 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 245 LKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HhccC---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 11111 1111222334788999999999999999999999999876544
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=361.83 Aligned_cols=266 Identities=25% Similarity=0.339 Sum_probs=213.2
Q ss_pred hcCCCccCcccccCCeeEEEEEc--------CCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecC
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL--------PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER 503 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 503 (755)
.++|...+.||+|+||.||+|.. ..+..||||++... .....+.+.+|++++.++ +||||++++++|...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 46788899999999999999964 23468999999765 344557899999999999 999999999999999
Q ss_pred CccEEEEeecCCCChhhhhcCCCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE
Q 004402 504 DENMLIYEYLPNKSLDLYLFDPIR-------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL 570 (755)
Q Consensus 504 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll 570 (755)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999864321 235899999999999999999999986 9999999999999
Q ss_pred cCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccc
Q 004402 571 DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLN 649 (755)
Q Consensus 571 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~ 649 (755)
+.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.|+..... ..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---~~ 301 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EE 301 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HH
Confidence 9999999999999987654433333444567889999999999999999999999999999999 8888753221 11
Q ss_pred hHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccccCCC
Q 004402 650 FLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAP 718 (755)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p 718 (755)
. ...+..... ..... .....+.+++.+||+.||++|||+.|+++.|++........
T Consensus 302 ~----~~~~~~~~~-----~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 302 L----FKLLKEGHR-----MDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp H----HHHHHTTCC-----CCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred H----HHHHHcCCC-----CCCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 1 111111111 11111 22346889999999999999999999999999876544333
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=351.62 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=201.8
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
++|+..+.||+|+||.||++.. .+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 5788899999999999999965 4799999999865432 2345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 87 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999998853 335899999999999999999999987 99999999999999999999999999987654433
Q ss_pred ccccccccccCCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
........||+.|+|||++.+..+ +.++|||||||++|||++|+.|+........ .... +.... ....
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~-----~~~~~--~~~~--- 229 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSD-----WKEKK--TYLN--- 229 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHH-----HHTTC--TTST---
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHH-----Hhccc--ccCC---
Confidence 333445679999999999987775 7899999999999999999999864433211 1111 11110 0000
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
........+.+++.+||+.||++|||+.|+++.
T Consensus 230 ---~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 ---PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 011223467899999999999999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=349.48 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=202.9
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35788899999999999999965 67999999998654 3445677899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999853 345899999999999999999999987 999999999999999999999999999865433
Q ss_pred CcccccccccccCCccccccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYS-MKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
. .....+||+.|+|||.+.+..++ .++|||||||++|||++|+.||..... ....... ..+..
T Consensus 168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i----~~~~~------ 231 (328)
T 3fe3_A 168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL---KELRERV----LRGKY------ 231 (328)
T ss_dssp C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH----HHCCC------
T ss_pred C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH---HHHHHHH----HhCCC------
Confidence 2 23345799999999999888775 899999999999999999999853221 1111111 11110
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+... ....+.+++.+||+.||++|||++|+++
T Consensus 232 ~~p~~----~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 232 RIPFY----MSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CCCTT----SCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCCC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111 2236789999999999999999999985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=360.81 Aligned_cols=258 Identities=26% Similarity=0.436 Sum_probs=196.6
Q ss_pred hcCCCccCcccccCCeeEEEEEcC----CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP----RGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
.++|+..+.||+|+||.||+|... ++..||||+++.. .....+.|.+|+.++.+++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357889999999999999999764 5778999999765 34456789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
||||+++|+|.+++... ...+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999643 335899999999999999999999986 9999999999999999999999999998765
Q ss_pred cCCccc-ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccc
Q 004402 589 KDVDEA-NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666 (755)
Q Consensus 589 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (755)
...... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.|+..... ....... .... .
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~i----~~~~--~- 268 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKAV----DEGY--R- 268 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHHH----HTTE--E-
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcCC--C-
Confidence 432211 1222345778999999999999999999999999999998 8988743221 1111111 1110 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 667 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
..........+.+++.+||+.||++||++.++++.|++..
T Consensus 269 ------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 269 ------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp ------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 0011123347889999999999999999999999998753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=363.76 Aligned_cols=261 Identities=27% Similarity=0.396 Sum_probs=207.6
Q ss_pred hcCCCccCcccccCCeeEEEEEc------CCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN 506 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 506 (755)
.++|...+.||+|+||.||+|.. .+++.||||++... .......+.+|+.++.+++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35788889999999999999974 24678999999654 344556789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCC----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC---CeEEE
Q 004402 507 MLIYEYLPNKSLDLYLFDPI----RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL---NPKIS 579 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~---~~kl~ 579 (755)
++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999986432 2245899999999999999999999987 99999999999999555 59999
Q ss_pred ecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHh
Q 004402 580 DFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQW 658 (755)
Q Consensus 580 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 658 (755)
|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+| |..|+..... ...... .
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---~~~~~~----i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEF----V 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHH----H
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----H
Confidence 9999986543333333344577899999999999999999999999999999998 8888753221 111111 1
Q ss_pred ccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 659 KDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 659 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
..... ... .......+.+++.+||+.||++|||+.||++.|+....
T Consensus 300 ~~~~~-----~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 300 TSGGR-----MDP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HTTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCC-----CCC----CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 11110 001 11223468899999999999999999999999986543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=343.56 Aligned_cols=271 Identities=21% Similarity=0.278 Sum_probs=213.8
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC--ccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD--ENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv~ 510 (755)
++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56888999999999999999654 58999999997543 334577889999999999999999999987765 679999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE----cCCCCeEEEecCCccc
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL----DNELNPKISDFGMAKL 586 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll----~~~~~~kl~Dfgla~~ 586 (755)
||+++++|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999976555555999999999999999999999987 9999999999999 7888899999999987
Q ss_pred cccCCcccccccccccCCcccccccc--------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccc-chHHHHHHH
Q 004402 587 FRKDVDEANTGRIVGTYGYVPPEYVK--------KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL-NFLEYAFEQ 657 (755)
Q Consensus 587 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~-~~~~~~~~~ 657 (755)
...... .....||+.|+|||.+. +..++.++|||||||++|||++|+.||......... .........
T Consensus 166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred cCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 644322 22356899999999886 578899999999999999999999998754443322 222222222
Q ss_pred hccCCCcccc---------CC--CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 658 WKDSKGKEFI---------DP--SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 658 ~~~~~~~~~~---------d~--~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
........+. .+ .............+.+++.+||+.||++|||+.|+++...+.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1111111100 00 111233456677788999999999999999999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=367.54 Aligned_cols=259 Identities=24% Similarity=0.399 Sum_probs=209.3
Q ss_pred HHhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 432 AATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 432 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
...++|...+.||+|+||.||+|...+++.||||+++... ...+.|.+|+.+|++++||||+++++++. .+..++|||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 3456788889999999999999998888999999997654 34678999999999999999999999986 567899999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 263 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 263 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred ecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 99999999999643 2235788999999999999999999987 9999999999999999999999999998754321
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
. .......+|..|+|||.+....++.++|||||||++|||+| |+.|+..... ......... +. ..
T Consensus 339 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~----~~--~~---- 404 (454)
T 1qcf_A 339 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALER----GY--RM---- 404 (454)
T ss_dssp H-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHH----TC--CC----
T ss_pred e-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc----CC--CC----
Confidence 1 11223346788999999998999999999999999999999 8888853221 111211111 10 00
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
..+...+..+.+++.+||+.||++|||+.+|++.|++...
T Consensus 405 ---~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 405 ---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 0111233478899999999999999999999999998654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=349.43 Aligned_cols=274 Identities=15% Similarity=0.119 Sum_probs=213.5
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
++|...+.||+|+||.||+|.. .+|+.||||++..... .+.+.+|+.+++++ +||||+++++++...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 5788899999999999999964 6799999999865432 24578999999999 999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC-----eEEEecCCcccc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN-----PKISDFGMAKLF 587 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~-----~kl~Dfgla~~~ 587 (755)
+ +++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+++.+
T Consensus 87 ~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 87 L-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred C-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 9 99999998543 346899999999999999999999987 999999999999999887 999999999876
Q ss_pred ccCCccc-----ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC
Q 004402 588 RKDVDEA-----NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 588 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 4432211 12356799999999999999999999999999999999999999976543332222222211100000
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccccCCCCCCccccC
Q 004402 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAPKRPAFSAK 726 (755)
Q Consensus 663 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~~~~ 726 (755)
.+.. .. ..+ .+.+++..||+.||.+||++.+|.+.|++.......+....+.|.
T Consensus 241 -~~~~----~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 241 -IEVL----CE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp -HHHH----TT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred -HHHH----hc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 0000 00 112 788999999999999999999999999876544433333334443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=354.25 Aligned_cols=256 Identities=24% Similarity=0.394 Sum_probs=200.7
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCE----EEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQE----FAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
++|...+.||+|+||.||+|.. .+++. ||+|.+.... ....+.+.+|+.++.+++||||++++++|. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 4677889999999999999965 34543 8888875442 233456788999999999999999999986 456899
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
|+||+++|+|.+++... +..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999998653 345888999999999999999999987 9999999999999999999999999999876
Q ss_pred cCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
............+|..|+|||.+.+..++.++|||||||++|||+| |+.|+........ .... .... ...
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~----~~~~--~~~ 237 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV---PDLL----EKGE--RLA 237 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH---HHHH----HTTC--BCC
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH---HHHH----HcCC--CCC
Confidence 5444444445677889999999999999999999999999999999 9999864332221 1111 1111 001
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
.+ . .....+.+++.+||+.||++|||+.|+++.|+...
T Consensus 238 ~~---~----~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 238 QP---Q----ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp CC---T----TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CC---C----cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 1 11124678999999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=353.94 Aligned_cols=265 Identities=25% Similarity=0.393 Sum_probs=211.6
Q ss_pred HHHhcCCCccCcccccCCeeEEEEEcC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecC
Q 004402 431 KAATNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER 503 (755)
Q Consensus 431 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 503 (755)
....++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 334678999999999999999999763 35899999997653 34467899999999999999999999999999
Q ss_pred CccEEEEeecCCCChhhhhcCCCc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecc
Q 004402 504 DENMLIYEYLPNKSLDLYLFDPIR---------------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRD 562 (755)
Q Consensus 504 ~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrD 562 (755)
+..++||||+++|+|.+++..... ...+++.+++.++.||++||.|||+.+ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 999999999999999999864321 146899999999999999999999987 99999
Q ss_pred cCCCCEEEcCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004402 563 LKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARY 641 (755)
Q Consensus 563 lk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~ 641 (755)
|||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+| |+.|+..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999987644332223334567889999999998899999999999999999999 8888743
Q ss_pred CCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 004402 642 YGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMA 714 (755)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 714 (755)
... ... ........... ... .....+.+++.+||+.||++|||+.++++.|++....
T Consensus 280 ~~~---~~~----~~~~~~~~~~~-----~~~----~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 280 MAH---EEV----IYYVRDGNILA-----CPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp SCH---HHH----HHHHHTTCCCC-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCh---HHH----HHHHhCCCcCC-----CCC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 221 111 11112211111 111 2234688999999999999999999999999987654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=342.24 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=207.5
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecC
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 514 (755)
++|+..+.||+|+||.||++...+++.||+|++..... ..+.+.+|++++.+++||||+++++++.+....++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 46788899999999999999888899999999976543 34678999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 594 (755)
+++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++....... .
T Consensus 89 ~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 162 (269)
T 4hcu_A 89 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 162 (269)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred CCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-c
Confidence 99999998543 345899999999999999999999987 99999999999999999999999999986543221 1
Q ss_pred ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+..... .... ....... ......
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~~~~----~~~~~~~-----~~~~~~ 230 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVV----EDISTGF-----RLYKPR 230 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHH----HHHHTTC-----CCCCCT
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---HHHH----HHHhcCc-----cCCCCC
Confidence 2223456788999999999999999999999999999999 8888753221 1111 1111110 011111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
.....+.+++.+||+.||++|||+.|+++.|++..
T Consensus 231 ----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 231 ----LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 12346889999999999999999999999998754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=354.01 Aligned_cols=264 Identities=27% Similarity=0.381 Sum_probs=209.0
Q ss_pred HhcCCCccCcccccCCeeEEEEEc------CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCC
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERD 504 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 504 (755)
..++|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 457888999999999999999974 346689999997542 33456799999999999 8999999999999999
Q ss_pred ccEEEEeecCCCChhhhhcCCCcc--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccC
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPIRR--------------------YVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLK 564 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk 564 (755)
..++||||+++|+|.+++...... ..+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999654321 34789999999999999999999986 9999999
Q ss_pred CCCEEEcCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004402 565 ASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYG 643 (755)
Q Consensus 565 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~ 643 (755)
|+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+| |+.|+....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987655433333445567889999999999999999999999999999998 888885433
Q ss_pred CCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 004402 644 TSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMA 714 (755)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 714 (755)
.... .... ..... .... +......+.+++.+||+.||++|||+.|+++.|+.....
T Consensus 280 ~~~~--~~~~----~~~~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 280 VDAN--FYKL----IQNGF-----KMDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CSHH--HHHH----HHTTC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cHHH--HHHH----HhcCC-----CCCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 2211 1111 11110 1111 112234688999999999999999999999999876544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=350.83 Aligned_cols=260 Identities=25% Similarity=0.385 Sum_probs=209.9
Q ss_pred hcCCCccCcccccCCeeEEEEEc------CCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN 506 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 506 (755)
.++|...+.||+|+||.||++.. .+++.||||++... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46788889999999999999964 34589999999764 344567899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCC
Q 004402 507 MLIYEYLPNKSLDLYLFDPIR---------------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKA 565 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~ 565 (755)
++||||+++|+|.+++..... ...+++..++.++.||++||.|||+.+ ++||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999864322 234789999999999999999999987 99999999
Q ss_pred CCEEEcCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 004402 566 SNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGT 644 (755)
Q Consensus 566 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~ 644 (755)
+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.|+.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654433333334567889999999999999999999999999999999 8888754332
Q ss_pred CcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 645 SENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
.. ..... ..... .... ......+.+++.+||+.||++|||+.|+++.|++..
T Consensus 259 ~~---~~~~~----~~~~~-----~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 259 ER---LFNLL----KTGHR-----MERP----DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp GG---HHHHH----HTTCC-----CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---HHHHh----hcCCc-----CCCC----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 21 11111 11110 1111 122346889999999999999999999999998753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=355.21 Aligned_cols=256 Identities=25% Similarity=0.415 Sum_probs=198.2
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCE----EEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQE----FAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
++|+..+.||+|+||.||+|.. .+++. ||+|.+... .....+.|.+|+.++++++||||++++++|... ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 5688889999999999999974 34543 688887544 334567899999999999999999999999875 4789
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
|+||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 99999999999998643 345899999999999999999999986 9999999999999999999999999998765
Q ss_pred cCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
............+|+.|+|||.+.+..++.++|||||||++|||+| |+.|+....... ..... ....
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~----~~~~----- 236 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL----EKGE----- 236 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH----HTTC-----
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHHHH----HcCC-----
Confidence 5443333334566889999999999999999999999999999999 998885432221 11111 1110
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
....+......+.+++.+||+.||++|||+.|+++.|+...
T Consensus 237 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 237 ----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ----CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00111223346889999999999999999999999998654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=367.20 Aligned_cols=260 Identities=24% Similarity=0.397 Sum_probs=204.2
Q ss_pred HhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
..++|...+.||+|+||.||+|...++..||||+++.... ..+.|.+|+.+|++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 3467888899999999999999988888999999976542 35689999999999999999999999876 678999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999999998532 2245899999999999999999999987 99999999999999999999999999987643221
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
.......+|..|+|||.+....++.++|||||||++|||+| |+.|+..... ..... ....+..
T Consensus 336 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~----~i~~~~~-------- 399 (452)
T 1fmk_A 336 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLD----QVERGYR-------- 399 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHH----HHHTTCC--------
T ss_pred -ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHHcCCC--------
Confidence 11223456789999999999999999999999999999999 8888753221 11111 1111110
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccc
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAI 715 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 715 (755)
...+...+..+.+++.+||+.||++|||+.+|++.|++.....
T Consensus 400 -~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 400 -MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 0111223347889999999999999999999999999865543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=337.89 Aligned_cols=257 Identities=27% Similarity=0.397 Sum_probs=208.6
Q ss_pred hcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
.++|+..+.||+|+||.||++...++..||+|++..... ..+.+.+|++++.+++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 457888899999999999999988888999999976543 3467899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999998542 335899999999999999999999987 999999999999999999999999999866443222
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
......+|+.|+|||.+.+..++.++||||||+++|||+| |+.|+....... .. ....... ....+
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~----~~~~~~~--~~~~~--- 227 (268)
T 3sxs_A 161 -SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE---VV----LKVSQGH--RLYRP--- 227 (268)
T ss_dssp -ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH----HHHHTTC--CCCCC---
T ss_pred -cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH---HH----HHHHcCC--CCCCC---
Confidence 2223456778999999998899999999999999999999 888875332211 11 1111111 11111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
.. ....+.+++.+||+.||++|||+.|+++.|+....
T Consensus 228 ~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 228 HL----ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp TT----SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred Cc----ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 11 12368899999999999999999999999987654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=348.66 Aligned_cols=262 Identities=21% Similarity=0.381 Sum_probs=193.3
Q ss_pred HhcCCCccCcccccCCeeEEEEEcCCC----CEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcc
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNLPRG----QEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN 506 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 506 (755)
..++|+..+.||+|+||.||+|..... ..||||++... .....+.+.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 356889999999999999999976443 27999998765 344567899999999999999999999999877655
Q ss_pred ------EEEEeecCCCChhhhhcCCC---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeE
Q 004402 507 ------MLIYEYLPNKSLDLYLFDPI---RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPK 577 (755)
Q Consensus 507 ------~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~k 577 (755)
++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 99999999999999985322 1225899999999999999999999987 99999999999999999999
Q ss_pred EEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHH
Q 004402 578 ISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFE 656 (755)
Q Consensus 578 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 656 (755)
|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.|+...... .......
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~~- 253 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYNYLI- 253 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHH-
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHHHHHh-
Confidence 999999987654333223333456788999999999999999999999999999999 88887543322 1211111
Q ss_pred HhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 657 QWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 657 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
.... .. ........+.+++.+||+.||++|||+.++++.|++...
T Consensus 254 ---~~~~-----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 254 ---GGNR-----LK----QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp ---TTCC-----CC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cCCC-----CC----CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1110 00 111223468899999999999999999999999997544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=340.66 Aligned_cols=275 Identities=17% Similarity=0.188 Sum_probs=216.1
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEEEe
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.++|...+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+.++.++ +|+|++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35788899999999999999964 6799999999865432 24578899999999 89999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC-----eEEEecCCccc
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN-----PKISDFGMAKL 586 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~-----~kl~Dfgla~~ 586 (755)
|+ +++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999998542 235899999999999999999999986 999999999999987776 99999999987
Q ss_pred cccCCcc-----cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccC
Q 004402 587 FRKDVDE-----ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDS 661 (755)
Q Consensus 587 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 661 (755)
....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.|+......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 6543221 12344678999999999999999999999999999999999999997654433332222222111111
Q ss_pred CCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccccCCCCCCcccc
Q 004402 662 KGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAPKRPAFSA 725 (755)
Q Consensus 662 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~~~ 725 (755)
..... ... .+..+.+++.+||+.||++|||+.+|++.|++....+.......++|
T Consensus 241 ~~~~~-----~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 295 (298)
T 1csn_A 241 PLREL-----CAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 295 (298)
T ss_dssp CHHHH-----TTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred cHHHH-----Hhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence 11111 111 12468899999999999999999999999998766555444444444
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=347.52 Aligned_cols=262 Identities=24% Similarity=0.391 Sum_probs=211.1
Q ss_pred hcCCCccCcccccCCeeEEEEEc------CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDE 505 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 505 (755)
.++|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++.++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 45788899999999999999963 357899999997653 34457899999999999 99999999999999999
Q ss_pred cEEEEeecCCCChhhhhcCCCc---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIR---------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL 570 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll 570 (755)
.++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999864322 124899999999999999999999986 9999999999999
Q ss_pred cCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccc
Q 004402 571 DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLN 649 (755)
Q Consensus 571 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~ 649 (755)
+.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+| |+.|+....... .
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~ 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--K 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--H
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--H
Confidence 9999999999999987655433333344567889999999999999999999999999999999 888875433221 1
Q ss_pred hHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 650 FLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
....... . ..... .......+.+++.+||+.||++|||+.|+++.|++...
T Consensus 257 ~~~~~~~----~-----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 257 FYKMIKE----G-----FRMLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHHHHHH----T-----CCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcc----C-----CCCCC----cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 1111111 1 00111 11223468899999999999999999999999987543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=337.66 Aligned_cols=252 Identities=27% Similarity=0.435 Sum_probs=194.5
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCCh----hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST----QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||+|+||.||+|.. .++.||||++..... ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 5778889999999999999987 589999999865432 33567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC--------CCCeEEEecC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN--------ELNPKISDFG 582 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~--------~~~~kl~Dfg 582 (755)
||+++++|.+++. ...+++..+..++.|++.||.|||+.+..+++||||||+|||++. ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999884 345899999999999999999999987556999999999999986 7789999999
Q ss_pred CccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC
Q 004402 583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
+++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.|+...... .. .... ....
T Consensus 162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~---~~~~-~~~~ 230 (271)
T 3dtc_A 162 LAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL---AV---AYGV-AMNK 230 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH---HH---HHHH-HTSC
T ss_pred ccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH---HHhh-hcCC
Confidence 998654322 22346899999999999999999999999999999999999998532211 11 1111 1111
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 663 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
....... .....+.+++.+||+.||++|||+.|+++.|++
T Consensus 231 ----~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 231 ----LALPIPS----TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ----CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ----CCCCCCc----ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 0111111 223468899999999999999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=342.08 Aligned_cols=261 Identities=23% Similarity=0.365 Sum_probs=204.7
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
.++|+..+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 35788899999999999999964 56899999998543 334457899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999853 345899999999999999999999987 99999999999999999999999999986543
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
.. ........||+.|+|||.+.+..++.++|||||||++|||+||+.|+..... ........... .... ..
T Consensus 164 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~-~~~~-~~ 234 (294)
T 4eqm_A 164 TS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDS-VPNV-TT 234 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSC-CCCH-HH
T ss_pred cc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhcc-CCCc-ch
Confidence 22 1223345789999999999999999999999999999999999999853221 11111111111 1000 00
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhcCcc
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRP-SMLEVSSMLKDDSM 713 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~~~ 713 (755)
.... ..+..+.+++.+||+.||++|| +++++.+.|+....
T Consensus 235 ~~~~----~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 235 DVRK----DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HSCT----TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred hccc----CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 1111 2234688999999999999998 99999999987654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=343.95 Aligned_cols=262 Identities=21% Similarity=0.324 Sum_probs=200.4
Q ss_pred hcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.++|+..+.||+|+||+||++...+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 35788899999999999999988889999999986543 2234678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++ +|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9985 777776542 335899999999999999999999986 9999999999999999999999999998764322
Q ss_pred cccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccc----
Q 004402 592 DEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEF---- 666 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 666 (755)
. ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......... ...............
T Consensus 174 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 174 R--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL---PKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH---HHHHHHHCCCCTTTSGGGT
T ss_pred c--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHHCCCChHHhhhhh
Confidence 1 2233468999999999876 56899999999999999999999998654443322 222221111110000
Q ss_pred -----cCCCCC--CCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 667 -----IDPSLD--DSS-----SPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 667 -----~d~~l~--~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+.... ... .+....++.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000 000 0112236789999999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=344.82 Aligned_cols=247 Identities=21% Similarity=0.275 Sum_probs=201.9
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||+|+||.||++.. .+|+.||||+++.. .....+.+.+|+.++..++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 5788899999999999999965 46999999999754 2234567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999988853 345899999999999999999999987 999999999999999999999999999854322
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.|+.... ........ .... ..
T Consensus 159 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i----~~~~------~~ 223 (337)
T 1o6l_A 159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELI----LMEE------IR 223 (337)
T ss_dssp T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH----HHCC------CC
T ss_pred C--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC---HHHHHHHH----HcCC------CC
Confidence 1 22334689999999999999999999999999999999999999985322 11111111 1111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRP-----SMLEVSS 706 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 706 (755)
+... ....+.+++.+||+.||++|| ++.|+++
T Consensus 224 ~p~~----~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 224 FPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCC----CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 1111 224678999999999999999 8999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=361.73 Aligned_cols=251 Identities=26% Similarity=0.385 Sum_probs=203.8
Q ss_pred hcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC-ccEEEEee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD-ENMLIYEY 512 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e~ 512 (755)
.++|...+.||+|+||.||+|.. .|+.||||+++... ..+.|.+|+.+|++++||||+++++++.+.. ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 45778889999999999999987 47899999997654 3478999999999999999999999987765 68999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
|++|+|.+++... ....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 9999999999643 2334789999999999999999999987 999999999999999999999999999854321
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
.....++..|+|||.+.+..++.++|||||||++|||+| |+.|+......+ ..... ..+. ...
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i----~~~~-----~~~- 406 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV----EKGY-----KMD- 406 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHHH----HTTC-----CCC-
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcCC-----CCC-
Confidence 112356889999999999999999999999999999999 998886443322 22111 1111 011
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
.+...+..+.+++.+||+.||++|||+.++++.|++..
T Consensus 407 ---~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 407 ---APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11223347889999999999999999999999998643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=368.47 Aligned_cols=257 Identities=26% Similarity=0.396 Sum_probs=209.1
Q ss_pred hcCCCccCcccccCCeeEEEEEcCC-CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
.++|...+.||+|+||.||+|.... ++.||||++..... ..+.|.+|+.+|++++||||++++++|......++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4567888999999999999997654 88999999976543 457899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
|++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 9999999998643 2345899999999999999999999987 99999999999999999999999999987643321
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
.......++..|+|||.+....++.++|||||||+||||+| |+.|+...... ...... ....
T Consensus 374 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~~----~~~~--------- 436 (495)
T 1opk_A 374 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELL----EKDY--------- 436 (495)
T ss_dssp -ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHH----HTTC---------
T ss_pred -eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCC---------
Confidence 12223456788999999999999999999999999999999 88887543221 112111 1110
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
....+......+.+++.+||+.||++|||+.+|++.|+...
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 01111223347889999999999999999999999998754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=340.60 Aligned_cols=264 Identities=23% Similarity=0.320 Sum_probs=198.5
Q ss_pred hcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhc--CCCCceeeeeeeeecC----CccE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTAR--LQHVNLLRVLGYCTER----DENM 507 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~----~~~~ 507 (755)
.++|+..+.||+|+||.||+|.. +++.||||++.... ...+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 45788999999999999999987 79999999986543 3455666666665 7999999999987543 4578
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCceecccCCCCEEEcCCCCeEEEecC
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY-----SNFRVIHRDLKASNILLDNELNPKISDFG 582 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~-----~~~~iiHrDlk~~NIll~~~~~~kl~Dfg 582 (755)
+||||+++|+|.+++. ...+++..++.++.|++.||.|||.. ++.+|+||||||+|||++.++.+||+|||
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence 9999999999999984 33589999999999999999999921 12349999999999999999999999999
Q ss_pred CccccccCCccc--ccccccccCCccccccccCC------CCCchhhHHHHHHHHHHHHcC----------CCCCCCCCC
Q 004402 583 MAKLFRKDVDEA--NTGRIVGTYGYVPPEYVKKG------IYSMKYDVYSFGVLLLQIISS----------KRNARYYGT 644 (755)
Q Consensus 583 la~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~sDVwS~Gvil~elltg----------~~p~~~~~~ 644 (755)
+++......... ......||+.|+|||.+.+. .++.++|||||||++|||+|| +.|+.....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 998654432221 12334789999999999876 556899999999999999999 666643222
Q ss_pred CcccchHHHHHHHhccCCCccccCCCCCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 645 SENLNFLEYAFEQWKDSKGKEFIDPSLDD-SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
.... ............ ..+.+.. .........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 239 ~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 239 NDPS--FEDMRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SSCC--HHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcc--hhhhhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2111 111111111111 1111111 11223566789999999999999999999999999863
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=339.57 Aligned_cols=256 Identities=25% Similarity=0.381 Sum_probs=205.1
Q ss_pred hcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
.++|+..+.||+|+||.||++...++..||||++..... ..+.+.+|++++.+++||||+++++++.+....++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 457888899999999999999988888999999976543 2467899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 175 (283)
T 3gen_A 102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY- 175 (283)
T ss_dssp TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence 999999998653 335899999999999999999999987 99999999999999999999999999986543221
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
.......+|+.|+|||.+.+..++.++||||||+++|||+| |+.|+...... .... ...... .....
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~~----~~~~~~-----~~~~~ 243 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAE----HIAQGL-----RLYRP 243 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHH----HHHTTC-----CCCCC
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHHH----HHhccc-----CCCCC
Confidence 12223456788999999998899999999999999999998 88887543221 1111 111110 01111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
.. ....+.+++.+||+.||++|||+.|+++.|++..
T Consensus 244 ~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 244 HL----ASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp TT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Cc----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 11 1246889999999999999999999999998653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=350.77 Aligned_cols=258 Identities=25% Similarity=0.398 Sum_probs=197.7
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCE----EEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQE----FAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM 507 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 507 (755)
.++|+..+.||+|+||.||+|.. .+++. ||+|.+... .....+.+.+|+.++.+++||||+++++++... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-Cce
Confidence 35788899999999999999964 34553 577877543 344567899999999999999999999999875 478
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
+|+||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999998643 345899999999999999999999987 999999999999999999999999999876
Q ss_pred ccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccc
Q 004402 588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666 (755)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (755)
.............+|+.|+|||.+.+..++.++|||||||++|||++ |+.|+....... ...... ...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~~----~~~---- 236 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILE----KGE---- 236 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHH----TTC----
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH----cCC----
Confidence 54433333334456789999999999999999999999999999999 998885433222 111111 110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 667 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
....+......+.+++.+||+.||++|||+.|+++.|++...
T Consensus 237 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 -----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred -----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 001111233468899999999999999999999999987654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=348.89 Aligned_cols=251 Identities=23% Similarity=0.301 Sum_probs=202.2
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChh------hHHHHHHHHHHHhcCCCCceeeeeeeeecCCcc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQ------GLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN 506 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 506 (755)
.++|+..+.||+|+||.||++.. .+|+.||+|++...... ..+.+.+|+.+|.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 45788899999999999999965 46999999999765321 357899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC----CeEEEecC
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL----NPKISDFG 582 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~----~~kl~Dfg 582 (755)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999999853 346899999999999999999999987 99999999999998877 79999999
Q ss_pred CccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC
Q 004402 583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||..... .... ..+....
T Consensus 165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~---~~~~----~~i~~~~ 234 (361)
T 2yab_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETL----ANITAVS 234 (361)
T ss_dssp SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHH----HHHHTTC
T ss_pred CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHH----HHHHhcC
Confidence 998765422 22345799999999999999999999999999999999999999853221 1111 1111111
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 663 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. . +++.... .....+.+++.+||+.||++|||+.|+++
T Consensus 235 ~-~-~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 Y-D-FDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp C-C-CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C-C-CCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0 0000001 11236789999999999999999999884
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=352.05 Aligned_cols=284 Identities=14% Similarity=0.154 Sum_probs=212.6
Q ss_pred hcCCCccCcccccCCeeEEEEEcCC------CCEEEEEEeccCChhhH-----------HHHHHHHHHHhcCCCCceeee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPR------GQEFAVKRLSATSTQGL-----------EEFKNEVSLTARLQHVNLLRV 496 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l 496 (755)
.++|...+.||+|+||.||+|.... ++.||||++........ ..+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578899999999999999997644 47899999876543211 124556677888899999999
Q ss_pred eeeeecC----CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc-
Q 004402 497 LGYCTER----DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD- 571 (755)
Q Consensus 497 ~g~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~- 571 (755)
++++... ...++||||+ +++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 9998765 3479999999 99999998542 346899999999999999999999986 99999999999999
Q ss_pred -CCCCeEEEecCCccccccCCcc-----cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 004402 572 -NELNPKISDFGMAKLFRKDVDE-----ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS 645 (755)
Q Consensus 572 -~~~~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~ 645 (755)
.++.+||+|||+++.+...... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8899999999999876433211 1113346999999999999999999999999999999999999999643222
Q ss_pred cccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccccCCCCCCcccc
Q 004402 646 ENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAPKRPAFSA 725 (755)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~~~ 725 (755)
. ........... ....+++++.+... ..+..+.+++..||+.||++||++.+|++.|++.......+....++|
T Consensus 268 ~--~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 341 (364)
T 3op5_A 268 P--KYVRDSKIRYR-ENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDL 341 (364)
T ss_dssp H--HHHHHHHHHHH-HCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC
T ss_pred H--HHHHHHHHHhh-hhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccce
Confidence 1 11111111111 11223333322211 112467899999999999999999999999998776666666566666
Q ss_pred CCCC
Q 004402 726 KGDE 729 (755)
Q Consensus 726 ~~~~ 729 (755)
....
T Consensus 342 ~~~~ 345 (364)
T 3op5_A 342 SVVE 345 (364)
T ss_dssp ----
T ss_pred Eecc
Confidence 5443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=347.63 Aligned_cols=267 Identities=26% Similarity=0.377 Sum_probs=209.4
Q ss_pred cCCCccCcccccCCeeEEEEE-----cCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeec--CCccE
Q 004402 435 NNFSSANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE--RDENM 507 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 507 (755)
++|+..+.||+|+||.||++. ..+++.||||++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 577888999999999999997 34688999999988777777889999999999999999999998864 45688
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 999999999999998542 235899999999999999999999986 999999999999999999999999999876
Q ss_pred ccCCcc-cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC--------cccchHHHHHHHh
Q 004402 588 RKDVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS--------ENLNFLEYAFEQW 658 (755)
Q Consensus 588 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~--------~~~~~~~~~~~~~ 658 (755)
...... .......+|..|+|||.+.+..++.++|||||||++|||++|+.|+...... .............
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 543222 1223346788899999999999999999999999999999999887432110 0001111111111
Q ss_pred ccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccc
Q 004402 659 KDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAI 715 (755)
Q Consensus 659 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 715 (755)
... .....+......+.+++.+||+.||++|||+.|+++.|+......
T Consensus 258 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 258 EEG---------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hcc---------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 111 111112223347889999999999999999999999999875543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=344.70 Aligned_cols=251 Identities=23% Similarity=0.314 Sum_probs=201.8
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCCh------hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST------QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN 506 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 506 (755)
.++|...+.||+|+||.||++.. .+|+.||+|++..... ...+.+.+|+.++.+++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34688899999999999999965 4689999999865432 1357899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC----CeEEEecC
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL----NPKISDFG 582 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~----~~kl~Dfg 582 (755)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999853 345899999999999999999999987 99999999999999887 79999999
Q ss_pred CccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC
Q 004402 583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ........ ...
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~----~~~ 233 (326)
T 2y0a_A 164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANVS----AVN 233 (326)
T ss_dssp TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHH----HTC
T ss_pred CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH---HHHHHHHH----hcC
Confidence 998764322 22345789999999999999999999999999999999999999853221 11111111 000
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 663 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. .+.+ .... .....+.+++.+||+.||++|||+.|+++
T Consensus 234 ~-~~~~-~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 Y-EFED-EYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp C-CCCH-HHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C-CcCc-cccc----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 0000 0000 11236789999999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=346.86 Aligned_cols=252 Identities=22% Similarity=0.336 Sum_probs=197.8
Q ss_pred hcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc------
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE------ 505 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------ 505 (755)
.++|+..+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356888999999999999999764 79999999997543 3456789999999999999999999999865432
Q ss_pred ---------------------------------------------------cEEEEeecCCCChhhhhcCCCccCCCCHH
Q 004402 506 ---------------------------------------------------NMLIYEYLPNKSLDLYLFDPIRRYVLDWQ 534 (755)
Q Consensus 506 ---------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~l~~~ 534 (755)
.++|||||++|+|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 78999999999999999765555567788
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc----------cccccccccCC
Q 004402 535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE----------ANTGRIVGTYG 604 (755)
Q Consensus 535 ~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~~gt~~ 604 (755)
.++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999987 999999999999999999999999999876543211 12233578999
Q ss_pred ccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHH
Q 004402 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCM 684 (755)
Q Consensus 605 y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 684 (755)
|+|||.+.+..++.++|||||||++|||++|..|.. ... ............ .........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~-~~~~~~~~~~~~---------~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERV-RIITDVRNLKFP---------LLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHH-HHHHHHHTTCCC---------HHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHH-HHHHHhhccCCC---------cccccCChhHH
Confidence 999999999999999999999999999999865431 000 011111111100 00112234568
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 004402 685 QVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 685 ~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+++.+||+.||++|||+.|+++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCCCcCCCHHHHhh
Confidence 8999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=335.25 Aligned_cols=260 Identities=25% Similarity=0.461 Sum_probs=194.3
Q ss_pred hcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.++|...+.||+|+||.||+|... ..||||++... .....+.|.+|+.++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 457888999999999999999863 36999998654 344567899999999999999999999976 4556899999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 99999999998543 345899999999999999999999987 9999999999999999999999999998654433
Q ss_pred cccccccccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 592 DEANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
.........||+.|+|||.+. ...++.++|||||||++|||++|+.|+....... ...... ..........
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~----~~~~~~~~~~ 248 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMV----GRGSLSPDLS 248 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHH----HHTSCCCCTT
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHh----cccccCcchh
Confidence 333334467899999999986 6678999999999999999999999985433221 111111 1111111000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
.+.. ..+..+.+++.+||+.||++|||+.|+++.|++..
T Consensus 249 -~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 249 -KVRS----NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp -SSCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -hccc----cCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1111 22347889999999999999999999999998764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=349.15 Aligned_cols=252 Identities=22% Similarity=0.282 Sum_probs=204.7
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
.++|+..+.||+|+||.||+|.. .+|+.||+|++..........+.+|+.+|..++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 45789999999999999999965 46899999999877666667899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC--CCCeEEEecCCccccccC
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN--ELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~--~~~~kl~Dfgla~~~~~~ 590 (755)
+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999988542 335899999999999999999999987 999999999999974 577999999999876433
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ........ .... ..++.
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~i~----~~~~--~~~~~ 272 (387)
T 1kob_A 205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVK----RCDW--EFDED 272 (387)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHH----HCCC--CCCSS
T ss_pred c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHHHHHH----hCCC--CCCcc
Confidence 2 12234789999999999999999999999999999999999999853221 11111111 1110 01111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
... .....+.+++.+||+.||++|||+.|+++
T Consensus 273 ~~~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 273 AFS----SVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp TTT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 111 22346889999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=348.52 Aligned_cols=270 Identities=24% Similarity=0.387 Sum_probs=213.7
Q ss_pred cCHHHHHHHhcCCCccCcccccCCeeEEEEEcC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeee
Q 004402 425 FSFSDIKAATNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVL 497 (755)
Q Consensus 425 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~ 497 (755)
+..+++....++|...+.||+|+||.||+|... .++.||||++.... ......+.+|+.++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 334455556778999999999999999999643 36789999997553 34456799999999999999999999
Q ss_pred eeeecCCccEEEEeecCCCChhhhhcCCCc-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE
Q 004402 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIR-------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL 570 (755)
Q Consensus 498 g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll 570 (755)
+++.+.+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence 999999999999999999999999854221 135689999999999999999999987 9999999999999
Q ss_pred cCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccc
Q 004402 571 DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLN 649 (755)
Q Consensus 571 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~ 649 (755)
+.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.|+..... ..
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~ 248 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQ 248 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HH
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HH
Confidence 9999999999999986544332223334467889999999999999999999999999999999 7777743221 11
Q ss_pred hHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 650 FLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
.. .......... . .......+.+++.+||+.||++|||+.|+++.|++...
T Consensus 249 ~~----~~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 249 VL----RFVMEGGLLD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HH----HHHHTTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HH----HHHHcCCcCC-----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11 1111111110 1 11223468899999999999999999999999987644
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.15 Aligned_cols=262 Identities=22% Similarity=0.285 Sum_probs=199.0
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
++|+..+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 4688899999999999999965 468999999987543 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|++++ |..++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~-l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQD-LKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEE-HHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCC-HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99864 4444432 2345899999999999999999999987 9999999999999999999999999998764322
Q ss_pred cccccccccccCCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCc------
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK------ 664 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 664 (755)
.......||+.|+|||.+.+.. ++.++|||||||++|||++|+.|+-.. ....................
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~--~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG--NDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC--SSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC--CCHHHHHHHHHHHhCCCChhhhhhhc
Confidence 2223457899999999997765 899999999999999999998886322 22222222222221111100
Q ss_pred cccCC---------CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 665 EFIDP---------SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 665 ~~~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
...+. .......+.....+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000 0000111123346789999999999999999999985
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=344.19 Aligned_cols=261 Identities=23% Similarity=0.339 Sum_probs=208.3
Q ss_pred hcCCCccCcccccCCeeEEEEEc--------CCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecC
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL--------PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER 503 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 503 (755)
.++|...+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++.++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 46788899999999999999965 34678999999765 344567899999999999 899999999999999
Q ss_pred CccEEEEeecCCCChhhhhcCCCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE
Q 004402 504 DENMLIYEYLPNKSLDLYLFDPIR-------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL 570 (755)
Q Consensus 504 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll 570 (755)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ ++||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999865332 234889999999999999999999987 9999999999999
Q ss_pred cCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccc
Q 004402 571 DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLN 649 (755)
Q Consensus 571 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~ 649 (755)
+.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.|+..... ..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~ 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EE 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---HH
Confidence 9999999999999987654333223334456789999999998899999999999999999999 8888753221 11
Q ss_pred hHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 650 FLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
..... ..... ..... .....+.+++.+||+.||++|||+.|+++.|++...
T Consensus 268 ~~~~~----~~~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 268 LFKLL----KEGHR-----MDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHHH----HHTCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHH----hcCCC-----CCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11111 11110 11111 223468899999999999999999999999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=343.73 Aligned_cols=251 Identities=18% Similarity=0.257 Sum_probs=202.5
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
.++|...+.||+|+||.||++.. .+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 35788899999999999999965 458899999987553 3346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC--CCCeEEEecCCccccccC
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN--ELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~--~~~~kl~Dfgla~~~~~~ 590 (755)
+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999998542 335899999999999999999999987 999999999999987 789999999999876433
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.|+..... ........ ..... .+..
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~----~~~~~--~~~~ 225 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENIM----NAEYT--FDEE 225 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHH----HTCCC--CCHH
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHHH----cCCCC--CChh
Confidence 2 22345789999999999998899999999999999999999999853221 11111111 11100 0000
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. .......+.+++.+||+.||++|||+.|+++
T Consensus 226 ~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 226 A----FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp H----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred h----hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0012346789999999999999999999996
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=335.01 Aligned_cols=248 Identities=22% Similarity=0.330 Sum_probs=192.9
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCCh--------------------------hhHHHHHHHHHHHhc
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST--------------------------QGLEEFKNEVSLTAR 487 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~ 487 (755)
++|...+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 5788899999999999999964 5689999999865421 123568999999999
Q ss_pred CCCCceeeeeeeeec--CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCC
Q 004402 488 LQHVNLLRVLGYCTE--RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKA 565 (755)
Q Consensus 488 l~H~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~ 565 (755)
++||||+++++++.+ ....++||||+++++|.+++ ....+++..+..++.||+.||.|||+.+ |+||||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 165 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP 165 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 999999999999986 45789999999999998765 2346899999999999999999999987 99999999
Q ss_pred CCEEEcCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004402 566 SNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI---YSMKYDVYSFGVLLLQIISSKRNARYY 642 (755)
Q Consensus 566 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDVwS~Gvil~elltg~~p~~~~ 642 (755)
+|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.|+...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999987643321 223457899999999997665 478999999999999999999998532
Q ss_pred CCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 643 GTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. .... ......... .... .......+.+++.+||+.||++|||+.|+++
T Consensus 244 ~---~~~~----~~~~~~~~~-~~~~-------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 R---IMCL----HSKIKSQAL-EFPD-------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp S---HHHH----HHHHHHCCC-CCCS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred c---HHHH----HHHHhcccC-CCCC-------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1 1111 111111110 0000 1112246889999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=354.51 Aligned_cols=252 Identities=21% Similarity=0.327 Sum_probs=201.6
Q ss_pred hcCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
.++|+..+.||+|+||.||++. ..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 5678899999999999999995 4579999999987653 334567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc---CCCCeEEEecCCcccc
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD---NELNPKISDFGMAKLF 587 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~---~~~~~kl~Dfgla~~~ 587 (755)
|||++|+|.+.+.. +..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 90 E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 90 DLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999888853 345899999999999999999999987 99999999999998 5678999999999866
Q ss_pred ccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....... +..+.. .+.
T Consensus 164 ~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~~~~~~----i~~~~~-~~~ 233 (444)
T 3soa_A 164 EGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQQ----IKAGAY-DFP 233 (444)
T ss_dssp CTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHH----HHHTCC-CCC
T ss_pred cCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---HHHHHHH----HHhCCC-CCC
Confidence 44322 2234579999999999999999999999999999999999999984322 1111111 111111 111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+.. ......+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~-----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 234 SPEW-----DTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TTTT-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccc-----ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1111 112346789999999999999999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=356.40 Aligned_cols=263 Identities=17% Similarity=0.229 Sum_probs=206.2
Q ss_pred CHHHHHHHhcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCceeeeeeeee
Q 004402 426 SFSDIKAATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST---QGLEEFKNEVSLTARLQHVNLLRVLGYCT 501 (755)
Q Consensus 426 ~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 501 (755)
.+.++....++|+..++||+|+||+||+++.. +++.||||++..... ...+.+.+|..++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34555566789999999999999999999764 478999999965321 12234889999999999999999999999
Q ss_pred cCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEec
Q 004402 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDF 581 (755)
Q Consensus 502 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Df 581 (755)
+.+..++|||||++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999999642 345899999999999999999999987 999999999999999999999999
Q ss_pred CCccccccCCcccccccccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHH
Q 004402 582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFE 656 (755)
Q Consensus 582 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 656 (755)
|+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||..... .........
T Consensus 220 Gla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~ 295 (437)
T 4aw2_A 220 GSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIMN 295 (437)
T ss_dssp TTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHT
T ss_pred hhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh---hHHHHhhhh
Confidence 99986543322 2233467999999999987 56789999999999999999999999853221 111111111
Q ss_pred HhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 004402 657 QWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPED--RPSMLEVSS 706 (755)
Q Consensus 657 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~ 706 (755)
... .+.-+...... ...+.+++.+||+.+|++ ||+++|+++
T Consensus 296 ~~~-----~~~~p~~~~~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 296 HKE-----RFQFPTQVTDV----SENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHH-----HCCCCSSCCCS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ccc-----cccCCcccccC----CHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 000 00011111112 236788999999888888 999999985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=333.73 Aligned_cols=261 Identities=22% Similarity=0.321 Sum_probs=198.1
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
++|+..+.||+|+||.||++...+|+.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888999999999999999887899999999865532 2346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++ +|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 985 888887542 245889999999999999999999986 99999999999999999999999999986543211
Q ss_pred ccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCc-------
Q 004402 593 EANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK------- 664 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 664 (755)
......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.|+..... .................
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHHCCCChhhchhhhc
Confidence 2223468999999999876 4589999999999999999999999854321 11122222211111000
Q ss_pred -cccCCCCCC-------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 665 -EFIDPSLDD-------SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 665 -~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
...++.... .........+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 001111100 001112346789999999999999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=348.15 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=195.1
Q ss_pred hcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCC--CceeeeeeeeecCCccEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQH--VNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv 509 (755)
.++|+..+.||+|+||.||++...+++.||||++... ..+..+.+.+|+.++.+++| |||+++++++......++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4568889999999999999998888999999998654 34456789999999999976 9999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|| +.+++|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++....
T Consensus 88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 568899999853 345899999999999999999999987 99999999999997 57899999999987654
Q ss_pred CCcccccccccccCCccccccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHh
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKK-----------GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQW 658 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 658 (755)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+..... ........
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~- 233 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAI- 233 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHH-
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHH-
Confidence 433333345679999999999864 6789999999999999999999999853211 11111111
Q ss_pred ccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 659 KDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 659 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
+++......+......+.+++..||+.||++|||+.|+++.
T Consensus 234 --------~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 234 --------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp --------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11111111111122367899999999999999999999853
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=335.13 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=201.6
Q ss_pred cCCCccCcccccCCeeEEEEEcCC-C-------CEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcc
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPR-G-------QEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN 506 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 506 (755)
++|...+.||+|+||.||+|.... + ..||+|++........+.+.+|+.++++++||||+++++++...+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 567888999999999999996432 3 57999999877667778899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC--------eEE
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN--------PKI 578 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~--------~kl 578 (755)
++||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++. +||
T Consensus 88 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp EEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred EEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence 9999999999999998642 234899999999999999999999987 999999999999998887 999
Q ss_pred EecCCccccccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHH
Q 004402 579 SDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQ 657 (755)
Q Consensus 579 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 657 (755)
+|||++..... .....+|+.|+|||.+.+ ..++.++|||||||++|||++|..|+.... ....... .
T Consensus 163 ~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~--~~~~~~~----~ 230 (289)
T 4fvq_A 163 SDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL--DSQRKLQ----F 230 (289)
T ss_dssp CCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHHH----H
T ss_pred ccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc--chHHHHH----H
Confidence 99999975422 123467899999999987 779999999999999999999765542211 1111111 1
Q ss_pred hccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 658 WKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 658 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
.... ..+.... ...+.+++.+||+.||++|||+.|+++.|++...
T Consensus 231 ~~~~-------~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 231 YEDR-------HQLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHTT-------CCCCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hhcc-------CCCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1110 0011111 1247789999999999999999999999997643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=342.16 Aligned_cols=245 Identities=21% Similarity=0.322 Sum_probs=198.9
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|...+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788899999999999999964 679999999986532 222357899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+ +|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 6888888743 345899999999999999999999987 999999999999999999999999999865432
Q ss_pred CcccccccccccCCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
. .....+||+.|+|||.+.+..+ +.++|||||||++|||++|+.||........... ... ...
T Consensus 162 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~------------i~~-~~~ 225 (336)
T 3h4j_B 162 N---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK------------VNS-CVY 225 (336)
T ss_dssp B---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC------------CCS-SCC
T ss_pred c---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH------------HHc-CCC
Confidence 2 2234578999999999988776 7899999999999999999999864332221100 000 000
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+.. .....+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~p~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 226 VMPD----FLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCCT----TSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCcc----cCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1111 12346789999999999999999999985
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.55 Aligned_cols=251 Identities=22% Similarity=0.347 Sum_probs=202.1
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
.++|+..+.||+|+||.||++.. .+|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56799999999999999999965 46899999999654 3344567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC---CeEEEecCCcccc
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL---NPKISDFGMAKLF 587 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~---~~kl~Dfgla~~~ 587 (755)
||+++|+|.+++.. +..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 108 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999988853 345899999999999999999999987 99999999999998654 5999999999876
Q ss_pred ccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....... +..... .+.
T Consensus 182 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~---~~~~~~~----i~~~~~-~~~ 250 (362)
T 2bdw_A 182 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQ----IKAGAY-DYP 250 (362)
T ss_dssp TTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH----HHHTCC-CCC
T ss_pred cCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHH----HHhCCC-CCC
Confidence 4322 2234578999999999999999999999999999999999999985322 1111111 111110 000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+ ........+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 251 SP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp TT-----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cc-----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 01122346789999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=343.83 Aligned_cols=249 Identities=20% Similarity=0.328 Sum_probs=202.0
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|...+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.+|..++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 5688899999999999999965 458999999986542 234567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999854 345899999999999999999999987 999999999999999999999999999876432
Q ss_pred CcccccccccccCCccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKK---GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
......+||+.|+|||++.. ..++.++|||||||++|||++|+.||................ ...
T Consensus 169 ---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~----~~~----- 236 (384)
T 4fr4_A 169 ---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE----TTV----- 236 (384)
T ss_dssp ---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH----HCC-----
T ss_pred ---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----hcc-----
Confidence 22334679999999999864 458999999999999999999999986544333222221111 100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPS-MLEVSS 706 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~evl~ 706 (755)
.... ......+.+++.+||+.||++||+ ++++.+
T Consensus 237 -~~~p----~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 -VTYP----SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -CCCC----TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -cCCC----CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0111 122346889999999999999998 777764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=347.05 Aligned_cols=264 Identities=27% Similarity=0.404 Sum_probs=209.7
Q ss_pred HHHhcCCCccCcccccCCeeEEEEEcCC-C-----CEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCceeeeeeeeec
Q 004402 431 KAATNNFSSANKLGEGGFGPVYKGNLPR-G-----QEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTE 502 (755)
Q Consensus 431 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 502 (755)
+...++|...+.||+|+||.||+|.... + ..||+|.+.... ....+.+.+|+.++.++ +||||+++++++..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3345788899999999999999996532 2 489999997653 34567799999999999 89999999999999
Q ss_pred CCccEEEEeecCCCChhhhhcCCCc-----------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc
Q 004402 503 RDENMLIYEYLPNKSLDLYLFDPIR-----------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD 571 (755)
Q Consensus 503 ~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~ 571 (755)
.+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEEC
Confidence 9999999999999999999854211 235789999999999999999999986 99999999999999
Q ss_pred CCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccch
Q 004402 572 NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNF 650 (755)
Q Consensus 572 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~ 650 (755)
.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+| |..|+....... ..
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~ 276 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KF 276 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HH
Confidence 999999999999987654433333344567889999999998999999999999999999999 888875432221 11
Q ss_pred HHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 651 LEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 651 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
...... .. ...... .....+.+++.+||+.||++|||+.|+++.|++..
T Consensus 277 ~~~~~~----~~-----~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 277 YKLVKD----GY-----QMAQPA----FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHHHHH----TC-----CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhc----CC-----CCCCCC----CCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 111111 10 011111 12346889999999999999999999999998653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=347.52 Aligned_cols=264 Identities=25% Similarity=0.330 Sum_probs=205.4
Q ss_pred CCccCcccccCCeeEEEEEc-----CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--CccEE
Q 004402 437 FSSANKLGEGGFGPVYKGNL-----PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DENML 508 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 508 (755)
|...+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 47889999999999998853 368899999997653 34567799999999999999999999999874 56789
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999843 34899999999999999999999987 9999999999999999999999999998765
Q ss_pred cCCcc-cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC--------cccchHHHHHHHhc
Q 004402 589 KDVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTS--------ENLNFLEYAFEQWK 659 (755)
Q Consensus 589 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~--------~~~~~~~~~~~~~~ 659 (755)
..... .......+|..|+|||.+.+..++.++|||||||++|||+||+.|+...... ............
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 263 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL-- 263 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH--
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH--
Confidence 43221 1223345788899999999999999999999999999999999887532110 000000001111
Q ss_pred cCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccccC
Q 004402 660 DSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIA 716 (755)
Q Consensus 660 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 716 (755)
+........+......+.+++.+||+.||++|||+.|+++.|++....+.
T Consensus 264 -------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 264 -------LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp -------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -------HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 11111111122233478899999999999999999999999998765544
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=348.66 Aligned_cols=250 Identities=21% Similarity=0.344 Sum_probs=197.4
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 508 (755)
.++|+..++||+|+||.||+++. .+++.||||+++... ....+.+..|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 35788899999999999999965 458899999997642 22334678899999887 89999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999988853 345899999999999999999999987 9999999999999999999999999998532
Q ss_pred cCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcc--cchHHHHHHHhccCCCccc
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN--LNFLEYAFEQWKDSKGKEF 666 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 666 (755)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ...............
T Consensus 205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---- 278 (396)
T 4dc2_A 205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---- 278 (396)
T ss_dssp CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC----
T ss_pred cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc----
Confidence 22 1223456899999999999999999999999999999999999999965432221 111111111111111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 004402 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSM 701 (755)
Q Consensus 667 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 701 (755)
..+... ....+.+++.+||+.||++||++
T Consensus 279 --~~~p~~----~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 --IRIPRS----LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --CCCCTT----SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred --cCCCCc----CCHHHHHHHHHHhcCCHhHcCCC
Confidence 111111 23467899999999999999995
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=343.28 Aligned_cols=269 Identities=27% Similarity=0.393 Sum_probs=213.1
Q ss_pred CHHHHHHHhcCCCccCcccccCCeeEEEEEc------CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCceeeee
Q 004402 426 SFSDIKAATNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVL 497 (755)
Q Consensus 426 ~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~ 497 (755)
....+....++|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3344455567899999999999999999963 356899999997653 34456799999999999 799999999
Q ss_pred eeeecCC-ccEEEEeecCCCChhhhhcCCCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceeccc
Q 004402 498 GYCTERD-ENMLIYEYLPNKSLDLYLFDPIR-------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDL 563 (755)
Q Consensus 498 g~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDl 563 (755)
+++...+ ..++||||+++|+|.+++..... +..+++..++.++.|++.||.|||+.+ ++||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9987755 48999999999999999865432 123789999999999999999999986 999999
Q ss_pred CCCCEEEcCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004402 564 KASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYY 642 (755)
Q Consensus 564 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~ 642 (755)
||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+| |+.|+...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987654433333445577889999999999999999999999999999998 88887543
Q ss_pred CCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 643 GTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
.... ...... ..... ...... ....+.+++.+||+.||++|||+.|+++.|++..
T Consensus 255 ~~~~--~~~~~~----~~~~~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 255 KIDE--EFCRRL----KEGTR-----MRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CCSH--HHHHHH----HHTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhH--HHHHHh----ccCcc-----CCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 3221 111111 11110 111111 2236889999999999999999999999998754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=331.72 Aligned_cols=253 Identities=21% Similarity=0.362 Sum_probs=202.6
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--CccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~ 510 (755)
++|...+.||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 4678889999999999999987 5899999998765 344556899999999999999999999999877 6789999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|+|.+++... ....+++..++.++.|++.||.|||+.+ .+++||||||+|||++.++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 999999999999653 2335899999999999999999999864 3599999999999999999999999998764221
Q ss_pred CcccccccccccCCccccccccCCCCCc---hhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSM---KYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
....||+.|+|||.+.+..++. ++|||||||++|||++|+.|+...... .... ...... .
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~---~~~~~~-----~ 228 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM---EIGM---KVALEG-----L 228 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH---HHHH---HHHHSC-----C
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH---HHHH---HHHhcC-----C
Confidence 2346789999999998765544 899999999999999999998532211 1111 111111 1
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
.+.+... ....+.+++..||+.||++|||+.|+++.|++..
T Consensus 229 ~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 229 RPTIPPG----ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1112222 2346889999999999999999999999998754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=369.28 Aligned_cols=259 Identities=24% Similarity=0.400 Sum_probs=208.1
Q ss_pred HhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
..++|...+.||+|+||.||+|....+..||||+++.... ..+.|.+|+++|++++||||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 3567788899999999999999988888999999976542 35789999999999999999999999876 678999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
|++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999998532 2235899999999999999999999987 99999999999999999999999999986543211
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
.......++..|+|||.+....++.++|||||||+||||+| |+.|+..... ..... ....+.. .
T Consensus 419 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~~----~i~~~~~-----~-- 483 (535)
T 2h8h_A 419 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLD----QVERGYR-----M-- 483 (535)
T ss_dssp -HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHHH----HHHTTCC-----C--
T ss_pred -ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHHcCCC-----C--
Confidence 11223356788999999999999999999999999999999 8888753221 11111 1111110 0
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMA 714 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 714 (755)
..+......+.+|+.+||+.||++|||+.+|+++|++....
T Consensus 484 --~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 484 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 11112334688999999999999999999999999976543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=331.48 Aligned_cols=253 Identities=25% Similarity=0.504 Sum_probs=200.2
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChh-------hHHHHHHHHHHHhcCCCCceeeeeeeeecCCcc
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQ-------GLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN 506 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 506 (755)
++|+..+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|+.++.+++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 5788889999999999999965 57899999998654321 1267899999999999999999999986544
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC-----eEEEec
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN-----PKISDF 581 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~-----~kl~Df 581 (755)
++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ .+++||||||+|||++.++. +||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 7999999999998888543 346899999999999999999999874 34999999999999988876 999999
Q ss_pred CCccccccCCcccccccccccCCccccccc--cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhc
Q 004402 582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYV--KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWK 659 (755)
Q Consensus 582 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 659 (755)
|+++.... ......||+.|+|||.+ ....++.++|||||||++|||++|+.|+........ ...... .
T Consensus 174 g~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~----~ 243 (287)
T 4f0f_A 174 GLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFINMI----R 243 (287)
T ss_dssp TTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-HHHHHH----H
T ss_pred Cccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-HHHHHH----h
Confidence 99975332 22335789999999998 455678999999999999999999999864433221 111111 1
Q ss_pred cCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 660 DSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 660 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
... ..+.+.. .....+.+++.+||+.||++|||+.|+++.|++
T Consensus 244 ~~~----~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 EEG----LRPTIPE----DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HSC----CCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ccC----CCCCCCc----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 111 1111222 223478899999999999999999999999985
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=347.14 Aligned_cols=251 Identities=24% Similarity=0.316 Sum_probs=197.4
Q ss_pred ccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCCC
Q 004402 439 SANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKS 517 (755)
Q Consensus 439 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 517 (755)
..+.||+|+||.||+|.. .+|+.||+|++........+.+.+|++++.+++||||+++++++...+..++||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 356899999999999964 5699999999988766667889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE--cCCCCeEEEecCCccccccCCcccc
Q 004402 518 LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL--DNELNPKISDFGMAKLFRKDVDEAN 595 (755)
Q Consensus 518 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll--~~~~~~kl~Dfgla~~~~~~~~~~~ 595 (755)
|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.......
T Consensus 173 L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--- 244 (373)
T 2x4f_A 173 LFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--- 244 (373)
T ss_dssp EHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred HHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence 98888532 345899999999999999999999987 9999999999999 6678899999999987643322
Q ss_pred cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCC
Q 004402 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSS 675 (755)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 675 (755)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ......... ... .+..+.
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~----~~~-~~~~~~----- 311 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND---AETLNNILA----CRW-DLEDEE----- 311 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHH----TCC-CSCSGG-----
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh----ccC-CCChhh-----
Confidence 2234689999999999999999999999999999999999999853321 111111111 100 000000
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhhc
Q 004402 676 SPCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKD 710 (755)
Q Consensus 676 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~ 710 (755)
.......+.+++.+||+.||++|||+.|+++ .+++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 0112346889999999999999999999996 5554
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=337.40 Aligned_cols=259 Identities=29% Similarity=0.453 Sum_probs=207.3
Q ss_pred hcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
.++|...+.||+|+||.||+|...+++.||||++..... ..+.+.+|++++++++||||+++++++.. +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 467888999999999999999988888999999976532 35789999999999999999999999864 5689999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.......
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 164 (279)
T 1qpc_A 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY- 164 (279)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc-
Confidence 999999998542 2235899999999999999999999987 99999999999999999999999999987654321
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ..... ...... .....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~----~~~~~~-----~~~~~ 232 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQ----NLERGY-----RMVRP 232 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHH----HHHTTC-----CCCCC
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HHHHH----HHhccc-----CCCCc
Confidence 12223456789999999998899999999999999999999 8888753221 11111 111111 01111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccc
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAI 715 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 715 (755)
. .....+.+++..||+.||++|||+.++++.|++.....
T Consensus 233 ~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 233 D----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred c----cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 1 22346889999999999999999999999998765443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=351.42 Aligned_cols=250 Identities=23% Similarity=0.355 Sum_probs=195.0
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCC--CCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQ--HVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||+|+||.||++...+++.||||++... .....+.+.+|+.+|.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458889999999999999998878999999998654 3455678999999999996 599999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
| +.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+...
T Consensus 136 E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 678899999854 236888999999999999999999986 99999999999996 579999999999876544
Q ss_pred CcccccccccccCCccccccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhc
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKK-----------GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWK 659 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 659 (755)
.........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... . ........
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~---~~~~~~~~- 281 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--Q---ISKLHAII- 281 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--H---HHHHHHHH-
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--H---HHHHHHHh-
Confidence 33333345679999999999865 4689999999999999999999999853221 1 11111111
Q ss_pred cCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 660 DSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 660 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
++......+......+.+++.+||+.||++|||+.|+++
T Consensus 282 --------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 282 --------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp --------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 111111111111246789999999999999999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=347.98 Aligned_cols=270 Identities=17% Similarity=0.216 Sum_probs=202.1
Q ss_pred hcCCCccCccccc--CCeeEEEEEcC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 434 TNNFSSANKLGEG--GFGPVYKGNLP-RGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 434 ~~~f~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
.++|+..+.||+| +||.||++... +|+.||||++... ..+..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3578889999999 99999999654 6999999999754 34455678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
|||||++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999985432 235899999999999999999999987 9999999999999999999999999987543
Q ss_pred cCCc-----ccccccccccCCccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccch-HHHHHHHhcc
Q 004402 589 KDVD-----EANTGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNF-LEYAFEQWKD 660 (755)
Q Consensus 589 ~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~ 660 (755)
.... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.|+........... .........+
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 2211 111223478899999999987 6799999999999999999999999865433221100 0000000000
Q ss_pred ------C-------------CCccccC---CC------CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 661 ------S-------------KGKEFID---PS------LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 661 ------~-------------~~~~~~d---~~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
. ...+... +. ............+.+|+.+||+.||++|||+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 0000000 00 0000111223468899999999999999999999853
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=343.02 Aligned_cols=267 Identities=16% Similarity=0.163 Sum_probs=198.9
Q ss_pred hcCCCccCcccccCCeeEEEEEcC----CCCEEEEEEeccCChh-----------hHHHHHHHHHHHhcCCCCceeeeee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP----RGQEFAVKRLSATSTQ-----------GLEEFKNEVSLTARLQHVNLLRVLG 498 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~g 498 (755)
.++|...+.||+|+||.||+|... .+..||||++...... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357888999999999999999764 5789999998765322 1124678889999999999999999
Q ss_pred eeec----CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC
Q 004402 499 YCTE----RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL 574 (755)
Q Consensus 499 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~ 574 (755)
++.. ....++||||+ +++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9887 67789999999 99999998542 26899999999999999999999986 99999999999999887
Q ss_pred --CeEEEecCCccccccCCcc-----cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 004402 575 --NPKISDFGMAKLFRKDVDE-----ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN 647 (755)
Q Consensus 575 --~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~ 647 (755)
.+||+|||+++.+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999876432211 112345789999999999999999999999999999999999999853222111
Q ss_pred cchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 648 LNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
............. ...+...... ......+.+++..||+.||++|||+.+|++.|++...
T Consensus 269 --~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 --AVQTAKTNLLDEL-PQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp --HHHHHHHHHHHTT-THHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred --HHHHHHHhhcccc-cHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1111111111110 1101000000 0122368899999999999999999999999987654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=346.94 Aligned_cols=249 Identities=22% Similarity=0.312 Sum_probs=197.4
Q ss_pred HhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccE
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENM 507 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 507 (755)
..++|+..+.||+|+||.||+++. .+|+.||||+++.. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 346899999999999999999965 46899999999754 233456788999999988 7999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
+||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999998853 345899999999999999999999987 999999999999999999999999999853
Q ss_pred ccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....... ....
T Consensus 175 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i----~~~~----- 240 (353)
T 3txo_A 175 ICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE---DDLFEAI----LNDE----- 240 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH----HHCC-----
T ss_pred ccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH---HHHHHHH----HcCC-----
Confidence 322 1223346899999999999988999999999999999999999999853321 1111111 1111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSM------LEVSS 706 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~evl~ 706 (755)
...... ....+.+++.+||+.||++||++ .|+++
T Consensus 241 -~~~p~~----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 -VVYPTW----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -CCCCTT----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -CCCCCC----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 011111 22367899999999999999998 66664
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=339.81 Aligned_cols=264 Identities=23% Similarity=0.307 Sum_probs=205.1
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeec----CCccEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE----RDENML 508 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~l 508 (755)
.++|...+.||+|+||.||++.. .+++.||||++........+.+.+|+++++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46788999999999999999965 6799999999977777777889999999999999999999999863 346789
Q ss_pred EEeecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 509 IYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999885421 2356899999999999999999999986 999999999999999999999999998764
Q ss_pred ccCCccc-------ccccccccCCccccccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHH
Q 004402 588 RKDVDEA-------NTGRIVGTYGYVPPEYVKKGI---YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQ 657 (755)
Q Consensus 588 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 657 (755)
....... ......||+.|+|||.+.... ++.++|||||||++|||++|+.|+........ .. ....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~-~~~~-- 260 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SV-ALAV-- 260 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CH-HHHH--
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hh-hHHh--
Confidence 3211110 112345789999999987554 68999999999999999999998853211110 01 1110
Q ss_pred hccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 004402 658 WKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMA 714 (755)
Q Consensus 658 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 714 (755)
.. . .. ..........+.+++.+||+.||++|||+.|+++.|+.....
T Consensus 261 -~~-~-~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 261 -QN-Q-LS-------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp -HC-C----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred -hc-c-CC-------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 00 0 00 001112234688999999999999999999999999976543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.70 Aligned_cols=263 Identities=25% Similarity=0.374 Sum_probs=204.0
Q ss_pred cCCCccCcccccCCeeEEEEE-----cCCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--Ccc
Q 004402 435 NNFSSANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER--DEN 506 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 506 (755)
+.|+..+.||+|+||.||++. ..+++.||||++.... ....+.+.+|+.++.+++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 457788999999999999997 3468999999997543 34457899999999999999999999999876 568
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 9999999999999998532 345899999999999999999999987 99999999999999999999999999987
Q ss_pred cccCCcc-cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------CCcccchHHHHHHH
Q 004402 587 FRKDVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG--------TSENLNFLEYAFEQ 657 (755)
Q Consensus 587 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~--------~~~~~~~~~~~~~~ 657 (755)
....... .......+|..|+|||.+.+..++.++|||||||++|||+||+.|+.... ..............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 6543321 22334567888999999999999999999999999999999988753210 00011111111111
Q ss_pred hccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 658 WKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 658 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
..... ....+......+.+++.+||+.||++|||+.|+++.|++.
T Consensus 256 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 256 LKEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 11111 1111122334788999999999999999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=334.61 Aligned_cols=266 Identities=25% Similarity=0.392 Sum_probs=210.3
Q ss_pred cCCCccC-cccccCCeeEEEEEc---CCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 435 NNFSSAN-KLGEGGFGPVYKGNL---PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 435 ~~f~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
++|...+ .||+|+||.||+|.. .+++.||||++... .....+.+.+|++++.+++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3455555 899999999999964 35788999999765 344567899999999999999999999999 45678999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999854 2345899999999999999999999987 99999999999999999999999999987654
Q ss_pred CCcc-cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 590 DVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 590 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
.... .......+|+.|+|||.+.+..++.++|||||||++|||+| |+.|+....... .... ......
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~----i~~~~~---- 231 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAF----IEQGKR---- 231 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHH----HHTTCC----
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHHH----HhcCCc----
Confidence 3221 12223456889999999998889999999999999999999 998885433211 1111 111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccccCCCCCCc
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAPKRPA 722 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~ 722 (755)
+.. +......+.+++..||+.||++||++.++++.|++...+...+..+.
T Consensus 232 -~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~ 281 (287)
T 1u59_A 232 -MEC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281 (287)
T ss_dssp -CCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSC
T ss_pred -CCC----CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCC
Confidence 111 11223478899999999999999999999999998776665555443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=339.38 Aligned_cols=268 Identities=24% Similarity=0.384 Sum_probs=199.0
Q ss_pred HHHHHhcCCCccCcccccCCeeEEEEEcC----CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeec
Q 004402 429 DIKAATNNFSSANKLGEGGFGPVYKGNLP----RGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE 502 (755)
Q Consensus 429 ~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 502 (755)
++....++|...+.||+|+||.||+|... .++.||||++... .....+.+.+|+.++++++||||+++++++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 33344567888999999999999999643 3458999998754 34456779999999999999999999999977
Q ss_pred CCc-----cEEEEeecCCCChhhhhcCC---CccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC
Q 004402 503 RDE-----NMLIYEYLPNKSLDLYLFDP---IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL 574 (755)
Q Consensus 503 ~~~-----~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~ 574 (755)
... .++||||+++|+|.+++... .....+++..++.++.|+++||.|||+.+ ++||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCC
Confidence 553 49999999999999998432 22356899999999999999999999986 99999999999999999
Q ss_pred CeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHH
Q 004402 575 NPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEY 653 (755)
Q Consensus 575 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~ 653 (755)
.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..|+...... .....
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~ 261 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYDY 261 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHH
Confidence 999999999987654332222333456889999999999999999999999999999999 77777543221 12211
Q ss_pred HHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccc
Q 004402 654 AFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAI 715 (755)
Q Consensus 654 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 715 (755)
.. .... +.. .......+.+++.+||+.||++|||+.++++.|++....+
T Consensus 262 ~~----~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 262 LL----HGHR-----LKQ----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HH----TTCC-----CCC----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HH----cCCC-----CCC----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11 1110 011 1122346889999999999999999999999999865543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=340.01 Aligned_cols=249 Identities=22% Similarity=0.347 Sum_probs=198.4
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 509 (755)
++|+..+.||+|+||.||+++. .+++.||||++... .....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 4688889999999999999975 45899999999754 334456788999999988 899999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999998853 345899999999999999999999987 99999999999999999999999999985432
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccc--chHHHHHHHhccCCCcccc
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL--NFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 667 (755)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..... ..............
T Consensus 163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~----- 235 (345)
T 3a8x_A 163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----- 235 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-----
T ss_pred CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-----
Confidence 21 2233468999999999999999999999999999999999999999654332211 11111111111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSM 701 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 701 (755)
..+... ....+.+++.+||+.||++||++
T Consensus 236 -~~~p~~----~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 -IRIPRS----LSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -CCCCTT----SCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -CCCCCC----CCHHHHHHHHHHhcCCHhHCCCC
Confidence 111112 22367899999999999999995
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=332.68 Aligned_cols=255 Identities=27% Similarity=0.400 Sum_probs=206.7
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecC
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 514 (755)
++|...+.||+|+||.||++...+++.||+|++..... ..+.+.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 56778899999999999999888889999999976543 34678999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 594 (755)
+++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...... ..
T Consensus 87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 160 (267)
T 3t9t_A 87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT 160 (267)
T ss_dssp TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc-cc
Confidence 99999998542 345889999999999999999999987 9999999999999999999999999998654321 11
Q ss_pred ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .... ....... . .....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~----~~i~~~~--~---~~~~~ 228 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVV----EDISTGF--R---LYKPR 228 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHH----HHHHTTC--C---CCCCT
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---HHHH----HHHhcCC--c---CCCCc
Confidence 2223456788999999998899999999999999999999 7888753221 1111 1111111 0 01111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
.....+.+++.+||+.||++|||+.|+++.|++..
T Consensus 229 ----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 229 ----LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 12346789999999999999999999999998754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.03 Aligned_cols=274 Identities=24% Similarity=0.330 Sum_probs=197.6
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHH--HhcCCCCceeeeeeeeec-----CCccE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSL--TARLQHVNLLRVLGYCTE-----RDENM 507 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~-----~~~~~ 507 (755)
++|...+.||+|+||.||+|+. +++.||||++..... ..+..|.++ +..++||||+++++.+.. ....+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 5788889999999999999976 789999999965432 344444444 555899999999985432 23568
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCceecccCCCCEEEcCCCCeEEEec
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS------NFRVIHRDLKASNILLDNELNPKISDF 581 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~------~~~iiHrDlk~~NIll~~~~~~kl~Df 581 (755)
+||||+++|+|.+++.. ...++..+..++.||++||.|||+.. ..+|+||||||+|||++.++.+||+||
T Consensus 89 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 99999999999999843 23588999999999999999999981 114999999999999999999999999
Q ss_pred CCccccccCCc------ccccccccccCCccccccccC-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccc
Q 004402 582 GMAKLFRKDVD------EANTGRIVGTYGYVPPEYVKK-------GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL 648 (755)
Q Consensus 582 gla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~ 648 (755)
|+++.+..... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.|+.........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 99987643211 112224568999999999976 45678999999999999999998776432221111
Q ss_pred -ch----------HHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccccCC
Q 004402 649 -NF----------LEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAA 717 (755)
Q Consensus 649 -~~----------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~ 717 (755)
.. ...............-+.... .........+.+++.+||+.||++|||+.|+++.|++.......
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred HHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence 00 001111111111111111111 11223556789999999999999999999999999987655443
Q ss_pred C
Q 004402 718 P 718 (755)
Q Consensus 718 p 718 (755)
-
T Consensus 323 ~ 323 (336)
T 3g2f_A 323 N 323 (336)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=343.27 Aligned_cols=259 Identities=21% Similarity=0.322 Sum_probs=194.1
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcc---
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN--- 506 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~--- 506 (755)
.++|+..+.||+|+||.||++.. .+++.||||++... .....+.+.+|+.++.+++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35788899999999999999964 67899999999765 334456789999999999999999999998776544
Q ss_pred -EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 507 -MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 507 -~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 999999999999999853 345899999999999999999999987 9999999999999999999999999998
Q ss_pred ccccCCcc-cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCc
Q 004402 586 LFRKDVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664 (755)
Q Consensus 586 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (755)
.+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.|+...... .............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCCC
Confidence 76443221 2233457899999999999999999999999999999999999998532211 1111111111100
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH-HHHHhhcC
Q 004402 665 EFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLE-VSSMLKDD 711 (755)
Q Consensus 665 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e-vl~~L~~~ 711 (755)
. ..... .....+.+++.+||+.||++||+..+ +.+.|...
T Consensus 239 ~---~~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 239 P---SARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp H---HHHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred c---ccccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0 00001 12236789999999999999996554 55555543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=346.96 Aligned_cols=272 Identities=21% Similarity=0.276 Sum_probs=212.3
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC--ccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD--ENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv~ 510 (755)
++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 56888899999999999999654 59999999997543 334577889999999999999999999988765 679999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE----cCCCCeEEEecCCccc
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL----DNELNPKISDFGMAKL 586 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll----~~~~~~kl~Dfgla~~ 586 (755)
||+++|+|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999976554555999999999999999999999987 9999999999999 7788899999999987
Q ss_pred cccCCcccccccccccCCccccccccC--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccc-chHHHHHHH
Q 004402 587 FRKDVDEANTGRIVGTYGYVPPEYVKK--------GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL-NFLEYAFEQ 657 (755)
Q Consensus 587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~-~~~~~~~~~ 657 (755)
..... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......... .........
T Consensus 166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp CCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred ccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 64322 2223578999999998864 56788999999999999999999999754433322 222222221
Q ss_pred hccCCCccc---------cCCC--CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 658 WKDSKGKEF---------IDPS--LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 658 ~~~~~~~~~---------~d~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
......... .... ............+.+++.+||+.||++||++.|+++.+++..
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 111111000 0001 112234566777889999999999999999999999887643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=333.45 Aligned_cols=256 Identities=20% Similarity=0.315 Sum_probs=193.9
Q ss_pred hcCCCccCcccccCCeeEEEEEcCC----CCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
.++|+..+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3578888999999999999996532 457999998764 3445667999999999999999999999984 467899
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999998532 345899999999999999999999986 9999999999999999999999999998764
Q ss_pred cCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
.... .......+|+.|+|||.+.+..++.++|||||||++|||++ |..|+...... ...... .....
T Consensus 168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~i----~~~~~---- 235 (281)
T 1mp8_A 168 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI----ENGER---- 235 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH----HTTCC----
T ss_pred cccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHHH----HcCCC----
Confidence 3321 12223456788999999998999999999999999999997 88887543222 122111 11110
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
..+. ......+.+++.+||+.||++|||+.|+++.|++..
T Consensus 236 -~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 236 -LPMP----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp -CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0111 122346889999999999999999999999998753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=342.55 Aligned_cols=252 Identities=22% Similarity=0.274 Sum_probs=191.5
Q ss_pred hcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
.++|...+.||+|+||.||++... +++.||||++..... ..+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 357888999999999999999654 689999999976533 235688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC--eEEEecCCccccccC
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN--PKISDFGMAKLFRKD 590 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~--~kl~Dfgla~~~~~~ 590 (755)
+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999998843 335899999999999999999999987 999999999999987766 999999999743221
Q ss_pred CcccccccccccCCccccccccCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMK-YDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
.......||+.|+|||.+.+..++.+ +|||||||++|||++|+.||.......... .. .........
T Consensus 172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--~~-~~~~~~~~~------ 239 (361)
T 3uc3_A 172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR--KT-IQRILSVKY------ 239 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH--HH-HHHHHTTCC------
T ss_pred ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH--HH-HHHHhcCCC------
Confidence 12234578999999999988887655 899999999999999999986543332221 11 111111100
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+.. .......+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 240 SIPD--DIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CCCT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 0000 0012246789999999999999999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=338.03 Aligned_cols=264 Identities=25% Similarity=0.350 Sum_probs=187.7
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.++|+..+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 45788899999999999999975 4589999999875532 334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCC---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 512 YLPNKSLDLYLFDPI---RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
|++ |+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 68988875321 1235889999999999999999999986 9999999999999999999999999998764
Q ss_pred cCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC---Cc
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK---GK 664 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ 664 (755)
.... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ............. ..
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhh
Confidence 3221 2233578999999999876 468999999999999999999999985432211 1111211111000 00
Q ss_pred c---c--cCCCCCCC------------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 665 E---F--IDPSLDDS------------SSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 665 ~---~--~d~~l~~~------------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. . ..+.+... ........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 0 00000000 00012236889999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=344.77 Aligned_cols=262 Identities=24% Similarity=0.269 Sum_probs=191.4
Q ss_pred HhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCceeeeeeeee--------c
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYCT--------E 502 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~--------~ 502 (755)
...+|...+.||+|+||.||++.. .+++.||||++........+.+.+|+.++.++. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 345788899999999999999964 578999999997777777788999999999996 999999999983 3
Q ss_pred CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecC
Q 004402 503 RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG 582 (755)
Q Consensus 503 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg 582 (755)
....++++||+. |+|.+++........+++..++.++.||+.||.|||+.+ .+++||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 344789999996 789888854334456999999999999999999999864 249999999999999999999999999
Q ss_pred CccccccCCccc----------ccccccccCCccccccc---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccc
Q 004402 583 MAKLFRKDVDEA----------NTGRIVGTYGYVPPEYV---KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLN 649 (755)
Q Consensus 583 la~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~ 649 (755)
+++......... ......||+.|+|||.+ .+..++.++|||||||++|||++|+.|+........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-- 261 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI-- 261 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh--
Confidence 998765432211 11134589999999998 567789999999999999999999999853221110
Q ss_pred hHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccc
Q 004402 650 FLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAI 715 (755)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 715 (755)
.. .. ........ ....+.+++.+||+.||++|||+.|+++.|+......
T Consensus 262 ----~~-----~~----~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 262 ----VN-----GK----YSIPPHDT----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp -----------------CCCCTTCC----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ----hc-----Cc----ccCCcccc----cchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 00 00 00000111 1124678999999999999999999999999876543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=331.86 Aligned_cols=261 Identities=23% Similarity=0.331 Sum_probs=204.3
Q ss_pred CCCccCcccccCCeeEEEEEcC-CC---CEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcc-EEE
Q 004402 436 NFSSANKLGEGGFGPVYKGNLP-RG---QEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN-MLI 509 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lv 509 (755)
.|...+.||+|+||.||+|... ++ ..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3455688999999999999642 22 379999987643 34567899999999999999999999999876655 999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
+||+.+|+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 9999999999998652 345789999999999999999999987 99999999999999999999999999986543
Q ss_pred CC--cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 590 DV--DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 590 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
.. .........+|+.|+|||.+.+..++.++|||||||++|||++|+.|+.... .......... ...
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~--~~~~~~~~~~----~~~----- 245 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI--DPFDLTHFLA----QGR----- 245 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CGGGHHHHHH----TTC-----
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC--CHHHHHHHhh----cCC-----
Confidence 22 1122334567889999999999999999999999999999999776653222 1222222111 111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccccC
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIA 716 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 716 (755)
.... +......+.+++.+||+.||++|||+.++++.|++....+.
T Consensus 246 ~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 246 RLPQ----PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred CCCC----CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 0001 11122468899999999999999999999999998765543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=335.32 Aligned_cols=244 Identities=23% Similarity=0.306 Sum_probs=200.5
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|..+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 5688899999999999999965 469999999997542 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 86 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 99999999999853 345889999999999999999999986 999999999999999999999999999865321
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
....+||+.|+|||++.+..++.++|||||||++|||++|+.|+.... ........ .... ..
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i----~~~~------~~ 221 (318)
T 1fot_A 160 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN---TMKTYEKI----LNAE------LR 221 (318)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHH----HHCC------CC
T ss_pred -----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHH----HhCC------CC
Confidence 224578999999999999999999999999999999999999985322 11111111 1111 01
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRP-----SMLEVSS 706 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 706 (755)
+... ....+.+++.+||+.||++|| +++|+++
T Consensus 222 ~p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 222 FPPF----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CCTT----SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCC----CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1111 223678999999999999999 8888883
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=342.23 Aligned_cols=254 Identities=22% Similarity=0.328 Sum_probs=201.1
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC-----hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-----TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM 507 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 507 (755)
.++|+..+.||+|+||.||++.. .+|+.||||++.... ....+.+.+|+.++..++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35688999999999999999965 569999999986431 123578999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC---eEEEecCC
Q 004402 508 LIYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN---PKISDFGM 583 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~---~kl~Dfgl 583 (755)
+|||||++|+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988775432 2345899999999999999999999987 999999999999987655 99999999
Q ss_pred ccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG 663 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (755)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.|+.... .... ........
T Consensus 180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~----~~i~~~~~ 249 (351)
T 3c0i_A 180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLF----EGIIKGKY 249 (351)
T ss_dssp CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHH----HHHHHTCC
T ss_pred eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHH----HHHHcCCC
Confidence 98765422 12234578999999999999999999999999999999999999985321 1111 11111110
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 664 KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 664 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. ..+.... .....+.+++.+||+.||++|||+.|+++
T Consensus 250 ~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 K--MNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp C--CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--CCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0000000 11246789999999999999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=336.94 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=209.3
Q ss_pred HhcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
..++|...+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4567888999999999999999764 48899999997654 345789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++++|.+++... ....+++..++.++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999998542 2345899999999999999999999987 9999999999999999999999999998765432
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
. .......+|+.|+|||.+.+..++.++||||||+++|||++ |..|+....... ...... .. ....
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~~~----~~-----~~~~ 232 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLE----KD-----YRME 232 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHH----TT-----CCCC
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHh----cc-----CCCC
Confidence 2 22233466889999999999999999999999999999999 888875432221 111111 11 0011
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
.+......+.+++.+||+.||++|||+.|+++.|+...
T Consensus 233 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 233 ----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 11122346889999999999999999999999998643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=339.57 Aligned_cols=244 Identities=20% Similarity=0.242 Sum_probs=190.8
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS--TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..++||+|+||+||+|... +|+.||||++.... ......+..|+..+.++ +||||++++++|.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999764 69999999986542 33334556666666555 9999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+ +++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 67888887542 345899999999999999999999986 999999999999999999999999999865432
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
. ......||+.|+|||++.+ .++.++|||||||++|||++|..++.... ....+...... +.
T Consensus 211 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~~~~~~~~~----~~ 272 (311)
T 3p1a_A 211 G---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQQLRQGYLP----PE 272 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHHHHTTTCCC----HH
T ss_pred C---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHHHHhccCCC----cc
Confidence 2 2223468999999999876 78999999999999999999976653210 11111111111 00
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+.. .....+.+++.+||+.||++|||+.|+++
T Consensus 273 ~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 FTA----GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccc----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111 12346889999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=368.96 Aligned_cols=251 Identities=25% Similarity=0.379 Sum_probs=198.1
Q ss_pred cccccCCeeEEEEEcC---CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCCCC
Q 004402 442 KLGEGGFGPVYKGNLP---RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKS 517 (755)
Q Consensus 442 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 517 (755)
.||+|+||.||+|... ++..||||+++... ....+.|.+|+++|++++||||++++++|.. +..++|||||++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999653 46689999997653 3456789999999999999999999999976 56899999999999
Q ss_pred hhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc-cc
Q 004402 518 LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA-NT 596 (755)
Q Consensus 518 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~ 596 (755)
|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....... ..
T Consensus 422 L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 99998543 345899999999999999999999987 9999999999999999999999999998764332211 12
Q ss_pred ccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCC
Q 004402 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSS 675 (755)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 675 (755)
....+|+.|+|||++.+..++.++|||||||++|||+| |+.|+...... .... .+..+... ..
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~----~i~~~~~~---------~~ 560 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA----FIEQGKRM---------EC 560 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHH----HHHTTCCC---------CC
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHH----HHHcCCCC---------CC
Confidence 22345689999999999999999999999999999998 99988543322 1111 11111110 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 004402 676 SPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMA 714 (755)
Q Consensus 676 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 714 (755)
+......+.+++..||+.||++||++.+|++.|+.....
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 122334788999999999999999999999999875443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=342.71 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=200.9
Q ss_pred HHHhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCc
Q 004402 431 KAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDE 505 (755)
Q Consensus 431 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 505 (755)
....++|...+.||+|+||.||++.. .+|+.||||+++... ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 34567899999999999999999975 468999999997542 23456678899999877 99999999999999999
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
.++||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999999853 345899999999999999999999987 9999999999999999999999999998
Q ss_pred ccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcc
Q 004402 586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665 (755)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (755)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ..... .+....
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~----~i~~~~--- 234 (345)
T 1xjd_A 167 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFH----SIRMDN--- 234 (345)
T ss_dssp CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHHCC---
T ss_pred hcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---HHHHH----HHHhCC---
Confidence 543221 223456899999999999999999999999999999999999999853221 11111 111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 004402 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSML-EVS 705 (755)
Q Consensus 666 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl 705 (755)
+.+... ....+.+++.+||+.||++||++. ++.
T Consensus 235 ---~~~p~~----~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 ---PFYPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ---CCCCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ---CCCCcc----cCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 111111 224678999999999999999997 665
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=342.96 Aligned_cols=267 Identities=21% Similarity=0.262 Sum_probs=202.4
Q ss_pred HHHHhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC-----ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC
Q 004402 430 IKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-----STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER 503 (755)
Q Consensus 430 l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 503 (755)
+....++|...+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 445667899999999999999999965 56889999998653 234567899999999999999999999999999
Q ss_pred CccEEEEeecCCCChhhhhcCCCc-------------------------------------cCCCCHHHHHHHHHHHHHH
Q 004402 504 DENMLIYEYLPNKSLDLYLFDPIR-------------------------------------RYVLDWQKRVNIIEGVTQG 546 (755)
Q Consensus 504 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~ia~~ 546 (755)
+..++||||+++|+|.+++..... ...+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999998842100 1123567788999999999
Q ss_pred HHHHHhcCCCCceecccCCCCEEEcCCC--CeEEEecCCccccccCCcc--cccccccccCCccccccccC--CCCCchh
Q 004402 547 LLYLQEYSNFRVIHRDLKASNILLDNEL--NPKISDFGMAKLFRKDVDE--ANTGRIVGTYGYVPPEYVKK--GIYSMKY 620 (755)
Q Consensus 547 l~~Lh~~~~~~iiHrDlk~~NIll~~~~--~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~~s 620 (755)
|.|||+.+ |+||||||+|||++.++ .+||+|||+++.+...... .......||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999987 99999999999998776 8999999999865432211 12334578999999999865 6789999
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 004402 621 DVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPS 700 (755)
Q Consensus 621 DVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 700 (755)
|||||||++|||++|+.|+...... ....... .... ....+ ........+.+++.+||+.||++|||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~---~~~~--~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA---DTISQVL---NKKL--CFENP-----NYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH---HCCC--CTTSG-----GGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH---HHHHHHH---hccc--ccCCc-----ccccCCHHHHHHHHHHcCCChhHCCC
Confidence 9999999999999999998533221 1111111 1100 00000 01112346889999999999999999
Q ss_pred HHHHHH--HhhcCc
Q 004402 701 MLEVSS--MLKDDS 712 (755)
Q Consensus 701 ~~evl~--~L~~~~ 712 (755)
+.|+++ .+++..
T Consensus 325 ~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 325 AMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHSHHHHTTS
T ss_pred HHHHhcChhhccCh
Confidence 999986 455433
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=350.51 Aligned_cols=212 Identities=26% Similarity=0.323 Sum_probs=181.1
Q ss_pred CCccccCHHHHHHHhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-----CCce
Q 004402 420 PNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-----HVNL 493 (755)
Q Consensus 420 ~~~~~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~ni 493 (755)
.+...+++.+.....++|...++||+|+||.||+|.. .+++.||||++... ....+.+..|+.++..++ ||||
T Consensus 20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 3445566666666678999999999999999999965 56899999999743 334566788999999986 9999
Q ss_pred eeeeeeeecCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC-
Q 004402 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN- 572 (755)
Q Consensus 494 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~- 572 (755)
+++++++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDP 173 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCT
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccc
Confidence 99999999999999999999 999999985432 234899999999999999999999987 999999999999975
Q ss_pred ------------------------CCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHH
Q 004402 573 ------------------------ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVL 628 (755)
Q Consensus 573 ------------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvi 628 (755)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 248 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence 789999999999864321 224578999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCC
Q 004402 629 LLQIISSKRNARYY 642 (755)
Q Consensus 629 l~elltg~~p~~~~ 642 (755)
+|||++|+.||...
T Consensus 249 l~ell~g~~pf~~~ 262 (360)
T 3llt_A 249 LAELYTGSLLFRTH 262 (360)
T ss_dssp HHHHHHSSCSCCCS
T ss_pred HHHHHHCCCCCCCC
Confidence 99999999998643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=330.63 Aligned_cols=275 Identities=19% Similarity=0.229 Sum_probs=212.2
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeee-ecCCccEEEEe
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC-TERDENMLIYE 511 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lv~e 511 (755)
.++|...+.||+|+||.||+|.. .+++.||||++...... +.+.+|+.++..++|++++..+.++ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46788999999999999999974 67999999998665432 4688999999999988877766665 55667899999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE---cCCCCeEEEecCCccccc
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLFR 588 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll---~~~~~~kl~Dfgla~~~~ 588 (755)
|+ +++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 99999998532 335899999999999999999999987 9999999999999 488999999999998765
Q ss_pred cCCccc-----ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC
Q 004402 589 KDVDEA-----NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG 663 (755)
Q Consensus 589 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (755)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.|+........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 432211 123457899999999999999999999999999999999999999765444333333222221111000
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccccCCCCCCcccc
Q 004402 664 KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAPKRPAFSA 725 (755)
Q Consensus 664 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~~~ 725 (755)
. .+.... +..+.+++.+||+.||++|||+.++++.|++.......+....+.|
T Consensus 240 -~----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw 292 (296)
T 3uzp_A 240 -E----VLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW 292 (296)
T ss_dssp -H----HHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGG
T ss_pred -H----HHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence 0 001111 2368899999999999999999999999998765554443333443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=352.29 Aligned_cols=258 Identities=20% Similarity=0.269 Sum_probs=203.1
Q ss_pred HHHHHHhcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecC
Q 004402 428 SDIKAATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER 503 (755)
Q Consensus 428 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 503 (755)
.++....++|+..++||+|+||.||++... +++.||+|++.... ....+.+.+|+.++..++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344455678999999999999999999654 58999999986532 11223578999999999999999999999999
Q ss_pred CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCC
Q 004402 504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM 583 (755)
Q Consensus 504 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl 583 (755)
+..++|||||++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999998843 35889999999999999999999987 99999999999999999999999999
Q ss_pred ccccccCCcccccccccccCCccccccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhc
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGI----YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWK 659 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 659 (755)
++....... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ............
T Consensus 215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~~ 290 (410)
T 3v8s_A 215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMNHKN 290 (410)
T ss_dssp CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTHHH
T ss_pred eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh---hhHHHHHHhccc
Confidence 987643321 1233468999999999997655 88999999999999999999999853221 111111111000
Q ss_pred cCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 004402 660 DSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPED--RPSMLEVSS 706 (755)
Q Consensus 660 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~ 706 (755)
. ..+.+ ... ....+.+++.+||+.+|.+ ||+++|+++
T Consensus 291 ~---~~~p~---~~~----~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 291 S---LTFPD---DND----ISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp H---CCCCT---TCC----CCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred c---ccCCC---ccc----ccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 0 00000 011 2236789999999999988 999999995
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=350.26 Aligned_cols=262 Identities=18% Similarity=0.247 Sum_probs=203.9
Q ss_pred CHHHHHHHhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeee
Q 004402 426 SFSDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501 (755)
Q Consensus 426 ~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 501 (755)
.++++....++|+..+.||+|+||.||+++. .+|+.||||++.+.. ....+.+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3445555678899999999999999999976 469999999996532 122345889999999999999999999999
Q ss_pred cCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEec
Q 004402 502 ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDF 581 (755)
Q Consensus 502 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Df 581 (755)
+.+..++||||+++|+|..++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 999999999999999999998532 235899999999999999999999987 999999999999999999999999
Q ss_pred CCccccccCCcccccccccccCCcccccccc-------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHH
Q 004402 582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVK-------KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYA 654 (755)
Q Consensus 582 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~ 654 (755)
|+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||...... ......
T Consensus 207 Gla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i 282 (412)
T 2vd5_A 207 GSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---ETYGKI 282 (412)
T ss_dssp TTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHH
T ss_pred hhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH---HHHHHH
Confidence 99987644322 1223457999999999987 467899999999999999999999998532211 111111
Q ss_pred HHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHH
Q 004402 655 FEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDR---PSMLEVSS 706 (755)
Q Consensus 655 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Pt~~evl~ 706 (755)
... .. .+.-+...... ...+.+++.+||+ +|++| |+++|+++
T Consensus 283 ~~~-~~----~~~~p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 283 VHY-KE----HLSLPLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HTH-HH----HCCCC----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred Hhc-cc----CcCCCccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 100 00 00011111112 2367899999999 99998 68999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=340.70 Aligned_cols=251 Identities=22% Similarity=0.349 Sum_probs=187.4
Q ss_pred HhcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
..++|+..+.||+|+||.||+|... +++.||||++.... ..+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3567899999999999999999764 58899999997653 23568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC---CCCeEEEecCCccccc
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGMAKLFR 588 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~---~~~~kl~Dfgla~~~~ 588 (755)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999998853 345899999999999999999999986 999999999999975 8899999999998654
Q ss_pred cCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.|+....... .. ...+..... ....
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~----~~~i~~~~~-~~~~ 272 (349)
T 2w4o_A 203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FM----FRRILNCEY-YFIS 272 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HH----HHHHHTTCC-CCCT
T ss_pred ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HH----HHHHHhCCC-ccCC
Confidence 321 2234578999999999999999999999999999999999999985322211 11 111111110 1111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+ ........+.+++.+||+.||++|||+.|+++
T Consensus 273 ~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 P-----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp T-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c-----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 11122346889999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=344.99 Aligned_cols=259 Identities=24% Similarity=0.364 Sum_probs=192.8
Q ss_pred CCCccCcccccCCeeEEEEEcC--C--CCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeec-CCccEEE
Q 004402 436 NFSSANKLGEGGFGPVYKGNLP--R--GQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE-RDENMLI 509 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~--~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv 509 (755)
.|...+.||+|+||.||+|... + +..||||.+... .....+.|.+|+.++++++||||++++++|.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4556789999999999999653 2 246899998654 33456789999999999999999999998755 4578999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||+++|+|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 9999999999999643 335788999999999999999999987 99999999999999999999999999986543
Q ss_pred CCcc--cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCcccchHHHHHHHhccCCCccc
Q 004402 590 DVDE--ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISS-KRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666 (755)
Q Consensus 590 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (755)
.... .......+|+.|+|||.+.+..++.++|||||||++|||+|| ..|+...... ....... ... ..
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---~~~~~~~----~~~--~~ 315 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYLL----QGR--RL 315 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---CHHHHHH----TTC--CC
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---HHHHHHH----cCC--CC
Confidence 2211 112234567899999999999999999999999999999994 5555432222 1221111 111 11
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccc
Q 004402 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAI 715 (755)
Q Consensus 667 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 715 (755)
..+ ......+.+++.+||+.||++|||+.|+++.|++....+
T Consensus 316 ~~p-------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 316 LQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp CCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111 112346889999999999999999999999999865443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=331.34 Aligned_cols=260 Identities=23% Similarity=0.350 Sum_probs=201.0
Q ss_pred cCCCccCcccccCCeeEEEEEcCC----CCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeec-CCccEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE-RDENML 508 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~l 508 (755)
.+|...+.||+|+||.||+|...+ ...||+|.+... .....+.+.+|+.++++++||||++++++|.. ....++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457778999999999999997532 236899998764 34456789999999999999999999998654 557899
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 105 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 99999999999999642 345789999999999999999999987 9999999999999999999999999998664
Q ss_pred cCCcc--cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCC-CCCCCCCcccchHHHHHHHhccCCCcc
Q 004402 589 KDVDE--ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRN-ARYYGTSENLNFLEYAFEQWKDSKGKE 665 (755)
Q Consensus 589 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (755)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++|..| +...... ....... ... .
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~~~~----~~~--~ 250 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYLL----QGR--R 250 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---THHHHHH----TTC--C
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HHHHHHh----cCC--C
Confidence 33211 122334677899999999999999999999999999999996554 3322211 1111111 110 0
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccc
Q 004402 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAI 715 (755)
Q Consensus 666 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 715 (755)
... .. .....+.+++.+||+.||++|||+.|+++.|++....+
T Consensus 251 ~~~---~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 251 LLQ---PE----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp CCC---CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred CCC---Cc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 010 11 12236889999999999999999999999999865543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=336.13 Aligned_cols=248 Identities=22% Similarity=0.286 Sum_probs=191.6
Q ss_pred hcCCCccCcccccCCeeEEEEEc----CCCCEEEEEEeccCC----hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL----PRGQEFAVKRLSATS----TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE 505 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 505 (755)
.++|+..+.||+|+||.||++.. .+|+.||+|++.... ......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35788899999999999999975 478999999997642 2334568899999999999999999999999999
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999998853 345889999999999999999999987 9999999999999999999999999997
Q ss_pred ccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcc
Q 004402 586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665 (755)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (755)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.|+..... ........ ...
T Consensus 170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~----~~~--- 237 (327)
T 3a62_A 170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---KKTIDKIL----KCK--- 237 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHH----HTC---
T ss_pred ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH---HHHHHHHH----hCC---
Confidence 543221 122345789999999999999999999999999999999999999853221 11111111 111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004402 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRP-----SMLEVSS 706 (755)
Q Consensus 666 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 706 (755)
..+.. .....+.+++.+||+.||++|| ++.|+++
T Consensus 238 ---~~~p~----~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 ---LNLPP----YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ---CCCCT----TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ---CCCCC----CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 01111 1234678999999999999999 6777764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=338.79 Aligned_cols=244 Identities=19% Similarity=0.241 Sum_probs=201.0
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||+|+||.||++.. .+|+.||||++.... ....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 4688889999999999999965 469999999986542 234567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999999853 235899999999999999999999987 999999999999999999999999999865432
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
....+||+.|+|||++.+..++.++|||||||++|||++|+.|+.... ...... .+.... ..
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~----~i~~~~------~~ 256 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQIYE----KIVSGK------VR 256 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH----HHHHCC------CC
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC---HHHHHH----HHHcCC------CC
Confidence 234578999999999999999999999999999999999999985321 111111 111111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPS-----MLEVSS 706 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 706 (755)
+... ....+.+++.+||+.||++||+ ++|+++
T Consensus 257 ~p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 FPSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCC----CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1112 2346789999999999999998 788874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=342.03 Aligned_cols=260 Identities=27% Similarity=0.389 Sum_probs=202.6
Q ss_pred hcCCCccCcccccCCeeEEEEEc------CCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN 506 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 506 (755)
.++|...+.||+|+||.||+|.. .+++.||||++... .......+.+|+.++++++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46788999999999999999973 34779999999754 344556799999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCc----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC---CCCeEEE
Q 004402 507 MLIYEYLPNKSLDLYLFDPIR----RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKIS 579 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~---~~~~kl~ 579 (755)
++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999864322 245899999999999999999999987 999999999999984 4569999
Q ss_pred ecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHh
Q 004402 580 DFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQW 658 (755)
Q Consensus 580 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 658 (755)
|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+| |+.|+..... ..... ..
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~----~~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLE----FV 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHH----HH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHHH----HH
Confidence 9999986544333333334567889999999998999999999999999999998 8887743221 11111 11
Q ss_pred ccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 659 KDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 659 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
..... .... ......+.+++.+||+.||++|||+.++++.|+...
T Consensus 259 ~~~~~-----~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 259 TSGGR-----MDPP----KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HTTCC-----CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCC-----CCCC----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 11111 0111 122346889999999999999999999999998654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=333.23 Aligned_cols=266 Identities=21% Similarity=0.329 Sum_probs=199.8
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4688899999999999999964 57999999999753 3445678999999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 511 EYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
||+++++|.+++.... ....+++..++.++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999999885322 2345899999999999999999999987 99999999999999999999999999986543
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+...... .... ...........
T Consensus 189 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~----~~~~~~~~~~~---- 257 (310)
T 2wqm_A 189 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSL----CKKIEQCDYPP---- 257 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHH----HHHHHTTCSCC----
T ss_pred CCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHH----HHHhhcccCCC----
Confidence 221 122346899999999999999999999999999999999999988532211 1111 11111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccccCCC
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAP 718 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p 718 (755)
+. .......+.+++.+||+.||++|||+.++++.|++..+....|
T Consensus 258 -~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 258 -LP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp -CC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred -Cc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 10 1112346889999999999999999999999999877655444
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=327.67 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=203.4
Q ss_pred hcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.++|+..+.||+|+||.||++... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 357888999999999999999654 68999999986543 3445788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999998853 345899999999999999999999986 9999999999999999999999999998764433
Q ss_pred cccccccccccCCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
.........||+.|+|||.+.+..+ +.++||||||+++|||++|+.|+........ .. ..+..... ...
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~-----~~~~~~~~--~~~-- 229 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EY-----SDWKEKKT--YLN-- 229 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HH-----HHHHTTCT--TST--
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HH-----HHhhhccc--ccC--
Confidence 2233344578999999999987765 7899999999999999999999865332211 11 11111100 000
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
........+.+++.+||+.||++|||+.|+++
T Consensus 230 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 ----PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 01122346789999999999999999999875
|
| >1nar_A Narbonin; plant SEED protein; 1.80A {Vicia narbonensis} SCOP: c.1.8.5 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=332.69 Aligned_cols=211 Identities=16% Similarity=0.141 Sum_probs=166.5
Q ss_pred eEEEEEe-cCCCCCCCCCCC------CCCcceEEEEEEEecCC-----CcEEecCCchhh-HHHHHHHHHHhhCCCceEE
Q 004402 27 WIKAGYW-LAGREFPLSDIN------SALFTHLICAFAEVDSS-----TYQLSISSANQQ-YFSIFANSVRRKNPSIKTL 93 (755)
Q Consensus 27 ~~~~gY~-~~~~~~~~~~i~------~~~~thi~~~f~~~~~~-----~~~~~~~~~~~~-~~~~~~~~~k~~~~~lk~~ 93 (755)
++-..|+ ...+.|.+++|| +.+||||+|||+.++++ ++.+.....+.. .+..+ ..+|++||++||+
T Consensus 3 ~~~~~Y~g~~~~~~~~~di~~~~~~~~~~~THi~yaFa~~~~~~~~~~~g~~~~~~~d~~~~~~~~-~~lk~~~~~~Kvl 81 (290)
T 1nar_A 3 PIFREYIGVKPNSTTLHDFPTEIINTETLEFHYILGFAIESYYESGKGTGTFEESWDVELFGPEKV-KNLKRRHPEVKVV 81 (290)
T ss_dssp CEEEEEESCCTTCCSCSSCCSTTCCCSSSEEEEEEEEEEEEECTTSCEEEEEEECSCHHHHSHHHH-HHHHHHCTTCEEE
T ss_pred cchheeeccCCCCCCHhHCCcccccCcccCcEEEEEeeeecCccccCCCceecccccccccCHHHH-HHHHHHCCCceEE
Confidence 3445677 567789999999 78999999999999863 233332222222 24444 7899999999999
Q ss_pred EEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcC------CCcccccccCCCCCCcccHHHHHH
Q 004402 94 LSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG------FQGIDLFWLWPNSTDLNSLGILLD 167 (755)
Q Consensus 94 isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~------~DGvdiDwe~p~~~~~~~~~~~l~ 167 (755)
+|||||.. +. .|+. +++++.|++|++++++++++|| |||||||||+|.. | ++|+.|++
T Consensus 82 lSiGG~~~------------s~-~fs~-~~~~~~r~~f~~s~~~~~~~~g~~~~~~fDGiDiDwE~p~~-d-~~~~~ll~ 145 (290)
T 1nar_A 82 ISIGGRGV------------NT-PFDP-AEENVWVSNAKESLKLIIQKYSDDSGNLIDGIDIHYEHIRS-D-EPFATLMG 145 (290)
T ss_dssp EEEEESST------------TS-CBCB-SCHHHHHHHHHHHHHHHHHHSEETTEECCCEEEEEESCBCS-S-TTHHHHHH
T ss_pred EEEECCCC------------CC-Ceec-cCCHHHHHHHHHHHHHHHHHhCCCcCCccceEEEeccCCCC-h-HHHHHHHH
Confidence 99966653 22 3777 5889999999999999999999 9999999999863 4 99999999
Q ss_pred HHHHHccCCC-ccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHHHH
Q 004402 168 EWKASASDQP-ELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREW 246 (755)
Q Consensus 168 ~lr~~l~~~~-~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~~~ 246 (755)
+||++|++.. .+++++++++.... .+++++.+.+++||||+|+|||||+ |.+ ..+++.+|++|
T Consensus 146 ~Lr~~l~~~~~~~~l~a~vap~~~~--~~~~~~~l~~~~D~i~vM~YD~~g~-~~~-------------~~~~~~~v~~~ 209 (290)
T 1nar_A 146 QLITELKKDDDLNINVVSIAPSENN--SSHYQKLYNAKKDYINWVDYQFSNQ-QKP-------------VSTDDAFVEIF 209 (290)
T ss_dssp HHHHHHHHCTTSCCCEEEECCCTTT--HHHHHHHHHHHTTTCCEEEEEGGGC-SSC-------------CCSHHHHHHHH
T ss_pred HHHHHhhhccCceeEEEEeCCCccc--ccCcHHHHHHhCCEEEEEeecCCCC-CCC-------------CCCHHHHHHHH
Confidence 9999998642 23677766654433 5589999999999999999999954 332 14789999999
Q ss_pred HHC--CCCCCceeecccccCCCcccC
Q 004402 247 LRR--GFPANKLVLGARASGPGITID 270 (755)
Q Consensus 247 ~~~--g~p~~KlvlG~p~yG~~~~~~ 270 (755)
++. |+|++||+||+|+||++|...
T Consensus 210 ~~~~~gvp~~Ki~lGlp~yg~~~~~~ 235 (290)
T 1nar_A 210 KSLEKDYHPHKVLPGFSTDPLDTKHN 235 (290)
T ss_dssp HHHHHHSCTTCEEEEEECCHHHHHHC
T ss_pred HHhccCCCHHHEEEEEeccCCccccC
Confidence 985 499999999999999887543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=337.83 Aligned_cols=266 Identities=26% Similarity=0.376 Sum_probs=207.8
Q ss_pred hcCCCccCcccccCCeeEEEEE-----cCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC--cc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGN-----LPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD--EN 506 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~ 506 (755)
.++|...+.||+|+||.||++. ..+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 3567888999999999999997 3468899999998877777788999999999999999999999987654 68
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999998543 235899999999999999999999986 99999999999999999999999999987
Q ss_pred cccCCccc-ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------CCcc-cchHHHHHH
Q 004402 587 FRKDVDEA-NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYG--------TSEN-LNFLEYAFE 656 (755)
Q Consensus 587 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~--------~~~~-~~~~~~~~~ 656 (755)
........ ......++..|+|||.+.+..++.++|||||||++|||+||+.|+.... .... .........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 65432211 1223456778999999998889999999999999999999998764221 0000 000001111
Q ss_pred HhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 657 QWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 657 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
...... ....+......+.+++.+||+.||++|||+.|+++.|++...
T Consensus 275 ~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 275 LLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhhcCC---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111110 001112233478899999999999999999999999987654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=331.00 Aligned_cols=269 Identities=19% Similarity=0.237 Sum_probs=206.2
Q ss_pred HhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeee-ecCCccEEEE
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC-TERDENMLIY 510 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lv~ 510 (755)
..++|+..+.||+|+||.||+|.. .+++.||||++...... +.+.+|++++..++|++++..++.+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 357899999999999999999964 67899999987554322 3578899999999988877777665 5566789999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE---cCCCCeEEEecCCcccc
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLF 587 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll---~~~~~~kl~Dfgla~~~ 587 (755)
||+ +++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999998532 335899999999999999999999987 9999999999999 78999999999999876
Q ss_pred ccCCcc-----cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC
Q 004402 588 RKDVDE-----ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 588 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.|+.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 543221 122345789999999999999999999999999999999999999976554443333322222111100
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccccCCC
Q 004402 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAP 718 (755)
Q Consensus 663 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p 718 (755)
. .. +.... +..+.+++.+||+.||++|||+.++++.|++........
T Consensus 239 ~-~~----~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 239 I-EV----LCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp H-HH----HTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred h-hh----hhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence 0 00 00111 236889999999999999999999999999866554433
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=347.82 Aligned_cols=251 Identities=22% Similarity=0.363 Sum_probs=204.2
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5688889999999999999965 479999999996542 223567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999853 345899999999999999999999986 999999999999999999999999999876432
Q ss_pred CcccccccccccCCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
. .....+||+.|+|||.+.+..+ +.++|||||||++|||++|+.|+..... .... ..+..+..
T Consensus 170 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~----~~i~~~~~------ 233 (476)
T 2y94_A 170 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTLF----KKICDGIF------ 233 (476)
T ss_dssp C---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHHH----HHHHTTCC------
T ss_pred c---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHHH----HHHhcCCc------
Confidence 2 2234578999999999988766 7899999999999999999999853221 1111 11111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhhcC
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKDD 711 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~ 711 (755)
..... ....+.+++.+||+.||++|||+.|+++ .+++.
T Consensus 234 ~~p~~----~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 234 YTPQY----LNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp CCCTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred CCCcc----CCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 01111 1236789999999999999999999996 56553
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=337.32 Aligned_cols=249 Identities=21% Similarity=0.256 Sum_probs=178.1
Q ss_pred cCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCccEEEEeecCCCC
Q 004402 440 ANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIYEYLPNKS 517 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~gs 517 (755)
.+.||+|+||.||++.. .+++.||||++... ....+.+|+.++..+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 47899999999999965 46899999999653 3456788999999996 9999999999999999999999999999
Q ss_pred hhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC---CeEEEecCCccccccCCccc
Q 004402 518 LDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL---NPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 518 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~---~~kl~Dfgla~~~~~~~~~~ 594 (755)
|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+++...... .
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~ 164 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--Q 164 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--C
Confidence 9999854 345899999999999999999999987 99999999999997765 79999999998654322 2
Q ss_pred ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS 674 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 674 (755)
......||+.|+|||.+.+..++.++|||||||++|||++|+.|+..................+..+... ....
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~ 238 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGE 238 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSH
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCcc
Confidence 2234578999999999999999999999999999999999999986544322211122222222222110 0000
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004402 675 SSPCKLLNCMQVALLCVQENPEDRPSMLEVS 705 (755)
Q Consensus 675 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 705 (755)
........+.+++.+||+.||++|||+.|++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 0011234688999999999999999999987
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=336.68 Aligned_cols=264 Identities=21% Similarity=0.307 Sum_probs=196.9
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
++|+..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 5788899999999999999965 459999999986543 3335678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999888743 335899999999999999999999987 9999999999999999999999999998754322
Q ss_pred cccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHH--------HHhccCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAF--------EQWKDSK 662 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 662 (755)
. ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.|+................ ..+....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 1 2234578999999999876 678999999999999999999999985433222111111100 0000000
Q ss_pred ---CccccCCCCCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 663 ---GKEFIDPSLDDS---SSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 663 ---~~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.....++..... ..+.....+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 001111100000 00112345789999999999999999999985
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=338.02 Aligned_cols=257 Identities=25% Similarity=0.424 Sum_probs=198.2
Q ss_pred cCCCccCcccccCCeeEEEEEcCC-----CCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPR-----GQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
++|...+.||+|+||.||+|.... +..||||++.... ......+.+|+.++.+++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456677899999999999996532 2469999997653 3445679999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 99999999999998542 345899999999999999999999987 9999999999999999999999999998765
Q ss_pred cCCccc-ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccc
Q 004402 589 KDVDEA-NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666 (755)
Q Consensus 589 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (755)
...... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.|+..... .... ........
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~----~~~~~~~~--- 268 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVM----KAINDGFR--- 268 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHH----HHHHTTCC---
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHH----HHHHCCCc---
Confidence 432211 1222345778999999999999999999999999999999 9988743221 1111 11111110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 667 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
.. ........+.+++.+||+.||++||++.++++.|++..
T Consensus 269 --~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 269 --LP----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp --CC----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --CC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 11122346889999999999999999999999998754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.02 Aligned_cols=269 Identities=27% Similarity=0.358 Sum_probs=199.7
Q ss_pred HHhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcC--CCCceeeeeeeeecC----Cc
Q 004402 432 AATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL--QHVNLLRVLGYCTER----DE 505 (755)
Q Consensus 432 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~~~~----~~ 505 (755)
...++|+..+.||+|+||.||+|+. .++.||||++..... ..+..|.+++..+ +||||+++++++... ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 3456899999999999999999987 489999999865432 3445556665554 999999999999876 67
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCceecccCCCCEEEcCCCCeEEEe
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS-----NFRVIHRDLKASNILLDNELNPKISD 580 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~-----~~~iiHrDlk~~NIll~~~~~~kl~D 580 (755)
.++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|
T Consensus 110 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred eEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 8999999999999999843 35899999999999999999999871 22499999999999999999999999
Q ss_pred cCCccccccCCccc--ccccccccCCccccccccCCCCCch------hhHHHHHHHHHHHHcCC----------CCCCCC
Q 004402 581 FGMAKLFRKDVDEA--NTGRIVGTYGYVPPEYVKKGIYSMK------YDVYSFGVLLLQIISSK----------RNARYY 642 (755)
Q Consensus 581 fgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~------sDVwS~Gvil~elltg~----------~p~~~~ 642 (755)
||+++.+....... ......||+.|+|||.+.+...+.+ +|||||||++|||+||. .|+...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 99998664432221 1224578999999999987766554 99999999999999994 444322
Q ss_pred CCCcccchHHHHHHHhccCCCccccCCCCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 004402 643 GTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS-SSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMA 714 (755)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 714 (755)
..... ............. ..+..... ........+.+++.+||+.||++|||+.|+++.|++...+
T Consensus 266 ~~~~~--~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 266 VPSDP--SYEDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp SCSSC--CHHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCCCC--chhhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 21111 1111111111111 11111111 1124566789999999999999999999999999876543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=327.26 Aligned_cols=251 Identities=22% Similarity=0.349 Sum_probs=201.7
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
.++|+..+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++......++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46788999999999999999965 46899999998654 3445577899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC---eEEEecCCcccc
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN---PKISDFGMAKLF 587 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~---~kl~Dfgla~~~ 587 (755)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999888753 345899999999999999999999987 999999999999987665 999999999865
Q ss_pred ccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.|+..... ....... ..... ...
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~----~~~~~-~~~ 227 (284)
T 3kk8_A 159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQI----KAGAY-DYP 227 (284)
T ss_dssp CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH----HHTCC-CCC
T ss_pred ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch---hHHHHHH----Hhccc-cCC
Confidence 43222 2235789999999999999999999999999999999999999843221 1111111 11110 111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+. .......+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 228 SPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chh-----hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111 1112246789999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=340.97 Aligned_cols=254 Identities=15% Similarity=0.117 Sum_probs=203.8
Q ss_pred HHhcCCCccCcccccCCeeEEEE------EcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC---CCceeeeeeeeec
Q 004402 432 AATNNFSSANKLGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ---HVNLLRVLGYCTE 502 (755)
Q Consensus 432 ~~~~~f~~~~~lG~G~~g~Vy~~------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~ 502 (755)
...++|...+.||+|+||.||+| ....++.||||++..... .++..|+.++.+++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 34577888999999999999999 355689999999976543 45677777777776 9999999999999
Q ss_pred CCccEEEEeecCCCChhhhhcCCC--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC--------
Q 004402 503 RDENMLIYEYLPNKSLDLYLFDPI--RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-------- 572 (755)
Q Consensus 503 ~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~-------- 572 (755)
.+..++|||||++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 999999999999999999985321 2456999999999999999999999986 999999999999998
Q ss_pred ---CCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccc
Q 004402 573 ---ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLN 649 (755)
Q Consensus 573 ---~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~ 649 (755)
++.+||+|||+++.+............+||+.|+|||++.+..++.++|||||||++|||+||+.|+.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 89999999999986543333333445679999999999999999999999999999999999999874322211
Q ss_pred hHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHhhcCc
Q 004402 650 FLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDR-PSMLEVSSMLKDDS 712 (755)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Pt~~evl~~L~~~~ 712 (755)
..+...+.... ....+.+++..|++.+|.+| |+++++.+.|++..
T Consensus 293 ---------------~~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 293 ---------------CKPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp ---------------EEECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred ---------------eeechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 00111111111 13356688999999999999 68899998887654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=328.93 Aligned_cols=249 Identities=27% Similarity=0.430 Sum_probs=202.1
Q ss_pred hcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeec----------
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE---------- 502 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---------- 502 (755)
.++|+..+.||+|+||.||++... +++.||+|++.... +.+.+|++++.+++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 457889999999999999999764 79999999997654 346789999999999999999998854
Q ss_pred ------CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCe
Q 004402 503 ------RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP 576 (755)
Q Consensus 503 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~ 576 (755)
....++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 34579999999999999998543 2346899999999999999999999986 9999999999999999999
Q ss_pred EEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHH
Q 004402 577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFE 656 (755)
Q Consensus 577 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 656 (755)
||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|..|+... .....
T Consensus 162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~~~ 229 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKFFT 229 (284)
T ss_dssp EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHHHH
T ss_pred EECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHHHH
Confidence 9999999987654321 22346899999999999999999999999999999999998775210 01111
Q ss_pred HhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 004402 657 QWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMA 714 (755)
Q Consensus 657 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 714 (755)
..... .+....+ ..+.+++.+||+.||++|||+.|+++.|+.....
T Consensus 230 ~~~~~--------~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 230 DLRDG--------IISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHTT--------CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred Hhhcc--------cccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 11111 1111222 3577899999999999999999999999876544
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=337.98 Aligned_cols=249 Identities=22% Similarity=0.283 Sum_probs=200.4
Q ss_pred HhcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccE
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENM 507 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 507 (755)
..++|+..+.||+|+||.||++... +++.||||++.... ....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3468899999999999999999764 48899999997542 23456788999999988 8999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
+||||+++|+|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999853 245899999999999999999999987 999999999999999999999999999854
Q ss_pred ccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.|+.... ........ ....
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i----~~~~----- 237 (353)
T 2i0e_A 172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSI----MEHN----- 237 (353)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH----HHCC-----
T ss_pred ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC---HHHHHHHH----HhCC-----
Confidence 3221 22334679999999999999999999999999999999999999985322 11111111 1111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPS-----MLEVSS 706 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 706 (755)
..+.. .....+.+++.+||+.||++||+ ++++++
T Consensus 238 -~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 238 -VAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -CCCCT----TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -CCCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11111 12346789999999999999995 466653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=338.77 Aligned_cols=246 Identities=27% Similarity=0.392 Sum_probs=196.9
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
.+.|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 34588889999999999999964 679999999987542 33456789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||+. |+|.+++.. ....+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 677777643 2346899999999999999999999987 99999999999999999999999999986532
Q ss_pred CCcccccccccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccc
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (755)
. ....||+.|+|||.+. .+.++.++|||||||++|||++|+.|+..... ....... ....
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---~~~~~~~----~~~~---- 269 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHI----AQNE---- 269 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHH----HHSC----
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHH----HhcC----
Confidence 2 2357899999999884 57789999999999999999999998743221 1111111 1111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 667 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+.+.. ......+.+++.+||+.||++|||+.++++
T Consensus 270 -~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 270 -SPALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp -CCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCCC---CCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 011111 112236789999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.06 Aligned_cols=268 Identities=22% Similarity=0.326 Sum_probs=195.7
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChhh-HHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
++|...+.||+|+||.||+|... +++.||||++....... ...+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999999999999654 68999999997543221 12456799999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
++ |+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 97 5888877542 345889999999999999999999987 9999999999999999999999999998644321
Q ss_pred ccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC---CccccC
Q 004402 593 EANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK---GKEFID 668 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d 668 (755)
.......||+.|+|||.+.+ ..++.++|||||||++|||++|+.|+...... .............. ......
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHhchhhhc
Confidence 12233467999999999876 56899999999999999999999998543322 12222222111110 000000
Q ss_pred ---------CCCCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhhcCcc
Q 004402 669 ---------PSLDDS----SSPCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKDDSM 713 (755)
Q Consensus 669 ---------~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~ 713 (755)
+..... ..+.....+.+++.+||+.||++|||+.|+++ .+.+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 000000 00112346789999999999999999999986 5555443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=333.19 Aligned_cols=270 Identities=23% Similarity=0.323 Sum_probs=205.4
Q ss_pred HHHHhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhc--CCCCceeeeeeeeecCC---
Q 004402 430 IKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTAR--LQHVNLLRVLGYCTERD--- 504 (755)
Q Consensus 430 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~--- 504 (755)
-....++|...+.||+|+||.||+|.. +|+.||||++... ..+.+.+|.+++.. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 344567899999999999999999987 6899999999654 23567788888887 79999999999998776
Q ss_pred -ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCceecccCCCCEEEcCCCCeEE
Q 004402 505 -ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY-----SNFRVIHRDLKASNILLDNELNPKI 578 (755)
Q Consensus 505 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~-----~~~~iiHrDlk~~NIll~~~~~~kl 578 (755)
..++||||+++|+|.+++.. ..+++..++.++.|++.||.|||.. ++.+++||||||+|||++.++.+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred ceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence 78999999999999999843 3589999999999999999999931 0224999999999999999999999
Q ss_pred EecCCccccccCCccc--ccccccccCCccccccccCC------CCCchhhHHHHHHHHHHHHcC----------CCCCC
Q 004402 579 SDFGMAKLFRKDVDEA--NTGRIVGTYGYVPPEYVKKG------IYSMKYDVYSFGVLLLQIISS----------KRNAR 640 (755)
Q Consensus 579 ~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~sDVwS~Gvil~elltg----------~~p~~ 640 (755)
+|||+++......... ......||+.|+|||.+.+. .++.++|||||||++|||+|| ..|+.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 9999998765432211 22345789999999998765 344789999999999999999 45553
Q ss_pred CCCCCcccchHHHHHHHhccCCCccccCCCCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 641 YYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS-SSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
....... ............. ..+.+... ........+.+++.+||+.||++|||+.|+++.|++...
T Consensus 269 ~~~~~~~--~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 269 DLVPSDP--SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp TTSCSSC--CHHHHHHHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCcCcc--cHHHHHHHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 3222111 1111111111111 11111111 123456678999999999999999999999999987543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=328.31 Aligned_cols=250 Identities=20% Similarity=0.289 Sum_probs=201.3
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
.++|...+.||+|+||.||+|.. .++..||+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 45788899999999999999965 45789999999876556678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE---cCCCCeEEEecCCcccccc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll---~~~~~~kl~Dfgla~~~~~ 589 (755)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||+ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999888853 345899999999999999999999987 9999999999999 8889999999999987653
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
.. ......||+.|+|||.+.+. ++.++||||||+++|||++|+.|+..... ..... ........ ....
T Consensus 162 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~----~~~~~~~~-~~~~ 229 (277)
T 3f3z_A 162 GK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD---SEVML----KIREGTFT-FPEK 229 (277)
T ss_dssp TS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHHCCCC-CCHH
T ss_pred cc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH---HHHHH----HHHhCCCC-CCch
Confidence 32 22334689999999998654 89999999999999999999999854221 11111 11111100 0000
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. .. .....+.+++.+||+.||++|||+.|+++
T Consensus 230 ~-~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 230 D-WL----NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp H-HT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred h-hh----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00 12346789999999999999999999984
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=352.63 Aligned_cols=248 Identities=22% Similarity=0.272 Sum_probs=192.2
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
.++|+..+.||+|+||.||++.. .+|+.||||++... .......+.+|+.++..++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 45788999999999999999964 56999999999753 333446788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE-YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~-~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
|||+++|+|..++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999988843 3468999999999999999999998 65 9999999999999999999999999998543
Q ss_pred cCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ........ ...
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~----~~~------ 365 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELIL----MEE------ 365 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH----HCC------
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHHHHH----hCC------
Confidence 221 223346799999999999999999999999999999999999999853221 11111111 111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRP-----SMLEVSS 706 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 706 (755)
..+... ....+.+++.+||+.||++|| +++|+++
T Consensus 366 ~~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 366 IRFPRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCCCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCcc----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 011111 224678999999999999999 9999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=341.68 Aligned_cols=275 Identities=15% Similarity=0.143 Sum_probs=209.0
Q ss_pred cCCCccCcccccCCeeEEEEEcCC---------CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceee----------
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPR---------GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLR---------- 495 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~---------- 495 (755)
++|...+.||+|+||.||+|.... ++.||||++... +.+.+|++++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 578889999999999999997653 789999998754 35789999999999999988
Q ss_pred -----eeeeeec-CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEE
Q 004402 496 -----VLGYCTE-RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNIL 569 (755)
Q Consensus 496 -----l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIl 569 (755)
+++++.. ....++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 5666665 56789999999 99999999643 2356999999999999999999999986 999999999999
Q ss_pred EcCCC--CeEEEecCCccccccCCcc-----cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004402 570 LDNEL--NPKISDFGMAKLFRKDVDE-----ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY 642 (755)
Q Consensus 570 l~~~~--~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~ 642 (755)
++.++ .+||+|||+++.+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.|+...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 8999999999876543211 1123357899999999999999999999999999999999999998654
Q ss_pred CCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccccCCCCCCc
Q 004402 643 GTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAPKRPA 722 (755)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~ 722 (755)
.... .........+. .....+.+..... ......+.+++.+||+.||++|||+.++++.|++............
T Consensus 272 ~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~ 345 (352)
T 2jii_A 272 LPNT--EDIMKQKQKFV-DKPGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDP 345 (352)
T ss_dssp TTCH--HHHHHHHHHHH-HSCCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSC
T ss_pred CcCH--HHHHHHHHhcc-CChhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCcc
Confidence 3221 11111111111 1111222211110 0112468899999999999999999999999998766554443333
Q ss_pred ccc
Q 004402 723 FSA 725 (755)
Q Consensus 723 ~~~ 725 (755)
++|
T Consensus 346 ~dw 348 (352)
T 2jii_A 346 IGL 348 (352)
T ss_dssp CCC
T ss_pred ccC
Confidence 433
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.74 Aligned_cols=252 Identities=24% Similarity=0.396 Sum_probs=198.2
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecC
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 514 (755)
.|.....||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 344556899999999999964 5689999999987766667789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC-CCCeEEEecCCccccccCCcc
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-ELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~ 593 (755)
+++|.+++........+++..+..++.|++.||.|||+.+ ++||||||+||+++. ++.+||+|||+++......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 177 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-- 177 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence 9999999865444445778999999999999999999986 999999999999987 8999999999998654321
Q ss_pred cccccccccCCccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGI--YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~--~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
.......||+.|+|||.+.+.. ++.++||||||+++|||++|+.|+........ .. ...... ...+.+
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~-~~~~~~-------~~~~~~ 247 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--AM-FKVGMF-------KVHPEI 247 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--HH-HHHHHH-------CCCCCC
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--HH-Hhhccc-------cccccc
Confidence 1223456899999999987643 88999999999999999999999854322111 00 000000 011112
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
... ....+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 PES----MSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CTT----SCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccc----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 222 2346789999999999999999999984
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=334.97 Aligned_cols=257 Identities=20% Similarity=0.283 Sum_probs=199.9
Q ss_pred HHHHhcCCCcc-CcccccCCeeEEEEEc-CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCC
Q 004402 430 IKAATNNFSSA-NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERD 504 (755)
Q Consensus 430 l~~~~~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 504 (755)
.+...+.|... +.||+|+||.||++.. .+++.||||++.... ......+.+|+.++.++ +||||+++++++.+.+
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 33445567666 8899999999999965 469999999987542 33467889999999999 5799999999999999
Q ss_pred ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC---CCCeEEEec
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDF 581 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~---~~~~kl~Df 581 (755)
..++||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+|||++. ++.+||+||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred eEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeC
Confidence 999999999999999988543 2346899999999999999999999987 999999999999998 789999999
Q ss_pred CCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccC
Q 004402 582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDS 661 (755)
Q Consensus 582 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 661 (755)
|+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.|+...... ....... ....
T Consensus 179 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~-~~~~- 250 (327)
T 3lm5_A 179 GMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ---ETYLNIS-QVNV- 250 (327)
T ss_dssp GGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH-HTCC-
T ss_pred ccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHH-hccc-
Confidence 9998764322 123357899999999999999999999999999999999999998542211 1111111 1000
Q ss_pred CCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 662 KGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 662 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
... ..........+.+++.+||+.||++|||+.|+++
T Consensus 251 ---~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 251 ---DYS-----EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp ---CCC-----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---ccC-----chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 000 1111122346789999999999999999999985
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=336.40 Aligned_cols=260 Identities=23% Similarity=0.291 Sum_probs=196.1
Q ss_pred cCCCcc-CcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEEEe
Q 004402 435 NNFSSA-NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 435 ~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 511 (755)
+.|... +.||+|+||.||++.. .+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 456663 7899999999999974 46999999999876666677899999999985 79999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC---eEEEecCCccccc
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN---PKISDFGMAKLFR 588 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~---~kl~Dfgla~~~~ 588 (755)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++....
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999853 345899999999999999999999986 999999999999998776 9999999998654
Q ss_pred cCCc-----ccccccccccCCccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccc--------h
Q 004402 589 KDVD-----EANTGRIVGTYGYVPPEYVKK-----GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLN--------F 650 (755)
Q Consensus 589 ~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~--------~ 650 (755)
.... ........||+.|+|||.+.. ..++.++|||||||++|||++|+.|+.......... .
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 111223468999999999875 558899999999999999999999986543222100 0
Q ss_pred HHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 651 LEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 651 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
............. .+..... ......+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~i~~~~~-~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 246 QNMLFESIQEGKY-EFPDKDW-----AHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHCCC-CCCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhccCc-ccCchhc-----ccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0111111111110 0000000 012246789999999999999999999987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=327.11 Aligned_cols=255 Identities=22% Similarity=0.343 Sum_probs=200.5
Q ss_pred hcCCCccCcccccCCeeEEEEEcCC----CCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
.++|...+.||+|+||.||+|...+ +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4578888999999999999996432 346999998765 34456789999999999999999999999865 46799
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....
T Consensus 90 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999853 2345899999999999999999999987 9999999999999999999999999998654
Q ss_pred cCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
.... .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.|+....... ....... ...
T Consensus 165 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~~~----~~~---- 232 (281)
T 3cc6_A 165 DEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVLEK----GDR---- 232 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHHHH----TCC----
T ss_pred cccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHHhc----CCC----
Confidence 3221 12223456789999999998999999999999999999998 998885433222 1211111 110
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
..... .....+.+++.+||+.||++|||+.|+++.|++.
T Consensus 233 -~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 233 -LPKPD----LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp -CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCC----CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 00111 1224688999999999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=333.99 Aligned_cols=263 Identities=23% Similarity=0.343 Sum_probs=195.8
Q ss_pred HhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC-----hhhHHHHHHHHHHHhcC---CCCceeeeeeeeecC
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-----TQGLEEFKNEVSLTARL---QHVNLLRVLGYCTER 503 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~ 503 (755)
..++|+..+.||+|+||+||+|.. .+++.||||++.... ......+.+|+.+++++ +||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999975 568999999986432 11124566777776666 599999999999765
Q ss_pred C-----ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEE
Q 004402 504 D-----ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKI 578 (755)
Q Consensus 504 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl 578 (755)
. ..++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999997 69999886432 234899999999999999999999987 999999999999999999999
Q ss_pred EecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHh
Q 004402 579 SDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQW 658 (755)
Q Consensus 579 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 658 (755)
+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.|+..... ...........
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~ 235 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---ADQLGKIFDLI 235 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH---HHHHHHHHHHH
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHh
Confidence 9999998654322 22345789999999999999999999999999999999999999854322 12222222221
Q ss_pred ccCCCccc------cCCCCCCC--C-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 659 KDSKGKEF------IDPSLDDS--S-----SPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 659 ~~~~~~~~------~d~~l~~~--~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
........ ....+... . .+.....+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 11100000 00000000 0 0112346789999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=345.05 Aligned_cols=264 Identities=22% Similarity=0.314 Sum_probs=189.8
Q ss_pred HhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCC--cc
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERD--EN 506 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~ 506 (755)
..++|+..+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999999964 56999999998653 3445567889999999997 999999999997544 68
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
++|||||+ ++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999997 588888742 36889999999999999999999987 99999999999999999999999999986
Q ss_pred cccCC-------------------cccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 004402 587 FRKDV-------------------DEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646 (755)
Q Consensus 587 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~ 646 (755)
+.... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 53211 1111234579999999999876 678999999999999999999999986432211
Q ss_pred ccchHHHHHHHhccCCCccc---------------------cCCCCCCCC------------CHHHHHHHHHHHHHcccC
Q 004402 647 NLNFLEYAFEQWKDSKGKEF---------------------IDPSLDDSS------------SPCKLLNCMQVALLCVQE 693 (755)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~---------------------~d~~l~~~~------------~~~~~~~l~~l~~~Cl~~ 693 (755)
................+ ......... .......+.+|+.+||+.
T Consensus 239 ---~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 239 ---QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp ---HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred ---HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 11111111110000000 000000000 001123678999999999
Q ss_pred CCCCCCCHHHHHHH
Q 004402 694 NPEDRPSMLEVSSM 707 (755)
Q Consensus 694 dP~~RPt~~evl~~ 707 (755)
||++|||+.|+++.
T Consensus 316 dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 316 NPNKRISANDALKH 329 (388)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=340.34 Aligned_cols=250 Identities=20% Similarity=0.248 Sum_probs=188.7
Q ss_pred cCCCcc-CcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhc-CCCCceeeeeeeeec----CCccE
Q 004402 435 NNFSSA-NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTAR-LQHVNLLRVLGYCTE----RDENM 507 (755)
Q Consensus 435 ~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~----~~~~~ 507 (755)
++|... +.||+|+||+||++.. .+|+.||||++... ..+.+|++++.+ .+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456555 6899999999999965 46899999999643 356788888754 589999999998865 55689
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC---CCCeEEEecCCc
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGMA 584 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~---~~~~kl~Dfgla 584 (755)
+|||||++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999999653 2345899999999999999999999986 999999999999998 789999999999
Q ss_pred cccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccc-hHHHHHHHhccCCC
Q 004402 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLN-FLEYAFEQWKDSKG 663 (755)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~ 663 (755)
+..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ...... .+..
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~ 284 (400)
T 1nxk_A 212 KETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQY 284 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCC
T ss_pred cccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCcc
Confidence 865432 12234578999999999999999999999999999999999999986543322111 111111 1110
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 664 KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 664 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+..+. .......+.+++.+||+.||++|||+.|+++
T Consensus 285 -~~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 285 -EFPNPE-----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp -CCCTTT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -cCCCcc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111110 1112346889999999999999999999996
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=334.86 Aligned_cols=251 Identities=23% Similarity=0.291 Sum_probs=201.9
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCCh------hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST------QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN 506 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 506 (755)
.++|+..+.||+|+||.||++.. .+|+.||||++..... ...+.+.+|+.++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 35688899999999999999965 4689999999865432 1357899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC----CeEEEecC
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL----NPKISDFG 582 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~----~~kl~Dfg 582 (755)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999854 345889999999999999999999986 99999999999999888 79999999
Q ss_pred CccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC
Q 004402 583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.|+..... ..... .+....
T Consensus 165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~----~i~~~~ 234 (321)
T 2a2a_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLA----NITSVS 234 (321)
T ss_dssp TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHH----HHHTTC
T ss_pred cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH---HHHHH----HHHhcc
Confidence 998765432 22345689999999999999999999999999999999999999853221 11111 111110
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 663 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. -.++.... .....+.+++.+||+.||++|||+.|+++
T Consensus 235 ~--~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 Y--DFDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp C--CCCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred c--ccChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 00000001 11236789999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=325.69 Aligned_cols=246 Identities=26% Similarity=0.388 Sum_probs=197.3
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
.++|+..+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 45788899999999999999964 457899999986542 22346789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999998853 245899999999999999999999886 99999999999999999999999999865432
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+...... .... ..... ..
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~----~~~~~------~~ 224 (279)
T 3fdn_A 162 S----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYK----RISRV------EF 224 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH----HHHHT------CC
T ss_pred c----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH---HHHH----HHHhC------CC
Confidence 2 223457899999999999999999999999999999999999998532211 1111 11110 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..... ....+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 225 TFPDF----VTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp CCCTT----SCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCc----CCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111 2236789999999999999999999995
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=333.63 Aligned_cols=258 Identities=26% Similarity=0.369 Sum_probs=201.8
Q ss_pred hcCCCccC-cccccCCeeEEEEEc---CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccE
Q 004402 434 TNNFSSAN-KLGEGGFGPVYKGNL---PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM 507 (755)
Q Consensus 434 ~~~f~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 507 (755)
.++|...+ .||+|+||.||+|.. ..++.||||++.... ....+.+.+|+.++..++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 34666666 899999999999943 346899999997653 33357899999999999999999999999 556789
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999854 335899999999999999999999987 999999999999999999999999999876
Q ss_pred ccCCccc-ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCcc
Q 004402 588 RKDVDEA-NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665 (755)
Q Consensus 588 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (755)
....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+..... .... ........
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~----~~~~~~~~-- 238 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVT----AMLEKGER-- 238 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHH----HHHHTTCC--
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHH----HHHHcCCC--
Confidence 5432221 1222345788999999998889999999999999999999 9988854221 1111 11111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 004402 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMA 714 (755)
Q Consensus 666 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 714 (755)
+... ......+.+++.+||+.||++|||+.++++.|++....
T Consensus 239 ---~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 239 ---MGCP----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp ---CCCC----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ---CCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1111 12234788999999999999999999999999875443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.12 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=195.2
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
++|...+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 5688899999999999999965 468999999986653 33467899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE---cCCCCeEEEecCCccccc
Q 004402 513 LPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLFR 588 (755)
Q Consensus 513 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll---~~~~~~kl~Dfgla~~~~ 588 (755)
+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999998885432 2356899999999999999999999987 9999999999999 556889999999998654
Q ss_pred cCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
... ......||+.|+|||.+. +.++.++|||||||++|||++|+.|+...... ...... ....... .
T Consensus 179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~---~~~~~~--~~~~~~~----~ 245 (285)
T 3is5_A 179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE---EVQQKA--TYKEPNY----A 245 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH--HHCCCCC----C
T ss_pred Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH---HHHhhh--ccCCccc----c
Confidence 322 223456899999999886 56899999999999999999999998532211 111111 0011000 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. .... ....+.+++.+||+.||++|||+.|+++
T Consensus 246 ~-~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 246 V-ECRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp C---CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred c-ccCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0011 1236779999999999999999999985
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=335.67 Aligned_cols=262 Identities=26% Similarity=0.364 Sum_probs=203.7
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCE--EEEEEeccC-ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQE--FAVKRLSAT-STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 509 (755)
++|...+.||+|+||.||++... ++.. ||+|.+... .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56788899999999999999653 4554 499998754 333456789999999999 899999999999999999999
Q ss_pred EeecCCCChhhhhcCCC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCe
Q 004402 510 YEYLPNKSLDLYLFDPI-------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP 576 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~ 576 (755)
|||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986532 2346899999999999999999999986 9999999999999999999
Q ss_pred EEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHH
Q 004402 577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAF 655 (755)
Q Consensus 577 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 655 (755)
||+|||+++..... .......+++.|+|||.+.+..++.++|||||||++|||+| |+.|+..... . ...
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~----~~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---A----ELY 251 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---H----HHH
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH---H----HHH
Confidence 99999999743221 11223456789999999998889999999999999999998 9988743221 1 111
Q ss_pred HHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccccCCC
Q 004402 656 EQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAP 718 (755)
Q Consensus 656 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p 718 (755)
....... .... +......+.+++.+||+.||++|||+.|+++.|++........
T Consensus 252 ~~~~~~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 305 (327)
T 1fvr_A 252 EKLPQGY-----RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 305 (327)
T ss_dssp HHGGGTC-----CCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred HHhhcCC-----CCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCc
Confidence 1211111 0111 1122346889999999999999999999999998765544333
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=337.03 Aligned_cols=242 Identities=21% Similarity=0.327 Sum_probs=199.2
Q ss_pred hcCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccCCh--------hhHHHHHHHHHHHhcCCCCceeeeeeeeecCC
Q 004402 434 TNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATST--------QGLEEFKNEVSLTARLQHVNLLRVLGYCTERD 504 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 504 (755)
.++|...+.||+|+||.||+|. ..+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 5689999999999999999996 45689999999876531 12345778999999999999999999999999
Q ss_pred ccEEEEeecCCC-ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCC
Q 004402 505 ENMLIYEYLPNK-SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM 583 (755)
Q Consensus 505 ~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl 583 (755)
..++||||+..| +|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence 999999999877 99888853 335899999999999999999999987 99999999999999999999999999
Q ss_pred ccccccCCcccccccccccCCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
++...... ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.|+.....
T Consensus 177 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------------ 235 (335)
T 3dls_A 177 AAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------------ 235 (335)
T ss_dssp CEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------------
T ss_pred ceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------------
Confidence 98764332 2234578999999999988877 8899999999999999999999843111
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 663 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
........ +......+.+++.+||+.||++|||+.|+++.
T Consensus 236 ---~~~~~~~~--~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ---TVEAAIHP--PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---GTTTCCCC--SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---HHhhccCC--CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 00122368899999999999999999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=351.17 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=204.2
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
.++|...+.||+|+||.||++.. .+|+.||||++.... ......+.+|+.+|..++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 35688889999999999999965 469999999996542 23346788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||+++|+|..++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999886532 335899999999999999999999987 99999999999999999999999999987643
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+....... ..
T Consensus 339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~---------~~ 406 (576)
T 2acx_A 339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---------PE 406 (576)
T ss_dssp TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC---------CC
T ss_pred Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc---------cc
Confidence 22 1223579999999999999999999999999999999999999986543322211111111110 01
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRP-----SMLEVSS 706 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 706 (755)
.+... ....+.+++.+||+.||++|| ++.|+++
T Consensus 407 ~~p~~----~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 EYSER----FSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CCCTT----SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred cCCcc----CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 11111 224678999999999999999 7788874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=336.72 Aligned_cols=251 Identities=21% Similarity=0.274 Sum_probs=198.0
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEEEe
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.++|+..+.||+|+||.||++.. .+|+.||||++...... +.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 45788999999999999999965 46899999999765432 35688888887 79999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC----CCeEEEecCCcccc
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE----LNPKISDFGMAKLF 587 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~----~~~kl~Dfgla~~~ 587 (755)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+.++ +.+||+|||+++..
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999998854 345899999999999999999999987 9999999999998543 34999999999876
Q ss_pred ccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.............. +..+...
T Consensus 171 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~----i~~~~~~--- 241 (342)
T 2qr7_A 171 RAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR----IGSGKFS--- 241 (342)
T ss_dssp BCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH----HHHCCCC---
T ss_pred cCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH----HccCCcc---
Confidence 44322 22345789999999999888899999999999999999999999864332222222221 1111110
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+...........+.+++.+||+.||++|||+.|+++
T Consensus 242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111122346789999999999999999999885
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.79 Aligned_cols=249 Identities=24% Similarity=0.425 Sum_probs=181.8
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35788899999999999999965 579999999986542 22346789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||+++++|.+++... ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999998643 245899999999999999999999986 99999999999999999999999999986543
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+......... ..... .+.
T Consensus 165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~------~~~ 229 (278)
T 3cok_A 165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------NKVVL------ADY 229 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCS------SCC
T ss_pred CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------HHHhh------ccc
Confidence 221 122356899999999999989999999999999999999999998643322110 00000 011
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.... .....+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 EMPS----FLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCcc----ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1111 12346789999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=326.67 Aligned_cols=261 Identities=19% Similarity=0.223 Sum_probs=197.7
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
.++|...+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 47899999999999999999975 468899999987542 33457799999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999853 245899999999999999999999987 99999999999999999999999999986543
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
... .......|++.|+|||.+.+..++.++||||||+++|||++|+.|+..... ... ....... .... .
T Consensus 187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~---~~~~~~~-~~~~--~ 255 (309)
T 2h34_A 187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL----SVM---GAHINQA-IPRP--S 255 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH----HHH---HHHHHSC-CCCG--G
T ss_pred ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH----HHH---HHHhccC-CCCc--c
Confidence 221 122345689999999999999999999999999999999999999853211 111 1111111 0000 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhcCcccc
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRP-SMLEVSSMLKDDSMAI 715 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~~~~~ 715 (755)
..... ....+.+++.+||+.||++|| +++++++.|+......
T Consensus 256 ~~~~~----~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 256 TVRPG----IPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp GTSTT----CCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred ccCCC----CCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 11111 223678999999999999999 9999999999765443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=327.99 Aligned_cols=251 Identities=27% Similarity=0.386 Sum_probs=196.1
Q ss_pred hcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC-CccEEEEee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTER-DENMLIYEY 512 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lv~e~ 512 (755)
.++|+..+.||+|+||.||++.. +|+.||||++.... ..+.+.+|+.++.+++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 35788899999999999999987 58999999987543 356789999999999999999999997654 478999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 9999999998532 2223788999999999999999999987 999999999999999999999999999854332
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
.....+++.|+|||.+.+..++.++||||||+++|||+| |+.|+...... .... ...... ....
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~----~~~~~~-----~~~~ 235 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP----RVEKGY-----KMDA 235 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHH----HHTTTC-----CCCC
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHhcCC-----CCCC
Confidence 112356889999999999999999999999999999998 88887543221 1111 111111 1111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
.. .....+.+++.+||+.||++|||+.|+++.|++..
T Consensus 236 ~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 236 PD----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cc----cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 11 22346889999999999999999999999998753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=348.24 Aligned_cols=258 Identities=21% Similarity=0.258 Sum_probs=192.2
Q ss_pred hcCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC------
Q 004402 434 TNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD------ 504 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 504 (755)
.++|+..+.||+|+||+||++. ..+++.||||++... .....+.+.+|+.+|+.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4678899999999999999995 456899999999754 3445667899999999999999999999986543
Q ss_pred ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCc
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla 584 (755)
..++||||++++ |...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 469999999865 544442 23889999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC--
Q 004402 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK-- 662 (755)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 662 (755)
+..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..............
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~---~~~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIEQLGTPCPE 285 (464)
T ss_dssp -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCSCCHH
T ss_pred eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCHH
Confidence 865432 1233467899999999999999999999999999999999999998543221 11111111111000
Q ss_pred --------CccccC---------------CCCCCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 663 --------GKEFID---------------PSLDDSS---SPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 663 --------~~~~~d---------------~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
...++. ..+.... .......+.+|+.+||+.||++|||+.|+++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 0000000 0111456889999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=331.89 Aligned_cols=266 Identities=23% Similarity=0.305 Sum_probs=195.3
Q ss_pred HHHhcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChh-----hHHHHHHHHHHHhcCCCCceeeeeeeeecCC
Q 004402 431 KAATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQ-----GLEEFKNEVSLTARLQHVNLLRVLGYCTERD 504 (755)
Q Consensus 431 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 504 (755)
....++|...+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++.+++||||+++++++...+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 344578999999999999999999764 5899999998654221 1246889999999999999999999999999
Q ss_pred ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCc
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla 584 (755)
..++||||+++ +|..++... ...+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred ceEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence 99999999986 788777542 345788899999999999999999987 999999999999999999999999999
Q ss_pred cccccCCcccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC
Q 004402 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG 663 (755)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (755)
+.+.... .......||+.|+|||.+.+. .++.++|||||||++|||++|..|+.... .................
T Consensus 160 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~---~~~~~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 160 KSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS---DLDQLTRIFETLGTPTE 234 (346)
T ss_dssp STTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCT
T ss_pred eeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHHHcCCCCh
Confidence 8764322 122345789999999998764 58999999999999999999988874322 22222222222211111
Q ss_pred cccc------CC---CCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 664 KEFI------DP---SLDDSSS-----PCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 664 ~~~~------d~---~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
.... +. ......+ ......+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 00 0000000 1123468899999999999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=332.46 Aligned_cols=275 Identities=21% Similarity=0.314 Sum_probs=198.5
Q ss_pred HHHhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 431 KAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 431 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
....++|+..+.||+|+||.||+|.... .||+|++.... ....+.+.+|+.++.+++||||+++++++.+....++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 3345688899999999999999998643 59999986542 2334567889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ ++||||||+|||++ ++.+||+|||+++...
T Consensus 107 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp ECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred EeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 99999999999998542 335888999999999999999999987 99999999999998 6799999999987653
Q ss_pred cCC---cccccccccccCCccccccccC---------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHH
Q 004402 589 KDV---DEANTGRIVGTYGYVPPEYVKK---------GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFE 656 (755)
Q Consensus 589 ~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 656 (755)
... .........||+.|+|||.+.. ..++.++|||||||++|||++|+.|+...... .. ..
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~----~~ 253 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AI----IW 253 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HH----HH
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH----HH
Confidence 211 1122233468999999999864 45789999999999999999999998532211 11 11
Q ss_pred HhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccccCCCCCCccccCCC
Q 004402 657 QWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAPKRPAFSAKGD 728 (755)
Q Consensus 657 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~~~~~~ 728 (755)
............. .. ...+.+++.+||+.||++|||+.+++++|++..........|...|+..
T Consensus 254 ~~~~~~~~~~~~~----~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~~~ 317 (319)
T 2y4i_B 254 QMGTGMKPNLSQI----GM----GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKSA 317 (319)
T ss_dssp HHHTTCCCCCCCS----SC----CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----------------
T ss_pred HhccCCCCCCCcC----CC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccccccc
Confidence 1111111111111 11 1257899999999999999999999999999877766666666666544
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=348.86 Aligned_cols=249 Identities=22% Similarity=0.338 Sum_probs=201.1
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|...+.||+|+||.||+++. .+|+.||||++.... ....+.+.+|+.++.+++||||+++++++...+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 5678889999999999999976 469999999996542 233567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 511 EYLPNKSLDLYLFDPIR-RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
||+++|+|..++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999865432 346899999999999999999999987 99999999999999999999999999987643
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ........ .
T Consensus 342 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~---~~~i~~~~------~ 410 (543)
T 3c4z_A 342 GQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL---KQRVLEQA------V 410 (543)
T ss_dssp TCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHH---HHHHHHCC------C
T ss_pred CCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHH---HHHHhhcc------c
Confidence 321 223458999999999999999999999999999999999999998654332211111 11111111 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSM 701 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 701 (755)
.... .....+.+++.+||+.||++||++
T Consensus 411 ~~p~----~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 411 TYPD----KFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CCCT----TSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred CCCc----ccCHHHHHHHHHhccCCHhHCCCC
Confidence 1111 223467899999999999999976
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=363.54 Aligned_cols=249 Identities=27% Similarity=0.390 Sum_probs=195.9
Q ss_pred CcccccCCeeEEEEEc---CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCC
Q 004402 441 NKLGEGGFGPVYKGNL---PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
+.||+|+||.||+|.. ..++.||||+++... ....+.+.+|+++|.+++||||++++++|.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999954 346789999997643 3446789999999999999999999999964 568899999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc-c
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE-A 594 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~ 594 (755)
|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999853 345899999999999999999999987 999999999999999999999999999876543222 1
Q ss_pred ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.|+...... ... ..+..... ..
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~----~~i~~~~~-----~~--- 592 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVT----AMLEKGER-----MG--- 592 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH----HHHHTTCC-----CC---
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCC-----CC---
Confidence 2223456788999999999999999999999999999999 99988543221 111 11111111 11
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
.+......+.+++..||+.||++|||+.+|+++|++.-
T Consensus 593 -~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 593 -CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11123347889999999999999999999999998643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=330.00 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=204.7
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
.++|...+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 46788899999999999999965 45889999998654 334567789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||+++++|.+++.. ...+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999988743 345899999999999999999999986 99999999999999999999999999987643
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.|+...... .... ...... .
T Consensus 194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~----~~~~~~------~ 258 (335)
T 2owb_A 194 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK---ETYL----RIKKNE------Y 258 (335)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH----HHHHTC------C
T ss_pred Ccc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH---HHHH----HHhcCC------C
Confidence 221 223457899999999999999999999999999999999999998532211 1111 111111 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhhc
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKD 710 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~ 710 (755)
.+.... ...+.+++.+||+.||++|||+.|+++ .+.+
T Consensus 259 ~~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 259 SIPKHI----NPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred CCCccC----CHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 111112 236788999999999999999999996 4554
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=338.69 Aligned_cols=248 Identities=19% Similarity=0.242 Sum_probs=190.4
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHH-HhcCCCCceeeeeeeeecCCccEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSL-TARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
.++|+..+.||+|+||.||+++. .+++.||||++.... ....+.+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 35788999999999999999965 458899999997643 2233456677776 577899999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999998853 345888999999999999999999987 9999999999999999999999999998643
Q ss_pred cCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........ .....
T Consensus 191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i----~~~~~----- 256 (373)
T 2r5t_A 191 EH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAEMYDNI----LNKPL----- 256 (373)
T ss_dssp CC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB---HHHHHHHH----HHSCC-----
T ss_pred cC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HHHHHHHH----Hhccc-----
Confidence 22 122345689999999999999999999999999999999999999985321 11111111 11110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+... ....+.+++.+||+.||++||++.+.++
T Consensus 257 -~~~~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 257 -QLKPN----ITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp -CCCSS----SCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred -CCCCC----CCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 11111 2236789999999999999999864433
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=328.57 Aligned_cols=254 Identities=21% Similarity=0.325 Sum_probs=201.5
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
.++|...+.||+|+||.||++.. .+|+.||+|++........+.+.+|+.++.+++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 45788899999999999999965 46999999999876554556789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE---cCCCCeEEEecCCcccccc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll---~~~~~~kl~Dfgla~~~~~ 589 (755)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999988843 345889999999999999999999986 9999999999999 7889999999999975432
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.|+..... ..... .+..... . ...
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~----~i~~~~~-~-~~~ 228 (304)
T 2jam_A 162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKLFE----KIKEGYY-E-FES 228 (304)
T ss_dssp B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHH----HHHHCCC-C-CCT
T ss_pred C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHH----HHHcCCC-C-CCc
Confidence 1 22335689999999999999999999999999999999999998853221 11111 1111110 0 011
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhhc
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKD 710 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~ 710 (755)
.. .......+.+++.+||+.||++|||+.|+++ .+++
T Consensus 229 ~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 229 PF----WDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp TT----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred cc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 11 1122346889999999999999999999986 4544
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=336.94 Aligned_cols=262 Identities=22% Similarity=0.302 Sum_probs=191.4
Q ss_pred HhcCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATST--QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
..++|...+.||+|+||+||++. ..+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 34689999999999999999996 45789999999975532 2345678999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc-----CCCCeEEEecCCc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-----NELNPKISDFGMA 584 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~-----~~~~~kl~Dfgla 584 (755)
|||++ |+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++
T Consensus 112 ~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99998 589888843 335899999999999999999999987 99999999999994 4556999999999
Q ss_pred cccccCCcccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC
Q 004402 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG 663 (755)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (755)
+....... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.|+..... ................
T Consensus 185 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 185 RAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE---IDQLFKIFEVLGLPDD 259 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCT
T ss_pred cccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH---HHHHHHHHHHhCCCch
Confidence 87643221 22335679999999999874 589999999999999999999999854321 1112222221111100
Q ss_pred cc---cc-----C---CCCCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 664 KE---FI-----D---PSLDDSS-----SPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 664 ~~---~~-----d---~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.. .. . +...... .......+.+++.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 00 0 0000000 0012246789999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=339.71 Aligned_cols=263 Identities=22% Similarity=0.301 Sum_probs=200.6
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
++|+..+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++.+++||||+++++++...+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 5788899999999999999965 46899999999765 344567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++++|.+++.. ...+++..+..++.+++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 113 ~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 113 MDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 999999999853 235889999999999999999999862 3999999999999999999999999999755322
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHH-----------------
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAF----------------- 655 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~----------------- 655 (755)
......||+.|+|||.+.+..++.++|||||||++|||++|+.|+................
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 2223578999999999999999999999999999999999999986432211000000000
Q ss_pred -HHh-----ccCCC----ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 656 -EQW-----KDSKG----KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 656 -~~~-----~~~~~----~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..+ ..... ..+................+.+++.+||+.||++|||+.|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000 00000 0000000000111112346889999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=346.79 Aligned_cols=261 Identities=20% Similarity=0.253 Sum_probs=204.9
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCC-CceeeeeeeeecCCccEEEEe
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH-VNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e 511 (755)
.++|...++||+|+||.||+|.. .+++.||||++...... ..+..|++++..++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 36788999999999999999964 67999999988654332 357889999999976 556666666677788899999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE---cCCCCeEEEecCCccccc
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL---DNELNPKISDFGMAKLFR 588 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll---~~~~~~kl~Dfgla~~~~ 588 (755)
|+ +++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999998532 335899999999999999999999987 9999999999999 688999999999998765
Q ss_pred cCCcc-----cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC
Q 004402 589 KDVDE-----ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG 663 (755)
Q Consensus 589 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (755)
..... .......||+.|+|||.+.+..++.++|||||||+||||++|+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 43321 1123567999999999999999999999999999999999999999765443333222222221111111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 664 KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 664 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
..+. ... ...+.+++..||+.+|++||++.+|+++|++.
T Consensus 238 ~~l~-----~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 238 EALC-----RGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHH-----TTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHh-----cCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1111 111 23688999999999999999999999999764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=325.84 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=203.7
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.+.|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 35688899999999999999964 568999999986553 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999998842 45899999999999999999999987 9999999999999999999999999998764332
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.|+..... ....... .... .+.+
T Consensus 174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~----~~~~-----~~~~ 239 (303)
T 3a7i_A 174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVLFLI----PKNN-----PPTL 239 (303)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHH----HHSC-----CCCC
T ss_pred --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHHHHh----hcCC-----CCCC
Confidence 122345789999999999999999999999999999999999998753221 1111111 1111 1112
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
.... ...+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 EGNY----SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CSSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred cccc----CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 2222 2368899999999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.10 Aligned_cols=245 Identities=22% Similarity=0.330 Sum_probs=196.3
Q ss_pred hcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT--STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 509 (755)
.++|+..+.||+|+||.||++... +++.||||++... .......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467889999999999999999664 7999999998764 233456788999999999 999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC----------------
Q 004402 510 YEYLPNKSLDLYLFDPIR-RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---------------- 572 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~---------------- 572 (755)
|||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999854322 245899999999999999999999987 999999999999984
Q ss_pred ---CCCeEEEecCCccccccCCcccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccc
Q 004402 573 ---ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL 648 (755)
Q Consensus 573 ---~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~ 648 (755)
...+||+|||++....... ...||+.|+|||.+.+. .++.++|||||||++|||++|..++... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~-- 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---D-- 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---H--
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---h--
Confidence 4479999999998654321 23589999999999766 6678999999999999999988664211 1
Q ss_pred chHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 649 NFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. ......... +.+.... ...+.+++.+||+.||++|||+.|+++
T Consensus 236 -~----~~~~~~~~~-----~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 -Q----WHEIRQGRL-----PRIPQVL----SQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -H----HHHHHTTCC-----CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -H----HHHHHcCCC-----CCCCccc----CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1 111111111 1111122 246889999999999999999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=327.17 Aligned_cols=259 Identities=22% Similarity=0.315 Sum_probs=202.1
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeec--CCccEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE--RDENML 508 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 508 (755)
.++|+..+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 35788899999999999999965 46899999999754 34456779999999999999999999998753 567899
Q ss_pred EEeecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 509 IYEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYS--NFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~--~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ..+++||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999986432 2345899999999999999999999975 2349999999999999999999999999998
Q ss_pred ccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcc
Q 004402 586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665 (755)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (755)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+..... .... ..+......
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~----~~i~~~~~~- 234 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELA----GKIREGKFR- 234 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHTCCC-
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHH----HHHhhcccc-
Confidence 6543221 12235689999999999999999999999999999999999998854321 1111 111111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 666 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
.+... ....+.+++.+||+.||++|||+.|+++.+..
T Consensus 235 ----~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 235 ----RIPYR----YSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ----CCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ----cCCcc----cCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11111 23468899999999999999999999987754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=336.50 Aligned_cols=264 Identities=22% Similarity=0.332 Sum_probs=196.7
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
++|+..+.||+|+||.||++.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 5688899999999999999965 458999999986543 3335668899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 105 FVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp CCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999999887643 235899999999999999999999987 9999999999999999999999999998654322
Q ss_pred cccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHH--------HHHHhcc-C
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEY--------AFEQWKD-S 661 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~-~ 661 (755)
. ......||+.|+|||.+.+. .++.++|||||||++|||++|+.|+.............. ....+.. .
T Consensus 179 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 179 E--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred c--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 1 22235689999999998775 789999999999999999999998854332211110000 0000000 0
Q ss_pred CCccccCCCCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 662 KGKEFIDPSLDDSSS-----PCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 662 ~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.......+.+..... +.....+.+++.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 001111111111111 112346889999999999999999999885
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.94 Aligned_cols=254 Identities=21% Similarity=0.304 Sum_probs=200.1
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCCh------hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST------QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM 507 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 507 (755)
++|+..+.||+|+||.||++... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888999999999999999764 689999999865421 23678999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC----CeEEEecCC
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL----NPKISDFGM 583 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~----~~kl~Dfgl 583 (755)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999853 345899999999999999999999986 99999999999998877 899999999
Q ss_pred ccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG 663 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (755)
+....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+..... .... ..+.....
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~----~~~~~~~~ 228 (283)
T 3bhy_A 159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK---QETL----TNISAVNY 228 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHH----HHHHTTCC
T ss_pred ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch---HHHH----HHhHhccc
Confidence 98654322 12234689999999999999999999999999999999999998853221 1111 11111100
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhhc
Q 004402 664 KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKD 710 (755)
Q Consensus 664 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~ 710 (755)
. ..+.... .....+.+++.+||+.||++|||+.|+++ .+++
T Consensus 229 ~--~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 229 D--FDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp C--CCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred C--Ccchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 0 0000001 11236789999999999999999999996 4443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=329.57 Aligned_cols=264 Identities=24% Similarity=0.376 Sum_probs=185.2
Q ss_pred HhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
..++|...+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++.+++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 356888999999999999999965 468999999986543 334567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCC-----CccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 511 EYLPNKSLDLYLFDP-----IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 511 e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
||+++++|.+++... .....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999988531 12345899999999999999999999986 9999999999999999999999999998
Q ss_pred ccccCCc---ccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccC
Q 004402 586 LFRKDVD---EANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDS 661 (755)
Q Consensus 586 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 661 (755)
....... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.|+....... ............
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~ 246 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VLMLTLQNDPPS 246 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHHHHHTSSCCC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HHHHHhccCCCc
Confidence 6543221 111234578999999999875 568999999999999999999999986443221 111111100000
Q ss_pred CCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 662 KGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 662 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
......++...... ...+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 247 LETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00111111121222 236789999999999999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=337.36 Aligned_cols=254 Identities=22% Similarity=0.293 Sum_probs=200.5
Q ss_pred cCCCccCcccccCCeeEEEEEc----CCCCEEEEEEeccCC----hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCc
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL----PRGQEFAVKRLSATS----TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDE 505 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 505 (755)
++|+..+.||+|+||.||++.. .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5788899999999999999976 478999999986532 22345677899999999 79999999999999999
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999853 345899999999999999999999986 9999999999999999999999999998
Q ss_pred ccccCCcccccccccccCCccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC
Q 004402 586 LFRKDVDEANTGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG 663 (755)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (755)
.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.|+...........+.... ...
T Consensus 208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~~-- 281 (355)
T 1vzo_A 208 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI---LKS-- 281 (355)
T ss_dssp ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH---HHC--
T ss_pred ecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH---hcc--
Confidence 6543222 22334579999999999985 347899999999999999999999986544332221111111 100
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 004402 664 KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRP-----SMLEVSSML 708 (755)
Q Consensus 664 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~L 708 (755)
.+... ......+.+++.+||+.||++|| ++.|+++..
T Consensus 282 ----~~~~~----~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 ----EPPYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----CCCCC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----CCCCC----cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11111 12234678999999999999999 999998654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=322.96 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=202.6
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|...+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888899999999999999654 57899999986542 223467899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999998853 235899999999999999999999986 999999999999999999999999999765332
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
......|++.|+|||.+.+..++.++||||||+++|||++|+.|+..... .... ...... +..
T Consensus 168 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~----~~~~~~------~~~ 230 (284)
T 2vgo_A 168 ----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH---TETH----RRIVNV------DLK 230 (284)
T ss_dssp ----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHH----HHHHTT------CCC
T ss_pred ----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH---hHHH----HHHhcc------ccC
Confidence 12235689999999999999999999999999999999999999853221 1111 111111 111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhhcC
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKDD 711 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~ 711 (755)
+.. .....+.+++.+||+.||++|||+.|+++ .++..
T Consensus 231 ~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 231 FPP----FLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp CCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred CCC----cCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 111 12246789999999999999999999985 55543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=336.68 Aligned_cols=263 Identities=19% Similarity=0.254 Sum_probs=195.0
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC------
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD------ 504 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 504 (755)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46788999999999999999965 56999999998653 3344567899999999999999999999987653
Q ss_pred ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCc
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla 584 (755)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 359999999 7899988843 35889999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccC--
Q 004402 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDS-- 661 (755)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 661 (755)
+..... .....+|+.|+|||.+.+ ..++.++|||||||+++||++|+.||....... .+..........
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKVTGTPPA 247 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCH
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence 875432 223578999999999877 679999999999999999999999985432211 111111110000
Q ss_pred ---------C-------CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhhcCcc
Q 004402 662 ---------K-------GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKDDSM 713 (755)
Q Consensus 662 ---------~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~ 713 (755)
. ........+.. ........+.+++.+||+.||++|||+.|+++ .+++...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 0 00000000000 01112346789999999999999999999997 4655433
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=343.96 Aligned_cols=194 Identities=21% Similarity=0.365 Sum_probs=153.2
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC-----Ccc
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER-----DEN 506 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 506 (755)
++|+..+.||+|+||+||+|.. .+++.||||++... .....+.+.+|+++|++++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 6799999999999999999964 46899999998654 334557899999999999999999999998443 468
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
++||||+ +++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 133 ~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence 9999998 4688888753 345899999999999999999999987 99999999999999999999999999987
Q ss_pred cccCCcc-------------------------cccccccccCCccccccc-cCCCCCchhhHHHHHHHHHHHHcC
Q 004402 587 FRKDVDE-------------------------ANTGRIVGTYGYVPPEYV-KKGIYSMKYDVYSFGVLLLQIISS 635 (755)
Q Consensus 587 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDVwS~Gvil~elltg 635 (755)
....... ......+||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 6432111 112345789999999976 566799999999999999999994
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=341.70 Aligned_cols=253 Identities=21% Similarity=0.290 Sum_probs=190.0
Q ss_pred HHhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC--------hhhHHHHHHHHHHHhcCCCCceeeeeeeeec
Q 004402 432 AATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--------TQGLEEFKNEVSLTARLQHVNLLRVLGYCTE 502 (755)
Q Consensus 432 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 502 (755)
...++|...+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+|++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3467899999999999999999954 568999999986532 1122358899999999999999999999854
Q ss_pred CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC---CeEEE
Q 004402 503 RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL---NPKIS 579 (755)
Q Consensus 503 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~---~~kl~ 579 (755)
+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred -CceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 457999999999999988853 345899999999999999999999987 99999999999997544 59999
Q ss_pred ecCCccccccCCcccccccccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHH
Q 004402 580 DFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFE 656 (755)
Q Consensus 580 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 656 (755)
|||+++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.|+....... ......
T Consensus 285 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i-- 357 (419)
T 3i6u_A 285 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI-- 357 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHH--
T ss_pred ecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHH--
Confidence 99999875432 1223457899999999985 3678899999999999999999999986433221 111111
Q ss_pred HhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 657 QWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 657 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
...... .. +.... .....+.+++.+||+.||++|||+.|+++
T Consensus 358 --~~~~~~-~~-~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 358 --TSGKYN-FI-PEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp --HTTCCC-CC-HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --hcCCCC-CC-chhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 111100 00 00000 12346789999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=323.87 Aligned_cols=248 Identities=24% Similarity=0.357 Sum_probs=202.2
Q ss_pred hcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
.++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357888899999999999999654 5889999998654 334567789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999988743 345899999999999999999999986 99999999999999999999999999987543
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+....... . ........ .
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~----~~~~~~~~------~ 232 (294)
T 2rku_A 168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---T----YLRIKKNE------Y 232 (294)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---H----HHHHHTTC------C
T ss_pred Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H----HHHHhhcc------C
Confidence 221 2233568999999999999899999999999999999999999985322111 1 11111111 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+... ....+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 SIPKH----INPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp CCCTT----SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCccc----cCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 11111 2236789999999999999999999996
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=320.24 Aligned_cols=255 Identities=20% Similarity=0.253 Sum_probs=198.1
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC----hhhHHHHHHHHHHHhcCCCCceeeeeeeee--cCCcc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS----TQGLEEFKNEVSLTARLQHVNLLRVLGYCT--ERDEN 506 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~ 506 (755)
.++|...+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46899999999999999999976 468999999996542 234577999999999999999999999984 44578
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
++||||++++ |.+++... ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999887 65665432 2346899999999999999999999987 99999999999999999999999999987
Q ss_pred cccCCcccccccccccCCccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCc
Q 004402 587 FRKDVDEANTGRIVGTYGYVPPEYVKKGI--YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664 (755)
Q Consensus 587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (755)
..............||+.|+|||.+.+.. ++.++|||||||++|||++|+.|+.... ..... ..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~----~~i~~~~-- 229 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---IYKLF----ENIGKGS-- 229 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHH----HHHHHCC--
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch---HHHHH----HHHhcCC--
Confidence 65433333333456899999999987644 4789999999999999999999985321 11111 1111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhhc
Q 004402 665 EFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKD 710 (755)
Q Consensus 665 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~ 710 (755)
..+... ....+.+++.+||+.||++|||+.|+++ .+++
T Consensus 230 ----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 230 ----YAIPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp ----CCCCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred ----CCCCCc----cCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence 011111 2236789999999999999999999995 4554
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=339.57 Aligned_cols=199 Identities=22% Similarity=0.377 Sum_probs=165.6
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC-----Cc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER-----DE 505 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 505 (755)
.++|...+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+++|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 45888999999999999999964 56889999999754 334456899999999999999999999998766 56
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
.++||||++ |+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999986 599888853 345899999999999999999999987 9999999999999999999999999999
Q ss_pred ccccCCcc--------------------cccccccccCCccccccc-cCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004402 586 LFRKDVDE--------------------ANTGRIVGTYGYVPPEYV-KKGIYSMKYDVYSFGVLLLQIISSKRNA 639 (755)
Q Consensus 586 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDVwS~Gvil~elltg~~p~ 639 (755)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 76433211 112456789999999986 5667999999999999999999865544
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=334.75 Aligned_cols=257 Identities=21% Similarity=0.368 Sum_probs=203.1
Q ss_pred HHHHHHhcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCCh--------hhHHHHHHHHHHHhcC-CCCceeeee
Q 004402 428 SDIKAATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST--------QGLEEFKNEVSLTARL-QHVNLLRVL 497 (755)
Q Consensus 428 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~ 497 (755)
.......++|...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334455678999999999999999999764 699999999865431 2245688999999999 799999999
Q ss_pred eeeecCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeE
Q 004402 498 GYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPK 577 (755)
Q Consensus 498 g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~k 577 (755)
+++......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+|
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 999999999999999999999999853 345899999999999999999999986 99999999999999999999
Q ss_pred EEecCCccccccCCcccccccccccCCccccccccC------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchH
Q 004402 578 ISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK------GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFL 651 (755)
Q Consensus 578 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~ 651 (755)
|+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|+.... .....
T Consensus 241 l~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~ 314 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILML 314 (365)
T ss_dssp ECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH
T ss_pred EEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HHHHH
Confidence 99999998765332 2234578999999998863 358899999999999999999999985321 11111
Q ss_pred HHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 652 EYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 652 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.... ..... ...+.. . .....+.+++.+||+.||++|||+.|+++
T Consensus 315 ~~i~----~~~~~-~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 315 RMIM----EGQYQ-FSSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHH----HTCCC-CCHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHH----hCCCC-CCCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 11100 000000 0 11236789999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=345.86 Aligned_cols=242 Identities=16% Similarity=0.202 Sum_probs=186.9
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHH---HHHhcCCCCceeeee-------ee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEV---SLTARLQHVNLLRVL-------GY 499 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------g~ 499 (755)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+ +.+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 35678889999999999999975 56999999998743 344567899999 555566899999998 55
Q ss_pred eecCC-----------------ccEEEEeecCCCChhhhhcCCCc----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 004402 500 CTERD-----------------ENMLIYEYLPNKSLDLYLFDPIR----RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558 (755)
Q Consensus 500 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~i 558 (755)
+...+ ..++||||+ +|+|.+++..... ...+++..++.++.||+.||.|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 54442 278999999 6899999854211 122446888899999999999999987 9
Q ss_pred eecccCCCCEEEcCCCCeEEEecCCccccccCCcccccccccccCCccccccccCC-----------CCCchhhHHHHHH
Q 004402 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG-----------IYSMKYDVYSFGV 627 (755)
Q Consensus 559 iHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDVwS~Gv 627 (755)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999985322 2223467 999999999887 8999999999999
Q ss_pred HHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 628 LLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 628 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
++|||++|+.|+......... ..+.. .. ... ...+.+++.+||+.||++|||+.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~~---------------~~~~~-~~-~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGS---------------EWIFR-SC-KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCS---------------GGGGS-SC-CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccch---------------hhhhh-hc-cCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999998543222111 01111 00 111 236889999999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=337.56 Aligned_cols=269 Identities=23% Similarity=0.298 Sum_probs=198.0
Q ss_pred CHHHHHHHhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCC-----------hhhHHHHHHHHHHHhcCCCCcee
Q 004402 426 SFSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATS-----------TQGLEEFKNEVSLTARLQHVNLL 494 (755)
Q Consensus 426 ~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~H~niv 494 (755)
...++....++|...+.||+|+||.||+|...+|+.||||++.... ....+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4567788889999999999999999999988889999999985432 12247899999999999999999
Q ss_pred eeeeeeecC-----CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEE
Q 004402 495 RVLGYCTER-----DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNIL 569 (755)
Q Consensus 495 ~l~g~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIl 569 (755)
++++++... ...++||||++ |+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999998442 35799999998 678777753 2346899999999999999999999987 999999999999
Q ss_pred EcCCCCeEEEecCCccccccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccc
Q 004402 570 LDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL 648 (755)
Q Consensus 570 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~ 648 (755)
++.++.+||+|||+++...... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.|+......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--- 240 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY--- 240 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---
T ss_pred EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH---
Confidence 9999999999999998543322 2234578899999999876 67899999999999999999999998543211
Q ss_pred chHHHHHHHhccCC-----------CccccCCCCCCC-------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 649 NFLEYAFEQWKDSK-----------GKEFIDPSLDDS-------SSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 649 ~~~~~~~~~~~~~~-----------~~~~~d~~l~~~-------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.............. ..+.+...+... ..+.....+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 11111111111000 000111111000 00112346789999999999999999999985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=333.41 Aligned_cols=266 Identities=18% Similarity=0.298 Sum_probs=196.5
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--------
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER-------- 503 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 503 (755)
++|+..+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5788899999999999999965 579999999986543 22345788999999999999999999998763
Q ss_pred CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCC
Q 004402 504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM 583 (755)
Q Consensus 504 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl 583 (755)
+..++||||+++ +|...+... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 457999999985 666666432 235899999999999999999999987 99999999999999999999999999
Q ss_pred ccccccCCc--ccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhcc
Q 004402 584 AKLFRKDVD--EANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKD 660 (755)
Q Consensus 584 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 660 (755)
++.+..... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.|+...........+.........
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 987643221 122334578999999998876 56899999999999999999999988543222111111111100000
Q ss_pred CCCcc-----ccCCC-C--CCCCCH-HH------HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 661 SKGKE-----FIDPS-L--DDSSSP-CK------LLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 661 ~~~~~-----~~d~~-l--~~~~~~-~~------~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..... ..+.. . ...... .. ...+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 00000 00000 0 000000 00 234779999999999999999999886
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=327.53 Aligned_cols=255 Identities=16% Similarity=0.270 Sum_probs=196.9
Q ss_pred cCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCceeeeeeeeec--CCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTE--RDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lv~ 510 (755)
++|+..+.||+|+||.||+|. ..+++.||||++.... .+.+.+|+.++.+++ ||||+++++++.. ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 578889999999999999995 4679999999997543 467889999999997 9999999999987 55689999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC-CeEEEecCCcccccc
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDFGMAKLFRK 589 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~-~~kl~Dfgla~~~~~ 589 (755)
||+++++|..++. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+++....
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999998873 3788999999999999999999987 99999999999999776 899999999987643
Q ss_pred CCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhcc--------
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKD-------- 660 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------- 660 (755)
... .....+|..|+|||.+.+ ..++.++|||||||++|||++|+.|+...... ...+.........
T Consensus 184 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 184 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHHH
T ss_pred CCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch--HHHHHHHHHhcCCchhhhHHH
Confidence 322 233468899999999877 67899999999999999999999998432221 1111111110000
Q ss_pred -C--------------CCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 661 -S--------------KGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 661 -~--------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. .....................+.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 000000011111111223457889999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=327.40 Aligned_cols=257 Identities=25% Similarity=0.364 Sum_probs=194.4
Q ss_pred cCCCccCcccccCCeeEEEEEcC--CCC--EEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP--RGQ--EFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM 507 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 507 (755)
++|+..+.||+|+||.||+|... +++ .||||++... .....+.+.+|+.++.+++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 57888999999999999999642 333 6899998654 3345678999999999999999999999998754 89
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
+|+||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 97 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 999999999999998542 245889999999999999999999986 999999999999999999999999999876
Q ss_pred ccCCcc-cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCcc
Q 004402 588 RKDVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665 (755)
Q Consensus 588 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (755)
...... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .... ........
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~----~~~~~~~~-- 242 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQIL----HKIDKEGE-- 242 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHH----HHHHTSCC--
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHHH----HHHHccCC--
Confidence 543222 12233456788999999998889999999999999999999 8888753321 1111 11111110
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 666 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
.... .......+.+++.+||+.||++|||+.++++.|++..
T Consensus 243 --~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 243 --RLPR----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp --CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred --CCCC----CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 0011 1122346889999999999999999999999998754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=324.92 Aligned_cols=252 Identities=23% Similarity=0.390 Sum_probs=196.6
Q ss_pred hcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
.++|+..+.||+|+||.||+|... +++.||+|++........+.+.+|+.++..++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467888999999999999999764 5899999999877666778899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+++++|..++... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 98 CPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 9999999887532 345899999999999999999999986 9999999999999999999999999986432111
Q ss_pred ccccccccccCCccccccc-----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 593 EANTGRIVGTYGYVPPEYV-----KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~-----~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
.......||+.|+|||.+ ....++.++|||||||++|||++|+.|+...... .... ...........
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~----~~~~~~~~~~~ 243 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLL----KIAKSDPPTLL 243 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH----HHHHSCCCCCS
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHH----HHhccCCcccC
Confidence 112234689999999988 4677899999999999999999999988543211 1111 11111111100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
........+.+++.+||+.||++|||+.++++
T Consensus 244 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 -------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11122346889999999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.43 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=184.9
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC-h-hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-T-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
.++|+..+.||+|+||.||++.. .+|+.||||++.... . ...+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46788899999999999999965 578999999997652 2 22334555666688889999999999999999999999
Q ss_pred eecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 511 EYLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGLLYLQEY-SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 511 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~Lh~~-~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
||++ |+|.+++... .....+++..+..++.|++.||.|||+. + ++||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 5887776432 1235689999999999999999999997 6 9999999999999999999999999998654
Q ss_pred cCCcccccccccccCCccccccc----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCc
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYV----KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (755)
.... .....||+.|+|||.+ .+..++.++|||||||++|||++|+.|+...... ..... ...... ..
T Consensus 162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~---~~~~~~-~~ 232 (290)
T 3fme_A 162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP--FQQLK---QVVEEP-SP 232 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH--HHHHH---HHHHSC-CC
T ss_pred cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch--HHHHH---HHhccC-CC
Confidence 3322 2234689999999996 5667899999999999999999999998543221 11111 111111 11
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 665 EFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 665 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. .. .......+.+++.+||+.||++|||+.|+++
T Consensus 233 ~-----~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 233 Q-----LP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp C-----CC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C-----cc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1 10 1112346889999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=317.38 Aligned_cols=246 Identities=20% Similarity=0.365 Sum_probs=192.7
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57888899999999999999764 69999999986542 234567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 91 EYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp ECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999853 235889999999999999999999987 999999999999999999999999999865432
Q ss_pred CcccccccccccCCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
. ......+++.|+|||.+.+..+ +.++||||||+++|||++|+.|+..... ... ........ .
T Consensus 165 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~----~~~~~~~~------~ 228 (276)
T 2h6d_A 165 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---PTL----FKKIRGGV------F 228 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH----HHHHHHCC------C
T ss_pred c---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHH----HHHhhcCc------c
Confidence 1 1223468999999999987765 6899999999999999999998853211 111 11111111 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+... ....+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 YIPEY----LNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp CCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCchh----cCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 01111 1236789999999999999999999996
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=345.98 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=198.6
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
.++|...+.||+|+||+||++.. .+++.||||++... .......+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 45788999999999999999965 46899999998643 2234578899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc---CCCCeEEEecCCcccc
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD---NELNPKISDFGMAKLF 587 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~---~~~~~kl~Dfgla~~~ 587 (755)
|||++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 101 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999888753 345899999999999999999999987 99999999999995 4567999999999865
Q ss_pred ccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.|+..... ....... ...... .
T Consensus 175 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i----~~~~~~--~ 241 (486)
T 3mwu_A 175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRV----ETGKYA--F 241 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH----HHTCCC--S
T ss_pred CCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH----HhCCCC--C
Confidence 4322 2234578999999999876 599999999999999999999999853221 1111111 111100 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+ ..........+.+++.+||+.||++|||+.|+++
T Consensus 242 ~----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 242 D----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp C----SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C----CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 0001122346789999999999999999999996
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=331.57 Aligned_cols=257 Identities=22% Similarity=0.344 Sum_probs=196.3
Q ss_pred HHHHHHhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCC--CCceeeeeeeeecC
Q 004402 428 SDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQ--HVNLLRVLGYCTER 503 (755)
Q Consensus 428 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~ 503 (755)
+.+....++|...+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++ ||||+++++++...
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 3334456789999999999999999998888999999998654 3445678999999999996 59999999999999
Q ss_pred CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCC
Q 004402 504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM 583 (755)
Q Consensus 504 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl 583 (755)
+..++||| +.+++|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||||+|||+++ +.+||+|||+
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred CEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccc
Confidence 99999999 668899999853 345889999999999999999999986 999999999999975 8999999999
Q ss_pred ccccccCCcccccccccccCCccccccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHH
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKK-----------GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLE 652 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~ 652 (755)
++...............||+.|+|||.+.+ ..++.++|||||||++|||++|+.|+...... ..
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~ 247 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----IS 247 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HH
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HH
Confidence 987654333323334578999999999875 47889999999999999999999998532211 11
Q ss_pred HHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 653 YAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 653 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
....... +......+......+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 248 KLHAIID---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHHHHC---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHh---------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 1111111 11111111111246789999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=347.07 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=195.1
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
.++|...+.||+|+||+||++.. .+++.||||++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45688999999999999999965 468999999987543 233567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC---CCeEEEecCCcccc
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE---LNPKISDFGMAKLF 587 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~---~~~kl~Dfgla~~~ 587 (755)
|||++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++..
T Consensus 116 e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999888743 345899999999999999999999987 9999999999999764 45999999999876
Q ss_pred ccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
.... ......||+.|+|||++. +.++.++|||||||++|||++|+.|+..... ....... ..... .+.
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i----~~~~~-~~~ 257 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD---QEILRKV----EKGKY-TFD 257 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH----HHTCC-CCC
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH----HhCCC-CCC
Confidence 5332 223457899999999886 5699999999999999999999999854322 1111111 11110 001
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+.. . .....+.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~-~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 SPEW-K----NVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp SGGG-T----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhc-c----cCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 1111 1 12246789999999999999999999984
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.00 Aligned_cols=248 Identities=24% Similarity=0.368 Sum_probs=194.9
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeec----CCccEE
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE----RDENML 508 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~l 508 (755)
.|...+.||+|+||.||+|.. .++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 356677899999999999965 56889999998654 34456789999999999999999999998865 345799
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc-CCCCeEEEecCCcccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLF 587 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~-~~~~~kl~Dfgla~~~ 587 (755)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ .+++||||||+|||++ .++.+||+|||++...
T Consensus 107 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 9999999999999853 245889999999999999999999874 3599999999999998 7899999999999754
Q ss_pred ccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
... ......||+.|+|||.+.+ .++.++|||||||++|||++|+.|+....... ...............
T Consensus 183 ~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~ 251 (290)
T 1t4h_A 183 RAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPASF 251 (290)
T ss_dssp CTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCGGG
T ss_pred ccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH------HHHHHHhccCCcccc
Confidence 332 2223568999999998864 58999999999999999999999985322211 111111111111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+ . .....+.+++.+||+.||++|||+.|+++
T Consensus 252 ~----~----~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 252 D----K----VAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G----G----CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C----C----CCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 1 11236889999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=321.29 Aligned_cols=251 Identities=21% Similarity=0.316 Sum_probs=200.5
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---------hhhHHHHHHHHHHHhcCC-CCceeeeeeeeec
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---------TQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTE 502 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~ 502 (755)
.++|...+.||+|+||.||++.. .+|+.||||++.... ....+.+.+|+.++.++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 46788899999999999999965 468999999986543 123457889999999995 9999999999999
Q ss_pred CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecC
Q 004402 503 RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFG 582 (755)
Q Consensus 503 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg 582 (755)
....++||||+++++|.+++.. +..+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999853 346899999999999999999999987 9999999999999999999999999
Q ss_pred CccccccCCcccccccccccCCcccccccc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHH
Q 004402 583 MAKLFRKDVDEANTGRIVGTYGYVPPEYVK------KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFE 656 (755)
Q Consensus 583 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 656 (755)
++....... ......+++.|+|||.+. ...++.++||||||+++|||++|+.|+..... .......
T Consensus 170 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~-- 241 (298)
T 1phk_A 170 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLRMI-- 241 (298)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH--
T ss_pred chhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH---HHHHHHH--
Confidence 998764322 222356899999999885 45689999999999999999999998853221 1111111
Q ss_pred HhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 657 QWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 657 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..... . ............+.+++.+||+.||++|||+.|+++
T Consensus 242 --~~~~~-~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 242 --MSGNY-Q-----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp --HHTCC-C-----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --hcCCc-c-----cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11110 0 001111123346889999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=337.27 Aligned_cols=253 Identities=13% Similarity=0.103 Sum_probs=178.0
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCCh---hhHHHHHHHHHHHhcC--CCCceeeee-------eeee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST---QGLEEFKNEVSLTARL--QHVNLLRVL-------GYCT 501 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~H~niv~l~-------g~~~ 501 (755)
.+|...+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.++..+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4577889999999999999975 4789999999987542 3345677885444444 699988755 3332
Q ss_pred cC-----------------CccEEEEeecCCCChhhhhcCCCccCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCc
Q 004402 502 ER-----------------DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKR------VNIIEGVTQGLLYLQEYSNFRV 558 (755)
Q Consensus 502 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~l~~Lh~~~~~~i 558 (755)
.. ...++|||||+ |+|.+++.... ..+.+..+ ..++.||+.||+|||+.+ |
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i 215 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence 22 23799999999 89999986431 23444555 788899999999999987 9
Q ss_pred eecccCCCCEEEcCCCCeEEEecCCccccccCCcccccccccccCCccccccccC--CCCCchhhHHHHHHHHHHHHcCC
Q 004402 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSK 636 (755)
Q Consensus 559 iHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvil~elltg~ 636 (755)
+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||.+.+ ..++.++|||||||++|||+||+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999865321 113456799999999987 67999999999999999999999
Q ss_pred CCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 637 RNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 637 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.|+.......... +........................+.+++.+||+.||++|||+.|+++
T Consensus 291 ~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9986543221100 0000000000111111111123347889999999999999999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=333.40 Aligned_cols=262 Identities=19% Similarity=0.275 Sum_probs=183.7
Q ss_pred hcCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC------C
Q 004402 434 TNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER------D 504 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 504 (755)
.++|...+.||+|+||.||+|. ..+|+.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 3688999999999999999996 456899999998654 334456789999999999999999999998654 4
Q ss_pred ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCc
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla 584 (755)
..++|+|++ +++|..++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 579999999 6899887742 45899999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC-
Q 004402 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK- 662 (755)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 662 (755)
+..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+...........
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPGA 251 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCH
T ss_pred cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCH
Confidence 864322 223578999999999876 67899999999999999999999998543321 11111111111000
Q ss_pred ----------CccccCCCCC-CCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhhcC
Q 004402 663 ----------GKEFIDPSLD-DSSS-----PCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKDD 711 (755)
Q Consensus 663 ----------~~~~~d~~l~-~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~ 711 (755)
...++..... .... ......+.+|+.+||+.||++|||+.|+++ .+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 0000000000 0000 011235789999999999999999999986 34443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=331.87 Aligned_cols=262 Identities=20% Similarity=0.284 Sum_probs=198.6
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecC-----Ccc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER-----DEN 506 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 506 (755)
.++|+..+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 45788999999999999999964 468899999997543 34457789999999999999999999998654 357
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
++|+||++ |+|.+++. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 58888874 235899999999999999999999987 99999999999999999999999999987
Q ss_pred cccCCccc-ccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCc
Q 004402 587 FRKDVDEA-NTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664 (755)
Q Consensus 587 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (755)
........ ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.|+........ ..............
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQE 254 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHCSCCHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhCCCCHH
Confidence 65432221 1234578999999998654 5589999999999999999999999854332222 11111111110000
Q ss_pred -----------cccCCCC-CCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 665 -----------EFIDPSL-DDSS-----SPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 665 -----------~~~d~~l-~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
....... .... .......+.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 0000 0112246789999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=348.23 Aligned_cols=250 Identities=26% Similarity=0.355 Sum_probs=197.3
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCCh-------------hhHHHHHHHHHHHhcCCCCceeeeeee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST-------------QGLEEFKNEVSLTARLQHVNLLRVLGY 499 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~g~ 499 (755)
.++|...+.||+|+||+||+|.. .+++.||||++..... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 56899999999999999999965 4588999999865421 235678999999999999999999999
Q ss_pred eecCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC---Ce
Q 004402 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL---NP 576 (755)
Q Consensus 500 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~---~~ 576 (755)
+.+....++|||||++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999888853 345899999999999999999999987 99999999999998776 69
Q ss_pred EEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHH
Q 004402 577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFE 656 (755)
Q Consensus 577 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 656 (755)
||+|||+++...... ......||+.|+|||++. +.++.++|||||||++|||++|+.|+..... .......
T Consensus 189 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i-- 259 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND---QDIIKKV-- 259 (504)
T ss_dssp EECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH--
T ss_pred EEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH--
Confidence 999999998765432 223457899999999987 4699999999999999999999999854322 1111111
Q ss_pred HhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 657 QWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 657 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
...... .+..... .....+.+++.+||+.||++|||+.|+++
T Consensus 260 --~~~~~~--~~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 260 --EKGKYY--FDFNDWK----NISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp --HHCCCC--CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --HcCCCC--CCccccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111100 0000000 11246789999999999999999999984
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=347.67 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=201.2
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
.++|...+.||+|+||.||++.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 45788899999999999999965 479999999986542 34567899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE---cCCCCeEEEecCCccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL---DNELNPKISDFGMAKL 586 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll---~~~~~~kl~Dfgla~~ 586 (755)
|||+.+|+|.+++.. +..+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999988854 345899999999999999999999987 9999999999999 5678999999999986
Q ss_pred cccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccc
Q 004402 587 FRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666 (755)
Q Consensus 587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (755)
+.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.|+..... ....... ...... +
T Consensus 179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i----~~~~~~-~ 246 (484)
T 3nyv_A 179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE---YDILKKV----EKGKYT-F 246 (484)
T ss_dssp BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH----HHCCCC-C
T ss_pred ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH----HcCCCC-C
Confidence 64332 2234578999999999876 699999999999999999999999854321 1111111 111110 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 667 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
...........+.+++.+||+.||++|||+.|+++
T Consensus 247 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 -----ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -----CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00001122346789999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=331.57 Aligned_cols=260 Identities=23% Similarity=0.370 Sum_probs=196.7
Q ss_pred cCHHHHHHHhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeeeeec
Q 004402 425 FSFSDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTE 502 (755)
Q Consensus 425 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 502 (755)
+.+.++....++|+..+.||+|+||.||+|.. .+++.||||++..... ..+.+.+|+.++.++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 33444445678899999999999999999965 5789999999875533 346788999999999 89999999999876
Q ss_pred ------CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCe
Q 004402 503 ------RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP 576 (755)
Q Consensus 503 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~ 576 (755)
....++||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 45789999999999999998643 2346889999999999999999999987 9999999999999999999
Q ss_pred EEEecCCccccccCCcccccccccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchH
Q 004402 577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFL 651 (755)
Q Consensus 577 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~ 651 (755)
||+|||++........ ......||+.|+|||.+. ...++.++|||||||++|||++|+.|+...... ...
T Consensus 169 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~ 243 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RAL 243 (326)
T ss_dssp EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH
T ss_pred EEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHH
Confidence 9999999986543221 223356899999999986 567899999999999999999999988432211 111
Q ss_pred HHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 652 EYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 652 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.. ...... +.+. .......+.+++.+||+.||++|||+.++++
T Consensus 244 ~~----~~~~~~-----~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 244 FL----IPRNPA-----PRLK---SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HH----HHHSCC-----CCCS---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HH----hhcCcc-----ccCC---ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11 111111 1111 1112246889999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=338.59 Aligned_cols=259 Identities=17% Similarity=0.278 Sum_probs=192.1
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc------cEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE------NML 508 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~l 508 (755)
.+|...+.||+|+||.||+|....+..||+|++...... ..+|+++++.++||||+++++++..... .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 468889999999999999998877777999988654322 2469999999999999999999865433 789
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc-CCCCeEEEecCCcccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLF 587 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~-~~~~~kl~Dfgla~~~ 587 (755)
||||++++.+............+++..+..++.||++||.|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999987655444322223456899999999999999999999987 99999999999999 7999999999999876
Q ss_pred ccCCcccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC----
Q 004402 588 RKDVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK---- 662 (755)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 662 (755)
..... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||....... .+...........
T Consensus 193 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 193 IAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID---QLVEIIKVLGTPSREQI 266 (394)
T ss_dssp CTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHH
T ss_pred cCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHH
Confidence 43322 2234679999999998764 58999999999999999999999985432211 1111111110000
Q ss_pred ---CccccCCCCCC--------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 663 ---GKEFIDPSLDD--------SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 663 ---~~~~~d~~l~~--------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
........+.. .........+.+++.+||+.||++|||+.|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00000000000 001112346889999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=322.54 Aligned_cols=251 Identities=24% Similarity=0.378 Sum_probs=197.3
Q ss_pred HhcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
..++|+..+.||+|+||.||+|... +|+.||||++.... ..+.+.+|+.++.+++||||+++++++......++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3568899999999999999999654 58999999997643 34678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+++++|.+++.. ....+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999998852 2346899999999999999999999987 9999999999999999999999999998654322
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+...... .... . ...... +.+
T Consensus 180 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~-~---~~~~~~-----~~~ 245 (314)
T 3com_A 180 A--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM---RAIF-M---IPTNPP-----PTF 245 (314)
T ss_dssp S--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH-H---HHHSCC-----CCC
T ss_pred c--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH---HHHH-H---HhcCCC-----ccc
Confidence 1 223456899999999999999999999999999999999999988532211 1111 0 011100 000
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.........+.+++.+||+.||++|||+.++++
T Consensus 246 --~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 --RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp --SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011122346889999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=327.10 Aligned_cols=258 Identities=24% Similarity=0.380 Sum_probs=202.1
Q ss_pred hcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChh-----------------hHHHHHHHHHHHhcCCCCceeee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQ-----------------GLEEFKNEVSLTARLQHVNLLRV 496 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~H~niv~l 496 (755)
.++|...+.||+|+||.||++.. +|+.||||++...... ..+.+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35788999999999999999988 9999999998654221 12789999999999999999999
Q ss_pred eeeeecCCccEEEEeecCCCChhhh------hcCCCccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecccCCCCEE
Q 004402 497 LGYCTERDENMLIYEYLPNKSLDLY------LFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE-YSNFRVIHRDLKASNIL 569 (755)
Q Consensus 497 ~g~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~-~~~~~iiHrDlk~~NIl 569 (755)
++++.+.+..++||||+++|+|.++ +.. .....+++..+..++.|++.||.|||+ .+ ++||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 432 124568999999999999999999998 65 999999999999
Q ss_pred EcCCCCeEEEecCCccccccCCcccccccccccCCccccccccCC-CCCc-hhhHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 004402 570 LDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG-IYSM-KYDVYSFGVLLLQIISSKRNARYYGTSEN 647 (755)
Q Consensus 570 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~sDVwS~Gvil~elltg~~p~~~~~~~~~ 647 (755)
++.++.+||+|||++...... ......||..|+|||.+.+. .++. ++|||||||++|||++|+.|+......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-- 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence 999999999999999875432 22345689999999999887 6766 999999999999999999998643331
Q ss_pred cchHHHHHHHhccCCCcc------ccCCCCC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 648 LNFLEYAFEQWKDSKGKE------FIDPSLD---DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~------~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
... ...+....... ...+... ..........+.+++.+||+.||++|||+.|+++
T Consensus 259 ~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 VEL----FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHH----HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHH----HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 11111111100 0000000 0000123346889999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=326.19 Aligned_cols=265 Identities=20% Similarity=0.292 Sum_probs=193.5
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeee------------
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT------------ 501 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~------------ 501 (755)
++|...+.||+|+||.||+|... +++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 57888999999999999999764 48999999998777777788999999999999999999998873
Q ss_pred --cCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc-CCCCeEE
Q 004402 502 --ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-NELNPKI 578 (755)
Q Consensus 502 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~-~~~~~kl 578 (755)
+....++||||++ |+|.+++. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++ +++.+||
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence 3456799999998 69998884 245889999999999999999999987 99999999999997 5679999
Q ss_pred EecCCccccccCCcc-cccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHH
Q 004402 579 SDFGMAKLFRKDVDE-ANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFE 656 (755)
Q Consensus 579 ~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 656 (755)
+|||+++........ .......+|..|+|||.+.. ..++.++|||||||++|||++|+.|+...... ........
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~~~~ 239 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL---EQMQLILE 239 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHH
Confidence 999999876432211 12234467899999998765 67899999999999999999999998543221 11111111
Q ss_pred HhccC----------CCccccCCCCCC-CC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhhc
Q 004402 657 QWKDS----------KGKEFIDPSLDD-SS-----SPCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKD 710 (755)
Q Consensus 657 ~~~~~----------~~~~~~d~~l~~-~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~ 710 (755)
..... .....+...... .. .......+.+++.+||+.||++|||+.|+++ .++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence 10000 000000000000 00 0112346889999999999999999999986 4553
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=335.14 Aligned_cols=198 Identities=22% Similarity=0.268 Sum_probs=168.6
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcC------CCCceeeeeeeeecCCcc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL------QHVNLLRVLGYCTERDEN 506 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~~ 506 (755)
..+|+..+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++..+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 45788999999999999999954 45899999999754 33345677888887776 577999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC--eEEEecCCc
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN--PKISDFGMA 584 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~--~kl~Dfgla 584 (755)
++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 68888875432 234899999999999999999999987 999999999999999987 999999999
Q ss_pred cccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004402 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY 642 (755)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~ 642 (755)
+..... .....||+.|+|||++.+..++.++|||||||++|||+||+.|+...
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 764322 22357899999999999999999999999999999999999988543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=333.93 Aligned_cols=262 Identities=20% Similarity=0.261 Sum_probs=192.6
Q ss_pred HHHhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC------
Q 004402 431 KAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTER------ 503 (755)
Q Consensus 431 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 503 (755)
+...++|...+.||+|+||+||+|.. .+|+.||||++...... ..+|+++|+.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 44567899999999999999999964 67999999998654322 24799999999999999999998443
Q ss_pred --------------------------------CccEEEEeecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHH
Q 004402 504 --------------------------------DENMLIYEYLPNKSLDLYLFDP-IRRYVLDWQKRVNIIEGVTQGLLYL 550 (755)
Q Consensus 504 --------------------------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~L 550 (755)
...++||||++ |+|.+.+... .....+++..+..++.||++||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 23789999998 5777776432 1235689999999999999999999
Q ss_pred HhcCCCCceecccCCCCEEEc-CCCCeEEEecCCccccccCCcccccccccccCCccccccccCC-CCCchhhHHHHHHH
Q 004402 551 QEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVL 628 (755)
Q Consensus 551 h~~~~~~iiHrDlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvi 628 (755)
|+.+ |+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++|||||||+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9886 99999999999998 688999999999987643322 2234679999999998765 58999999999999
Q ss_pred HHHHHcCCCCCCCCCCCcccchHHHHHHHhccC----------CCccccCCCCCCC-----CCHHHHHHHHHHHHHcccC
Q 004402 629 LLQIISSKRNARYYGTSENLNFLEYAFEQWKDS----------KGKEFIDPSLDDS-----SSPCKLLNCMQVALLCVQE 693 (755)
Q Consensus 629 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~ 693 (755)
+|||++|+.||......+ ............ ...+..-+.+... .+......+.+++.+||+.
T Consensus 232 l~ell~g~~pf~~~~~~~---~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSID---QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 999999999985432211 111111111100 0000000111000 1111234678999999999
Q ss_pred CCCCCCCHHHHHH
Q 004402 694 NPEDRPSMLEVSS 706 (755)
Q Consensus 694 dP~~RPt~~evl~ 706 (755)
||++|||+.|+++
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999983
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=329.57 Aligned_cols=258 Identities=21% Similarity=0.234 Sum_probs=189.0
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC------
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD------ 504 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 504 (755)
.++|...+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 35788999999999999999964 56899999998754 3344567899999999999999999999987654
Q ss_pred ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCc
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla 584 (755)
..++||||+++ +|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 57999999975 6777763 24888999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhcc----
Q 004402 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKD---- 660 (755)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 660 (755)
+...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ...........
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPCPE 248 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHC-CCCCCHH
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHH
Confidence 8654321 2234578999999999999999999999999999999999999985432111 11111000000
Q ss_pred --------------C--C-----CccccCCCCCCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 661 --------------S--K-----GKEFIDPSLDDSS---SPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 661 --------------~--~-----~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. . ............. .......+.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0 0 0000000000000 1122457889999999999999999999985
|
| >3sim_A Protein, family 18 chitinase; family 18 plant chitinase, TIM barrel, chitin binding, glyco hydrolase, hydrolase; 2.10A {Crocus vernus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=319.20 Aligned_cols=207 Identities=15% Similarity=0.180 Sum_probs=160.4
Q ss_pred eEEEEEecC-CCCCCCCCCCCCC-cceEEEEEEEecCCCcE--------EecCCchhhHHHHHHHHHHhhCCCceEEEEe
Q 004402 27 WIKAGYWLA-GREFPLSDINSAL-FTHLICAFAEVDSSTYQ--------LSISSANQQYFSIFANSVRRKNPSIKTLLSI 96 (755)
Q Consensus 27 ~~~~gY~~~-~~~~~~~~i~~~~-~thi~~~f~~~~~~~~~--------~~~~~~~~~~~~~~~~~~k~~~~~lk~~isi 96 (755)
+.++||-.. .-.++..+||+.+ ||||+|+|+ ++.++.. +.....+.......++.+|++||++||++||
T Consensus 4 ~~~~~~~~~~~~~~~d~pid~~l~ctHliyaFa-i~~~~~~~~~~~~g~~~~~w~~~~~~~~~~~~lK~~~~~lKvllSi 82 (275)
T 3sim_A 4 VEYIGYPLFSGVKFSDVPINPHITKFQFVLSFA-VDYTASSPHTSTNGKFNVFWDSSILGPDQISAIKSSHPNVRVAVSL 82 (275)
T ss_dssp EEEESCSTTCCCCGGGSCCCTTCSEEEEEEEEE-ESBCSSSSCCBCTTCCEECSCTTTSCHHHHHHHHHHCTTEEEEEEE
T ss_pred HHhccccccCCCCCccCCCCCCccccEEEEEEE-ecccCccccCCCCCccccccccccccHHHHHHHHHhCCCCEEEEEE
Confidence 557776433 3346777889999 999999999 8743321 1122212222134448899999999999999
Q ss_pred cCCCCCccccccCCCCCCc-ccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCCCcccHHHHHHHHHHHccC
Q 004402 97 WNGQNSTYQSILGNKNINP-SVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASD 175 (755)
Q Consensus 97 gg~~~~~~~~~~gg~~~~~-~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~~~~~~~~~l~~lr~~l~~ 175 (755)
|||+ .+. ..|..++++++.|++||+++++++++|||||||||||+|.++|+++|+.|+++||++|++
T Consensus 83 GG~~------------~~~~~~~~~~~~~~~~r~~fi~si~~~l~~~gfDGiDiDwE~p~~~d~~~~~~ll~eLr~~l~~ 150 (275)
T 3sim_A 83 GGAS------------VGSNTVQFQAASVDSWVSNAVTSLTRIIQRYNLDGIDIDYEHFQNTDKNTFAECIGRLITTLKK 150 (275)
T ss_dssp ECSE------------ETTEECCCCCSCHHHHHHHHHHHHHHHHHHTTCCEEEEECCCCTTSCHHHHHHHHHHHHHHHHH
T ss_pred cCCC------------CCCcchhhhhhcCHHHHHHHHHHHHHHHHHhCCCeEEEEeecCCcccHHHHHHHHHHHHHHhcc
Confidence 6655 332 235778889999999999999999999999999999999989999999999999999986
Q ss_pred CCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHHHHHHCCC--CC
Q 004402 176 QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGF--PA 253 (755)
Q Consensus 176 ~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~~~~~~g~--p~ 253 (755)
. ++ ||+++++....... ++++.+.+++||||+|+||+| + |++ ..+++.++++|.+.|. |+
T Consensus 151 ~-~~-ls~a~~~p~~~~~~-~~~~~~~~~~D~i~vm~YD~~-~-~~~-------------~~~~~~~v~~~~~~g~~~p~ 212 (275)
T 3sim_A 151 N-GV-ISFASISPFPSVDE-YYLALFNEYKNAINHINYQFK-A-YDS-------------STSVDKFLGYYNNAASKYKG 212 (275)
T ss_dssp T-TS-CSEEEECCCGGGHH-HHHHHHHHSGGGCCEEECCGG-G-SCT-------------TCCHHHHHHHHHHHHHHTTT
T ss_pred C-Ce-EEEEEcCChHHhhh-ccHHHHHHhCCEEEEEeccCC-C-CCC-------------CccHHHHHHHHHHHhccCCh
Confidence 5 45 77776654433333 458999999999999999999 3 221 1267889999999877 99
Q ss_pred CceeecccccC
Q 004402 254 NKLVLGARASG 264 (755)
Q Consensus 254 ~KlvlG~p~yG 264 (755)
+||+||+|+++
T Consensus 213 ~KlvlGlpa~~ 223 (275)
T 3sim_A 213 GNVLISFSTGP 223 (275)
T ss_dssp SCEEEEEECSS
T ss_pred hheEEEEeecC
Confidence 99999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.60 Aligned_cols=251 Identities=21% Similarity=0.279 Sum_probs=193.6
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC--------hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--------TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD 504 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 504 (755)
.++|...+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++++++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 45788999999999999999965 458999999986542 122345889999999999999999999987654
Q ss_pred ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC---eEEEec
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN---PKISDF 581 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~---~kl~Df 581 (755)
.++||||+++++|.+++.. ...+++.....++.||+.||.|||+.+ ++||||||+|||++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 8999999999999988853 345899999999999999999999986 999999999999987665 999999
Q ss_pred CCccccccCCcccccccccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHh
Q 004402 582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQW 658 (755)
Q Consensus 582 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 658 (755)
|+++...... ......||+.|+|||.+. ...++.++|||||||++|||++|+.|+....... ........
T Consensus 162 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~-- 234 (322)
T 2ycf_A 162 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITS-- 234 (322)
T ss_dssp TTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHHH--
T ss_pred ccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHHh--
Confidence 9998654321 122356899999999873 5678999999999999999999999986433322 11111111
Q ss_pred ccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 659 KDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 659 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.... . .+.... .....+.+++.+||+.||++|||+.|+++
T Consensus 235 --~~~~-~-~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 --GKYN-F-IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --TCCC-C-CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --Cccc-c-Cchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1100 0 000001 12346789999999999999999999984
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=332.13 Aligned_cols=262 Identities=21% Similarity=0.243 Sum_probs=199.1
Q ss_pred hcCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC--------CCceeeeeeeee---
Q 004402 434 TNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ--------HVNLLRVLGYCT--- 501 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~--- 501 (755)
.++|...+.||+|+||+||++. ..+++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 3679999999999999999996 456889999999754 344567899999999985 788999999987
Q ss_pred -cCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecccCCCCEEEcCCC-----
Q 004402 502 -ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY-SNFRVIHRDLKASNILLDNEL----- 574 (755)
Q Consensus 502 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~-~~~~iiHrDlk~~NIll~~~~----- 574 (755)
.....++||||+ +++|.+++... ....+++..++.++.||+.||.|||+. + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 556789999999 45555555332 224589999999999999999999997 5 99999999999999775
Q ss_pred --------------------------------------------CeEEEecCCccccccCCcccccccccccCCcccccc
Q 004402 575 --------------------------------------------NPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610 (755)
Q Consensus 575 --------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~ 610 (755)
.+||+|||+++..... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 8999999999875432 223478999999999
Q ss_pred ccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccc---chHHHHHHHhcc---------CCCccccCCC-----C--
Q 004402 611 VKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL---NFLEYAFEQWKD---------SKGKEFIDPS-----L-- 671 (755)
Q Consensus 611 ~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~---------~~~~~~~d~~-----l-- 671 (755)
+.+..++.++|||||||++|||+||+.||......... ............ .....++... +
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999754433321 111111111100 0000000000 0
Q ss_pred ------------CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 672 ------------DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 672 ------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
...........+.+|+.+||+.||++|||+.|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00123455667889999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=331.28 Aligned_cols=268 Identities=19% Similarity=0.225 Sum_probs=187.7
Q ss_pred HHHHHHhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc-
Q 004402 428 SDIKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE- 505 (755)
Q Consensus 428 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~- 505 (755)
.+.....++|...+.||+|+||.||+|.. .+|+.||||++..... ....+.+|+..+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 45566778999999999999999999975 4689999999865432 23456788888999999999999999865433
Q ss_pred ------cEEEEeecCCCChhhhhcC-CCccCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCceecccCCCCEEEcC-CCC
Q 004402 506 ------NMLIYEYLPNKSLDLYLFD-PIRRYVLDWQKRVNIIEGVTQGLLYLQ--EYSNFRVIHRDLKASNILLDN-ELN 575 (755)
Q Consensus 506 ------~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~~Lh--~~~~~~iiHrDlk~~NIll~~-~~~ 575 (755)
.++||||++++ |...+.. ......+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 78999999874 4333321 223456889999999999999999999 665 999999999999997 899
Q ss_pred eEEEecCCccccccCCcccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHH
Q 004402 576 PKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYA 654 (755)
Q Consensus 576 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~ 654 (755)
+||+|||+++....... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||....... .....
T Consensus 171 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~~ 244 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHEI 244 (360)
T ss_dssp EEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH
T ss_pred EEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHHH
Confidence 99999999987653322 2234689999999998665 48999999999999999999999985432221 11111
Q ss_pred HHHhc-----------cCCC-ccccCCC------CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 655 FEQWK-----------DSKG-KEFIDPS------LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 655 ~~~~~-----------~~~~-~~~~d~~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..... .... ....+.. ............+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11110 0000 0000000 000111123457889999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=339.21 Aligned_cols=258 Identities=21% Similarity=0.309 Sum_probs=189.7
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC------ccE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD------ENM 507 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~ 507 (755)
.+|+..+.||+|+||.||+|.. .+|+.||||++..... .+.+|+++|++++||||+++++++.... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 3578889999999999999976 4699999999865432 2347999999999999999999885421 267
Q ss_pred EEEeecCCCChhhhhcC-CCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC-CCeEEEecCCcc
Q 004402 508 LIYEYLPNKSLDLYLFD-PIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMAK 585 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~-~~~kl~Dfgla~ 585 (755)
+||||+++ +|...+.. ......+++..+..++.||++||.|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 55444432 123456899999999999999999999986 9999999999999965 568999999998
Q ss_pred ccccCCcccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhc-----
Q 004402 586 LFRKDVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWK----- 659 (755)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 659 (755)
.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+........
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~---~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEIIKVLGTPTRE 279 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCSCCHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHH
Confidence 7543322 2235789999999998764 7999999999999999999999998543221 11111111111
Q ss_pred -----cCCCccccCCCCCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 660 -----DSKGKEFIDPSLDDS-----SSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 660 -----~~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.....++.-+.+... ........+.+|+.+||+.||++|||+.|+++
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 011111111111110 01112346889999999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=352.13 Aligned_cols=249 Identities=22% Similarity=0.285 Sum_probs=201.5
Q ss_pred HhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccE
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENM 507 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 507 (755)
..++|+..++||+|+||.||++.. .+++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 456899999999999999999965 45889999999753 223346788899999988 7999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
+||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999853 245899999999999999999999987 999999999999999999999999999854
Q ss_pred ccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 588 RKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
.... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||..... .... ..+....
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---~~~~----~~i~~~~----- 558 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELF----QSIMEHN----- 558 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHSSC-----
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---HHHH----HHHHhCC-----
Confidence 3222 223456899999999999999999999999999999999999999854221 1111 1111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSM-----LEVSS 706 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~ 706 (755)
..+.. .....+.+|+..||+.||++||++ +||++
T Consensus 559 -~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 -VAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -CCCCT----TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -CCCCc----cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 01111 223468899999999999999997 66653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=324.85 Aligned_cols=266 Identities=21% Similarity=0.305 Sum_probs=197.5
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecC-----Ccc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTER-----DEN 506 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 506 (755)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 35788899999999999999975 468999999997543 34456788999999999999999999988654 568
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
++||||+. ++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 688888743 35899999999999999999999986 99999999999999999999999999987
Q ss_pred cccCCccc--------ccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHH
Q 004402 587 FRKDVDEA--------NTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQ 657 (755)
Q Consensus 587 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 657 (755)
........ ......||+.|+|||.+.. ..++.++|||||||++|||++|+.|+....... ........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~ 238 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFGI 238 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHH
Confidence 64322111 1223468999999998754 778999999999999999999999985432111 11111111
Q ss_pred hccCCCc------------cccCC--CCCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhhc
Q 004402 658 WKDSKGK------------EFIDP--SLDDS----SSPCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKD 710 (755)
Q Consensus 658 ~~~~~~~------------~~~d~--~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~ 710 (755)
....... +.+.. ..... ..+.....+.+++.+||+.||++|||+.|+++ .++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 1100000 00000 00000 00112346789999999999999999999986 4443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=352.78 Aligned_cols=261 Identities=20% Similarity=0.306 Sum_probs=203.1
Q ss_pred HHHHHhcCCCccCcccccCCeeEEEEEcC----CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC
Q 004402 429 DIKAATNNFSSANKLGEGGFGPVYKGNLP----RGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER 503 (755)
Q Consensus 429 ~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 503 (755)
+.....++|+..+.||+|+||.||+|... .+..||||++... .....+.|.+|+.++++++||||+++++++. .
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 33344567888899999999999999653 2467999998764 3444578999999999999999999999985 4
Q ss_pred CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCC
Q 004402 504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM 583 (755)
Q Consensus 504 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl 583 (755)
+..++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCC
Confidence 5689999999999999998532 345899999999999999999999986 99999999999999999999999999
Q ss_pred ccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCC
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |..|+..... ....... ....
T Consensus 538 a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~~~~~~i----~~~~ 609 (656)
T 2j0j_A 538 SRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRI----ENGE 609 (656)
T ss_dssp CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHH----HHTC
T ss_pred CeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHH----HcCC
Confidence 987643321 12223456789999999998999999999999999999997 8888753221 1111111 1111
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 663 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
. ..+. ......+.+++.+||+.||++|||+.|+++.|++..
T Consensus 610 ~-----~~~~----~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 610 R-----LPMP----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp C-----CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C-----CCCC----ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 0 0111 122347889999999999999999999999998753
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=322.78 Aligned_cols=255 Identities=23% Similarity=0.346 Sum_probs=176.9
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC-hhhHHHHHHHHH-HHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVS-LTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
.++|...+.||+|+||.||++.. .+|+.||||++.... ......+..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 35788889999999999999976 468999999997653 333445666666 777789999999999999999999999
Q ss_pred eecCCCChhhhhcCC--CccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 511 EYLPNKSLDLYLFDP--IRRYVLDWQKRVNIIEGVTQGLLYLQEY-SNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 511 e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~l~~Lh~~-~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
||+++ +|.+++... .....+++..+..++.+++.||.|||+. + ++||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 777766421 1245689999999999999999999997 6 999999999999999999999999999865
Q ss_pred ccCCcccccccccccCCccccccc----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC
Q 004402 588 RKDVDEANTGRIVGTYGYVPPEYV----KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG 663 (755)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (755)
.... ......||+.|+|||.+ .+..++.++|||||||++|||++|+.|+........ ... ..
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------~~~--~~ 242 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---------QLT--QV 242 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------C--CC
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------HHH--HH
Confidence 4322 12234689999999998 466789999999999999999999999864321100 000 00
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 664 KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 664 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.....+.+...........+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0001111111111122347889999999999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=332.22 Aligned_cols=264 Identities=20% Similarity=0.308 Sum_probs=179.9
Q ss_pred CCCc-cCcccccCCeeEEEEEcC---CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeec--CCccEEE
Q 004402 436 NFSS-ANKLGEGGFGPVYKGNLP---RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE--RDENMLI 509 (755)
Q Consensus 436 ~f~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv 509 (755)
.|+. .++||+|+||.||+|... +++.||||++..... ...+.+|+.+|++++||||+++++++.. ....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3544 458999999999999754 578999999975532 2467899999999999999999999954 5678999
Q ss_pred EeecCCCChhhhhcCC------CccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE----cCCCCeEEE
Q 004402 510 YEYLPNKSLDLYLFDP------IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL----DNELNPKIS 579 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll----~~~~~~kl~ 579 (755)
|||+++ +|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999975 676666321 11234899999999999999999999987 9999999999999 778999999
Q ss_pred ecCCccccccCCcc-cccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc------ccchH
Q 004402 580 DFGMAKLFRKDVDE-ANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE------NLNFL 651 (755)
Q Consensus 580 Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~------~~~~~ 651 (755)
|||+++.+...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 99999876533211 22334678999999999887 458999999999999999999999986433210 11112
Q ss_pred HHHHHHhccCCC---ccc-------------cCCCCCCCCCH---------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 652 EYAFEQWKDSKG---KEF-------------IDPSLDDSSSP---------CKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 652 ~~~~~~~~~~~~---~~~-------------~d~~l~~~~~~---------~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
......+..... ..+ ...... .... .....+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYT-NCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGT-TCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCC-cchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 222221111100 000 000000 0000 00235779999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=317.26 Aligned_cols=252 Identities=25% Similarity=0.400 Sum_probs=190.2
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeec----------
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE---------- 502 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---------- 502 (755)
.++|+..+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45788899999999999999975 57999999999653 3445788999999999999999999998754
Q ss_pred ---CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEE
Q 004402 503 ---RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKIS 579 (755)
Q Consensus 503 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~ 579 (755)
....++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 34578999999999999998642 235778899999999999999999987 9999999999999999999999
Q ss_pred ecCCccccccCCc------------ccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 004402 580 DFGMAKLFRKDVD------------EANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646 (755)
Q Consensus 580 Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~ 646 (755)
|||+++....... ........||+.|+|||.+.+. .++.++|||||||++|||++ |+.. ...
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~--~~~ 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST--GME 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS--HHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC--chh
Confidence 9999986543211 1122345689999999999764 78999999999999999998 3321 000
Q ss_pred ccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 647 NLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.. .......... ..+...........+.+++.+||+.||++|||+.++++
T Consensus 234 ~~----~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 RV----NILKKLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HH----HHHHHHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH----HHHHhccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 01 1111111111 11111222233346789999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=320.21 Aligned_cols=263 Identities=23% Similarity=0.335 Sum_probs=196.8
Q ss_pred HhcCCCccCcccccCCeeEEEEEc--CCCCEEEEEEeccCCh--hhHHHHHHHHHHHhcC---CCCceeeeeeeee----
Q 004402 433 ATNNFSSANKLGEGGFGPVYKGNL--PRGQEFAVKRLSATST--QGLEEFKNEVSLTARL---QHVNLLRVLGYCT---- 501 (755)
Q Consensus 433 ~~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~---- 501 (755)
..++|+..+.||+|+||.||++.. .+|+.||||++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 356899999999999999999976 4688999999864321 1223456677766665 8999999999987
Q ss_pred -cCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEe
Q 004402 502 -ERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISD 580 (755)
Q Consensus 502 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~D 580 (755)
.....++||||++ |+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 69998885432 234899999999999999999999987 99999999999999999999999
Q ss_pred cCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhcc
Q 004402 581 FGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKD 660 (755)
Q Consensus 581 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 660 (755)
||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.|+..... .............
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~ 237 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGL 237 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCC
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHcCC
Confidence 99998654321 22345789999999999999999999999999999999999999854322 1122222221111
Q ss_pred CCCccc----------cCCCC---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 661 SKGKEF----------IDPSL---DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 661 ~~~~~~----------~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
...... ..... ...........+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 00000 00011122346789999999999999999999984
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=324.37 Aligned_cols=262 Identities=19% Similarity=0.277 Sum_probs=199.3
Q ss_pred hcCCCccCcccccCCeeEEEEEc--CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCC------ceeeeeeeeecCCc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL--PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHV------NLLRVLGYCTERDE 505 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~------niv~l~g~~~~~~~ 505 (755)
.++|+..+.||+|+||.||++.. .+++.||||++... ....+.+.+|+.++..++|+ +++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 35788899999999999999964 46889999999654 34456788999999888765 49999999999999
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC-------------
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN------------- 572 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~------------- 572 (755)
.++||||+ +++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 88999888543 2235889999999999999999999987 999999999999987
Q ss_pred ------CCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 004402 573 ------ELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646 (755)
Q Consensus 573 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~ 646 (755)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.|+.......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 678999999999864322 223578999999999999999999999999999999999999986543222
Q ss_pred ccchHHHHHHHhc-----cCCCcccc---------------------CCCC-CCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 004402 647 NLNFLEYAFEQWK-----DSKGKEFI---------------------DPSL-DDSSSPCKLLNCMQVALLCVQENPEDRP 699 (755)
Q Consensus 647 ~~~~~~~~~~~~~-----~~~~~~~~---------------------d~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 699 (755)
............. ........ .+.. ...........+.+++.+||+.||++||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 1111111100000 00000000 0000 0011223456788999999999999999
Q ss_pred CHHHHHH
Q 004402 700 SMLEVSS 706 (755)
Q Consensus 700 t~~evl~ 706 (755)
|+.|+++
T Consensus 322 t~~ell~ 328 (339)
T 1z57_A 322 TLREALK 328 (339)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999984
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=324.25 Aligned_cols=256 Identities=20% Similarity=0.289 Sum_probs=193.2
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcc----
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN---- 506 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~---- 506 (755)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46888899999999999999964 56899999999764 334457789999999999999999999999877655
Q ss_pred --EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCc
Q 004402 507 --MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584 (755)
Q Consensus 507 --~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla 584 (755)
++||||+. ++|..++. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 68877762 23899999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC-
Q 004402 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK- 662 (755)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 662 (755)
+..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.|+...... ..............
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGT 263 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCH
T ss_pred cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCcH
Confidence 864332 223568999999999877 68899999999999999999999998543211 11111111100000
Q ss_pred ----------Ccccc---CCCCCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 663 ----------GKEFI---DPSLDDS---SSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 663 ----------~~~~~---d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..... ....... ........+.+++.+||+.||++|||+.|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00000 0000000 00112346889999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=324.05 Aligned_cols=254 Identities=20% Similarity=0.269 Sum_probs=193.0
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc------
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE------ 505 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------ 505 (755)
++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 5788889999999999999965 56999999999654 33345678999999999999999999999987654
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
.++||||+. ++|.+++. ..+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 68877763 23899999999999999999999987 9999999999999999999999999998
Q ss_pred ccccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccC---
Q 004402 586 LFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDS--- 661 (755)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 661 (755)
..... .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.|+....... ............
T Consensus 175 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 175 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGTE 246 (353)
T ss_dssp C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHHHHHHHCBCCHH
T ss_pred CCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHH
Confidence 64322 223467999999999876 678999999999999999999999986433211 111111110000
Q ss_pred ---------------CCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 662 ---------------KGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 662 ---------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.......+.+. .........+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000001111 011122347889999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=314.37 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=199.6
Q ss_pred HHhcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 432 AATNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 432 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
...++|...+.||+|+||.||++... +++.||||++... .....+.+.+|++++++++||||+++++++......++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34568999999999999999999764 6899999998654 23446789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC---CCeEEEecCCcc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE---LNPKISDFGMAK 585 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~---~~~kl~Dfgla~ 585 (755)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999888753 235899999999999999999999986 9999999999999764 469999999998
Q ss_pred ccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcc
Q 004402 586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665 (755)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (755)
...... ......+|+.|+|||.+.+ .++.++||||||+++|||++|+.|+..... ..... .+......
T Consensus 173 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~----~~~~~~~~- 240 (287)
T 2wei_A 173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILK----RVETGKYA- 240 (287)
T ss_dssp TBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHHCCCC-
T ss_pred eecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH---HHHHH----HHHcCCCC-
Confidence 654322 1223468899999998875 489999999999999999999998853221 11111 11111110
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 666 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+..... .....+.+++.+||+.||++|||+.|+++
T Consensus 241 -~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 -FDLPQWR----TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -CCSGGGT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCchhhh----hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0000001 12246889999999999999999999997
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=320.30 Aligned_cols=265 Identities=18% Similarity=0.229 Sum_probs=198.3
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-----------CCceeeeeeeeec
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-----------HVNLLRVLGYCTE 502 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~ 502 (755)
++|...+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++.+++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5788899999999999999964 57899999999753 334567889999998886 8999999999876
Q ss_pred CC----ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecccCCCCEEEc------
Q 004402 503 RD----ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY-SNFRVIHRDLKASNILLD------ 571 (755)
Q Consensus 503 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~-~~~~iiHrDlk~~NIll~------ 571 (755)
.. ..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||+. + |+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence 54 689999999 889999885432 33489999999999999999999997 6 99999999999994
Q ss_pred CCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccc---
Q 004402 572 NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL--- 648 (755)
Q Consensus 572 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~--- 648 (755)
..+.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||+||+.|+.........
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4457999999999865432 22346899999999999999999999999999999999999998654322111
Q ss_pred chHHHHHHHhcc------------------C-CCccccCCC---------CCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 004402 649 NFLEYAFEQWKD------------------S-KGKEFIDPS---------LDDSSSPCKLLNCMQVALLCVQENPEDRPS 700 (755)
Q Consensus 649 ~~~~~~~~~~~~------------------~-~~~~~~d~~---------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 700 (755)
............ . ....+.... -....+......+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 111111111000 0 000000000 001233456678899999999999999999
Q ss_pred HHHHHH--Hhhc
Q 004402 701 MLEVSS--MLKD 710 (755)
Q Consensus 701 ~~evl~--~L~~ 710 (755)
+.|+++ .+++
T Consensus 328 ~~ell~hp~f~~ 339 (373)
T 1q8y_A 328 AGGLVNHPWLKD 339 (373)
T ss_dssp HHHHHTCGGGTT
T ss_pred HHHHhhChhhhc
Confidence 999986 4554
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=331.31 Aligned_cols=252 Identities=21% Similarity=0.251 Sum_probs=184.7
Q ss_pred CCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEEEeecC
Q 004402 436 NFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEYLP 514 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~ 514 (755)
.|...+.||+|+||+||.+...+|+.||||++.... .+.+.+|+.++.++ +||||+++++++.+.+..++|||||.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 344567899999999987766689999999986532 35678899999886 89999999999999999999999995
Q ss_pred CCChhhhhcCCCccC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC-------------CCeE
Q 004402 515 NKSLDLYLFDPIRRY----VLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-------------LNPK 577 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~-------------~~~k 577 (755)
|+|.+++....... ..++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999986532211 1123345789999999999999986 9999999999999754 4899
Q ss_pred EEecCCccccccCCccc--ccccccccCCccccccccC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcc
Q 004402 578 ISDFGMAKLFRKDVDEA--NTGRIVGTYGYVPPEYVKK-------GIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSEN 647 (755)
Q Consensus 578 l~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~ 647 (755)
|+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.|+.......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 99999998765432211 2234579999999999865 678999999999999999999 888874322111
Q ss_pred cchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 648 LNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
....... .. .+.............+.+++.+||+.||++|||+.|+++
T Consensus 248 ----~~i~~~~--~~-----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 ----SNIIRGI--FS-----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ----HHHHHTC--CC-----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHHhcCC--CC-----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111100 00 011112223445667899999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=321.55 Aligned_cols=200 Identities=22% Similarity=0.274 Sum_probs=167.9
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CC-----ceeeeeeeeecCCcc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HV-----NLLRVLGYCTERDEN 506 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~~~~~~~ 506 (755)
.++|...+.||+|+||+||+|.. .+++.||||++... ....+.+..|+.++..++ |+ +++++++++...+..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 56899999999999999999965 46889999999754 334567788888888884 55 499999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc--CCCCeEEEecCCc
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD--NELNPKISDFGMA 584 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~--~~~~~kl~Dfgla 584 (755)
++||||++ |+|.+++.... ...+++..+..++.|++.||.|||.. ..+|+||||||+|||++ .++.+||+|||++
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 99999996 59988885432 23489999999999999999999952 23599999999999995 4788999999999
Q ss_pred cccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004402 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYY 642 (755)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~ 642 (755)
+..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 875432 22357899999999999999999999999999999999999998643
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=318.16 Aligned_cols=256 Identities=17% Similarity=0.207 Sum_probs=172.5
Q ss_pred hcCCCccC-cccccCCeeEEEEEcC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeec----CCccE
Q 004402 434 TNNFSSAN-KLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE----RDENM 507 (755)
Q Consensus 434 ~~~f~~~~-~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 507 (755)
.++|...+ .||+|+||.||+|... +|+.||||++.... . ...+....+..++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 45777754 6999999999999654 69999999986532 1 11223334566799999999999876 34579
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC---CCCeEEEecCCc
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGMA 584 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~---~~~~kl~Dfgla 584 (755)
+||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999996532 246899999999999999999999987 999999999999986 455999999999
Q ss_pred cccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCc
Q 004402 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664 (755)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (755)
+..... ......+|+.|+|||.+.+..++.++|||||||++|||++|+.|+............ .......
T Consensus 179 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~--- 248 (336)
T 3fhr_A 179 KETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRLG--- 248 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred eecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhcc---
Confidence 865432 222356799999999999899999999999999999999999998543322111000 0000000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhhc
Q 004402 665 EFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKD 710 (755)
Q Consensus 665 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~ 710 (755)
...............+.+++.+||+.||++|||+.|+++ .+++
T Consensus 249 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 249 ---QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred ---ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 000011111122346889999999999999999999997 5554
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.57 Aligned_cols=262 Identities=19% Similarity=0.268 Sum_probs=195.6
Q ss_pred hcCCCccCcccccCCeeEEEEEcC-CC-CEEEEEEeccCChhhHHHHHHHHHHHhcCCCCc------eeeeeeeeecCCc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP-RG-QEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN------LLRVLGYCTERDE 505 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 505 (755)
.++|...+.||+|+||.||++... ++ +.||||+++.. ....+.+.+|+.++++++|++ ++.+.+++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 368889999999999999999653 34 68999999754 344567888999999987765 8999999999999
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE---------------
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL--------------- 570 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll--------------- 570 (755)
.++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 55666665432 2235899999999999999999999986 9999999999999
Q ss_pred ----cCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 004402 571 ----DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646 (755)
Q Consensus 571 ----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~ 646 (755)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.|+.......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 66889999999999864322 223578999999999999999999999999999999999999986433221
Q ss_pred ccchHHHHHHHh-----ccCCCcc-ccCCC--C-------------------CCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 004402 647 NLNFLEYAFEQW-----KDSKGKE-FIDPS--L-------------------DDSSSPCKLLNCMQVALLCVQENPEDRP 699 (755)
Q Consensus 647 ~~~~~~~~~~~~-----~~~~~~~-~~d~~--l-------------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 699 (755)
............ ....... +.... . ...........+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 111111100000 0000000 00000 0 0011223345788999999999999999
Q ss_pred CHHHHHH
Q 004402 700 SMLEVSS 706 (755)
Q Consensus 700 t~~evl~ 706 (755)
|+.|+++
T Consensus 327 t~~e~l~ 333 (355)
T 2eu9_A 327 TLAEALL 333 (355)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999973
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.49 Aligned_cols=244 Identities=25% Similarity=0.404 Sum_probs=188.5
Q ss_pred HHHHhcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChh------hHHHHHHHHHHHhcC----CCCceeeeee
Q 004402 430 IKAATNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQ------GLEEFKNEVSLTARL----QHVNLLRVLG 498 (755)
Q Consensus 430 l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~H~niv~l~g 498 (755)
.....++|...+.||+|+||.||+|.. .+++.||||++...... ....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 334467899999999999999999965 56899999999655321 223466789999888 8999999999
Q ss_pred eeecCCccEEEEee-cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc-CCCCe
Q 004402 499 YCTERDENMLIYEY-LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-NELNP 576 (755)
Q Consensus 499 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~-~~~~~ 576 (755)
++...+..++|+|+ +.+++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++ .++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 99999999999999 789999999853 335899999999999999999999987 99999999999999 88999
Q ss_pred EEEecCCccccccCCcccccccccccCCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHH
Q 004402 577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAF 655 (755)
Q Consensus 577 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~ 655 (755)
||+|||+++...... .....||..|+|||.+.+..+ +.++|||||||++|||++|+.|+... ....
T Consensus 180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---------~~~~ 246 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD---------QEIL 246 (312)
T ss_dssp EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---------HHHH
T ss_pred EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh---------HHHh
Confidence 999999998764322 223568999999999877666 45899999999999999999987421 0000
Q ss_pred HHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 656 EQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 656 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. .. ..+... ....+.+++.+||+.||++|||+.|+++
T Consensus 247 ~----~~------~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 247 E----AE------LHFPAH----VSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp H----TC------CCCCTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred h----hc------cCCccc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00 011111 2236789999999999999999999987
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=337.92 Aligned_cols=263 Identities=23% Similarity=0.268 Sum_probs=197.5
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeec------CCcc
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE------RDEN 506 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~ 506 (755)
++|...+.||+|+||.||++.. .+|+.||||++... .....+.+.+|++++.+++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6799999999999999999965 56899999998764 44456789999999999999999999998765 5678
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC---eEEEecCC
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN---PKISDFGM 583 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~---~kl~Dfgl 583 (755)
++||||+++|+|.+++........+++..+..++.+++.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 999999999999999976554456888999999999999999999986 999999999999997765 99999999
Q ss_pred ccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccc--hHHHHHHH-hcc
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLN--FLEYAFEQ-WKD 660 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~--~~~~~~~~-~~~ 660 (755)
++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.|+.......... ........ ...
T Consensus 171 a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 171 AKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred cccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 98764332 2234578999999999999999999999999999999999999985421110000 00000000 000
Q ss_pred CCCcc--ccCCC--CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 004402 661 SKGKE--FIDPS--LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLE 703 (755)
Q Consensus 661 ~~~~~--~~d~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 703 (755)
..... ..... ............+.+++..||+.||++|||+.|
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 00000 00011 112233446678899999999999999999966
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=316.94 Aligned_cols=242 Identities=24% Similarity=0.393 Sum_probs=195.8
Q ss_pred HHhcCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccCChh------hHHHHHHHHHHHhcCC--CCceeeeeeeeec
Q 004402 432 AATNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATSTQ------GLEEFKNEVSLTARLQ--HVNLLRVLGYCTE 502 (755)
Q Consensus 432 ~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~g~~~~ 502 (755)
...++|...+.||+|+||.||+|. ..+++.||||++...... ..+.+.+|+.++.+++ ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 345689999999999999999996 457899999998654221 2245678999999996 5999999999999
Q ss_pred CCccEEEEeecCC-CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc-CCCCeEEEe
Q 004402 503 RDENMLIYEYLPN-KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-NELNPKISD 580 (755)
Q Consensus 503 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~-~~~~~kl~D 580 (755)
.+..++|+|++.. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ +++.+||+|
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred CCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999976 899998853 346899999999999999999999987 99999999999999 788999999
Q ss_pred cCCccccccCCcccccccccccCCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhc
Q 004402 581 FGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWK 659 (755)
Q Consensus 581 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 659 (755)
||+++..... ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.|+.... ... .
T Consensus 194 fg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---------~~~---~ 257 (320)
T 3a99_A 194 FGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EII---R 257 (320)
T ss_dssp CTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHH---H
T ss_pred Cccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------hhh---c
Confidence 9999876432 1223568999999999877665 788999999999999999999884210 000 0
Q ss_pred cCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 660 DSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 660 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.. . ...... ...+.+++.+||+.||++|||+.|+++
T Consensus 258 -~~--~----~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 258 -GQ--V----FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -CC--C----CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -cc--c----cccccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0 011112 236789999999999999999999987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=311.34 Aligned_cols=251 Identities=21% Similarity=0.331 Sum_probs=177.1
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCCh-h-hHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST-Q-GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
.++|+..+.||+|+||.||++.. .+|+.||||++..... . ..+.+.++..++..++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 45788889999999999999976 4689999999976532 2 2334455556788889999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY-SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~-~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
||+ ++.+..+... ....+++..+..++.|+++||.|||+. + ++||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 4455444421 234589999999999999999999985 5 99999999999999999999999999976543
Q ss_pred CCcccccccccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCc
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (755)
.. ......+|+.|+|||.+. ...++.++|||||||++|||++|+.|+..... .......... ...
T Consensus 178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~----~~~- 247 (318)
T 2dyl_A 178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTKVLQ----EEP- 247 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHH----SCC-
T ss_pred Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHHHHhc----cCC-
Confidence 22 122346899999999984 56788999999999999999999998854221 1111111111 110
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 665 EFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 665 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+.+.. .......+.+++.+||+.||++|||+.|+++
T Consensus 248 ----~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 ----PLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ----CCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----CCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 01110 0012236789999999999999999999985
|
| >3n12_A Chitinase A, chinctu2; zinc atoms, complex, hydrolase; 1.20A {Bacillus cereus} PDB: 3n11_A 3n15_A* 3n13_A* 3n17_A* 3n18_A* 3n1a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=311.08 Aligned_cols=233 Identities=19% Similarity=0.281 Sum_probs=168.0
Q ss_pred cCCcceEEEEEecCCCC----CCCCCCCCCCcceEEEEEEEecCCCcEEecCCc--hhhHHHHHHHHHHhhCCCceEEEE
Q 004402 22 SDAQTWIKAGYWLAGRE----FPLSDINSALFTHLICAFAEVDSSTYQLSISSA--NQQYFSIFANSVRRKNPSIKTLLS 95 (755)
Q Consensus 22 ~~~~~~~~~gY~~~~~~----~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~--~~~~~~~~~~~~k~~~~~lk~~is 95 (755)
+....++++|||..|+. +++++|+..+ |||+|+|+.++.++..+..+.. .+..+...++.+|++ ++||++|
T Consensus 2 ~~~~~~~vvgYy~~~~~~~~~~~~~~i~~~l-thi~~aF~~~~~~~~~~~~~~~~~~~~~~~~~i~~~k~~--g~kvlls 78 (333)
T 3n12_A 2 NNLGSKLLVGYWHNFDNGTGIIKLKDVSPKW-DVINVSFGETGGDRSTVEFSPVYGTDADFKSDISYLKSK--GKKVVLS 78 (333)
T ss_dssp CCCCSSEEEEEEESSCSSSCCCCGGGSCTTC-SEEEEEEEEECTTSCSEECCCSSSCHHHHHHHHHHHHHT--TCEEEEE
T ss_pred CCCCCCEEEEEECcccCCCCccCHHHCCCCC-cEEEEEEEEecCCCCeEEecCCccchHHHHHHHHHHHhC--CCeEEEE
Confidence 34567899999988775 7899998765 9999999999976644444322 344455566778887 6999999
Q ss_pred ecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCC----------CCcccHHHH
Q 004402 96 IWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS----------TDLNSLGIL 165 (755)
Q Consensus 96 igg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~----------~~~~~~~~~ 165 (755)
||||. ++.++++++.|++||+++++++++|||||||||||+|.. +|+++|+.|
T Consensus 79 iGG~~-----------------~s~~~~~~~~r~~fi~si~~~~~~~gfDGiDiDwE~p~~~~~~d~~~~~~d~~~~~~l 141 (333)
T 3n12_A 79 IGGQN-----------------GVVLLPDNAAKDRFINSIQSLIDKYGFDGIDIDLESGIYLNGNDTNFKNPTTPQIVNL 141 (333)
T ss_dssp EESTT-----------------CCCCCCSHHHHHHHHHHHHHHHHHHCCSEEEEECCTTCCBCTTCCCTTSCCCHHHHHH
T ss_pred ecCCC-----------------CccccCCHHHHHHHHHHHHHHHHHcCCCeEEEeccCCCCCCCCCcCCCcccHHHHHHH
Confidence 95544 367899999999999999999999999999999999832 256699999
Q ss_pred HHHHHHHccC-CCccEEEeeeecCCccc--------cccc--CcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCC
Q 004402 166 LDEWKASASD-QPELTLSMAVRYSPTHE--------TVSY--PIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPS 234 (755)
Q Consensus 166 l~~lr~~l~~-~~~~~ls~~~~~~~~~~--------~~~~--~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~ 234 (755)
+++||++|++ +++++||++++...... ..+| +++++++++||||||+||+||.+ + .++++ +..
T Consensus 142 l~eLr~~l~~~g~~~~lT~Ap~~~~~~~~~~~y~~~~~~y~~d~~~i~~~lD~invMtYD~hg~~-g-~~g~~---~~~- 215 (333)
T 3n12_A 142 ISAIRTISDHYGPDFLLSMAPETAYVQGGYSAYGSIWGAYLPIIYGVKDKLTYIHVQHYNAGSGI-G-MDGNN---YNQ- 215 (333)
T ss_dssp HHHHHHHHHHHCTTCEEEECCBGGGTGGGGTCCBBTBTTTHHHHHHTTTTCCEEEEECSSCCEEE-C-TTSCE---EET-
T ss_pred HHHHHHHHHhcCCCEEEEEccCcccccccccccccccchhHHHHHHHhcccCEEEeeeecCCCcC-C-CCCcc---ccc-
Confidence 9999999976 55799999987542111 1235 88999999999999999999542 2 23332 211
Q ss_pred CCCcHHHHHHHHHHCC-------------CCCCceeecccccCCCcccCCCcchHHHHH
Q 004402 235 SNISTDFGIREWLRRG-------------FPANKLVLGARASGPGITIDGSMGYKFIRA 280 (755)
Q Consensus 235 ~~~~~~~~v~~~~~~g-------------~p~~KlvlG~p~yG~~~~~~~~~~y~~~~~ 280 (755)
.......++..++..| +|++||+||+|+....-...|.++-.++..
T Consensus 216 ~~~~~~~a~~~~l~~g~~~~g~~~~~~~~ip~~KlvlGlPa~~~aa~~~gy~~~~~~~~ 274 (333)
T 3n12_A 216 GTADYEVAMADMLLHGFPVGGNANNIFPALRSDQVMIGLPAAPAAAPSGGYISPTEMKK 274 (333)
T ss_dssp TSHHHHHHHHHHHHHEEEETTEEEEEEECCCGGGEEEEEESSGGGSTTSCCCCHHHHHH
T ss_pred CcchHHHHHHHHHHhcccccCcccccccccCHHHeeeccccCCCcCCCCCcCCHHHHHH
Confidence 1111222333444433 999999999999764322334444444433
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=325.42 Aligned_cols=250 Identities=21% Similarity=0.292 Sum_probs=183.8
Q ss_pred hcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEEEee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
..+|...++||+|+||+|+.....+++.||||++...... .+.+|+.+|+++ +||||+++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 3468888999999999966555568999999999654322 356799999999 899999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC-----CCCeEEEecCCcccc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-----ELNPKISDFGMAKLF 587 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~-----~~~~kl~Dfgla~~~ 587 (755)
|. |+|.+++..... ...+.....++.||+.||.|||+.+ |+||||||+|||++. ...+||+|||+++..
T Consensus 100 ~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 96 699998864322 2344456789999999999999987 999999999999953 346889999999876
Q ss_pred ccCCcc-cccccccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCC
Q 004402 588 RKDVDE-ANTGRIVGTYGYVPPEYVK---KGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 588 ~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
...... .......||+.|+|||++. ...++.++|||||||++|||+| |..|+...... .. .......
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~----~~----~~~~~~~ 245 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR----QA----NILLGAC 245 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH----HH----HHHTTCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH----HH----HHHhccC
Confidence 533211 2233467999999999997 4667889999999999999999 88777422111 00 0011110
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 663 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..... .........+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 SLDCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCTTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Ccccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00101 111233445789999999999999999999983
|
| >2y8v_A CHIC, class III chitinase, putative; afchic, hydrolase; 1.99A {Aspergillus fumigatus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=306.19 Aligned_cols=208 Identities=14% Similarity=0.164 Sum_probs=155.4
Q ss_pred CcceEEEEEecCCCC----C---CCCCCCCCCcceEEEEEEEecCCCcEEecCCchh-----hHHHHHHHHHHhhCCCce
Q 004402 24 AQTWIKAGYWLAGRE----F---PLSDINSALFTHLICAFAEVDSSTYQLSISSANQ-----QYFSIFANSVRRKNPSIK 91 (755)
Q Consensus 24 ~~~~~~~gY~~~~~~----~---~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~-----~~~~~~~~~~k~~~~~lk 91 (755)
+..++++|||..|+. + .+++++.+.||||+|+|+.++++++.+...+..+ ..+...++.+|++ ++|
T Consensus 10 ~~~~~vv~Y~~~~~~~~g~~~~~~~~~i~~~~~Thii~af~~i~~~~g~~~~~~~~~~~~~~~~~~~~i~~~k~~--g~k 87 (290)
T 2y8v_A 10 PEHRRVICYHQTLCPNRGDYVSVLPLVKNNTGVTHIIIAAFHLNEDPGHITLNDDPPDHEMYNPLWAEVPVLKRS--GVK 87 (290)
T ss_dssp CCCSEEEEEECCCSGGGCSCCCCTHHHHTTCCCCEEEEEEEEECSSTTCEEETTBCTTSGGGHHHHHHHHHHHHT--TCE
T ss_pred CCCCeEEEEECCEeCCCCceeecChhhcCCccCcEEEEEEEEecCCCCceeecCCCcccchHHHHHHHHHHHHHC--CCE
Confidence 357889999988753 4 5567899999999999999987655555544321 1334455778877 599
Q ss_pred EEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCCCcccHHHHHHHHHH
Q 004402 92 TLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKA 171 (755)
Q Consensus 92 ~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~~~~~~~~~l~~lr~ 171 (755)
|++|||||. .+. |+.++++++.|++|++++++++++|||||||||||+|. ++++|+.|+++||+
T Consensus 88 vllSiGG~~------------~~~--fs~~~~~~~~r~~f~~s~~~~~~~~~~DGiDiDwE~p~--~~~~~~~ll~~Lr~ 151 (290)
T 2y8v_A 88 VMGMLGGAA------------QGS--YRCLDGDQEKFERYYQPLLAMVRRHQLDGLDLDVEEEM--SLPGIIRLIDRLKL 151 (290)
T ss_dssp EEEEEECSS------------TTT--TGGGSSCHHHHHHHHHHHHHHHHHHTCSEEEEECCSCB--CHHHHHHHHHHHHH
T ss_pred EEEEECCCC------------CCC--chhccCCHHHHHHHHHHHHHHHHHhCCCeEEEcccccc--hHHHHHHHHHHHHH
Confidence 999995553 221 88899999999999999999999999999999999994 58999999999999
Q ss_pred HccCCCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCC---cccccCCCCCCCCCCCcHHHHHHHHHH
Q 004402 172 SASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKE---NVTGIHAALYNPSSNISTDFGIREWLR 248 (755)
Q Consensus 172 ~l~~~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~---~~~~~~a~l~~~~~~~~~~~~v~~~~~ 248 (755)
+|++ .++||+|+++.. ++|++|+|+|||++.+.. ...++++++|...........++.|+.
T Consensus 152 ~~~~--~~~lt~A~~~~~--------------~~d~~~~~~yD~~~~~~~~~~~~d~~~~~~Y~~~~~~~~~~~~~~~~~ 215 (290)
T 2y8v_A 152 DLGD--DFIITLAPVAAA--------------LLGIGNLSGFDYRQLEQQRGSKISWYNAQFYNGWGLAEDPRMYAAIVA 215 (290)
T ss_dssp HHCT--TSEEEECCBGGG--------------GGTSCCSSBSCHHHHHHHHGGGCCEEEEECCTTSCCTTCTHHHHHHHH
T ss_pred HhCC--CEEEEecccccc--------------ccCccccccccHHHHHhhcccccceeeecccCCCCCCCCchHHHHHHH
Confidence 9953 589999888641 345566666666532211 134555555543322222346889999
Q ss_pred CCCCCCceeecccccCC
Q 004402 249 RGFPANKLVLGARASGP 265 (755)
Q Consensus 249 ~g~p~~KlvlG~p~yG~ 265 (755)
.|+|++||+||+|+|..
T Consensus 216 ~g~p~~KivlGlp~~~~ 232 (290)
T 2y8v_A 216 QGWSPQRVVYGLLTNPG 232 (290)
T ss_dssp TTCCGGGEEEEEESSGG
T ss_pred cCCCHHHEEEeccCCCC
Confidence 99999999999999863
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=338.88 Aligned_cols=238 Identities=20% Similarity=0.310 Sum_probs=190.8
Q ss_pred hcCCCccCcccccCCeeEEEEEcC--CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc-----
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP--RGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE----- 505 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 505 (755)
.++|...+.||+|+||.||++... +|+.||||++... .....+.+.+|+.++.+++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999764 5899999998654 34455678999999999999999999999987665
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
.++||||+++++|.+++.. .+++.+++.++.||+.||.|||+.+ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999887632 5899999999999999999999987 9999999999999986 99999999998
Q ss_pred ccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcc
Q 004402 586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665 (755)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (755)
..... ....||+.|+|||++.+.. +.++|||||||++|||++|..|+.......
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------- 283 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------- 283 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-------------------
Confidence 65432 3457899999999987654 899999999999999999987764211000
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhc
Q 004402 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRP-SMLEVSSMLKD 710 (755)
Q Consensus 666 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~ 710 (755)
+. ...........+.+++.+||+.||++|| +++++.+.|.+
T Consensus 284 ~~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 284 LP----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp CC----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cc----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00 0000111224678999999999999999 56667666654
|
| >4axn_A Chitinase C1; hydrolase; 1.68A {Serratia marcescens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=305.30 Aligned_cols=257 Identities=16% Similarity=0.229 Sum_probs=181.8
Q ss_pred cceEEEEEecCCCC-------------CCCCCCCCCCcceEEEEEEEecCCCcEEecCCchhhHHHHHHHHHHhhCCCce
Q 004402 25 QTWIKAGYWLAGRE-------------FPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIK 91 (755)
Q Consensus 25 ~~~~~~gY~~~~~~-------------~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lk 91 (755)
..++++|||..|+. .++++|+ ..||||+|||+.++.+. .+......+..+...++.+|++ ++|
T Consensus 23 ~~~~~vgY~~~w~~~~~~~~~~~~~~~~~l~~i~-~~~~~i~~aF~~~~~~~-~~~~~~~~~~~~~~~i~~~~~~--g~k 98 (328)
T 4axn_A 23 NKKILMGFWHNWAAGASDGYQQGQFANMNLTDIP-TEYNVVAVAFMKGQGIP-TFKPYNLSDTEFRRQVGVLNSQ--GRA 98 (328)
T ss_dssp TSCEEEEEEESSCCCSSCSTTSCBCCCCCGGGSC-TTCCEEEEEEEBCSSSC-BCCCSSSCHHHHHHHHHHHHHT--TCE
T ss_pred CCeEEEEEeCcccccCCCCccCCcCCCCchhhCC-CCCCEEEEEEEccCCCc-eeccCCCCHHHHHHHHHHHHHC--CCE
Confidence 47899999987753 2334554 56899999999887643 3344444556677777778876 799
Q ss_pred EEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCC---CcccHHHHHHH
Q 004402 92 TLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNST---DLNSLGILLDE 168 (755)
Q Consensus 92 ~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~---~~~~~~~~l~~ 168 (755)
||||||||.+ .+..+++.|++|++++++++++|||||||||||+|... +..+|..++++
T Consensus 99 vllSiGG~~~------------------~~~~~~~~r~~F~~s~~~~l~~ygfDGiDiDwE~p~~~~~~~~~~~~~~l~~ 160 (328)
T 4axn_A 99 VLISLGGADA------------------HIELKTGDEDKLKDEIIRLVEVYGFDGLDIDLEQAAIGAANNKTVLPAALKK 160 (328)
T ss_dssp EEEEEEETTC------------------CCCCCTTCHHHHHHHHHHHHHHHCCCEEEEEECTTTTTSTTHHHHHHHHHHH
T ss_pred EEEEeCCCCC------------------CccCChHHHHHHHHHHHHHHHHhCCCeEEEecccCCCCCcchHHHHHHHHHH
Confidence 9999966551 23445678999999999999999999999999999643 45668888899
Q ss_pred HHHHccC-CCccEEEeeeecCCccccccc--CcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHH---HH
Q 004402 169 WKASASD-QPELTLSMAVRYSPTHETVSY--PIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTD---FG 242 (755)
Q Consensus 169 lr~~l~~-~~~~~ls~~~~~~~~~~~~~~--~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~---~~ 242 (755)
|++.+++ +++++||++++.........| .++++.+++||||||+||++ +.|...++++++++......... ..
T Consensus 161 l~~~~~~~g~~~~lt~Ap~~~~~~~~~~y~~~~~~~~~~~D~invm~Yd~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T 4axn_A 161 VKDHYAAQGKNFIISMAPEFPYLRTNGTYLDYINALEGYYDFIAPQYYNQG-GDGIWVDELNAWITQNNDAMKEDFLYYL 239 (328)
T ss_dssp HHHHHHTTTCCCEEEECCBGGGGBTTCTTHHHHHHTTTTCCEECCBCSSCT-TCEEEETTTTEEEETTCSTTHHHHHHHH
T ss_pred HHHHHHhcCCceEEEEcccccccCCCcchhhHHHHhhccccEEeeecccCC-CcccCCCCcccccccCCcccchhHHHHH
Confidence 9888765 568999999776433333333 36788999999999999998 56777788888886443322111 11
Q ss_pred HHHHH-----HCCCCCCceeecccccCCCcccCCCcchHHHHHHHhhcCCCcccccccceeeeeeecCcEEEeeCCcchh
Q 004402 243 IREWL-----RRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETI 317 (755)
Q Consensus 243 v~~~~-----~~g~p~~KlvlG~p~yG~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~yd~~~S~ 317 (755)
...+. ..|+|++||+||+|+|+..-.. + ++..+..+
T Consensus 240 ~~~~~~~~~~~~g~p~~KivlGlPa~~~aa~~------------------G---------------------y~~~~~~~ 280 (328)
T 4axn_A 240 TESLVTGTRGYAKIPAAKFVIGLPSNNDAAAT------------------G---------------------YVVNKQAV 280 (328)
T ss_dssp HHHHHHTCTTBCCCCGGGBEEEEESSTTTCSS------------------C---------------------CCSSTHHH
T ss_pred HHHHHHHHhhhcCCChhceEEeeccccCCCCC------------------C---------------------cccCHHHH
Confidence 12222 2599999999999998743110 0 12333344
Q ss_pred hhhhhc--ccccCccccccccccccchh
Q 004402 318 KAKISY--AKEKNLLGYKAFQLSNDDNW 343 (755)
Q Consensus 318 ~~K~~~--a~~~~l~Gi~~W~l~~dd~~ 343 (755)
...+.. .+..++||+|+|+++.|+..
T Consensus 281 ~~~~~~~~~k~~~lgGvM~WSi~~Dd~~ 308 (328)
T 4axn_A 281 YNAFSRLDAKNLSIKGLMTWSINWDNGK 308 (328)
T ss_dssp HHHHHHHHHTTCCCCEEEEECHHHHTCB
T ss_pred HHHHHHHHhcCCCceEEEEEehhhcCCC
Confidence 333322 24568999999999999854
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=299.07 Aligned_cols=229 Identities=11% Similarity=0.042 Sum_probs=181.1
Q ss_pred cCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|...+.||+|+||.||+|... +++.||||++.... .+..+.+.+|+..+.+++||||+++++++...+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57888999999999999999764 48999999997653 344578999999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+++++|.+++.. . ....+..+++.|++.||.|||+.+ |+||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 99999999999842 1 345678899999999999999987 9999999999999999999997443
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
|++| ++.++|||||||++|||+||+.||............ ...+...
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~------------~~~~~~~ 221 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------------ERDTAGQ 221 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC------------CBCTTSC
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH------------HHHhccC
Confidence 3333 688999999999999999999998654332211000 0000000
Q ss_pred CCC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 671 LDD--SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 671 l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
... .........+.+++.+||+.||++| |+.|+++.|++...
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 000 0001123468899999999999999 99999999987544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=316.90 Aligned_cols=240 Identities=15% Similarity=0.169 Sum_probs=175.8
Q ss_pred cCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccCCh---hhHHHHHHHHHHHhcCCC-Cceeeee------------
Q 004402 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATST---QGLEEFKNEVSLTARLQH-VNLLRVL------------ 497 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H-~niv~l~------------ 497 (755)
.+|...+.||+|+||+||+|. ..+|+.||||++..... ...+.|.+|+.++..++| +|...+.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 456677899999999999997 56799999999874322 235779999999999987 3221111
Q ss_pred ---------eeeec-----CCccEEEEeecCCCChhhhhcC----CCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCce
Q 004402 498 ---------GYCTE-----RDENMLIYEYLPNKSLDLYLFD----PIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559 (755)
Q Consensus 498 ---------g~~~~-----~~~~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~ii 559 (755)
.++.. ....+++|+++ .++|.+++.. ......+++..++.++.||++||.|||+.+ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 11111 12345666654 6899888731 112345778899999999999999999987 99
Q ss_pred ecccCCCCEEEcCCCCeEEEecCCccccccCCcccccccccccCCccccccc----------cCCCCCchhhHHHHHHHH
Q 004402 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV----------KKGIYSMKYDVYSFGVLL 629 (755)
Q Consensus 560 HrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~sDVwS~Gvil 629 (755)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999999999999999864432 233467 999999999 556689999999999999
Q ss_pred HHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004402 630 LQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVS 705 (755)
Q Consensus 630 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 705 (755)
|||+||+.|+......... ...+... ... +..+.+++.+||+.||++|||+.+++
T Consensus 308 ~elltg~~Pf~~~~~~~~~---------------~~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGS---------------EWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCS---------------GGGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHCCCCCCCcchhhhH---------------HHHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999998543221111 1111110 111 24688999999999999999966554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=294.99 Aligned_cols=232 Identities=18% Similarity=0.231 Sum_probs=176.8
Q ss_pred cCCCcc-CcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHH-hcCCCCceeeeeeeeec----CCccE
Q 004402 435 NNFSSA-NKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLT-ARLQHVNLLRVLGYCTE----RDENM 507 (755)
Q Consensus 435 ~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~ 507 (755)
++|... +.||+|+||.||++.. .+++.||||++... ..+.+|+.++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456665 7799999999999965 56899999999643 4567888887 55699999999999876 56789
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC---CCCeEEEecCCc
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGMA 584 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~---~~~~kl~Dfgla 584 (755)
+||||+++|+|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+|||++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999998643 2235899999999999999999999987 999999999999998 788999999998
Q ss_pred cccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCc
Q 004402 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664 (755)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (755)
.... +..++.++|||||||++|||++|+.|+......... .....
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~ 212 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKT 212 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCC
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHH
Confidence 6432 234678999999999999999999998543221100 00000
Q ss_pred cccCCCCCCCC--CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhhc
Q 004402 665 EFIDPSLDDSS--SPCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKD 710 (755)
Q Consensus 665 ~~~d~~l~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~ 710 (755)
.+......... .......+.+++.+||+.||++|||+.|+++ .+.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~ 262 (299)
T 3m2w_A 213 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 262 (299)
T ss_dssp SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence 00000000000 0112346889999999999999999999996 4544
|
| >3ebv_A Chinitase A; chitinase A, CHIA, glycosidase, structural genomics, unknown function, hydrolase, PSI-2, protein structure initiative; 1.50A {Streptomyces coelicolor} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=289.95 Aligned_cols=225 Identities=20% Similarity=0.267 Sum_probs=161.6
Q ss_pred cceEEEEEecCCCC----CCCCCCCCCCcceEEEEEEEecCCCcEEec--CCc-----hhhHHHHHHHHHHhhCCCceEE
Q 004402 25 QTWIKAGYWLAGRE----FPLSDINSALFTHLICAFAEVDSSTYQLSI--SSA-----NQQYFSIFANSVRRKNPSIKTL 93 (755)
Q Consensus 25 ~~~~~~gY~~~~~~----~~~~~i~~~~~thi~~~f~~~~~~~~~~~~--~~~-----~~~~~~~~~~~~k~~~~~lk~~ 93 (755)
..++++|||..|.. +++++|+ +.||||+|+|+.++++.+.+.. +.. ....+...++.++ ++++||+
T Consensus 3 ~~~~vvgY~~~w~~~~~~~~~~~i~-~~~thi~~aFa~~~~~~G~i~~~~~~~~~~~~~~~~~~~~i~~~~--~~g~kvl 79 (302)
T 3ebv_A 3 LKHAVTGYWQNFNNGATVQKISDVP-SAYDIIAVAFADATTTPGAVTFNLDSAGLGGYTVDQFKADVRAKQ--AAGKKVI 79 (302)
T ss_dssp CSSEEEEEEESSCSSSCCCCGGGSC-TTCSEEEEEEEEECSSTTCEECCCCTTTTTSCCHHHHHHHHHHHH--HTTCEEE
T ss_pred CCceEEEEEccccCCCCCCCHHHcC-CCCCEEEEEEEEEECCCCeEEEeeccccccccCHHHHHHHHHHHH--cCCCEEE
Confidence 36789999987653 6799998 8999999999999874333322 211 2334445545554 3589999
Q ss_pred EEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCCCcccHHHHHHHHHHHc
Q 004402 94 LSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASA 173 (755)
Q Consensus 94 isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~~~~~~~~~l~~lr~~l 173 (755)
+|||||. .+.++++++.|++|++++++++++|||||||||||+| .+..+|+.||++||+++
T Consensus 80 lsiGG~~-----------------~s~~~~~~~~r~~f~~~~~~~~~~~~~DGiDiD~E~p--~~~~~~~~~l~~l~~~~ 140 (302)
T 3ebv_A 80 ISVGGEK-----------------GTVSVNSSASATNFANSVYSVMREYGFDGVDIDLENG--LNPTYMTQALRALSAKA 140 (302)
T ss_dssp EEEEETT-----------------CCCCCCSHHHHHHHHHHHHHHHHHHTCCEEEEEECSC--CCHHHHHHHHHHHHHHH
T ss_pred EEEECCC-----------------CCcccCCHHHHHHHHHHHHHHHHHhCCCeEEEecccc--cCHHHHHHHHHHHHHhc
Confidence 9996554 2456889999999999999999999999999999998 46778999999999998
Q ss_pred cCCCccEEEeeeecCCcc-cccccCcc--hhcccCChhhhhhhhccCCCCCcccccCCCCCCCCC-CCcHHHHHHHHHHC
Q 004402 174 SDQPELTLSMAVRYSPTH-ETVSYPID--SMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSS-NISTDFGIREWLRR 249 (755)
Q Consensus 174 ~~~~~~~ls~~~~~~~~~-~~~~~~~~--~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~-~~~~~~~v~~~~~~ 249 (755)
. ++++||+|++..... ....|... ++.+++||+|+|+||. |++ +++++++|.... .+.+..+ ..++..
T Consensus 141 g--~~~~lt~Ap~~~~~~~~~~~y~~~~~~~~~~lD~vnvq~Yd~-g~~----~~c~~~~y~~~~~~~~~~~a-~~~~~~ 212 (302)
T 3ebv_A 141 G--PDMILTMAPQTIDMQSTQGGYFQTALNVKDILTVVNMQYYNS-GTM----LGCDGKVYAQGTVDFLTALA-CIQLEG 212 (302)
T ss_dssp C--TTCEEEECCBGGGSSSTTSHHHHHHHHTGGGCCEEEEECSSC-CCE----ECTTSCEECTTSHHHHHHHH-HHHHTT
T ss_pred C--CCEEEEEeeccccccccchhHHHHHHHhcCcceEEEeecccC-CCc----CCCCccccCCCCccHHHHHH-HHHHhc
Confidence 3 579999998863211 12223322 3467999999999997 343 778888875432 1222222 234567
Q ss_pred CCCCCceeecccccCCCcccCCCcchHHHHH
Q 004402 250 GFPANKLVLGARASGPGITIDGSMGYKFIRA 280 (755)
Q Consensus 250 g~p~~KlvlG~p~yG~~~~~~~~~~y~~~~~ 280 (755)
|+|++||+||+|+|...- ..|.++-.++..
T Consensus 213 gvp~~KIvlGlPa~~~aa-g~Gyv~~~~l~~ 242 (302)
T 3ebv_A 213 GLAPSQVGLGLPASTRAA-GGGYVSPSVVNA 242 (302)
T ss_dssp TCCGGGEEEEEESSTTSC-SSCCCCHHHHHH
T ss_pred CCCHHHEEEecccCCCcC-CCCCcCHHHHHH
Confidence 999999999999996432 235555444443
|
| >3ian_A Chitinase; structural genomics, hydrolase, glycosidase, PSI-2, protein structure initiative; 1.75A {Lactococcus lactis subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-34 Score=297.76 Aligned_cols=214 Identities=14% Similarity=0.240 Sum_probs=154.9
Q ss_pred cceEEEEEecCCCC-------------CCCCCCCCCCcceEEEEEEEecCCCcEEecC--CchhhHHHHHHHHHHhhCCC
Q 004402 25 QTWIKAGYWLAGRE-------------FPLSDINSALFTHLICAFAEVDSSTYQLSIS--SANQQYFSIFANSVRRKNPS 89 (755)
Q Consensus 25 ~~~~~~gY~~~~~~-------------~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~--~~~~~~~~~~~~~~k~~~~~ 89 (755)
..++++|||..|.. +++++||+. ||||+|+|+.++++++....+ ......+...++.+|++ +
T Consensus 3 ~~~~~vgYy~~w~~~~~~gyr~g~~~~~~~~~i~~~-~thv~~aFa~i~~~~g~~~~~~~~~~~~~~~~~i~~~k~~--g 79 (321)
T 3ian_A 3 LDKVLVGYWHNWKSTGKDGYKGGSSADFNLSSTQEG-YNVINVSFMKTPEGQTLPTFKPYNKTDTEFRAEISKLNAE--G 79 (321)
T ss_dssp CCBEEEEEEESSCCCSSCSTTSCBCCCCCGGGCCTT-CSEEEEEEEBCCTTCCSCBCCCSSSCHHHHHHHHHHHHHT--T
T ss_pred CCcEEEEEECcccccccccccCCccCccCHHHCCCC-CCEEEEEEEEecCCCCeEEecCCcccchhHHHHHHHHHHC--C
Confidence 47899999876643 678999988 789999999998544433322 22344455666788887 5
Q ss_pred ceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCC---CCCcccHHHHH
Q 004402 90 IKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN---STDLNSLGILL 166 (755)
Q Consensus 90 lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~---~~~~~~~~~~l 166 (755)
+|||+|||||.. + + ..+++.|++||+++++++++|||||||||||+|. +++..+|+.||
T Consensus 80 ~kvllsiGG~~~------------~---~---~~~~~~r~~f~~~~~~~~~~~g~DGiDiD~E~p~~~~~~~~~~~~~~l 141 (321)
T 3ian_A 80 KSVLIALGGADA------------H---I---ELKKSQESDFVNEIIRLVDTYGFDGLDIDLEQAAIEAADNQTVIPSAL 141 (321)
T ss_dssp CEEEEEEEETTC------------C---C---CCCGGGHHHHHHHHHHHHHHHCCCEEEEEECHHHHTSTTHHHHHHHHH
T ss_pred CEEEEEeccCCC------------C---c---ccChHHHHHHHHHHHHHHHHhCCCeEEEecccCCcccccCHHHHHHHH
Confidence 999999966552 1 1 1245689999999999999999999999999995 46788899999
Q ss_pred HHHHHHccC-CCccEEEeeeecCCcccccccC--cchhcccCChhhhhhhhccCC-CCCcccccCCCCCCCCCC-----C
Q 004402 167 DEWKASASD-QPELTLSMAVRYSPTHETVSYP--IDSMKKNLNWAHLVAYDYHMP-SKENVTGIHAALYNPSSN-----I 237 (755)
Q Consensus 167 ~~lr~~l~~-~~~~~ls~~~~~~~~~~~~~~~--~~~l~~~vD~~~vm~Yd~~~~-~~~~~~~~~a~l~~~~~~-----~ 237 (755)
++||+++++ +++++||++++.........|+ ++++.+++||||||+||+++. .|... ..+++..... +
T Consensus 142 ~~lr~~~~~~g~~~~LT~Ap~~~~~~~~~~y~~~i~~l~~~~D~invm~YD~~~~g~~~~~---~~~~~~~~~~~~~~~f 218 (321)
T 3ian_A 142 KKVKDHYRKDGKNFMITMAPEFPYLTSSGKYAPYINNLDSYYDFINPQYYNQGGDGFWDSD---LNMWISQSNDEKKEDF 218 (321)
T ss_dssp HHHHHHHHTTTCCCEEEECCBGGGCBTTSTTHHHHHHTTTTCCEECCBCSSCTTCEEEETT---TTEEEETTCSTTHHHH
T ss_pred HHHHHHHhhccCCEEEEEcccCccccccchHHHHHHHHhCCEeEEEEccCCCCCCCCcccc---cchhhccCCCccccch
Confidence 999999865 4579999997754332333465 788999999999999999732 12211 1133222211 2
Q ss_pred cHHHHHHHHHHC-----CCCCCceeeccccc
Q 004402 238 STDFGIREWLRR-----GFPANKLVLGARAS 263 (755)
Q Consensus 238 ~~~~~v~~~~~~-----g~p~~KlvlG~p~y 263 (755)
+.+ ....++.. ++|++||+||+|+.
T Consensus 219 ~~~-~~~~~l~~~~~~~~iP~~KlvlGlPa~ 248 (321)
T 3ian_A 219 LYG-LTQRLVTGTDGFIKIPASKFVIGLPSN 248 (321)
T ss_dssp HHH-HHHHHHHTCTTBCCCCGGGBEEEEESS
T ss_pred hHH-HHHHHHhccccccCCChHHEEEecccC
Confidence 222 23445654 89999999999984
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.82 Aligned_cols=241 Identities=15% Similarity=0.165 Sum_probs=179.2
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCC--------hhhHHHHHHHHHHHhcCC---------CCceeeee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATS--------TQGLEEFKNEVSLTARLQ---------HVNLLRVL 497 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l~ 497 (755)
++|+..+.||+|+||+||+|.. +|+.||||++.... ....+.+.+|+.+++.++ ||||+++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 5677889999999999999987 78999999997542 223477889999988886 66666665
Q ss_pred ee-----------------eec-------------CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHH
Q 004402 498 GY-----------------CTE-------------RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547 (755)
Q Consensus 498 g~-----------------~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l 547 (755)
+. +.+ ....++|||||++|++.+.+.. ..+++..+..++.||+.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence 54 332 6789999999999976666532 4579999999999999999
Q ss_pred HHHH-hcCCCCceecccCCCCEEEcCCC--------------------CeEEEecCCccccccCCcccccccccccCCcc
Q 004402 548 LYLQ-EYSNFRVIHRDLKASNILLDNEL--------------------NPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606 (755)
Q Consensus 548 ~~Lh-~~~~~~iiHrDlk~~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~ 606 (755)
.||| +.+ |+||||||+|||++.++ .+||+|||+++..... ...||+.|+
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~ 244 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTT
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeeccc
Confidence 9999 776 99999999999999887 8999999999865431 347899999
Q ss_pred ccccccCCCCCchhhHHHHHHH-HHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHH
Q 004402 607 PPEYVKKGIYSMKYDVYSFGVL-LLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQ 685 (755)
Q Consensus 607 aPE~~~~~~~s~~sDVwS~Gvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 685 (755)
|||++.+.. +.++||||++++ .+++++|..|+.. ............... .................+.+
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN------VLWLHYLTDKMLKQM---TFKTKCNTPAMKQIKRKIQE 314 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH------HHHHHHHHHHHHHTC---CCSSCCCSHHHHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc------hhhhhHHHHhhhhhh---ccCcccchhhhhhcCHHHHH
Confidence 999998766 999999998777 7778888877621 000011111111000 00000111112245667899
Q ss_pred HHHHcccCCCCCCCCHHHHH
Q 004402 686 VALLCVQENPEDRPSMLEVS 705 (755)
Q Consensus 686 l~~~Cl~~dP~~RPt~~evl 705 (755)
|+.+||+.| |+.|++
T Consensus 315 li~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHGGGSS-----SHHHHH
T ss_pred HHHHHhccC-----CHHHHH
Confidence 999999976 898887
|
| >4ac1_X Endo-N-acetyl-beta-D-glucosaminidase; hydrolase, glycoside hydrolase family 18, deglycosylation; HET: NAG; 1.30A {Hypocrea jecorina} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=258.72 Aligned_cols=202 Identities=13% Similarity=0.193 Sum_probs=145.0
Q ss_pred eEEEEEecCCCCC--------CCCCCCCCCcceEEEEEEEecCCCcEEecC-CchhhHHHH---HHHHHHhhCCCceEEE
Q 004402 27 WIKAGYWLAGREF--------PLSDINSALFTHLICAFAEVDSSTYQLSIS-SANQQYFSI---FANSVRRKNPSIKTLL 94 (755)
Q Consensus 27 ~~~~gY~~~~~~~--------~~~~i~~~~~thi~~~f~~~~~~~~~~~~~-~~~~~~~~~---~~~~~k~~~~~lk~~i 94 (755)
.++||||..|+.. ++..+|...||||+|||+.+++++.....+ ...+..+.. .++++|+ +++||+|
T Consensus 3 pR~i~Yy~t~~~~~~~~~~~~p~~~~p~~~~THi~~af~~~~~~g~i~~~d~~p~~~~~~~l~~~i~~~q~--~g~Kvll 80 (283)
T 4ac1_X 3 PRLIVYFQTTHDSSNRPISMLPLITEKGIALTHLIVCSFHINQGGVVHLNDFPPDDPHFYTLWNETITMKQ--AGVKVMG 80 (283)
T ss_dssp SEEEEEECCCBCTTSCBCCSTHHHHSSSCCCCEEEEEEEECCTTSCCEETTBCTTSGGGHHHHHHHHHHHH--TTCEEEE
T ss_pred CeEEEEEeccccCCCCccccCCcccCCCCCccEEEEEEEEECCCCeEEECCCCccchHHHHHHHHHHHHHc--CCCEEEE
Confidence 3699999876542 233456778999999999999876532221 222222222 2344444 4799999
Q ss_pred EecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCCCcccHHHHHHHHHHHcc
Q 004402 95 SIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASAS 174 (755)
Q Consensus 95 sigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~~~~~~~~~l~~lr~~l~ 174 (755)
|||||..+.+ ..++...++++.|++|++++++++++|+|||||||||+| .+.++|..|+++||+.+.
T Consensus 81 siGG~~~g~~-----------~~~~~~~~~~~~~~~f~~~~~~~~~~~~~dG~D~d~e~~--~~~~~~~~li~~Lr~~~g 147 (283)
T 4ac1_X 81 MVGGAAPGSF-----------NTQTLDSPDSATFEHYYGQLRDAIVNFQLEGMDLDVEQP--MSQQGIDRLIARLRADFG 147 (283)
T ss_dssp EEETTSSCSS-----------STTTTTCSSHHHHHHHHHHHHHHHHHTTCSEEEEECCSC--BCHHHHHHHHHHHHHHHC
T ss_pred EEcCCCCCCC-----------cccccccccHHHHHHHHHHHHHHHHHcCCCceEeecccC--CCHHHHHHHHHHHHHHcC
Confidence 9987763221 225667788999999999999999999999999999999 466789999999999995
Q ss_pred CCCccEEEeeeecCC---cccccccCcc----hhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHHHHH
Q 004402 175 DQPELTLSMAVRYSP---THETVSYPID----SMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWL 247 (755)
Q Consensus 175 ~~~~~~ls~~~~~~~---~~~~~~~~~~----~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~~~~ 247 (755)
+++.||+|++... .....++++. ....++||+|+|.||..+.+.. ..++..++
T Consensus 148 --~~~~lT~Ap~~~~~~~~~~~~~~~~~~l~~~~~~~~D~vnvQfYn~~~~~~~------------------~~~~~~~~ 207 (283)
T 4ac1_X 148 --PDFLITLAPVASALEDSSNLSGFSYTALQQTQGNDIDWYNTQFYSGFGSMAD------------------TSDYDRIV 207 (283)
T ss_dssp --TTSEEEECCBGGGGTTSCCSSBSCHHHHHHHHGGGCCEEEEECCTTSCCSSS------------------SHHHHHHH
T ss_pred --CCceEEEccccccccccccccchhHHHHHHhhcccccEEEecCCCCCCCcCC------------------HHHHHHHH
Confidence 4689999876432 1111223333 3356899999999997632211 13567888
Q ss_pred HCCCCCCceeeccccc
Q 004402 248 RRGFPANKLVLGARAS 263 (755)
Q Consensus 248 ~~g~p~~KlvlG~p~y 263 (755)
.+|+|++||+||+|+.
T Consensus 208 ~~g~p~~KivlGlpa~ 223 (283)
T 4ac1_X 208 ANGFAPAKVVAGQLTT 223 (283)
T ss_dssp HTTCCGGGEEEEEESS
T ss_pred HhCCCcccEEEEeecC
Confidence 9999999999999964
|
| >2gsj_A Protein PPL-2; mimosoideae, chimerolectin, endochitinase, glycosyl hydrolase family 18, equilibrium sedimentation, X-RAY; 1.73A {Parkia platycephala} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=255.30 Aligned_cols=196 Identities=16% Similarity=0.144 Sum_probs=139.1
Q ss_pred EEEEEecCCCCCCCCCCC----CCCcceEEEEEEEecCCCc--EEecCCc------hhhHHHHHHHHHHhhCCCceEEEE
Q 004402 28 IKAGYWLAGREFPLSDIN----SALFTHLICAFAEVDSSTY--QLSISSA------NQQYFSIFANSVRRKNPSIKTLLS 95 (755)
Q Consensus 28 ~~~gY~~~~~~~~~~~i~----~~~~thi~~~f~~~~~~~~--~~~~~~~------~~~~~~~~~~~~k~~~~~lk~~is 95 (755)
.+++||-.. +...+++ .+.||||+|||+.+..++. .+..... ....+...++.+ +++++||++|
T Consensus 2 ~i~~YWg~n--~~~~~L~~~c~~~~~t~i~~AF~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~i~~l--q~~g~KVllS 77 (271)
T 2gsj_A 2 GIVVYWGQN--GGEGTLTSTCESGLYQIVNIAFLSQFGGGRRPQINLAGHCDPANNGCRTVSDGIRAC--QRRGIKVMLS 77 (271)
T ss_dssp EEEEEESSC--TTSCCHHHHHHTSCCSEEEEEEEEEBSTTCCCEECCGGGCCTGGGTTTTHHHHHHHH--HTTTCEEEEE
T ss_pred CEEEEeCCC--CCCCChHHhccCCCCCEEEEEEEEecCCCCCcCccccccCCCccccHHHHHHHHHHH--HhCCCEEEEE
Confidence 489999542 1222333 6689999999999987543 2332211 011223333334 4569999999
Q ss_pred ecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHH----------HHHHHHcCCCcccccccCCCCCCcccHHHH
Q 004402 96 IWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESS----------IRTARLYGFQGIDLFWLWPNSTDLNSLGIL 165 (755)
Q Consensus 96 igg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i----------~~~~~~~~~DGvdiDwe~p~~~~~~~~~~~ 165 (755)
||||.+ + |+ +++++.|++|++++ ++++++|+|||||||||+|. ++|..|
T Consensus 78 iGG~~g------------s---~~--~~s~~~~~~fa~s~~~~f~~~~s~~~~~~~~~~DGiDiDwE~p~----~~~~~l 136 (271)
T 2gsj_A 78 IGGGAG------------S---YS--LSSVQDARSVADYIWNNFLGGRSSSRPLGDAVLDGVDFDIEHGG----AYYDAL 136 (271)
T ss_dssp EECSSS------------C---BC--CCSHHHHHHHHHHHHHHHSSSCCTTCTTCSCCCSEEEEECCSCC----TTHHHH
T ss_pred eCCCCC------------c---ee--cCCHHHHHHHHHHHHHHhcCCcchhhhHHHcCCceEEEeecCch----HHHHHH
Confidence 966542 1 33 56789999999999 56789999999999999996 899999
Q ss_pred HHHHHHHccCCCccEEEeeeecCCcccccccCcchh-cccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHH
Q 004402 166 LDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSM-KKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIR 244 (755)
Q Consensus 166 l~~lr~~l~~~~~~~ls~~~~~~~~~~~~~~~~~~l-~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~ 244 (755)
+++||+.++++++++||+|++... ..+|....+ .+++||+|||+||+++.. +.+....++..+++
T Consensus 137 ~~~Lr~~~~~g~~~~LTaAp~~~~---~~~~~~~~~~~~~~D~invm~Yd~~~~~-----------~~~~~~~~~~~~~~ 202 (271)
T 2gsj_A 137 ARRLSEHNRGGKKVFLSAAPQCPF---PDQSLNKALSTGLFDYVWVQFYNNPQCE-----------FNSGNPSNFRNSWN 202 (271)
T ss_dssp HHHHHGGGGSSSCCEEEECCBSSS---SCTTTHHHHHTSCCSEEEEECSSCTTTS-----------CCTTCTHHHHHHHH
T ss_pred HHHHHHHhhcCCCeEEEEeccCCc---chhhHHHHHhhccCCeEEEEcccCCCcc-----------CCCCchhHHHHHHH
Confidence 999999887666899999987631 122444455 579999999999987311 11111225677889
Q ss_pred HHHHCCCCCCceeecccccC
Q 004402 245 EWLRRGFPANKLVLGARASG 264 (755)
Q Consensus 245 ~~~~~g~p~~KlvlG~p~yG 264 (755)
.|+. |+|+ ||+||+|++-
T Consensus 203 ~w~~-~~p~-Kl~lGlp~~~ 220 (271)
T 2gsj_A 203 KWTS-SFNA-KFYVGLPASP 220 (271)
T ss_dssp HHHH-HCSS-EEEEEEESSG
T ss_pred HHHh-cCCC-cEEEeccCCc
Confidence 9987 6999 9999999964
|
| >2hvm_A Hevamine; hydrolase, chitinase/lysozyme; 1.80A {Hevea brasiliensis} SCOP: c.1.8.5 PDB: 1hvq_A* 1llo_A 1kr0_A* 1kr1_A* 1kqy_A* 1kqz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=257.20 Aligned_cols=200 Identities=17% Similarity=0.124 Sum_probs=140.6
Q ss_pred EEEEEecC-CCCCCC-CCCCCCCcceEEEEEEEecCCCc--EEecCCc------hhhHHHHHHHHHHhhCCCceEEEEec
Q 004402 28 IKAGYWLA-GREFPL-SDINSALFTHLICAFAEVDSSTY--QLSISSA------NQQYFSIFANSVRRKNPSIKTLLSIW 97 (755)
Q Consensus 28 ~~~gY~~~-~~~~~~-~~i~~~~~thi~~~f~~~~~~~~--~~~~~~~------~~~~~~~~~~~~k~~~~~lk~~isig 97 (755)
.+++||-. ...-++ +..+...||||+|||+.+..++. .+.+... ....+...++.+| ++++||++|||
T Consensus 2 ~iavYWg~n~~~~~L~~~c~~~~~t~i~~AF~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~q--~~g~KVllSiG 79 (273)
T 2hvm_A 2 GIAIYWGQNGNEGTLTQTCSTRKYSYVNIAFLNKFGNGQTPQINLAGHCNPAAGGCTIVSNGIRSCQ--IQGIKVMLSLG 79 (273)
T ss_dssp EEEEEESSCGGGCCHHHHHHTSCCSEEEEEEEEECSTTCCCEECCGGGCCCGGGTTTTHHHHHHHHH--HTTCEEEEEEE
T ss_pred CEEEEcCCCCCCCchHhhcCCCCCCEEEEEEEEEeCCCceeeeeecCCCCcccccHHHHHHHHHHHH--cCCCEEEEEeC
Confidence 47899943 222121 12335679999999999987643 2222111 1122333334444 46899999996
Q ss_pred CCCCCccccccCCCCCCcccccccccChhhHHHHHHHH----------HHHHHHcCCCcccccccCCCCCCcccHHHHHH
Q 004402 98 NGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESS----------IRTARLYGFQGIDLFWLWPNSTDLNSLGILLD 167 (755)
Q Consensus 98 g~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i----------~~~~~~~~~DGvdiDwe~p~~~~~~~~~~~l~ 167 (755)
||.+ + |+ +++++.|++|++++ ++++++|+|||||||||+|. ..+|..|++
T Consensus 80 G~~g------------~---~~--~~s~~~~~~fa~~~~~~f~~g~s~~~~~~~~~~DGiDiDwE~p~---~~~~~~l~~ 139 (273)
T 2hvm_A 80 GGIG------------S---YT--LASQADAKNVADYLWNNFLGGKSSSRPLGDAVLDGIDFDIEHGS---TLYWDDLAR 139 (273)
T ss_dssp CSSC------------C---CC--CCSHHHHHHHHHHHHHHTSSSCCSCCTTCSCCCSEEEEECCSSC---CSSHHHHHH
T ss_pred CCCC------------c---cC--CCCHHHHHHHHHHHHHHhcCCchhhhHHHHcCCceEEeeccCCC---chhHHHHHH
Confidence 5541 1 55 67889999999998 77899999999999999996 578999999
Q ss_pred HHHHHccCCCccEEEeeeecCCcccccccCcchh-cccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHHHH
Q 004402 168 EWKASASDQPELTLSMAVRYSPTHETVSYPIDSM-KKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREW 246 (755)
Q Consensus 168 ~lr~~l~~~~~~~ls~~~~~~~~~~~~~~~~~~l-~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~~~ 246 (755)
+||+.+++++++.||+|++... ...|....+ .+++||+|||+||+++.. ..+ ....++..+++.|
T Consensus 140 ~Lr~~~~~g~~~~LT~A~~~~~---~~~~~~~~l~~~~~D~invm~Yd~~~~~------~~~-----~~~~~~~~~~~~w 205 (273)
T 2hvm_A 140 YLSAYSKQGKKVYLTAAPQCPF---PDRYLGTALNTGLFDYVWVQFYNNPPCQ------YSS-----GNINNIINSWNRW 205 (273)
T ss_dssp HHHHGGGGSSCCEEEECCBSSS---SCTTTHHHHHTTCCSEEEEECSSCGGGS------CBT-----TBCHHHHHHHHHH
T ss_pred HHHHHHhcCCCeEEEECCCCCC---cchhHHHHHhcccCCEEEEeccCCCCCc------CCC-----CCHHHHHHHHHHH
Confidence 9999886556899999987631 122444555 479999999999998311 100 1111456678888
Q ss_pred HHCCCCCCceeecccccC
Q 004402 247 LRRGFPANKLVLGARASG 264 (755)
Q Consensus 247 ~~~g~p~~KlvlG~p~yG 264 (755)
+. |+|++||+||+|++-
T Consensus 206 ~~-g~p~~KlvlGlp~~~ 222 (273)
T 2hvm_A 206 TT-SINAGKIFLGLPAAP 222 (273)
T ss_dssp HH-HCCCSEEEEEEESSG
T ss_pred Hh-cCCcccEEEEEecCc
Confidence 87 899999999999973
|
| >2uy2_A Endochitinase; carbohydrate metabolism, polysaccharide degradation, glycopr chitin-binding, chitin degradation, CAZY, hydrolase; 1.60A {Saccharomyces cerevisiae} PDB: 2uy3_A* 2uy4_A* 2uy5_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-28 Score=249.75 Aligned_cols=198 Identities=18% Similarity=0.184 Sum_probs=141.8
Q ss_pred ceEEEEEecC---CCCCCCCCC-CCCCcceEEEEEEEecCCCcEEecCCc----------hhhHHHHHHHHHHhhCCCce
Q 004402 26 TWIKAGYWLA---GREFPLSDI-NSALFTHLICAFAEVDSSTYQLSISSA----------NQQYFSIFANSVRRKNPSIK 91 (755)
Q Consensus 26 ~~~~~gY~~~---~~~~~~~~i-~~~~~thi~~~f~~~~~~~~~~~~~~~----------~~~~~~~~~~~~k~~~~~lk 91 (755)
...+++||.. ....++.++ +.+.||||+|||+.+.+++ .+.+.+. ....+...++.+|++ ++|
T Consensus 5 ~~~v~~Ywgqn~~~~~~~L~~~c~~~~~t~v~~AF~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~i~~~q~~--g~K 81 (294)
T 2uy2_A 5 NTNIAVYWGQNSAGTQESLATYCESSDADIFLLSFLNQFPTL-GLNFANACSDTFSDGLLHCTQIAEDIETCQSL--GKK 81 (294)
T ss_dssp CCEEEEEESSCTTSCCCCHHHHHTSSSCSEEEEEEEEEBTTT-EECCGGGCCCBCTTSCBCCHHHHHHHHHHHHT--TCE
T ss_pred CCCEEEEcCCCCCCCCCCHHHhCCCCCCCEEEEeeEEecCCC-eEEecCcCCCCCCCcccchHHHHHHHHHHHHC--CCE
Confidence 4679999975 333455555 5678999999999998753 3444321 122333443445544 899
Q ss_pred EEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHH--------HHHcC---CCcccccccCCCCCCcc
Q 004402 92 TLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRT--------ARLYG---FQGIDLFWLWPNSTDLN 160 (755)
Q Consensus 92 ~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~--------~~~~~---~DGvdiDwe~p~~~~~~ 160 (755)
||||||||.++ +. +++++.|++|+++++++ ++.|| |||||||||+|. ..
T Consensus 82 VllSiGG~~g~---------------~~--~~s~~~~~~fa~s~~~~f~~~~~~~~r~~g~~~~DGiDiD~E~p~---~~ 141 (294)
T 2uy2_A 82 VLLSLGGASGS---------------YL--FSDDSQAETFAQTLWDTFGEGTGASERPFDSAVVDGFDFDIENNN---EV 141 (294)
T ss_dssp EEEEEECSCCC---------------BC--CSSHHHHHHHHHHHHHHHSSCCSCCCCTTTTCCCSEEEEECCSSC---CT
T ss_pred EEEEeCCCCCC---------------Cc--CCCHHHHHHHHHHHHHHhcccccccccccCcccccceEEecccCC---cc
Confidence 99999666521 11 36789999999999987 57788 999999999996 67
Q ss_pred cHHHHHHHHHHHccC-CCccEEEeeeecCCcccccccCcchh-cccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCc
Q 004402 161 SLGILLDEWKASASD-QPELTLSMAVRYSPTHETVSYPIDSM-KKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNIS 238 (755)
Q Consensus 161 ~~~~~l~~lr~~l~~-~~~~~ls~~~~~~~~~~~~~~~~~~l-~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~ 238 (755)
+|+.|+++||+.+++ +++++||+|++.... ...+. +.+ ..++||+|||+||+. . +.++ .++
T Consensus 142 ~~~~L~~~Lr~~~~~~g~~~~LTaAp~~~~~--~~~~~-~~l~~~~~D~invq~Yd~~-~------~~~~-------~~~ 204 (294)
T 2uy2_A 142 GYSALATKLRTLFAEGTKQYYLSAAPQCPYP--DASVG-DLLENADIDFAFIQFYNNY-C------SVSG-------QFN 204 (294)
T ss_dssp THHHHHHHHHHHHTTSSSCCEEEECCBSSSS--CTTTH-HHHHHSCCSEEEEECSSST-T------STTS-------SCC
T ss_pred cHHHHHHHHHHHHhhcCCceEEEECCCcccc--hhhhH-HHHhcCCcCeEEeecccCC-C------CCCC-------CcC
Confidence 999999999999975 558999999876421 11122 234 689999999999983 1 1111 244
Q ss_pred HHHHHHHHHHC--CCCCCceeecccccC
Q 004402 239 TDFGIREWLRR--GFPANKLVLGARASG 264 (755)
Q Consensus 239 ~~~~v~~~~~~--g~p~~KlvlG~p~yG 264 (755)
++ +...|+.. |+|++||+||+|++.
T Consensus 205 ~~-~~~~~~~~~~g~p~~KivlGlPa~~ 231 (294)
T 2uy2_A 205 WD-TWLTYAQTVSPNKNIKLFLGLPGSA 231 (294)
T ss_dssp HH-HHHHHHHHTCSSTTCEEEEEEESST
T ss_pred HH-HHHHHHHhcCCCCchhEEEeccCCc
Confidence 54 46778775 799999999999974
|
| >1edt_A Endo-beta-N-acetylglucosaminidase H, endo H; hydrolase (glucosidase); 1.90A {Streptomyces plicatus} SCOP: c.1.8.5 PDB: 1c90_A 1c8x_A 1c91_A 1c3f_A 1c92_A 1c8y_A 1c93_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=243.41 Aligned_cols=175 Identities=16% Similarity=0.173 Sum_probs=127.1
Q ss_pred CCcceEEEEEec--CC-----CCCCCC-CCCCCCcceEEEEEEEecCCC--cEEe--cCCchhhHHHHHHHHHHh-hCCC
Q 004402 23 DAQTWIKAGYWL--AG-----REFPLS-DINSALFTHLICAFAEVDSST--YQLS--ISSANQQYFSIFANSVRR-KNPS 89 (755)
Q Consensus 23 ~~~~~~~~gY~~--~~-----~~~~~~-~i~~~~~thi~~~f~~~~~~~--~~~~--~~~~~~~~~~~~~~~~k~-~~~~ 89 (755)
.....+++|||. .+ ..|.++ +|++..||||+|+ +.++.++ +... .++..........+.++. ++|+
T Consensus 5 ~~~~~~~vcY~~~~~~~~~~~g~~~~~~di~~~~~thiiya-a~i~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~g 83 (271)
T 1edt_A 5 VKQGPTSVAYVEVNNNSMLNVGKYTLADGGGNAFDVAVIFA-ANINYDTGTKTAYLHFNENVQRVLDNAVTQIRPLQQQG 83 (271)
T ss_dssp -CCSCEEEEEEETTTSCGGGGGGEEETTTCSBSCSEEEEEE-EEEEEETTTTEEEEECCHHHHHHHHTHHHHTHHHHHTT
T ss_pred CCCCCEEEEEEeccceeccCCceeeecccCCccccEEEEee-cccCCCccccceEEEeCcchhhhhhhHHHHHHHHhcCC
Confidence 334678999986 23 236788 8999999999999 8887543 2222 221111111111122222 4579
Q ss_pred ceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCC-------CCcccH
Q 004402 90 IKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-------TDLNSL 162 (755)
Q Consensus 90 lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~-------~~~~~~ 162 (755)
+||++|||||.. +..|+.+. +++.|++||+++++++++|+|||||||||||.. .|+.+|
T Consensus 84 ~KvllsiGG~~~-------------~~~~~~l~-s~~~r~~f~~s~~~~~~~~~fDGiDiDwE~p~~~~~g~~~~d~~~~ 149 (271)
T 1edt_A 84 IKVLLSVLGNHQ-------------GAGFANFP-SQQAASAFAKQLSDAVAKYGLDGVDFDDEYAEYGNNGTAQPNDSSF 149 (271)
T ss_dssp CEEEEEEEECTT-------------SCCTTCCS-SHHHHHHHHHHHHHHHHHHTCCEEEEECSSCCTTGGGCCCCCSSHH
T ss_pred CEEEEEECCCCC-------------CCCceecC-CHHHHHHHHHHHHHHHHHhCCCeEEEecccCCCCCCCCCCCCHHHH
Confidence 999999966552 12367764 899999999999999999999999999999952 378999
Q ss_pred HHHHHHHHHHccCCCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCC
Q 004402 163 GILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPS 219 (755)
Q Consensus 163 ~~~l~~lr~~l~~~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~ 219 (755)
+.|+++||++|+ +++||+++++. .....+|+++++++++||+ +||+||+|
T Consensus 150 ~~ll~eLr~~l~---~~~Ls~a~~~~-~~~~~~yd~~~~~~~lD~i---~~d~yg~w 199 (271)
T 1edt_A 150 VHLVTALRANMP---DKIISLYNIGP-AASRLSYGGVDVSDKFDYA---WNPYYGTW 199 (271)
T ss_dssp HHHHHHHHHHCT---TSEEEEESCHH-HHTCCEETTEECGGGCSEE---ECCSTTEE
T ss_pred HHHHHHHHHHCC---CCEEEEEecCC-cchhccCCHHHHHhhCCEE---EEcccCCC
Confidence 999999999994 48999998753 2333468999999999999 67777544
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=272.10 Aligned_cols=184 Identities=17% Similarity=0.157 Sum_probs=129.5
Q ss_pred cccccCCeeEEEE-EcCCCCEEEEEEeccCC----------hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEE
Q 004402 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATS----------TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 442 ~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 509 (755)
.++.|++|.+..+ +.-.|+.+|+|++.... ....++|.+|+++|+++ +|+||+++++++++....|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3566666666554 23358999999986541 23456799999999999 799999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||+++++|.+++... ..++.. +|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++....
T Consensus 321 MEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999999542 345543 58899999999999997 99999999999999999999999999987644
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR 637 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~ 637 (755)
.. ......+||+.|||||++.+ .+..++|+||+|++++++.++..
T Consensus 392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 32 22345689999999999875 46778999999999988776543
|
| >1cnv_A Concanavalin B; plant chitinase, chitin binding protein, SEED protein; 1.65A {Canavalia ensiformis} SCOP: c.1.8.5 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=236.63 Aligned_cols=204 Identities=14% Similarity=0.122 Sum_probs=139.4
Q ss_pred ceEEEEEecCCCCCCCC-CCCCCCcceEEEEEEEecCCC-c--EEecCCc-------hhhHHHHHHHHHHhhCCCceEEE
Q 004402 26 TWIKAGYWLAGREFPLS-DINSALFTHLICAFAEVDSST-Y--QLSISSA-------NQQYFSIFANSVRRKNPSIKTLL 94 (755)
Q Consensus 26 ~~~~~gY~~~~~~~~~~-~i~~~~~thi~~~f~~~~~~~-~--~~~~~~~-------~~~~~~~~~~~~k~~~~~lk~~i 94 (755)
...+++||.....-++. .-+...||||++||+.+..++ . .+.+... ....+...++.+++ +++||++
T Consensus 4 ~~~i~~YWg~~~~g~L~~~c~~~~~~~V~~aF~~~~~~G~~~p~~~l~~~~~~~~~~~~~~~~~~Ik~~q~--~g~KVll 81 (299)
T 1cnv_A 4 STEIAVYWGQREDGLLRDTCKTNNYKIVFISFLDKFGCEIRKPELELEGVCGPSVGNPCSFLESQIKECQR--MGVKVFL 81 (299)
T ss_dssp GCEEEEEECSGGGCCHHHHHHTCCCSEEEEEEECEECTTCSSCCCCBTTTBBTTTTBCGGGGHHHHHHHHH--TTCEEEE
T ss_pred CCcEEEEcCCCCCCCcccccCCCCCCEEEEEEEEecCCCCcchhhhhcccCCcccCcchHhHHHHHHHHHh--CCCEEEE
Confidence 34589999861111111 012446999999999987644 1 2222211 12334444455555 4899999
Q ss_pred EecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHH---------HHHHHcCCCcccccccCCCCCCcccHHHH
Q 004402 95 SIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSI---------RTARLYGFQGIDLFWLWPNSTDLNSLGIL 165 (755)
Q Consensus 95 sigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~---------~~~~~~~~DGvdiDwe~p~~~~~~~~~~~ 165 (755)
|||||.+ + |+ +++++.|++|++++. +++.+|+|||||||||+|.. ..+|..|
T Consensus 82 SiGG~~g------------s---~~--~~s~~~~~~fa~~~~~~f~~g~~~~~~~~~~~DGiDiD~E~~~~--~~~~~~L 142 (299)
T 1cnv_A 82 ALGGPKG------------T---YS--ACSADYAKDLAEYLHTYFLSERREGPLGKVALDGIHFDIQKPVD--ELNWDNL 142 (299)
T ss_dssp EEECSSS------------E---EC--CCSHHHHHHHHHHHHHHHBSSSSCBTTBSCBCSEEEEECSSCSC--STTHHHH
T ss_pred EecCCcc------------c---cc--cCCHHHHHHHHHHHHHHhcCccccchHHhcCCceEEeeccCCCc--hhHHHHH
Confidence 9966552 1 33 678999999999995 88899999999999999964 4899999
Q ss_pred HHHHHHHccC-CCccEEEeeeecCCcccccccCcchh-cccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHH
Q 004402 166 LDEWKASASD-QPELTLSMAVRYSPTHETVSYPIDSM-KKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGI 243 (755)
Q Consensus 166 l~~lr~~l~~-~~~~~ls~~~~~~~~~~~~~~~~~~l-~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v 243 (755)
+++||+.+.+ ++++.||+|++.... ..+.-..+ ..++||+|||+||..+- +..+ ....+...++
T Consensus 143 ~~~Lr~~~~~~g~~~~LTaAp~~~~~---~~~~~~~~~~~~lD~invq~Yn~~~c------~~~~-----g~~~~~~~a~ 208 (299)
T 1cnv_A 143 LEELYQIKDVYQSTFLLSAAPGCLSP---DEYLDNAIQTRHFDYIFVRFYNDRSC------QYST-----GNIQRIRNAW 208 (299)
T ss_dssp HHHHHHHHHHHTCCCEEEECCBSSSS---CTTTHHHHTTTCCSEEEEECSSCTTT------SCBT-----TBCHHHHHHH
T ss_pred HHHHHHhhhhcCCCeEEEEeccCCCc---chhHHHHHhcCCcCEEEEEeecCCCc------CCCC-----CChhhHHHHH
Confidence 9999997753 468999999876321 11222233 68999999999997411 1111 0111456788
Q ss_pred HHHHHCC-CCCCceeecccccC
Q 004402 244 REWLRRG-FPANKLVLGARASG 264 (755)
Q Consensus 244 ~~~~~~g-~p~~KlvlG~p~yG 264 (755)
+.|++.+ .|++||+||+|+..
T Consensus 209 ~~w~~~~~~p~~Kl~lGlPa~~ 230 (299)
T 1cnv_A 209 LSWTKSVYPRDKNLFLELPASQ 230 (299)
T ss_dssp HHHHHHSSSCSSCEEEEEESSG
T ss_pred HHHHHhCCCCcccEEEEecCCc
Confidence 9999876 49999999999965
|
| >1eok_A Endo-beta-N-acetylglucosaminidase F3; alpha/beta-barrel, hydrolase; 1.80A {Elizabethkingia meningoseptica} SCOP: c.1.8.5 PDB: 1eom_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-26 Score=240.02 Aligned_cols=198 Identities=17% Similarity=0.209 Sum_probs=132.2
Q ss_pred CCcceEEEEEecC---CCCCCCCCCCCCCcceEEEEEEE-ecCCCcEEec--CCchh-------hHHHHHHHHHHhhCCC
Q 004402 23 DAQTWIKAGYWLA---GREFPLSDINSALFTHLICAFAE-VDSSTYQLSI--SSANQ-------QYFSIFANSVRRKNPS 89 (755)
Q Consensus 23 ~~~~~~~~gY~~~---~~~~~~~~i~~~~~thi~~~f~~-~~~~~~~~~~--~~~~~-------~~~~~~~~~~k~~~~~ 89 (755)
.+..++++|||.. ...+.+++++. .++||++ |+. +.. ++.+.. ..... ..+...++.+| +++
T Consensus 5 ~~~~~~vv~Y~~~~~~~~~~~l~~i~~-~~~~i~~-F~~~~~~-~g~~~~~p~~~~~~~~~~~~~~~~~~i~~~q--~~g 79 (290)
T 1eok_A 5 AGSNGVCIAYYITDGRNPTFKLKDIPD-KVDMVIL-FGLKYWS-LQDTTKLPGGTGMMGSFKSYKDLDTQIRSLQ--SRG 79 (290)
T ss_dssp ---CCEEEEEEECSCSSTTSCGGGCCT-TCCEEEE-ESSCHHH-HHCTTSSCTTSGGGTTCSSHHHHHHHHHHHH--TTT
T ss_pred CCCCCEEEEEEecCCCCCcccHhHCCC-CCCEEEE-ccccCCC-CCcceeCCCCcccccccccHHHHHHHHHHHH--hCC
Confidence 3457899999964 22368889984 4566666 763 221 111111 11101 22333334444 568
Q ss_pred ceEEEEecCCCCCccccccCCCCCCccccccc-ccChhhHHHHHHHHHH-HHHHcCCCcccccccCCCC-----------
Q 004402 90 IKTLLSIWNGQNSTYQSILGNKNINPSVLSSM-VGDSSHRKSFIESSIR-TARLYGFQGIDLFWLWPNS----------- 156 (755)
Q Consensus 90 lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~-~~~~~~r~~fi~~i~~-~~~~~~~DGvdiDwe~p~~----------- 156 (755)
+|||+|||| +..|+.+ +++.+.|++|++++++ ++++|||||||||||||..
T Consensus 80 ~KVllSIGG----------------~~~~~~~~~~~~~~r~~fa~s~~~~~l~~yg~DGiDiDwEy~~~~~~~~~~~pg~ 143 (290)
T 1eok_A 80 IKVLQNIDD----------------DVSWQSSKPGGFASAAAYGDAIKSIVIDKWKLDGISLDIEHSGAKPNPIPTFPGY 143 (290)
T ss_dssp CEEEEEEEC----------------CGGGGSSSGGGSSSHHHHHHHHHHHHTTTTCCCEEEEECCCCCCCCSSCCCCCCH
T ss_pred CEEEEEeCC----------------CcCCCCccccchhHHHHHHHHHHHHHHHhcCCCcEEEecCCCCcccccccccccc
Confidence 999999954 1136666 6667889999999999 9999999999999999753
Q ss_pred -----------CC--cccHHHHHHHHHHHccCC--CccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCC
Q 004402 157 -----------TD--LNSLGILLDEWKASASDQ--PELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKE 221 (755)
Q Consensus 157 -----------~~--~~~~~~~l~~lr~~l~~~--~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~ 221 (755)
++ .++|+.||++||+++.+. ..+.++++.+... +....+++++.+++||+|||+||+++
T Consensus 144 ~~~g~~~~~~~~~~~~~~~~~~l~el~~~~~~~a~~~~~l~i~~~~~~--y~~~~~~~~~~~~lD~invm~Yd~~~---- 217 (290)
T 1eok_A 144 AATGYNGWYSGSMAATPAFLNVISELTKYFGTTAPNNKQLQIASGIDV--YAWNKIMENFRNNFNYIQLQSYGANV---- 217 (290)
T ss_dssp HHHSCSSCCTTSCCCCHHHHHHHHHHTTTSSTTSSSCCEEEEEECTTS--TTHHHHHHHHTTTCSEEEECCTTCCH----
T ss_pred cccccccccCcchHHHHHHHHHHHHHHHHhCCCCCCceEEEecCCccc--ccchHHHHHHhhccCEEEEecCCCCC----
Confidence 11 578999999999998642 2467777654321 11111467889999999999999862
Q ss_pred cccccCCCCCCCCCCCcHHHHHHHHH--HCCCCCCceeeccccc
Q 004402 222 NVTGIHAALYNPSSNISTDFGIREWL--RRGFPANKLVLGARAS 263 (755)
Q Consensus 222 ~~~~~~a~l~~~~~~~~~~~~v~~~~--~~g~p~~KlvlG~p~y 263 (755)
. .....++ |. ..|+|++||+||+|+|
T Consensus 218 ------~---------~~~~~~~-~~~~~~g~p~~Ki~lG~Pa~ 245 (290)
T 1eok_A 218 ------S---------RTQLMMN-YATGTNKIPASKMVFGAYAE 245 (290)
T ss_dssp ------H---------HHHHHHH-HHHHTSCCCGGGEEEEECTT
T ss_pred ------c---------HHHHHHH-HhhccCCCCHHHEEeccccC
Confidence 0 1222334 52 1799999999999998
|
| >2xtk_A CHIA1, class III chitinase CHIA1; hydrolase, GH18; HET: AZM; 2.00A {Aspergillus fumigatus} PDB: 2xuc_A 2xvp_A 2xvn_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=232.15 Aligned_cols=206 Identities=16% Similarity=0.110 Sum_probs=141.2
Q ss_pred EEEEEecCC-CCCCCCCC-CCCCcceEEEEEEEecCCCc-----EEecC-----------C-------chhhHHHHHHHH
Q 004402 28 IKAGYWLAG-REFPLSDI-NSALFTHLICAFAEVDSSTY-----QLSIS-----------S-------ANQQYFSIFANS 82 (755)
Q Consensus 28 ~~~gY~~~~-~~~~~~~i-~~~~~thi~~~f~~~~~~~~-----~~~~~-----------~-------~~~~~~~~~~~~ 82 (755)
.+++||-.. ..-++.+. +...+++|++||+.....++ .+.+. + .....+...++.
T Consensus 3 ~i~vYWGq~~~~~~L~~~c~~~~ydii~laF~~~~~~~~~~~~P~~n~~~~c~~~~~~~~~g~~t~~l~~c~~l~~~I~~ 82 (310)
T 2xtk_A 3 NLAIYWGQGPNQLRLSHFCQETSLDIINIGFINYFPDMSPGHWPGSNFGNQCDGSVYVTNDGVVTKLLSGCHQIMEDIPI 82 (310)
T ss_dssp EEEEEESCCTTCCCHHHHHTCTTCSEEEEEEEEECTTTSGGGSCEECCTTCSCSCEEECTTCCEEEEESCCHHHHHHHHH
T ss_pred CEEEEECCCCCCCChHHhcCCCCccEEEEeeeeccCCCCCCCCccceeccccCccccccCCCcccccccCcHhHHHHHHH
Confidence 488999653 22344444 23479999999998765321 11110 0 012345556566
Q ss_pred HHhhCCCceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHH----------HHHHcC---CCcccc
Q 004402 83 VRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIR----------TARLYG---FQGIDL 149 (755)
Q Consensus 83 ~k~~~~~lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~----------~~~~~~---~DGvdi 149 (755)
+|++ ++|||||||||.. ++ ++ +++++.|++|++++++ +++.|| ||||||
T Consensus 83 ~q~~--g~KVllSiGG~~~------------~~--~~--~~s~~~r~~fa~s~~~~f~~~~~~~~~~r~~g~~~fDGiDi 144 (310)
T 2xtk_A 83 CQAA--GKKVLLSIGGAYP------------PD--QS--ILSEDSAVAFATFLWGAFGPVAEGWEGPRPFGDVVVDGFDF 144 (310)
T ss_dssp HHHT--TCEEEEEEEESSC------------SC--CC--CCCHHHHHHHHHHHHHHHSSCCTTCCSCCTTTTCCCSEEEE
T ss_pred HHhC--CCEEEEEeCCCcC------------Cc--cc--cCCHHHHHHHHHHHHHHhcCcccccccccccCCcccceEEE
Confidence 6665 8999999966663 11 12 4678999999999986 478899 999999
Q ss_pred cccCCCCCCcccHHHHHHHHHHHccC--CCccEEEeeeecCCcccccccCcchhc-ccCChhhhhhhhccCCCCCccccc
Q 004402 150 FWLWPNSTDLNSLGILLDEWKASASD--QPELTLSMAVRYSPTHETVSYPIDSMK-KNLNWAHLVAYDYHMPSKENVTGI 226 (755)
Q Consensus 150 Dwe~p~~~~~~~~~~~l~~lr~~l~~--~~~~~ls~~~~~~~~~~~~~~~~~~l~-~~vD~~~vm~Yd~~~~~~~~~~~~ 226 (755)
|||+|. ..+|..|+++||+.+.+ +++++||+|++... ...+....|. .++||+|||+||+++-... ...
T Consensus 145 DwE~p~---~~~~~~L~~~Lr~~~~~~~~~~~~LTaAp~~~~---~~~~~~~~l~~~~lD~invq~Yd~~~~~~~--~~~ 216 (310)
T 2xtk_A 145 DIEHNG---GFGYATMVNTFRQYFNQVPERKFYLSAAPQCII---PDAQLSDAIFNAAFDFIWIQYYNTAACSAK--SFI 216 (310)
T ss_dssp EECSSC---CTTHHHHHHHHHHHHHTCTTSCCEEEECCBSSS---SCTTTHHHHHHSCCSEEEEECSSCTTTCTH--HHH
T ss_pred eecCCC---chhHHHHHHHHHHhhccccCCCeEEEeCCcCCC---cchHHHHHHHhCCCCceeeeeccCCCCCcc--ccc
Confidence 999995 57899999999999964 35899999988641 1225556774 6999999999999731110 000
Q ss_pred CCCCCCCCCCCcHHHHHHHHHHC-CCCCCceeecccccC
Q 004402 227 HAALYNPSSNISTDFGIREWLRR-GFPANKLVLGARASG 264 (755)
Q Consensus 227 ~a~l~~~~~~~~~~~~v~~~~~~-g~p~~KlvlG~p~yG 264 (755)
. .....++++.. ..|+.. ++|++||+||+|++-
T Consensus 217 -~---~~~~~~~~~~~-~~~~~~~~~p~~KlvlGlPa~~ 250 (310)
T 2xtk_A 217 -D---TSLGTFNFDAW-VTVLKASASKDAKLYVGLPASE 250 (310)
T ss_dssp -S---TTSCCCCHHHH-HHHHTTSTTTTCEEEEEEESST
T ss_pred -c---CccccccHHHH-HHHHHhcCCCchhEEEeecCCc
Confidence 0 11123566654 467765 689999999999974
|
| >2ebn_A Endo-beta-N-acetylglucosaminidase F1; hydrolase(glucosidase); 2.00A {Elizabethkingia meningoseptica} SCOP: c.1.8.5 | Back alignment and structure |
|---|
Probab=99.92 E-value=5e-24 Score=216.17 Aligned_cols=218 Identities=14% Similarity=0.162 Sum_probs=149.9
Q ss_pred CCcceEEEEEecCC--C-----CCCC-CCCCCCCcceEEEEEEEecC--CCcEEecCCchh-----hHHHHHHHHHHhhC
Q 004402 23 DAQTWIKAGYWLAG--R-----EFPL-SDINSALFTHLICAFAEVDS--STYQLSISSANQ-----QYFSIFANSVRRKN 87 (755)
Q Consensus 23 ~~~~~~~~gY~~~~--~-----~~~~-~~i~~~~~thi~~~f~~~~~--~~~~~~~~~~~~-----~~~~~~~~~~k~~~ 87 (755)
.....+++||+..+ + .|.+ +++++. ||||+++|+.++. +++.+......+ ......++.+|++
T Consensus 6 ~~~~~kvVcY~~~~~~~p~~~g~f~l~~~~~p~-~d~vi~~fa~in~d~~~g~~~l~~n~~~~~~~~~~~~~i~~lq~~- 83 (289)
T 2ebn_A 6 TKANIKLFSFTEVNDTNPLNNLNFTLKNSGKPL-VDMVVLFSANINYDAANDKVFVSNNPNVQHLLTNRAKYLKPLQDK- 83 (289)
T ss_dssp CCCSCEEEEEEETTTCCGGGGGGEEETTTCCBS-CCEEEEEEEEEEEETTTTEEEEECCHHHHHHHHTHHHHTHHHHHT-
T ss_pred cCCCCEEEEEEEecCCCCCcCceEEeccCCCCc-eeEEEEEEEecccCCCCCeeEEecCccccccccchHHHHHHHHhC-
Confidence 33467899997533 2 3667 688774 9999999999863 334443332221 1123444666654
Q ss_pred CCceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCC----------C
Q 004402 88 PSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS----------T 157 (755)
Q Consensus 88 ~~lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~----------~ 157 (755)
++||++|||||.. + ..|..+. ++.|++|++++++++++|||||||||||||.. .
T Consensus 84 -glKVllSIGG~~~--------~-----~g~~~l~--~~~r~~Fa~sv~~~v~~ygfDGiDiDwEyp~~~~~g~~g~~~~ 147 (289)
T 2ebn_A 84 -GIKVILSILGNHD--------R-----SGIANLS--TARAKAFAQELKNTCDLYNLDGVFFDDEYSAYQTPPPSGFVTP 147 (289)
T ss_dssp -TCEEEEEEECCSS--------S-----CCTTCBC--HHHHHHHHHHHHHHHHHHTCCEEEEECCSCCCCSSCCTTBCCC
T ss_pred -CCEEEEEeCCCCC--------C-----CCeecCC--HHHHHHHHHHHHHHHHHhCCCcEEEeeecCCCCccCCCCCCCc
Confidence 7999999966431 1 1144443 68999999999999999999999999999732 2
Q ss_pred CcccHHHHHHHHHHHccCCCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCC
Q 004402 158 DLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNI 237 (755)
Q Consensus 158 ~~~~~~~~l~~lr~~l~~~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~ 237 (755)
++++|+.|+++||++|+ +++||++++..+.....+|+.+++++++||+.. +|+ . |+.... |
T Consensus 148 d~~n~~~Ll~eLR~~l~---~klLT~Av~g~~~~~~~~~d~~~~~~ylDy~~~-~Yg---~-~~~~~~---~-------- 208 (289)
T 2ebn_A 148 SNNAAARLAYETKQAMP---NKLVTVYVYSRTSSFPTAVDGVNAGSYVDYAIH-DYG---G-SYDLAT---N-------- 208 (289)
T ss_dssp CHHHHHHHHHHHHHHCT---TSEEEEEESGGGSCCCSCBTTBCGGGTCSEEEE-CTT---C-CSCCTT---T--------
T ss_pred cHHHHHHHHHHHHHHCC---CCEEEEEecCCccccccccCHHHHHhcCCEEEe-ccc---C-cccCCC---c--------
Confidence 67899999999999993 579999998665554567999999999999766 463 2 221111 1
Q ss_pred cHHHHHHHHHHCCCCCCceeecccccCCCcccCCCcchHHHHHHHhhcCCCcccc
Q 004402 238 STDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPV 292 (755)
Q Consensus 238 ~~~~~v~~~~~~g~p~~KlvlG~p~yG~~~~~~~~~~y~~~~~~~~~~~~~~~~~ 292 (755)
-.|+|++|+..+-..+++++.. +.. ..+.+.+.|+|+-..
T Consensus 209 ----------~~g~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~gyg~~~~ 248 (289)
T 2ebn_A 209 ----------YPGLAKSGMVMSSQEFNQGRYA----TAQ-ALRNIVTKGYGGHMI 248 (289)
T ss_dssp ----------STTCCGGGEEEEEEETTTTBCC----CHH-HHHHHHHHTCCEEEE
T ss_pred ----------CCCCChhceecceeEecCCCcc----hHH-HHHHHHhCCcceEEE
Confidence 0489999999988777765443 222 333445566665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-25 Score=250.78 Aligned_cols=185 Identities=18% Similarity=0.219 Sum_probs=145.3
Q ss_pred CccCcccccCCeeEEEEEcCCCCEEEEEEeccCCh--------hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 438 SSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST--------QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 438 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
...+.||+|+||.||+|.. .++.+++|+...... ...+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999954 688999998644321 1234689999999999999999777777777888999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
|||+++++|.+++.. +..++.|+++||.|||+.+ |+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999853 5689999999999999987 999999999999999 999999999997654
Q ss_pred CCccc-----ccccccccCCccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCC
Q 004402 590 DVDEA-----NTGRIVGTYGYVPPEYVKK--GIYSMKYDVYSFGVLLLQIISSKRNA 639 (755)
Q Consensus 590 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwS~Gvil~elltg~~p~ 639 (755)
..... ......||+.|||||++.. ..|+..+|+||..+-..+-+.++.++
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32211 1235689999999999986 66888999999999988888766543
|
| >1ta3_A XIP-1, xylanase inhibitor protein I; beta alpha barrel (XIP-I), beta alpha barrel (xylanase), HYD inhibitor-hydrolase complex; HET: NAG; 1.70A {Triticum aestivum} SCOP: c.1.8.5 PDB: 1om0_A* 1te1_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-23 Score=210.81 Aligned_cols=198 Identities=15% Similarity=0.179 Sum_probs=131.0
Q ss_pred ceEEEEEecCCCCCCCCCCC----CCCcceEEEEEEEecCCCcE--EecCCchhhHHHHHHHHHHhhCCCceEEEEecCC
Q 004402 26 TWIKAGYWLAGREFPLSDIN----SALFTHLICAFAEVDSSTYQ--LSISSANQQYFSIFANSVRRKNPSIKTLLSIWNG 99 (755)
Q Consensus 26 ~~~~~gY~~~~~~~~~~~i~----~~~~thi~~~f~~~~~~~~~--~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg~ 99 (755)
...+++||-... ....+. ...+|||++||+.+.++.+. +...+.....+...++.++. .++|||+|||||
T Consensus 5 ~~~i~~YWGqn~--~~~~L~~~c~~~~~~~V~~AF~~~~~~~G~~~~d~~g~~~~~~~~~I~~cq~--~g~kVlLSiGG~ 80 (274)
T 1ta3_A 5 TGQVTVFWGRNK--AEGSLREACDSGMYTMVTMSFLDVFGANGKYHLDLSGHDLSSVGADIKHCQS--KGVPVSLSIGGY 80 (274)
T ss_dssp CCCEEEEESSCG--GGCCHHHHHHTTCCSEEEEEEEEEBSSSSCCEECCTTCCGGGHHHHHHHHHH--TTCCEEEEEEES
T ss_pred CCcEEEEeCCCC--CCCchHhhcccCCCcEEEEccEeecCCCCceeeccCCCChHHHHHHHHHHHh--CCCEEEEecCCC
Confidence 345899995421 122333 45799999999998873332 22322222334444454544 489999999666
Q ss_pred CCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHH------------HHcCCCcccccccCCCCCCcccHHHHHH
Q 004402 100 QNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTA------------RLYGFQGIDLFWLWPNSTDLNSLGILLD 167 (755)
Q Consensus 100 ~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~------------~~~~~DGvdiDwe~p~~~~~~~~~~~l~ 167 (755)
.++ ++ +.+++.+++|++++.+.. .+++|||||||||+|. +..+|..|++
T Consensus 81 ~gs---------------~~--l~s~~~a~~fa~~l~~~f~~g~~~~~~r~~g~~~lDGiDiD~E~~~--~~~~~~~L~~ 141 (274)
T 1ta3_A 81 GTG---------------YS--LPSNRSALDLFDHLWNSYFGGSKPSVPRPFGDAWLDGVDLFLEHGT--PADRYDVLAL 141 (274)
T ss_dssp SSC---------------BC--CCSHHHHHHHHHHHHHHHSSCCCTTSCCTTTTCCCSEEEEEESSCC--TTCCHHHHHH
T ss_pred cCc---------------cc--cCCHHHHHHHHHHHHHHhcCcccccccccHhhcCcCeEEEeccCCC--CchhHHHHHH
Confidence 521 11 556788999999998764 4567999999999984 6789999999
Q ss_pred HHHHHccC---CCccEEEeeeecCCcccccccCcchh-cccCChhhhhhh-hccCCCCCcccccCCCCCCCCCCCcHHHH
Q 004402 168 EWKASASD---QPELTLSMAVRYSPTHETVSYPIDSM-KKNLNWAHLVAY-DYHMPSKENVTGIHAALYNPSSNISTDFG 242 (755)
Q Consensus 168 ~lr~~l~~---~~~~~ls~~~~~~~~~~~~~~~~~~l-~~~vD~~~vm~Y-d~~~~~~~~~~~~~a~l~~~~~~~~~~~~ 242 (755)
+||+.+++ ++++.||+|+...... ..... ..+ ..++||+|||.| +.. + .+..+ ....+
T Consensus 142 ~Lr~~~~~~~~g~~~~LTaAPq~p~~~-d~~~~-~~l~~~~~D~v~vqfYdnn~-~-----c~~~~---------~~~~~ 204 (274)
T 1ta3_A 142 ELAKHNIRGGPGKPLHLTATVRCGYPP-AAHVG-RALATGIFERVHVRTYESDK-W-----CNQNL---------GWEGS 204 (274)
T ss_dssp HHHTTCCSSSSSCCCEEEEEECSSSSC-CHHHH-HHHTTSCCCEEEEECSSCCT-T-----SBTTB---------BHHHH
T ss_pred HHHHHHhhccCCCCEEEEECCcCCCCC-ChhHH-HHHhcCCCCeEEeeeecCCC-C-----Ccccc---------ccHHH
Confidence 99998852 5689999997542110 11011 122 568999999999 421 0 11110 12346
Q ss_pred HHHHHHCCCCCCceeecccccC
Q 004402 243 IREWLRRGFPANKLVLGARASG 264 (755)
Q Consensus 243 v~~~~~~g~p~~KlvlG~p~yG 264 (755)
++.|++ ++|++||+||+|++.
T Consensus 205 ~~~w~~-~~p~~Ki~lGlPa~~ 225 (274)
T 1ta3_A 205 WDKWTA-AYPATRFYVGLTADD 225 (274)
T ss_dssp HHHHHH-HCTTSEEEEEEECCT
T ss_pred HHHHHh-cCCcccEEEeeecCc
Confidence 777876 699999999999975
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.8e-22 Score=207.41 Aligned_cols=153 Identities=18% Similarity=0.165 Sum_probs=122.5
Q ss_pred HHHHHHHhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCCh------------------hhHHHHHHHHHHHhcC
Q 004402 427 FSDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST------------------QGLEEFKNEVSLTARL 488 (755)
Q Consensus 427 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l 488 (755)
+..+......|...+.||+|+||.||+|...+|+.||||+++.... .....+.+|+.+|+++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3444445566777799999999999999887799999999965321 1345789999999999
Q ss_pred CCCceeeeeeeeecCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCE
Q 004402 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNI 568 (755)
Q Consensus 489 ~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NI 568 (755)
+ | +++.+++. .+..++||||+++++|.+ +.. .....++.|++.||.|||+.+ |+||||||+||
T Consensus 162 ~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 162 Q--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp T--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred c--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 9 5 66666554 356799999999999987 421 124469999999999999987 99999999999
Q ss_pred EEcCCCCeEEEecCCccccccCCcccccccccccCCcccccccc
Q 004402 569 LLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612 (755)
Q Consensus 569 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 612 (755)
|++ ++.+||+|||+++. +..++|||++.
T Consensus 225 Ll~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp EEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred EEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 999 99999999999963 34578999874
|
| >3poh_A Endo-beta-N-acetylglucosaminidase F1; TIM barrel, structural genomics, joint center for structural genomics, JCSG; 1.55A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.9e-19 Score=189.94 Aligned_cols=162 Identities=13% Similarity=0.145 Sum_probs=121.0
Q ss_pred ceEEEEEecC--CC-----CCCCCCCCCCCcceEEEEEEEec--CCCcEE--ecCCchhhHH---HHHHHHHHhhCCCce
Q 004402 26 TWIKAGYWLA--GR-----EFPLSDINSALFTHLICAFAEVD--SSTYQL--SISSANQQYF---SIFANSVRRKNPSIK 91 (755)
Q Consensus 26 ~~~~~gY~~~--~~-----~~~~~~i~~~~~thi~~~f~~~~--~~~~~~--~~~~~~~~~~---~~~~~~~k~~~~~lk 91 (755)
...+++|..- .+ .|..++ --...+|++++.+.|+ +.++.. ...+.....+ ..+++.++++ ++|
T Consensus 167 ~~~~~~y~evn~~npln~~~y~l~~-~~~~~d~v~lfaanin~d~~~~~~~l~~n~~~~~~L~~~~~~v~~lq~~--glK 243 (451)
T 3poh_A 167 VMQGYLFFEVNDVNPLNTLSFQLEN-GKLLWDVVVLFAANINYDAEAGRPRVQCNPNVQYLLDNNETLLQPLRRR--GVK 243 (451)
T ss_dssp CCEEEEEEETTTCCGGGGGGCBBTT-SCBSCSEEEEEEEEEEEETTTTEEEEECCHHHHHHHHTHHHHTHHHHHT--TCE
T ss_pred CceEEEEEEeCCCCccccceeEecC-CCceeeEEEEeeeecCCCcccCeEEEEcCCchHHhhhChHHHHHHHHHC--CCE
Confidence 4678888632 11 244432 1237899999999998 434443 3343333333 5566777776 699
Q ss_pred EEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCC----------CCccc
Q 004402 92 TLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS----------TDLNS 161 (755)
Q Consensus 92 ~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~----------~~~~~ 161 (755)
|++|||||.. ...|+.+ +++.|++|++++++++++|||||||||||||.. .+.++
T Consensus 244 VllSIgGg~~-------------~~gf~~l--s~~~r~~Fa~~v~~~v~~yglDGIDiDwEYp~~~~~g~~~~~~~d~~n 308 (451)
T 3poh_A 244 VLLGLLGNHD-------------ITGLAQL--SEQGAKDFAREVAQYCKAYNLDGVNYDDEYSNSPDLSNPSLTNPSTAA 308 (451)
T ss_dssp EEEEEECCSS-------------SCCTTCB--CHHHHHHHHHHHHHHHHHTTCCEEEEECCSCCCCCTTSTTBCSCCHHH
T ss_pred EEEEECcCCC-------------CCCcccC--CHHHHHHHHHHHHHHHHHhCCCcEEEeccCCCCCCCCCCCcCCCCHHH
Confidence 9999954331 1226666 789999999999999999999999999999943 46889
Q ss_pred HHHHHHHHHHHccCCCccEEEeeeecCCcccccccCcchhcccCChhh
Q 004402 162 LGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAH 209 (755)
Q Consensus 162 ~~~~l~~lr~~l~~~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~ 209 (755)
|+.|+++||++|+ +++||+++|..... ...+|..++++++||+.
T Consensus 309 f~~Ll~eLR~~lp---~kllT~A~~g~~~~-~~~~d~~~~~~ylDy~~ 352 (451)
T 3poh_A 309 AARLCYETKQAMP---DKLVTVFDWGQMYG-VATVDGVDAKEWIDIVV 352 (451)
T ss_dssp HHHHHHHHHHHCT---TSEEEEECCTTSSC-CCEETTEEGGGTCCEEE
T ss_pred HHHHHHHHHHhCC---CCEEEEEeccCccc-ccccChhhHhhhceeee
Confidence 9999999999994 57999999988764 45599999999999965
|
| >3mu7_A XAIP-II, xylanase and alpha-amylase inhibitor protein; TIM barell, amylase/xylanase inhibitory protein, hydrolase I; 1.29A {Scadoxus multiflorus} SCOP: c.1.8.0 PDB: 3o9n_A 3oih_A* 3hu7_A 3m7s_A* 3d5h_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=5e-19 Score=177.50 Aligned_cols=199 Identities=17% Similarity=0.157 Sum_probs=134.3
Q ss_pred EEEEEecCCCC-CCCCC-CCCCCcceEEEEEEEecCCCc--EEecCCchhhHHHHHHHHHHhhCCCceEEEEecCCCCCc
Q 004402 28 IKAGYWLAGRE-FPLSD-INSALFTHLICAFAEVDSSTY--QLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNST 103 (755)
Q Consensus 28 ~~~gY~~~~~~-~~~~~-i~~~~~thi~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg~~~~~ 103 (755)
.++.||-.... -++.+ =+...+++|+++|+....++. .+.+.......+...++.++++ ++|||+||||+.+
T Consensus 4 ~iavYWGqn~~~~~L~~~C~~~~y~~v~laFl~~~g~g~~p~~nl~~~c~~~l~~dI~~cQ~~--G~kVlLSiGG~~g-- 79 (273)
T 3mu7_A 4 DIAVYWGQSFDERSLEATCDSGNYAYVIIGFLNTFGGGQTPALDISGHSPKGLEPQIKHCQSK--NVKVLLSIGGPAG-- 79 (273)
T ss_dssp CEEEEECSCTTSCCHHHHHHTSCCSEEEEEEEEEBSTTCCCEECSTTCCTTTHHHHHHHHHHT--TCEEEEEEEESSC--
T ss_pred CEEEECCCCCCCCCHHHHhcCCCCCEEEEEeEeccCCCCCccccccccchHHHHHHHHHHHHC--CCEEEEEeccCCC--
Confidence 47889954321 11111 112368999999998876542 3455544446677777777776 7999999966542
Q ss_pred cccccCCCCCCcccccccccChhhHHHHHHHHHHHH----------HHcC---CCcccccccCCCCCCcccHHHHHHHHH
Q 004402 104 YQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTA----------RLYG---FQGIDLFWLWPNSTDLNSLGILLDEWK 170 (755)
Q Consensus 104 ~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~----------~~~~---~DGvdiDwe~p~~~~~~~~~~~l~~lr 170 (755)
+.-+.+++.+++|++++.+.. +.+| |||||||||++. ..+|..|+++||
T Consensus 80 ---------------~~~l~s~~~a~~fa~~l~~~f~p~~~g~~~~rp~g~~~lDGiD~D~E~~~---~~~~~~l~~~Lr 141 (273)
T 3mu7_A 80 ---------------PYSLDSRNDANDLAVYLHKNFLLPPAGTSESRPFGNAVLDGIDFHIEHGG---PSQYQLLANILS 141 (273)
T ss_dssp ---------------SBCCCSHHHHHHHHHHHHHHHTSCCCSSCCCCTTTTCCCSEEEEEECSSC---STTHHHHHHHHH
T ss_pred ---------------ceecCCHHHHHHHHHHHHHHhccccCCCcccccccccccCceEeecccCC---chhHHHHHHHHH
Confidence 112677888999999999865 4555 999999999995 478999999999
Q ss_pred HHccCCCccEEEeeeecCCcccccccCcchh-cccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHHHHHHC
Q 004402 171 ASASDQPELTLSMAVRYSPTHETVSYPIDSM-KKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRR 249 (755)
Q Consensus 171 ~~l~~~~~~~ls~~~~~~~~~~~~~~~~~~l-~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~~~~~~ 249 (755)
+.+++++++.||+|+..... .. +.-..| ..++||+++|.||-.+-.+. .....+...+...|+.
T Consensus 142 ~~~~~g~~~~LTaAPqcp~p--d~-~l~~~l~~~~~D~v~vQfYNn~~C~~~-----------~~~~~~f~~~w~~w~~- 206 (273)
T 3mu7_A 142 SFRLSGSEFALTAAPQCVYP--DP-NLGTVINSATFDAIWVQFYNNPQCSYS-----------ASNASALMNAWKEWSM- 206 (273)
T ss_dssp HHHTTSSCCEEEECCBSSSS--CT-TTHHHHHTTCCSEEEEECSSCGGGSCB-----------TTBCHHHHHHHHHHHH-
T ss_pred HHhccCCceEEEEcccCCCc--ch-hHHHHhhcCcccEEEEEeccCCCcccc-----------cCChhHHHHHHHHHHh-
Confidence 99876568999999754311 11 222334 36899999999985210000 0011122334556664
Q ss_pred CCCCCceeeccccc
Q 004402 250 GFPANKLVLGARAS 263 (755)
Q Consensus 250 g~p~~KlvlG~p~y 263 (755)
++|.+||+||+|+-
T Consensus 207 ~~p~~Kv~lGlPAs 220 (273)
T 3mu7_A 207 KARTDKVFLGFPAH 220 (273)
T ss_dssp HCCSSCEEEEEESS
T ss_pred cCCcceEEEEeecC
Confidence 79999999999983
|
| >2dsk_A Chitinase; catalytic domain, active domain, crystalline CHIT barrel, hydrolase; 1.50A {Pyrococcus furiosus} PDB: 3a4w_A* 3a4x_A* 3afb_A | Back alignment and structure |
|---|
Probab=99.76 E-value=4.3e-19 Score=182.20 Aligned_cols=169 Identities=13% Similarity=0.055 Sum_probs=108.8
Q ss_pred cceEEEEEecCC--CCCCCC-CCCCCCcceEEEEEEEecCCCcEEecCC-chhhHHHHHHHHHHhhCCCceEEEEecCCC
Q 004402 25 QTWIKAGYWLAG--REFPLS-DINSALFTHLICAFAEVDSSTYQLSISS-ANQQYFSIFANSVRRKNPSIKTLLSIWNGQ 100 (755)
Q Consensus 25 ~~~~~~gY~~~~--~~~~~~-~i~~~~~thi~~~f~~~~~~~~~~~~~~-~~~~~~~~~~~~~k~~~~~lk~~isigg~~ 100 (755)
...+.+-|..-. ...++. ......++|+++||+.....+......+ .....+...++.+|++ ++||+||||||.
T Consensus 8 ~~~~faPYvd~~~~~~~~l~~~~~~~g~~~v~lAFl~~~~g~c~p~w~g~~~~~~~~~~I~~~q~~--G~kVllSiGGa~ 85 (311)
T 2dsk_A 8 PEHFFAPYIDMSLSVHKPLVEYAKLTGTKYFTLAFILYSSVYNGPAWAGSIPLEKFVDEVRELREI--GGEVIIAFGGAV 85 (311)
T ss_dssp CSSEECCEEETTCTTCCCHHHHHHHHSCSEEEEEEEEEETTTTEEEETTTBCGGGGHHHHHHHHTT--TCEEEEEEEESS
T ss_pred CcccccceEecccCCCCCHHHHHHhcCCCEEEEEEEeccCCCCcccCCCCCchHHHHHHHHHHHHC--CCeEEEEecCCC
Confidence 355566664421 112221 1234568999999998633222222221 1223455666777766 799999997666
Q ss_pred CCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCCCcccHHHHHHHHHHHccCCCccE
Q 004402 101 NSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELT 180 (755)
Q Consensus 101 ~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~~~~~~~~~l~~lr~~l~~~~~~~ 180 (755)
+ +.++.+.+.+++|++...+++.+|+|||||||||++... +.+...|+.|+++. +++.
T Consensus 86 G-----------------s~~~~s~~~~~~~a~~~~~~i~~ygldGIDfDiE~~~~~--d~~~~aL~~l~~~~---p~~~ 143 (311)
T 2dsk_A 86 G-----------------PYLCQQASTPEQLAEWYIKVIDTYNATYLDFDIEAGIDA--DKLADALLIVQRER---PWVK 143 (311)
T ss_dssp C-----------------CCHHHHCSSHHHHHHHHHHHHHHHTCSEEEEEECSCCCH--HHHHHHHHHHHHHS---TTCE
T ss_pred C-----------------ccccccccCHHHHHHHHHHHHHHhCCCcEEEeccCCccH--HHHHHHHHHHHhhC---CCcE
Confidence 3 224555667899999999999999999999999999543 46777788887643 3567
Q ss_pred EEeeeecCCccccc-cc----CcchhcccCChhhhhhhhccC
Q 004402 181 LSMAVRYSPTHETV-SY----PIDSMKKNLNWAHLVAYDYHM 217 (755)
Q Consensus 181 ls~~~~~~~~~~~~-~~----~~~~l~~~vD~~~vm~Yd~~~ 217 (755)
+++++|+.+.-... +. +....+..+|+||||+|||++
T Consensus 144 vs~TL~~~p~gl~~~g~~~l~~a~~~g~~ld~VniM~~Df~~ 185 (311)
T 2dsk_A 144 FSFTLPSDPGIGLAGGYGIIETMAKKGVRVDRVNPMTMDYYW 185 (311)
T ss_dssp EEEEEEEETTTEESTHHHHHHHHHHHTCCCCEEEEECCCCSS
T ss_pred EEEEeccCCCCCCcchHHHHHHHHHcCccccEEEEEeeccCC
Confidence 77766654332211 11 122333468999999999974
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=7.1e-18 Score=172.95 Aligned_cols=136 Identities=19% Similarity=0.210 Sum_probs=104.4
Q ss_pred CCccCcccccCCeeEEEEEc-CCCCE--EEEEEeccCChh------------------------hHHHHHHHHHHHhcCC
Q 004402 437 FSSANKLGEGGFGPVYKGNL-PRGQE--FAVKRLSATSTQ------------------------GLEEFKNEVSLTARLQ 489 (755)
Q Consensus 437 f~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 489 (755)
|+..+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+..|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 55678999999999999976 67888 999987543211 1236789999999998
Q ss_pred CCce--eeeeeeeecCCccEEEEeecCC-C----ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCceec
Q 004402 490 HVNL--LRVLGYCTERDENMLIYEYLPN-K----SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ-EYSNFRVIHR 561 (755)
Q Consensus 490 H~ni--v~l~g~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh-~~~~~~iiHr 561 (755)
|+++ ..++.+ ...++||||+.+ | +|.++... .++.....++.|++.+|.||| +.+ |+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 8754 333332 367999999942 4 55554321 123456789999999999999 775 9999
Q ss_pred ccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 562 DLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 562 Dlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
||||+|||++. .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=1.3e-15 Score=162.22 Aligned_cols=141 Identities=14% Similarity=0.165 Sum_probs=100.4
Q ss_pred HHHHhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCCh--------------hhHHH--------HHHHHHHHhc
Q 004402 430 IKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST--------------QGLEE--------FKNEVSLTAR 487 (755)
Q Consensus 430 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~ 487 (755)
+.....-|+..+.||+|++|.||+|...+|+.||||+++.... ..... ..+|...|.+
T Consensus 90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 3333344888999999999999999988999999998754210 00111 2345556666
Q ss_pred CCCCcee--eeeeeeecCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCC
Q 004402 488 LQHVNLL--RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKA 565 (755)
Q Consensus 488 l~H~niv--~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~ 565 (755)
+.+.++. ..+.+ ...++||||+++++|..+... .....++.|++.+|.+||..+ ||||||||
T Consensus 170 L~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp 233 (397)
T 4gyi_A 170 LYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNE 233 (397)
T ss_dssp HHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCST
T ss_pred HHhcCCCCCeeeec----cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCH
Confidence 6443321 11221 234799999999888655421 123567899999999999986 99999999
Q ss_pred CCEEEcCCCC----------eEEEecCCccc
Q 004402 566 SNILLDNELN----------PKISDFGMAKL 586 (755)
Q Consensus 566 ~NIll~~~~~----------~kl~Dfgla~~ 586 (755)
.|||+++++. +.|+||+-+..
T Consensus 234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 234 FNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp TSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 9999988773 89999997764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=5.2e-11 Score=121.96 Aligned_cols=147 Identities=16% Similarity=0.127 Sum_probs=113.8
Q ss_pred HHHHhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCccEE
Q 004402 430 IKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENML 508 (755)
Q Consensus 430 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 508 (755)
+......|.....++.|+.+.||+... .++.+++|+...........+.+|+.+++.+. |.++.++++++...+..++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 344456787778889899999999976 47899999986532122345788999999884 6778889999888888999
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS---------------------------------- 554 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~---------------------------------- 554 (755)
||||+++.+|...+.. ......++.+++++|..||+..
T Consensus 88 v~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 9999999998765311 1223477889999999999821
Q ss_pred ----------------------CCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 555 ----------------------NFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 555 ----------------------~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
...++|+|++|.|||++++..+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1348999999999999876667799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.02 E-value=2.4e-10 Score=116.64 Aligned_cols=129 Identities=19% Similarity=0.184 Sum_probs=97.3
Q ss_pred cccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCc--eeeeeeeeecCCccEEEEeecCCCChhhh
Q 004402 444 GEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN--LLRVLGYCTERDENMLIYEYLPNKSLDLY 521 (755)
Q Consensus 444 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lv~e~~~~gsL~~~ 521 (755)
+.|..+.||+....+|+.+++|+..... ...+..|+.+++.+.+.+ +.+++++....+..++||||+++.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 4566699999988778899999976542 245678999998885444 455888887777889999999998884
Q ss_pred hcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------
Q 004402 522 LFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS----------------------------------------------- 554 (755)
Q Consensus 522 l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~----------------------------------------------- 554 (755)
... .+ ...++.++++.|..||...
T Consensus 104 ~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 104 SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 211 11 2356777888888888643
Q ss_pred --------CCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 555 --------NFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 555 --------~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998876677999999863
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.86 E-value=8.8e-09 Score=110.50 Aligned_cols=142 Identities=15% Similarity=0.277 Sum_probs=106.9
Q ss_pred ccCcccccCCeeEEEEEcCCCCEEEEEEec--cCC-hhhHHHHHHHHHHHhcCC--CCceeeeeeeeecC---CccEEEE
Q 004402 439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLS--ATS-TQGLEEFKNEVSLTARLQ--HVNLLRVLGYCTER---DENMLIY 510 (755)
Q Consensus 439 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lv~ 510 (755)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|..+++.+. +.++.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4578999999999999874 4688888775 322 122356788999999886 45678888888776 3479999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS------------------------------------ 554 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~------------------------------------ 554 (755)
||+++..+.+.. -..++..++..++.++++.|..||...
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998874321 123677888899999999999999731
Q ss_pred -------------------CCCceecccCCCCEEEcCCCC--eEEEecCCccc
Q 004402 555 -------------------NFRVIHRDLKASNILLDNELN--PKISDFGMAKL 586 (755)
Q Consensus 555 -------------------~~~iiHrDlk~~NIll~~~~~--~kl~Dfgla~~ 586 (755)
...++|+|+++.|||++.++. +.|.||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.72 E-value=9.8e-09 Score=107.41 Aligned_cols=187 Identities=22% Similarity=0.238 Sum_probs=121.0
Q ss_pred cCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCc--eeeeeeeeecCC---ccEEEEeec
Q 004402 440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVN--LLRVLGYCTERD---ENMLIYEYL 513 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~n--iv~l~g~~~~~~---~~~lv~e~~ 513 (755)
.+.++.|....||+.. +.+++|+.... .....+.+|..+|+.+ .+.. +.+++....... ..++||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 56889986432 3456788999999887 3332 334444443333 358899999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS--------------------------------------- 554 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~--------------------------------------- 554 (755)
++.+|..... ..++..++..++.++++.|..||...
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988864331 23566777788888888888888621
Q ss_pred ----------------CCCceecccCCCCEEEcC--CCCeEEEecCCccccccCCccccccc------------ccccCC
Q 004402 555 ----------------NFRVIHRDLKASNILLDN--ELNPKISDFGMAKLFRKDVDEANTGR------------IVGTYG 604 (755)
Q Consensus 555 ----------------~~~iiHrDlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~------------~~gt~~ 604 (755)
...++|+|++|.||++++ +..+.|+||+.+.......+-..... .....+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 134899999999999998 45688999999875432111100000 000001
Q ss_pred ccc-cccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004402 605 YVP-PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNA 639 (755)
Q Consensus 605 y~a-PE~~~~~~~s~~sDVwS~Gvil~elltg~~p~ 639 (755)
... |+.... .....+.|+++.++|++.+|..++
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 222111 112368999999999999987543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=9.1e-06 Score=84.72 Aligned_cols=137 Identities=20% Similarity=0.213 Sum_probs=94.2
Q ss_pred cCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCC---ceeeeeeeee-cCCccEEEEeecCC
Q 004402 440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHV---NLLRVLGYCT-ERDENMLIYEYLPN 515 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lv~e~~~~ 515 (755)
.+.++.|....||+. |+.+++|+-. .......+..|..+|..+.+. .+.+++.++. ..+..++|||++++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888988999987 5778888853 233456789999999999642 3455666664 34557899999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY------------------------------------------ 553 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~------------------------------------------ 553 (755)
..+...... .++..+...++.++++.|..||..
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888653211 123444455555555555555542
Q ss_pred ---------------CCCCceecccCCCCEEEcC---CCC-eEEEecCCcccc
Q 004402 554 ---------------SNFRVIHRDLKASNILLDN---ELN-PKISDFGMAKLF 587 (755)
Q Consensus 554 ---------------~~~~iiHrDlk~~NIll~~---~~~-~kl~Dfgla~~~ 587 (755)
....++|+|+.+.||+++. ++. +.|+||+.+...
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2234799999999999998 455 489999988753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=8.3e-06 Score=83.28 Aligned_cols=135 Identities=18% Similarity=0.190 Sum_probs=95.3
Q ss_pred cccccCCe-eEEEEEcC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCccEEEEeecCCCCh
Q 004402 442 KLGEGGFG-PVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIYEYLPNKSL 518 (755)
Q Consensus 442 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~gsL 518 (755)
.+..|..| .||+.... ++..+++|+-... ....+.+|...|+.+. +-.+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 68987654 4678999986533 3456788999988874 44467788888888889999999999887
Q ss_pred hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 004402 519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS-------------------------------------------- 554 (755)
Q Consensus 519 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~-------------------------------------------- 554 (755)
.+..... ......+..+++..|..||...
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 6553210 1122345556666666666421
Q ss_pred -----------CCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 555 -----------NFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 555 -----------~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
...++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11279999999999999887778999998863
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=1.1e-05 Score=85.94 Aligned_cols=81 Identities=10% Similarity=0.018 Sum_probs=55.2
Q ss_pred cCcc-cccCCeeEEEEEcC-------CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCC-C--CceeeeeeeeecC--
Q 004402 440 ANKL-GEGGFGPVYKGNLP-------RGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQ-H--VNLLRVLGYCTER-- 503 (755)
Q Consensus 440 ~~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~-- 503 (755)
.+.| +.|....+|+.... +++.+++|+..... ......+..|..+++.+. + ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88888999998654 26788999765432 001235677888888773 3 3566778777655
Q ss_pred -CccEEEEeecCCCChhh
Q 004402 504 -DENMLIYEYLPNKSLDL 520 (755)
Q Consensus 504 -~~~~lv~e~~~~gsL~~ 520 (755)
...++|||++++..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 34689999999877653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00019 Score=75.74 Aligned_cols=140 Identities=15% Similarity=0.208 Sum_probs=78.5
Q ss_pred CcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-----CCCceeeee-e--eeecCCccEEEEee
Q 004402 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-----QHVNLLRVL-G--YCTERDENMLIYEY 512 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~-g--~~~~~~~~~lv~e~ 512 (755)
+.|+.|..+.||+....+| .+++|+.... . ..+..|..++..+ ..|.++... | +....+..+++++|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999977554 5899988753 2 2233444444444 234443311 1 11234567899999
Q ss_pred cCCCChhh--------------hhcCCCc----c-------CCCCHHHHH------------------------------
Q 004402 513 LPNKSLDL--------------YLFDPIR----R-------YVLDWQKRV------------------------------ 537 (755)
Q Consensus 513 ~~~gsL~~--------------~l~~~~~----~-------~~l~~~~~~------------------------------ 537 (755)
+++..+.. .+|.... . ....|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99876530 0111000 0 112232210
Q ss_pred -HHHHHHHHHHHHHHh----------cCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 538 -NIIEGVTQGLLYLQE----------YSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 538 -~i~~~ia~~l~~Lh~----------~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
.+...+..++.+|+. .....++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223345666653 123569999999999999888899999999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00015 Score=78.51 Aligned_cols=75 Identities=16% Similarity=0.237 Sum_probs=49.2
Q ss_pred cCcccccCCeeEEEEEcC-CCCEEEEEEeccCCh-------hhHHHHHHHHHHHhcCCC--Ccee-eeeeeeecCCccEE
Q 004402 440 ANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATST-------QGLEEFKNEVSLTARLQH--VNLL-RVLGYCTERDENML 508 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~niv-~l~g~~~~~~~~~l 508 (755)
.+.||.|..+.||++... +++.++||....... ...+.+..|.+++..+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999754 468999998643211 123456778888887732 3333 45543 3455789
Q ss_pred EEeecCCC
Q 004402 509 IYEYLPNK 516 (755)
Q Consensus 509 v~e~~~~g 516 (755)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00022 Score=73.38 Aligned_cols=79 Identities=18% Similarity=0.214 Sum_probs=58.0
Q ss_pred CCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCC---CceeeeeeeeecCCccEEEEee
Q 004402 436 NFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH---VNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~~~~~lv~e~ 512 (755)
.....+.+|.|..+.||+.++.+|+.|.+|+...........|..|...|+.|.- -.+.+++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 4455678999999999999999999999998765444444567889998888742 1234445442 35899999
Q ss_pred cCCCCh
Q 004402 513 LPNKSL 518 (755)
Q Consensus 513 ~~~gsL 518 (755)
++.+..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0015 Score=67.78 Aligned_cols=139 Identities=19% Similarity=0.145 Sum_probs=92.3
Q ss_pred ccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC---CCceeeeeeeeecCCccEEEEeecCC
Q 004402 439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ---HVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 439 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
..+.|+.|....+|+... +++.+++|+.... ....+..|...|+.|. ...+.+++.++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346789999999999986 5778899987543 3467888998888883 35678888888777889999999998
Q ss_pred CChhh-----------hhcCCCc--c-----------------CCCCHHHHH---HHHH----------------HHHH-
Q 004402 516 KSLDL-----------YLFDPIR--R-----------------YVLDWQKRV---NIIE----------------GVTQ- 545 (755)
Q Consensus 516 gsL~~-----------~l~~~~~--~-----------------~~l~~~~~~---~i~~----------------~ia~- 545 (755)
..+.. .||.... . -.-+|.... ++.. .+..
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 87521 1221111 0 012454322 1111 1111
Q ss_pred HHHHHHh-cCCCCceecccCCCCEEEcCCCCeEEEecC
Q 004402 546 GLLYLQE-YSNFRVIHRDLKASNILLDNELNPKISDFG 582 (755)
Q Consensus 546 ~l~~Lh~-~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg 582 (755)
....|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1223422 2245699999999999999887 8888973
|
| >2vtf_A Endo-beta-N-acetylglucosaminidase; hydrolase, family 85, glycosidase, carbohydrat binding; HET: B3P PGE; 1.79A {Arthrobacter protophormiae} PDB: 3fhq_A* 3fha_A* | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00026 Score=79.47 Aligned_cols=157 Identities=10% Similarity=0.086 Sum_probs=94.7
Q ss_pred HHHHHHhhCCCceEEEEec-CCCCCccccccCCCCCCcccccccc-cChhhHHHHHHHHHHHHHHcCCCcccccccCC--
Q 004402 79 FANSVRRKNPSIKTLLSIW-NGQNSTYQSILGNKNINPSVLSSMV-GDSSHRKSFIESSIRTARLYGFQGIDLFWLWP-- 154 (755)
Q Consensus 79 ~~~~~k~~~~~lk~~isig-g~~~~~~~~~~gg~~~~~~~f~~~~-~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p-- 154 (755)
.+.++|++ |++|+=.+. .|.. . || ..+....++ .+++.+..+|+.++++++.|||||+.||+|..
T Consensus 114 widaAHrn--GV~VlGt~~fe~~~--~----gg---~~~~~~~lL~~~~~~~~~~a~kLv~~a~~yGFDGw~IN~E~~~~ 182 (626)
T 2vtf_A 114 VIDASHRN--GVPILGNVFFPPTV--Y----GG---QLEWLEQMLEQEEDGSFPLADKLLEVADYYGFDGWFINQQTEGA 182 (626)
T ss_dssp HHHHHHHT--TCCEEEEEEECCGG--G----TC---CHHHHHHHTCCCTTCCCHHHHHHHHHHHHHTCCEEEEEECCTTC
T ss_pred HHHHHHHc--CCEEEEEEecCccc--C----Cc---HHHHHHHHhccCccchHHHHHHHHHHHHHhCCCceEEeeccccC
Confidence 44667777 799986551 1110 0 11 123356777 67778889999999999999999999999974
Q ss_pred CCCCcccHHHHHHHHHHHccCCCccEEEeee--ecCCccccccc---Ccchh----cccCChhhhhhhhccCCCCCcccc
Q 004402 155 NSTDLNSLGILLDEWKASASDQPELTLSMAV--RYSPTHETVSY---PIDSM----KKNLNWAHLVAYDYHMPSKENVTG 225 (755)
Q Consensus 155 ~~~~~~~~~~~l~~lr~~l~~~~~~~ls~~~--~~~~~~~~~~~---~~~~l----~~~vD~~~vm~Yd~~~~~~~~~~~ 225 (755)
..++.+++..|+++|++....+ ..++--.. ..+.-.++..+ +.+-+ .+.+|-+ --+|. |.
T Consensus 183 ~~~~~~~l~~F~~~L~~~~~~~-~~v~WYDs~t~~G~l~wQn~Ln~~N~~ff~~~~~~v~D~~---FlNY~---W~---- 251 (626)
T 2vtf_A 183 DEGTAEAMQAFLVYLQEQKPEG-MHIMWYDSMIDTGAIAWQNHLTDRNKMYLQNGSTRVADSM---FLNFW---WR---- 251 (626)
T ss_dssp CHHHHHHHHHHHHHHHHHSCTT-CEEEEESCBCTTSCBCCCSSCCTTTGGGTEETTEECCSEE---EECSC---CS----
T ss_pred CHHHHHHHHHHHHHHHHhCCCC-cEEEEeeccccCCCEeeccccCHHHHHHHhccCCCccceE---EEccC---CC----
Confidence 4457889999999999987432 12222211 11111112211 10000 0112211 11221 11
Q ss_pred cCCCCCCCCCCCcHHHHHHHHHHCCCCCCceeecccccCCCccc
Q 004402 226 IHAALYNPSSNISTDFGIREWLRRGFPANKLVLGARASGPGITI 269 (755)
Q Consensus 226 ~~a~l~~~~~~~~~~~~v~~~~~~g~p~~KlvlG~p~yG~~~~~ 269 (755)
..+..+..-...|.++..|.+|+-..||++..
T Consensus 252 ------------~l~~S~~~A~~~g~~~~dvy~GiDv~grg~~~ 283 (626)
T 2vtf_A 252 ------------DQRQSNELAQALGRSPYDLYAGVDVEARGTST 283 (626)
T ss_dssp ------------CCHHHHHHHHHTTCCGGGEEEEEECTTTGGGC
T ss_pred ------------ChHHHHHHHHHhCCCHHHEEEEEEEecCccCC
Confidence 23445566667799999999999999987653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0017 Score=70.72 Aligned_cols=78 Identities=10% Similarity=0.103 Sum_probs=50.2
Q ss_pred CCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcccccccccc--cCCccccccccCC---CCCchhhHHHHHHHH
Q 004402 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG--TYGYVPPEYVKKG---IYSMKYDVYSFGVLL 629 (755)
Q Consensus 555 ~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~s~~sDVwS~Gvil 629 (755)
...++|+|++|.|||++.++ ++|+||+.+..-....+-. .... ...|++|+..... .-....++.+....+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla---~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIG---AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHH---HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHH---HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 34699999999999999876 9999999987543221110 1111 2346676655321 112345666888888
Q ss_pred HHHHcCC
Q 004402 630 LQIISSK 636 (755)
Q Consensus 630 ~elltg~ 636 (755)
|+.+++.
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8887653
|
| >2w91_A Endo-beta-N-acetylglucosaminidase D; hydrolase, N-glycan, secreted, oxazoline, NAG-thiazoline, substrate-participation; 1.40A {Streptococcus pneumoniae} PDB: 2w92_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=0.00023 Score=80.25 Aligned_cols=86 Identities=10% Similarity=0.092 Sum_probs=65.3
Q ss_pred HHHHHHhhCCCceEEEEecCCCCCccccccCCCCC--Ccccccccc-cChhhHHHHHHHHHHHHHHcCCCcccccccCC-
Q 004402 79 FANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNI--NPSVLSSMV-GDSSHRKSFIESSIRTARLYGFQGIDLFWLWP- 154 (755)
Q Consensus 79 ~~~~~k~~~~~lk~~isigg~~~~~~~~~~gg~~~--~~~~f~~~~-~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p- 154 (755)
.+.++|++ |++|+-.+ .|..... +......++ .+++.+..+|+.++++++.|||||+.||+|..
T Consensus 106 widaAHrn--GV~VlGT~----------~fe~~~~~~~~~~~~~lL~~~~~~~~~~a~kLv~la~~yGFDGw~IN~E~~~ 173 (653)
T 2w91_A 106 VIDAGHRN--GVPVYGTL----------FFNWSNSIADQERFAEALKQDADGSFPIARKLVDMAKYYGYDGYFINQETTG 173 (653)
T ss_dssp HHHHHHHT--TCCEEEEE----------EEEEECCHHHHHHHHHHTCCCTTSCCHHHHHHHHHHHHHTCCEEEEEEEECS
T ss_pred HHHHHHHC--CCEEEEEE----------ecCcccCCcHHHHHHHHhccCccchHHHHHHHHHHHHHhCCCceEEeecccC
Confidence 44667777 79999655 1111110 112356777 67888899999999999999999999999974
Q ss_pred --CCCCcccHHHHHHHHHHHccCC
Q 004402 155 --NSTDLNSLGILLDEWKASASDQ 176 (755)
Q Consensus 155 --~~~~~~~~~~~l~~lr~~l~~~ 176 (755)
..++.+++..|+++|++.++..
T Consensus 174 ~~~~~~~~~l~~F~~~L~~~~~~~ 197 (653)
T 2w91_A 174 DLVKPLGEKMRQFMLYSKEYAAKV 197 (653)
T ss_dssp TTTGGGHHHHHHHHHHHHHHHHHT
T ss_pred CCCHHHHHHHHHHHHHHHHHHhcc
Confidence 4568899999999999998753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0018 Score=67.48 Aligned_cols=158 Identities=13% Similarity=0.127 Sum_probs=86.8
Q ss_pred cCHHHHHHHhcCCCc-----cCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCc--eeeee
Q 004402 425 FSFSDIKAATNNFSS-----ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN--LLRVL 497 (755)
Q Consensus 425 ~~~~~l~~~~~~f~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~ 497 (755)
++.+++......|.. .+.|+.|....+|+....+| .+++|+...... .+.+..|+.++..+.... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC--HHHHHHHHHHHHHHHHCCCCCCccc
Confidence 455666666666654 24566788889999977555 688998865211 123455666666663212 22333
Q ss_pred ee------eecCCccEEEEeecCCCChhhh--------------hcCCCc----c--CCC---CHHHHHH----------
Q 004402 498 GY------CTERDENMLIYEYLPNKSLDLY--------------LFDPIR----R--YVL---DWQKRVN---------- 538 (755)
Q Consensus 498 g~------~~~~~~~~lv~e~~~~gsL~~~--------------l~~~~~----~--~~l---~~~~~~~---------- 538 (755)
.. ....+..+++++|+++..+... +|.... . ... .|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 1123456899999988654210 111000 0 001 1222110
Q ss_pred --HHHHHHHHHHHHHhc----CCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 539 --IIEGVTQGLLYLQEY----SNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 539 --i~~~ia~~l~~Lh~~----~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
+...+.+.+..++.. ....++|+|+.+.|||++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244455555532 13459999999999999987666899999875
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0044 Score=66.02 Aligned_cols=142 Identities=18% Similarity=0.222 Sum_probs=82.8
Q ss_pred cCcccccCCeeEEEEEcC--------CCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCccEEEE
Q 004402 440 ANKLGEGGFGPVYKGNLP--------RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ 510 (755)
.+.|..|-...+|+.... +++.+++|+.... ......+.+|..+++.+. +.-..++++++.+ .+|+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 356777888889998764 2578999986332 223456678998888874 3223556666653 3999
Q ss_pred eecCCCChhhh-----------------hcCCC---ccCCC-CHHHHHHHHHHHHH-------------------HHHH-
Q 004402 511 EYLPNKSLDLY-----------------LFDPI---RRYVL-DWQKRVNIIEGVTQ-------------------GLLY- 549 (755)
Q Consensus 511 e~~~~gsL~~~-----------------l~~~~---~~~~l-~~~~~~~i~~~ia~-------------------~l~~- 549 (755)
||+++..|..- ||... .+... -|.++.++..++.. .+..
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998666421 11110 11111 13344444433321 2233
Q ss_pred ---HHhc-CCCCceecccCCCCEEEcCC----CCeEEEecCCccc
Q 004402 550 ---LQEY-SNFRVIHRDLKASNILLDNE----LNPKISDFGMAKL 586 (755)
Q Consensus 550 ---Lh~~-~~~~iiHrDlk~~NIll~~~----~~~kl~Dfgla~~ 586 (755)
|... ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3222 22359999999999999876 7899999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.70 E-value=0.014 Score=60.72 Aligned_cols=158 Identities=13% Similarity=0.162 Sum_probs=88.1
Q ss_pred cCHHHHHHHhcCCC-----ccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCC--ceeeee
Q 004402 425 FSFSDIKAATNNFS-----SANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHV--NLLRVL 497 (755)
Q Consensus 425 ~~~~~l~~~~~~f~-----~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~ 497 (755)
.+.+++....+.|. ....|+ |....||+....+|+.+++|....... ..+.+..|..++..+... .+.+++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeeccee
Confidence 44455554444342 234566 888899998777788899999864321 234566677777776321 234444
Q ss_pred ee-----eecCCccEEEEeecCCCChhh-----h---------hcC----C--CccCCCCHHHH----HHH---------
Q 004402 498 GY-----CTERDENMLIYEYLPNKSLDL-----Y---------LFD----P--IRRYVLDWQKR----VNI--------- 539 (755)
Q Consensus 498 g~-----~~~~~~~~lv~e~~~~gsL~~-----~---------l~~----~--~~~~~l~~~~~----~~i--------- 539 (755)
.. ....+..+++++++++..+.. . +|. . ......++... ..+
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 33 112334578999998865431 0 111 0 00111222211 001
Q ss_pred ------HHHHHHHHHHHHhc----CCCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 540 ------IEGVTQGLLYLQEY----SNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 540 ------~~~ia~~l~~Lh~~----~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
...+...+..+... ....++|+|+.+.|||++ + .+.|+||+.+..
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11112223333321 234589999999999999 4 899999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0039 Score=64.33 Aligned_cols=138 Identities=12% Similarity=0.104 Sum_probs=74.6
Q ss_pred cCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCce-eeeeeeeecCCccEEEEeec-CCCC
Q 004402 440 ANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL-LRVLGYCTERDENMLIYEYL-PNKS 517 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e~~-~~gs 517 (755)
.+.|+.|....+|+. +.+++|+........ ....+|...+..+....+ .++++++ .+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 578889999999998 568888876532211 122457777766632222 3455543 33457899999 6555
Q ss_pred hhhh------------------hcCCCcc--CCCCH-HHHHHHHH--------------HHHHHH----HHHHh-cCCCC
Q 004402 518 LDLY------------------LFDPIRR--YVLDW-QKRVNIIE--------------GVTQGL----LYLQE-YSNFR 557 (755)
Q Consensus 518 L~~~------------------l~~~~~~--~~l~~-~~~~~i~~--------------~ia~~l----~~Lh~-~~~~~ 557 (755)
+... +|..... ...+. ........ .+.+.+ ..|.. .....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 5310 1111000 00111 11111100 011111 11211 12334
Q ss_pred ceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 558 VIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 558 iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
++|+|+.+.||+ ..++.+.++||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5667889999998875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0033 Score=68.48 Aligned_cols=73 Identities=15% Similarity=0.229 Sum_probs=49.4
Q ss_pred cCcccccCCeeEEEEEcCC--------CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCce-eeeeeeeecCCccEEEE
Q 004402 440 ANKLGEGGFGPVYKGNLPR--------GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL-LRVLGYCTERDENMLIY 510 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~ 510 (755)
.+.|+.|-...+|+....+ ++.+++|+...... .+.+..|..++..+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3568888889999997653 57899998844211 1445578888888743333 556666542 3899
Q ss_pred eecCCCCh
Q 004402 511 EYLPNKSL 518 (755)
Q Consensus 511 e~~~~gsL 518 (755)
||+++.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0084 Score=62.75 Aligned_cols=142 Identities=18% Similarity=0.150 Sum_probs=71.7
Q ss_pred CcccccCCee-EEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-C-CceeeeeeeeecCCccEEEEeecCCCC
Q 004402 441 NKLGEGGFGP-VYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-H-VNLLRVLGYCTERDENMLIYEYLPNKS 517 (755)
Q Consensus 441 ~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~niv~l~g~~~~~~~~~lv~e~~~~gs 517 (755)
+.|+.|.... +|+....+|+.+++|....... +.+..|+.++..+. + -.+.+++.+..+. -+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4565555444 6677654477788876543321 22344566665553 2 2345566654333 378999997766
Q ss_pred hhhhhc---------------------CCCcc--CCCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 004402 518 LDLYLF---------------------DPIRR--YVLDWQKRV-------N-------------IIEGVTQGLLYLQ--- 551 (755)
Q Consensus 518 L~~~l~---------------------~~~~~--~~l~~~~~~-------~-------------i~~~ia~~l~~Lh--- 551 (755)
+.+++. ..... ...+..... . ....+...+..|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 543321 10000 011111100 0 0011112222221
Q ss_pred hcCCCCceecccCCCCEEEcCC----CCeEEEecCCcccc
Q 004402 552 EYSNFRVIHRDLKASNILLDNE----LNPKISDFGMAKLF 587 (755)
Q Consensus 552 ~~~~~~iiHrDlk~~NIll~~~----~~~kl~Dfgla~~~ 587 (755)
......++|+|+.+.|||++.+ ..+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1123469999999999999875 67999999998753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0073 Score=66.11 Aligned_cols=74 Identities=12% Similarity=0.143 Sum_probs=47.4
Q ss_pred cCcccccCCeeEEEEEcCC-CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCce-eeeeeeeecCCccEEEEeecCCCC
Q 004402 440 ANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL-LRVLGYCTERDENMLIYEYLPNKS 517 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e~~~~gs 517 (755)
.+.|+.|-...+|+....+ ++.+++|+......... .-..|..++..+...++ .++++++.. .+|+||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 3568888889999998754 47888998754322111 12478888888864444 456776632 35999998765
Q ss_pred h
Q 004402 518 L 518 (755)
Q Consensus 518 L 518 (755)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.91 E-value=0.039 Score=57.82 Aligned_cols=31 Identities=32% Similarity=0.491 Sum_probs=27.9
Q ss_pred CCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 556 FRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 556 ~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999888899999988764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.89 E-value=0.0079 Score=64.04 Aligned_cols=74 Identities=12% Similarity=0.123 Sum_probs=43.5
Q ss_pred cCcccccCCeeEEEEEcCC---------CCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCc-eeeeeeeeecCCccEEE
Q 004402 440 ANKLGEGGFGPVYKGNLPR---------GQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVN-LLRVLGYCTERDENMLI 509 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lv 509 (755)
.+.|+.|....+|+....+ ++.+++|+....... ......|..++..+...+ ..++++.. .-++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence 3567788888999987643 268888887543221 112356777777774223 33555543 23789
Q ss_pred EeecCCCCh
Q 004402 510 YEYLPNKSL 518 (755)
Q Consensus 510 ~e~~~~gsL 518 (755)
+||+++..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987554
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.59 E-value=0.061 Score=51.64 Aligned_cols=99 Identities=12% Similarity=0.018 Sum_probs=63.9
Q ss_pred ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccccc
Q 004402 517 SLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596 (755)
Q Consensus 517 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 596 (755)
+|.+.|.. ...++++.++|.++.|.+..|.-+-.... + ..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 34 SL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 67777743 34579999999999999999877622111 1 1333457999999999988764 1111
Q ss_pred ccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcC
Q 004402 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISS 635 (755)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg 635 (755)
.....+.+||... ...+.+.-|||+|+++|.-+--
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 0122456888763 3457889999999999998753
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.84 E-value=0.012 Score=40.57 Aligned_cols=30 Identities=17% Similarity=0.242 Sum_probs=15.8
Q ss_pred EEEeehHHHHHHHHHHHHHHhhhhhccchh
Q 004402 362 LLLLILLPIGLVLILIASLICYFRRTAIKS 391 (755)
Q Consensus 362 ~~~~i~~~~~~v~~~~~~~~~~~~r~~~~~ 391 (755)
+...+++++++++++++++++|+|||++++
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~~~ 42 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRHIVR 42 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTTCCS
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhHhhc
Confidence 333444444444455555566667666554
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.23 E-value=0.03 Score=38.44 Aligned_cols=27 Identities=26% Similarity=0.442 Sum_probs=14.1
Q ss_pred ehHHHHHHHHHHHHHHhhhhhccchhh
Q 004402 366 ILLPIGLVLILIASLICYFRRTAIKSK 392 (755)
Q Consensus 366 i~~~~~~v~~~~~~~~~~~~r~~~~~~ 392 (755)
+++++++++++++++++|+|||+++++
T Consensus 16 VVgGv~~v~ii~~~~~~~~RRRr~~~k 42 (44)
T 2l2t_A 16 VIGGLFILVIVGLTFAVYVRRKSIKKK 42 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCSSCC
T ss_pred ehHHHHHHHHHHHHHHHHhhhhhhhhc
Confidence 333344444555555666666665543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.93 E-value=0.32 Score=52.39 Aligned_cols=74 Identities=9% Similarity=0.042 Sum_probs=47.1
Q ss_pred cCcccccCCeeEEEEEcCC--------CCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCccEEEE
Q 004402 440 ANKLGEGGFGPVYKGNLPR--------GQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ 510 (755)
.+.|..|-...+|+....+ ++.+++|+........ -.-.+|..+++.+. +.-..++++.+. -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 4567778888999997653 6889999865432211 12246777777774 222344555332 37899
Q ss_pred eecCCCCh
Q 004402 511 EYLPNKSL 518 (755)
Q Consensus 511 e~~~~gsL 518 (755)
||+++..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998765
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=91.51 E-value=0.048 Score=37.36 Aligned_cols=28 Identities=21% Similarity=0.250 Sum_probs=13.5
Q ss_pred EEeehHHHHHHHHHHHHHHhhhhhccch
Q 004402 363 LLLILLPIGLVLILIASLICYFRRTAIK 390 (755)
Q Consensus 363 ~~~i~~~~~~v~~~~~~~~~~~~r~~~~ 390 (755)
+++.++++.+++++.+++++|+|||+++
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR~~~ 41 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRRQQK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred hHHHHHHHHHHHHHHHHHHhheehhhhh
Confidence 3333444444444444455666666544
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.65 E-value=0.68 Score=49.48 Aligned_cols=29 Identities=28% Similarity=0.429 Sum_probs=25.2
Q ss_pred ceecccCCCCEEE------cCCCCeEEEecCCccc
Q 004402 558 VIHRDLKASNILL------DNELNPKISDFGMAKL 586 (755)
Q Consensus 558 iiHrDlk~~NIll------~~~~~~kl~Dfgla~~ 586 (755)
++|+|+.+.|||+ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567799999998874
|
| >3k1d_A 1,4-alpha-glucan-branching enzyme; mycobacterium tuberculosis H37RV, mesophilic human pathogen, RV1326C gene, glycosyl transferase; 2.33A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=86.95 E-value=4.8 Score=46.16 Aligned_cols=102 Identities=10% Similarity=0.076 Sum_probs=62.9
Q ss_pred hhhHHHHHHHHHHhhCCCceEEEEe-cCCCCC--ccccccCCCCCC----c------c--cccccccChhhHHHHHHHHH
Q 004402 72 NQQYFSIFANSVRRKNPSIKTLLSI-WNGQNS--TYQSILGNKNIN----P------S--VLSSMVGDSSHRKSFIESSI 136 (755)
Q Consensus 72 ~~~~~~~~~~~~k~~~~~lk~~isi-gg~~~~--~~~~~~gg~~~~----~------~--~f~~~~~~~~~r~~fi~~i~ 136 (755)
+.+.|+.++++++++ |++|++=+ -+.... -....|.|.... + . .+.--..+++.|+.+++++.
T Consensus 311 t~~dfk~lV~~~H~~--GI~VilD~V~NH~~~~~~~~~~fdg~~~y~~~d~~~~~~~~Wg~~~ln~~~p~Vr~~l~~~~~ 388 (722)
T 3k1d_A 311 TPDDFRALVDALHQA--GIGVIVDWVPAHFPKDAWALGRFDGTPLYEHSDPKRGEQLDWGTYVFDFGRPEVRNFLVANAL 388 (722)
T ss_dssp CHHHHHHHHHHHHHT--TCEEEEEECTTCCCCCTTTTTTTTSSCCSBCCCCCSSSTTCCCCCCBCTTSHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHc--CCEEEEEEEeeccCCccchhhcCCCCcccccCCcccCccCCCCCeeecCCCHHHHHHHHHHHH
Confidence 456789999999988 79999988 111100 001112221110 0 0 01112467899999999999
Q ss_pred HHHHHcCCCcccccc----------------cCCCCCCccc--HHHHHHHHHHHccC
Q 004402 137 RTARLYGFQGIDLFW----------------LWPNSTDLNS--LGILLDEWKASASD 175 (755)
Q Consensus 137 ~~~~~~~~DGvdiDw----------------e~p~~~~~~~--~~~~l~~lr~~l~~ 175 (755)
.|+++||+||+-+|- .........| =..|++++++.++.
T Consensus 389 ~Wl~~~gvDGfR~Dav~~mly~d~~r~~g~w~~n~~gg~~n~~~~~fl~~l~~~v~~ 445 (722)
T 3k1d_A 389 YWLQEFHIDGLRVDAVASMLYLDYSRPEGGWTPNVHGGRENLEAVQFLQEMNATAHK 445 (722)
T ss_dssp HHHHHSCCCEEEECCTHHHHBCCCCCCSSCCSCCCSSCSBCHHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCEEEEcchhhhhhccccccccccccccCCCccChHHHHHHHHHHHHHHH
Confidence 999999999999993 1100011233 35788998888754
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A | Back alignment and structure |
|---|
Probab=81.74 E-value=0.69 Score=53.45 Aligned_cols=85 Identities=12% Similarity=0.095 Sum_probs=55.4
Q ss_pred HHHHHHHhhCCCceEEEEe-cCCCCCccccccCCCCCCcccccc-cccChhhHHHHHHHHHHHHHHcCCCcccccccCCC
Q 004402 78 IFANSVRRKNPSIKTLLSI-WNGQNSTYQSILGNKNINPSVLSS-MVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN 155 (755)
Q Consensus 78 ~~~~~~k~~~~~lk~~isi-gg~~~~~~~~~~gg~~~~~~~f~~-~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~ 155 (755)
.++.++|++ ||+|+=.| ..|.. | ..+...|.. +..+++....+++.++++++.|||||.=|+-|...
T Consensus 256 ~winaAHrn--GV~VLGT~i~ew~~--------~-~~~~~~~~~~L~~d~~g~~~~A~KLveiAkyyGFDGWlINiE~~~ 324 (937)
T 3gdb_A 256 DVIDAGHRN--GVPVYGTLFFNWSN--------S-IADQERFAEALKQDADGSFPIARKLVDMAKYYGYDGYFINQETTG 324 (937)
T ss_dssp HHHHHHHHT--TCCEEEEEEEEEEC--------C-HHHHHHHHHHTCCCTTSCCHHHHHHHHHHHHHTCCEEEEEEEECS
T ss_pred hHHHHHHhc--CCeEEEEEecCccc--------c-hhhHHHHHHHhccCccchhHHHHHHHHHHHHcCcCceEecccccc
Confidence 445778887 89998777 11110 0 001112333 34566677899999999999999999999999864
Q ss_pred CC---CcccHHHHHHHHHHHc
Q 004402 156 ST---DLNSLGILLDEWKASA 173 (755)
Q Consensus 156 ~~---~~~~~~~~l~~lr~~l 173 (755)
.. ...++..|++.+++..
T Consensus 325 ~~~~~~~~~l~~Fl~yl~e~~ 345 (937)
T 3gdb_A 325 DLVKPLGEKMRQFMLYSKEYA 345 (937)
T ss_dssp TTTGGGHHHHHHHHHHHHHHH
T ss_pred ccchhhHHHHHHHHHHHHHHH
Confidence 32 2345666776666544
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 755 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-56 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-55 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-47 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-40 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-39 | |
| d1wb0a1 | 297 | c.1.8.5 (A:22-266,A:337-388) Chitotriosidase {Huma | 2e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-38 | |
| d1goia2 | 356 | c.1.8.5 (A:3-291,A:380-446) Chitinase B, catalytic | 7e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-36 | |
| d2pi6a1 | 292 | c.1.8.5 (A:1-239,A:308-361) Signal processing prot | 1e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-34 | |
| d1w9pa1 | 333 | c.1.8.5 (A:39-298,A:361-433) Chitinase 1 {Aspergil | 2e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-32 | |
| d1vf8a1 | 302 | c.1.8.5 (A:1-245,A:316-372) Chitinase-like lectin | 3e-32 | |
| d1jnda1 | 327 | c.1.8.5 (A:2-278,A:371-420) Imaginal disc growth f | 6e-32 | |
| d1itxa1 | 347 | c.1.8.5 (A:33-337,A:410-451) Chitinase A1 {Bacillu | 4e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-30 | |
| d1edqa2 | 358 | c.1.8.5 (A:133-443,A:517-563) Chitinase A, catalyt | 2e-29 | |
| d1ll7a1 | 330 | c.1.8.5 (A:36-292,A:355-427) Chitinase 1 {Fungus ( | 9e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-28 | |
| d1kfwa1 | 374 | c.1.8.5 (A:10-327,A:389-444) Psychrophilic chitina | 6e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-23 | |
| d1nara_ | 289 | c.1.8.5 (A:) Seed storage protein {Vicia narbonens | 7e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-20 | |
| d2ebna_ | 285 | c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Fl | 7e-19 | |
| d1edta_ | 265 | c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {St | 2e-15 | |
| d2hvma_ | 273 | c.1.8.5 (A:) Hevamine A (chitinase/lysozyme) {Para | 6e-15 | |
| d1ta3a_ | 274 | c.1.8.5 (A:) Xylanase inhibitor protein I, XIP-I { | 2e-11 | |
| d1eoka_ | 282 | c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Fl | 9e-07 | |
| d1vf8a2 | 70 | d.26.3.1 (A:246-315) Chitinase-like lectin ym1 {Mo | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 1e-67
Identities = 73/288 (25%), Positives = 138/288 (47%), Gaps = 22/288 (7%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
+ ++G G FG VYKG + ++A + Q L+ FKNEV + + +HVN+L
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
+GY T + ++ ++ SL +L + K ++I QG+ YL
Sbjct: 68 LFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLH--- 121
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK-- 612
+IHRDLK++NI L +L KI DFG+A + + ++ G+ ++ PE ++
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 613 -KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671
K YS + DVY+FG++L ++++ + Y + +Q G+ ++ P L
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNR--------DQIIFMVGRGYLSPDL 231
Query: 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAPK 719
S C ++ C+++ ++RP ++ + + + +A + PK
Sbjct: 232 SKVRSNC-PKAMKRLMAECLKKKRDERPLFPQILASI--ELLARSLPK 276
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 4e-62
Identities = 69/276 (25%), Positives = 116/276 (42%), Gaps = 22/276 (7%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
+ + ++G G FG V+ G + A+K + E+F E + +L H L+
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
++ G C E+ L++E++ + L YL + + + + V +G+ YL+E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGMAYLEEA- 120
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
VIHRDL A N L+ K+SDFGM + D ++ + PE
Sbjct: 121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFSFS 177
Query: 615 IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS 674
YS K DV+SFGVL+ ++ S + ++ + S G P L +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--------VEDISTGFRLYKPRLAST 229
Query: 675 SSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
Q+ C +E PEDRP+ + L +
Sbjct: 230 H-------VYQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 6e-62
Identities = 82/276 (29%), Positives = 135/276 (48%), Gaps = 22/276 (7%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
+LG G FG V+ G + AVK L S + F E +L +LQH L+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
R+ T+ + +I EY+ N SL +L P L K +++ + +G+ +++E +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
IHRDL+A+NIL+ + L+ KI+DFG+A+L + A G + PE + G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYG 185
Query: 615 IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS 674
+++K DV+SFG+LL +I++ R Y N ++ +G + P D+
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGR--IPYPGMTNPEVIQ------NLERGYRMVRP--DNC 235
Query: 675 SSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
Q+ LC +E PEDRP+ + S+L+D
Sbjct: 236 PEELY-----QLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 4e-61
Identities = 65/290 (22%), Positives = 120/290 (41%), Gaps = 28/290 (9%)
Query: 442 KLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501
+G+G FG V++G RG+E AVK S+ + + E+ T L+H N+L +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67
Query: 502 ERDEN----MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE----- 552
+ + L+ +Y + S LFD + RY + + + + GL +L
Sbjct: 68 KDNGTWTQLWLVSDYHEHGS----LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD--EANTGRIVGTYGYVPPEY 610
+ HRDLK+ NIL+ I+D G+A D + VGT Y+ PE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 611 ------VKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE----NLNFLEYAFEQWKD 660
+K + D+Y+ G++ +I + + +L + + E+ +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 661 SKGKEFIDPSLDDSSSPCKLLNCM-QVALLCVQENPEDRPSMLEVSSMLK 709
++ + P++ + C+ L M ++ C N R + L + L
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (520), Expect = 1e-60
Identities = 70/303 (23%), Positives = 135/303 (44%), Gaps = 37/303 (12%)
Query: 425 FSFSDIKAATNNFSSA---------NKLGEGGFGPVYKGNLP----RGQEFAVKRL-SAT 470
F+F D A F+ +G G FG V G+L R A+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 471 STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV 530
+ + +F +E S+ + H N++ + G T+ M+I E++ N SLD +L ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 531 LDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590
+ V ++ G+ G+ YL ++ +HRDL A NIL+++ L K+SDFG+++ D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 591 VDEANTGRIVG---TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN 647
+ +G + PE ++ ++ DV+S+G+++ +++S
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231
Query: 648 LNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707
+ + + ++ +++ P D S Q+ L C Q++ RP ++ +
Sbjct: 232 RPYWDMTNQDVINAIEQDYRLPPPMDCPSALH-----QLMLDCWQKDRNHRPKFGQIVNT 286
Query: 708 LKD 710
L
Sbjct: 287 LDK 289
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 3e-60
Identities = 67/276 (24%), Positives = 125/276 (45%), Gaps = 22/276 (7%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
+ + +LG G FG V G + A+K + S +EF E + L H L+
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
++ G CT++ +I EY+ N L YL + R+ Q+ + + + V + + YL+
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLE--- 117
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
+ + +HRDL A N L++++ K+SDFG+++ D + ++ + PPE +
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLMYS 176
Query: 615 IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS 674
+S K D+++FGVL+ +I S + +E++ +S+ E I L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLY 221
Query: 675 SSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
+ C E ++RP+ + S + D
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (506), Expect = 9e-59
Identities = 72/319 (22%), Positives = 125/319 (39%), Gaps = 51/319 (15%)
Query: 419 TPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPR------GQEFAVKRLSATST 472
P L + NN +GEG FG V++ P AVK L ++
Sbjct: 2 NPKLLSLEY-----PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS 56
Query: 473 QGLE-EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV- 530
++ +F+ E +L A + N++++LG C L++EY+ L+ +L V
Sbjct: 57 ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVC 116
Query: 531 --------------------LDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL 570
L +++ I V G+ YL E + +HRDL N L+
Sbjct: 117 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLV 173
Query: 571 DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLL 630
+ KI+DFG+++ G ++PPE + Y+ + DV+++GV+L
Sbjct: 174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 233
Query: 631 QIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLC 690
+I S YYG + E +D + ++ + LC
Sbjct: 234 EIFSYGLQ-PYYGMAH-----EEVIYYVRDGN-----ILACPENCPL----ELYNLMRLC 278
Query: 691 VQENPEDRPSMLEVSSMLK 709
+ P DRPS + +L+
Sbjct: 279 WSKLPADRPSFCSIHRILQ 297
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 2e-58
Identities = 65/288 (22%), Positives = 125/288 (43%), Gaps = 22/288 (7%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
+ KLG+G FG V+ G A+K L T E F E + +L+H L+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
++ + + ++ EY+ SL +L +Y+ + V++ + G+ Y++
Sbjct: 76 QLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERM- 132
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKG 614
+HRDL+A+NIL+ L K++DFG+A+L + A G + PE G
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189
Query: 615 IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS 674
+++K DV+SFG+LL ++ + R + + + + ++
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMP 234
Query: 675 SSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAPKRPA 722
P + + C ++ PE+RP+ + + L+D + +P
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 8e-57
Identities = 73/277 (26%), Positives = 117/277 (42%), Gaps = 28/277 (10%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
+G+G FG V G+ RG + AVK + +T + F E S+ +L+H NL+
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 495 RVLGYCTERDENM-LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
++LG E + ++ EY+ SL YL R VL + V + + YL+
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG- 121
Query: 554 SNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
+HRDL A N+L+ + K+SDFG+ K D + PE +++
Sbjct: 122 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALRE 174
Query: 614 GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673
+S K DV+SFG+LL +I S R Y + + + +K D
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGR--VPYPRIPLKDVVPRVEKGYK---------MDAPD 223
Query: 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P +V C + RPS L++ L+
Sbjct: 224 GCPP----AVYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-56
Identities = 67/292 (22%), Positives = 119/292 (40%), Gaps = 27/292 (9%)
Query: 433 ATNNFSSAN-KLGEGGFGPVYKG---NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTAR 487
+N A+ +LG G FG V +G + + A+K L + + EE E + +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
L + ++R++G C + + ML+ E L +L +R + ++ V+ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN-TGRIVGTYGYV 606
YL+ +HRDL A N+LL N KISDFG++K D +
Sbjct: 123 KYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666
PE + +S + DV+S+GV + + +S + +++ K + F
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQ---------------KPYKKMKGPEVMAF 224
Query: 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIAAP 718
I+ P + C EDRP L V ++ ++A+
Sbjct: 225 IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (487), Expect = 3e-56
Identities = 73/296 (24%), Positives = 128/296 (43%), Gaps = 27/296 (9%)
Query: 416 DSDTPNLQVFSFSDIKAATNNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLSATSTQG 474
D +PN + + + +KLG G +G VY+G + AVK L + +
Sbjct: 3 DPSSPNYDKWEME-----RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME- 56
Query: 475 LEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQ 534
+EEF E ++ ++H NL+++LG CT +I E++ +L YL + R +
Sbjct: 57 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAV 115
Query: 535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594
+ + ++ + YL++ IHRDL A N L+ K++DFG+++L D A
Sbjct: 116 VLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172
Query: 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYA 654
+ G + PE + +S+K DV++FGVLL +I + +
Sbjct: 173 HAG-AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------P 216
Query: 655 FEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
+ S+ E ++ ++ C Q NP DRPS E+ +
Sbjct: 217 YPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-55
Identities = 67/276 (24%), Positives = 112/276 (40%), Gaps = 28/276 (10%)
Query: 441 NKLGEGGFGPVYKGNLPR---GQEFAVKRLSATSTQG--LEEFKNEVSLTARLQHVNLLR 495
+LG G FG V KG + AVK L + +E E ++ +L + ++R
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 496 VLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSN 555
++G C E + ML+ E L+ YL + + + ++ V+ G+ YL+
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE---E 125
Query: 556 FRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTG-RIVGTYGYVPPEYVKKG 614
+HRDL A N+LL + KISDFG++K R D + + PE +
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 615 IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS 674
+S K DV+SFGVL+ + S + + K S+ ++
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQ---------------KPYRGMKGSEVTAMLEKGERMG 230
Query: 675 SSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
+ LC + E+RP V L++
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 4e-55
Identities = 69/273 (25%), Positives = 121/273 (44%), Gaps = 23/273 (8%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS-ATSTQGLEEFKNEVSLTARLQHVN 492
++ LGEG +G V N + AVK + + E K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
+++ G+ E + L EY L + + + G++YL
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
+ HRD+K N+LLD N KISDFG+A +FR + E ++ GT YV PE +K
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 613 -KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671
+ ++ DV+S G++L +++ + + S++ + WK + K +++P
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELP--WDQPSDSCQE----YSDWK--EKKTYLNPWK 230
Query: 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
S+P LL+ + ENP R ++ ++
Sbjct: 231 KIDSAPLALLHK------ILVENPSARITIPDI 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 4e-55
Identities = 56/301 (18%), Positives = 112/301 (37%), Gaps = 38/301 (12%)
Query: 433 ATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGL-EEFKNEVSLTARLQH 490
++F ++LG G G V+K + P G A K + + + E+ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL 550
++ G E + E++ SLD L + + Q + V +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
+++HRD+K SNIL+++ K+ DFG++ ++ VGT Y+ PE
Sbjct: 121 --REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 611 VKKGIYSMKYDVYSFGVLLLQIISSKR-----------------------NARYYGTSEN 647
++ YS++ D++S G+ L+++ + +
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 648 LNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVAL----LCVQENPEDRPSMLE 703
Y + E +D +++ C+ +NP +R + +
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 704 V 704
+
Sbjct: 295 L 295
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 6e-55
Identities = 72/339 (21%), Positives = 142/339 (41%), Gaps = 40/339 (11%)
Query: 422 LQVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEF----AVKRLS-ATSTQGL 475
L++ ++ F LG G FG VYKG +P G++ A+K L ATS +
Sbjct: 3 LRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN 55
Query: 476 EEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQK 535
+E +E + A + + ++ R+LG C LI + +P L Y+ + + + Q
Sbjct: 56 KEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQY 112
Query: 536 RVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEAN 595
+N + +G+ YL+ + R++HRDL A N+L+ + KI+DFG+AKL + E +
Sbjct: 113 LLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 169
Query: 596 TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAF 655
++ E + IY+ + DV+S+GV + ++++ +
Sbjct: 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS---------------KPY 214
Query: 656 EQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK------ 709
+ S+ ++ P ++ + + C + + RP E+
Sbjct: 215 DGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274
Query: 710 DDSMAIAAPKRPAFSAKGDENAETSSTSRQEIYSFNDPE 748
+ I +R + D N + +++ D +
Sbjct: 275 QRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDAD 313
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 1e-54
Identities = 63/283 (22%), Positives = 120/283 (42%), Gaps = 30/283 (10%)
Query: 436 NFSSANKLGEGGFGPVYKGNLP----RGQEFAVKRLSATSTQG-LEEFKNEVSLTARLQH 490
+F+ +G G FG VY G L + AVK L+ + G + +F E + H
Sbjct: 30 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 491 VNLLRVLGYCTERDEN-MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
N+L +LG C + + +++ Y+ + L + + + + V +G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF--IRNETHNPTVKDLIGFGLQVAKGM-- 143
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVGTYGYVP 607
+ ++ + +HRDL A N +LD + K++DFG+A+ ++ + ++
Sbjct: 144 -KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667
E ++ ++ K DV+SFGVLL ++++ Y + Y +G+ +
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGA--PPYPDVNTFDITVYLL------QGRRLL 254
Query: 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P + P +V L C E RPS E+ S +
Sbjct: 255 QP--EYCPDPLY-----EVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 6e-54
Identities = 64/282 (22%), Positives = 124/282 (43%), Gaps = 27/282 (9%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQE-----FAVKRLSATSTQG-LEEFKNEVSLTARL 488
+ + +G G FG VYKG L A+K L A T+ +F E + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 489 QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLL 548
H N++R+ G ++ M+I EY+ N +LD +L + + + V ++ G+ G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 549 YLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT-GRIVGTYGYVP 607
Y +N +HRDL A NIL+++ L K+SDFG++++ D + T +
Sbjct: 125 Y---LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667
PE + ++ DV+SFG+++ ++++ + + + + + I
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGE---------------RPYWELSNHEVMKAI 226
Query: 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709
+ + Q+ + C Q+ RP ++ S+L
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-53
Identities = 73/303 (24%), Positives = 118/303 (38%), Gaps = 45/303 (14%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR------GQEFAVKRLSATSTQG-LEEFKNEVSLTAR 487
N LG G FG V + AVK L + E +E+ + +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 488 L-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRY----------------- 529
L H N++ +LG CT LI+EY L YL ++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 530 ---VLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKL 586
VL ++ + V +G+ +L+ +HRDL A N+L+ + KI DFG+A+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 587 FRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE 646
D + G ++ PE + +GIY++K DV+S+G+LL +I S N Y G
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-YPGIPV 272
Query: 647 NLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706
+ NF + +K ++ + C + RPS ++S
Sbjct: 273 DANFYKLIQNGFK---------MDQPFYATE----EIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 707 MLK 709
L
Sbjct: 320 FLG 322
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (469), Expect = 3e-53
Identities = 69/293 (23%), Positives = 117/293 (39%), Gaps = 38/293 (12%)
Query: 420 PNL-QVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG--- 474
P++ ++F D + FS ++G G FG VY ++ + A+K++S + Q
Sbjct: 2 PDVAELFFKDDPE---KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK 58
Query: 475 LEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQ 534
++ EV +L+H N ++ G L+ EY + DL + + L
Sbjct: 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEV 115
Query: 535 KRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594
+ + G QGL YL + +IHRD+KA NILL K+ DFG A +
Sbjct: 116 EIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167
Query: 595 NTGRIVGTYGYVPPEYV---KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFL 651
VGT ++ PE + +G Y K DV+S G+ +++ K + +
Sbjct: 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP--LFNMNA----- 219
Query: 652 EYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
E S + C+Q+ P+DRP+ +
Sbjct: 220 ---MSALYHIAQNESPALQSGHWSEYFR-----NFVDSCLQKIPQDRPTSEVL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 4e-53
Identities = 68/284 (23%), Positives = 110/284 (38%), Gaps = 28/284 (9%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLP----RGQEFAVKRLS---ATSTQGLEEFKNEVSLTAR 487
+ KLG+G FG V +G + AVK L + + +++F EV+
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
L H NL+R+ G ++ E P SL L ++L R V +G+
Sbjct: 68 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGM 124
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE-ANTGRIVGTYGYV 606
YL+ R IHRDL A N+LL KI DFG+ + ++ D + +
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666
PE +K +S D + FGV L ++ + + ++ Q KE
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ----------EPWIGLNGSQILHKIDKEG 231
Query: 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
+ + V + C PEDRP+ + + L +
Sbjct: 232 ERLPRPEDCPQ----DIYNVMVQCWAHKPEDRPTFVALRDFLLE 271
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 5e-53
Identities = 60/270 (22%), Positives = 118/270 (43%), Gaps = 27/270 (10%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGY 499
+LG+G FG VYK N A K + S + LE++ E+ + A H N++++L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 500 CTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVI 559
+ ++ E+ ++D + + R L + + + L YL + ++I
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHD---NKII 132
Query: 560 HRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV-----KKG 614
HRDLKA NIL + + K++DFG++ + + ++ +GT ++ PE V K
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDR 190
Query: 615 IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS 674
Y K DV+S G+ L+++ + ++ + L+ A + + D
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEP--PHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD- 247
Query: 675 SSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
L C+++N + R + ++
Sbjct: 248 -----FLKK------CLEKNVDARWTTSQL 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-52
Identities = 62/272 (22%), Positives = 111/272 (40%), Gaps = 31/272 (11%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVL 497
++G G F VYKG + E A L + + FK E + LQH N++R
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 498 GYCTERDEN----MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
+ +L+ E + + +L YL R V+ + + + +GL +L
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT- 130
Query: 554 SNFRVIHRDLKASNILLDNELN-PKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
+IHRDLK NI + KI D G+A L R ++GT ++ PE +
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYE 186
Query: 613 KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672
+ Y DVY+FG+ +L++ +S+ Y K + + P +
Sbjct: 187 EK-YDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243
Query: 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
+ + C+++N ++R S+ ++
Sbjct: 244 E------------IIEGCIRQNKDERYSIKDL 263
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-52
Identities = 62/277 (22%), Positives = 112/277 (40%), Gaps = 26/277 (9%)
Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRL--SATSTQGLEEFKNEVSLTARLQHVN 492
++ +G G +G K G+ K L + + + +EV+L L+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 493 LLRVLGYCTERDENML--IYEYLPNKSLDLYLFDPIR-RYVLDWQKRVNIIEGVTQGLLY 549
++R +R L + EY L + + R LD + + ++ +T L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 550 L--QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
+ V+HRDLK +N+ LD + N K+ DFG+A++ D A VGT Y+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMS 182
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667
PE + + Y+ K D++S G LL ++ + T+ + L + K +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCA----LMPPFTAFSQKELAGKIREGKFRRIPYRY 238
Query: 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
L++ + + RPS+ E+
Sbjct: 239 SDELNE------------IITRMLNLKDYHRPSVEEI 263
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 5e-52
Identities = 71/291 (24%), Positives = 124/291 (42%), Gaps = 32/291 (10%)
Query: 435 NNFSSANKLGEGGFGPVYKG------NLPRGQEFAVKRLS-ATSTQGLEEFKNEVSLTAR 487
+ + +LG+G FG VY+G A+K ++ A S + EF NE S+
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF-------DPIRRYVLDWQKRVNII 540
+++R+LG ++ ++I E + L YL + K + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIV 600
+ G+ YL + +HRDL A N ++ + KI DFGM + + G+ +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 601 GTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKD 660
++ PE +K G+++ DV+SFGV+L +I + Y G S E +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSN-----EQVLRFVME 250
Query: 661 SKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711
+ D D ++ +C Q NP+ RPS LE+ S +K++
Sbjct: 251 GGLLDKPDNCPDM---------LFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 8e-52
Identities = 63/298 (21%), Positives = 114/298 (38%), Gaps = 40/298 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQG-LEEFKNEVSLTAR 487
N S LG G FG V + AVK L ++ E +E+ + +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 488 L-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYV---------------L 531
L H+N++ +LG CT ++I EY L +L ++ L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
D + ++ V +G+ +L IHRDL A NILL + KI DFG+A+ + D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFL 651
+ G ++ PE + +Y+ + DV+S+G+ L ++ S + ++
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256
Query: 652 EYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709
F + + + C +P RP+ ++ +++
Sbjct: 257 ---FYKMIKEGFRMLSPEHAPAE--------MYDIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-51
Identities = 72/321 (22%), Positives = 128/321 (39%), Gaps = 44/321 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRG---QEFAVKRLS-ATSTQGLEEFKNEVSLTARL-Q 489
N+ + +GEG FG V K + + + A+KR+ S +F E+ + +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYL-------------FDPIRRYVLDWQKR 536
H N++ +LG C R L EY P+ +L +L L Q+
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT 596
++ V +G+ YL + + IHRDL A NIL+ KI+DFG+++ V
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183
Query: 597 GRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFE 656
++ E + +Y+ DV+S+GVLL +I+S +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG----------TPYCGMTCA 233
Query: 657 QWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV----SSMLKDDS 712
+ + + + + + C +E P +RPS ++ + ML++
Sbjct: 234 ELYEKLPQGYRLEKPLNCDDEVY-----DLMRQCWREKPYERPSFAQILVSLNRMLEERK 288
Query: 713 MAIAAPKRPAFSAKG-DENAE 732
+ F+ G D +AE
Sbjct: 289 TYVNTTLYEKFTYAGIDCSAE 309
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 1e-50
Identities = 70/277 (25%), Positives = 114/277 (41%), Gaps = 37/277 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPR-GQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQH 490
+F LG+G FG VY + A+K L + + EV + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL 550
N+LR+ GY + LI EY P ++ L + D Q+ I + L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
RVIHRD+K N+LL + KI+DFG + + + GT Y+PPE
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 175
Query: 611 VKKGIYSMKYDVYSFGVLLLQIISSKR---NARYYGTSENLNFLEYAFEQWKDSKGKEFI 667
++ ++ K D++S GVL + + K Y T + ++ +E+ F + ++ I
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 235
Query: 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
++ NP RP + EV
Sbjct: 236 S--------------------RLLKHNPSQRPMLREV 252
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-50
Identities = 67/283 (23%), Positives = 121/283 (42%), Gaps = 27/283 (9%)
Query: 423 QVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNE 481
+ S D K ++ K+G+G G VY ++ GQE A+++++ E NE
Sbjct: 11 SIVSVGDPK---KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
Query: 482 VSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIE 541
+ + ++ N++ L DE ++ EYL S L D + +D + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCR 123
Query: 542 GVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVG 601
Q L +L +VIHRD+K+ NILL + + K++DFG +++ +VG
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVG 178
Query: 602 TYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDS 661
T ++ PE V + Y K D++S G++ +++I + Y + A +
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRALYLIATNGTPEL 236
Query: 662 KGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
+ E + D LN C+ + E R S E+
Sbjct: 237 QNPEKLSAIFRD------FLNR------CLDMDVEKRGSAKEL 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 3e-49
Identities = 52/274 (18%), Positives = 107/274 (39%), Gaps = 27/274 (9%)
Query: 442 KLGEGGFGPVYKGNLPR----GQEFAVKRLSATSTQGL-EEFKNEVSLTARLQHVNLLRV 496
+GEG FG V++G A+K ++ + E+F E + H +++++
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 497 LGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
+G TE + +I E L +L LD + ++ L YL+
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLESK--- 127
Query: 557 RVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY 616
R +HRD+ A N+L+ + K+ DFG+++ +D + ++ PE + +
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 617 SMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSS 676
+ DV+ FGV + +I+ + ++ + ++ + + +
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIENGE-----RLPMPPNCP 235
Query: 677 PCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
P + C +P RP E+ + L
Sbjct: 236 P----TLYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 1e-47
Identities = 73/298 (24%), Positives = 118/298 (39%), Gaps = 39/298 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKG------NLPRGQEFAVKRLSATSTQG-LEEFKNEVS-LTA 486
+ LG G FG V + + AVK L +T +E+ L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 487 RLQHVNLLRVLGYCTERDEN-MLIYEYLPNKSLDLYLF-------------DPIRRYVLD 532
H+N++ +LG CT+ M+I E+ +L YL + + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 533 WQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592
+ + V +G+ +L + IHRDL A NILL + KI DFG+A+ KD D
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLE 652
G ++ PE + +Y+++ DV+SFGVLL +I + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF----------SLGASPYPG 239
Query: 653 YAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
++ + KE D ++P Q L C P RP+ E+ L +
Sbjct: 240 VKIDEEFCRRLKEGTRMRAPDYTTP----EMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 6e-47
Identities = 59/281 (20%), Positives = 106/281 (37%), Gaps = 33/281 (11%)
Query: 431 KAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS---ATSTQGLEEFKNEVSLTA 486
K +F LGEG F V L +E+A+K L + E + +
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 487 RLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
RL H +++ + ++ Y N L Y+ D +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTA---EI 117
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
+ L+ +IHRDLK NILL+ +++ +I+DFG AK+ + +A VGT YV
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177
Query: 607 PPEYVKKGIYSMKYDVYSFGVLLLQIISSK---RNARYYGTSENLNFLEYAFEQWKDSKG 663
PE + + D+++ G ++ Q+++ R Y + + LEY F + K
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 237
Query: 664 KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
++ ++ + + R E+
Sbjct: 238 RDLVE--------------------KLLVLDATKRLGCEEM 258
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 1e-45
Identities = 70/298 (23%), Positives = 116/298 (38%), Gaps = 41/298 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLP--------RGQEFAVKRLSATSTQ-GLEEFKNEVSLT 485
+ LGEG FG V R + AVK L + +T+ L + +E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 486 ARL-QHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLF-------------DPIRRYVL 531
+ +H N++ +LG CT+ +I EY +L YL L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
+ V+ V +G+ YL + IHRDL A N+L+ + KI+DFG+A+
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFL 651
T ++ PE + IY+ + DV+SFGVLL +I + + E L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--- 246
Query: 652 EYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709
F+ K+ + ++ + C P RP+ ++ L
Sbjct: 247 ---FKLLKEGHRMDKPSNCTNE---------LYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 162 bits (411), Expect = 6e-45
Identities = 53/273 (19%), Positives = 103/273 (37%), Gaps = 24/273 (8%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
+++ +LG G FG V++ G FA K + E + E+ + L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
+ + + +E ++IYE++ L + D + + V + V +GL ++ E
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 554 SNFRVIHRDLKASNILLDNELNP--KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV 611
+H DLK NI+ + + K+ DFG+ + + GT + PE
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD---PKQSVKVTTGTAEFAAPEVA 197
Query: 612 KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671
+ D++S GVL ++S + G +++ W D +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSP--FGGENDDETLRNVKSCDWN------MDDSAF 249
Query: 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
S K + +P R ++ +
Sbjct: 250 SGISEDGK-----DFIRKLLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (406), Expect = 3e-44
Identities = 57/266 (21%), Positives = 103/266 (38%), Gaps = 24/266 (9%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
+LG G FG V++ G+ F K ++ KNE+S+ +L H L+ +
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
++ E +LI E+L L + Y + + +N + +GL ++ E ++H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVH 150
Query: 561 RDLKASNILLDNELNP--KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
D+K NI+ + + KI DFG+A D T + PE V +
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPVGF 207
Query: 619 KYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPC 678
D+++ GVL ++S + G + W EF + + S
Sbjct: 208 YTDMWAIGVLGYVLLSGLSP--FAGEDDLETLQNVKRCDW------EFDEDAFSSVSPEA 259
Query: 679 KLLNCMQVALLCVQENPEDRPSMLEV 704
K +Q+ P R ++ +
Sbjct: 260 K-----DFIKNLLQKEPRKRLTVHDA 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 153 bits (388), Expect = 2e-42
Identities = 59/285 (20%), Positives = 111/285 (38%), Gaps = 29/285 (10%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQ 489
++ + LG GG V+ +L ++ AVK L A F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 490 HVNLLRVLGYCTERDEN----MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
H ++ V ++ EY+ +L + + ++ + +I Q
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE-ANTGRIVGTYG 604
L + + +IHRD+K +NI++ K+ DFG+A+ + T ++GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664
Y+ PE + + DVYS G +L ++++ + + G S +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPV--------SVAYQHVRE 229
Query: 665 EFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRP-SMLEVSSML 708
+ I PS L + + +NPE+R + E+ + L
Sbjct: 230 DPIPPSARHEGLSADLDAVVL---KALAKNPENRYQTAAEMRADL 271
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-41
Identities = 61/300 (20%), Positives = 117/300 (39%), Gaps = 27/300 (9%)
Query: 423 QVFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG-LEEFKN 480
QVF D+ +++ + +GEG +G V + A+K++S Q +
Sbjct: 2 QVF---DV---GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 55
Query: 481 EVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNII 540
E+ + R +H N++ + + YL + L+ ++ L +
Sbjct: 56 EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFL 115
Query: 541 EGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANT-GRI 599
+ +GL Y+ V+HRDLK SN+LL+ + KI DFG+A++ D D
Sbjct: 116 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 172
Query: 600 VGTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLN--------F 650
V T Y PE + Y+ D++S G +L +++S++ + LN
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232
Query: 651 LEYAFEQWKDSKGKEFIDPSLDDSSSPCKLL------NCMQVALLCVQENPEDRPSMLEV 704
+ + K + ++ + P L + + + NP R + +
Sbjct: 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (377), Expect = 1e-40
Identities = 54/266 (20%), Positives = 105/266 (39%), Gaps = 21/266 (7%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEE-FKNEVSLTARLQHVNLLRVLG 498
+ LG G F V + + A+K ++ + +G E +NE+++ +++H N++ +
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 499 YCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRV 558
LI + + L + + + + +I V + YL +
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 559 IHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
+ LD + ISDFG++K+ + GT GYV PE + + YS
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPG---SVLSTACGTPGYVAPEVLAQKPYSK 188
Query: 619 KYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPC 678
D +S GV+ ++ +Y ++ FEQ ++ + F P DD S
Sbjct: 189 AVDCWSIGVIAYILLCGYPP--FYDEND-----AKLFEQILKAEYE-FDSPYWDDISDSA 240
Query: 679 KLLNCMQVALLCVQENPEDRPSMLEV 704
K ++++PE R + +
Sbjct: 241 K-----DFIRHLMEKDPEKRFTCEQA 261
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (375), Expect = 1e-40
Identities = 48/278 (17%), Positives = 94/278 (33%), Gaps = 25/278 (8%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
K+G G FG +Y G ++ G+E A+K + + E + +Q + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
+ ++ L SL+ R+ + + + + + + Y+ IH
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHSK---NFIH 126
Query: 561 RDLKASNIL---LDNELNPKISDFGMAKLFRKDVDEAN-----TGRIVGTYGYVPPEYVK 612
RD+K N L I DFG+AK +R + + GT Y
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 613 KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672
S + D+ S G +L+ + + +E+ + K I+
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR----QKYERISEKKMSTPIEVLCK 242
Query: 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
S C +D+P + + ++
Sbjct: 243 GYPSEFA-----TYLNFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-40
Identities = 46/267 (17%), Positives = 103/267 (38%), Gaps = 27/267 (10%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYC 500
LG G FG V++ + + K + T K E+S+ +H N+L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560
+E ++I+E++ + + + L+ ++ V+ + V + L +L + H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 561 RDLKASNILLDNELNP--KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSM 618
D++ NI+ + KI +FG A+ + N + Y PE + + S
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 619 KYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPC 678
D++S G L+ ++S + + + E +++ F + + + S
Sbjct: 183 ATDMWSLGTLVYVLLSGINP--FLAETN-----QQIIENIMNAEYT-FDEEAFKEISIEA 234
Query: 679 K-LLNCMQVALLCVQENPEDRPSMLEV 704
++ + + + R + E
Sbjct: 235 MDFVDR------LLVKERKSRMTASEA 255
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (373), Expect = 4e-40
Identities = 58/280 (20%), Positives = 107/280 (38%), Gaps = 42/280 (15%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQH 490
+F LG G FG V+ + G+ +A+K L + +E +E + + + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL 550
++R+ G + + +I +Y+ L L R + + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
+ + +I+RDLK NILLD + KI+DFG AK + GT Y+ PE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEV 172
Query: 611 VKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFL-----EYAFEQWKDSKGKE 665
V Y+ D +SFG+L+ ++++ +Y ++ + E F + + K+
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT--PFYDSNTMKTYEKILNAELRFPPFFNEDVKD 230
Query: 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVS 705
+ + + R L+
Sbjct: 231 LLS--------------------RLITRDLSQRLGNLQNG 250
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 146 bits (370), Expect = 6e-40
Identities = 45/287 (15%), Positives = 98/287 (34%), Gaps = 27/287 (9%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL 493
++ ++GEG FG +++G NL Q+ A+K S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 494 LRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY 553
+ + Y + + ++ L SL+ L R+ + + + + + E
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIHEK 120
Query: 554 SNFRVIHRDLKASNILLDNELNP-----KISDFGMAKLFRKDVDEAN-----TGRIVGTY 603
+++RD+K N L+ + + DFGM K +R V + + + GT
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 604 GYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG 663
Y+ S + D+ + G + + + + + N E + +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE------RIGEK 231
Query: 664 KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710
K+ + P + M + P + +
Sbjct: 232 KQSTPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSK 275
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 148 bits (375), Expect = 8e-40
Identities = 65/279 (23%), Positives = 103/279 (36%), Gaps = 32/279 (11%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS---ATSTQGLEEFKNEV---SLTAR 487
N+FS +G GGFG VY G+ +A+K L QG NE SL +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 488 LQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGL 547
++ + D+ I + + L +L + V + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 548 LYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
++ V++RDLK +NILLD + +ISD G+A F K VGT+GY+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMA 173
Query: 608 PEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666
PE ++KG+ Y D +S G +L +++ + + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEIDRMTLTMAVELPDS 231
Query: 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVS 705
P L LL +Q + R L
Sbjct: 232 FSPELRS------LLEG------LLQRDVNRRLGCLGRG 258
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 145 bits (366), Expect = 2e-39
Identities = 58/286 (20%), Positives = 111/286 (38%), Gaps = 39/286 (13%)
Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGL---------EEFKNEVSLT 485
N+ LG G V + + P +E+AVK + T E EV +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 486 ARLQ-HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVT 544
++ H N++++ L+++ + L YL + L ++ I+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120
Query: 545 QGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
+ + L + ++HRDLK NILLD+++N K++DFG + + GT
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGTPS 174
Query: 605 YVPPEYV------KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQW 658
Y+ PE + Y + D++S GV++ +++ ++ + L +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP--PFWHRKQMLMLRMIMSGNY 232
Query: 659 KDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
+ F P DD S K + + P+ R + E
Sbjct: 233 Q------FGSPEWDDYSDTVK-----DLVSRFLVVQPQKRYTAEEA 267
|
| >d1wb0a1 c.1.8.5 (A:22-266,A:337-388) Chitotriosidase {Human (Homo sapiens) [TaxId: 9606]} Length = 297 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitotriosidase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 90/329 (27%), Positives = 143/329 (43%), Gaps = 81/329 (24%)
Query: 30 AGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPS 89
A Y F D++ +L THLI AFA + + +QLS + N + N +++ NP
Sbjct: 11 AQYRQGEARFLPKDLDPSLCTHLIYAFAGMTN--HQLSTTEWNDETLYQEFNGLKKMNPK 68
Query: 90 IKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDL 149
+KTLL+I T + + MV +++R++F+ S+IR R Y F G+DL
Sbjct: 69 LKTLLAIGGWNFGTQK------------FTDMVATANNRQTFVNSAIRFLRKYSFDGLDL 116
Query: 150 FWLWPNS-----TDLNSLGILLDEWK------ASASDQPELTLSMAVRYSPTHETVSYPI 198
W +P S D L+ + A S + L LS AV T+ Y +
Sbjct: 117 DWEYPGSQGSPAVDKERFTTLVQDLANAFQQEAQTSGKERLLLSAAVPAGQTYVDAGYEV 176
Query: 199 DSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSS------NISTDFGIREWLRRGFP 252
D + +NL++ +L+AYD+H E VTG ++ LY +++ D +++WL++G P
Sbjct: 177 DKIAQNLDFVNLMAYDFHGSW-EKVTGHNSPLYKRQEESGAAASLNVDAAVQQWLQKGTP 235
Query: 253 ANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFD 312
A+KL+LG + D
Sbjct: 236 ASKLILG-------------------------------------------------MPTD 246
Query: 313 GVETIKAKISYAKEKNLLGYKAFQLSNDD 341
VE+ K K+SY K+K L G + L DD
Sbjct: 247 DVESFKTKVSYLKQKGLGGAMVWALDLDD 275
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 4e-39
Identities = 62/274 (22%), Positives = 97/274 (35%), Gaps = 43/274 (15%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEE------FKNEVSLTARLQ--HVN 492
LG GGFG VY G + A+K + E EV L ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
++R+L + D +LI E R L + + V + + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCHN 128
Query: 553 YSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV 611
V+HRD+K NIL+D N K+ DFG L + GT Y PPE++
Sbjct: 129 C---GVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 181
Query: 612 KKGIY-SMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670
+ Y V+S G+LL ++ + E + + F Q S+ + I
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEEIIRGQVFFRQRVSSECQHLIR-- 236
Query: 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
C+ P DRP+ E+
Sbjct: 237 ------------------WCLALRPSDRPTFEEI 252
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 4e-39
Identities = 75/332 (22%), Positives = 119/332 (35%), Gaps = 40/332 (12%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS---ATSTQGLEEFKNEVS-LTARLQ 489
+F LG+G FG V+ Q FA+K L +E E L+ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 490 HVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
H L + ++ + EYL L ++ + D + + GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
L +++RDLK NILLD + + KI+DFGM K + NT GT Y+ PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669
+ Y+ D +SFGVLL +++ + ++G E E + + P
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSP--FHGQDEE--------ELFHSIRMDNPFYP 223
Query: 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSM---------LEVSSMLKDDSMAIAAPKR 720
LL PE R + + + + I P R
Sbjct: 224 R-WLEKEAKDLLVK------LFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFR 276
Query: 721 PAFSAKGD-ENAETSSTSRQEIYSFNDPELSQ 751
P + D N + + + SF D L
Sbjct: 277 PKVKSPFDCSNFDKEFLNEKPRLSFADRALIN 308
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 7e-39
Identities = 61/286 (21%), Positives = 109/286 (38%), Gaps = 25/286 (8%)
Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHVN 492
NF K+GEG +G VYK N G+ A+K RL + E+SL L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
++++L ++ L++E+L + + + + + QGL +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 120
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
+ RV+HRDLK N+L++ E K++DFG+A+ F T +V + P +
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPEILLG 176
Query: 613 KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSEN----------LNFLEYAFEQWKDSK 662
YS D++S G + ++++ + + G SE E +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRAL--FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 663 GKEFIDPSLDDSSSPCKLLNCMQVAL----LCVQENPEDRPSMLEV 704
+ P + + + +P R S
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 141 bits (357), Expect = 3e-38
Identities = 62/286 (21%), Positives = 113/286 (39%), Gaps = 25/286 (8%)
Query: 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHVN 492
+ K+GEG +G VYK G+ FA+K RL E+S+ L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 493 LLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE 552
++++ + +L++E+L L L+ + + + G+ Y +
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 553 YSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVK 612
RV+HRDLK N+L++ E KI+DFG+A+ F V + IV + P +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMG 174
Query: 613 KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE--------------NLNFLEYAFEQW 658
YS D++S G + ++++ + G SE N E
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTP--LFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 659 KDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
K +P +S + + + ++ +P R + +
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1goia2 c.1.8.5 (A:3-291,A:380-446) Chitinase B, catalytic domain {Serratia marcescens [TaxId: 615]} Length = 356 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase B, catalytic domain species: Serratia marcescens [TaxId: 615]
Score = 142 bits (359), Expect = 7e-38
Identities = 66/342 (19%), Positives = 126/342 (36%), Gaps = 47/342 (13%)
Query: 32 YWLAGREFPLSDINSAL---FTHLICAFAEVDSSTYQLSISSANQQYFSIFAN---SVRR 85
+ FP+S+I A TH+ +F +++S+ + N N +++
Sbjct: 22 TDTSVVPFPVSNITPAKAKQLTHINFSFLDINSNLECAWDPATNDAKARDVVNRLTALKA 81
Query: 86 KNPSIKTLLSI--WNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG 143
NPS++ + SI W N + ++ + + V + R F +S +R + YG
Sbjct: 82 HNPSLRIMFSIGGWYYSN--------DLGVSHANYVNAVKTPASRAKFAQSCVRIMKDYG 133
Query: 144 FQGIDLFWLWPNSTDLNSLGILLDEWK--------ASASDQPELTLSMAVRYSPTHETVS 195
F G+++ W +P + +++ L E + L++A +
Sbjct: 134 FDGVNIDWEYPQAAEVDGFIAALQEIRTLLNQQTITDGRQALPYQLTIAGAGGAFFLSRY 193
Query: 196 Y-PIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPAN 254
Y + + L++ +L+ YD P E VT AAL+ ++ + +R G+
Sbjct: 194 YSKLAQIVAPLDYINLMTYDLAGPW-EKVTNHQAALFGDAAGPTFYNALR-EANLGWSWE 251
Query: 255 KLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGV 314
+L + + V +A V+ + FD
Sbjct: 252 ELTRAFPSPFSLTVDAAVQQH-----------LMMEGVPSAKIVM--------GVPFDDA 292
Query: 315 ETIKAKISYAKEKNLLGYKAFQLSNDD-NWALSRAAQIEENN 355
E+ K K Y K++ L G + L D+ N L A N
Sbjct: 293 ESFKYKAKYIKQQQLGGVMFWHLGQDNRNGDLLAALDRYFNA 334
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-37
Identities = 59/297 (19%), Positives = 106/297 (35%), Gaps = 45/297 (15%)
Query: 436 NFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLL 494
+++ +G G FG VY+ G+ A+K++ Q E+ + +L H N++
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 495 RVLGYCTERDENM------LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLL 548
R+ + E L+ +Y+P + + L + + + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 549 YLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVP 607
Y+ + + HRD+K N+LLD + K+ DFG AK + E N I Y P
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRYYRAP 191
Query: 608 PEYVKKGIYSMKYDVYSFGVLLLQIISSKR--------------------NARYYGTSEN 647
Y+ DV+S G +L +++ + R N
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 648 LNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
N+ E+ F Q K + P + + ++ P R + LE
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPE--------AIALCSRLLEYTPTARLTPLEA 300
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-37
Identities = 59/292 (20%), Positives = 117/292 (40%), Gaps = 36/292 (12%)
Query: 424 VFSFSDIKAATNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG------LE 476
VF ++ + + + +LG G F V K G ++A K + T+ E
Sbjct: 2 VFRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58
Query: 477 EFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKR 536
+ + EVS+ +QH N++ + + + +LI E + L + L ++
Sbjct: 59 DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEA 115
Query: 537 VNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP----KISDFGMAKLFRKDVD 592
++ + L + + ++ H DLK NI+L + P KI DFG+A +
Sbjct: 116 TEFLKQI---LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172
Query: 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLE 652
I GT +V PE V ++ D++S GV+ ++S + G ++
Sbjct: 173 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--FLGDTKQETLAN 227
Query: 653 YAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
+ + EF D ++S+ K + ++P+ R ++ +
Sbjct: 228 VSAVNY------EFEDEYFSNTSALAK-----DFIRRLLVKDPKKRMTIQDS 268
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-37
Identities = 64/297 (21%), Positives = 117/297 (39%), Gaps = 36/297 (12%)
Query: 433 ATNNFSSANKLGEGGFGPVYKG--NLPRGQEFAVKRLSATSTQG--LEEFKNEVSLTARL 488
A + ++GEG +G V+K G+ A+KR+ + + EV++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 489 ---QHVNLLRVLGYCTERDENMLIYEYLPNKSLD---LYLFDPIRRYVLDWQKRVNIIEG 542
+H N++R+ CT + L + +D D + + + +++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 543 VTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGT 602
+ +GL +L RV+HRDLK NIL+ + K++DFG+A+++ + +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVT 178
Query: 603 YGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR---------------NARYYGTSEN 647
Y PE + + Y+ D++S G + ++ K + E+
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 648 LNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
Q SK + I+ + D K L L C+ NP R S
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDL-----LLKCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-37
Identities = 59/282 (20%), Positives = 105/282 (37%), Gaps = 26/282 (9%)
Query: 441 NKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEE-----FKNEVSLTARLQHVNLL 494
+ LGEG F VYK + Q A+K++ ++ E+ L L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 495 RVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS 554
+L + L+++++ + VL + QGL YL ++
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 555 NFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK- 613
++HRDLK +N+LLD K++DFG+AK F V T Y PE +
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT--HQVVTRWYRAPELLFGA 175
Query: 614 GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAF-----EQWKDSKGKEFID 668
+Y + D+++ G +L +++ + L + EQW D
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 669 PSLDDSSSPCKLL------NCMQVALLCVQENPEDRPSMLEV 704
P + + + + NP R + +
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 8e-36
Identities = 56/288 (19%), Positives = 107/288 (37%), Gaps = 27/288 (9%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVK--RLSATSTQGLEEFKNEVSLTARLQHV 491
+ K+GEG +G V+K N + A+K RL E+ L L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 492 NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQ 551
N++R+ + L++E+ + + + Q L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 552 EYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYV 611
+ V+HRDLK N+L++ K+++FG+A+ F + +V + P
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLF 174
Query: 612 KKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID--- 668
+YS D++S G + ++ ++ R + ++ + L+ F +++
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR--PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 669 ----------PSLDDSSSPCKLLNCMQVALL--CVQENPEDRPSMLEV 704
P+ + LN LL ++ NP R S E
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d2pi6a1 c.1.8.5 (A:1-239,A:308-361) Signal processing protein (SPC-40, MGP-40) {Sheep (Ovis aries) [TaxId: 9940]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Signal processing protein (SPC-40, MGP-40) species: Sheep (Ovis aries) [TaxId: 9940]
Score = 134 bits (338), Expect = 1e-35
Identities = 74/322 (22%), Positives = 121/322 (37%), Gaps = 74/322 (22%)
Query: 30 AGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPS 89
+ Y I+ L TH+I FA + ++ + Y ++ N+++ +NP
Sbjct: 11 SQYREGDGSCFPDAIDPFLCTHVIYTFANISNNEIDTWEWNDVTLYDTL--NTLKNRNPK 68
Query: 90 IKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDL 149
+KTLLS+ P S + + R++FI+S R +GF G+DL
Sbjct: 69 LKTLLSVGGWNFG------------PERFSKIASKTQSRRTFIKSVPPFLRTHGFDGLDL 116
Query: 150 FWLWPNSTDLNSLGILLDEW-----KASASDQPELTLSMAVRYSPTHETVSYPIDSMKKN 204
WL+P D L L+ E + + + +L LS AV Y I + ++
Sbjct: 117 AWLYPGRRDKRHLTTLVKEMKAEFIREAQAGTEQLLLSAAVSAGKIAIDRGYDIAQISRH 176
Query: 205 LNWAHLVAYDYHMPSKENVTGIHAALYNPSSNI-----STDFGIREWLRRGFPANKLVLG 259
L++ L+ YD+H G H+ L+ + + + D+ + LR G PANKLV+G
Sbjct: 177 LDFISLLTYDFHGAW-RQTVGHHSPLFRGNEDASSRFSNADYAVSYMLRLGAPANKLVMG 235
Query: 260 ARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKA 319
I D E++K
Sbjct: 236 -------------------------------------------------IPTDDQESVKN 246
Query: 320 KISYAKEKNLLGYKAFQLSNDD 341
K Y K + L G + L DD
Sbjct: 247 KARYLKNRQLAGAMVWALDLDD 268
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 5e-35
Identities = 55/271 (20%), Positives = 102/271 (37%), Gaps = 29/271 (10%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQH 490
N+F LG+G FG V G+ +A+K L + + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL 550
L + D + EY L +L R V ++ + + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYG---AEIVSAL 118
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
+ + V++RD+K N++LD + + KI+DFG+ K D A GT Y+ PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEV 176
Query: 611 VKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670
++ Y D + GV++ +++ + +Y F E+ + + + P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHERLFELILMEEIRFPRT---LSPE 231
Query: 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSM 701
LL ++++P+ R
Sbjct: 232 AKS------LLAG------LLKKDPKQRLGG 250
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 7e-35
Identities = 57/271 (21%), Positives = 107/271 (39%), Gaps = 30/271 (11%)
Query: 443 LGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYC 500
LG G G V + N ++FA+K L Q + + EV L R Q +++R++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 501 ----TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNF 556
R +++ E L L + D + ++ I++ + + + YL
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHSI--- 130
Query: 557 RVIHRDLKASNILLDNELNP---KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKK 613
+ HRD+K N+L ++ K++DFG AK T YV PE +
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187
Query: 614 GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673
Y D++S GV++ ++ + ++ L + + + EF +P +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGY---PPFYSNHGLAISPGMKTRIRMGQ-YEFPNPEWSE 243
Query: 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
S K+L ++ P R ++ E
Sbjct: 244 VSEEVKML-----IRNLLKTEPTQRMTITEF 269
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 1e-34
Identities = 53/299 (17%), Positives = 113/299 (37%), Gaps = 35/299 (11%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQG--LEEFKNEVSLTARLQHV 491
+ + K+G+G FG V+K + GQ+ A+K++ + + E+ + L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 492 NLLRVLGYCTERDENM--------LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGV 543
N++ ++ C + L++++ + L + + ++ L KRV +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRV-----M 123
Query: 544 TQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGR--IVG 601
L L +++HRD+KA+N+L+ + K++DFG+A+ F + V
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 602 TYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSKR---------------NARYYGTS 645
T Y PPE + Y D++ G ++ ++ + T
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 646 ENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704
E ++ K K D + + + + + +P R +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1w9pa1 c.1.8.5 (A:39-298,A:361-433) Chitinase 1 {Aspergillus fumigatus [TaxId: 5085]} Length = 333 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase 1 species: Aspergillus fumigatus [TaxId: 5085]
Score = 126 bits (318), Expect = 2e-32
Identities = 71/335 (21%), Positives = 130/335 (38%), Gaps = 57/335 (17%)
Query: 36 GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFA--------------- 80
GR D+ TH++ AFA V T ++ ++ + +
Sbjct: 18 GRNHNPQDLPVERLTHVLYAFANVRPETGEVYMTDSWADIEKHYPGDSWSDTGNNVYGCI 77
Query: 81 ---NSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIR 137
++++N ++K LLSI S + + RK+F +++++
Sbjct: 78 KQLYLLKKQNRNLKVLLSIGGWTYSPNF-------------APAASTDAGRKNFAKTAVK 124
Query: 138 TARLYGFQGIDLFWLWPN--------STDLNSLGILLDEWKASASDQPELTLSMAVRYSP 189
+ GF G+D+ W +P L + LD + A+ + L++A P
Sbjct: 125 LLQDLGFDGLDIDWEYPENDQQANDFVLLLKEVRTALDSYSAANAGGQHFLLTVASPAGP 184
Query: 190 THETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN-----ISTDFGIR 244
+ M + L++ +L+AYDY +++G A +YN +SN +T +
Sbjct: 185 DK-IKVLHLKDMDQQLDFWNLMAYDYAGSF-SSLSGHQANVYNDTSNPLSTPFNTQTALD 242
Query: 245 EWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTS 304
+ G PANK+VLG P + GY I++ G G A +++S S
Sbjct: 243 LYRAGGVPANKIVLGMPLDNPQ-VANLKSGY------IKSLGLGGAMWWDSSSDKTGSDS 295
Query: 305 GATWINFDGVETIKAKISYAKEKNLLGYKAFQLSN 339
T + V + + + +N L Y Q N
Sbjct: 296 LITTV----VNALGGTGVFEQSQNELDYPVSQYDN 326
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-32
Identities = 57/322 (17%), Positives = 117/322 (36%), Gaps = 27/322 (8%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLG 498
+G G +G V + G + A+K+L S + E+ L ++H N++ +L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 499 YCTERDENMLIYE-YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFR 557
T + + YL + L ++ L + ++ + +GL Y+
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII- 143
Query: 558 VIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYS 617
HRDLK N+ ++ + KI DFG+A+ D TG +V + P + Y+
Sbjct: 144 --HRDLKPGNLAVNEDCELKILDFGLARQ----ADSEMTGYVVTRWYRAPEVILNWMRYT 197
Query: 618 MKYDVYSFGVLLLQIIS--------SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID- 668
D++S G ++ ++I+ + ++ + + K ++
Sbjct: 198 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257
Query: 669 -PSLDDSSSPCKLLNCMQVAL----LCVQENPEDRPSMLEV--SSMLKDDSMAIAAPKRP 721
P L+ L N +A+ + + E R + E + P+
Sbjct: 258 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ 317
Query: 722 AFSAKGDENAETSSTSRQEIYS 743
+ D+ T ++ Y
Sbjct: 318 KYDDSFDDVDRTLDEWKRVTYK 339
|
| >d1vf8a1 c.1.8.5 (A:1-245,A:316-372) Chitinase-like lectin ym1, saccharide binding domain {Mouse (Mus musculus) [TaxId: 10090]} Length = 302 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase-like lectin ym1, saccharide binding domain species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (313), Expect = 3e-32
Identities = 75/329 (22%), Positives = 122/329 (37%), Gaps = 81/329 (24%)
Query: 30 AGYWLAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPS 89
A F +I+ L THLI AFA + ++ + + Y ++ N ++ KN
Sbjct: 11 AKDRPIEGSFKPGNIDPCLCTHLIYAFAGMQNNEITYTHEQDLRDYEAL--NGLKDKNTE 68
Query: 90 IKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDL 149
+KTLL+I G P+ S+MV +R+ FI+S IR R Y F G++L
Sbjct: 69 LKTLLAI------------GGWKFGPAPFSAMVSTPQNRQIFIQSVIRFLRQYNFDGLNL 116
Query: 150 FWLWPNSTDLNS-----LGILLDEWK------ASASDQPELTLSMAVRYSPTHETVSYPI 198
W +P S +L+ E + + D P L L+ Y I
Sbjct: 117 DWQYPGSRGSPPKDKHLFSVLVKEMRKAFEEESVEKDIPRLLLTSTGAGIIDVIKSGYKI 176
Query: 199 DSMKKNLNWAHLVAYDYHMPSKENVTGIHAALY------NPSSNISTDFGIREWLRRGFP 252
+ ++L++ ++ YD H P + TG ++ LY S++++ D I W G
Sbjct: 177 PELSQSLDYIQVMTYDLHDPK-DGYTGENSPLYKSPYDIGKSADLNVDSIISYWKDHGAA 235
Query: 253 ANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFD 312
+ KL++G D
Sbjct: 236 SEKLIVG-------------------------------------------------FPAD 246
Query: 313 GVETIKAKISYAKEKNLLGYKAFQLSNDD 341
V + K K + K+ NL G + L DD
Sbjct: 247 NVRSFKLKAQWLKDNNLGGAVVWPLDMDD 275
|
| >d1jnda1 c.1.8.5 (A:2-278,A:371-420) Imaginal disc growth factor-2 {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 327 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Imaginal disc growth factor-2 species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 124 bits (313), Expect = 6e-32
Identities = 65/355 (18%), Positives = 117/355 (32%), Gaps = 101/355 (28%)
Query: 30 AGYWLAGREFPLSDINSALF--THLICAFAEVDSSTYQLSISS----ANQQYFSIFANSV 83
+ + D+ AL +HL+ +A + Q + + FS S+
Sbjct: 11 SYTREGLGKLLNPDLEIALQFCSHLVYGYAGLRGENLQAYSMNENLDIYKHQFSEV-TSL 69
Query: 84 RRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYG 143
+RK P +K LLS+ + + + + G+ + FI S+ + YG
Sbjct: 70 KRKYPHLKVLLSVGGDHDIDP-------DHPNKYIDLLEGEKVRQIGFIRSAYELVKTYG 122
Query: 144 FQGIDLFWLWPNSTDLNSLGILLDEWK------------------------------ASA 173
F G+DL + +P + G L WK +
Sbjct: 123 FDGLDLAYQFPKNKPRKVHGDLGLAWKSIKKLFTGDFIVDPHAALHKEQFTALVRDVKDS 182
Query: 174 SDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYH-MPSKENVTGIHAALYN 232
LS+ V + T + I ++ +++ +L +D+ A +Y+
Sbjct: 183 LRADGFLLSLTVLPNVNS-TWYFDIPALNGLVDFVNLATFDFLTPARNPEEADYSAPIYH 241
Query: 233 PS------SNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYG 286
P ++++ DF + WL +GFP+NK+ L
Sbjct: 242 PDGSKDRLAHLNADFQVEYWLSQGFPSNKINL---------------------------- 273
Query: 287 YGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341
+ D ++ K +YA+ KNL G F LS DD
Sbjct: 274 ---------------------GVATDDPDSASNKAAYARVKNLGGVALFDLSYDD 307
|
| >d1itxa1 c.1.8.5 (A:33-337,A:410-451) Chitinase A1 {Bacillus circulans [TaxId: 1397]} Length = 347 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase A1 species: Bacillus circulans [TaxId: 1397]
Score = 119 bits (300), Expect = 4e-30
Identities = 66/383 (17%), Positives = 125/383 (32%), Gaps = 133/383 (34%)
Query: 36 GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFA--------------- 80
GR + ++DI+ TH+ AFA++ + + + +
Sbjct: 25 GRNYNVADIDPTKVTHINYAFADICWNGIHGNPDPSGPNPVTWTCQNEKSQTINVPNGTI 84
Query: 81 -----------------------------NSVRRKNPSIKTLLSIWNGQNSTYQSILGNK 111
N +++ NP++KT++S+ S S
Sbjct: 85 VLGDPWIDTGKTFAGDTWDQPIAGNINQLNKLKQTNPNLKTIISVGGWTWSNRFSD---- 140
Query: 112 NINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWK- 170
+ ++ R+ F S++ R Y F G+DL W +P S L+ ++ +
Sbjct: 141 ---------VAATAATREVFANSAVDFLRKYNFDGVDLDWEYPVSGGLDGNSKRPEDKQN 191
Query: 171 --------------ASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYH 216
A A D + L++A S T+ + + + ++W +++ YD++
Sbjct: 192 YTLLLSKIREKLDAAGAVDGKKYLLTIASGASATYAA-NTELAKIAAIVDWINIMTYDFN 250
Query: 217 MPSKENVTGIHAALY----------NPSSNISTDFGIREWLRRGFPANKLVLGARASGPG 266
+ ++ +A L ++ + G + L G PA KLVLG
Sbjct: 251 GAW-QKISAHNAPLNYDPAASAAGVPDANTFNVAAGAQGHLDAGVPAAKLVLG------- 302
Query: 267 ITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKE 326
+ FD E++ K +Y K
Sbjct: 303 ------------------------------------------VPFDDAESVGYKTAYIKS 320
Query: 327 KNLLGYKAFQLSNDDNWALSRAA 349
K L G ++LS D N L
Sbjct: 321 KGLGGAMFWELSGDRNKTLQNKL 343
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 119 bits (299), Expect = 6e-30
Identities = 53/275 (19%), Positives = 99/275 (36%), Gaps = 32/275 (11%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS---ATSTQGLEEFKNEVSLTARLQH 490
+ F LG G FG V + G +A+K L + +E NE + +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL 550
L+++ + ++ EY+ + +L R + YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 551 QEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEY 610
+I+RDLK N+L+D + +++DFG AK + T + GT + PE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI 209
Query: 611 VKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670
+ Y+ D ++ GVL+ ++ + ++ + ++ + PS
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP--FFADQP--------IQIYEKIVSGKVRFPS 259
Query: 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVS 705
S L N +QV + R L+
Sbjct: 260 HFSSDLKDLLRNLLQV-------DLTKRFGNLKNG 287
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 9e-30
Identities = 56/278 (20%), Positives = 105/278 (37%), Gaps = 31/278 (11%)
Query: 435 NNFSSANKLGEGGFGPVYKG----NLPRGQEFAVKRLS----ATSTQGLEEFKNEVSLTA 486
NF LG G +G V+ G+ +A+K L + E + E +
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 487 RLQHV-NLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
++ L+ + + LI +Y+ L +L R + Q V +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGY 605
+L L+ +I+RD+K NILLD+ + ++DFG++K F + GT Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCGTIEY 196
Query: 606 VPPEYVKKGI--YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG 663
+ P+ V+ G + D +S GVL+ ++++ + E + E + K
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS--PFTVDGEKNSQAEISRRILKS--- 251
Query: 664 KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSM 701
+P S + + ++P+ R
Sbjct: 252 ----EPPYPQEMSA----LAKDLIQRLLMKDPKKRLGC 281
|
| >d1edqa2 c.1.8.5 (A:133-443,A:517-563) Chitinase A, catalytic domain {Serratia marcescens [TaxId: 615]} Length = 358 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase A, catalytic domain species: Serratia marcescens [TaxId: 615]
Score = 118 bits (296), Expect = 2e-29
Identities = 52/370 (14%), Positives = 113/370 (30%), Gaps = 102/370 (27%)
Query: 28 IKAGYW----LAGREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSV 83
+ Y+ + GR F + I + THL+ F + + F S
Sbjct: 27 VVGSYFVEWGVYGRNFTVDKIPAQNLTHLLYGFIPICGGNGINDSLKEIEGSFQALQRSC 86
Query: 84 RRKNPSIKTLLSIW--------------NGQNSTYQSILGNKNINPSVL----------- 118
+ + ++ + + + ++ K +P +
Sbjct: 87 QGREDFKVSIHDPFAALQKAQKGVTAWDDPYKGNFGQLMALKQAHPDLKILPSIGGWTLS 146
Query: 119 --SSMVGDSSHRKSFIESSIRTARLYG-FQGIDLFWLWP----------NSTDLNSLGIL 165
+GD R F+ S + + F G+D+ W +P + D + +L
Sbjct: 147 DPFFFMGDKVKRDRFVGSVKEFLQTWKFFDGVDIDWEFPGGKGANPNLGSPQDGETYVLL 206
Query: 166 LDEWKA-----SASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSK 220
+ E +A S + L+ A+ + + + + +++ L++YD++
Sbjct: 207 MKELRAMLDQLSVETGRKYELTSAI-SAGKDKIDKVAYNVAQNSMDHIFLMSYDFYGAFD 265
Query: 221 ENVTGIHAALY----NPSSNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYK 276
G AL P + +T G+ L +G K+V+G
Sbjct: 266 LKNLGHQTALNAPAWKPDTAYTTVNGVNALLAQGVKPGKIVVG----------------- 308
Query: 277 FIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQ 336
+++AK Y +K L G +++
Sbjct: 309 -----TAMDA----------------------------RSVQAKGKYVLDKQLGGLFSWE 335
Query: 337 LSNDDNWALS 346
+ D+ L+
Sbjct: 336 IDADNGDILN 345
|
| >d1ll7a1 c.1.8.5 (A:36-292,A:355-427) Chitinase 1 {Fungus (Coccidioides immitis) [TaxId: 5501]} Length = 330 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase 1 species: Fungus (Coccidioides immitis) [TaxId: 5501]
Score = 115 bits (289), Expect = 9e-29
Identities = 66/335 (19%), Positives = 124/335 (37%), Gaps = 58/335 (17%)
Query: 36 GREFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFA--------------- 80
GR D+ + FTH++ AFA + + ++ +S +
Sbjct: 16 GRGHNPQDLKADQFTHILYAFANIRP-SGEVYLSDTWADTDKHYPGDKWDEPGNNVYGCI 74
Query: 81 ---NSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIR 137
+++ N ++KTLLSI S + RK F ++S++
Sbjct: 75 KQMYLLKKNNRNLKTLLSIGGWTYSPN-------------FKTPASTEEGRKKFADTSLK 121
Query: 138 TARLYGFQGIDLFWLWPNSTD--------LNSLGILLDEWKASASDQPELTLSMAVRYSP 189
+ GF GID+ W +P L + LD + A + + L++A P
Sbjct: 122 LMKDLGFDGIDIDWQYPEDEKQANDFVLLLKACREALDAYSAKHPNGKKFLLTIASPAGP 181
Query: 190 THETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSN-----ISTDFGIR 244
+ + M K L++ +L+AYD+ + V+G + ++ ++ S+D ++
Sbjct: 182 QNYN-KLKLAEMDKYLDFWNLMAYDFSGS-WDKVSGHMSNVFPSTTKPESTPFSSDKAVK 239
Query: 245 EWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTS 304
++++ G PANK+VLG Y I G G + +S +
Sbjct: 240 DYIKAGVPANKIVLGMPLDTVK-IAGKKAEY------ITKNGMGGGMWWESSS----DKT 288
Query: 305 GATWINFDGVETIKAKISYAKEKNLLGYKAFQLSN 339
G + V + + +N L Y N
Sbjct: 289 GNESLVGTVVNGLGGTGKLEQRENELSYPESVYDN 323
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 4e-28
Identities = 64/340 (18%), Positives = 127/340 (37%), Gaps = 35/340 (10%)
Query: 434 TNNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLS--ATSTQGLEEFKNEVSLTARLQH 490
+ + + +G G +G V + G AVK+LS S + E+ L ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 491 VNLLRVLGYCTERDENMLI-YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLY 549
N++ +L T YL + L + ++ L +I + +GL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 550 LQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
+ HRDLK SN+ ++ + KI DFG+A+ D+ TG + + P
Sbjct: 137 IHSADII---HRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEI 189
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSE--------------NLNFLEYAF 655
+ Y+ D++S G ++ ++++ + + GT L+
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 656 EQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALL--CVQENPEDRPSMLEV------SSM 707
+ + + + ++ N + V LL + + + R + + +
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 708 LKDDSMAIAAPKRPAFSAKGDENAETSSTSRQEIYSFNDP 747
D +A P +F ++ E S + E+ SF P
Sbjct: 308 HDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPP 347
|
| >d1kfwa1 c.1.8.5 (A:10-327,A:389-444) Psychrophilic chitinase B {Arthrobacter sp., tad20 [TaxId: 1667]} Length = 374 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Psychrophilic chitinase B species: Arthrobacter sp., tad20 [TaxId: 1667]
Score = 114 bits (285), Expect = 6e-28
Identities = 65/397 (16%), Positives = 114/397 (28%), Gaps = 145/397 (36%)
Query: 36 GREFPLSDINS----ALFTHLICAFAEVDSSTYQLSISSANQQYFSIFA----------- 80
GR F ++ TH+ +F +++ T +++ Q +
Sbjct: 22 GRAFQAKQLDVSGTAKNLTHINYSFGNINNQTLTCFMANKAQGTGPNGSDGAGDAWADFG 81
Query: 81 ---------------------------NSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNI 113
++ KNP +K ++S+ S
Sbjct: 82 MGYAADKSVSGKADTWDQPLAGSFNQLKQLKAKNPKLKVMISLGGWTWSKNF-------- 133
Query: 114 NPSVLSSMVGDSSHRKSFIESSIRTARLYG----------------FQGIDLFWLWPNST 157
S + R+ + S I F GID+ W WP +
Sbjct: 134 -----SKAAATEASRQKLVSSCIDLYIKGNLPNFEGRGGAGAAAGIFDGIDIDWEWPGTN 188
Query: 158 ------------DLNSLGILLDEWKA-----SASDQPELTLSMAVRYSPTH-ETVSYPID 199
D + LL E++ +++ + LS + +P + +
Sbjct: 189 SGLAGNGVDTVNDRANFKALLAEFRKQLDAYGSTNNKKYVLSAFLPANPADIDAGGWDDP 248
Query: 200 SMKKNLNWAHLVAYDYHMPSKENVTGIHAALYN-------PSSNISTDFGIREWLRRGFP 252
+ K+L++ + YD H +TG A LY+ PS S D ++++L G
Sbjct: 249 ANFKSLDFGSIQGYDLHGAWNPTLTGHQANLYDDPADPRAPSKKFSADKAVKKYLAAGID 308
Query: 253 ANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFD 312
+L LG + D
Sbjct: 309 PKQLGLG-------------------------------------------------LAAD 319
Query: 313 GVETIKAKISYAKEKNLLGYKAFQLSNDDNWALSRAA 349
+ T K K Y K L G ++LS D N L A
Sbjct: 320 NIATTKQKTDYIVSKGLGGGMWWELSGDRNGELVGAM 356
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 111 bits (277), Expect = 3e-27
Identities = 48/296 (16%), Positives = 103/296 (34%), Gaps = 40/296 (13%)
Query: 435 NNFSSANKLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVN 492
+++ KLG G + V++ N+ ++ VK L ++ K E+ + L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 493 LLRVLGYCTERDENM--LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYL 550
++ + + L++E++ N + L + + + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTD----FKQLYQT--LTDYDIRFYMYEILKALDYC 145
Query: 551 QEYSNFRVIHRDLKASNILLDNE-LNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPE 609
++HRD+K N+++D+E ++ D+G+A+ + + R+ Y P
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--GQEYNVRVASRYFKGPEL 200
Query: 610 YVKKGIYSMKYDVYSFGVLLLQIISSKR-----NARYYGTSENLNFLEYAFEQWKDSKGK 664
V +Y D++S G +L +I K + Y L K
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 665 EFIDPSLDDSSSPCKLLNCMQVALL----------------CVQENPEDRPSMLEV 704
+DP +D + ++ + + R + E
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 2e-26
Identities = 69/364 (18%), Positives = 127/364 (34%), Gaps = 62/364 (17%)
Query: 427 FSDIKAATNNFSSANK------LGEGGFGPVYKG-NLPRGQEFAVKRLS--ATSTQGLEE 477
F ++ + F+ + +G G G V + + A+K+LS + +
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR 62
Query: 478 FKNEVSLTARLQHVNLLRVLGYCT------ERDENMLIYEYLPNKSLDLYLFDPIRRYVL 531
E+ L + H N++ +L T E + L+ E + + +
Sbjct: 63 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------ 116
Query: 532 DWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591
D ++ ++ + G+ +L IHRDLK SNI++ ++ KI DFG+A+
Sbjct: 117 DHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173
Query: 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENL--- 648
V T Y PE + Y D++S G ++ +++ K +
Sbjct: 174 ---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230
Query: 649 --------------------NFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVAL 688
N++E + + K F D S KL L
Sbjct: 231 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290
Query: 689 L--CVQENPEDRPSMLEVSSMLKD-------DSMAIAAPKRPAFSAKGDENAETSSTSRQ 739
L + +P R S+ + L+ D + AP + + DE T ++
Sbjct: 291 LSKMLVIDPAKRISVDDA---LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKE 347
Query: 740 EIYS 743
IY
Sbjct: 348 LIYK 351
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 100 bits (250), Expect = 1e-23
Identities = 42/212 (19%), Positives = 84/212 (39%), Gaps = 22/212 (10%)
Query: 442 KLGEGGFGPVYKG-NLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL------- 493
KLG G F V+ ++ A+K + E ++E+ L R+ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 494 ----LRVLGYCTERDEN----MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQ 545
L++L + + N ++++E L L L R L + K+ I + +
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ--ISKQLLL 136
Query: 546 GLLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRKDVDEANTGRIVGTYG 604
GL Y+ +IH D+K N+L++ + + +A L + + + T
Sbjct: 137 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 605 YVPPEYVKKGIYSMKYDVYSFGVLLLQIISSK 636
Y PE + + D++S L+ ++I+
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1nara_ c.1.8.5 (A:) Seed storage protein {Vicia narbonensis, Narbonin [TaxId: 3912]} Length = 289 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Seed storage protein species: Vicia narbonensis, Narbonin [TaxId: 3912]
Score = 91.3 bits (226), Expect = 7e-21
Identities = 41/296 (13%), Positives = 87/296 (29%), Gaps = 38/296 (12%)
Query: 32 YWLA-GREFPLSDI------NSALFTHLICAFAEVD-----SSTYQLSISSANQQYFSIF 79
Y L D L H I FA T S + +
Sbjct: 8 YIGVKPNSTTLHDFPTEIINTETLEFHYILGFAIESYYESGKGTGTFEESWDVELFGPEK 67
Query: 80 ANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTA 139
+++R++P +K ++SI +T P+ + V ++ I
Sbjct: 68 VKNLKRRHPEVKVVISIGGRGVNTPFD--------PAEENVWVSNAKESLKLIIQKYSDD 119
Query: 140 RLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPID 199
GID+ + S + L+ + +L +++ +P+ S+
Sbjct: 120 SGNLIDGIDIHYEHIRSDE--PFATLMGQLITELKKDDDLNINVVS-IAPSENNSSHYQK 176
Query: 200 SMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLG 259
++ + V Y + ++ V+ A + I + L + + +K++ G
Sbjct: 177 LYNAKKDYINWVDYQFSN-QQKPVSTDDAFVE-----------IFKSLEKDYHPHKVLPG 224
Query: 260 ARASGPGITIDGSMGYKFIRA--FIQNYG-YGAAPVYNASYVVNLFTSGATWINFD 312
+ FI + +NA+ V G +
Sbjct: 225 FSTDPLDTKHNKITRDIFIGGCTRLVQTFSLPGVFFWNANDSVIPKRDGDKPFIVE 280
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.9 bits (217), Expect = 1e-20
Identities = 33/198 (16%), Positives = 63/198 (31%), Gaps = 33/198 (16%)
Query: 441 NKLGEGGFGPVYKGNLPRGQEFAVKRLSATST----------QGLEEFKNEVSLTARLQH 490
+GEG V+ + E VK T G F +AR +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 491 VNLLRVLGYCTER----DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQG 546
L ++ G + + N ++ E + R ++ +++ + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMEL--------IDAKELYRVRVENPDE--VLDMILEE 115
Query: 547 LLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYV 606
+ ++H DL N+L+ E I DF + +V E I+
Sbjct: 116 VAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQS----VEVGEEGWREILERDVRN 167
Query: 607 PPEYVKKGIYSMKYDVYS 624
Y + Y + D+ S
Sbjct: 168 IITYFSRT-YRTEKDINS 184
|
| >d2ebna_ c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Flavobacterium meningosepticum, endoglycosidase F1 [TaxId: 238]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Endo-beta-N-acetylglucosaminidase species: Flavobacterium meningosepticum, endoglycosidase F1 [TaxId: 238]
Score = 85.6 bits (211), Expect = 7e-19
Identities = 35/283 (12%), Positives = 78/283 (27%), Gaps = 33/283 (11%)
Query: 38 EFPLSDINSALFTHLICAFAEV--DSSTYQLSISSANQQYFSI--FANSVRR-KNPSIKT 92
F L + L ++ A + D++ ++ +S+ + A ++ ++ IK
Sbjct: 24 NFTLKNSGKPLVDMVVLFSANINYDAANDKVFVSNNPNVQHLLTNRAKYLKPLQDKGIKV 83
Query: 93 LLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWL 152
+LSI + + + L ++ K+F + T LY G+
Sbjct: 84 ILSILGNHDRSGIANL---------------STARAKAFAQELKNTCDLYNLDGVFFDDE 128
Query: 153 WPNSTDLNSLGILLDEW-------KASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNL 205
+ G + + P +++ V + +
Sbjct: 129 YSAYQTPPPSGFVTPSNNAAARLAYETKQAMPNKLVTVYVYSRTSSFPTAV---DGVNAG 185
Query: 206 NWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGARASGP 265
++ +DY S + T + S +F + N + G
Sbjct: 186 SYVDYAIHDYG-GSYDLATNYPGLAKSGMVMSSQEFNQGRYATAQALRNIVTKGYGGHMI 244
Query: 266 GITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATW 308
F + A +Y V + W
Sbjct: 245 FAMDPN--RSNFTSGQLPALKLIAKELYGDELVYSNTPYSKDW 285
|
| >d1edta_ c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Streptomyces plicatus, endoglycosidase H [TaxId: 1922]} Length = 265 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Endo-beta-N-acetylglucosaminidase species: Streptomyces plicatus, endoglycosidase H [TaxId: 1922]
Score = 74.7 bits (183), Expect = 2e-15
Identities = 32/240 (13%), Positives = 61/240 (25%), Gaps = 35/240 (14%)
Query: 32 YWLAGREFPLSDINSALFTHLICAFAEV--DSSTYQLSISSANQQYFSI--FANSVRR-K 86
L ++ L+D F + A + D+ T + + +R +
Sbjct: 16 SMLNVGKYTLADGGGNAFDVAVIFAANINYDTGTKTAYLHFNENVQRVLDNAVTQIRPLQ 75
Query: 87 NPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQG 146
IK LLS+ + +F + YG G
Sbjct: 76 QQGIKVLLSVLGNHQGAG--------------FANFPSQQAASAFAKQLSDAVAKYGLDG 121
Query: 147 IDLFWLWP-------NSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPID 199
+D + + +S L+ +A+ D +S+ P +SY
Sbjct: 122 VDFDDEYAEYGNNGTAQPNDSSFVHLVTALRANMPD---KIISLYN-IGPAASRLSYGGV 177
Query: 200 SMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLG 259
+ ++ Y+ V GI S + G
Sbjct: 178 DVSDKFDY---AWNPYYGTW--QVPGIALPKAQLSPAAVEIGRTSRSTVADLARRTVDEG 232
|
| >d2hvma_ c.1.8.5 (A:) Hevamine A (chitinase/lysozyme) {Para rubber tree (Hevea brasiliensis) [TaxId: 3981]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Hevamine A (chitinase/lysozyme) species: Para rubber tree (Hevea brasiliensis) [TaxId: 3981]
Score = 73.6 bits (180), Expect = 6e-15
Identities = 42/280 (15%), Positives = 86/280 (30%), Gaps = 36/280 (12%)
Query: 30 AGYWLA-GREFPLSD-INSALFTHLICAFAEVDSS--TYQLSISSANQQYFS----IFAN 81
A YW G E L+ ++ ++++ AF + T Q++++ +
Sbjct: 4 AIYWGQNGNEGTLTQTCSTRKYSYVNIAFLNKFGNGQTPQINLAGHCNPAAGGCTIVSNG 63
Query: 82 SVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARL 141
+ IK +LS+ G S + + + ++ + +SS R
Sbjct: 64 IRSCQIQGIKVMLSLGGGIGSYTLA-------SQADAKNVADYLWNNFLGGKSSSRPLGD 116
Query: 142 YGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSM 201
GID ++ + L L + S Q + A P +
Sbjct: 117 AVLDGIDFDIEHGSTLYWDDLARYLS----AYSKQGKKVYLTAAPQCPFPDR-YLGTALN 171
Query: 202 KKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLG-- 259
++ + Y+ S NI+ A K+ LG
Sbjct: 172 TGLFDYVWVQFYNNPPC------------QYSSGNINNIINSWNRWTTSINAGKIFLGLP 219
Query: 260 --ARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASY 297
A+G G + + + ++ YG +++ Y
Sbjct: 220 AAPEAAGSGYVPPDVLISRILPEIKKSPKYGGVMLWSKFY 259
|
| >d1ta3a_ c.1.8.5 (A:) Xylanase inhibitor protein I, XIP-I {Wheat (Triticum aestivum) [TaxId: 4565]} Length = 274 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Xylanase inhibitor protein I, XIP-I species: Wheat (Triticum aestivum) [TaxId: 4565]
Score = 63.2 bits (153), Expect = 2e-11
Identities = 35/272 (12%), Positives = 73/272 (26%), Gaps = 24/272 (8%)
Query: 30 AGYW-LAGREFPLSD-INSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKN 87
+W E L + +S ++T + +F +V + + + + S+ A+ ++
Sbjct: 9 TVFWGRNKAEGSLREACDSGMYTMVTMSFLDVFGANGKYHLDLSGHDLSSVGADIKHCQS 68
Query: 88 PSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGI 147
+ LSI + L +S+ S R G+
Sbjct: 69 KGVPVSLSIGGYGTGYSLPSNRSALDLFDHL-----WNSYFGGSKPSVPRPFGDAWLDGV 123
Query: 148 DLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNW 207
DLF D + L + A
Sbjct: 124 DLFLEHGTPADRYDVLALELAKHNIRGGPGKPLHLTATVRCGYPPAAHVGRALATGIFER 183
Query: 208 AHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGARASGPGI 267
H+ Y+ +N G + ++ +PA + +G A
Sbjct: 184 VHVRTYESDKWCNQN-LGWEGSWDKWTA--------------AYPATRFYVGLTADDKSH 228
Query: 268 T-IDGSMGYKFIRAFIQNYG-YGAAPVYNASY 297
+ Y + Q YG +++ +
Sbjct: 229 QWVHPKNVYYGVAPVAQKKDNYGGIMLWDRYF 260
|
| >d1eoka_ c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Flavobacterium meningosepticum, endoglycosidase F3 [TaxId: 238]} Length = 282 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Endo-beta-N-acetylglucosaminidase species: Flavobacterium meningosepticum, endoglycosidase F3 [TaxId: 238]
Score = 49.1 bits (116), Expect = 9e-07
Identities = 36/276 (13%), Positives = 65/276 (23%), Gaps = 28/276 (10%)
Query: 33 WLAGREFPLSDINSA--LFTHLICAFAEVDSSTYQLSISSANQQYFS--IFANSVRR-KN 87
F L DI + + + +T + + S +R ++
Sbjct: 11 DGRNPTFKLKDIPDKVDMVILFGLKYWSLQDTTKLPGGTGMMGSFKSYKDLDTQIRSLQS 70
Query: 88 PSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGI 147
IK L +I S S G +S + GI
Sbjct: 71 RGIKVLQNID-DDVSWQSSKPGG-------------FASAAAYGDAIKSIVIDKWKLDGI 116
Query: 148 DLFWLWPNSTDLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNW 207
L + + + E Y + N
Sbjct: 117 SLDIEHSGAKPNPIPTFPGYAATGYNGWYSGSMAATPAFLNVISELTKYFGTTAPNNKQL 176
Query: 208 AHLVAYDYHMPSKE------NVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVLGAR 261
D + +K N I Y + + + PA+K+V GA
Sbjct: 177 QIASGIDVYAWNKIMENFRNNFNYIQLQSYGANVSRTQLMMNYATGTNKIPASKMVFGAY 236
Query: 262 ASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASY 297
A G + + + + G +Y +
Sbjct: 237 AEGG---TNQANDVEVAKWTPTQGAKGGMMIYTYNS 269
|
| >d1vf8a2 d.26.3.1 (A:246-315) Chitinase-like lectin ym1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 70 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Chitinase-like lectin ym1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 35.6 bits (82), Expect = 0.002
Identities = 13/59 (22%), Positives = 21/59 (35%), Gaps = 8/59 (13%)
Query: 258 LGARASGPGI-----TIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINF 311
+GA G G + Y + F+ GA V++A V G W+ +
Sbjct: 15 IGAPTISTGPPGKYTDESGLLAYYEVCTFLNE---GATEVWDAPQEVPYAYQGNEWVGY 70
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 755 | |||
| d1itxa1 | 347 | Chitinase A1 {Bacillus circulans [TaxId: 1397]} | 100.0 | |
| d1kfwa1 | 374 | Psychrophilic chitinase B {Arthrobacter sp., tad20 | 100.0 | |
| d2pi6a1 | 292 | Signal processing protein (SPC-40, MGP-40) {Sheep | 100.0 | |
| d1edqa2 | 358 | Chitinase A, catalytic domain {Serratia marcescens | 100.0 | |
| d1w9pa1 | 333 | Chitinase 1 {Aspergillus fumigatus [TaxId: 5085]} | 100.0 | |
| d1wb0a1 | 297 | Chitotriosidase {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1jnda1 | 327 | Imaginal disc growth factor-2 {Fruit fly (Drosophi | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1vf8a1 | 302 | Chitinase-like lectin ym1, saccharide binding doma | 100.0 | |
| d1ll7a1 | 330 | Chitinase 1 {Fungus (Coccidioides immitis) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1goia2 | 356 | Chitinase B, catalytic domain {Serratia marcescens | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1nara_ | 289 | Seed storage protein {Vicia narbonensis, Narbonin | 99.96 | |
| d2hvma_ | 273 | Hevamine A (chitinase/lysozyme) {Para rubber tree | 99.94 | |
| d2ebna_ | 285 | Endo-beta-N-acetylglucosaminidase {Flavobacterium | 99.93 | |
| d1edta_ | 265 | Endo-beta-N-acetylglucosaminidase {Streptomyces pl | 99.92 | |
| d1ta3a_ | 274 | Xylanase inhibitor protein I, XIP-I {Wheat (Tritic | 99.89 | |
| d1cnva_ | 283 | Seed storage protein {Jack bean (Canavalia ensifor | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1eoka_ | 282 | Endo-beta-N-acetylglucosaminidase {Flavobacterium | 99.74 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.38 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.76 | |
| d1vf8a2 | 70 | Chitinase-like lectin ym1 {Mouse (Mus musculus) [T | 97.51 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.08 | |
| d2pi6a2 | 68 | Signal processing protein (SPC-40, MGP-40) {Sheep | 97.06 | |
| d1wb0a2 | 68 | Chitotriosidase {Human (Homo sapiens) [TaxId: 9606 | 96.62 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.24 | |
| d1edqa3 | 73 | Chitinase A {Serratia marcescens [TaxId: 615]} | 96.0 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.86 | |
| d1itxa2 | 72 | Chitinase A1 {Bacillus circulans [TaxId: 1397]} | 95.83 | |
| d1kfwa2 | 61 | Psychrophilic chitinase B {Arthrobacter sp., tad20 | 95.39 | |
| d1jnda2 | 92 | Imaginal disc growth factor-2 {Fruit fly (Drosophi | 95.27 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.95 | |
| d2bhua3 | 420 | Glycosyltrehalose trehalohydrolase, central domain | 87.56 | |
| d2nt0a2 | 354 | Glucosylceramidase, catalytic domain {Human (Homo | 80.15 |
| >d1itxa1 c.1.8.5 (A:33-337,A:410-451) Chitinase A1 {Bacillus circulans [TaxId: 1397]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase A1 species: Bacillus circulans [TaxId: 1397]
Probab=100.00 E-value=6.5e-52 Score=440.60 Aligned_cols=264 Identities=25% Similarity=0.419 Sum_probs=220.0
Q ss_pred hccCCcceEEEEEecCC----CCCCCCCCCCCCcceEEEEEEEecCCCcEEecCC-------------------------
Q 004402 20 EFSDAQTWIKAGYWLAG----REFPLSDINSALFTHLICAFAEVDSSTYQLSISS------------------------- 70 (755)
Q Consensus 20 ~~~~~~~~~~~gY~~~~----~~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~------------------------- 70 (755)
+...+.+++|+|||..| +.|.+++||+++||||+|||+.++.++.....+.
T Consensus 5 ~~~a~~~~rvv~Yy~~W~~y~~~~~~~~i~~~~~THi~yaF~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (347)
T d1itxa1 5 TAEAADSYKIVGYYPSWAAYGRNYNVADIDPTKVTHINYAFADICWNGIHGNPDPSGPNPVTWTCQNEKSQTINVPNGTI 84 (347)
T ss_dssp CCCGGGGCEEEEEEEGGGGTTTCCCGGGCCGGGCSEEEEEEEEECBTTEEEECCTTSSCCEEEECBCTTSCBCCCCTTCE
T ss_pred CCCCCCCCEEEEEECcccccCCCCChhHCCHhhCCeEEEeeEeecCCcccccCcccccccccccccccccccccCCCceE
Confidence 34456689999998775 3488999999999999999999976543222111
Q ss_pred --------------------chhhHHHHHHHHHHhhCCCceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHH
Q 004402 71 --------------------ANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKS 130 (755)
Q Consensus 71 --------------------~~~~~~~~~~~~~k~~~~~lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~ 130 (755)
.....+.++ ..+|++||++||+||||||+ . +..|+.+++|++.|++
T Consensus 85 ~~~d~~~d~~~~~~~~~~~~~~~g~~~~~-~~lK~~~p~lKvllSiGGw~------------~-s~~Fs~~~~~~~~R~~ 150 (347)
T d1itxa1 85 VLGDPWIDTGKTFAGDTWDQPIAGNINQL-NKLKQTNPNLKTIISVGGWT------------W-SNRFSDVAATAATREV 150 (347)
T ss_dssp EESSHHHHHTSCCTTCCSSSSCCHHHHHH-HHHHHHSTTCEEEEEEECSS------------S-CTTHHHHHTSHHHHHH
T ss_pred EecCchhhhccccccccccccchhHHHHH-HHHHHhCCCCEEEEEEcCCC------------C-CcchhhhhcCHHHHHH
Confidence 111245555 67999999999999995544 3 2349999999999999
Q ss_pred HHHHHHHHHHHcCCCcccccccCCC----------CCCcccHHHHHHHHHHHccC-----CCccEEEeeeecCCcccccc
Q 004402 131 FIESSIRTARLYGFQGIDLFWLWPN----------STDLNSLGILLDEWKASASD-----QPELTLSMAVRYSPTHETVS 195 (755)
Q Consensus 131 fi~~i~~~~~~~~~DGvdiDwe~p~----------~~~~~~~~~~l~~lr~~l~~-----~~~~~ls~~~~~~~~~~~~~ 195 (755)
||+++++|+++|||||||||||||. ++++++|+.|+++||++|+. .+.+++|+++|+..... ..
T Consensus 151 Fi~siv~~l~~~~fDGIDiDWE~P~~~g~~~~~~~~~d~~nf~~ll~eLr~~l~~~~~~~~~~~~ls~a~~~~~~~~-~~ 229 (347)
T d1itxa1 151 FANSAVDFLRKYNFDGVDLDWEYPVSGGLDGNSKRPEDKQNYTLLLSKIREKLDAAGAVDGKKYLLTIASGASATYA-AN 229 (347)
T ss_dssp HHHHHHHHHHHHTCSEEEEECSCSSSCSCTTSCCCTTHHHHHHHHHHHHHHHHHHHHHHHTSCCEEEEEECCSHHHH-HT
T ss_pred HHHHHHHHHHHhCCCcEEEecccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHHhhhhcCCccceeecccchhhhh-hh
Confidence 9999999999999999999999983 35688999999999999863 34689999999876544 44
Q ss_pred cCcchhcccCChhhhhhhhccCCCCCcccccCCCCCC----------CCCCCcHHHHHHHHHHCCCCCCceeecccccCC
Q 004402 196 YPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYN----------PSSNISTDFGIREWLRRGFPANKLVLGARASGP 265 (755)
Q Consensus 196 ~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~----------~~~~~~~~~~v~~~~~~g~p~~KlvlG~p~yG~ 265 (755)
|++++++++||||||||||||| .|.+.+||+|||+. ....++++.+|+.|+++|+|++|||||+|
T Consensus 230 ~d~~~i~~~vD~vnvMtYD~~g-~w~~~~g~~apL~~~~~~~~~~~~~~~~~~v~~~v~~~~~~G~p~~KlvlGip---- 304 (347)
T d1itxa1 230 TELAKIAAIVDWINIMTYDFNG-AWQKISAHNAPLNYDPAASAAGVPDANTFNVAAGAQGHLDAGVPAAKLVLGVP---- 304 (347)
T ss_dssp SCHHHHHHHSSEEEECCCCSSC-TTSSBCCCSSCSSCCHHHHHTTCTTTTTCSHHHHHHHHHHHTCCGGGEEEEEE----
T ss_pred ccHHHHhhccCEEEeeeccccC-CCCCcccccCCCcCCcccccccCCCCCceeHHHHHHHHHHCCCCHHHeEEEec----
Confidence 9999999999999999999994 57778999999974 23457899999999999999999999987
Q ss_pred CcccCCCcchHHHHHHHhhcCCCcccccccceeeeeeecCcEEEeeCCcchhhhhhhcccccCccccccccccccchhhh
Q 004402 266 GITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWAL 345 (755)
Q Consensus 266 ~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~dd~~~~ 345 (755)
|||++|++.|++|++++||||+|+|++++|++..+
T Consensus 305 ---------------------------------------------fd~~~si~~K~~y~k~~~LgGvmiW~l~~Dd~~~L 339 (347)
T d1itxa1 305 ---------------------------------------------FDDAESVGYKTAYIKSKGLGGAMFWELSGDRNKTL 339 (347)
T ss_dssp ---------------------------------------------SCCHHHHHHHHHHHHHHTCCEEEEECGGGCTTCHH
T ss_pred ---------------------------------------------cCCHHHHHHHHHHHHhCCCCEEEEEEecCCCCcHH
Confidence 69999999999999999999999999999987655
Q ss_pred hhh
Q 004402 346 SRA 348 (755)
Q Consensus 346 ~~~ 348 (755)
..+
T Consensus 340 ~~a 342 (347)
T d1itxa1 340 QNK 342 (347)
T ss_dssp HHH
T ss_pred HHH
Confidence 444
|
| >d1kfwa1 c.1.8.5 (A:10-327,A:389-444) Psychrophilic chitinase B {Arthrobacter sp., tad20 [TaxId: 1667]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Psychrophilic chitinase B species: Arthrobacter sp., tad20 [TaxId: 1667]
Probab=100.00 E-value=1.8e-51 Score=437.76 Aligned_cols=266 Identities=24% Similarity=0.362 Sum_probs=219.7
Q ss_pred cCCcceEEEEEecCCCC----CC----CCCCCCCCcceEEEEEEEecCCCcEEecC------------------------
Q 004402 22 SDAQTWIKAGYWLAGRE----FP----LSDINSALFTHLICAFAEVDSSTYQLSIS------------------------ 69 (755)
Q Consensus 22 ~~~~~~~~~gY~~~~~~----~~----~~~i~~~~~thi~~~f~~~~~~~~~~~~~------------------------ 69 (755)
+...+++++|||.+|.. +. +.++++++||||+|||+.|++++..+...
T Consensus 4 ~~~~g~rvvgYy~~W~~y~r~~~~~~l~~~i~~~~lTHi~YAFa~i~~~~~~~~~~~~~~~~~~~g~~~~~d~~~d~~~~ 83 (374)
T d1kfwa1 4 STVNGYRNVGYFAQWGVYGRAFQAKQLDVSGTAKNLTHINYSFGNINNQTLTCFMANKAQGTGPNGSDGAGDAWADFGMG 83 (374)
T ss_dssp SSBTTBEEEEEEEGGGGSTTCCCHHHHHHTSCGGGCSEEEEEEECBCTTTCSBCCCEECCCSSTTTTTTCEEHHHHHTCC
T ss_pred CCCCCCEEEEEECcceecCCCCChhhCcCCCChhhCCEEEEeeeeecCCcceeeccccccccCCCCccccCcchhhhccc
Confidence 44568899999887643 33 46788899999999999999866443221
Q ss_pred ---------------CchhhHHHHHHHHHHhhCCCceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHH
Q 004402 70 ---------------SANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIES 134 (755)
Q Consensus 70 ---------------~~~~~~~~~~~~~~k~~~~~lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~ 134 (755)
......+.++ .++|++||++|++||||||+ .+ ..|+.+++|++.|++||++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~l-~~lK~~~p~lKvllSiGGw~------------~s-~~F~~~a~~~~~R~~Fi~s 149 (374)
T d1kfwa1 84 YAADKSVSGKADTWDQPLAGSFNQL-KQLKAKNPKLKVMISLGGWT------------WS-KNFSKAAATEASRQKLVSS 149 (374)
T ss_dssp CCTTTSSSSSCCCTTCSCCHHHHHH-HHHHTTCTTCEEEEEEECSS------------SC-TTHHHHTSSHHHHHHHHHH
T ss_pred cccccccccccccccccchhhHHHH-HHHHhhCCCCeEEEEEeCCC------------CC-CccchhhcCHHHHHHHHHH
Confidence 1122345555 77999999999999995554 32 2399999999999999999
Q ss_pred HHHHHHHcC----------------CCcccccccCCC------------CCCcccHHHHHHHHHHHccC-----CCccEE
Q 004402 135 SIRTARLYG----------------FQGIDLFWLWPN------------STDLNSLGILLDEWKASASD-----QPELTL 181 (755)
Q Consensus 135 i~~~~~~~~----------------~DGvdiDwe~p~------------~~~~~~~~~~l~~lr~~l~~-----~~~~~l 181 (755)
+++|+++|+ |||||||||||. ++|+++|+.||++||++|+. ++.++|
T Consensus 150 ~v~~~~~~~l~~~~~~~~~~~~~~~FDGiDiDWEyP~~~~~~~~~~~~~~~D~~nf~~Ll~eLR~~ld~~~~~~~k~~~L 229 (374)
T d1kfwa1 150 CIDLYIKGNLPNFEGRGGAGAAAGIFDGIDIDWEWPGTNSGLAGNGVDTVNDRANFKALLAEFRKQLDAYGSTNNKKYVL 229 (374)
T ss_dssp HHHHHTSCCEEEETTEEETTTTTTTCCEEEEECSCTTSSCSSTTCCCCTTTHHHHHHHHHHHHHHHHHHHHHHTTCCCEE
T ss_pred HHHHHHHcCCcccccccccccccccccccceeeeecccccCCCCCCCCChhHHHHHHHHHHHHHHHHHHHhcccCceEEE
Confidence 999999999 799999999994 35688999999999999843 457999
Q ss_pred EeeeecCCcccc-cccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCC-------CCcHHHHHHHHHHCCCCC
Q 004402 182 SMAVRYSPTHET-VSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSS-------NISTDFGIREWLRRGFPA 253 (755)
Q Consensus 182 s~~~~~~~~~~~-~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~-------~~~~~~~v~~~~~~g~p~ 253 (755)
|++++..+.... .+|+.+++.++|||+|||||||||+|....+||+||||.... .++++.+|++|++.|+|+
T Consensus 230 s~A~~~~~~~~~~~~~d~~~i~~~vD~invMtYD~~G~w~~~~tg~~apLy~~~~~~~~~~~~~svd~aV~~~~~~Gvp~ 309 (374)
T d1kfwa1 230 SAFLPANPADIDAGGWDDPANFKSLDFGSIQGYDLHGAWNPTLTGHQANLYDDPADPRAPSKKFSADKAVKKYLAAGIDP 309 (374)
T ss_dssp EEEECSSHHHHHHHTTTCGGGGGTCSEEEECCSCSSCTTSTTBCCCSSCSSCCTTCCSCGGGCCCHHHHHHHHHHTTCCG
T ss_pred EEEeccccccccccCcchhhhhceeEEEEEEecccccCCCCCCCCccCcCCCCCCCCCCCCCCeeHHHHHHHHHHCCCCH
Confidence 999998765543 358999999999999999999998766667999999996442 358999999999999999
Q ss_pred CceeecccccCCCcccCCCcchHHHHHHHhhcCCCcccccccceeeeeeecCcEEEeeCCcchhhhhhhcccccCccccc
Q 004402 254 NKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYK 333 (755)
Q Consensus 254 ~KlvlG~p~yG~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~yd~~~S~~~K~~~a~~~~l~Gi~ 333 (755)
+||+|||| ||+++|+++|++||+++||||+|
T Consensus 310 ~KlvlGip-------------------------------------------------yd~~~si~~K~~y~~~~glgG~m 340 (374)
T d1kfwa1 310 KQLGLGLA-------------------------------------------------ADNIATTKQKTDYIVSKGLGGGM 340 (374)
T ss_dssp GGEEEEEE-------------------------------------------------SCCHHHHHHHHHHHHHTTCCEEE
T ss_pred HHeEEEec-------------------------------------------------CCCHHHHHHHHHHHHhcCCceEE
Confidence 99999987 67889999999999999999999
Q ss_pred cccccccchhhhhhhhh
Q 004402 334 AFQLSNDDNWALSRAAQ 350 (755)
Q Consensus 334 ~W~l~~dd~~~~~~~~~ 350 (755)
+|++++|++..+..+..
T Consensus 341 ~W~~~~D~~g~Ll~a~~ 357 (374)
T d1kfwa1 341 WWELSGDRNGELVGAMS 357 (374)
T ss_dssp EECGGGCTTCHHHHHHH
T ss_pred EEEccCCCCCcHHHHHH
Confidence 99999998665555443
|
| >d2pi6a1 c.1.8.5 (A:1-239,A:308-361) Signal processing protein (SPC-40, MGP-40) {Sheep (Ovis aries) [TaxId: 9940]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Signal processing protein (SPC-40, MGP-40) species: Sheep (Ovis aries) [TaxId: 9940]
Probab=100.00 E-value=3.8e-51 Score=426.03 Aligned_cols=254 Identities=30% Similarity=0.485 Sum_probs=220.1
Q ss_pred eEEEEEecCCC-------CCCCCCCCCCCcceEEEEEEEecCCCcEEecCCchhhHHHHHHHHHHhhCCCceEEEEecCC
Q 004402 27 WIKAGYWLAGR-------EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNG 99 (755)
Q Consensus 27 ~~~~gY~~~~~-------~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg~ 99 (755)
++|+|||..|. .|.+++||+++||||+|+|+.+++++... ........+.. +.++|++||++|+++||
T Consensus 1 ~kvv~Yy~~w~~~r~~~~~~~~~~i~~~~~THiiyafa~i~~~~~~~-~~~~~~~~~~~-~~~lk~~~~~lKvllSv--- 75 (292)
T d2pi6a1 1 YKLICYYTSWSQYREGDGSCFPDAIDPFLCTHVIYTFANISNNEIDT-WEWNDVTLYDT-LNTLKNRNPKLKTLLSV--- 75 (292)
T ss_dssp CEEEEEEEGGGGGSSGGGCCCGGGSCTTTCSEEEEEEEEEETTEEEC-CSTTHHHHHHH-HHHHHHHCTTCEEEEEE---
T ss_pred CeEEEEEccccccCCCCCCCChhHCCcccCCEEEEEEEEecCCCcee-cccccHHHHHH-HHHHHhhCCCceEEEEE---
Confidence 46889987652 36899999999999999999999765433 22233334444 47899999999999999
Q ss_pred CCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCCCcccHHHHHHHHHHHcc-----
Q 004402 100 QNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASAS----- 174 (755)
Q Consensus 100 ~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~~~~~~~~~l~~lr~~l~----- 174 (755)
|||+.++..|+.+++|++.|++||+++++++++|||||||||||+|...++.+|+.|+++||++|.
T Consensus 76 ---------GG~~~~~~~fs~~~~~~~~r~~fi~si~~~l~~~~fDGiDiDwE~p~~~~~~~~~~l~~~lr~~l~~~~~~ 146 (292)
T d2pi6a1 76 ---------GGWNFGPERFSKIASKTQSRRTFIKSVPPFLRTHGFDGLDLAWLYPGRRDKRHLTTLVKEMKAEFIREAQA 146 (292)
T ss_dssp ---------ETTTSCHHHHHHHHTSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCGGGHHHHHHHHHHHHHHHHHHHTT
T ss_pred ---------eccccCchHHHHHhccHHHHHHHHHHHHHHHHhcCCCeEEEeccccccccccccchhHHHHHHHHHHHHhc
Confidence 666666677999999999999999999999999999999999999999999999999999999983
Q ss_pred CCCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCC-----CCcHHHHHHHHHHC
Q 004402 175 DQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSS-----NISTDFGIREWLRR 249 (755)
Q Consensus 175 ~~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~-----~~~~~~~v~~~~~~ 249 (755)
..+.+.++++++..+.....+|+++++.++|||||||+||+|| .|.+.+|++||||.... ..+++.+|++|++.
T Consensus 147 ~~~~~~~s~~~~~~~~~~~~~~~~~~l~~~vD~invMtYD~~g-~~~~~~g~~apL~~~~~~~~~~~~~v~~~v~~~~~~ 225 (292)
T d2pi6a1 147 GTEQLLLSAAVSAGKIAIDRGYDIAQISRHLDFISLLTYDFHG-AWRQTVGHHSPLFRGNEDASSRFSNADYAVSYMLRL 225 (292)
T ss_dssp SSCCCEEEEEEECCHHHHHHHCCHHHHHHHCSEEEEETTCCSC-TTCCBCCCSSCSSCCSSSCSCTTSSHHHHHHHHHHT
T ss_pred cCCCcceecccCchhhHHhccccHHHHHhhCCEEEEecccccC-CCCCccccCCCCCCCCcccCcCCccHHHHHHHHHHC
Confidence 2346899999998887777779999999999999999999995 56778999999985442 35799999999999
Q ss_pred CCCCCceeecccccCCCcccCCCcchHHHHHHHhhcCCCcccccccceeeeeeecCcEEEeeCCcchhhhhhhcccccCc
Q 004402 250 GFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNL 329 (755)
Q Consensus 250 g~p~~KlvlG~p~yG~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~yd~~~S~~~K~~~a~~~~l 329 (755)
|+|++||+|||| |||++|++.|++|++++||
T Consensus 226 Gvp~~KlvlGip-------------------------------------------------ydd~~Si~~K~~~~~~~~l 256 (292)
T d2pi6a1 226 GAPANKLVMGIP-------------------------------------------------TDDQESVKNKARYLKNRQL 256 (292)
T ss_dssp TCCGGGEEEEEE-------------------------------------------------SCCHHHHHHHHHHHHHTTC
T ss_pred CCCHHHeEEEec-------------------------------------------------CCCHHHHHHHHHHHHHCCC
Confidence 999999999987 6899999999999999999
Q ss_pred cccccccccccchhh
Q 004402 330 LGYKAFQLSNDDNWA 344 (755)
Q Consensus 330 ~Gi~~W~l~~dd~~~ 344 (755)
||+|+|++++||..+
T Consensus 257 gGv~iW~l~~DD~~G 271 (292)
T d2pi6a1 257 AGAMVWALDLDDFRG 271 (292)
T ss_dssp SEEEEECGGGSCSSS
T ss_pred ceEEEEecccccCCC
Confidence 999999999998655
|
| >d1edqa2 c.1.8.5 (A:133-443,A:517-563) Chitinase A, catalytic domain {Serratia marcescens [TaxId: 615]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase A, catalytic domain species: Serratia marcescens [TaxId: 615]
Probab=100.00 E-value=7.2e-51 Score=431.16 Aligned_cols=253 Identities=21% Similarity=0.351 Sum_probs=212.9
Q ss_pred cceEEEEEecCC----CCCCCCCCCCCCcceEEEEEEEecCCCcEE-------------------------ec-------
Q 004402 25 QTWIKAGYWLAG----REFPLSDINSALFTHLICAFAEVDSSTYQL-------------------------SI------- 68 (755)
Q Consensus 25 ~~~~~~gY~~~~----~~~~~~~i~~~~~thi~~~f~~~~~~~~~~-------------------------~~------- 68 (755)
.+++|+|||..| +.|.+++||+++||||+|||+.+++++... ..
T Consensus 24 ~~~~v~~Yy~~W~~y~~~~~~~~I~~~~~THi~YAFa~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 103 (358)
T d1edqa2 24 SGKVVGSYFVEWGVYGRNFTVDKIPAQNLTHLLYGFIPICGGNGINDSLKEIEGSFQALQRSCQGREDFKVSIHDPFAAL 103 (358)
T ss_dssp SSCEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEECBCCCTTTSGGGGGSTTHHHHHHHHTTTCCTTSBCCSCHHHHH
T ss_pred CCCEEEEEeCcccccCCCCChhhCCHhHCCeEEEeeEEecCCCCcccccccccccccccccccccCCCcceeecCchhhh
Confidence 478999998776 468999999999999999999998765321 10
Q ss_pred ----------CCchhhHHHHHHHHHHhhCCCceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHH
Q 004402 69 ----------SSANQQYFSIFANSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRT 138 (755)
Q Consensus 69 ----------~~~~~~~~~~~~~~~k~~~~~lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~ 138 (755)
++.....+.++ .++|++||++|||||||||+. +.. |. +++|++.|++||+++++|
T Consensus 104 ~~~~~~~~~~~~~~~g~~~~~-~~LK~~~p~lKvllSiGGw~~------------s~~-~~-~~a~~~~R~~Fi~svv~~ 168 (358)
T d1edqa2 104 QKAQKGVTAWDDPYKGNFGQL-MALKQAHPDLKILPSIGGWTL------------SDP-FF-FMGDKVKRDRFVGSVKEF 168 (358)
T ss_dssp TSCBTTBCSTTCSSCHHHHHH-HHHHHHCTTCEEEEEEECSSS------------CGG-GG-GTTSHHHHHHHHHHHHHH
T ss_pred hccccCccccccccccHHHHH-HHHHHhCCCCeEEEEEECCCC------------CCC-cc-cccCHHHHHHHHHHHHHH
Confidence 11122346666 679999999999999966554 322 44 678999999999999999
Q ss_pred HHHcC-CCcccccccCCC----------CCCcccHHHHHHHHHHHccC-----CCccEEEeeeecCCcccccccCcchhc
Q 004402 139 ARLYG-FQGIDLFWLWPN----------STDLNSLGILLDEWKASASD-----QPELTLSMAVRYSPTHETVSYPIDSMK 202 (755)
Q Consensus 139 ~~~~~-~DGvdiDwe~p~----------~~~~~~~~~~l~~lr~~l~~-----~~~~~ls~~~~~~~~~~~~~~~~~~l~ 202 (755)
+++|| |||||||||||. ++|+++|+.||++||++|+. ++.+++++++++.+..... +++++++
T Consensus 169 l~~y~~fDGIDIDWEyP~~~g~~~~~~~~~D~~nf~~Ll~eLR~~l~~~~~~~~~~~~ls~a~~~~~~~~~~-~~~~~l~ 247 (358)
T d1edqa2 169 LQTWKFFDGVDIDWEFPGGKGANPNLGSPQDGETYVLLMKELRAMLDQLSVETGRKYELTSAISAGKDKIDK-VAYNVAQ 247 (358)
T ss_dssp HHHCTTCCEEEEECSCTTSCSSCTTCCCTTHHHHHHHHHHHHHHHHHHHHHHHTCCCEEEEEEECSHHHHTT-SCHHHHG
T ss_pred HHHhccCCcccceeeecccccCCCCCCCHHHHHHHHHHHHHHHHHHHHhhhhcCCccceeeeecCchhhhhh-hhHHHHh
Confidence 99999 999999999993 46789999999999999854 3578999999988766654 8999999
Q ss_pred ccCChhhhhhhhccCCCCCcccccCCCCCCCC----CCCcHHHHHHHHHHCCCCCCceeecccccCCCcccCCCcchHHH
Q 004402 203 KNLNWAHLVAYDYHMPSKENVTGIHAALYNPS----SNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFI 278 (755)
Q Consensus 203 ~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~----~~~~~~~~v~~~~~~g~p~~KlvlG~p~yG~~~~~~~~~~y~~~ 278 (755)
++|||||||||||||+|....+||+++|+++. ...+++.+|++|++.|+|++|||||+|+|||
T Consensus 248 ~~vD~inlMtYD~~G~w~~~~~g~~t~l~~~~~~~~~~~~v~~~v~~~~~~Gvp~~KlvlGip~YGR------------- 314 (358)
T d1edqa2 248 NSMDHIFLMSYDFYGAFDLKNLGHQTALNAPAWKPDTAYTTVNGVNALLAQGVKPGKIVVGTAMDAR------------- 314 (358)
T ss_dssp GGCSEEEEECCCSSCTTCSSSCCCSSCSSCCTTCTTCSCCHHHHHHHHHHHTCCGGGEEEEEESCHH-------------
T ss_pred hcCCEEEEeeccccCCCCCCCCCCCCCCCCCccCCCCcccHHHHHHHHHHCCCCHHHeEEEeCccHH-------------
Confidence 99999999999999877777799999987533 4468999999999999999999999999995
Q ss_pred HHHHhhcCCCcccccccceeeeeeecCcEEEeeCCcchhhhhhhcccccCccccccccccccchh
Q 004402 279 RAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNW 343 (755)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~dd~~ 343 (755)
|++.|.+|++++||||+|+|++++|+..
T Consensus 315 -------------------------------------s~~~K~~y~~~~~lgG~~~W~~~~D~g~ 342 (358)
T d1edqa2 315 -------------------------------------SVQAKGKYVLDKQLGGLFSWEIDADNGD 342 (358)
T ss_dssp -------------------------------------HHHHHHHHHHHHTCCEEEEECGGGCCSH
T ss_pred -------------------------------------HHHHHHHHHhcCCCceEEEEeccCCccH
Confidence 5588999999999999999999999744
|
| >d1w9pa1 c.1.8.5 (A:39-298,A:361-433) Chitinase 1 {Aspergillus fumigatus [TaxId: 5085]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase 1 species: Aspergillus fumigatus [TaxId: 5085]
Probab=100.00 E-value=7.8e-51 Score=429.36 Aligned_cols=253 Identities=25% Similarity=0.415 Sum_probs=216.5
Q ss_pred CcceEEEEEecCC----CCCCCCCCCCCCcceEEEEEEEecCCCcEEecCCchh-------------------hHHHHHH
Q 004402 24 AQTWIKAGYWLAG----REFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQ-------------------QYFSIFA 80 (755)
Q Consensus 24 ~~~~~~~gY~~~~----~~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~-------------------~~~~~~~ 80 (755)
+.+++|+|||..| +.|++++||+++||||+|||+.++++++.+...+... ..+..+
T Consensus 2 ~~g~kvv~Yy~~W~~y~~~~~~~~i~~~~~THI~yaFa~i~~~~g~~~~~d~~~d~~~~~~~~~~~~~~~~~~~~~~~~- 80 (333)
T d1w9pa1 2 SSGYRSVVYFVNWAIYGRNHNPQDLPVERLTHVLYAFANVRPETGEVYMTDSWADIEKHYPGDSWSDTGNNVYGCIKQL- 80 (333)
T ss_dssp BCCBEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEEEECTTTCCEEESCHHHHHTCCCTTCCSSCCSSCCCHHHHHH-
T ss_pred CCCCEEEEEECcccccCCCCChhHCCcccCCeEEEeeEEecCCCCeEEecChHHhhccccCCccccccccchhhHHHHH-
Confidence 4578999998765 3489999999999999999999998877766554322 123444
Q ss_pred HHHHhhCCCceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCC-CCc
Q 004402 81 NSVRRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-TDL 159 (755)
Q Consensus 81 ~~~k~~~~~lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~-~~~ 159 (755)
.++|++||++|++||||||+ . +..|+.+++|++.|++||+++++|+++|+|||||||||+|.. ++.
T Consensus 81 ~~lk~~~p~lKvllSiGGw~------------~-s~~f~~~~~~~~~R~~Fi~siv~~l~~y~fDGiDiDWE~p~~~~~~ 147 (333)
T d1w9pa1 81 YLLKKQNRNLKVLLSIGGWT------------Y-SPNFAPAASTDAGRKNFAKTAVKLLQDLGFDGLDIDWEYPENDQQA 147 (333)
T ss_dssp HHHHHHCTTCEEEEEEECTT------------T-GGGHHHHHTSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCSHHHH
T ss_pred HHHHhccCCceEEEEEeCCc------------C-CCcccccccCHHHHHHHHHHHHHHHHHhcCCceeeeeeeccccccc
Confidence 67999999999999995544 3 234999999999999999999999999999999999999966 567
Q ss_pred ccHHHHHHHHHHHccC-------CCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCC
Q 004402 160 NSLGILLDEWKASASD-------QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYN 232 (755)
Q Consensus 160 ~~~~~~l~~lr~~l~~-------~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~ 232 (755)
.+|+.|+++||++|+. ++.+.||+++|+.+..... ||+++++++|||||||||||| +.|++.+||+||||.
T Consensus 148 ~~~~~llkelr~~L~~~~~~~~~~~~~~ls~a~~~~~~~~~~-~d~~~i~~~vD~invMtYD~~-g~~~~~tg~~aply~ 225 (333)
T d1w9pa1 148 NDFVLLLKEVRTALDSYSAANAGGQHFLLTVASPAGPDKIKV-LHLKDMDQQLDFWNLMAYDYA-GSFSSLSGHQANVYN 225 (333)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHSTTCCCEEEEEECCSHHHHHH-SCHHHHHTTCSEEEECCCCCS-STTSSSCCCSSCSSC
T ss_pred chHHHHHHHHHHHHHhhhhhhccCCceEEEEEccCChhhhhc-cchHHHhhcCCeEEEeeeccC-CCCCCCCCCCccccC
Confidence 8999999999999842 3579999999988766554 999999999999999999999 557788999999996
Q ss_pred CC-----CCCcHHHHHHHHHHCCCCCCceeecccccCCCcccCCCcchHHHHHHHhhcCCCcccccccceeeeeeecCcE
Q 004402 233 PS-----SNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGAT 307 (755)
Q Consensus 233 ~~-----~~~~~~~~v~~~~~~g~p~~KlvlG~p~yG~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (755)
.. ..++++.+|++|++.|+|++|||||+|+||+
T Consensus 226 ~~~~~~~~~~nv~~av~~~~~~Gvp~~KlvlGiPfyg~------------------------------------------ 263 (333)
T d1w9pa1 226 DTSNPLSTPFNTQTALDLYRAGGVPANKIVLGMPLDNP------------------------------------------ 263 (333)
T ss_dssp CTTCGGGCSCCHHHHHHHHHHTTCCGGGEEEEEESCCH------------------------------------------
T ss_pred CCCCCccCCccHHHHHHHHHHCCCCHHHeEEEeCCCch------------------------------------------
Confidence 44 3468999999999999999999999999985
Q ss_pred EEeeCCcchhhhhhhcccccCccccccccccccc
Q 004402 308 WINFDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341 (755)
Q Consensus 308 ~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~dd 341 (755)
.+++.|+.|++++||||+|+|++++|.
T Consensus 264 -------~~~~~k~~y~~~~~lgG~m~We~~~D~ 290 (333)
T d1w9pa1 264 -------QVANLKSGYIKSLGLGGAMWWDSSSDK 290 (333)
T ss_dssp -------HHHHHHHHHHHHHTCCEEEEECGGGSC
T ss_pred -------HHHHHhHHHHHhCCCceEEEEeccCCC
Confidence 336669999999999999999999985
|
| >d1wb0a1 c.1.8.5 (A:22-266,A:337-388) Chitotriosidase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitotriosidase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=421.22 Aligned_cols=254 Identities=34% Similarity=0.566 Sum_probs=219.4
Q ss_pred EEEEEecCCC-------CCCCCCCCCCCcceEEEEEEEecCCCcEEecCCchhhHHHHHHHHHHhhCCCceEEEEecCCC
Q 004402 28 IKAGYWLAGR-------EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNGQ 100 (755)
Q Consensus 28 ~~~gY~~~~~-------~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg~~ 100 (755)
+|+|||..|. .|.+++||+++||||+|+|+.+++++. ......+..+...++++|++||++||+|||
T Consensus 2 kvvcYy~~w~~~~~~~~~~~~~~i~~~~~THi~yaf~~~~~~~~--~~~~~~~~~~~~~~~~lk~~~p~lKvllSi---- 75 (297)
T d1wb0a1 2 KLVCYFTNWAQYRQGEARFLPKDLDPSLCTHLIYAFAGMTNHQL--STTEWNDETLYQEFNGLKKMNPKLKTLLAI---- 75 (297)
T ss_dssp EEEEEEETTGGGSCGGGCCCGGGCCTTTCSEEEEEEEEEETTEE--ECSSTTHHHHHHHHHHGGGTCTTCEEEEEE----
T ss_pred eEEEEECcCcccCCCCCCCChhHCCcccCCEEEEEEEEccCCcc--ccCCcccHHHHHHHHHHHHhCCCCeEEEEE----
Confidence 6899986642 378999999999999999999987543 333334444444458899999999999999
Q ss_pred CCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCC-----CCcccHHHHHHHHHHHccC
Q 004402 101 NSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-----TDLNSLGILLDEWKASASD 175 (755)
Q Consensus 101 ~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~-----~~~~~~~~~l~~lr~~l~~ 175 (755)
|||+.++..|+.+++|++.|++||+++++|+++|||||||||||+|.. .|+.+|+.|+++||++|+.
T Consensus 76 --------GG~~~~~~~fs~~~~~~~~R~~Fi~siv~~l~~y~fDGiDiDWE~p~~~~~~~~d~~n~~~l~~~Lr~~l~~ 147 (297)
T d1wb0a1 76 --------GGWNFGTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQGSPAVDKERFTTLVQDLANAFQQ 147 (297)
T ss_dssp --------ECTTTCSHHHHHHHTSHHHHHHHHHHHHHHHHHTTCCEEEEECSCTTSTTCCTTHHHHHHHHHHHHHHHHHH
T ss_pred --------eccccccchHHHHhhhhHHHHHHHHHHHHHHHHcCCCceeEEEEeccccCCChHHHHHHHHHHHHHHHHHhh
Confidence 666666677999999999999999999999999999999999999953 5789999999999999953
Q ss_pred ------CCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCC------CCcHHHHH
Q 004402 176 ------QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSS------NISTDFGI 243 (755)
Q Consensus 176 ------~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~------~~~~~~~v 243 (755)
.+.+.+++++|+.+.....+|++.++.+++||+|||+||+| +.|++.+|++||||.... .++++.+|
T Consensus 148 ~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~i~~~vD~invmtYD~~-g~~~~~tg~~aply~~~~~~~~~~~~~~d~~v 226 (297)
T d1wb0a1 148 EAQTSGKERLLLSAAVPAGQTYVDAGYEVDKIAQNLDFVNLMAYDFH-GSWEKVTGHNSPLYKRQEESGAAASLNVDAAV 226 (297)
T ss_dssp HHHHHCSCCCEEEEEECCCHHHHHHHCCHHHHHHHCSEEEECCCCSS-CTTSSBCCCSSCSSCCTTCCGGGGGCSHHHHH
T ss_pred hhhhcCCCceeEEEEccCchhHhhhccCHHHHHhhCCEEEEEecccC-CCCCCCCCCCCcCCCCccccCCCCCCCHHHHH
Confidence 23689999999887766667999999999999999999999 457788999999996543 35799999
Q ss_pred HHHHHCCCCCCceeecccccCCCcccCCCcchHHHHHHHhhcCCCcccccccceeeeeeecCcEEEeeCCcchhhhhhhc
Q 004402 244 REWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISY 323 (755)
Q Consensus 244 ~~~~~~g~p~~KlvlG~p~yG~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~yd~~~S~~~K~~~ 323 (755)
++|+++|+|++||||||| |||++|++.|++|
T Consensus 227 ~~~~~~G~p~~KlvlGip-------------------------------------------------yd~~~si~~K~~~ 257 (297)
T d1wb0a1 227 QQWLQKGTPASKLILGMP-------------------------------------------------TDDVESFKTKVSY 257 (297)
T ss_dssp HHHHHTTCCGGGEEEEEE-------------------------------------------------SCCHHHHHHHHHH
T ss_pred HHHHHcCCCHHHeEEEec-------------------------------------------------cCCHHHHHHHHHH
Confidence 999999999999999987 6899999999999
Q ss_pred ccccCccccccccccccchhhh
Q 004402 324 AKEKNLLGYKAFQLSNDDNWAL 345 (755)
Q Consensus 324 a~~~~l~Gi~~W~l~~dd~~~~ 345 (755)
++++||||+|+|++++||..+.
T Consensus 258 ~~~~glgGv~~W~l~~DD~~G~ 279 (297)
T d1wb0a1 258 LKQKGLGGAMVWALDLDDFAGF 279 (297)
T ss_dssp HHHTTCCEEEEECGGGSCTTCS
T ss_pred HHhcCCceEEEEeCccccCCCC
Confidence 9999999999999999986654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-49 Score=407.88 Aligned_cols=263 Identities=25% Similarity=0.442 Sum_probs=203.5
Q ss_pred hcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.++|+..+.||+|+||+||+|+.+ ..||||+++.. ..+..+.|.+|+++|.+++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 457888999999999999999864 36999998654 44567889999999999999999999999865 56899999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
||++|+|.+++... +..+++..+..++.||++||+|||+.+ ||||||||+||||+.++.+||+|||+++......
T Consensus 84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999998643 335899999999999999999999986 9999999999999999999999999998765443
Q ss_pred cccccccccccCCccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKK---GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
.........||+.|||||++.. +.|+.++|||||||+||||+||+.||....... ................
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~~~~~~~~~p~~~---- 232 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSPDLS---- 232 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHHTSCCCCGG----
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHHHHHhcCCCCCcch----
Confidence 4344455689999999999864 458999999999999999999999985432211 1111111111111110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccc
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAI 715 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 715 (755)
.... ..+..+.+++.+||+.||++|||++||++.|+....++
T Consensus 233 -~~~~----~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 233 -KVRS----NCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp -GSCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -hccc----cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 1111 22347889999999999999999999999998765443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=408.96 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=199.4
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecC
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 514 (755)
++|+..+.||+|+||+||+|.+.+++.||||+++... ...++|.+|++++++++|||||+++|+|...+..++|||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4677889999999999999998888999999997643 335789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 594 (755)
+|+|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 157 (263)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-e
Confidence 99999998643 345899999999999999999999987 99999999999999999999999999987654322 2
Q ss_pred ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS 674 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 674 (755)
......||+.|+|||++.+..++.++|||||||++|||+|++.|+... ............ +. ....+
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~--~~~~~~~~~i~~----~~--~~~~p----- 224 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--RSNSEVVEDIST----GF--RLYKP----- 224 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS--CCHHHHHHHHHH----TC--CCCCC-----
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC--CCHHHHHHHHHh----cC--CCCCc-----
Confidence 223457899999999999999999999999999999999965554221 111122222211 11 11111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 675 SSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 675 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
.....++.+++.+||+.||++||||+||++.|+++.
T Consensus 225 --~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 225 --RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 122346889999999999999999999999998754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.6e-49 Score=410.41 Aligned_cols=266 Identities=24% Similarity=0.412 Sum_probs=200.1
Q ss_pred cCHHHHHHHhcC---------CCccCcccccCCeeEEEEEcCC-C---CEEEEEEeccC-ChhhHHHHHHHHHHHhcCCC
Q 004402 425 FSFSDIKAATNN---------FSSANKLGEGGFGPVYKGNLPR-G---QEFAVKRLSAT-STQGLEEFKNEVSLTARLQH 490 (755)
Q Consensus 425 ~~~~~l~~~~~~---------f~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H 490 (755)
++++++..++.+ |+..++||+|+||+||+|.... + ..||||++... .....+.|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 445555555443 4456789999999999997642 3 36899998654 44556789999999999999
Q ss_pred CceeeeeeeeecCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE
Q 004402 491 VNLLRVLGYCTERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL 570 (755)
Q Consensus 491 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll 570 (755)
||||+++|+|.+.+..++|||||++|+|.+++... ...+++.++..++.||++||.|||+.+ |+||||||+||||
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl 161 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILV 161 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEE
Confidence 99999999999999999999999999999988642 345899999999999999999999986 9999999999999
Q ss_pred cCCCCeEEEecCCccccccCCcccc---cccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 004402 571 DNELNPKISDFGMAKLFRKDVDEAN---TGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSE 646 (755)
Q Consensus 571 ~~~~~~kl~Dfgla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~ 646 (755)
+.++.+||+|||+++.+........ .....||+.|||||.+.++.++.++|||||||++|||+| |+.|+.....
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-- 239 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-- 239 (299)
T ss_dssp CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--
T ss_pred CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999987654332211 222457899999999999999999999999999999998 7888753221
Q ss_pred ccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 647 NLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
....... ..+. ....+...+..+.+++.+||+.||++|||+.||++.|++.
T Consensus 240 -~~~~~~i----~~~~---------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 240 -QDVINAI----EQDY---------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp -HHHHHHH----HTTC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -HHHHHHH----HcCC---------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1122111 1111 0111222345788999999999999999999999999864
|
| >d1jnda1 c.1.8.5 (A:2-278,A:371-420) Imaginal disc growth factor-2 {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Imaginal disc growth factor-2 species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=100.00 E-value=3e-49 Score=417.83 Aligned_cols=259 Identities=25% Similarity=0.456 Sum_probs=216.2
Q ss_pred EEEEEecCCC-------CCCCCCC--CCCCcceEEEEEEEecCCCcEEecCCch----hhHHHHHHHHHHhhCCCceEEE
Q 004402 28 IKAGYWLAGR-------EFPLSDI--NSALFTHLICAFAEVDSSTYQLSISSAN----QQYFSIFANSVRRKNPSIKTLL 94 (755)
Q Consensus 28 ~~~gY~~~~~-------~~~~~~i--~~~~~thi~~~f~~~~~~~~~~~~~~~~----~~~~~~~~~~~k~~~~~lk~~i 94 (755)
.|+|||..|. .|.+++| +..+||||+|+|+++++++..+...+.. ...+.++ .++|++||++|++|
T Consensus 2 ~ivcYy~~ws~~r~g~~~~~~~~id~~~~~cTHiiyafa~i~~~~~~~~~~d~~~d~~~~~~~~~-~~lk~~~p~lKvll 80 (327)
T d1jnda1 2 NLVCYYDSSSYTREGLGKLLNPDLEIALQFCSHLVYGYAGLRGENLQAYSMNENLDIYKHQFSEV-TSLKRKYPHLKVLL 80 (327)
T ss_dssp EEEEEEEGGGGGCSSTTCCCHHHHHHHGGGCSEEEEEEEEECTTTCCEEETTHHHHTTTCHHHHH-HGGGGTSTTCEEEE
T ss_pred eEEEEECCCcccCCCCCCcCHhhcCCCcccCCeEEEEEEEecCCCCEEEecCchhhhhHHHHHHH-HHHHHhCCCCeEEE
Confidence 5899987663 3666666 5677999999999999887766654433 2235545 67999999999999
Q ss_pred EecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCC-----------------
Q 004402 95 SIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNST----------------- 157 (755)
Q Consensus 95 sigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~----------------- 157 (755)
|||||..+ ++...+..|+.++++++.|++||+++++|+++|||||||||||||...
T Consensus 81 SiGGw~~~-------~~~~~~~~~~~~~~~~~rr~~Fi~svv~~l~~~~fDGIDiDWEyP~~~~~~~~~~~~~~~~~~~~ 153 (327)
T d1jnda1 81 SVGGDHDI-------DPDHPNKYIDLLEGEKVRQIGFIRSAYELVKTYGFDGLDLAYQFPKNKPRKVHGDLGLAWKSIKK 153 (327)
T ss_dssp EEETTCCC-------CTTSTTHHHHHHTCCHHHHHHHHHHHHHHHHHTTCSEEEEECCCCCCCCCCC-------------
T ss_pred EEECCCCC-------CCCcccchhHHHhCCHHHHHHHHHHHHHHHHHCCCCceEEEeeccCCCCcccccccchhhhhhhh
Confidence 99887753 223344457888888888899999999999999999999999999542
Q ss_pred --------------CcccHHHHHHHHHHHccCCCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCC-CCc
Q 004402 158 --------------DLNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPS-KEN 222 (755)
Q Consensus 158 --------------~~~~~~~~l~~lr~~l~~~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~-~~~ 222 (755)
++++|+.|++++|+++... ++.+++++++.+.... +|++++++++|||||+|||||||++ +..
T Consensus 154 ~~~~~~~~~~~~~~d~~~~~~l~~elr~~l~~~-~~~ls~a~~~~~~~~~-~~d~~~l~~~vD~vnlmtYD~~g~~~~~~ 231 (327)
T d1jnda1 154 LFTGDFIVDPHAALHKEQFTALVRDVKDSLRAD-GFLLSLTVLPNVNSTW-YFDIPALNGLVDFVNLATFDFLTPARNPE 231 (327)
T ss_dssp ------CCCTTHHHHHHHHHHHHHHHHHHHHTT-TCEEEEEECTTCCHHH-HCCHHHHHTTCSEEEECCCCSSCTTTCTT
T ss_pred ccccccccccccHHHHHHHHHHHHHHHHhhccC-CceEEEEecCChHHhh-cccHHHHhhhhhhHhhhhhhhcCccccCC
Confidence 3568999999999999865 7999999998876543 5999999999999999999999765 456
Q ss_pred ccccCCCCCCCCC------CCcHHHHHHHHHHCCCCCCceeecccccCCCcccCCCcchHHHHHHHhhcCCCcccccccc
Q 004402 223 VTGIHAALYNPSS------NISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNAS 296 (755)
Q Consensus 223 ~~~~~a~l~~~~~------~~~~~~~v~~~~~~g~p~~KlvlG~p~yG~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~ 296 (755)
.++++|||+.+.. .++++.+|++|++.|+|++||++|||
T Consensus 232 ~~g~~apL~~~~~~~~~~~~~~~d~~v~~~~~~G~p~~Kl~lGi~----------------------------------- 276 (327)
T d1jnda1 232 EADYSAPIYHPDGSKDRLAHLNADFQVEYWLSQGFPSNKINLGVA----------------------------------- 276 (327)
T ss_dssp CBCCSSCSSCCTTSTTCCTTCSHHHHHHHHHHTTCCGGGEEEEEE-----------------------------------
T ss_pred cccccCCCCCCCCCCCcccCccHHHHHHHHHHcCCCHHHeEEEEc-----------------------------------
Confidence 7999999995442 35899999999999999999999875
Q ss_pred eeeeeeecCcEEEeeCCcchhhhhhhcccccCccccccccccccchhhh
Q 004402 297 YVVNLFTSGATWINFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNWAL 345 (755)
Q Consensus 297 ~~~~~~~~~~~~i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~dd~~~~ 345 (755)
|||++|++.|++|++++||||+|+|+++.||..+.
T Consensus 277 --------------ydd~~Si~~K~~~~~~~~lgGv~~W~l~~DDf~G~ 311 (327)
T d1jnda1 277 --------------TDDPDSASNKAAYARVKNLGGVALFDLSYDDFRGQ 311 (327)
T ss_dssp --------------SCCHHHHHHHHHHHHHTTCSEEEEECGGGSCTTCT
T ss_pred --------------CCCHHHHHHHHHHHHhcCCCEEEEEeccCCCCCCc
Confidence 89999999999999999999999999999997664
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=407.79 Aligned_cols=255 Identities=30% Similarity=0.468 Sum_probs=206.2
Q ss_pred hcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
.++|+..+.||+|+||+||+|.+++++.||||+++... ...+.|.+|+++|++++|||||+++|++.+ +..++|||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 35678889999999999999998888999999997654 345789999999999999999999998864 5679999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++|+|.+++... ....+++..++.++.||++||.|||+.+ |+||||||+||||++++.+||+|||+++.+.....
T Consensus 90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~- 164 (272)
T d1qpca_ 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY- 164 (272)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc-
Confidence 999999887543 2345899999999999999999999986 99999999999999999999999999997654322
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
.......||+.|||||++.++.++.++|||||||++|||+||+.|+.... ....... .+..+. .+....
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~--~~~~~~~----~i~~~~-----~~~~p~ 233 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--TNPEVIQ----NLERGY-----RMVRPD 233 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHH----HHHTTC-----CCCCCT
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC--CHHHHHH----HHHhcC-----CCCCcc
Confidence 22334578999999999999999999999999999999999776653221 1111111 111111 111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
..+..+.+|+.+||+.||++||||.||+++|++
T Consensus 234 ----~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 234 ----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp ----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 223468899999999999999999999999986
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=403.12 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=202.2
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
++|+..+.||+|+||+||+|.. .+|+.||||++.... .+..+.+.+|+++|++++||||+++++++.+.+..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 4688899999999999999965 569999999987653 23446789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
|++|+|.+++.. +..+++.++..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 85 ~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999853 346899999999999999999999987 99999999999999999999999999997755443
Q ss_pred ccccccccccCCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
.......+||+.|||||++.+..+ +.++|||||||++|||+||+.|+........ .... ...... ..
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~~~----~~~~~~--~~---- 226 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSD----WKEKKT--YL---- 226 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--HHHH----HHTTCT--TS----
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--HHHH----HhcCCC--CC----
Confidence 334455789999999999988776 6789999999999999999999864332211 1110 111100 00
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.........+.+++.+||+.||++|||++|+++
T Consensus 227 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 --NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011122346778999999999999999999854
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-49 Score=409.79 Aligned_cols=258 Identities=26% Similarity=0.370 Sum_probs=209.7
Q ss_pred hcCCCccCcccccCCeeEEEEEcC-CCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP-RGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
.++|+..+.||+|+||+||+|... +|+.||||+++... ...++|.+|+++|++++|||||+++++|.+.+..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 457888899999999999999754 58899999987654 3457899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
|++|+|..++... ....+++..+..++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 95 ~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 9999999998543 3346899999999999999999999986 99999999999999999999999999987654322
Q ss_pred ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 593 EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
. ......||+.|||||++.++.++.++|||||||++|||++|+.|+..... ..... .....+. .+..
T Consensus 171 ~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~----~~i~~~~-----~~~~- 237 (287)
T d1opja_ 171 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVY----ELLEKDY-----RMER- 237 (287)
T ss_dssp E-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHH----HHHHTTC-----CCCC-
T ss_pred e-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHH----HHHhcCC-----CCCC-
Confidence 2 23345688999999999999999999999999999999998777632221 11111 1111111 1111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
+...+..+.+|+.+||+.||++|||+.||++.|+...
T Consensus 238 ---~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 238 ---PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1122347889999999999999999999999998653
|
| >d1vf8a1 c.1.8.5 (A:1-245,A:316-372) Chitinase-like lectin ym1, saccharide binding domain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase-like lectin ym1, saccharide binding domain species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4e-49 Score=412.68 Aligned_cols=255 Identities=28% Similarity=0.481 Sum_probs=213.8
Q ss_pred eEEEEEecCCC-------CCCCCCCCCCCcceEEEEEEEecCCCcEEecCCchhhHHHHHHHHHHhhCCCceEEEEecCC
Q 004402 27 WIKAGYWLAGR-------EFPLSDINSALFTHLICAFAEVDSSTYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWNG 99 (755)
Q Consensus 27 ~~~~gY~~~~~-------~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg~ 99 (755)
++|+|||..|. .|++++||+++||||+|+|+.+++++.. ...+.....+..+ .++|++||++|+++||
T Consensus 1 ~kvvcYy~~w~~~r~~~~~~~~~~i~~~~cTHiiyaf~~i~~~~~~-~~~~~~~~~~~~~-~~lk~~~p~lKvllSi--- 75 (302)
T d1vf8a1 1 YQLMCYYTSWAKDRPIEGSFKPGNIDPCLCTHLIYAFAGMQNNEIT-YTHEQDLRDYEAL-NGLKDKNTELKTLLAI--- 75 (302)
T ss_dssp CEEEEEEEGGGGGSCGGGCCCGGGSCTTTCSEEEEEEEEEETTEEE-CSSTTHHHHHHHH-HHGGGTCTTCEEEEEE---
T ss_pred CeEEEEECcccccCCCCCCCChhHCCcccCcEEEEEEEEecCCceE-EcCcccHHHHHHH-HHHHHhCCCcEEEEEE---
Confidence 47999987652 4889999999999999999999975433 3344444455555 6799999999999999
Q ss_pred CCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCC-----CCCcccHHHHHHHHHHHcc
Q 004402 100 QNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN-----STDLNSLGILLDEWKASAS 174 (755)
Q Consensus 100 ~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~-----~~~~~~~~~~l~~lr~~l~ 174 (755)
|||..++..|+.++++++.|++||+++++++++|||||||||||+|. ++|+.+|+.|+++||++|+
T Consensus 76 ---------GG~~~~~~~fs~~~~~~~~R~~fi~si~~~l~~~~fDGIDIDWE~p~~~~~~~~d~~n~~~ll~elr~~l~ 146 (302)
T d1vf8a1 76 ---------GGWKFGPAPFSAMVSTPQNRQIFIQSVIRFLRQYNFDGLNLDWQYPGSRGSPPKDKHLFSVLVKEMRKAFE 146 (302)
T ss_dssp ---------ECTTTCSHHHHHHHTSHHHHHHHHHHHHHHHHHTTCCEEEEECSCTTSTTCCTHHHHHHHHHHHHHHHHHH
T ss_pred ---------ecCCCCCcchHHHhcchHHHHHHHHHHHHHHHHhCCCeeeeeeeecccccccchhHhHHHHHHHHHHHHHH
Confidence 66666666799999999999999999999999999999999999995 4568889999999999985
Q ss_pred CC------CccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCC------CCcHHHH
Q 004402 175 DQ------PELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSS------NISTDFG 242 (755)
Q Consensus 175 ~~------~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~------~~~~~~~ 242 (755)
+. +...++.++++.......+||++++.++|||+|+|+||+|| .|.+.+|++||||..+. .++++.+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~yd~~~~~~~vD~inlmtYD~~g-~~~~~tg~~apl~~~~~~~~~~~~~~v~~~ 225 (302)
T d1vf8a1 147 EESVEKDIPRLLLTSTGAGIIDVIKSGYKIPELSQSLDYIQVMTYDLHD-PKDGYTGENSPLYKSPYDIGKSADLNVDSI 225 (302)
T ss_dssp HHHHHHTSCCCEEEEEECSSHHHHHHHCCHHHHHHHCSEEEECCCCCSC-GGGSBCCCSSCSSCCTTCCGGGGGCSHHHH
T ss_pred HhhhhcCCCceeeeecccchhhhhhhcCcchhhccccCeeeeeccccCC-CCCCCCCCCCCCCCCCCCCCCCCCccHHHH
Confidence 42 23455555555545555669999999999999999999995 56778999999986542 3579999
Q ss_pred HHHHHHCCCCCCceeecccccCCCcccCCCcchHHHHHHHhhcCCCcccccccceeeeeeecCcEEEeeCCcchhhhhhh
Q 004402 243 IREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKIS 322 (755)
Q Consensus 243 v~~~~~~g~p~~KlvlG~p~yG~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~yd~~~S~~~K~~ 322 (755)
|++|++.|+|++||+||||+|| ++|++.|++
T Consensus 226 v~~~~~~Gvp~~KlvlGip~~g-------------------------------------------------~rs~~~K~~ 256 (302)
T d1vf8a1 226 ISYWKDHGAASEKLIVGFPADN-------------------------------------------------VRSFKLKAQ 256 (302)
T ss_dssp HHHHHHTTCCGGGEEEEEESCC-------------------------------------------------HHHHHHHHH
T ss_pred HHHHHHcCCCHHHeEEEEecCC-------------------------------------------------hHHHHHHHH
Confidence 9999999999999999999875 579999999
Q ss_pred cccccCccccccccccccchhhh
Q 004402 323 YAKEKNLLGYKAFQLSNDDNWAL 345 (755)
Q Consensus 323 ~a~~~~l~Gi~~W~l~~dd~~~~ 345 (755)
|++++||||+|+|++++||..+.
T Consensus 257 ~~~~~~lgGv~~W~~d~DDf~G~ 279 (302)
T d1vf8a1 257 WLKDNNLGGAVVWPLDMDDFSGS 279 (302)
T ss_dssp HHHHTTCCEEEEETGGGSCTTST
T ss_pred HHHhCCCeeEEEeccccCCCCCC
Confidence 99999999999999999986653
|
| >d1ll7a1 c.1.8.5 (A:36-292,A:355-427) Chitinase 1 {Fungus (Coccidioides immitis) [TaxId: 5501]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase 1 species: Fungus (Coccidioides immitis) [TaxId: 5501]
Probab=100.00 E-value=3.6e-49 Score=416.78 Aligned_cols=251 Identities=24% Similarity=0.426 Sum_probs=212.7
Q ss_pred ceEEEEEecCC----CCCCCCCCCCCCcceEEEEEEEecCCCcEEecCCc------------------hhhHHHHHHHHH
Q 004402 26 TWIKAGYWLAG----REFPLSDINSALFTHLICAFAEVDSSTYQLSISSA------------------NQQYFSIFANSV 83 (755)
Q Consensus 26 ~~~~~gY~~~~----~~~~~~~i~~~~~thi~~~f~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~ 83 (755)
+++|+|||..| +.|.+++||+++||||+|||+.+++++.....+.. ....+..+ .++
T Consensus 2 g~kvv~Yy~~W~~y~~~~~~~~i~~~~~THi~yaFa~i~~~g~~~~~d~~~d~~~~~~~~~~~~~~~~~~~~~~~~-~~l 80 (330)
T d1ll7a1 2 GFRSVVYFVNWAIYGRGHNPQDLKADQFTHILYAFANIRPSGEVYLSDTWADTDKHYPGDKWDEPGNNVYGCIKQM-YLL 80 (330)
T ss_dssp CBEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEEEECTTSCEEESCHHHHTTCCCTTCCSSCSSCCCCHHHHHH-HHH
T ss_pred CcEEEEEECcccccCCCCChhHCCcccCceeEEeeEEECCCCCEEecChhHhhcccCCccccccccchhhHHHHHH-HHH
Confidence 57899998775 34899999999999999999999987654433211 12234444 679
Q ss_pred HhhCCCceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCC-CCcccH
Q 004402 84 RRKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNS-TDLNSL 162 (755)
Q Consensus 84 k~~~~~lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~-~~~~~~ 162 (755)
|++||+||||||| |||+. +..|+.++++++.|++||+++++++++|+|||||||||+|.. .+..+|
T Consensus 81 k~~~p~lKvllSv------------GGw~~-s~~f~~~~~~~~~R~~Fi~siv~~l~~y~fDGIDiDWE~p~~~~~~~~~ 147 (330)
T d1ll7a1 81 KKNNRNLKTLLSI------------GGWTY-SPNFKTPASTEEGRKKFADTSLKLMKDLGFDGIDIDWQYPEDEKQANDF 147 (330)
T ss_dssp HHHCTTCEEEEEE------------EHHHH-GGGSHHHHTSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCSHHHHHHH
T ss_pred HhcCCCCeEEEEE------------eCCCC-CCCchhhhcCHHHHHHHHHHHHHHHHHhcccccceEEEeeccccccccH
Confidence 9999999999999 44443 334999999999999999999999999999999999999965 567889
Q ss_pred HHHHHHHHHHcc-------CCCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCC-
Q 004402 163 GILLDEWKASAS-------DQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPS- 234 (755)
Q Consensus 163 ~~~l~~lr~~l~-------~~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~- 234 (755)
+.|+++||++|. .++.+.||+++|+.+.... .|++++++++|||||||+||+| +.|+..+||++||+...
T Consensus 148 ~~~l~~lr~~l~~~~~~~~~g~~~~lt~a~~~~~~~~~-~~~~~~l~~~vD~invmtYD~~-g~w~~~tg~~s~l~~~~~ 225 (330)
T d1ll7a1 148 VLLLKACREALDAYSAKHPNGKKFLLTIASPAGPQNYN-KLKLAEMDKYLDFWNLMAYDFS-GSWDKVSGHMSNVFPSTT 225 (330)
T ss_dssp HHHHHHHHHHHHHHHHTSTTSCCCEEEEEEECSHHHHT-TSCHHHHHTTCSEEEEECCCSS-STTSSBCCCSSCSSCCSS
T ss_pred HHHHHHHHHHHHHHHHHhhcCCceeEEEeccCChHhhc-cccHHHHhhcCCEEEEEEeecc-CCCCCCCCcCcccCCCcC
Confidence 999999999983 2457999999998876655 4999999999999999999999 55788899999998543
Q ss_pred ----CCCcHHHHHHHHHHCCCCCCceeecccccCCCcccCCCcchHHHHHHHhhcCCCcccccccceeeeeeecCcEEEe
Q 004402 235 ----SNISTDFGIREWLRRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWIN 310 (755)
Q Consensus 235 ----~~~~~~~~v~~~~~~g~p~~KlvlG~p~yG~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 310 (755)
..++++.+|++|+++|+|++|||||||+|||+|.
T Consensus 226 ~~~~~~~sv~~av~~~~~~Gvp~~KlvlGiP~ygr~~~------------------------------------------ 263 (330)
T d1ll7a1 226 KPESTPFSSDKAVKDYIKAGVPANKIVLGMPLDTVKIA------------------------------------------ 263 (330)
T ss_dssp CGGGCSCCHHHHHHHHHHTTCCGGGEEEEEESCCHHHH------------------------------------------
T ss_pred CCCCCCccHHHHHHHHHHCCCCHHHeEEEecCCCchhh------------------------------------------
Confidence 3368999999999999999999999999997643
Q ss_pred eCCcchhhhhhhcccccCccccccccccccc
Q 004402 311 FDGVETIKAKISYAKEKNLLGYKAFQLSNDD 341 (755)
Q Consensus 311 yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~dd 341 (755)
..|++|++++|+||+|+|++++|.
T Consensus 264 -------~~k~~~~~~~g~gG~m~We~~~D~ 287 (330)
T d1ll7a1 264 -------GKKAEYITKNGMGGGMWWESSSDK 287 (330)
T ss_dssp -------HHHHHHHHHTTCCEEEEECTTSCC
T ss_pred -------hhhhHhHhhcCCCceEEEeeccCC
Confidence 349999999999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=394.18 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=209.6
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecC
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 514 (755)
++|+..++||+|+||+||+|+.++++.||||+++.... ..++|++|++++++++||||++++|+|.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57888999999999999999988888999999976543 34789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 594 (755)
+|+|..++... ...+++..+.+++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..... .
T Consensus 83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~ 156 (258)
T d1k2pa_ 83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T 156 (258)
T ss_dssp TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-C
T ss_pred CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc-e
Confidence 99999987543 345889999999999999999999986 99999999999999999999999999987654322 2
Q ss_pred ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.|+...... ... ..+.... ....+
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~----~~i~~~~--~~~~p---- 223 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETA----EHIAQGL--RLYRP---- 223 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHH----HHHHTTC--CCCCC----
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHH----HHHHhCC--CCCCc----
Confidence 3334578999999999999999999999999999999998 78787543221 111 1222211 11111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
......+.+++.+||+.||++|||++|+++.|.+
T Consensus 224 ---~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 ---HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ---ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1223468899999999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=398.49 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=205.6
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
++|+..+.||+|+||+||+|.. .+|+.||||++........+.+.+|+++|++++|||||++++++.+.+..++|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4689999999999999999964 569999999997765556678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++|+|.+++. +..+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 100 ~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-- 170 (293)
T d1yhwa1 100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (293)
T ss_dssp TTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred CCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--
Confidence 9999998874 235899999999999999999999987 9999999999999999999999999998764432
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
......+||+.|||||++.+..++.++|||||||++|||+||+.||..... ......... ... .. +
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~~~~---~~~-~~-----~-- 236 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIAT---NGT-PE-----L-- 236 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHH---HCS-CC-----C--
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH---HHHHHHHHh---CCC-CC-----C--
Confidence 223446799999999999999999999999999999999999999853221 111111111 110 00 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..+......+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011122346889999999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-48 Score=401.41 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=203.5
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecC
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLP 514 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 514 (755)
++|+..+.||+|+||+||+|...+++.||||+++... ...+.|.+|+.+|++++|||||+++|+|.+ +..++|||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 5688899999999999999998888899999996543 345789999999999999999999999854 56899999999
Q ss_pred CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc
Q 004402 515 NKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA 594 (755)
Q Consensus 515 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 594 (755)
+|+|..++... ....++|.+++.++.||++||+|||+.+ |+||||||+||||+.++++||+|||+++....... .
T Consensus 95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~ 169 (285)
T d1fmka3 95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 169 (285)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence 99999888543 2345899999999999999999999987 99999999999999999999999999987644322 2
Q ss_pred ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDS 674 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 674 (755)
......||+.|+|||++..+.++.++|||||||++|||+||+.|+..... ........ .... .+..
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i----~~~~-----~~~~--- 235 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQV----ERGY-----RMPC--- 235 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHH----HTTC-----CCCC---
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHH----HhcC-----CCCC---
Confidence 23345789999999999999999999999999999999998776643222 11122211 1111 1111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccc
Q 004402 675 SSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAI 715 (755)
Q Consensus 675 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 715 (755)
+......+.+++.+||+.||++|||+++|+++|++.-.+.
T Consensus 236 -~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 236 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 1222346889999999999999999999999999855443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-48 Score=408.50 Aligned_cols=258 Identities=27% Similarity=0.390 Sum_probs=205.6
Q ss_pred hcCCCccCcccccCCeeEEEEEcCC-C-----CEEEEEEeccC-ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPR-G-----QEFAVKRLSAT-STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDE 505 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 505 (755)
.++|+..++||+|+||+||+|+... + ..||||++... .......+.+|+.+|.++ +|||||+++++|.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3578888999999999999996532 2 36999998654 333456789999999998 89999999999999999
Q ss_pred cEEEEeecCCCChhhhhcCCCc--------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCC
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIR--------------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKA 565 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~ 565 (755)
.++|||||++|+|.+++..... ...+++..++.++.||++||.|||+.+ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999965422 235899999999999999999999986 99999999
Q ss_pred CCEEEcCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 004402 566 SNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGT 644 (755)
Q Consensus 566 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~ 644 (755)
+|||++.++.+||+|||+|+...............||+.|||||.+.++.++.++|||||||++|||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987665444444445678999999999999999999999999999999998 7888754332
Q ss_pred CcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 004402 645 SENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLK 709 (755)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 709 (755)
.. .+.... ..+. .+.. +......+.+|+.+||+.||++|||++||+++|.
T Consensus 273 ~~--~~~~~~----~~~~-----~~~~----p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DA--NFYKLI----QNGF-----KMDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SH--HHHHHH----HTTC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH--HHHHHH----hcCC-----CCCC----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 22 111111 1111 1111 1122347889999999999999999999999995
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=398.52 Aligned_cols=258 Identities=25% Similarity=0.422 Sum_probs=199.1
Q ss_pred cCCCccCcccccCCeeEEEEEcCCC-----CEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRG-----QEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
++|+..++||+|+||.||+|.+... ..||||++... ......+|.+|+++|++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577789999999999999975432 37999999765 33445679999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
|||||.+|++.+++... ...+++.++..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999998877532 346899999999999999999999986 9999999999999999999999999998765
Q ss_pred cCCcc-cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 589 KDVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 589 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
..... .......||+.|||||++.++.++.++|||||||++|||+|++.|+..... ...... .+..+.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~~----~i~~~~----- 230 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMK----AINDGF----- 230 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHH----HHHTTC-----
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHHHH----HHhccC-----
Confidence 43222 223345689999999999999999999999999999999997766532221 111121 111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
....+...+..+.+|+.+||+.||++||||.||+++|++..
T Consensus 231 ----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 231 ----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp ----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 11112223457889999999999999999999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-48 Score=398.46 Aligned_cols=256 Identities=25% Similarity=0.385 Sum_probs=205.2
Q ss_pred cCCCccC-cccccCCeeEEEEEcC---CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEE
Q 004402 435 NNFSSAN-KLGEGGFGPVYKGNLP---RGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 435 ~~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 509 (755)
++|...+ +||+|+||+||+|... ++..||||+++.. .....++|.+|+++|++++|||||+++|+|.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 3455556 4999999999999653 3558999999765 34456789999999999999999999999865 568999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
||||++|+|.+++... +..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 9999999999987542 346899999999999999999999986 99999999999999999999999999997654
Q ss_pred CCcc-cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 590 DVDE-ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 590 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
.... .......||+.|||||++.++.++.++|||||||++|||+| |+.||...... .... .+..+...
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~----~i~~~~~~--- 231 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA----FIEQGKRM--- 231 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHH----HHHTTCCC---
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCC---
Confidence 3322 22334568999999999999999999999999999999998 89888643221 1111 12222111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
.. +...+..+.+|+.+||+.||++||||.+|++.|+...
T Consensus 232 --~~----p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 232 --EC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp --CC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CC----CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11 1223347889999999999999999999999998643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=391.62 Aligned_cols=245 Identities=27% Similarity=0.387 Sum_probs=202.8
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||+|+||+||+|.. .+++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4688889999999999999965 56899999998643 2234567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
|||++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999853 345899999999999999999999987 999999999999999999999999999865432
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
......||+.|||||++.+..++.++|||||||++|||++|+.||.... ..... ....... ..
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~----~~i~~~~------~~ 222 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETY----KRISRVE------FT 222 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHH----HHHHTTC------CC
T ss_pred ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC---HHHHH----HHHHcCC------CC
Confidence 2234679999999999999999999999999999999999999985322 11111 1111111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+... ....+.+++.+||+.||++|||++|+++
T Consensus 223 ~p~~----~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 FPDF----VTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCcc----CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1112 2246789999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-48 Score=395.76 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=193.4
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeec--CCccEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE--RDENMLI 509 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv 509 (755)
++|+..+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+++|++++|||||++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5788999999999999999964 56999999998765 34446679999999999999999999999865 3457999
Q ss_pred EeecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 510 YEYLPNKSLDLYLFDPI-RRYVLDWQKRVNIIEGVTQGLLYLQEYS--NFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~~--~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
||||++|+|.+++.... .+..+++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999985432 2456999999999999999999999865 23599999999999999999999999999987
Q ss_pred cccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccc
Q 004402 587 FRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666 (755)
Q Consensus 587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (755)
+..... ......||+.|||||++.+..++.++|||||||++|||+||+.||..... .... ..+.......
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~~----~~i~~~~~~~- 233 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELA----GKIREGKFRR- 233 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH----HHHHHTCCCC-
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHHH----HHHHcCCCCC-
Confidence 654322 23346899999999999999999999999999999999999999853221 1111 1122222111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 667 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+.... ..++.+|+.+||+.||++|||+.|+++
T Consensus 234 ----~~~~~----s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 ----IPYRY----SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ----CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCccc----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11122 236889999999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=395.66 Aligned_cols=247 Identities=27% Similarity=0.387 Sum_probs=196.6
Q ss_pred CcccccCCeeEEEEEcC---CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeecCC
Q 004402 441 NKLGEGGFGPVYKGNLP---RGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYLPN 515 (755)
Q Consensus 441 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 515 (755)
++||+|+||+||+|.+. .++.||||+++.. +....+.|.+|+++|++++|||||+++|+|.. +..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999653 3568999999654 33345789999999999999999999999965 567899999999
Q ss_pred CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCccc-
Q 004402 516 KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDEA- 594 (755)
Q Consensus 516 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 594 (755)
|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999853 345899999999999999999999986 9999999999999999999999999998765443222
Q ss_pred ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCCC
Q 004402 595 NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDD 673 (755)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 673 (755)
......||+.|||||.+.+..++.++|||||||++|||+| |+.|+..... .... ..+..+.. +...
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~----~~i~~~~~-----~~~p- 232 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVT----AMLEKGER-----MGCP- 232 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHH----HHHHTTCC-----CCCC-
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHH----HHHHcCCC-----CCCC-
Confidence 2334578999999999999999999999999999999998 8888854321 1111 11122111 1111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 674 SSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 674 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
...+..+.+|+.+||+.||++|||+++|+++|+.
T Consensus 233 ---~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 233 ---AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp ---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 1223478899999999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=396.05 Aligned_cols=251 Identities=23% Similarity=0.347 Sum_probs=204.5
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
+.|+..+.||+|+||+||+|.. .+|+.||||++.....+..+.|.+|+++|++++|||||++++++.+.+..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 3578889999999999999965 569999999998776667788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++|+|.+++... ...+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence 999999987532 345899999999999999999999987 9999999999999999999999999997653321
Q ss_pred cccccccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 594 ANTGRIVGTYGYVPPEYVK-----KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
.......||+.|||||++. ...|+.++|||||||++|||+||+.||...... ........ .....
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~~~~~i~~----~~~~~--- 234 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---RVLLKIAK----SEPPT--- 234 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHHHHHH----SCCCC---
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---HHHHHHHc----CCCCC---
Confidence 1223467999999999984 456899999999999999999999998543322 22211111 11101
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+ ..+......+.+++.+||+.||++|||+.|+++
T Consensus 235 --~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 --L--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp --C--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --C--CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 011223347889999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-47 Score=399.02 Aligned_cols=265 Identities=25% Similarity=0.409 Sum_probs=211.1
Q ss_pred HHHHHhcCCCccCcccccCCeeEEEEEcC------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeee
Q 004402 429 DIKAATNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCT 501 (755)
Q Consensus 429 ~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 501 (755)
+++...++|+..+.||+|+||+||+|+.. +++.||||+++... .+..++|.+|+++|++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34445678999999999999999999752 45789999997653 344668999999999999999999999999
Q ss_pred cCCccEEEEeecCCCChhhhhcCCC---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcee
Q 004402 502 ERDENMLIYEYLPNKSLDLYLFDPI---------------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIH 560 (755)
Q Consensus 502 ~~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiH 560 (755)
.....+++|||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ +||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 9999999999999999999985321 1234889999999999999999999987 999
Q ss_pred cccCCCCEEEcCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCC-CC
Q 004402 561 RDLKASNILLDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR-NA 639 (755)
Q Consensus 561 rDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~-p~ 639 (755)
|||||+||||+.++.+||+|||+++...............||+.|+|||.+.+..+|.++|||||||++|||++|.. |+
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 99999999999999999999999987654443344445678899999999999999999999999999999999975 44
Q ss_pred CCCCCCcccchHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 640 RYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
... ........ ...+.... ... ..+..+.+|+.+||+.||++||||.||+++|+++.
T Consensus 244 ~~~---~~~e~~~~----v~~~~~~~-----~p~----~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGM---AHEEVIYY----VRDGNILA-----CPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTS---CHHHHHHH----HHTTCCCC-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCC---CHHHHHHH----HHcCCCCC-----CCc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 322 11122222 22222111 111 22346889999999999999999999999998754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=401.92 Aligned_cols=268 Identities=23% Similarity=0.302 Sum_probs=204.7
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.++|+..+.||+|+||+||+|.. .+|+.||+|+++.. .....+.+.+|+.+|++++|||||+++++|.+.+..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 56899999999999999999964 56899999999765 33445679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
||++|+|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 9999999999853 345899999999999999999999752 3999999999999999999999999999865432
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchH-HHHHHHhc-----------
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFL-EYAFEQWK----------- 659 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~-~~~~~~~~----------- 659 (755)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||............ ........
T Consensus 159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred ---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 223468999999999999999999999999999999999999999653322110000 00000000
Q ss_pred -------cCC----Ccc----ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhhc
Q 004402 660 -------DSK----GKE----FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKD 710 (755)
Q Consensus 660 -------~~~----~~~----~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~ 710 (755)
... ..+ ................++.+++.+||+.||++|||++|+++ .+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 000 000 00000000000112246789999999999999999999986 4543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=384.58 Aligned_cols=246 Identities=24% Similarity=0.384 Sum_probs=193.9
Q ss_pred CccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeec----CCccEEEE
Q 004402 438 SSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE----RDENMLIY 510 (755)
Q Consensus 438 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~ 510 (755)
...++||+|+||+||+|.. .+++.||+|++... .....+.|.+|+++|++++|||||++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 3456799999999999965 56889999998654 34456789999999999999999999999864 34578999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc-CCCCeEEEecCCcccccc
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD-NELNPKISDFGMAKLFRK 589 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~-~~~~~kl~Dfgla~~~~~ 589 (755)
|||++|+|.+++.. ...+++..+..++.||++||+|||+++ .+|+||||||+|||++ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999853 346899999999999999999999864 3599999999999996 578999999999986432
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
. .....+||+.|||||++.+ .++.++|||||||++|||++|+.||...... .. .......+... +
T Consensus 168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~----~~~~i~~~~~~----~ 232 (270)
T d1t4ha_ 168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQ----IYRRVTSGVKP----A 232 (270)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HH----HHHHHTTTCCC----G
T ss_pred C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HH----HHHHHHcCCCC----c
Confidence 2 2234689999999999875 5999999999999999999999998532211 11 11121211111 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+.... ..++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~----~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 SFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCccC----CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111112 235789999999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=392.99 Aligned_cols=249 Identities=21% Similarity=0.315 Sum_probs=201.2
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4688999999999999999965 56999999998653 2334567999999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
|||++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999988743 346899999999999999999999987 999999999999999999999999999977654
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
.........+||+.|||||++.+..++.++|||||||++|||+||+.||.... ..... ..+.... ..
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~----~~i~~~~------~~ 228 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EYLIF----QKIIKLE------YD 228 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH----HHHHTTC------CC
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC---HHHHH----HHHHcCC------CC
Confidence 44444445689999999999999999999999999999999999999985321 11111 1111111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+.... ...+.+|+.+||+.||++|||++|+++
T Consensus 229 ~p~~~----s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 229 FPEKF----FPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCTTC----CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCccC----CHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 11222 236789999999999999999998753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.9e-47 Score=395.29 Aligned_cols=245 Identities=27% Similarity=0.414 Sum_probs=198.8
Q ss_pred cCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATS---TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
+.|+..+.||+|+||+||+|. ..+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 358889999999999999996 4568999999987653 334567999999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
|||++|+|..++. .+..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999977663 2346899999999999999999999987 99999999999999999999999999986432
Q ss_pred CcccccccccccCCccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKK---GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
.....||+.|||||++.+ +.|+.++|||||||++|||++|+.|+..... ........ ....
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~---~~~~~~i~----~~~~---- 231 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIA----QNES---- 231 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH----HSCC----
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHH----hCCC----
Confidence 223579999999999853 4689999999999999999999999853221 11111111 1111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
+.+.. ......+.+++.+||+.||++|||++|+++
T Consensus 232 -~~~~~---~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 -PALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -CCCSC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCC---CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11111 112246889999999999999999999986
|
| >d1goia2 c.1.8.5 (A:3-291,A:380-446) Chitinase B, catalytic domain {Serratia marcescens [TaxId: 615]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase B, catalytic domain species: Serratia marcescens [TaxId: 615]
Probab=100.00 E-value=1.2e-46 Score=402.99 Aligned_cols=285 Identities=20% Similarity=0.248 Sum_probs=218.3
Q ss_pred cceEEEEEec-------CCC-------CCCCCCCCC---CCcceEEEEEEEecCCCcEEecCCchhhH---HHHHHHHHH
Q 004402 25 QTWIKAGYWL-------AGR-------EFPLSDINS---ALFTHLICAFAEVDSSTYQLSISSANQQY---FSIFANSVR 84 (755)
Q Consensus 25 ~~~~~~gY~~-------~~~-------~~~~~~i~~---~~~thi~~~f~~~~~~~~~~~~~~~~~~~---~~~~~~~~k 84 (755)
+.+.|+|||. .+. .|++++|++ ++||||+|||+.+++++.........+.. +...+.++|
T Consensus 1 ~~~~~~~yy~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~lTHi~yaFa~i~~~g~~~~~~~~~~~~~~~~~~~~~~lK 80 (356)
T d1goia2 1 TRKAVIGYYFIPTNQINNYTETDTSVVPFPVSNITPAKAKQLTHINFSFLDINSNLECAWDPATNDAKARDVVNRLTALK 80 (356)
T ss_dssp CCCEEEEEEECCHHHHHTCCSSCTTTCSSCGGGSCHHHHHHCSEEEEEEEEECTTSSEECCTTCCHHHHHHHHHHHHHGG
T ss_pred CCcEEEEEEeCCccCcCcccccCCccCCcChhcCCcchHhhCCeEEEEEEEECCCccEEecCCccchHHHHHHHHHHHHH
Confidence 3678999983 222 366777765 67899999999999877655443333332 223346799
Q ss_pred hhCCCceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCCCcccHHH
Q 004402 85 RKNPSIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGI 164 (755)
Q Consensus 85 ~~~~~lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~~~~~~~~ 164 (755)
++||+||||||||||+.++ +...+...|+.+++|++.|++||+++++|+++|||||||||||+|..+++.+|+.
T Consensus 81 ~~~p~lKvllSiGGW~~s~------~~~~~~~~fs~~~~~~~~R~~Fi~siv~~l~~ygfDGIDIDWE~P~~~~~~~~~~ 154 (356)
T d1goia2 81 AHNPSLRIMFSIGGWYYSN------DLGVSHANYVNAVKTPASRAKFAQSCVRIMKDYGFDGVNIDWEYPQAAEVDGFIA 154 (356)
T ss_dssp GGCTTCEEEEEEECHHHHS------TTSTTHHHHHHHTSSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCHHHHHHHHH
T ss_pred HHCCCCeEEEEEcCCcCCC------CCcccccchHHHhCCHHHHHHHHHHHHHHHHHhCCCceeeeeccccccccccchh
Confidence 9999999999997776431 1233445699999999999999999999999999999999999999899999999
Q ss_pred HHHHHHHHcc--------CCCccEEEeeeecCCcccccc-cCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCC
Q 004402 165 LLDEWKASAS--------DQPELTLSMAVRYSPTHETVS-YPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSS 235 (755)
Q Consensus 165 ~l~~lr~~l~--------~~~~~~ls~~~~~~~~~~~~~-~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~ 235 (755)
|++++|..++ ....+.+++++++.+...... +++++|+++||||||||||+|| .|++.+||+|||+..
T Consensus 155 l~~el~~~~~~~~~~~~~~~~~~~ls~a~~~~~~~~~~~~~d~~~l~~~vD~invMtYD~~g-~w~~~tg~~spLy~~-- 231 (356)
T d1goia2 155 ALQEIRTLLNQQTITDGRQALPYQLTIAGAGGAFFLSRYYSKLAQIVAPLDYINLMTYDLAG-PWEKVTNHQAALFGD-- 231 (356)
T ss_dssp HHHHHHHHHHHHHHHTTCTTSCCEEEEEEESSHHHHTTTGGGHHHHHTTCSEEEEECCCSSC-TTSSSCCCTTCSSBC--
T ss_pred HHHHHHHHHHHHHHHhccccccceeEEeccCCHHHHhhhhhHHHHhhcccCeeEEEeecccC-CCCCCCCCCCcccCC--
Confidence 9999997763 223578899998776554443 5899999999999999999995 578889999999753
Q ss_pred CCcHHHHHHHHHHCCCCCCceeecccccCCCcccC-------CCcchHHHHHHHhhcCCCcccccccceeeeeeecCcEE
Q 004402 236 NISTDFGIREWLRRGFPANKLVLGARASGPGITID-------GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATW 308 (755)
Q Consensus 236 ~~~~~~~v~~~~~~g~p~~KlvlG~p~yG~~~~~~-------~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (755)
.+.|..+.++|.+.||+.|... +...+....... ......++ .....|
T Consensus 232 -------------~~~p~~~~~~~~~~~G~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~p~-~~~~~~ 286 (356)
T d1goia2 232 -------------AAGPTFYNALREANLGWSWEELTRAFPSPFSLTVDAAVQQH-----------LMMEGVPS-AKIVMG 286 (356)
T ss_dssp -------------TTSCCBCCGGGGSSCCCCHHHHHHHCCSSBCCCHHHHHHHH-----------HTSTTCCG-GGEEEE
T ss_pred -------------CCCChhhccccccccccChhhcccccCCCcceeccHHHHHH-----------HHhcCCCc-cceeEE
Confidence 3578899999999999988643 222222221111 11111121 234579
Q ss_pred EeeCCcchhhhhhhcccccCccccccccccccchh
Q 004402 309 INFDGVETIKAKISYAKEKNLLGYKAFQLSNDDNW 343 (755)
Q Consensus 309 i~yd~~~S~~~K~~~a~~~~l~Gi~~W~l~~dd~~ 343 (755)
|+|||++|+++|++||+++||||+|+|++++||..
T Consensus 287 vsydd~~Si~~K~~y~~~~~LgGv~iW~l~~Dd~~ 321 (356)
T d1goia2 287 VPFDDAESFKYKAKYIKQQQLGGVMFWHLGQDNRN 321 (356)
T ss_dssp EESCCHHHHHHHHHHHHHTTCCEEEEECGGGSCTT
T ss_pred eccCCHHHHHHHHHHHHhCCCCEEEEEecCCCCCC
Confidence 99999999999999999999999999999999853
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.6e-46 Score=395.31 Aligned_cols=252 Identities=21% Similarity=0.297 Sum_probs=206.5
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
++|+..+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..++|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999965 569999999998877766788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC--CCCeEEEecCCccccccCC
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN--ELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~--~~~~kl~Dfgla~~~~~~~ 591 (755)
++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+....
T Consensus 106 ~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 999999988542 345899999999999999999999987 999999999999964 6789999999998765332
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
......||+.|||||++.+..++.++|||||||++|||+||+.||.... ........ ..... ..
T Consensus 181 ---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i----~~~~~------~~ 244 (350)
T d1koaa2 181 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETLRNV----KSCDW------NM 244 (350)
T ss_dssp ---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH----HHTCC------CS
T ss_pred ---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHH----HhCCC------CC
Confidence 2234678999999999999999999999999999999999999985322 11111111 11110 00
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSM 707 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 707 (755)
...........+.+++.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011111223467899999999999999999999873
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-46 Score=389.98 Aligned_cols=251 Identities=20% Similarity=0.265 Sum_probs=188.0
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST-QGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
.+.|+..+.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|+++|++++|||||++++++.+.+..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 35688899999999999999965 4689999999976532 334568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc---CCCCeEEEecCCccccc
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD---NELNPKISDFGMAKLFR 588 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~---~~~~~kl~Dfgla~~~~ 588 (755)
||++|+|.+++.. +..+++..+..++.||+.||.|||+.+ |+||||||+|||++ +++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999854 346999999999999999999999987 99999999999994 57899999999998654
Q ss_pred cCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccC
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFID 668 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 668 (755)
... .....+||+.|||||++.+..++.++|||||||++|||++|+.||..... ...... ...... . ..
T Consensus 162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~----i~~~~~-~-~~ 229 (307)
T d1a06a_ 162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---AKLFEQ----ILKAEY-E-FD 229 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHH----HHTTCC-C-CC
T ss_pred CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH---HHHHHH----HhccCC-C-CC
Confidence 321 22346799999999999999999999999999999999999999853221 111111 111110 0 11
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 669 PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 669 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..........+.+++.+||+.||++|||++|+++
T Consensus 230 ----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 230 ----SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp ----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1111122346889999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=381.66 Aligned_cols=249 Identities=27% Similarity=0.387 Sum_probs=194.6
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeec-CCccEEEEeec
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTE-RDENMLIYEYL 513 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~ 513 (755)
++|+..+.||+|+||.||+|.. +|+.||||+++... ..+.|.+|++++++++||||++++|+|.+ .+..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 4567789999999999999988 68899999997543 34789999999999999999999999865 45689999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++|+|.+++... ....+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 999999998542 2335899999999999999999999986 999999999999999999999999999865332
Q ss_pred cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCCC
Q 004402 594 ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSLD 672 (755)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 672 (755)
.....+|..|+|||++.++.++.++|||||||++|||+| |+.|+.... ........ ..+. .+.+.
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~---~~~~~~~i----~~~~-----~~~~~ 222 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRV----EKGY-----KMDAP 222 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC---GGGHHHHH----TTTC-----CCCCC
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC---HHHHHHHH----HcCC-----CCCCC
Confidence 223467889999999999999999999999999999999 565553322 12222222 1111 11111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 673 DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 673 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
. ....++.+|+.+||+.||++|||+.||+++|++.
T Consensus 223 ~----~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 223 D----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c----cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 2 2234788999999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-45 Score=392.51 Aligned_cols=255 Identities=23% Similarity=0.311 Sum_probs=207.7
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEeec
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEYL 513 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 513 (755)
++|+..+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..++|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4688999999999999999964 579999999998776666678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc--CCCCeEEEecCCccccccCC
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD--NELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~--~~~~~kl~Dfgla~~~~~~~ 591 (755)
++|+|.+++.. ....+++.++..++.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||+++.+....
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999887643 2345899999999999999999999987 99999999999998 67899999999998765432
Q ss_pred cccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
......||+.|||||++.+..++.++|||||||++|||+||+.||..... ....... ..... . +....
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i----~~~~~-~-~~~~~ 251 (352)
T d1koba_ 184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNV----KRCDW-E-FDEDA 251 (352)
T ss_dssp ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHH----HHCCC-C-CCSST
T ss_pred ---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH----HhCCC-C-CCccc
Confidence 22345789999999999999999999999999999999999999853221 1111111 11110 0 11111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhhc
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKD 710 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~ 710 (755)
.......+.+|+.+||+.||++|||+.|+++ .+++
T Consensus 252 ----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 252 ----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp ----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred ----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 1122346789999999999999999999987 3544
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-46 Score=390.38 Aligned_cols=255 Identities=25% Similarity=0.409 Sum_probs=199.0
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCC----EEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQ----EFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
.+|+..++||+|+||+||+|.. .+|+ .||+|+++.. ..+..++|.+|++++++++|||||+++|+|.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 3588899999999999999965 3444 6899988654 344567899999999999999999999999864 5678
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
++||+.+|+|.+++.. ....+++..+++++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999888754 3446899999999999999999999986 9999999999999999999999999999876
Q ss_pred cCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
............||+.|||||.+.++.++.++|||||||++|||+| |+.|+...... ........ +. .
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~~i~~----~~--~-- 231 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILEK----GE--R-- 231 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHHHHHH----TC--C--
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHc----CC--C--
Confidence 5444444445578999999999999999999999999999999999 67776533222 22222211 11 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
+ ..+......+.+++.+||+.||++|||+.||++.|+..
T Consensus 232 -~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 232 -L----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -C----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 0 11122334688999999999999999999999988764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=387.15 Aligned_cols=262 Identities=27% Similarity=0.389 Sum_probs=199.0
Q ss_pred HHhcCCCccCcccccCCeeEEEEEcC------CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecC
Q 004402 432 AATNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSAT-STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTER 503 (755)
Q Consensus 432 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 503 (755)
...++|+..++||+|+||.||+|... +++.||||+++.. .....+.+.+|...+.++ +|+||+.+++++.+.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 33467889999999999999999642 3468999999754 334456788888888877 789999999998765
Q ss_pred C-ccEEEEeecCCCChhhhhcCCCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEE
Q 004402 504 D-ENMLIYEYLPNKSLDLYLFDPIR-------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNIL 569 (755)
Q Consensus 504 ~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIl 569 (755)
+ ..++|||||++|+|.+++..... +..+++..+..++.||++||.|||+.+ |+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcccee
Confidence 4 68999999999999999864321 235889999999999999999999987 999999999999
Q ss_pred EcCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCC-CCCCCCCCccc
Q 004402 570 LDNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR-NARYYGTSENL 648 (755)
Q Consensus 570 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~-p~~~~~~~~~~ 648 (755)
|++++.+||+|||+++...............||+.|||||.+.++.++.++|||||||++|||+||.. |+...... .
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~ 244 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--E 244 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--H
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--H
Confidence 99999999999999987665544445556789999999999999999999999999999999999765 45322211 1
Q ss_pred chHHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 649 NFLEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
...... ..+.. +..... ....+.+++.+||+.||++|||+.||++.|++.
T Consensus 245 ~~~~~~----~~~~~-----~~~~~~----~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 245 EFCRRL----KEGTR-----MRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHHHHH----HHTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHH----hcCCC-----CCCCcc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111111 11111 111112 223688999999999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=387.78 Aligned_cols=262 Identities=24% Similarity=0.380 Sum_probs=210.1
Q ss_pred hcCCCccCcccccCCeeEEEEEc------CCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL------PRGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDE 505 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 505 (755)
.++|+..++||+|+||.||+|+. .+++.||||+++... ......|.+|+.++.++ +|||||+++|+|.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 35778889999999999999964 346789999997653 34456799999999999 79999999999999999
Q ss_pred cEEEEeecCCCChhhhhcCCC---------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEE
Q 004402 506 NMLIYEYLPNKSLDLYLFDPI---------------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILL 570 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll 570 (755)
.++|||||++|+|.+++.... ....+++..+..++.||++||+|||+++ ++||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999986432 2235899999999999999999999987 9999999999999
Q ss_pred cCCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccch
Q 004402 571 DNELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNF 650 (755)
Q Consensus 571 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~ 650 (755)
+.++.+|++|||+++...............||+.|+|||.+.++.++.++|||||||++|||+|++.|+....... ..+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-~~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SKF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-HHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-HHH
Confidence 9999999999999997765444444556789999999999999999999999999999999999655543222211 111
Q ss_pred HHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 651 LEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 651 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
...... +. .+.. +......+.+|+.+||+.||++||||.||+++|++..
T Consensus 258 ~~~i~~----~~-----~~~~----~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 258 YKMIKE----GF-----RMLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HHHHHH----TC-----CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhc----CC-----CCCC----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 111111 11 1111 1122346889999999999999999999999998753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-46 Score=382.04 Aligned_cols=255 Identities=25% Similarity=0.361 Sum_probs=193.9
Q ss_pred cCCCccCcccccCCeeEEEEEcC--CC--CEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP--RG--QEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM 507 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 507 (755)
++|+..+.||+|+||.||+|... ++ ..||||++... ..+..++|.+|+++|++++||||++++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56888899999999999999642 23 37899998654 33446789999999999999999999999975 4678
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
+|||||++|++.+++... ...+++..++.++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999999887542 345899999999999999999999986 999999999999999999999999999977
Q ss_pred ccCCccc-ccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCcc
Q 004402 588 RKDVDEA-NTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKE 665 (755)
Q Consensus 588 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (755)
....... ......||..|+|||.+.+..++.++|||||||++|||+| |+.||..... ....... ...+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~---~~~~~~i---~~~~~--- 232 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKI---DKEGE--- 232 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHH---HTSCC---
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH---HHHHHHH---HhCCC---
Confidence 5543322 2334567889999999999999999999999999999998 7888743211 1111111 11111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 004402 666 FIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKD 710 (755)
Q Consensus 666 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 710 (755)
.+.. +...+..+.+++.+||+.||++||||.||.++|++
T Consensus 233 --~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 233 --RLPR----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp --CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCC----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 0111 11223468899999999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=383.04 Aligned_cols=250 Identities=22% Similarity=0.309 Sum_probs=202.0
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC------hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS------TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENM 507 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 507 (755)
++|+..+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5789999999999999999965 569999999986532 223678999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC----CeEEEecCC
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL----NPKISDFGM 583 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~----~~kl~Dfgl 583 (755)
+|||||++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999853 346999999999999999999999987 99999999999998776 499999999
Q ss_pred ccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG 663 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (755)
++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .... ..+.....
T Consensus 164 a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~----~~i~~~~~ 233 (293)
T d1jksa_ 164 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETL----ANVSAVNY 233 (293)
T ss_dssp CEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHTTCC
T ss_pred hhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH---HHHH----HHHHhcCC
Confidence 98764332 22345789999999999999999999999999999999999999853221 1111 11111110
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 664 KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 664 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.............+.+++.+||+.||++|||++|+++
T Consensus 234 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 ------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000112236789999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=386.85 Aligned_cols=261 Identities=25% Similarity=0.397 Sum_probs=209.8
Q ss_pred hcCCCccCcccccCCeeEEEEEcC------CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLP------RGQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDEN 506 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 506 (755)
.++|...+.||+|+||+||+|.+. .++.||||+++.. ..+....|.+|++++++++||||++++|+|...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 357788899999999999999652 3578999999754 344456799999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCC-------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEE
Q 004402 507 MLIYEYLPNKSLDLYLFDPI-------RRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKIS 579 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~ 579 (755)
++|||||++|+|.+++.... ....+++..+.+++.|+++||.|||+.+ |+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 99999999999999885321 1234789999999999999999999986 9999999999999999999999
Q ss_pred ecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCC-CCCCCCCCcccchHHHHHHHh
Q 004402 580 DFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKR-NARYYGTSENLNFLEYAFEQW 658 (755)
Q Consensus 580 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~ 658 (755)
|||+++...............||+.|+|||.+.++.++.++|||||||++|||+||+. |+.. ......... .
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~---~~~~~~~~~----i 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSNEQVLRF----V 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT---SCHHHHHHH----H
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC---CCHHHHHHH----H
Confidence 9999987655444444445678999999999999999999999999999999999864 4422 111111211 1
Q ss_pred ccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 659 KDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 659 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
..+.... . +...+..+.+++.+||+.||++||||++|+++|++...
T Consensus 249 ~~~~~~~-----~----p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 MEGGLLD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HTTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HhCCCCC-----C----cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1221111 1 11223468899999999999999999999999987543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=378.59 Aligned_cols=255 Identities=20% Similarity=0.321 Sum_probs=194.2
Q ss_pred hcCCCccCcccccCCeeEEEEEcCC----CCEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEE
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNLPR----GQEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENML 508 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 508 (755)
.++|+..+.||+|+||.||+|.... +..||||.++.. .....+.|.+|+++|++++||||++++|++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578888999999999999996532 357999998654 3444678999999999999999999999996 467899
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
||||+++|+|..++.. ....+++..++.++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++.+.
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999988753 3346899999999999999999999987 9999999999999999999999999998764
Q ss_pred cCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccchHHHHHHHhccCCCcccc
Q 004402 589 KDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNFLEYAFEQWKDSKGKEFI 667 (755)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (755)
.... .......||+.|+|||.+.+..++.++|||||||++|||+| |..|+..... ....... ..+...
T Consensus 160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~---~~~~~~i----~~~~~~--- 228 (273)
T d1mp8a_ 160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRI----ENGERL--- 228 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHH----HTTCCC---
T ss_pred CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH---HHHHHHH----HcCCCC---
Confidence 3322 23334578999999999999999999999999999999998 7777754322 2222222 111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 668 DPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 668 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
... ...+..+.+|+.+||+.||++|||+.||++.|+..
T Consensus 229 --~~~----~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 229 --PMP----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp --CCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCC----CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111 12234788999999999999999999999999764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-45 Score=380.99 Aligned_cols=269 Identities=23% Similarity=0.294 Sum_probs=199.8
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC----ccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD----ENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lv~ 510 (755)
+.|...+.||+|+||.||+|+. +|+.||||+++..... ...+..|+..+.+++||||++++++|.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 3566778999999999999987 7899999999654322 122334555566789999999999997654 478999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEY-----SNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~-----~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
|||++|+|.+++.. ..++|..+++++.+++.||.|||+. +..+|+||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999953 3589999999999999999999974 23469999999999999999999999999999
Q ss_pred ccccCCcc--cccccccccCCccccccccCCC------CCchhhHHHHHHHHHHHHcCCCCCCCCCCCcc--------cc
Q 004402 586 LFRKDVDE--ANTGRIVGTYGYVPPEYVKKGI------YSMKYDVYSFGVLLLQIISSKRNARYYGTSEN--------LN 649 (755)
Q Consensus 586 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~--------~~ 649 (755)
........ .......||+.|||||++.+.. ++.++|||||||+||||+||..|+........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 76543322 2234567999999999987643 67899999999999999999877643222111 01
Q ss_pred hHHHHHHHhccCCCccccCCCCCCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 650 FLEYAFEQWKDSKGKEFIDPSLDDSS-SPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
............ ..+|.+.... .......+.+++.+||+.||++|||+.||++.|++...
T Consensus 237 ~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 237 SVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 111111111111 1222222211 22345568899999999999999999999999987543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-45 Score=380.62 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=201.3
Q ss_pred cCcccccCCeeEEEEEcCCC----CEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC-CccEEEEeec
Q 004402 440 ANKLGEGGFGPVYKGNLPRG----QEFAVKRLSAT-STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER-DENMLIYEYL 513 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lv~e~~ 513 (755)
.++||+|+||+||+|.+.++ ..||||+++.. .....++|.+|+++|++++||||++++|+|... ...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999976432 26899999753 555668899999999999999999999998764 5789999999
Q ss_pred CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCcc
Q 004402 514 PNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVDE 593 (755)
Q Consensus 514 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 593 (755)
++|+|.+++... ....++..+++++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999988643 345778899999999999999999987 999999999999999999999999999976543222
Q ss_pred --cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCCC
Q 004402 594 --ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPSL 671 (755)
Q Consensus 594 --~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 671 (755)
.......||+.|+|||.+..+.++.++||||||+++|||+||+.|+...... ........ .+. ....+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i~----~g~--~~~~p-- 256 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLL----QGR--RLLQP-- 256 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH----TTC--CCCCC--
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHHH----cCC--CCCCc--
Confidence 2233457899999999999999999999999999999999988887532221 12222221 111 11111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 672 DDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 672 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
......+.+++.+||+.||++||||.||++.|+++..
T Consensus 257 -----~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 257 -----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp -----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1223468899999999999999999999999987643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=386.86 Aligned_cols=257 Identities=26% Similarity=0.392 Sum_probs=201.8
Q ss_pred cCCCccCcccccCCeeEEEEEcCC-CC--EEEEEEeccC-ChhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCccEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPR-GQ--EFAVKRLSAT-STQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 509 (755)
++|+..++||+|+||+||+|...+ |. .||||+++.. ..+..+.|.+|+++|.++ +|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 467778999999999999997643 44 5788887644 334556899999999999 799999999999999999999
Q ss_pred EeecCCCChhhhhcCC-------------CccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCe
Q 004402 510 YEYLPNKSLDLYLFDP-------------IRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNP 576 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~ 576 (755)
|||+++|+|.++++.. .....+++..+.+++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998653 22456899999999999999999999986 9999999999999999999
Q ss_pred EEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCC-CCCCCCCcccchHHHHH
Q 004402 577 KISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRN-ARYYGTSENLNFLEYAF 655 (755)
Q Consensus 577 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p-~~~~~~~~~~~~~~~~~ 655 (755)
||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|..| +... .... ..
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~---~~~~----~~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAE----LY 236 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHH----HH
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC---CHHH----HH
Confidence 999999998654322 22245689999999999999999999999999999999998754 4321 1111 11
Q ss_pred HHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 004402 656 EQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSM 713 (755)
Q Consensus 656 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 713 (755)
..+..+. .+.. +......+.+|+.+||+.||++||||+||++.|++...
T Consensus 237 ~~i~~~~-----~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 237 EKLPQGY-----RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp HHGGGTC-----CCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcC-----CCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 2222211 1111 12233478899999999999999999999999987643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=383.15 Aligned_cols=259 Identities=26% Similarity=0.343 Sum_probs=205.3
Q ss_pred cCCCccCcccccCCeeEEEEEcC--------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCC
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLP--------RGQEFAVKRLSATS-TQGLEEFKNEVSLTARL-QHVNLLRVLGYCTERD 504 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 504 (755)
++|+..+.||+|+||.||+|+.. ++..||||+++... .....++.+|...+.++ +|||||+++++|.+.+
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 56778899999999999999642 23479999997654 34457889999999888 8999999999999999
Q ss_pred ccEEEEeecCCCChhhhhcCCCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEc
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPIR-------------RYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLD 571 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~ 571 (755)
..++|||||++|+|.+++..... ...+++.+++.++.||+.||.|||+.+ ||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence 99999999999999999964321 245899999999999999999999987 99999999999999
Q ss_pred CCCCeEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccch
Q 004402 572 NELNPKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIIS-SKRNARYYGTSENLNF 650 (755)
Q Consensus 572 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ellt-g~~p~~~~~~~~~~~~ 650 (755)
.++.+||+|||+++...............+|+.|+|||.+.++.|+.++|||||||++|||+| |..|+..... .
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---~-- 244 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---E-- 244 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---H--
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---H--
Confidence 999999999999998766555445556678999999999999999999999999999999998 5666642221 1
Q ss_pred HHHHHHHhccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 004402 651 LEYAFEQWKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDS 712 (755)
Q Consensus 651 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 712 (755)
.....+..+.. +..... ....+.+|+.+||+.||++|||+.||++.|+++.
T Consensus 245 --~~~~~i~~~~~-----~~~p~~----~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 245 --ELFKLLKEGHR-----MDKPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp --HHHHHHHTTCC-----CCCCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHHHcCCC-----CCCCcc----chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 12222222211 111112 2346889999999999999999999999998764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-44 Score=377.46 Aligned_cols=244 Identities=24% Similarity=0.310 Sum_probs=201.3
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688899999999999999975 56999999999653 2334678999999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
|||++|+|..++.. ...+++.....++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999888743 345788899999999999999999987 999999999999999999999999999875432
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
....+||+.|||||++.+..++.++|||||||++|||+||+.||..... ....... .... ..
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~i----~~~~------~~ 219 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKTYEKI----LNAE------LR 219 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHH----HHCC------CC
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH---HHHHHHH----HcCC------CC
Confidence 2246899999999999999999999999999999999999999853221 1111111 1111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRP-----SMLEVSS 706 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 706 (755)
+... ....+.+++.+||+.||++|| |++|+++
T Consensus 220 ~p~~----~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 FPPF----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCTT----SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCC----CCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1111 223678999999999999996 8999985
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=380.89 Aligned_cols=247 Identities=21% Similarity=0.269 Sum_probs=203.3
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+..+.||+|+||.||++.. .+|+.||||++++. .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5688999999999999999964 57999999999754 2334577899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
|||++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999988853 345889999999999999999999987 999999999999999999999999999865432
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
. ......+||+.|||||++.+..|+.++|||||||++|||++|+.|+..... ..+. ....... ..
T Consensus 159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~----~~i~~~~------~~ 223 (337)
T d1o6la_ 159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLF----ELILMEE------IR 223 (337)
T ss_dssp T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHCC------CC
T ss_pred C--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---HHHH----HHHhcCC------CC
Confidence 2 223346899999999999999999999999999999999999999854321 1111 1111111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPS-----MLEVSS 706 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 706 (755)
+.... ...+.+|+.+||+.||++||+ ++|+++
T Consensus 224 ~p~~~----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 FPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCccC----CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 11222 236789999999999999995 778875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=375.43 Aligned_cols=261 Identities=22% Similarity=0.281 Sum_probs=195.5
Q ss_pred ccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChh-----hHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 439 SANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQ-----GLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 439 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
.+++||+|+||+||+|.. .+|+.||||+++..... ..+.+.+|+.+|++++|||||++++++...+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999975 46999999998654321 124688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+.++++..+.. .+..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 99988776653 3345888899999999999999999987 99999999999999999999999999986554322
Q ss_pred ccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC--
Q 004402 593 EANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP-- 669 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-- 669 (755)
.....+||+.|+|||.+... .++.++|||||||++|||+||+.||..... .+.+....+...........+.
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~---~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH---HHHHHHHHHhcCCCChhhccchhc
Confidence 22235789999999988654 679999999999999999999988854322 2222222222111110000000
Q ss_pred -----CCCC--CCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhhc
Q 004402 670 -----SLDD--SSS-----PCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKD 710 (755)
Q Consensus 670 -----~l~~--~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~ 710 (755)
.... ..+ ......+.+|+.+||+.||++|||++|+++ .|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 0000 000 011246889999999999999999999986 5654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.2e-44 Score=372.81 Aligned_cols=259 Identities=21% Similarity=0.329 Sum_probs=198.6
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc----
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDE---- 505 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---- 505 (755)
.++|+..+.||+|+||+||+|.. .+|+.||||+++.. +.+..+.|.+|+++|++++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 35788999999999999999964 67999999999754 23445679999999999999999999999876543
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
.++|||||++|+|..++.. ...+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++..+|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 7899999999999988743 346899999999999999999999987 9999999999999999999999999998
Q ss_pred ccccCCc-ccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCc
Q 004402 586 LFRKDVD-EANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664 (755)
Q Consensus 586 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (755)
....... .......+||+.|||||++.+..++.++|||||||++|||+||+.||..... ... ..........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~---~~~~~~~~~~- 232 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---VSV---AYQHVREDPI- 232 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHH---HHHHHHCCCC-
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH---HHH---HHHHHhcCCC-
Confidence 6543322 2233456899999999999999999999999999999999999999853221 111 1111111110
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhcC
Q 004402 665 EFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRP-SMLEVSSMLKDD 711 (755)
Q Consensus 665 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~ 711 (755)
........ .+..+.+++.+||+.||++|| |++++++.|.+.
T Consensus 233 --~~~~~~~~----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 233 --PPSARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp --CGGGTSSS----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --CCchhccC----CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 00011111 224688999999999999999 899999888653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.9e-44 Score=368.01 Aligned_cols=250 Identities=21% Similarity=0.323 Sum_probs=201.5
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCCh---------hhHHHHHHHHHHHhcCC-CCceeeeeeeeecC
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST---------QGLEEFKNEVSLTARLQ-HVNLLRVLGYCTER 503 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 503 (755)
++|+..+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788999999999999999965 5799999999865421 12346889999999996 99999999999999
Q ss_pred CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCC
Q 004402 504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM 583 (755)
Q Consensus 504 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl 583 (755)
+..++|||||++|+|.+++.. +..+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999953 346899999999999999999999987 99999999999999999999999999
Q ss_pred ccccccCCcccccccccccCCcccccccc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHH
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVK------KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQ 657 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 657 (755)
++.+.... ......||+.|+|||.+. ...++.++||||+||++|||++|+.||.... .........
T Consensus 157 a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---~~~~~~~i~-- 228 (277)
T d1phka_ 157 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLRMIM-- 228 (277)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH--
T ss_pred eeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC---HHHHHHHHH--
Confidence 98765432 223457899999999885 3457889999999999999999999985322 111111111
Q ss_pred hccCCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 658 WKDSKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 658 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.+.. . ...........++.+++.+||+.||++|||++|+++
T Consensus 229 --~~~~-~-----~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 --SGNY-Q-----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp --HTCC-C-----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --hCCC-C-----CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111 0 111111223347889999999999999999999865
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-43 Score=375.46 Aligned_cols=244 Identities=19% Similarity=0.241 Sum_probs=202.0
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 510 (755)
++|+.++.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+|+.++|||||++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4688999999999999999965 56999999998643 2234567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccC
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKD 590 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 590 (755)
||+.+|+|..++.. ...+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++.+...
T Consensus 121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999988853 345899999999999999999999987 999999999999999999999999999876432
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
.....||+.|||||++.+..++.++|||||||++|||+||+.||... ......... .... ..
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i----~~~~------~~ 256 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKI----VSGK------VR 256 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH----HHCC------CC
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc---CHHHHHHHH----hcCC------CC
Confidence 22467999999999999999999999999999999999999998532 111111111 1111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRP-----SMLEVSS 706 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 706 (755)
.... ....+.+++.+||+.||.+|+ |++|+++
T Consensus 257 ~p~~----~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 FPSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCcc----CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1112 223678999999999999994 8999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.1e-43 Score=376.87 Aligned_cols=248 Identities=26% Similarity=0.298 Sum_probs=196.7
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC---hhhHHHH---HHHHHHHhcCCCCceeeeeeeeecCCccE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS---TQGLEEF---KNEVSLTARLQHVNLLRVLGYCTERDENM 507 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 507 (755)
++|+..++||+|+||.||+|+. .+|+.||||++.... ......+ .+|+.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5788899999999999999965 569999999986432 1122233 44577788889999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccc
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLF 587 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~ 587 (755)
+|||||++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999853 345789999999999999999999987 999999999999999999999999999876
Q ss_pred ccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccc
Q 004402 588 RKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEF 666 (755)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (755)
... ......||+.|||||++.. ..++.++|||||||+||||+||+.||.......... .......
T Consensus 158 ~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----~~~~~~~------ 223 (364)
T d1omwa3 158 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------ 223 (364)
T ss_dssp SSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH----HHHHSSS------
T ss_pred CCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhccc------
Confidence 433 2334579999999999865 568999999999999999999999986543322111 1111110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 004402 667 IDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPS-----MLEVSS 706 (755)
Q Consensus 667 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 706 (755)
....+.... ...+.+++.+||+.||++||| ++|+++
T Consensus 224 ~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 224 MAVELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCCCCSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCCCC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 011111122 236789999999999999999 688864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=373.35 Aligned_cols=255 Identities=19% Similarity=0.266 Sum_probs=203.8
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
.++|+..+.||+|+||+||+|.. .+|+.||||+++....+ ...+.+|+++|++++|||||++++++.+.+..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 35788999999999999999965 56899999999766433 35688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC--CCeEEEecCCccccccC
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE--LNPKISDFGMAKLFRKD 590 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~--~~~kl~Dfgla~~~~~~ 590 (755)
|++|+|.+++... ...+++.++..++.||+.||.|||+.+ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999998542 335899999999999999999999987 9999999999999854 58999999999875432
Q ss_pred CcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCCC
Q 004402 591 VDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDPS 670 (755)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 670 (755)
. ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||..... ........ ..... ++..
T Consensus 158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---~~~~~~i~----~~~~~--~~~~ 225 (321)
T d1tkia_ 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENIM----NAEYT--FDEE 225 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHH----HTCCC--CCHH
T ss_pred C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH---HHHHHHHH----hCCCC--CChh
Confidence 2 22345789999999999999999999999999999999999999854321 11111111 11100 0000
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhhc
Q 004402 671 LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKD 710 (755)
Q Consensus 671 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~ 710 (755)
... .....+.+++.+||+.||++|||+.|+++ .+++
T Consensus 226 ~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 226 AFK----EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred hcc----CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 000 11236789999999999999999999997 4544
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=373.18 Aligned_cols=251 Identities=19% Similarity=0.221 Sum_probs=195.3
Q ss_pred cCCCccC-cccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCceeeeeeeeec----CCccE
Q 004402 435 NNFSSAN-KLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARL-QHVNLLRVLGYCTE----RDENM 507 (755)
Q Consensus 435 ~~f~~~~-~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~ 507 (755)
++|...+ .||+|+||+||+|.. .+++.||||+++.. ..+.+|++++.++ +|||||++++++.+ ....+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5787764 599999999999964 67999999998643 4567899887655 89999999999865 35689
Q ss_pred EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC---CCCeEEEecCCc
Q 004402 508 LIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGMA 584 (755)
Q Consensus 508 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~---~~~~kl~Dfgla 584 (755)
+|||||++|+|.+++... ....+++.++..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 999999999999999643 2345899999999999999999999987 999999999999985 567999999999
Q ss_pred cccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCc
Q 004402 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664 (755)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (755)
+...... ......||+.|||||++.+..|+.++|||||||++|||+||+.||........... .......
T Consensus 162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~~~~i~~---- 231 (335)
T d2ozaa1 162 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRM---- 231 (335)
T ss_dssp EECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCS----
T ss_pred eeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---HHHHHhc----
Confidence 8765432 22345799999999999999999999999999999999999999964433221110 0000000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 665 EFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 665 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
....+...........+.+|+.+||+.||++|||+.|+++
T Consensus 232 --~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 232 --GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp --CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0001111111123457889999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=372.35 Aligned_cols=247 Identities=24% Similarity=0.340 Sum_probs=199.5
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC---ChhhHHHHHHHHHHHh-cCCCCceeeeeeeeecCCccEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT---STQGLEEFKNEVSLTA-RLQHVNLLRVLGYCTERDENMLI 509 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lv 509 (755)
++|+..+.||+|+||+||+|.. .+|+.||||+++.. .....+.+..|..++. .++|||||++++++.+.+..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 4788899999999999999965 56999999999653 2234556677777665 68999999999999999999999
Q ss_pred EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcccccc
Q 004402 510 YEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRK 589 (755)
Q Consensus 510 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 589 (755)
||||++|+|..++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999853 345889999999999999999999987 99999999999999999999999999986543
Q ss_pred CCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCccccCC
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGKEFIDP 669 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 669 (755)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .... ...... .+
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~----~~i~~~------~~ 220 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELF----HSIRMD------NP 220 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHC------CC
T ss_pred cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH---HHHH----HHHHcC------CC
Confidence 32 223346799999999999999999999999999999999999999853221 1111 111111 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 004402 670 SLDDSSSPCKLLNCMQVALLCVQENPEDRPSML-EVSS 706 (755)
Q Consensus 670 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl~ 706 (755)
.+.... ...+.+|+.+||+.||++|||+. |+++
T Consensus 221 ~~p~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 FYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCccC----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 111122 23678999999999999999995 6753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-43 Score=367.10 Aligned_cols=269 Identities=23% Similarity=0.320 Sum_probs=200.9
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
++|+..++||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+....++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788999999999999999964 679999999996543 2335678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
|+.++.+...... ....+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9976555433322 2345899999999999999999999987 9999999999999999999999999998764332
Q ss_pred cccccccccccCCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC---Cccc-
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK---GKEF- 666 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~- 666 (755)
.......||+.|+|||.+.... ++.++|||||||++|||++|+.||..... ............... ....
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGG
T ss_pred --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH---HHHHHHHHHhcCCCchhhccccc
Confidence 2233457899999999887665 58899999999999999999999853221 111111111111100 0000
Q ss_pred --cC--CCCCC--CC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhhcCcc
Q 004402 667 --ID--PSLDD--SS-----SPCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKDDSM 713 (755)
Q Consensus 667 --~d--~~l~~--~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~ 713 (755)
.+ ..... .. .......+.+++.+||+.||++|||+.|+++ .+++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 00 00000 00 0011246789999999999999999999997 4765543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-42 Score=360.93 Aligned_cols=261 Identities=22% Similarity=0.340 Sum_probs=199.1
Q ss_pred cCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATS--TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 512 (755)
++|+..++||+|+||+||+|...+|+.||||++.... ....+.+.+|+.+|++++||||+++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788999999999999999988889999999996653 23357899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCCc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDVD 592 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 592 (755)
+.++++..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 98887776653 2356999999999999999999999986 99999999999999999999999999987643322
Q ss_pred ccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCc------c
Q 004402 593 EANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK------E 665 (755)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 665 (755)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||..... ................. .
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH---HHHHHHHHHhhCCCChhhccchhh
Confidence 22334688999999998754 569999999999999999999999854321 11122222111111000 0
Q ss_pred c--cCCCCC-------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 666 F--IDPSLD-------DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 666 ~--~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
. .+.... ..........+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000 0001112346789999999999999999999973
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=358.87 Aligned_cols=239 Identities=24% Similarity=0.384 Sum_probs=192.1
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCCh------hhHHHHHHHHHHHhcCC--CCceeeeeeeeecCCc
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATST------QGLEEFKNEVSLTARLQ--HVNLLRVLGYCTERDE 505 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~ 505 (755)
++|+..+.||+|+||+||+|.. .+|+.||||++..... .....+.+|+.+|++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5788899999999999999964 5799999999865321 11234678999999986 9999999999999999
Q ss_pred cEEEEeecCC-CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCC-CCeEEEecCC
Q 004402 506 NMLIYEYLPN-KSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNE-LNPKISDFGM 583 (755)
Q Consensus 506 ~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~-~~~kl~Dfgl 583 (755)
.++||||+.+ +++.+++. .+..+++..+..++.||++||.|||+.+ |+||||||+|||++.+ +.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 56666663 2346899999999999999999999987 9999999999999854 7899999999
Q ss_pred ccccccCCcccccccccccCCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC
Q 004402 584 AKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIY-SMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 584 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
++..... ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||.... .... ..
T Consensus 158 a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---------~i~~----~~ 220 (273)
T d1xwsa_ 158 GALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIR----GQ 220 (273)
T ss_dssp CEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHH----CC
T ss_pred ceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch---------HHhh----cc
Confidence 9865432 2334679999999999987665 677999999999999999999985310 0110 00
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 663 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
..+....+ .++.+++.+||+.||++|||++|+++
T Consensus 221 ------~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 ------VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ------CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------cCCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01111222 36789999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=358.05 Aligned_cols=262 Identities=21% Similarity=0.297 Sum_probs=193.6
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CC-CCEEEEEEeccCC--hhhHHHHHHHHHHHhcC---CCCceeeeeeeeec----
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PR-GQEFAVKRLSATS--TQGLEEFKNEVSLTARL---QHVNLLRVLGYCTE---- 502 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~---- 502 (755)
.++|+..++||+|+||+||+|.. .+ ++.||||+++... ......+.+|+.+|+.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999965 44 6679999986532 22223456677766655 89999999999853
Q ss_pred -CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEec
Q 004402 503 -RDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDF 581 (755)
Q Consensus 503 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Df 581 (755)
....++++||++++++...... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 2457899999998877655432 3445889999999999999999999987 999999999999999999999999
Q ss_pred CCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccC
Q 004402 582 GMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDS 661 (755)
Q Consensus 582 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 661 (755)
|+++..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||...... .............
T Consensus 161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLP 234 (305)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCC
T ss_pred hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCC
Confidence 999865432 2233568999999999999999999999999999999999999998543221 1121111111110
Q ss_pred CCcc----------ccCCCCC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 662 KGKE----------FIDPSLD---DSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 662 ~~~~----------~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.... ....... ..........+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 0000000 0001112346778999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=363.65 Aligned_cols=266 Identities=19% Similarity=0.278 Sum_probs=193.0
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC------CccEE
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRVLGYCTER------DENML 508 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 508 (755)
+|...++||+|+||+||+|+. .+|+.||||++...... +.+|+++|++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 466778999999999999965 56999999999765322 34799999999999999999998543 23689
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC-CeEEEecCCcccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDFGMAKLF 587 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~-~~kl~Dfgla~~~ 587 (755)
|||||+++.+..+.........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755544432234556999999999999999999999986 99999999999999775 8999999999876
Q ss_pred ccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHH--------HHHHh
Q 004402 588 RKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEY--------AFEQW 658 (755)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~--------~~~~~ 658 (755)
..... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+.. .+...
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 44322 223578999999998765 5789999999999999999999999854332111111000 00111
Q ss_pred ccCCCccccC----CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhhcC
Q 004402 659 KDSKGKEFID----PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKDD 711 (755)
Q Consensus 659 ~~~~~~~~~d----~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~ 711 (755)
.......... ..............+.+|+.+||+.||++|||+.|+++ .+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 1000000000 00000011122346789999999999999999999985 45543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.5e-41 Score=347.83 Aligned_cols=265 Identities=17% Similarity=0.190 Sum_probs=206.4
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCC-CceeeeeeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH-VNLLRVLGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e~ 512 (755)
++|...+.||+|+||+||+|.. .+|+.||||++...... ..+.+|++.+..++| +|++.+++++......++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc--HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 5788999999999999999964 56899999998654322 356788899999865 8999999999999999999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC-----CCCeEEEecCCcccc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN-----ELNPKISDFGMAKLF 587 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~-----~~~~kl~Dfgla~~~ 587 (755)
+ +++|.+++... ...+++.+...++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+
T Consensus 83 ~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 83 L-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred c-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 8 68998887532 335899999999999999999999987 999999999999974 578999999999976
Q ss_pred ccCCcc-----cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC
Q 004402 588 RKDVDE-----ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK 662 (755)
Q Consensus 588 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 662 (755)
...... ......+||+.|||||.+.+..++.++|||||||++|||+||+.|+.......................
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 543221 123356899999999999999999999999999999999999999975544433322222111111111
Q ss_pred CccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccccC
Q 004402 663 GKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDDSMAIA 716 (755)
Q Consensus 663 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 716 (755)
..++ .... +.++.+++..|++.+|++||+++.+.+.|++......
T Consensus 237 ~~~l-----~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 237 LREL-----CAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp HHHH-----TTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred hHHh-----cCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 1111 1111 2367889999999999999999999999887554433
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-41 Score=354.83 Aligned_cols=263 Identities=17% Similarity=0.268 Sum_probs=193.4
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeec--------C
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTE--------R 503 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~ 503 (755)
++|+..+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+++|++++|||++++++.+.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6788999999999999999965 57999999998544 23345678999999999999999999998855 3
Q ss_pred CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCC
Q 004402 504 DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGM 583 (755)
Q Consensus 504 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl 583 (755)
...++||||+.++++..+.. ....++......++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 45789999999887765542 2345788999999999999999999987 99999999999999999999999999
Q ss_pred ccccccCCcc--cccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhcc
Q 004402 584 AKLFRKDVDE--ANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKD 660 (755)
Q Consensus 584 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 660 (755)
++.+...... ......+||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... .............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~---~~~~~~i~~~~~~ 240 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE---QHQLALISQLCGS 240 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH---HHHHHHHHHhcCC
Confidence 9876533211 122335789999999998765 689999999999999999999999853222 1111111111111
Q ss_pred ---CCCcccc--------CCCCCCCCCH-H------HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 661 ---SKGKEFI--------DPSLDDSSSP-C------KLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 661 ---~~~~~~~--------d~~l~~~~~~-~------~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
....... .......... + ....+.+|+.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0000000 0000000111 1 1224568999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=354.70 Aligned_cols=266 Identities=19% Similarity=0.260 Sum_probs=192.7
Q ss_pred hcCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC------
Q 004402 434 TNNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD------ 504 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 504 (755)
.++|+..+.||+|+||+||+|.. .+|+.||||+++.. .....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 35788999999999999999964 56999999999754 3344567899999999999999999999997654
Q ss_pred ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCc
Q 004402 505 ENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMA 584 (755)
Q Consensus 505 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla 584 (755)
..++||||| +.+|..+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 556766652 345999999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCcccccccccccCCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHH--------H
Q 004402 585 KLFRKDVDEANTGRIVGTYGYVPPEYVKK-GIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYA--------F 655 (755)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~--------~ 655 (755)
+..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.|+............... .
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 865432 234578999999998876 45689999999999999999999998543221111000000 0
Q ss_pred HHhcc-------CCCccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhhcCcc
Q 004402 656 EQWKD-------SKGKEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKDDSM 713 (755)
Q Consensus 656 ~~~~~-------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~ 713 (755)
..... ....+.....+.. ........+.+|+.+||+.||++|||+.|+++ .|++...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred hhhcchhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 00000 0000000000000 00111235779999999999999999999997 3665443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-40 Score=353.63 Aligned_cols=266 Identities=21% Similarity=0.297 Sum_probs=196.5
Q ss_pred cCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC----ccEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSATS-TQGLEEFKNEVSLTARLQHVNLLRVLGYCTERD----ENML 508 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~l 508 (755)
.+|+.++.||+|+||+||+|. ..+|+.||||++.... ....+.+++|+.+|++++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 468899999999999999995 4679999999997543 445678999999999999999999999986643 2356
Q ss_pred EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccc
Q 004402 509 IYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFR 588 (755)
Q Consensus 509 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 588 (755)
+++|+.+|+|.+++.. ..+++..+..++.|+++||.|||+++ ||||||||+|||++.++.+||+|||+++...
T Consensus 88 l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 6677889999999842 35899999999999999999999987 9999999999999999999999999998764
Q ss_pred cCCcc-cccccccccCCcccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC---
Q 004402 589 KDVDE-ANTGRIVGTYGYVPPEYVK-KGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG--- 663 (755)
Q Consensus 589 ~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 663 (755)
..... ......+||+.|+|||.+. ...++.++||||+||+++||++|+.||......+. .............
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQEDL 237 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHH
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH---HHHHhhhccCCChhhh
Confidence 43222 2234567899999999985 45678999999999999999999999854322111 1111110000000
Q ss_pred --------ccc-c-CCCCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcC
Q 004402 664 --------KEF-I-DPSLDDSSS-----PCKLLNCMQVALLCVQENPEDRPSMLEVSSM--LKDD 711 (755)
Q Consensus 664 --------~~~-~-d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~ 711 (755)
... . .+.. ...+ +.....+.+++.+||+.||++|||+.|+++. |+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HTCCCHHHHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhcccccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 000 0 0000 0000 0112357899999999999999999999863 5433
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-41 Score=350.53 Aligned_cols=260 Identities=19% Similarity=0.210 Sum_probs=195.1
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCceeee-eeeeecCCccEEEEee
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNLLRV-LGYCTERDENMLIYEY 512 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l-~g~~~~~~~~~lv~e~ 512 (755)
++|+..+.||+|+||+||+|.. .+|+.||||++...... +++..|+++++.++|+|++.. .++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4688999999999999999964 56899999998665332 457889999999987765555 4555667788999999
Q ss_pred cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcC---CCCeEEEecCCcccccc
Q 004402 513 LPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDN---ELNPKISDFGMAKLFRK 589 (755)
Q Consensus 513 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~---~~~~kl~Dfgla~~~~~ 589 (755)
+. ++|...+.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. +..+||+|||+++.+..
T Consensus 85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 95 556555432 2345899999999999999999999987 999999999999854 55799999999997654
Q ss_pred CCcc-----cccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCCc
Q 004402 590 DVDE-----ANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKGK 664 (755)
Q Consensus 590 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (755)
.... .......||+.|||||.+.+..++.++|||||||++|||+||+.|+........................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI- 237 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH-
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh-
Confidence 3221 1234568999999999999999999999999999999999999999765444333222111111000000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 004402 665 EFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSSMLKDD 711 (755)
Q Consensus 665 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 711 (755)
+.+.... +.++.+++..||+.+|++||++.++.+.|++.
T Consensus 238 ----~~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 238 ----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp ----HHHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ----hHhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0011112 23678999999999999999999999998864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-40 Score=341.98 Aligned_cols=262 Identities=21% Similarity=0.262 Sum_probs=201.2
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCccEEEEe
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTERDENMLIYE 511 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 511 (755)
++|+.+++||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.+|+.++||||+++++++......++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5788999999999999999964 57899999998654 33446789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCccccccCC
Q 004402 512 YLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAKLFRKDV 591 (755)
Q Consensus 512 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 591 (755)
++.+++|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999998887743 345789999999999999999999987 9999999999999999999999999998765432
Q ss_pred cccccccccccCCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC---C---c
Q 004402 592 DEANTGRIVGTYGYVPPEYVKKGI-YSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK---G---K 664 (755)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~---~ 664 (755)
. ......++..|+|||.+.... ++.++|||||||++|||++|+.|+..... ................ . .
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhhhhh
Confidence 2 222345678999999887665 69999999999999999999998733221 1111221111111100 0 0
Q ss_pred cccC--------C-CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 665 EFID--------P-SLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 665 ~~~d--------~-~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
...+ . .-...........+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0 0000111122346789999999999999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-40 Score=346.37 Aligned_cols=252 Identities=22% Similarity=0.306 Sum_probs=198.6
Q ss_pred cCCCccCcccccCCeeEEEEEc----CCCCEEEEEEeccCC----hhhHHHHHHHHHHHhcCCC-CceeeeeeeeecCCc
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL----PRGQEFAVKRLSATS----TQGLEEFKNEVSLTARLQH-VNLLRVLGYCTERDE 505 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~ 505 (755)
++|+..+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 4688999999999999999953 248899999986532 2334568899999999966 899999999999999
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
.+++|||+.+|+|.+++.. ...+.......++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999998853 334678889999999999999999987 9999999999999999999999999998
Q ss_pred ccccCCcccccccccccCCccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCCC
Q 004402 586 LFRKDVDEANTGRIVGTYGYVPPEYVKKG--IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSKG 663 (755)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (755)
.+...... ......|++.|+|||.+.+. .++.++|||||||+||||++|+.||...........+.... ...
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~---~~~-- 251 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI---LKS-- 251 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH---HHC--
T ss_pred hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc---ccC--
Confidence 76443222 23345789999999998764 46889999999999999999999986554433322221111 111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004402 664 KEFIDPSLDDSSSPCKLLNCMQVALLCVQENPEDRP-----SMLEVSS 706 (755)
Q Consensus 664 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 706 (755)
.+.+.. .....+.+++.+||+.||++|| |++|+++
T Consensus 252 ----~~~~~~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 ----EPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----CCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----CCCCcc----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111111 2234788999999999999999 4788875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.7e-39 Score=344.70 Aligned_cols=257 Identities=16% Similarity=0.266 Sum_probs=194.1
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCceeeeeeeeecC--CccEEEE
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTER--DENMLIY 510 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lv~ 510 (755)
++|+..++||+|+||+||+|+. .+|+.||||+++... .+++.+|+++|.+++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999965 579999999997543 457889999999995 99999999998743 4689999
Q ss_pred eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCC-CeEEEecCCcccccc
Q 004402 511 EYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNEL-NPKISDFGMAKLFRK 589 (755)
Q Consensus 511 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~-~~kl~Dfgla~~~~~ 589 (755)
|||++++|..+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997654 24889999999999999999999987 99999999999998655 599999999987654
Q ss_pred CCcccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccc-hHHH---------HHHHh
Q 004402 590 DVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLN-FLEY---------AFEQW 658 (755)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~-~~~~---------~~~~~ 658 (755)
.. ......+|+.|+|||.+.+. .++.++||||+||+++||++|+.|+.......... .... .....
T Consensus 183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 32 22345789999999998765 57999999999999999999999986433221110 0000 00000
Q ss_pred ccCCCccc---cC--------CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 659 KDSKGKEF---ID--------PSLDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 659 ~~~~~~~~---~d--------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.......+ .. .............++.+|+.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 00 00111111122346789999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-39 Score=343.65 Aligned_cols=257 Identities=21% Similarity=0.255 Sum_probs=187.0
Q ss_pred cCCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC------Cc
Q 004402 435 NNFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER------DE 505 (755)
Q Consensus 435 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 505 (755)
++|+..++||+|+||+||+|.. .+|+.||||++... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 5788999999999999999965 46999999999754 344456789999999999999999999998643 56
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
.|+|||||.++++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 79999999776554432 24789999999999999999999987 9999999999999999999999999998
Q ss_pred ccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhc------
Q 004402 586 LFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWK------ 659 (755)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 659 (755)
..... .......+|+.|+|||++.+..++.++||||+||+++||++|+.||....... ..........
T Consensus 168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~---~~~~i~~~~~~~~~~~ 241 (355)
T d2b1pa1 168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCPEF 241 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHH
T ss_pred ccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH---HHHHHHHhccCCCHHH
Confidence 65432 22334578999999999999999999999999999999999999985332111 1111110000
Q ss_pred ------------cCCC-------ccccCCCCCCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004402 660 ------------DSKG-------KEFIDPSLDDSS---SPCKLLNCMQVALLCVQENPEDRPSMLEVSS 706 (755)
Q Consensus 660 ------------~~~~-------~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 706 (755)
.... ............ .......+.+|+.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 000100111111 1223456789999999999999999999984
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-39 Score=344.78 Aligned_cols=264 Identities=19% Similarity=0.262 Sum_probs=195.1
Q ss_pred hcCCCccCcccccCCeeEEEEE-cCCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCceeeeeeeeecC-----Cc
Q 004402 434 TNNFSSANKLGEGGFGPVYKGN-LPRGQEFAVKRLSAT--STQGLEEFKNEVSLTARLQHVNLLRVLGYCTER-----DE 505 (755)
Q Consensus 434 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 505 (755)
.++|+..+.||+|+||+||+|. ..+|+.||||+++.. .....+.+.+|+++|++++|||+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4579999999999999999996 467999999999754 334456789999999999999999999998643 33
Q ss_pred cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 506 NMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 506 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
.+++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 5677888899999998842 35899999999999999999999987 9999999999999999999999999997
Q ss_pred ccccCCcccccccccccCCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHHHHHHhccCC--
Q 004402 586 LFRKDVDEANTGRIVGTYGYVPPEYVKKG-IYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEYAFEQWKDSK-- 662 (755)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 662 (755)
.... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||....... .............
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~---~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPGAE 241 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCHH
T ss_pred ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChH
Confidence 5432 22335789999999987665 46899999999999999999999985432111 1111111100000
Q ss_pred ---------CccccCC--CCCCCC----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhhcCc
Q 004402 663 ---------GKEFIDP--SLDDSS----SPCKLLNCMQVALLCVQENPEDRPSMLEVSS--MLKDDS 712 (755)
Q Consensus 663 ---------~~~~~d~--~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~ 712 (755)
....... ...... .......+.+|+.+||+.||++|||+.|+++ .+.+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 0000000 000000 0011235779999999999999999999997 566543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-34 Score=311.84 Aligned_cols=281 Identities=18% Similarity=0.204 Sum_probs=196.7
Q ss_pred CCCccCcccccCCeeEEEEEc-CCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-----------CCceeeeeeeeecC
Q 004402 436 NFSSANKLGEGGFGPVYKGNL-PRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-----------HVNLLRVLGYCTER 503 (755)
Q Consensus 436 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~~ 503 (755)
+|+..++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 588899999999999999965 579999999997543 23467788998888775 57899999887653
Q ss_pred --CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCC------
Q 004402 504 --DENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELN------ 575 (755)
Q Consensus 504 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~------ 575 (755)
...+++++++..+..............+++..+..++.||+.||.|||+.. +|+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccce
Confidence 345677777666554444333334556888999999999999999999833 4999999999999986654
Q ss_pred eEEEecCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccchHHH--
Q 004402 576 PKISDFGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLLQIISSKRNARYYGTSENLNFLEY-- 653 (755)
Q Consensus 576 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~elltg~~p~~~~~~~~~~~~~~~-- 653 (755)
++++|||.+...... .....||+.|+|||.+....++.++||||+||+++||++|+.||..............
T Consensus 171 ~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 899999999864322 2345789999999999999999999999999999999999999865432221111111
Q ss_pred -HHHHhcc---------CCCccccC---------CC----------CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 004402 654 -AFEQWKD---------SKGKEFID---------PS----------LDDSSSPCKLLNCMQVALLCVQENPEDRPSMLEV 704 (755)
Q Consensus 654 -~~~~~~~---------~~~~~~~d---------~~----------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev 704 (755)
....+.. .......+ .. ............+.+|+.+||+.||++|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 1110000 00000000 00 0112234556678999999999999999999999
Q ss_pred HH--HhhcC--ccccCCCCCCccc
Q 004402 705 SS--MLKDD--SMAIAAPKRPAFS 724 (755)
Q Consensus 705 l~--~L~~~--~~~~~~p~~p~~~ 724 (755)
++ .+++. ......|..|.+.
T Consensus 326 L~Hp~f~~~~~~~~~~~p~~~~~~ 349 (362)
T d1q8ya_ 326 VNHPWLKDTLGMEEIRVPDRELYG 349 (362)
T ss_dssp HTCGGGTTCTTCTTCCCTTSCTTC
T ss_pred hcCcccCCCCCcccCCCCCcccCC
Confidence 86 35533 2234455555543
|
| >d1nara_ c.1.8.5 (A:) Seed storage protein {Vicia narbonensis, Narbonin [TaxId: 3912]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Seed storage protein species: Vicia narbonensis, Narbonin [TaxId: 3912]
Probab=99.96 E-value=5.6e-32 Score=278.13 Aligned_cols=217 Identities=14% Similarity=0.168 Sum_probs=158.5
Q ss_pred EEec-CCCCCCCCCCCCCCc------ceEEEEEEEecCC-----CcEEecCCchhhHHHHHHHHHHhhCCCceEEEEecC
Q 004402 31 GYWL-AGREFPLSDINSALF------THLICAFAEVDSS-----TYQLSISSANQQYFSIFANSVRRKNPSIKTLLSIWN 98 (755)
Q Consensus 31 gY~~-~~~~~~~~~i~~~~~------thi~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~isigg 98 (755)
.||- ..+..+++++|...+ +|++|+|+..... ++.+.............++++|++||++||||||||
T Consensus 7 ~Y~g~~~~~~~~~d~p~~~~~~~~~~~h~i~aFa~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~lK~~~~~~KvllSiGG 86 (289)
T d1nara_ 7 EYIGVKPNSTTLHDFPTEIINTETLEFHYILGFAIESYYESGKGTGTFEESWDVELFGPEKVKNLKRRHPEVKVVISIGG 86 (289)
T ss_dssp EEESCCTTCCSCSSCCSTTCCCSSSEEEEEEEEEEEEECTTSCEEEEEEECSCHHHHSHHHHHHHHHHCTTCEEEEEEEE
T ss_pred hhcCCCCCCCccccCChhhcCCCceEEEEEEecccccCCCCCCCCCeeccccccccccHHHHHHHHHHCCCCeEEEEecC
Confidence 4553 233355666665554 4999999964421 122223322233334455889999999999999988
Q ss_pred CCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCCCcccHHHHHHHHHHHccCCCc
Q 004402 99 GQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQPE 178 (755)
Q Consensus 99 ~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~~~~~~~~~l~~lr~~l~~~~~ 178 (755)
|+. +..+++..++.++++...|.+|+.++++++++|+|||||||||+|. +.++|+.|+++||++|++...
T Consensus 87 ~~~--------~~~f~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~DGiDiDwE~p~--~~~~~~~ll~~Lr~~l~~~~~ 156 (289)
T d1nara_ 87 RGV--------NTPFDPAEENVWVSNAKESLKLIIQKYSDDSGNLIDGIDIHYEHIR--SDEPFATLMGQLITELKKDDD 156 (289)
T ss_dssp SST--------TSCBCBSCHHHHHHHHHHHHHHHHHHSEETTEECCCEEEEEESCBC--SSTTHHHHHHHHHHHHHHCTT
T ss_pred CCC--------CCccChhhhHHHHhCHHHHHHHHHHHHHHHHhcCCCceeeeeeecC--CHHHHHHHHHHHHHHHhhCCC
Confidence 884 3344555678889999999999999999999999999999999984 667999999999999987544
Q ss_pred cEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHHHHHHCCCCCCceee
Q 004402 179 LTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKLVL 258 (755)
Q Consensus 179 ~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~~~~~~g~p~~Klvl 258 (755)
+.++++.++.. .....++.+.+.+++||||+|+||+| +.|...++++++++ ....| ..|+|++||+|
T Consensus 157 ~~~~~~~~ap~-~~~~~~~~~~~~~~~D~in~m~ydfy-g~w~~~~g~~~~~~----------~~~~~-~~~~p~~Kv~l 223 (289)
T d1nara_ 157 LNINVVSIAPS-ENNSSHYQKLYNAKKDYINWVDYQFS-NQQKPVSTDDAFVE----------IFKSL-EKDYHPHKVLP 223 (289)
T ss_dssp SCCCEEEECCC-TTTHHHHHHHHHHHTTTCCEEEEEGG-GCSSCCCSHHHHHH----------HHHHH-HHHSCTTCEEE
T ss_pred cEEEEEEecCc-CccccchHHHHHhhCCEEEEEEEecc-CCCCCCCChhHHHH----------HHHHh-hcCCChhheEE
Confidence 44444433322 22334667888999999999999999 56777788887642 23333 34799999999
Q ss_pred cccccCCCcccC
Q 004402 259 GARASGPGITID 270 (755)
Q Consensus 259 G~p~yG~~~~~~ 270 (755)
|+|+++.++...
T Consensus 224 G~pa~~~~~~~g 235 (289)
T d1nara_ 224 GFSTDPLDTKHN 235 (289)
T ss_dssp EEECCHHHHHHC
T ss_pred eeecchhhhhcC
Confidence 999998877554
|
| >d2hvma_ c.1.8.5 (A:) Hevamine A (chitinase/lysozyme) {Para rubber tree (Hevea brasiliensis) [TaxId: 3981]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Hevamine A (chitinase/lysozyme) species: Para rubber tree (Hevea brasiliensis) [TaxId: 3981]
Probab=99.94 E-value=1.7e-28 Score=251.21 Aligned_cols=212 Identities=15% Similarity=0.051 Sum_probs=137.3
Q ss_pred EEEEEecCCCC-CCCC-CCCCCCcceEEEEEEEecCCCcEEecCC--------chhhHHHHHHHHHHhhCCCceEEEEec
Q 004402 28 IKAGYWLAGRE-FPLS-DINSALFTHLICAFAEVDSSTYQLSISS--------ANQQYFSIFANSVRRKNPSIKTLLSIW 97 (755)
Q Consensus 28 ~~~gY~~~~~~-~~~~-~i~~~~~thi~~~f~~~~~~~~~~~~~~--------~~~~~~~~~~~~~k~~~~~lk~~isig 97 (755)
.+++||-.+.. .++. ..+.+.||||++||+.+.+++.....+- .....+...++.+|++ ++||+||||
T Consensus 2 ~~~~YWg~~~~~~~l~~~c~~~~~~~I~laF~~~~~~g~~~~~~~~~~~~~~~~~~~~l~~~I~~~q~~--g~KVllSiG 79 (273)
T d2hvma_ 2 GIAIYWGQNGNEGTLTQTCSTRKYSYVNIAFLNKFGNGQTPQINLAGHCNPAAGGCTIVSNGIRSCQIQ--GIKVMLSLG 79 (273)
T ss_dssp EEEEEESSCGGGCCHHHHHHTSCCSEEEEEEEEECSTTCCCEECCGGGCCCGGGTTTTHHHHHHHHHHT--TCEEEEEEE
T ss_pred CEEEEcCCCCCCCchHHHcCCCCCCEEEEEEEeEECCCCeeeccccccCCCccCchhhHHHHHHHHHhC--CCEEEEEEe
Confidence 58999943222 2222 1234689999999999887654332221 1123344545555554 799999998
Q ss_pred CCCCCccccccCCCCC-CcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCCCcccHHHHHHHHHHHccCC
Q 004402 98 NGQNSTYQSILGNKNI-NPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKASASDQ 176 (755)
Q Consensus 98 g~~~~~~~~~~gg~~~-~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~~~~~~~~~l~~lr~~l~~~ 176 (755)
||.+ +... +...+..++.+...|..|++++++++++|+|||||||||+|.. .+|..|+++||+.++.+
T Consensus 80 G~~~--------~~~~~s~~~~~~~a~~~~~~~~~~~~~~~~~~~~~~DGiDiD~E~~~~---~~~~~li~~Lr~~~~~~ 148 (273)
T d2hvma_ 80 GGIG--------SYTLASQADAKNVADYLWNNFLGGKSSSRPLGDAVLDGIDFDIEHGST---LYWDDLARYLSAYSKQG 148 (273)
T ss_dssp CSSC--------CCCCCSHHHHHHHHHHHHHHTSSSCCSCCTTCSCCCSEEEEECCSSCC---SSHHHHHHHHHHGGGGS
T ss_pred cCCC--------CccccCHHHHHHHHHhHHHHhccchhhhhhhhcccccceeeccccCcc---hhHHHHHHHHHhhhccC
Confidence 7763 2221 2223445555555666666666778999999999999999953 68999999999999877
Q ss_pred CccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHHHHHHCCCCCCce
Q 004402 177 PELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLRRGFPANKL 256 (755)
Q Consensus 177 ~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~~~~~~g~p~~Kl 256 (755)
+.+++|+++... .. ...+.......++||+|+|+||+++.+ ....+..+ .......|. .|+|++||
T Consensus 149 ~~~~it~ap~~~-~~-~~~~~~~~~~~~~D~invq~Yn~~~~~-~~~~~~~~----------~~~~~~~~~-~g~~~~Ki 214 (273)
T d2hvma_ 149 KKVYLTAAPQCP-FP-DRYLGTALNTGLFDYVWVQFYNNPPCQ-YSSGNINN----------IINSWNRWT-TSINAGKI 214 (273)
T ss_dssp SCCEEEECCBSS-SS-CTTTHHHHHTTCCSEEEEECSSCGGGS-CBTTBCHH----------HHHHHHHHH-HHCCCSEE
T ss_pred CeEEEEeccccc-cc-hhhhHHHhhcCcccEEEEEeecCCCcc-ccccchhH----------HHHHHHHHh-hcCCcccE
Confidence 678887765432 11 222333344578999999999998443 22121111 112233333 58999999
Q ss_pred eecccccCCC
Q 004402 257 VLGARASGPG 266 (755)
Q Consensus 257 vlG~p~yG~~ 266 (755)
+||+|+|+..
T Consensus 215 vlGlp~~~~~ 224 (273)
T d2hvma_ 215 FLGLPAAPEA 224 (273)
T ss_dssp EEEEESSGGG
T ss_pred EEEEecCCCC
Confidence 9999998853
|
| >d2ebna_ c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Flavobacterium meningosepticum, endoglycosidase F1 [TaxId: 238]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Endo-beta-N-acetylglucosaminidase species: Flavobacterium meningosepticum, endoglycosidase F1 [TaxId: 238]
Probab=99.93 E-value=6.9e-28 Score=247.55 Aligned_cols=179 Identities=14% Similarity=0.158 Sum_probs=131.8
Q ss_pred CCcceEEEEEecCCC-------CCCCCCCCCCCcceEEEEEEEecCCC--cEEecCCchh--h---HHHHHHHHHHhhCC
Q 004402 23 DAQTWIKAGYWLAGR-------EFPLSDINSALFTHLICAFAEVDSST--YQLSISSANQ--Q---YFSIFANSVRRKNP 88 (755)
Q Consensus 23 ~~~~~~~~gY~~~~~-------~~~~~~i~~~~~thi~~~f~~~~~~~--~~~~~~~~~~--~---~~~~~~~~~k~~~~ 88 (755)
.+.+.++++||.-.. .|.+++++...||||+++|+.++.++ .......... . .....++.++++
T Consensus 2 ~~~~~~~~~y~~~~~~n~~n~~~~~~~~~~~~~~d~v~~~~a~i~~d~~~~~~~~~~~~~~~~~~~~~~~~i~~~q~~-- 79 (285)
T d2ebna_ 2 TKANIKLFSFTEVNDTNPLNNLNFTLKNSGKPLVDMVVLFSANINYDAANDKVFVSNNPNVQHLLTNRAKYLKPLQDK-- 79 (285)
T ss_dssp CCCSCEEEEEEETTTCCGGGGGGEEETTTCCBSCCEEEEEEEEEEEETTTTEEEEECCHHHHHHHHTHHHHTHHHHHT--
T ss_pred CcCCceEEEEEEccCCCccccccceeecCCCCcccEEEEEeeeccCCcCCceeeeccCcchhhhhhhHHHHHHHHHhC--
Confidence 355788999985322 37789999999999999999987543 3332222111 1 123334455554
Q ss_pred CceEEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCC----------CCC
Q 004402 89 SIKTLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN----------STD 158 (755)
Q Consensus 89 ~lk~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~----------~~~ 158 (755)
++||++|||||..+ . .|+.+ +++.|++|++++++++++|||||||||||+|. ..+
T Consensus 80 g~KvllsigG~~~~--------~-----~~~~~--~~~~~~~F~~~~~~~~~~y~lDGiDiD~Ey~~~~~~~~~~~~~~~ 144 (285)
T d2ebna_ 80 GIKVILSILGNHDR--------S-----GIANL--STARAKAFAQELKNTCDLYNLDGVFFDDEYSAYQTPPPSGFVTPS 144 (285)
T ss_dssp TCEEEEEEECCSSS--------C-----CTTCB--CHHHHHHHHHHHHHHHHHHTCCEEEEECCSCCCCSSCCTTBCCCC
T ss_pred CCEEEEEeccCCCC--------c-----ccccC--CHHHHHHHHHHHHHHHHHcCCcEEeccccCccccCCCccccCcch
Confidence 89999999776531 1 15554 67899999999999999999999999999984 357
Q ss_pred cccHHHHHHHHHHHccCCCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccc
Q 004402 159 LNSLGILLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTG 225 (755)
Q Consensus 159 ~~~~~~~l~~lr~~l~~~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~ 225 (755)
+++|+.|+++||++|+ +.+||++++.........++ +.+++|||++|+||+||. |.+.++
T Consensus 145 ~~~~~~li~eLr~~~~---~~~lt~a~~~~~~~~~~~~~---~~~~~d~id~m~Yd~~g~-w~~~~~ 204 (285)
T d2ebna_ 145 NNAAARLAYETKQAMP---NKLVTVYVYSRTSSFPTAVD---GVNAGSYVDYAIHDYGGS-YDLATN 204 (285)
T ss_dssp HHHHHHHHHHHHHHCT---TSEEEEEESGGGSCCCSCBT---TBCGGGTCSEEEECTTCC-SCCTTT
T ss_pred HHHHHHHHHHHHHHCC---CCeEEEEEecccccccccch---HHHHhhheeEEeecccCc-cCCCCC
Confidence 8899999999999995 56889998876555544443 567899999999999955 444333
|
| >d1edta_ c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Streptomyces plicatus, endoglycosidase H [TaxId: 1922]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Endo-beta-N-acetylglucosaminidase species: Streptomyces plicatus, endoglycosidase H [TaxId: 1922]
Probab=99.92 E-value=1.7e-25 Score=225.61 Aligned_cols=171 Identities=14% Similarity=0.134 Sum_probs=125.3
Q ss_pred ceEEEEEecCCCC-------CCCCCCCCCCcceEEEEEEEecCC--CcEEec--CCchhh---HHHHHHHHHHhhCCCce
Q 004402 26 TWIKAGYWLAGRE-------FPLSDINSALFTHLICAFAEVDSS--TYQLSI--SSANQQ---YFSIFANSVRRKNPSIK 91 (755)
Q Consensus 26 ~~~~~gY~~~~~~-------~~~~~i~~~~~thi~~~f~~~~~~--~~~~~~--~~~~~~---~~~~~~~~~k~~~~~lk 91 (755)
+.+++||+.-++. |.+++++...||||+++|+.++.+ +..... ++.... .....++.+|++ ++|
T Consensus 3 ~p~~v~y~~~~~~~~~n~g~y~~~~~~~~~~d~v~~~~a~i~~d~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~--g~K 80 (265)
T d1edta_ 3 GPTSVAYVEVNNNSMLNVGKYTLADGGGNAFDVAVIFAANINYDTGTKTAYLHFNENVQRVLDNAVTQIRPLQQQ--GIK 80 (265)
T ss_dssp SCEEEEEEETTTSCGGGGGGEEETTTCSBSCSEEEEEEEEEEEETTTTEEEEECCHHHHHHHHTHHHHTHHHHHT--TCE
T ss_pred CCEEEEEEEeccccCCcCCeeeeccCCCcceeEEEEeeeecccCCCCCeeEEecCcchhhhhhhHHHHHHHHHhC--CCE
Confidence 5678999754332 788999999999999999988743 333222 221121 223333455554 799
Q ss_pred EEEEecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCC-------CCCcccHHH
Q 004402 92 TLLSIWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN-------STDLNSLGI 164 (755)
Q Consensus 92 ~~isigg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~-------~~~~~~~~~ 164 (755)
|++|||||..+ . .|+.+ ++++.|++||+++++++++|||||||||||||. .+++++|+.
T Consensus 81 vllsiGG~~~~------------~-~f~~~-~s~~~~~~Fa~~~~~~~~~~~~DGiDiD~Eyp~~~~~~~~~~d~~~~~~ 146 (265)
T d1edta_ 81 VLLSVLGNHQG------------A-GFANF-PSQQAASAFAKQLSDAVAKYGLDGVDFDDEYAEYGNNGTAQPNDSSFVH 146 (265)
T ss_dssp EEEEEEECTTS------------C-CTTCC-SSHHHHHHHHHHHHHHHHHHTCCEEEEECSSCCTTGGGCCCCCSSHHHH
T ss_pred EEEEEccCcCC------------C-Cceec-CCHHHHHHHHHHHHHHHHhcCCCceEeccccCcccCCCCCcccHHHHHH
Confidence 99999666532 1 27765 578999999999999999999999999999993 367899999
Q ss_pred HHHHHHHHccCCCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCC
Q 004402 165 LLDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPS 219 (755)
Q Consensus 165 ~l~~lr~~l~~~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~ 219 (755)
|+++||++|+ .++||++++..+.. ...++. .+..||+++|+||+||.|
T Consensus 147 ll~~lR~~l~---~~~is~a~~~~~~~-~~~~~~---~~~~d~id~m~YD~~g~w 194 (265)
T d1edta_ 147 LVTALRANMP---DKIISLYNIGPAAS-RLSYGG---VDVSDKFDYAWNPYYGTW 194 (265)
T ss_dssp HHHHHHHHCT---TSEEEEESCHHHHT-CCEETT---EECGGGCSEEECCSTTEE
T ss_pred HHHHHHHhhh---hcEEEEEecCChhh-hcCcCH---hHhcCeEEEEeccCCCcC
Confidence 9999999994 46888887765433 333554 455688889999999654
|
| >d1ta3a_ c.1.8.5 (A:) Xylanase inhibitor protein I, XIP-I {Wheat (Triticum aestivum) [TaxId: 4565]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Xylanase inhibitor protein I, XIP-I species: Wheat (Triticum aestivum) [TaxId: 4565]
Probab=99.89 E-value=6.3e-24 Score=216.42 Aligned_cols=200 Identities=16% Similarity=0.181 Sum_probs=131.0
Q ss_pred EEEEEecCCC-CCCCCCC-CCCCcceEEEEEEEecCCCcEEecC--CchhhHHHHHHHHHHhhCCCceEEEEecCCCCCc
Q 004402 28 IKAGYWLAGR-EFPLSDI-NSALFTHLICAFAEVDSSTYQLSIS--SANQQYFSIFANSVRRKNPSIKTLLSIWNGQNST 103 (755)
Q Consensus 28 ~~~gY~~~~~-~~~~~~i-~~~~~thi~~~f~~~~~~~~~~~~~--~~~~~~~~~~~~~~k~~~~~lk~~isigg~~~~~ 103 (755)
.+++||-... ..++.+. +...+|||++||+.+.++++....+ ......+...++.+|++ ++|||||||||.+
T Consensus 7 ~i~~YWGq~~~~~~L~~~c~~~~~~~I~laF~~~~~~~~~~~~~~~~~~~~~~~~~I~~~q~~--g~KVllSiGG~~~-- 82 (274)
T d1ta3a_ 7 QVTVFWGRNKAEGSLREACDSGMYTMVTMSFLDVFGANGKYHLDLSGHDLSSVGADIKHCQSK--GVPVSLSIGGYGT-- 82 (274)
T ss_dssp CEEEEESSCGGGCCHHHHHHTTCCSEEEEEEEEEBSSSSCCEECCTTCCGGGHHHHHHHHHHT--TCCEEEEEEESSS--
T ss_pred cEEEEcCCCCCCCChHHHcCCCCCCEEEEEEEEEcCCCCeeeccCCCCChhHHHHHHHHHHhC--CCEEEEEEcCCCC--
Confidence 5888994322 2233322 2456999999999987655543332 22234455555666655 7999999976652
Q ss_pred cccccCCCCCCcccccccccChhhHHHHHH------------HHHHHHHHcCCCcccccccCCCCCCcccHHHHHHHHHH
Q 004402 104 YQSILGNKNINPSVLSSMVGDSSHRKSFIE------------SSIRTARLYGFQGIDLFWLWPNSTDLNSLGILLDEWKA 171 (755)
Q Consensus 104 ~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~------------~i~~~~~~~~~DGvdiDwe~p~~~~~~~~~~~l~~lr~ 171 (755)
+ . -+.++.....|++ ++++++.+|+|||||||||+|. +..++..|+++||+
T Consensus 83 ------~----~-----~~~~~~~~~~~a~~l~~~~~~~~~~s~~~~~~~~~~DGiDiD~E~~~--~~~~~~~li~~Lr~ 145 (274)
T d1ta3a_ 83 ------G----Y-----SLPSNRSALDLFDHLWNSYFGGSKPSVPRPFGDAWLDGVDLFLEHGT--PADRYDVLALELAK 145 (274)
T ss_dssp ------C----B-----CCCSHHHHHHHHHHHHHHHSSCCCTTSCCTTTTCCCSEEEEEESSCC--TTCCHHHHHHHHHT
T ss_pred ------C----c-----cccchhHHHHHHHHHHHhhcccchhhHHHHhhccceeeEEeccccCC--CcchHHHHHHHHHH
Confidence 1 1 1233444455554 4566899999999999999994 45689999999999
Q ss_pred HccC---CCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHHHHHH
Q 004402 172 SASD---QPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIREWLR 248 (755)
Q Consensus 172 ~l~~---~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~~~~~ 248 (755)
.+++ ++.++||+++....... ..+.......++|++++|.||.++. +.. ......++..|.+
T Consensus 146 ~~~~~~~~~~~litaAp~~~~~~~-~~~~~~~~~~~fD~i~vq~Yn~~~~-~~~-------------~~~~~~s~~~w~~ 210 (274)
T d1ta3a_ 146 HNIRGGPGKPLHLTATVRCGYPPA-AHVGRALATGIFERVHVRTYESDKW-CNQ-------------NLGWEGSWDKWTA 210 (274)
T ss_dssp TCCSSSSSCCCEEEEEECSSSSCC-HHHHHHHTTSCCCEEEEECSSCCTT-SBT-------------TBBHHHHHHHHHH
T ss_pred HHhhccCCCceEEEecccCccCch-hhhhhhhhccccceEEEEEecCCCC-CCC-------------ChHHHHHHHHHHh
Confidence 8754 34688888776532211 1122233345789999999998732 221 1234456777764
Q ss_pred CCCCCCceeecccccC
Q 004402 249 RGFPANKLVLGARASG 264 (755)
Q Consensus 249 ~g~p~~KlvlG~p~yG 264 (755)
|+|++||+||+|+..
T Consensus 211 -~~p~~Ki~lGlPa~~ 225 (274)
T d1ta3a_ 211 -AYPATRFYVGLTADD 225 (274)
T ss_dssp -HCTTSEEEEEEECCT
T ss_pred -cCCCceEEEeeccCc
Confidence 799999999999743
|
| >d1cnva_ c.1.8.5 (A:) Seed storage protein {Jack bean (Canavalia ensiformis), Concanavalin B [TaxId: 3823]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Seed storage protein species: Jack bean (Canavalia ensiformis), Concanavalin B [TaxId: 3823]
Probab=99.87 E-value=9e-23 Score=208.99 Aligned_cols=245 Identities=12% Similarity=0.066 Sum_probs=152.1
Q ss_pred eEEEEEecCCCCCCCCCC-CCCCcceEEEEEEEecCCCc-E--Eec-------CCchhhHHHHHHHHHHhhCCCceEEEE
Q 004402 27 WIKAGYWLAGREFPLSDI-NSALFTHLICAFAEVDSSTY-Q--LSI-------SSANQQYFSIFANSVRRKNPSIKTLLS 95 (755)
Q Consensus 27 ~~~~gY~~~~~~~~~~~i-~~~~~thi~~~f~~~~~~~~-~--~~~-------~~~~~~~~~~~~~~~k~~~~~lk~~is 95 (755)
..|+.||-....-++.+. +...||||+++|+...+++. . +.. .......+...++.++++ ++|||||
T Consensus 5 ~~v~vYWgq~~~g~L~~~c~~~~~diI~laF~~~~~~~~~~p~~n~~~~~~~~~~~~~~~l~~dI~~~q~~--G~KVllS 82 (283)
T d1cnva_ 5 TEIAVYWGQREDGLLRDTCKTNNYKIVFISFLDKFGCEIRKPELELEGVCGPSVGNPCSFLESQIKECQRM--GVKVFLA 82 (283)
T ss_dssp CEEEEEECSGGGCCHHHHHHTCCCSEEEEEEECEECTTCSSCCCCBTTTBBTTTTBCGGGGHHHHHHHHHT--TCEEEEE
T ss_pred CCEEEECCCCCCCCHHHHccCCCCCEEEEEEEeeeCCCCCCcceecccCCCcccCCchHHHHHHHHHHHhC--CCEEEEE
Confidence 457779954333233322 23469999999997654331 1 111 111224556666777766 7999999
Q ss_pred ecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHH---------HHHcCCCcccccccCCCC-CCcccHHHH
Q 004402 96 IWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRT---------ARLYGFQGIDLFWLWPNS-TDLNSLGIL 165 (755)
Q Consensus 96 igg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~---------~~~~~~DGvdiDwe~p~~-~~~~~~~~~ 165 (755)
||||.+ ..-+.+.+..+.|++++.+. +.+++|||||||||+|.. ....+|..+
T Consensus 83 lGG~~~-----------------~~~~~~~~~a~~fa~~~~~~~~~~~~~~~~~~~~lDGiDiD~E~p~~~~~~~~~~~~ 145 (283)
T d1cnva_ 83 LGGPKG-----------------TYSACSADYAKDLAEYLHTYFLSERREGPLGKVALDGIHFDIQKPVDELNWDNLLEE 145 (283)
T ss_dssp EECSSS-----------------EECCCSHHHHHHHHHHHHHHHBSSSSCBTTBSCBCSEEEEECSSCSCSTTHHHHHHH
T ss_pred ecCCCC-----------------CcccccHHHHHHHHHHHHHhhcCccccccccccccCcccccccCCCCcccHHHHHHH
Confidence 976652 22344567788999988765 578999999999999954 456778888
Q ss_pred HHHHHHHccCCCccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCCCCCCCCCCcHHHHHHH
Q 004402 166 LDEWKASASDQPELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAALYNPSSNISTDFGIRE 245 (755)
Q Consensus 166 l~~lr~~l~~~~~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~l~~~~~~~~~~~~v~~ 245 (755)
++++|+.+. +.+.||+++.... ....+...-...++||+|||+||.++. +. ++.. ..... .+...
T Consensus 146 l~~l~~~~~--~~~~it~AP~~~~--~d~~~~~~~~~~~~D~i~vq~Yn~~~~-~~----~~~~-----~~~~~-~~~~~ 210 (283)
T d1cnva_ 146 LYQIKDVYQ--STFLLSAAPGCLS--PDEYLDNAIQTRHFDYIFVRFYNDRSC-QY----STGN-----IQRIR-NAWLS 210 (283)
T ss_dssp HHHHHHHHT--CCCEEEECCBSSS--SCTTTHHHHTTTCCSEEEEECSSCTTT-SC----BTTB-----CHHHH-HHHHH
T ss_pred HHHHHHhcC--CCeEEEeccCCcc--CchhhHHHhhcccccEEEEEeccCCcc-cC----CCcc-----HHHHH-HHHHH
Confidence 888888774 4688888854321 111122122346899999999998732 11 1111 01122 33444
Q ss_pred HH-HCCCCCCceeecccccCCCcccCCCcchHHHHHHHhhcCCCcccccccceeeeeeecCcEEEeeCCcchhhhhhhcc
Q 004402 246 WL-RRGFPANKLVLGARASGPGITIDGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINFDGVETIKAKISYA 324 (755)
Q Consensus 246 ~~-~~g~p~~KlvlG~p~yG~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~yd~~~S~~~K~~~a 324 (755)
|+ ..++|++|+++|+|++..+-...|. ..+..+..++...
T Consensus 211 ~~~~~~~~~~k~~lGlp~~~~~a~~~gy---------------------------------------~~~~~~~~~v~~~ 251 (283)
T d1cnva_ 211 WTKSVYPRDKNLFLELPASQATAPGGGY---------------------------------------IPPSALIGQVLPY 251 (283)
T ss_dssp HHHHSSSCSSCEEEEEESSGGGCTTSCC---------------------------------------CCHHHHHHHTGGG
T ss_pred HHHhcCCCccceEEEecCCCcccCCCCC---------------------------------------cCHHHHHHHHHHH
Confidence 44 5689999999999998754332233 3333343333222
Q ss_pred -cc--cCccccccccccccchhh
Q 004402 325 -KE--KNLLGYKAFQLSNDDNWA 344 (755)
Q Consensus 325 -~~--~~l~Gi~~W~l~~dd~~~ 344 (755)
++ .++||+|+|+++.|+..+
T Consensus 252 ~~~~~~~~GGvM~W~~~~D~~~g 274 (283)
T d1cnva_ 252 LPDLQTRYAGIALWNRQADKETG 274 (283)
T ss_dssp STTHHHHEEEEEEECHHHHHHHT
T ss_pred HHhcCCCCCEEEEEeCccccCCC
Confidence 21 358999999999987543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=1.3e-21 Score=188.85 Aligned_cols=169 Identities=19% Similarity=0.194 Sum_probs=119.8
Q ss_pred ccCcccccCCeeEEEEEcCCCCEEEEEEeccCCh------------------hhHHHHHHHHHHHhcCCCCceeeeeeee
Q 004402 439 SANKLGEGGFGPVYKGNLPRGQEFAVKRLSATST------------------QGLEEFKNEVSLTARLQHVNLLRVLGYC 500 (755)
Q Consensus 439 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~g~~ 500 (755)
..++||+|+||+||+|...+|+.||||+++.... .....+..|...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 4678999999999999888899999998753211 1123456788999999999998887653
Q ss_pred ecCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecccCCCCEEEcCCCCeEEEe
Q 004402 501 TERDENMLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYSNFRVIHRDLKASNILLDNELNPKISD 580 (755)
Q Consensus 501 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~~~~iiHrDlk~~NIll~~~~~~kl~D 580 (755)
..+++|||+++..+.. ++......++.|+++++.|||+.+ |+||||||+|||++++ .++|+|
T Consensus 84 ----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred ----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEE
Confidence 3489999998866543 222345678999999999999987 9999999999999965 489999
Q ss_pred cCCccccccCCcccccccccccCCccccccccCCCCCchhhHHHHHHHHH
Q 004402 581 FGMAKLFRKDVDEANTGRIVGTYGYVPPEYVKKGIYSMKYDVYSFGVLLL 630 (755)
Q Consensus 581 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwS~Gvil~ 630 (755)
||+|+............. .... -.|. ..+.|+.++|+||..--++
T Consensus 146 FG~a~~~~~~~~~~~l~r---d~~~-~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 146 FPQSVEVGEEGWREILER---DVRN-IITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CTTCEETTSTTHHHHHHH---HHHH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred CCCcccCCCCCcHHHHHH---HHHH-HHHH-HcCCCCCcccHHHHHHHHh
Confidence 999976432211100000 0000 0011 1356788899999865443
|
| >d1eoka_ c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Flavobacterium meningosepticum, endoglycosidase F3 [TaxId: 238]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Endo-beta-N-acetylglucosaminidase species: Flavobacterium meningosepticum, endoglycosidase F3 [TaxId: 238]
Probab=99.74 E-value=2.9e-18 Score=175.95 Aligned_cols=200 Identities=18% Similarity=0.145 Sum_probs=128.4
Q ss_pred eEEEEEecCCCC---CCCCCCCCCCcceEEEEEEEecC--C------CcEEecCCchhhHHHHHHHHHHhhCCCceEEEE
Q 004402 27 WIKAGYWLAGRE---FPLSDINSALFTHLICAFAEVDS--S------TYQLSISSANQQYFSIFANSVRRKNPSIKTLLS 95 (755)
Q Consensus 27 ~~~~gY~~~~~~---~~~~~i~~~~~thi~~~f~~~~~--~------~~~~~~~~~~~~~~~~~~~~~k~~~~~lk~~is 95 (755)
-+++|||..+.. ++++++| +.++.|+++|+.... + +..+.........+...++.++++ ++||++|
T Consensus 2 ~~~~~y~~~~~~~~~~~l~~~p-~~~d~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~q~~--g~kVllS 78 (282)
T d1eoka_ 2 GVCIAYYITDGRNPTFKLKDIP-DKVDMVILFGLKYWSLQDTTKLPGGTGMMGSFKSYKDLDTQIRSLQSR--GIKVLQN 78 (282)
T ss_dssp CEEEEEEECSCSSTTSCGGGCC-TTCCEEEEESSCHHHHHCTTSSCTTSGGGTTCSSHHHHHHHHHHHHTT--TCEEEEE
T ss_pred CeEEEEEeccCCCCceeeccCC-CCCCEEEEEccccccccccccccCCcceeecccchhHHHHHHHHHhhc--CceEEEE
Confidence 479999976554 6777885 668999998875421 1 111222223344555665667776 7999999
Q ss_pred ecCCCCCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCCCC------------------
Q 004402 96 IWNGQNSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPNST------------------ 157 (755)
Q Consensus 96 igg~~~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~~~------------------ 157 (755)
|||+.. +.. .....+.+.++.+.+.+.+++.+|||||||||||+|...
T Consensus 79 iGG~~~--------~~~------~~~~~~~~~~~~~~~~~~~~i~~yglDGiDiD~E~~~~~~~~~~~~~~~~~~~~~~~ 144 (282)
T d1eoka_ 79 IDDDVS--------WQS------SKPGGFASAAAYGDAIKSIVIDKWKLDGISLDIEHSGAKPNPIPTFPGYAATGYNGW 144 (282)
T ss_dssp EECCGG--------GGS------SSGGGSSSHHHHHHHHHHHHTTTTCCCEEEEECCCCCCCCSSCCCCCCHHHHSCSSC
T ss_pred EecCCC--------CCc------cCCccHHHHHHHHHHHHHHHHHHhCCCceeecccCCcccCCchhhhhhhhhhhhhhh
Confidence 977652 111 122234456777778888999999999999999998421
Q ss_pred ------CcccHHHHHHHHHHHccCCC--ccEEEeeeecCCcccccccCcchhcccCChhhhhhhhccCCCCCcccccCCC
Q 004402 158 ------DLNSLGILLDEWKASASDQP--ELTLSMAVRYSPTHETVSYPIDSMKKNLNWAHLVAYDYHMPSKENVTGIHAA 229 (755)
Q Consensus 158 ------~~~~~~~~l~~lr~~l~~~~--~~~ls~~~~~~~~~~~~~~~~~~l~~~vD~~~vm~Yd~~~~~~~~~~~~~a~ 229 (755)
...+|...+.+++..+.... ...+....+.. .......+..+...+||+++|+|+..+
T Consensus 145 ~~~~~~~~~~~~~~~a~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~d~v~~q~Y~~~~------------ 210 (282)
T d1eoka_ 145 YSGSMAATPAFLNVISELTKYFGTTAPNNKQLQIASGID--VYAWNKIMENFRNNFNYIQLQSYGANV------------ 210 (282)
T ss_dssp CTTSCCCCHHHHHHHHHHTTTSSTTSSSCCEEEEEECTT--STTHHHHHHHHTTTCSEEEECCTTCCH------------
T ss_pred hhcccccchhcchhHHHHHHhhccccCcceEEEeecCcc--ccccccchhccccccceeeeeeecccC------------
Confidence 13467788888888775532 22232222221 111223456778899999999998641
Q ss_pred CCCCCCCCcHHHHHHHHH--HCCCCCCceeecccccCC
Q 004402 230 LYNPSSNISTDFGIREWL--RRGFPANKLVLGARASGP 265 (755)
Q Consensus 230 l~~~~~~~~~~~~v~~~~--~~g~p~~KlvlG~p~yG~ 265 (755)
+....+..|. ..++|++|+++|+++++.
T Consensus 211 --------~~~~~~~~~~~~~~~~pa~k~~~G~~~~~~ 240 (282)
T d1eoka_ 211 --------SRTQLMMNYATGTNKIPASKMVFGAYAEGG 240 (282)
T ss_dssp --------HHHHHHHHHHHHTSCCCGGGEEEEECTTTC
T ss_pred --------CchhhHHhhhhccCCCCccceEeeecCCCC
Confidence 1112233333 358999999999998874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.38 E-value=4.3e-07 Score=90.04 Aligned_cols=150 Identities=15% Similarity=0.135 Sum_probs=102.4
Q ss_pred HHHHHHhcCCCccCcccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCcc
Q 004402 428 SDIKAATNNFSSANKLGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDEN 506 (755)
Q Consensus 428 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 506 (755)
.++...-+.|...+..+.++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.++...+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 35666667777666655555678999875 56778889876554433445677888877763 44456777887778888
Q ss_pred EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 004402 507 MLIYEYLPNKSLDLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQEYS-------------------------------- 554 (755)
Q Consensus 507 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~~-------------------------------- 554 (755)
++||+++++.++....... .....++.++++.+..||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 9999999998875543211 112234455555555565421
Q ss_pred ------------------------CCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 555 ------------------------NFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 555 ------------------------~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
...++|+|+.|.|||+++++.+-|.||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11278999999999999877677999998863
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.76 E-value=2.9e-05 Score=75.86 Aligned_cols=131 Identities=19% Similarity=0.166 Sum_probs=85.5
Q ss_pred cccccC-CeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCC--CCceeeeeeeeecCCccEEEEeecCCCCh
Q 004402 442 KLGEGG-FGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQ--HVNLLRVLGYCTERDENMLIYEYLPNKSL 518 (755)
Q Consensus 442 ~lG~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv~e~~~~gsL 518 (755)
.+..|. .+.||+....++..+++|........ .+..|...++.+. .-.+.+++.++.+.+..++||+++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344554 36899998878888999987554332 3566777776663 33456678888888888999999988766
Q ss_pred hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 004402 519 DLYLFDPIRRYVLDWQKRVNIIEGVTQGLLYLQE---------------------------------------------- 552 (755)
Q Consensus 519 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~Lh~---------------------------------------------- 552 (755)
.... ... ...+.++++.|.-||.
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 4321 010 1112223333333332
Q ss_pred -----cC----CCCceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 553 -----YS----NFRVIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 553 -----~~----~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
.. ...++|+|+.|.|||++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 11 12379999999999999887778999998753
|
| >d1vf8a2 d.26.3.1 (A:246-315) Chitinase-like lectin ym1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Chitinase-like lectin ym1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.51 E-value=1.6e-05 Score=60.36 Aligned_cols=56 Identities=25% Similarity=0.466 Sum_probs=44.6
Q ss_pred CCceeecccccCCCccc-----CCCcchHHHHHHHhhcCCCcccccccceeeeeeecCcEEEee
Q 004402 253 ANKLVLGARASGPGITI-----DGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINF 311 (755)
Q Consensus 253 ~~KlvlG~p~yG~~~~~-----~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~y 311 (755)
+++--+|-|+-|.+-.. .|.++|.|||+++++ +|+..||....++|...+++||+|
T Consensus 10 ~~~~~~gap~~g~g~~G~~t~~~G~l~y~EIc~~~~~---~~~~~~D~~~~~~y~~~~~qWisY 70 (70)
T d1vf8a2 10 PSKTGIGAPTISTGPPGKYTDESGLLAYYEVCTFLNE---GATEVWDAPQEVPYAYQGNEWVGY 70 (70)
T ss_dssp TTCCSTTCBEEEECCCCTTTCCTTEEEHHHHHHHHHT---TCEEEEETTTTEEEEEETTEEEEC
T ss_pred CccCCCCCccccCCCCCCccCCCCeEeHHHHHHHHhC---CCeEEEeCCCCccEEEECCEEEeC
Confidence 45555677777765433 389999999998864 488899999999999999999998
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.08 E-value=0.00063 Score=70.69 Aligned_cols=76 Identities=16% Similarity=0.204 Sum_probs=48.1
Q ss_pred cCcccccCCeeEEEEEcCC-CCEEEEEEeccC-------ChhhHHHHHHHHHHHhcC-CC--CceeeeeeeeecCCccEE
Q 004402 440 ANKLGEGGFGPVYKGNLPR-GQEFAVKRLSAT-------STQGLEEFKNEVSLTARL-QH--VNLLRVLGYCTERDENML 508 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l-~H--~niv~l~g~~~~~~~~~l 508 (755)
.+.||.|....||+....+ ++.++||.-... .....++...|.+.|..+ .+ ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3578999999999997654 678999974321 111223455677777766 23 234455554 4456789
Q ss_pred EEeecCCCC
Q 004402 509 IYEYLPNKS 517 (755)
Q Consensus 509 v~e~~~~gs 517 (755)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d2pi6a2 d.26.3.1 (A:240-307) Signal processing protein (SPC-40, MGP-40) {Sheep (Ovis aries) [TaxId: 9940]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Signal processing protein (SPC-40, MGP-40) species: Sheep (Ovis aries) [TaxId: 9940]
Probab=97.06 E-value=8.2e-05 Score=55.90 Aligned_cols=51 Identities=31% Similarity=0.505 Sum_probs=40.1
Q ss_pred eecccccCCCccc-----CCCcchHHHHHHHhhcCCCcccccccceeeeeeecCcEEEee
Q 004402 257 VLGARASGPGITI-----DGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINF 311 (755)
Q Consensus 257 vlG~p~yG~~~~~-----~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~y 311 (755)
-+|.|+-|.+-.. .|.++|.|||++++. |...+|....++|...+++||+|
T Consensus 13 ~~g~p~~Gpg~~G~~T~~~G~lay~EIc~~~~~----~~~~~d~~~~~pyay~g~qWi~Y 68 (68)
T d2pi6a2 13 DVGAPVSGPGIPGRFTKEKGILAYYEICDFLHG----ATTHRFRDQQVPYATKGNQWVAY 68 (68)
T ss_dssp STTCBEEEECCCCTTTCCTTEEEHHHHHHHTTT----CEEEEETTTTEEEEEETTEEEEC
T ss_pred CCCCccccCCCCCCccCCCceEEHHHHHHHHhC----CcEEEecCccccEEEECCEEEcC
Confidence 4677777776543 389999999998754 45567777788999999999998
|
| >d1wb0a2 d.26.3.1 (A:267-336) Chitotriosidase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Chitotriosidase species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.62 E-value=0.00026 Score=53.11 Aligned_cols=54 Identities=22% Similarity=0.377 Sum_probs=41.6
Q ss_pred CCceeecccccCCCccc-----CCCcchHHHHHHHhhcCCCcccccccceeeeeeecCcEEEee
Q 004402 253 ANKLVLGARASGPGITI-----DGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINF 311 (755)
Q Consensus 253 ~~KlvlG~p~yG~~~~~-----~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~y 311 (755)
+++--+|.|+-|.+-.. .|.++|.|||+. .+|+..+|....++|...+++||+|
T Consensus 10 ~~~~~~gap~~Gpg~~G~~T~~~G~l~y~EIc~~-----~~~~~~~d~~~~~py~~~~~qWisY 68 (68)
T d1wb0a2 10 SSDTRVGAPATGSGTPGPFTKEGGMLAYYEVCSW-----KGATKQRIQDQKVPYIFRDNQWVGF 68 (68)
T ss_dssp TTCCSTTCBEEEECCCCTTTCCTTEEEHHHHTTC-----TTCEEEEETTTTEEEEEETTEEEEC
T ss_pred CCCCCCCCccccCCCCCCccCCCeeEEhHHhhhh-----cCCcEEEeccccccEEEECCEEEeC
Confidence 44555677777765432 389999999963 2478889999999999999999998
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.24 E-value=0.006 Score=61.21 Aligned_cols=136 Identities=13% Similarity=0.159 Sum_probs=77.4
Q ss_pred CeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCCCce--eeeee-----eeecCCccEEEEeecCCCChhh
Q 004402 448 FGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQHVNL--LRVLG-----YCTERDENMLIYEYLPNKSLDL 520 (755)
Q Consensus 448 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g-----~~~~~~~~~lv~e~~~~gsL~~ 520 (755)
--.||+.+.++|+.+++|+.+.... ..+++..|...+..|....+ +..+. ........+.+++++++..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 3589999999999999999865422 34567778888877742221 11111 1233455688999987654321
Q ss_pred h--------------hc----C--CCccCCCCHH-------------------HHHHHHHHHHHHHHHHHh----cCCCC
Q 004402 521 Y--------------LF----D--PIRRYVLDWQ-------------------KRVNIIEGVTQGLLYLQE----YSNFR 557 (755)
Q Consensus 521 ~--------------l~----~--~~~~~~l~~~-------------------~~~~i~~~ia~~l~~Lh~----~~~~~ 557 (755)
. +| . ...+...++. .+..+...+.+.+..+.. .....
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 1 01 0 0011112211 111122222233333322 22345
Q ss_pred ceecccCCCCEEEcCCCCeEEEecCCccc
Q 004402 558 VIHRDLKASNILLDNELNPKISDFGMAKL 586 (755)
Q Consensus 558 iiHrDlk~~NIll~~~~~~kl~Dfgla~~ 586 (755)
+||+|+.+.|||++++ ..+.||+-++.
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 46899998874
|
| >d1edqa3 d.26.3.1 (A:444-516) Chitinase A {Serratia marcescens [TaxId: 615]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Chitinase A species: Serratia marcescens [TaxId: 615]
Probab=96.00 E-value=0.00096 Score=50.74 Aligned_cols=40 Identities=20% Similarity=0.225 Sum_probs=33.3
Q ss_pred CCcchHHHHHHHhhcCCCcccccccceeeeeeec--CcEEEeeC
Q 004402 271 GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTS--GATWINFD 312 (755)
Q Consensus 271 ~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~i~yd 312 (755)
|.+.|++||..+... ++...||+....+|..+ ++.||+||
T Consensus 32 G~~~Y~~l~~~~~~~--g~~~~wD~~a~apY~Y~~~~~~~isYD 73 (73)
T d1edqa3 32 GIVDYRQIAGQFMSG--EWQYTYDATAEAPYVFKPSTGDLITFD 73 (73)
T ss_dssp TEEEHHHHHHHSSST--TCEEEEETTTTEEEEEETTTTEEEECC
T ss_pred chhHHHHHHHHhccC--CeeEEEeccccccEEEeCCCCeEEeCC
Confidence 788999999987654 59999999998888864 56899997
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.86 E-value=0.0081 Score=62.02 Aligned_cols=73 Identities=12% Similarity=0.156 Sum_probs=48.9
Q ss_pred cCcccccCCeeEEEEEcCC--------CCEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCccEEEE
Q 004402 440 ANKLGEGGFGPVYKGNLPR--------GQEFAVKRLSATSTQGLEEFKNEVSLTARLQ-HVNLLRVLGYCTERDENMLIY 510 (755)
Q Consensus 440 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ 510 (755)
++.|+.|-.-.+|+...++ .+.|.+++..... ......+|..+++.+. +.-..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4578888888999997643 3567777665322 2234567888888884 4333467777653 6899
Q ss_pred eecCCCCh
Q 004402 511 EYLPNKSL 518 (755)
Q Consensus 511 e~~~~gsL 518 (755)
||+++..+
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987655
|
| >d1itxa2 d.26.3.1 (A:338-409) Chitinase A1 {Bacillus circulans [TaxId: 1397]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Chitinase A1 species: Bacillus circulans [TaxId: 1397]
Probab=95.83 E-value=0.0012 Score=50.01 Aligned_cols=41 Identities=20% Similarity=0.278 Sum_probs=33.3
Q ss_pred CCCcchHHHHHHHhhcCCCcccccccceeeeeeec--CcEEEee
Q 004402 270 DGSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTS--GATWINF 311 (755)
Q Consensus 270 ~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~i~y 311 (755)
.|.++|.+||+.+... .+|...||+.+..+|..+ +++||+|
T Consensus 30 ~G~~~Y~ei~~~~~~~-~g~~~~~D~~a~apY~y~~~~~~~isY 72 (72)
T d1itxa2 30 AGSFDFYDLEANYINK-NGYTRYWNDTAKVPYLYNASNKRFISY 72 (72)
T ss_dssp TTEEEHHHHHHHTTTC-TTEEEEEETTTTEEEEEETTTCCEEEC
T ss_pred cccChHHHHHHHhccC-CCCEEEEcCCCccceEEeCCCCeEEeC
Confidence 4788999999987553 369999999999999865 5589987
|
| >d1kfwa2 d.26.3.1 (A:328-388) Psychrophilic chitinase B {Arthrobacter sp., tad20 [TaxId: 1667]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Psychrophilic chitinase B species: Arthrobacter sp., tad20 [TaxId: 1667]
Probab=95.39 E-value=0.0016 Score=47.29 Aligned_cols=34 Identities=15% Similarity=0.314 Sum_probs=29.9
Q ss_pred CCcchHHHHHHHhhcCCCcccccccceeeeeeecCcEEEee
Q 004402 271 GSMGYKFIRAFIQNYGYGAAPVYNASYVVNLFTSGATWINF 311 (755)
Q Consensus 271 ~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~y 311 (755)
|.+.|++||. +++..||+....+|..++.+||+|
T Consensus 28 G~~~Y~~l~~-------~~~~~~D~~a~a~Y~y~g~~wisY 61 (61)
T d1kfwa2 28 ANEDYDKLKT-------LGTDHYDAATGSAWRYDGTQWWSY 61 (61)
T ss_dssp TEEEHHHHTT-------SSEEEEETTTTEEEEECSSCEEEE
T ss_pred hhhhHHhhcC-------CCEEEeeCCCcEeEEEeCCEEEeC
Confidence 7889999862 588999999999999999999997
|
| >d1jnda2 d.26.3.1 (A:279-370) Imaginal disc growth factor-2 {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Imaginal disc growth factor-2 species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=95.27 E-value=0.0051 Score=48.37 Aligned_cols=41 Identities=15% Similarity=0.252 Sum_probs=26.4
Q ss_pred CCcchHHHHHHHhhcCCCccc--------ccccceee-eeee-------cCcEEEee
Q 004402 271 GSMGYKFIRAFIQNYGYGAAP--------VYNASYVV-NLFT-------SGATWINF 311 (755)
Q Consensus 271 ~~~~y~~~~~~~~~~~~~~~~--------~~~~~~~~-~~~~-------~~~~~i~y 311 (755)
|.++|.|||+++.+....+.. ++|..... +|+. .+++||+|
T Consensus 36 G~lsy~EIC~~l~~~~~~~~~~~~a~lrrV~D~~~~~g~YAyr~~d~~~~~~qWVsY 92 (92)
T d1jnda2 36 GLLSYAEICGKLSNPQNQFLKGNESPLRRVSDPTKRFGGIAYRPVDGQITEGIWVSY 92 (92)
T ss_dssp TEEEHHHHHHHBCCTTTTTCCGGGSCBEEECCTTCCSCEEEEECSBTTBCCCEEEEE
T ss_pred ceEEHHHHHHHhccCCcceeecccCceeEecCcccceeeeEEecccCCCcCCEeecC
Confidence 899999999999886644322 22322221 4443 46789998
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.95 E-value=0.098 Score=51.48 Aligned_cols=158 Identities=13% Similarity=0.042 Sum_probs=80.5
Q ss_pred cCHHHHHHHhcCCCccCc-----ccccCCeeEEEEEcCCCCEEEEEEeccCChhhHHHHHHHHHHHhcCCC-----Ccee
Q 004402 425 FSFSDIKAATNNFSSANK-----LGEGGFGPVYKGNLPRGQEFAVKRLSATSTQGLEEFKNEVSLTARLQH-----VNLL 494 (755)
Q Consensus 425 ~~~~~l~~~~~~f~~~~~-----lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-----~niv 494 (755)
.+.+++.....+|...+. |..|---+.|+.+..+|+ +++|+...... .+++..|++++..+.+ |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 456778888888876443 335555778999876654 89998865322 1234445666666532 2221
Q ss_pred eee-e--eeecCCccEEEEeecCCCChhhhh--------------c----CC--CccCCCC------------------H
Q 004402 495 RVL-G--YCTERDENMLIYEYLPNKSLDLYL--------------F----DP--IRRYVLD------------------W 533 (755)
Q Consensus 495 ~l~-g--~~~~~~~~~lv~e~~~~gsL~~~l--------------~----~~--~~~~~l~------------------~ 533 (755)
... | +.........++.++.+....... + .. ....... .
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 111 1 111233455666666554332110 0 00 0000000 0
Q ss_pred HHHHHHHHHHHHHHHHHHh-cCCCCceecccCCCCEEEcCCCCeEEEecCCcc
Q 004402 534 QKRVNIIEGVTQGLLYLQE-YSNFRVIHRDLKASNILLDNELNPKISDFGMAK 585 (755)
Q Consensus 534 ~~~~~i~~~ia~~l~~Lh~-~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~ 585 (755)
......+..+...+.-.+. .-+.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111112222222222221 123469999999999999998877899999986
|
| >d2bhua3 c.1.8.1 (A:111-530) Glycosyltrehalose trehalohydrolase, central domain {Deinococcus radiodurans [TaxId: 1299]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Amylase, catalytic domain domain: Glycosyltrehalose trehalohydrolase, central domain species: Deinococcus radiodurans [TaxId: 1299]
Probab=87.56 E-value=0.9 Score=46.04 Aligned_cols=99 Identities=13% Similarity=0.151 Sum_probs=59.0
Q ss_pred hhhHHHHHHHHHHhhCCCceEEEEe-cCCCCC--ccccccCCCCCCccc-----ccccccChhhHHHHHHHHHHHHHHcC
Q 004402 72 NQQYFSIFANSVRRKNPSIKTLLSI-WNGQNS--TYQSILGNKNINPSV-----LSSMVGDSSHRKSFIESSIRTARLYG 143 (755)
Q Consensus 72 ~~~~~~~~~~~~k~~~~~lk~~isi-gg~~~~--~~~~~~gg~~~~~~~-----f~~~~~~~~~r~~fi~~i~~~~~~~~ 143 (755)
..+.+..+++++|++ |+||++-+ -+.... .+...+++..+.... ..--..+++.|+.+++.+..|++++|
T Consensus 81 ~~~d~~~lv~~aH~~--gi~VilD~V~NH~~~~~~~~~~~~~~~~~~~~~~~~~~dlN~~np~v~~~~~~~~~~Wl~~~G 158 (420)
T d2bhua3 81 RPEDLMALVDAAHRL--GLGVFLDVVYNHFGPSGNYLSSYAPSYFTDRFSSAWGMGLDYAEPHMRRYVTGNARMWLRDYH 158 (420)
T ss_dssp CHHHHHHHHHHHHHT--TCEEEEEECCSCCCSSSCCHHHHCGGGEEEEEECSSSEEECTTSHHHHHHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHHHhc--cccccccccccccCCCCccccccccccccccccccccccccccChHHHHHHHHHhheeeeccc
Confidence 466789999999998 79999998 121111 010001111000000 00114689999999999999999999
Q ss_pred CCcccccccC-CCCCCcccHHHHHHHHHHHccC
Q 004402 144 FQGIDLFWLW-PNSTDLNSLGILLDEWKASASD 175 (755)
Q Consensus 144 ~DGvdiDwe~-p~~~~~~~~~~~l~~lr~~l~~ 175 (755)
+||+-||--. ...+.. ..++++++++++.
T Consensus 159 VDGfR~D~~~~l~~~~~---~~~~~~~~~~~~~ 188 (420)
T d2bhua3 159 FDGLRLDATPYMTDDSE---THILTELAQEIHE 188 (420)
T ss_dssp CSEEEETTGGGCCCCSS---SCHHHHHHHHHHT
T ss_pred ccEEEEeeeeeeccccc---cccHHHHHHHHHh
Confidence 9999999532 111111 2355666666544
|
| >d2nt0a2 c.1.8.3 (A:78-431) Glucosylceramidase, catalytic domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: beta-glycanases domain: Glucosylceramidase, catalytic domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.15 E-value=1.3 Score=43.91 Aligned_cols=129 Identities=7% Similarity=0.032 Sum_probs=71.5
Q ss_pred HHHHHHh-hCCCceEEEEecCCC--CCccccccCCCCCCcccccccccChhhHHHHHHHHHHHHHHcCCCcccccccCCC
Q 004402 79 FANSVRR-KNPSIKTLLSIWNGQ--NSTYQSILGNKNINPSVLSSMVGDSSHRKSFIESSIRTARLYGFQGIDLFWLWPN 155 (755)
Q Consensus 79 ~~~~~k~-~~~~lk~~isigg~~--~~~~~~~~gg~~~~~~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGvdiDwe~p~ 155 (755)
+++++++ .+|++|++.+.|... +.+....-||. ...---.++..+.|++-++++++.|.=.||+||.=.|.
T Consensus 83 ~l~~a~~~~~~~l~i~aspWSpP~wMk~n~~~~~~~------~~~~~l~~~~~~~yA~Yl~~~v~~y~~~Gi~i~~isp~ 156 (354)
T d2nt0a2 83 LIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKG------SLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAE 156 (354)
T ss_dssp HHHHHHHHCSSCCEEEEEESCCCGGGBTTCSSSSSC------BBSSCTTSHHHHHHHHHHHHHHHHHHHTTCCCSEEESC
T ss_pred HHHHHHHhcCCCeEEEEcCCCCchhhhcCCcccCCC------CcCCccchhHHHHHHHHHHHHHHHHHHcCCCceEeccC
Confidence 3444444 589999999985443 11110001111 11112245789999999999999999889999875542
Q ss_pred CC----------------CcccHHHHHHH-HHHHccCCC-ccEEEeeeecCCccc----ccccCcchhcccCChhhhhhh
Q 004402 156 ST----------------DLNSLGILLDE-WKASASDQP-ELTLSMAVRYSPTHE----TVSYPIDSMKKNLNWAHLVAY 213 (755)
Q Consensus 156 ~~----------------~~~~~~~~l~~-lr~~l~~~~-~~~ls~~~~~~~~~~----~~~~~~~~l~~~vD~~~vm~Y 213 (755)
.+ ..+....|+++ |+.+|++.. .-+..+......... ..-+.-++..++||-+..-.|
T Consensus 157 NEP~~~~~~~~~~~~~~~t~~~~~~fi~~~L~~~l~~~g~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~v~~ia~H~Y 236 (354)
T d2nt0a2 157 NEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWY 236 (354)
T ss_dssp SSGGGGGSTTCCSSCCBCCHHHHHHHHHHTHHHHHHTSTTTTSEEEEEEEEGGGTTHHHHHHHTSHHHHTTCCEEEEEEE
T ss_pred cCcCcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCceEEEeeCCcccchHHHHHHHhcCHhHHHhcCeEEEecC
Confidence 11 23456788875 899887632 111212222111110 011223566677776666655
|